PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gould, J				Gould, Julie			LEARNING FROM NATURE'S BEST	NATURE			English	Editorial Material																			0	21	21	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S3	S4		10.1098/rsif.2014.06	http://dx.doi.org/10.1098/rsif.2014.06			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VC0LI	25806495				2022-12-28	WOS:000426172400001
J	Cox, TM; Drelichman, G; Cravo, R; Balwani, M; Burrow, TA; Martins, AM; Lukina, E; Rosenbloom, B; Ross, L; Angell, J; Puga, AC				Cox, Timothy M.; Drelichman, Guillermo; Cravo, Renata; Balwani, Manisha; Burrow, Thomas Andrew; Martins, Ana Maria; Lukina, Elena; Rosenbloom, Barry; Ross, Leorah; Angell, Jennifer; Puga, Ana Cristina			Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial	LANCET			English	Article							MAINTENANCE THERAPY; TALIGLUCERASE ALPHA; MIGLUSTAT; RECOMMENDATIONS; MANIFESTATIONS; PROPORTIONS; DIAGNOSIS	Background The mainstay of treatment for Gaucher's disease type 1 is alternate-week infusion of enzyme replacement therapy (ERT). We investigated whether patients stable on such treatment would remain so after switching to oral eliglustat, a selective inhibitor of glucosylceramide synthase. Methods In this phase 3, randomised, multinational, open-label, non-inferiority trial, we enrolled adults (aged >= 18 years) who had received ERT for 3 years or more for Gaucher's disease. Patients were randomly allocated 2:1 at 39 clinics (stratified by ERT dose; block sizes of four; computer-generated centrally) to receive either oral eliglustat or imiglucerase infusions for 12 months. Participants and investigators were aware of treatment assignment, but the central reader who assessed organ volumes was masked. The composite primary efficacy endpoint was percentage of patients whose haematological variables and organ volumes remained stable for 12 months (ie, haemoglobin decrease not more than 15 g/L, platelet count decrease not more than 25%, spleen volume increase not more than 25%, and liver volume increase not more than 20%, in multiples of normal from baseline). The non-inferiority margin was 25% for eliglustat relative to imiglucerase, assessed in all patients who completed 12 months of treatment. This trial is registered with ClinicalTrials.gov, number NCT00943111, and EudraCT, number 2008-005223-28. Findings Between Sept 15, 2009, and Nov 9, 2011, we randomly allocated 106 (66%) patients to eliglustat and 54 (34%) to imiglucerase. In the per-protocol population, 84 (85%) of 99 patients who completed eliglustat treatment and 44 (94%) of 47 patients who completed imiglucerase treatment met the composite primary endpoint (between-group difference -8.8%; 95% CI -17.6 to 4.2). The lower bound of the 95% CI of -17.6% was within the prespecified threshold for non-inferiority. Dropouts occurred due to palpitations (one patient on eliglustat), myocardial infarction (one patient on eliglustat), and psychotic disorder (one patient on imiglucerase). No deaths occurred. 97 (92%) of 106 patients in the eliglustat group had treatment-emergent adverse events, as did 42 (79%) of 53 in the imiglucerase group (mostly mild or moderate in severity). Interpretation Oral eliglustat maintained haematological and organ volume stability in adults with Gaucher's disease type 1 already controlled by intravenous ERT and could be a useful therapeutic option.	[Cox, Timothy M.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England; [Drelichman, Guillermo] Hosp Ninos Dr Ricardo Gutierrez, Buenos Aires, DF, Argentina; [Cravo, Renata] State Inst Haematol Arthur de Siqueira Cavalcanti, Rio De Janeiro, Brazil; [Balwani, Manisha] Mt Sinai Hosp, New York, NY 10029 USA; [Burrow, Thomas Andrew] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Martins, Ana Maria] Univ Fed Sao Paulo, Sao Paulo, SP, Brazil; [Lukina, Elena] Minist Publ Hlth Russia, Hematol Res Ctr, Moscow, Russia; [Rosenbloom, Barry] Cedars Sinai Oncol, Beverly Hills, CA USA; [Rosenbloom, Barry] Tower Hematol Oncol, Beverly Hills, CA USA; [Ross, Leorah; Angell, Jennifer; Puga, Ana Cristina] Genzyme, Cambridge, MA USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Icahn School of Medicine at Mount Sinai; Cincinnati Children's Hospital Medical Center; Universidade Federal de Sao Paulo (UNIFESP); Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Sanofi-Aventis; Genzyme Corporation	Cox, TM (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England.	tmc12@medschl.cam.ac.uk	Lukina, Elena/N-4536-2014	Lukina, Elena/0000-0002-8774-850X	Genzyme, a Sanofi company; UK Medical Research Council [MR/K015338/1]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000067]; MRC [MR/K015338/1, MR/K025570/1] Funding Source: UKRI; Medical Research Council [MR/K015338/1, MR/K025570/1] Funding Source: researchfish; Sparks Charity [14CAM03] Funding Source: researchfish	Genzyme, a Sanofi company(Sanofi-AventisGenzyme Corporation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Sparks Charity	Genzyme, a Sanofi company.; This work was funded by Genzyme, a Sanofi company. The authors thank the patients and health-care professionals (appendix) who participated; Laurie LaRusso for medical writing support funded by Genzyme, a Sanofi company; Raymond Mankoski and Lisa Underhill, Genzyme Global Medical Affairs, and M Judith Peterschmitt and Gerald F Cox, Genzyme Clinical Development, for critical review. Work at the University of Cambridge was supported by grant MR/K015338/1 from the UK Medical Research Council and at Mount Sinai Hospital by grant UL1TR000067 from the National Center for Advancing Translational Sciences, National Institutes of Health.	Agresti A, 2000, AM STAT, V54, P280, DOI 10.2307/2685779; [Anonymous], 2009, CEREZYME SUMMARY PRO; [Anonymous], 2013, ZAVESCA SUMMARY PROD; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Chen M, 2008, ARCH PATHOL LAB MED, V132, P851, DOI 10.1043/1543-2165(2008)132[851:GDROTL]2.0.CO;2; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; Cox TM, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-102; Dann RS, 2008, PHARM STAT, V7, P130, DOI 10.1002/pst.287; Deegan PB, 2011, MEDICINE, V90, P52, DOI 10.1097/MD.0b013e3182057be4; Elstein D, 2007, BLOOD, V110, P2296, DOI 10.1182/blood-2007-02-075960; Giraldo P, 2006, HAEMATOLOGICA, V91, P703; Giraldo P, 2009, HAEMATOL-HEMATOL J, V94, P1771, DOI 10.3324/haematol.2009.008078; Grabowski G.A., 2006, ONLINE METABOLIC MOL; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; Haddley K, 2012, DRUG TODAY, V48, P525, DOI [10.1358/dot.2012.48.8.1844608, 10.1358/dot.2012.48.8.1844808]; Hollak CEM, 2012, CORE EVID, V7, P15, DOI 10.2147/CE.S20201; Kamath RS, 2014, SKELETAL RADIOL, V43, P1353, DOI 10.1007/s00256-014-1891-9; Kaplan P, 2013, EUR J PEDIATR, V172, P447, DOI 10.1007/s00431-012-1771-z; Kishnani PS, 2009, MOL GENET METAB, V96, P164, DOI 10.1016/j.ymgme.2008.12.015; Kuter DJ, 2013, BLOOD CELL MOL DIS, V51, P116, DOI 10.1016/j.bcmd.2013.04.005; Lukina E, 2014, BLOOD CELL MOL DIS, V53, P274, DOI 10.1016/j.bcmd.2014.04.002; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; Maas M, 2008, SKELETAL RADIOL, V37, P185, DOI 10.1007/s00256-007-0425-0; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; Mistry PK, 1996, LANCET, V348, P1555, DOI 10.1016/S0140-6736(96)04451-0; Mistry PK, 2015, JAMA-J AM MED ASSOC, V313, P695, DOI 10.1001/jama.2015.459; Mistry PK, 2009, BRIT J HAEMATOL, V147, P561, DOI 10.1111/j.1365-2141.2009.07872.x; Pastores GM, 2004, SEMIN HEMATOL, V41, P4, DOI 10.1053/j.seminhematol.2004.07.009; Robertson PL, 2007, AM J ROENTGENOL, V188, P1521, DOI 10.2214/AJR.06.1410; Ross DJ, 1997, NEW ENGL J MED, V336, P379, DOI 10.1056/NEJM199701303360516; Taddei TH, 2010, J INHERIT METAB DIS, V33, P291, DOI 10.1007/s10545-010-9070-1; Weinreb Neal J., 2013, Critical Reviews in Oncogenesis, V18, P177	32	93	96	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2355	2362		10.1016/S0140-6736(14)61841-9	http://dx.doi.org/10.1016/S0140-6736(14)61841-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1XV	25819691				2022-12-28	WOS:000356003700028
J	Moskowitz, CH; Nademanee, A; Masszi, T; Agura, E; Holowiecki, J; Abidi, MH; Chen, AI; Stiff, P; Gianni, AM; Carella, A; Osmanov, D; Bachanova, V; Sweetenham, J; Sureda, A; Huebner, D; Sievers, EL; Chi, A; Larsen, EK; Hunder, NN; Walewski, J				Moskowitz, Craig H.; Nademanee, Auayporn; Masszi, Tamas; Agura, Edward; Holowiecki, Jerzy; Abidi, Muneer H.; Chen, Andy I.; Stiff, Patrick; Gianni, Alessandro M.; Carella, Angelo; Osmanov, Dzhelil; Bachanova, Veronika; Sweetenham, John; Sureda, Anna; Huebner, Dirk; Sievers, Eric L.; Chi, Andy; Larsen, Emily K.; Hunder, Naomi N.; Walewski, Jan		AETHERA Study Grp	Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial	LANCET			English	Article							HIGH-DOSE CHEMOTHERAPY; BONE-MARROW-TRANSPLANTATION; PROGNOSTIC-FACTORS; FDG-PET; COMBINATION CHEMOTHERAPY; FREE SURVIVAL; 1ST RELAPSE; DISEASE; MODEL; CHEMORADIOTHERAPY	Background High-dose therapy followed by autologous stem-cell transplantation is standard of care for patients with relapsed or primary refractory Hodgkin's lymphoma. Roughly 50% of patients might be cured after autologous stem-cell transplantation; however, most patients with unfavourable risk factors progress after transplantation. We aimed to assess whether brentuximab vedotin improves progression-free survival when given as early consolidation after autologous stem-cell transplantation. Methods We did this randomised, double-blind, placebo-controlled, phase 3 trial at 78 sites in North America and Europe. Patients with unfavourable-risk relapsed or primary refractory classic Hodgkin's lymphoma who had undergone autologous stem-cell transplantation were randomly assigned, by fixed-block randomisation with a computer-generated random number sequence, to receive 16 cycles of 1.8 mg/kg brentuximab vedotin or placebo intravenously every 3 weeks, starting 30-45 days after transplantation. Randomisation was stratified by best clinical response after completion of salvage chemotherapy (complete response vs partial response vs stable disease) and primary refractory Hodgkin's lymphoma versus relapsed disease less than 12 months after completion of frontline therapy versus relapse 12 months or more after treatment completion. Patients and study investigators were masked to treatment assignment. The primary endpoint was progression-free survival by independent review, defined as the time from randomisation to the first documentation of tumour progression or death. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01100502. Findings Between April 6, 2010, and Sept 21, 2012, we randomly assigned 329 patients to the brentuximab vedotin group (n=165) or the placebo group (n=164). Progression-free survival by independent review was significantly improved in patients in the brentuximab vedotin group compared with those in the placebo group (hazard ratio [HR] 0.57, 95% CI 0.40-0.81; p=0.0013). Median progression-free survival by independent review was 42.9 months (95% CI 30.4-42.9) for patients in the brentuximab vedotin group compared with 24.1 months (11.5-not estimable) for those in the placebo group. We recorded consistent benefit (HR < 1) of brentuximab vedotin consolidation across subgroups. The most frequent adverse events in the brentuximab vedotin group were peripheral sensory neuropathy (94 [56%] of 167 patients vs 25 [16%] of 160 patients in the placebo group) and neutropenia (58 [35%] vs 19 [12%] patients). At time of analysis, 28 (17%) of 167 patients had died in the brentuximab vedotin group compared with 25 (16%) of 160 patients in the placebo group. Interpretation Early consolidation with brentuximab vedotin after autologous stem-cell transplantation improved progression-free survival in patients with Hodgkin's lymphoma with risk factors for relapse or progression after transplantation. This treatment provides an important therapeutic option for patients undergoing autologous stem-cell transplantation.	[Moskowitz, Craig H.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Nademanee, Auayporn] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Masszi, Tamas] Szent Istvan & Szent Laszlo Corp Hosp, Hematol & Stem Cell Dept, Budapest, Hungary; [Agura, Edward] Baylor Univ, Med Ctr, Dallas, TX USA; [Holowiecki, Jerzy] Maria Sklodowska Curie Inst Oncol, Dept Bone Marrow Transplantat & Oncohematol, Gliwice, Poland; [Abidi, Muneer H.] Karmanos Canc Inst, Detroit, MI USA; [Chen, Andy I.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Stiff, Patrick] Loyola Univ, Med Ctr, Maywood, IL 60153 USA; [Gianni, Alessandro M.] Ist Nazl Tumori, I-20133 Milan, Italy; [Carella, Angelo] IRCCS Azienda Osped Univ San Martino IST, Genoa, Italy; [Osmanov, Dzhelil] Russian Acad Med Sci, Blokhin Canc Res Ctr, Moscow, Russia; [Bachanova, Veronika] Univ Minnesota, Minneapolis, MN USA; [Sweetenham, John] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Sureda, Anna] Hosp Duran & Reynals, Inst Catala Oncol, Barcelona, Spain; [Huebner, Dirk] Takeda Pharmaceut Int, Cambridge, MA USA; [Sievers, Eric L.; Larsen, Emily K.; Hunder, Naomi N.] Seattle Genet, Bothell, WA USA; [Walewski, Jan] Maria Sklodowska Curie Inst & Oncol Ctr, Warsaw, Poland	Memorial Sloan Kettering Cancer Center; City of Hope; Baylor University; Baylor University Medical Center; Maria Sklodowska-Curie National Research Institute of Oncology; Barbara Ann Karmanos Cancer Institute; Oregon Health & Science University; Loyola University Chicago; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Genoa; IRCCS AOU San Martino IST; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences; University of Minnesota System; University of Minnesota Twin Cities; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.; Seattle Genetics; Maria Sklodowska-Curie National Research Institute of Oncology	Moskowitz, CH (corresponding author), Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.	moskowic@mskcc.org	Holowiecki, Jerzy/AAW-7928-2021; Stiff, Patrick/S-2676-2019; Walewski, Jan/ABC-9523-2020	Bachanova, Veronika/0000-0002-9325-432X; Masszi, Tamas/0000-0003-2322-9863; Sievers, Eric/0000-0002-0794-9441; Abidi, Muneer/0000-0002-9936-6031; Walewski, Jan/0000-0003-4247-2674	Seattle Genetics; Takeda Pharmaceuticals International	Seattle Genetics; Takeda Pharmaceuticals International	Seattle Genetics and Takeda Pharmaceuticals International.; Direct funding for this research was issued by Seattle Genetics through the joint financial support of Seattle Genetics and Takeda Pharmaceuticals International. We thank the patients who participated in the study and their families and caregivers; Dana A Kennedy for her role in the development of the original protocol and J Christian Hesketh for assistance in manuscript preparation, as employees of Seattle Genetics Inc.	Akhtar S, 2013, BONE MARROW TRANSPL, V48, P1530, DOI 10.1038/bmt.2013.88; [Anonymous], 2013, BLOOD, V122, P4382; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Arai S, 2013, LEUKEMIA LYMPHOMA, V54, P2531, DOI 10.3109/10428194.2013.798868; Bartlett NL, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-24; Brice P, 1997, BONE MARROW TRANSPL, V20, P21, DOI 10.1038/sj.bmt.1700838; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Ferme C, 2002, J CLIN ONCOL, V20, P467, DOI 10.1200/JCO.20.2.467; Fung HC, 2007, BIOL BLOOD MARROW TR, V13, P594, DOI 10.1016/j.bbmt.2007.01.072; Gopal AK, 2015, BLOOD, V125, P1236, DOI 10.1182/blood-2014-08-595801; Hahn T, 2013, BIOL BLOOD MARROW TR, V19, P1740, DOI 10.1016/j.bbmt.2013.09.018; Josting A, 2002, J CLIN ONCOL, V20, P221, DOI 10.1200/JCO.20.1.221; Josting A, 2010, J CLIN ONCOL, V28, P5074, DOI 10.1200/JCO.2010.30.5771; LINCH DC, 1993, LANCET, V341, P1051, DOI 10.1016/0140-6736(93)92411-L; Majhail NS, 2006, BIOL BLOOD MARROW TR, V12, P1065, DOI 10.1016/j.bbmt.2006.06.006; Martinez C, 2013, ANN ONCOL, V24, P2430, DOI 10.1093/annonc/mdt206; Morschhauser F, 2008, J CLIN ONCOL, V26, P5980, DOI 10.1200/JCO.2007.15.5887; Moskowitz AJ, 2010, BLOOD, V116, P4934, DOI 10.1182/blood-2010-05-282756; Moskowitz AJ, 2009, BRIT J HAEMATOL, V146, P158, DOI 10.1111/j.1365-2141.2009.07727.x; Moskowitz CH, 2001, BLOOD, V97, P616, DOI 10.1182/blood.V97.3.616; Moskowitz CH, 2012, BLOOD, V119, P1665, DOI 10.1182/blood-2011-10-388058; Rapoport AP, 2004, BONE MARROW TRANSPL, V34, P883, DOI 10.1038/sj.bmt.1704661; REECE DE, 1995, BLOOD, V86, P451, DOI 10.1182/blood.V86.2.451.bloodjournal862451; REECE DE, 1994, BLOOD, V83, P1193; Schmitz N, 2002, LANCET, V359, P2065, DOI 10.1016/S0140-6736(02)08938-9; Sirohi B, 2008, ANN ONCOL, V19, P1312, DOI 10.1093/annonc/mdn052; Smeltzer JP, 2011, BIOL BLOOD MARROW TR, V17, P1646, DOI 10.1016/j.bbmt.2011.04.011; Smith SD, 2011, BRIT J HAEMATOL, V153, P358, DOI 10.1111/j.1365-2141.2011.08616.x; Sureda A, 2005, ANN ONCOL, V16, P625, DOI 10.1093/annonc/mdi119; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; von Tresckow B, 2013, BLOOD, V122, P4648; Younes A, 2012, J CLIN ONCOL, V30, P2183, DOI 10.1200/JCO.2011.38.0410; Younes A, 2012, J CLIN ONCOL, V30, P2197, DOI 10.1200/JCO.2011.38.1350	33	445	463	1	119	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1853	1862		10.1016/S0140-6736(15)60165-9	http://dx.doi.org/10.1016/S0140-6736(15)60165-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6ZE	25796459				2022-12-28	WOS:000354184500029
J	Lau, RM; Herter, TL; Morris, MR; Li, Z; Adams, D				Lau, R. M.; Herter, T. L.; Morris, M. R.; Li, Z.; Adams, D.			Old supernova dust factory revealed at the Galactic center	SCIENCE			English	Article							SAGITTARIUS-A-EAST; PASCHEN-ALPHA SURVEY; II REGION COMPLEX; INTERSTELLAR-MEDIUM; SPACE-TELESCOPE; DATA REDUCTION; EARLY UNIVERSE; HIGH-REDSHIFT; ARRAY CAMERA; EVOLUTION	Dust formation in supernova ejecta is currently the leading candidate to explain the large quantities of dust observed in the distant, early universe. However, it is unclear whether the ejecta-formed dust can survive the hot interior of the supernova remnant (SNR). We present infrared observations of similar to 0.02 solar masses of warm (similar to 100 kelvin) dust seen near the center of the similar to 10,000-year-old Sagittarius A East SNR at the Galactic center. Our findings indicate the detection of dust within an older SNR that is expanding into a relatively dense surrounding medium (electron density similar to 10(3) centimeters(-3)) and has survived the passage of the reverse shock. The results suggest that supernovae may be the dominant dust-production mechanism in the dense environment of galaxies of the early universe.	[Lau, R. M.; Herter, T. L.; Adams, D.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Morris, M. R.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Li, Z.] Nanjing Univ, Sch Astron & Space Sci, Nanjing 210093, Jiangsu, Peoples R China; [Adams, D.] NASA, Ames Res Ctr, Stratospher Observ Infrared Astron SOFIA Sci Ctr, Univ Space Res Assoc, Moffett Field, CA 94035 USA	Cornell University; University of California System; University of California Los Angeles; Nanjing University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Universities Space Research Association (USRA)	Lau, RM (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	ryanl@astro.cornell.edu	li, zhiyuan/HGD-9581-2022	Herter, Terry/0000-0002-3856-8385; Morris, Mark/0000-0002-6753-2066	Recruitment Program of Global Youth Experts; USRA under NASA [NAS2-97001]; Deutsches SOFIA Institut under DLR [50 OK 0901]; NASA [8500-98-014]	Recruitment Program of Global Youth Experts; USRA under NASA; Deutsches SOFIA Institut under DLR; NASA(National Aeronautics & Space Administration (NASA))	We thank the rest of the FORCAST team, M. Hankins, G. Gull, J. Schoenwald, and C. Henderson, the Universities Space Research Association (USRA) Science and Mission Ops teams, and the entire SOFIA staff. Additionally, we thank E. Dwek and the anonymous referees for their insightful comments. Z.L. acknowledges support from the Recruitment Program of Global Youth Experts. This work is based on observations made with the NASA/German Aerospace Center (DLR) SOFIA. SOFIA science mission operations are conducted jointly by the USRA (under NASA contract NAS2-97001) and the Deutsches SOFIA Institut (under DLR contract 50 OK 0901). Financial support for FORCAST was provided by NASA through award 8500-98-014 issued by USRA. Data presented in this paper can be accessed from supplementary materials data S1 (23).	Bernard JP, 2008, ASTRON J, V136, P919, DOI 10.1088/0004-6256/136/3/919; Bianchi S, 2007, MON NOT R ASTRON SOC, V378, P973, DOI 10.1111/j.1365-2966.2007.11829.x; Compiegne M, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015292; Dong H, 2011, MON NOT R ASTRON SOC, V417, P114, DOI 10.1111/j.1365-2966.2011.19013.x; Dwek E, 1998, ASTROPHYS J, V501, P643, DOI 10.1086/305829; Dwek E, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/2/L30; Dwek E, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/63; Dwek E, 2010, ASTROPHYS J, V722, P425, DOI 10.1088/0004-637X/722/1/425; EKERS RD, 1983, ASTRON ASTROPHYS, V122, P143; Gall C, 2011, ASTRON ASTROPHYS REV, V19, P1, DOI 10.1007/s00159-011-0043-7; Gnat O, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/1/20; Herter TL, 2013, PUBL ASTRON SOC PAC, V125, P1393, DOI 10.1086/674144; Indebetouw R, 2014, ASTROPHYS J LETT, V782, DOI 10.1088/2041-8205/782/1/L2; Jones AP, 1996, ASTROPHYS J, V469, P740, DOI 10.1086/177823; Lakicevic M, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/50; Lau RM, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/2/108; Lau RM, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/37; Maeda Y, 2002, ASTROPHYS J, V570, P671, DOI 10.1086/339773; Matsuura M, 2011, SCIENCE, V333, P1258, DOI 10.1126/science.1205983; Mills E, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/84; Morris M, 1996, ANNU REV ASTRON ASTR, V34, P645, DOI 10.1146/annurev.astro.34.1.645; Nozawa T, 2007, ASTROPHYS J, V666, P955, DOI 10.1086/520621; Park S, 2005, ASTROPHYS J, V631, P964, DOI 10.1086/432639; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Poglitsch A, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014535; REID MJ, 1993, ANNU REV ASTRON ASTR, V31, P345; Schodel R, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201423481; SERABYN E, 1992, ASTROPHYS J, V395, P166, DOI 10.1086/171640; Shirazi M, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/120; Silvia DW, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/12; Stolovy S, 2006, J PHYS CONF SER, V54, P176, DOI 10.1088/1742-6596/54/1/030; Temim T., 2014, ASTROPHYS J IN PRESS; Uchida K. I., 1998, IAU S, V184, P317; Wang QD, 2010, MON NOT R ASTRON SOC, V402, P895, DOI 10.1111/j.1365-2966.2009.15973.x; Yusef-Zadeh F, 1999, ASTROPHYS J, V512, P230, DOI 10.1086/306769; YUSEFZADEH F, 1987, ASTROPHYS J, V320, P545, DOI 10.1086/165572; Zhao J.-H., 2013, ASTROPHYS J, V146, P8	38	30	30	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					413	418		10.1126/science.aaa2208	http://dx.doi.org/10.1126/science.aaa2208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25791082	Green Submitted			2022-12-28	WOS:000353338000028
J	Marzi, A; Halfmann, P; Hill-Batorski, L; Feldmann, F; Shupert, WL; Neumann, G; Feldmann, H; Kawaoka, Y				Marzi, Andrea; Halfmann, Peter; Hill-Batorski, Lindsay; Feldmann, Friederike; Shupert, W. Lesley; Neumann, Gabriele; Feldmann, Heinz; Kawaoka, Yoshihiro			An Ebola whole-virus vaccine is protective in nonhuman primates	SCIENCE			English	Article							I CLINICAL-TRIAL; CELLULAR-IMMUNITY; MARBURG VIRUSES; INFECTION; CHALLENGE; IMMUNOGENICITY; INFLUENZA; RESPONSES; MACAQUES	Zaire ebolavirus is the causative agent of the current outbreak of hemorrhagic fever disease in West Africa. Previously, we showed that a whole Ebola virus (EBOV) vaccine based on a replication-defective EBOV (EBOV Delta VP30) protects immunized mice and guinea pigs against lethal challenge with rodent-adapted EBOV. Here, we demonstrate that EBOV Delta VP30 protects nonhuman primates against lethal infection with EBOV. Although EBOV Delta VP30 is replication-incompetent, we additionally inactivated the vaccine with hydrogen peroxide; the chemically inactivated vaccine remained antigenic and protective in nonhuman primates. EBOV Delta VP30 thus represents a safe, efficacious, whole-EBOV vaccine candidate that differs from other EBOV vaccine platforms in that it presents all viral proteins and the viral RNA to the host immune system, which might contribute to protective immune responses.	[Marzi, Andrea; Shupert, W. Lesley; Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA; [Halfmann, Peter; Hill-Batorski, Lindsay; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Influenza Res Inst, Madison, WI 53706 USA; [Feldmann, Friederike] NIAID, Rocky Mt Vet Branch, Div Intramural Res, NIH, Hamilton, MT USA; [Kawaoka, Yoshihiro] Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Dept Microbiol & Immunol,Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Saitama, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Tokyo; Japan Science & Technology Agency (JST)	Kawaoka, Y (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Influenza Res Inst, Madison, WI 53706 USA.	kawaokay@svm.vetmed.wisc.edu	Halfmann, Peter/W-8084-2019; Marzi, Andrea/AAF-4617-2020	Marzi, Andrea/0000-0003-0186-9587	Region V "Great Lakes" Regional Center of Excellence (GLRCE) [U54 AI 57153]; Health and Labour Sciences Research Grants, Japan; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089, ZIAAI001163, U54AI057153] Funding Source: NIH RePORTER	Region V "Great Lakes" Regional Center of Excellence (GLRCE); Health and Labour Sciences Research Grants, Japan; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Ollmann-Saphire (Scripps Research Institute, La Jolla, CA) for purified EBOV NP. We also thank S. Watson for editing the manuscript, T. Armbrust for excellent technical assistance, and staff of the Rocky Mountain Veterinary Branch for assistance with animal work. Y.K. and G.N. are inventors on a patent (held by the University of Wisconsin Alumni Research Foundation) for EBOV reverse genetics; therefore, a Material Transfer Agreement (MTA) is required to obtain this system. Funding for this research was provided by the Region V "Great Lakes" Regional Center of Excellence (GLRCE; U54 AI 57153) and by Health and Labour Sciences Research Grants, Japan. The study was partially funded by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH. Raw data can be found at https://docs.google.com/spreadsheets/d/1dBgzt5_z4rp-qOuxXcI_FbUz8wNqMvHy6kVP_tpW0MY/edit?usp=sharing.	Amanna IJ, 2012, NAT MED, V18, P974, DOI 10.1038/nm.2763; Amanna IJ, 2009, ANTIVIR RES, V84, P119, DOI 10.1016/j.antiviral.2009.08.008; Blaney JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003389; Brining DL, 2010, COMPARATIVE MED, V60, P389; Dembinski JL, 2014, J VIROL METHODS, V207, P232, DOI 10.1016/j.jviromet.2014.07.003; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Geisbert TW, 2008, VACCINE, V26, P6894, DOI 10.1016/j.vaccine.2008.09.082; Geisbert TW, 2002, EMERG INFECT DIS, V8, P503; Halfmann P, 2008, P NATL ACAD SCI USA, V105, P1129, DOI 10.1073/pnas.0708057105; Halfmann P, 2009, J VIROL, V83, P3810, DOI 10.1128/JVI.00074-09; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kempner ES, 2001, J PHARM SCI, V90, P1637, DOI 10.1002/jps.1114; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; Pinto AK, 2013, J VIROL, V87, P1926, DOI 10.1128/JVI.02903-12; Qiu XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005547; Sarwar UN, 2015, J INFECT DIS, V211, P549, DOI 10.1093/infdis/jiu511; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Swenson DL, 2005, VACCINE, V23, P3033, DOI 10.1016/j.vaccine.2004.11.070; Takada A, 2003, J VIROL, V77, P1069, DOI 10.1128/JVI.77.2.1069-1074.2003; Walker JM, 2012, J VIROL, V86, P13735, DOI 10.1128/JVI.02178-12; Warfield KL, 2007, J INFECT DIS, V196, pS421, DOI 10.1086/520612; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Warfield KL, 2005, J IMMUNOL, V175, P1184, DOI 10.4049/jimmunol.175.2.1184	27	60	69	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					439	442		10.1126/science.aaa4919	http://dx.doi.org/10.1126/science.aaa4919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25814063	Green Accepted			2022-12-28	WOS:000353338000035
J	MacNeil, MA; Graham, NAJ; Cinner, JE; Wilson, SK; Williams, ID; Maina, J; Newman, S; Friedlander, AM; Jupiter, S; Polunin, NVC; McClanahan, TR				MacNeil, M. Aaron; Graham, Nicholas A. J.; Cinner, Joshua E.; Wilson, Shaun K.; Williams, Ivor D.; Maina, Joseph; Newman, Steven; Friedlander, Alan M.; Jupiter, Stacy; Polunin, Nicholas V. C.; McClanahan, Tim R.			Recovery potential of the world's coral reef fishes	NATURE			English	Article							MARINE PROTECTED AREAS; UNDERWATER VISUAL CENSUS; OCEAN; RESILIENCE; BIOMASS; RATES; COMMUNITIES; FUTURE	Continuing degradation of coral reef ecosystems has generated substantial interest in how management can support reef resilience(1,2). Fishing is the primary source of diminished reef function globally(3-5), leading to widespread calls for additional marine reserves to recover fish biomass and restore key ecosystem functions(6). Yet there are no established baselines for determining when these conservation objectives have been met or whether alternative management strategies provide similar ecosystem benefits. Here we establish empirical conservation benchmarks and fish biomass recovery timelines against which coral reefs can be assessed and managed by studying the recovery potential of more than 800 coral reefs along an exploitation gradient. We show that resident reef fish biomass in the absence of fishing (B-0) averages similar to 1,000 kg ha(-1), and that the vast majority (83%) of fished reefs are missing more than half their expected biomass, with severe consequences for key ecosystem functions such as predation. Given protection from fishing, reef fish biomass has the potential to recover within 35 years on average and less than 60 years when heavily depleted. Notably, alternative fisheries restrictions are largely (64%) successful at maintaining biomass above 50% of B-0, sustaining key functions such as herbivory. Our results demonstrate that crucial ecosystem functions can be maintained through a range of fisheries restrictions, allowing coral reef managers to develop recovery plans that meet conservation and livelihood objectives in areas where marine reserves are not socially or politically feasible solutions.	[MacNeil, M. Aaron] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [MacNeil, M. Aaron] Dalhousie Univ, Dept Math & Stat, Halifax, NS B3H 3J5, Canada; [MacNeil, M. Aaron; Graham, Nicholas A. J.; Cinner, Joshua E.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Wilson, Shaun K.] Dept Pk & Wildlife, Perth, WA 6151, Australia; [Wilson, Shaun K.] Univ Western Australia, Oceans Inst, Crawley, WA 6009, Australia; [Williams, Ivor D.] NOAA, Coral Reef Ecosyst Div, Pacific Isl Fisheries Sci Ctr, Honolulu, HI 96818 USA; [Maina, Joseph] Univ Queensland, Australian Res Council, CEED, St Lucia, Qld 4074, Australia; [Maina, Joseph; Jupiter, Stacy; McClanahan, Tim R.] Wildlife Conservat Soc, Marine Programs, Bronx, NY 10460 USA; [Newman, Steven; Polunin, Nicholas V. C.] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Friedlander, Alan M.] Univ Hawaii, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Friedlander, Alan M.] Pristine Seas Natl Geog, Washington, DC 20036 USA	Australian Institute of Marine Science; Dalhousie University; James Cook University; University of Western Australia; National Oceanic Atmospheric Admin (NOAA) - USA; University of Queensland; Wildlife Conservation Society; Newcastle University - UK; University of Hawaii System; National Geographic Society	MacNeil, MA (corresponding author), Australian Inst Marine Sci, PMB 3 Townsville MC, Townsville, Qld 4810, Australia.	a.macneil@aims.gov.au	Graham, Nicholas AJ/C-8360-2014; MacNeil, Aaron/E-8196-2017; Cinner, Joshua e/E-8966-2011; Cinner, Joshua/AAA-6823-2021; McClanahan, Tim/K-4998-2019; MacNeil, M. Aaron/ABD-6444-2021	Graham, Nicholas AJ/0000-0002-0304-7467; MacNeil, Aaron/0000-0001-8406-325X; Cinner, Joshua e/0000-0003-2675-9317; MacNeil, M. Aaron/0000-0001-8406-325X; Jupiter, Stacy/0000-0001-9742-1677; Williams, Ivor/0000-0002-9444-1020; Wilson, Shaun/0000-0002-4590-0948; McClanahan, Timothy/0000-0001-5821-3584; Polunin, Nick/0000-0002-1480-8794; Maina, Joseph/0000-0003-1268-6137	Australian Institute of Marine Science; ARC Centre of Excellence for Coral Reef Studies; John D. and Catherine T. MacArthur Foundation	Australian Institute of Marine Science; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); John D. and Catherine T. MacArthur Foundation	We thank M. Emslie, A. Cheal, J. Wetherall, C. Hutchery and K. Anthony for comments on early drafts of the manuscript. The Australian Institute of Marine Science, the ARC Centre of Excellence for Coral Reef Studies, and the John D. and Catherine T. MacArthur Foundation supported this research.	Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Brooks SP, 2000, STAT SCI, V15, P357; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Dulvy NK, 2004, CAN J FISH AQUAT SCI, V61, P466, DOI 10.1139/F03-169; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2013, FRONT ECOL ENVIRON, V11, P541, DOI 10.1890/120305; Hamner WM, 2007, MAR ECOL PROG SER, V334, P83, DOI 10.3354/meps334083; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jennings S, 1996, J APPL ECOL, V33, P400, DOI 10.2307/2404761; Lambert GI, 2014, J APPL ECOL, V51, P1326, DOI 10.1111/1365-2664.12277; MacNeil M. A., 2015, ECOLOGY FISHES CORAL; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McClanahan TR, 2012, ENVIRON CONSERV, V39, P357, DOI 10.1017/S0376892912000197; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Mumby PJ, 2013, CORAL REEFS, V32, P213, DOI 10.1007/s00338-012-0966-0; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Patil A, 2010, J STAT SOFTW, V35, P1; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Russ GR, 2010, OECOLOGIA, V163, P1103, DOI 10.1007/s00442-010-1692-3; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; Watson RA, 1997, ECOL MODEL, V104, P103, DOI 10.1016/S0304-3800(97)00117-8; Westberry T, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003078; Worm B, 2012, TRENDS ECOL EVOL, V27, P594, DOI 10.1016/j.tree.2012.07.005; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	40	224	229	15	305	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					341	+		10.1038/nature14358	http://dx.doi.org/10.1038/nature14358			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25855298	Green Submitted			2022-12-28	WOS:000352974200037
J	Tanabe, H; Fujii, Y; Okada-Iwabu, M; Iwabu, M; Nakamura, Y; Hosaka, T; Motoyama, K; Ikeda, M; Wakiyama, M; Terada, T; Ohsawa, N; Hato, M; Ogasawara, S; Hino, T; Murata, T; Iwata, S; Hirata, K; Kawano, Y; Yamamoto, M; Kimura-Someya, T; Shirouzu, M; Yamauchi, T; Kadowaki, T; Yokoyama, S				Tanabe, Hiroaki; Fujii, Yoshifumi; Okada-Iwabu, Miki; Iwabu, Masato; Nakamura, Yoshihiro; Hosaka, Toshiaki; Motoyama, Kanna; Ikeda, Mariko; Wakiyama, Motoaki; Terada, Takaho; Ohsawa, Noboru; Hato, Masakatsu; Ogasawara, Satoshi; Hino, Tomoya; Murata, Takeshi; Iwata, So; Hirata, Kunio; Kawano, Yoshiaki; Yamamoto, Masaki; Kimura-Someya, Tomomi; Shirouzu, Mikako; Yamauchi, Toshimasa; Kadowaki, Takashi; Yokoyama, Shigeyuki			Crystal structures of the human adiponectin receptors	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; COMPLEMENT-RELATED PROTEIN; GLUCOSE-TRANSPORT; ADIPOSE; CRYSTALLIZATION; EXPRESSION; RHODOPSIN; FEATURES; AGONIST	Adiponectin stimulation of its receptors, AdipoR1 and AdipoR2, increases the activities of 59AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR), respectively, thereby contributing to healthy longevity as key anti-diabetic molecules. AdipoR1 and AdipoR2 were predicted to contain seven transmembrane helices with the opposite topology to G-protein-coupled receptors. Here we report the crystal structures of human AdipoR1 and AdipoR2 at 2.9 and 2.4 angstrom resolution, respectively, which represent a novel class of receptor structure. The seven-transmembrane helices, conformationally distinct from those of G-protein-coupled receptors, enclose a large cavity where three conserved histidine residues coordinate a zinc ion. The zinc-binding structure may have a role in the adiponectin-stimulated AMPK phosphorylation and UCP2 upregulation. Adiponectin may broadly interact with the extracellular face, rather than the carboxy-terminal tail, of the receptors. The present information will facilitate the understanding of novel structure-function relationships and the development and optimization of AdipoR agonists for the treatment of obesity-related diseases, such as type 2 diabetes.	[Tanabe, Hiroaki; Fujii, Yoshifumi; Nakamura, Yoshihiro; Hosaka, Toshiaki; Motoyama, Kanna; Ikeda, Mariko; Wakiyama, Motoaki; Terada, Takaho; Ohsawa, Noboru; Hato, Masakatsu; Murata, Takeshi; Iwata, So; Kimura-Someya, Tomomi; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Tanabe, Hiroaki; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Tanabe, Hiroaki; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Struct Biol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Tanabe, Hiroaki; Nakamura, Yoshihiro; Hosaka, Toshiaki; Ikeda, Mariko; Wakiyama, Motoaki; Ohsawa, Noboru; Hato, Masakatsu; Kimura-Someya, Tomomi; Shirouzu, Mikako] RIKEN, Ctr Life Sci Technol, Div Struct & Synthet Biol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Tanabe, Hiroaki; Fujii, Yoshifumi; Nakamura, Yoshihiro; Terada, Takaho; Yokoyama, Shigeyuki] RIKEN, Struct Biol Lab, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Okada-Iwabu, Miki; Iwabu, Masato; Yamauchi, Toshimasa; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Bunkyo Ku, Tokyo 1130033, Japan; [Okada-Iwabu, Miki; Iwabu, Masato; Yamauchi, Toshimasa; Kadowaki, Takashi] Univ Tokyo, Dept Integrated Mol Sci Metab Dis, Century Med & Res Ctr 22, Bunkyo Ku, Tokyo 1130033, Japan; [Iwabu, Masato] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ogasawara, Satoshi; Hino, Tomoya; Murata, Takeshi; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Hino, Tomoya; Murata, Takeshi; Iwata, So] JST, Res Accelerat Program, Membrane Prot Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan; [Iwata, So] Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Div Mol Biosci, London SW7 2AZ, England; [Iwata, So] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Iwata, So; Hirata, Kunio; Kawano, Yoshiaki; Yamamoto, Masaki] RIKEN, SPring Ctr 8, Harima Inst, Sayo, Hyogo 6795148, Japan; [Yamauchi, Toshimasa] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	RIKEN; University of Tokyo; University of Tokyo; RIKEN; RIKEN; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Kyoto University; Japan Science & Technology Agency (JST); Chiba University; Imperial College London; Diamond Light Source; RIKEN; Japan Science & Technology Agency (JST)	Yokoyama, S (corresponding author), RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	tyamau-tky@umin.net; kadowaki-3im@h.u-tokyo.ac.jp; yokoyama@riken.jp	Shirouzu, Mikako/A-6521-2016; Kawano, Yoshiaki/C-7585-2017; Wakiyama, Motoaki/N-6928-2015; Kimura-Someya, Tomomi/C-4169-2017; Yokoyama, Shigeyuki/N-6911-2015; Murata, Takeshi/J-6181-2017; Yamamoto, Masaki/B-7844-2015	Wakiyama, Motoaki/0000-0002-8029-4795; Kimura-Someya, Tomomi/0000-0003-2232-1801; Yokoyama, Shigeyuki/0000-0003-3133-7338; Murata, Takeshi/0000-0002-5748-4670; Yamamoto, Masaki/0000-0002-1311-1768; Hirata, Kunio/0000-0002-1491-6509	Targeted Proteins Research Program; Platform for Drug Discovery, Informatics and Structural Life Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [26000012, 20229008, 25221307, 26293216, 30557236]; Japan Science and Technology Agency; BBSRC [BB/G02325/1]; Wellcome Trust [062164/Z/00/Z]; Biotechnology and Biological Sciences Research Council [BB/G023425/1] Funding Source: researchfish; BBSRC [BB/G023425/1] Funding Source: UKRI	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform for Drug Discovery, Informatics and Structural Life Science; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to the staffs of BL32XU at SPring-8 (proposals 2012A1332, 201281453, 2013A1008, 2013A1008, 201381034, 201381007, 2014A1007, 2014A1008 and 2014A1186), beamline X06SA at Diamond Light Source, and beamline X06SA at the Swiss Light Source for their assistance in data collection. We thank R. Akasaka for protein analysis, M. Toyama, M. Inoue, M. Goto, M. Aoki and K. Ishii for expression plasmid preparation, M. Nishimoto, Y. Tomabechi and Y. Terazawa for technical assistance with protein expression and purification, and Y. Nishibaba, M. Yuasa and A. Hayashi for technical assistance and support with the activity assays of the mutants. This work was supported by grants from the Targeted Proteins Research Program (S.Y., T.K., S.I. and M.Y.), the Platform for Drug Discovery, Informatics and Structural Life Science (S.Y. and M.Y.), a Grant-in-Aid for Specially Promoted Research (26000012) (T.K.), Grants-in-Aid for Scientific Research (S) (20229008, 25221307) (T.K.), a Grant-in-Aid for Scientific Research (B) (26293216) (M.O.-I.), a Grant-in-Aid for Young Scientists (A) (30557236) (M. Iwabu), and the Translational Research Network Program (M.O.-I.), from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by the research acceleration program of the Japan Science and Technology Agency (S.I.), and by the BBSRC (BB/G02325/1) (S.I.). The authors are grateful for the use of the Membrane Protein Laboratory funded bythe Wellcome Trust(grant062164/Z/00/Z)(S.I.)atthe Diamond Light Source Limited.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; de Graaf C, 2011, J MED CHEM, V54, P8195, DOI 10.1021/jm2011589; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERIKSSON AE, 1988, PROTEINS, V4, P274, DOI 10.1002/prot.340040406; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hato Masakatsu, 2014, Journal of Structural and Functional Genomics, V15, P165, DOI 10.1007/s10969-014-9187-9; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Hirata K, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/1/012002; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lyons TJ, 2004, P NATL ACAD SCI USA, V101, P5506, DOI 10.1073/pnas.0306324101; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Murakami I, 2012, J GYNECOL ONCOL, V23, P153, DOI 10.3802/jgo.2012.23.3.153; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Tanabe Hiroaki, 2015, Journal of Structural and Functional Genomics, V16, P11, DOI 10.1007/s10969-014-9192-z; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P45, DOI 10.1107/S0907444902018048; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Ueno G, 2005, J SYNCHROTRON RADIAT, V12, P380, DOI 10.1107/S0909049505004735; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vogeley L, 2004, SCIENCE, V306, P1390, DOI 10.1126/science.1103943; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557	58	130	137	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					312	+		10.1038/nature14301	http://dx.doi.org/10.1038/nature14301			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25855295	Green Accepted			2022-12-28	WOS:000352974200030
J	Wilczek, F				Wilczek, Frank			A weighty mass difference	NATURE			English	News Item								The neutron-proton mass difference, one of the most consequential parameters of physics, has now been calculated from fundamental theories. This landmark calculation portends revolutionary progress in nuclear physics.	MIT, Ctr Theoret Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Wilczek, F (corresponding author), MIT, Ctr Theoret Phys, Cambridge, MA 02139 USA.	wilczek@mit.edu						Borsanyi S, 2015, SCIENCE, V347, P1452, DOI 10.1126/science.1257050; Kinoshita T., 1990, QUANTUM ELECTRODYNAM; Kronfeld AS, 2010, AM J PHYS, V78, P1081, DOI 10.1119/1.3454865	3	5	5	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					303	304		10.1038/nature14381	http://dx.doi.org/10.1038/nature14381			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25855293				2022-12-28	WOS:000352974200027
J	Angirekula, V; Multani, A				Angirekula, Venkata; Multani, Ashrit			Epiglottitis in an Adult	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Angirekula, Venkata; Multani, Ashrit] Sinai Hosp Baltimore, Baltimore, MD 21215 USA	Sinai Hospital of Baltimore	Angirekula, V (corresponding author), Sinai Hosp Baltimore, Baltimore, MD 21215 USA.	ravi0809@gmail.com							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2015	372	15					E20	E20		10.1056/NEJMicm1400061	http://dx.doi.org/10.1056/NEJMicm1400061			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF2ZV	25853768				2022-12-28	WOS:000352417900010
J	Baldwin, ME				Baldwin, Mary E.			The Care of the Babys Eyes in the Perambulator (Reprinted from JAMA, vol 29, pg 1246-1247, 1897)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		BALDWIN ME, 1897, JAMA-J AM MED ASSOC, V29, P1246	1	0	0	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2015	313	13					1376	1376		10.1001/jama.2014.11674	http://dx.doi.org/10.1001/jama.2014.11674			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF1OL	25849194				2022-12-28	WOS:000352315900035
J	Baltimore, D; Berg, P; Botchan, M; Carroll, D; Charo, RA; Church, G; Corn, JE; Daley, GQ; Doudna, JA; Fenner, M; Greely, HT; Jinek, M; Martin, GS; Penhoet, E; Puck, J; Sternberg, SH; Weissman, JS; Yamamoto, KR				Baltimore, David; Berg, Paul; Botchan, Michael; Carroll, Dana; Charo, R. Alta; Church, George; Corn, Jacob E.; Daley, George Q.; Doudna, Jennifer A.; Fenner, Marsha; Greely, Henry T.; Jinek, Martin; Martin, G. Steven; Penhoet, Edward; Puck, Jennifer; Sternberg, Samuel H.; Weissman, Jonathan S.; Yamamoto, Keith R.			A prudent path forward for genomic engineering and germline gene modification	SCIENCE			English	Editorial Material							GENERATION		[Baltimore, David] CALTECH, Pasadena, CA 91125 USA; [Berg, Paul] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Botchan, Michael] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Botchan, Michael; Corn, Jacob E.; Doudna, Jennifer A.; Fenner, Marsha; Weissman, Jonathan S.; Yamamoto, Keith R.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Carroll, Dana] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Charo, R. Alta] Univ Wisconsin, Sch Law, Sch Med & Publ Hlth, Dept Med Hist & Bioeth, Madison, WI 53706 USA; [Church, George] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Daley, George Q.] Boston Childrens Hosp, Boston, MA 02115 USA; [Daley, George Q.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; [Greely, Henry T.] Ctr Law & Biosci, Stanford, CA 94305 USA; [Jinek, Martin] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Martin, G. Steven] Univ Calif Berkeley, Coll Letters & Sci, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Penhoet, Edward] Alta Partners, Embarcadero Ctr 1, San Francisco, CA 94111 USA; [Puck, Jennifer] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Sternberg, Samuel H.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Yamamoto, Keith R.] UCSF Sch Med, San Francisco, CA 94158 USA	California Institute of Technology; Stanford University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Zurich; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Berg, P (corresponding author), Stanford Univ, Sch Med, 291 Campus Dr, Stanford, CA 94305 USA.	doudna@berkeley.edu	Jinek, Martin/E-6621-2011	Jinek, Martin/0000-0002-7601-210X; Weissman, Jonathan/0000-0003-2445-670X; Sternberg, Samuel/0000-0001-8240-9114; church, george/0000-0001-6232-9969; Charo, Robin Alta/0000-0003-3710-1043	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [P50 HG005550] Funding Source: Medline; NIGMS NIH HHS [T32 GM066698, R01 GM078571] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2015, IGI FOR BIOETH NAP C; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; U.S. Food and Drug Administration, CELL TISS GEN THER A; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhu ZR, 2014, METHOD ENZYMOL, V546, P215, DOI 10.1016/B978-0-12-801185-0.00011-8	9	413	431	6	266	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					36	38		10.1126/science.aab1028	http://dx.doi.org/10.1126/science.aab1028			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25791083	Green Accepted			2022-12-28	WOS:000352079500016
J	Barbee, LA; Centor, RM; Goldberger, ZD; Saint, S; Dhanireddy, S				Barbee, Lindley A.; Centor, Robert M.; Goldberger, Zachary D.; Saint, Sanjay; Dhanireddy, Shireesha			A History Lesson	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PRIMARY-CARE; ORAL SEX; TRANSMISSION	A 34-year-old man presented to an ambulatory care center with a 3-day history of a sore throat. He reported associated subjective fevers, chills, sinus pressure, occasional coughing, and fatigue. He did not have dyspnea or headaches. He reported no weight loss, abdominal pain, or chest pain.	[Barbee, Lindley A.; Goldberger, Zachary D.; Dhanireddy, Shireesha] Univ Washington, Sch Med, Harborview Med Ctr, Dept Med, Seattle, WA 98104 USA; [Barbee, Lindley A.; Dhanireddy, Shireesha] Univ Washington, Sch Med, Harborview Med Ctr, Div Infect Dis, Seattle, WA 98104 USA; [Goldberger, Zachary D.] Univ Washington, Sch Med, Harborview Med Ctr, Div Cardiol, Seattle, WA 98104 USA; [Barbee, Lindley A.] Publ Hlth Seattle & King Cty HIV STD Program, Seattle, WA USA; [Centor, Robert M.] Univ Alabama Birmingham, Dept Internal Med, Huntsville, AL USA; [Saint, Sanjay] Univ Michigan, Sch Med, Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Saint, Sanjay] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Dhanireddy, S (corresponding author), Univ Washington, 325 9th Ave,Box 359930, Seattle, WA 98104 USA.	sdhanir@uw.edu	Saint, Sanjay/AAF-5126-2019		Doximity; Jvion	Doximity; Jvion	Dr. Saint reports receiving fees for board membership from Doximity and Jvion. No other potential conflict of interest relevant to this article was reported.	BAARSMA EA, 1985, J LARYNGOL OTOL, V99, P601, DOI 10.1017/S0022215100097322; Byers ES, 2009, ARCH SEX BEHAV, V38, P665, DOI 10.1007/s10508-007-9289-6; Centers for Disease Control and Prevention, 2012, SEX TRANSM DIS SURV; Dolin R, 2009, MANDELL DOUGLAS BENN; DUNCAN WC, 1974, ARCH DERMATOL, V110, P77, DOI 10.1001/archderm.110.1.77; Edwards S, 1998, SEX TRANSM INFECT, V74, P6, DOI 10.1136/sti.74.1.6; Edwards S, 1998, SEX TRANSM INFECT, V74, P95, DOI 10.1136/sti.74.2.95; Gedela K, 2012, BRIT J GEN PRACT, V62, P219, DOI 10.3399/bjgp12X636254; Katz MH, 1998, J ACQ IMMUN DEF SYND, V19, P178, DOI 10.1097/00042560-199810010-00012; Kolios AGA, 2010, ARCH DERMATOL, V146, P570, DOI 10.1001/archdermatol.2010.73; MERRILL JM, 1990, SOUTHERN MED J, V83, P613, DOI 10.1097/00007611-199006000-00004; Mosher William D, 2005, Adv Data, P1; Temple-Smith M, 1996, Aust Fam Physician, V25, pS71; Wimberly YH, 2006, J NATL MED ASSOC, V98, P1924; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	15	2	2	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14					1360	1364		10.1056/NEJMcps1308900	http://dx.doi.org/10.1056/NEJMcps1308900			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NL	25830427				2022-12-28	WOS:000352028500013
J	Opperer, M; Poeran, J; Rasul, R; Mazumdar, M; Memtsoudis, SG				Opperer, Mathias; Poeran, Jashvant; Rasul, Rehana; Mazumdar, Madhu; Memtsoudis, Stavros G.			Use of perioperative hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasty and association with adverse outcomes: a retrospective population based analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EUROPEAN MEDICINES AGENCY; ACUTE KIDNEY INJURY; FLUID RESUSCITATION; EXECUTIVE DIRECTOR; RANDOMIZED-TRIALS; HIP-ARTHROPLASTY; MORTALITY; ICD-9-CM; THERAPY; SALINE	OBJECTIVE To determine whether the perioperative use of hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasties are associated with an increased risk for perioperative complications. DESIGN Retrospective cohort study of population based data between 2006 and 2013. SETTING Data from 510 different hospitals across the United States participating in the Premier Perspective database. PARTICIPANTS 1 051 441 patients undergoing elective total hip and knee arthroplasties. EXPOSURES Perioperative fluid resuscitation with hydroxyethyl starch 6% or albumin 5%, or neither. MAIN OUTCOME MEASURES Acute renal failure and thromboembolic, cardiac, and pulmonary complications. RESULTS Compared with patients who received neither colloid, perioperative fluid resuscitation with hydroxyethyl starch 6% or albumin 5% was associated with an increased risk of acute renal failure (odds ratios 1.23 (95% confidence interval 1.13 to 1.34) and 1.56 (1.36 to 1.78), respectively) and most other complications. A recent decrease in hydroxyethyl starch 6% use was noted, whereas that of albumin 5% increased. CONCLUSIONS Similar to studies in critically ill patients, we showed that use of hydroxyethyl starch 6% was associated with an increased risk of acute renal failure and other complications in the elective perioperative orthopedic setting. This increased risk also applied to albumin 5%. These findings raise questions regarding the widespread use of these colloids in elective joint arthroplasty procedures.	[Opperer, Mathias; Memtsoudis, Stavros G.] Hosp Special Surg, Dept Anesthesiol, New York, NY 10021 USA; [Opperer, Mathias; Memtsoudis, Stavros G.] Paracelsus Med Univ, Dept Anesthesiol Perioperat Med & Intens Care Med, A-5020 Salzburg, Austria; [Poeran, Jashvant; Rasul, Rehana; Mazumdar, Madhu] Icahn Sch Med Mt Sinai, Inst Healthcare Delivery Sci, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Poeran, Jashvant] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Memtsoudis, Stavros G.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA	Paracelsus Private Medical University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cornell University	Memtsoudis, SG (corresponding author), Hosp Special Surg, Dept Anesthesiol, 535 E 70th St, New York, NY 10021 USA.	memtsoudiss@hss.edu			Anna Maria and Stephen Kellen Career Development Award, New York; Cardiothoracic Surgical Trials Network (CTSN); Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, New York	Anna Maria and Stephen Kellen Career Development Award, New York; Cardiothoracic Surgical Trials Network (CTSN); Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, New York	SGM is funded by the Anna Maria and Stephen Kellen Career Development Award, New York. RR and MM are partially funded by Cardiothoracic Surgical Trials Network (CTSN) and the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, New York.	Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; Bellomo R, 2014, BRIT J ANAESTH, V112, P595, DOI 10.1093/bja/aeu025; Broderick JS, 2014, J ORTHOP TRAUMA, V28, pS12, DOI 10.1097/BOT.0000000000000178; Bunn F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001319.pub5; Chappell D, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-61; Coriat P, 2014, BRIT J ANAESTH, V113, P194, DOI 10.1093/bja/aeu217; Danielson E, 2014, WHITE PAPER HLTH RES; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dieterich HJ, 2003, J TRAUMA, V54, pS26, DOI 10.1097/01.TA.0000028408.13858.7A; Donaldson AJ, 2009, BRIT J ANAESTH, V102, P12, DOI 10.1093/bja/aen328; DONNELLY AJ, 1987, DRUG INTEL CLIN PHAR, V21, P286, DOI 10.1177/106002808702100312; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Haase N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f839; Hand WR, 2015, ANESTH ANALG, V120, P619, DOI 10.1213/ANE.0000000000000374; Irwin MG, 2014, ANESTH ANALG, V119, P737, DOI 10.1213/ANE.0000000000000221; Kancir ASP, 2014, ANESTHESIOLOGY, V121, P948, DOI 10.1097/ALN.0000000000000413; Kashy BK, 2014, ANESTHESIOLOGY, V121, P730, DOI 10.1097/ALN.0000000000000375; Martin C, 2013, ANESTHESIOLOGY, V118, P387, DOI 10.1097/ALN.0b013e31827e5569; McDonald JS, 2014, AM J NEURORADIOL, V35, P164, DOI 10.3174/ajnr.A3642; Memtsoudis SG, 2014, ANESTHESIOLOGY, V120, P551, DOI 10.1097/ALN.0000000000000120; Memtsoudis SG, 2010, REGION ANESTH PAIN M, V35, P417, DOI 10.1097/AAP.0b013e3181e85a07; Miletin MS, 2002, INTENS CARE MED, V28, P917, DOI 10.1007/s00134-002-1337-z; Moineddin R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-34; Mutter TC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007594.pub3; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Patel A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4561; Patel A, 2013, INTENS CARE MED, V39, P811, DOI 10.1007/s00134-013-2863-6; Perel P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub6; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Premier, PREM PERSP DAT; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Roberts I, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001208.pub3, 10.1002/14651858.CD001208.pub4]; Rothberg MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087382; Skhirtladze K, 2014, BRIT J ANAESTH, V112, P255, DOI 10.1093/bja/aet348; Tinti F, 2010, TRANSPL P, V42, P1233, DOI 10.1016/j.transproceed.2010.03.128; US Food and Drug Administration, 2013, HYDR STARCH SOL FDA; Van Der Linden P, 2013, ANESTH ANALG, V116, P35, DOI 10.1213/ANE.0b013e31827175da; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430	40	34	34	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2015	350								h1567	10.1136/bmj.h1567	http://dx.doi.org/10.1136/bmj.h1567			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7OK	25817299	hybrid, Green Published			2022-12-28	WOS:000352031000003
J	Hawkes, N				Hawkes, Nigel			BMJ AWARDS 2015 Diabetes team award	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2015	350									10.1136/bmj.h1553	http://dx.doi.org/10.1136/bmj.h1553			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7OC	25812978				2022-12-28	WOS:000352030200008
J	Karimi-Shah, BA; Chowdhury, BA				Karimi-Shah, Banu A.; Chowdhury, Badrul A.			Forced Vital Capacity in Idiopathic Pulmonary Fibrosis - FDA Review of Pirfenidone and Nintedanib	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Karimi-Shah, Banu A.; Chowdhury, Badrul A.] US FDA, Div Pulm Allergy & Rheumatol Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Karimi-Shah, BA (corresponding author), US FDA, Div Pulm Allergy & Rheumatol Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.							Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; FDA, DRUGS FDA FDA APPR D; Karimi-Shah BA, 2010, PULM ALL DRUGS ADV C; Raghu G, 2012, AM J RESP CRIT CARE, V185, P1044, DOI 10.1164/rccm.201201-0006PP	4	184	187	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2015	372	13					1189	1191		10.1056/NEJMp1500526	http://dx.doi.org/10.1056/NEJMp1500526			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1QD	25806913				2022-12-28	WOS:000351585900004
J	Lee, DI; Zhu, GS; Sasaki, T; Cho, GS; Hamdani, N; Holewinski, R; Jo, SH; Danner, T; Zhang, ML; Rainer, PP; Bedja, D; Kirk, JA; Ranek, MJ; Dostmann, WR; Kwon, C; Margulies, KB; Van Eyk, JE; Paulus, WJ; Takimoto, E; Kass, DA				Lee, Dong I.; Zhu, Guangshuo; Sasaki, Takashi; Cho, Gun-Sik; Hamdani, Nazha; Holewinski, Ronald; Jo, Su-Hyun; Danner, Thomas; Zhang, Manling; Rainer, Peter P.; Bedja, Djahida; Kirk, Jonathan A.; Ranek, Mark J.; Dostmann, Wolfgang R.; Kwon, Chulan; Margulies, Kenneth B.; Van Eyk, Jennifer E.; Paulus, Walter J.; Takimoto, Eiki; Kass, David A.			Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease	NATURE			English	Article							PRESERVED EJECTION FRACTION; NATRIURETIC PEPTIDES; CYCLIC-GMP; INHIBITION; FAILURE; DELETION	Cyclic guanosine monophosphate (cGMP) is a second messenger molecule that transduces nitric-oxide-and natriuretic-peptide-coupled signalling, stimulating phosphorylation changes by protein kinase G. Enhancing cGMP synthesis or blocking its degradation by phosphodiesterase type 5A (PDE5A) protects against cardiovascular disease(1,2). However, cGMP stimulation alone is limited by counter-adaptions including PDE upregulation(3). Furthermore, although PDE5A regulates nitric-oxide-generated cGMP(4,5), nitric oxide signalling is often depressed by heart disease(6). PDEs controlling natriuretic-peptide-coupled cGMP remain uncertain. Here we show that cGMP-selective PDE9A (refs 7, 8) is expressed in the mammalian heart, including humans, and is upregulated by hypertrophy and cardiac failure. PDE9A regulates natriuretic-peptide-rather than nitric-oxide-stimulated cGMP in heart myocytes and muscle, and its genetic or selective pharmacological inhibition protects against pathological responses to neurohormones, and sustained pressure-overload stress. PDE9A inhibition reverses pre-established heart disease independent of nitric oxide synthase (NOS) activity, whereas PDE5A inhibition requires active NOS. Transcription factor activation and phosphoproteome analyses of myocytes with each PDE selectively inhibited reveals substantial differential targeting, with phosphorylation changes from PDE5A inhibition being more sensitive to NOS activation. Thus, unlike PDE5A, PDE9A can regulate cGMP signalling independent of the nitric oxide pathway, and its role in stress-induced heart disease suggests potential as a therapeutic target.	[Lee, Dong I.; Zhu, Guangshuo; Cho, Gun-Sik; Holewinski, Ronald; Danner, Thomas; Zhang, Manling; Rainer, Peter P.; Bedja, Djahida; Kirk, Jonathan A.; Ranek, Mark J.; Kwon, Chulan; Van Eyk, Jennifer E.; Takimoto, Eiki; Kass, David A.] Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Sasaki, Takashi] Mitsubishi Tanabe Pharma Corp, Div Res, Adv Med Res Labs, Yokohama, Kanagawa 2270033, Japan; [Hamdani, Nazha; Paulus, Walter J.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Physiol, NL-1081 BT Amsterdam, Netherlands; [Holewinski, Ronald; Van Eyk, Jennifer E.] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Holewinski, Ronald; Van Eyk, Jennifer E.] Cedars Sinai Med Ctr, Adv Clin Biosyst Res Inst, Los Angeles, CA 90048 USA; [Jo, Su-Hyun] Kangwon Natl Univ, Inst Biosci & Biotechnol, Plus Grad Program BK21, Dept Physiol,Coll Med, Chunchon 200701, South Korea; [Dostmann, Wolfgang R.] Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA; [Margulies, Kenneth B.] Univ Penn, Dept Med, Perelman Sch Med, Div Cardiovasc Med,Cardiovasc Inst, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Medicine; Mitsubishi Tanabe Pharma Corporation; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Kangwon National University; University of Vermont; University of Pennsylvania; Pennsylvania Medicine	Kass, DA (corresponding author), Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	dkass@jhmi.edu	Kirk, Jonathan/N-3878-2019; Takimoto, Eiki/AAC-5100-2021; Ranek, Mark/GYA-1420-2022; Kirk, Jonathan A/Q-2522-2015; Rainer, Peter P/M-2145-2016	Kirk, Jonathan/0000-0002-5192-2860; Kirk, Jonathan A/0000-0002-5192-2860; Rainer, Peter P/0000-0002-2840-6454	National Institutes of Health (NIH) [HL-119012, HL-089297, HL-07227]; Fondation Leducq TransAtlantic Network of Excellence; Peter Belfer Foundation; Abraham and Virginia Weiss Professorship; American Heart Association; Austrian Academy of Sciences; National Institutes of Health [HL089847, HL105993]; European Commission [261409]; Johns Hopkins Innovation Proteomics Center in Heart Failure [NHLBI-HV-10-05 (2), HHSN268201000032C]; NIH [HL68891]; Totman Trust for Biomedical Research;  [HL-093432]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093432, R01HL111198, T32HL007227, R01HL089847, R01HL105993, P01HL107153, R01HL119012, R01HL089297, R01HL068891] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq TransAtlantic Network of Excellence(Leducq Foundation); Peter Belfer Foundation; Abraham and Virginia Weiss Professorship; American Heart Association(American Heart Association); Austrian Academy of Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); Johns Hopkins Innovation Proteomics Center in Heart Failure; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Totman Trust for Biomedical Research; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank students R. D. Wardlow and X. Hu for their assistance with some of the assays and studies. This research was supported by: the National Institutes of Health (NIH) (HL-119012, HL-089297, HL-07227), Fondation Leducq TransAtlantic Network of Excellence, The Peter Belfer Foundation, Abraham and Virginia Weiss Professorship (D.A.K.); HL-093432 (E.T.), American Heart Association (D.I.L.) and Max Kade Fellowship of the Austrian Academy of Sciences (P.P.R). Procurement of human heart tissue was enabled by grants from the National Institutes of Health (HL089847 and HL105993) to K.B.M. N.H. and W.J.P. were supported by the European Commission FP7 project 2010 Health (MEDIA; 261409). R.H. and J.E.V.E. were supported by The Johns Hopkins Innovation Proteomics Center in Heart Failure (NHLBI-HV-10-05 (2) and HHSN268201000032C). W.R.D. was supported by NIH grant HL68891 and the Totman Trust for Biomedical Research. We thank Pfizer and in particular C. Schmidt and R. Kleiman for providing the Pde9a<SUP>-/-</SUP> mouse and PF-04449613, and L. Jaffe at the University of Connecticut Health Center for providing the PDE9A antibody.	Carnicer R, 2013, ANTIOXID REDOX SIGN, V18, P1078, DOI 10.1089/ars.2012.4824; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Davis J, 2012, DEV CELL, V23, P705, DOI 10.1016/j.devcel.2012.08.017; Fisher DA, 1998, J BIOL CHEM, V273, P15559, DOI 10.1074/jbc.273.25.15559; Greene SJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000536; Heckman PRA, 2015, CURR PHARM DESIGN, V21, P317; Kinoshita H, 2010, CIRC RES, V106, P1849, DOI 10.1161/CIRCRESAHA.109.208314; Kirk JA, 2014, J CLIN INVEST, V124, P129, DOI 10.1172/JCI69253; Kleiman RJ, 2012, J PHARMACOL EXP THER, V341, P396, DOI 10.1124/jpet.111.191353; Koitabashi N, 2010, J MOL CELL CARDIOL, V48, P713, DOI 10.1016/j.yjmcc.2009.11.015; Kukreja RC, 2012, J AM COLL CARDIOL, V59, P1921, DOI 10.1016/j.jacc.2011.09.086; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Mullershausen F, 2004, MOL BIOL CELL, V15, P4023, DOI 10.1091/mbc.E03-12-0890; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Pilz RB, 2005, FRONT BIOSCI-LANDMRK, V10, P1239, DOI 10.2741/1616; Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024; Seo K, 2014, P NATL ACAD SCI USA, V111, P1551, DOI 10.1073/pnas.1308963111; Sharma K, 2014, CIRC RES, V115, P79, DOI 10.1161/CIRCRESAHA.115.302922; Singh G, 2006, CIRC RES, V99, P183, DOI 10.1161/01.RES.0000232322.06633.d3; Soderling SH, 1998, J BIOL CHEM, V273, P15553, DOI 10.1074/jbc.273.25.15553; Stangherlin A, 2011, CIRC RES, V108, P929, DOI 10.1161/CIRCRESAHA.110.230698; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Takimoto E, 2007, CIRCULATION, V115, P2159, DOI 10.1161/CIRCULATIONAHA.106.643536; van Heerebeek L, 2012, CIRCULATION, V126, P830, DOI 10.1161/CIRCULATIONAHA.111.076075; Verhoest PR, 2012, J MED CHEM, V55, P9045, DOI 10.1021/jm3007799; Zakeri R, 2011, CAN J PHYSIOL PHARM, V89, P593, DOI [10.1139/Y11-048, 10.1139/y11-048]; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	30	222	232	4	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					472	+		10.1038/nature14332	http://dx.doi.org/10.1038/nature14332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25799991	Green Accepted			2022-12-28	WOS:000351602800056
J	[Anonymous]				[Anonymous]			Japan	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S56	S57		10.1038/519S56a	http://dx.doi.org/10.1038/519S56a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE1WF	25806695	Bronze			2022-12-28	WOS:000351602800010
J	Gluckman, P; Nishtar, S; Armstrong, T				Gluckman, Peter; Nishtar, Sania; Armstrong, Timothy			Ending childhood obesity: a multidimensional challenge	LANCET			English	Editorial Material									[Gluckman, Peter] Off Prime Ministers Chief Sci Advisor, Auckland 1150, New Zealand; [Nishtar, Sania] Heartfile, Islamabad, Pakistan; [Armstrong, Timothy] WHO, CH-1211 Geneva, Switzerland	World Health Organization	Gluckman, P (corresponding author), Off Prime Ministers Chief Sci Advisor, Auckland 1150, New Zealand.	peter.gluckman@pmcsa.org.nz			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Lobstein T, 2015, LANCET; WHO, 2010, GLOB STAT REP NONC D; WHO Commission on Ending Childhood Obesity, 2015, INT REP COMM END CHI; World Health Organization, 2014, WORLD HLTH STAT 2014	4	27	29	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1048	1050		10.1016/S0140-6736(15)60509-8	http://dx.doi.org/10.1016/S0140-6736(15)60509-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD7KX	25797547				2022-12-28	WOS:000351270400006
J	Asvany, O; Yamada, KMT; Brunken, S; Potapov, A; Schlemmer, S				Asvany, Oskar; Yamada, Koichi M. T.; Bruenken, Sandra; Potapov, Alexey; Schlemmer, Stephan			Experimental ground-state combination differences of CH5+	SCIENCE			English	Article							INFRARED-SPECTRUM	Protonation of methane (CH4), a rather rigid molecule well described by quantum mechanics, produces CH5+, a prototypical floppy molecule that has eluded definitive spectroscopic description. Experimental measurement of high-resolution spectra of pure CH5+ samples poses a formidable challenge. By applying two types of action spectroscopy predicated on photoinduced reaction with CO2 and photoinhibition of helium cluster growth, we obtained low-temperature, high-resolution spectra of mass-selected CH5+. On the basis of the very high accuracy of the line positions, we determined a spectrum of combination differences. Analysis of this spectrum enabled derivation of equally accurate ground state-level schemes of the corresponding nuclear spin isomers of CH5+, as well as tentative quantum number assignment of this enfant terrible of molecular spectroscopy.	[Asvany, Oskar; Bruenken, Sandra; Potapov, Alexey; Schlemmer, Stephan] Univ Cologne, Phys Inst 1, D-50937 Cologne, Germany; [Yamada, Koichi M. T.] EMTech, Environm Mol Sci Grp, Tsukuba, Ibaraki 3058569, Japan	University of Cologne; National Institute of Advanced Industrial Science & Technology (AIST)	Schlemmer, S (corresponding author), Univ Cologne, Phys Inst 1, D-50937 Cologne, Germany.	schlemmer@ph1.uni-koeln.de	Brünken, Sandra/B-1880-2010; Schlemmer, Stephan/E-2903-2015	Brünken, Sandra/0000-0001-7175-4828; Schlemmer, Stephan/0000-0002-1421-7281	Deutsche Forschungsgemeinschaft [SCHL 341/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank T. Carrington, P. Bunker, D. Nesbitt, P. Jensen, and U. Manthe for fruitful discussions on theoretical aspects of CH<INF>5</INF><SUP>+</SUP>, as well as J. Krieg in the initial stage of the experiment. Supported by Deutsche Forschungsgemeinschaft grant SCHL 341/6-1. We gratefully acknowledge the support of the workshops of the I. Physikalisches Institut. The two line lists (for 10 K and 4 K) associated with Fig. 1 are available as supplementary material; the raw data are archived at the University of Cologne and are available upon request.	Asvany O, 2005, SCIENCE, V309, P1219, DOI 10.1126/science.1113729; Asvany O, 2014, APPL PHYS B-LASERS O, V114, P203, DOI 10.1007/s00340-013-5684-y; Asvany O, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4753930; Asvany O, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3460265; Asvany O, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.233004; Brunken S, 2014, ASTROPHYS J LETT, V783, DOI 10.1088/2041-8205/783/1/L4; Bunker PR, 2004, J MOL STRUCT, V695, P253, DOI 10.1016/j.molstruc.2003.12.020; Chakrabarty S, 2013, J PHYS CHEM LETT, V4, P4051, DOI 10.1021/jz402264n; Deskevich MP, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2828478; DYCZMONS V, 1974, THEOR CHIM ACTA, V33, P239, DOI 10.1007/BF00551258; Huang XC, 2006, SCIENCE, V311, P60, DOI 10.1126/science.1121166; Jin Z, 2006, J PHYS CHEM A, V110, P1569, DOI 10.1021/jp053848o; Kolbuszewski M, 1996, J CHEM PHYS, V105, P3649, DOI 10.1063/1.472210; Kumar P, 2006, PHYS CHEM CHEM PHYS, V8, P573, DOI 10.1039/b513089c; MARX D, 1995, NATURE, V375, P216, DOI 10.1038/375216a0; Oka T, 2004, J MOL SPECTROSC, V228, P635, DOI 10.1016/j.jms.2004.08.015; OLAH GA, 1995, J AM CHEM SOC, V117, P1336, DOI 10.1021/ja00109a018; Schlemmer S, 2002, J CHEM PHYS, V117, P2068, DOI 10.1063/1.1487373; SCHREINER PR, 1993, J CHEM PHYS, V99, P3716, DOI 10.1063/1.466147; Tal'roze V. L., 1952, DOKL AKAD NAUK SSSR, V86, P909; Wang XG, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3027825; White ET, 1999, SCIENCE, V284, P135, DOI 10.1126/science.284.5411.135	22	88	88	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1346	1349		10.1126/science.aaa3304	http://dx.doi.org/10.1126/science.aaa3304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792326				2022-12-28	WOS:000351219600037
J	Popp, MW; Maquat, LE				Popp, Maximilian W.; Maquat, Lynne E.			A TRICK'n way to see the pioneer round of translation	SCIENCE			English	Editorial Material							MESSENGER-RNA; NUCLEAR TRANSLATION; PROTEIN-SYNTHESIS; MAMMALIAN-CELLS; DECAY		[Popp, Maximilian W.; Maquat, Lynne E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY USA; [Popp, Maximilian W.; Maquat, Lynne E.] Univ Rochester, Ctr RNA Biol, Rochester, NY USA	University of Rochester; University of Rochester	Popp, MW (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY USA.	lynne_maquat@urmc.rochester.edu		Maquat, Lynne/0000-0002-2789-2075	NIH [R01GM59614]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059614] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research on NMD in the Maquat lab is supported by NIH grant R01GM59614 (L.E.M.). M.W.P. is a Howard Hughes Medical Institute Fellow of the Damon Runyon Cancer Research Foundation (DRG-2119-12).	ALLFREY VG, 1954, P NATL ACAD SCI USA, V40, P881, DOI 10.1073/pnas.40.10.881; Apcher S, 2013, P NATL ACAD SCI USA, V110, P17951, DOI 10.1073/pnas.1309956110; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Dahlberg JE, 2003, RNA, V9, P1, DOI 10.1261/rna.2121703; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Halstead JM, 2015, SCIENCE, V347, P1367, DOI 10.1126/science.aaa3380; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lloyd R. E., 2013, INTERDISCIP REV RNA, V4, P317; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424	15	4	4	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1316	1317		10.1126/science.aaa9484	http://dx.doi.org/10.1126/science.aaa9484			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792317				2022-12-28	WOS:000351219600022
J	Alper, BS; Malone-Moses, M; McLellan, JS; Prasad, K; Manheimer, E				Alper, Brian S.; Malone-Moses, Meghan; McLellan, James S.; Prasad, Kameshwar; Manheimer, Eric			Thrombolysis in acute ischaemic stroke: time for a rethink?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TISSUE-PLASMINOGEN ACTIVATOR; POOLED ANALYSIS; ALTEPLASE; TRIAL; GUIDELINES; ATLANTIS; THERAPY; TREAT; NINDS; ECASS		[Alper, Brian S.; Malone-Moses, Meghan; McLellan, James S.] EBSCO Hlth, EBSCO Informat Serv, DynaMed, Ipswich, MA 01938 USA; [Prasad, Kameshwar] All India Inst Med Sci, Dept Neurol, New Delhi, India; [Manheimer, Eric] Cochrane Collaborat, Bahrain Branch, Awali, Bahrain	All India Institute of Medical Sciences (AIIMS) New Delhi	Alper, BS (corresponding author), EBSCO Hlth, EBSCO Informat Serv, DynaMed, Ipswich, MA 01938 USA.	balper@EBSCO.com						Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Altman Douglas G, 2002, BMC Med Res Methodol, V2, P3, DOI 10.1186/1471-2288-2-3; American Academy of Emergency Medicine Work Group on Thrombolytic Therapy in Stroke, 2002, POS STAT US INTR THR; American College of Emergency Physicians, 2013, Ann Emerg Med, V61, P225, DOI 10.1016/j.annemergmed.2012.11.005; American College of Emergency Physicians, 2015, CLIN POL US INTR TPA; Australasian College for Emergency Medicine, 2014, STAT INTR THROMB ISC; Australian Government Department of Health Therapeutic goods administration, PROD CONS MED INF AC; Bryer Alan, 2010, S Afr Med J, V100, P747; Canadian Association of Emergency Physicians, 2014, POS STAT AC ISCH STR; Canadian Association of Emergency Physicians Committee on Thrombolytic Therapy for Acute Ischemic Stroke, THROMB THER AC ISCH; Electronic Medicines Compendium, SUMM PROD CHAR ACT; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Genentech, ACT ALT; Gilhus NE, 2011, EUROPEAN HDB NEUROLO, V1, P101; Hacke W, 2004, LANCET, V363, P768; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Haute Autorite de Sante, 2009, TREATING TOBACCO USE; Hudson I, 2014, LANCET, V384, P662, DOI 10.1016/S0140-6736(14)61388-X; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Lansberg MG, 2012, CHEST, V141, pE601S, DOI 10.1378/chest.11-2302; Lees Kennedy R, 2010, Lancet, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lindsay MP, 2013, CANADIAN BEST PRACTI; Minematsu K, 2013, J STROKE CEREBROVASC, V22, P571, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.001; National Institute for Health and Care Excellence, 2012, REV TECHN APPR GUID; National Stroke Foundation, 2010, CLIN GUID STROK MAN; New Zealand Faculty of the Australasian College for Emergency Medicine, 2013, CONS STAT THROMB AC; Newcombe RG, 1999, STAT MED, V18, P1293, DOI 10.1002/(SICI)1097-0258(19990530)18:10<1293::AID-SIM175>3.0.CO;2-7; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Sandercock P, 2012, INT J STROKE, V7, P186, DOI 10.1111/j.1747-4949.2012.00782.x; Shy BD, 2014, J EMERG MED, V46, P385, DOI 10.1016/j.jemermed.2012.05.014; Stroke Thrombolysis Trialists' Collaborative Group, 2013, STROKE, V8, P278; van Zuuren EJ, J EVID BASE IN PRESS; Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3; Xu AD, 2013, CNS NEUROSCI THER, V19, P543, DOI 10.1111/cns.12126	35	38	41	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2015	350								h1075	10.1136/bmj.h1075	http://dx.doi.org/10.1136/bmj.h1075			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KO	25786912				2022-12-28	WOS:000351570700002
J	Wiviott, SD; Steg, PG				Wiviott, Stephen D.; Steg, Philippe Gabriel			Clinical evidence for oral antiplatelet therapy in acute coronary syndromes	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; OPTIMIZING PLATELET INHIBITION; ATRIAL-FIBRILLATION PATIENTS; PERCUTANEOUS CORONARY; DOSE CLOPIDOGREL; DOUBLE-BLIND; PRASUGREL-THROMBOLYSIS; CARDIOVASCULAR EVENTS; ASSESS IMPROVEMENT; STENT PLACEMENT	Platelet-mediated thrombosis is a major pathophysiological mechanism that underlies acute coronary syndromes, and therefore, antiplatelet therapy is an important foundation in the treatment and prevention of recurrence of these syndromes. Nearly 30 years ago, aspirin was the first agent to show a benefit for acute coronary syndromes and is still a key therapeutic agent. The landmark CURE trial showed that the addition of a P2Y12 antagonist, clopidogrel, to aspirin was beneficial in the treatment of acute coronary syndromes. Despite substantial benefits with clopidogrel, limitations include the slow speed of onset, variable response, and a modest antiplatelet effect. Next-generation P2Y12 antagonists, prasugrel and ticagrelor, overcome these limitations and have been shown, in large-scale clinical trials for acute coronary syndromes, to reduce ischaemic events more than clopidogrel, at the expense of an increase in bleeding. Additional agents that target platelets by alternate mechanisms, including the protease-activated receptor-1 antagonist vorapaxar, have shown ischaemic benefit. These large-scale trials inform treatment decisions that need to balance ischaemic benefit and bleeding risk in patients with acute coronary syndromes. This Series paper describes major trial results, implications for clinical practice, and summarises continuing controversy.	[Wiviott, Stephen D.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Wiviott, Stephen D.] Harvard Univ, Sch Med, Boston, MA USA; [Steg, Philippe Gabriel] Dept Hosp Univ FIRE, AP HP, Hop Bichat, French Alliance Cardiovasc Clin Trials, Paris, France; [Steg, Philippe Gabriel] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Steg, Philippe Gabriel] INSERM, U 1148, Paris, France; [Steg, Philippe Gabriel] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Royal Brompton Hospital	Steg, PG (corresponding author), Hop Bichat Claude Bernard, F-75018 Paris, France.	gabriel.steg@bch.aphp.fr	Wiviott, Stephen/HIK-2534-2022; STEG, Philippe Gabriel/Z-1567-2019	STEG, Philippe Gabriel/0000-0001-6896-2941	Institut National de la Sante et de la Recherche Medicale	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	Jenny Lloyd (Medlink Healthcare Communications) provided editorial assistance with formatting and manuscript preparation and was funded by Institut National de la Sante et de la Recherche Medicale U1148.	Alexopoulos D, 2012, CIRC-CARDIOVASC INTE, V5, P797, DOI 10.1161/CIRCINTERVENTIONS.112.972323; Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], REUTERS; Aradi D, 2014, EUR HEART J, V35, P209, DOI 10.1093/eurheartj/eht375; Bangalore S, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000068; Bellemain-Appaix A, 2012, JAMA-J AM MED ASSOC, V308, P2507, DOI 10.1001/jama.2012.50788; Bertrand ME, 2000, CIRCULATION, V102, P624, DOI 10.1161/01.CIR.102.6.624; Bhatt DL, 2007, J AM COLL CARDIOL, V49, P1982, DOI 10.1016/j.jacc.2007.03.025; Bhatt DL, 2013, NEW ENGL J MED, V368, P1303, DOI 10.1056/NEJMoa1300815; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bonaca MP, 2014, AM HEART J, V167, P437, DOI 10.1016/j.ahj.2013.12.020; Bonello L, 2014, J AM COLL CARDIOL, V63, P872, DOI 10.1016/j.jacc.2013.09.067; Bonello L, 2010, J AM COLL CARDIOL, V56, P1630, DOI 10.1016/j.jacc.2010.07.004; Brar SS, 2011, J AM COLL CARDIOL, V58, P1945, DOI 10.1016/j.jacc.2011.06.059; Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Elmariah S, 2015, LANCET, V385, P792, DOI 10.1016/S0140-6736(14)62052-3; Fiedler KA, J AM COLL C IN PRESS; Fox KAA, 2010, EUR HEART J, V31, P2755, DOI 10.1093/eurheartj/ehq326; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Held C, 2011, J AM COLL CARDIOL, V57, P672, DOI 10.1016/j.jacc.2010.10.029; Husted S, 2012, CIRC-CARDIOVASC QUAL, V5, P680, DOI 10.1161/CIRCOUTCOMES.111.964395; James SK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3527; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Lamberts M, 2013, J AM COLL CARDIOL, V62, P981, DOI 10.1016/j.jacc.2013.05.029; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Lindholm D, 2014, EUR HEART J, V35, P2083, DOI 10.1093/eurheartj/ehu160; Lip GYH, 2014, EUR HEART J, V35, P3155, DOI 10.1093/eurheartj/ehu298; Mahaffey KW, 2011, CIRCULATION, V124, P544, DOI 10.1161/CIRCULATIONAHA.111.047498; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mega JL, 2015, LANCET, V385, P2264, DOI 10.1016/S0140-6736(14)61730-X; Mega JL, 2011, JAMA-J AM MED ASSOC, V306, P2221, DOI 10.1001/jama.2011.1703; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mehran R, 2013, LANCET, V382, P1714, DOI 10.1016/S0140-6736(13)61720-1; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Montalescot G, 2006, J AM COLL CARDIOL, V48, P931, DOI 10.1016/j.jacc.2006.04.090; Montalescot G, 2014, NEW ENGL J MED, V371, P1016, DOI 10.1056/NEJMoa1407024; Montalescot G, 2013, NEW ENGL J MED, V369, P999, DOI 10.1056/NEJMoa1308075; Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Morrow DA, 2009, CIRCULATION, V119, P2758, DOI 10.1161/CIRCULATIONAHA.108.833665; Nanhwan MK, 2014, ARTERIOSCL THROM VAS, V34, P2078, DOI 10.1161/ATVBAHA.114.304002; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Schomig A, 1997, J AM COLL CARDIOL, V29, P28, DOI 10.1016/S0735-1097(96)00450-0; Serebruany VL, 2005, J AM COLL CARDIOL, V45, P246, DOI 10.1016/j.jacc.2004.09.067; Silberman S, 2005, AM J CARDIOL, V95, P509, DOI 10.1016/j.amjcard.2004.10.022; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Smith PK, 2012, J AM COLL CARDIOL, V60, P388, DOI 10.1016/j.jacc.2012.03.030; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Steg PG, 2013, CIRCULATION, V128, P1055, DOI 10.1161/CIRCULATIONAHA.113.002589; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Steg PG, 2013, LANCET, V382, P1981, DOI 10.1016/S0140-6736(13)61615-3; Steg PG, 2010, CIRCULATION, V122, P2131, DOI 10.1161/CIRCULATIONAHA.109.927582; Storey RF, 2011, EUR HEART J, V32, P2945, DOI 10.1093/eurheartj/ehr231; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Valgimigli M, 2012, JACC-CARDIOVASC INTE, V5, P268, DOI 10.1016/j.jcin.2012.01.006; Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Whellan DJ, 2014, J AM COLL CARDIOL, V63, P1048, DOI 10.1016/j.jacc.2013.10.048; Wiviott SD, 2008, CIRCULATION, V118, P1626, DOI 10.1161/CIRCULATIONAHA.108.791061; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2013, LANCET, V382, P605, DOI 10.1016/S0140-6736(13)61451-8; Wiviott SD, 2010, CIRCULATION, V122, P394, DOI 10.1161/CIRCULATIONAHA.109.921502; Yusuf S, 2001, NEW ENGL J MED, V345, P494	78	47	51	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2015	386	9990					292	302		10.1016/S0140-6736(15)60213-6	http://dx.doi.org/10.1016/S0140-6736(15)60213-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN1XI	25777663				2022-12-28	WOS:000358213700034
J	Boersma, V; Moatti, N; Segura-Bayona, S; Peuscher, MH; van der Torre, J; Wevers, BA; Orthwein, A; Durocher, D; Jacobs, JJL				Boersma, Vera; Moatti, Nathalie; Segura-Bayona, Sandra; Peuscher, Marieke H.; van der Torre, Jaco; Wevers, Brigitte A.; Orthwein, Alexandre; Durocher, Daniel; Jacobs, Jacqueline J. L.			MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5 ' end resection	NATURE			English	Article							DAMAGE RESPONSE; POLYMERASE-ZETA; PROTECTION; HALLMARKS; MUTATION; ROLES; RIF1; REV7; TRF2; NHEJ	Appropriate repair of DNA lesions and the inhibition of DNA repair activities at telomeres are crucial to prevent genomic instability. By fuelling the generation of genetic alterations and by compromising cell viability, genomic instability is a driving force in cancer and ageing(1,2). Here we identify MAD2L2 (also known as MAD2B or REV7) through functional genetic screening as a novel factor controlling DNA repair activities at mammalian telomeres. We show that MAD2L2 accumulates at uncapped telomeres and promotes non-homologous end-joining (NHEJ)-mediated fusion of deprotected chromosome ends and genomic instability. MAD2L2 depletion causes elongated 39 telomeric overhangs, indicating that MAD2L2 inhibits 59 end resection. End resection blocks NHEJ while committing to homology-directed repair, and is under the control of 53BP1, RIF1 and PTIP3. Consistent with MAD2L2 promoting NHEJ-mediated telomere fusion by inhibiting 5' end resection, knockdown of the nucleases CTIP or EXO1 partially restores telomere-driven genomic instability in MAD2L2-depleted cells. Control of DNA repair by MAD2L2 is not limited to telomeres. MAD2L2 also accumulates and inhibits end resection at irradiation-induced DNA double-strand breaks and promotes end-joining of DNA double-strand breaks in several settings, including during immunoglobulin class switch recombination. These activities of MAD2L2 depend on ATM kinase activity, RNF8, RNF168, 53BP1 and RIF1, but not on PTIP, REV1 and REV3, the latter two acting with MAD2L2 in translesion synthesis(4). Together, our data establish MAD2L2 as a crucial contributor to the control of DNA repair activity by 53BP1 that promotes NHEJ by inhibiting 5' end resection downstream of RIF1.	[Boersma, Vera; Moatti, Nathalie; Segura-Bayona, Sandra; Peuscher, Marieke H.; van der Torre, Jaco; Wevers, Brigitte A.; Jacobs, Jacqueline J. L.] Netherlands Canc Inst, Div Mol Oncol, NL-1066 CX Amsterdam, Netherlands; [Orthwein, Alexandre; Durocher, Daniel] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	Netherlands Cancer Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Jacobs, JJL (corresponding author), Netherlands Canc Inst, Div Mol Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.jacobs@nki.nl	Durocher, Daniel/A-7733-2010; Jacobs, Jacqueline/ABA-5652-2020; Segura-Bayona, Sandra/W-8156-2019	Durocher, Daniel/0000-0003-3863-8635; Jacobs, Jacqueline/0000-0002-7704-4795; Segura-Bayona, Sandra/0000-0001-7788-9889; Peuscher, Marieke/0000-0001-9410-4350; van der Torre, Jaco/0000-0002-5405-3824; Orthwein, Alexandre/0000-0002-7350-3413	European Research Council [ERCStG 311565]; Dutch Cancer Society [KWF-NKI2007-3907]; Canadian Institutes for Health Research [CIHR MOP89754]; La Caixa fellowship; CIHR	European Research Council(European Research Council (ERC)European Commission); Dutch Cancer Society(KWF Kankerbestrijding); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); La Caixa fellowship(La Caixa Foundation); CIHR(Canadian Institutes of Health Research (CIHR))	We thank A. Konishi, G. Celli and T. de Lange for TRF2(Ile468Ala), Trf2<SUP>flox/-</SUP> p53<SUP>-/-</SUP> MEFs and Trf2<SUP>flox/-</SUP> p53<SUP>-/-</SUP> Lig4<SUP>-/-</SUP> MEFs, P. Bouwman, M. Pieterse, T. Halazonetis, O. Kallioniemi, B. Gerritsen, B. Morris and P. Halonen for composing and providing the DDR TRC shRNA sub-library, members of the NKI Genomics Core Facility for technical support, A. van Kessel for MAD2L2 cDNA, E. Hendrickson for repair plasmids, R. Chapman and S. Boulton for mRIF1 antibody, 53bp1<SUP>-/-</SUP> and Rif1<SUP>-/-</SUP> MEFs, E. Callen and A. Nussenzweig for 53BP1 and PTIP expression vectors and for Ptip<SUP>-/-</SUP> MEFs, N. de Wind for Rev1<SUP>-/-</SUP> and Rev3<SUP>-/-</SUP> MEFs, B. van den Broek for help with telomere mobility analysis, I. de Krijger, Z. Yalcin and M. Simonetta from the Jacobs group for contributing to end resection and interaction analysis and members of the R. Medema laboratory for discussion. This work was supported by grants from the European Research Council (ERCStG 311565) and Dutch Cancer Society (KWF-NKI2007-3907) to J.J.L.J., a grant from the Canadian Institutes for Health Research (CIHR MOP89754) to D.D., a La Caixa fellowship to S. S. B. and a CIHR post-doctoral fellowship to A.O. D.D. is a Canada Research Chair (tier 1) in the Molecular Mechanisms of Genome Integrity and J.J.L.J. is an EMBO Young Investigator.	Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Daniel JA, 2013, MOL CELL, V50, P309, DOI 10.1016/j.molcel.2013.04.017; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng YB, 2009, NATURE, V460, P914, DOI 10.1038/nature08196; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dimitrova N, 2009, MOL CELL BIOL, V29, P5552, DOI 10.1128/MCB.00476-09; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Kato H, 1997, DEVELOPMENT, V124, P4133; Khalaj M, 2014, J BIOL CHEM, V289, P3811, DOI 10.1074/jbc.M113.514752; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Murnane JP, 2012, MUTAT RES-FUND MOL M, V730, P28, DOI 10.1016/j.mrfmmm.2011.04.008; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Peuscher MH, 2011, NAT CELL BIOL, V13, P1139, DOI 10.1038/ncb2326; Rimkus C, 2007, INT J CANCER, V120, P207, DOI 10.1002/ijc.22155; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sharma S, 2012, NUCLEIC ACIDS RES, V40, P682, DOI 10.1093/nar/gkr769; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Zimmerman M, 2014, TRENDS CELL BIOL, V24, P108, DOI 10.1016/j.tcb.2013.09.003; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	32	197	200	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					537	U291		10.1038/nature14216	http://dx.doi.org/10.1038/nature14216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25799990	Green Accepted			2022-12-28	WOS:000355286600047
J	Chen, ZS; Shojaee, S; Buchner, M; Geng, HM; Lee, J; Klemm, L; Titz, B; Graeber, TG; Park, E; Tan, YX; Satterthwaite, A; Paietta, E; Hunger, SP; Willman, CL; Melnick, A; Loh, ML; Jung, JU; Coligan, JE; Bolland, S; Mak, TW; Limnander, A; Jumaa, H; Reth, M; Weiss, A; Lowell, CA; Muschen, M				Chen, Zhengshan; Shojaee, Seyedmehdi; Buchner, Maike; Geng, Huimin; Lee, JaeWoong; Klemm, Lars; Titz, Boern; Graeber, Thomas G.; Park, Eugene; Tan, Ying Xim; Satterthwaite, Anne; Paietta, Elisabeth; Hunger, Stephen P.; Willman, Cheryl L.; Melnick, Ari; Loh, Mignon L.; Jung, Jae U.; Coligan, John E.; Bolland, Silvia; Mak, Tak W.; Limnander, Andre; Jumaa, Hassan; Reth, Michael; Weiss, Arthur; Lowell, Clifford A.; Mueschen, Markus			Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia	NATURE			English	Article							IN-VIVO; RECEPTOR; DELETION; ACTIVATION; MOTIFS	B cells are selected for an intermediate level of B-cell antigen receptor (BCR) signalling strength: attenuation below minimum(for example, non-functional BCR)(1) or hyperactivation above maximum (for example, self-reactive BCR)(2,3) thresholds of signalling strength causes negative selection. In similar to 25% of cases, acute lymphoblastic leukaemia (ALL) cells carry the oncogenic BCR-ABL1 tyrosine kinase (Philadelphia chromosome positive), which mimics constitutively active pre-BCR signalling(4,5). Current therapeutic approaches are largely focused on the development of more potent tyrosine kinase inhibitors to suppress oncogenic signalling below a minimum threshold for survival(6). We tested the hypothesis that targeted hyperactivation-above a maximum threshold-will engage a deletional checkpoint for removal of self-reactive B cells and selectively kill ALL cells. Here we find, by testing various components of proximal pre-BCR signalling in mouse BCR-ABL1 cells, that an incremental increase of Syk tyrosine kinase activity was required and sufficient to induce cell death. Hyperactive Syk was functionally equivalent to acute activation of a self-reactive BCR on ALL cells. Despite oncogenic transformation, this basic mechanism of negative selection was still functional in ALL cells. Unlike normal pre-B cells, patient-derived ALL cells express the inhibitory receptors PECAM1, CD300A and LAIR1 at high levels. Genetic studies revealed that Pecam1, Cd300a and Lair1 are critical to calibrate oncogenic signalling strength through recruitment of the inhibitory phosphatases Ptpn6 (ref. 7) and Inpp5d (ref. 8). Using a novel small-molecule inhibitor of INPP5D (also known as SHIP1)(9), we demonstrated that pharmacological hyperactivation of SYK and engagement of negative B-cell selection represents a promising new strategy to overcome drug resistance in human ALL.	[Chen, Zhengshan; Shojaee, Seyedmehdi; Buchner, Maike; Geng, Huimin; Lee, JaeWoong; Klemm, Lars; Park, Eugene; Lowell, Clifford A.; Mueschen, Markus] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Titz, Boern; Graeber, Thomas G.] Univ Calif Los Angeles, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Tan, Ying Xim; Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med,Div Rheumatol, Rosalind Russell Ephraim P Engleman Med Res Ctr A, San Francisco, CA 94143 USA; [Satterthwaite, Anne] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Paietta, Elisabeth] Albert Einstein Coll Med, Dept Med, Bronx, NY 10466 USA; [Hunger, Stephen P.] Childrens Hosp Philadelphia, Div Pediat Oncol, Philadelphia, PA 19104 USA; [Hunger, Stephen P.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Willman, Cheryl L.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87102 USA; [Melnick, Ari] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Melnick, Ari] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Loh, Mignon L.] Univ Calif San Francisco, Pediat Hematol Oncol, San Francisco, CA 94143 USA; [Jung, Jae U.] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Coligan, John E.] NIAID, Receptor Cell Biol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Bolland, Silvia] NIAID, Autoimmun & Funct Genom Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Mak, Tak W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada; [Limnander, Andre] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Jumaa, Hassan] Univ Clin Ulm, Inst Immunol, D-89081 Ulm, Germany; [Reth, Michael] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Reth, Michael] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Reth, Michael] MPI Immunbiol & Epigenet, D-79104 Freiburg, Germany	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of New Mexico; Cornell University; Cornell University; University of California System; University of California San Francisco; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California San Francisco; Ulm University; University of Freiburg; University of Freiburg	Muschen, M (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	markus.muschen@ucsf.edu	Melnick, Ari/AAA-5763-2020; Titz, Bjoern/G-6317-2017	Titz, Bjoern/0000-0003-4414-4105; Lee, Jaewoong/0000-0001-7952-5544; Graeber, Thomas/0000-0001-8574-9181; Loh, Mignon/0000-0003-4099-4700	National Institutes of Health/National Cancer Institute [R01CA137060, R01CA139032, R01CA169458, R01CA172558, R01CA157644]; ECOG-ACRIN [CA180820, CA180794]; Leukemia and Lymphoma Society; California Institute for Regenerative Medicine [TR02-1816]; William Lawrence and Blanche Hughes Foundation; DFG [EXC294, TRR130, SFB746]; Cancer Research UK [18131] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U24CA196172, U10CA180827, U10CA180794, R01CA169458, U10CA180886, U24CA114737, R01CA157644, R01CA172558, U01CA157937, R01CA137060, U10CA021115, U10CA180820, R01CA139032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068150, ZIAAI000964, ZIAAI000912, R01AI113272] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ECOG-ACRIN; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); William Lawrence and Blanche Hughes Foundation; DFG(German Research Foundation (DFG)); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. W. Hendriks for encouragement and critical discussions, A. Park and C. Lin and all the members of the Muschen laboratory, L. Tian and B. Scott for their support. This work is supported by grants from the National Institutes of Health/National Cancer Institute through R01CA137060, R01CA139032, R01CA169458, R01CA172558 and R01CA157644 (to M.M.), ECOG-ACRIN grants CA180820 and CA180794 (to E.P.), grants from the Leukemia and Lymphoma Society (to M.M.), the California Institute for Regenerative Medicine through TR02-1816 (M.M.), and the William Lawrence and Blanche Hughes Foundation. M.M. is a Scholar of The Leukemia and Lymphoma Society and a Senior Investigator of the Wellcome Trust. M.R. is supported by the DFG through EXC294, TRR130 and SFB746.	Anderson LJ, 2008, J GEN VIROL, V89, P1563, DOI 10.1099/vir.0.2008/001461-0; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Bolland S, 1999, ADV IMMUNOL, V72, P149, DOI 10.1016/S0065-2776(08)60019-X; Brooks R, 2010, J IMMUNOL, V184, P3582, DOI 10.4049/jimmunol.0902844; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Feldhahn N, 2005, J EXP MED, V201, P1837, DOI 10.1084/jem.20042101; Keenan RA, 2008, SCIENCE, V321, P696, DOI 10.1126/science.1157533; Klein F, 2004, J EXP MED, V199, P673, DOI 10.1084/jem.20031637; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Limnander A, 2011, NAT IMMUNOL, V12, P425, DOI 10.1038/ni.2016; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; O'Neill SK, 2011, IMMUNITY, V35, P746, DOI 10.1016/j.immuni.2011.10.011; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Staub E, 2004, CELL SIGNAL, V16, P435, DOI 10.1016/j.cellsig.2003.08.013; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	22	88	89	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					357	+		10.1038/nature14231	http://dx.doi.org/10.1038/nature14231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25799995	Green Accepted, Green Submitted			2022-12-28	WOS:000354816500057
J	Urnavicius, L; Zhang, K; Diamant, AG; Motz, C; Schlager, MA; Yu, MM; Patel, NA; Robinson, CV; Carter, AP				Urnavicius, Linas; Zhang, Kai; Diamant, Aristides G.; Motz, Carina; Schlager, Max A.; Yu, Minmin; Patel, Nisha A.; Robinson, Carol V.; Carter, Andrew P.			The structure of the dynactin complex and its interaction with dynein	SCIENCE			English	Article							ACTIN-RELATED PROTEIN; CYTOPLASMIC DYNEIN; INTERMEDIATE CHAIN; HEAVY-CHAIN; BARBED-END; BICAUDAL-D; IN-VITRO; RECRUITMENT; COMPONENT; FILAMENT	Dynactin is an essential cofactor for the microtubule motor cytoplasmic dynein-1. We report the structure of the 23-subunit dynactin complex by cryo-electronmicroscopy to 4.0 angstroms. Our reconstruction reveals how dynactin is built around a filament containing eight copies of the actin-related protein Arp1 and one of beta-actin. The filament is capped at each end by distinct protein complexes, and its length is defined by elongated peptides that emerge from the a-helical shoulder domain. A further 8.2 angstrom structure of the complex between dynein, dynactin, and the motility-inducing cargo adaptor Bicaudal-D2 shows how the translational symmetry of the dynein tail matches that of the dynactin filament. The Bicaudal-D2 coiled coil runs between dynein and dynactin to stabilize the mutually dependent interactions between all three components.	[Urnavicius, Linas; Zhang, Kai; Diamant, Aristides G.; Motz, Carina; Schlager, Max A.; Yu, Minmin; Carter, Andrew P.] MRC, Mol Biol Lab, Div Struct Studies, Cambridge CB2 0QH, England; [Patel, Nisha A.; Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	MRC Laboratory Molecular Biology; University of Oxford	Carter, AP (corresponding author), MRC, Mol Biol Lab, Div Struct Studies, Francis Crick Ave, Cambridge CB2 0QH, England.	cartera@mrc-lmb.cam.ac.uk		robinson, carol/0000-0001-7829-5505; Carter, Andrew/0000-0001-7292-5430; Zhang, Kai/0000-0001-8617-2855	Medical Research Council, UK [MC_UP_A025_1011]; Wellcome Trust New Investigator Award [WT100387]; Medical Research Council [MC_UP_A025_1011, 1352465] Funding Source: researchfish; MRC [MC_UP_A025_1011] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust New Investigator Award(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Scheres and X. Bai for cryo-EM advice; G. McMullan, C. Savva, J. Grimmett, and T. Darling for technical support; S. Leech for fresh pig brains; V. Beilsten-Edmands for assistance with proteomic analyses; S. Bullock, R. McKenney, and J. Pennell for comments on the manuscript; and Y. Toyoshima for sharing her unpublished negative-stain EM model of the p150<SUP>Glued</SUP> projection, which helped us to interpret our observations. This work was funded by the Medical Research Council, UK (MC_UP_A025_1011), and a Wellcome Trust New Investigator Award (WT100387). Cryo-EM maps are deposited with the Electron Microscopy Data Bank (EMD-2854, EMD-2855, EMD-2856, EMD-2857, EMD-2860, EMD-2861, and EMD-2862), and coordinates are deposited with the Protein Data Bank (5AFT, 5AFU, and 5AFR). Author contributions: L.U. prepared dynactin and determined the TDB structure. K.Z. determined the structure of dynactin. A.G.D. and M.Y. determined the crystal structure of the DHC N terminus. C.M. and M.A.S. prepared the dynein tail complex. N.A.P. and C. V. R performed MS. A.P.C. initiated the project and designed the experiments.	Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Bingham JB, 1999, CURR BIOL, V9, P223, DOI 10.1016/S0960-9822(99)80095-5; Cheong FKY, 2014, MOL BIOL CELL, V25, P2171, DOI 10.1091/mbc.E14-03-0842; Dienstbier M, 2009, BIOCHEM SOC T, V37, P1066, DOI 10.1042/BST0371066; Dodding MP, 2011, EMBO J, V30, P3527, DOI 10.1038/emboj.2011.283; Duellberg C, 2014, NAT CELL BIOL, V16, P804, DOI 10.1038/ncb2999; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Hammesfahr B, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-95; Hodgkinson JL, 2005, P NATL ACAD SCI USA, V102, P3667, DOI 10.1073/pnas.0409506102; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Imai H, 2014, J MOL BIOL, V426, P3262, DOI 10.1016/j.jmb.2014.07.010; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; LEESMILLER JP, 1992, NATURE, V359, P244, DOI 10.1038/359244a0; Liu Y, 2013, GENE DEV, V27, P1233, DOI 10.1101/gad.212381.112; MCGRAIL M, 1995, J CELL BIOL, V131, P411, DOI 10.1083/jcb.131.2.411; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Narita A, 2006, EMBO J, V25, P5626, DOI 10.1038/sj.emboj.7601395; Pfister KK, 1998, CELL MOTIL CYTOSKEL, V41, P154, DOI 10.1002/(SICI)1097-0169(1998)41:2<154::AID-CM6>3.0.CO;2-E; PLAMANN M, 1994, J CELL BIOL, V127, P139, DOI 10.1083/jcb.127.1.139; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Schiavo G, 2013, TRENDS NEUROSCI, V36, P641, DOI 10.1016/j.tins.2013.08.001; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Siglin AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059453; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Torisawa T, 2014, NAT CELL BIOL, V16, P1118, DOI 10.1038/ncb3048; Tripathy SK, 2014, NAT CELL BIOL, V16, P1192, DOI 10.1038/ncb3063; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167; Yeh TY, 2013, EMBO J, V32, P1023, DOI 10.1038/emboj.2013.30; Yeh TY, 2012, MOL BIOL CELL, V23, P3827, DOI 10.1091/mbc.E12-07-0496	39	224	225	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1441	1446		10.1126/science.aaa4080	http://dx.doi.org/10.1126/science.aaa4080			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814576	Green Accepted			2022-12-28	WOS:000352136400032
J	Brestoff, JR; Artis, D				Brestoff, Jonathan R.; Artis, David			Immune Regulation of Metabolic Homeostasis in Health and Disease	CELL			English	Review							INNATE LYMPHOID-CELLS; BROWN ADIPOSE-TISSUE; BODY-MASS INDEX; TUMOR-NECROSIS-FACTOR; INDUCED INSULIN-RESISTANCE; ANTIGEN-PRESENTING CELLS; CD4(+) T-CELLS; ALTERNATIVE ACTIVATION; OXIDATIVE STRESS; PROTEIN CARBONYLATION	Obesity is an increasingly prevalent disease worldwide. While genetic and environmental factors are known to regulate the development of obesity and associated metabolic diseases, emerging studies indicate that innate and adaptive immune cell responses in adipose tissue have critical roles in the regulation of metabolic homeostasis. In the lean state, type 2 cytokine-associated immune cell responses predominate in white adipose tissue and protect against weight gain and insulin resistance through direct effects on adipocytes and elicitation of beige adipose. In obesity, these metabolically beneficial immune pathways become dysregulated, and adipocytes and other factors initiate metabolically deleterious type 1 inflammation that impairs glucose metabolism. This review discusses our current understanding of the functions of different types of adipose tissue and how immune cells regulate adipocyte function and metabolic homeostasis in the context of health and disease and highlights. We also highlight the potential of targeting immuno-metabolic pathways as a therapeutic strategy to treat obesity and associated diseases.	[Brestoff, Jonathan R.; Artis, David] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Dept Microbiol & Immunol, Joan & Sanford I Weill Dept Med,Weill Cornell Med, New York, NY 14850 USA; [Brestoff, Jonathan R.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Cornell University; University of Pennsylvania; Pennsylvania Medicine	Artis, D (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Dept Microbiol & Immunol, Joan & Sanford I Weill Dept Med,Weill Cornell Med, New York, NY 14850 USA.	dartis@med.cornell.edu	Brestoff, Jonathan R./I-7000-2019	Brestoff, Jonathan R./0000-0002-7018-7400; Artis, David/0000-0002-1753-4100	NIH [AI061570, AI074878, AI095466, AI095608, AI102942, AI106697, AI097333, F30-AI112023, T32-AI060516]; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095466, F30AI112023, P01AI106697, R01AI102942, T32AI060516, R01AI097333, R01AI074878, U01AI095608, R01AI061570] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to thank members of the Artis laboratory for the critical reading of this manuscript. Research in the Artis lab is supported by the NIH (AI061570, AI074878, AI095466, AI095608, AI102942, AI106697, and AI097333 to D.A.), the Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (D.A.) and Crohn's and Colitis Foundation of America (D.A.). Additional funding was provided by NIH F30-AI112023 and T32-AI060516 to J.R.B.	Allison MB, 2014, J ENDOCRINOL, V223, pT25, DOI 10.1530/JOE-14-0404; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Arner P, 2011, NATURE, V478, P110, DOI 10.1038/nature10426; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; Bouchard C, 2008, OBESITY, V16, pS5, DOI 10.1038/oby.2008.528; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Calder PC, 2002, P NUTR SOC, V61, P345, DOI 10.1079/PNS2002166; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Carey AL, 2013, DIABETOLOGIA, V56, P147, DOI 10.1007/s00125-012-2748-1; Carey AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091997; Carriere A, 2014, DIABETES, V63, P3253, DOI 10.2337/db13-1885; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Chang YH, 2012, INT J OBESITY, V36, P993, DOI 10.1038/ijo.2011.168; Cho KW, 2014, CELL REP, V9, P605, DOI 10.1016/j.celrep.2014.09.004; Cildir G, 2013, TRENDS MOL MED, V19, P487, DOI 10.1016/j.molmed.2013.05.001; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Curtis JM, 2012, J BIOL CHEM, V287, P32967, DOI 10.1074/jbc.M112.400663; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; Deng T, 2013, CELL METAB, V17, P411, DOI 10.1016/j.cmet.2013.02.009; Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hams E, 2013, J IMMUNOL, V191, P5349, DOI 10.4049/jimmunol.1301176; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hill AA, 2014, IMMUNOL REV, V262, P134, DOI 10.1111/imr.12216; Hondares E, 2014, METABOLISM, V63, P312, DOI 10.1016/j.metabol.2013.11.014; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huh JY, 2013, MOL CELL BIOL, V33, P328, DOI 10.1128/MCB.00552-12; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Itoh N, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00107; Jin CC, 2013, CELL METAB, V17, P873, DOI 10.1016/j.cmet.2013.05.011; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kain L, 2014, IMMUNITY, V41, P543, DOI 10.1016/j.immuni.2014.08.017; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim BS, 2015, J INVEST DERMATOL, V135, P673, DOI 10.1038/jid.2014.401; Kim BS, 2014, J IMMUNOL, V193, P3717, DOI 10.4049/jimmunol.1401307; Kotnik P, 2011, EUR J ENDOCRINOL, V165, P703, DOI 10.1530/EJE-11-0431; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lazar MA, 2007, HORM METAB RES, V39, P710, DOI 10.1055/s-2007-985897; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lee P, 2014, INT J OBESITY, V38, P170, DOI 10.1038/ijo.2013.82; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Miller AM, 2010, CIRC RES, V107, P650, DOI 10.1161/CIRCRESAHA.110.218867; Moisan A, 2015, NAT CELL BIOL, V17, P57, DOI 10.1038/ncb3075; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monticelli LA, 2012, CURR OPIN IMMUNOL, V24, P284, DOI 10.1016/j.coi.2012.03.012; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Moraes-Vieira PM, 2014, CELL METAB, V19, P512, DOI 10.1016/j.cmet.2014.01.018; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Morris DL, 2013, DIABETES, V62, P2762, DOI 10.2337/db12-1404; Mraz M, 2014, J ENDOCRINOL, V222, pR113, DOI 10.1530/JOE-14-0283; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; NENCINI P, 1981, PHARMACOL RES COMMUN, V13, P535, DOI 10.1016/S0031-6989(81)80023-9; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Oliveros H, 2008, OBESITY, V16, P515, DOI 10.1038/oby.2007.102; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Park HK, 2015, METABOLISM, V64, P24, DOI 10.1016/j.metabol.2014.08.004; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Pfeifer A, 2015, ANNU REV PHARMACOL, V55, P207, DOI 10.1146/annurev-pharmtox-010814-124346; Pi-Sunyer FX, 1999, MED SCI SPORT EXER, V31, pS602, DOI 10.1097/00005768-199911001-00019; Pontiroli AE, 2011, ANN SURG, V253, P484, DOI 10.1097/SLA.0b013e31820d98cb; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rakhshandehroo M, 2014, J BIOL CHEM, V289, P22128, DOI 10.1074/jbc.M114.551242; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Revelo XS, 2015, DIABETES, V64, P90, DOI 10.2337/db13-1524; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Ridker PM, 2012, CIRCULATION, V126, P2739, DOI 10.1161/CIRCULATIONAHA.112.122556; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Rosell M, 2011, BBA-MOL BASIS DIS, V1812, P919, DOI 10.1016/j.bbadis.2010.12.016; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sanchez-Gurmaches J, 2014, BBA-MOL BASIS DIS, V1842, P340, DOI 10.1016/j.bbadis.2013.05.027; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Song HY, 2002, BIOCHEM BIOPH RES CO, V299, P291, DOI 10.1016/S0006-291X(02)02551-2; Sonnenberg Gregory F, 2013, Immunity, V39, P622, DOI 10.1016/j.immuni.2013.08.021; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Stelekati E, 2012, CELL HOST MICROBE, V12, P458, DOI 10.1016/j.chom.2012.10.001; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Stolarczyk E, 2013, CELL METAB, V17, P520, DOI 10.1016/j.cmet.2013.02.019; Tajima S, 2012, AM J PHYSIOL-ENDOC M, V302, pE77, DOI 10.1152/ajpendo.00033.2011; Terra XM, 2011, EUR J ENDOCRINOL, V164, P539, DOI 10.1530/EJE-10-1195; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wagner NM, 2013, OBESITY, V21, P461, DOI 10.1002/oby.20087; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Wang GX, 2014, NAT MED, V20, P1436, DOI 10.1038/nm.3713; Wang JQ, 2013, NAT CELL BIOL, V15, P1455, DOI 10.1038/ncb2867; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wascher TC, 2011, MOL MED, V17, P189, DOI 10.2119/molmed.2010.00221; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yang ZH, 2013, INFECT IMMUN, V81, P1905, DOI 10.1128/IAI.00053-13; Yu YH, 2015, INT IMMUNOPHARMACOL, V25, P74, DOI 10.1016/j.intimp.2015.01.005; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zeyda M, 2013, INT J OBESITY, V37, P658, DOI 10.1038/ijo.2012.118; Zeyda M, 2010, INT J OBESITY, V34, P1684, DOI 10.1038/ijo.2010.103	174	286	297	1	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					146	160		10.1016/j.cell.2015.02.022	http://dx.doi.org/10.1016/j.cell.2015.02.022			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815992	Green Accepted, Bronze			2022-12-28	WOS:000351952200015
J	Le Bot, N				Le Bot, Nathalie			DEVELOPMENTAL BIOLOGY Earn your wings	NATURE			English	Editorial Material																		Xu HJ, 2015, NATURE, V519, P464, DOI 10.1038/nature14286	1	0	0	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					420	420		10.1038/519420a	http://dx.doi.org/10.1038/519420a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25810200				2022-12-28	WOS:000351602800042
J	Bosch, FH; Fleming, DA				Bosch, Frank H.; Fleming, David A.			Moving to High-Value Care: More Thoughtful Use of Cardiopulmonary Resuscitation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HOSPITAL CARDIAC-ARREST; SURVIVAL; TRENDS		[Bosch, Frank H.] Rijnstate Hosp, Dept Internal Med, NL-6800 TA Arnhem, Netherlands; Univ Missouri, Sch Med, Columbia, MO USA	Rijnstate Hospital; University of Missouri System; University of Missouri Columbia	Bosch, FH (corresponding author), Rijnstate Hosp, Dept Internal Med, POB 9555, NL-6800 TA Arnhem, Netherlands.	fhbosch@gmail.com	Bosch, Frank/AAW-6704-2020					Alahmar AE, 2014, HEART, V100, P1125, DOI 10.1136/heartjnl-2014-305696; Chan PS, 2014, CIRCULATION, V130, P1876, DOI 10.1161/CIRCULATIONAHA.114.009711; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Green Michael J, 2015, Ann Intern Med, V162, pW74, DOI 10.7326/G14-0009; Institute of Medicine, 2014, DYING AM IMPR QUAL H; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; Pizzo PA, 2015, ANN INTERN MED, V162, P228, DOI 10.7326/M14-2399; SAFAR P, 1958, NEW ENGL J MED, V258, P671, DOI 10.1056/NEJM195804032581401; Smith CD, 2012, ANN INTERN MED, V157, P284, DOI 10.7326/0003-4819-157-4-201208210-00496; Stapleton RD, 2014, CHEST, V146, P1214, DOI 10.1378/chest.13-2110	10	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2015	162	11					790	791		10.7326/M15-0492	http://dx.doi.org/10.7326/M15-0492			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ5ZH	25844884				2022-12-28	WOS:000355572300008
J	Ramshaw, BJ; Sebastian, SE; McDonald, RD; Day, J; Tan, BS; Zhu, Z; Betts, JB; Liang, RX; Bonn, DA; Hardy, WN; Harrison, N				Ramshaw, B. J.; Sebastian, S. E.; McDonald, R. D.; Day, James; Tan, B. S.; Zhu, Z.; Betts, J. B.; Liang, Ruixing; Bonn, D. A.; Hardy, W. N.; Harrison, N.			Quasiparticle mass enhancement approaching optimal doping in a high-T-c superconductor	SCIENCE			English	Article							QUANTUM-CRITICAL-POINT; FERMI-SURFACE; CHARGE ORDER; PSEUDOGAP PHASE; NORMAL-STATE; OSCILLATIONS; TRANSITIONS; SYMMETRY; HEAVY	In the quest for superconductors with higher transition temperatures (T-c), one emerging motif is that electronic interactions favorable for superconductivity can be enhanced by fluctuations of a broken-symmetry phase. Recent experiments have suggested the existence of the requisite broken-symmetry phase in the high-T-c cuprates, but the impact of such a phase on the ground-state electronic interactions has remained unclear. We used magnetic fields exceeding 90 tesla to access the underlying metallic state of the cuprate YBa2Cu3O6+delta over a wide range of doping, and observed magnetic quantum oscillations that reveal a strong enhancement of the quasiparticle effective mass toward optimal doping. This mass enhancement results from increasing electronic interactions approaching optimal doping, and suggests a quantum critical point at a hole doping of p(crit) approximate to 0.18.	[Ramshaw, B. J.; McDonald, R. D.; Zhu, Z.; Betts, J. B.; Harrison, N.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Sebastian, S. E.; Tan, B. S.] Univ Cambridge, Cavendish Lab, Cambridge CB3 OHE, England; [Day, James; Liang, Ruixing; Bonn, D. A.; Hardy, W. N.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z4, Canada; [Liang, Ruixing; Bonn, D. A.; Hardy, W. N.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Cambridge; University of British Columbia; Canadian Institute for Advanced Research (CIFAR)	Ramshaw, BJ (corresponding author), Los Alamos Natl Lab, Mail Stop E536, Los Alamos, NM 87545 USA.	bradramshaw@gmail.com	Ramshaw, Brad/AAU-5603-2020; Hardy, Walter Newbold/AAN-7827-2020; Ramshaw, Brad/J-3121-2013	Mcdonald, Ross/0000-0002-5819-4739; Ramshaw, Brad/0000-0002-3222-5007; Harrison, Neil/0000-0001-5456-7756	U.S. Department of Energy Office of Basic Energy Sciences; NSF [DMR-1157490]; State of Florida; Natural Science and Engineering Research Council of Canada; Canadian Institute for Advanced Research; Royal Society; European Research Council under the European Union [337425]	U.S. Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); State of Florida; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Royal Society(Royal Society of London); European Research Council under the European Union(European Research Council (ERC))	This work was performed at the National High Magnetic Field Laboratory and was supported by the U.S. Department of Energy Office of Basic Energy Sciences "Science at 100 T" program, NSF grant DMR-1157490, the State of Florida, the Natural Science and Engineering Research Council of Canada, and the Canadian Institute for Advanced Research. S.E.S. acknowledges support from the Royal Society and the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement 337425. We thank S. Chakravarty, S. Kivelson, M. Le Tacon, K. A. Modic, C. Proust, A. Shekhter, and L. Taillefer for discussions; J. Baglo for sharing his results on the effect of quenched oxygen disorder on the microwave scattering rate in YBa<INF>2</INF>Cu<INF>3</INF>O<INF>6+delta</INF>, without which oscillations would not have been observed; and the entire 100 T operations team at the pulsed-field facility for their support during the experiment. Full resistivity curves are available in the supplementary materials. B.J.R., S.E.S., R.D.M., B.T., Z.Z., J.B.B., and N.H. performed the high-field resistivity measurements at the National High Magnetic Field Laboratory Pulsed Field Facility. B.J.R., J.D., R. L., D.A.B., and W.N.H. grew and prepared the samples at the University of British Columbia. B.J.R. analyzed the data and wrote the manuscript, with contributions from S.E.S., R.D.M., N.H., J. D., D.A.B., and W.N.H.	Anderson PW, 2004, J PHYS-CONDENS MAT, V16, pR755, DOI 10.1088/0953-8984/16/24/R02; Ando Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.267001; Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Balakirev FF, 2003, NATURE, V424, P912, DOI 10.1038/nature01890; Bangura AF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.047004; Barisic N, 2013, NAT PHYS, V9, P761, DOI [10.1038/NPHYS2792, 10.1038/nphys2792]; Blanco-Canosa S, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.054513; Boebinger GS, 1996, PHYS REV LETT, V77, P5417, DOI 10.1103/PhysRevLett.77.5417; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; Coleman P, 2001, J PHYS-CONDENS MAT, V13, pR723, DOI 10.1088/0953-8984/13/35/202; Comin R, 2014, SCIENCE, V343, P390, DOI 10.1126/science.1242996; Coneri F, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.104507; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Fujita K, 2014, SCIENCE, V344, P612, DOI 10.1126/science.1248783; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Grissonnanche G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4280; Hucker M, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.054514; Hucker M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.104506; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Le Tacon M, 2011, NAT PHYS, V7, P725, DOI [10.1038/nphys2041, 10.1038/NPHYS2041]; LeBoeuf D, 2007, NATURE, V450, P533, DOI 10.1038/nature06332; LeBoeuf D, 2013, NAT PHYS, V9, P79, DOI 10.1038/nphys2502; LeBoeuf D, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054506; Lee PA, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/1/012501; LEGGETT AJ, 1968, ANN PHYS-NEW YORK, V46, P76, DOI 10.1016/0003-4916(68)90304-7; Loram JW, 1998, J PHYS CHEM SOLIDS, V59, P2091, DOI 10.1016/S0022-3697(98)00180-2; LORAM JW, 1993, PHYS REV LETT, V71, P1740, DOI 10.1103/PhysRevLett.71.1740; Monthoux P, 2007, NATURE, V450, P1177, DOI 10.1038/nature06480; Ramshaw BJ, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.174501; Ramshaw BJ, 2011, NAT PHYS, V7, P234, DOI [10.1038/nphys1873, 10.1038/NPHYS1873]; Sachdev S., 2007, QUANTUM PHASE TRANSI, DOI 10.1002/9780470022184; Sebastian SE, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.140505; Sebastian SE, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/102501; Sebastian SE, 2010, P NATL ACAD SCI USA, V107, P6175, DOI 10.1073/pnas.0913711107; Settai R, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.051003; Shekhter A, 2013, NATURE, V498, P75, DOI 10.1038/nature12165; Shen ZX, 2002, PHILOS MAG B, V82, P1349, DOI 10.1080/13642810210142735; Shishido H, 2005, J PHYS SOC JPN, V74, P1103, DOI 10.1143/JPSJ.74.1103; Shoenberg D., 1984, MAGNETIC OSCILLATION; Singleton J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.086403; Taillefer L, 2010, ANNU REV CONDEN MA P, V1, P51, DOI 10.1146/annurev-conmatphys-070909-104117; Tallon JL, 2001, PHYSICA C, V349, P53, DOI 10.1016/S0921-4534(00)01524-0; Varma CM, 1999, PHYS REV LETT, V83, P3538, DOI 10.1103/PhysRevLett.83.3538; Vignolle B, 2008, NATURE, V455, P952, DOI 10.1038/nature07323; Vignolle B, 2011, CR PHYS, V12, P446, DOI 10.1016/j.crhy.2011.04.011; Walmsley P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.257002; Wu T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3113; Yelland EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.047003; Yuan HQ, 2003, SCIENCE, V302, P2104, DOI 10.1126/science.1091648	56	138	138	6	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					317	320		10.1126/science.aaa4990	http://dx.doi.org/10.1126/science.aaa4990			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25814065	Green Submitted			2022-12-28	WOS:000352999000039
J	Gundem, G; Van Loo, P; Kremeyer, B; Alexandrov, LB; Tubio, JMC; Papaemmanuil, E; Brewer, DS; Kallio, HML; Hoegnas, G; Annala, M; Kivinummi, K; Goody, V; Latimer, C; O'Meara, S; Dawson, KJ; Isaacs, W; Emmert-Buck, MR; Nykter, M; Foster, C; Kote-Jarai, Z; Easton, D; Whitaker, HC; Neal, DE; Cooper, CS; Eeles, RA; Visakorpi, T; Campbell, PJ; McDermott, U; Wedge, DC; Bova, GS				Gundem, Gunes; Van Loo, Peter; Kremeyer, Barbara; Alexandrov, Ludmil B.; Tubio, Jose M. C.; Papaemmanuil, Elli; Brewer, Daniel S.; Kallio, Heini M. L.; Hoegnas, Gunilla; Annala, Matti; Kivinummi, Kati; Goody, Victoria; Latimer, Calli; O'Meara, Sarah; Dawson, Kevin J.; Isaacs, William; Emmert-Buck, Michael R.; Nykter, Matti; Foster, Christopher; Kote-Jarai, Zsofia; Easton, Douglas; Whitaker, Hayley C.; Neal, David E.; Cooper, Colin S.; Eeles, Rosalind A.; Visakorpi, Tapio; Campbell, Peter J.; McDermott, Ultan; Wedge, David C.; Bova, G. Steven		ICGC Prostate UK Grp	The evolutionary history of lethal metastatic prostate cancer	NATURE			English	Article							ANDROGEN DEPRIVATION THERAPY; PANCREATIC-CANCER; CLONAL EVOLUTION; HETEROGENEITY; PROGRESSION; RESISTANCE; PATHOGENESIS; MUTATIONS; SIGNATURE; PATTERNS	Cancers emerge from an ongoing Darwinian evolutionary process, often leading to multiple competing subdones within a single primary tumour(1-4). This evolutionary process culminates in the formation of metastases, which is the cause of 90% of cancer-related deaths(5). However, despite its clinical importance, little is known about the principles governing the dissemination of cancer cells to distant organs. Although the hypothesis that each metastasis originates from a single tumour cell is generally supported(6-8), recent studies using mouse models of cancer demonstrated the existence of polyclonal seeding from and interclonal cooperation between multiple subdonee(9,10). Here we sought definitive evidence for the existence of polydonal seeding in human malignancy and to establish the clonal relationship among different metastases in the context of androgendeprived metastatic prostate cancer. Using whole-genome sequencing, we characterized multiple metastases arising from prostate tumours in ten patients. Integrated analyses of subdonal architecture revealed the patterns of metastatic spread in unprecedented detail. Metastasis-to-metastasis spread was found to be common, either through de novo monoclonal seeding of daughter metastases or, in five cases, through the transfer of multiple tumour clones between metastatic sites. Lesions affecting tumour suppressor genes usually occur as single events, whereas mutations in genes involved in androgen receptor signalling commonly involve multiple, convergent events in different metastases. Our results elucidate in detail the complex patterns of metastatic spread and further our understanding of the development of resistance to androgen-deprivation therapy in prostate cancer.	[Gundem, Gunes; Van Loo, Peter; Kremeyer, Barbara; Alexandrov, Ludmil B.; Tubio, Jose M. C.; Papaemmanuil, Elli; Goody, Victoria; Latimer, Calli; O'Meara, Sarah; Dawson, Kevin J.; Campbell, Peter J.; McDermott, Ultan; Wedge, David C.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Van Loo, Peter] Katholieke Univ Leuven, Dept Human Genet, B-3000 Leuven, Belgium; [Van Loo, Peter] Canc Res UK London Res Inst, London WC2A 3LY, England; [Brewer, Daniel S.; Cooper, Colin S.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Brewer, Daniel S.; Cooper, Colin S.] Univ E Anglia, Dept Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Brewer, Daniel S.] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Kallio, Heini M. L.; Hoegnas, Gunilla; Annala, Matti; Kivinummi, Kati; Nykter, Matti; Visakorpi, Tapio; Bova, G. Steven] Univ Tampere, BioMediTech, Inst Biosci & Med Technol, FI-33520 Tampere, Finland; [Kallio, Heini M. L.; Hoegnas, Gunilla; Annala, Matti; Kivinummi, Kati; Nykter, Matti; Visakorpi, Tapio; Bova, G. Steven] Tampere Univ Hosp, Fimlab Labs, FI-33520 Tampere, Finland; [Isaacs, William] Johns Hopkins Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; [Emmert-Buck, Michael R.] NCI, Lab Pathol, NIH, Bethesda, MD 20892 USA; [Foster, Christopher] Univ Liverpool, London WC1E 6JA, England; [Foster, Christopher] HCA Pathol Labs, London WC1E 6JA, England; [Kote-Jarai, Zsofia; Cooper, Colin S.; Eeles, Rosalind A.] Inst Canc Res, Div Genet & Epidemiol, London SW7 3RP, England; [Easton, Douglas] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England; [Whitaker, Hayley C.; Neal, David E.] Canc Res UK Cambridge Inst, Urooncol Res Grp, Cambridge CB2 0RE, England; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Surg Oncol, Cambridge CB2 0QQ, England; [Eeles, Rosalind A.] Royal Marsden NHS Fdn Trust, London SW3 6JJ, England; [Eeles, Rosalind A.] Royal Marsden NHS Fdn Trust, Sutton SM2 5PT, Surrey, England	Wellcome Trust Sanger Institute; KU Leuven; Cancer Research UK; University of East Anglia; University of East Anglia; The Genome Analysis Centre (TGAC); Tampere University; Tampere University; Tampere University Hospital; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Liverpool; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust	Bova, GS (corresponding author), Univ Tampere, BioMediTech, Inst Biosci & Med Technol, FI-33520 Tampere, Finland.	um1@sanger.ac.uk; dw9@sanger.ac.uk; g.steven.bova@uta.fi	Brewer, Daniel S/D-6201-2018; Tubio, Jose M.C./H-5076-2015; Alexandrov, Ludmil/AAS-1454-2021; Tubio, Jose/AAG-7345-2019; Wedge, David/AAC-4977-2021	Brewer, Daniel S/0000-0003-4753-9794; Tubio, Jose M.C./0000-0003-3540-2459; Alexandrov, Ludmil/0000-0003-3596-4515; Tubio, Jose/0000-0003-3540-2459; Kallio, Heini M.L./0000-0003-4345-1787; Lynch, Andy/0000-0002-7876-7338; Neal, David/0000-0002-6033-5086; Van Loo, Peter/0000-0003-0292-1949; Bova, George/0000-0003-1639-3104; Nykter, Matti/0000-0001-6956-2843; Wedge, David/0000-0002-7572-3196; Massie, Charlie/0000-0003-2314-4843; Berney, Daniel/0000-0001-5474-8696; McDermott, Ultan/0000-0001-9032-4700; Dudderidge, Tim/0000-0001-6373-3613; Eeles, Rosalind/0000-0002-3698-6241; Visakorpi, Tapio/0000-0002-5004-0364	Cancer Research UK; NIH NCI Intramural Program; Academy of Finland; Cancer Society of Finland; PELICAN Autopsy Study family members and friends; John and Kathe Dyson; US National Cancer Institute [CA92234]; American Cancer Society; Johns Hopkins University Department of Pathology; Women's Board of Johns Hopkins Hospital; Grove Foundation; Association for the Cure of Cancer of the Prostate; American Foundation for Urologic Disease; Bob Champion Cancer Trust; Research Foundation - Flanders (FWO) [FWO-G.0687.12]; Cancer Research UK [15007, 17528] Funding Source: researchfish; Versus Arthritis [20406] Funding Source: researchfish; The Francis Crick Institute [10202] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA092234] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NIH NCI Intramural Program; Academy of Finland(Academy of Finland); Cancer Society of Finland; PELICAN Autopsy Study family members and friends; John and Kathe Dyson; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Johns Hopkins University Department of Pathology; Women's Board of Johns Hopkins Hospital; Grove Foundation; Association for the Cure of Cancer of the Prostate; American Foundation for Urologic Disease; Bob Champion Cancer Trust; Research Foundation - Flanders (FWO)(FWO); Cancer Research UK(Cancer Research UK); Versus Arthritis(Versus Arthritis); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the men and their families who participated in the PELICAN (Project to ELIminate lethal CANcer) integrated clinical-molecular autopsy study of prostate cancer. We thank M. A. Eisenberger, M. A. Carducci, V. Sinibaldi, T. B. Smyth and G. J. Mamo for oncologic and urologic clinical support; T. Tolonen for uropathology support; P. Martikainen, M. Vaha-Jaakkola, M. Vakkuri, K. Leinonen, T. Vormisto, M. Rohrer, A. Koskenalho, J. Silander, T. Lahtinen, C. Hardy, G. Hutchins, B. Crain,S. Jhavar, C. Talbot, L. Kasch, M. Penno, A. Warner and Y. Golubeva for technical support; and M. R. Stratton and P.A. Futreal for their comments on the manuscript. This is an ICGC Prostate Cancer study funded by: Cancer Research UK(2011-present); NIH NCI Intramural Program (2013-2014); Academy of Finland (2011-present); Cancer Society of Finland (2013-present); PELICAN Autopsy Study family members and friends (1998-2004); John and Kathe Dyson (2000); US National Cancer Institute CA92234 (2000-2005); American Cancer Society (1998-2000); Johns Hopkins University Department of Pathology (1997-2011); Women's Board of Johns Hopkins Hospital (1998); The Grove Foundation (1998); Association for the Cure of Cancer of the Prostate (1994-1998); American Foundation for Urologic Disease (1991-1994); Bob Champion Cancer Trust (2013-present); Research Foundation - Flanders (FWO) [FWO-G.0687.12] (2012-present). E.P. is a European Hematology Association Research Fellow.	Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bernard D, 2003, J CLIN INVEST, V112, P1724; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Francis JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003180; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Karantanos T, 2013, CANCER CELL, V24, P11, DOI 10.1016/j.ccr.2013.06.007; Lee YF, 2004, CANCER RES, V64, P7201, DOI 10.1158/0008-5472.CAN-04-1673; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Maley CC, 2004, CANCER RES, V64, P3414, DOI 10.1158/0008-5472.CAN-03-3249; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	29	883	901	4	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					353	+		10.1038/nature14347	http://dx.doi.org/10.1038/nature14347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25830880	Green Submitted, Green Accepted			2022-12-28	WOS:000352974200040
J	Rubin, M; Altwegg, K; Balsiger, H; Bar-Nun, A; Berthelier, JJ; Bieler, A; Bochsler, P; Briois, C; Calmonte, U; Combi, M; De Keyser, J; Dhooghe, F; Eberhardt, P; Fiethe, B; Fuselier, SA; Gasc, S; Gombosi, TI; Hansen, KC; Hassig, M; Jackel, A; Kopp, E; Korth, A; Le Roy, L; Mall, U; Marty, B; Mousis, O; Owen, T; Reme, H; Semon, T; Tzou, CY; Waite, JH; Wurz, P				Rubin, M.; Altwegg, K.; Balsiger, H.; Bar-Nun, A.; Berthelier, J. -J.; Bieler, A.; Bochsler, P.; Briois, C.; Calmonte, U.; Combi, M.; De Keyser, J.; Dhooghe, F.; Eberhardt, P.; Fiethe, B.; Fuselier, S. A.; Gasc, S.; Gombosi, T. I.; Hansen, K. C.; Haessig, M.; Jaeckel, A.; Kopp, E.; Korth, A.; Le Roy, L.; Mall, U.; Marty, B.; Mousis, O.; Owen, T.; Reme, H.; Semon, T.; Tzou, C. -Y.; Waite, J. H.; Wurz, P.			Molecular nitrogen in comet 67P/Churyumov-Gerasimenko indicates a low formation temperature	SCIENCE			English	Article							AMORPHOUS ICE; SURFACE; ION; N-2; CO	Molecular nitrogen (N-2) is thought to have been the most abundant form of nitrogen in the protosolar nebula. It is the main N-bearing molecule in the atmospheres of Pluto and Triton and probably the main nitrogen reservoir from which the giant planets formed. Yet in comets, often considered the most primitive bodies in the solar system, N-2 has not been detected. Here we report the direct in situ measurement of N-2 in the Jupiter family comet 67P/Churyumov-Gerasimenko, made by the Rosetta Orbiter Spectrometer for Ion and Neutral Analysis mass spectrometer aboard the Rosetta spacecraft. A N-2/CO ratio of (5.70 +/- 0.66) x 10(-3) (2s standard deviation of the sampled mean) corresponds to depletion by a factor of -25.4 +/- 8.9 as compared to the protosolar value. This depletion suggests that cometary grains formed at low-temperature conditions below similar to 30 kelvin.	[Rubin, M.; Altwegg, K.; Balsiger, H.; Bieler, A.; Bochsler, P.; Calmonte, U.; Eberhardt, P.; Gasc, S.; Haessig, M.; Jaeckel, A.; Kopp, E.; Semon, T.; Tzou, C. -Y.; Wurz, P.] Univ Bern, Inst Phys, Sidlerstr 5, CH-3012 Bern, Switzerland; [Altwegg, K.] Univ Bern, Ctr Space & Habitabil, CH-3012 Bern, Switzerland; [Bar-Nun, A.] Tel Aviv Univ, Dept Geosci, IL-69978 Tel Aviv, Israel; [Berthelier, J. -J.] UPMC,UVSQ, Inst Pierre Simon Laplace CNRS, Observat Spatiales LATMOS, Milieux,Lab Atmospheres, F-94100 St Maur, France; [Bieler, A.; Combi, M.; Gombosi, T. I.; Hansen, K. C.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Briois, C.] Univ Orleans, CNRS, Lab Phys & Chim Environm & Espace LPC2E, UMR 6115, Orleans, France; [De Keyser, J.; Dhooghe, F.] Inst Aeron Spatiale Belg BIRA IASB, Belgisch Inst Ruimte, Belgian Inst Space Aeron, B-1180 Brussels, Belgium; [Fiethe, B.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Comp & Network Engn, D-38106 Braunschweig, Germany; [Fuselier, S. A.; Haessig, M.; Waite, J. H.] SW Res Inst, Dept Space Sci, San Antonio, TX 78228 USA; [Korth, A.; Mall, U.] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Marty, B.] Univ Lorraine, CNRS, CRPG, F-54501 Vandoeuvre Les Nancy, France; [Mousis, O.] Aix Marseille Univ, CNRS, Lab Astrophys Marseille, UMR 7326, F-13388 Marseille, France; [Owen, T.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Reme, H.] Univ Toulouse, UPS OMP, IRAP, Toulouse, France; [Reme, H.] CNRS, IRAP, F-31028 Toulouse, France	University of Bern; University of Bern; Tel Aviv University; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Braunschweig University of Technology; Southwest Research Institute; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; University of Hawaii System; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Rubin, M (corresponding author), Univ Bern, Inst Phys, Sidlerstr 5, CH-3012 Bern, Switzerland.	martin.rubin@space.unibe.ch	Combi, Michael/J-1697-2012; Hansen, Kenneth C/F-3693-2011; Gombosi, Tamas I/G-4238-2011; Rubin, Martin/I-7777-2013; briois, christelle/B-2170-2015; Wurz, Peter/R-2273-2017; Mousis, Olivier/X-2712-2019	Combi, Michael/0000-0002-9805-0078; Hansen, Kenneth C/0000-0002-8502-1980; Gombosi, Tamas I/0000-0001-9360-4951; Rubin, Martin/0000-0001-6549-3318; Wurz, Peter/0000-0002-2603-1169; Le Roy, Lena/0000-0002-5984-6153; Dhooghe, Frederik/0000-0001-7334-833X; BRIOIS, Christelle/0000-0002-5616-0180	State of Bern; Swiss National Science Foundation; European Space Agency PRODEX Program; Max-Planck Society; Bundesministerium fur Wirtschaft und Energie [50QP1302]; Jet Propulsion Laboratory (JPL) [1496541]; Belgian Science Policy Office via PRODEX/ROSINA PEA [90020]; A*MIDEX project - "Investissements d'Avenir" French government program [ANR-11-IDEX-0001-02]; CNES at IRAP; LATMOS; LPC2E; Univers, Transport, Interfaces, Nanostructures, Atmosphere et Environnement, Molecules (UTINAM); CRPG; European Research Council [267255]; Ministry of Science; Israel Space agency; NASA [JPL-1266313]; NASA JPL [NAS703001TONMO710889]	State of Bern; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Space Agency PRODEX Program(European Space Agency); Max-Planck Society(Max Planck SocietyFoundation CELLEX); Bundesministerium fur Wirtschaft und Energie; Jet Propulsion Laboratory (JPL)(National Aeronautics & Space Administration (NASA)); Belgian Science Policy Office via PRODEX/ROSINA PEA; A*MIDEX project - "Investissements d'Avenir" French government program(French National Research Agency (ANR)); CNES at IRAP; LATMOS; LPC2E; Univers, Transport, Interfaces, Nanostructures, Atmosphere et Environnement, Molecules (UTINAM); CRPG; European Research Council(European Research Council (ERC)European Commission); Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Israel Space agency; NASA(National Aeronautics & Space Administration (NASA)); NASA JPL(National Aeronautics & Space Administration (NASA))	The authors thank the following institutions and agencies, which supported this work: Work at the University of Bern was funded by the State of Bern, the Swiss National Science Foundation, and the European Space Agency PRODEX Program. Work at the Max Planck Institute for Solar System Research was funded by the Max-Planck Society and Bundesministerium fur Wirtschaft und Energie under contract 50QP1302. Work at the Southwest Research Institute was supported by subcontract no. 1496541 from the Jet Propulsion Laboratory (JPL). Work at BIRA-IASB was supported by the Belgian Science Policy Office via PRODEX/ROSINA PEA 90020. This work has been carried out thanks to the support of the A*MIDEX project (no. ANR-11-IDEX-0001-02) funded by the "Investissements d'Avenir" French government program, managed by the French National Research Agency (ANR). This work was supported by CNES grants at IRAP; LATMOS; LPC2E; Univers, Transport, Interfaces, Nanostructures, Atmosphere et Environnement, Molecules (UTINAM); and CRPG and by the European Research Council (grant no. 267255 to B.M.). A.B.-N. thanks the Ministry of Science and the Israel Space agency. Work at the University of Michigan was funded by NASA under contract JPL-1266313. Work by J.H.W. at the Southwest Research Institute was funded by NASA JPL subcontract NAS703001TONMO710889. The results from ROSINA would not be possible without the work of the many engineers, technicians, and scientists involved in the mission, in the Rosetta spacecraft, and in the ROSINA instrument team over the past 20 years, whose contributions are gratefully acknowledged. We thank herewith the work of the whole European Space Agency (ESA) Rosetta team. Rosetta is an ESA mission with contributions from its member states and NASA. All ROSINA data are available on request until they are released to the Planetary Science Archive of ESA and the Planetary Data System archive of NASA.	Altwegg K, 2015, SCIENCE, V347, DOI 10.1126/science.1261952; Balsiger H, 2007, SPACE SCI REV, V128, P745, DOI 10.1007/s11214-006-8335-3; Bar-Nun A, 2007, ICARUS, V190, P655, DOI 10.1016/j.icarus.2007.03.021; Bockelee-Morvan D, 2004, SPACE SCI S, P391; Chick KM, 1997, ASTROPHYS J, V477, P398, DOI 10.1086/303700; Cochran AL, 2002, ASTROPHYS J, V576, pL165, DOI 10.1086/343763; Cochran AL, 2000, ICARUS, V146, P583, DOI 10.1006/icar.2000.6413; CRUIKSHANK DP, 1993, SCIENCE, V261, P742, DOI 10.1126/science.261.5122.742; EBERHARDT P, 1987, ASTRON ASTROPHYS, V187, P481; Fegley B.J., 1989, FORMATION EVOLUTION, P171; Glassmeier KH, 2007, SPACE SCI REV, V128, P1, DOI 10.1007/s11214-006-9140-8; Hassig M, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0276; Herri JM, 2012, PLANET SPACE SCI, V73, P376, DOI 10.1016/j.pss.2012.07.028; Iro N, 2003, ICARUS, V161, P511, DOI 10.1016/S0019-1035(02)00038-6; Korsun PP, 2014, ICARUS, V232, P88, DOI 10.1016/j.icarus.2014.01.006; KOUCHI A, 1994, ASTRON ASTROPHYS, V290, P1009; KRANKOWSKY D, 1986, NATURE, V321, P326, DOI 10.1038/321326a0; Lodders K., 2009, TEH SOLAR SYSTEM, V4B; LUNINE JI, 1985, ASTROPHYS J SUPPL S, V58, P493, DOI 10.1086/191050; Marty B, 2011, SCIENCE, V332, P1533, DOI 10.1126/science.1204656; Mousis O, 2014, PLANET SPACE SCI, V104, P29, DOI 10.1016/j.pss.2014.09.014; Mousis O, 2000, ICARUS, V148, P513, DOI 10.1006/icar.2000.6499; Mousis O, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/146; OWEN T, 1993, NATURE, V361, P693, DOI 10.1038/361693b0; OWEN TC, 1993, SCIENCE, V261, P745, DOI 10.1126/science.261.5122.745; Rousselot P, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/2/L17; Schlappi B, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015734; Sloan D. E., 2007, CLATHRATE HYDRATES N	28	159	160	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					232	235		10.1126/science.aaa6100	http://dx.doi.org/10.1126/science.aaa6100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25791084	Green Submitted			2022-12-28	WOS:000352613700045
J	Jiang, L; Kon, N; Li, TY; Wang, SJ; Su, T; Hibshoosh, H; Baer, R; Gu, W				Jiang, Le; Kon, Ning; Li, Tongyuan; Wang, Shang-Jui; Su, Tao; Hibshoosh, Hanina; Baer, Richard; Gu, Wei			Ferroptosis as a p53-mediated activity during tumour suppression	NATURE			English	Article							CELL-DEATH; CYSTINE/GLUTAMATE ANTIPORTER; P53-INDUCIBLE REGULATOR; METABOLIC-REGULATION; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; REACTIVE OXYGEN; SYSTEM X(C)(-); P53 FUNCTION; CANCER	Although p53-mediated cell-cycle arrest, senescence and apoptosis serve as critical barriers to cancer development, emerging evidence suggests that the metabolic activities of p53 are also important. Here we show that p53 inhibits cystine uptake and sensitizes cells to ferroptosis, a non-apoptotic form of cell death, by repressing expression of SLC7A11, a key component of the cystine/glutamate antiporter. Notably, p53(3KR), an acetylation-defective mutant that fails to induce cell-cycle arrest, senescence and apoptosis, fully retains the ability to regulate SLC7A11 expression and induce ferroptosis upon reactive oxygen species (ROS)-induced stress. Analysis of mutant mice shows that these non-canonical p53 activities contribute to embryonic development and the lethality associated with loss of Mdm2. Moreover, SLC7A11 is highly expressed in human tumours, and its overexpression inhibits ROS-induced ferroptosis and abrogates p53(3KR)-mediated tumour growth suppression in xenograft models. Our findings uncover a new mode of tumour suppression based on p53 regulation of cystine metabolism, ROS responses and ferroptosis.	[Jiang, Le; Kon, Ning; Li, Tongyuan; Wang, Shang-Jui; Baer, Richard; Gu, Wei] Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Su, Tao; Hibshoosh, Hanina; Baer, Richard; Gu, Wei] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Su, Tao; Hibshoosh, Hanina; Baer, Richard; Gu, Wei] Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu			National Cancer Institute of the National Institutes of Health [5R01CA172023, 5RO1CA166294, 5RO1CA169246, 5RO1CA085533, 2P01CA080058]; National Cancer Institute [2P01CA097403]; NIH cancer biology training grant [T32-CA09503]; NATIONAL CANCER INSTITUTE [R01CA169246, R01CA085533, T32CA009503, R01CA172023, R01CA166294, P01CA080058, R01CA172272, P01CA097403] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH cancer biology training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute of the National Institutes of Health under awards 5R01CA172023, 5RO1CA166294, 5RO1CA169246, 5RO1CA085533 and 2P01CA080058 to W.G. It was also supported by the National Cancer Institute under award 2P01CA097403 to R.B. and W.G. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. L.J. and S.-J.W. were supported by NIH cancer biology training grant T32-CA09503. We thank S. Mendrysa for Mdm2 mutant mice.	Aylon Y, 2011, CURR OPIN GENET DEV, V21, P86, DOI 10.1016/j.gde.2010.10.002; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chavez-Reyes A, 2003, CANCER RES, V63, P8664; Cheung EC, 2013, DEV CELL, V25, P463, DOI 10.1016/j.devcel.2013.05.001; Cheung EC, 2012, P NATL ACAD SCI USA, V109, P20491, DOI 10.1073/pnas.1206530109; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Gannon Hugh S, 2012, Genes Cancer, V3, P209, DOI 10.1177/1947601912455324; Guo WJ, 2011, CANCER LETT, V312, P55, DOI 10.1016/j.canlet.2011.07.024; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Huang Y, 2005, CANCER RES, V65, P7446, DOI 10.1158/0008-5472.CAN-04-4267; Hughes RH, 2014, BRAIN RES, V1543, P308, DOI 10.1016/j.brainres.2013.11.020; Jackson JG, 2013, ONCOGENE, V32, P4325, DOI 10.1038/onc.2012.610; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liang YJ, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-9; Liu XX, 2011, FEBS LETT, V585, P1363, DOI 10.1016/j.febslet.2011.04.018; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; Lu M, 2013, CANCER CELL, V23, P618, DOI 10.1016/j.ccr.2013.03.013; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Sato H, 2000, ANTIOXID REDOX SIGN, V2, P665, DOI 10.1089/ars.2000.2.4-665; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Valente LJ, 2013, CELL REP, V3, P1339, DOI 10.1016/j.celrep.2013.04.012; Vu BT, 2011, CURR TOP MICROBIOL, V348, P151, DOI 10.1007/82_2010_110; Wade M, 2009, MOL CANCER RES, V7, P1, DOI 10.1158/1541-7786.MCR-08-0423; Wang PY, 2013, NEW ENGL J MED, V368, P1027, DOI 10.1056/NEJMoa1214091; Wang SJ, 2014, CURR OPIN ONCOL, V26, P78, DOI 10.1097/CCO.0000000000000024; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zheng H, 2013, MOL CELL, V50, P699, DOI 10.1016/j.molcel.2013.04.013	40	1221	1283	80	797	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					57	+		10.1038/nature14344	http://dx.doi.org/10.1038/nature14344			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25799988	Green Accepted			2022-12-28	WOS:000352027700035
J	Roth, GA; Forouzanfar, MH; Moran, AE; Barber, R; Nguyen, G; Feigin, VL; Naghavi, M; Mensah, GA; Murray, CJL				Roth, Gregory A.; Forouzanfar, Mohammad H.; Moran, Andrew E.; Barber, Ryan; Nguyen, Grant; Feigin, Valery L.; Naghavi, Mohsen; Mensah, George A.; Murray, Christopher J. L.			Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE; DEATH; COUNTRIES; BURDEN	BACKGROUND Global deaths from cardiovascular disease are increasing as a result of population growth, the aging of populations, and epidemiologic changes in disease. Disentangling the effects of these three drivers on trends in mortality is important for planning the future of the health care system and benchmarking progress toward the reduction of cardiovascular disease. METHODS We used mortality data from the Global Burden of Disease Study 2013, which includes data on 188 countries grouped into 21 world regions. We developed three counterfactual scenarios to represent the principal drivers of change in cardiovascular deaths (population growth alone, population growth and aging, and epidemiologic changes in disease) from 1990 to 2013. Secular trends and correlations with changes in national income were examined. RESULTS Global deaths from cardiovascular disease increased by 41% between 1990 and 2013 despite a 39% decrease in age-specific death rates; this increase was driven by a 55% increase in mortality due to the aging of populations and a 25% increase due to population growth. The relative contributions of these drivers varied by region; only in Central Europe and Western Europe did the annual number of deaths from cardiovascular disease actually decline. Change in gross domestic product per capita was correlated with change in age-specific death rates only among upper-middle income countries, and this correlation was weak; there was no significant correlation elsewhere. CONCLUSIONS The aging and growth of the population resulted in an increase in global cardiovascular deaths between 1990 and 2013, despite a decrease in age-specific death rates in most regions. Only Central and Western Europe had gains in cardiovascular health that were sufficient to offset these demographic forces.	[Roth, Gregory A.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98121 USA; [Roth, Gregory A.; Forouzanfar, Mohammad H.; Barber, Ryan; Nguyen, Grant; Naghavi, Mohsen; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Moran, Andrew E.] Columbia Univ, Dept Med, Div Gen Med, New York, NY USA; [Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Sci, Auckland, New Zealand; [Mensah, George A.] NHLBI, Ctr Translat Res & Implementat Sci, NIH, Bethesda, MD 20892 USA	University of Washington; University of Washington Seattle; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Columbia University; Auckland University of Technology; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Roth, GA (corresponding author), Univ Washington, Dept Med, Div Cardiol, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	rothg@uw.edu	Feigin, Valery/AAF-2313-2019	Feigin, Valery L./0000-0002-6372-1740	Bill and Melinda Gates Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089675] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the Bill and Melinda Gates Foundation and others.	Beaglehole R, 2012, LANCET, V380, P1283, DOI 10.1016/S0140-6736(12)61692-4; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; James SL, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-12; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; O'Flaherty M, 2013, HEART, V99, P159, DOI 10.1136/heartjnl-2012-302300; Reddy KS, 1998, CIRCULATION, V97, P596; Shorrocks AF, 2013, J ECON INEQUAL, V11, P99, DOI 10.1007/s10888-011-9214-z; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	13	640	668	2	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14					1333	1341		10.1056/NEJMoa1406656	http://dx.doi.org/10.1056/NEJMoa1406656			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NL	25830423	Green Accepted			2022-12-28	WOS:000352028500008
J	Zabow, G; Dodd, SJ; Koretsky, AP				Zabow, G.; Dodd, S. J.; Koretsky, A. P.			Shape-changing magnetic assemblies as high-sensitivity NMR-readable nanoprobes	NATURE			English	Article							INTRACELLULAR PH; RESPONSIVE HYDROGEL; MULTISPECTRAL MRI; CONTRAST AGENTS; PARACEST AGENTS; RESONANCE; COMPLEXES; BIOLOGY; PROBES	Fluorescent and plasmonic labels and sensors have revolutionized molecular biology, helping visualize cellular and biomolecular processes(1-3). Increasingly, such probes are now being designed to respond to wavelengths in the near-infrared region, where reduced tissue autofluorescence and photon attenuation enable subsurface in vivo sensing(4). But even in the near-infrared region, optical resolution and sensitivity decrease rapidly with increasing depth. Here we present a sensor design that obviates the need for optical addressability by operating in the nuclear magnetic resonance (NMR) radio-frequency spectrum, where signal attenuation and distortion by tissue and biological media are negligible, where background interferences vanish, and where sensors can be spatially located using standard magnetic resonance imaging(MRI) equipment. The radio-frequency-addressable sensor assemblies presented here comprise pairs of magnetic disks spaced by swellable hydrogel material; they reversibly reconfigure in rapid response to chosen stimuli, to give geometry-dependent, dynamic NMR spectral signatures. The sensors can be made from biocompatible materials, are themselves detectable down to low concentrations, and offer potential responsive NMR spectral shifts that are close to a million times greater than those of traditional magnetic resonance spectroscopies. Inherent adaptability should allow such shape-changing systems to measure numerous different environmental and physiological indicators, thus providing broadly generalizable, MRI-compatible, radio-frequency analogues to optically based probes for use in basic chemical, biological, medical and engineering research.	[Zabow, G.; Dodd, S. J.; Koretsky, A. P.] NINDS, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA; [Zabow, G.] NIST, Electromagnet Div, Phys Measurements Lab, Boulder, CO 80305 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of Standards & Technology (NIST) - USA	Zabow, G (corresponding author), NINDS, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA.	gary.zabow@nist.gov	Koretsky, Alan P/C-7940-2015	Koretsky, Alan P/0000-0002-8085-4756; Zabow, Gary/0000-0002-1421-8540	NIH NINDS Intramural Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003047] Funding Source: NIH RePORTER	NIH NINDS Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the NIH NINDS Intramural Research Program. We thank the NIH Mouse Imaging Facility for use of their 14 T MRI, Y. Chen for providing the MDCK cells, and J. Moreland for discussion and NIST Boulder cleanroom access.	Aime S, 2003, ANGEW CHEM INT EDIT, V42, P4527, DOI 10.1002/anie.200352132; Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Byrne ME, 2002, ADV DRUG DELIVER REV, V54, P149, DOI 10.1016/S0169-409X(01)00246-0; DECKER C, 1985, MACROMOLECULES, V18, P1241, DOI 10.1021/ma00148a034; FISCHELGHODSIAN F, 1988, P NATL ACAD SCI USA, V85, P2403, DOI 10.1073/pnas.85.7.2403; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; GRAD J, 1990, J MAGN RESON, V90, P1, DOI 10.1016/0022-2364(90)90361-C; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029; Jindal AK, 2010, J AM CHEM SOC, V132, P1784, DOI 10.1021/ja910278e; Jorjani P, 1999, BIOTECHNOL BIOENG, V64, P349, DOI 10.1002/(SICI)1097-0290(19990805)64:3<349::AID-BIT11>3.0.CO;2-V; Kabiri K, 2008, J APPL POLYM SCI, V110, P3420, DOI 10.1002/app.28148; Madou M. J, 2002, FUNDAMENTALS MICROFA, V2nd; Martinez GV, 2011, NMR BIOMED, V24, P1380, DOI 10.1002/nbm.1701; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619; MOON RB, 1973, J BIOL CHEM, V248, P7276; PAN JW, 1988, P NATL ACAD SCI USA, V85, P7836, DOI 10.1073/pnas.85.21.7836; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Plunkett KN, 2005, BIOMACROMOLECULES, V6, P632, DOI 10.1021/bm049349v; Schroder L, 2006, SCIENCE, V314, P446, DOI 10.1126/science.1131847; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; TAYLOR JS, 1983, BIOPHYS J, V43, P261, DOI 10.1016/S0006-3495(83)84349-5; Ulijn RV, 2007, MATER TODAY, V10, P40, DOI 10.1016/S1369-7021(07)70049-4; Wang CS, 2014, SENSOR ACTUAT B-CHEM, V196, P670, DOI 10.1016/j.snb.2014.01.096; Wang XF, 2013, CARDIOLOGY, V126, P110; Ward KM, 2000, MAGN RESON MED, V44, P799, DOI 10.1002/1522-2594(200011)44:5<799::AID-MRM18>3.0.CO;2-S; Woods M, 2006, CHEM SOC REV, V35, P500, DOI 10.1039/b509907m; Wu YK, 2008, J AM CHEM SOC, V130, P13854, DOI 10.1021/ja805775u; Wu YK, 2010, J AM CHEM SOC, V132, P14002, DOI 10.1021/ja106018n; Yoo B, 2008, FRONT BIOSCI-LANDMRK, V13, P1733, DOI 10.2741/2796; Yoon JW, 2010, SOFT MATTER, V6, P6004, DOI 10.1039/c0sm00434k; Zabow G, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/38/385301; Zabow G, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/2/025020; Zabow G, 2008, NATURE, V453, P1058, DOI 10.1038/nature07048; Zabow G, 2014, SMALL, V10, P1902, DOI 10.1002/smll.201303045; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhang J., 2003, NAT REV MOL CELL BIO, V4, P80	39	42	47	5	289	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					73	U157		10.1038/nature14294	http://dx.doi.org/10.1038/nature14294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25778701	Green Accepted			2022-12-28	WOS:000352027700039
J	Holmes, J; Angus, C; Meier, PS				Holmes, John; Angus, Colin; Meier, Petra S.			UK alcohol industry's "billion units pledge": interim evaluation flawed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Holmes, John; Angus, Colin] Univ Sheffield, Sch Hlth & Related Res, Sheffield Alcohol Res Grp, Sheffield S1 4DA, S Yorkshire, England; [Meier, Petra S.] Univ Sheffield, Sch Hlth & Related Res, Sheffield Alcohol Res Grp, Publ Hlth, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield; University of Sheffield	Angus, C (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield Alcohol Res Grp, Sheffield S1 4DA, S Yorkshire, England.	c.r.angus@sheffield.ac.uk	Meier, Petra/P-7504-2019; Angus, Colin/AAT-2786-2020; Meier, Petra S/L-7387-2017	Meier, Petra/0000-0001-5354-1933; Angus, Colin/0000-0003-0529-4135; Meier, Petra S/0000-0001-5354-1933; Holmes, John/0000-0001-9283-2151	Medical Research Council [MR/K023195/1B, G1000043, MR/K023195/1] Funding Source: researchfish; MRC [G1000043] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2012, GUARDIAN; British Beer and Pub Association, 2014, STATISTICAL HANDBOOK; Department of Health, 2014, LIVING WELL FOR LONG; Department of Health, 2014, RESPONSIBILITY DEAL; Department of Health, 2011, THE PUBLIC HEALTH RE; Department of Health, 2014, ALCOHOL UNIT REDUCTI; Department of Health, 2015, ALCOHOL UNIT REDUCTI; Department of Health, 2014, FIRST INTERIM MONITO; HM Government, 2012, THE GOVERNMENTS ALCO; HMRC, 2012, ALCOHOL FACT SHEET 2; HMRC, 2014, ALCOHOL DUTY; HMRC, ALCOHOL FACTSHEET 20; Home Office, 2013, NEXT STEPS FOLLOWING; Jones L, 2012, CAN PROMOTION OF LOW; Meng Y, 2014, ADDICTION, V109, P206, DOI 10.1111/add.12330; NHS Health Scotland, 2012, MONITORING AND EVALU; Patrick AO, 2008, WALL STREET JOURNAL	17	12	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2015	350								h1301	10.1136/bmj.h1301	http://dx.doi.org/10.1136/bmj.h1301			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NO	25810497	Green Accepted			2022-12-28	WOS:000352028800004
J	Boltasseva, A; Shalaev, VM				Boltasseva, Alexandra; Shalaev, Vladimir M.			All that glitters need not be gold	SCIENCE			English	Editorial Material							METAMATERIALS; PLASMONICS		[Boltasseva, Alexandra; Shalaev, Vladimir M.] Purdue Univ, Birck Nanotechnol Ctr, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Boltasseva, Alexandra; Shalaev, Vladimir M.] Nanometa Technol Inc, W Lafayette, IN 47906 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Boltasseva, A (corresponding author), Purdue Univ, Birck Nanotechnol Ctr, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA.	aeb@purdue.edu	Boltasseva, Alexandra/C-1674-2019; Shalaev, Vladimir M./B-9331-2019	Boltasseva, Alexandra/0000-0001-8905-2605; Shalaev, Vladimir M./0000-0001-8976-1102	AFOSR MURI [123885-5079396]; ARO [W911 NF-13-1-0226]; NSF [DMR-1120923]	AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); ARO; NSF(National Science Foundation (NSF))	We thank A. Kildishev, U. Guler, and R. T. Bonnecaze for fruitful discussions. Support from AFOSR MURI grant 123885-5079396, ARO grant W911 NF-13-1-0226, and NSF grant DMR-1120923.	Atwater HA, 2007, SCI AM, V296, P56, DOI 10.1038/scientificamerican0407-56; Boltasseva A, 2011, SCIENCE, V331, P290, DOI 10.1126/science.1198258; Boyd DA, 2006, NANO LETT, V6, P2592, DOI 10.1021/nl062061m; Challener WA, 2009, NAT PHOTONICS, V3, P220, DOI 10.1038/NPHOTON.2009.26; Clavero C, 2014, NAT PHOTONICS, V8, P95, DOI [10.1038/nphoton.2013.238, 10.1038/NPHOTON.2013.238]; Fan SH, 2014, NAT NANOTECHNOL, V9, P92, DOI 10.1038/nnano.2014.9; Guler U, 2015, MATER TODAY, V18, P227, DOI 10.1016/j.mattod.2014.10.039; Guler U, 2014, SCIENCE, V344, P263, DOI 10.1126/science.1252722; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Kraemer D, 2011, NAT MATER, V10, P532, DOI [10.1038/NMAT3013, 10.1038/nmat3013]; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Zheludev NI, 2012, NAT MATER, V11, P917, DOI [10.1038/NMAT3431, 10.1038/nmat3431]	12	51	51	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1308	1310		10.1126/science.aaa8282	http://dx.doi.org/10.1126/science.aaa8282			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6SM	25792313				2022-12-28	WOS:000351219600017
J	Sada, N; Lee, S; Katsu, T; Otsuki, T; Inoue, T				Sada, Nagisa; Lee, Suni; Katsu, Takashi; Otsuki, Takemi; Inoue, Tsuyoshi			Targeting LDH enzymes with a stiripentol analog to treat epilepsy	SCIENCE			English	Article							KETOGENIC DIET; ANTIEPILEPTIC DRUG; BRAIN; NEURONS; METABOLISM; TRANSPORT; GLUCOSE	Neuronal excitation is regulated by energy metabolism, and drug-resistant epilepsy can be suppressed by special diets. Here, we report that seizures and epileptiform activity are reduced by inhibition of the metabolic pathway via lactate dehydrogenase (LDH), a component of the astrocyte-neuron lactate shuttle. Inhibition of the enzyme LDH hyperpolarized neurons, which was reversed by the downstream metabolite pyruvate. LDH inhibition also suppressed seizures in vivo in a mouse model of epilepsy. We further found that stiripentol, a clinically used antiepileptic drug, is an LDH inhibitor. By modifying its chemical structure, we identified a previously unknown LDH inhibitor, which potently suppressed seizures in vivo. We conclude that LDH inhibitors are a promising new group of antiepileptic drugs.	[Sada, Nagisa; Katsu, Takashi; Inoue, Tsuyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biophys Chem, Okayama 7008530, Japan; [Lee, Suni; Otsuki, Takemi] Kawasaki Med Sch, Dept Hyg, Kurashiki, Okayama 7010192, Japan	Okayama University; Kawasaki Medical School	Inoue, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biophys Chem, Okayama 7008530, Japan.	tinoue@pharm.okayama-u.ac.jp	INOUE, Tsuyoshi/B-1604-2011		Japan Society for the Promotion of Science [24590114]; Takeda Science Foundation; Ryobi-Teien Memory Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ryobi-Teien Memory Foundation(Ryobi Teien Memory Foundation)	We thank K. Imoto for comments on this manuscript, D. Kase for technical advice on in vivo recordings at the initial stage, and A. Wakasa and K. Urakawa for their technical support on the intrahippocampal kainate model. N.S., S.L., T.O., and T.I. are inventors on a patent (World Intellectual Property Organization WO2014/115764) related to clinical use of stiripentol as LDH inhibitors, and N.S. and T.I. are also inventors on a patent (Japan JP2015-023572) related to isosafrole as antiepileptic compounds. These patent applications have been filed by Okayama University. All data described in the paper are presented in this report and supplementary materials. This work was supported by grants from the Japan Society for the Promotion of Science (24590114) and by research grants from Takeda Science Foundation and Ryobi-Teien Memory Foundation.	Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899; Caraballo RH, 2005, EPILEPSIA, V46, P1539, DOI 10.1111/j.1528-1167.2005.05705.x; Chiron C, 2000, LANCET, V356, P1638, DOI 10.1016/S0140-6736(00)03157-3; Cunningham MO, 2006, P NATL ACAD SCI USA, V103, P5597, DOI 10.1073/pnas.0600604103; D'Ambrosio R, 1998, J NEUROSCI, V18, P4425; Deck LM, 1998, J MED CHEM, V41, P3879, DOI 10.1021/jm980334n; Dybdal D, 2000, J NEUROSCI, V20, P6728, DOI 10.1523/JNEUROSCI.20-17-06728.2000; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Granchi C, 2011, J MED CHEM, V54, P1599, DOI 10.1021/jm101007q; IADAROLA MJ, 1982, SCIENCE, V218, P1237, DOI 10.1126/science.7146907; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Lutas A, 2013, TRENDS NEUROSCI, V36, P32, DOI 10.1016/j.tins.2012.11.005; Ma WY, 2007, J NEUROSCI, V27, P3618, DOI 10.1523/JNEUROSCI.0132-07.2007; Masino SA, 2011, J CLIN INVEST, V121, P2679, DOI 10.1172/JCI57813; Meldrum BS, 2007, NEUROTHERAPEUTICS, V4, P18, DOI 10.1016/j.nurt.2006.11.010; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Parsons MP, 2010, J NEUROSCI, V30, P8061, DOI 10.1523/JNEUROSCI.5741-09.2010; Quilichini PP, 2006, EPILEPSIA, V47, P704, DOI 10.1111/j.1528-1167.2006.00497.x; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Samala R, 2011, NEUROCHEM INT, V58, P5, DOI 10.1016/j.neuint.2010.10.011; Shimizu H, 2007, NEURON, V54, P59, DOI 10.1016/j.neuron.2007.03.014; SILVER IA, 1994, J NEUROSCI, V14, P5068; Song ZT, 2001, DIABETES, V50, P2673, DOI 10.2337/diabetes.50.12.2673; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tanner GR, 2011, J NEUROSCI, V31, P8689, DOI 10.1523/JNEUROSCI.5951-10.2011; Trojnar MK, 2005, PHARMACOL REP, V57, P154	30	224	230	9	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1362	1367		10.1126/science.aaa1299	http://dx.doi.org/10.1126/science.aaa1299			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792327				2022-12-28	WOS:000351219600042
J	Hedin, LO				Hedin, Lars O.			BIOGEOCHEMISTRY Signs of saturation in the tropical carbon sink	NATURE			English	Editorial Material							NITROGEN; LAND		Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA	Princeton University	Hedin, LO (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA.	lhedin@princeton.edu						Arrhenius S., 1896, LOND EDINB DUBLIN PH, V41, P237, DOI [10.1080/14786449608620846, DOI 10.1080/14786449608620846]; Ballantyne AP, 2012, NATURE, V488, P70, DOI 10.1038/nature11299; Batterman SA, 2013, NATURE, V502, P224, DOI 10.1038/nature12525; Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; Clark DA, 2013, J GEOPHYS RES-BIOGEO, V118, P783, DOI 10.1002/jgrg.20067; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Gatti LV, 2014, NATURE, V506, P76, DOI 10.1038/nature12957; Gerber S, 2013, GEOPHYS RES LETT, V40, P5218, DOI 10.1002/grl.50957; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Lambers H, 2009, PLANT SOIL, V321, P83, DOI 10.1007/s11104-009-0042-x; Le Quere C, 2013, EARTH SYST SCI DATA, V5, P165, DOI 10.5194/essd-5-165-2013; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609	12	5	5	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					295	296		10.1038/519295a	http://dx.doi.org/10.1038/519295a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25788092				2022-12-28	WOS:000351171900026
J	Miller, LG; Daum, RS; Creech, CB; Young, D; Downing, MD; Eells, SJ; Pettibone, S; Hoagland, RJ; Chambers, HF				Miller, Loren G.; Daum, Robert S.; Creech, C. Buddy; Young, David; Downing, Michele D.; Eells, Samantha J.; Pettibone, Stephanie; Hoagland, Rebecca J.; Chambers, Henry F.		DMID 07-0051 Team	Clindamycin versus Trimethoprim-Sulfamethoxazole for Uncomplicated Skin Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAPHYLOCOCCUS-AUREUS SKIN; SOFT-TISSUE INFECTIONS; RESISTANT; PREVENTION; STRATEGIES; CELLULITIS; MANAGEMENT; CHILDREN; VISITS; ADULT	BACKGROUND Skin and skin-structure infections are common in ambulatory settings. However, the efficacy of various antibiotic regimens in the era of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) is unclear. METHODS We enrolled outpatients with uncomplicated skin infections who had cellulitis, abscesses larger than 5 cm in diameter (smaller for younger children), or both. Patients were enrolled at four study sites. All abscesses underwent incision and drainage. Patients were randomly assigned in a 1: 1 ratio to receive either clindamycin or trimethoprim-sulfamethoxazole (TMP-SMX) for 10 days. Patients and investigators were unaware of the treatment assignments and microbiologic test results. The primary outcome was clinical cure 7 to 10 days after the end of treatment. RESULTS A total of 524 patients were enrolled (264 in the clindamycin group and 260 in the TMP-SMX group), including 155 children (29.6%). One hundred sixty patients (30.5%) had an abscess, 280 (53.4%) had cellulitis, and 82 (15.6%) had mixed infection, defined as at least one abscess lesion and one cellulitis lesion. S. aureus was isolated from the lesions of 217 patients (41.4%); the isolates in 167 (77.0%) of these patients were MRSA. The proportion of patients cured was similar in the two treatment groups in the intention-to-treat population (80.3% in the clindamycin group and 77.7% in the TMP-SMX group; difference, -2.6 percentage points; 95% confidence interval [ CI], -10.2 to 4.9; P = 0.52) and in the populations of patients who could be evaluated (466 patients; 89.5% in the clindamycin group and 88.2% in the TMP-SMX group; difference, -1.2 percentage points; 95% CI, -7.6 to 5.1; P = 0.77). Cure rates did not differ significantly between the two treatments in the subgroups of children, adults, and patients with abscess versus cellulitis. The proportion of patients with adverse events was similar in the two groups. CONCLUSIONS We found no significant difference between clindamycin and TMP-SMX, with respect to either efficacy or side-effect profile, for the treatment of uncomplicated skin infections, including both cellulitis and abscesses.	[Miller, Loren G.; Eells, Samantha J.] Harbor UCLA Univ Calif Los Angeles Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA USA; [Miller, Loren G.; Eells, Samantha J.] Harbor UCLA Univ Calif Los Angeles Med Ctr, Div Infect Dis, Torrance, CA USA; [Miller, Loren G.; Eells, Samantha J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Young, David] Univ Calif San Francisco, Div Plast & Reconstruct Surg, San Francisco, CA 94143 USA; [Downing, Michele D.; Chambers, Henry F.] San Francisco Gen Hosp, Div Infect Dis, San Francisco, CA 94110 USA; [Downing, Michele D.; Chambers, Henry F.] UCSF, San Francisco, CA USA; [Daum, Robert S.] Univ Chicago, Div Pediat Infect Dis, Chicago, IL 60637 USA; [Creech, C. Buddy] Vanderbilt Univ, Div Pediat Infect Dis, Nashville, TN 37235 USA; [Pettibone, Stephanie] EMMES Corp, Rockville, MD USA; [Hoagland, Rebecca J.] Cota Enterprises, Meriden, KS USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Chicago; Vanderbilt University; Emmes Corporation	Miller, LG (corresponding author), Harbor UCLA Med Ctr, Div Infect Dis, 1000 W Carson St,Box 466, Torrance, CA 90509 USA.	lgmiller@ucla.edu	Rodriguez, Renee/GYR-1896-2022	Self, Wesley/0000-0002-9300-3045; Rodriguez, Robert/0000-0003-1354-1773	National Institute of Allergy and Infectious Diseases; National Center for Advancing Translational Sciences, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funded by the National Institute of Allergy and Infectious Diseases and the National Center for Advancing Translational Sciences, National Institutes of Health; ClinicalTrials.gov number, NCT00730028.	Bowen AC, 2012, J CLIN MICROBIOL, V50, P4067, DOI 10.1128/JCM.02195-12; Carratala J, 2003, EUR J CLIN MICROBIOL, V22, P151, DOI 10.1007/s10096-003-0902-x; Chen CJ, 2005, PEDIATR INFECT DIS J, V24, P40, DOI 10.1097/01.inf.0000148926.11227.1c; Chira S, 2010, EPIDEMIOL INFECT, V138, P313, DOI 10.1017/S0950268809990483; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2013, GUID IND AC BACT SKI; Edelsberg J, 2009, EMERG INFECT DIS, V15, P1516, DOI 10.3201/eid1509.081228; Eells SJ, 2011, EPIDEMIOL INFECT, V139, P606, DOI 10.1017/S0950268810001408; Fritz SA, 2012, CLIN INFECT DIS, V54, P743, DOI 10.1093/cid/cir919; Gorwitz RJ., 2006, STRATEGIES CLIN MANA; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Ho Joanne M-W, 2011, CMAJ, V183, P1851, DOI 10.1503/cmaj.111152; Hyun DY, 2009, PEDIATR INFECT DIS J, V28, P57, DOI 10.1097/INF.0b013e3181826e5e; Itani KMF, 2014, CLIN INFECT DIS, V58, pS4, DOI 10.1093/cid/cit612; Jeng A, 2010, MEDICINE, V89, P217, DOI 10.1097/MD.0b013e3181e8d635; Kyne L, 2002, INFECT CONT HOSP EP, V23, P653, DOI 10.1086/501989; Lee MC, 2004, PEDIATR INFECT DIS J, V23, P123, DOI 10.1097/01.inf.0000109288.06912.21; Lipsky BA, 2010, INFECT CONT HOSP EP, V31, P828, DOI 10.1086/654007; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Mascitti KB, 2010, AM J INFECT CONTROL, V38, P324, DOI 10.1016/j.ajic.2009.11.007; Miller LG, 2011, 51 ANN INT C ANT AG; Miller LG, 2012, ANTIMICROB AGENTS CH, V56, P1084, DOI 10.1128/AAC.01608-10; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Pallin DJ, 2008, ANN EMERG MED, V51, P291, DOI 10.1016/j.annemergmed.2007.12.004; Pallin DJ, 2013, CLIN INFECT DIS, V56, P1754, DOI 10.1093/cid/cit122; Ray GT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-252; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; Wikler M.A., 2012, CLIN LAB STANDARDS I, V26, pM07; Williams DJ, 2011, PEDIATRICS, V128, pE479, DOI 10.1542/peds.2010-3681	30	115	120	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2015	372	12					1093	1103		10.1056/NEJMoa1403789	http://dx.doi.org/10.1056/NEJMoa1403789			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EZ	25785967	Green Accepted			2022-12-28	WOS:000351183600004
J	Jones, P				Jones, Paul			Review: <= 7 and > 7 days of systemic corticosteroids do not differ for efficacy in COPD exacerbations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									St Georges Univ London, London, England	St Georges University London	Jones, P (corresponding author), St Georges Univ London, London, England.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6							JC7	10.7326/ACPJC-2015-162-6-007	http://dx.doi.org/10.7326/ACPJC-2015-162-6-007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775350				2022-12-28	WOS:000351279600006
J	Jha, P				Jha, Prabhat			Deaths and taxes: stronger global tobacco control by 2025	LANCET			English	Editorial Material							MORTALITY; SMOKING		[Jha, Prabhat] Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada.	prabhat.jha@utoronto.ca		Jha, Prabhat/0000-0001-7067-8341				Alam DS, 2013, B WORLD HEALTH ORGAN, V91, P757, DOI 10.2471/BLT.13.120196; Arora P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002724; Cancer Research UK, 2015, PLAIN PACK CAMP SETT; Gilmore AB, 2015, LANCET, V385, P1029, DOI 10.1016/S0140-6736(15)60312-9; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; International Agency for Research on Cancer, 2011, EFF TAX PRIC POL TOB; Jha P, CANC DIS CO IN PRESS; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Mukherjee W, 2015, EC TIMES INDIA  0228; Sitas F, 2013, LANCET, V382, P685, DOI 10.1016/S0140-6736(13)61610-4; Smith M, 2013, INT J EPIDEMIOL, V42, P803, DOI 10.1093/ije/dyt079; WHO, 2010, WHO TECHNICAL MANUAL ON TOBACCO TAX ADMINISTRARTION, P1; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP	14	12	12	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					918	920		10.1016/S0140-6736(15)60464-0	http://dx.doi.org/10.1016/S0140-6736(15)60464-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD2EK	25784330				2022-12-28	WOS:000350886900006
J	Dudley, RWR; Smith, C; Dishop, M; Mirsky, D; Handler, MH; Rao, S				Dudley, Roy W. R.; Smith, Christiana; Dishop, Megan; Mirsky, David; Handler, Michael H.; Rao, Suchitra			A cervical spine mass caused by Onchocerca lupi	LANCET			English	Editorial Material									[Dudley, Roy W. R.] Montreal Childrens Hosp, Dept Pediat Surg, Div Neurosurg, Montreal, PQ H3H 1P3, Canada; [Smith, Christiana; Rao, Suchitra] Univ Colorado, Dept Infect Dis, Aurora, CO USA; [Dishop, Megan] Univ Colorado, Dept Pathol, Aurora, CO USA; [Mirsky, David] Univ Colorado, Dept Radiol, Aurora, CO USA; [Handler, Michael H.] Univ Colorado, Dept Neurosurg, Aurora, CO USA; [Rao, Suchitra] Univ Colorado, Dept Hosp Med, Aurora, CO USA; Childrens Hosp Colorado, Aurora, CO USA	McGill University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Dudley, RWR (corresponding author), Montreal Childrens Hosp, Dept Pediat Surg, Div Neurosurg, 2300 Tupper St, Montreal, PQ H3H 1P3, Canada.	roy.dudley@mail.mcgill.ca	Rao, Suchitra/U-2745-2019; Smith, Christiana/AAK-7917-2020	Rao, Suchitra/0000-0002-0334-6301; 					0	23	23	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1372	1372		10.1016/S0140-6736(14)62255-8	http://dx.doi.org/10.1016/S0140-6736(14)62255-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8DP	25843892	Bronze			2022-12-28	WOS:000362316200030
J	Mack, MJ; Leon, MB; Smith, CR; Miller, DC; Moses, JW; Tuzcu, EM; Webb, JG; Douglas, PS; Anderson, WN; Blackstone, EH; Kodali, SK; Makkar, RR; Fontana, GP; Kapadia, S; Bavaria, J; Hahn, RT; Thourani, VH; Babaliaros, V; Pichard, A; Herrmann, HC; Brown, DL; Williams, M; Akin, J; Davidson, MJ; Svensson, LG				Mack, Michael J.; Leon, Martin B.; Smith, Craig R.; Miller, D. Craig; Moses, Jeffrey W.; Tuzcu, E. Murat; Webb, John G.; Douglas, Pamela S.; Anderson, William N.; Blackstone, Eugene H.; Kodali, Susheel K.; Makkar, Raj R.; Fontana, Gregory P.; Kapadia, Samir; Bavaria, Joseph; Hahn, Rebecca T.; Thourani, Vinod H.; Babaliaros, Vasilis; Pichard, Augusto; Herrmann, Howard C.; Brown, David L.; Williams, Mathew; Akin, Jodi; Davidson, Michael J.; Svensson, Lars G.		PARTNER 1 Trial Investigators	5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial	LANCET			English	Article							LONG-TERM OUTCOMES; IMPLANTATION IMPACT; INOPERABLE PATIENTS; SAPIEN 3; REGURGITATION; MULTICENTER; DURABILITY; TAVR	Background The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that mortality at 1 year, 2 years, and 3 years is much the same with transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) for high-risk patients with aortic stenosis. We report here the 5-year outcomes. Methods We did this randomised controlled trial at 25 hospitals, in Canada (two), Germany (one), and the USA (23). We used a computer-generated randomisation sequence to randomly assign high-risk patients with severe aortic stenosis to either SAVR or TAVR with a balloon-expandable bovine pericardial tissue valve by either a transfemoral or transapical approach. Patients and their treating physicians were not masked to treatment allocation. The primary outcome of the trial was all-cause mortality in the intention-to-treat population at 1 year, we present here predefined outcomes at 5 years. The study is registered with ClinicalTrials.gov, number NCT00530894. Findings We screened 3105 patients, of whom 699 were enrolled (348 assigned to TAVR, 351 assigned to SAVR). Overall mean Society of Thoracic Surgeons Predicted Risk of Mortality score was 11.7%. At 5 years, risk of death was 67.8% in the TAVR group compared with 62.4% in the SAVR group (hazard ratio 1.04, 95% CI 0.86-1.24; p = 0.76). We recorded no structural valve deterioration requiring surgical valve replacement in either group. Moderate or severe aortic regurgitation occurred in 40 (14%) of 280 patients in the TAVR group and two (1%) of 228 in the SAVR group (p < 0.0001), and was associated with increased 5-year risk of mortality in the TAVR group (72.4% for moderate or severe aortic regurgitation vs 56.6% for those with mild aortic regurgitation or less; p = 0.003). Interpretation Our findings show that TAVR as an alternative to surgery for patients with high surgical risk results in similar clinical outcomes. Funding Edwards Lifesciences.	[Mack, Michael J.] Baylor Scott & White Hlth, Plano, TX USA; [Leon, Martin B.; Smith, Craig R.; Moses, Jeffrey W.; Kodali, Susheel K.; Hahn, Rebecca T.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Miller, D. Craig] Stanford Univ, Sch Med, Dept Cardiovasc Surg, Falk CV Res Ctr, Stanford, CA 94305 USA; [Tuzcu, E. Murat; Blackstone, Eugene H.; Kapadia, Samir; Svensson, Lars G.] Cleveland Clin, Cleveland, OH 44106 USA; [Webb, John G.] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Douglas, Pamela S.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Makkar, Raj R.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Fontana, Gregory P.] Lenox Hill Hosp, New York, NY 10021 USA; [Bavaria, Joseph; Herrmann, Howard C.] Univ Penn, Philadelphia, PA 19104 USA; [Thourani, Vinod H.; Babaliaros, Vasilis] Emory Univ, Sch Med, Atlanta, GA USA; [Pichard, Augusto] Medstar Washington Hosp Ctr, Washington, DC USA; [Brown, David L.] Heart Hosp, Plano, TX USA; [Williams, Mathew] NYU Langone Med Ctr, New York, NY USA; [Davidson, Michael J.] Brigham & Womens Hosp, Boston, MA 02115 USA	Baylor Health Care System; Columbia University; NewYork-Presbyterian Hospital; Stanford University; Cleveland Clinic Foundation; St. Paul's Hospital; University of Saskatchewan; Duke University; Cedars Sinai Medical Center; Northwell Health; University of Pennsylvania; Emory University; MedStar Washington Hospital Center; NYU Langone Medical Center; Harvard University; Brigham & Women's Hospital	Mack, MJ (corresponding author), 1100 Allied Dr, Plano, TX 75093 USA.	michael.mack@baylorhealth.edu	Doğan, Ali/AAN-5331-2020; thourani, vinod/AAP-5968-2020; Hahn, Rebecca/ABE-6221-2020	Douglas, Pamela/0000-0001-9876-4049; Hahn, Rebecca/0000-0003-1342-9191; Williams, Mathew/0000-0003-2055-8741; Miller, D. Craig/0000-0001-7619-0080	Edwards Lifesciences	Edwards Lifesciences	Edwards Lifesciences.	Abdel-Wahab M, 2011, HEART, V97, P899, DOI 10.1136/hrt.2010.217158; Alli OO, 2012, JACC-CARDIOVASC INTE, V5, P72, DOI 10.1016/j.jcin.2011.09.014; Amat-Santos IJ, 2014, AM J CARDIOL, V114, P1075, DOI 10.1016/j.amjcard.2014.07.019; Athappan G, 2013, J AM COLL CARDIOL, V61, P1585, DOI 10.1016/j.jacc.2013.01.047; Babaliaros V, 2014, J AM COLL CARDIOL, V63, pA1687, DOI 10.1016/S0735-1097(14)61690-9; Binder RK, 2013, J AM COLL CARDIOL, V62, P431, DOI 10.1016/j.jacc.2013.04.036; Binder RK, 2013, JACC-CARDIOVASC INTE, V6, P293, DOI 10.1016/j.jcin.2012.09.019; Brennan JM, 2014, ANN THORAC SURG, V98, P2016, DOI 10.1016/j.athoracsur.2014.07.051; Colli A, 2011, J THORAC CARDIOV SUR, V142, P1229, DOI 10.1016/j.jtcvs.2011.04.026; Detaint D, 2009, JACC-CARDIOVASC INTE, V2, P821, DOI 10.1016/j.jcin.2009.07.003; Dewey T, 2016, ANN THORAC SURG, V96, P2083; Douglas PS, 2013, J AM SOC ECHOCARDIOG, V26, P348, DOI 10.1016/j.echo.2013.01.013; Genereux P, 2012, J AM COLL CARDIOL, V60, P1043, DOI 10.1016/j.jacc.2012.07.003; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Gurvitch R, 2010, CIRCULATION, V122, P1319, DOI 10.1161/CIRCULATIONAHA.110.948877; Haensig M, 2012, EUR J CARDIO-THORAC, V41, P1234, DOI 10.1093/ejcts/ezr244; Jilaihawi H, 2012, J AM COLL CARDIOL, V59, P1275, DOI 10.1016/j.jacc.2011.11.045; Kapadia SR, 2014, CIRCULATION, V130, P1483, DOI 10.1161/CIRCULATIONAHA.114.009834; Kapadia SR, 2015, LANCET; Kempfert J, 2011, CIRCULATION, V124, pS124, DOI 10.1161/CIRCULATIONAHA.110.013425; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Koos R, 2011, INT J CARDIOL, V150, P142, DOI 10.1016/j.ijcard.2010.03.004; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Miller DC, 2012, J THORAC CARDIOV SUR, V143, P832, DOI 10.1016/j.jtcvs.2012.01.055; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Rodes-Cabau J, 2012, J AM COLL CARDIOL, V60, P1864, DOI 10.1016/j.jacc.2012.08.960; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510	29	1075	1117	5	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2477	2484		10.1016/S0140-6736(15)60308-7	http://dx.doi.org/10.1016/S0140-6736(15)60308-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK9AR	25788234				2022-12-28	WOS:000356532500022
J	Marzi, A; Falzarano, D				Marzi, Andrea; Falzarano, Darryl			An updated Ebola vaccine: immunogenic, but will it protect?	LANCET			English	Editorial Material									[Marzi, Andrea] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA; [Falzarano, Darryl] Univ Saskatchewan, VIDO InterVac, Saskatoon, SK S7N 5E3, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Saskatchewan	Falzarano, D (corresponding author), Univ Saskatchewan, VIDO InterVac, Saskatoon, SK S7N 5E3, Canada.	darryl.falzarano@usask.ca	Marzi, Andrea/AAF-4617-2020	Marzi, Andrea/0000-0003-0186-9587	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001163] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AI999999] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		[Anonymous], 2015, EB SIT REP 11 MARCH; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10; Kibuuka H, 2014, LANCET; Lai LL, 2015, JAMA-J AM MED ASSOC, V313, P1249, DOI 10.1001/jama.2015.1995; Ledgerwood JE, 2010, VACCINE, V29, P304, DOI 10.1016/j.vaccine.2010.10.037; Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Sarwar UN, 2015, J INFECT DIS, V211, P549, DOI 10.1093/infdis/jiu511; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Zhu F-C, 2015, LANCET	12	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2229	2230		10.1016/S0140-6736(15)60613-4	http://dx.doi.org/10.1016/S0140-6736(15)60613-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	25817375	Green Accepted			2022-12-28	WOS:000355943500006
J	Adam, RC; Yang, H; Rockowitz, S; Larsen, SB; Nikolova, M; Oristian, DS; Polak, L; Kadaja, M; Asare, A; Zheng, DY; Fuchs, E				Adam, Rene C.; Yang, Hanseul; Rockowitz, Shira; Larsen, Samantha B.; Nikolova, Maria; Oristian, Daniel S.; Polak, Lisa; Kadaja, Meelis; Asare, Amma; Zheng, Deyou; Fuchs, Elaine			Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice	NATURE			English	Article							IDENTITY GENES; SELF-RENEWAL; NICHE; SKIN; GENOME; DIFFERENTIATION; REGENERATION; INHIBITION	Adult stem cells occur in niches that balance self-renewal with lineage selection and progression during tissue homeostasis. Following injury, culture or transplantation, stem cells outside their niche often display fate flexibility(1-4). Here we show that super-enhancers(5) underlie the identity, lineage commitment and plasticity of adult stem cells in vivo. Using hair follicle as a model, we map the global chromatin domains of hair follicle stem cells and their committed progenitors in their native microenvironments. We show that super-enhancers and their dense clusters ('epicentres') of transcription factor binding sites undergo remodelling upon lineage progression. New fate is acquired by decommissioning old and establishing new super-enhancers and/or epicentres, an auto-regulatory process that abates one master regulator subset while enhancing another. We further show that when outside their niche, either in vitro or in wound-repair, hair follicle stem cells dynamically remodel super-enhancers in response to changes in their microenvironment. Intriguingly, some key super-enhancers shift epicentres, enabling their genes to remain active and maintain a transitional state in an ever-changing transcriptional landscape. Finally, we identify SOX9 as a crucial chromatin rheostat of hair follicle stem cell super-enhancers, and provide functional evidence that super-enhancers are dynamic, dense transcription-factor-binding platforms which are acutely sensitive to pioneer master regulators whose levels define not only spatial and temporal features of lineage-status but also stemness, plasticity in transitional states and differentiation.	[Adam, Rene C.; Yang, Hanseul; Larsen, Samantha B.; Nikolova, Maria; Oristian, Daniel S.; Polak, Lisa; Kadaja, Meelis; Asare, Amma; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Rockowitz, Shira; Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Howard Hughes Medical Institute; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Larsen, Samantha/0000-0001-6392-2350; Zheng, Deyou/0000-0003-4354-5337; Asare, Amma/0000-0002-4865-6864	Anderson Cancer Center Graduate Student Fellowship; National Institutes of Health [R01-AR31737, R21MH099452]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, T32GM066699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099452] Funding Source: NIH RePORTER	Anderson Cancer Center Graduate Student Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Mazel, L. Li, S. Semova, and S. Tadesse for FACS sorting (Rockefeller University FACS facility); and C. Lai for assistance in high-throughput sequencing (Rockefeller University Genomics Resource Center). We thank E.F. laboratory members A. Aldeguer, S. Hacker, M. Sribour and J. Levorse for assistance in mouse research; I. Matos for advice on image acquisition; J. Racelis, S. Chai, and E. Wong for technical assistance; and Y. Ge, S. Naik, A. Kulukian, and N. Oshimori for discussions. R.C.A. was supported by the Anderson Cancer Center Graduate Student Fellowship. E.F. is an HHMI Investigator. This work was supported by grants from the National Institutes of Health (R01-AR31737 to E.F. and R21MH099452 to D.Z.).	Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Chang CY, 2013, NATURE, V495, P98, DOI 10.1038/nature11847; Chen T, 2012, NATURE, V485, P104, DOI 10.1038/nature10940; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Folgueras AR, 2013, CELL STEM CELL, V13, P314, DOI 10.1016/j.stem.2013.06.018; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Kadaja M, 2014, GENE DEV, V28, P328, DOI 10.1101/gad.233247.113; Keyes BE, 2013, P NATL ACAD SCI USA, V110, pE4950, DOI 10.1073/pnas.1320301110; Kim TH, 2014, NATURE, V506, P511, DOI 10.1038/nature12903; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lien WH, 2014, NAT CELL BIOL, V16, P179, DOI 10.1038/ncb2903; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Liu ZJ, 2014, CELL, V159, P358, DOI 10.1016/j.cell.2014.08.027; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Luyten A, 2014, GENE DEV, V28, P1827, DOI 10.1101/gad.240101.114; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	37	256	259	4	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					366	+		10.1038/nature14289	http://dx.doi.org/10.1038/nature14289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25799994	Green Accepted			2022-12-28	WOS:000354816500059
J	Yang, SY; Fujikado, N; Kolodin, D; Benoist, C; Mathis, D				Yang, Siyoung; Fujikado, Noriyuki; Kolodin, Dmitriy; Benoist, Christophe; Mathis, Diane			Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance	SCIENCE			English	Article							AIRE CONTROL; HLA-DO; ANTIGEN; AUTOIMMUNITY; EXPRESSION; DISEASE; THYMUS; WINDOW; MICE	Aire is an important regulator of immunological tolerance, operating in a minute subset of thymic stromal cells to induce transcripts encoding peptides that guide T cell selection. Expression of Aire during a perinatal age window is necessary and sufficient to prevent the multiorgan autoimmunity characteristic of Aire-deficient mice. We report that Aire promotes the perinatal generation of a distinct compartment of Foxp3(+)CD4(+) regulatory T (T-reg) cells, which stably persists in adult mice. This population has a role in maintaining self-tolerance, a transcriptome and an activation profile distinguishable from those of T-regs produced in adults. Underlying the distinct T-reg populations are age-dependent, Aire-independent differences in the processing and presentation of thymic stromal-cell peptides, resulting in different Tcell receptor repertoires. Our findings expand the notion of a developmentally layered immune system.	[Yang, Siyoung; Fujikado, Noriyuki; Kolodin, Dmitriy; Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Yang, Siyoung] Korea Res Inst Biosci & Biotechnol KRIBB, Aging Intervent Res Ctr, Taejon 305806, South Korea; [Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Harvard University; Harvard Medical School	Mathis, D (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu	Yang, Siyoung/ACC-8755-2022	Yang, Siyoung/0000-0002-6374-0140; Fujikado, Noriyuki/0000-0002-0415-5929; Fujikado, Noriyuki/0000-0002-3183-5866	NIH [R01 DK060027]; National Research Foundation of Korea [NRF-2013M3A9B6076413]; Japan Society for the Promotion of Science; National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060027] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Rudensky, M. Anderson, and A. Lichtman for providing valuable mouse strains; F. Depis and H.-K. Kwon for insightful discussions; and A. Ortiz-Lopez, L. Denu, and K. Hattori for technical assistance. The data presented in this paper are tabulated in the main paper and in the supplementary materials. Microarray data can be found at Gene Expression Omnibus under accession numbers GSE66332 and GSE66402. This work was supported by NIH grant R01 DK060027 (to D.M.). S.Y., N.F., and D.K. were supported by fellowships from the National Research Foundation of Korea (NRF-2013M3A9B6076413), Japan Society for the Promotion of Science, and National Science Foundation, respectively.	Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; BOGUE M, 1992, P NATL ACAD SCI USA, V89, P11011, DOI 10.1073/pnas.89.22.11011; Chen ZB, 2005, P NATL ACAD SCI USA, V102, P14735, DOI 10.1073/pnas.0507014102; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Dujardin HC, 2004, P NATL ACAD SCI USA, V101, P14473, DOI 10.1073/pnas.0403303101; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gotsman I, 2006, CIRCULATION, V114, P2047, DOI 10.1161/CIRCULATIONAHA.106.633263; Guerau-De-Arellano M, 2009, J EXP MED, V206, P1245, DOI 10.1084/jem.20090300; HERZENBERG LA, 1989, CELL, V59, P953, DOI 10.1016/0092-8674(89)90748-4; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; JOTEREAU F, 1987, J IMMUNOL, V138, P1026; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kisand K, 2011, ANN NY ACAD SCI, V1246, P77, DOI 10.1111/j.1749-6632.2011.06308.x; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Mellins ED, 2014, CURR OPIN IMMUNOL, V26, P115, DOI 10.1016/j.coi.2013.11.005; Nishio J, 2010, J EXP MED, V207, P1879, DOI 10.1084/jem.20100205; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Polanczyk MJ, 2007, INT IMMUNOL, V19, P337, DOI 10.1093/intimm/dxl151; Poluektov YO, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00260; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Samy ET, 2008, J IMMUNOL, V180, P4366, DOI 10.4049/jimmunol.180.7.4366; Shalev I, 2008, J IMMUNOL, V180, P249, DOI 10.4049/jimmunol.180.1.249; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; Tung KSK, 2005, CURR TOP MICROBIOL, V293, P209; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822	30	272	283	4	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					589	594		10.1126/science.aaa7017	http://dx.doi.org/10.1126/science.aaa7017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25791085	Green Accepted			2022-12-28	WOS:000353778100046
J	Mire, CE; Matassov, D; Geisbert, JB; Latham, TE; Agans, KN; Xu, R; Ota-Setlik, A; Egan, MA; Fenton, KA; Clarke, DK; Eldridge, JH; Geisbert, TW				Mire, Chad E.; Matassov, Demetrius; Geisbert, Joan B.; Latham, Theresa E.; Agans, Krystle N.; Xu, Rong; Ota-Setlik, Ayuko; Egan, Michael A.; Fenton, Karla A.; Clarke, David K.; Eldridge, John H.; Geisbert, Thomas W.			Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus	NATURE			English	Article							STOMATITIS-VIRUS; NEUROVIRULENCE; IMMUNOGENICITY; VECTORS	The family Filoviridae contains three genera, Ebolavirus, Marburgvirus, and Cuevavirusl. Some members of the genus, including Zaire ebolavirus (ZEBOV), can cause lethal haemorrhagic fever in humans. During 2014 an unprecedented ZEBOV outbreak occurred in West Africa and is still ongoing, resulting in over 10,000 deaths, and causing global concern of uncontrolled disease. To meet this challenge a rapid-acting vaccine is needed. Many vaccine approaches have shown promise in being able to protect nonhuman primates against ZEBOV2. In response to the current ZEBOV outbreak several of these vaccines have been fast tracked for human use. However, it is not known whether any of these vaccines can provide protection against the new outbreak Makona strain of ZEBOV. One of these approaches is a first-generation recombinant vesicular stomatitis virus (rVSV)-based vaccine expressing the ZEBOV glycoprotein (GP) (rVSV/ZEBOV). To address safety concerns associated with this vector, we developed two candidate, further-attenuated rVSV/ZEBOV vaccines. Both attenuated vaccines produced an approximately tenfold lower vaccine-associated viraemia compared to the first-generation vaccine and both provided complete, single-dose protection of macaques from lethal challenge with the Makona outbreak strain of ZEBOV.	[Mire, Chad E.; Geisbert, Joan B.; Agans, Krystle N.; Fenton, Karla A.; Geisbert, Thomas W.] Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA; [Mire, Chad E.; Geisbert, Joan B.; Agans, Krystle N.; Fenton, Karla A.; Geisbert, Thomas W.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Matassov, Demetrius; Latham, Theresa E.; Clarke, David K.; Eldridge, John H.] Profectus BioSci Inc, Dept Virol & Vaccine Vectors, Tarrytown, NY 10591 USA; [Xu, Rong; Ota-Setlik, Ayuko; Egan, Michael A.; Eldridge, John H.] Profectus BioSci Inc, Dept Immunol, Tarrytown, NY 10591 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Geisbert, TW (corresponding author), Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA.	twgeisbe@utmb.edu	Mire, Chad/Z-6338-2019	Mire, Chad/0000-0001-7596-1808	Department of Microbiology and Immunology at UTMB; Department of Health and Human Services, National Institutes of Health [R01AI09881701]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098817, U19AI109711] Funding Source: NIH RePORTER	Department of Microbiology and Immunology at UTMB; Department of Health and Human Services, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank V. Borisevich and D. Deer for assistance with clinical pathology assays performed in the GNL BSL-4 laboratory, and the staff of the UTMB Animal Resources Center for animal care. This study was supported by the funds from the Department of Microbiology and Immunology at UTMB to T.W.G. and in part by the Department of Health and Human Services, National Institutes of Health grant R01A109881701 to J.H.E. and T.W.G.	Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Clarke DK, 2007, J VIROL, V81, P2056, DOI 10.1128/JVI.01911-06; Clarke DK, 2014, J VIROL, V88, P6690, DOI 10.1128/JVI.03441-13; Cooper D, 2008, J VIROL, V82, P207, DOI 10.1128/JVI.01515-07; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Geisbert T. W., 2013, FIELDS VIROLOGY; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Hirschberg R, 2014, VIRUSES-BASEL, V6, P2673, DOI 10.3390/v6072673; Hoenen T., 2015, SCIENCE; Johnson JE, 2009, VACCINE, V27, P2930, DOI 10.1016/j.vaccine.2009.03.006; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kugelman JR, 2015, MBIO, V6, DOI 10.1128/mBio.02227-14; Kugelman JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050316; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Mire C. E., 2014, BIOL PATHOLOGY RHABD; Mire CE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001567; Mohan GS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003065; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Thi EP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009706; Volchkova VA, 2011, J INFECT DIS, V204, pS941, DOI 10.1093/infdis/jir321; Witko SE, 2006, J VIROL METHODS, V135, P91, DOI 10.1016/j.jviromet.2006.02.006	21	65	67	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					688	U253		10.1038/nature14428	http://dx.doi.org/10.1038/nature14428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25853476	Green Accepted			2022-12-28	WOS:000353689700052
J	Agyepong, I; Corrah, T; Guo, Y; Hollingsworth, B; Klag, M; Longfield, K; Souza, MDM; Piot, P; Rao, JVRP; Rottingen, JA; Smith, P; Sprenger, M; Sutton, T; Curran, S; Ng, ESW				Agyepong, Irene; Corrah, Tumani; Guo, Yan; Hollingsworth, Bruce; Klag, Michael; Longfield, Kim; de Fatima Marinho de Souza, Maria; Piot, Peter; Rao, J. V. R. Prasada; Rottingen, John-Arne; Smith, Peter; Sprenger, Marc; Sutton, Trevor; Curran, Sarah; Ng, Edmond SW		Independent Advisory Comm Globa	Making sense of health estimates	LANCET			English	Editorial Material							MORTALITY; SYSTEMS; DISEASE; AFRICA; EBOLA		[Agyepong, Irene] Univ Ghana, Sch Publ Hlth, Accra, Ghana; [Corrah, Tumani] MRC Unit, Banjul, Gambia; [Guo, Yan] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China; [Hollingsworth, Bruce] Univ Lancaster, Div Hlth Res, Lancaster LA1 4YW, England; [Klag, Michael] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Longfield, Kim] Populat Serv Int, Washington, DC USA; [de Fatima Marinho de Souza, Maria] Minist Hlth, Brasilia, DF, Brazil; [Piot, Peter; Smith, Peter; Curran, Sarah; Ng, Edmond SW] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Rao, J. V. R. Prasada] UNAIDS, Bangalore, Karnataka, India; [Rottingen, John-Arne] Norwegian Inst Publ Hlth, Oslo, Norway; [Sprenger, Marc] European Ctr Dis Prevent & Control, Stockholm, Sweden; [Sutton, Trevor] Australian Bur Stat, Canberra, ACT, Australia	University of Ghana; University of London; London School of Hygiene & Tropical Medicine; Peking University; Lancaster University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; Norwegian Institute of Public Health (NIPH); European Centre for Disease Prevention & Control	Smith, P (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	peter.piot@lshtm.ac.uk	lehmann, jennifer/AAB-8110-2019; Hollingsworth, Bruce/ABH-7283-2020; smith, peter/ABH-9627-2020; Ng, Edmond/L-5871-2019	smith, peter/0000-0003-0080-7560; Hollingsworth, Bruce/0000-0002-4314-6523; Agyepong, Irene Akua/0000-0002-0193-5882	Medical Research Council [MR/K012126/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Alkema L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001288; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001006; Horton R, 2014, LANCET, V383, P1792, DOI 10.1016/S0140-6736(14)60839-4; Kassebaum NJ, 2014, LANCET, V384, P2209, DOI 10.1016/S0140-6736(14)62425-9; Kovacs SD, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0728-4; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Murray CJL, 2013, LANCET, V382, P9, DOI 10.1016/S0140-6736(13)60225-1; Piot P, 2014, LANCET INFECT DIS, V14, P1034, DOI 10.1016/S1473-3099(14)70956-9; Tambo E, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-29; UNAIDS, 2014, THE GAP REP; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Ye Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-741	13	7	7	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1377	1379		10.1016/S0140-6736(15)60024-1	http://dx.doi.org/10.1016/S0140-6736(15)60024-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF7EU	25796458				2022-12-28	WOS:000352719800010
J	Genders, TSS; Petersen, SE; Pugliese, F; Dastidar, AG; Fleischmann, KE; Nieman, K; Hunink, MGM				Genders, Tessa S. S.; Petersen, Steffen E.; Pugliese, Francesca; Dastidar, Amardeep G.; Fleischmann, Kirsten E.; Nieman, Koen; Hunink, M. G. Myriam			The Optimal Imaging Strategy for Patients With Stable Chest Pain A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; EMISSION COMPUTED-TOMOGRAPHY; CARDIOVASCULAR MAGNETIC-RESONANCE; QUALITY-OF-LIFE; AMERICAN-HEART-ASSOCIATION; FRACTIONAL FLOW RESERVE; DIAGNOSTIC PERFORMANCE; CT ANGIOGRAPHY; PROGNOSTIC VALUE; TASK-FORCE	Background: The optimal imaging strategy for patients with stable chest pain is uncertain. Objective: To determine the cost-effectiveness of different imaging strategies for patients with stable chest pain. Design: Microsimulation state-transition model. Data Sources: Published literature. Target Population: 60-year-old patients with a low to intermediate probability of coronary artery disease (CAD). Time Horizon: Lifetime. Perspective: The United States, the United Kingdom, and the Netherlands. Intervention: Coronary computed tomography (CT) angiography, cardiac stress magnetic resonance imaging, stress single-photon emission CT, and stress echocardiography. Outcome Measures: Lifetime costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios. Results of Base-Case Analysis: The strategy that maximized QALYs and was cost-effective in the United States and the Netherlands began with coronary CT angiography, continued with cardiac stress imaging if angiography found at least 50% stenosis in at least 1 coronary artery, and ended with catheter-based coronary angiography if stress imaging induced ischemia of any severity. For U. K. men, the preferred strategy was optimal medical therapy without catheter-based coronary angiography if coronary CT angiography found only moderate CAD or stress imaging induced only mild ischemia. In these strategies, stress echocardiography was consistently more effective and less expensive than other stress imaging tests. For U. K. women, the optimal strategy was stress echocardiography followed by catheter-based coronary angiography if echocardiography induced mild or moderate ischemia. Results of Sensitivity Analysis: Results were sensitive to changes in the probability of CAD and assumptions about false-positive results. Limitations: All cardiac stress imaging tests were assumed to be available. Exercise electrocardiography was included only in a sensitivity analysis. Differences in QALYs among strategies were small. Conclusion: Coronary CT angiography is a cost-effective triage test for 60-year-old patients who have nonacute chest pain and a low to intermediate probability of CAD.	Erasmus Univ, Med Ctr, NL-3000 CA Rotterdam, Netherlands; Univ London, London, England; UCSF, Med Ctr, San Francisco, CA USA; Harvard Univ, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; University of London; University of California System; University of California San Francisco; UCSF Medical Center; Harvard University	Hunink, MGM (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.hunink@erasmusmc.nl	Dastidar, Amardeep/Y-1083-2019; Petersen, Steffen E/A-8389-2011	Dastidar, Amardeep/0000-0002-8688-5326; Petersen, Steffen E/0000-0003-4622-5160	Erasmus University Medical Center; National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts; Barts and The London Charity [437/1412]; National Institutes of Health (National Heart, Lung, and Blood Institute) [R21HL112255]	Erasmus University Medical Center; National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts; Barts and The London Charity; National Institutes of Health (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By a Health Care Efficiency grant from the Erasmus University Medical Center. Drs. Petersen and Pugliese were directly funded by the National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts. Dr. Dastidar received direct funding from Barts and The London Charity (437/1412). Dr. Fleischmann was directly funded by a grant from the National Institutes of Health (National Heart, Lung, and Blood Institute award R21HL112255).	Ara R, 2008, VALUE HEALTH, V11, P1131, DOI 10.1111/j.1524-4733.2008.00352.x; Arias E., 2007, US LIFE TABLES; Berger JS, 2008, AM J MED, V121, P43, DOI 10.1016/j.amjmed.2007.10.002; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bravata DM, 2007, ANN INTERN MED, V147, P703, DOI 10.7326/0003-4819-147-10-200711200-00185; Budoff MJ, 2008, INT J CARDIOL, V129, P32, DOI 10.1016/j.ijcard.2007.06.062; Cohen DJ, 2011, NEW ENGL J MED, V364, P1016, DOI 10.1056/NEJMoa1001508; Cooper A, 2010, CHEST PAIN RECENT ON, P9; Council of Europe, 2006, SG INF, P5; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Daly CA, 2005, EUR HEART J, V26, P1011, DOI 10.1093/eurheartj/ehi109; de Jong MC, 2012, EUR RADIOL, V22, P1881, DOI 10.1007/s00330-012-2434-1; Deckers JW, 2006, EUR HEART J, V27, P796, DOI 10.1093/eurheartj/ehi809; Dedic A, 2011, RADIOLOGY, V261, P428, DOI 10.1148/radiol.11110744; Dutch Central Bureau of Statistics, 2010, LIF TABL 2010; Dutch National Authority of Health Care, 2008, DUTCH TAR HLTH CAR P; Fearon WF, 2010, CIRCULATION, V122, P2545, DOI 10.1161/CIRCULATIONAHA.109.925396; Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Genders TSS, 2013, INT J CARDIOL, V167, P1268, DOI 10.1016/j.ijcard.2012.03.151; Genders TSS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3485; Genders TSS, 2009, RADIOLOGY, V253, P734, DOI 10.1148/radiol.2533090507; Gold MR, 1996, COST EFFECTIVENESS H; Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4; Groothuis JGJ, 2010, RADIOLOGY, V254, P384, DOI 10.1148/radiol.09090802; Hachamovitch R, 2002, CIRCULATION, V105, P823, DOI 10.1161/hc0702.103973; Hakkaart-van Roijen L, 2010, DUTCH MANUAL COST AN, V17, P87; Hamon M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-29; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Heijenbrok-Kal MH, 2007, AM HEART J, V154, P415, DOI 10.1016/j.ahj.2007.04.061; Hulten EA, 2011, J AM COLL CARDIOL, V57, P1237, DOI 10.1016/j.jacc.2010.10.011; Jaarsma C, 2012, J AM COLL CARDIOL, V59, P1719, DOI 10.1016/j.jacc.2011.12.040; Kappetein AP, 2011, EUR HEART J, V32, P2125, DOI 10.1093/eurheartj/ehr213; KATAYAMA H, 1990, RADIOLOGY, V175, P621, DOI 10.1148/radiology.175.3.2343107; Kwok Y, 1999, AM J CARDIOL, V83, P660, DOI 10.1016/S0002-9149(98)00963-1; Lazar LD, 2011, CIRCULATION, V124, P146, DOI 10.1161/CIRCULATIONAHA.110.986349; MacHaalany J, 2009, J AM COLL CARDIOL, V54, P1533, DOI 10.1016/j.jacc.2009.06.026; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P636, DOI 10.1016/j.jacc.2008.05.024; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Min JK, 2010, RADIOLOGY, V254, P801, DOI 10.1148/radiol.09090349; Moschetti K, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-35; Mowatt G, 2008, HEART, V94, P1386, DOI 10.1136/hrt.2008.145292; Mudrick DW, 2012, AM HEART J, V163, P454, DOI 10.1016/j.ahj.2011.11.022; National Health Service, 2011, EL DRUG TAR; National Institute for Health and Care Excellence, 2008, GUID METH TECHN APPR, V41, P57; Nieman K, 2009, HEART, V95, P1669, DOI 10.1136/hrt.2009.169441; NOTO TJ, 1991, CATHETER CARDIO DIAG, V24, P75, DOI 10.1002/ccd.1810240202; Office for National Statistics, 2010, UK INT LIF TABL; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; Schuetz GM, 2010, ANN INTERN MED, V152, P167, DOI 10.7326/0003-4819-152-3-201002020-00008; Schwitter J, 2008, EUR HEART J, V29, P480, DOI 10.1093/eurheartj/ehm617; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Shreibati JB, 2011, JAMA-J AM MED ASSOC, V306, P2128, DOI 10.1001/jama.2011.1652; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Van Loenen A, 2011, PHARMACOTHERAPEUTIC; Voko Z, 2011, EUR J EPIDEMIOL, V26, P375, DOI 10.1007/s10654-011-9558-5; von Ballmoos MW, 2011, ANN INTERN MED, V154, P413, DOI 10.7326/0003-4819-154-6-201103150-00007; Walker S, 2013, HEART, V99, P873, DOI 10.1136/heartjnl-2013-303624; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771; Wolk MJ, 2014, J AM COLL CARDIOL, V63, P380, DOI 10.1016/j.jacc.2013.11.009	63	49	49	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2015	162	7					474	U145		10.7326/M14-0027	http://dx.doi.org/10.7326/M14-0027			25	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4UT	25844996				2022-12-28	WOS:000353283400002
J	Steinle, A; Cerwenka, A				Steinle, Alexander; Cerwenka, Adelheid			MULT1plying cancer immunity	SCIENCE			English	Editorial Material							CELL ACTIVATION; NKG2D; LIGANDS; NK; EXPRESSION; RECEPTOR; RAE-1		[Steinle, Alexander] Goethe Univ Frankfurt, Inst Mol Med, D-60054 Frankfurt, Germany; [Cerwenka, Adelheid] German Canc Res Ctr, Innate Immun Grp, Heidelberg, Germany	Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ)	Cerwenka, A (corresponding author), German Canc Res Ctr, Innate Immun Grp, Heidelberg, Germany.	a.cerwenka@dkfz-heidelberg.de		Steinle, Alexander/0000-0001-5081-8503; Cerwenka, Adelheid/0000-0001-6977-3536				Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Carayannopoulos L. N., 2002, J IMMUNOL, V15, P169; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Coudert JD, 2008, BLOOD, V111, P3571, DOI 10.1182/blood-2007-07-100057; Deng WW, 2015, SCIENCE, V348, P136, DOI 10.1126/science.1258867; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Nausch N, 2008, BLOOD, V112, P4080, DOI 10.1182/blood-2008-03-143776; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Salih HR, 2008, FRONT BIOSCI, V13, P3448; Ullrich E, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26097; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	14	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					45	46		10.1126/science.aaa9842	http://dx.doi.org/10.1126/science.aaa9842			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838370				2022-12-28	WOS:000352079500022
J	Sussman, R; Murdock, J				Sussman, Rachael; Murdock, Jonah			Peritoneal Loose Body	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sussman, Rachael] Georgetown Univ Hosp, Washington, DC 20007 USA; [Murdock, Jonah] Washington DC Vet Affairs Med Ctr, Washington, DC USA	Georgetown University	Sussman, R (corresponding author), Georgetown Univ Hosp, Washington, DC 20007 USA.	sussman.rachael@gmail.com							0	11	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14					1359	1359		10.1056/NEJMicm1316094	http://dx.doi.org/10.1056/NEJMicm1316094			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NL	25830426				2022-12-28	WOS:000352028500011
J	Turner, TN; Sharma, K; Oh, EC; Liu, YFP; Collins, RL; Sosa, MX; Auer, DR; Brand, H; Sanders, SJ; Moreno-De-Luca, D; Pihur, V; Plona, T; Pike, K; Soppet, DR; Smith, MW; Cheung, SW; Martin, CL; State, MW; Talkowski, ME; Cook, E; Huganir, R; Katsanis, N; Chakravarti, A				Turner, Tychele N.; Sharma, Kamal; Oh, Edwin C.; Liu, Yangfan P.; Collins, Ryan L.; Sosa, Maria X.; Auer, Dallas R.; Brand, Harrison; Sanders, Stephan J.; Moreno-De-Luca, Daniel; Pihur, Vasyl; Plona, Teri; Pike, Kristen; Soppet, Daniel R.; Smith, Michael W.; Cheung, Sau Wai; Martin, Christa Lese; State, Matthew W.; Talkowski, Michael E.; Cook, Edwin; Huganir, Richard; Katsanis, Nicholas; Chakravarti, Aravinda			Loss of delta-catenin function in severe autism	NATURE			English	Article							STRUCTURAL VARIATION; SPECTRUM DISORDER; PROTEIN; MORPHOGENESIS; GENETICS; COMPLEX; SYNAPSE; SPINE; KAISO; RARE	Autism is a multifactorial neurodevelopmental disorder affecting more males than females; consequently, under a multifactorial genetic hypothesis, females are affected only when they cross a higher biological threshold. We hypothesize that deleterious variants at conserved residues are enriched in severely affected patients arising from female-enriched multiplex families with severe disease, enhancing the detection of key autism genes in modest numbers of cases. Here we show the use of this strategy by identifying missense and dosage sequence variants in the gene encoding the adhesive junction-associated delta-catenin protein (CTNND2) in female-enriched multiplex families and demonstrating their loss-of-function effect by functional analyses in zebrafish embryos and cultured hippocampal neurons from wild-type and Ctnnd2 null mouse embryos. Finally, through gene expression and network analyses, we highlight a critical role for CTNND2 in neuronal development and an intimate connection to chromatin biology. Our data contribute to the understanding of the genetic architecture of autism and suggest that genetic analyses of phenotypic extremes, such as female-enriched multiplex families, are of innate value in multifactorial disorders.	[Turner, Tychele N.; Sosa, Maria X.; Auer, Dallas R.; Pihur, Vasyl; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA; [Turner, Tychele N.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Predoctoral Training Program Human Genet & Mol Bi, Baltimore, MD 21205 USA; [Turner, Tychele N.; Sosa, Maria X.; Auer, Dallas R.; Sanders, Stephan J.; Moreno-De-Luca, Daniel; Pihur, Vasyl; Martin, Christa Lese; State, Matthew W.; Chakravarti, Aravinda] Univ Calif Los Angeles, NIMH, Autism Ctr Excellence ACE Genet Consortium, Los Angeles, CA 90095 USA; [Sharma, Kamal; Huganir, Richard] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Oh, Edwin C.; Liu, Yangfan P.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Collins, Ryan L.; Brand, Harrison; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Collins, Ryan L.; Brand, Harrison; Talkowski, Michael E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Brand, Harrison; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Sanders, Stephan J.; State, Matthew W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Moreno-De-Luca, Daniel] Yale Univ, Dept Psychiat, New Haven, CT 06511 USA; [Plona, Teri; Pike, Kristen; Soppet, Daniel R.] Leidos Biomed Res Inc, Frederick, MD 21702 USA; [Smith, Michael W.] NHGRI, Bethesda, MD 20892 USA; [Cheung, Sau Wai] Baylor Coll Med, Houston, TX 77030 USA; [Martin, Christa Lese] Geisinger Hlth Syst, Autism & Dev Med Inst, Lewisburg, PA 17837 USA; [Cook, Edwin] Univ Illinois, Chicago, IL 60608 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of California System; University of California Los Angeles; Johns Hopkins University; Duke University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Baylor College of Medicine; Geisinger Health System; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA.	aravinda@jhmi.edu	State, Matthew/W-2256-2019; Sanders, Stephan/S-8645-2019; /AAD-2060-2020	/0000-0003-4651-0084; State, Matthew/0000-0003-1624-8302; Collins, Ryan/0000-0003-1268-9995; Turner, Tychele/0000-0001-8246-6477; Collins, Rachel/0000-0002-1559-8135; Talkowski, Michael/0000-0003-2889-0992; Katsanis, Nicholas/0000-0002-2480-0171; Sanders, Stephan/0000-0001-9112-5148; Auer, Dallas/0000-0003-4466-4135	National Institute of Mental Health [1U24MH081810]; Simons Foundation; NIMH [MH095867, 5R25MH071584-07, MH19961-14, R01MH081754]; National Institutes of Health [RO1MH074090]; Autism Speaks Dennis Weatherstone pre-doctoral fellowship [7863]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060007, K99MH095867, R01MH074090, T32MH019961, R00MH095867, R01MH081754, R25MH071584, U24MH081810] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks Dennis Weatherstone pre-doctoral fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge the participation of all of the families in the AGRE, NIMH and SSC studies that have been amodel of public participatory research. The AGRE is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health. The SSC used here was developed by the following principal investigators: A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, E. Wijsman. We thank the Allen Brain Atlas for use of their publicly available developing human brain expression data. Finally, we thank V. Kustanovich (AGRE) for helping with access to Autism Diagnostic Observation Schedule severity score data, D. Arking for sharing DNA from the SSC for Taqman genotyping, S. Maragh for zebrafish complementary DNA (cDNA) libraries and eef1a1l1 primers, A. Kapoor for discussions, Q. Jiang for the translation of ref. 43, and J. A. Rosenfeld, L. G. Shaffer, Y. Shenand B.-L. Wufor sharing CNV data sets. Sequencing services were provided by the Johns Hopkins University Next Generation Sequencing Center, Sidney Kimmel Comprehensive Cancer Center, Illumina Sequencing Services and the Johns Hopkins University Genetic Resources Core Facility. E. C. O. is a National Alliance for Research on Schizophrenia and Depression young investigator. N.K. is a Distinguished George W. Brumley Professor. This work was funded by grants from the Simons Foundation to A. C. and to N.K., NIMH grant MH095867 to M.E.T., NIMH grants 5R25MH071584-07 and MH19961-14 to D. M. D. L. (Malison), National Institutes of Health grant RO1MH074090 to C. L. M., NIMH grant R01MH081754 to A. C. and an Autism Speaks Dennis Weatherstone pre-doctoral fellowship (number 7863) to T.T.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Arikkath J, 2009, J NEUROSCI, V29, P5435, DOI 10.1523/JNEUROSCI.0835-09.2009; Bareiss S, 2010, J NEUROSCI RES, V88, P2350, DOI 10.1002/jnr.22414; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Brigidi GS, 2014, NAT NEUROSCI, V17, P522, DOI 10.1038/nn.3657; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; Chakravarti A, 2014, AM J HUM GENET, V94, P326, DOI 10.1016/j.ajhg.2013.11.014; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Davis LK, 2008, HUM GENET, V123, P371, DOI 10.1007/s00439-008-0484-x; De Rubeis S, 2013, NEURON, V79, P1169, DOI 10.1016/j.neuron.2013.06.039; Duparc RH, 2006, DEV BIOL, V300, P647, DOI 10.1016/j.ydbio.2006.07.045; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Fujita T, 2004, BIOCHEM J, V382, P717, DOI 10.1042/BJ20040141; Gai X, 2012, MOL PSYCHIATR, V17, P402, DOI 10.1038/mp.2011.10; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Harvard C, 2005, CLIN GENET, V67, P341, DOI 10.1111/j.1399-0004.2005.00406.x; He Wen-zhi, 2012, Zhonghua Yixue Yichuanxue Zazhi, V29, P266, DOI 10.3760/cma.j.issn.1003-9406.2012.03.004; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Itoh K, 1997, MECH DEVELOP, V61, P113, DOI 10.1016/S0925-4773(96)00627-2; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; JORDE LB, 1991, AM J HUM GENET, V49, P932; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Kim K, 2002, EXP CELL RES, V275, P171, DOI 10.1006/excr.2002.5503; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Koutras C, 2011, J ALZHEIMERS DIS, V27, P307, DOI 10.3233/JAD-2011-110536; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Nojima H, 2004, MECH DEVELOP, V121, P371, DOI 10.1016/j.mod.2004.02.003; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Qiao Y, 2009, J MED GENET, V46, P680, DOI 10.1136/jmg.2009.066795; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Umeda T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015500; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang MH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-514; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Zhang J, 2010, EXP CELL RES, V316, P1070, DOI 10.1016/j.yexcr.2010.01.006; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054	54	103	109	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					51	+		10.1038/nature14186	http://dx.doi.org/10.1038/nature14186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25807484	Green Submitted, Green Accepted			2022-12-28	WOS:000352027700034
J	Eisenstein, M				Eisenstein, Michael			ARTIFICIAL ORGANS Honey, I shrunk the lungs	NATURE			English	Editorial Material																		Huh D, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004249; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Stevens KR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2853; Wikswo JP, 2013, LAB CHIP, V13, P3496, DOI 10.1039/c3lc50243k	4	16	17	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S16	S18		10.1038/519S16a	http://dx.doi.org/10.1038/519S16a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25806493	Bronze			2022-12-28	WOS:000351602800006
J	Skelton, E; Moody, AB; Anderson, HJ; Howlett, DC				Skelton, Emily; Moody, Andrew B.; Anderson, Hugh J.; Howlett, David C.			CASE REVIEW A post-traumatic pulsatile nodule in the right pre-auricular region	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUPERFICIAL TEMPORAL ARTERY; TRAUMATIC PSEUDOANEURYSM; ANEURYSM; EMBOLIZATION		[Skelton, Emily; Anderson, Hugh J.; Howlett, David C.] Eastbourne Dist Gen Hosp, East Sussex Healthcare NHS Trust, Dept Radiol, Eastbourne BN21 2UD, England; [Moody, Andrew B.] Eastbourne Dist Gen Hosp, East Sussex Healthcare NHS Trust, Dept Maxillofacial Surg, Eastbourne, England		Skelton, E (corresponding author), Eastbourne Dist Gen Hosp, East Sussex Healthcare NHS Trust, Dept Radiol, Eastbourne BN21 2UD, England.	e.skelton@nhs.net		Skelton, Emily/0000-0003-0132-7948				Chen SSH, 2009, J CLIN ULTRASOUND, V37, P312, DOI 10.1002/jcu.20558; Evans CC, 2003, J AM ACAD DERMATOL, V49, pS286, DOI 10.1067/S0190-9622(03)01487-7; Grasso RF, 2007, CARDIOVASC INTER RAD, V30, P286, DOI 10.1007/s00270-005-0307-6; Hong JT, 2006, SURG NEUROL, V66, P86, DOI 10.1016/j.surneu.2005.10.022; Isaacson G, 2004, LARYNGOSCOPE, V114, P1000, DOI 10.1097/00005537-200406000-00008; Ishikawa E, 2000, SURG NEUROL, V53, P543, DOI 10.1016/S0090-3019(00)00205-6; Kaczynski Jakub, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-02-2012-5818; Kim SW, 2013, J CRANIOFAC SURG, V24, P295, DOI 10.1097/SCS.0b013e31827136f6; Levisianos I, 2008, EMERG MED J, V25, P239, DOI 10.1136/emj.2007.055418; Mann GS, 2007, PEDIATR RADIOL, V37, P578, DOI 10.1007/s00247-007-0447-8; Mohler ER, 2001, VASC MED, V6, P241, DOI 10.1177/1358836X0100600407; Murphy M, 2006, BRIT J NEUROSURG, V20, P159, DOI 10.1080/02688690600777034; Park SK, 2012, AESTHET PLAST SURG, V36, P934, DOI 10.1007/s00266-012-9909-y; Rancic Z, 2014, GEN THORAC CARDIOVAS, V62, P68, DOI 10.1007/s11748-013-0219-3; Sardana V, 2012, INDIAN J NEUROTRAUM, V9, P56, DOI 10.1016/j.ijnt.2012.04.008; Shalhoub J, 2006, GRAND ROUNDS, V6, P15; SHIMODA M, 1988, Neurological Surgery, V16, P797; Ten L, 2003, AUSTRALAS RADIOL, V47, P64; Vvan Uden D, 2012, HEAD NECK-J SCI SPEC, V35, P608; Walker MT, 2003, AM J NEURORADIOL, V24, P147; Yamakado K, 2000, J VASC INTERV RADIOL, V11, P66, DOI 10.1016/S1051-0443(07)61284-6	21	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2015	350								h1441	10.1136/bmj.h1441	http://dx.doi.org/10.1136/bmj.h1441			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NO	25804625				2022-12-28	WOS:000352028800010
J	Yordanov, Y; Dechartres, A; Porcher, R; Boutron, I; Altman, DG; Ravaud, P				Yordanov, Youri; Dechartres, Agnes; Porcher, Raphal; Boutron, Isabelle; Altman, Douglas G.; Ravaud, Philippe			Avoidable waste of research related to inadequate methods in clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; MEDICAL JOURNALS; INCREASING VALUE; REDUCING WASTE; REPORTING GUIDELINES; CONSORT STATEMENT; BIAS; QUALITY; IMPACT; RISK	OBJECTIVE To assess the waste of research related to inadequate methods in trials included in Cochrane reviews and to examine to what extent this waste could be avoided. A secondary objective was to perform a simulation study to re-estimate this avoidable waste if all trials were adequately reported. DESIGN Methodological review and simulation study. DATA SOURCES Trials included in the meta-analysis of the primary outcome of Cochrane reviews published between April 2012 and March 2013. DATA EXTRACTION AND SYNTHESIS We collected the risk of bias assessment made by the review authors for each trial. For a random sample of 200 trials with at least one domain at high risk of bias, we re-assessed risk of bias and identified all related methodological problems. For each problem, possible adjustments were proposed that were then validated by an expert panel also evaluating their feasibility (easy or not) and cost. Avoidable waste was defined as trials with at least one domain at high risk of bias for which easy adjustments with no or minor cost could change all domains to low risk. In the simulation study, after extrapolating our re-assessment of risk of bias to all trials, we considered each domain rated as unclear risk of bias as missing data and used multiple imputations to determine whether they were at high or low risk. RESULTS Of 1286 trials from 205 meta-analyses, 556 (43%) had at least one domain at high risk of bias. Among the sample of 200 of these trials, 142 were confirmed as high risk; in these, we identified 25 types of methodological problem. Adjustments were possible in 136 trials (96%). Easy adjustments with no or minor cost could be applied in 71 trials (50%), resulting in 17 trials (12%) changing to low risk for all domains. So the avoidable waste represented 12% (95% CI 7% to 18%) of trials with at least one domain at high risk. After correcting for incomplete reporting, avoidable waste due to inadequate methods was estimated at 42% (95% CI 36% to 49%). CONCLUSIONS An important burden of wasted research is related to inadequate methods. This waste could be partly avoided by simple and inexpensive adjustments.	[Yordanov, Youri; Dechartres, Agnes; Porcher, Raphal; Boutron, Isabelle] INSERM, U1153, Ctr Rech Epidemiol & Stat, Paris, France; [Yordanov, Youri] Hop St Antoine, AP HP, Serv Urgences, F-75571 Paris, France; [Dechartres, Agnes; Porcher, Raphal; Boutron, Isabelle; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75004 Paris, France; [Dechartres, Agnes; Porcher, Raphal; Boutron, Isabelle; Ravaud, Philippe] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [Boutron, Isabelle; Ravaud, Philippe] French Cochrane Ctr, Paris, France; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England; [Ravaud, Philippe] Columbia Univ, Mailman Sch Publ, Dept Epidemiol, New York, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Oxford; Columbia University	Dechartres, A (corresponding author), Hop Hotel Dieu, INSERM, U1153, Ctr Epidemiol Clin,Ctr Rech Epidemiol & Stat, 1 Pl Parvis Notre Dame, F-75004 Paris, France.	agnes.dechartres@htd.aphp.fr	ravaud, philippe/C-1694-2009	Ravaud, Philippe/0000-0001-8264-9206; Boutron, Isabelle/0000-0002-5263-6241; Porcher, Raphael/0000-0002-5277-4679	programme "Equipe espoir de la Recherche"; Fondation pour la Recherche Medicale (FRM), Paris, France [DEQ20101221475]; Institut National de la Sante et de la Recherche Medicale (INSERM); Cancer Research UK [C5529]; Cancer Research UK [16895] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10131] Funding Source: researchfish	programme "Equipe espoir de la Recherche"; Fondation pour la Recherche Medicale (FRM), Paris, France(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This study did not receive any specific funding. The team Centre d'Epidemiologie Clinique is supported by an academic grant from the programme "Equipe espoir de la Recherche", Fondation pour la Recherche Medicale (FRM), Paris, France (No DEQ20101221475). AD is funded by the Institut National de la Sante et de la Recherche Medicale (INSERM). DGA is supported by Cancer Research UK (C5529). These funders had no role in the design and conduct of the study, collection, management, analysis, interpretation of the data, and preparation, review, or approval of the manuscript.	Altman DG, 2002, JAMA-J AM MED ASSOC, V287, P2817, DOI 10.1001/jama.287.21.2817; [Anonymous], 2010, LANCET, V376, P1437, DOI 10.1016/S0140-6736(10)61973-3; Boutron I, 2004, J CLIN EPIDEMIOL, V57, P543, DOI 10.1016/j.jclinepi.2003.12.010; Boutron I, 2006, PLOS MED, V3, P1931, DOI 10.1371/journal.pmed.0030425; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Hartling L, 2013, J CLIN EPIDEMIOL, V66, P973, DOI 10.1016/j.jclinepi.2012.07.005; Hartling L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017242; Hartling L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4012; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoffmann TC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3755; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; Hopewell S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4178; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Larson EL, 2012, J CLIN EPIDEMIOL, V65, P239, DOI 10.1016/j.jclinepi.2011.07.008; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liberati A, 2004, BMJ-BRIT MED J, V328, P531, DOI 10.1136/bmj.328.7438.531; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Mhaskar R, 2012, J CLIN EPIDEMIOL, V65, P602, DOI 10.1016/j.jclinepi.2011.10.016; Moher D, 2011, J CLIN EPIDEMIOL, V64, P718, DOI 10.1016/j.jclinepi.2010.09.013; Nuesch E, 2009, ARTHRIT RHEUM-ARTHR, V61, P1633, DOI 10.1002/art.24894; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; Psaty BM, 2010, JAMA-J AM MED ASSOC, V304, P793, DOI 10.1001/jama.2010.1161; Salman RA, 2014, LANCET, V383, P176, DOI 10.1016/S0140-6736(13)62297-7; Samaan Z, 2013, J MULTIDISCIP HEALTH, V6, P169, DOI 10.2147/JMDH.S43952; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Scott IA, 2012, MED J AUSTRALIA, V196, P304, DOI 10.5694/mja11.10364; Simera I, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2471; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79, DOI 10.1093/ije/dyh300; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; Vale CL, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1798; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	38	67	68	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2015	350								h809	10.1136/BMJ.h809	http://dx.doi.org/10.1136/BMJ.h809			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NO	25804210	hybrid, Green Published			2022-12-28	WOS:000352028800028
J	Moynihan, R				Moynihan, Ray			REALITY CHECK Preventing overdiagnosis: the myth, the music, and the medical meeting	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TOO					raymoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					Barratt A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h867; Carter SM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h869; Cundy T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1567; Johansson M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h825; Lawrence L., 2015, CANCERNETWORK; Martin Stephen A, 2014, BMJ, V349, pg5432, DOI 10.1136/bmj.g5432; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368	7	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2015	350								h1370	10.1136/bmj.h1370	http://dx.doi.org/10.1136/bmj.h1370			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KT	25787718				2022-12-28	WOS:000351571200006
J	Jones, P				Jones, Paul			Review: Systemic corticosteroids reduce treatment failure but increase hyperglycemia in COPD exacerbations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ London, London, England	University of London	Jones, P (corresponding author), Univ London, London, England.							Leuppi JD, 2013, JAMA-J AM MED ASSOC, V309, P2223, DOI 10.1001/jama.2013.5023	1	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6							JC6	10.7326/ACPJC-2015-162-6-006	http://dx.doi.org/10.7326/ACPJC-2015-162-6-006			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775349				2022-12-28	WOS:000351279600005
J	Abidi, SH; Raees, M; Ali, S				Abidi, Syed H.; Raees, Muhammad; Ali, Syed			How Pakistan's media spreads the message about reproductive and sexual health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSMITTED INFECTIONS; ADOLESCENTS; PREVALENCE; HIV		[Abidi, Syed H.] Aga Khan Univ, Biol & Biomed Sci, Karachi 74800, Pakistan; [Raees, Muhammad] Aga Khan Univ, Med Coll, Karachi 74800, Pakistan; [Ali, Syed] Nazarbayev Univ, Nazarbayev Sch Med, Dept Biomed Sci, Astana, Kazakhstan	Aga Khan University; Aga Khan University; Nazarbayev University	Ali, S (corresponding author), Nazarbayev Univ, Nazarbayev Sch Med, Dept Biomed Sci, Astana, Kazakhstan.	syed.ali@nu.edu.kz						Afsar H A, 2002, J Pak Med Assoc, V52, P21; Agha S, 2012, J HEALTH COMMUN, V17, P601, DOI 10.1080/10810730.2011.635768; Agha S, 2010, STUD FAMILY PLANN, V41, P277, DOI 10.1111/j.1728-4465.2010.00253.x; Ali SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011059; Ali Tazeen Saeed, 2006, JPMA Journal of the Pakistan Medical Association, V56, P68; [Anonymous], 2013, EXP DISC FAM PLANN R; [Anonymous], 2013, DAILY TIMES     0316; Anwerzada M., FEMALE SEX WORKERS P; Atta-Ur-Rahman, 2004, Nature, V432, P273; Black Box Sounds, DOC CHILD RIGHTS; Carton TW, 2012, HEALTH POLICY PLANN, V27, P166, DOI 10.1093/heapol/czr022; Chinoy SO., 2011, TRANSGENDERS PAKISTA; Husain S., 2012, NEWS INT        1228; Ilyas F., 2012, DAWN            0115; Iqbal Z., 2012, EUR SCI J, V8; Khan MS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-119; Khanani MR, 2010, J INFECTION, V61, P507, DOI 10.1016/j.jinf.2010.09.035; Maan MA, 2011, ANN SAUDI MED, V31, P263, DOI 10.4103/0256-4947.81541; Musharraf P., 2004, WASHINGTON POST; Nasir JA, 2009, PAK J STAT, V25, P251; Qazi H. A., 2010, Journal of Family and Reproductive Health, V4, P41; Raheel Hafsa, 2007, JPMA Journal of the Pakistan Medical Association, V57, P8; Shahzad K., 2013, HUFFINGTON POST; Sultan K, 2010, KHYBER MED U J, V2, P58; Thompson LH, 2013, SEX TRANSM INFECT, V89, P43, DOI 10.1136/sextrans-2012-050901; Wahedna D'Arcy, ALWAYS ULTRAPAKISTAN; World Bank, 2010, FERT DEC PAK 1980 20; Ybarra Michele L, 2007, Curr HIV/AIDS Rep, V4, P201, DOI 10.1007/s11904-007-0029-2	28	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2015	350								h1309	10.1136/bmj.h1309	http://dx.doi.org/10.1136/bmj.h1309			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KM	25779596	Green Published			2022-12-28	WOS:000351570500004
J	Zhu, FC; Hou, LH; Li, JX; Wu, SP; Liu, P; Zhang, GR; Hu, YM; Meng, FY; Xu, JJ; Tang, R; Zhang, JL; Wang, WJ; Duan, L; Chu, K; Liang, Q; Hu, JL; Luo, L; Zhu, T; Wang, JZ; Chen, W				Zhu, Feng-Cai; Hou, Li-Hua; Li, Jing-Xin; Wu, Shi-Po; Liu, Pei; Zhang, Gui-Rong; Hu, Yue-Mei; Meng, Fan-Yue; Xu, Jun-Jie; Tang, Rong; Zhang, Jin-Long; Wang, Wen-Juan; Duan, Lei; Chu, Kai; Liang, Qi; Hu, Jia-Lei; Luo, Li; Zhu, Tao; Wang, Jun-Zhi; Chen, Wei			Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial	LANCET			English	Article							TEST-OF-CONCEPT; SOUTH-AFRICA; T-CELLS; NEUTRALIZING ANTIBODIES; HVTN 503/PHAMBILI; NONHUMAN-PRIMATES; GENE-THERAPY; HIV VACCINE; VIRUS; IMMUNITY	Background Up to now, all tested Ebola virus vaccines have been based on the virus strain from the Zaire outbreak in 1976. We aimed to assess the safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine expressing the glycoprotein of the 2014 epidemic strain. Methods We did this randomised, double-blind, placebo-controlled, phase 1 clinical trial at one site in Taizhou County, Jiangsu Province, China. Healthy adults (aged 18-60 years) were sequentially enrolled and randomly assigned (2: 1), by computer-generated block randomisation (block size of six), to receive placebo, low-dose adenovirus type-5 vector-based Ebola vaccine, or high-dose vaccine. Randomisation was pre-stratified by dose group. All participants, investigators, and laboratory staff were masked to treatment allocation. The primary safety endpoint was occurrence of solicited adverse reactions within 7 days of vaccination. The primary immunogenicity endpoints were glycoproteinspecific antibody titres and T-cell responses at day 28 after the vaccination. Analysis was by intention to treat. The study is registered with ClinicalTrials.gov, number NCT02326194. Findings Between Dec 28, 2014, and Jan 9, 2015, 120 participants were enrolled and randomly assigned to receive placebo (n=40), low-dose vaccine (n=40), or high-dose vaccine. Participants were followed up for 28 days. Overall, 82 (68%) participants reported at least one solicited adverse reaction within 7 days of vaccination (n=19 in the placebo group vs n=27 in the low-dose group vs n=36 in the high-dose group; p=0.0002). The most common reaction was mild pain at the injection site, which was reported in eight (20%) participants in the placebo group, 14 (35%) participants in the low-dose group, and 29 (73%) participants in the high-dose vaccine group (p<0.0001). We recorded no statistical differences in other adverse reactions and laboratory tests across groups. Glycoprotein-specific antibody titres were significantly increased in participants in the low-dose and high-dose vaccine groups at both day 14 (geometric mean titre 421.4 [95% CI 249.7-711.3] and 820.5 [598.9-1124.0], respectively; p<0.0001) and day 28 (682.7 [424.3-1098.5] and 1305.7 [970.1-1757.2], respectively; p<0.0001). T-cell responses peaked at day 14 at a median of 465.0 spot-forming cells (IQR 180.0-1202.5) in participants in the low-dose group and 765.0 cells (400.0-1460.0) in those in the high-dose group. 21 (18%) participants had mild fever (n=9 in the placebo group, n=6 in the low-dose group, and n=6 in the high-dose group). No serious adverse events were recorded. Interpretation Our findings show that the high-dose vaccine is safe and robustly immunogenic. One shot of the high-dose vaccine could mount glycoprotein-specific humoral and T-cell response against Ebola virus in 14 days.	[Zhu, Feng-Cai; Li, Jing-Xin; Hu, Yue-Mei; Meng, Fan-Yue; Tang, Rong; Wang, Wen-Juan; Chu, Kai; Liang, Qi; Hu, Jia-Lei] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Hou, Li-Hua; Wu, Shi-Po; Xu, Jun-Jie; Zhang, Jin-Long; Chen, Wei] Beijing Inst Biotechnol, Beijing 100071, Peoples R China; [Zhang, Gui-Rong] Beijing Inst Drug & Instrument Qual Control, Beijing, Peoples R China; [Duan, Lei; Zhu, Tao] Tianjin CanSino Biotechnol Inc, Tianjin, Peoples R China; [Liu, Pei; Luo, Li] Southeast Univ, Dept Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Wang, Jun-Zhi] Natl Inst Food & Drug Control, Beijing, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Southeast University - China; National Institute of Food & Drug Control - China	Chen, W (corresponding author), Beijing Inst Biotechnol, Beijing 100071, Peoples R China.	cw0226@foxmail.com	Hu, Yue/HGE-1673-2022		China National Science and Technology; Beijing Institute of Biotechnology; Tianjin CanSino Biotechnology	China National Science and Technology; Beijing Institute of Biotechnology; Tianjin CanSino Biotechnology	China National Science and Technology, Beijing Institute of Biotechnology, and Tianjin CanSino Biotechnology.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Balter M, 2000, SCIENCE, V290, P923, DOI 10.1126/science.290.5493.923; Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003; Centers for Disease Control and Prevention, 2015, 2014 EB OUTBR W AFR; China Food and Drug Administration, STAND GUID ADV REACT; Feldmann H, 1996, ADV VIRUS RES, V47, P1, DOI 10.1016/S0065-3527(08)60733-2; Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10; Gray G, 2010, CURR OPIN HIV AIDS, V5, P357, DOI 10.1097/COH.0b013e32833d2d2b; Gray GE, 2014, LANCET INFECT DIS, V14, P388, DOI 10.1016/S1473-3099(14)70020-9; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Hu HT, 2014, P NATL ACAD SCI USA, V111, P13439, DOI 10.1073/pnas.1400446111; Kibuuka H, 2014, LANCET; Ledgerwood JE, 2010, VACCINE, V29, P304, DOI 10.1016/j.vaccine.2010.10.037; Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]; Malaeb BS, 2005, UROLOGY, V66, P830, DOI 10.1016/j.urology.2005.04.041; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Qiu XG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006605; Rampling T, 2015, NEW ENGL J MED, DOI [10.1056/NEJMoa1411627, DOI 10.1056/NEJMOA1411627, 10.1056/NEJMoa1411627.]; Schoenberger SP, 2012, P NATL ACAD SCI USA, V109, P8358, DOI 10.1073/pnas.1204616109; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; World Health Organization, 2014, WHAT THIS LARG EB OU	27	119	137	2	42	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2272	2279		10.1016/S0140-6736(15)60553-0	http://dx.doi.org/10.1016/S0140-6736(15)60553-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	25817373				2022-12-28	WOS:000355943500029
J	Yang, YT; Silverman, RD				Yang, Y. Tony; Silverman, Ross D.			Social Distancing and the Unvaccinated	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yang, Y. Tony] George Mason Univ, Dept Hlth Adm & Policy, Fairfax, VA 22030 USA; [Silverman, Ross D.] Indiana Univ, Fairbanks Sch Publ Hlth, Dept Hlth Policy & Management, Indianapolis, IN 46204 USA; [Silverman, Ross D.] Indiana Univ, McKinney Sch Law, Indianapolis, IN 46204 USA	George Mason University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Yang, YT (corresponding author), George Mason Univ, Dept Hlth Adm & Policy, Fairfax, VA 22030 USA.			Silverman, Ross D./0000-0003-4492-3096				American Academy of Pediatrics, 2013, PEDIATRICS, V131, pe1696; Centers for Disease Control and Prevention, MEASL CAS OUTBR	2	16	16	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2015	372	16					1481	1483		10.1056/NEJMp1501198	http://dx.doi.org/10.1056/NEJMp1501198			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF9BL	25806793				2022-12-28	WOS:000352856500001
J	Schoors, S; Bruning, U; Missiaen, R; Queiroz, KCS; Borgers, G; Elia, I; Zecchin, A; Cantelmo, AR; Christen, S; Goveia, J; Heggermont, W; Godde, L; Vinckier, S; Van Veldhoven, PP; Eelen, G; Schoonjans, L; Gerhardt, H; Dewerchin, M; Baes, M; De Bock, K; Ghesquiere, B; Lunt, SY; Fendt, SM; Carmeliet, P				Schoors, Sandra; Bruning, Ulrike; Missiaen, Rindert; Queiroz, Karla C. S.; Borgers, Gitte; Elia, Ilaria; Zecchin, Annalisa; Cantelmo, Anna Rita; Christen, Stefan; Goveia, Jermaine; Heggermont, Ward; Godde, Lucica; Vinckier, Stefan; Van Veldhoven, Paul P.; Eelen, Guy; Schoonjans, Luc; Gerhardt, Holger; Dewerchin, Mieke; Baes, Myriam; De Bock, Katrien; Ghesquiere, Bart; Lunt, Sophia Y.; Fendt, Sarah-Maria; Carmeliet, Peter			Fatty acid carbon is essential for dNTP synthesis in endothelial cells	NATURE			English	Article							GROWTH-FACTOR; METABOLISM; OXIDATION; TUMOR; ANGIOGENESIS; GLYCOLYSIS; CULTURE; KINASE; POOLS	The metabolism of endothelial cells during vessel sprouting remains poorly studied. Here we report that endothelial loss of CFT1A, a rate-limiting enzyme of fatty acid oxidation (FAO), causes vascular sprouting defects due to impaired proliferation, not migration, of human and murine endothelial cells. Reduction of FAO in endothelial cells did not cause energy depletion or disturb redox homeostasis, but impaired de novo nucleotide synthesis for DNA replication. Isotope labelling studies in control endothelial cells showed that fatty acid carbons substantially replenished the Krebs cycle, and were incorporated into aspartate (a nucleotide precursor), uridine monophosphate (a precursor of pyrimidine nucleoside triphosphates) and DNA. CPT1A silencing reduced these processes and depleted endothelial cell stores of aspartate and deoxyribonucleoside triphosphates. Acetate (metabolized to acetyl-CoA, thereby substituting for the depleted FAO-derived acetyl-CoA) or a nucleoside mix rescued the phenotype of CPT1A-silenceil endothelial cells. Finally, CPT1 blockade inhibited pathological ocular angiogenesis in mice, suggesting a novel strategy for blocking angiogenesis.	[Schoors, Sandra; Bruning, Ulrike; Missiaen, Rindert; Queiroz, Karla C. S.; Borgers, Gitte; Zecchin, Annalisa; Cantelmo, Anna Rita; Goveia, Jermaine; Godde, Lucica; Vinckier, Stefan; Eelen, Guy; Schoonjans, Luc; Dewerchin, Mieke; De Bock, Katrien; Ghesquiere, Bart; Carmeliet, Peter] Katholieke Univ Leuven, Dept Oncol, Lab Angiogenesis & Neurovasc Link, B-3000 Leuven, Belgium; [Schoors, Sandra; Bruning, Ulrike; Missiaen, Rindert; Queiroz, Karla C. S.; Borgers, Gitte; Zecchin, Annalisa; Cantelmo, Anna Rita; Goveia, Jermaine; Godde, Lucica; Vinckier, Stefan; Eelen, Guy; Schoonjans, Luc; Dewerchin, Mieke; De Bock, Katrien; Ghesquiere, Bart; Carmeliet, Peter] VIB, Lab Angiogenesis & Neurovasc Link, Vesalius Res Ctr, B-3000 Leuven, Belgium; [Elia, Ilaria; Christen, Stefan; Fendt, Sarah-Maria] Katholieke Univ Leuven, Dept Oncol, Lab Cellular Metab & Metab Regulat, B-3000 Leuven, Belgium; [Elia, Ilaria; Christen, Stefan; Fendt, Sarah-Maria] VIB, Lab Cellular Metab & Metab Regulat, Vesalius Res Ctr, B-3000 Leuven, Belgium; [Heggermont, Ward] Katholieke Univ Leuven, Dept Cardiovasc Res, Ctr Mol & Vasc Biol, B-3000 Leuven, Belgium; [Heggermont, Ward] UZ Leuven, Div Clin Cardiol, B-3000 Leuven, Belgium; [Van Veldhoven, Paul P.] Katholieke Univ Leuven, Lab Lipid Biochem & Prot Interact, B-3000 Leuven, Belgium; [Gerhardt, Holger] Katholieke Univ Leuven, Dept Oncol, Vasc Patterning Lab, B-3000 Leuven, Belgium; [Gerhardt, Holger] VIB, Vesalius Res Ctr, Vasc Patterning Lab, B-3000 Leuven, Belgium; [Gerhardt, Holger] Max Delbruck Ctr Mol Med, Integrat Vasc Biol Lab, D-13125 Berlin, Germany; [Baes, Myriam] Katholieke Univ Leuven, Lab Cell Metab, Dept Pharmaceut & Pharmacol Sci, B-3000 Leuven, Belgium; [De Bock, Katrien] Katholieke Univ Leuven, Exercise Physiol Res Grp, Dept Kinesiol, B-3000 Leuven, Belgium; [Lunt, Sophia Y.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Helmholtz Association; Max Delbruck Center for Molecular Medicine; KU Leuven; KU Leuven; Michigan State University	Carmeliet, P (corresponding author), Katholieke Univ Leuven, Dept Oncol, Lab Angiogenesis & Neurovasc Link, B-3000 Leuven, Belgium.	sarah-maria.fendt@vib-kuleuven.be; peter.carmeliet@vib-kuleuven.be	De Bock, Katrien/L-2273-2013; Cantelmo, Anna Rita/G-6766-2018; , Van Veldhoven Paul/U-6359-2019; Ghesquiere, Bart/HGU-8736-2022; Carmeliet, Peter/AAQ-5140-2020; Gerhardt, Holger/G-4610-2011	De Bock, Katrien/0000-0001-8232-4663; Cantelmo, Anna Rita/0000-0002-2748-264X; , Van Veldhoven Paul/0000-0002-4478-2564; Ghesquiere, Bart/0000-0003-1547-1705; Carmeliet, Peter/0000-0001-7961-1821; Gerhardt, Holger/0000-0002-3030-0384; Lunt, Sophia/0000-0003-4522-6065; Elia, Ilaria/0000-0003-0922-9429; Baes, Myriam/0000-0002-2525-2269; Fendt, Sarah-Maria/0000-0001-6018-9296	Institution of Research/Innovation (IWT); Research Foundation Flanders (FWO); Marie Curie-IEF Fellowship; CAPES (Brazil); KU Leuven; Marie Curie CIG; FWO-Odysseusll; Concern Foundation; Bayer Healthcare Pharmaceuticals; Methusalem funding (Flemish Government); FWO; Foundation Leducq Transatlantic Network (ARTEMIS); Foundation against Cancer; European Research Council (ERC) Advanced Research Grant [EU-ERC269073]; AXA Research grant; Department of Defense CDMRP Visionary Postdoctoral Award [W81XWH-12-1-0466];  [IUAP7/03]	Institution of Research/Innovation (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO)(FWO); Marie Curie-IEF Fellowship(European Commission); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); KU Leuven(KU Leuven); Marie Curie CIG; FWO-Odysseusll; Concern Foundation; Bayer Healthcare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals); Methusalem funding (Flemish Government); FWO(FWO); Foundation Leducq Transatlantic Network (ARTEMIS); Foundation against Cancer; European Research Council (ERC) Advanced Research Grant(European Research Council (ERC)); AXA Research grant(AXA Research Fund); Department of Defense CDMRP Visionary Postdoctoral Award(United States Department of Defense); 	We thank M. Vander Heiden and D. Tollervey for discussion, R. Adams for providing VE-cadherin(PAC)-Cre<SUP>ERT2</SUP> mice, and S. Rodriguez-Aristegui for synthesis of etomoxir. S.S. is funded by the Institution of Research/Innovation (IWT); R.M., B.G., A.R.C. and J.G. by the Research Foundation Flanders (FWO); U.B. by a Marie Curie-IEF Fellowship; K.C.S.Q. by CAPES (Brazil) and G.B. by KU Leuven. The work of S.-M.F. is supported by Marie Curie CIG, FWO-Odysseusll, Concern Foundation, Bayer Healthcare Pharmaceuticals. The work of P.C. is supported by IUAP7/03, Methusalem funding (Flemish Government), FWO grants, Foundation Leducq Transatlantic Network (ARTEMIS), Foundation against Cancer, European Research Council (ERC) Advanced Research Grant (EU-ERC269073) and AXA Research grant S.Y.L. was supported by the Department of Defense CDMRP Visionary Postdoctoral Award (W81XWH-12-1-0466). Views and opinions of, and endorsements by, the authors do not reflect those of the US Army or the Department of Defense. The authors thank the MSU LC-MS Core.	Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Buscher JM, 2009, ANAL CHEM, V81, P2135, DOI 10.1021/ac8022857; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Cheung EC, 2013, DEV CELL, V25, P463, DOI 10.1016/j.devcel.2013.05.001; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Dagher Z, 2001, CIRC RES, V88, P1276, DOI 10.1161/hh1201.092998; De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; FAIRBANKS LD, 1995, J BIOL CHEM, V270, P29682; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Fendt SM, 2013, CANCER RES, V73, P4429, DOI 10.1158/0008-5472.CAN-13-0080; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Geudens I, 2010, ARTERIOSCL THROM VAS, V30, P1695, DOI 10.1161/ATVBAHA.110.203034; Henry TD, 2014, NAT REV CARDIOL, V11, P78, DOI 10.1038/nrcardio.2013.200; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Korff T, 2004, EXP CELL RES, V297, P415, DOI 10.1016/j.yexcr.2004.03.043; Lunt SY, 2015, MOL CELL, V57, P95, DOI 10.1016/j.molcel.2014.10.027; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Morris GW, 2009, BIOCHEM J, V422, P513, DOI 10.1042/BJ20082427; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Scott A, 2010, EYE, V24, P416, DOI 10.1038/eye.2009.306; Thompson CB, 2014, EMBO J, V33, P1420, DOI 10.15252/embj.201488785; Vander Heiden MG, 2013, J CLIN INVEST, V123, P3648, DOI 10.1172/JCI72391; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Wilson PM, 2011, NUCLEIC ACIDS RES, V39, pE112, DOI 10.1093/nar/gkr350	35	355	361	5	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					192	U113		10.1038/nature14362	http://dx.doi.org/10.1038/nature14362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25830893	Green Accepted			2022-12-28	WOS:000352454600032
J	Perkel, JM				Perkel, Jeffrey M.			RATE THAT JOURNAL	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008					0	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					119	120		10.1038/520119a	http://dx.doi.org/10.1038/520119a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE7NE	25832406	Bronze			2022-12-28	WOS:000352027700049
J	McCormick, D; Hanchate, AD; Lasser, KE; Manze, MG; Lin, MY; Chu, C; Kressin, NR				McCormick, Danny; Hanchate, Amresh D.; Lasser, Karen E.; Manze, Meredith G.; Lin, Mengyun; Chu, Chieh; Kressin, Nancy R.			Effect of Massachusetts healthcare reform on racial and ethnic disparities in admissions to hospital for ambulatory care sensitive conditions: retrospective analysis of hospital episode statistics	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREVENTABLE HOSPITALIZATIONS; INSURANCE EXPANSION; MEDICAID COVERAGE; ACCESS; IMPACT; IMPLEMENTATION; MORTALITY; REMAINS; ADULTS; RISK	OBJECTIVES To examine the impact of Massachusetts healthcare reform on changes in rates of admission to hospital for ambulatory care sensitive conditions (ACSCs), which are potentially preventable with good access to outpatient medical care, and racial and ethnic disparities in such rates, using complete inpatient discharge data (hospital episode statistics) from Massachusetts and three control states. DESIGN Difference in differences analysis to identify the change, overall and according to race/ethnicity, adjusted for secular changes unrelated to reform. SETTING Hospitals in Massachusetts, New York, New Jersey, and Pennsylvania, United States. PARTICIPANTS Adults aged 18-64 (those most likely to have been affected by the reform) admitted for any of 12 ACSCs in the 21 months before and after the period during which reform was implemented (July 2006 to December 2007). MAIN OUTCOME MEASURES Admission rates for a composite of all 12 ACSCs, and subgroup composites of acute and chronic ACSCs. RESULTS After adjustment for potential confounders, including age, race and ethnicity, sex, and county income, unemployment rate and physician supply, we found no evidence of a change in the admission rate for overall composite ACSC (1.2%, 95% confidence interval -1.6% to 4.1%) or for subgroup composites of acute and chronic ACSCs. Nor did we find a change in disparities in admission rates between black and white people (-1.9%, -8.5% to 5.1%) or white and Hispanic people (2.0%, -7.5% to 12.4%) for overall composite ACSC that existed in Massachusetts before reform. In analyses limited to Massachusetts only, we found no evidence of a change in admission rate for overall composite ACSC between counties with higher and lower rates of uninsurance at baseline (1.4%, -2.3% to 5.3%). CONCLUSIONS Massachusetts reform was not associated with significantly lower overall or racial and ethnic disparities in rates of admission to hospital for ACSCs. In the US, and Massachusetts in particular, additional efforts might be needed to improve access to outpatient care and reduce preventable admissions.	[McCormick, Danny] Harvard Univ, Sch Med, Dept Med, Cambridge Hlth Alliance, Cambridge, MA 02139 USA; [Hanchate, Amresh D.; Kressin, Nancy R.] Vet Affairs Boston Healthcare Syst, Boston, MA 02130 USA; [Hanchate, Amresh D.; Lasser, Karen E.; Manze, Meredith G.; Lin, Mengyun; Chu, Chieh; Kressin, Nancy R.] Boston Univ, Sch Med, Sect Gen Internal Med, Boston, MA 02118 USA	Harvard University; Cambridge Health Alliance; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University	McCormick, D (corresponding author), Harvard Univ, Sch Med, Dept Med, Cambridge Hlth Alliance, Cambridge, MA 02139 USA.	mccormick@hms.harvard.edu	Dalla Zuanna, Teresa/G-3133-2015; Lin, Meng-Yun/AAF-5875-2019	Lin, Meng-Yun/0000-0002-8507-031X; Kressin, Nancy/0000-0003-2767-4286; Hanchate, Amresh/0000-0002-7038-4463	US National Institutes of Health [1U01HL105342-01]; Rx foundation; Department of Veterans Affairs, Health Services Research and Development Service [RCS 02-066-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105342] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007705] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rx foundation; Department of Veterans Affairs, Health Services Research and Development Service(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was funded by US National Institutes of Health grants (1U01HL105342-01, NRK, principal investigator) and a grant from the Rx foundation. NRK is supported in part by a senior research career scientist award from the Department of Veterans Affairs, Health Services Research and Development Service (RCS 02-066-1). The views expressed in this article are those of the authors and do not necessarily represent the views of the National Institutes of Health, the Rx foundation, Boston University, or the Department of Veterans Affairs. The funders had no role in conducting the research or writing of the manuscript.	Agency for Health Care Research and Quality, PREV QUAL IND TECHN; Agency for Health care Research and Quality (AHRQ), 2012, NAT HEALTHC DISP REP; AHRQ Quality Indicator, 2011, NAT QUAL FOR NQF END; Albert MA, 2014, CIRCULATION, V129, P2528, DOI 10.1161/CIRCULATIONAHA.113.005231; [Anonymous], 2010, HISP OR STAT COUNT T; Ansari Z, 2006, MED CARE RES REV, V63, P719, DOI 10.1177/1077558706293637; Baicker K, 2011, NEW ENGL J MED, V365, P683, DOI 10.1056/NEJMp1108222; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Bindman AB, 2008, MED CARE, V46, P1049, DOI 10.1097/MLR.0b013e318185ce24; Bindman AB, 2008, ANN INTERN MED, V149, P854, DOI 10.7326/0003-4819-149-12-200812160-00004; Buchmueller TC, 2005, MED CARE RES REV, V62, P3, DOI 10.1177/1077558704271718; Cameron A, 2005, MICROECONOMETRICS ME, DOI DOI 10.1017/CBO9780511811241; CARTER GM, 1990, J HEALTH ECON, V9, P411, DOI 10.1016/0167-6296(90)90003-L; Chandra A, 2013, BROOKINGS PAP ECO AC, P261, DOI 10.1353/eca.2013.0014; Chang CF, 2008, MED CARE RES REV, V65, P596, DOI 10.1177/1077558708318283; Clark CR, 2011, HEALTH AFFAIR, V30, P247, DOI 10.1377/hlthaff.2010.0319; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Davis K, 2014, NEW ENGL J MED, V371, P1567, DOI 10.1056/NEJMp1406707; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Galbraith AA, 2011, HEALTH AFFAIR, V30, P322, DOI 10.1377/hlthaff.2010.0584; Gaskin DJ, 2000, MED CARE RES REV, V57, P85, DOI 10.1177/107755800773743619; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Hall MA, 2010, COST ADEQUACY SAFETY; Hanchate AD, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h440; Health Resources and Services Administration, HLTH PROF SHORT AR D; Health Resources and Services Administration US Department of Health and Human Services, AR RES FIL; HRQ Quality Indicators, PREV QUAL IND OV; Institute of Medicine of the National Academies, 2003, UNEQUAL TREATMENT CO; Joynt KE, 2013, HEALTH AFFAIR, V32, P571, DOI 10.1377/hlthaff.2012.1018; Keating NL, 2011, CANCER, V41, P1; kff.org, STAT MARK PROF; Kolstad JT, 2012, J PUBLIC ECON, V96, P909, DOI 10.1016/j.jpubeco.2012.07.003; Kolstad JT, 2010, 16012 NAT BUR EC RES; Kowalczyk L., BOSTON GLOBE; Kressin NR, 2001, ANN INTERN MED, V135, P352, DOI 10.7326/0003-4819-135-5-200109040-00012; Laditka JN, 2003, SOC SCI MED, V57, P1429, DOI 10.1016/S0277-9536(02)00539-7; Lasser KE, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2329; Levy H, 2008, ANNU REV PUBL HEALTH, V29, P399, DOI 10.1146/annurev.publhealth.28.021406.144042; Link CL, 2010, INT J HEALTH SERV, V40, P507, DOI 10.2190/HS.40.3.g; Long SK, 2008, HEALTH AFFAIR, V27, pW270, DOI 10.1377/hlthaff.27.4.w270; Long SK, 2012, HEALTH AFFAIR, V31, P444, DOI 10.1377/hlthaff.2011.0653; Long SK, 2009, AM ECON REV, V99, P508, DOI 10.1257/aer.99.2.508; Mass.gov, HLTH CAR REF GEN INF; Massachusetts Medical Society, 2009, PHYS WORKF STUD; Maxwell J, 2011, HEALTH AFFAIR, V30, P1451, DOI 10.1377/hlthaff.2011.0347; McCormick D, 2012, J GEN INTERN MED, V27, P1548, DOI 10.1007/s11606-012-2173-7; McDonough JE, 2008, HEALTH AFFAIR, V27, pW285, DOI 10.1377/hlthaff.27.4.w285; McWilliams JM, 2007, JAMA-J AM MED ASSOC, V298, P2886, DOI 10.1001/jama.298.24.2886; Miller S, 2012, INQUIRY-J HEALTH CAR, V49, P317, DOI 10.5034/inquiryjrnl_49.04.05; Miller S, 2012, J PUBLIC ECON, V96, P893, DOI 10.1016/j.jpubeco.2012.07.004; Millett C, 2010, AM J PUBLIC HEALTH, V100, P2235, DOI 10.2105/AJPH.2009.182451; New California Media (NCM), 2003, BRIDG LANG BARR HLTH; O'Neil SS, 2010, AM J PREV MED, V38, P381, DOI 10.1016/j.amepre.2009.12.026; Office of the Asistant Secretary of Planning and Evaluation/US Department of Health and Human Services, 2013, SEC 2013 POV GUID; Pande AH, 2011, AM J PREV MED, V41, P1, DOI 10.1016/j.amepre.2011.03.010; Rosano A, 2013, EUR J PUBLIC HEALTH, V23, P356, DOI 10.1093/eurpub/cks053; Schneider EC, 2002, JAMA-J AM MED ASSOC, V287, P1288, DOI 10.1001/jama.287.10.1288; Smedley BD, 2008, HEALTH AFFAIR, V27, P447, DOI 10.1377/hlthaff.27.2.447; Smulowitz PB, 2011, ANN EMERG MED, V58, P225, DOI 10.1016/j.annemergmed.2011.02.020; Sommers BD, 2014, ANN INTERN MED, V160, P585, DOI 10.7326/M13-2275; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; Stryjewski TP, 2014, HEALTH SERV RES, V49, P2086, DOI 10.1111/1475-6773.12196; Truffer CJ, 2010, HEALTH AFFAIR, V29, P522, DOI 10.1377/hlthaff.2009.1074; US Census Bureau, 2006, SMALL AR HLTH INS ES; Van der Wees PJ, 2013, MILBANK Q, V91, P663, DOI 10.1111/1468-0009.12029; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WEISSMAN JS, 1992, JAMA-J AM MED ASSOC, V268, P2388, DOI 10.1001/jama.268.17.2388; Wennberg JE, 2013, BMJ-BRIT MED J, V346, pf549; Woodword M, 2005, EPIDEMIOLOGY STUDY D; Zhu J, 2010, J GEN INTERN MED, V25, P1356, DOI 10.1007/s11606-010-1482-y	70	29	28	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2015	350								h1480	10.1136/bmj.h1480	http://dx.doi.org/10.1136/bmj.h1480			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF3HO	25833157	Green Published, hybrid			2022-12-28	WOS:000352439300003
J	Bell, KJL; Bossuyt, P; Glasziou, P; Irwig, L				Bell, Katy J. L.; Bossuyt, Patrick; Glasziou, Paul; Irwig, Les			Assessment of changes to screening programmes: why randomisation is important	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COLORECTAL-CANCER; TESTS		[Bell, Katy J. L.; Glasziou, Paul] Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia; [Bossuyt, Patrick] AMC, Clin Epidemiol, Amsterdam, Netherlands; [Irwig, Les] Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Epidemiol, Sydney, NSW 2006, Australia	Bond University; University of Amsterdam; Academic Medical Center Amsterdam; University of Sydney	Bell, KJL (corresponding author), Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia.	katy.bell@sydney.edu.au	Bell, Katy/B-9650-2013; Bossuyt, Patrick M./B-4557-2016; Glasziou, Paul/A-7832-2008; Bossuyt, Patrick M/AAR-1183-2021	Bell, Katy/0000-0002-0137-3218; Bossuyt, Patrick M./0000-0003-4427-0128; Glasziou, Paul/0000-0001-7564-073X; Bossuyt, Patrick M/0000-0003-4427-0128				Australian Government, 2005, AUSTR BOW CANC SCREE; Australian Institute of Health and Welfare Australian Government, 2012, AUSTR GOV CANC SER, V65; Davey E, 2006, LANCET, V367, P122, DOI 10.1016/S0140-6736(06)67961-0; Hol L, 2010, EUR J CANCER, V46, P2059, DOI 10.1016/j.ejca.2010.03.022; Hol L, 2009, BRIT J CANCER, V100, P1103, DOI 10.1038/sj.bjc.6604961; Houssami N, 2006, LANCET ONCOL, V7, P259, DOI 10.1016/S1470-2045(06)70617-9; Houssami N, 2013, MED J AUSTRALIA, V199, P308, DOI 10.5694/mja13.10638; Irwig L, 2006, BMJ-BRIT MED J, V332, P678, DOI 10.1136/bmj.332.7543.678; Medew J. B, 2010, SYDNEY MORNING HERAL; Stegeman I, 2014, GUT, V63, P466, DOI 10.1136/gutjnl-2013-305013; Stoffelen A., 2013, VOLKSKRANTNL; van Roon AHC, 2013, GUT, V62, P409, DOI 10.1136/gutjnl-2011-301583; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040	13	14	15	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2015	350								h1566	10.1136/bmj.h1566	http://dx.doi.org/10.1136/bmj.h1566			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3GV	25825377				2022-12-28	WOS:000352437200002
J	McEvoy, MA; Correll, N				McEvoy, M. A.; Correll, N.			Materials that couple sensing, actuation, computation, and communication	SCIENCE			English	Review							PIEZOELECTRIC SENSOR/ACTUATOR NETWORK; VARIABLE STIFFNESS MATERIALS; DISTRIBUTED CONTROL DESIGN; AD HOC; SENSOR; SYSTEMS; LOCALIZATION; CHALLENGES; CAMOUFLAGE; PRESSURE	Tightly integrating sensing, actuation, and computation into composites could enable a new generation of truly smart material systems that can change their appearance and shape autonomously. Applications for such materials include airfoils that change their aerodynamic profile, vehicles with camouflage abilities, bridges that detect and repair damage, or robotic skins and prosthetics with a realistic sense of touch. Although integrating sensors and actuators into composites is becoming increasingly common, the opportunities afforded by embedded computation have only been marginally explored. Here, the key challenge is the gap between the continuous physics of materials and the discrete mathematics of computation. Bridging this gap requires a fundamental understanding of the constituents of such robotic materials and the distributed algorithms and controls that make these structures smart.	[McEvoy, M. A.; Correll, N.] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Correll, N (corresponding author), Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA.	ncorrell@colorado.edu			Air Force Office of Scientific Research; NASA; NSF; Defense Advanced Research Projects Agency; Army Research Office	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Army Research Office	We are grateful to the Air Force Office of Scientific Research, NASA, NSF, Defense Advanced Research Projects Agency, and Army Research Office for support of this work.	Abelson H, 2000, COMMUN ACM, V43, P74, DOI 10.1145/332833.332842; Al-Karaki JN, 2004, IEEE WIREL COMMUN, V11, P6, DOI 10.1109/MWC.2004.1368893; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Beal J, 2013, FORMAL AND PRACTICAL ASPECTS OF DOMAIN-SPECIFIC LANGUAGES: RECENT DEVELOPMENTS, P436, DOI 10.4018/978-1-4666-2092-6.ch016; Berlin AA, 1997, IEEE COMPUT SCI ENG, V4, P12, DOI 10.1109/99.590851; Blaiszik BJ, 2010, ANNU REV MATER RES, V40, P179, DOI 10.1146/annurev-matsci-070909-104532; Brown E, 2010, P NATL ACAD SCI USA, V107, P18809, DOI 10.1073/pnas.1003250107; Budelmann C, 2013, J INTEL MAT SYST STR, V24, P2183, DOI 10.1177/1045389X12462647; Butera W, 2007, First IEEE International Conference on Self-Adaptive and Self-Organizing Systems, P45, DOI 10.1109/SASO.2007.60; Correll N., 2014, EXPT ROBOTICS, P227, DOI [10.1007/978-3-642-28572-1_16, DOI 10.1007/978-3-642-28572-1_16]; D'Andrea R, 2003, IEEE T AUTOMAT CONTR, V48, P1478, DOI 10.1109/TAC.2003.816954; Dahiya RS, 2010, IEEE T ROBOT, V26, P1, DOI 10.1109/TRO.2009.2033627; De Volder M, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/4/043001; Duckham M, 2012, DECENTRALIZED SPATIA; Farrow N., 2014, P 8 INT C TANG EMB E, P245, DOI [10.1145/2540930.2540967, DOI 10.1145/2540930.2540967]; FRANCESCHINI N, 1992, PHILOS T R SOC B, V337, P283, DOI 10.1098/rstb.1992.0106; Furst SJ, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/1/014011; Gandhi F, 2007, SMART MATER STRUCT, V16, P1179, DOI 10.1088/0964-1726/16/4/028; Ghasemi-Nejhad MN, 2005, J INTEL MAT SYST STR, V16, P319, DOI 10.1177/1045389X05050103; Gibson RF, 2010, COMPOS STRUCT, V92, P2793, DOI 10.1016/j.compstruct.2010.05.003; Goldstein SC, 2005, COMPUTER, V38, P99, DOI 10.1109/MC.2005.198; Greaves GN, 2011, NAT MATER, V10, P823, DOI [10.1038/NMAT3134, 10.1038/nmat3134]; Haines CS, 2014, SCIENCE, V343, P868, DOI 10.1126/science.1246906; Haroon M, 2007, PROC SPIE, V6532, DOI 10.1117/12.716644; He T., 2005, P 23 INT C DISTR COM, P46, DOI [DOI 10.1109/ICDCS.2003.1203451, 10.1109/ICDCS.2003.1203451]; Henry C, 2006, PROC SPIE, V6170, DOI 10.1117/12.659633; Hofstein A, 2004, SCI EDUC, V88, P28, DOI 10.1002/sce.10106; Hosseinmardi H, 2012, LECT NOTES COMPUT SC, V7405, P595, DOI 10.1007/978-3-642-31869-6_52; Hughes D., 2014, IEEE INT C ROB AUT I, DOI [10.1109/ICRA.2014.6907101, DOI 10.1109/ICRA.2014.6907101]; Ihn JB, 2004, SMART MATER STRUCT, V13, P609, DOI 10.1088/0964-1726/13/3/020; Intanagonwiwat C, 2002, INT CON DISTR COMP S, P457, DOI 10.1109/ICDCS.2002.1022289; Ishii Hiroshi, 2012, Interactions, V19, P38, DOI 10.1145/2065327.2065337; Ishii H., 1997, P SIGCHI C HUM FACT, P234, DOI [DOI 10.1145/258549.258715, 10.1145/258549.258715]; Islam A, 2009, INT J ADV MANUF TECH, V42, P831, DOI 10.1007/s00170-008-1660-9; Jang S, 2010, SMART STRUCT SYST, V6, P439, DOI 10.12989/sss.2010.6.5_6.439; Johnson ER, 2009, IEEE T ROBOT, V25, P1249, DOI 10.1109/TRO.2009.2032955; Kahn J. M., 1999, MobiCom'99. Proceedings of Fifth Annual ACM/IEEE International Conference on Mobile Computing and Networking, P271, DOI 10.1145/313451.313558; Katzschmann R. K., 2014, INT S EXPT ROB ISER; Klute G. K., 1999, 1999 IEEE/ASME International Conference on Advanced Intelligent Mechatronics (Cat. No.99TH8399), P221, DOI 10.1109/AIM.1999.803170; Langbort C, 2004, IEEE T AUTOMAT CONTR, V49, P1502, DOI 10.1109/TAC.2004.834123; Lanzara G, 2010, ADV MATER, V22, P4643, DOI 10.1002/adma.201000661; Leigh SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049365; Leithinger D, 2014, P 27 ANN ACM S US IN, DOI [10.1145/2642918.2647377, DOI 10.1145/2642918.2647377]; Leonhardt U, 2009, NAT MATER, V8, P537, DOI 10.1038/nmat2472; Levis P., 2005, AMBIENT INTELLIGENCE, P115, DOI [10.1007/3-540-27139-2_7, DOI 10.1007/3-540-27139-2_7]; Lifton J., 2002, Pervasive Computing. First International Conference, Pervasive 2002. Proceedings (Lecture Notes in Computer Science Vol.2414), P139; Ma KY, 2013, SCIENCE, V340, P603, DOI 10.1126/science.1231806; Ma S, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON GREEN COMPUTING AND COMMUNICATIONS, CONFERENCE ON INTERNET OF THINGS, AND CONFERENCE ON CYBER, PHYSICAL AND SOCIAL COMPUTING (GREENCOM 2012), P311, DOI 10.1109/GreenCom.2012.74; Majidi C, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/10/105017; Marchese AD, 2014, IEEE INT CONF ROBOT, P2189, DOI 10.1109/ICRA.2014.6907161; Marsden JE, 1998, COMMUN MATH PHYS, V199, P351, DOI 10.1007/s002200050505; McEvoy M. A., 2014, INT S EXPT ROB ISER; McEvoy MA, 2015, J COMPOS MATER, V49, P1799, DOI 10.1177/0021998314525982; McKnight G, 2005, P SOC PHOTO-OPT INS, V5761, P119, DOI 10.1117/12.601495; Mcknight G, 2010, J INTEL MAT SYST STR, V21, P1783, DOI 10.1177/1045389X10386399; Meng QH, 2009, COMPOS PART A-APPL S, V40, P1661, DOI 10.1016/j.compositesa.2009.08.011; Menguc Y, 2014, INT J ROBOT RES, V33, P1748, DOI 10.1177/0278364914543793; Merz R., 1994, P 1994 INT SOL FREE; Morin SA, 2012, SCIENCE, V337, P828, DOI 10.1126/science.1222149; Murray G, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/4/045002; Nespoli A, 2010, SENSOR ACTUAT A-PHYS, V158, P149, DOI 10.1016/j.sna.2009.12.020; Niiyama R., 2014, P 8 INT C TEI, VC, P49, DOI [10.1145/2540930.2540953, DOI 10.1145/2540930.2540953]; Onal CD, 2011, IEEE INT CONF ROBOT; Ou J., 2014, P 8 INT C TANG EMB E, P65, DOI [10.1145/2540930.2540971, DOI 10.1145/2540930.2540971]; Park YL, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/12/125029; Pfeifer R., 2005, JAPANESE SCI MON, V58, P48, DOI DOI 10.1007/978-3-642-00616-6_; Profita Halley, 2015, 9 INT C TANG EMB EMB, P359, DOI [10.1145/2677199.2680586, DOI 10.1145/2677199.2680586]; Salowitz N, 2013, J COMPOS MATER, V47, P97, DOI 10.1177/0021998312442900; Santi P, 2005, ACM COMPUT SURV, V37, P164, DOI 10.1145/1089733.1089736; Scattolini R, 2009, J PROCESS CONTR, V19, P723, DOI 10.1016/j.jprocont.2009.02.003; Shaikh KA, 2008, J MICROELECTROMECH S, V17, P1195, DOI 10.1109/JMEMS.2008.2003055; Shalaev VM, 2005, OPT LETT, V30, P3356, DOI 10.1364/OL.30.003356; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Skabara P. J., 2014, OXFORD MASTER SERIES, V22, DOI [10.1002/anie.201310074, DOI 10.1002/ANIE.201310074]; Someya T, 2005, P NATL ACAD SCI USA, V102, P12321, DOI 10.1073/pnas.0502392102; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Suomela J, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2431211.2431223; Takashima K, 2010, SENSOR ACTUAT A-PHYS, V164, P116, DOI 10.1016/j.sna.2010.09.010; Tan HZ, 2001, IEEE-ASME T MECH, V6, P261, DOI 10.1109/3516.951364; Teichler A, 2013, J MATER CHEM C, V1, P1910, DOI 10.1039/c2tc00255h; Thill C, 2008, AERONAUT J, V112, P117, DOI 10.1017/S0001924000002062; Tilak S., 2002, ACM SIGMOBILE MOB CO, V6, P28, DOI [10.1145/565702.565708, DOI 10.1145/565702.565708]; TOFFOLI T, 1991, PHYSICA D, V47, P263, DOI 10.1016/0167-2789(91)90296-L; Vasista S, 2012, J AIRCRAFT, V49, P11, DOI 10.2514/1.C031060; Walser RM, 2001, PROC SPIE, V4467, P1, DOI 10.1117/12.432921; Weisshaar TA, 2013, J AIRCRAFT, V50, P337, DOI 10.2514/1.C031456; Werner-Allen G., 2005, P 3 INT C EMB NETW S, P142, DOI DOI 10.1145/1098918.1098934; Yamada T, 2011, NAT NANOTECHNOL, V6, P296, DOI [10.1038/nnano.2011.36, 10.1038/NNANO.2011.36]; Yim M, 2007, IEEE ROBOT AUTOM MAG, V14, P43, DOI 10.1109/MRA.2007.339623; Yoshida K, 2012, SENSOR ACTUAT A-PHYS, V175, P101, DOI 10.1016/j.sna.2011.12.049; Yu CH, 2007, 2007 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-9, P2359; Zhao XL, 2007, SMART MATER STRUCT, V16, P1208, DOI 10.1088/0964-1726/16/4/032; Zhao XL, 2007, SMART MATER STRUCT, V16, P1218, DOI 10.1088/0964-1726/16/4/033; Zhou J, 2008, NANO LETT, V8, P3035, DOI 10.1021/nl802367t	96	345	357	31	740	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228							1261689	10.1126/science.1261689	http://dx.doi.org/10.1126/science.1261689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792332				2022-12-28	WOS:000351219600031
J	Semsarian, C; Sweeting, J; Ackerman, MJ				Semsarian, Christopher; Sweeting, Joanna; Ackerman, Michael J.			Sudden cardiac death in athletes	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COMPETITIVE SPORTS PARTICIPATION; CARDIOVASCULAR-ABNORMALITIES; HYPERTROPHIC CARDIOMYOPATHY; PERICARDIAL DISEASES; EXERCISE PHYSIOLOGY; EUROPEAN-SOCIETY; WORKING GROUP; YOUNG; RECOMMENDATIONS; CARDIOLOGY		[Semsarian, Christopher; Sweeting, Joanna] Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Newtown, NSW 2042, Australia; [Semsarian, Christopher; Sweeting, Joanna] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Semsarian, Christopher] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia; [Ackerman, Michael J.] Mayo Clin, Dept Med, Div Cardiovasc Dis, Windland Smith Rice Sudden Death Genom Lab, Rochester, MN USA; [Ackerman, Michael J.] Mayo Clin, Dept Pediat, Div Cardiovasc Dis, Windland Smith Rice Sudden Death Genom Lab, Rochester, MN USA; [Ackerman, Michael J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Div Cardiovasc Dis, Windland Smith Rice Sudden Death Genom Lab, Rochester, MN USA; [Ackerman, Michael J.] Mayo Clin, Dept Med, Div Pediat Cardiol, Windland Smith Rice Sudden Death Genom Lab, Rochester, MN USA; Mayo Clin, Dept Pediat, Div Pediat Cardiol, Windland Smith Rice Sudden Death Genom Lab, Rochester, MN USA; [Ackerman, Michael J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Div Pediat Cardiol, Windland Smith Rice Sudden Death Genom Lab, Rochester, MN USA	University of Sydney; Centenary Institute; University of Sydney; University of Sydney; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Semsarian, C (corresponding author), Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Newtown, NSW 2042, Australia.	c.semsarian@centenary.org.au	Sweeting, Joanna/AAC-2516-2020; shabana, adel M/I-6302-2013; Sweeting, Joanna/GLV-2617-2022; shabana, adel/L-4557-2019	shabana, adel M/0000-0001-8874-7341; Sweeting, Joanna/0000-0001-9497-601X; shabana, adel/0000-0001-8874-7341	NHMRC [571084]; University of Sydney; Mayo Clinic Windland Smith Rice comprehensive sudden cardiac death programme	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); Mayo Clinic Windland Smith Rice comprehensive sudden cardiac death programme	We have read and understood the BMJ policy on declaration of interests and declare: CS is the recipient of a NHMRC practitioner fellowship (No 571084). JS is the recipient of the Elizabeth and Henry Hamilton-Browne scholarship from the University of Sydney. MJA is supported by the Mayo Clinic Windland Smith Rice comprehensive sudden cardiac death programme.	Adabag AS, 2010, NAT REV CARDIOL, V7, P216, DOI 10.1038/nrcardio.2010.3; Basavarajaiah S, 2008, J AM COLL CARDIOL, V51, P1033, DOI 10.1016/j.jacc.2007.10.055; Bessem B, 2009, BRIT J SPORT MED, V43, P708, DOI 10.1136/bjsm.2008.056929; Blom MT, 2014, CIRCULATION, V130, P1868, DOI 10.1161/CIRCULATIONAHA.114.010905; BURKE AP, 1991, AM HEART J, V121, P568, DOI 10.1016/0002-8703(91)90727-Y; Hevia AC, 2011, BRIT J SPORT MED, V45, P776, DOI 10.1136/bjsm.2009.063958; Chaitman BR, 2007, CIRCULATION, V116, P2610, DOI 10.1161/CIRCULATIONAHA.107.711465; Chandra N, 2013, J AM COLL CARDIOL, V61, P1027, DOI 10.1016/j.jacc.2012.08.1032; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Corrado D, 2003, J AM COLL CARDIOL, V42, P1959, DOI 10.1016/j.jacc.2003.03.002; Corrado D, 2001, Cardiol Rev, V9, P259, DOI 10.1097/00045415-200109000-00005; Corrado D, 2007, HEART RHYTHM, V4, P520, DOI 10.1016/j.hrthm.2007.01.002; Corrado D, 2006, HERZ, V31, P553, DOI 10.1007/s00059-006-2885-8; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; Corrado D, 2013, HEART, V99, P1365, DOI 10.1136/heartjnl-2012-302160; Corrado D, 2010, EUR HEART J, V31, P243, DOI 10.1093/eurheartj/ehp473; Corrado D, 2008, J AM COLL CARDIOL, V52, P1981, DOI 10.1016/j.jacc.2008.06.053; de Noronha SV, 2009, HEART, V95, P1409, DOI 10.1136/hrt.2009.168369; Drezner JA, 2013, BRIT J SPORT MED, V47, P122, DOI 10.1136/bjsports-2012-092067; Dvorak J, 2013, BRIT J SPORT MED, V47, P1199, DOI 10.1136/bjsports-2013-092767; Ettl F, 2011, RESUSCITATION, V82, P730, DOI 10.1016/j.resuscitation.2011.02.005; Fudge J, 2014, BRIT J SPORT MED, V48, P1172, DOI 10.1136/bjsports-2014-093840; Harmon KG, 2014, BRIT J SPORT MED, V48, P1185, DOI 10.1136/bjsports-2014-093872; Harmon KG, 2014, CIRC-ARRHYTHMIA ELEC, V7, P198, DOI 10.1161/CIRCEP.113.001376; Heidbuchel H, 2012, Herzschrittmacherther Elektrophysiol, V23, P82; Heidbuchel H, 2014, EUR HEART J, V35, P3097, DOI 10.1093/eurheartj/ehu130; Iemitsu M, 2005, ACTA PHYSIOL SCAND, V185, P259, DOI 10.1111/j.1365-201X.2005.01494.x; Johnson JN, 2013, BRIT J SPORT MED, V47, P28, DOI 10.1136/bjsports-2012-091751; Johnson JN, 2012, JAMA-J AM MED ASSOC, V308, P764, DOI 10.1001/jama.2012.9334; Kuramoto N, 2008, RESUSCITATION, V79, P475, DOI 10.1016/j.resuscitation.2008.07.005; La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397; Lampert R, 2013, CIRCULATION, V127, P2021, DOI 10.1161/CIRCULATIONAHA.112.000447; Maron BJ, 2007, CIRCULATION, V115, P1643, DOI 10.1161/CIRCULATIONAHA.107.181423; Maron BJ, 2014, J AM COLL CARDIOL, V64, P83, DOI 10.1016/j.jacc.2014.05.003; Maron BJ, 2011, HEART RHYTHM, V8, P1969, DOI 10.1016/j.hrthm.2011.07.014; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1340, DOI 10.1016/j.jacc.2005.02.011; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1318, DOI 10.1016/j.jacc.2005.02.006; Papadakis M, 2013, CIRC-ARRHYTHMIA ELEC, V6, P588, DOI 10.1161/CIRCEP.113.000111; Patel V, 2012, CLIN MED, V12, P253, DOI 10.7861/clinmedicine.12-3-253; Pelliccia A, 2005, EUR HEART J, V26, P1422, DOI 10.1093/eurheartj/ehi325; Prior DL, 2012, HEART, V98, P947, DOI 10.1136/heartjnl-2011-301329; Risgaard B, 2014, HEART RHYTHM, V11, P1673, DOI 10.1016/j.hrthm.2014.05.026; Semsarian C, 2014, HEART RHYTHM, V11, P1682, DOI 10.1016/j.hrthm.2014.05.039; Sheikh N, 2014, EUR HEART J, V35, P3078; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; Toresdahl BG, 2014, HEART RHYTHM, V11, P1190, DOI 10.1016/j.hrthm.2014.04.017; van der Werf C, 2010, CIRC-ARRHYTHMIA ELEC, V3, P96, DOI 10.1161/CIRCEP.109.877142; Viskin S, 2007, HEART RHYTHM, V4, P525, DOI 10.1016/j.hrthm.2007.01.003; Wilde AAM, 2014, J AM COLL CARDIOL, V64, P1359, DOI 10.1016/j.jacc.2014.06.1192; Zipes DP, 2005, J AM COLL CARDIOL, V45, P1354, DOI 10.1016/j.jacc.2005.02.014	52	22	23	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2015	350								h1218	10.1136/bmj.h1218	http://dx.doi.org/10.1136/bmj.h1218			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KT	25786772				2022-12-28	WOS:000351571200003
J	Gopal, AD; Desai, NR; Tse, T; Ross, JS				Gopal, Anand D.; Desai, Nihar R.; Tse, Tony; Ross, Joseph S.			Reporting of Noninferiority Trials in ClinicalTrials.gov and Corresponding Publications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							EQUIVALENCE RANDOMIZED-TRIALS		[Gopal, Anand D.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Desai, Nihar R.; Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Tse, Tony] NIH, Natl Lib Med, Bethesda, MD 20892 USA	Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Ross, JS (corresponding author), Yale Univ, Sch Med, Gen Internal Med Sect, POB 208093, New Haven, CT 06520 USA.	joseph.ross@yale.edu		Ross, Joseph/0000-0002-9218-3320; Gopal, Anand/0000-0002-5386-5396; Tse, Tony/0000-0002-9906-6864	NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM008926] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 LM999999] Funding Source: Medline; NIA NIH HHS [K08 AG032886] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Dekkers OM, 2011, J CLIN EPIDEMIOL, V64, P1034, DOI 10.1016/j.jclinepi.2010.12.008; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1172, DOI 10.1001/jama.295.10.1172; Le Henanff A, 2006, JAMA-J AM MED ASSOC, V295, P1147, DOI 10.1001/jama.295.10.1147; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Schumi J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-106; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	6	16	16	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1163	1165		10.1001/jama.2015.1697	http://dx.doi.org/10.1001/jama.2015.1697			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25781447	Green Accepted, Bronze			2022-12-28	WOS:000351102500020
J	Nan, HM; Hutter, CM; Lin, Y; Jacobs, EJ; Ulrich, CM; White, E; Baron, JA; Berndt, SI; Brenner, H; Butterbach, K; Caan, BJ; Campbell, PT; Carlson, CS; Casey, G; Chang-Claude, J; Chanock, SJ; Cotterchio, M; Duggan, D; Figueiredo, JC; Fuchs, CS; Giovannucci, EL; Gong, J; Haile, RW; Harrison, TA; Hayes, RB; Hoffmeister, M; Hopper, JL; Hudson, TJ; Jenkins, MA; Jiao, S; Lindor, NM; Lemire, M; Le Marchand, L; Newcomb, PA; Ogino, S; Pflugeisen, BM; Potter, JD; Qu, CH; Rosse, SA; Rudolph, A; Schoen, RE; Schumacher, FR; Seminara, D; Slattery, ML; Thibodeau, SN; Thomas, F; Thornquist, M; Warnick, GS; Zanke, BW; Gauderman, WJ; Peters, U; Hsu, L; Chan, AT				Nan, Hongmei; Hutter, Carolyn M.; Lin, Yi; Jacobs, Eric J.; Ulrich, Cornelia M.; White, Emily; Baron, John A.; Berndt, Sonja I.; Brenner, Hermann; Butterbach, Katja; Caan, Bette J.; Campbell, Peter T.; Carlson, Christopher S.; Casey, Graham; Chang-Claude, Jenny; Chanock, Stephen J.; Cotterchio, Michelle; Duggan, David; Figueiredo, Jane C.; Fuchs, Charles S.; Giovannucci, Edward L.; Gong, Jian; Haile, Robert W.; Harrison, Tabitha A.; Hayes, Richard B.; Hoffmeister, Michael; Hopper, John L.; Hudson, Thomas J.; Jenkins, Mark A.; Jiao, Shuo; Lindor, Noralane M.; Lemire, Mathieu; Le Marchand, Loic; Newcomb, Polly A.; Ogino, Shuji; Pflugeisen, Bethann M.; Potter, John D.; Qu, Conghui; Rosse, Stephanie A.; Rudolph, Anja; Schoen, Robert E.; Schumacher, Fredrick R.; Seminara, Daniela; Slattery, Martha L.; Thibodeau, Stephen N.; Thomas, Fridtjof; Thornquist, Mark; Warnick, Greg S.; Zanke, Brent W.; Gauderman, W. James; Peters, Ulrike; Hsu, Li; Chan, Andrew T.		CCFR; GECCO	Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROSTAGLANDIN E-2 BIOSYNTHESIS; COLON-CANCER; PIK3CA MUTATION; METAANALYSIS; CYCLOOXYGENASE-2; CHEMOPREVENTION; INTERLEUKIN-16; POLYMORPHISMS	IMPORTANCE Use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with lower risk of colorectal cancer. OBJECTIVE To identify common genetic markers that may confer differential benefit from aspirin or NSAID chemoprevention, we tested gene x environment interactions between regular use of aspirin and/or NSAIDs and single-nucleotide polymorphisms (SNPs) in relation to risk of colorectal cancer. DESIGN, SETTING, AND PARTICIPANTS Case-control study using data from 5 case-control and 5 cohort studies initiated between 1976 and 2003 across the United States, Canada, Australia, and Germany and including colorectal cancer cases (n=8634) and matched controls (n=8553) ascertained between 1976 and 2011. Participants were all of European descent. EXPOSURES Genome-wide SNP data and information on regular use of aspirin and/or NSAIDs and other risk factors. MAIN OUTCOMES AND MEASURES Colorectal cancer. RESULTS Regular use of aspirin and/or NSAIDs was associated with lower risk of colorectal cancer (prevalence, 28% vs 38%; odds ratio [OR], 0.69 [95% Cl, 0.64-0.74]; P = 6.2 x 10(-28)) compared with nonregular use. In the conventional logistic regression analysis, the SNP rs2965667 at chromosome 12p12.3 near the MGST1 gene showed a genome-wide significant interaction with aspirin and/or NSAID use (P = 4.6 x 10(-9) for interaction). Aspirin and/or NSAID use was associated with a lower risk of colorectal cancer among individuals with rs2965667-TT genotype (prevalence, 28% vs 38%; OR, 0.66 [95% CI, 0.61-0.70]; P =7.7 x 10(-33)) but with a higher risk among those with rare (4%) TA or AA genotypes (prevalence, 35% vs 29%; OR, 1.89 [95% Cl, 1.27-2.81]; P = .002). In case-only interaction analysis, the SNP rs16973225 at chromosome 15q25.2 near the IL16 gene showed a genome-wide significant interaction with use of aspirin and/or NSAIDs (P = 8.2 x 10(-9) for interaction). Regular use was associated with a lower risk of colorectal cancer among individuals with rs16973225-AA genotype (prevalence, 28% vs 38%; OR, 0.66 [95% CI, 0.62-0.71]; P = 1.9 x 10(-30)) but was not associated with risk of colorectal cancer among those with less common (9%) AC or CC genotypes (prevalence, 36% vs 39%; OR, 0.97 [95% Cl, 0.78-1.20]; P = .76). CONCLUSIONS AND RELEVANCE In this genome-wide investigation of gene x environment interactions, use of aspirin and/or NSAIDs was associated with lower risk of colorectal cancer, and this association differed according to genetic variation at 2 SNPs at chromosomes 12 and 15. Validation of these findings in additional populations may facilitate targeted colorectal cancer prevention strategies.	[Nan, Hongmei] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46204 USA; [Nan, Hongmei] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Hutter, Carolyn M.; Seminara, Daniela] NHGRI, NIH, Bethesda, MD 20892 USA; [Lin, Yi; Ulrich, Cornelia M.; White, Emily; Carlson, Christopher S.; Gong, Jian; Harrison, Tabitha A.; Jiao, Shuo; Newcomb, Polly A.; Pflugeisen, Bethann M.; Potter, John D.; Qu, Conghui; Rosse, Stephanie A.; Thornquist, Mark; Warnick, Greg S.; Peters, Ulrike; Hsu, Li] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Jacobs, Eric J.; Campbell, Peter T.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Ulrich, Cornelia M.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [White, Emily; Peters, Ulrike] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Baron, John A.] Univ N Carolina, Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Berndt, Sonja I.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Brenner, Hermann; Butterbach, Katja; Hoffmeister, Michael] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Consortium DKTK, Heidelberg, Germany; [Caan, Bette J.] Kaiser Permanente Med Care Program No Calif, Div Res, Oakland, CA USA; [Casey, Graham; Figueiredo, Jane C.; Haile, Robert W.; Schumacher, Fredrick R.; Gauderman, W. James] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Chang-Claude, Jenny; Rudolph, Anja] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Cotterchio, Michelle] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada; [Duggan, David] Translat Genom Res Inst TGen, Genet Basis Human Dis Div, Phoenix, AZ USA; [Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Giovannucci, Edward L.; Chan, Andrew T.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Div Network Med, Boston, MA 02115 USA; [Hayes, Richard B.] NYU, Sch Med, Dept Populat Hlth, Div Epidemiol, New York, NY USA; [Hopper, John L.; Jenkins, Mark A.] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic 3010, Australia; [Hudson, Thomas J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Hudson, Thomas J.; Lemire, Mathieu] Ontario Inst Canc Res, Toronto, ON, Canada; [Lindor, Noralane M.] Mayo Clin, Dept Hlth Sci Res, Scottsdale, AZ USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Schoen, Robert E.] Univ Pittsburgh, Med Ctr, Dept Med & Epidemiol, Pittsburgh, PA USA; [Slattery, Martha L.] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Salt Lake City, UT USA; [Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Thibodeau, Stephen N.] Mayo Clin, Dept Med Genet, Rochester, MN USA; [Thomas, Fridtjof] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Div Biostat & Epidemiol, Memphis, TN 38163 USA; [Zanke, Brent W.] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Hsu, Li] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Chan, Andrew T.] Harvard Univ, Sch Med, Boston, MA USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Fred Hutchinson Cancer Center; American Cancer Society; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Kaiser Permanente; University of Southern California; Helmholtz Association; German Cancer Research Center (DKFZ); Cancer Care Ontario; Translational Genomics Research Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; New York University; University of Melbourne; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Mayo Clinic; Mayo Clinic Phoenix; Cancer Research Center of Hawaii; University of Hawaii System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Massey University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah; Mayo Clinic; Mayo Clinic; University of Tennessee System; University of Tennessee Health Science Center; University of Ottawa; Ottawa Hospital Research Institute; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Hsu, L (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave North,M2-B500, Seattle, WA 98109 USA.	lih@fredhutch.org; achan@mgh.harvard.edu	Jenkins, Mark/P-7803-2015; Brenner, Hermann/B-4627-2017; Berndt, Sonja I/J-8423-2016; Hoffmeister, Michael/AAB-2321-2022; Schumacher, Fredrick/R-6043-2019; Umar, Asad/AAI-4560-2020; Hoffmeister, Michael/B-5745-2012; Hoffmeister, Michael/T-7187-2019; Brenner, Hermann/ABE-6383-2020	Jenkins, Mark/0000-0002-8964-6160; Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197; Schumacher, Fredrick/0000-0002-3073-7463; Umar, Asad/0000-0002-6239-8494; Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197; Brenner, Hermann/0000-0002-6129-1572; Ogino, Shuji/0000-0002-3909-2323; Thomas, Fridtjof/0000-0003-1325-4870; Harrison, Tabitha/0000-0002-4173-7530; Caan, Bette/0000-0002-5803-310X; Cotterchio, Michelle/0000-0003-2862-7895; Potter, John/0000-0001-5439-1500; Hayes, Richard/0000-0002-0918-661X	National Cancer Institute (NCI), National Institutes of Health (NIH), US Department of Health and Human Services [U01 CA137088, RO1 CA059045]; NIH [RFA CA-95-011, R01 CA48998, P01 CA 055075, UM1 CA167552, R01137178, R01 CA137178, P01 CA 087969, RO1 CA151993, P50 CA 127003, U01 CA074783, R01 CA076366, K05 CA154337]; NCI, NIH [U01 CA122839]; NIH: Australasian Colorectal Cancer Family Registry [U01 CA097735]; Ontario Registry for Studies of Familial Colorectal Cancer [U01 CA074783]; Seattle Colorectal Cancer Family Registry [U01 CA074794]; German Research Council (Deutsche Forschungsgemeinschaft) [BR 1704/6-1, BR 1704163, BR 1704/6-4, CH 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]; Ontario Research Fund [GL2]; Canadian Institutes of Health Research; Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society Research Institute; Ontario Institute for Cancer Research through Ontario Ministry of Research and Innovation; Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, NCI, NIH, Department of Health and Human Services; National Heart, Lung, and Blood Institute, NIH, US Department of Health and Human Services [HHSN268201100046C, HH5N268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C];  [K24 DK098311]; NATIONAL CANCER INSTITUTE [U24CA097735, P50CA127003, UM1CA167551, P30CA071789, U24CA074794, K22CA095011, P30CA015083, R01CA151993, U01CA074794, U01CA164930, U01CA122839, P01CA087969, P01CA055075, R01CA137178, U24CA074783, K05CA154337, R01CA048998, P01CA053996, UM1CA167552, R01CA059045, U01CA137088, U01CA074783, U01CA097735, R01CA076366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK098311] Funding Source: NIH RePORTER	National Cancer Institute (NCI), National Institutes of Health (NIH), US Department of Health and Human Services; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH: Australasian Colorectal Cancer Family Registry; Ontario Registry for Studies of Familial Colorectal Cancer; Seattle Colorectal Cancer Family Registry; German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ontario Research Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society Research Institute; Ontario Institute for Cancer Research through Ontario Ministry of Research and Innovation; Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Division of Cancer Prevention, NCI, NIH, Department of Health and Human Services; National Heart, Lung, and Blood Institute, NIH, US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	GECCO (Genetics and Epidemiology of Colorectal Cancer Consortium) was supported by the National Cancer Institute (NCI), National Institutes of Health (NIH), US Department of Health and Human Services (U01 CA137088; RO1 CA059045). CCFR (Colon Cancer Family Registry) was supported by the NIH (RFA CA-95-011) and through cooperative agreements with members of the Colon Cancer Family Registry and prinicipal investigators. This genome wide scan was supported by the NCI, NIH, by U01 CA122839. The following Colon CFR centers contributed data to this manuscript and were supported by NIH: Australasian Colorectal Cancer Family Registry (U01 CA097735), Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783), and Seattle Colorectal Cancer Family Registry (U01 CA074794). DACHS (Darmkrebs: Chancen der Verhutung durch Screening Study) is supported by the German Research Council (Deutsche Forschungsgemeinschaft, BR 1704/6-1, BR 1704163, BR 1704/6-4 and CH 117/1-1) and the German Federal Ministry of Education and Research (01KH0404 and 01ER0814). DALS (Diet, Activity and Lifestyle Study) is suported by the NIH (R01 CA48998 to Dr Slattery). HPFS (Health Professionals Follow-up Study) is supported by the NIH (P01 CA 055075, UM1 CA167552, R01137178, RO1 CA151993, and P50 CA 127003) and the NHS (Nurses Health Study) by the NIH (R01 CA137178, P01 CA 087969, RO1 CA151993, and P50 CA 127003). Dr Chan is also supported by K24 DK098311 and is a Damon Runyon Clinical Investigator. OFCCR (Ontario Familial Colorectal Cancer Registry) is supported by the NIH through funding allocated to the Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783) (see CCFR section above). As subset of ARCTIC, OFCCR is supported by a GL2 grant from the Ontario Research Fund, the Canadian Institutes of Health Research, and the Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society Research Institute. Dr Hudson and Dr Zanke are recipients of Senior Investigator Awards from the Ontario Institute for Cancer Research, through generous support from the Ontario Ministry of Research and Innovation. PLCO (Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial) is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and by contracts from the Division of Cancer Prevention, NCI, NIH, Department of Health and Human Services. PMH-CCFR (Postmenopausal Hormone Study-Colon Cancer Family Registry) is suported by the NIH (R01 CA076366 to Dr Newcomb). VITAL (VITamins And Lifestyle) is supported by the NIH (K05 CA154337). WHI (Women's Health Initiative) is supported by the National Heart, Lung, and Blood Institute, NIH, US Department of Health and Human Services, through contracts HHSN268201100046C, HH5N268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C.	Aoyama M, 2005, CANCER RES, V65, P4587, DOI 10.1158/0008-5472.CAN-04-4630; Azimzadeh P, 2011, J GASTROINTEST LIVER, V20, P371; Begum F, 2012, NUCLEIC ACIDS RES, V40, P3777, DOI 10.1093/nar/gkr1255; Castellone MD, 2006, CANCER RES, V66, P11085, DOI 10.1158/0008-5472.CAN-06-2233; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chan AT, 2012, CANCER PREV RES, V5, P164, DOI 10.1158/1940-6207.CAPR-11-0391; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cruikshank WW, 2000, J LEUKOCYTE BIOL, V67, P757, DOI 10.1002/jlb.67.6.757; Dihlmann S, 2001, ONCOGENE, V20, P645, DOI 10.1038/sj.onc.1204123; Domingo E, 2013, J CLIN ONCOL, V31, P4297, DOI 10.1200/JCO.2013.50.0322; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Friis S, 2009, CANCER CAUSE CONTROL, V20, P731, DOI 10.1007/s10552-008-9286-7; Gala MK, 2015, CLIN CANCER RES, V21, P1543, DOI 10.1158/1078-0432.CCR-14-0877; Gerhard R, 2011, N-S ARCH PHARMACOL, V383, P285, DOI 10.1007/s00210-010-0592-8; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Hutter CM, 2012, CANCER RES, V72, P2036, DOI 10.1158/0008-5472.CAN-11-4067; Hutter CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-670; Jiao S, 2011, GENET EPIDEMIOL, V35, P597, DOI 10.1002/gepi.20608; Kamei D, 2003, J BIOL CHEM, V278, P19396, DOI 10.1074/jbc.M213290200; Kaur J, 2010, TUMOR BIOL, V31, P623, DOI 10.1007/s13277-010-0078-9; Klampfer L, 2011, CURR CANCER DRUG TAR, V11, P451, DOI 10.2174/156800911795538066; Kwon YJ, 2012, J THORAC ONCOL, V7, P20, DOI 10.1097/JTO.0b013e3182307f62; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Makar KW, 2013, CANCER CAUSE CONTROL, V24, P2059, DOI 10.1007/s10552-013-0282-1; Morgenstern R, 2011, DRUG METAB REV, V43, P300, DOI 10.3109/03602532.2011.558511; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nakanishi M, 2010, BIOCHIMIE, V92, P660, DOI 10.1016/j.biochi.2010.02.006; Nan H, 2013, JNCI-J NATL CANCER I, V105, P1852, DOI 10.1093/jnci/djt331; Pearce CL, 2013, CANCER EPIDEM BIOMAR, V22, P880, DOI 10.1158/1055-9965.EPI-12-1030-T; Pfeiffer RM, 2009, STAT SCI, V24, P547, DOI 10.1214/09-STS286; Prage EB, 2011, BIOCHEMISTRY-US, V50, P7684, DOI 10.1021/bi2010448; Rodriguez LAG, 2000, EPIDEMIOLOGY, V11, P376, DOI 10.1097/00001648-200007000-00003; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Seufert BL, 2013, CARCINOGENESIS, V34, P79, DOI 10.1093/carcin/bgs296; Sherratt PJ, 2003, BIOCHEM PHARMACOL, V66, P51, DOI 10.1016/S0006-2952(03)00206-5; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007	40	133	137	1	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1133	1142		10.1001/jama.2015.1815	http://dx.doi.org/10.1001/jama.2015.1815			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25781442	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000351102500015
J	Sisk, B				Sisk, Bryan			Time Will Tell	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ATTITUDES		St Louis Childrens Hosp, Dept Pediat, St Louis, MO 63178 USA	St. Louis Children's Hospital; Washington University (WUSTL)	Sisk, B (corresponding author), St Louis Childrens Hosp, Dept Pediat, St Louis, MO 63178 USA.	sisk_b@kids.wustl.edu		Sisk, Bryan/0000-0002-2456-2476				Mack JW, 2007, J CLIN ONCOL, V25, P5636, DOI 10.1200/JCO.2007.12.6110; Mapes CC, 1898, N Y MED J, V5, P560; NOVACK DH, 1979, JAMA-J AM MED ASSOC, V241, P897, DOI 10.1001/jama.241.9.897; OKEN D, 1961, JAMA-J AM MED ASSOC, V175, P1120, DOI 10.1001/jama.1961.03040130004002	4	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1107	1108		10.1001/jama.2015.0837	http://dx.doi.org/10.1001/jama.2015.0837			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25781437				2022-12-28	WOS:000351102500010
J	Sedgwick, P				Sedgwick, Philip			Meta-analyses: what is heterogeneity?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Gates S, 2008, BRIT MED J, V336, P130, DOI 10.1136/bmj.39412.525243.BE; Sedgwick P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8335; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e344	3	62	63	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2015	350								h1435	10.1136/bmj.h1435	http://dx.doi.org/10.1136/bmj.h1435			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KM	25778910				2022-12-28	WOS:000351570500007
J	Proctor, RN				Proctor, Robert N.			The art of medicine The cigarette catastrophe continues	LANCET			English	Editorial Material									Stanford Univ, Dept Hist, Stanford, CA 94305 USA	Stanford University	Proctor, RN (corresponding author), Stanford Univ, Dept Hist, Stanford, CA 94305 USA.	rproctor@stanford.edu						[Anonymous], 2013, TOB CONTROL SUPPL 1, V22, pi1; Brandt A, 2007, CIGARETTE CENTURY; Cunningham R, 1996, SMOKE MIRRORS THE CA; KLUGER R, 1996, ASHES TO ASHES AMERI; Oreskes N., 2010, MERCHANTS OF DOUBT; Proctor RN, 2011, GOLDEN HOLOCAUST: ORIGINS OF THE CIGARETTE CATASTROPHE AND THE CASE FOR ABOLITION, P1; Proctor RN, 2012, TOB CONTROL, V21, P87, DOI 10.1136/tobaccocontrol-2011-050338; Proctor Robert N., 1999, NAZI WAR CANC	8	8	8	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					938	939		10.1016/S0140-6736(15)60519-0	http://dx.doi.org/10.1016/S0140-6736(15)60519-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	CD2EK	25784338				2022-12-28	WOS:000350886900016
J	Hezode, C; Asselah, T; Reddy, KR; Hassanein, T; Berenguer, M; Fleischer-Stepniewska, K; Marcellin, P; Hall, C; Schnell, G; Pilot-Matias, T; Mobashery, N; Redman, R; Vilchez, RA; Pol, S				Hezode, Christophe; Asselah, Tarik; Reddy, K. Rajender; Hassanein, Tarek; Berenguer, Marina; Fleischer-Stepniewska, Katarzyna; Marcellin, Patrick; Hall, Coleen; Schnell, Gretja; Pilot-Matias, Tami; Mobashery, Niloufar; Redman, Rebecca; Vilchez, Regis A.; Pol, Stanislas			Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial	LANCET			English	Article							HCV; DASABUVIR; ABT-450/R-OMBITASVIR; SOFOSBUVIR; LEDIPASVIR; INHIBITOR	Background Hepatitis C virus (HCV) genotype 4 accounts for about 13% of global HCV infections. Because interferon-containing treatments for genotype 4 infection have low efficacy and poor tolerability, an unmet need exists for effective all-oral regimens. We examined the efficacy and safety of an all-oral interferon-free regimen of ombitasvir, an NS5A inhibitor, and paritaprevir (ABT-450), an NS3/4A protease inhibitor dosed with ritonavir (ombitasvir plus paritaprevir plus ritonavir), given with or without ribavirin. Methods In this multicentre ongoing phase 2b, randomised, open-label combination trial (PEARL-I), patients were recruited from academic, public, and private hospitals and clinics in France, Hungary, Italy, Poland, Romania, Spain, Turkey, and the USA. Eligible participants were aged 18-70 years with non-cirrhotic, chronic HCV genotype 4 infection (documented >= 6 months before screening) and plasma HCV RNA levels higher than 10 000 IU/mL. Previously untreated (treatment-naive) patients were randomly assigned (1: 1) by computer-generated randomisation lists to receive once-daily ombitasvir (25 mg) plus paritaprevir (150 mg) plus ritonavir (100 mg) with or without weight-based ribavirin for 12 weeks. Previously treated (treatment-experienced) patients who had received pegylated interferon plus ribavirin all received the ribavirin-containing regimen. The primary endpoint was a sustained virological response (HCV RNA <25 IU/mL) 12 weeks after the end of treatment (SVR 12). Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT01685203. Findings Between Aug 14, 2012, and Nov 19, 2013, 467 patients with HCV infection were screened, of whom 174 were infected with genotype 4. 135 patients were randomly assigned to treatment and received at least one dose of study medication; 86 patients were treatment-naive, of whom 44 received ombitasvir plus paritaprevir plus ritonavir and 42 received ombitasvir plus paritaprevir plus ritonavir with ribavirin, and 49 treatment-experienced patients received the ribavirin-containing regimen. In previously untreated patients, SVR 12 rates were 100% (42/42 [95% CI 91.6-100]) in the ribavirin-containing regimen and 90.9% (40/44 [95% CI 78.3-97.5]) in the ribavirin-free regimen. No statistically signifi cant differences in SVR 12 rates were noted between the treatment-naive groups (mean difference -9.16% [95% CI -1961 to 1.29]; p=0.086). All treatment-experienced patients achieved SVR 12 (49/49; 100% [95% CI 92.7-100]). In the ribavirin-free group, two (5%) of 42 treatment-naive patients had virological relapse, and one (2%) of 44 had virological breakthrough; no virological failures were recorded in the ribavirin-containing regimen. The most common adverse event was headache (14 [29%] of 49 treatment-experienced patients and 14 [33%] of 42 treatment-naive patients). No adverse event-related discontinuations or dose interruptions of study medications, including ribavirin, were noted, and only four patients (4%) of 91 receiving ribavirin required dose modification for haemoglobin less than 100 g/L or anaemia. Interpretation An interferon-free regimen of ombitasvir plus paritaprevir plus ritonavir with or without ribavirin achieved high sustained virological response rates at 12 weeks after the end of treatment and was generally well tolerated, with low rates of anaemia and treatment discontinuation in non-cirrhotic previously untreated and previously treated patients with HCV genotype 4 infection.	[Hezode, Christophe] Univ Paris Est, Hop Henri Mondor, AP HP, INSERM,Dept Hepatol & Gastroenterol, Creteil, France; [Asselah, Tarik] Univ Paris Diderot, Hop Beaujon, AP HP, INSERM,UMR,CRI,Serv Hepatol, Clichy, France; [Reddy, K. Rajender] Univ Penn, Div Gastroenterol & Hepatol, Philadelphia, PA 19104 USA; [Hassanein, Tarek] Southern Calif Liver Ctr, Coronado, CA USA; [Hassanein, Tarek] Southern Calif Res Ctr, Coronado, CA USA; [Berenguer, Marina] Univ Valencia, Hosp Univ La Fe, Hepatol Unit, Valencia, Spain; [Berenguer, Marina] Ciberehd, Valencia, Spain; [Fleischer-Stepniewska, Katarzyna] Wroclaw Med Univ, Liver Dis & Acquired Immune Deficiencies, Dept Infect Dis, Wroclaw, Poland; [Marcellin, Patrick] Hop Beaujon, AP HP, Serv Hepatol, Clichy, France; [Hall, Coleen; Schnell, Gretja; Pilot-Matias, Tami; Mobashery, Niloufar; Redman, Rebecca; Vilchez, Regis A.] AbbVie Inc, N Chicago, IL USA; [Pol, Stanislas] Univ Paris 05, Grp Hosp Cochin St Vincent De Paul, Inst Pasteur, INSERM, Paris, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania; Hospital Universitari i Politecnic La Fe; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Wroclaw Medical University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; AbbVie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Hezode, C (corresponding author), Hop Henri Mondor, Serv Hepatol & Gastroenterol, F-94010 Creteil, France.	christophe.hezode@hmn.aphp.fr	Iliescu, Laura/S-2853-2018; Berenguer, Marina/ABG-8602-2020; Hezode, Christophe/U-4659-2018	Iliescu, Laura/0000-0002-8800-4940; Berenguer, Marina/0000-0001-9246-4264; Fleischer-Stepniewska, Katarzyna/0000-0002-5188-1384	AbbVie; AbbVie Inc.	AbbVie(AbbVie); AbbVie Inc.(AbbVie)	AbbVie.; We thank Kerstin Krauss, Charles Meyer, Ingrid Facey, Cordula Ubrig, Christina Giannoulis, Christine Collins, Rakesh Tripathi, Jill Beyer, Thomas Reisch, and Preethi Krishnan of AbbVie for assistance provided in the preparation and operation of the study. This study was funded by AbbVie Inc. Editorial and medical writing support was provided by Jillian Gee, Complete Publication Solutions (Horsham, PA, USA), which was funded by AbbVie.	Abdel-Hamid M, 2007, J GEN VIROL, V88, P1526, DOI 10.1099/vir.0.82626-0; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; American Association for the Study of Liver Diseases Infectious Diseases Society of America International Antiviral Society, 2014, REC TEST MAN TREAT H; Andreone P, 2014, GASTROENTEROLOGY, V147, P359, DOI 10.1053/j.gastro.2014.04.045; Asselah T, 2012, J HEPATOL, V56, P527, DOI 10.1016/j.jhep.2011.09.008; Benhamou Y, 2013, J INFECT DIS, V208, P1000, DOI 10.1093/infdis/jit274; Brok J, 2009, COCHRANE DB SYST REV, V4; Bronowicki JP, 2014, J HEPATOL, V61, P1220, DOI 10.1016/j.jhep.2014.07.011; DeGoey DA, 2014, J MED CHEM, V57, P2047, DOI 10.1021/jm401398x; Di Lello FA, 2013, J MED VIROL, V85, P1734, DOI 10.1002/jmv.23657; Esmat G, 2012, LIVER INT, V32, P146, DOI 10.1111/j.1478-3231.2011.02704.x; Esmat GE, 2014, HEPATOLOGY, V60, p662A; European Association for the Study of the Liver, 2014, EASL REC TREATM HEP; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hezode C, 2015, GUT, V64, P948, DOI 10.1136/gutjnl-2014-307498; Kamal SM, 2007, AM J GASTROENTEROL, V102, P2582, DOI 10.1111/j.1572-0241.2007.01538.x; Kapoor R, 2014, HEPATOLOGY, V60, p321A; Koletzki D, 2010, CLIN CHEM LAB MED, V48, P1095, DOI 10.1515/CCLM.2010.236; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Krishnan P, 2015, ANTIMICROB AGENTS CH, V59, P979, DOI 10.1128/AAC.04226-14; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Menon RM, 2009, GLOBAL ANTIVIRAL J, V5, P53; Pilot-Matias T, 2015, ANTIMICROB AGENTS CH, V59, P988, DOI 10.1128/AAC.04227-14; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; World Health Organization, 2014, HEP C; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557	32	205	207	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2502	2509		10.1016/S0140-6736(15)60159-3	http://dx.doi.org/10.1016/S0140-6736(15)60159-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK9AR	25837829				2022-12-28	WOS:000356532500025
J	Shen, MM				Shen, Michael M.			The complex seeds of metastasis	NATURE			English	News Item							TUMOR-CELL HETEROGENEITY; CANCER METASTASIS; PROSTATE-CANCER; MOUSE MODEL	Analyses of prostate-cancer metastases reveal a complex cellular architecture, and show that secondary sites can be seeded by multiple cell populations derived from both the primary tumour and other metastases.	[Shen, Michael M.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Shen, Michael M.] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA; [Shen, Michael M.] Columbia Univ, Med Ctr, Dept Urol, New York, NY 10032 USA; [Shen, Michael M.] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA; [Shen, Michael M.] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Shen, MM (corresponding author), Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA.	mshen@columbia.edu	Shen, Michael M/C-7546-2009	Shen, Michael M/0000-0002-4042-1657; Shen, Mouquan/0000-0001-6448-4866	NATIONAL CANCER INSTITUTE [P01CA154293] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA154293] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Aytes A, 2013, P NATL ACAD SCI USA, V110, pE3506, DOI 10.1073/pnas.1303558110; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Hong M. K. H., 2015, NATURE COMMUN; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125	12	13	13	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					298	299		10.1038/nature14377	http://dx.doi.org/10.1038/nature14377			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25830892				2022-12-28	WOS:000352974200023
J	Zhang, DD; Gao, ZG; Zhang, KH; Kiselev, E; Crane, S; Wang, J; Paoletta, S; Yi, CY; Ma, LM; Zhang, WR; Han, GW; Liu, H; Cherezov, V; Katritch, V; Jiang, HL; Stevens, RC; Jacobson, KA; Zhao, Q; Wu, BL				Zhang, Dandan; Gao, Zhan-Guo; Zhang, Kaihua; Kiselev, Evgeny; Crane, Steven; Wang, Jiang; Paoletta, Silvia; Yi, Cuiying; Ma, Limin; Zhang, Wenru; Han, Gye Won; Liu, Hong; Cherezov, Vadim; Katritch, Vsevolod; Jiang, Hualiang; Stevens, Raymond C.; Jacobson, Kenneth A.; Zhao, Qiang; Wu, Beili			Two disparate ligand-binding sites in the human P2Y(1) receptor	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; NUCLEOTIDE RECEPTORS; PURINERGIC RECEPTORS; SMALL-MOLECULE; ANTAGONISTS; AGONIST; DISCOVERY; COMPLEX; RECOGNITION	In response to adenosine 59-diphosphate, the P2Y(1) receptor (P2Y(1)R) facilitates platelet aggregation, and thus serves as an important antithrombotic drug target. Here we report the crystal structures of the human P2Y(1)R in complex with a nucleotide antagonist MRS2500 at 2.7 angstrom resolution, and with a non-nucleotide antagonist BPTU at 2.2 angstrom resolution. The structures reveal two distinct ligand-binding sites, providing atomic details of P2Y(1)R's unique ligand-binding modes. MRS2500 recognizes a binding site within the seven transmembrane bundle of P2Y(1)R, which is different in shape and location from the nucleotide binding site in the previously determined structure of P2Y(12)R, representative of another P2YR subfamily. BPTU binds to an allosteric pocket on the external receptor interface with the lipid bilayer, making it the first structurally characterized selective G-protein-coupled receptor (GPCR) ligand located entirely outside of the helical bundle. These high-resolutioninsights into P2Y(1)R should enable discovery of new orthosteric and allosteric antithrombotic drugs with reduced adverse effects.	[Zhang, Dandan; Zhang, Kaihua; Wang, Jiang; Yi, Cuiying; Ma, Limin; Zhang, Wenru; Liu, Hong; Zhao, Qiang; Wu, Beili] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Gao, Zhan-Guo; Kiselev, Evgeny; Crane, Steven; Paoletta, Silvia; Jacobson, Kenneth A.] NIDDK, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Han, Gye Won; Cherezov, Vadim; Stevens, Raymond C.] Univ So Calif, Dept Chem, Bridge Inst, Los Angeles, CA 90089 USA; [Katritch, Vsevolod] Univ So Calif, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90089 USA; [Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China; [Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Southern California; University of Southern California; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; ShanghaiTech University	Wu, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	zhaoq@simm.ac.cn; beiliwu@simm.ac.cn	Katritch, Vsevolod/Y-2721-2019; Han, Gye Won/GLQ-8724-2022; Stevens, Raymond/K-7272-2015; Han, Gye Won/GLT-1531-2022; Zhang, Kaihua/AAD-7882-2022; Katritch, Vsevolod/Q-8357-2016; Jacobson, Kenneth Alan/A-1530-2009; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLQ-8673-2022	Han, Gye Won/0000-0003-4107-835X; Stevens, Raymond/0000-0002-4522-8725; Zhang, Kaihua/0000-0003-3734-3624; Katritch, Vsevolod/0000-0003-3883-4505; Jacobson, Kenneth Alan/0000-0001-8104-1493; Cherezov, Vadim/0000-0002-5265-3914; Zhang, Dandan/0000-0002-8863-5806	National Basic Research Program of China [2012CB518000, 2014CB910400, 2012CB910400]; CAS Strategic Priority Research Program [XDB08020300]; National Science Foundation of China [31422017, 31370729, 91313000]; National Science and Technology Major Project [2013ZX09507001]; NIDDK; NIH Intramural Research Program [Z01 DK031116-26]; National Institutes of Health [U54 GM094618]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031126, Z01DK031116, ZIADK031116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); CAS Strategic Priority Research Program; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Basic Research Program of China grants 2012CB518000, 2014CB910400 and 2012CB910400 (Q.Z., B.W.), CAS Strategic Priority Research Program XDB08020300 (B.W.), the National Science Foundation of China grants 31422017 (B.W.), 31370729 (Q.Z.) and 91313000 (H.J.), the National Science and Technology Major Project 2013ZX09507001 (H.J., Q.Z., B.W.), NIDDK, NIH Intramural Research Program grant Z01 DK031116-26 (K.A.J.), and the National Institutes of Health grant U54 GM094618 (V.C., V.K., R.C.S.). The authors thank A. Walker for assistance with manuscript preparation and S. M. Moss for technical assistance. The synchrotron radiation experiments were performed at the BL41XU of Spring-8 with approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposal no. 2014A1094 and 2014B1056). We thank the beamline staff members of the BL41XU for help with X-ray data collection.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chao HG, 2013, J MED CHEM, V56, P1704, DOI 10.1021/jm301708u; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Costanzi S, 2004, J MED CHEM, V47, P5393, DOI 10.1021/jm049914c; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fam SR, 2000, J NEUROSCI, V20, P2800; Gachet C, 2008, THROMB HAEMOSTASIS, V99, P466, DOI 10.1160/TH07-11-0673; Guo DP, 2002, DRUG DEVELOP RES, V57, P173, DOI 10.1002/ddr.10145; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hechler B, 2006, J PHARMACOL EXP THER, V316, P556, DOI 10.1124/jpet.105.094037; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Jacobson KA, 2011, PURINERG SIGNAL, V7, P305, DOI 10.1007/s11302-011-9216-0; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim HS, 2003, J MED CHEM, V46, P4974, DOI 10.1021/jm030127+; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moro S, 1998, J MED CHEM, V41, P1456, DOI 10.1021/jm970684u; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Qiao JX, 2013, J MED CHEM, V56, P9275, DOI 10.1021/jm4013906; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Srivastava A, 2014, NATURE, V513, P124, DOI 10.1038/nature13494; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Wang TC, 2013, BIOORG MED CHEM LETT, V23, P3239, DOI 10.1016/j.bmcl.2013.03.125; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yang W, 2014, J MED CHEM, V57, P6150, DOI 10.1021/jm5006226; Zerr M, 2011, CIRCULATION, V123, P2404, DOI 10.1161/CIRCULATIONAHA.110.002139; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhang J, 2014, NATURE, V509, P119, DOI 10.1038/nature13288; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	37	238	241	6	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					317	+		10.1038/nature14287	http://dx.doi.org/10.1038/nature14287			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25822790	Green Accepted			2022-12-28	WOS:000352974200031
J	Davis, JR; Luchici, A; Mosis, F; Thackery, J; Salazar, JA; Mao, YL; Dunn, GA; Betz, T; Miodownik, M; Stramer, BM				Davis, John R.; Luchici, Andrei; Mosis, Fuad; Thackery, James; Salazar, Jesus A.; Mao, Yanlan; Dunn, Graham A.; Betz, Timo; Miodownik, Mark; Stramer, Brian M.			Inter-Cellular Forces Orchestrate Contact Inhibition of Locomotion	CELL			English	Article							MICROTUBULE DYNAMICS; ACTIN CYTOSKELETON; RETROGRADE FLOW; STRESS FIBERS; CELLS; MECHANISMS; ADHESION; REORGANIZATION; FIBROBLASTS; REPULSION	Contact inhibition of locomotion (CIL) is a multifaceted process that causes many cell types to repel each other upon collision. During development, this seemingly uncoordinated reaction is a critical driver of cellular dispersion within embryonic tissues. Here, we show that Drosophila hemocytes require a precisely orchestrated CIL response for their developmental dispersal. Hemocyte collision and subsequent repulsion involves a stereotyped sequence of kinematic stages that are modulated by global changes in cytoskeletal dynamics. Tracking actin retrograde flow within hemocytes in vivo reveals synchronous reorganization of colliding actin networks through engagement of an inter-cellular adhesion. This inter-cellular actin-clutch leads to a subsequent build-up in lamellar tension, triggering the development of a transient stress fiber, which orchestrates cellular repulsion. Our findings reveal that the physical coupling of the flowing actin networks during CIL acts as a mechanotransducer, allowing cells to haptically sense each other and coordinate their behaviors.	[Davis, John R.; Luchici, Andrei; Mosis, Fuad; Thackery, James; Salazar, Jesus A.; Dunn, Graham A.; Stramer, Brian M.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Luchici, Andrei; Miodownik, Mark] UCL, Dept Mech Engn, London WC2R 2LS, England; [Mao, Yanlan] UCL, Mol Cell Biol Lab, London WC1E 6BT, England; [Betz, Timo] Inst Curie, Ctr Rech, UMR168, Paris, France	University of London; King's College London; University of London; University College London; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Miodownik, M (corresponding author), UCL, Dept Mech Engn, London WC2R 2LS, England.	m.miodownik@ucl.ac.uk; brian.m.stramer@kcl.ac.uk	Betz, Timo/ABF-9946-2021	Betz, Timo/0000-0002-1548-0655; Davis, John Robert/0000-0002-6022-0369; Stramer, Brian/0000-0001-7034-3269	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F020635/1]; French Agence Nationale de la Recherche (ANR) [ANR-11-JSV5-0002]; Medical Research Council (MRC); BBSRC; CMCBI at KCL; BBSRC [BB/F020635/2] Funding Source: UKRI; MRC [MR/L009056/1, G0401026] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F020635/2, BBS/B/02495, 1112060] Funding Source: researchfish; Medical Research Council [MR/L009056/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CMCBI at KCL; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank M. Peifer and D. Kiehart for fly lines. We appreciate comments on the manuscript from B. Baum, G. Charras, N. Davis, M. Dionne, P. Martin, E. Paluch, and W. Razzell. We also would like to thank N. Tapon, and P. Jordan and D. Alibhai from LRI Light Microscopy for help with laser ablations. B.M.S. was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) project grant BB/F020635/1. T.B. was supported by French Agence Nationale de la Recherche (ANR) grant ANR-11-JSV5-0002. J.R.D. was funded by the Medical Research Council (MRC). A.L. was funded by the BBSRC. We also thank the CMCBI at KCL for their support.	ABERCROMBIE M, 1970, EUR J CANCER, V6, P7, DOI 10.1016/0014-2964(70)90048-4; ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Betz T, 2011, P NATL ACAD SCI USA, V108, P13420, DOI 10.1073/pnas.1106145108; Betz T, 2009, BIOPHYS J, V96, P5130, DOI 10.1016/j.bpj.2009.03.045; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Davis JR, 2012, DEVELOPMENT, V139, P4555, DOI 10.1242/dev.082248; Doyle AD, 2012, J CELL SCI, V125, P2244, DOI 10.1242/jcs.098806; DUNN GA, 1982, PHILOS T ROY SOC B, V299, P147, DOI 10.1098/rstb.1982.0121; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; Gloushankova NA, 1998, P NATL ACAD SCI USA, V95, P4362, DOI 10.1073/pnas.95.8.4362; HEAYSMAN JE, 1973, EXP CELL RES, V78, P71, DOI 10.1016/0014-4827(73)90039-6; Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192; Homem CCF, 2009, MOL BIOL CELL, V20, P5138, DOI 10.1091/mbc.E09-02-0144; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kadir S, 2011, J CELL SCI, V124, P2642, DOI 10.1242/jcs.087965; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Peglion F, 2014, NAT CELL BIOL, V16, P639, DOI 10.1038/ncb2985; Roh-Johnson M, 2012, SCIENCE, V335, P1232, DOI 10.1126/science.1217869; Rossier OM, 2010, EMBO J, V29, P1055, DOI 10.1038/emboj.2010.2; Sandbo N, 2013, J BIOL CHEM, V288, P15466, DOI 10.1074/jbc.M113.464461; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Stramer BM, 2013, J MICROSC-OXFORD, V251, P206, DOI 10.1111/jmi.12045; Stramer B, 2010, J CELL BIOL, V189, P681, DOI 10.1083/jcb.200912134; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; VESELY P, 1973, INT J CANCER, V11, P64, DOI 10.1002/ijc.2910110108; Villar-Cervino V, 2013, NEURON, V77, P457, DOI 10.1016/j.neuron.2012.11.023; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Yam PT, 2007, J CELL BIOL, V178, P1207, DOI 10.1083/jcb.200706012; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29	42	73	73	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					361	373		10.1016/j.cell.2015.02.015	http://dx.doi.org/10.1016/j.cell.2015.02.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25799385	Green Published, hybrid			2022-12-28	WOS:000352708300027
J	Mulcahy, AW; Wynn, B; Burgette, L; Mehrotra, A				Mulcahy, Andrew W.; Wynn, Barbara; Burgette, Lane; Mehrotra, Ateev			Medicare's Step Back from Global Payments - Unbundling Postoperative Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mulcahy, Andrew W.; Wynn, Barbara; Burgette, Lane; Mehrotra, Ateev] RAND, Arlington, VA 22202 USA; [Mehrotra, Ateev] Harvard Univ, Sch Med, Boston, MA USA	RAND Corporation; Harvard University; Harvard Medical School	Mulcahy, AW (corresponding author), RAND, Arlington, VA 22202 USA.		Mehrotra, Ateev/AAO-8454-2021	Mehrotra, Ateev/0000-0003-2223-1582; Burgette, Lane/0000-0001-5945-1760				Centers for Medicare & Medicaid Services (CMS). HHS, 2014, FED REGISTER, V79, P67547; HUSSEY PS, 2012, EVID REP TECHNOL ASS, V208, P1; Miller HD, 2009, HEALTH AFFAIR, V28, P1418, DOI 10.1377/hlthaff.28.5.1418; Office of Inspector General Department of Health and Human Services, 2012, MUSC SKEL GLOB SURG; Wynn BO, 2015, DEV MODEL VALIDATION	5	7	7	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2015	372	15					1385	1387		10.1056/NEJMp1415483	http://dx.doi.org/10.1056/NEJMp1415483			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF2ZV	25853742				2022-12-28	WOS:000352417900002
J	Gupta, S; Mak, S; Detsky, AS				Gupta, Shlok; Mak, Susanna; Detsky, Allan S.			The Other Generation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gupta, Shlok; Mak, Susanna; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Gupta, Shlok; Mak, Susanna; Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Gupta, Shlok; Mak, Susanna; Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Univ Toronto, Inst Hlth Care Policy Management & Evaluat, Toronto, ON, Canada.	adetsky@mtsinai.on.ca	Mak, Susanna/C-4617-2015	Mak, Susanna/0000-0003-2193-602X				Biondi Eric, 2013, Hosp Pediatr, V3, P76; Leckie, 2013, ANCILLARY JUSTICE	2	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2015	313	13					1319	1320		10.1001/jama.2015.1082	http://dx.doi.org/10.1001/jama.2015.1082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF1OL	25849178				2022-12-28	WOS:000352315900016
J	Shah, BJ; Rughwani, N; Rose, S				Shah, Brijen J.; Rughwani, Nisha; Rose, Suzanne			Constipation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DIETARY FIBER; THERAPIES; ASSOCIATION; DYSFUNCTION; DEFECATION; MANAGEMENT; PATTERNS; PSYLLIUM; SODIUM; ADULTS											American Gastroenterological Association, 2013, Gastroenterology, V144, P211, DOI 10.1053/j.gastro.2012.10.029; Andrews CN, 2011, CAN J GASTROENTEROL, V25, P16, DOI DOI 10.1155/2011/169319; Bassotti G, 2003, ARCH SURG-CHICAGO, V138, P1302, DOI 10.1001/archsurg.138.12.1302; Belsey J, 2009, ALIMENT PHARM THER, V29, P15, DOI 10.1111/j.1365-2036.2008.03837.x; Belsey JD, 2010, INT J CLIN PRACT, V64, P944, DOI 10.1111/j.1742-1241.2010.02397.x; Bernini A, 1998, DIS COLON RECTUM, V41, P1363, DOI 10.1007/BF02237050; Beto JA, 2014, J ACAD NUTR DIET, V114, P1077, DOI 10.1016/j.jand.2013.12.009; Cash BD, 2007, REV GASTROENTEROL DI, V7, P116; Chiarioni G, 2005, GASTROENTEROLOGY, V129, P86, DOI 10.1053/j.gastro.2005.05.015; Dinning PG, 2010, NEUROGASTROENT MOTIL, V22, pE340, DOI 10.1111/j.1365-2982.2010.01597.x; Drossman DA, 2011, AM J GASTROENTEROL, V106, P14, DOI 10.1038/ajg.2010.453; Dukas L, 2003, AM J GASTROENTEROL, V98, P1790, DOI 10.1111/j.1572-0241.2003.07591.x; Fernandez-Fraga X, 2003, DIS COLON RECTUM, V46, P1218, DOI 10.1007/s10350-004-6718-7; Fleming V, 2010, AM J GERIATR PHARMAC, V8, P514, DOI 10.1016/S1543-5946(10)80003-0; Ford AC, 2014, AM J GASTROENTEROL, V109, pS2, DOI 10.1038/ajg.2014.187; Ford AC, 2011, GUT, V60, P209, DOI 10.1136/gut.2010.227132; Fukudo S, 2014, CLIN GASTROENTEROL H, VS1542-3565, P01245; Gomez-Pinilla PJ, 2011, NEUROGASTROENT MOTIL, V23, P36, DOI 10.1111/j.1365-2982.2010.01590.x; Harris Lucinda A, 2005, Manag Care Interface, V18, P23; Higgins PDR, 2004, AM J GASTROENTEROL, V99, P750, DOI 10.1111/j.1572-0241.2004.04114.x; HINDS JP, 1990, GASTROENTEROLOGY, V98, P1538, DOI 10.1016/0016-5085(90)91087-M; Kamm MA, 2011, CLIN GASTROENTEROL H, V9, P577, DOI 10.1016/j.cgh.2011.03.026; Karlbom U, 1998, INT J COLORECTAL DIS, V13, P141, DOI 10.1007/s003840050152; Landmann Ron G, 2008, Clin Colon Rectal Surg, V21, P138, DOI 10.1055/s-2008-1075863; Lembo A, 2003, NEW ENGL J MED, V349, P1360, DOI 10.1056/NEJMra020995; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lunniss PJ, 2009, NEUROGASTROENT MOTIL, V21, P31, DOI 10.1111/j.1365-2982.2009.01402.x; Markland AD, 2013, AM J GASTROENTEROL, V108, P796, DOI 10.1038/ajg.2013.73; MARLETT JA, 1987, AM J GASTROENTEROL, V82, P333; Maughan RJ, 2012, NUTR REV, V70, pS152, DOI 10.1111/j.1753-4887.2012.00531.x; McRorie JW, 1998, ALIMENT PHARM THERAP, V12, P491; Muller-Lissner SA, 2005, AM J GASTROENTEROL, V100, P232, DOI 10.1111/j.1572-0241.2005.40885.x; Patel M, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.003; Phillips RJ, 2007, AUTON NEUROSCI-BASIC, V136, P1, DOI 10.1016/j.autneu.2007.04.005; Portalatin Meredith, 2012, Clin Colon Rectal Surg, V25, P12, DOI 10.1055/s-0032-1301754; Ramkumar D, 2005, AM J GASTROENTEROL, V100, P936, DOI 10.1111/j.1572-0241.2005.40925.x; Rao Satish S C, 2009, Curr Gastroenterol Rep, V11, P278; Rao SSC, 1999, AM J PHYSIOL-GASTR L, V276, pG1221, DOI 10.1152/ajpgi.1999.276.5.G1221; Rao SSC, 2004, AM J GASTROENTEROL, V99, P2405, DOI 10.1111/j.1572-0241.2004.40453.x; Rao SSC, 2004, J CLIN GASTROENTEROL, V38, P680, DOI 10.1097/01.mcg.0000135929.78074.8c; Rao SSC, 1998, AM J GASTROENTEROL, V93, P1042; Rao SSC, 2001, NEUROGASTROENT MOTIL, V13, P591, DOI 10.1046/j.1365-2982.2001.00292.x; Reshef A, 2013, INT J COLORECTAL DIS, V28, P841, DOI 10.1007/s00384-012-1498-3; Saad RJ, 2010, AM J GASTROENTEROL, V105, P403, DOI 10.1038/ajg.2009.612; Sach Joel A., 2002, Curr Treat Options Gastroenterol, V5, P267, DOI 10.1007/s11938-002-0049-3; Schiller LR, 2001, ALIMENT PHARM THER, V15, P749, DOI 10.1046/j.1365-2036.2001.00982.x; Suares NC, 2011, ALIMENT PHARM THER, V33, P895, DOI 10.1111/j.1365-2036.2011.04602.x; Talley NJ, 2008, AM J GASTROENTEROL, V103, P820, DOI 10.1111/j.1572-0241.2008.01832.x; Thomas J, 2008, NEW ENGL J MED, V358, P2332, DOI 10.1056/NEJMoa0707377; Vuksan V, 2008, AM J CLIN NUTR, V88, P1256, DOI 10.3945/ajcn.2008.25956; WESSELIU.A, 1968, GUT, V9, P84, DOI 10.1136/gut.9.1.84; Yang J, 2012, WORLD J GASTROENTERO, V18, P7378, DOI 10.3748/wjg.v18.i48.7378	53	7	8	1	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2015	162	7								10.7326/AITC201504070	http://dx.doi.org/10.7326/AITC201504070			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW0CW	25845017				2022-12-28	WOS:000364658000002
J	Schwarz, UD				Schwarz, Udo D.			Tracking antiwear film formation	SCIENCE			English	Editorial Material							LUBRICATION					udo.schwarz@yale.edu	Schwarz, Udo/AGX-7706-2022	Schwarz, Udo/0000-0002-5361-0342				Barnes AM, 2001, TRIBOL INT, V34, P389, DOI 10.1016/S0301-679X(01)00028-7; Dowson D, 1979, HIST TRIBOLOGY; Gosvami NN, 2015, SCIENCE, V348, P102, DOI 10.1126/science.1258788; Holmberg K, 2012, TRIBOL INT, V47, P221, DOI 10.1016/j.triboint.2011.11.022; Hsu SM, 2004, TRIBOL INT, V37, P553, DOI 10.1016/j.triboint.2003.12.004; Mortier RM, 2010, CHEMISTRY AND TECHNOLOGY OF LUBRICANTS, THIRD EDITION, P1, DOI 10.1023/b105569; Nicholls MA, 2005, TRIBOL INT, V38, P15, DOI 10.1016/j.triboint.2004.05.009; Spikes H, 2004, TRIBOL LETT, V17, P469, DOI 10.1023/B:TRIL.0000044495.26882.b5; Spikes H, 2008, LUBR SCI, V20, P103, DOI 10.1002/ls.57; Tung SC, 2004, TRIBOL INT, V37, P517, DOI 10.1016/j.triboint.2004.01.013	10	28	28	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					40	41		10.1126/science.aaa3276	http://dx.doi.org/10.1126/science.aaa3276			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838366				2022-12-28	WOS:000352079500018
J	Pace, D; Khatami, A; McKenna, J; Campbell, D; Attard-Montalto, S; Birks, J; Voysey, M; White, C; Finn, A; Macloed, E; Faust, SN; Kent, AL; Heath, PT; Borrow, R; Snape, MD; Pollard, AJ				Pace, David; Khatami, Ameneh; McKenna, Jennifer; Campbell, Danielle; Attard-Montalto, Simon; Birks, Jacqueline; Voysey, Merryn; White, Catherine; Finn, Adam; Macloed, Emma; Faust, Saul N.; Kent, Alison Louise; Heath, Paul T.; Borrow, Ray; Snape, Matthew D.; Pollard, Andrew J.			Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-KINGDOM; PERSISTENCE; PROTECTION; AGE	OBJECTIVE To determine whether the immunogenicity of a single dose infant priming schedule of serogroup C meningococcal (MenC) conjugate vaccine is noninferior to a two dose priming schedule when followed by a booster dose at age 12 months. DESIGN Phase IV open label randomised controlled trial carried out from July 2010 until August 2013 SETTING Four centres in the United Kingdom and one centre in Malta. PARTICIPANTS Healthy infants aged 6-12 weeks followed up until age 24 months. INTERVENTIONS In the priming phase of the trial 509 infants were randomised in a 10: 10: 7: 4 ratio into four groups to receive either a single MenC-cross reacting material 197 (CRM) dose at 3 months; two doses of MenC-CRM at 3 and 4 months; a single MenC-polysaccharide-tetanus toxoid (TT) dose at 3 months; or no MenC doses, respectively. Haemophilus influenzae type b (Hib)-MenC-TT vaccine was administered to all infants at 12 months of age. All infants also received the nationally routinely recommended vaccines. Blood samples were taken at age 5, 12, 13, and 24 months. MAIN OUTCOME MEASURE MenC serum bactericidal antibody assay with rabbit complement (rSBA) one month after the Hib-MenC-TT vaccine. Non-inferiority was met if the lower 95% confidence limit of the difference in the mean log(10) MenC rSBA between the single dose MenC-CRM and the two dose MenC-CRM groups was >-0.35. RESULTS The primary objective was met: after a Hib-MenC-TT booster dose at 12 months of age the MenC rSBA geometric mean titres induced in infants primed with a single MenC-CRM dose were not inferior to those induced in participants primed with two MenC-CRM doses in infancy (660 (95% confidence interval 498 to 876) v 295 (220 to 398)) with a corresponding difference in the mean log10 MenC rSBA of 0.35 (0.17 to 0.53) that showed superiority of the single over the two dose schedule). Exploration of differences between the priming schedules showed that one month after Hib-MenC-TT vaccination, MenC rSBA >= 1: 8 was observed in > 96% of participants previously primed with any of the MenC vaccine schedules in infancy and in 83% of those who were not vaccinated against MenC in infancy. The MenC rSBA geometric mean titres induced by the Hib-MenC-TT boost were significantly higher in children who were primed with one rather than two MenC-CRM doses in infancy. Only priming with MenC-TT, however, induced robust MenC bactericidal antibody after the Hib-MenC-TT booster that persisted until 24 months of age. CONCLUSIONS MenC vaccination programmes with two MenC infant priming doses could be reduced to a single priming dose without reducing post-boost antibody titres. When followed by a Hib-MenC-TT booster dose, infant priming with a single MenC-TT vaccine dose induces a more robust antibody response than one or two infant doses of MenC-CRM. Bactericidal antibody induced by a single Hib-MenC-TT conjugate vaccine dose at 12 months of age (that is, a toddler only schedule), without infant priming, is not well sustained at 24 months. Because of rapid waning of MenC antibody, programmes using toddler only schedules will still need to rely on herd protection to protect infants and young children.	[Pace, David; Attard-Montalto, Simon] Mater Dei Hosp, Malta Childrens Vaccine Grp, Msida 2090, Msd, Malta; [Khatami, Ameneh; McKenna, Jennifer; Campbell, Danielle; Snape, Matthew D.; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Khatami, Ameneh; McKenna, Jennifer; Campbell, Danielle; Snape, Matthew D.; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Birks, Jacqueline] Univ Oxford, NIHR Oxford Biomed Res Ctr, Ctr Stat Med, Oxford, England; [Voysey, Merryn] Univ Oxford, Primary Care Clin Trials Unit, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [White, Catherine; Finn, Adam] Univ Hosp Bristol NHS Fdn Trust, Bristol Childrens Vaccine Ctr, Bristol, Avon, England; [White, Catherine; Finn, Adam] Univ Bristol, Bristol, Avon, England; [Macloed, Emma; Faust, Saul N.] Univ Hosp Southampton NHS Fdn Trust, Southampton NIHR Wellcome Trust Clin Res Facil, Southampton, Hants, England; [Faust, Saul N.] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Faust, Saul N.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Kent, Alison Louise; Heath, Paul T.] St Georges Univ London, St Georges Vaccine Inst, London, England; [Borrow, Ray] Manchester Royal Infirm, Publ Hlth Lab Manchester, Vaccine Evaluat Unit, Publ Hlth England, Manchester M13 9WL, Lancs, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Bristol; University of Bristol; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Southampton; St Georges University London; Public Health England; University of Manchester	Pace, D (corresponding author), Mater Dei Hosp, Malta Childrens Vaccine Grp, Msida 2090, Msd, Malta.	dpace@go.net.mt	Pace, David/AAO-8928-2021; Khatami, Ameneh/ABH-9982-2020; Faust, Saul/J-9779-2014	Pace, David/0000-0002-3275-1189; Faust, Saul/0000-0003-3410-7642; Snape, Matthew/0000-0003-0531-5426; Finn, Adam/0000-0003-1756-5668; Voysey, Merryn/0000-0001-6324-6559; Khatami, Ameneh/0000-0001-9114-6694; Heath, Paul/0000-0002-7540-7433	NIHR Oxford Biomedical Research Centre, UK; NIHR Clinical Research Network: Paediatrics; Southampton NIHR Wellcome Trust Clinical Research Facility; NIHR Respiratory Biomedical Research Unit; GlaxoSmithKline Biologicals, Belgium; European Society of Paediatric Infectious Diseases	NIHR Oxford Biomedical Research Centre, UK(National Institute for Health Research (NIHR)); NIHR Clinical Research Network: Paediatrics; Southampton NIHR Wellcome Trust Clinical Research Facility; NIHR Respiratory Biomedical Research Unit; GlaxoSmithKline Biologicals, Belgium(GlaxoSmithKline); European Society of Paediatric Infectious Diseases	The study was funded by the NIHR Oxford Biomedical Research Centre, UK, the NIHR Medicines for Children Network South West and London (now NIHR Clinical Research Network: Paediatrics), the Southampton NIHR Wellcome Trust Clinical Research Facility and NIHR Respiratory Biomedical Research Unit, GlaxoSmithKline Biologicals, Belgium, and European Society of Paediatric Infectious Diseases. This study was conducted independently from the funders. The funders were not involved in study design, data collection and analysis, interpretation of the data or in the writing of the report or its submission for publication. The final manuscript was reviewed and approved by GlaxoSmithKline Biologicals.	Ali A, 2014, PATHOG GLOB HEALTH, V108, P11, DOI 10.1179/2047773214Y.0000000126; Andrews N, 2003, CLIN DIAGN LAB IMMUN, V10, P780, DOI 10.1128/CDLI.10.5.780-786.2003; Australian Government Department of Health, NATIONAL IMMUNISATIO; Borrow R, 2003, INFECT IMMUN, V71, P5549, DOI 10.1128/IAI.71.10.5549-5555.2003; Borrow R, 2002, J INFECT DIS, V186, P1353, DOI 10.1086/344324; Borrow R, 2001, INFECT IMMUN, V69, P1568, DOI 10.1128/IAI.69.3.1568-1573.2001; Borrow R, 2013, VACCINE, V31, P4477, DOI 10.1016/j.vaccine.2013.07.083; Borrow R, 2010, CLIN VACCINE IMMUNOL, V17, P154, DOI 10.1128/CVI.00384-09; Brady MT, 2014, PEDIATRICS, V134, P400, DOI 10.1542/peds.2014-1383; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; Centers for Disease Control and Prevention (CDC), IMMUNIZATION SCHEDUL; De Wals P, 2011, PEDIATR INFECT DIS J, V30, P566, DOI 10.1097/INF.0b013e31820e8638; Diez-Domingo J, 2010, PEDIATR INFECT DIS J, V29, P768, DOI 10.1097/INF.0b013e3181d9e653; European Centre for Disease Prevention and Control (ECDC), VACCINE SCHEDULE; Fairley CK, 1996, J INFECT DIS, V174, P1360, DOI 10.1093/infdis/174.6.1360; Findlow H, 2012, PEDIATR INFECT DIS J, V31, P616, DOI 10.1097/INF.0b013e31824f34e6; Granoff DM, 2007, PEDIATR INFECT DIS J, V26, P716, DOI 10.1097/INF.0b013e3180cc2c25; Kaaijk P, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-35; Khatami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101672; Khatami A, 2011, PEDIATR INFECT DIS J, V30, P197, DOI 10.1097/INF.0b013e3181f728fd; Leach A, 1997, J INFECT DIS, V175, P200, DOI 10.1093/infdis/175.1.200; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; Pan American Health Organization, REGIONAL OFFICE FOR; Pollard AJ, 2014, LANCET, V383, P1103, DOI 10.1016/S0140-6736(14)60226-9; Pollard AJ, 2013, ARCH DIS CHILD, V98, P248, DOI 10.1136/archdischild-2012-303103; Public Health Agency of Canada, PROVINCIAL AND TERRI; Richmond P, 1999, J INFECT DIS, V179, P1569, DOI 10.1086/314753; Simpkins D, 2009, PEDIATR INFECT DIS J, V28, P1119, DOI 10.1097/INF.0b013e3181accde8; Southern J, 2006, VACCINE, V24, P215, DOI 10.1016/j.vaccine.2005.07.060; Southern J, 2009, CLIN VACCINE IMMUNOL, V16, P194, DOI 10.1128/CVI.00420-08; Stoof SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100651; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1	32	23	24	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2015	350								h1554	10.1136/bmj.h1554	http://dx.doi.org/10.1136/bmj.h1554			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3HO	25832102	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000352439300005
J	Hawkes, N				Hawkes, Nigel			Future proofing the NHS: the new care models	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Hawkes N, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3345; Iacobucci G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1362; Iacobucci G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1110	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2015	350								h1505	10.1136/bmj.h1505	http://dx.doi.org/10.1136/bmj.h1505			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3HD	25828418				2022-12-28	WOS:000352438100003
J	May, M; Brody, H				May, Mike; Brody, Herb			INDEX 2015 ASIA-PACIFIC	NATURE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S49	S49		10.1038/519S49a	http://dx.doi.org/10.1038/519S49a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VC0TG	25806692	Bronze			2022-12-28	WOS:000427294100001
J	Wolfe, BE; Dutton, RJ				Wolfe, Benjamin E.; Dutton, Rachel J.			Fermented Foods as Experimentally Tractable Microbial Ecosystems	CELL			English	Review							COMMUNITY STRUCTURE; LACTOCOCCUS-LACTIS; EVOLUTION; BACTERIAL; PATTERNS; FERMENTATIONS; DOMESTICATION; DIVERSITY; DYNAMICS; GENOMICS	Microbial communities of fermented foods have provided humans with tools for preservation and flavor development for thousands of years. These simple, reproducible, accessible, culturable, and easy-to-manipulate systems also provide opportunities for dissecting the mechanisms of microbial community formation. Fermented foods can be valuable models for processes in less tractable microbiota.	[Wolfe, Benjamin E.] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Dutton, Rachel J.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Tufts University; Harvard University	Dutton, RJ (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	rdutton@cgr.harvard.edu						Almeida M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1101; Bachmann H, 2012, GENOME RES, V22, P115, DOI 10.1101/gr.121285.111; Bayjanov JR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-68; Bokulich NA, 2014, APPL ENVIRON MICROB, V80, P5522, DOI 10.1128/AEM.00663-14; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bokulich NA, 2012, BMB REP, V45, P377, DOI 10.5483/BMBRep.2012.45.7.148; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035507; Celiker H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5643; Cheeseman K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3876; Ciani M, 2010, FEMS YEAST RES, V10, P123, DOI 10.1111/j.1567-1364.2009.00579.x; Cocolin L, 2011, MEAT SCI, V89, P296, DOI 10.1016/j.meatsci.2011.04.011; Cordero OX, 2012, P NATL ACAD SCI USA, V109, P20059, DOI 10.1073/pnas.1213344109; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Douglas GL, 2010, ANNU REV FOOD SCI T, V1, P397, DOI 10.1146/annurev.food.102308.124134; Douillard FP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S8; Fierer N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00614; German JB, 2002, CURR OPIN CLIN NUTR, V5, P653, DOI 10.1097/00075197-200211000-00007; Gibbons JG, 2012, CURR BIOL, V22, P1403, DOI 10.1016/j.cub.2012.05.033; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Grosskopf T, 2014, CURR OPIN MICROBIOL, V18, P72, DOI 10.1016/j.mib.2014.02.002; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Harcombe WR, 2014, CELL REP, V7, P1104, DOI 10.1016/j.celrep.2014.03.070; Hom EFY, 2014, SCIENCE, V345, P94, DOI 10.1126/science.1253320; Hutkins R., 2006, MICROBIOLOGY AND TEC; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Jung JY, 2011, APPL ENVIRON MICROB, V77, P2264, DOI 10.1128/AEM.02157-10; Knight S, 2015, ISME J, V9, P361, DOI 10.1038/ismej.2014.132; Lawrence D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001330; Lin XXB, 2014, APPL ENVIRON MICROB, V80, P5782, DOI 10.1128/AEM.01783-14; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Marsh AJ, 2014, FOOD MICROBIOL, V38, P171, DOI 10.1016/j.fm.2013.09.003; Marsh AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069371; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Meersman E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081559; Minervini F, 2014, INT J FOOD MICROBIOL, V171, P136, DOI 10.1016/j.ijfoodmicro.2013.11.021; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Monnet C, 2012, APPL ENVIRON MICROB, V78, P3185, DOI 10.1128/AEM.00085-12; Montel MC, 2014, INT J FOOD MICROBIOL, V177, P136, DOI 10.1016/j.ijfoodmicro.2014.02.019; Mounier J, 2008, APPL ENVIRON MICROB, V74, P172, DOI 10.1128/AEM.01338-07; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; Peay KG, 2012, P ROY SOC B-BIOL SCI, V279, P749, DOI 10.1098/rspb.2011.1230; Rossi F, 2014, FOOD MICROBIOL, V42, P232, DOI 10.1016/j.fm.2014.04.004; Sieuwerts S, 2008, APPL ENVIRON MICROB, V74, P4997, DOI 10.1128/AEM.00113-08; Steensels J, 2014, ANNU REV MICROBIOL, V68, P61, DOI 10.1146/annurev-micro-091213-113025; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Vilela DM, 2010, FOOD MICROBIOL, V27, P1128, DOI 10.1016/j.fm.2010.07.024; Watrous JD, 2011, NAT REV MICROBIOL, V9, P683, DOI 10.1038/nrmicro2634; Wolfe BE, 2014, CELL, V158, P422, DOI 10.1016/j.cell.2014.05.041	51	181	199	20	168	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					49	55		10.1016/j.cell.2015.02.034	http://dx.doi.org/10.1016/j.cell.2015.02.034			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815984	Bronze			2022-12-28	WOS:000351952200007
J	[Anonymous]				[Anonymous]			Australia	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S64	S65		10.1038/519S64a	http://dx.doi.org/10.1038/519S64a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE1WF	25806697	Bronze			2022-12-28	WOS:000351602800012
J	Jain, Y				Jain, Yogesh			PERSONAL VIEW India should screen all tuberculosis patients for drug resistant disease at diagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Jan Swasthya Sahyog Peoples Hlth Support Grp, Bilaspur 495112, India		Jain, Y (corresponding author), Jan Swasthya Sahyog Peoples Hlth Support Grp, Village & PO Ganiyari, Bilaspur 495112, India.	yogeshjain.jssbilaspur@gmail.com						Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Central TB Division Directorate General of Health Services Ministry of Health and Family Welfare, 2012, GUID PROGR MAN DRUG; Chang KC, 2011, THORAX, V66, P997, DOI 10.1136/thx.2010.148585; Denkinger CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084197; Farmer P., 1999, INFECT INEQUALITIES, P244; Government of India, 2018, GUIDELINES CLIN OPER; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; Srivastava K., 2015, DNA; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, GLOB TUB REP 2014; World Health Organization, TUB COUNTR PROF IND; World Health Organization, TB DIAGN LAB STRENGT; World Health Organization, MAPS IND DIAGN NOT T; World Health Organization, GUID PROGR MAN DRUG, P11	14	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2015	350								h1235	10.1136/bmj.h1235	http://dx.doi.org/10.1136/bmj.h1235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NK	25805835				2022-12-28	WOS:000352028400002
J	Stupple, A				Stupple, Aaron			PERSONAL VIEW Training in communication skills should be integrated with mandatory resuscitation training	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Stupple, A (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.	astupple@gmail.com						Institute of Medicine, 2014, DYING IN AMERICA IMP	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2015	350								h1405	10.1136/bmj.h1405	http://dx.doi.org/10.1136/bmj.h1405			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KV	25791831				2022-12-28	WOS:000351571400003
J	Bruins, FG; van Deudekom, FJA; de Vries, HJC				Bruins, F. G.; van Deudekom, F. J. A.; de Vries, H. J. C.			Syphilitic condylomata lata mimicking anogenital warts	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS		[Bruins, F. G.] DermaPark, Clin Dermatol, Uden, Netherlands; [van Deudekom, F. J. A.] Kennemergasthuis, Dept Internal Med, Haarlem, Netherlands; [de Vries, H. J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1100 DD Amsterdam, Netherlands; [de Vries, H. J. C.] Publ Hlth Serv Amsterdam, STI Outpatient Clin, Amsterdam, Netherlands; [de Vries, H. J. C.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands	Spaarne Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Vries, HJC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1100 DD Amsterdam, Netherlands.	h.j.devries@amc.nl	de Vries, Henry/K-5963-2012	de Vries, Henry/0000-0001-9784-547X				ANDERSON J, 1989, GENITOURIN MED, V65, P239; de Vries HJC, 2014, CLIN DERMATOL, V32, P196, DOI 10.1016/j.clindermatol.2013.08.003; Edwards L, 2011, GENITAL DERMATOLOGY, P205; Gearhart PA, HUMAN PAPILLOMAVIRUS; Heymans R, 2010, J CLIN MICROBIOL, V48, P497, DOI 10.1128/JCM.00720-09; Kohl KS, 1999, SEX TRANSM DIS, V26, P201, DOI 10.1097/00007435-199904000-00003; Public Health England, 2014, HLTH PROTECTION REPO, V8	7	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2015	350								h1259	10.1136/bmj.h1259	http://dx.doi.org/10.1136/bmj.h1259			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KO	25784708				2022-12-28	WOS:000351570700004
J	Valgimigli, M; Gagnor, A; Calabro, P; Frigoli, E; Leonardi, S; Zaro, T; Rubartelli, P; Briguori, C; Ando, G; Repetto, A; Limbruno, U; Cortese, B; Sganzerla, P; Lupi, A; Galli, M; Colangelo, S; Ierna, S; Ausiello, A; Presbitero, P; Sardella, G; Varbella, F; Esposito, G; Santarelli, A; Tresoldi, S; Nazzaro, M; Zingarelli, A; de Cesare, N; Rigattieri, S; Tosi, P; Palmieri, C; Brugaletta, S; Rao, SV; Heg, D; Rothenbuhler, M; Vranckx, P; Juni, P				Valgimigli, Marco; Gagnor, Andrea; Calabro, Paolo; Frigoli, Enrico; Leonardi, Sergio; Zaro, Tiziana; Rubartelli, Paolo; Briguori, Carlo; Ando, Giuseppe; Repetto, Alessandra; Limbruno, Ugo; Cortese, Bernardo; Sganzerla, Paolo; Lupi, Alessandro; Galli, Mario; Colangelo, Salvatore; Ierna, Salvatore; Ausiello, Arturo; Presbitero, Patrizia; Sardella, Gennaro; Varbella, Ferdinando; Esposito, Giovanni; Santarelli, Andrea; Tresoldi, Simone; Nazzaro, Marco; Zingarelli, Antonio; de Cesare, Nicoletta; Rigattieri, Stefano; Tosi, Paolo; Palmieri, Cataldo; Brugaletta, Salvatore; Rao, Sunil V.; Heg, Dik; Rothenbuehler, Martina; Vranckx, Pascal; Jueni, Peter		MATRIX Investigators	Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial	LANCET			English	Article							ST-SEGMENT ELEVATION; ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR DATA REGISTRY; LEARNING-CURVE; INTERVENTION; ASSOCIATION; SITE; ANGIOGRAPHY; OUTCOMES; METAANALYSIS	Background It is unclear whether radial compared with femoral access improves outcomes in unselected patients with acute coronary syndromes undergoing invasive management. Methods We did a randomised, multicentre, superiority trial comparing transradial against transfemoral access in patients with acute coronary syndrome with or without ST-segment elevation myocardial infarction who were about to undergo coronary angiography and percutaneous coronary intervention. Patients were randomly allocated (1: 1) to radial or femoral access with a web-based system. The randomisation sequence was computer generated, blocked, and stratified by use of ticagrelor or prasugrel, type of acute coronary syndrome (ST-segment elevation myocardial infarction, troponin positive or negative, non-ST-segment elevation acute coronary syndrome), and anticipated use of immediate percutaneous coronary intervention. Outcome assessors were masked to treatment allocation. The 30-day coprimary outcomes were major adverse cardiovascular events, defined as death, myocardial infarction, or stroke, and net adverse clinical events, defined as major adverse cardiovascular events or Bleeding Academic Research Consortium (BARC) major bleeding unrelated to coronary artery bypass graft surgery. The analysis was by intention to treat. The two-sided a was prespecified at 0.025. The trial is registered at ClinicalTrials.gov, number NCT01433627. Findings We randomly assigned 8404 patients with acute coronary syndrome, with or without ST-segment elevation, to radial (4197) or femoral (4207) access for coronary angiography and percutaneous coronary intervention. 369 (8.8%) patients with radial access had major adverse cardiovascular events, compared with 429 (10.3%) patients with femoral access (rate ratio [RR] 0.85, 95% CI 0.74-0.99; p = 0.0307), non-significant at a of 0.025. 410 (9.8%) patients with radial access had net adverse clinical events compared with 486 (11.7%) patients with femoral access (0.83, 95% CI 0.73-0.96; p = 0.0092). The difference was driven by BARC major bleeding unrelated to coronary artery bypass graft surgery (1.6% vs 2.3%, RR 0.67, 95% CI 0.49-0.92; p= 0.013) and all-cause mortality (1.6% vs 2.2%, RR 0.72, 95% CI 0.53-0.99; p = 0.045). Interpretation In patients with acute coronary syndrome undergoing invasive management, radial as compared with femoral access reduces net adverse clinical events, through a reduction in major bleeding and all-cause mortality. Funding The Medicines Company and Terumo.	[Valgimigli, Marco] Erasmus MC, Thoraxctr, Rotterdam, Netherlands; [Gagnor, Andrea; Frigoli, Enrico; Varbella, Ferdinando] Osped Riuniti Rivoli, ASL Torino 3, Cardiol Unit, Turin, Italy; [Calabro, Paolo] Univ Naples 2, Div Cardiol, Dept Cardiothorac Sci, Naples, Italy; [Frigoli, Enrico] EUSTRATEGY Assoc, Forli, Italy; [Leonardi, Sergio; Repetto, Alessandra] Fdn IRCCS Policlin San Matteo, Dipartimento CardioToracoVasc, UOC Cardiol, Pavia, Italy; [Zaro, Tiziana] AO Osped Civile Vimercate MB, Vimercate, Italy; [Rubartelli, Paolo] ASL3 Osped Villa Scassi, Dept Cardiol, Genoa, Italy; [Briguori, Carlo] Clin Mediterranea, Naples, Italy; [Ando, Giuseppe] Univ Messina, Azienda Osped Univ Policlin Gaetano Martino, Messina, Italy; [Limbruno, Ugo] ASL 9 Grosseto, UO Cardiol, Grosseto, Italy; [Cortese, Bernardo] Osped Fate Bene Fratelli, Milan, Italy; [Sganzerla, Paolo] AO Osped Treviglio Caravaggio, Treviglio Bg, Italy; [Lupi, Alessandro] Univ Hosp Maggiore della Carita, Novara, Italy; [Galli, Mario] Osped St Anna, Como, Italy; [Colangelo, Salvatore] San Giovanni Bosco Hosp, Turin, Italy; [Ierna, Salvatore] Osped Sirai Carbonia, Carbonia, Italy; [Ausiello, Arturo] Casa Cura Villa Verde, Taranto, Italy; [Presbitero, Patrizia] IRCCS Humanitas, Rozzano, Italy; [Sardella, Gennaro] Univ Roma La Sapienza, Dept Cardiovasc Resp Nephrol Anesthesiol & Geriat, Policlin Umberto 1, I-00185 Rome, Italy; [Esposito, Giovanni] Univ Naples Federico II, Div Cardiol, Dept Adv Biomed Sci, Naples, Italy; [Santarelli, Andrea] Infermi Hosp, Cardiovasc Dept, Rimini, Italy; [Tresoldi, Simone] AO Osped Desio MB, Desio, Italy; [Nazzaro, Marco] San Camillo Forlanini, Rome, Italy; [Zingarelli, Antonio] IRCCS AOU San Martino, Genoa, Italy; [de Cesare, Nicoletta] Policlin San Marco, Zingonia, Italy; [Rigattieri, Stefano] Sandro Pertini Hosp, Intervent Cardiol, Rome, Italy; [Tosi, Paolo] Mater Salutis Hosp Legnago, Verona, Italy; [Palmieri, Cataldo] Osped Pasquinucci, Massa, Italy; [Brugaletta, Salvatore] Univ Barcelona, Hosp Clin, Thorax Inst, Dept Cardiol, Barcelona, Spain; [Rao, Sunil V.] Duke Clin Res Inst, Durham, NC USA; [Vranckx, Pascal] Jessa Ziekenhuis, Hartctr Hasselt, Dept Cardiol & Crit Care Med, Hasselt, Belgium; [Heg, Dik; Rothenbuehler, Martina; Jueni, Peter] Univ Bern, Clin Trials Unit, Bern, Switzerland; [Jueni, Peter] Univ Bern, Inst Primary Hlth Care, Bern, Switzerland; Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	Erasmus University Rotterdam; Erasmus MC; Universita della Campania Vanvitelli; IRCCS Fondazione San Matteo; Mediterranean Clinic; University of Messina; Ospedale di Treviglio-Caravaggio; University of Eastern Piedmont Amedeo Avogadro; Ospedale Sant'Anna di Como; IRCCS Humanitas Research Hospital; Sapienza University Rome; University Hospital Sapienza Rome; University of Naples Federico II; Hospital of Rimini; Azienda Ospedaliera San Camillo-Forlanini; Ospedale Sandro Pertini; ULSS 9 Scaligera; Ospedale Mater Salutis di Legnago; University of Barcelona; Hospital Clinic de Barcelona; Duke University; University of Bern; University of Bern; University of Bern	Valgimigli, M (corresponding author), Erasmus MC, Thoraxctr, Ba 587, Rotterdam, Netherlands.	m.valgimigli@erasmusmc.nl	De+Servi, Stefano/AAT-2631-2021; Lupi, Alessandro/AAH-8299-2020; Portolan, Monica/E-5577-2016; Diletti, Roberto/P-2214-2014; De Caterina, Raffaele/K-3857-2016; Rigattieri, Stefano/AAL-9063-2020; Valgimigli, Marco/AAE-9103-2019; Andò, Giuseppe/E-6368-2015; Brugaletta, Salvatore/AAJ-2090-2020; Romagnoli, Enrico/M-7725-2017; Leonardi, Sergio/K-4334-2018; VARBELLA, FERDINANDO/AAA-9428-2019; Limbruno, Ugo/ACC-3935-2022; Cortese, Bernardo/M-4374-2016; Juni, Peter/Q-8700-2016; Leonardi, Sergio/AAK-1490-2020; Calabro, Paolo/AAC-2704-2022; limbruno, ugo/GPG-3729-2022; Santarelli, Andrea/AAW-9703-2021; ESPOSITO, Giovanni/F-2880-2010	Lupi, Alessandro/0000-0003-3644-0449; Portolan, Monica/0000-0002-1785-2854; De Caterina, Raffaele/0000-0003-1637-574X; Rigattieri, Stefano/0000-0001-5116-2737; Valgimigli, Marco/0000-0002-4353-7110; Andò, Giuseppe/0000-0001-5552-6382; Romagnoli, Enrico/0000-0003-1611-7708; Leonardi, Sergio/0000-0002-4800-6132; VARBELLA, FERDINANDO/0000-0002-8213-359X; Cortese, Bernardo/0000-0002-5808-7810; Juni, Peter/0000-0002-5985-0670; Leonardi, Sergio/0000-0002-4800-6132; limbruno, ugo/0000-0002-1538-2967; Heg, Dik/0000-0002-8766-7945; Santarelli, Andrea/0000-0001-7575-6118; ESPOSITO, Giovanni/0000-0003-0565-7127; Zingarelli, Antonio/0000-0002-8240-2622; Rothenbuhler, Martina/0000-0001-8009-4104; calabro, paolo/0000-0002-5018-830X; Mazzarotto, Pietro/0000-0003-3183-1141; Costa, Francesco/0000-0002-3097-2834	Medicines Company; Terumo; GISE	Medicines Company; Terumo; GISE	The Medicines Company and Terumo.; We are grateful for statistical advice from Marcel Zwahlen about the nested case-control study. Editorial support restricted to editing for style was provided by Sophie Rushton-Smith (MedLink Healthcare Communications) and was funded by the GISE.	Agostoni P, 2004, J AM COLL CARDIOL, V44, P349, DOI 10.1016/j.jacc.2004.04.034; Ball WT, 2011, CIRC-CARDIOVASC INTE, V4, P336, DOI 10.1161/CIRCINTERVENTIONS.110.960864; Bernat I, 2014, J AM COLL CARDIOL, V63, P964, DOI 10.1016/j.jacc.2013.08.1651; Bradley SM, 2014, CIRC-CARDIOVASC QUAL, V7, P550, DOI 10.1161/CIRCOUTCOMES.114.001020; Caputo RP, 2011, CATHETER CARDIO INTE, V78, P823, DOI 10.1002/ccd.23052; Chase AJ, 2008, HEART, V94, P1019, DOI 10.1136/hrt.2007.136390; Chhatriwalla AK, 2013, JAMA-J AM MED ASSOC, V309, P1022, DOI 10.1001/jama.2013.1556; Chodor P, 2009, CARDIOL J, V16, P332; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dauerman HL, 2011, J AM COLL CARDIOL, V58, P1, DOI 10.1016/j.jacc.2011.02.039; Eleid MF, 2013, JACC-CARDIOVASC INTE, V6, P1145, DOI 10.1016/j.jcin.2013.08.002; Hamon M, 2013, EUROINTERVENTION, V8, P1242, DOI 10.4244/EIJV8I11A192; Hess CN, 2014, CIRCULATION, V129, P2277, DOI 10.1161/CIRCULATIONAHA.113.006356; Jneid H, 2012, CIRCULATION, V126, P875, DOI 10.1161/CIR.0b013e318256f1e0; Jolly SS, 2014, J AM COLL CARDIOL, V63, P954, DOI 10.1016/j.jacc.2013.10.052; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Joyal D, 2012, AM J CARDIOL, V109, P813, DOI 10.1016/j.amjcard.2011.11.007; King Spencer B 3rd, 2008, J Am Coll Cardiol, V51, P172, DOI 10.1016/j.jacc.2007.10.002; Lee MS, 2013, JACC-CARDIOVASC INTE, V6, P1149, DOI 10.1016/j.jcin.2013.08.003; Majure DT, 2006, NEW ENGL J MED, V354, P2829; Mehta SR, 2012, J AM COLL CARDIOL, V60, P2490, DOI 10.1016/j.jacc.2012.07.050; Ratib K, 2015, JACC-CARDIOVASC INTE, V8, P20, DOI 10.1016/j.jcin.2014.06.026; Romagnoli E, 2012, J AM COLL CARDIOL, V60, P2481, DOI 10.1016/j.jacc.2012.06.017; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Valgimigli M, 2014, AM HEART J, V168, P838, DOI 10.1016/j.ahj.2014.08.013; Valgimigli M, 2014, J AM COLL CARDIOL, V63, P1833, DOI 10.1016/j.jacc.2013.12.043; Valgimigli M, 2014, J CARDIOVASC TRANSL, V7, P101, DOI 10.1007/s12265-013-9537-1; Valgimigli M, 2012, JACC-CARDIOVASC INTE, V5, P23, DOI 10.1016/j.jcin.2011.08.018; Vranckx P, 2012, EUROINTERVENTION, V8, P71, DOI 10.4244/EIJV8I1A12	30	813	845	6	54	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2465	2476		10.1016/S0140-6736(15)60292-6	http://dx.doi.org/10.1016/S0140-6736(15)60292-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK9AR	25791214				2022-12-28	WOS:000356532500021
J	Palmerini, T; Benedetto, U; Bacchi-Reggiani, L; Della Riva, D; Biondi-Zoccai, G; Feres, F; Abizaid, A; Hong, MK; Kim, BK; Jang, Y; Kim, HS; Park, KW; Genereux, P; Bhatt, DL; Orlandi, C; De Servi, S; Petrou, M; Rapezzi, C; Stone, GW				Palmerini, Tullio; Benedetto, Umberto; Bacchi-Reggiani, Letizia; Della Riva, Diego; Biondi-Zoccai, Giuseppe; Feres, Fausto; Abizaid, Alexandre; Hong, Myeong-Ki; Kim, Byeong-Keuk; Jang, Yangsoo; Kim, Hyo-Soo; Park, Kyung Woo; Genereux, Philippe; Bhatt, Deepak L.; Orlandi, Carlotta; De Servi, Stefano; Petrou, Mario; Rapezzi, Claudio; Stone, Gregg W.			Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials	LANCET			English	Article							THROMBOSIS; EFFICACY; OUTCOMES; SAFETY	Background Despite recent studies, the optimum duration of dual antiplatelet therapy (DAPT) after coronary drug-eluting stent placement remains uncertain. We performed a meta-analysis with several analytical approaches to investigate mortality and other clinical outcomes with different DAPT strategies. Methods We searched Medline, Embase, Cochrane databases, and proceedings of international meetings on Nov 20, 2014, for randomised controlled trials comparing different DAPT durations after drug-eluting stent implantation. We extracted study design, inclusion and exclusion criteria, sample characteristics, and clinical outcomes. DAPT duration was categorised in each study as shorter versus longer, and as 6 months or shorter versus 1 year versus longer than 1 year. Analyses were done by both frequentist and Bayesian approaches. Findings We identified ten trials published between Dec 16, 2011, and Nov 16, 2014, including 31 666 randomly assigned patients. By frequentist pairwise meta-analysis, shorter DAPT was associated with significantly lower all-cause mortality compared with longer DAPT (HR 0.82, 95% CI 0.69-0.98; p=0.02; number needed to treat [NNT]=325), with no significant heterogeneity apparent across trials. The reduced mortality with shorter compared with longer DAPT was attributable to lower non-cardiac mortality (0.67, 0.51-0.89; p=0.006; NNT=347), with similar cardiac mortality (0.93, 0.73-1.17; p=0.52). Shorter DAPT was also associated with a lower risk of major bleeding, but a higher risk of myocardial infarction and stent thrombosis. We noted similar results in a Bayesian framework with non-informative priors. By network meta-analysis, patients treated with 6-month or shorter DAPT and 1-year DAPT had higher risk of myocardial infarction and stent thrombosis but lower risk of mortality compared with patients treated with DAPT for longer than 1 year. Patients treated with DAPT for 6 months or shorter had similar rates of mortality, myocardial infarction, and stent thrombosis, but lower rates of major bleeding than did patients treated with 1-year DAPT. Interpretation Although treatment with DAPT beyond 1 year after drug-eluting stent implantation reduces myocardial infarction and stent thrombosis, it is associated with increased mortality because of an increased risk of non-cardiovascular mortality not off set by a reduction in cardiac mortality.	[Palmerini, Tullio; Bacchi-Reggiani, Letizia; Della Riva, Diego; Orlandi, Carlotta; Rapezzi, Claudio] Univ Bologna, Dipartimento Cardiotoracovasc, I-40126 Bologna, Italy; [Benedetto, Umberto; Petrou, Mario] Univ Oxford, Oxford Heart Ctr, Oxford, England; [Biondi-Zoccai, Giuseppe] Sapienza Univ Rome, Dept Med Surg Sci & Biotechnol, Latina, Italy; [Feres, Fausto; Abizaid, Alexandre] Ist Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Hong, Myeong-Ki; Kim, Byeong-Keuk; Jang, Yangsoo] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Seoul, South Korea; [Hong, Myeong-Ki; Kim, Byeong-Keuk; Jang, Yangsoo] Yonsei Univ, Coll Med, Inst Sci, Seoul, South Korea; [Kim, Hyo-Soo; Park, Kyung Woo] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Genereux, Philippe; Stone, Gregg W.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Genereux, Philippe; Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA; [Genereux, Philippe] Hop Sacre Coeur, Montreal, PQ H4J 1C5, Canada; [Bhatt, Deepak L.] Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA; [De Servi, Stefano] Policlin San Matteo, I-27100 Pavia, Italy	University of Bologna; University of Oxford; Sapienza University Rome; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University Hospital; Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF); Universite de Montreal; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; IRCCS Fondazione San Matteo	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY 10022 USA.	gs2184@columbia.edu	Palmerini, Tullio/K-4543-2016; De+Servi, Stefano/AAT-2631-2021; Biondi-Zoccai, Giuseppe/C-9670-2012; Abizaid, Alexandre Antônio Cunha/H-6955-2012; Park, Kyung Woo/AAX-3046-2020; Bacchi Reggiani, Maria Letizia/O-2311-2014	Biondi-Zoccai, Giuseppe/0000-0001-6103-8510; Jang, Yangsoo/0000-0002-2169-3112; Kim, Byeong-Keuk/0000-0003-2493-066X; Bacchi Reggiani, Maria Letizia/0000-0003-3985-1542; Benedetto, Umberto/0000-0002-7074-7949; Hong, Myeong-Ki/0000-0002-2090-2031; Rapezzi, Claudio/0000-0002-9198-2657	Abbott Vascular; Eli Lilly; Medtronic; Abbott; Cardiovascular System Inc.; Biosensors; Amarin; AstraZeneca; Bristol-Myers Squibb; Eisai; Ethicon; Forest Laboratories; Ischemix; Pfizer; Roche; Sanofi-Aventis; The Medicines Company	Abbott Vascular(Abbott Laboratories); Eli Lilly(Eli Lilly); Medtronic(Medtronic); Abbott(Abbott Laboratories); Cardiovascular System Inc.; Biosensors; Amarin; AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Eisai(Eisai Co Ltd); Ethicon; Forest Laboratories; Ischemix; Pfizer(Pfizer); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); The Medicines Company	None of the funders of any of the individual trials had any role in the study design, data collection, data interpretation or drafting or review of the manuscript. TP has received speaker fee from Abbott Vascular and research grant from Eli Lilly. GB-Z has consulted for Bayer Pharma, and Novartis, has lectured for Abbott Vascular, AstraZeneca, DirectFlow Medical, and St Jude Medical, and has received career grant support from Medtronic. PG has received speaker fees from Abbott and Cardiovascular System Inc. FF has received speaker fees from Biosensors and Eli Lilly, and has been consultant for Medtronic and Scitech. DLB discloses the following relationships: advisory board of Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, Regado Biosciences; Board of Directors of Boston VA Research Institute, Society of Cardiovascular Patient Care; Chair of American Heart Association Get With The Guidelines Steering Committee; Data Monitoring Committees of Duke Clinical Research Institute, Harvard Clinical Research Institute, Mayo Clinic, and Population Health Research Institute; Honoraria from American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org), Belvoir Publications (Editor in Chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), Harvard Clinical Research Institute (clinical trial steering committee), HMP Communications (Editor in Chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (Associate Editor; Section Editor, Pharmacology), Population Health Research Institute (clinical trial steering committee), Slack Publications (Chief Medical Editor, Cardiology Today's Intervention), WebMD (CME steering committees); and Clinical Cardiology (Deputy Editor); research funding from Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Forest Laboratories, Ischemix, Medtronic, Pfizer, Roche, Sanofi-Aventis, and The Medicines Company; and unfunded research from FlowCo, PLx Pharma, Takeda. GWS has served as a consultant for Osprey, Reva, Boston Scientific, AstraZeneca, Eli Lilly, Daiichi Sankyo partnership, Gilead, InspireMD, TherOx, Atrium, Volcano, InfraReDx, Miracor, Velomedix, CSI, AGA, and Thoratec, and has equity in the Biostar family of funds, the MedFocus family of funds, Caliber, Guided Delivery Systems, Micardia, Embrella, and VNT. The other authors declare no competing interests.	Anie KA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001916.pub2; Armstrong EJ, 2014, AM HEART J, V168, P560, DOI 10.1016/j.ahj.2014.07.020; Bailar JC, 1997, NEW ENGL J MED, V337, P559, DOI 10.1056/NEJM199708213370810; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Collet JP, 2014, LANCET, V384, P1577, DOI 10.1016/S0140-6736(14)60612-7; Colombo A, 2014, J AM COLL CARDIOL, V64, P2086, DOI 10.1016/j.jacc.2014.09.008; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Dias S, 2013, MED DECIS MAKING, V33, P671, DOI 10.1177/0272989X13487257; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Elmariah S, 2015, LANCET, V385, P792, DOI 10.1016/S0140-6736(14)62052-3; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Gelman A, 1996, Stat Methods Med Res, V5, P339, DOI 10.1177/096228029600500402; Gilard M, 2015, J AM COLL CARDIOL, V65, P777, DOI 10.1016/j.jacc.2014.11.008; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Hu T, 2012, AM J CARDIOL, V109, p85S, DOI 10.1016/j.amjcard.2012.01.196; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Lee CW, 2014, CIRCULATION, V129, P304, DOI 10.1161/CIRCULATIONAHA.113.003303; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mehran R, 2010, J AM COLL CARDIOL, V55, P2556, DOI 10.1016/j.jacc.2009.09.076; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Ndrepepa G, 2008, J AM COLL CARDIOL, V51, P690, DOI 10.1016/j.jacc.2007.10.040; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Palmerini T, 2011, CIRC-CARDIOVASC INTE, V4, P577, DOI 10.1161/CIRCINTERVENTIONS.111.963884; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Patel Manesh R, 2012, J Am Coll Cardiol, V59, P857, DOI 10.1016/j.jacc.2011.12.001; Schulz-Schupke S, 2014, INVESTIGATORS OBOIS; Song F, 2008, J CLIN EPIDEMIOL, V61, P455, DOI 10.1016/j.jclinepi.2007.06.006; Spoon DB, 2014, CIRCULATION, V129, P1286, DOI 10.1161/CIRCULATIONAHA.113.006518; Sterne JA, 2009, META ANAL STATA UPDA; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2014, J AM COLL CARDIOL, V63, P15, DOI 10.1016/j.jacc.2013.09.027; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Waksman R, 2014, JACC-CARDIOVASC INTE, V7, P1093, DOI 10.1016/j.jcin.2014.04.017; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	35	299	316	3	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2371	2382		10.1016/S0140-6736(15)60263-X	http://dx.doi.org/10.1016/S0140-6736(15)60263-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1XV	25777667				2022-12-28	WOS:000356003700030
J	Lee, ASY; Kranzusch, PJ; Cate, JHD				Lee, Amy S. Y.; Kranzusch, Philip J.; Cate, Jamie H. D.			eIF3 targets cell-proliferation messenger RNAs for translational activation or repression	NATURE			English	Article							C-JUN; PREINITIATION COMPLEX; VIRAL TRANSLATION; BINDING PROTEIN; PAR-CLIP; INITIATION; SITES; IDENTIFICATION; TRANSFORMATION; SPECIFICITY	Regulation of protein synthesis is fundamental for all aspects of eukaryotic biology by controlling development, homeostasis and stress responses(1,2). The 13-subunit, 800-kilodalton eukaryotic initiation factor 3 (eIF3) organizes initiation factor and ribosome interactions required for productive translation(3). However, current understanding of eIF3 function does not explain genetic evidence correlating eIF3 deregulation with tissue-specific cancers and developmental defects(4). Here we report the genome-wide discovery of human transcripts that interact with eIF3 using photoactivatable ribonucleoside-enhanced cross-linking and immunoprecipitation (PAR-CLIP)(5). eIF3 binds to a highly specific program of messenger RNAs involved in cell growth control processes, including cell cycling, differentiation and apoptosis, via them RNA 5' untranslated region. Surprisingly, functional analysis of the interaction between eIF3 and two mRNAs encoding the cell proliferation regulators c-JUN and BTG1 reveals that eIF3 uses different modes of RNA stem-loop binding to exert either translational activation or repression. Our findings illuminate a new role for eIF3 in governing a specialized repertoire of gene expression and suggest that binding of eIF3 to specific mRNAs could be targeted to control carcinogenesis.	[Lee, Amy S. Y.; Kranzusch, Philip J.; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Lee, Amy S. Y.; Cate, Jamie H. D.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Kranzusch, Philip J.] Univ Calif Berkeley, HHMI, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	jcate@lbl.gov			National Institutes of Health (NIH) [S10RR029668, S10RR027303]; NIH [S10RR025622]; National Institute of General Medical Sciences Center for RNA Systems Biology; American Cancer Society [PF-14-108-01-RMC]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029668, S10RR027303, S10RR025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM102706] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences Center for RNA Systems Biology; American Cancer Society(American Cancer Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Doudna, D. Ruggero, D. Black, M. Truitt, A. Tambe, Y. Bai and K. Chat for discussions. HeLa cytoplasm was a gift from J. Fang. This work used the Vincent J. Coates Genomics Sequencing Laboratory at University of California, Berkeley, supported by National Institutes of Health (NIH) S10 Instrumentation Grants S10RR029668 and S10RR027303; and the Vincent J. Proteomics/Mass Spectrometry Laboratory at University of California, Berkeley, supported in part by NIH S10 Instrumentation Grant S10RR025622. This work was funded by the National Institute of General Medical Sciences Center for RNA Systems Biology (A.S.Y.L. and J.H.D.C.). A.S.Y.L is supported as an American Cancer Society Postdoctoral Fellow (PF-14-108-01-RMC) and P.J.K. is supported as a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation.	Andaya A, 2014, INT J MOL SCI, V15, P11523, DOI 10.3390/ijms150711523; Bai Y, 2013, NUCLEIC ACIDS RES, V41, P7861, DOI 10.1093/nar/gkt543; Bakker WJ, 2004, J CELL BIOL, V164, P175, DOI 10.1083/jcb.200307056; Blau L, 2012, P NATL ACAD SCI USA, V109, pE2875, DOI 10.1073/pnas.1203659109; Carlsten JOP, 2013, TRENDS BIOCHEM SCI, V38, P531, DOI 10.1016/j.tibs.2013.08.007; Choudhuri A, 2013, P NATL ACAD SCI USA, V110, P9818, DOI 10.1073/pnas.1302934110; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Erzberger JP, 2014, CELL, V158, P1123, DOI 10.1016/j.cell.2014.07.044; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; Hafner M, 2012, METHODS, V58, P164, DOI 10.1016/j.ymeth.2012.07.030; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hashem Y, 2013, NATURE, V503, P539, DOI 10.1038/nature12658; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hershey JWB, 2010, BRAZ J MED BIOL RES, V43, P920, DOI 10.1590/S0100-879X2010001000002; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; Kranzusch PJ, 2014, CELL, V158, P1011, DOI 10.1016/j.cell.2014.07.028; Kranzusch PJ, 2010, P NATL ACAD SCI USA, V107, P20069, DOI 10.1073/pnas.1007152107; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lee ASY, 2013, P NATL ACAD SCI USA, V110, P324, DOI 10.1073/pnas.1216454109; Pincheira R, 2001, BRIT J CANCER, V84, P1520, DOI 10.1054/bjoc.2001.1828; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rakotondrafara AM, 2011, NAT PROTOC, V6, P563, DOI 10.1038/nprot.2011.314; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Stumpf CR, 2011, CURR OPIN GENET DEV, V21, P474, DOI 10.1016/j.gde.2011.03.007; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Vasa SM, 2008, RNA, V14, P1979, DOI 10.1261/rna.1166808; Waanders E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002533; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200	42	231	241	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					111	U292		10.1038/nature14267	http://dx.doi.org/10.1038/nature14267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25849773	Green Accepted			2022-12-28	WOS:000355543400040
J	Paulsen, CE; Armache, JP; Gao, Y; Cheng, YF; Julius, D				Paulsen, Candice E.; Armache, Jean-Paul; Gao, Yuan; Cheng, Yifan; Julius, David			Structure of the TRPA1 ion channel suggests regulatory mechanisms	NATURE			English	Article							RECEPTOR POTENTIAL A1; MOLECULAR DETERMINANTS; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; ACTIVATION; PROTEIN; COLD; PAIN; IDENTIFICATION; VISUALIZATION	The TRPA1 ion channel (also known as the wasabi receptor) is a detector of noxious chemical agents encountered in our environment or produced endogenously during tissue injury or drug metabolism. These include a broad class of electrophiles that activate the channel through covalent protein modification. TRPA1 antagonists hold potential for treating neurogenic inflammatory conditions provoked or exacerbated by irritant exposure. Despite compelling reasons to understand TRPA1 function, structural mechanisms underlying channel regulation remain obscure. Here we use single-particle electron cryomicroscopy to determine the structure of full-length human TRPA1 to similar to 4 angstrom resolution in the presence of pharmacophores, including a potent antagonist. Several unexpected features are revealed, including an extensive coiled-coil assembly domain stabilized by polyphosphate co-factors and a highly integrated nexus that converges on an unpredicted transient receptor potential (TRP)-like allosteric domain. These findings provide new insights into the mechanisms of TRPA1 regulation, and establish a blueprint for structure-based design of analgesic and anti-inflammatory agents.	[Paulsen, Candice E.; Gao, Yuan; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Armache, Jean-Paul; Gao, Yuan; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, Keck Adv Microscopy Lab, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	ycheng@ucsf.edu; david.julius@ucsf.edu	Armache, Jean-Paul/U-3113-2019	Armache, Jean-Paul/0000-0001-9195-2282; Gao, Yuan/0000-0003-1248-1828; Cheng, Yifan/0000-0001-9535-0369	National Institutes of Health [R01NS055299, R01GM098672]; UCSF Program for Breakthrough Biomedical Research; UCSF CVRI; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098672, T32GM008284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Program for Breakthrough Biomedical Research; UCSF CVRI; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Liao for initial electron microscopy analysis of vampire bat TRPA1, and S. Wu and M. Zhao for help with refining the atomic model. This work was supported by grants from the National Institutes of Health (R01NS055299 to D.J. and R01GM098672 to Y.C.) and the UCSF Program for Breakthrough Biomedical Research (Y.C.). C.E.P. was supported by a T32 Postdoctoral Training Grant from the UCSF CVRI, and is currently a HHMI Fellow of the Helen Hay Whitney Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Andrade EL, 2012, PHARMACOL THERAPEUT, V133, P189, DOI 10.1016/j.pharmthera.2011.10.008; Bagneris C, 2014, P NATL ACAD SCI USA, V111, P8428, DOI 10.1073/pnas.1406855111; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Banzawa N, 2014, J BIOL CHEM, V289, P31927, DOI 10.1074/jbc.M114.586891; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caspani O, 2009, J GEN PHYSIOL, V133, P245, DOI 10.1085/jgp.200810136; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chen J, 2008, J NEUROSCI, V28, P5063, DOI 10.1523/JNEUROSCI.0047-08.2008; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; Elmlund H, 2013, STRUCTURE, V21, P1299, DOI 10.1016/j.str.2013.07.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Gray MJ, 2014, MOL CELL, V53, P689, DOI 10.1016/j.molcel.2014.01.012; Gruber M, 2005, NUCLEIC ACIDS RES, V33, pW239, DOI 10.1093/nar/gki405; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jabba S, 2014, NEURON, V82, P1017, DOI 10.1016/j.neuron.2014.04.016; Jaquemar D, 1999, J BIOL CHEM, V274, P7325, DOI 10.1074/jbc.274.11.7325; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Klement G, 2013, BIOPHYS J, V104, P798, DOI 10.1016/j.bpj.2013.01.008; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McGaraughty S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-14; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moparthi L, 2014, P NATL ACAD SCI USA, V111, P16901, DOI 10.1073/pnas.1412689111; Nakatsuka K, 2013, J MOL NEUROSCI, V51, P754, DOI 10.1007/s12031-013-0060-2; Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Penczek P, 1999, J STRUCT BIOL, V128, P44, DOI 10.1006/jsbi.1999.4157; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rohacs T, 2014, HANDB EXP PHARMACOL, V223, P1143, DOI 10.1007/978-3-319-05161-1_18; Samad A, 2011, BIOCHEM J, V433, P197, DOI 10.1042/BJ20101256; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Susankova K, 2007, J NEUROSCI, V27, P7578, DOI 10.1523/JNEUROSCI.1956-07.2007; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Zayats V, 2013, J MOL MODEL, V19, P4689, DOI 10.1007/s00894-012-1505-1; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002	72	418	428	7	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					511	+		10.1038/nature14367	http://dx.doi.org/10.1038/nature14367			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25855297	Green Accepted, Green Submitted			2022-12-28	WOS:000353334500036
J	Greber, BJ; Bieri, P; Leibundgut, M; Leitner, A; Aebersold, R; Boehringer, D; Ban, N				Greber, Basil J.; Bieri, Philipp; Leibundgut, Marc; Leitner, Alexander; Aebersold, Ruedi; Boehringer, Daniel; Ban, Nenad			The complete structure of the 55S mammalian mitochondrial ribosome	SCIENCE			English	Article							MESSENGER-RNAS; PROTEINS; SUBUNIT; IDENTIFICATION; MUTATION; ANTIBIOTICS; OTOTOXICITY; APOPTOSIS; INSIGHTS; SITES	Mammalian mitochondrial ribosomes (mitoribosomes) synthesize mitochondrially encoded membrane proteins that are critical for mitochondrial function. Here we present the complete atomic structure of the porcine 55S mitoribosome at 3.8 angstrom resolution by cryo-electron microscopy and chemical cross-linking/mass spectrometry. The structure of the 28S subunit in the complex was resolved at 3.6 angstrom resolution by focused alignment, which allowed building of a detailed atomic structure including all of its 15 mitoribosomal-specific proteins. The structure reveals the intersubunit contacts in the 55S mitoribosome, the molecular architecture of the mitoribosomal messenger RNA (mRNA) binding channel and its interaction with transfer RNAs, and provides insight into the highly specialized mechanism of mRNA recruitment to the 28S subunit. Furthermore, the structure contributes to a mechanistic understanding of aminoglycoside ototoxicity.	[Greber, Basil J.; Bieri, Philipp; Leibundgut, Marc; Boehringer, Daniel; Ban, Nenad] Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Leitner, Alexander; Aebersold, Ruedi] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Ban, N (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, Otto Stern Weg 5, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch	Leitner, Alexander/U-1601-2019	Leitner, Alexander/0000-0003-4126-0725; Bieri, Philipp/0000-0001-9031-2945; Greber, Basil/0000-0001-9379-7159	Swiss National Science Foundation (SNSF); National Center of Excellence in Research (NCCR) Structural Biology and RNA & Disease programs of the SNSF; European Research Council under the European Community [250071]; Commission of the European Communities through the PROSPECTS consortium (European Union) [201648, 233226]; European Research Council [ERC-2008-AdG 233226]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR) Structural Biology and RNA & Disease programs of the SNSF; European Research Council under the European Community(European Research Council (ERC)); Commission of the European Communities through the PROSPECTS consortium (European Union); European Research Council(European Research Council (ERC)European Commission)	EM data were collected at the ScopeM facility of ETH Zurich. We thank P. Tittmann (ScopeM) for support and J. Erzberger for discussions. This work was supported by the Swiss National Science Foundation (SNSF), the National Center of Excellence in Research (NCCR) Structural Biology and RNA & Disease programs of the SNSF, European Research Council grant 250071 under the European Community's Seventh Framework Programme (to N.B.), the Commission of the European Communities through the PROSPECTS consortium (European Union FP7 projects 201648 and 233226) (R.A.), and the European Research Council (grant ERC-2008-AdG 233226) (R.A.). The 3.6 angstrom cryo-EM map of the 28S mitoribosomal subunit and the 3.8 angstrom cryo-EM map of the 55S mitoribosome have been deposited at the Electron Microscopy Data Bank (EMDB) with accession codes EMD-2913 and EMD-2914. Coordinates of the refined 28S subunit and the 55S mitoribosome in the canonical state have been deposited in the Protein Data Bank (PDB) with PDB codes 5AJ3 (28S) and 5AJ4 (55S). A PyMol script for display of the 55S mitoribosome is available from the Ban Lab website (www.mol.biol.ethz.ch/groups/ban_group/). ETH Zurich has filed a patent application to use the coordinates of the porcine mitoribosome structure for development of compounds that can (i) specifically interfere with mitochondrial translation by binding to mitoribosomes or (ii) specifically inhibit translation in pathogenic organisms without interfering with mitoribosomes.	Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; DENSLOW ND, 1991, J BIOL CHEM, V266, P9586; Desmond E, 2011, RES MICROBIOL, V162, P53, DOI 10.1016/j.resmic.2010.10.004; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Filipovska A, 2013, RNA BIOL, V10, P1426, DOI 10.4161/rna.24769; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Haque ME, 2008, MITOCHONDRION, V8, P254, DOI 10.1016/j.mito.2008.04.004; Jones CN, 2008, RNA, V14, P862, DOI 10.1261/rna.909208; Kaushal PS, 2014, P NATL ACAD SCI USA, V111, P7284, DOI 10.1073/pnas.1401657111; Koc EC, 2001, FEBS LETT, V492, P166, DOI 10.1016/S0014-5793(01)02250-5; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Koc EC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00183; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Longen S, 2014, DEV CELL, V28, P30, DOI 10.1016/j.devcel.2013.11.007; Matt T, 2012, P NATL ACAD SCI USA, V109, P10984, DOI 10.1073/pnas.1204073109; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Miller JL, 2008, PROTEIN SCI, V17, P251, DOI 10.1110/ps.073185608; Miyazaki T, 2001, NAT IMMUNOL, V2, P493, DOI 10.1038/88684; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0; OBRIEN TW, 1971, J BIOL CHEM, V246, P3409; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Rotig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010; Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Smits P, 2011, EUR J HUM GENET, V19, P394, DOI 10.1038/ejhg.2010.214; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Suzuki T, 2001, J BIOL CHEM, V276, P33181, DOI 10.1074/jbc.M103236200; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Xie J, 2011, HEARING RES, V281, P28, DOI 10.1016/j.heares.2011.05.008; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	40	262	269	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					303	308		10.1126/science.aaa3872	http://dx.doi.org/10.1126/science.aaa3872			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25837512	Green Submitted			2022-12-28	WOS:000352999000035
J	Hitz, MP; Andelfinger, G				Hitz, Marc-Phillip; Andelfinger, Gregor			CARDIOLOGY Race for healthy hearts	NATURE			English	Editorial Material							PREVALENCE; MUTATION; DEFECTS; DISEASE	Transplantation experiments in mice reveal that the increased risk of congenital heart disease in the pups of older mothers is not conferred by ageing eggs, but by the mothers' age, and can be mitigated by exercise. See Letter p. 230	[Hitz, Marc-Phillip] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Hitz, Marc-Phillip] Univ Hosp Schleswig Holstein, Kiel, Germany; [Hitz, Marc-Phillip] Univ Kiel, Kiel, Germany; [Andelfinger, Gregor] Univ Montreal, CHU St Justine Res Ctr, Dept Pediat, Montreal, PQ H3T 1C5, Canada	Wellcome Trust Sanger Institute; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Hitz, MP (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	gregor.andelfinger@recherche-ste-justine.qc.ca	Hitz, Marc/ABD-9495-2021; Hitz, Marc-Phillip/Q-5571-2018	Hitz, Marc-Phillip/0000-0001-9894-6897				DELACRUZ MV, 1983, AM J ANAT, V166, P63, DOI 10.1002/aja.1001660105; Ferencz C, 1993, EPIDEMIOLOGY CONGENI; Ionescu-Ittu R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1673; Kasahara H, 2000, J CLIN INVEST, V106, P299, DOI 10.1172/JCI9860; Lescroart F, 2014, NAT CELL BIOL, V16, P829, DOI 10.1038/ncb3024; Miller A, 2011, AM J MED GENET A, V155A, P2137, DOI 10.1002/ajmg.a.34130; Mitchell LE, 2015, HUM MOL GENET, V24, P265, DOI 10.1093/hmg/ddu420; Nitert MD, 2012, DIABETES, V61, P3322, DOI 10.2337/db11-1653; Padmanabhan N, 2013, CELL, V155, P81, DOI 10.1016/j.cell.2013.09.002; Ronn T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003572; Schulkey CE, 2015, NATURE, V520, P230, DOI 10.1038/nature14361; Winston JB, 2012, CIRC-CARDIOVASC GENE, V5, P293, DOI 10.1161/CIRCGENETICS.111.961136	12	1	1	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					160	161		10.1038/nature14379	http://dx.doi.org/10.1038/nature14379			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25830886				2022-12-28	WOS:000352454600021
J	Smith, JM				Smith, Jeanette M.			Abstraction: Windows	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		COTTINGTON D, 1998, CUBISM SHADOW WAR AV, P168; MURRAY P, 1997, PENGUIN DICT ART ART, P365	2	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2015	313	13					1298	1299		10.1001/jama.2014.11667	http://dx.doi.org/10.1001/jama.2014.11667			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF1OL	25849166				2022-12-28	WOS:000352315900001
J	Jallow, T; D'Cruz, D; Lempp, H				Jallow, Tracy; D'Cruz, David; Lempp, Heidi			A PATIENT'S JOURNEY Antiphospholipid syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jallow, Tracy] Sydenham, London, England; [D'Cruz, David] Guys & St Thomas Hosp, Louise Coote Lupus Unit, London SE1 9RT, England; [Lempp, Heidi] Kings Coll London, Fac Life Sci & Med, Acad Rheumatol, Clin Trials Grp, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University College London	Jallow, T (corresponding author), Sydenham, London, England.	david.d'cruz@kcl.ac.uk	Lempp, Heidi/T-2914-2017	Lempp, Heidi/0000-0003-2509-3656					0	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2015	350								h1426	10.1136/bmj.h1426	http://dx.doi.org/10.1136/bmj.h1426			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3IB	25838412	Bronze			2022-12-28	WOS:000352440700002
J	Asher, G; Sassone-Corsi, P				Asher, Gad; Sassone-Corsi, Paolo			Time for Food: The Intimate Interplay between Nutrition, Metabolism, and the Circadian Clock	CELL			English	Review							HIGH-FAT DIET; CALORIC-INTAKE; DIFFERENTIAL ROLES; DIURNAL REGULATION; LIPID-METABOLISM; GENE-EXPRESSION; GUT MICROBIOTA; OBESITY; BREAKFAST; SYSTEM	The circadian clock, a highly specialized, hierarchical network of biological pacemakers, directs and maintains proper rhythms in endocrine and metabolic pathways required for organism homeostasis. The clock adapts to environmental changes, specifically daily light-dark cycles, as well as rhythmic food intake. Nutritional challenges reprogram the clock, while time-specific food intake has been shown to have profound consequences on physiology. Importantly, a critical role in the clock-nutrition interplay appears to be played by the microbiota. The circadian clock appears to operate as a critical interface between nutrition and homeostasis, calling for more attention on the beneficial effects of chrono-nutrition.	[Asher, Gad] Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel; [Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Biol Chem, Ctr Epigenet & Metab, INSERM U904, Irvine, CA 92697 USA	Weizmann Institute of Science; University of California System; University of California Irvine	Asher, G (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel.	gad.asher@weizmann.ac.il; psc@uci.edu	Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Asher, Gad/0000-0001-9403-7856	Israel Science Foundation (ISF) [138/12]; Abish-Frenkel Foundation; HFSP Career Development Award (HFSP) [CDA00014/2012]; European Research Council [ERC-2011 METACYCLES 310320]; NIH; ABOCA SpA (Italy); Institut National de la Sante et Recherche Medicale (INSERM, France); Novo Nordisk Foundation Challenge Grant	Israel Science Foundation (ISF)(Israel Science Foundation); Abish-Frenkel Foundation; HFSP Career Development Award (HFSP); European Research Council(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ABOCA SpA (Italy); Institut National de la Sante et Recherche Medicale (INSERM, France); Novo Nordisk Foundation Challenge Grant	Due to space limitations, we were, unfortunately, unable to comment on all of the relevant studies and thus apologize for not citing all pertinent references. Work in the laboratory of G.A. was supported by the Israel Science Foundation (ISF 138/12), the Abish-Frenkel Foundation, the HFSP Career Development Award (HFSP CDA00014/2012), and the European Research Council (ERC-2011 METACYCLES 310320). Work in the laboratory of P.S.-C. is supported by the NIH, ABOCA SpA (Italy), Institut National de la Sante et Recherche Medicale (INSERM, France), and a Novo Nordisk Foundation Challenge Grant.	Adamovich Y., 2014, BIOCH BIOPHYS ACTA; Adamovich Y, 2014, CELL METAB, V19, P319, DOI 10.1016/j.cmet.2013.12.016; Ang JE, 2012, CHRONOBIOL INT, V29, P868, DOI 10.3109/07420528.2012.699122; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Baron KG, 2011, OBESITY, V19, P1374, DOI 10.1038/oby.2011.100; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P9897, DOI 10.1073/pnas.1120636110; Brown SA, 2012, DEV CELL, V22, P477, DOI 10.1016/j.devcel.2012.02.007; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Chua ECP, 2013, P NATL ACAD SCI USA, V110, P14468, DOI 10.1073/pnas.1222647110; Colles SL, 2007, INT J OBESITY, V31, P1722, DOI 10.1038/sj.ijo.0803664; Crane BR, 2014, ANNU REV BIOCHEM, V83, P191, DOI 10.1146/annurev-biochem-060713-035644; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Fuse Yuta, 2012, J Circadian Rhythms, V10, P4, DOI 10.1186/1740-3391-10-4; Gooley JJ, 2014, J GENET GENOMICS, V41, P231, DOI 10.1016/j.jgg.2014.04.001; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Hariri N, 2011, CHRONOBIOL INT, V28, P216, DOI 10.3109/07420528.2010.548614; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Henao-Mejia J, 2013, ADV IMMUNOL, V117, P73, DOI 10.1016/B978-0-12-410524-9.00003-7; Hsieh SD, 2011, INTERNAL MED, V50, P2499, DOI 10.2169/internalmedicine.50.5844; Hussain MM, 2014, ANNU REV NUTR, V34, P357, DOI 10.1146/annurev-nutr-071813-105322; Hussain MM, 2012, CURR OPIN CLIN NUTR, V15, P336, DOI 10.1097/MCO.0b013e3283548629; Jakubowicz D, 2013, OBESITY, V21, P2504, DOI 10.1002/oby.20460; Kasukawa T, 2012, P NATL ACAD SCI USA, V109, P15036, DOI 10.1073/pnas.1207768109; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lax P, 1998, PHYSIOL BEHAV, V65, P69, DOI 10.1016/S0031-9384(98)00123-1; Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Masri S, 2014, CELL, V158, P659, DOI 10.1016/j.cell.2014.06.050; Masri S, 2013, P NATL ACAD SCI USA, V110, P3339, DOI 10.1073/pnas.1217632110; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; Mauvoisin D, 2014, P NATL ACAD SCI USA, V111, P167, DOI 10.1073/pnas.1314066111; Mayer EA, 2014, J NEUROSCI, V34, P15490, DOI 10.1523/JNEUROSCI.3299-14.2014; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Pan XY, 2007, J BIOL CHEM, V282, P24707, DOI 10.1074/jbc.M701305200; Patel VR, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2111; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Robles MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004047; Robles Maria S, 2013, Handb Exp Pharmacol, P389, DOI 10.1007/978-3-642-25950-0_17; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sahar S, 2012, TRENDS ENDOCRIN MET, V23, P1, DOI 10.1016/j.tem.2011.10.005; Saini C, 2011, COLD SH Q B, V76, P39, DOI 10.1101/sqb.2011.76.010918; Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016; Sherman H, 2012, FASEB J, V26, P3493, DOI 10.1096/fj.12-208868; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Tahara Y, 2013, NEUROSCIENCE, V253, P78, DOI 10.1016/j.neuroscience.2013.08.049; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Timlin MT, 2008, PEDIATRICS, V121, pE638, DOI 10.1542/peds.2007-1035; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Voigt RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097500; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; WesterterpPlantenga MS, 1996, EUR J CLIN NUTR, V50, P580; Wu T, 2011, CHRONOBIOL INT, V28, P890, DOI 10.3109/07420528.2011.622599; Yoshida C, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-78; Yoshizaki T, 2013, EUR J APPL PHYSIOL, V113, P2603, DOI 10.1007/s00421-013-2702-z; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zarrinpar A, 2014, CELL METAB, V20, P1006, DOI 10.1016/j.cmet.2014.11.008; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	77	452	467	32	247	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					84	92		10.1016/j.cell.2015.03.015	http://dx.doi.org/10.1016/j.cell.2015.03.015			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815987	Bronze			2022-12-28	WOS:000351952200010
J	Rando, OJ; Simmons, RA				Rando, Oliver J.; Simmons, Rebecca A.			I'm Eating for Two: Parental Dietary Effects on Offspring Metabolism	CELL			English	Review							INTRAUTERINE GROWTH-RETARDATION; HIGH-FAT DIET; MATERNAL PROTEIN RESTRICTION; IMPAIRED OXIDATIVE-PHOSPHORYLATION; THRIFTY PHENOTYPE HYPOTHESIS; SPERM MICRORNA CONTENT; IN-UTERO EXPOSURE; DNA METHYLATION; TRANSGENERATIONAL INHERITANCE; SKELETAL-MUSCLE	It has long been understood that the pathogenesis of complex diseases such as diabetes includes both genetic and environmental components. More recently, it has become clear that not only does an individual's environment influence their own metabolism, but in some cases, the environment experienced by their parents may also contribute to their risk of metabolic disease. Here, we review the evidence that parental diet influences metabolic phenotype in offspring in mammals and provide a current survey of our mechanistic understanding of these effects.	[Rando, Oliver J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Simmons, Rebecca A.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Rando, OJ (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	oliver.rando@umassmed.edu; rsimmons@mail.med.upenn.edu		Simmons, Rebecca/0000-0002-2901-8904; Rando, Oliver/0000-0003-1516-9397	NIH [R01HD080224, DP1ES02545, R01DK55704, RO1DK062965, R01ES023284]; March of Dimes [FY13-1268]; March of Dimes Prematurity Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD080224] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP002545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055704, R01DK062965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, R01ES023284, DP1ES025458] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); March of Dimes Prematurity Research Center(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	O.J.R. is supported by NIH grants R01HD080224 and DP1ES02545, and March of Dimes grant FY13-1268. R.A.S. is supported by NIH grants R01DK55704, RO1DK062965, and R01ES023284 and March of Dimes Prematurity Research Center.	Aiken CE, 2014, HUM REPROD UPDATE, V20, P63, DOI 10.1093/humupd/dmt043; Amanai M, 2006, BIOL REPROD, V75, P877, DOI 10.1095/biolreprod.106.056499; Arteaga-Vazquez MA, 2010, CURR OPIN GENET DEV, V20, P156, DOI 10.1016/j.gde.2010.01.008; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Bayol SA, 2005, J PHYSIOL-LONDON, V567, P951, DOI 10.1113/jphysiol.2005.088989; Benyshek DC, 2006, DIABETOLOGIA, V49, P1117, DOI 10.1007/s00125-006-0196-5; Blondeau B, 2002, DIABETOLOGIA, V45, P394, DOI 10.1007/s00125-001-0767-4; Bonnefond A, 2010, TRENDS MOL MED, V16, P407, DOI 10.1016/j.molmed.2010.06.004; Borengasser SJ, 2014, PHYSIOL GENOMICS, V46, P841, DOI 10.1152/physiolgenomics.00059.2014; Bromfield JJ, 2014, P NATL ACAD SCI USA, V111, P2200, DOI 10.1073/pnas.1305609111; Bygren LO, 2001, ACTA BIOTHEOR, V49, P53, DOI 10.1023/A:1010241825519; Carone BR, 2014, DEV CELL, V30, P11, DOI 10.1016/j.devcel.2014.05.024; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; Chang YL, 2013, FERTIL STERIL, V100, P241, DOI 10.1016/j.fertnstert.2013.03.003; Cooney CA, 2002, J NUTR, V132, p2393S; Frantz EDC, 2011, MECH AGEING DEV, V132, P110, DOI 10.1016/j.mad.2011.01.003; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; DAHRI S, 1991, DIABETES, V40, P115, DOI 10.2337/diab.40.2.S115; Davis MM, 2008, J AM BOARD FAM MED, V21, P549, DOI 10.3122/jabfm.2008.06.070140; Dietz WH, 2004, NEW ENGL J MED, V350, P855, DOI 10.1056/NEJMp048008; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Drake AJ, 2005, AM J PHYSIOL-REG I, V288, pR34, DOI 10.1152/ajpregu.00106.2004; Drake AJ, 2011, EPIGENETICS-US, V6, P1334, DOI 10.4161/epi.6.11.17942; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; Duque-Guimaraes DE, 2013, TRENDS ENDOCRIN MET, V24, P525, DOI 10.1016/j.tem.2013.05.006; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; Figueroa-Colon R, 2000, AM J CLIN NUTR, V71, P829, DOI 10.1093/ajcn/71.3.829; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fowden AL, 2004, REPRODUCTION, V127, P515, DOI 10.1530/rep.1.00033; Fu Q, 2004, PHYSIOL GENOMICS, V20, P108, DOI 10.1152/physiolgenomics.00175.2004; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gniuli D, 2008, J LIPID RES, V49, P1936, DOI 10.1194/jlr.M800033-JLR200; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Grissom NM, 2014, NEUROPSYCHOPHARMACOL, V39, P801, DOI 10.1038/npp.2013.193; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Harrison M, 2009, BRIT J NUTR, V101, P1020, DOI 10.1017/S0007114508057607; Hauguel-de Mouzon S, 2006, PLACENTA, V27, P794, DOI 10.1016/j.placenta.2005.08.009; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Jungheim ES, 2010, AM J OBSTET GYNECOL, V203, P525, DOI 10.1016/j.ajog.2010.06.043; Jungheim ES, 2010, ENDOCRINOLOGY, V151, P4039, DOI 10.1210/en.2010-0098; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kermack WO, 1934, J HYG-CAMBRIDGE, V34, P433, DOI 10.1017/S0022172400043230; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liu JB, 2012, ARCH ANIM NUTR, V66, P357, DOI 10.1080/1745039X.2012.710084; Lumey LH, 2007, INT J EPIDEMIOL, V36, P1196, DOI 10.1093/ije/dym126; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; Marquard KL, 2011, FERTIL STERIL, V95, P2146, DOI 10.1016/j.fertnstert.2010.10.026; Martin DIK, 2008, NUTR REV, V66, pS12, DOI 10.1111/j.1753-4887.2008.00057.x; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; McPherson NO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071459; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/NMETH.2078, 10.1038/nmeth.2078]; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ortega FJ, 2013, HORM METAB RES, V45, P1009, DOI 10.1055/s-0033-1358690; Ozanne SE, 2003, J ENDOCRINOL, V177, P235, DOI 10.1677/joe.0.1770235; Park HK, 2004, ANN NY ACAD SCI, V1011, P205, DOI 10.1196/annals.1293.021; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Park KS, 2003, J NUTR, V133, P3085, DOI 10.1093/jn/133.10.3085; Pejznochova M, 2010, MITOCHONDRION, V10, P321, DOI 10.1016/j.mito.2010.01.006; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Peterside IE, 2003, AM J PHYSIOL-ENDOC M, V285, pE1258, DOI 10.1152/ajpendo.00437.2002; Petry C J, 2001, Int J Exp Diabetes Res, V2, P139; Pinney SE, 2011, DIABETOLOGIA, V54, P2606, DOI 10.1007/s00125-011-2250-1; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Raychaudhuri N, 2008, J BIOL CHEM, V283, P13611, DOI 10.1074/jbc.M800128200; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; Rinaudo P, 2012, ANNU REV PHYSIOL, V74, P107, DOI 10.1146/annurev-physiol-020911-153245; Roberts KA, 2011, PLACENTA, V32, P247, DOI 10.1016/j.placenta.2010.12.023; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; Sakai C, 2013, MITOCHONDRION, V13, P602, DOI 10.1016/j.mito.2013.08.009; Samans B, 2014, DEV CELL, V30, P23, DOI 10.1016/j.devcel.2014.05.023; Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108; Sasson IE, 2015, DIABETOLOGIA, V58, P615, DOI 10.1007/s00125-014-3466-7; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Selak MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE130, DOI 10.1152/ajpendo.00322.2002; Sen S, 2010, DIABETES, V59, P3058, DOI 10.2337/db10-0301; Simmons R, 2005, EXP GERONTOL, V40, P863, DOI 10.1016/j.exger.2005.09.007; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; SIMMONS RA, 1992, PEDIATR RES, V31, P59, DOI 10.1203/00006450-199201000-00011; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Simmons R, 2011, P NUTR SOC, V70, P73, DOI 10.1017/S0029665110003988; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Sobala A, 2011, WIRES RNA, V2, P853, DOI 10.1002/wrna.96; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Sullivan EL, 2011, NEUROENDOCRINOLOGY, V93, P1, DOI 10.1159/000322038; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Thamotharan M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1270, DOI 10.1152/ajpendo.00462.2006; Travers ME, 2011, HUM GENET, V130, P41, DOI 10.1007/s00439-011-1023-8; VALDEZ R, 1994, DIABETOLOGIA, V37, P624, DOI 10.1007/s001250050157; van Vliet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064545; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Watkins AJ, 2014, AM J PHYSIOL-HEART C, V306, DOI 10.1152/ajpheart.00981.2013; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Yang QY, 2013, DIABETES, V62, P3727, DOI 10.2337/db13-0433; Zaretsky MV, 2004, OBSTET GYNECOL, V103, P546, DOI 10.1097/01.AOG.0000114980.40445.83; Zhu MJ, 2010, PLACENTA, V31, P387, DOI 10.1016/j.placenta.2010.02.002; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	121	168	173	3	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					93	105		10.1016/j.cell.2015.02.021	http://dx.doi.org/10.1016/j.cell.2015.02.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815988	Green Accepted, Bronze			2022-12-28	WOS:000351952200011
J	Arias, CA; Murray, BE				Arias, Cesar A.; Murray, Barbara E.			A New Antibiotic and the Evolution of Resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DRUGS		[Arias, Cesar A.; Murray, Barbara E.] Univ Texas Med Sch Houston, Div Infect Dis, Dept Internal Med, Houston, TX 77030 USA; [Arias, Cesar A.; Murray, Barbara E.] Univ Texas Med Sch Houston, Dept Microbiol & Mol Genet, Houston, TX USA; [Arias, Cesar A.] Univ El Bosque, Mol Genet & Antimicrobial Resistance Unit, Bogota, Colombia; [Arias, Cesar A.] Univ El Bosque, Int Ctr Microbial Genom, Bogota, Colombia	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Universidad El Bosque; Universidad El Bosque	Arias, CA (corresponding author), Univ Texas Med Sch Houston, Div Infect Dis, Dept Internal Med, Houston, TX 77030 USA.				NIAID NIH HHS [R01 AI093749] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093749] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boucher HW, 2013, CLIN INFECT DIS, V56, P1685, DOI 10.1093/cid/cit152; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Nichols D, 2010, APPL ENVIRON MICROB, V76, P2445, DOI 10.1128/AEM.01754-09; O'Neill J, 2014, ANTIMICROBIAL RESIST; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201	5	79	82	0	294	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2015	372	12					1168	1170		10.1056/NEJMcibr1500292	http://dx.doi.org/10.1056/NEJMcibr1500292			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD6EZ	25785976	Green Accepted			2022-12-28	WOS:000351183600015
J	Bonten, MJM; Huijts, SM; Bolkenbaas, M; Webber, C; Patterson, S; Gault, S; van Werkhoven, CH; van Deursen, AMM; Sanders, EAM; Verheij, TJM; Patton, M; McDonough, A; Moradoghli-Haftvani, A; Smith, H; Mellelieu, T; Pride, MW; Crowther, G; Schmoele-Thoma, B; Scott, DA; Jansen, KU; Lobatto, R; Oosterman, B; Visser, N; Caspers, E; Smorenburg, A; Emini, EA; Gruber, WC; Grobbee, DE				Bonten, M. J. M.; Huijts, S. M.; Bolkenbaas, M.; Webber, C.; Patterson, S.; Gault, S.; van Werkhoven, C. H.; van Deursen, A. M. M.; Sanders, E. A. M.; Verheij, T. J. M.; Patton, M.; McDonough, A.; Moradoghli-Haftvani, A.; Smith, H.; Mellelieu, T.; Pride, M. W.; Crowther, G.; Schmoele-Thoma, B.; Scott, D. A.; Jansen, K. U.; Lobatto, R.; Oosterman, B.; Visser, N.; Caspers, E.; Smorenburg, A.; Emini, E. A.; Gruber, W. C.; Grobbee, D. E.			Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; INFLUENZA VACCINE; DOUBLE-BLIND; EFFICACY; SAFETY; IMMUNOGENICITY; TRIAL; RESPONSES; CHILDREN	BACKGROUND Pneumococcal polysaccharide conjugate vaccines prevent pneumococcal disease in infants, but their efficacy against pneumococcal community-acquired pneumonia in adults 65 years of age or older is unknown. METHODS In a randomized, double-blind, placebo-controlled trial involving 84,496 adults 65 years of age or older, we evaluated the efficacy of 13-valent polysaccharide conjugate vaccine (PCV13) in preventing first episodes of vaccine-type strains of pneumococcal community-acquired pneumonia, nonbacteremic and noninvasive pneumococcal community-acquired pneumonia, and invasive pneumococcal disease. Standard laboratory methods and a serotype-specific urinary antigen detection assay were used to identify community-acquired pneumonia and invasive pneumococcal disease. RESULTS In the per-protocol analysis of first episodes of infections due to vaccine-type strains, community-acquired pneumonia occurred in 49 persons in the PCV13 group and 90 persons in the placebo group (vaccine efficacy, 45.6%; 95.2% confidence interval [CI], 21.8 to 62.5), nonbacteremic and noninvasive community-acquired pneumonia occurred in 33 persons in the PCV13 group and 60 persons in the placebo group (vaccine efficacy, 45.0%; 95.2% CI, 14.2 to 65.3), and invasive pneumococcal disease occurred in 7 persons in the PCV13 group and 28 persons in the placebo group (vaccine efficacy, 75.0%; 95% CI, 41.4 to 90.8). Efficacy persisted throughout the trial (mean follow-up, 3.97 years). In the modified intention-totreat analysis, similar efficacy was observed (vaccine efficacy, 37.7%, 41.1%, and 75.8%, respectively), and community-acquired pneumonia occurred in 747 persons in the PCV13 group and 787 persons in placebo group (vaccine efficacy, 5.1%; 95% CI, -5.1 to 14.2). Numbers of serious adverse events and deaths were similar in the two groups, but there were more local reactions in the PCV13 group. CONCLUSIONS Among older adults, PCV13 was effective in preventing vaccine-type pneumococcal, bacteremic, and nonbacteremic community-acquired pneumonia and vaccine-type invasive pneumococcal disease but not in preventing community-acquired pneumonia from any cause.	[Bonten, M. J. M.; Huijts, S. M.; Bolkenbaas, M.; van Werkhoven, C. H.; van Deursen, A. M. M.; Verheij, T. J. M.] Univ Med Ctr UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bonten, M. J. M.; Huijts, S. M.; Bolkenbaas, M.; van Werkhoven, C. H.; van Deursen, A. M. M.; Verheij, T. J. M.] Univ Med Ctr UMC Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [van Deursen, A. M. M.; Sanders, E. A. M.] UMC Utrecht, Wilhelmina Childrens Hosp, Dept Immunol & Infect Dis, Utrecht, Netherlands; [van Deursen, A. M. M.] Spaarne Hosp, Res Ctr Linnaeus Inst, Hoofddorp, Netherlands; [Lobatto, R.; Oosterman, B.; Visser, N.; Caspers, E.; Smorenburg, A.; Grobbee, D. E.] Julius Clin, Zeist, Netherlands; [Webber, C.; Gault, S.; Patton, M.; McDonough, A.; Moradoghli-Haftvani, A.; Smith, H.; Mellelieu, T.; Crowther, G.] Pfizer Vaccine Clin Res, Maidenhead, Berks, England; [Patterson, S.; Emini, E. A.] Pfizer Vaccine Clin Res, Collegeville, PA USA; [Pride, M. W.; Jansen, K. U.] Pfizer Vaccine Res & Early Dev, Pearl River, NY USA; [Scott, D. A.; Emini, E. A.; Gruber, W. C.] Pfizer Vaccine Clin Res, Pearl River, NY USA; [Schmoele-Thoma, B.] Pfizer Vaccine Clin Res, Berlin, Germany	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Spaarne Hospital; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer	Bonten, MJM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, POB 85500, NL-3508 GA Utrecht, Netherlands.	mbonten@umcutrecht.nl; bill.gruber@pfizer.com	van Werkhoven, Henri/F-7915-2013	van Werkhoven, Henri/0000-0002-0626-4635	Pfizer	Pfizer(Pfizer)	Funded by Pfizer; CAPITA ClinicalTrials.gov number NCT00744263.	BALTIMORE RS, 1992, JAMA-J AM MED ASSOC, V268, P3366, DOI 10.1001/jama.268.23.3366; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Conaty S, 2004, VACCINE, V22, P3214, DOI 10.1016/j.vaccine.2003.08.050; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Fedson DS, 2004, VACCINE, V22, P927, DOI 10.1016/j.vaccine.2003.09.027; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Greenberg RN, 2014, VACCINE, V32, P2364, DOI 10.1016/j.vaccine.2014.02.002; Hak E, 2008, NETH J MED, V66, P378; Health Council of the Netherlands, 2003, HLTH COUNC NETH PUBL; Health Council of the Netherlands, 2007, HLTH COUNC NETH PUBL; Honkanen PO, 1999, VACCINE, V17, P2493, DOI 10.1016/S0264-410X(99)00069-9; Huijts SM, 2013, EUR RESPIR J, V42, P1283, DOI 10.1183/09031936.00137412; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Jackson LA, 2003, NEW ENGL J MED, V348, P1747, DOI 10.1056/NEJMoa022678; Jackson LA, 2013, VACCINE, V31, P3594, DOI 10.1016/j.vaccine.2013.04.084; Jackson LA, 2013, VACCINE, V31, P3577, DOI 10.1016/j.vaccine.2013.04.085; Jackson LA, 2013, VACCINE, V31, P3585, DOI 10.1016/j.vaccine.2013.05.010; Jansen B, 2012, MONITORING VACCINATI; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Kim JO, 1999, INFECT IMMUN, V67, P2327, DOI 10.1128/IAI.67.5.2327-2333.1999; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; KOSKELA M, 1986, PEDIATR INFECT DIS J, V5, P45, DOI 10.1097/00006454-198601000-00009; LEINONEN M, 1986, PEDIATR INFECT DIS J, V5, P39, DOI 10.1097/00006454-198601000-00008; Mangtani P, 2003, LANCET INFECT DIS, V3, P71, DOI 10.1016/S1473-3099(03)00514-0; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Peto L, 2014, T ROY SOC TROP MED H, V108, P326, DOI 10.1093/trstmh/tru058; Pride MW, 2012, CLIN VACCINE IMMUNOL, V19, P1131, DOI 10.1128/CVI.00064-12; Rozenbaum MH, 2013, EUR J CLIN MICROBIOL, V32, P305, DOI 10.1007/s10096-012-1778-4; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Schwarz TF, 2011, VACCINE, V29, P5195, DOI 10.1016/j.vaccine.2011.05.031; Schwarz TF, 2013, WORLD J VACCINES, V3, P123, DOI DOI 10.4236/WJV.2013.34017; Sherwin RL, 2013, J INFECT DIS, V208, P1813, DOI 10.1093/infdis/jit506; Shinefield HR, 2000, PEDIATR INFECT DIS J, V19, P394, DOI 10.1097/00006454-200004000-00036; van Deursen AMM, 2012, EMERG INFECT DIS, V18, P1729, DOI 10.3201/eid1811.120329; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502	38	722	750	2	89	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2015	372	12					1114	1125		10.1056/NEJMoa1408544	http://dx.doi.org/10.1056/NEJMoa1408544			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EZ	25785969	Green Published, Bronze			2022-12-28	WOS:000351183600006
J	Chiarchiaro, J; Arnold, RM; White, DB				Chiarchiaro, Jared; Arnold, Robert M.; White, Douglas B.			Reengineering Advance Care Planning to Create Scalable, Patient- and Family-Centered Interventions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WEBSITE; TRIAL; LIFE; WILL		[Chiarchiaro, Jared] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA 15213 USA; [Chiarchiaro, Jared; White, Douglas B.] Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness CRI, Dept Crit Care Med, Pittsburgh, PA 15213 USA; [Arnold, Robert M.] Univ Pittsburgh, Sect Palliat Care & Med Eth, Dept Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chiarchiaro, J (corresponding author), Univ Pittsburgh, 3459 Fifth Ave,628 NW, Pittsburgh, PA 15213 USA.	chiarchiaroj@upmc.edu						Abhyankar P, 2011, HEALTH EXPECT, V14, P20, DOI 10.1111/j.1369-7625.2010.00615.x; Coleman R, 2008, NEW MEDIA SOC, V10, P179, DOI 10.1177/1461444807086474; Day JA, 2006, IEEE T EDUC, V49, P420, DOI 10.1109/TE.2006.879792; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Institute of Medicine, 2014, DYING IN AMERICA IMP; Kaltenthaler E, 2011, VALUE HEALTH, V14, P1158, DOI 10.1016/j.jval.2011.06.007; Ng CJ, 2013, AUSTRALAS MED J, V6, P95, DOI 10.4066/AMJ.2013.1655; Sudore RL, 2014, J PAIN SYMPTOM MANAG, V47, P674, DOI 10.1016/j.jpainsymman.2013.05.023	9	14	14	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1103	1104		10.1001/jama.2015.0569	http://dx.doi.org/10.1001/jama.2015.0569			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25781435				2022-12-28	WOS:000351102500008
J	Wolfe, S				Wolfe, Sidney			Rosuvastatin: winner in the statin wars, patients' health notwithstanding	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA		Wolfe, S (corresponding author), Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA.	swolfe@citizen.org						[Anonymous], 2003, LANCET, V362, P1341; Anzalone DA, 2015, LANCET DIABETES 0204; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Brault M, 2014, METABOLISM, V63, P735, DOI 10.1016/j.metabol.2014.02.014; FDA, COMMUNICATION; FDA Advisory Committee, 2009, COMM RIDK REAS INCL; FDA Center for Drug Evaluation and Research, END MET DRUGS ADV CO; Food and Drug Administration, DRUG LAB; Freeman DJ, 2001, CIRCULATION, V103, P357; IMS Health, 2013, TOP GLOB PROD 2013; IMS Health, 2014, 1 OCT 2013 30 SEPT 2; Kaufman M, 2004, WASHINGTON POST; Koh KK, 2013, INT J CARDIOL, V166, P509, DOI 10.1016/j.ijcard.2011.11.028; McKillop T, 2003, LANCET, V362, P1498, DOI 10.1016/S0140-6736(03)14698-3; MCKILLOP T, 2003, LANCET          OCT; Morrissey RP, 2011, CURR ATHEROSCLER REP, V13, P413, DOI 10.1007/s11883-011-0197-9; Navarese EP, 2013, AM J CARDIOL, V111, P1123, DOI 10.1016/j.amjcard.2012.12.037; Public Citizen's Health Research Group, PET BAN CHOL LOW DRU; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; van Staa TP, 2014, BRIT J CLIN PHARMACO, V78, P649, DOI 10.1111/bcp.12367; Zaharan NL, 2013, BRIT J CLIN PHARMACO, V75, P1118, DOI 10.1111/j.1365-2125.2012.04403.x	21	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2015	350								h1388	10.1136/bmj.h1388	http://dx.doi.org/10.1136/bmj.h1388			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KO	25787130	Bronze			2022-12-28	WOS:000351570700007
J	Lane, R				Lane, Richard			Tariana Turia: looking ahead to a tobacco-free New Zealand	LANCET			English	Biographical-Item																		TURIA T, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					937	937		10.1016/S0140-6736(15)60518-9	http://dx.doi.org/10.1016/S0140-6736(15)60518-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD2EK	25784337				2022-12-28	WOS:000350886900015
J	Collins, SH; Wiggin, MB; Sawicki, GS				Collins, Steven H.; Wiggin, M. Bruce; Sawicki, Gregory S.			Reducing the energy cost of human walking using an unpowered exoskeleton	NATURE			English	Article							WORK; EXPENDITURE; ENERGETICS; MECHANICS; BIOMECHANICS; GAIT; MASS	With efficiencies derived from evolution, growth and learning, humans are very well-tuned for locomotion(1). Metabolic energy used during walking can be partly replaced by power input from an exoskeleton(2), but is it possible to reduce metabolic rate without providing an additional energy source? This would require an improvement in the efficiency of the human-machine system as a whole, and would be remarkable given the apparent optimality of human gait. Here we show that the metabolic rate of human walking can be reduced by an unpowered ankle exoskeleton. We built a lightweight elastic device that acts in parallel with the user's calf muscles, off-loading muscle force and thereby reducing the metabolic energy consumed in contractions. The device uses a mechanical clutch to hold a spring as it is stretched and relaxed by ankle movements when the foot is on the ground, helping to fulfil one function of the calf muscles and Achilles tendon. Unlike muscles, however, the clutch sustains force passively. The exoskeleton consumes no chemical or electrical energy and delivers no net positive mechanical work, yet reduces the metabolic cost of walking by 7.2 +/- 2.6% for healthy human users under natural conditions, comparable to savings with powered devices. Improving upon walking economy in this way is analogous to altering the structure of the body such that it is more energy-effective at walking. While strong natural pressures have already shaped human locomotion, improvements in efficiency are still possible. Much remains to be learned about this seemingly simple behaviour.	[Collins, Steven H.] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Wiggin, M. Bruce; Sawicki, Gregory S.] N Carolina State Univ, Joint Dept Biomed Engn, Raleigh, NC 27695 USA; [Wiggin, M. Bruce; Sawicki, Gregory S.] Univ North Carolina Chapel Hill, Raleigh, NC 27695 USA	Carnegie Mellon University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill	Collins, SH (corresponding author), Carnegie Mellon Univ, Dept Mech Engn, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.	stevecollins@cmu.edu; greg_sawicki@ncsu.edu		Collins, Steve/0000-0002-3997-3374	North Carolina State Faculty Research and Professional Development Fund; North Carolina State Chancellors Innovation Fund; United States - Israel Binational Science Foundation [2011152]; National Institute of Nursing Research of the National Institutes of Health [R01NR014756]; National Science Foundation [IIS-1355716]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014756] Funding Source: NIH RePORTER	North Carolina State Faculty Research and Professional Development Fund; North Carolina State Chancellors Innovation Fund; United States - Israel Binational Science Foundation(US-Israel Binational Science Foundation); National Institute of Nursing Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	We thank A. Westbrook for data collection, K. Takahashi and R. Nuckols for stiffness characterizations, B. Reich for discussions on statistical analysis, R. Jackson for data collection and manuscript editing, and J. Caputo, P. Collins, S. Diller, N. Donahue, A. Kuo, I. Lau, L. Lau, C. Majidi, J. Malen, T. Roberts, A. Robinson, A. Ruina, P. Taggart, K. Witte, M. Wu and others for editorial suggestions. The photograph in Fig. 1b is by S. Thrift. Funding for this research was provided by grants to G.S.S. from the North Carolina State Faculty Research and Professional Development Fund; the North Carolina State Chancellors Innovation Fund; grant number 2011152 from the United States - Israel Binational Science Foundation; and award number R01NR014756 from the National Institute of Nursing Research of the National Institutes of Health. This material is based upon work supported by the National Science Foundation under grant number IIS-1355716 to S.H.C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funding agencies listed.	Alexander RM., 2003, PRINCIPLES ANIMAL LO; Bregman DJJ, 2011, CLIN BIOMECH, V26, P955, DOI 10.1016/j.clinbiomech.2011.05.007; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; Collins SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009307; Collins SH, 2009, P ROY SOC B-BIOL SCI, V276, P3679, DOI 10.1098/rspb.2009.0664; Davidson PR, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S11; Dietz V, 2003, CLIN NEUROPHYSIOL, V114, P1379, DOI 10.1016/S1388-2457(03)00120-2; Donelan JM, 2008, SCIENCE, V319, P807, DOI 10.1126/science.1149860; Donelan JM, 2002, J BIOMECH, V35, P117, DOI 10.1016/S0021-9290(01)00169-5; ERICSSON KA, 1994, AM PSYCHOL, V49, P725, DOI 10.1037/0003-066X.49.8.725; Farris DJ, 2013, J APPL PHYSIOL, V115, P579, DOI 10.1152/japplphysiol.00253.2013; Farris DJ, 2012, J APPL PHYSIOL, V113, P1862, DOI 10.1152/japplphysiol.00802.2012; FORSSBERG H, 1985, EXP BRAIN RES, V57, P480; Galle S, 2013, GAIT POSTURE, V38, P495, DOI 10.1016/j.gaitpost.2013.01.029; Grabowski A, 2005, J APPL PHYSIOL, V98, P579, DOI 10.1152/japplphysiol.00734.2004; Grabowski AM, 2009, J APPL PHYSIOL, V107, P670, DOI 10.1152/japplphysiol.91609.2008; HEGLUND NC, 1995, NATURE, V375, P52, DOI 10.1038/375052a0; Holt NC, 2014, J EXP BIOL, V217, P4365, DOI 10.1242/jeb.112813; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; Kao PC, 2010, J BIOMECH, V43, P203, DOI 10.1016/j.jbiomech.2009.09.030; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; Mooney LM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-80; Roberts TJ, 2002, COMP BIOCHEM PHYS A, V133, P1087, DOI 10.1016/S1095-6433(02)00244-1; Rome LC, 2006, NATURE, V444, P1023, DOI 10.1038/4441023a; Ryschon TW, 1997, J APPL PHYSIOL, V83, P867, DOI 10.1152/jappl.1997.83.3.867; Sawicki GS, 2008, J EXP BIOL, V211, P1402, DOI 10.1242/jeb.009241; TUCKER VA, 1975, AM SCI, V63, P413; Tudor-Locke C, 2009, MED SCI SPORT EXER, V41, P1384, DOI 10.1249/MSS.0b013e318199885c; Umberger BR, 2011, EXERC SPORT SCI REV, V39, P59, DOI 10.1097/JES.0b013e31820d7bc5; van Dijk W., 2011, IEEE INT C REHABIL R, V2011, P5975470; Westerterp KR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00090; Yagn N., 1890, U.S. Patent, Patent No. [420,179, 420179, 4 201 79]; ZARRUGH MY, 1974, EUR J APPL PHYSIOL O, V33, P293, DOI 10.1007/BF00430237; Zelik KE, 2014, J THEOR BIOL, V346, P75, DOI 10.1016/j.jtbi.2013.12.014; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297; Zoss A, 2006, ADV ROBOTICS, V20, P967, DOI 10.1163/156855306778394030	38	500	532	63	606	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					212	+		10.1038/nature14288	http://dx.doi.org/10.1038/nature14288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	25830889	Green Accepted, Green Submitted			2022-12-28	WOS:000356016700038
J	Berwick, DM; Feeley, D; Loehrer, S				Berwick, Donald M.; Feeley, Derek; Loehrer, Saranya			Change From the Inside Out Health Care Leaders Taking the Helm	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Berwick, Donald M.; Feeley, Derek; Loehrer, Saranya] Inst Healthcare Improvement, Cambridge, MA 02138 USA	Institute for Healthcare Improvement	Loehrer, S (corresponding author), Inst Healthcare Improvement, 20 Univ Rd,Seventh Floor, Cambridge, MA 02138 USA.	sloehrer@ihi.org						Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Centers for Medicare & Medicaid Services, PROJ NATL HLTH EXP M; Gerhardt G, 2013, MEDICARE MEDICAID RE, V3; Leavitt Partners, GRWOTH DISP ACC CAR; National Committee for Quality Assurance, PAT CTR MED HOM; Splaine M, 1998, J Ambul Care Manage, V21, P1; U.S. Department of Health and Human Services, NEW HHS DAT SHOWS MA	7	18	18	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2015	313	17					1707	1708		10.1001/jama.2015.2830	http://dx.doi.org/10.1001/jama.2015.2830			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3HQ	25812026				2022-12-28	WOS:000353921000011
J	Lin, MC; Gong, M; Lu, BG; Wu, YP; Wang, DY; Guan, MY; Angell, M; Chen, CX; Yang, J; Hwang, BJ; Dai, HJ				Lin, Meng-Chang; Gong, Ming; Lu, Bingan; Wu, Yingpeng; Wang, Di-Yan; Guan, Mingyun; Angell, Michael; Chen, Changxin; Yang, Jiang; Hwang, Bing-Joe; Dai, Hongjie			An ultrafast rechargeable aluminium-ion battery	NATURE			English	Article							GRAPHITE-INTERCALATION; ELECTROLYTE; CHLORIDE; LIQUIDS; ELECTRODEPOSITION; DEPOSITION; ANIONS; ALLOY	The development of new rechargeable battery systems could fuel various energy applications, from personal electronics to grid storage(1,2). Rechargeable aluminium-based batteries offer the possibilities of low cost and low flammability, together with three-electron-redox properties leading to high capacity'. However, research efforts over the past 30 years have encountered numerous problems, such as cathode material disintegration'', low cell discharge voltage (about 0.55 volts; ref. 5), capacitive behaviour without discharge voltage plateaus (1.1-0.2 volts(6) or 1.8-0.8 volts(7)) and insufficient cycle life (less than 100 cycles) with rapid capacity decay (by 26-85 per cent over 100 cydes)(4-7). Here we present a rechargeable aluminium battery with high-rate capability that uses an aluminium metal anode and a three-dimensional graphitic-foam cathode. The battery operates through the electrochemical deposition and dissolution of aluminium at the anode, and intercalation/de-intercalation of chloroaluminate anions in the graphite, using a non-flammable ionic liquid electrolyte. The cell exhibits well-defined discharge voltage plateaus near 2 volts, a specific capacity of about 70 mA h g(-1) and a Coulombic efficiency of approximately 98 per cent. The cathode was found to enable fast anion diffusion and intercalation, affording charging times of around one minute with a current density of similar to 4,000 mA g(-1) (equivalent to similar to 3,000 W kg(-1)) and to withstand more than 7,500 cycles without capacity decay.	[Lin, Meng-Chang; Gong, Ming; Lu, Bingan; Wu, Yingpeng; Wang, Di-Yan; Guan, Mingyun; Angell, Michael; Chen, Changxin; Yang, Jiang; Dai, Hongjie] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Lin, Meng-Chang] Ind Technol Res Inst, Green Energy & Environm Res Labs, Hsinchu 31040, Taiwan; [Lu, Bingan] Hunan Univ, Sch Phys & Elect, Changsha 410082, Hunan, Peoples R China; [Wang, Di-Yan] Natl Taiwan Normal Univ, Dept Chem, Taipei 11677, Taiwan; [Wang, Di-Yan] Acad Sinica, Inst Atom & Mol Sci, Taipei 10617, Taiwan; [Hwang, Bing-Joe] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei 10607, Taiwan	Stanford University; Industrial Technology Research Institute - Taiwan; Hunan University; National Taiwan Normal University; Academia Sinica - Taiwan; National Taiwan University of Science & Technology	Dai, HJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	hdai@stanford.edu	Hwang, Bing Joe/AAH-7859-2021; Dai, Hongjie/ABC-4574-2021; Hwang, Bing Joe/A-4553-2010	Hwang, Bing Joe/0000-0002-3873-2149; Hwang, Bing Joe/0000-0002-3873-2149; Gong, Ming/0000-0002-1584-1211; Yang, Jiang/0000-0001-5934-1537; Lin, Meng-Chang/0000-0003-1337-272X	Bureau of Energy, Ministry of Economic Affairs, Taiwan; National Natural Science Foundation of China [21303046]; China Scholarship Council [201308430178]; Hunan University Fund for Multidisciplinary Developing [531107040762]; US Department of Energy for novel carbon materials development and electrical characterization work [DOE DE-SC0008684]; Stanford GCEP; Precourt Institute of Energy; Global Networking Talent 3.0 plan from the Ministry of Education of Taiwan [NTUST 104DI005]	Bureau of Energy, Ministry of Economic Affairs, Taiwan(Ministry of Economic Affairs, Taiwan); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); Hunan University Fund for Multidisciplinary Developing; US Department of Energy for novel carbon materials development and electrical characterization work(United States Department of Energy (DOE)); Stanford GCEP; Precourt Institute of Energy; Global Networking Talent 3.0 plan from the Ministry of Education of Taiwan	We thank M. D. Fayer for discussions. We also than kY. Cui's group for use of an argon-filled glove box and a vacuum oven. M.-C.L thanks the Bureau of Energy, Ministry of Economic Affairs, Taiwan, for supporting international cooperation between Stanford University and ITRI. B.L. acknowledges support from the National Natural Science Foundation of China (grant no. 21303046), the China Scholarship Council (no. 201308430178), and the Hunan University Fund for Multidisciplinary Developing (no. 531107040762). We also acknowledge support from the US Department of Energy for novel carbon materials development and electrical characterization work (DOE DE-SC0008684), Stanford GCEP, the Precourt Institute of Energy, and the Global Networking Talent 3.0 plan (NTUST 104DI005) from the Ministry of Education of Taiwan.	Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; AUBORN JJ, 1985, J ELECTROCHEM SOC, V132, P598, DOI 10.1149/1.2113913; Bao WZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5224; Borg R. J., 1988, INTRO SOLID STATE DI; CARLIN RT, 1994, J ELECTROCHEM SOC, V141, pL73, DOI 10.1149/1.2055041; Chen ZP, 2011, NAT MATER, V10, P424, DOI [10.1038/NMAT3001, 10.1038/nmat3001]; Endres F, 2008, ELECTRODEPOSITION IO; GIFFORD PR, 1988, J ELECTROCHEM SOC, V135, P650, DOI 10.1149/1.2095685; Hardwick LJ, 2006, ELECTROCHIM ACTA, V52, P675, DOI 10.1016/j.electacta.2006.05.053; Hudak NS, 2014, J PHYS CHEM C, V118, P5203, DOI 10.1021/jp500593d; Huskinson B, 2014, NATURE, V505, P195, DOI 10.1038/nature12909; Jayaprakash N, 2011, CHEM COMMUN, V47, P12610, DOI 10.1039/c1cc15779e; Jiang T, 2006, SURF COAT TECH, V201, P1, DOI 10.1016/j.surfcoat.2005.10.046; LAI PK, 1988, J ELECTROANAL CHEM, V248, P431, DOI 10.1016/0022-0728(88)85103-9; Lee JJ, 2000, J ELECTROCHEM SOC, V147, P562, DOI 10.1149/1.1393233; Li QF, 2002, J POWER SOURCES, V110, P1, DOI 10.1016/S0378-7753(01)01014-X; Ozmen-Monkul B, 2010, CARBON, V48, P3205, DOI 10.1016/j.carbon.2010.05.005; Pan SJ, 2010, ELECTROCHIM ACTA, V55, P2158, DOI 10.1016/j.electacta.2009.11.050; Rani JV, 2013, J ELECTROCHEM SOC, V160, pA1781, DOI 10.1149/2.072310jes; Schmuelling G, 2013, J POWER SOURCES, V239, P563, DOI 10.1016/j.jpowsour.2013.03.064; Tabakman SM, 2011, SMALL, V7, P499, DOI 10.1002/smll.201001836; Takahashi S., 1999, Plasmas & Ions, V2, P91, DOI 10.1016/S1288-3255(99)00105-7; Wasserscheid P, 2000, ANGEW CHEM INT EDIT, V39, P3772, DOI 10.1002/1521-3773(20001103)39:21<3772::AID-ANIE3772>3.0.CO;2-5; WILKES JS, 1982, INORG CHEM, V21, P1263, DOI 10.1021/ic00133a078; Yang ZG, 2011, CHEM REV, V111, P3577, DOI 10.1021/cr100290v; Yu XZ, 2014, ADV MATER, V26, P1044, DOI 10.1002/adma.201304148; Zhang B, 2014, CHEM SCI, V5, P4070, DOI 10.1039/c4sc01206b; Zhang XR, 1999, MATER RES BULL, V34, P363, DOI 10.1016/S0025-5408(99)00035-5; Zhu YJ, 2001, J PHYS CHEM B, V105, P7632, DOI 10.1021/jp011377	29	1572	1617	90	2273	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					325	+		10.1038/nature14340	http://dx.doi.org/10.1038/nature14340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25849777				2022-12-28	WOS:000352974200033
J	Aronow, WS				Aronow, Wilbert S.			Multiple Blood Pressure Medications and Mortality Among Elderly Individuals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HYPERTENSION	IMPORTANCE Clinical evidence supports the beneficial effects of lowering blood pressure (BP) levels in community-living, robust, hypertensive individuals older than 80 years. However, observational studies in frail elderly patients have shown no or even an inverse relationship between BP and morbidity and mortality. OBJECTIVE To assess all-cause mortality in institutionalized individuals older than 80 years according to systolic BP (SBP) levels and number of a ntihypertensive drugs. DESIGN, SETTING, AND PARTICIPANTS This longitudinal study included elderly residents of nursing homes. The interaction between low (<130 mm Hg) SBP and the presence of combination antihypertensive treatment on 2-year all-cause mortality was analyzed. A total of 1127 women and men older than 80 years (mean, 87.6 years; 78.1% women) living in nursing homes in France and Italy were recruited, examined, and monitored for 2 years. Blood pressure was measured with assisted self-measurements in the nursing home during 3 consecutive days (mean, 18 measurements). Patients with an SBP less than 130 mm Hg who were receiving combination antihypertensive treatment were compared with all other participants. MAIN OUTCOMES AND MEASURES All-cause mortality over a 2-year follow-up period. RESULTS A significant interaction was found between low SBP and treatment with 2 or more BP-lowering agents, resulting in a higher risk of mortality (unadjusted hazard ratio [HR], 1.81; 95% Cl, 1.36-2.41); adjusted HR, 1.78; 95% Cl, 1.34-2.37; both P <.001) in patients with low SBP who were receiving multiple BP medicines compared with the other participants. Three sensitivity analyses confirmed the significant excess of risk: propensity score-matched subsets (unadjusted HR, 1.97; 95% Cl, 1.32-2.93; P <.001; adjusted HR, 2.05; 95% Cl, 1.37-3.06; P <.001), adjustment for cardiovascular comorbidities (HR, 1.73; 95% Cl, 1.29-2.32; P <.001), and exclusion of patients without a history of hypertension who were receiving BP-lowering agents (unadjusted HR, 1.82; 95% Cl, 1.33-2.48; P <.001; adjusted HR, 1.76; 95% Cl, 1.28-2.41; P <.001). CONCLUSIONS AND RELEVANCE The findings of this study raise a cautionary note regarding the safety of using combination antihypertensive therapy in frail elderly patients with low SBP (<130 mm Hg). Dedicated, controlled interventional studies are warranted to assess the corresponding benefit to risk ratio in this growing population.	[Aronow, Wilbert S.] New York Med Coll, Div Cardiol, Dept Med, Westchester Med Ctr, Valhalla, NY 10595 USA	New York Medical College; Westchester Medical Center	Aronow, WS (corresponding author), New York Med Coll, Div Cardiol, Macy Pavil,Room 138, Valhalla, NY 10595 USA.	wsaronow@aol.com						Aronow WS, 2011, J AM COLL CARDIOL, V57, P2037, DOI 10.1016/j.jacc.2011.01.008; Aronow WS, 2015, MATURITAS, V80, P31, DOI 10.1016/j.maturitas.2014.10.001; Banach M, 2012, CURR HYPERTENS REP, V14, P556, DOI 10.1007/s11906-012-0314-3; Bangalore S, 2010, CIRCULATION, V122, P2142, DOI 10.1161/CIRCULATIONAHA.109.905687; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Benetos A, 2015, JAMA INTERN MED, V175, P989, DOI 10.1001/jamainternmed.2014.8012; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255; Voko Z, 1999, HYPERTENSION, V34, P1181, DOI 10.1161/01.HYP.34.6.1181	10	5	5	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2015	313	13					1362	+		10.1001/jama.2015.248	http://dx.doi.org/10.1001/jama.2015.248			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF1OL	25849180				2022-12-28	WOS:000352315900022
J	Gudzune, KA; Doshi, RS; Mehta, AK; Chaudhry, ZW; Jacobs, DK; Vakil, RM; Lee, CJ; Bleich, SN; Clark, JM				Gudzune, Kimberly A.; Doshi, Ruchi S.; Mehta, Ambereen K.; Chaudhry, Zoobia W.; Jacobs, David K.; Vakil, Rachit M.; Lee, Clare J.; Bleich, Sara N.; Clark, Jeanne M.			Efficacy of Commercial Weight-Loss Programs An Updated Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; LOW-CALORIE DIET; LOW-FAT DIET; LOW-CARBOHYDRATE DIET; OLDER OBESE ADULTS; MEAL REPLACEMENTS; GLYCEMIC CONTROL; OVERWEIGHT WOMEN; KETOGENIC DIET; RISK-FACTORS	Background: Commercial and proprietary weight-loss programs are popular obesity treatment options, but their efficacy is unclear. Purpose: To compare weight loss, adherence, and harms of commercial or proprietary weight-loss programs versus control/education (no intervention, printed materials only, health education curriculum, or <3 sessions with a provider) or behavioral counseling among overweight and obese adults. Data Sources: MEDLINE and the Cochrane Database of Systematic Reviews from inception to November 2014; references identified by program staff. Study Selection: Randomized, controlled trials (RCTs) of at least 12 weeks' duration; prospective case series of at least 12 months' duration (harms only). Data Extraction: Two reviewers extracted information on study design, population characteristics, interventions, and mean percentage of weight change and assessed risk of bias. Data Synthesis: We included 45 studies, 39 of which were RCTs. At 12 months, Weight Watchers participants achieved at least 2.6% greater weight loss than those assigned to control/education. Jenny Craig resulted in at least 4.9% greater weight loss at 12 months than control/education and counseling. Nutri-system resulted in at least 3.8% greater weight loss at 3 months than control/education and counseling. Very-low-calorie programs (Health Management Resources, Medifast, and OPTIFAST) resulted in at least 4.0% greater short-term weight loss than counseling, but some attenuation of effect occurred beyond 6 months when reported. Atkins resulted in 0.1% to 2.9% greater weight loss at 12 months than counseling. Results for SlimFast were mixed. We found limited evidence to evaluate adherence or harms for all programs and weight outcomes for other commercial programs. Limitation: Many trials were short (<12 months), had high attrition, and lacked blinding. Conclusion: Clinicians could consider referring overweight or obese patients to Weight Watchers or Jenny Craig. Other popular programs, such as Nutrisystem, show promising weight-loss results; however, additional studies evaluating long-term outcomes are needed.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; Johns Hopkins Bayview Med Ctr, Baltimore, MD USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Rutgers Robert Wood Johnson Med Sch, Piscataway, NJ USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; Rutgers State University New Brunswick; Rutgers State University Medical Center	Gudzune, KA (corresponding author), Johns Hopkins Univ, Sch Med, Div Gen Internal Med, 2024 East Monument St,Room 2-621, Baltimore, MD 21287 USA.	gudzune@jhu.edu	Clark, Jeanne/AGG-8199-2022	Clark, Jeanne/0000-0003-1194-0092; Lee, Clare/0000-0002-0824-0207	career development award from the National Heart, Lung, and Blood Institute [K23HL116601, 1K01HL096409]; Johns Hopkins medical student summer research program; medical student research program in diabetes at JHU-UMD Diabetes Research Center (National Institute of Diabetes and Digestive and Kidney Diseases) [P30DK079637]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001077, TL1TR001078] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL096409, K23HL116601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	career development award from the National Heart, Lung, and Blood Institute; Johns Hopkins medical student summer research program; medical student research program in diabetes at JHU-UMD Diabetes Research Center (National Institute of Diabetes and Digestive and Kidney Diseases); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Gudzune was supported by a career development award from the National Heart, Lung, and Blood Institute (K23HL116601). Ms. Doshi was supported by the Johns Hopkins medical student summer research program. Mr. Jacobs was supported by the medical student research program in diabetes at JHU-UMD Diabetes Research Center (National Institute of Diabetes and Digestive and Kidney Diseases grant P30DK079637). Dr. Bleich was supported by a career development award from the National Heart, Lung, and Blood Institute (1K01HL096409).	Ahrens Renee A, 2003, J Am Pharm Assoc (2003), V43, P583; Allen JK, 2013, J OBES, V2013, DOI 10.1155/2013/151597; Anderson JW, 2011, POSTGRAD MED, V123, P205, DOI 10.3810/pgm.2011.09.2476; ANDERSON JW, 1994, DIABETES CARE, V17, P602, DOI 10.2337/diacare.17.6.602; ANDERSON JW, 1991, J AM DIET ASSOC, V91, P1582; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Ashley JM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-12; Bischoff SC, 2012, INT J OBESITY, V36, P614, DOI 10.1038/ijo.2011.107; Bleich SN, 2013, J GEN INTERN MED, V28, P3, DOI 10.1007/s11606-012-2201-7; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Clifton PM, 2005, INT J OBESITY, V29, P1445, DOI 10.1038/sj.ijo.0803039; Collins CE, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1980; Collins CE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-669; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Davis LM, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-11; Davis NJ, 2009, DIABETES CARE, V32, P1147, DOI 10.2337/dc08-2108; Ditschuneit HH, 1999, AM J CLIN NUTR, V69, P198; Ditschuneit HH, 2002, EUR J CLIN NUTR, V56, P264, DOI 10.1038/sj.ejcn.1601375; Ditschuneit HH, 2001, OBES RES, V9, p284S, DOI 10.1038/oby.2001.132; DOHERTY JU, 1991, AM J CLIN NUTR, V53, P854, DOI 10.1093/ajcn/53.4.854; Donnelly JE, 2007, INT J OBESITY, V31, P1270, DOI 10.1038/sj.ijo.0803568; Dow CA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000152; Figueroa A, 2013, AM J HYPERTENS, V26, P416, DOI 10.1093/ajh/hps050; Finkelstein EA, 2014, OBESITY, V22, P1942, DOI 10.1002/oby.20824; Finley CE, 2007, INT J OBESITY, V31, P292, DOI 10.1038/sj.ijo.0803395; Flechtner-Mors M, 2000, OBES RES, V8, P399, DOI 10.1038/oby.2000.48; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Foster GD, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.3; Foster GD, 2010, ANN INTERN MED, V153, P147, DOI 10.7326/0003-4819-153-3-201008030-00005; Foster GD, 2009, POSTGRAD MED, V121, P113, DOI 10.3810/pgm.2009.09.2046; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Friedman AN, 2012, CLIN J AM SOC NEPHRO, V7, P1103, DOI 10.2215/CJN.11741111; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Greenberg I, 2009, J AM COLL NUTR, V28, P159, DOI 10.1080/07315724.2009.10719767; Heshka S, 2000, AM J MED, V109, P282, DOI 10.1016/S0002-9343(00)00494-0; Heshka S, 2003, JAMA-J AM MED ASSOC, V289, P1792, DOI 10.1001/jama.289.14.1792; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hutchesson MJ, 2014, EUR J CLIN NUTR, V68, P64, DOI 10.1038/ejcn.2013.194; IBISWorld, 2014, WEIGHT LOSS SERV US; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Johansson K, 2014, INT J OBESITY, V38, P279, DOI 10.1038/ijo.2013.83; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; Johnston CA, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.04.025; Jolly K, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6500; Jolly K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-439; Kaiser Commission on Medicaid and the Uninsured, 2012, COV PREV SERV AD MED; Kirschner M A, 1979, J Med Soc N J, V76, P175; Lee JS, 2010, PUBLIC HEALTH REP, V125, P596, DOI 10.1177/003335491012500415; Li Z, 2005, EUR J CLIN NUTR, V59, P411, DOI 10.1038/sj.ejcn.1602089; Madigan CD, 2014, BRIT J GEN PRACT, V64, pE128, DOI 10.3399/bjgp14X677491; McAuley KA, 2005, DIABETOLOGIA, V48, P8, DOI 10.1007/s00125-004-1603-4; Miller GD, 2010, J NUTR HEALTH AGING, V14, P461; Miller GD, 2006, OBESITY, V14, P1219, DOI 10.1038/oby.2006.139; Mitchell NS, 2013, J GEN INTERN MED, V28, P12, DOI 10.1007/s11606-012-2083-8; Moore SD, 2011, EAT BEHAV, V12, P60, DOI 10.1016/j.eatbeh.2010.08.007; Morgan LM, 2009, PUBLIC HEALTH NUTR, V12, P799, DOI 10.1017/S1368980008003236; Noakes M, 2004, J NUTR, V134, P1894, DOI 10.1093/jn/134.8.1894; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Perna F, 1999, J EXERC PHYSL ONLINE, V2, P2; Pinto AM, 2013, OBESITY, V21, P673, DOI 10.1002/oby.20044; Rippe JM, 1998, OBES RES, V6, P208, DOI 10.1002/j.1550-8528.1998.tb00339.x; Rock CL, 2007, OBESITY, V15, P939, DOI 10.1038/oby.2007.614; Rock CL, 2014, DIABETES CARE, V37, P1573, DOI 10.2337/dc13-2900; Rock CL, 2010, JAMA-J AM MED ASSOC, V304, P1803, DOI 10.1001/jama.2010.1503; Saad L, 2011, GALLUP POLL SOCIAL S; Sebelius K., 2014, REPORT C PREVENTIVE; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Tirosh A, 2013, DIABETES CARE, V36, P2225, DOI 10.2337/dc12-1846; Truby H, 2006, BMJ-BRIT MED J, V332, P1309, DOI 10.1136/bmj.38833.411204.80; Tsai AG, 2005, ANN INTERN MED, V142, P56, DOI 10.7326/0003-4819-142-1-200501040-00012; Tsertsvadze A, 2011, AHRQ PUBLICATION; US Preventive Services Task Force, 2012, OB AD SCREEN MAN; WADDEN TA, 1992, ARCH INTERN MED, V152, P961, DOI 10.1001/archinte.152.5.961; Wadden TA, 1998, J CLIN ENDOCR METAB, V83, P214, DOI 10.1210/jc.83.1.214; Wadden TA, 2004, AM J CLIN NUTR, V80, P560; Walker CG, 2013, OBESITY, V21, P2589, DOI 10.1002/oby.20328; Westman EC, 2006, INT J CARDIOL, V110, P212, DOI 10.1016/j.ijcard.2005.08.034; WING RR, 1994, AM J MED, V97, P354, DOI 10.1016/0002-9343(94)90302-6; Womble LG, 2004, OBES RES, V12, P1011, DOI 10.1038/oby.2004.124; Yancy WS, 2009, QUAL LIFE RES, V18, P281, DOI 10.1007/s11136-009-9444-8; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006; Yip I, 2001, OBES RES, V9, p341S, DOI 10.1038/oby.2001.140	84	194	198	0	105	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2015	162	7					501	+		10.7326/M14-2238	http://dx.doi.org/10.7326/M14-2238			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4UT	25844997	Green Accepted			2022-12-28	WOS:000353283400005
J	Schulz, L				Schulz, Laura			Infants explore the unexpected	SCIENCE			English	Editorial Material							PLAY		MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Schulz, L (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	lschulz@mit.edu						[Anonymous], 2006, PLAY LEARNING PLAY M; Cook C, 2011, COGNITION, V120, P341, DOI 10.1016/j.cognition.2011.03.003; Gerken L, 2011, DEVELOPMENTAL SCI, V14, P972, DOI 10.1111/j.1467-7687.2011.01046.x; Kidd C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036399; Klahr D, 2011, SCIENCE, V333, P971, DOI 10.1126/science.1204528; Legare CH, 2012, CHILD DEV, V83, P173, DOI 10.1111/j.1467-8624.2011.01691.x; Piaget J, 1930, CHILDS CONCEPTION PH; Schulz LE, 2007, DEV PSYCHOL, V43, P1045, DOI 10.1037/0012-1649.43.4.1045; SPELKE ES, 1992, PSYCHOL REV, V99, P605, DOI 10.1037/0033-295X.99.4.605; Stahl AE, 2015, SCIENCE, V348, P91, DOI 10.1126/science.aaa3799; Teglas E, 2011, SCIENCE, V332, P1054, DOI 10.1126/science.1196404; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; van Hoof J.A.R.A.M., 1976, PLAY ITS ROLE DEV EV; van Schijndel TJP, 2015, J EXP CHILD PSYCHOL, V131, P104, DOI 10.1016/j.jecp.2014.11.008	14	13	13	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					42	43		10.1126/science.aab0582	http://dx.doi.org/10.1126/science.aab0582			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8GJ	25838368				2022-12-28	WOS:000352079500020
J	Lopes, R; Imanaliev, A; Aspect, A; Cheneau, M; Boiron, D; Westbrook, CI				Lopes, R.; Imanaliev, A.; Aspect, A.; Cheneau, M.; Boiron, D.; Westbrook, C. I.			Atomic Hong-Ou-Mandel experiment	NATURE			English	Article							4TH-ORDER INTERFERENCE; QUANTUM INTERFERENCE; MATTER WAVES; PHOTONS; INDISTINGUISHABILITY; INTERFEROMETRY; ENTANGLEMENT; VIOLATION; OPTICS; STATES	Two-particle interference is a fundamental feature of quantum mechanics, and is even less intuitive than wave-particle duality for a single particle. In this duality, classical concepts-wave or particle-are still referred to, and interference happens in ordinary space-time. On the other hand, two-particle interference takes place in a mathematical space that has no classical counterpart. Entanglement lies at the heart of this interference, as it does in the fundamental tests of quantum mechanics involving the violation of Bell's inequalities(1-4). The Hong, Ou and Mandel experiment(5) is a conceptually simpler situation, in which the interference between two-photon amplitudes also leads to behaviour impossible to describe using a simple classical model. Here we report the realization of the Hong, Ou and Mandel experiment using atoms instead of photons. We create a source that emits pairs of atoms, and cause one atom of each pair to enter one of the two input channels of a beam-splitter, and the other atom to enter the other input channel. When the atoms are spatially overlapped so that the two inputs are indistinguishable, the atoms always emerge together in one of the output channels. This result opens the way to testing Bell's inequalities involving mechanical observables of massive particles, such as momentum, using methods inspired by quantum optics(6,7), and to testing theories of the quantum-to-classical transition(8-11). Our work also demonstrates a new way to benchmark non-classical atom sources(12,13) that may be of interest for quantum information processing(14) and quantum simulation(15).	[Lopes, R.; Imanaliev, A.; Aspect, A.; Cheneau, M.; Boiron, D.; Westbrook, C. I.] Univ Paris Sud, CNRS, Grad Sch, Lab Charles Fabry,Inst Opt, 2 Ave Augustin Fresnel, F-91127 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Lopes, R (corresponding author), Univ Paris Sud, CNRS, Grad Sch, Lab Charles Fabry,Inst Opt, 2 Ave Augustin Fresnel, F-91127 Palaiseau, France.	raphael.lopes@institutoptique.fr; marc.cheneau@institutoptique.fr	Lopes, Raphael/W-8139-2019; Westbrook, Christoph I/B-6092-2009; Cheneau, Marc/O-9312-2014	Lopes, Raphael/0000-0003-3877-8478; Westbrook, Christoph I/0000-0002-6490-0468; Cheneau, Marc/0000-0001-7261-566X; Imanaliev, Almazbek/0000-0002-8397-6927	IFRAF; Triangle de la Physique; Labex PALM; ANR (PROQUP, QEAGE); FCT [SFRH/BD/74352/2010]; ESF; POPH/QREN; EU; EU (ERC) [267775]; EU (QUANTATOP); EU (Marie Curie) [CIG 618760]; EU (CORENT)	IFRAF(European Commission); Triangle de la Physique; Labex PALM; ANR (PROQUP, QEAGE)(French National Research Agency (ANR)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ESF(European Commission); POPH/QREN; EU(European Commission); EU (ERC)(European Research Council (ERC)European Commission); EU (QUANTATOP); EU (Marie Curie)(European Commission); EU (CORENT)	We thank J. Ruaudel and M. Bonneau for contributions to the early steps of the experiment. We also thank K. Kheruntsyan, J. Chwedenczuk and P. Deuar for discussions. We acknowledge funding by IFRAF, Triangle de la Physique, Labex PALM, ANR (PROQUP, QEAGE), FCT (scholarship SFRH/BD/74352/2010 co-financed by ESF, POPH/QREN and EU to R.L.) and EU (ERC grant 267775, QUANTATOP, and Marie Curie CIG 618760, CORENT).	Andersson E, 1999, PHYS REV A, V59, P3841, DOI 10.1103/PhysRevA.59.3841; Aspect A, 1999, NATURE, V398, P189, DOI 10.1038/18296; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Beugnon J, 2006, NATURE, V440, P779, DOI 10.1038/nature04628; Bocquillon E, 2013, SCIENCE, V339, P1054, DOI 10.1126/science.1232572; Bonneau M, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.061603; Bookjans EM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.210406; Bucker R, 2011, NAT PHYS, V7, P608, DOI [10.1038/NPHYS1992, 10.1038/nphys1992]; Campbell GK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.020406; Christensen BG, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.130406; Cronin AD, 2009, REV MOD PHYS, V81, P1051, DOI 10.1103/RevModPhys.81.1051; Dubois J, 2013, NATURE, V502, P659, DOI 10.1038/nature12713; Giustina M, 2013, NATURE, V497, P227, DOI 10.1038/nature12012; Gross C, 2011, NATURE, V480, P219, DOI 10.1038/nature10654; Grynberg G., 2010, INTRO QUANTUM OPTICS; Hilligsoe KM, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.041602; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Jaskula JC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.190402; Kaufman AM, 2014, SCIENCE, V345, P306, DOI 10.1126/science.1250057; Kitagawa T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.115302; Lang C, 2013, NAT PHYS, V9, P345, DOI [10.1038/nphys2612, 10.1038/NPHYS2612]; Leggett AJ, 2007, J PHYS A-MATH THEOR, V40, P3141, DOI 10.1088/1751-8113/40/12/S15; Lewis-Swan RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4752; Lewis-Swan R. J., 2014, PREPRINT; Lucke B, 2011, SCIENCE, V334, P773, DOI 10.1126/science.1208798; Morizur JF, 2011, EUR PHYS J D, V61, P237, DOI 10.1109/CLEOE.2011.5943362; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Ou Z.-Y. J., 2007, MULTIPHOTON QUANTUM; OU ZY, 1988, PHYS REV A, V37, P1607, DOI 10.1103/PhysRevA.37.1607; Penrose R, 1998, PHILOS T R SOC A, V356, P1927, DOI 10.1098/rsta.1998.0256; RARITY JG, 1990, PHYS REV LETT, V64, P2495, DOI 10.1103/PhysRevLett.64.2495; RARITY JG, 1989, J OPT SOC AM B, V6, P1221, DOI 10.1364/JOSAB.6.001221; Schellekens M, 2005, SCIENCE, V310, P648, DOI 10.1126/science.1118024; Schlosshauer M, 2004, REV MOD PHYS, V76, P1267, DOI 10.1103/RevModPhys.76.1267; Treps N, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.013820; Zurek WH, 2003, REV MOD PHYS, V75, P715, DOI 10.1103/RevModPhys.75.715	36	117	117	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					66	+		10.1038/nature14331	http://dx.doi.org/10.1038/nature14331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25832404	Green Submitted			2022-12-28	WOS:000352027700037
J	Fontana, L; Partridge, L				Fontana, Luigi; Partridge, Linda			Promoting Health and Longevity through Diet: From Model Organisms to Humans	CELL			English	Review							LIFE-SPAN EXTENSION; CALORIE RESTRICTION; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; GENE-EXPRESSION; GUT MICROBIOTA; C. ELEGANS; PROTEIN RESTRICTION; NUTRITIONAL CONTROL; MEDIATES LONGEVITY	Reduced food intake, avoiding malnutrition, can ameliorate aging and aging-associated diseases in invertebrate model organisms, rodents, primates, and humans. Recent findings indicate that meal timing is crucial, with both intermittent fasting and adjusted diurnal rhythm of feeding improving health and function, in the absence of changes in overall intake. Lowered intake of particular nutrients rather than of overall calories is also key, with protein and specific amino acids playing prominent roles. Nutritional modulation of the microbiome can also be important, and there are long-term, including inter-generational, effects of diet. The metabolic, molecular, and cellular mechanisms that mediate both improvement in health during aging to diet and genetic variation in the response to diet are being identified. These new findings are opening the way to specific dietary and pharmacological interventions to recapture the full potential benefits of dietary restriction, which humans can find difficult to maintain voluntarily.	[Fontana, Luigi] Washington Univ, Sch Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA; [Fontana, Luigi] Univ Brescia, Dept Clin & Expt Sci, I-25123 Brescia, Italy; [Fontana, Luigi] CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [Partridge, Linda] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Partridge, Linda] UCL, Inst Hlth Ageing, London WC1E 6BT, England; [Partridge, Linda] UCL, Dept Genet Environm & Evolut, London WC1E 6BT, England	Washington University (WUSTL); University of Brescia; CEINGE Biotecnologie Avanzate; Max Planck Society; University of London; University College London; University of London; University College London	Fontana, L (corresponding author), Washington Univ, Sch Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA.	lfontana@dom.wustl.edu; linda.partridge@age.mpg.de		Fontana, Luigi/0000-0001-8500-5537; Partridge, Linda/0000-0001-9615-0094	Bakewell Foundation; Longer Life Foundation (an RGA/Washington University Partnership); National Center for Research Resources [UL1 RR024992]; Italian Federation of Sport Medicine (FMSI); European Union's Seventh Framework Programme MOPACT [320333]; Max Planck Society; ERC; Wellcome Trust (UK); NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER	Bakewell Foundation; Longer Life Foundation (an RGA/Washington University Partnership); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Italian Federation of Sport Medicine (FMSI); European Union's Seventh Framework Programme MOPACT; Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC(European Research Council (ERC)European Commission); Wellcome Trust (UK)(Wellcome Trust); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We apologize for omission of relevant works due to space constraints. The research of L.F. is supported by grants from the Bakewell Foundation, the Longer Life Foundation (an RGA/Washington University Partnership), the National Center for Research Resources (UL1 RR024992), the Italian Federation of Sport Medicine (FMSI), and the European Union's Seventh Framework Programme MOPACT ("Mobilising the potential of active ageing in Europe"; FP7-SSH-2012-1 grant agreement number 320333). L.P. is supported by the Max Planck Society, the ERC, and the Wellcome Trust (UK). All of the authors contributed equally to conceive and elaborate upon the ideas presented in this Review. All of the authors can be contacted for discussions or clarifications.	Abada EAE, 2009, MOL CELLS, V28, P209, DOI 10.1007/s10059-009-0124-x; Ables GP, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00122; Aiken CE, 2014, HUM REPROD UPDATE, V20, P63, DOI 10.1093/humupd/dmt043; Ailshire JA, 2015, J GERONTOL A-BIOL, V70, P193, DOI 10.1093/gerona/glu124; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Allen E. N., 2014, NEUROSCIENCE; [Anonymous], 2012, LONGEV HEALTHSPAN; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Baugh LR, 2013, GENETICS, V194, P539, DOI 10.1534/genetics.113.150847; Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; Brown-Borg HM, 2014, AGING CELL, V13, P1019, DOI 10.1111/acel.12269; Brown-Borg HM, 2013, EXP GERONTOL, V48, P905, DOI 10.1016/j.exger.2013.06.009; Burkewitz K, 2014, CELL METAB, V20, P10, DOI 10.1016/j.cmet.2014.03.002; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Cameron Kerry M, 2012, Longev Healthspan, V1, P3, DOI 10.1186/2046-2395-1-3; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Cava E, 2013, AGING-US, V5, P507, DOI 10.18632/aging.100581; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Cheng CW, 2014, CELL STEM CELL, V14, P810, DOI 10.1016/j.stem.2014.04.014; Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Colaneri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072670; Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557; Cypser JR, 2013, EXP GERONTOL, V48, P1014, DOI 10.1016/j.exger.2013.02.018; Dacks PA, 2013, FRONT NEUROENDOCRIN, V34, P95, DOI 10.1016/j.yfrne.2012.12.001; Dang W, 2014, CELL METAB, V19, P952, DOI 10.1016/j.cmet.2014.04.004; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dilova I, 2007, CELL MOL LIFE SCI, V64, P752, DOI 10.1007/s00018-007-6381-y; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Edrey YH, 2011, ILAR J, V52, P41, DOI 10.1093/ilar.52.1.41; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Erkosar B, 2014, FEBS LETT, V588, P4250, DOI 10.1016/j.febslet.2014.06.041; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; Fontana L., 2010, HDB BIOL AGING, P447; Fontana L, 2008, AGING CELL, V7, P681, DOI 10.1111/j.1474-9726.2008.00417.x; Fontana L, 2014, NATURE, V511, P405, DOI 10.1038/511405a; Fontana L, 2013, ONCOTARGET, V4, P2451, DOI 10.18632/oncotarget.1586; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Gems D, 2002, AGING CELL, V1, P1, DOI 10.1046/j.1474-9728.2002.00003.x; Gill S, 2011, CELL METAB, V13, P613, DOI 10.1016/j.cmet.2011.05.003; Goldman DP, 2013, HEALTH AFFAIR, V32, P1698, DOI 10.1377/hlthaff.2013.0052; GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Hunt ND, 2012, AGE, V34, P1453, DOI 10.1007/s11357-011-9321-6; Ikeno Y, 2006, AGE, V28, P163, DOI 10.1007/s11357-006-9007-7; Jakubowicz D, 2013, CLIN SCI, V125, P423, DOI 10.1042/CS20130071; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67; Kabil H, 2011, P NATL ACAD SCI USA, V108, P16831, DOI 10.1073/pnas.1102008108; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Killick R, 2009, BIOCHEM BIOPH RES CO, V386, P257, DOI 10.1016/j.bbrc.2009.06.032; Kristan DM, 2008, AGE, V30, P147, DOI 10.1007/s11357-008-9056-1; Kroeger CM, 2014, J OBES, V2014, DOI 10.1155/2014/614519; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Li WQ, 2014, AGING CELL, V13, P1012, DOI 10.1111/acel.12264; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Liu ZW, 2014, CELL REP, V7, P1509, DOI 10.1016/j.celrep.2014.04.032; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Martin-Montalvo A, 2011, ONCOGENE, V30, P505, DOI 10.1038/onc.2010.492; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Mattson MP, 2014, P NATL ACAD SCI USA, V111, P16647, DOI 10.1073/pnas.1413965111; Menzies FM, 2010, AUTOPHAGY, V6, P286, DOI 10.4161/auto.6.2.11078; Mercken EM, 2013, AGING CELL, V12, P645, DOI 10.1111/acel.12088; Metaxakis A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001824; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Mirzaei H, 2014, TRENDS ENDOCRIN MET, V25, P558, DOI 10.1016/j.tem.2014.07.002; Mott R, 2014, CELL, V156, P332, DOI 10.1016/j.cell.2013.11.043; Mouchiroud L, 2013, CRIT REV BIOCHEM MOL, V48, P397, DOI 10.3109/10409238.2013.789479; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nakagawa S, 2012, AGING CELL, V11, P401, DOI 10.1111/j.1474-9726.2012.00798.x; Ost A, 2014, CELL, V159, P1352, DOI 10.1016/j.cell.2014.11.005; Ostojic I, 2014, P NATL ACAD SCI USA, V111, P8143, DOI 10.1073/pnas.1315466111; Pamplona R, 2006, BBA-BIOENERGETICS, V1757, P496, DOI 10.1016/j.bbabio.2006.01.009; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Partridge L, 2010, PHILOS T R SOC B, V365, P147, DOI 10.1098/rstb.2009.0222; Pembrey M, 2014, J MED GENET, V51, P563, DOI 10.1136/jmedgenet-2014-102577; Peng W., 2012, SCI TRANSL MED, V4; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Pollin TI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002895; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Rechavi O, 2014, CELL, V158, P277, DOI 10.1016/j.cell.2014.06.020; Safdie FM, 2009, AGING-US, V1, P988, DOI 10.18632/aging.100114; Saiki R, 2008, AGING CELL, V7, P291, DOI 10.1111/j.1474-9726.2008.00378.x; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schleit J, 2013, AGING CELL, V12, P1050, DOI 10.1111/acel.12130; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Simons MJP, 2013, AGING CELL, V12, P410, DOI 10.1111/acel.12061; Simpson SJ, 2015, CELL, V161, P18, DOI 10.1016/j.cell.2015.02.033; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Stein Geneva M., 2012, Frontiers in Genetics, V3, P259, DOI 10.3389/fgene.2012.00259; Stohr O, 2013, AGE, V35, P83; Tarry-Adkins JL, 2014, P NUTR SOC, V73, P289, DOI 10.1017/S002966511300387X; Tatar M, 2014, TRENDS ENDOCRIN MET, V25, P509, DOI 10.1016/j.tem.2014.02.006; Tessitore L, 2006, CELL PROLIFERAT, V39, P105, DOI 10.1111/j.1365-2184.2006.00371.x; Thondamal M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5879; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Uno M, 2013, CELL REP, V3, P79, DOI 10.1016/j.celrep.2012.12.018; Uthus EO, 2006, MECH AGEING DEV, V127, P444, DOI 10.1016/j.mad.2006.01.001; Vickers MH, 2014, NUTRIENTS, V6, P2165, DOI 10.3390/nu6062165; Wang LF, 2014, J EXP BIOL, V217, P109, DOI 10.1242/jeb.089920; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Waterson MJ, 2014, P NATL ACAD SCI USA, V111, P8137, DOI 10.1073/pnas.1315461111; Watson E, 2014, CELL, V156, P759, DOI 10.1016/j.cell.2014.01.047; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Whitaker R, 2014, AGING-US, V6, P355, DOI 10.18632/aging.100662; Withers S. S., 2014, TRANSL ONCOL; Wolfe RR, 2008, CLIN NUTR, V27, P675, DOI 10.1016/j.clnu.2008.06.008; Wong ACN, 2014, J EXP BIOL, V217, P1894, DOI 10.1242/jeb.101725; Wu DQ, 2009, AGING CELL, V8, P666, DOI 10.1111/j.1474-9726.2009.00523.x; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079319; Wu ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064448; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zarrinpar A, 2014, CELL METAB, V20, P1006, DOI 10.1016/j.cmet.2014.11.008; Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163; Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3	145	689	705	40	449	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					106	118		10.1016/j.cell.2015.02.020	http://dx.doi.org/10.1016/j.cell.2015.02.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815989	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000351952200012
J	Goldstein, JL; Brown, MS				Goldstein, Joseph L.; Brown, Michael S.			A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins	CELL			English	Review							LOW-DENSITY-LIPOPROTEIN; STEROL REGULATORY ELEMENT; COENZYME-A REDUCTASE; HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; CLEAVAGE-ACTIVATING PROTEIN; BOUND TRANSCRIPTION FACTOR; HEART-DISEASE; 3-HYDROXY-3-METHYLGLUTARYL COENZYME; MONOCLONAL-ANTIBODY; RECEPTOR GENE	One-fourth of all deaths in industrialized countries result from coronary heart disease. A century of research has revealed the essential causative agent: cholesterol-carrying low-density lipoprotein (LDL). LDL is controlled by specific receptors (LDLRs) in liver that remove it from blood. Mutations that eliminate LDLRs raise LDL and cause heart attacks in childhood, whereas mutations that raise LDLRs reduce LDL and diminish heart attacks. If we are to eliminate coronary disease, lowering LDL should be the primary goal. Effective means to achieve this goal are currently available. The key questions are: who to treat, when to treat, and how long to treat.	[Goldstein, Joseph L.; Brown, Michael S.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu			NIH [HL-20948]; Perot Foundation; Moss Heart Foundation; O'Donnell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Foundation; Moss Heart Foundation; O'Donnell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors gratefully acknowledge the many talented students, postdoctoral fellows, and collaborators who have conducted the experiments described from our laboratory. Their names are included in the cited references. Our experimental work over the last 40 years has been supported by grants from the NIH (HL-20948), the Perot Foundation, Moss Heart Foundation, and the O'Donnell Foundation. J.L.G. and M.S.B. are members of the Board of Directors and shareholders in Regeneron Pharmaceuticals.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0439-8; ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; Anitschkow N., 1913, ZENTRALBL ALLG PATHO, V24, P1; [Anonymous], 1965, ARTERIOSCLER THROMB; [Anonymous], 1987, BUS WEEK; Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Brody Jane E., 1987, NY TIMES; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1978, J BIOL CHEM, V253, P1121; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; BUCHER NLR, 1960, BIOCHIM BIOPHYS ACTA, V40, P491, DOI 10.1016/0006-3002(60)91390-1; CHAPMAN MJ, 1976, ATHEROSCLEROSIS, V25, P267; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; FREDRICK.DS, 1967, NEW ENGL J MED, V276, P273, DOI 10.1056/NEJM196702022760507; Gertler M. M., 1954, CORONARY HEART DISEA, P218; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOFMAN JOHN W., 1954, PLASMA [MILAN], V2, P413; GOFMAN JW, 1954, AM J MED, V17, P514, DOI 10.1016/0002-9343(54)90126-6; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1973, P NATL ACAD SCI USA, V70, P2804, DOI 10.1073/pnas.70.10.2804; GOLDSTEIN JL, 1982, CLIN RES, V30, P417; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Hansson GK, 2009, ARTERIOSCL THROM VAS, V29, P1714, DOI 10.1161/ATVBAHA.108.179713; Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1; Herrick JB, 1944, AM HEART J, V27, P1, DOI 10.1016/S0002-8703(44)90602-2; Herrick JB, 1919, J AMER MED ASSOC, V72, P387, DOI 10.1001/jama.1919.02610060001001; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Junshi C., 1990, DIET LIFE STYLE MORT, P42; Kathiresan S, 2008, NEW ENGL J MED, V358, P2299, DOI 10.1056/NEJMc0707445; KEYS A, 1958, ANN INTERN MED, V48, P83, DOI 10.7326/0003-4819-48-1-83; Keys A., 1980, 7 COUNTRIES MULTIVAR, P1; KHACHADURIAN AK, 1964, AM J MED, V37, P402, DOI 10.1016/0002-9343(64)90196-2; KOVANEN PT, 1981, P NATL ACAD SCI-BIOL, V78, P1194, DOI 10.1073/pnas.78.2.1194; KWITEROVICH PO, 1973, LANCET, V1, P118; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Leibowitz J, 1970, HIST CORONARY HEART, P227; Levy D, 2012, JAMA-J AM MED ASSOC, V308, P2624, DOI 10.1001/jama.2012.164971; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; MABUCHI H, 1981, NEW ENGL J MED, V305, P478, DOI 10.1056/NEJM198108273050902; McPherson R, 2007, LANCET, V369, P1078, DOI 10.1016/S0140-6736(07)60516-9; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; MILLS GL, 1971, COMP BIOCHEM PHYSIOL, V40, P489, DOI 10.1016/0305-0491(71)90234-3; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Muller C, 1938, ACTA MED SCAND, P75; Pardee AB, 2003, GENE, V321, P17, DOI 10.1016/S0378-1119(03)00839-4; PEDERSEN TR, 1994, LANCET, V344, P1383; Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; SCHNEIDER WJ, 1982, J BIOL CHEM, V257, P2664; Schoenheimer R, 1933, J BIOL CHEM, V103, P439; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Stein EA, 2013, CIRCULATION, V128, P2113, DOI 10.1161/CIRCULATIONAHA.113.004678; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Steinberg D, 2005, J LIPID RES, V46, P179, DOI 10.1194/jlr.R400012-JLR200; Steinberg D, 2010, ARTERIOSCL THROM VAS, V30, P2311, DOI 10.1161/ATVBAHA.108.179697; Stitziel NO, 2014, NEW ENGL J MED, V371, P2072, DOI 10.1056/NEJMoa1405386; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; UAUY R, 1988, J PEDIATR-US, V113, P387, DOI 10.1016/S0022-3476(88)80289-0; UMBARGER HE, 1992, PROTEIN SCI, V1, P1392, DOI 10.1002/pro.5560011019; Urban S, 2013, BBA-BIOMEMBRANES, V1828, P2797, DOI 10.1016/j.bbamem.2013.07.001; Usifo E, 2012, ANN HUM GENET, V76, P387, DOI 10.1111/j.1469-1809.2012.00724.x; VEGA GL, 1991, J INTERN MED, V230, P341, DOI 10.1111/j.1365-2796.1991.tb00454.x; Vogel RA, 2012, J AM COLL CARDIOL, V59, P2354, DOI 10.1016/j.jacc.2012.03.011; WANG XD, 1993, J BIOL CHEM, V268, P14497; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zetterstrom R, 2009, ACTA PAEDIATR, V98, P1223, DOI 10.1111/j.1651-2227.2009.01282.x; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	102	578	598	13	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					161	172		10.1016/j.cell.2015.01.036	http://dx.doi.org/10.1016/j.cell.2015.01.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815993	Green Accepted, Bronze			2022-12-28	WOS:000351952200016
J	Spitale, RC; Flynn, RA; Zhang, QC; Crisalli, P; Lee, B; Jung, JW; Kuchelmeister, HY; Batista, PJ; Torre, EA; Kool, ET; Chang, HY				Spitale, Robert C.; Flynn, Ryan A.; Zhang, Qiangfeng Cliff; Crisalli, Pete; Lee, Byron; Jung, Jong-Wha; Kuchelmeister, Hannes Y.; Batista, Pedro J.; Torre, Eduardo A.; Kool, Eric T.; Chang, Howard Y.			Structural imprints in vivo decode RNA regulatory mechanisms	NATURE			English	Article							GENOME-WIDE MEASUREMENT; SECONDARY STRUCTURE; REVEALS; METHYLATION; SEQUENCES; RECOGNITION; EXPRESSION; VERTEBRATE; PROTEINS	Visualizing the physical basis for molecular behaviour inside living cells is a great challenge for biology. RNAs are central to biological regulation, and the ability of RNA to adopt specific structures intimately controls every step of the gene expression program(1). However, our understanding of physiological RNA structures is limited; current in vivo RNA structure profiles include only two of the four nucleotides that make up RNA(2,3). Here we present a novel biochemical approach, in vivo click selective 2'-hydroxyl acylation and profiling experiment (icSHAPE), which enables the first global view, to our knowledge, of RNA secondary structures in living cells for all four bases. icSHAPE of the mouse embryonic stem cell transcriptome versus purified RNA folded in vitro shows that the structural dynamics of RNA in the cellular environment distinguish different classes of RNAs and regulatory elements. Structural signatures at translational start sites and ribosome pause sites are conserved from in vitro conditions, suggesting that these RNA elements are programmed by sequence. In contrast, focal structural rearrangements in vivo reveal precise interfaces of RNA with RNA-binding proteins or RNA-modification sites that are consistent with atomic-resolution structural data. Such dynamic structural footprints enable accurate prediction of RNA-protein interactions and N-6-methyladenosine (m(6)A) modification genome wide. These results open the door for structural genomics of RNA in living cells and reveal key physiological structures controlling gene expression.	[Spitale, Robert C.; Flynn, Ryan A.; Zhang, Qiangfeng Cliff; Lee, Byron; Batista, Pedro J.; Torre, Eduardo A.; Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Spitale, Robert C.; Flynn, Ryan A.; Zhang, Qiangfeng Cliff; Lee, Byron; Batista, Pedro J.; Torre, Eduardo A.; Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA; [Crisalli, Pete; Jung, Jong-Wha; Kuchelmeister, Hannes Y.; Kool, Eric T.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Chang, HY (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kool@stanford.edu; howchang@stanford.edu	Zhang, Qiangfeng/C-2902-2011; Batista, Pedro J/K-5303-2012	Flynn, Ryan/0000-0001-5013-0442; Kool, Eric/0000-0002-7310-2935; Lee, Byron/0000-0001-7132-2662	National Institutes of Health (NIH) [R01HG004361, P50HG007735]; California Institute for Regenerative Medicine; NIH [R01068122, T32AR007422, F30CA189514]; A.P. Giannini Foundation; Stanford Dean's Fellowship; Stanford Medical Scientist Training Program; NATIONAL CANCER INSTITUTE [T32CA009302, F30CA189514] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361, P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068122] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A.P. Giannini Foundation; Stanford Dean's Fellowship; Stanford Medical Scientist Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Chang laboratory, J. Weissman and J. Doudna for comments. This work was supported by National Institutes of Health (NIH) R01HG004361 and P50HG007735, and the California Institute for Regenerative Medicine (H.Y.C.), NIH R01068122 (E.T.K.), the A.P. Giannini Foundation (R.C.S.), a Stanford Dean's Fellowship (Q.C.Z.), NIH T32AR007422 (P.J.B.), and the Stanford Medical Scientist Training Program and NIH F30CA189514 (R.A.F.). H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Dvir S, 2013, P NATL ACAD SCI USA, V110, pE2792, DOI 10.1073/pnas.1222534110; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Flynn RA, 2015, RNA, V21, P135, DOI 10.1261/rna.047803.114; Gherghe C, 2010, P NATL ACAD SCI USA, V107, P19248, DOI 10.1073/pnas.1006897107; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jangi M, 2014, GENE DEV, V28, P637, DOI 10.1101/gad.235770.113; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kierzek E, 2003, NUCLEIC ACIDS RES, V31, P4472, DOI 10.1093/nar/gkg633; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; McGinnis JL, 2014, BIOCHEMISTRY-US, V53, P3237, DOI 10.1021/bi500198b; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Schroeder R, 2002, CURR OPIN STRUC BIOL, V12, P296, DOI 10.1016/S0959-440X(02)00325-1; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spitale RC, 2013, NAT CHEM BIOL, V9, P18, DOI [10.1038/NCHEMBIO.1131, 10.1038/nchembio.1131]; Vandivier LE, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24301; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Wan Y, 2012, MOL CELL, V48, P169, DOI 10.1016/j.molcel.2012.08.008; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Weeks KM, 2011, ACCOUNTS CHEM RES, V44, P1280, DOI 10.1021/ar200051h; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	38	438	467	11	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					486	+		10.1038/nature14263	http://dx.doi.org/10.1038/nature14263			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25799993	Green Submitted, Green Accepted			2022-12-28	WOS:000351602800059
J	[Anonymous]				[Anonymous]			THE ASIA-PACIFIC IMPACT	NATURE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S52	S53		10.1038/519S52a	http://dx.doi.org/10.1038/519S52a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE1WF	25806693	Bronze			2022-12-28	WOS:000351602800008
J	El Emam, K; Rodgers, S; Malin, B				El Emam, Khaled; Rodgers, Sam; Malin, Bradley			Anonymising and sharing individual patient data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS; ACCESS; PRIVACY; RECORDS	There is a strong movement to share individual patient data for secondary purposes, particularly for research. A major obstacle to broad data sharing has been the concern for patient privacy. One of the methods for protecting the privacy of patients in accordance with privacy laws and regulations is to anonymise the data before it is shared. This article describes the key concepts and principles for anonymising health data while ensuring it remains suitable for meaningful analysis.	[El Emam, Khaled] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [El Emam, Khaled] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [El Emam, Khaled] Univ Ottawa, Sch Elect Engn & Comp Sci, Ottawa, ON, Canada; [Rodgers, Sam] Earls Court Hlth & Wellbeing Ctr, London, England; [Malin, Bradley] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; Vanderbilt University	El Emam, K (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada.	kelemam@ehealthinformation.ca			National Library or Medicine, National Institutes of Health [R01LM009989]; National Human Genome Research Institute, National Institutes of Health [U01HG006385]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006844, U01HG006378, U01HG004603, U01HG006385] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009989] Funding Source: NIH RePORTER	National Library or Medicine, National Institutes of Health; National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	BM's work on this article was funded by grants R01LM009989 (National Library or Medicine, National Institutes of Health) and U01HG006385 (National Human Genome Research Institute, National Institutes of Health).	[Anonymous], 2012, AN MAN DAT PROT RISK; Arbuckle L., 2013, ANONYMIZING HLTH DAT; Article 29 Data Protection Working Party, 2014, ARTICLE 29 DATA PROT; Bhattacharjee Y, 2012, SCIENCE, V338, P29, DOI 10.1126/science.338.6103.29; Castellani J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f1881; Duncan GT, 2011, STAT SOC BEHAV SC, P1, DOI 10.1007/978-1-4419-7802-8; Eguale Tewodros, 2005, AMIA Annu Symp Proc, P947; Eichler HG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001202; El Emam K., 2013, GUIDE DE IDENTIFICAT; El Emam K, 2007, PAN CANADIAN DEIDENT; El Emam K, 2015, INT DATA PRIV LAW, V5, P73, DOI 10.1093/idpl/ipu033; El Emam Khaled, 2011, PLoS One, V6, pe28071, DOI 10.1371/journal.pone.0028071; El Emam K, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-114; El Emam K, 2013, AM J BIOETHICS, V13, P42, DOI 10.1080/15265161.2013.767958; El Emam K, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2001; El Emam K, 2009, J AM MED INFORM ASSN, V16, P670, DOI 10.1197/jamia.M3144; European Medicines Agency, 2014, EUR MED AG POL PUBL; European Medicines Agency, 2013, 14 ADVANTAGES DATA C; Gkoulalas-Divanis A, 2014, J BIOMED INFORM, V50, P4, DOI 10.1016/j.jbi.2014.06.002; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Haggie E, 2013, PLOS BIOL; Harrison C, 2012, NAT REV DRUG DISCOV, V11, P891, DOI 10.1038/nrd3907; Health System Use Technical Advisory Committee Data De-identification Working Group, 2010, BEST PRACT GUID MAN; Hede K, 2013, JNCI-J NATL CANCER I, V105, P1159, DOI 10.1093/jnci/djt232; Hrynaszkiewicz Iain, 2010, BMJ, V340, pc181, DOI [10.1186/1745-6215-11-9, 10.1136/bmj.c181]; Hughes S, 2014, PHARM STAT, V13, P179, DOI 10.1002/pst.1615; Kho Michelle E, 2009, BMJ, V338, pb866, DOI 10.1136/bmj.b866; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P1593, DOI 10.1001/jama.2011.1459; Malin BA, 2013, J AM MED INFORM ASSN, V20, P2, DOI 10.1136/amiajnl-2012-001509; Medical Research Council, 2015, RES POL ETH DAT SHAR; National Institutes of Health (NIH), 2003, FIN NIH STAT SHAR RE; Nisen P, 2013, NEW ENGL J MED, V369, P475, DOI 10.1056/NEJMsr1302541; Olson S., 2013, SHAR CLIN RES DAT WO; PhRMA, 2013, PRINC RESP CLIN TRIA; Robertson J, 2013, BLOOMBERG NEWS; Sandercock PAG, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-101; Shostak J, 2006, DE IDENTIFICATION CL; Sweeney L, 2013, MATCHING KNOWN PATIE; US Department of Health & Human Services, 2012, GUID REG METH DEID P; Vallance P, 2013, LANCET, V382, P1073, DOI 10.1016/S0140-6736(13)62001-2; Wellcome Trust, 2011, SHAR RES DAT IMPR PU; Willenborg L, 1996, STAT DISCLOSURE CONT; Willison DJ, 2008, J MED ETHICS, V34, P308, DOI 10.1136/jme.2006.020032; Yale School of Medicine, YODA PROJ	44	95	97	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2015	350								h1139	10.1136/bmj.h1139	http://dx.doi.org/10.1136/bmj.h1139			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CE1KX	25794882	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000351571600001
J	Fei, JY; Singh, D; Zhang, QC; Park, S; Balasubramanian, D; Golding, I; Vanderpool, CK; Ha, T				Fei, Jingyi; Singh, Digvijay; Zhang, Qiucen; Park, Seongjin; Balasubramanian, Divya; Golding, Ido; Vanderpool, Carin K.; Ha, Taekjip			Determination of in vivo target search kinetics of regulatory noncoding RNA	SCIENCE			English	Article							MESSENGER-RNA; ESCHERICHIA-COLI; POSTTRANSCRIPTIONAL REGULATION; HFQ; SGRS; CELL; COMPETITION; EXPRESSION; BACTERIA; SYSTEMS	Base-pairing interactions between nucleic acids mediate target recognition in many biological processes. We developed a super-resolution imaging and modeling platform that enabled the in vivo determination of base pairing-mediated target recognition kinetics. We examined a stress-induced bacterial small RNA, SgrS, which induces the degradation of target messenger RNAs (mRNAs). SgrS binds to a primary target mRNA in a reversible and dynamic fashion, and formation of SgrS-mRNA complexes is rate-limiting, dictating the overall regulation efficiency in vivo. Examination of a secondary target indicated that differences in the target search kinetics contribute to setting the regulation priority among different target mRNAs. This super-resolution imaging and analysis approach provides a conceptual framework that can be generalized to other small RNA systems and other target search processes.	[Fei, Jingyi; Zhang, Qiucen; Park, Seongjin; Golding, Ido; Ha, Taekjip] Univ Illinois, Dept Phys, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Singh, Digvijay; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Balasubramanian, Divya; Vanderpool, Carin K.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Golding, Ido] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ha, Taekjip] Howard Hughes Med Inst, Carl R Woese Inst Genom Biol, Urbana, IL USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Baylor College of Medicine; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Vanderpool, CK (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	cvanderp@life.uiuc.edu; tjha@illinois.edu	Singh, Digvijay/J-3091-2019; Ha, Taekjip/B-9506-2009; Park, Seongjin/AAU-9963-2020	Singh, Digvijay/0000-0002-7411-4436; Ha, Taekjip/0000-0003-2195-6258; Vanderpool, Carin/0000-0002-2850-5532	National Science Foundation [PHY 082265, PHY 1147498]; National Institutes of Health [GM 112659, GM065367, GM082837, GM092830]; Welch Foundation [Q-1759]; Jane Coffin Childs Memorial Fund for Medical Research; Division Of Physics [1430124, 1147498] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082837, R01GM065367, R01GM092830, R01GM112659] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Jane Coffin Childs Memorial Fund for Medical Research; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. A. Sepulveda, L. H. So, M. Bates, X. Zhuang, Y. Liu, J. E. Stone, K. Schulten, H. Aiba, Z. Luthey-Schulten, T. E. Kuhlman, Y. Wang, and T. Lu for discussion, reagents, and software (12). This work was supported by grants from the National Science Foundation (PHY 082265 and PHY 1147498), the National Institutes of Health (GM 112659, GM065367, GM082837, and GM092830), the Welch Foundation (Q-1759), and the Jane Coffin Childs Memorial Fund for Medical Research.	Arluison V, 2007, NUCLEIC ACIDS RES, V35, P999, DOI 10.1093/nar/gkl1124; Bobrovskyy M, 2013, ANNU REV GENET, V47, P209, DOI 10.1146/annurev-genet-111212-133445; Daszykowski M, 2001, CHEMOMETR INTELL LAB, V56, P83, DOI 10.1016/S0169-7439(01)00111-3; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Ester M., 1996, P 2 INT C KNOWL DISC, V1996, P226, DOI DOI 10.1023/A:1009745219419; Fender A, 2010, GENE DEV, V24, P2621, DOI 10.1101/gad.591310; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Hussein R, 2011, P NATL ACAD SCI USA, V108, P1110, DOI 10.1073/pnas.1010082108; Hwang W, 2011, NUCLEIC ACIDS RES, V39, P5131, DOI 10.1093/nar/gkr075; Jost D, 2013, BIOPHYS J, V104, P1773, DOI 10.1016/j.bpj.2013.02.020; Kawamoto H, 2006, MOL MICROBIOL, V61, P1013, DOI 10.1111/j.1365-2958.2006.05288.x; Kimata K, 2001, EMBO J, V20, P3587, DOI 10.1093/emboj/20.13.3587; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; Malkova A, 2013, CURR OPIN GENET DEV, V23, P271, DOI 10.1016/j.gde.2013.05.007; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rice JB, 2011, NUCLEIC ACIDS RES, V39, P3806, DOI 10.1093/nar/gkq1219; Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Sun Y, 2013, J BACTERIOL, V195, P4804, DOI 10.1128/JB.00722-13; Vanderpool CK, 2004, MOL MICROBIOL, V54, P1076, DOI 10.1111/j.1365-2958.2004.04348.x; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wadler CS, 2009, NUCLEIC ACIDS RES, V37, P5477, DOI 10.1093/nar/gkp591; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	28	84	86	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1371	1374		10.1126/science.1258849	http://dx.doi.org/10.1126/science.1258849			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792329	Green Accepted			2022-12-28	WOS:000351219600044
J	Clavien, PA; Deiss, J				Clavien, Pierre-Alain; Deiss, Joseph			Ten tips for choosing an academic chair	NATURE			English	Editorial Material							RECOMMENDATIONS		[Clavien, Pierre-Alain] Univ Zurich Hosp, Dept Surg, CH-8091 Zurich, Switzerland; [Clavien, Pierre-Alain] Univ Paris 11, Paul Brousse Hosp, Paris, France; [Deiss, Joseph] United Nations Gen Assembly, New York, NY USA	University of Zurich; University Zurich Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay	Clavien, PA (corresponding author), Univ Zurich Hosp, Dept Surg, CH-8091 Zurich, Switzerland.	clavien@access.uzh.ch		Raptis, Dimitri Aristotle/0000-0002-0898-3270				Abbott A, 2010, NATURE, V465, P860, DOI 10.1038/465860a; Clavien PA, 2012, LANCET ONCOL, V13, pE11, DOI 10.1016/S1470-2045(11)70175-9; Frilling A, 2014, LANCET ONCOL, V15, pE8, DOI 10.1016/S1470-2045(13)70362-0; Grigsby RK, 2004, ACAD MED, V79, P571, DOI 10.1097/00001888-200406000-00014; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Lesurtel M, 2014, SURGERY, V155, P390, DOI 10.1016/j.surg.2013.10.003; Shore DA, 2014, J HEALTH COMMUN, V19, P275, DOI 10.1080/10810730.2014.888903; SHUMACKER HB, 1983, ANN ROY COLL SURG, V65, P59; Wakabayashi G, 2015, ANN SURG, V261, P619, DOI [10.1097/SLA.0000000000001184, 10.1097/SLA.0000000000001180]	9	5	5	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					286	287		10.1038/519286a	http://dx.doi.org/10.1038/519286a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6AY	25788080	Bronze			2022-12-28	WOS:000351171900013
J	Miller, BL; Dickerson, BC; Lucente, DE; Larvie, M; Frosch, MP				Miller, Bruce L.; Dickerson, Bradford C.; Lucente, Diane E.; Larvie, Mykol; Frosch, Matthew P.			Case 9-2015: A 31-Year-Old Man with Personality Changes and Progressive Neurologic Decline	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; PICKS-DISEASE; G389R CAUSES; TAU-PROTEIN; DEMENTIA; MANAGEMENT; MUTATIONS; DIAGNOSIS; GENE; CHROMOSOME-17		[Miller, Bruce L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Dickerson, Bradford C.; Frosch, Matthew P.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Larvie, Mykol] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Frosch, Matthew P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lucente, Diane E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Dickerson, Bradford C.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Larvie, Mykol] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Frosch, Matthew P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Miller, BL (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.		Frosch, Matthew P/ABD-7456-2021	Frosch, Matthew P/0000-0002-3940-9861	Massachusetts Alzheimer's Disease Research Center (National Institutes of Health) [P50 AG05134]; Krupp Foundation; National Institutes of Health [NS084156]; Larry L. Hillblom Foundation; John Douglas French Alzheimer's Foundation; Tau Consortium; TauRx; Allon Therapeutics; Bristol-Myers Squibb; Eli Lilly; Merck; Forum; Med Learning Group; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG023501, P01AG019724, P50AG005134] Funding Source: NIH RePORTER	Massachusetts Alzheimer's Disease Research Center (National Institutes of Health); Krupp Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; John Douglas French Alzheimer's Foundation; Tau Consortium; TauRx; Allon Therapeutics; Bristol-Myers Squibb(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); Merck(Merck & Company); Forum; Med Learning Group; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The pathological examination was supported by the Massachusetts Alzheimer's Disease Research Center (National Institutes of Health grant P50 AG05134). Dr. Dickerson was supported by the Krupp Foundation and the National Institutes of Health (grant NS084156). This case was the first in the Betty U. and William F. McNeely Memorial Clinicopathological Conference series, supported by a gift from Dr. Sarah Weinberg and the Hon. John Weinberg.r Dr. Miller reports receiving fees for board membership (paid to his institution) from the Larry L. Hillblom Foundation, the John Douglas French Alzheimer's Foundation, and the Tau Consortium and consulting fees from TauRx, Allon Therapeutics, Bristol-Myers Squibb, and Eli Lilly. Dr. Dickerson reports receiving consulting fees from Merck, Forum, and the Med Learning Group and payment for development of educational presentations from the Med Learning Group. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1958, N Engl J Med, V258, P652; [Anonymous], 1992, NEW ENGL J MED, V326, P397; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bermingham N, 2008, NEUROPATH APPL NEURO, V34, P366, DOI 10.1111/j.1365-2990.2007.00918.x; Bird TD, 2000, ARCH NEUROL-CHICAGO, V57, P309, DOI 10.1001/archneur.57.3.309; Cardarelli R, 2010, AM FAM PHYSICIAN, V82, P1372; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dickerson Bradford C, 2012, Neurol Clin Pract, V2, P154; Feany MB, 1996, J NEUROPATH EXP NEUR, V55, P53, DOI 10.1097/00005072-199601000-00006; Ghetti B, 2000, ANN NY ACAD SCI, V920, P52; Gitlin LN, 2012, JAMA-J AM MED ASSOC, V308, P2020, DOI 10.1001/jama.2012.36918; Goedert M, 2000, J NEUROCHEM, V75, P2155, DOI 10.1046/j.1471-4159.2000.0752155.x; Goldman JS, 2011, NEUROLOGY, V76, P475, DOI 10.1212/WNL.0b013e31820a0d13; Hong M, 2002, NEUROLOGY, V58, P1285, DOI 10.1212/WNL.58.8.1285; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Jicha GA, 2011, NEURODEGENER DIS MAN, V1, P141, DOI 10.2217/NMT.11.9; Klassen BT, 2011, NEUROLOGY, V77, P1119, DOI 10.1212/WNL.0b013e31822f02f5; Knopman DS, 2004, NEUROLOGY, V62, P506, DOI 10.1212/01.WNL.0000106827.39764.7E; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Loy CT, 2014, LANCET, V383, P828, DOI 10.1016/S0140-6736(13)60630-3; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Manoochehri M, 2012, CURR NEUROL NEUROSCI, V12, P528, DOI 10.1007/s11910-012-0302-7; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller B.L., 2013, FRONTOTEMPORAL DEMEN; Munoz DG, 2011, NEURODEGENERATION MO; Murrell JR, 1999, J NEUROPATH EXP NEUR, V58, P1207, DOI 10.1097/00005072-199912000-00002; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Paterson RW, 2012, ARCH NEUROL-CHICAGO, V69, P1578, DOI 10.1001/2013.jamaneurol.79; Pick A, 1892, PRAG MED WCHNSCHR, V17, P165, DOI DOI 10.1080/02687030600739463; Pickering-Brown S, 2000, ANN NEUROL, V48, P859, DOI 10.1002/1531-8249(200012)48:6<859::AID-ANA6>3.0.CO;2-1; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Piguet O, 2011, ANN NEUROL, V69, P312, DOI 10.1002/ana.22244; Probst A, 1996, ACTA NEUROPATHOL, V92, P588, DOI 10.1007/s004010050565; Rankin KP, 2006, BRAIN, V129, P2945, DOI 10.1093/brain/awl254; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Seelaar H, 2008, NEUROLOGY, V71, P1220, DOI 10.1212/01.wnl.0000319702.37497.72; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shnall A, 2013, INT REV PSYCHIATR, V25, P246, DOI 10.3109/09540261.2013.767780; Tillema JM, 2012, SEMIN NEUROL, V32, P85, DOI 10.1055/s-0032-1306391; Urwin H, 2010, ACTA NEUROPATHOL, V120, P33, DOI 10.1007/s00401-010-0698-6; Wylie MA, 2013, INT REV PSYCHIATR, V25, P230, DOI 10.3109/09540261.2013.776949	45	3	4	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2015	372	12					1151	1162		10.1056/NEJMcpc1409839	http://dx.doi.org/10.1056/NEJMcpc1409839			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EZ	25785973	Green Accepted			2022-12-28	WOS:000351183600012
J	Kereiakes, DJ; Yeh, RW; Massaro, JM; Driscoll-Shempp, P; Cutlip, DE; Steg, PG; Gershlick, AH; Darius, H; Meredith, IT; Ormiston, J; Tanguay, JF; Windecker, S; Garratt, KN; Kandzari, DE; Lee, DP; Simon, DI; Iancu, AC; Trebacz, J; Mauri, L				Kereiakes, Dean J.; Yeh, Robert W.; Massaro, Joseph M.; Driscoll-Shempp, Priscilla; Cutlip, Donald E.; Steg, P. Gabriel; Gershlick, Anthony H.; Darius, Harald; Meredith, Ian T.; Ormiston, John; Tanguay, Jean Francois; Windecker, Stephan; Garratt, Kirk N.; Kandzari, David E.; Lee, David P.; Simon, Daniel I.; Iancu, Adrian Corneliu; Trebacz, Jaroslaw; Mauri, Laura		Dual Antiplatelet Therapy DAPT	Antiplatelet Therapy Duration Following Bare Metal or Drug-Eluting Coronary Stents The Dual Antiplatelet Therapy Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-COLLEGE; OUTCOMES; INTERVENTION; IMPLANTATION; MULTICENTER; RESTENOSIS; EVENTS; IMPACT	IMPORTANCE Despite antirestenotic efficacy of coronary drug-eluting stents (DES) compared with bare metal stents (BMS), the relative risk of stent thrombosis and adverse cardiovascular events is unclear. Although dual antiplatelet therapy (DAPT) beyond 1 year provides ischemic event protection after DES, ischemic event risk is perceived to be less after BMS, and the appropriate duration of DAPT after BMS is unknown. OBJECTIVE To compare (1) rates of stent thrombosis and major adverse cardiac and cerebrovascular events (MACCE; composite of death, myocardial infarction, or stroke) after 30 vs 12 months of thienopyridine in patients treated with BMS taking aspirin and (2) treatment duration effect within the combined cohorts of randomized patients treated with DES or BMS as prespecified secondary analyses. DESIGN, SETTING, AND PARTICIPANTS International, multicenter, randomized, double-blinded, placebo-controlled trial comparing extended (30-months) thienopyridine vs placebo in patients taking aspirin who completed 12 months of DAPT without bleeding or ischemic events after receiving stents. The study was initiated in August 2009 with the last follow-up visit in May 2014. INTERVENTIONS Continued thienopyridine or placebo at months 12 through 30 after stent placement, in 11 648 randomized patients treated with aspirin, of whom 1687 received BMS and 9961 DES. MAIN OUTCOMES AND MEASURES Stent thrombosis, MACCE, and moderate or severe bleeding. RESULTS Among 1687 patients treated with BMS who were randomized to continued thienopyridine vs placebo, rates of stent thrombosis were 0.5% vs 1.11% (n = 4 vs 9; hazard ratio [HR], 0.49; 95% CI, 0.15-1.64; P = .24), rates of MACCE were 4.04% vs 4.69%(n = 33 vs 38; HR, 0.92; 95% CI, 0.57-1.47; P = .72), and rates of moderate/severe bleeding were 2.03% vs 0.90% (n = 16 vs 7; P = .07), respectively. Among all 11 648 randomized patients (both BMS and DES), stent thrombosis rates were 0.41% vs 1.32%(n = 23 vs 74; HR, 0.31; 95% CI, 0.19-0.50; P < .001), rates of MACCE were 4.29% vs 5.74%(n = 244 vs 323; HR, 0.73; 95% CI, 0.62-0.87; P < .001), and rates of moderate/severe bleeding were 2.45% vs 1.47%(n = 135 vs 80; P < .001). CONCLUSIONS AND RELEVANCE Among patients undergoing coronary stent placement with BMS and who tolerated 12 months of thienopyridine, continuing thienopyridine for an additional 18 months compared with placebo did not result in statistically significant differences in rates of stent thrombosis, MACCE, or moderate or severe bleeding. However, the BMS subset may have been underpowered to identify such differences, and further trials are suggested.	[Kereiakes, Dean J.] Christ Hosp Heart & Vasc Ctr, Cincinnati, OH USA; [Kereiakes, Dean J.] Lindner Res Ctr, Cincinnati, OH USA; [Yeh, Robert W.; Massaro, Joseph M.; Driscoll-Shempp, Priscilla; Cutlip, Donald E.; Mauri, Laura] Harvard Clin Res Inst, Boston, MA USA; [Yeh, Robert W.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Massaro, Joseph M.] Boston Univ, Boston, MA 02215 USA; [Cutlip, Donald E.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Steg, P. Gabriel] Univ Paris Diderot, Paris, France; [Steg, P. Gabriel] Hop Bichat Claude Bernard, Dept Hosp Univ FIRE, F-75877 Paris, France; [Steg, P. Gabriel] Royal Brompton Hosp, Imperial Coll, Natl Heart & Lung Inst, London SW3 6LY, England; [Gershlick, Anthony H.] Univ Hosp Leicester, Leicester, Leics, England; [Darius, Harald] Vivantes Neukoelln Med Ctr, Berlin, Germany; [Meredith, Ian T.] Monash Heart, Clayton, Vic, Australia; [Ormiston, John] Mercy Hosp, Auckland, New Zealand; [Tanguay, Jean Francois] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Windecker, Stephan] Univ Hosp Bern, CH-3010 Bern, Switzerland; [Garratt, Kirk N.] Lenox Hill Hosp, New York, NY 10021 USA; [Kandzari, David E.] Piedmont Heart Inst, Atlanta, GA USA; [Lee, David P.] Stanford Univ, Stanford, CA 94305 USA; [Simon, Daniel I.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Iancu, Adrian Corneliu] Inst Heart, Cluj Napoca, Romania; [Trebacz, Jaroslaw] Jan Pawel II Hosp Krakow, Krakow, Poland; [Mauri, Laura] Brigham & Womens Hosp, Boston, MA 02115 USA	Christ Hospital - Ohio; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Boston University; Harvard University; Beth Israel Deaconess Medical Center; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Royal Brompton Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Universite de Montreal; University of Bern; University Hospital of Bern; Northwell Health; Piedmont Heart Institute; Stanford University; Case Western Reserve University; Case Western Reserve University Hospital; Nicolae Stancioiu Heart Institute; Harvard University; Brigham & Women's Hospital	Mauri, L (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, Dept Med, 75 Francis St, Boston, MA 02115 USA.	lmauri1@partners.org	Yeh, Robert/AAJ-3463-2020; STEG, Philippe Gabriel/Z-1567-2019; mauri, laura/GPS-4868-2022; Iancu, Adrian Corneliu/ABI-4828-2020	Iancu, Adrian Corneliu/0000-0002-9764-1888; STEG, Philippe Gabriel/0000-0001-6896-2941; Mansouri, Vahid/0000-0001-8472-9058; TEIGER, emmanuel/0000-0001-7515-4344	Harvard Clinical Research Institute (HCRI); Abbott; Boston Scientific; Cordis; Medtronic; Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership; Eli Lilly; Daiichi Sankyo; US Department of Health and Human Services [1RO1FD003870-01]; FOOD AND DRUG ADMINISTRATION [R01FD003870] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL057506, R01HL057506] Funding Source: NIH RePORTER	Harvard Clinical Research Institute (HCRI); Abbott(Abbott Laboratories); Boston Scientific(Boston Scientific); Cordis; Medtronic(Medtronic); Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); Daiichi Sankyo(Daiichi Sankyo Company Limited); US Department of Health and Human Services; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was sponsored by the Harvard Clinical Research Institute (HCRI) and funded by Abbott, Boston Scientific, Cordis, Medtronic, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, Eli Lilly, and Daiichi Sankyo and the US Department of Health and Human Services (1RO1FD003870-01).	Badheka AO, 2014, AM J CARDIOL, V114, P1629, DOI 10.1016/j.amjcard.2014.08.033; Chacko R, 2009, JACC-CARDIOVASC INTE, V2, P498, DOI 10.1016/j.jcin.2009.03.013; Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011; Colombo A, 2014, J AM COLL CARDIOL, V64, P2086, DOI 10.1016/j.jacc.2014.09.008; Cutlip DE, 2004, CIRCULATION, V110, P1226, DOI 10.1161/01.CIR.0000140721.27004.4B; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Douglas PS, 2009, J AM COLL CARDIOL, V53, P1629, DOI 10.1016/j.jacc.2009.03.005; ELLIS SG, 1990, CIRCULATION, V82, P1193, DOI 10.1161/01.CIR.82.4.1193; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Gilard M, 2015, J AM COLL CARDIOL, V65, P777, DOI 10.1016/j.jacc.2014.11.008; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Kereiakes DJ, 2014, CIRCULATION, V130, P2113; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mauri L, 2010, AM HEART J, V160, P1035, DOI 10.1016/j.ahj.2010.07.038; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Takano M, 2009, JACC-CARDIOVASC INTE, V2, P1286, DOI 10.1016/j.jcin.2009.08.025; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Yamaji K, 2010, CIRC-CARDIOVASC INTE, V3, P468, DOI 10.1161/CIRCINTERVENTIONS.110.958249; Yusuf S, 2001, NEW ENGL J MED, V345, P494	22	82	83	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1113	1121		10.1001/jama.2015.1671	http://dx.doi.org/10.1001/jama.2015.1671			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25781440	Green Published, Green Accepted			2022-12-28	WOS:000351102500013
J	McNeill, D				McNeill, Desmond		Independent Panel Global Governanc	Trade and investment agreements: a call for evidence	LANCET			English	Editorial Material									[McNeill, Desmond; Independent Panel Global Governanc] Univ Oslo, Ctr Dev & Environm SUM, N-0317 Oslo, Norway	University of Oslo	McNeill, D (corresponding author), Univ Oslo, Ctr Dev & Environm SUM, N-0317 Oslo, Norway.			Stuckler, David/0000-0002-1288-8401; mcneill, desmond/0000-0002-8948-3197				Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1	1	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					928	929		10.1016/S0140-6736(15)60267-7	http://dx.doi.org/10.1016/S0140-6736(15)60267-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD2EK	25784332				2022-12-28	WOS:000350886900011
J	Broekhuijsen, K; van Baaren, GJ; van Pampus, MG; Ganzevoort, W; Sikkema, JM; Woiski, MD; Oudijk, MA; Bloemenkamp, KWM; Scheepers, HCJ; Bremer, HA; Rijnders, RJP; van Loon, AJ; Perquin, DAM; Sporken, JMJ; Papatsonis, DNM; van Huizen, ME; Vredevoogd, CB; Brons, JTJ; Kaplan, M; van Kaam, AH; Groen, H; Porath, MM; van den Berg, PP; Mol, BJ; Franssen, MTM; Langenveld, J				Broekhuijsen, Kim; van Baaren, Gert-Jan; van Pampus, Maria G.; Ganzevoort, Wessel; Sikkema, J. Marko; Woiski, Mallory D.; Oudijk, Martijn A.; Bloemenkamp, Kitty W. M.; Scheepers, Hubertina C. J.; Bremer, Henk A.; Rijnders, Robbert J. P.; van Loon, Aren J.; Perquin, Denise A. M.; Sporken, Jan M. J.; Papatsonis, Dimitri N. M.; van Huizen, Marloes E.; Vredevoogd, Corla B.; Brons, Jozien T. J.; Kaplan, Mesrure; van Kaam, Anton H.; Groen, Henk; Porath, Martina M.; van den Berg, Paul P.; Mol, Ben W. J.; Franssen, Maureen T. M.; Langenveld, Josje		HYPITAT-II Study Grp	Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial	LANCET			English	Article							SEVERE PREECLAMPSIA; MANAGEMENT; INDUCTION; LABOR	Background There is little evidence to guide the management of women with hypertensive disorders in late preterm pregnancy. We investigated the effect of immediate delivery versus expectant monitoring on maternal and neonatal outcomes in such women. Methods We did an open-label, randomised controlled trial, in seven academic hospitals and 44 non-academic hospitals in the Netherlands. Women with non-severe hypertensive disorders of pregnancy between 34 and 37 weeks of gestation were randomly allocated to either induction of labour or caesarean section within 24 h (immediate delivery) or a strategy aimed at prolonging pregnancy until 37 weeks of gestation (expectant monitoring). The primary outcomes were a composite of adverse maternal outcomes (thromboembolic disease, pulmonary oedema, eclampsia, HELLP syndrome, placental abruption, or maternal death), and neonatal respiratory distress syndrome, both analysed by intention-to-treat. This study is registered with the Netherlands Trial Register (NTR1792). Findings Between March 1, 2009, and Feb 21, 2013, 897 women were invited to participate, of whom 703 were enrolled and randomly assigned to immediate delivery (n=352) or expectant monitoring (n=351). The composite adverse maternal outcome occurred in four (1.1%) of 352 women allocated to immediate delivery versus 11 (3.1%) of 351 women allocated to expectant monitoring (relative risk [ RR] 0.36, 95% CI 012-111; p=0069). Respiratory distress syndrome was diagnosed in 20 (5.7%) of 352 neonates in the immediate delivery group versus six (1.7%) of 351 neonates in the expectant monitoring group (RR 3.3, 95% CI 1.4-8.2; p=0.005). No maternal or perinatal deaths occurred. Interpretation For women with non-severe hypertensive disorders at 34-37 weeks of gestation, immediate delivery might reduce the already small risk of adverse maternal outcomes. However, it significantly increases the risk of neonatal respiratory distress syndrome, therefore, routine immediate delivery does not seem justified and a strategy of expectant monitoring until the clinical situation deteriorates can be considered.	[van Baaren, Gert-Jan; Ganzevoort, Wessel] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands; [van Kaam, Anton H.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Neonatol, NL-1105 AZ Amsterdam, Netherlands; [van Pampus, Maria G.] Onze Lieve Vrouw Hosp, Dept Obstet & Gynaecol, Amsterdam, Netherlands; [Sikkema, J. Marko] ZGT Almelo, Dept Obstet & Gynaecol, Almelo, Netherlands; [Woiski, Mallory D.] Radboud Univ Nijmegen, Dept Obstet & Gynaecol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Oudijk, Martijn A.] Univ Med Ctr Utrecht, Dept Obstet, Utrecht, Netherlands; [Bloemenkamp, Kitty W. M.] Leiden Univ, Dept Obstet, Med Ctr, Leiden, Netherlands; [Scheepers, Hubertina C. J.] Maastricht Univ, Dept Obstet & Gynaecol, Grow, Sch Oncol & Dev Biol,Med Ctr, NL-6200 MD Maastricht, Netherlands; [Bremer, Henk A.] Reinier de Graaf Gasthuis, Dept Obstet & Gynaecol, Delft, Netherlands; [Rijnders, Robbert J. P.] Jeroen Bosch Hosp, Dept Obstet & Gynaecol, Shertogenbosch, Netherlands; [van Loon, Aren J.] Martini Hosp, Dept Obstet & Gynaecol, Groningen, Netherlands; [Perquin, Denise A. M.] Med Ctr Leeuwarden, Dept Obstet & Gynaecol, Leeuwarden, Netherlands; [Sporken, Jan M. J.] Canisius Wilhelmina Hosp, Dept Obstet & Gynaecol, Nijmegen, Netherlands; [Papatsonis, Dimitri N. M.] Amphia Hosp Breda, Dept Obstet & Gynaecol, Breda, Netherlands; [van Huizen, Marloes E.] HagaZiekenhuis, Dept Obstet & Gynaecol, The Hague, Netherlands; [Vredevoogd, Corla B.] Med Ctr Haaglanden, Dept Obstet & Gynaecol, The Hague, Netherlands; [Brons, Jozien T. J.] Medisch Spectrum Twente, Dept Obstet & Gynaecol, Enschede, Netherlands; [Kaplan, Mesrure] Ropcke Zweers Hosp, Dept Obstet & Gynaecol, Hardenberg, Netherlands; [Groen, Henk] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, HPC FA40, Groningen, Netherlands; [Broekhuijsen, Kim; van den Berg, Paul P.; Franssen, Maureen T. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, Groningen, Netherlands; [Porath, Martina M.] Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands; [Mol, Ben W. J.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Langenveld, Josje] Atrium Med Ctr Parkstad, Dept Obstet & Gynaecol, Heerlen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Onze Lieve Vrouwe Gasthuis Hospital; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Reinier de Graaf Hospital; Jeroen Bosch Ziekenhuis; Martini Hospital; Medical Center Leeuwarden; Canisius-Wilhelmina Hospital; Amphia Hospital; Haga Hospital; Haaglanden Medical Center; Medical Spectrum Twente; University of Groningen; University of Groningen; Maxima Medical Center; University of Adelaide; Atrium Medical Center	Broekhuijsen, K (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, CB21,POB 30 001, NL-9700 RB Groningen, Netherlands.	k.broekhuijsen@gmail.com	Ganzevoort, Wessel/AAH-4468-2020; Groen, Henk/B-2163-2013; Woiski, Mallory D/AAN-6632-2021; Oudijk, Martijn A/C-1520-2019; Woiski, Mallory D/L-4763-2015	Ganzevoort, Wessel/0000-0002-7243-2115; Groen, Henk/0000-0002-6629-318X; Woiski, Mallory D/0000-0002-7553-5929; Oudijk, Martijn A/0000-0001-8672-4365; Woiski, Mallory D/0000-0002-7553-5929; van Pampus, Maria/0000-0002-3020-8908; Roumen, Frans JME/0000-0003-2319-4808	ZonMw; ZonMw, The Netherlands Organisation for Health Research and Development [171102012]	ZonMw(Netherlands Organization for Health Research and Development); ZonMw, The Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	ZonMw.; We thank the research nurses and midwives of our consortium, and residents, midwives, nurses, and gynaecologists of the participating centres for their help with recruitment and data collection. This trial was funded by ZonMw, The Netherlands Organisation for Health Research and Development, programme Doelmatigheidsonderzoek (Health Care Efficiency Research, grant 171102012).	Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005; Barton JR, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.030; Bewley S, 2010, LANCET, V375, P119, DOI 10.1016/S0140-6736(10)60043-8; BISHOP EH, 1964, OBSTET GYNECOL, V24, P266; Broekhuijsen K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-232; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Fisher L.D., 1990, STAT ISSUES DRUG RES, P331, DOI DOI 10.1201/9780203738610; Ganzevoort W, 2011, BEST PRACT RES CL OB, V25, P463, DOI 10.1016/j.bpobgyn.2011.01.004; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Habli M, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.059; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; Langenveld J, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.003; Langenveld J, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-50; Mesbah EMM, 2003, MED J CAIRO U, V71, P175; Mishanina E, 2014, CAN MED ASSOC J, V186, P665, DOI 10.1503/cmaj.130925; Nederlandse vereniging voor obstetrie en gynaecologie, 2005, CHR HYP ZWANG; Nederlandse vereniging voor obstetrie en gynaecologie, 2011, RICHTL HYP AAND ZWAN; ODENDAAL HJ, 1990, OBSTET GYNECOL, V76, P1070; Owens Michelle Y, 2014, J Miss State Med Assoc, V55, P208; Rana S, 2014, HYPERTENSION, V63, P198, DOI 10.1161/HYPERTENSIONAHA.113.02293; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P311, DOI 10.1016/0002-9378(90)90376-I; SIBAI BM, 1994, AM J OBSTET GYNECOL, V171, P818, DOI 10.1016/0002-9378(94)90104-X; Teune MJ, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.015; Vigil-De Gracia P, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.016	27	91	96	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2492	2501		10.1016/S0140-6736(14)61998-X	http://dx.doi.org/10.1016/S0140-6736(14)61998-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK9AR	25817374				2022-12-28	WOS:000356532500024
J	Hughes, DA; Pastores, GM				Hughes, Derralynn A.; Pastores, Gregory M.			Eliglustat for Gaucher's disease: trippingly on the tongue	LANCET			English	Editorial Material							GLUCOSYLCERAMIDE SYNTHASE; THERAPY; TYPE-1; INHIBITION; PHASE-2		[Hughes, Derralynn A.] UCL, Royal Free London NHS Fdn Trust, Dept Haematol, Lysosomal Storage Disorders Unit, London NW3 2QG, England; [Pastores, Gregory M.] Mater Misericordiae Univ Hosp, Natl Ctr Inherited Metab Dis, Dept Med, Dublin, Ireland	University of London; University College London; Royal Free London NHS Foundation Trust; Mater Misericordiae University Hospital; University College Dublin	Hughes, DA (corresponding author), UCL, Royal Free London NHS Fdn Trust, Dept Haematol, Lysosomal Storage Disorders Unit, London NW3 2QG, England.	rmgvdah@ucl.ac.uk	Pastores, Gregory M./AAE-8647-2020; hughes, derralynn/J-8012-2013	hughes, derralynn/0000-0003-4531-9173				Arends M, 2013, BRIT J HAEMATOL, V161, P832, DOI 10.1111/bjh.12335; Cerdelga, 2014, HIGHL PRESCR INF; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; Cox TM, 2015, LANCET; Kamath RS, 2014, SKELETAL RADIOL, V43, P1353, DOI 10.1007/s00256-014-1891-9; Kuter DJ, 2013, BLOOD CELL MOL DIS, V51, P116, DOI 10.1016/j.bcmd.2013.04.005; Lukina E, 2014, BLOOD CELL MOL DIS, V53, P274, DOI 10.1016/j.bcmd.2014.04.002; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; Packman S, 2013, 63 AM SOC HUM GEN AN; Pavlova EV, 2013, J PATHOL, V231, P88, DOI 10.1002/path.4227; Pavlova EV, 2015, J PATHOL, V235, P113, DOI 10.1002/path.4452; Thomas AS, 2014, BRIT J HAEMATOL, V165, P427, DOI 10.1111/bjh.12804	13	5	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2328	2330		10.1016/S0140-6736(15)60206-9	http://dx.doi.org/10.1016/S0140-6736(15)60206-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1XV	25819692				2022-12-28	WOS:000356003700007
J	Ciancanelli, MJ; Huang, SXL; Luthra, P; Garner, H; Itan, Y; Volpi, S; Lafaille, FG; Trouillet, C; Schmolke, M; Albrecht, RA; Israelsson, E; Lim, HK; Casadio, M; Hermesh, T; Lorenzo, L; Leung, LW; Pedergnana, V; Boisson, B; Okada, S; Picard, C; Ringuier, B; Troussier, F; Chaussabel, D; Abel, L; Pellier, I; Notarangelo, LD; Garcia-Sastre, A; Basler, CF; Geissmann, F; Zhang, SY; Snoeck, HW; Casanova, JL				Ciancanelli, Michael J.; Huang, Sarah X. L.; Luthra, Priya; Garner, Hannah; Itan, Yuval; Volpi, Stefano; Lafaille, Fabien G.; Trouillet, Celine; Schmolke, Mirco; Albrecht, Randy A.; Israelsson, Elisabeth; Lim, Hye Kyung; Casadio, Melina; Hermesh, Tamar; Lorenzo, Lazaro; Leung, Lawrence W.; Pedergnana, Vincent; Boisson, Bertrand; Okada, Satoshi; Picard, Capucine; Ringuier, Benedicte; Troussier, Francoise; Chaussabel, Damien; Abel, Laurent; Pellier, Isabelle; Notarangelo, Luigi D.; Garcia-Sastre, Adolfo; Basler, Christopher F.; Geissmann, Frederic; Zhang, Shen-Ying; Snoeck, Hans-Willem; Casanova, Jean-Laurent			Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency	SCIENCE			English	Article							RIG-I; PANDEMIC INFLUENZA; POSITIVE FEEDBACK; EXPRESSION; RNA; RECOGNITION; ACTIVATION; MUTATIONS; PROTEIN; GENES	Severe influenza disease strikes otherwise healthy children and remains unexplained. We report compound heterozygous null mutations in IRF7, which encodes the transcription factor interferon regulatory factor 7, in an otherwise healthy child who suffered life-threatening influenza during primary infection. In response to influenza virus, the patient's leukocytes and plasmacytoid dendritic cells produced very little type I and III interferons (IFNs). Moreover, the patient's dermal fibroblasts and induced pluripotent stem cell (iPSC)-derived pulmonary epithelial cells produced reduced amounts of type I IFN and displayed increased influenza virus replication. These findings suggest that IRF7-dependent amplification of type I and III IFNs is required for protection against primary infection by influenza virus in humans. They also show that severe influenza may result from single-gene inborn errors of immunity.	[Ciancanelli, Michael J.; Itan, Yuval; Lafaille, Fabien G.; Lim, Hye Kyung; Casadio, Melina; Hermesh, Tamar; Boisson, Bertrand; Okada, Satoshi; Picard, Capucine; Abel, Laurent; Zhang, Shen-Ying; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA; [Huang, Sarah X. L.; Snoeck, Hans-Willem] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY USA; [Huang, Sarah X. L.; Snoeck, Hans-Willem] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Luthra, Priya; Schmolke, Mirco; Albrecht, Randy A.; Leung, Lawrence W.; Garcia-Sastre, Adolfo; Basler, Christopher F.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Garner, Hannah; Trouillet, Celine; Geissmann, Frederic] Kings Coll London, CMCBI, London SE1 1UL, England; [Volpi, Stefano; Notarangelo, Luigi D.] Harvard Univ, Sch Med, Childrens Hosp, Div Immunol, Boston, MA USA; [Volpi, Stefano; Notarangelo, Luigi D.] Harvard Univ, Sch Med, Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA; [Volpi, Stefano] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, I-16132 Genoa, Italy; [Albrecht, Randy A.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Israelsson, Elisabeth; Chaussabel, Damien] Virginia Mason, Benaroya Res Inst, Dept Syst Immunol, Seattle, WA USA; [Lorenzo, Lazaro; Pedergnana, Vincent; Picard, Capucine; Abel, Laurent; Zhang, Shen-Ying; Casanova, Jean-Laurent] INSERM, UMR1163, Lab Human Genet Infect Dis, Necker Branch, Paris, France; [Lorenzo, Lazaro; Pedergnana, Vincent; Picard, Capucine; Abel, Laurent; Zhang, Shen-Ying; Casanova, Jean-Laurent] Univ Paris 05, Imagine Inst, Paris, France; [Okada, Satoshi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pediat, Hiroshima, Japan; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Study Ctr Primary Immunodeficiencies, Paris, France; [Ringuier, Benedicte] Univ Hosp, Pediat Intens Care Unit, Angers, France; [Troussier, Francoise] Univ Hosp, Gen Pediat Unit, Angers, France; [Chaussabel, Damien] Sidra Med & Res Ctr, Dept Syst Biol, Doha, Qatar; [Pellier, Isabelle] Univ Hosp, Ctr Angers, Pediat Immunol Hematol & Oncol Unit, Angers, France; [Pellier, Isabelle] CNRS, U6299, INSERM, U892, Angers, France; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Casanova, Jean-Laurent] Necker Hosp Sick Children, AP HP, Pediat Immunohematol Unit, Paris, France; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY USA	Rockefeller University; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; University of London; King's College London; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Genoa; Icahn School of Medicine at Mount Sinai; Benaroya Research Institute; Virginia Mason Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Hiroshima University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Sidra Medical & Research Center; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Icahn School of Medicine at Mount Sinai; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute	Casanova, JL (corresponding author), Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA.	jean-laurent.casanova@rockefeller.edu	isabelle, pellier/L-5683-2015; Notarangelo, Luigi D/F-9718-2016; Okada, Satoshi/B-8901-2011; Chaussabel, Damien/AAX-1909-2020; Schmolke, Mirco/AAI-9081-2020; Boisson, Bertrand/I-2485-2017; Boisson, Bertrand/AAC-6058-2019; Zhang, Shen-Ying/I-2685-2017; Basler, Christopher/AAG-8346-2019; Abel, Laurent/H-8888-2017; Albrecht, Randy A./H-5119-2019; Casanova, Jean-Laurent/I-3418-2017; Volpi, Stefano/O-3717-2014; Lorenzo, Lazaro/H-7902-2017; Leung, Lawrence/E-4439-2010	Notarangelo, Luigi D/0000-0002-8335-0262; Okada, Satoshi/0000-0002-4622-5657; Schmolke, Mirco/0000-0002-2491-3029; Boisson, Bertrand/0000-0001-5240-3555; Boisson, Bertrand/0000-0001-5240-3555; Zhang, Shen-Ying/0000-0002-9449-3672; Basler, Christopher/0000-0003-4195-425X; Abel, Laurent/0000-0001-7016-6493; Albrecht, Randy A./0000-0003-4008-503X; Volpi, Stefano/0000-0002-7129-868X; Lorenzo, Lazaro/0000-0001-6648-8684; Ciancanelli, Michael/0000-0002-4623-852X; Casanova, Jean-Laurent/0000-0002-7782-4169; Chaussabel, Damien/0000-0002-6131-7242; Leung, Lawrence/0000-0003-3333-3242; Pedergnana, Vincent/0000-0002-7852-5339; geissmann, frederic/0000-0001-5029-2468; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Casadio, Melina/0000-0003-2389-2243	National Center for Research Resources; National Center for Advancing Translational Sciences [8UL1TR000043]; NIH [5R01NS072381, 5R01AI100887, 1U19AI109945]; Rockefeller University; St. Giles Foundation; French National Research Agency under the "Investments for the Future" program [ANR-10-IAHU-01]; Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases [ANR-10-LABX-62-IBEID]; INSERM; Paris Descartes University; ERC [2010-StG-261299]; Center for Research on Influenza Pathogenesis; NIAID [HHSN272201400008C];  [SRP055919]; Biotechnology and Biological Sciences Research Council [1168004] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100887, U19AI109945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072381] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; St. Giles Foundation; French National Research Agency under the "Investments for the Future" program(French National Research Agency (ANR)); Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Descartes University; ERC(European Research Council (ERC)European Commission); Center for Research on Influenza Pathogenesis; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We warmly thank our patient and her family. We thank S. Boucherit, T. Kochetkov, M. Fenner, M. Duchamp, A. Abhyankar, A. Belkadi, L. Shang, Y. Liang, L. Amar, and Y. Nemirovskaya for their contributions and all members of the laboratory for fruitful discussions. Plasmids used to generate recombinant influenza viruses are subject to a material transfer agreement. We thank members of the French Memo-Flu-ARDS study group (PIs: B. Autran, Inserm U945, and C.-E. Luyt, Service de reanimation medicale, Hopital Pitie-Salpetriere, Paris) for recruiting adult severe flu patients. Supported by National Center for Research Resources and National Center for Advancing Translational Sciences grant 8UL1TR000043; NIH grants 5R01NS072381 (J.-L.C. and L.D.N.), 5R01AI100887 (L.D.N.), and 1U19AI109945 (C.F.B.); the Rockefeller University, the St. Giles Foundation, the French National Research Agency under the "Investments for the Future" program grant ANR-10-IAHU-01, the Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID), INSERM, Paris Descartes University, and ERC grant 2010-StG-261299 (F.G.); and Center for Research on Influenza Pathogenesis and the NIAID-funded Center of Excellence for Influenza Research and Surveillance contract HHSN272201400008C (A.G.-S.). The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Raw data for the microarray analyses performed in this study are available from the public repository of GEO DataSets (accession no. GSE66486). The raw sequence data are available on the Sequence Read Archive (SRA) database: Bioproject SRP055919.	Agrati C, 2010, J INFECT DIS, V202, P681, DOI 10.1086/655469; Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; BARON S, 1962, Br Med J, V1, P18; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Caillaud A, 2005, J BIOL CHEM, V280, P17671, DOI 10.1074/jbc.M411389200; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Casanova JL, 2013, COLD SH Q B, V78, P157, DOI 10.1101/sqb.2013.78.019968; Casanova JL, 2013, ANNU REV GENOM HUM G, V14, P215, DOI 10.1146/annurev-genom-091212-153448; Centers for Disease Control and Prevention, 2013, FLUVIEW INFLUENZA AS; Conley ME, 2014, CURR OPIN IMMUNOL, V30, P17, DOI 10.1016/j.coi.2014.05.004; Dawood FS, 2011, PEDIATRICS, V128, pE27, DOI 10.1542/peds.2010-3343; Dittmann M, 2015, CELL, V160, P631, DOI 10.1016/j.cell.2015.01.040; Gennery AR, 2001, J CLIN PATHOL, V54, P191, DOI 10.1136/jcp.54.3.191; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Mangeat B, 2012, J BIOL CHEM, V287, P22015, DOI 10.1074/jbc.M111.319996; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Palese P., 2007, FIELDS VIROLOGY, P1647; Pasquet M, 2013, BLOOD, V121, P822, DOI 10.1182/blood-2012-08-447367; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	34	274	280	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					448	453		10.1126/science.aaa1578	http://dx.doi.org/10.1126/science.aaa1578			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25814066	Green Accepted			2022-12-28	WOS:000353338000038
J	Booth, D; Rittenhouse, ST; Yang, J; Sadeghpour, HR; Shaffer, JP				Booth, D.; Rittenhouse, S. T.; Yang, J.; Sadeghpour, H. R.; Shaffer, J. P.			Production of trilobite Rydberg molecule dimers with kilo-Debye permanent electric dipole moments	SCIENCE			English	Article							COLLISIONS; STATES	Permanent electric dipole moments are important for understanding symmetry breaking in molecular physics, control of chemical reactions, and realization of strongly correlated many-body quantum systems. However, large molecular permanent electric dipole moments are challenging to realize experimentally. We report the observation of ultralong-range Rydberg molecules with bond lengths of similar to 100 nanometers and kilo-Debye permanent electric dipole moments that form when an ultracold ground-state cesium (Cs) atom becomes bound within the electronic cloud of an extended Cs electronic orbit. The electronic character of this hybrid class of "trilobite" molecules is dominated by degenerate Rydberg manifolds, making them difficult to produce by conventional photoassociation. We used detailed coupled-channel calculations to reproduce their properties quantitatively. Our findings may lead to progress in ultracold chemistry and strongly correlated many-body physics.	[Booth, D.; Yang, J.; Shaffer, J. P.] Univ Oklahoma, Homer L Dodge Dept Phys & Astron, Norman, OK 73019 USA; [Rittenhouse, S. T.] Western Washington Univ, Dept Phys & Astron, Bellingham, WA 98225 USA; [Sadeghpour, H. R.] Harvard Smithsonian Ctr Astrophys, Inst Theoret Atom & Mol Phys, Cambridge, MA 02138 USA	University of Oklahoma System; University of Oklahoma - Norman; Western Washington University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Sadeghpour, HR (corresponding author), Harvard Smithsonian Ctr Astrophys, Inst Theoret Atom & Mol Phys, Cambridge, MA 02138 USA.	hrs@cfa.harvard.edu	Yang, Jin/AAR-5424-2021		NSF [PHY-1205392]; NSF grant through ITAMP at the Harvard-Smithsonian Center for Astrophysics; Division Of Physics [1205923, 1205635, 1521560] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NSF grant through ITAMP at the Harvard-Smithsonian Center for Astrophysics; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Supported by NSF grant PHY-1205392 (D.B., J.Y., and J.P.S.) and by an NSF grant through ITAMP at the Harvard-Smithsonian Center for Astrophysics (H.R.S.). S.T.R. thanks B. M. Peden and B. L. Johnson for insightful discussions. All data are available upon request.	Anderson DA, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.163201; ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Bahrim C, 2001, J PHYS B-AT MOL OPT, V34, pL195, DOI 10.1088/0953-4075/34/6/107; Balewski JB, 2013, NATURE, V502, P664, DOI 10.1038/nature12592; Bellos MA, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.053001; Bendkowsky V, 2009, NATURE, V458, P1005, DOI 10.1038/nature07945; Beterov II, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.052504; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; COOPER JW, 1962, PHYS REV, V128, P681, DOI 10.1103/PhysRev.128.681; Fermi E., 1934, NUOVO CIMENTO, V11, P157, DOI DOI 10.1007/BF02959829; Gallagher T. F., 1994, RYDBERG ATOMS; Greene CH, 2000, PHYS REV LETT, V85, P2458, DOI 10.1103/PhysRevLett.85.2458; Greene CH, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.233002; Hamilton EL, 2002, J PHYS B-AT MOL OPT, V35, pL199, DOI 10.1088/0953-4075/35/10/102; Krupp AT, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.143008; Li W, 2011, SCIENCE, V334, P1110, DOI 10.1126/science.1211255; Lukin MD, 2000, PHYS REV LETT, V84, P2818, DOI 10.1103/PhysRevLett.84.2818; Lukin MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037901; OMONT A, 1977, J PHYS-PARIS, V38, P1343, DOI 10.1051/jphys:0197700380110134300; Ospelkaus S, 2010, SCIENCE, V327, P853, DOI 10.1126/science.1184121; Tallant J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.173202; Weimer H, 2010, NAT PHYS, V6, P382, DOI 10.1038/NPHYS1614	23	94	94	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					99	102		10.1126/science.1260722	http://dx.doi.org/10.1126/science.1260722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838380	Green Submitted			2022-12-28	WOS:000352079500034
J	LeBlanc, LJ				LeBlanc, Lindsay J.			Two-atom bunching	NATURE			English	Editorial Material							BEAM-SPLITTER; INTERFERENCE		Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada	University of Alberta	LeBlanc, LJ (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada.	lindsay.leblanc@ualberta.ca	LeBlanc, Lindsay/ABA-8511-2020					Bonneau M, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.061603; Campbell GK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.020406; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Lopes R, 2015, NATURE, V520, P66, DOI 10.1038/nature14331; Loudon R, 1998, PHYS REV A, V58, P4904, DOI 10.1103/PhysRevA.58.4904; Neder I, 2007, NATURE, V448, P333, DOI 10.1038/nature05955; OU ZY, 1989, AM J PHYS, V57, P66, DOI 10.1119/1.15873	7	0	0	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					36	37		10.1038/520036a	http://dx.doi.org/10.1038/520036a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25832398				2022-12-28	WOS:000352027700027
J	Denning, DW; Bromley, MJ				Denning, David W.; Bromley, Michael J.			How to bolster the antifungal pipeline	SCIENCE			English	Editorial Material							INVASIVE ASPERGILLOSIS; VORICONAZOLE; THERAPY; DRUG		[Denning, David W.; Bromley, Michael J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Denning, David W.] Univ S Manchester Hosp, Natl Aspergillosis Ctr, Manchester M20 8LR, Lancs, England; [Bromley, Michael J.] Univ Manchester, Manchester Fungal Infect Grp, Manchester, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester	Denning, DW (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	ddenning@manchester.ac.uk	Denning, David/AAC-6931-2019	Denning, David/0000-0001-5626-2251; Bromley, Michael/0000-0002-7611-0201	Medical Research Council Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashbee HR, 2014, J ANTIMICROB CHEMOTH, V69, P1162, DOI 10.1093/jac/dkt508; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Cadranel J, 2012, EUR J CLIN MICROBIOL, V31, P3231, DOI 10.1007/s10096-012-1690-y; Denning DW, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-14; Denning DW, 2002, CLIN INFECT DIS, V34, P563, DOI 10.1086/324620; European Crop Protection Association, ASS EC IMP AZ EUR AG; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Perkhofer S, 2010, INT J ANTIMICROB AG, V36, P531, DOI 10.1016/j.ijantimicag.2010.08.010; Rex JH, 2013, LANCET INFECT DIS, V13, P269, DOI 10.1016/S1473-3099(12)70293-1; Roemer T, 2013, NAT CHEM BIOL, V9, P222, DOI [10.1038/NCHEMBIO.1205, 10.1038/nchembio.1205]; Slavin M, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.12.021; Snelders E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031801; Valdez JM, 2011, CLIN INFECT DIS, V52, P726, DOI 10.1093/cid/ciq245; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2	14	310	324	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1414	1416		10.1126/science.aaa6097	http://dx.doi.org/10.1126/science.aaa6097			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814567				2022-12-28	WOS:000352136400020
J	Geach, JE				Geach, James E.			GALAXY FORMATION When the wind blows	NATURE			English	Editorial Material							EVOLUTION; QUASARS; DRIVEN		Univ Hertfordshire, CAR, Hatfield AL10 9AB, Herts, England	University of Hertfordshire	Geach, JE (corresponding author), Univ Hertfordshire, CAR, Hatfield AL10 9AB, Herts, England.	j.geach@herts.ac.uk						Crain R. A., 2015, PREPRINT; Faucher-Giguere CA, 2012, MON NOT R ASTRON SOC, V425, P605, DOI 10.1111/j.1365-2966.2012.21512.x; Hopkins PF, 2005, ASTROPHYS J, V630, P705, DOI 10.1086/432438; Schaye J, 2015, MON NOT R ASTRON SOC, V446, P521, DOI 10.1093/mnras/stu2058; Silk J, 1998, ASTRON ASTROPHYS, V331, pL1; Tombesi F, 2015, NATURE, V519, P436, DOI 10.1038/nature14261	8	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					423	424		10.1038/519423a	http://dx.doi.org/10.1038/519423a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25810203				2022-12-28	WOS:000351602800045
J	Sommers, BD; Parmet, WE				Sommers, Benjamin D.; Parmet, Wendy E.			Health Care for Immigrants - Implications of Obama's Executive Action	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sommers, Benjamin D.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Parmet, Wendy E.] Northeastern Univ, Sch Law, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Northeastern University	Sommers, BD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							Bustamante AV, 2012, HEALTH SERV RES, V47, P794, DOI 10.1111/j.1475-6773.2011.01278.x; Capps R., 2013, DEMOGRAPHIC SOCIOECO; Sommers BD, 2012, HEALTH AFFAIR, V31, P2831; Watson, 2010, 16278 NAT BUR EC RES; Young Andrew, 2014, WASHINGTON POST 1231	5	6	6	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2015	372	13					1187	1189		10.1056/NEJMp1414949	http://dx.doi.org/10.1056/NEJMp1414949			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CE1QD	25806912	Green Published			2022-12-28	WOS:000351585900003
J	Skelton, E; Howlett, D				Skelton, Emily; Howlett, David			ANATOMY QUIZ Axial T2 weighted magnetic resonance image at the level of the lateral ventricles	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Skelton, Emily; Howlett, David] Eastbourne Dist Gen Hosp, Eastbourne BN1 2UD, E Sussex, England		Skelton, E (corresponding author), Eastbourne Dist Gen Hosp, Eastbourne BN1 2UD, E Sussex, England.	e.skelton@nhs.net		Skelton, Emily/0000-0003-0132-7948					0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2015	350								h1609	10.1136/bmj.h1609	http://dx.doi.org/10.1136/bmj.h1609			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NV	25810506				2022-12-28	WOS:000352029500004
J	Hlatky, MA				Hlatky, Mark A.			Review: In diabetes with multivessel or left main CAD, PCI increases death/MI/stroke combo compared with CABG	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; BYPASS SURGERY		Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Hlatky, MA (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.		Brophy, James/H-6673-2019	Brophy, James/0000-0001-8049-6875; Hlatky, Mark/0000-0003-4686-9441				Hlatky MA, 2015, AM HEART J, V169, P149, DOI 10.1016/j.ahj.2014.10.004; Hlatky MA, 2013, ANN INTERN MED, V158, P727, DOI 10.7326/0003-4819-158-10-201305210-00639	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6							JC8	10.7326/ACPJC-2015-162-6-008	http://dx.doi.org/10.7326/ACPJC-2015-162-6-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775351				2022-12-28	WOS:000351279600007
J	Jarvik, JG; Gold, LS; Comstock, BA; Heagerty, PJ; Rundell, SD; Turner, JA; Avins, AL; Bauer, Z; Bresnahan, BW; Friedly, JL; James, K; Kessler, L; Nedeljkovic, SS; Nerenz, DR; Shi, X; Sullivan, SD; Chan, L; Schwalb, JM; Deyo, RA				Jarvik, Jeffrey G.; Gold, Laura S.; Comstock, Bryan A.; Heagerty, Patrick J.; Rundell, Sean D.; Turner, Judith A.; Avins, Andrew L.; Bauer, Zoya; Bresnahan, Brian W.; Friedly, Janna L.; James, Kathryn; Kessler, Larry; Nedeljkovic, Srdjan S.; Nerenz, David R.; Shi, Xu; Sullivan, Sean D.; Chan, Leighton; Schwalb, Jason M.; Deyo, Richard A.			Associaion of Early Imaging for Back Pain With Clinical Outcomes in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONGITUDINAL DATA; AMERICAN-COLLEGE; DISABILITY; PREVALENCE; MANAGEMENT; PHYSICIANS; STATE; SCORE; CARE	IMPORTANCE In contrast to the recommendations for younger adults, many guidelines allow for older adults with back pain to undergo imaging without waiting 4 to 6 weeks. However, early imaging may precipitate interventions that do not improve outcomes. OBJECTIVE To compare function and pain at the 12-month follow-up visit among older adults who received early imaging with those who did not receive early imaging after a new primary care visit for back pain without radiculopathy. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort of 5239 patients 65 years or older with a new primary care visit for back pain (2011-2013) in 3 US health care systems. We matched controls 1:1 using propensity score matching of demographic and clinical characteristics, including diagnosis, pain severity, pain duration, functional status, and prior resource use. EXPOSURES Diagnostic imaging (plain films, computed tomography [CT], magnetic resonance imaging [MRI]) of the lumbar or thoracic spine within 6 weeks of the index visit. MAIN OUTCOME AND MEASURES Primary outcome: back or leg pain-related disability measured by the modified Roland-Morris Disability Questionnaire (score range, 0-24; higher scores indicate greater disability) 12 months after enrollment. RESULTS Among the 5239 patients, 1174 had early radiographs and 349 had early MRI/CT. At 12 months, neither the early radiograph group nor the early MRI/CT group differed significantly from controls on the disability questionnaire. The mean score for patients who underwent early radiography was 8.54 vs 8.74 among the control group (difference, -0.10 [95% Cl, -0.71 to 0.50]; mixed model, P = .36). The mean score for the early MRI/CT group was 9.81 vs 10.50 for the control group (difference,-0.51[-1.62 to 0.60]; mixed model, P=.18). CONCLUSIONS AND RELEVANCE Among older adults with a new primary care visit for back pain, early imaging was not associated with better 1-year outcomes. The value of early diagnostic imaging in older adults for back pain without radiculopathy is uncertain.	[Jarvik, Jeffrey G.; Gold, Laura S.; Bauer, Zoya; Bresnahan, Brian W.; James, Kathryn] Univ Washington, Dept Radiol, Seattle, WA 98104 USA; [Jarvik, Jeffrey G.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Jarvik, Jeffrey G.; Kessler, Larry] Univ Washington, Dept Hlth Serv, Seattle, WA 98104 USA; [Jarvik, Jeffrey G.; Gold, Laura S.; Comstock, Bryan A.; Heagerty, Patrick J.; Rundell, Sean D.; Turner, Judith A.; Bauer, Zoya; Bresnahan, Brian W.; Friedly, Janna L.] Univ Washington, Comparat Effectiveness Cost & Outcomes Res Ctr, Seattle, WA 98104 USA; [Comstock, Bryan A.; Heagerty, Patrick J.; Shi, Xu] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Turner, Judith A.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Rundell, Sean D.; Friedly, Janna L.] Univ Washington, Dept Rehabil Med, Seattle, WA 98104 USA; [Nedeljkovic, Srdjan S.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Nedeljkovic, Srdjan S.] Harvard Vanguard Med Associates, Spine Unit, Boston, MA USA; [Nerenz, David R.] Henry Ford Hosp, Neurosci Inst, Detroit, MI 48202 USA; [Avins, Andrew L.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Jarvik, Jeffrey G.; Gold, Laura S.; Sullivan, Sean D.] Univ Washington, Dept Pharm, Seattle, WA 98104 USA; [Chan, Leighton] NIH, Dept Rehabil Med, Mark O Hatfield Clin Res Ctr, Bethesda, MD 20892 USA; [Schwalb, Jason M.] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI USA; [Schwalb, Jason M.] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Family Med Internal Med & Publ Hlth & Preven, Portland, OR 97201 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard Vanguard Medical Associates; Henry Ford Health System; Henry Ford Hospital; Kaiser Permanente; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oregon Health & Science University; Oregon Health & Science University	Jarvik, JG (corresponding author), Univ Washington, CECORC, Dept Radiol, POB 359728,325 Ninth Ave, Seattle, WA 98104 USA.	jarvikj@uw.edu	Schwalb, Jason M./AAQ-4932-2021; Jarvik, Jeffrey/AAL-4292-2021	Schwalb, Jason M./0000-0002-8714-161X; Rundell, Sean/0000-0003-0782-5999	Agency for Healthcare Research and Quality (AHRQ) [1R01HS01922201, 1R01HS022972-01]; NIH Intramural Research Program; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS022972] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by grants 1R01HS01922201 and 1R01HS022972-01 from the Agency for Healthcare Research and Quality (AHRQ) and from the NIH Intramural Research Program (Dr Chan's time).	Aetna, CLIN POL B MAGN RES; Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Analytics TH, 2014, MARKETSCAN RES; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P225; [Anonymous], 2010, IM GUID LUMB SPIN MR; Bigos S, 1994, AHCPR PUBLICATION, V14; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Bressler HB, 1999, SPINE, V24, P1813, DOI 10.1097/00007632-199909010-00011; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Centers for Medicare & Medicaid Services, 2010, FED REGISTER, V75, P73169; Centers for Medicare & Medicaid Services, 2011, FED REGISTER, V76, P73026; Centers for Medicare & Medicaid Services (CMS) HHS, 2009, Fed Regist, V74, P61737; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cleeland CS, 1996, PAIN, V67, P267, DOI 10.1016/0304-3959(96)03131-4; Davis Patricia C, 2009, J Am Coll Radiol, V6, P401, DOI 10.1016/j.jacr.2009.02.008; Friedly JL, 2014, NEW ENGL J MED, V371, P11, DOI 10.1056/NEJMoa1313265; Graves JM, 2012, SPINE, V37, P1617, DOI 10.1097/BRS.0b013e318251887b; Health AS, 2013, CLIN GUID; Jarvik JG, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-134; Jarvik JG, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-64; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; Jarvik JG, 2003, JAMA-J AM MED ASSOC, V289, P2810, DOI 10.1001/jama.289.21.2810; Jarvik JG, 2000, RADIOL CLIN N AM, V38, P1255, DOI 10.1016/S0033-8389(08)70005-8; Jarvik JJ, 2001, SPINE, V26, P1158, DOI 10.1097/00007632-200105150-00014; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Jordan K, 2006, J CLIN EPIDEMIOL, V59, P45, DOI 10.1016/j.jclinepi.2005.03.018; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Martin B, 2013, COMMUNICATION   0514; Modic MT, 2005, RADIOLOGY, V237, P597, DOI 10.1148/radiol.2372041509; Paeck T, 2014, ARTHRIT CARE RES, V66, P1220, DOI 10.1002/acr.22261; Parsons LS, 2004, SAS US GROUP INT 29; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Shye D, 1998, INT J QUAL HEALTH C, V10, P83, DOI 10.1093/intqhc/10.2.83; Stadnik TW, 1998, RADIOLOGY, V206, P49, DOI 10.1148/radiology.206.1.9423651; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Webster BS, 2014, SPINE, V39, P1433, DOI 10.1097/BRS.0000000000000408; Webster BS, 2010, J OCCUP ENVIRON MED, V52, P900, DOI 10.1097/JOM.0b013e3181ef7e53	43	70	72	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1143	1153		10.1001/jama.2015.1871	http://dx.doi.org/10.1001/jama.2015.1871			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25781443	Bronze			2022-12-28	WOS:000351102500016
J	Linas, BP; Barter, DM; Morgan, JR; Pho, MT; Leff, JA; Schackman, BR; Horsburgh, CR; Assoumou, SA; Salomon, JA; Weinstein, MC; Freedberg, KA; Kim, AY				Linas, Benjamin P.; Barter, Devra M.; Morgan, Jake R.; Pho, Mai T.; Leff, Jared A.; Schackman, Bruce R.; Horsburgh, C. Robert; Assoumou, Sabrina A.; Salomon, Joshua A.; Weinstein, Milton C.; Freedberg, Kenneth A.; Kim, Arthur Y.			The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; SUSTAINED VIROLOGICAL RESPONSE; FIBROSIS PROGRESSION; NATURAL-HISTORY; UNITED-STATES; ALL-CAUSE; RIBAVIRIN; CIRRHOSIS; THERAPY; PEGINTERFERON	Background: Chronic infection with hepatitis C virus (HCV) genotype 2 or 3 can be treated with sofosbuvir without interferon. Because sofosbuvir is costly, its benefits should be compared with the additional resources used. Objective: To estimate the cost-effectiveness of sofosbuvir-based treatments for HCV genotype 2 or 3 infection in the United States. Design: Monte Carlo simulation, including deterministic and probabilistic sensitivity analyses. Data Sources: Randomized trials, observational cohorts, and national health care spending surveys. Target Population: 8 patient types defined by HCV genotype (2 vs. 3), treatment history (naive vs. experienced), and cirrhosis status (noncirrhotic vs. cirrhotic). Time Horizon: Lifetime. Perspective: Payer. Intervention: Sofosbuvir-based therapies, pegylated interferon-ribavirin, and no therapy. Outcome Measures: Discounted quality-adjusted life-years (QALYs), costs, and incremental cost-effectiveness ratios (ICERs). Results of Base-Case Analysis: The ICER of sofosbuvir-based treatment was less than $100 000 per QALY in cirrhotic patients (genotype 2 or 3 and treatment-naive or treatment-experienced) and in treatment-experienced noncirrhotic patients but was greater than $200 000 per QALY in treatment-naive noncirrhotic patients. Results of Sensitivity Analysis: The ICER of sofosbuvir-based therapy for treatment-naive noncirrhotic patients with genotype 2 or 3 infection was less than $100 000 per QALY when the cost of sofosbuvir was reduced by approximately 40% and 60%, respectively. In probabilistic sensitivity analyses, cost-effectiveness conclusions were robust to uncertainty in treatment efficacy. Limitation: The analysis did not consider possible benefits of preventing HCV transmission. Conclusion: Sofosbuvir provides good value for money for treatment-experienced patients with HCV genotype 2 or 3 infection and those with cirrhosis. At their current cost, sofosbuvir-based regimens for treatment-naive noncirrhotic patients exceed willingness-to-pay thresholds commonly cited in the United States.	Boston Univ, Harvard Univ, Sch Publ Hlth, Boston Med Ctr, Boston, MA 02118 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Chicago, Chicago, IL 60637 USA; Weill Cornell Med Coll, New York, NY USA	Boston Medical Center; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; University of Chicago; Cornell University	Linas, BP (corresponding author), Boston Med Ctr, HIV Epidemiol & Outcomes Res Unit, 850 Harrison Ave,Dowling 3N,Room 3205, Boston, MA 02118 USA.	Benjamin.Linas@BMC.org	Salomon, Joshua A/D-3898-2009; Leff, Jared A./B-7631-2014; Morgan, Jake R/H-3487-2019; Assoumou, Sabrina/AAF-2087-2021; Schackman, Bruce R./J-8208-2019; Salomon, Joshua/S-1929-2019	Salomon, Joshua A/0000-0003-3929-5515; Leff, Jared A./0000-0001-6995-6009; Morgan, Jake R/0000-0002-1559-3983; Assoumou, Sabrina/0000-0002-5169-620X; Schackman, Bruce R./0000-0002-1132-2932; Salomon, Joshua/0000-0003-3929-5515; Horsburgh, C./0000-0001-6838-7895	National Institute on Drug Abuse; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042006, R37AI042006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027379, R01DA031059] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institute on Drug Abuse and National Institute of Allergy and Infectious Diseases.	Agency for Healthcare Research and Quality, 2013, TOT HLTH SERV MEAN M; American Association for the Study of Liver Diseases Infectious Diseases Society of America International Antiviral Society-USA, 2015, REC TEST MAN TREAT H; [Anonymous], 2013, MICR 2 0 DRUG TOP RE; Armstrong D, 2014, BLOOMBERG BUSIN 0305; Barnett PG, 2001, ADDICTION, V96, P1267, DOI 10.1046/j.1360-0443.2001.96912676.x; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Bruno S, 2009, AM J GASTROENTEROL, V104, P1147, DOI 10.1038/ajg.2009.31; CANTOR SB, 1994, MED DECIS MAKING, V14, P259, DOI 10.1177/0272989X9401400308; Center for Medicare and Medicaid Services, 2013, CLIN LAB FEE SCHED; Centers for Medicare and Medicaid Services, 2013, PHYS FEE SCHED; Chaiwat O, 2009, ANESTHESIOLOGY, V110, P351, DOI 10.1097/ALN.0b013e3181948a97; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Claxton K, 2005, HEALTH ECON, V14, P339, DOI 10.1002/hec.985; Daltron-Oliveira R, 2013, ANN HEPATOL, V12, P399, DOI 10.1016/S1665-2681(19)31002-6; Davis KL, 2011, J CLIN GASTROENTEROL, V45, pE17, DOI 10.1097/MCG.0b013e3181e12c09; Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131; Dias PT, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-208; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gold MR, 1996, COST EFFECTIVENESS H; Grieve R, 2006, GUT, V55, P1332, DOI 10.1136/gut.2005.064774; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Kim Arthur Y, 2013, F1000Prime Rep, V5, P24, DOI 10.12703/P5-24; Lawitz E, 2015, HEPATOLOGY, V61, P769, DOI 10.1002/hep.27567; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Linas BP, 2011, J VIRAL HEPATITIS, V18, P506, DOI 10.1111/j.1365-2893.2010.01325.x; Linas BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097317; Linas BP, 2014, AIDS, V28, P365, DOI 10.1097/QAD.0000000000000093; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; McAdam-Marx C, 2011, J MANAGE CARE PHARM, V17, P531, DOI 10.18553/jmcp.2011.17.7.531; Mehta SH, 2008, J COMMUN HEALTH, V33, P126, DOI 10.1007/s10900-007-9083-3; Pearlman BL, 2011, CLIN INFECT DIS, V52, P889, DOI 10.1093/cid/cir076; Pianko S, 2014, AM ASS STUD LIV DIS; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Quest Diagnostics, 2013, HEP C VIR HCV FIBROS; Reau NS, 2014, HEPATOLOGY, V59, P1246, DOI 10.1002/hep.27039; Rodger AJ, 1999, HEPATOLOGY, V30, P1299, DOI 10.1002/hep.510300504; Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176; Schackman BR, 2008, MED DECIS MAKING, V28, P233, DOI 10.1177/0272989X07311753; Sherman K, 2013, J HEPATOL, V58, pS372, DOI 10.1016/S0168-8278(13)60906-X; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Siebert U, 2003, GUT, V52, P425, DOI 10.1136/gut.52.3.425; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Stein K, 2002, Health Technol Assess, V6, P1; Stepanova M, 2014, ALIMENT PHARM THER, V40, P676, DOI 10.1111/apt.12880; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; US Food and Drug Administration, 2013, APPR SOV SOF TABL TR; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vera-Llonch M, 2013, ALIMENT PHARM THER, V38, P124, DOI 10.1111/apt.12354; Whitaker B., 2005, 2005 NATIONWIDE BLOO, P1; Yoshida H, 2002, GASTROENTEROLOGY, V123, P483, DOI 10.1053/gast.2002.34785; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	55	81	82	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					619	U220		10.7326/M14-1313	http://dx.doi.org/10.7326/M14-1313			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6AZ	25820703	Green Accepted			2022-12-28	WOS:000354119100006
J	Berry, SM; Connor, JT; Lewis, RJ				Berry, Scott M.; Connor, Jason T.; Lewis, Roger J.			The Platform Trial An Efficient Strategy for Evaluating Multiple Treatments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Berry, Scott M.; Connor, Jason T.; Lewis, Roger J.] Berry Consultants LLC, Austin, TX USA; [Berry, Scott M.] Univ Kansas, Dept Biostat, Med Ctr, Kansas City, KS USA; [Connor, Jason T.] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA; [Lewis, Roger J.] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA	University of Kansas; University of Kansas Medical Center; State University System of Florida; University of Central Florida; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Lewis, RJ (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, 1000 W Carson St,Bldg D9, Torrance, CA 90509 USA.	roger@emedharbor.edu		Berry, Scott/0000-0002-3541-0443				Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Esserman LJ, 2011, JAMA-J AM MED ASSOC, V306, P2608, DOI 10.1001/jama.2011.1837; Innovative Medicines Initiative (IMI), IMI 11 CALL PROP; Marini JJ, 2015, JAMA-J AM MED ASSOC, V313, P893, DOI 10.1001/jama.2014.18484; Meurer WJ, 2012, JAMA-J AM MED ASSOC, V307, P2377, DOI 10.1001/jama.2012.4174; Minnerup Jens, 2014, Exp Transl Stroke Med, V6, P2, DOI 10.1186/2040-7378-6-2; Mullard A, 2014, NAT MED, V20, P3, DOI 10.1038/nm0114-3; Saville BR, 2014, CLIN TRIALS, V11, P485, DOI 10.1177/1740774514531352	8	195	202	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1619	1620		10.1001/jama.2015.2316	http://dx.doi.org/10.1001/jama.2015.2316			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25799162				2022-12-28	WOS:000353595200009
J	Rebbeck, TR; Mitra, N; Wan, F; Sinilnikova, OM; Healey, S; McGuffog, L; Mazoyer, S; Chenevix-Trench, G; Easton, DF; Antoniou, AC; Nathanson, KL				Rebbeck, Timothy R.; Mitra, Nandita; Wan, Fei; Sinilnikova, Olga M.; Healey, Sue; McGuffog, Lesley; Mazoyer, Sylvie; Chenevix-Trench, Georgia; Easton, Douglas F.; Antoniou, Antonis C.; Nathanson, Katherine L.		CIMBA Consortium	Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MESSENGER-RNA DECAY; UNKNOWN CLINICAL-SIGNIFICANCE; DNA-SEQUENCE VARIANTS; SUSCEPTIBILITY GENE; GERMLINE MUTATIONS; MOUSE MODELS; CARRIERS; PROTEINS; POSITION; REGION	IMPORTANCE Limited information about the relationship between specific mutations in BRCA1 or BRCA2 (BRCA1/2) and cancer risk exists. OBJECTIVE To identify mutation-specific cancer risks for carriers of BRCA1/2. DESIGN, SETTING, AND PARTICIPANTS Observational study of women who were ascertained between 1937 and 2011 (median, 1999) and found to carry disease-associated BRCA1 or BRCA2 mutations. The international sample comprised 19 581 carriers of BRCA1 mutations and 11 900 carriers of BRCA2 mutations from 55 centers in 33 countries on 6 continents. We estimated hazard ratios for breast and ovarian cancer based on mutation type, function, and nucleotide position. We also estimated RHR, the ratio of breast vs ovarian cancer hazard ratios. A value of RHR greater than 1 indicated elevated breast cancer risk; a value of RHR less than 1 indicated elevated ovarian cancer risk. EXPOSURES Mutations of BRCA1 or BRCA2. MAIN OUTCOMES AND MEASURES Breast and ovarian cancer risks. RESULTS Among BRCA1 mutation carriers, 9052 women (46%) were diagnosed with breast cancer, 2317(12%) with ovarian cancer, 1041 (5%) with breast and ovarian cancer, and 7171 (37%) without cancer. Among BRCA2 mutation carriers, 6180 women (52%) were diagnosed with breast cancer, 682(6%) with ovarian cancer, 272(2%) with breast and ovarian cancer, and 4766 (40%) without cancer. In BRCA1, we identified 3 breast cancer cluster regions (BCCRs) located at c.179 to c.505 (BCCR1; RHR = 1.46; 95% Cl, 1.22-1.74; P = 2 x 10(-6)), c.4328 to c.4945 (BCCR2; RH R = 1.34; 95% Cl, 1.01-1.78; P =.04), and c. 5261 to c.5563 (BCCR2', RHR = 1.38; 95% Cl, 1.22-1.55; P = 6 x 10(-9)). We also identified an ovarian cancer cluster region (OCCR) from c.1380 to c.4062 (approximately exon 11) with RHR = 0.62 (95% Cl, 0.56-0.70; P = 9 x 10(-17)). In BRCA2, we observed multiple BCCRs spanning c.1 to c.596 (BCCR1; RHR = 1.71; 95% Cl, 1.06-2.78; P =.03), c.772 to c.1806 (BCCRI; RHR = 1.63; 95% Cl, 1.10-2.40; P =.01), and c.7394 to c.8904 (BCCR2; RHR = 2.31; 95% Cl, 1.69-3.16; P =.00002). We also identified 3 OCCRs: the first (OCCR1) spanned c.3249 to c.5681 that was adjacent to c.5946delT (6174delT; RHR = 0.51; 95% Cl, 0.44-0.60; P = 6 x 10(-17)). The second OCCR spanned c.6645 to c.7471 (OCCR2; RHR = 0.57; 95% Cl, 0.41-0.80; P =.001). Mutations conferring nonsense-mediated decay were associated with differential breast or ovarian cancer risks and an earlier age of breast cancer diagnosis for both BRCA1 and BRCA2 mutation carriers. CONCLUSIONS AND RELEVANCE Breast and ovarian cancer risks varied by type and location of BRCA1/2 mutations. With appropriate validation, these data may have implications for risk assessment and cancer prevention decision making for carriers of BRCA1 and BRCA2 mutations.	[Rebbeck, Timothy R.; Nathanson, Katherine L.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Rebbeck, Timothy R.; Mitra, Nandita; Wan, Fei] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Sinilnikova, Olga M.; Mazoyer, Sylvie] Ctr Leon Berard, Ctr Rech Cancerol Lyon, UMR Inserm, F-69373 Lyon, France; [Healey, Sue; Chenevix-Trench, Georgia] Queensland Inst Med Res, Dept Genet & Computat Biol, Brisbane, Qld 4006, Australia; [McGuffog, Lesley; Easton, Douglas F.; Antoniou, Antonis C.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England; [Nathanson, Katherine L.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; QIMR Berghofer Medical Research Institute; University of Cambridge; University of Pennsylvania; Pennsylvania Medicine	Rebbeck, TR (corresponding author), Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, 217 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	rebbeck@upenn.edu	Ehrencrona, Hans/Q-4621-2019; Jakubowska, Anna/O-8050-2014; Teixeira, Manuel António Rodrigues/E-4885-2011; Andrulis, Irene L./E-7267-2013; Jensen, Uffe Birk/ABA-8306-2021; Ehrencrona, Hans/M-5619-2014; Pasini, Barbara/AHI-2004-2022; Claes, Kathleen/AFR-6830-2022; Tischkowitz, Marc/O-4452-2018; TEJADA, Maria-Isabel/O-5051-2019; Peissel, Bernard/E-8187-2017; Aretini, Paolo/AAF-1205-2020; Chenevix-Trench, Georgia/AAV-2014-2020; Mazoyer, Sylvie/N-7559-2017; BYRSKI, Tomasz/I-2844-2014; Genuardi, Maurizio/K-3049-2018; Godino, Javier/M-3753-2018; Gronwald, Jacek/A-4576-2017; Radice, Paolo/O-3119-2013; montagna, marco/E-2225-2012; Pinheiro, Maísa/E-7424-2012; Osorio, Ana/I-4324-2014; Zaffaroni, Daniela/I-8731-2017; van Rensburg, Elizabeth J./B-9104-2011; Arnold, Norbert/E-3012-2010; Huzarski, Tomasz/AAQ-2161-2021; Romero, Atocha/AAS-2862-2021; Giannini, Giuseppe/B-5672-2013; Mensenkamp, Arjen/L-4520-2015; manoukian, siranoush/E-7132-2017; Sunde, Lone/AAG-7303-2019; Mundhenke, Christoph/D-2593-2010; Rebbeck, Timothy/GLU-8348-2022; Menkiszak, Janusz JM/I-4036-2014; Romero-Alfonso, Atocha/AAC-9879-2021; Dolcetti, Riccardo/O-3832-2015; Blanco, Ignacio/AAN-5426-2021; Ross, Eric A./S-8478-2019; Caligo, Adelaide Maria/K-4289-2018; Blanco, Ignacio/D-2565-2013; Spurdle, Amanda/A-4978-2011; Joseph, Vijai/J-9158-2013; Kwong, Ava/D-8005-2013; benitez, javier/H-5232-2015; Zlowocka-Perlowska, Elzbieta/W-9862-2018	Ehrencrona, Hans/0000-0002-5589-3622; Jakubowska, Anna/0000-0002-5650-0501; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Jensen, Uffe Birk/0000-0002-6205-6355; Ehrencrona, Hans/0000-0002-5589-3622; Pasini, Barbara/0000-0002-4373-1212; Claes, Kathleen/0000-0003-0841-7372; Tischkowitz, Marc/0000-0002-7880-0628; TEJADA, Maria-Isabel/0000-0002-7334-1864; Peissel, Bernard/0000-0001-9233-3571; Aretini, Paolo/0000-0003-1075-4319; Chenevix-Trench, Georgia/0000-0002-1878-2587; BYRSKI, Tomasz/0000-0001-9181-5026; Genuardi, Maurizio/0000-0002-7410-8351; Godino, Javier/0000-0002-5653-2722; Gronwald, Jacek/0000-0002-3643-2871; Radice, Paolo/0000-0001-6298-4111; montagna, marco/0000-0002-4929-2150; Osorio, Ana/0000-0001-8124-3984; Zaffaroni, Daniela/0000-0002-6995-2216; Arnold, Norbert/0000-0003-4523-8808; Huzarski, Tomasz/0000-0003-3857-4854; Romero, Atocha/0000-0002-1634-7397; Giannini, Giuseppe/0000-0003-0299-4056; Mensenkamp, Arjen/0000-0003-3805-877X; manoukian, siranoush/0000-0002-6034-7562; Sunde, Lone/0000-0002-8479-165X; Mundhenke, Christoph/0000-0002-6989-6250; Rebbeck, Timothy/0000-0002-4799-1900; Menkiszak, Janusz JM/0000-0001-8279-7196; Dolcetti, Riccardo/0000-0003-1625-9853; Blanco, Ignacio/0000-0002-7414-7481; Caligo, Adelaide Maria/0000-0003-0589-1829; Blanco, Ignacio/0000-0002-7414-7481; Gerdes, Anne-Marie/0000-0002-0328-3320; Spurdle, Amanda/0000-0003-1337-7897; Simard, Jacques/0000-0001-6906-3390; Joseph, Vijai/0000-0002-7933-151X; Senter, Leigha/0000-0001-9270-8847; Skytte, Anne-Bine/0000-0002-0067-9557; Eccles, Diana M/0000-0002-9935-3169; Kwong, Ava/0000-0002-6968-9489; Durocher, Francine/0000-0001-8012-4641; Rashid, Muhammad Usman/0000-0002-7684-3122; Darder Bernabeu, Esther/0000-0002-7764-1397; benitez, javier/0000-0002-0923-7202; Ganz, Patricia/0000-0002-1841-4143; Terry, Mary Beth/0000-0002-4106-5033; diez, orland/0000-0001-7339-0570; Sharma, Priyanka/0000-0001-8592-2239; Devilee, Peter/0000-0002-8023-2009; Kauff, Noah/0000-0001-7242-6156; Lubinski, Jan/0000-0003-2931-3003; Yannoukakos, Drakoulis/0000-0001-7509-3510; Thorne, Heather/0000-0003-3610-2511; Gille, Johan/0000-0003-4526-298X; Friebel, Tara/0000-0002-3726-9527; Damiola, Francesca/0000-0002-0238-1252; Houdayer, Claude/0000-0002-5190-0389; Bojesen, Anders/0000-0003-4289-8595; Engel, Christoph/0000-0002-7247-282X; Adlard, Julian/0000-0002-1693-0435; duran, Mercedes/0000-0002-6301-9732; Torres-Lopez, Diana Maria/0000-0002-9879-9775; Zlowocka-Perlowska, Elzbieta/0000-0002-5143-6387; Sand, Sharon/0000-0002-9390-5583; Peixoto, Ana/0000-0002-1404-5897; Foretova, Lenka/0000-0003-0494-2620; Evans, Gareth/0000-0002-8482-5784; Robson, Mark/0000-0002-3109-1692; Mazoyer, Sylvie/0000-0002-2135-0160; de la Hoya, Miguel/0000-0002-8113-1410; Gomez-Garcia, Encarna/0000-0003-4999-8847; Hutten, Christina/0000-0001-9957-5952; Eeles, Rosalind/0000-0002-3698-6241; van Rensburg, Elizabeth/0000-0003-2077-230X; Phillips, Kelly-Anne/0000-0002-0475-1771	Cancer Research UK; National Institutes of Health (NIH) [R01-CA083855, R01-CA102776, P50-CA083638]; Basser Research Center at the University of Pennsylvania; Breast Cancer Research Foundation; Rooney Family Foundation; NIH [R01-CA112520]; NATIONAL CANCER INSTITUTE [R01CA083855, P30CA016672, U01CA113916, U10CA037517, R01CA140323, P30CA051008, RC4CA153828, U01CA069631, R01CA112520, P30CA016520, P50CA116201, P50CA083638, U01CA116167, P50CA159981, U10CA180868, U10CA101165, R01CA074415, UM1CA164920, R01CA102776, U10CA180822, P30CA168524, U10CA027469, U01CA069398, U24CA196067] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; Cancer Research UK [15007, 11174, 17528, 16563] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10096] Funding Source: researchfish; National Breast Cancer Foundation [PRAC-13-04, IF-12-06] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basser Research Center at the University of Pennsylvania; Breast Cancer Research Foundation; Rooney Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); National Breast Cancer Foundation	Dr Antoniou and the CIMBA data management are funded by Cancer Research UK. Dr Easton is a Principal Research Fellow of Cancer Research UK. Dr Rebbeck is supported by R01-CA083855, R01-CA102776, and P50-CA083638 from the National Institutes of Health (NIH). Dr Rebbeck, Dr Nathanson, Ms Friebel, and Dr Domchek are supported by the Basser Research Center at the University of Pennsylvania. Dr Nathanson is supported by the Breast Cancer Research Foundation. Drs Domchek and Nathanson are supported by the Rooney Family Foundation. Dr Poppe is supported by R01-CA112520 from NIH. Cancer Research UK provided financial support for this work. Dr Antoniou is a Senior Cancer Research UK Cancer Research Fellow. Dr Phillips is a National Breast Cancer Foundation (Australia) Practitioner Fellow.	Anczukow O, 2008, HUM MUTAT, V29, P65, DOI 10.1002/humu.20590; Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Antoniou AC, 2007, AM J HUM GENET, V81, P1186, DOI 10.1086/522611; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bienstock RJ, 1996, CANCER RES, V56, P2539; Bignell G, 1997, HUM MOL GENET, V6, P53, DOI 10.1093/hmg/6.1.53; Borgan O., 2000, MODELING SURVIVAL DA, P169, DOI [10.1007/978-1-4757-3294-8, DOI 10.1007/978-1-4757-3294-8]; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buisson M, 2006, HUM MUTAT, V27, P1024, DOI 10.1002/humu.20384; Chenevix-Trench G, 2006, CANCER RES, V66, P2019, DOI 10.1158/0008-5472.CAN-05-3546; Chenevix-Trench G, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1670; Claes K, 2003, GENE CHROMOSOME CANC, V37, P314, DOI 10.1002/gcc.10221; Dine J, 2013, CANCER METAST REV, V32, P25, DOI 10.1007/s10555-012-9403-7; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Huyton T, 2000, MUTAT RES-DNA REPAIR, V460, P319, DOI 10.1016/S0921-8777(00)00034-3; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lubinski Jan, 2004, Fam Cancer, V3, P1; Ludwig T, 2001, GENE DEV, V15, P1188, DOI 10.1101/gad.879201; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Palacios IM, 2013, BRIEF FUNCT GENOMICS, V12, P25, DOI 10.1093/bfgp/els051; Perrin-Vidoz L, 2002, HUM MOL GENET, V11, P2805, DOI 10.1093/hmg/11.23.2805; Thompson D, 2002, CANCER EPIDEM BIOMAR, V11, P329; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Ware MD, 2006, ONCOGENE, V25, P323, DOI 10.1038/sj.onc.1209033; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837	33	298	310	5	94	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2015	313	13					1347	1361		10.1001/jama.2014.5985	http://dx.doi.org/10.1001/jama.2014.5985			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF1OL	25849179	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000352315900021
J	Renati, S; Raff, A; Burgin, S				Renati, Sruthi; Raff, Adam; Burgin, Susan			Painful Rash in a Patient With Bronchiectasis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHURG-STRAUSS-SYNDROME; TERM-FOLLOW-UP; POLYARTERITIS-NODOSA; POLYANGIITIS; COHORT		[Renati, Sruthi] Harvard Univ, Sch Med, Boston, MA USA; [Raff, Adam; Burgin, Susan] Beth Israel Deaconess Med Ctr, Dept Dermatol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Burgin, S (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.	sburgin@bidmc.harvard.edu						CHURG J, 1951, AM J PATHOL, V27, P277; Comarmond C, 2013, ARTHRITIS RHEUM-US, V65, P270, DOI 10.1002/art.37721; Gayraud M, 2001, ARTHRITIS RHEUM, V44, P666, DOI 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A; Guillevin L, 1996, MEDICINE, V75, P17, DOI 10.1097/00005792-199601000-00003; Guillevin L, 2011, MEDICINE, V90, P19, DOI 10.1097/MD.0b013e318205a4c6; Kawakami T, 2005, ARCH DERMATOL, V141, P873, DOI 10.1001/archderm.141.7.873; Ribi C, 2008, ARTHRITIS RHEUM-US, V58, P586, DOI 10.1002/art.23198; Sable-Fourtassou G, 2005, ANN INTERN MED, V143, P632, DOI 10.7326/0003-4819-143-9-200511010-00006; Sinico RA, 2009, BEST PRACT RES CL RH, V23, P355, DOI 10.1016/j.berh.2009.02.004	9	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2015	313	13					1366	1367		10.1001/jama.2015.0985	http://dx.doi.org/10.1001/jama.2015.0985			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF1OL	25849182				2022-12-28	WOS:000352315900024
J	Macilwain, C				Macilwain, Colin			Change the cancer conversation	NATURE			English	Editorial Material												cfnworldview@googlemail.com							0	7	7	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					7	7		10.1038/520007a	http://dx.doi.org/10.1038/520007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE7NE	25832371	Bronze			2022-12-28	WOS:000352027700010
J	Brody, H				Brody, Herb			Biomaterials	NATURE			English	Editorial Material																			0	10	10	4	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S1	S1		10.1038/519S1a	http://dx.doi.org/10.1038/519S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25806489	Bronze			2022-12-28	WOS:000351602800062
J	Loxterkamp, D				Loxterkamp, David			LETTER FROM NEW ENGLAND An inconvenient truth: urgent care is not primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Seaport Community Hlth Ctr, Belfast, ME 04915 USA		Loxterkamp, D (corresponding author), Seaport Community Hlth Ctr, Belfast, ME 04915 USA.	david.loxterkamp@gmail.com						Japsen B., 2013, FORBES MAGAZINE; PR Newswire, 2014, PR NEWSWIRE     1103; Ziobro P., 2014, WALL STREET J	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2015	350									10.1136/bmj.h1657	http://dx.doi.org/10.1136/bmj.h1657			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7OC	25813141				2022-12-28	WOS:000352030200012
J	Cole, TB				Cole, Thomas B.			Clown With Folded Arms Walt Kuhn	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHAGAS-DISEASE											[Anonymous], 2010, MMWR-MORBID MORTAL W, V61, P477; Bern C, 2009, CLIN INFECT DIS, V49, pE52, DOI 10.1086/605091; Garcia MN, 2015, AM J TROP MED HYG, V92, P325, DOI 10.4269/ajtmh.14-0238	3	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1192	1193		10.1001/jama.2014.11653	http://dx.doi.org/10.1001/jama.2014.11653			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25803330				2022-12-28	WOS:000351435500001
J	Holst, LB; Petersen, MW; Haase, N; Perner, A; Wetterslev, J				Holst, Lars B.; Petersen, Marie W.; Haase, Nicolai; Perner, Anders; Wetterslev, Jorn			Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PEDIATRIC CARDIAC-SURGERY; MYOCARDIAL-INFARCTION; HEMOGLOBIN THRESHOLD; PREMATURE-INFANTS; CLINICAL-PRACTICE; PRETERM INFANTS; MANAGEMENT; CARE; RISK; REQUIREMENTS	OBJECTIVE To compare the benefit and harm of restrictive versus liberal transfusion strategies to guide red blood cell transfusions. DESIGN Systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. DATA SOURCES Cochrane central register of controlled trials, SilverPlatter Medline (1950 to date), SilverPlatter Embase (1980 to date), and Science Citation Index Expanded (1900 to present). Reference lists of identified trials and other systematic reviews were assessed, and authors and experts in transfusion were contacted to identify additional trials. TRIAL SELECTION Published and unpublished randomised clinical trials that evaluated a restrictive compared with a liberal transfusion strategy in adults or children, irrespective of language, blinding procedure, publication status, or sample size. DATA EXTRACTION Two authors independently screened titles and abstracts of trials identified, and relevant trials were evaluated in full text for eligibility. Two reviewers then independently extracted data on methods, interventions, outcomes, and risk of bias from included trials. random effects models were used to estimate risk ratios and mean differences with 95% confidence intervals. RESULTS 31 trials totalling 9813 randomised patients were included. The proportion of patients receiving red blood cells (relative risk 0.54, 95% confidence interval 0.47 to 0.63, 8923 patients, 24 trials) and the number of red blood cell units transfused (mean difference -1.43, 95% confidence interval -2.01 to -0.86) were lower with the restrictive compared with liberal transfusion strategies. Restrictive compared with liberal transfusion strategies were not associated with risk of death (0.86, 0.74 to 1.01, 5707 patients, nine lower risk of bias trials), overall morbidity (0.98, 0.85 to 1.12, 4517 patients, six lower risk of bias trials), or fatal or non-fatal myocardial infarction (1.28, 0.66 to 2.49, 4730 patients, seven lower risk of bias trials). Results were not affected by the inclusion of trials with unclear or high risk of bias. Using trial sequential analyses on mortality and myocardial infarction, the required information size was not reached, but a 15% relative risk reduction or increase in overall morbidity with restrictive transfusion strategies could be excluded. CONCLUSIONS Compared with liberal strategies, restrictive transfusion strategies were associated with a reduction in the number of red blood cell units transfused and number of patients being transfused, but mortality, overall morbidity, and myocardial infarction seemed to be unaltered. Restrictive transfusion strategies are safe in most clinical settings. Liberal transfusion strategies have not been shown to convey any benefit to patients.	[Holst, Lars B.; Petersen, Marie W.; Haase, Nicolai; Perner, Anders] Rigshosp, Copenhagen Univ Hosp, Dept Intens Care 4131, DK-2100 Copenhagen, Denmark; [Wetterslev, Jorn] Rigshosp, Copenhagen Univ Hosp, Copenhagen Trial Unit, Ctr Clin Intervent Res 7812, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Holst, LB (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Intens Care 4131, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	lars.broksoe.holst@regionh.dk	Wetterslev, Jørn/ABF-1251-2020	Wetterslev, Jørn/0000-0001-7778-1771; Perner, Anders/0000-0002-4668-0123	Danish Strategic Research Council - Copenhagen University Hospital, Rigshospitalet [09-066938]	Danish Strategic Research Council - Copenhagen University Hospital, Rigshospitalet	This review was funded by the Danish Strategic Research Council (09-066938), supported by Copenhagen University Hospital, Rigshospitalet. The funders had no influence on the protocol, data analyses, or reporting.	Almeida J, 2013, CRIT CARE, V17, ps137, DOI [10.1186/cc11939, DOI 10.1186/CC11939]; Atilla E, 2011, VOX SANG, V101, P121; Bangalore S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2234; BERGAMIN F, 2014, CRIT CARE, V18, P112; BLAIR SD, 1986, BRIT J SURG, V73, P783, DOI 10.1002/bjs.1800731007; Bracey AW, 1999, TRANSFUSION, V39, P1070, DOI 10.1046/j.1537-2995.1999.39101070.x; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Brown CH, 2014, ANESTH ANALG, V119, P242, DOI 10.1213/ANE.0000000000000134; Bush RL, 1997, AM J SURG, V174, P143, DOI 10.1016/S0002-9610(97)00073-1; Carson JL, 2013, AM HEART J, V165, P964, DOI 10.1016/j.ahj.2013.03.001; Carson JL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub3; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Carson JL, 1998, TRANSFUSION, V38, P522, DOI 10.1046/j.1537-2995.1998.38698326331.x; Chatterjee S, 2013, JAMA INTERN MED, V173, P132, DOI 10.1001/2013.jamainternmed.1001; Chen HL, 2009, PEDIATR NEONATOL, V50, P110, DOI 10.1016/S1875-9572(09)60045-0; Cholette JM, 2011, PEDIATR CRIT CARE ME, V12, P39, DOI 10.1097/PCC.0b013e3181e329db; Colomo A, 2008, HEPATOLOGY, V48, p413A; Cooper HA, 2011, AM J CARDIOL, V108, P1108, DOI 10.1016/j.amjcard.2011.06.014; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Dawson N, 2014, EMERG MED J, V31, P207, DOI 10.1136/emermed-2012-202147; de Gast-Bakker DH, 2013, INTENS CARE MED, V39, P2011, DOI 10.1007/s00134-013-3085-7; DEMETS DL, 1987, STAT MED, V6, P341, DOI 10.1002/sim.4780060325; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; FISHER M R, 1956, Br J Clin Pract, V10, P770; FORTUNE JB, 1987, J TRAUMA, V27, P243, DOI 10.1097/00005373-198703000-00003; Foss NB, 2009, TRANSFUSION, V49, P227, DOI 10.1111/j.1537-2995.2008.01967.x; Franz AR, 2012, NEONATOLOGY, V101, P301, DOI 10.1159/000335030; Fredrickson LK, 2011, ARCH DIS CHILD-FETAL, V96, pF249, DOI 10.1136/adc.2010.191023; Gregersen M, 2012, EUR GERIATR MED SUPP, V3, pS74, DOI [10.1016/j.eurger.2012.07.139, DOI 10.1016/J.EURGER.2012.07.139]; Grover M, 2006, VOX SANG, V90, P105, DOI 10.1111/j.1423-0410.2006.00730.x; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; HEBERT PC, 1995, JAMA-J AM MED ASSOC, V273, P1439, DOI 10.1001/jama.273.18.1439; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; JOHNSON RG, 1992, J THORAC CARDIOV SUR, V104, P307; Karam O, 2011, PEDIATR CRIT CARE ME, V12, P512, DOI 10.1097/PCC.0b013e3181fe344b; Karkouti K, 2012, ANESTHESIOLOGY, V116, P613, DOI 10.1097/ALN.0b013e3182475e39; Kirpalani H, 2006, J PEDIATR-US, V149, P301, DOI 10.1016/j.jpeds.2006.05.011; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Lotke PA, 1999, J ARTHROPLASTY, V14, P647, DOI 10.1016/S0883-5403(99)90216-4; Mccoy TE, 2011, CHILD NEUROPSYCHOL, V17, P347, DOI 10.1080/09297049.2010.544647; Moher D, 2009, ANN INTERN MED, V151, P399; Nakamura R, 2014, CRIT CARE, V18, pP107; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b; Nopoulos PC, 2011, ARCH PEDIAT ADOL MED, V165, P443, DOI 10.1001/archpediatrics.2010.269; Olgun H, 2009, J PEDIAT HEMATOL ONC, V31, P843, DOI 10.1097/MPH.0b013e3181b27073; Parker MJ, 2013, INJURY, V44, P1916, DOI 10.1016/j.injury.2013.04.033; Pike K, 2011, TRIALS S1, V12, pA121; Prick BW, 2014, BJOG-INT J OBSTET GY, V121, P1005, DOI 10.1111/1471-0528.12531; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rohde JM, 2014, JAMA-J AM MED ASSOC, V311, P1317, DOI 10.1001/jama.2014.2726; Rosland RG, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-14; Rouette J, 2010, ANN SURG, V251, P421, DOI 10.1097/SLA.0b013e3181c5dc2e; Salpeter SR, 2014, AM J MED, V127, P124, DOI 10.1016/j.amjmed.2013.09.017; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Shehata N, 2012, TRANSFUSION, V52, P91, DOI 10.1111/j.1537-2995.2011.03236.x; So-Osman C, 2010, VOX SANG, V98, P56, DOI 10.1111/j.1423-0410.2009.01225.x; So-Osman C, 2014, ANESTHESIOLOGY, V120, P839, DOI 10.1097/ALN.0000000000000134; So-Osman C, 2014, ANESTHESIOLOGY, V120, P852, DOI 10.1097/ALN.0000000000000135; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Turner RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059202; VICHINSKY EP, 1995, NEW ENGL J MED, V333, P206, DOI 10.1056/NEJM199507273330402; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Walsh TS, 2013, CRIT CARE MED, V41, P2354, DOI 10.1097/CCM.0b013e318291cce4; Webert KE, 2008, TRANSFUSION, V48, P81, DOI 10.1111/j.1537-2995.2007.01485.x; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Whyte RK, 2009, PEDIATRICS, V123, P207, DOI 10.1542/peds.2008-0338; Willems A, 2010, CRIT CARE MED, V38, P649, DOI 10.1097/CCM.0b013e3181bc816c; Wu JF, 2011, INTENS CARE MED, V37, pS256; Zheng H, 2013, EXP THER MED, V5, P511, DOI 10.3892/etm.2012.834; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	77	276	280	1	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2015	350								h1354	10.1136/bmj.h1354	http://dx.doi.org/10.1136/bmj.h1354			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NO	25805204	Green Published, hybrid			2022-12-28	WOS:000352028800006
J	Comin, R; Sutarto, R; Neto, EHDS; Chauviere, L; Liang, R; Hardy, WN; Bonn, DA; He, F; Sawatzky, GA; Damascelli, A				Comin, R.; Sutarto, R.; Neto, E. H. da Silva; Chauviere, L.; Liang, R.; Hardy, W. N.; Bonn, D. A.; He, F.; Sawatzky, G. A.; Damascelli, A.			Broken translational and rotational symmetry via charge stripe order in underdoped YBa2Cu3O6+y	SCIENCE			English	Article							QUASI-PARTICLE STATES; FERMI-SURFACE; CRYSTAL-STATE; PSEUDOGAP; PHASE; SUPERCONDUCTIVITY; FLUCTUATIONS	After the discovery of stripelike order in lanthanum-based copper oxide superconductors, charge-ordering instabilities were observed in all cuprate families. However, it has proven difficult to distinguish between unidirectional (stripes) and bidirectional (checkerboard) charge order in yttrium-and bismuth-based materials. We used resonant x-ray scattering to measure the two-dimensional structure factor in the superconductor YBa2Cu3O6+y in reciprocal space. Our data reveal the presence of charge stripe order (i.e., locally unidirectional density waves), which may represent the true microscopic nature of charge modulation in cuprates. At the same time, we find that the well-established competition between charge order and superconductivity is stronger for charge correlations across the stripes than along them, which provides additional evidence for the intrinsic unidirectional nature of the charge order.	[Comin, R.; Neto, E. H. da Silva; Chauviere, L.; Liang, R.; Hardy, W. N.; Bonn, D. A.; Sawatzky, G. A.; Damascelli, A.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Comin, R.; Neto, E. H. da Silva; Chauviere, L.; Liang, R.; Hardy, W. N.; Bonn, D. A.; Sawatzky, G. A.; Damascelli, A.] Univ British Columbia, Quantum Matter Inst, Vancouver, BC V6T 1Z4, Canada; [Sutarto, R.; He, F.] Canadian Light Source, Saskatoon, SK S7N 2V3, Canada; [Neto, E. H. da Silva] Canadian Inst Adv Res, Quantum Mat Program, Toronto, ON M5G 1Z8, Canada; [Neto, E. H. da Silva; Chauviere, L.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany	University of British Columbia; University of British Columbia; University of Saskatchewan; Canadian Institute for Advanced Research (CIFAR); Max Planck Society	Comin, R (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada.	r.comin@utoronto.ca; damascelli@physics.ubc.ca	damascelli, andrea/P-6329-2014; He, Feizhou/G-8493-2015; Hardy, Walter Newbold/AAN-7827-2020; Comin, Riccardo/H-7731-2016	damascelli, andrea/0000-0001-9895-2226; He, Feizhou/0000-0002-3125-1406; Comin, Riccardo/0000-0002-1069-9973; da Silva Neto, Eduardo/0000-0001-6902-6100	Max Planck-UBC Centre for Quantum Materials; Killam Foundation; Alfred P. Sloan Foundation; Alexander von Humboldt Foundation; Natural Sciences and Engineering Research Council (NSERC); Canada Research Chairs Program; NSERC; CFI; CIFAR Quantum Materials; NRC; CIHR; Government of Saskatchewan; WD Canada; University of Saskatchewan; CLS Graduate Student Travel Support Program; CIFAR Global Academy	Max Planck-UBC Centre for Quantum Materials; Killam Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFI(Canada Foundation for Innovation); CIFAR Quantum Materials; NRC(National Research Centre (NRC)); CIHR(Canadian Institutes of Health Research (CIHR)); Government of Saskatchewan; WD Canada; University of Saskatchewan; CLS Graduate Student Travel Support Program; CIFAR Global Academy	We thank P. Abbamonte, E. Blackburn, L. Braicovich, J. Geck, G. Ghiringhelli, B. Keimer, S. Kivelson, M. Le Tacon, and S. Sachdev for insightful discussions. Supported by the Max Planck-UBC Centre for Quantum Materials, fellowships from the Killam, Alfred P. Sloan, and Alexander von Humboldt Foundations, and a Natural Sciences and Engineering Research Council (NSERC) Steacie Memorial Fellowship (A.D.); the Canada Research Chairs Program (A.D., G.A.S.); and NSERC, CFI, and CIFAR Quantum Materials. All of the experiments were performed at beamline REIXS of the Canadian Light Source, which is funded by the CFI, NSERC, NRC, CIHR, the Government of Saskatchewan, WD Canada, and the University of Saskatchewan. R.C. acknowledges the receipt of support from the CLS Graduate Student Travel Support Program. E.H.d.S.N. acknowledges support from the CIFAR Global Academy.	Abbamonte P, 2005, NAT PHYS, V1, P155, DOI 10.1038/nphys178; Achkar AJ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.017001; Achkar AJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.167001; Blackburn E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.137004; Blanco-Canosa S, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.054513; Blanco-Canosa S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.187001; Comin R, 2014, SCIENCE, V343, P390, DOI 10.1126/science.1242996; Cyr-Choiniere O, 2009, NATURE, V458, P743, DOI 10.1038/nature07931; Neto EHD, 2014, SCIENCE, V343, P393, DOI 10.1126/science.1243479; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Fournier D, 2010, NAT PHYS, V6, P905, DOI [10.1038/NPHYS1763, 10.1038/nphys1763]; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Hanaguri T, 2004, NATURE, V430, P1001, DOI 10.1038/nature02861; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Hinkov V, 2004, NATURE, V430, P650, DOI 10.1038/nature02774; Hinton JP, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.060508; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; Hossain MA, 2008, NAT PHYS, V4, P527, DOI 10.1038/nphys998; Howald C, 2003, P NATL ACAD SCI USA, V100, P9705, DOI 10.1073/pnas.1233768100; Laliberte F, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1440; LeBoeuf D, 2007, NATURE, V450, P533, DOI 10.1038/nature06332; LeBoeuf D, 2013, NAT PHYS, V9, P79, DOI 10.1038/nphys2502; Lubashevsky Y, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.147001; Meingast C, 2001, PHYS REV LETT, V86, P1606, DOI 10.1103/PhysRevLett.86.1606; Parker CV, 2010, NATURE, V468, P677, DOI 10.1038/nature09597; Ramshaw BJ, 2011, NAT PHYS, V7, P234, DOI [10.1038/nphys1873, 10.1038/NPHYS1873]; Tabis W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6875; Torchinsky DH, 2013, NAT MATER, V12, P387, DOI [10.1038/NMAT3571, 10.1038/nmat3571]; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Wise WD, 2008, NAT PHYS, V4, P696, DOI 10.1038/nphys1021; Wu T, 2011, NATURE, V477, P191, DOI 10.1038/nature10345; Zimmermann M., 1998, EPL-EUROPHYS LETT, V41, P629	36	134	136	6	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1335	1339		10.1126/science.1258399	http://dx.doi.org/10.1126/science.1258399			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792325	Green Submitted			2022-12-28	WOS:000351219600034
J	Ocampo, A; Belmonte, JCI				Ocampo, Alejandro; Belmonte, Juan Carlos Izpisua			Holding your breath for longevity	SCIENCE			English	Editorial Material							PROGENITOR CELLS; STEM-CELLS; REJUVENATION; SWITCH; MUSCLE		[Ocampo, Alejandro; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Ocampo, A (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu		Ocampo, Alejandro/0000-0002-3731-3647	NATIONAL INSTITUTE ON AGING [F32AG047770] Funding Source: NIH RePORTER; NIA NIH HHS [F32 AG047770] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Rimmele P, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.04.015; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ryu D, 2014, CELL METAB, V20, P856, DOI 10.1016/j.cmet.2014.08.001; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005	13	11	11	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1319	1320		10.1126/science.aaa9608	http://dx.doi.org/10.1126/science.aaa9608			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792319	Green Accepted			2022-12-28	WOS:000351219600024
J	Qiu, HB; Hudson, ZM; Winnik, MA; Manners, I				Qiu, Huibin; Hudson, Zachary M.; Winnik, Mitchell A.; Manners, Ian			Multidimensional hierarchical self-assembly of amphiphilic cylindrical block comicelles	SCIENCE			English	Article							CO-MICELLES; DIBLOCK COPOLYMERS; NANOPARTICLES; NANOSTRUCTURES; POLYMERIZATION; ARCHITECTURES; UNIFORM; GROWTH; LENGTH	Self-assembly of molecular and block copolymer amphiphiles represents a well-established route to micelles with a wide variety of shapes and gel-like phases. We demonstrate an analogous process, but on a longer length scale, in which amphiphilic P-H-P and H-P-H cylindrical triblock comicelles with hydrophobic (H) or polar (P) segments that are monodisperse in length are able to self-assemble side by side or end to end in nonsolvents for the central or terminal segments, respectively. This allows the formation of cylindrical supermicelles and one-dimensional (1D) or 3D superstructures that persist in both solution and the solid state. These assemblies possess multiple levels of structural hierarchy in combination with existence on a multimicrometer-length scale, features that are generally only found in natural materials.	[Qiu, Huibin; Hudson, Zachary M.; Manners, Ian] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Winnik, Mitchell A.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada	University of Bristol; University of Toronto	Manners, I (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	mwinnik@chem.utoronto.ca; ian.manners@bristol.ac.uk	Qiu, Huibin/AAB-1319-2019; Qiu, Huibin/B-1663-2013; Hudson, Zachary/I-8452-2012; Winnik, Mitchell A/R-8621-2018	Qiu, Huibin/0000-0002-4699-6558; Qiu, Huibin/0000-0002-4699-6558; Hudson, Zachary/0000-0002-8033-4136; 	European Union (EU); European Research Council (ERC); EU; Natural Sciences and Engineering Research Council of Canada	European Union (EU)(CGIAREuropean Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); EU(European Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	H.Q. acknowledges the European Union (EU) for a Marie Curie Postdoctoral Fellowship and the European Research Council (ERC) for a Postdoctoral Fellowship. Z.M.H. is grateful to the EU for a Marie Curie Postdoctoral Fellowship. I.M. thanks the EU for an ERC Advanced Investigator Grant. M.A.W. thanks the Natural Sciences and Engineering Research Council of Canada for financial support. The authors also thank J. Mantell and A. Leard (Wolfson Bioimaging Facility, University of Bristol) for TEM, CLSM, and optical microscopy imaging and tomography analysis. H.Q. and I.M. conceived the project, and H.Q. performed the experiments. Z.M.H. prepared the fluorescent PFS block copolymers. H.Q., Z.M. H, and I.M. prepared the manuscript with input from M.A.W. The project was supervised by I.M., with input from M.A.W.	Chen Q, 2011, NATURE, V469, P381, DOI 10.1038/nature09713; Chen Q, 2011, SCIENCE, V331, P199, DOI 10.1126/science.1197451; Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768; Dupont J, 2010, SOFT MATTER, V6, P3654, DOI 10.1039/c0sm00044b; Gilroy JB, 2010, NAT CHEM, V2, P566, DOI [10.1038/NCHEM.664, 10.1038/nchem.664]; Groschel AH, 2013, NATURE, V503, P247, DOI 10.1038/nature12610; Lee IH, 2013, J AM CHEM SOC, V135, P17695, DOI 10.1021/ja409206p; Li F, 2011, ANGEW CHEM INT EDIT, V50, P360, DOI 10.1002/anie.201001451; Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350; Liu K, 2010, SCIENCE, V329, P197, DOI 10.1126/science.1189457; Miszta K, 2011, NAT MATER, V10, P872, DOI [10.1038/NMAT3121, 10.1038/nmat3121]; Myers D., 2005, SURFACTANT SCI TECHN; Nie ZH, 2007, NAT MATER, V6, P609, DOI 10.1038/nmat1954; O'Reilly RK, 2006, CHEM SOC REV, V35, P1068, DOI 10.1039/b514858h; Qian JS, 2014, J AM CHEM SOC, V136, P4121, DOI 10.1021/ja500661k; Qian J, 2013, ACS NANO, V7, P3754, DOI 10.1021/nn400124x; Qiu HB, 2013, J AM CHEM SOC, V135, P17739, DOI 10.1021/ja410176n; Qiu HB, 2012, ANGEW CHEM INT EDIT, V51, P11882, DOI 10.1002/anie.201205764; Quan ZW, 2010, NANO TODAY, V5, P390, DOI 10.1016/j.nantod.2010.08.011; Rupar PA, 2012, SCIENCE, V337, P559, DOI 10.1126/science.1221206; Schmelz J, 2012, J AM CHEM SOC, V134, P14217, DOI 10.1021/ja306264d; Sun L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6746; Walther A, 2013, CHEM REV, V113, P5194, DOI 10.1021/cr300089t; Walther A, 2009, J AM CHEM SOC, V131, P4720, DOI 10.1021/ja808614q; Wang JY, 2012, J AM CHEM SOC, V134, P5801, DOI 10.1021/ja2066187; Wang T, 2012, SCIENCE, V338, P358, DOI 10.1126/science.1224221; Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382; Yan XH, 2004, J AM CHEM SOC, V126, P10059, DOI 10.1021/ja0479890; Yoon KY, 2012, J AM CHEM SOC, V134, P14291, DOI 10.1021/ja305150c; Zhang W, 2011, SCIENCE, V334, P340, DOI 10.1126/science.1210369	31	379	384	17	704	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1329	1332		10.1126/science.1261816	http://dx.doi.org/10.1126/science.1261816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792323	Green Submitted			2022-12-28	WOS:000351219600032
J	Scheffer, M; Barrett, S; Carpenter, SR; Folke, C; Green, AJ; Holmgren, M; Hughes, TP; Kosten, S; van de Leemput, IA; Nepstad, DC; van Nes, EH; Peeters, ETHM; Walker, B				Scheffer, M.; Barrett, S.; Carpenter, S. R.; Folke, C.; Green, A. J.; Holmgren, M.; Hughes, T. P.; Kosten, S.; van de Leemput, I. A.; Nepstad, D. C.; van Nes, E. H.; Peeters, E. T. H. M.; Walker, B.			Creating a safe operating space for iconic ecosystems	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; CORAL-REEFS; DEFORESTATION; RESILIENCE; IMPACTS; AMAZON; SHIFTS; FIRE		[Scheffer, M.; van de Leemput, I. A.; van Nes, E. H.; Peeters, E. T. H. M.] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AA Wageningen, Netherlands; [Barrett, S.] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA; [Carpenter, S. R.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Folke, C.] Stockholm Univ, Royal Swedish Acad Sci, Beijer Inst Ecol Econ, SE-10405 Stockholm, Sweden; [Folke, C.] Stockholm Univ, Stockholm Resilience Ctr, SE-10405 Stockholm, Sweden; [Green, A. J.] CSIC, EBD, E-41080 Seville, Spain; [Holmgren, M.] Wageningen Univ, Resource Ecol Grp, NL-6700 AA Wageningen, Netherlands; [Hughes, T. P.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Kosten, S.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Aquat Ecol & Environm Biol, NL-6525 AJ Nijmegen, Netherlands; [Nepstad, D. C.] Earth Innovat Inst, San Francisco, CA 94110 USA; [Walker, B.] CSIRO Land & Water, Canberra, ACT 2601, Australia	Wageningen University & Research; Columbia University; University of Wisconsin System; University of Wisconsin Madison; Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics; Stockholm University; Stockholm University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Wageningen University & Research; James Cook University; Radboud University Nijmegen; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Scheffer, M (corresponding author), Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AA Wageningen, Netherlands.	marten.scheffer@wur.nl	Folke, Carl/Z-1545-2019; Green, Andy J/A-5189-2008; Carpenter, Stephen/AAQ-6404-2020; van Nes, Egbert H/F-2681-2011; Kosten, Sarian/D-7550-2011; Hughes, Terry/L-4721-2013	Green, Andy J/0000-0002-1268-4951; Kosten, Sarian/0000-0003-2031-0965; Hughes, Terry/0000-0002-5257-5063; van Nes, Egbert/0000-0002-6345-104X; Folke, Carl/0000-0002-4050-3281; Carpenter, Stephen/0000-0001-8097-8700; Peeters, Edwin T.H.M./0000-0003-2541-1829	European Research Council; Spinoza award; Stellenbosch Institute for Advanced Study; NSF; WIMEK research fellowship; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [86312012]	European Research Council(European Research Council (ERC)European Commission); Spinoza award; Stellenbosch Institute for Advanced Study; NSF(National Science Foundation (NSF)); WIMEK research fellowship; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO))	M.S. is supported by a European Research Council advanced grant and Spinoza award. C.F. is supported by the Stellenbosch Institute for Advanced Study. S.R.C.'s research is supported by NSF. A.J.G. was supported by a WIMEK research fellowship and S.K. by Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Veni grant 86312012. M.S., C.F., and S.R.C. are also at the South American Institute for Resilience and Sustainability Studies. This work was carried out under the program of the Netherlands Earth System Science Centre (NESSC).	[Anonymous], 2014, GREAT BARR REET MAR; Barrett S, 2014, NAT CLIM CHANGE, V4, P36, DOI [10.1038/nclimate2059, 10.1038/NCLIMATE2059]; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Feeley KJ, 2007, ECOL LETT, V10, P461, DOI 10.1111/j.1461-0248.2007.01033.x; Feinberg M, 2011, PSYCHOL SCI, V22, P34, DOI 10.1177/0956797610391911; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; Guardiola-Albert C, 2011, WETLANDS, V31, P907, DOI 10.1007/s13157-011-0205-4; Holmgren M, 2013, NAT CLIM CHANGE, V3, P755, DOI [10.1038/nclimate1906, 10.1038/NCLIMATE1906]; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kelly RP, 2011, SCIENCE, V332, P1036, DOI 10.1126/science.1203815; Kosten S, 2012, GLOBAL CHANGE BIOL, V18, P118, DOI 10.1111/j.1365-2486.2011.02488.x; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Moss B, 2011, INLAND WATERS, V1, P101, DOI 10.5268/IW-1.2.359; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Normile D, 2014, SCIENCE, V346, P683, DOI 10.1126/science.346.6210.683; Oreskes N., 2010, MERCHANTS DOUBT; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Rockstrom J, 2009, ECOL SOC, V14; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000	21	162	167	1	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1317	1319		10.1126/science.aaa3769	http://dx.doi.org/10.1126/science.aaa3769			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792318	Green Submitted			2022-12-28	WOS:000351219600023
J	Boyd, R				Boyd, Robert			Charles H. Townes (1915-2015)	NATURE			English	Biographical-Item									[Boyd, Robert] Univ Ottawa, Quantum Nonlinear Opt, Ottawa, ON K1N 6N5, Canada; [Boyd, Robert] Univ Rochester, Opt & Phys, New York, NY USA	University of Ottawa; University of Rochester	Boyd, R (corresponding author), Univ Ottawa, Quantum Nonlinear Opt, Ottawa, ON K1N 6N5, Canada.	boydrw@mac.com						TOWNES CH, PUBLICATION LIST	1	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					292	292		10.1038/519292a	http://dx.doi.org/10.1038/519292a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25788091	Bronze			2022-12-28	WOS:000351171900024
J	Seydel, KB; Kampondeni, SD; Valim, C; Potchen, MJ; Milner, DA; Muwalo, FW; Birbeck, GL; Bradley, WG; Fox, LL; Glover, SJ; Hammond, CA; Heyderman, RS; Chilingulo, CA; Molyneux, ME; Taylor, TE				Seydel, Karl B.; Kampondeni, Samuel D.; Valim, Clarissa; Potchen, Michael J.; Milner, Danny A.; Muwalo, Francis W.; Birbeck, Gretchen L.; Bradley, William G.; Fox, Lindsay L.; Glover, Simon J.; Hammond, Colleen A.; Heyderman, Robert S.; Chilingulo, Cowles A.; Molyneux, Malcolm E.; Taylor, Terrie E.			Brain Swelling and Death in Children with Cerebral Malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FALCIPARUM-MALARIA; CONTINUOUS EEG; ACTIVATION; COAGULATION; SEQUESTRATION; INFLAMMATION; PATTERNS	BACKGROUND Case fatality rates among African children with cerebral malaria remain in the range of 15 to 25%. The key pathogenetic processes and causes of death are unknown, but a combination of clinical observations and pathological findings suggests that increased brain volume leading to raised intracranial pressure may play a role. Magnetic resonance imaging (MRI) became available in Malawi in 2009, and we used it to investigate the role of brain swelling in the pathogenesis of fatal cerebral malaria in African children. METHODS We enrolled children who met a stringent definition of cerebral malaria (one that included the presence of retinopathy), characterized them in detail clinically, and obtained MRI scans on admission and daily thereafter while coma persisted. RESULTS Of 348 children admitted with cerebral malaria (as defined by the World Health Organization), 168 met the inclusion criteria, underwent all investigations, and were included in the analysis. A total of 25 children (15%) died, 21 of whom (84%) had evidence of severe brain swelling on MRI at admission. In contrast, evidence of severe brain swelling was seen on MRI in 39 of 143 survivors (27%). Serial MRI scans showed evidence of decreasing brain volume in the survivors who had had brain swelling initially. CONCLUSIONS Increased brain volume was seen in children who died from cerebral malaria but was uncommon in those who did not die from the disease, a finding that suggests that raised intracranial pressure may contribute to a fatal outcome. The natural history indicates that increased intracranial pressure is transient in survivors.	[Seydel, Karl B.; Fox, Lindsay L.; Taylor, Terrie E.] Michigan State Univ, Dept Osteopath Med Specialties, Coll Osteopath Med, E Lansing, MI 48824 USA; [Potchen, Michael J.; Hammond, Colleen A.] Michigan State Univ, Dept Radiol, E Lansing, MI 48824 USA; [Birbeck, Gretchen L.] Michigan State Univ, Dept Neurol & Ophthal, Int Neurol & Psychiat Epidemiol Program, E Lansing, MI 48824 USA; [Seydel, Karl B.; Kampondeni, Samuel D.; Milner, Danny A.; Muwalo, Francis W.; Fox, Lindsay L.; Taylor, Terrie E.] Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; [Heyderman, Robert S.; Molyneux, Malcolm E.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Kampondeni, Samuel D.; Chilingulo, Cowles A.] Univ Malawi, Coll Med, Queen Elizabeth Cent Hosp, Blantyre, Malawi; [Glover, Simon J.] Univ Malawi, Coll Med, Dept Anat, Blantyre, Malawi; [Valim, Clarissa; Milner, Danny A.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Milner, Danny A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bradley, William G.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Molyneux, Malcolm E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Michigan State University; Michigan State University College of Osteopathic Medicine; Michigan State University; Michigan State University; University of Malawi; University of Malawi; University of Malawi; University of Malawi; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Diego; Liverpool School of Tropical Medicine; University of Liverpool	Taylor, TE (corresponding author), Michigan State Univ, W Fee Hall,909 Fee Rd,Rm B305-B, E Lansing, MI 48824 USA.	ttmalawi@msu.edu	Milner, Danny/K-3568-2019	Potchen, Michael/0000-0002-2603-9355; Heyderman, Robert/0000-0003-4573-449X; Milner, Jr, Danny Arnold/0000-0002-6685-8208	National Institutes of Health; Wellcome Trust U.K.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust U.K.(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health and Wellcome Trust U.K.	Barrow G.I., 1993, COWAN STEELS MANUAL, V3rd; Bauer G, 2013, J CLIN NEUROPHYSIOL, V30, P477, DOI 10.1097/WNP.0b013e3182a73e47; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beare NAV, 2011, FUTURE MICROBIOL, V6, P349, DOI [10.2217/fmb.11.3, 10.2217/FMB.11.3]; Beare NAV, 2009, J INFECT DIS, V199, P263, DOI 10.1086/595735; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; CLARK IA, 1995, J INFECT DIS, V171, P1068, DOI 10.1093/infdis/171.4.1068; CLARK IA, 1993, Q J MED, V86, P217; CLEMENS R, 1994, BRIT J HAEMATOL, V87, P100, DOI 10.1111/j.1365-2141.1994.tb04877.x; Crepeau AZ, 2013, NEUROLOGY, V80, P339, DOI 10.1212/WNL.0b013e31827f089d; Dondorp AM, 2008, CLIN INFECT DIS, V47, P151, DOI 10.1086/589287; Dorovini-Zis K, 2011, AM J PATHOL, V178, P2146, DOI 10.1016/j.ajpath.2011.01.016; ELHASSAN IM, 1994, AM J TROP MED HYG, V51, P372, DOI 10.4269/ajtmh.1994.51.372; Enwere G, 2005, TROP MED INT HEALTH, V10, P1171, DOI 10.1111/j.1365-3156.2005.01505.x; Faiz MA, 2005, LANCET, V366, P717; Fingelkurts AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025967; Hawkes M, 2013, VIRULENCE, V4, P543, DOI 10.4161/viru.25949; HEMMER CJ, 1991, AM J MED, V91, P37, DOI 10.1016/0002-9343(91)90071-5; Hirsch LJ, 2005, J CLIN NEUROPHYSIOL, V22, P128, DOI 10.1097/01.WNP.0000158701.89576.4C; Jimmy EO, 2003, ANN TROP MED PARASIT, V97, P879, DOI 10.1179/000349803225002426; Lewallen S, 2008, T ROY SOC TROP MED H, V102, P1089, DOI 10.1016/j.trstmh.2008.06.014; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MEDER JF, 1994, J NEURORADIOLOGY, V21, P118; Milner DA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00104; Mohanty D, 1997, AM J HEMATOL, V54, P23, DOI 10.1002/(SICI)1096-8652(199701)54:1&lt;23::AID-AJH4&gt;3.0.CO;2-6; Moxon CA, 2013, BLOOD, V122, P842, DOI 10.1182/blood-2013-03-490219; NEWTON CRJC, 1994, ARCH DIS CHILD, V70, P281, DOI 10.1136/adc.70.4.281; NEWTON CRJC, 1991, LANCET, V337, P573, DOI 10.1016/0140-6736(91)91638-B; Newton CRJC, 1997, ARCH DIS CHILD, V76, P219, DOI 10.1136/adc.76.3.219; Oemichem M, 2006, FORENSIC NEUROPATHOL; Ponsford MJ, 2012, J INFECT DIS, V205, P663, DOI 10.1093/infdis/jir812; Potchen MJ, 2012, AM J NEURORADIOL, V33, P1740, DOI 10.3174/ajnr.A3035; Potchen MJ, 2013, NEUROLOGY, V81, P585, DOI 10.1212/WNL.0b013e31829e6ed5; PROHOVNIK I, 1989, NEUROLOGY, V39, P344, DOI 10.1212/WNL.39.3.344; RDCT, 2011, R LANG ENV STAT COMP; Romano Andrea, 2003, Radiol Med, V106, P521; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Taylor Terrie E, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS6, DOI 10.1016/j.trstmh.2008.10.049; Teksam M, 2008, AM J NEURORADIOL, V29, P1961, DOI 10.3174/ajnr.A1246; Turner GDH, 1998, AM J PATHOL, V152, P1477; WHITE NJ, 1985, LANCET, V1, P776; WHO, 2013, WORLD MALARIA REPORT 2013, P1	42	213	215	2	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2015	372	12					1126	1137		10.1056/NEJMoa1400116	http://dx.doi.org/10.1056/NEJMoa1400116			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EZ	25785970	Green Published, Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000351183600007
J	Romeo, GR; Abrahamson, MJ				Romeo, Giulio R.; Abrahamson, Martin J.			The 2015 Standards for Diabetes Care: Maintaining a Patient-Centered Approach	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISK		Joslin Diabet Ctr, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Abrahamson, MJ (corresponding author), Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	martin.abrahamson@joslin.harvard.edu						Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; [Anonymous], 2015, DIABETES CARE, V38, pS5, DOI 10.2337/dc15-S004; D'Agostino Ralph B Sr, 2014, N Engl J Med, V370, P1652, DOI 10.1056/NEJMclde1314766; Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Nathan DM, 2013, DIABETES CARE, V36, P2254, DOI 10.2337/dc13-0356; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Wright JT, 2014, ANN INTERN MED, V160, P499, DOI 10.7326/M13-2981	10	10	10	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2015	162	11					785	786		10.7326/M15-0385	http://dx.doi.org/10.7326/M15-0385			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ5ZH	25798733				2022-12-28	WOS:000355572300006
J	Gillinov, AM; Gelijns, AC; Parides, MK; DeRose, JJ; Moskowitz, AJ; Voisine, P; Ailawadi, G; Bouchard, D; Smith, PK; Mack, MJ; Acker, MA; Mullen, JC; Rose, EA; Chang, HL; Puskas, JD; Couderc, JP; Gardner, TJ; Varghese, R; Horvath, KA; Bolling, SF; Michler, RE; Geller, NL; Ascheim, DD; Miller, MA; Bagiella, E; Moquete, EG; Williams, P; Taddei-Peters, WC; O'Gara, PT; Blackstone, EH; Argenziano, M				Gillinov, A. Marc; Gelijns, Annetine C.; Parides, Michael K.; DeRose, Joseph J., Jr.; Moskowitz, Alan J.; Voisine, Pierre; Ailawadi, Gorav; Bouchard, Denis; Smith, Peter K.; Mack, Michael J.; Acker, Michael A.; Mullen, John C.; Rose, Eric A.; Chang, Helena L.; Puskas, John D.; Couderc, Jean-Philippe; Gardner, Timothy J.; Varghese, Robin; Horvath, Keith A.; Bolling, Steven F.; Michler, Robert E.; Geller, Nancy L.; Ascheim, Deborah D.; Miller, Marissa A.; Bagiella, Emilia; Moquete, Ellen G.; Williams, Paula; Taddei-Peters, Wendy C.; O'Gara, Patrick T.; Blackstone, Eugene H.; Argenziano, Michael		CTSN Investigators	Surgical Ablation of Atrial Fibrillation during Mitral-Valve Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RADIOFREQUENCY ABLATION; CONSENSUS-STATEMENT; CARDIAC-SURGERY; FOLLOW-UP; MAZE; APPENDAGE; CLOSURE; DISEASE; STROKE	Background Among patients undergoing mitral-valve surgery, 30 to 50% present with atrial fibrillation, which is associated with reduced survival and increased risk of stroke. Surgical ablation of atrial fibrillation has been widely adopted, but evidence regarding its safety and effectiveness is limited. Methods We randomly assigned 260 patients with persistent or long-standing persistent atrial fibrillation who required mitral-valve surgery to undergo either surgical ablation (ablation group) or no ablation (control group) during the mitral-valve operation. Patients in the ablation group underwent further randomization to pulmonary-vein isolation or a biatrial maze procedure. All patients underwent closure of the left atrial appendage. The primary end point was freedom from atrial fibrillation at both 6 months and 12 months (as assessed by means of 3-day Holter monitoring). Results More patients in the ablation group than in the control group were free from atrial fibrillation at both 6 and 12 months (63.2% vs. 29.4%, P< 0.001). There was no significant difference in the rate of freedom from atrial fibrillation between patients who underwent pulmonary-vein isolation and those who underwent the biatrial maze procedure (61.0% and 66.0%, respectively; P = 0.60). One-year mortality was 6.8% in the ablation group and 8.7% in the control group (hazard ratio with ablation, 0.76; 95% confidence interval, 0.32 to 1.84; P = 0.55). Ablation was associated with more implantations of a permanent pacemaker than was no ablation (21.5 vs. 8.1 per 100 patient-years, P = 0.01). There were no significant between-group differences in major cardiac or cerebrovascular adverse events, overall serious adverse events, or hospital readmissions. Conclusions The addition of atrial fibrillation ablation to mitral-valve surgery significantly increased the rate of freedom from atrial fibrillation at 1 year among patients with persistent or long-standing persistent atrial fibrillation, but the risk of implantation of a permanent pacemaker was also increased.	[Gillinov, A. Marc; Blackstone, Eugene H.] Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA; [Gelijns, Annetine C.; Parides, Michael K.; Moskowitz, Alan J.; Chang, Helena L.; Ascheim, Deborah D.; Bagiella, Emilia; Moquete, Ellen G.; Williams, Paula] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Int Ctr Hlth Outcomes & Innovat Res, New York, NY 10029 USA; [DeRose, Joseph J., Jr.; Michler, Robert E.] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Cardiothorac Surg, New York, NY USA; [Rose, Eric A.; Puskas, John D.; Varghese, Robin] Mt Sinai Hlth Syst, Dept Cardiac Surg, New York, NY USA; [Argenziano, Michael] Columbia Univ Coll Phys & Surg, Dept Surg, Div Cardiothorac Surg, New York, NY 10032 USA; [Couderc, Jean-Philippe] Univ Rochester, Med Ctr, Dept Cardiol, Heart Res Follow Up Program, Rochester, NY 14642 USA; [Voisine, Pierre] Hop Laval, Inst Univ Cardiol Quebec, Quebec City, PQ, Canada; [Bouchard, Denis] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Mullen, John C.] Univ Alberta, Div Cardiac Surg, Edmonton, AB, Canada; [Ailawadi, Gorav] Univ Virginia, Sch Med, Div Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA; [Smith, Peter K.] Duke Univ, Med Ctr, Dept Surg, Div Cardiovasc & Thorac Surg, Durham, NC 27710 USA; [Mack, Michael J.] Baylor Hlth Care Syst, Baylor Res Inst, Div Cardiothorac Surg, Plano, TX USA; [Acker, Michael A.] Univ Penn, Sch Med, Dept Surg, Div Cardiovasc Surg, Philadelphia, PA 19104 USA; [Gardner, Timothy J.] Christiana Care Hlth Syst, Ctr Heart & Vasc Hlth, Newark, DE USA; [Horvath, Keith A.] Suburban Hosp, Ctr Heart, NIH, Dept Cardiothorac Surg, Bethesda, MD USA; [Geller, Nancy L.] NHLBI, Off Biostat Res, Bethesda, MD 20892 USA; [Miller, Marissa A.; Taddei-Peters, Wendy C.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Bolling, Steven F.] Univ Michigan Hlth Syst, Dept Cardiac Surg, Ann Arbor, MI USA; [O'Gara, Patrick T.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Cleveland Clinic Foundation; Icahn School of Medicine at Mount Sinai; Montefiore Medical Center; Yeshiva University; Icahn School of Medicine at Mount Sinai; Columbia University; University of Rochester; Laval University; Universite de Montreal; University of Alberta; University of Virginia; Duke University; Baylor Health Care System; Baylor Scott & White Health; Baylor University Medical Center; University of Pennsylvania; Christiana Care Health System; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital	Gelijns, AC (corresponding author), Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, 1 Gustave L Levy Pl,Box 1077, New York, NY 10029 USA.	annetine.gelijns@mssm.edu	Parides, Michael/GON-8474-2022; Rose, Eric/AAJ-2281-2020; Mullen, John/M-7705-2019	Moskowitz, Alan/0000-0002-4412-9450; Holubkov, Richard/0000-0003-0431-3381	National Institutes of Health; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL088939, UM1HL088955, U01HL088942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Institutes of Health and the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00903370.	Abreu CAC, 2005, CIRCULATION, V112, pI20, DOI 10.1161/CIRCULATIONAHA.104.526301; Ad N, 2013, CURR OPIN CARDIOL, V28, P170, DOI 10.1097/HCO.0b013e32835ced9c; Ad N, 2012, J THORAC CARDIOV SUR, V144, P1051, DOI 10.1016/j.jtcvs.2012.07.065; Ad N, 2010, INNOVATIONS, V5, P74, DOI 10.1097/IMI.0b013e3181d72939; Ad N, 2009, ANN THORAC SURG, V88, P101, DOI 10.1016/j.athoracsur.2009.04.014; Akpinar B, 2003, EUR J CARDIO-THORAC, V24, P223, DOI 10.1016/S1010-7940(03)00258-6; Albrecht A, 2009, J THORAC CARDIOV SUR, V138, P454, DOI 10.1016/j.jtcvs.2009.04.023; Blomstrom Lundqvist C, 2007, EUR HEART J, V28, P2902, DOI 10.1093/eurheartj/ehm378; Bogachev-Prokophiev A, 2012, INTERACT CARDIOV TH, V15, P37, DOI 10.1093/icvts/ivs053; Budera P, 2012, EUR HEART J, V33, P2644, DOI 10.1093/eurheartj/ehs290; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Cox J L, 2000, Semin Thorac Cardiovasc Surg, V12, P2; Cox JL, 2013, J THORAC CARDIOV SUR, V146, P1018, DOI 10.1016/j.jtcvs.2013.07.011; Damiano RJ, 2011, J THORAC CARDIOV SUR, V141, P113, DOI 10.1016/j.jtcvs.2010.08.067; de Lima GG, 2004, ANN THORAC SURG, V77, P2089, DOI 10.1016/j.athoracsur.2003.11.018; Doukas G, 2005, JAMA-J AM MED ASSOC, V294, P2323, DOI 10.1001/jama.294.18.2323; Gammie JS, 2008, ANN THORAC SURG, V85, P909, DOI 10.1016/j.athoracsur.2007.10.097; Gillinov AM, 2007, SEMIN THORAC CARDIOV, V19, P25, DOI 10.1053/j.semtcvs.2007.01.002; Gillinov AM, 2006, ANN THORAC SURG, V82, P502, DOI 10.1016/j.athoracsur.2006.02.030; Gillinov AM, 2011, J THORAC CARDIOV SUR, V142, P257, DOI 10.1016/j.jtcvs.2011.04.010; Gillinov AM, 2005, CURR OPIN CARDIOL, V20, P107, DOI 10.1097/01.hco.0000153554.48122.86; Gillinov M, 2013, SEMIN THORAC CARDIOV, V25, P197, DOI 10.1053/j.semtcvs.2013.09.003; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Jessurun ER, 2003, J CARDIOVASC SURG, V44, P9; Khargi K, 2001, ANN THORAC SURG, V72, pS1090, DOI 10.1016/S0003-4975(01)02940-X; Lee R, 2012, J THORAC CARDIOV SUR, V143, P1341, DOI 10.1016/j.jtcvs.2012.02.006; Melo J, 2008, J THORAC CARDIOV SUR, V135, P863, DOI 10.1016/j.jtcvs.2007.08.069; Reddy VY, 2013, CIRCULATION, V127, P720, DOI 10.1161/CIRCULATIONAHA.112.114389; Schuetz A, 2003, EUR J CARDIO-THORAC, V24, P475, DOI 10.1016/S1010-7940(03)00377-4; Soni LK, 2013, J THORAC CARDIOV SUR, V145, P356, DOI 10.1016/j.jtcvs.2012.09.091; Vasconcelos JT, 2004, ARQ BRAS CARDIOL, V83, P211; von Oppell UO, 2009, EUR J CARDIO-THORAC, V35, P641, DOI 10.1016/j.ejcts.2008.12.042	34	260	295	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2015	372	15					1399	1409		10.1056/NEJMoa1500528	http://dx.doi.org/10.1056/NEJMoa1500528			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF2ZV	25853744	Green Accepted			2022-12-28	WOS:000352417900004
J	Jefferies, MT; Cox, AC; Gupta, A; Proctor, A				Jefferies, Matthew T.; Cox, Adam C.; Gupta, Ameet; Proctor, Andrew			The management of acute testicular pain in children and adolescents	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PEDIATRIC-PATIENTS; ACUTE SCROTUM		[Jefferies, Matthew T.; Cox, Adam C.; Gupta, Ameet] Univ Wales Hosp, Dept Urol, Cardiff CF4 4XW, S Glam, Wales; [Jefferies, Matthew T.] Cardiff Univ, Sch Med, Inst Canc & Genet, Cardiff CF10 3AX, S Glam, Wales; [Proctor, Andrew] Roath House Surg, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Jefferies, MT (corresponding author), Univ Wales Hosp, Dept Urol, Cardiff CF4 4XW, S Glam, Wales.	Jefferiesmt1@cardiffac.uk						Albers P, 2014, GUIDELINES TESTICULA; [Anonymous], 2013, HOSP EP STAT ADM PAT; Brook G, 2014, INT J STD AIDS, V25, P391, DOI 10.1177/0956462413512807; Campobasso P, 1994, Pediatr Med Chir, V16, P521; Dogra V, 2004, RADIOL CLIN N AM, V42, P349, DOI 10.1016/j.rcl.2003.12.002; Emberton M, 2010, VIVA PRACTICE FRCS U, P147; Kalfa N, 2007, J UROLOGY, V177, P297, DOI 10.1016/j.juro.2006.08.128; Klin B, 2002, J PEDIATR SURG, V37, P1200, DOI 10.1053/jpsu.2002.34472; Lazaro N., 2013, SEXUALLY TRANSMITTED; LEWIS AG, 1995, J PEDIATR SURG, V30, P277, DOI 10.1016/0022-3468(95)90574-X; Makela E, 2007, SCAND J SURG, V96, P62; Mushtaq I, 2003, ANZ J SURG, V73, P55, DOI 10.1046/j.1445-2197.2003.02612.x; O'Brien M, 2008, SURGERY, V22, P255; Sidler D, 1997, S AFR MED J, V87, P1696; Summerton DJ, 2013, GUIDELINES UROLOGICA, P66; Tekgul S, 2014, GUIDELINES PAEDIAT U, P17; Thomas DFM, 2008, ESSENTIALS PAEDIAT U, P265; Varga J, 2007, UROL INT, V78, P73, DOI 10.1159/000096939; Zhao LC, 2011, J UROLOGY, V186, P2009, DOI 10.1016/j.juro.2011.07.024	19	11	12	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2015	350								h1563	10.1136/bmj.h1563	http://dx.doi.org/10.1136/bmj.h1563			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3IB	25838433				2022-12-28	WOS:000352440700003
J	Lock, D				Lock, David			BRIEFING Avastin and Lucentis: a guide through the legal maze	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Queens Counsel, London, England		Lock, D (corresponding author), Queens Counsel, London, England.	DLock@landmarkchambers.co.uk						NICE, 2008, RAN PEG TREATM AG RE, P155	1	5	5	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2015	350								h1377	10.1136/bmj.h1377	http://dx.doi.org/10.1136/bmj.h1377			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3HO	25834023				2022-12-28	WOS:000352439300002
J	Nerland, US; Jakola, AS; Solheim, O; Weber, C; Rao, V; Lonne, G; Solberg, TK; Salvesen, O; Carlsen, SM; Nygaard, OP; Gulati, S				Nerland, Ulf S.; Jakola, Asgeir S.; Solheim, Ole; Weber, Clemens; Rao, Vidar; Lonne, Greger; Solberg, Tore K.; Salvesen, Oyvind; Carlsen, Sven M.; Nygaard, Oystein P.; Gulati, Sasha			Minimally invasive decompression versus open laminectomy for central stenosis of the lumbar spine: pragmatic comparative effectiveness study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NONSURGICAL MANAGEMENT; NONOPERATIVE TREATMENT; SURGERY; OUTCOMES; PAIN; COMPLICATIONS; FUSION; BACK; TRENDS	OBJECTIVE To test the equivalence for clinical effectiveness between microdecompression and laminectomy in patients with central lumbar spinal stenosis. DESIGN Multicentre observational study. SETTING Prospective data from the Norwegian Registry for Spine Surgery. PARTICIPANTS 885 patients with central stenosis of the lumbar spine who underwent surgery at 34 Norwegian orthopaedic or neurosurgical departments. Patients were treated from October 2006 to December 2011. INTERVENTIONS Laminectomy and microdecompression. MAIN OUTCOME MEASURES The primary outcome was change in Oswestry disability index score one year after surgery. Secondary endpoints were quality of life (EuroQol EQ-5D), perioperative complications, and duration of surgical procedures and hospital stays. A blinded biostatistician performed predefined statistical analyses in unmatched and propensity matched cohorts. RESULTS The study was powered to detect a difference between the groups of eight points on the Oswestry disability index at one year. 721 patients (81%) completed the one year follow-up. Equivalence between microdecompression and laminectomy was shown for the Oswestry disability index (difference 1.3 points, 95% confidence interval -1.36 to 3.92, P<0.001 for equivalence). Equivalence was confirmed in the propensity matched cohort and full information regression analyses. No difference was found between groups in quality of life (EQ-5D) one year after surgery. The number of patients with complications was higher in the laminectomy group (15.0% v 9.8%, P=0.018), but after propensity matching for complications the groups did not differ (P=0.23). The duration of surgery for single level decompression was shorter in the microdecompression group (difference 11.2 minutes, 95% confidence interval 4.9 to 17.5, P<0.001), but after propensity matching the groups did not differ (P=0.15). Patients in the microdecompression group had shorter hospital stays, both for single level decompression (difference 1.5 days, 95% confidence interval 1.7 to 2.6, P<0.001) and two level decompression (0.8 days, 1.0 to 2.2, P=0.003). CONCLUSION At one year the effectiveness of microdecompression is equivalent to laminectomy in the surgical treatment of central stenosis of the lumbar spine. Favourable outcomes were observed at one year in both treatment groups.	[Nerland, Ulf S.; Jakola, Asgeir S.; Solheim, Ole; Weber, Clemens; Rao, Vidar; Nygaard, Oystein P.; Gulati, Sasha] St Olavs Univ Hosp, Dept Neurosurg, N-7006 Trondheim, Norway; [Nerland, Ulf S.; Solheim, Ole; Weber, Clemens; Rao, Vidar; Lonne, Greger; Nygaard, Oystein P.; Gulati, Sasha] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Jakola, Asgeir S.] Sahlgrens Univ Hosp, Dept Neurosurg, Gothenburg, Sweden; [Jakola, Asgeir S.; Solheim, Ole] St Olavs Univ Hosp, Natl Advisory Unit Ultrasound & Image Guided Surg, N-7006 Trondheim, Norway; [Weber, Clemens; Nygaard, Oystein P.; Gulati, Sasha] St Olavs Univ Hosp, Natl Advisory Unit Spinal Surg, Ctr Spinal Disorders, N-7006 Trondheim, Norway; [Lonne, Greger] Innlandet Hosp Trust, Dept Orthopaed, Brumunddal, Norway; [Solberg, Tore K.] Univ Hosp Northern Norway, Dept Neurosurg, Tromso, Norway; [Solberg, Tore K.] Univ Hosp Northern Norway, Norwegian Natl Registry Spine Surg, Tromso, Norway; [Salvesen, Oyvind; Carlsen, Sven M.] Norwegian Univ Sci & Technol, Unit Appl Clin Res, N-7034 Trondheim, Norway; [Carlsen, Sven M.] St Olavs Univ Hosp, Dept Endocrinol, N-7006 Trondheim, Norway; [Gulati, Sasha] St Olavs Univ Hosp, Norwegian Ctr Competence Deep Brain Stimulat Move, N-7006 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Sahlgrenska University Hospital; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Innlandet Hospital Trust; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Gulati, S (corresponding author), St Olavs Univ Hosp, Dept Neurosurg, N-7006 Trondheim, Norway.	sashagulati@hotmail.com	Carlsen, Sven Magnus/AAI-4635-2020; Jakola, Asgeir S/J-1738-2018; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022	Jakola, Asgeir S/0000-0002-2860-9331; Solheim, Ole/0000-0002-5954-4817; Weber, Clemens/0000-0001-7007-5719	Norwegian Medical Association	Norwegian Medical Association	This study received a grant (for quality improvement and patient safety) from the Norwegian Medical Association (www.legeforeningen.no). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen T, 2000, SPINE, V25, P1424, DOI 10.1097/00007632-200006010-00016; Atlas SJ, 2000, SPINE, V25, P556, DOI 10.1097/00007632-200003010-00005; Atlas SJ, 2005, SPINE, V30, P936, DOI 10.1097/01.brs.0000158953.57966.c0; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Benoist M, 2002, JOINT BONE SPINE, V69, P450, DOI 10.1016/S1297-319X(02)00429-3; Bresnahan L, 2010, SPINE, V35, pE761, DOI 10.1097/BRS.0b013e3181e45a6e; Brox JI, 2006, PAIN, V122, P145, DOI 10.1016/j.pain.2006.01.027; Ciol MA, 1996, J AM GERIATR SOC, V44, P285, DOI 10.1111/j.1532-5415.1996.tb00915.x; Deyo RA, 2004, NEW ENGL J MED, V350, P722, DOI 10.1056/NEJMsb031771; Deyo RA, 2010, SPINE J, V10, P625, DOI 10.1016/j.spinee.2010.05.006; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Fairbank J C, 1980, Physiotherapy, V66, P271; Friedly JL, 2014, NEW ENGL J MED, V371, P11, DOI 10.1056/NEJMoa1313265; Grotle M, 2003, J REHABIL MED, V35, P241, DOI 10.1080/16501970306094; Gunzburg R, 2003, EUR SPINE J, V12, pS176, DOI 10.1007/s00586-003-0611-2; Hellum C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2786; Hemmila MR, 2010, ARCH SURG-CHICAGO, V145, P939, DOI 10.1001/archsurg.2010.193; Hicks GE, 2008, ARTHRIT RHEUM-ARTHR, V59, P1306, DOI 10.1002/art.24006; Jakola AS, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-34; Katz JN, 2008, NEW ENGL J MED, V358, P818, DOI 10.1056/NEJMcp0708097; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Knutsson B, 2013, SPINE, V38, P435, DOI 10.1097/BRS.0b013e318270b243; Malmivaara A, 2007, SPINE, V32, P1, DOI 10.1097/01.brs.0000251014.81875.6d; Nerland US, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004651; Ong KL, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.4.FOCUS1440; Pearson A, 2012, SPINE, V37, P1791, DOI 10.1097/BRS.0b013e3182634b04; R Development Core Team, 2007, R LANG ENV STAT COMP; Schizas C, 2010, SPINE, V35, P1919, DOI 10.1097/BRS.0b013e3181d359bd; Simotas AC, 2000, SPINE, V25, P197, DOI 10.1097/00007632-200001150-00009; Smith ZA, 2012, NAT REV NEUROL, V8, P443, DOI 10.1038/nrneurol.2012.110; Solberg TK, 2005, EUR SPINE J, V14, P1000, DOI 10.1007/s00586-005-0898-2; Solberg TK, 2011, ACTA ORTHOP, V82, P56, DOI 10.3109/17453674.2010.548024; Suri P, 2010, JAMA-J AM MED ASSOC, V304, P2628, DOI 10.1001/jama.2010.1833; Thome C, 2005, J NEUROSURG-SPINE, V3, P129, DOI 10.3171/spi.2005.3.2.0129; Twisk J, 2013, J CLIN EPIDEMIOL, V66, P1022, DOI 10.1016/j.jclinepi.2013.03.017; Vogt MT, 2006, SPINE, V31, P1445, DOI 10.1097/01.brs.0000219875.19688.a6; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136	39	85	87	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2015	350								h1603	10.1136/bmj.h1603	http://dx.doi.org/10.1136/bmj.h1603			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3HO	25833966	hybrid, Green Published			2022-12-28	WOS:000352439300006
J	Kirby, T				Kirby, Tony			Sheena McCormack: helping to prepare the world for PrEP	LANCET			English	Biographical-Item																		PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1173	1173		10.1016/S0140-6736(15)60624-9	http://dx.doi.org/10.1016/S0140-6736(15)60624-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE3GQ	25845781				2022-12-28	WOS:000351715100016
J	Gerling, T; Wagenbauer, KF; Neuner, AM; Dietz, H				Gerling, Thomas; Wagenbauer, Klaus F.; Neuner, Andrea M.; Dietz, Hendrik			Dynamic DNA devices and assemblies formed by shape-complementary, non-base pairing 3D components	SCIENCE			English	Article							NANOSCALE SHAPES; RIBONUCLEASE-P; STRAND DISPLACEMENT; TRANSFER-RNA; FOLDING DNA; NANOSTRUCTURES; COMPLEX; HOLOENZYME; NETWORK; SYSTEM	We demonstrate that discrete three-dimensional (3D) DNA components can specifically self-assemble in solution on the basis of shape-complementarity and without base pairing. Using this principle, we produced homo-and heteromultimeric objects, including micrometer-scale one- and two-stranded filaments and lattices, as well as reconfigurable devices, including an actuator, a switchable gear, an unfoldable nanobook, and a nanorobot. These multidomain assemblies were stabilized via short-ranged nucleobase stacking bonds that compete against electrostatic repulsion between the components' interfaces. Using imaging by electron microscopy, ensemble and single-molecule fluorescence resonance energy transfer spectroscopy, and electrophoretic mobility analysis, we show that the balance between attractive and repulsive interactions, and thus the conformation of the assemblies, may be finely controlled by global parameters such as cation concentration or temperature and by an allosteric mechanism based on strand-displacement reactions.	[Gerling, Thomas; Wagenbauer, Klaus F.; Neuner, Andrea M.; Dietz, Hendrik] Tech Univ Munich, Walter Schottky Inst, Dept Phys, D-85748 Garching, Germany	Technical University of Munich	Dietz, H (corresponding author), Tech Univ Munich, Walter Schottky Inst, Dept Phys, Coulombwall 4a, D-85748 Garching, Germany.	dietz@tum.de		Dietz, Hendrik/0000-0003-1270-3662	European Research Council [256270]; Deutsche Forschungsgemeinschaft; NIM (Nanosystems Initiative Munich); Technische Universitat Munchen (TUM) Institute for Advanced Study; TUM International Graduate School of Science and Engineering (IGSSE);  [Sonderforschungsbereich SFB863]	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIM (Nanosystems Initiative Munich); Technische Universitat Munchen (TUM) Institute for Advanced Study; TUM International Graduate School of Science and Engineering (IGSSE); 	We thank E. Stahl, T. Martin, J. Funke, M. Schickinger, F. Kilchherr, C. Wachauf, L. Meregalli, and V. Hechtl for technical assistance. F. Praetorius is acknowledged for scaffold DNA preparations. This work was supported by a European Research Council Starting Grant to H.D. (GA no. 256270) and the Deutsche Forschungsgemeinschaft through grants provided within the Excellence Clusters CIPSM (Center for Integrated Protein Science Munich), NIM (Nanosystems Initiative Munich), the Sonderforschungsbereich SFB863, the Technische Universitat Munchen (TUM) Institute for Advanced Study, and the TUM International Graduate School of Science and Engineering (IGSSE). K.F.W. and H.D. are grateful for additional support from the Hans L. Merkle Foundation. T.G., K.F.W., and A.N. performed research. H.D. designed research and wrote the manuscript. T.G., K.F.W., and H.D. prepared figures. T.G., K.F.W., and H.D. analyzed and discussed data and edited the manuscript. We confirm no competing financial interests. The data reported in this paper are tabulated in the supplementary materials.	Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Endo M, 2010, CHEM-EUR J, V16, P5362, DOI 10.1002/chem.200903057; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Goodman RP, 2008, NAT NANOTECHNOL, V3, P93, DOI 10.1038/nnano.2008.3; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hsieh J, 2009, RNA, V15, P1565, DOI 10.1261/rna.1639409; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Krishnan Y, 2011, ANGEW CHEM INT EDIT, V50, P3124, DOI 10.1002/anie.200907223; Lund K, 2010, NATURE, V465, P206, DOI 10.1038/nature09012; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; SMITH D, 1992, J BIOL CHEM, V267, P2429; Sobczak JPJ, 2012, SCIENCE, V338, P1458, DOI 10.1126/science.1229919; Srinivas N, 2013, NUCLEIC ACIDS RES, V41, P10641, DOI 10.1093/nar/gkt801; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wang F, 2014, CHEM REV, V114, P2881, DOI 10.1021/cr400354z; Wang RS, 2010, CHEM COMMUN, V46, P4905, DOI 10.1039/c0cc01167c; Wickham SFJ, 2012, NAT NANOTECHNOL, V7, P169, DOI [10.1038/nnano.2011.253, 10.1038/NNANO.2011.253]; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532	29	396	402	18	376	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1446	1452		10.1126/science.aaa5372	http://dx.doi.org/10.1126/science.aaa5372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814577				2022-12-28	WOS:000352136400033
J	Tan, J; Jakob, C; Rossow, WB; Tselioudis, G				Tan, Jackson; Jakob, Christian; Rossow, William B.; Tselioudis, George			Increases in tropical rainfall driven by changes in frequency of organized deep convection	NATURE			English	Article							PACIFIC CLOUD REGIMES; WESTERN PACIFIC; WEATHER STATES; GLOBAL PRECIPITATION; HYDROLOGICAL CYCLE; ISCCP; IDENTIFICATION; PATTERNS; RICHER	Increasing global precipitation has been associated with a warming climate resulting from a strengthening of the hydrological cycle(1). This increase, however, is not spatially uniform. Observations and models have found that changes in rainfall show patterns characterized as 'wet-gets-wetter'(1-7) and 'warmer-gets-wetter'(5,8,9). These changes in precipitation are largely located in the tropics and hence are probably associated with convection. However, the underlying physical processes for the observed changes are not entirely clear. Here we show from observations that most of the regional increase in tropical precipitation is associated with changes in the frequency of organized deep convection. By assessing the contributions of various convective regimes to precipitation, we find that the spatial patterns of change in the frequency of organized deep convection are strongly correlated with observed change in rainfall, both positive and negative (correlation of 0.69), and can explain most of the patterns of increase in rainfall. In contrast, changes in less organized forms of deep convection or changes in precipitation within organized deep convection contribute less to changes in precipitation. Our results identify organized deep convection as the link between changes in rainfall and in the dynamics of the tropical atmosphere, thus providing a framework for obtaining a better understanding of changes in rainfall. Given the lack of a distinction between the different degrees of organization of convection in climate models(10), our results highlight an area of priority for future climate model development in order to achieve accurate rainfall projections in a warming climate.	[Tan, Jackson; Jakob, Christian] Monash Univ, Sch Earth Atmosphere & Environm, ARC Ctr Excellence Climate Syst Sci, Clayton, Vic 3800, Australia; [Rossow, William B.] CUNY City Coll, CREST Inst, New York, NY 10031 USA; [Tselioudis, George] NASA, Goddard Inst Space Studies, New York, NY 10027 USA	Monash University; City University of New York (CUNY) System; City College of New York (CUNY); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Tan, J (corresponding author), Monash Univ, Sch Earth Atmosphere & Environm, ARC Ctr Excellence Climate Syst Sci, Clayton, Vic 3800, Australia.	jackson.tan@nasa.gov	Rossow, William B/F-3138-2015; Tan, Jackson/H-5640-2019; Jakob, Christian/A-1082-2010	Tan, Jackson/0000-0001-7085-3074; Jakob, Christian/0000-0002-5012-3207	Australian Research Council Centre of Excellence for Climate System Science [CE110001028]; NASA [NNX13AO39G]; NASA; Monash University	Australian Research Council Centre of Excellence for Climate System Science(Australian Research Council); NASA(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); Monash University(Monash University)	We thank S. Sherwood and B. Stevens for comments on the study. The GPCP combined precipitation data were developed and computed by the NASA/Goddard Space Flight Centre's Mesoscale Atmospheric Processes Laboratory as a contribution to the GEWEX Global Precipitation Climatology Project, and provided by National Oceanic and Atmospheric Administration (NOAA) Office of Oceanic and Atmospheric Research and Earth System Research Laboratory Physical Sciences Division (PSD) at http://www.esrl.noaa.gov/psd/. The TRMM 3B42 and 3A25 data were provided by the NASA/Goddard Space Flight Center's Mesoscale Atmospheric Processes Laboratory and Precipitation Processing System as a contribution to TRMM, and archived at the NASA Goddard Earth Sciences Data and Information Services Center. J.T. and C.J. are funded under the Australian Research Council Centre of Excellence for Climate System Science (CE110001028). W.B.R. is supported by NASA grant NNX13AO39G. G.T. acknowledges the support of the NASA Modeling Analysis and Prediction (MAP) programme managed by D. Considine. J.T. acknowledges support from the Monash University Postgraduate Publication Award.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Allan RP, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/025205; Chadwick R, 2013, J CLIMATE, V26, P3803, DOI 10.1175/JCLI-D-12-00543.1; Chou C, 2013, NAT GEOSCI, V6, P263, DOI [10.1038/ngeo1744, 10.1038/NGEO1744]; Chou C, 2009, J CLIMATE, V22, P1982, DOI 10.1175/2008JCLI2471.1; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Handlos ZJ, 2014, J CLIMATE, V27, P7667, DOI 10.1175/JCLI-D-13-00602.1; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Huang P, 2013, NAT GEOSCI, V6, P357, DOI [10.1038/NGEO1792, 10.1038/ngeo1792]; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Huffman GJ, 2001, J HYDROMETEOROL, V2, P36, DOI 10.1175/1525-7541(2001)002<0036:GPAODD>2.0.CO;2; Iguchi T, 2000, J APPL METEOROL, V39, P2038, DOI 10.1175/1520-0450(2001)040<2038:RPAFTT>2.0.CO;2; Jakob C, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018367; Jakob C, 2005, J CLIMATE, V18, P1203, DOI 10.1175/JCLI3326.1; Jakob C, 2008, J CLIMATE, V21, P4348, DOI 10.1175/2008JCLI2122.1; Laing AG, 1997, Q J ROY METEOR SOC, V123, P389, DOI 10.1002/qj.49712353807; Lee D, 2013, J CLIMATE, V26, P772, DOI 10.1175/JCLI-D-11-00718.1; Li W, 2013, J GEOPHYS RES-ATMOS, V118, P592, DOI 10.1002/jgrd.50114; Liu CL, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016568; Mapes B, 2011, J ADV MODEL EARTH SY, V3, DOI 10.1029/2011MS000042; Oreopoulos L, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015472; Rossow WB, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024584; Rossow WB, 1999, B AM METEOROL SOC, V80, P2261, DOI 10.1175/1520-0477(1999)080<2261:AIUCFI>2.0.CO;2; ROSSOW WB, 1993, J CLIMATE, V6, P2394, DOI 10.1175/1520-0442(1993)006<2394:COIAOC>2.0.CO;2; Rossow WB, 2013, J CLIMATE, V26, P1457, DOI 10.1175/JCLI-D-11-00725.1; Seager R, 2010, J CLIMATE, V23, P4651, DOI 10.1175/2010JCLI3655.1; Stachnik JP, 2013, J CLIMATE, V26, P7097, DOI 10.1175/JCLI-D-12-00673.1; Tan J, 2013, J CLIMATE, V26, P6618, DOI 10.1175/JCLI-D-12-00624.1; Tselioudis G, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044092; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1	30	106	107	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					451	+		10.1038/nature14339	http://dx.doi.org/10.1038/nature14339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25810207				2022-12-28	WOS:000351602800052
J	Muench, U; Sindelar, J; Busch, SH; Buerhaus, PI				Muench, Ulrike; Sindelar, Jody; Busch, Susan H.; Buerhaus, Peter I.			Salary Differences Between Male and Female Registered Nurses in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Muench, Ulrike] Univ Calif San Francisco, Dept Social & Behav Sci, San Francisco, CA 94118 USA; [Sindelar, Jody; Busch, Susan H.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Buerhaus, Peter I.] Vanderbilt Univ, Med Ctr, Dept Hlth Policy, Nashville, TN USA	University of California System; University of California San Francisco; Yale University; Vanderbilt University	Muench, U (corresponding author), Univ Calif San Francisco, Dept Social & Behav Sci, 3333 Calif St, San Francisco, CA 94118 USA.	ulrike.muench@ucsf.edu						Jagsi R, 2012, JAMA-J AM MED ASSOC, V307, P2410, DOI 10.1001/jama.2012.6183; Jones CB, 2004, ECON EDUC REV, V23, P615, DOI 10.1016/j.econedurev.2004.06.001; Kalist David E, 2002, Nurs Econ, V20, P155; Lo Sasso AT, 2011, HEALTH AFFAIR, V30, P193, DOI 10.1377/hlthaff.2010.0597; Seabury SA, 2013, JAMA INTERN MED, V173, P1748	5	54	54	2	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1265	1267		10.1001/jama.2015.1487	http://dx.doi.org/10.1001/jama.2015.1487			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25803350	Bronze			2022-12-28	WOS:000351435500028
J	Bird, AN; Davis, AM				Bird, Amber-Nicole; Davis, Andrew M.			Screening for Abdominal Aortic Aneurysm	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bird, Amber-Nicole; Davis, Andrew M.] Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Bird, AN (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 7082, Chicago, IL 60637 USA.	amber-nicole.bird@uchospitals.edu						Abdominal aortic aneurysm: screening, 2014, ABD AORT AN SCREEN; Bjorck M, 2015, EUR J VASC ENDOVASC, V49, P113, DOI 10.1016/j.ejvs.2014.08.015; Dua A, 2014, J VASC SURG, V59, P1512, DOI 10.1016/j.jvs.2014.01.007; Greco G, 2010, ANN SURG, V252, P675, DOI 10.1097/SLA.0b013e3181f621c8; Guirguis-Blake JM, 2014, ANN INTERN MED, V160, P321, DOI 10.7326/M13-1844; Guirguis-Blake JM, 2014, PRIMARY CARE SCREENI, P1; Hye RJ, 2014, J VASC SURG, V59, P1535, DOI 10.1016/j.jvs.2013.12.016; LeFevre ML, 2014, ANN INTERN MED, V161, P281, DOI 10.7326/M14-1204; Scott RAP, 2002, BRIT J SURG, V89, P283, DOI 10.1046/j.0007-1323.2001.02014.x; Thompson SG, 2012, BRIT J SURG, V99, P1649, DOI 10.1002/bjs.8897	10	13	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1156	1157		10.1001/jama.2015.0996	http://dx.doi.org/10.1001/jama.2015.0996			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25781445				2022-12-28	WOS:000351102500018
J	Spencer, FA; Guyatt, G				Spencer, Frederick A.; Guyatt, Gordon			Dual antiplatelets for 30 mo after drug-eluting stents reduced stent thrombosis and CV and cerebrovascular events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED-TRIAL; THERAPY; IMPLANTATION; DURATION		[Spencer, Frederick A.; Guyatt, Gordon] McMaster Univ, Hamilton, ON, Canada	McMaster University	Spencer, FA (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Collet JP, 2014, LANCET, V384, P1577, DOI 10.1016/S0140-6736(14)60612-7; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Lee CW, 2014, CIRCULATION, V129, P304, DOI 10.1161/CIRCULATIONAHA.113.003303; Valgimigli M, 2013, EUR HEART J, V34, P909, DOI 10.1093/eurheartj/ehs460	5	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6							JC9	10.7326/ACPJC-2015-162-6-009	http://dx.doi.org/10.7326/ACPJC-2015-162-6-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775352				2022-12-28	WOS:000351279600008
J	Mesa, KR; Rompolas, P; Zito, G; Myung, P; Sun, TY; Brown, S; Gonzalez, DG; Blagoev, KB; Haberman, AM; Greco, V				Mesa, Kailin R.; Rompolas, Panteleimon; Zito, Giovanni; Myung, Peggy; Sun, Thomas Y.; Brown, Samara; Gonzalez, David G.; Blagoev, Krastan B.; Haberman, Ann M.; Greco, Valentina			Niche-induced cell death and epithelial phagocytosis regulate hair follicle stem cell pool	NATURE			English	Article							DERMAL PAPILLA; REGRESSION; CATENIN; ACTIVATION; APOPTOSIS; DYNAMICS; PROGENY; GROWTH	Tissue homeostasis is achieved through a balance of cell production (growth) and elimination (regression)(1,2). In contrast to tissue growth, the cells and molecular signals required for tissue regression remain unknown. To investigate physiological tissue regression, we use the mouse hair follicle, which cycles stereotypically between phases of growth and regression while maintaining a pool of stem cells to perpetuate tissue regeneration(3). Here we show by intravital microscopy in live mice(4-6) that the regression phase eliminates the majority of the epithelial cells by two distinct mechanisms: terminal differentiation of suprabasal cells and a spatial gradient of apoptosis of basal cells. Furthermore, we demonstrate that basal epithelial cells collectively act as phagocytes to clear dying epithelial neighbours. Through cellular and genetic ablation we show that epithelial cell death is extrinsically induced through transforming growth factor (TGF)-beta activation and mesenchymal crosstalk. Strikingly, our data show that regression acts to reduce the stem cell pool, as inhibition of regression results in excess basal epithelial cells with regenerative abilities. This study identifies the cellular behaviours and molecular mechanisms of regression that counterbalance growth to maintain tissue homeostasis.	[Mesa, Kailin R.; Rompolas, Panteleimon; Myung, Peggy; Sun, Thomas Y.; Brown, Samara; Greco, Valentina] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Zito, Giovanni] Univ Palermo, Dept Biopathol & Med Biotechnol, I-90100 Palermo, Italy; [Myung, Peggy; Greco, Valentina] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Gonzalez, David G.; Haberman, Ann M.] Yale Univ, Sch Med, Dept Immunobiol, Dept Lab Med, New Haven, CT 06510 USA; [Blagoev, Krastan B.] Natl Sci Fdn, Arlington, VA 22230 USA; [Blagoev, Krastan B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, AA Martinos Ctr Biomed Imaging,Dept Radiol, Boston, MA 02114 USA; [Greco, Valentina] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Greco, Valentina] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA	Yale University; University of Palermo; Yale University; Yale University; National Science Foundation (NSF); Harvard University; Harvard Medical School; Massachusetts General Hospital; Yale University; Yale University	Greco, V (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	valentina.greco@yale.edu	Sun, Thomas/AAG-4824-2020; Zito, Giovanni/AAC-3639-2022; , Zito/O-3836-2019; Zito, Giovanni/J-7238-2016	, Zito/0000-0002-0482-6729; Zito, Giovanni/0000-0002-0482-6729; Sun, Thomas Yang/0000-0001-7436-0138; Mesa, Kailin/0000-0003-4452-9048; Rompolas, Panteleimon/0000-0001-9135-7651	National Institutes of Health (NIH) [5T32 GM007223]; American Cancer Society [RSG-12-059-02]; National Cancer Institute, NIH [2P50CA121974]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH [1R01AR063663-01]; New York Stem Cell Foundation; NIAMS Rheumatic Diseases Research Core Centers [5 P30 AR053495-07]; NSF; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063663, P30AR053495, K08AR066790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); New York Stem Cell Foundation; NIAMS Rheumatic Diseases Research Core Centers; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Fuchs for the K14-H2BGFP, Lef1-RFP and K14-GFPActin mice; M. Taketo for the Cttnb1<SUP>fl(Ex3)/+</SUP> mice; A. Horwich and A. Mesa for critical feedback; M. Rendl for technical advice; M. Graham and X. Liu for technical support with electron microscopy; D. Egli for the H2BmCherry construct; and T. Nottoli for generating the K14-H2BmCherry mouse line. K.R.M. and S.B. were supported by the National Institutes of Health (NIH) Predoctoral Program in Cellular and Molecular Biology, grant no. 5T32 GM007223. K.R.M. is currently a National Science Foundation (NSF) Graduate Research Fellow. This work is supported by the American Cancer Society, grant no. RSG-12-059-02; Yale Spore Grant National Cancer Institute, NIH, grant no. 2P50CA121974; the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, grant no. 1R01AR063663-01; and by The New York Stem Cell Foundation. V.G. is a New York Stem Cell Foundation-Robertson Investigator. P.R. is a New York Stem Cell Foundation-Druckenmiller Fellow. A.M.H. is supported by NIAMS Rheumatic Diseases Research Core Centers grant no. 5 P30 AR053495-07. K.B.B. was supported by the NSF. The NSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views presented here are not those of the NSF and represent solely the views of the authors.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Clavel C, 2012, DEV CELL, V23, P981, DOI 10.1016/j.devcel.2012.10.013; Deschene ER, 2014, SCIENCE, V343, P1353, DOI 10.1126/science.1248373; Foitzik K, 2000, FASEB J, V14, P752, DOI 10.1096/fasebj.14.5.752; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Lindner G, 1997, AM J PATHOL, V151, P1601; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Poon I. K., 2014, NATURE REV IMMUNOL; Rahmani W, 2014, DEV CELL, V31, P543, DOI 10.1016/j.devcel.2014.10.022; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rogers GE, 2004, INT J DEV BIOL, V48, P163, DOI 10.1387/ijdb.15272381; Rompolas P., 2013, NATURE; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Zito G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4543	28	82	85	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					94	U236		10.1038/nature14306	http://dx.doi.org/10.1038/nature14306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25849774	Green Submitted, Green Accepted			2022-12-28	WOS:000355543400036
J	Porazinski, S; Wang, HJ; Asaoka, Y; Behrndt, M; Miyamoto, T; Morita, H; Hata, S; Sasaki, T; Krens, SFG; Osada, Y; Asaka, S; Momoi, A; Linton, S; Miesfeld, JB; Link, BA; Senga, T; Castillo-Morales, A; Urrutia, AO; Shimizu, N; Nagase, H; Matsuura, S; Bagby, S; Kondoh, H; Nishina, H; Heisenberg, CP; Furutani-Seiki, M				Porazinski, Sean; Wang, Huijia; Asaoka, Yoichi; Behrndt, Martin; Miyamoto, Tatsuo; Morita, Hitoshi; Hata, Shoji; Sasaki, Takashi; Krens, S. F. Gabriel; Osada, Yumi; Asaka, Satoshi; Momoi, Akihiro; Linton, Sarah; Miesfeld, Joel B.; Link, Brian A.; Senga, Takeshi; Castillo-Morales, Atahualpa; Urrutia, Araxi O.; Shimizu, Nobuyoshi; Nagase, Hideaki; Matsuura, Shinya; Bagby, Stefan; Kondoh, Hisato; Nishina, Hiroshi; Heisenberg, Carl-Philipp; Furutani-Seiki, Makoto			YAP is essential for tissue tension to ensure vertebrate 3D body shape	NATURE			English	Article							EXTRACELLULAR-MATRIX; CELL-ADHESION; ZEBRAFISH; MEDAKA; ORGANIZATION; DYNAMICS; PATHWAY; YAP/TAZ; PROTEIN; FORCES	Vertebrates have a unique 3D body shape in which correct tissue and organ shape and alignment are essential for function. For example, vision requires the lens to be centred in the eye cup which must in turn be correctly positioned in the head(1). Tissue morphogenesis depends on force generation, force transmission through the tissue, and response of tissues and extracellular matrix to force(2,3). Although a century ago D'Arcy Thompson postulated that terrestrial animal body shapes are conditioned by gravity(4), there has been no animal model directly demonstrating how the aforementioned mechano-morphogenetic processes are coordinated to generate a body shape that withstands gravity. Here we report a unique medaka fish (Oryzias latipes) mutant, hirame (hir), which is sensitive to deformation by gravity. hir embryos display a markedly flattened body caused by mutation of YAP, a nuclear executor of Hippo signalling that regulates organ size. We show that actomyosin-mediated tissue tension is reduced in hir embryos, leading to tissue flattening and tissue misalignment, both of which contribute to body flattening. By analysing YAP function in 3D spheroids of human cells, we identify the Rho GTPase activating protein ARHGAP18 as an effector of YAP in controlling tissue tension. Together, these findings reveal a previously unrecognised function of YAP in regulating tissue shape and alignment required for proper 3D body shape. Understanding this morphogenetic function of YAP could facilitate the use of embryonic stem cells to generate complex organs requiring correct alignment of multiple tissues.	[Porazinski, Sean; Wang, Huijia; Linton, Sarah; Castillo-Morales, Atahualpa; Urrutia, Araxi O.; Bagby, Stefan; Furutani-Seiki, Makoto] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Asaoka, Yoichi; Hata, Shoji; Asaka, Satoshi; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo 1138510, Japan; [Behrndt, Martin; Morita, Hitoshi; Krens, S. F. Gabriel; Heisenberg, Carl-Philipp] IST Austria, A-3400 Klosterneuburg, Austria; [Miyamoto, Tatsuo; Matsuura, Shinya] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Genet & Cell Biol, Hiroshima 7348553, Japan; [Sasaki, Takashi; Shimizu, Nobuyoshi] Keio Univ, Sch Med, Dept Mol Biol, Tokyo 1608582, Japan; [Osada, Yumi; Momoi, Akihiro; Kondoh, Hisato; Furutani-Seiki, Makoto] Japan Sci & Technol Agcy JST, ERATO SORST Kondoh Differentiat Signaling Project, Kyoto 6068305, Japan; [Miesfeld, Joel B.; Link, Brian A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Senga, Takeshi] Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi 4668550, Japan; [Nagase, Hideaki] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kennedy Inst Rheumatol, Oxford OX3 7FY, England; [Kondoh, Hisato] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Kondoh, Hisato] Kyoto Sangyo Univ, Fac Life Sci, Kyoto 6038555, Japan	University of Bath; Tokyo Medical & Dental University (TMDU); Institute of Science & Technology - Austria; Hiroshima University; Keio University; Japan Science & Technology Agency (JST); Medical College of Wisconsin; Nagoya University; University of Oxford; Osaka University; Kyoto Sangyo University	Heisenberg, CP (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	nishina.dbio@mri.tmd.ac.jp; heisenberg@ist.ac.at; furutaniseiki@gmail.com	Matsuura, Shinya/U-4182-2017; Miyamoto, Tatsuo/J-5187-2014; Sasaki, Takashi/AAD-1461-2019; Porazinski, Sean/M-6973-2015; Krens, Gabriel/U-6760-2017; Miyamoto, Tatsuo/ABG-8292-2021	Matsuura, Shinya/0000-0001-5294-081X; Miyamoto, Tatsuo/0000-0002-1097-0647; Porazinski, Sean/0000-0003-3804-1150; Krens, Gabriel/0000-0003-4761-5996; Miyamoto, Tatsuo/0000-0002-1097-0647; Urrutia, Araxi/0000-0001-9011-8675; Sasaki, Takashi/0000-0002-6275-046X; Heisenberg, Carl-Philipp/0000-0002-0912-4566; Castillo Morales, Atahualpa/0000-0001-9733-6923; Bagby, Stefan/0000-0003-2302-9511; Morita, Hitoshi/0000-0002-9073-2664	ERATO/SORST projects of JST, Japan; National Institutes of Health [R01EY014167]; Medical Research Council, UK; NATIONAL EYE INSTITUTE [R01EY016060, R01EY014167, T32EY014537, P30EY001931] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [I 930] Funding Source: researchfish; Medical Research Council [G117/563] Funding Source: researchfish; Grants-in-Aid for Scientific Research [26114005, 25460358] Funding Source: KAKEN; MRC [G117/563] Funding Source: UKRI	ERATO/SORST projects of JST, Japan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Raff, T. Perry, A. Ward, M. Wills, J. Caunt, J. Clarke, L. Hurst and C. Tickle for critical reading and comments. We thank M. Tada, M. Furuse, N. Wada, Y. Nakai, J. Robinson and R. Kelsh for contributions to the paper and University of Bath for fish and bioimaging facilities. This work was funded by the ERATO/SORST projects of JST, Japan (H.K.), National Institutes of Health R01EY014167 (B.A.L.) and Medical Research Council, UK (M.F.-S.).	Alexandre P, 2010, NAT NEUROSCI, V13, P673, DOI 10.1038/nn.2547; Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Chauhan BK, 2009, DEVELOPMENT, V136, P3657, DOI 10.1242/dev.042242; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P647, DOI 10.1016/j.mod.2004.04.016; FurutaniSeiki M, 1996, DEVELOPMENT, V123, P229; Gee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020309; Guevorkian K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218101; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hilman D, 2011, MOL BIOL EVOL, V28, P2403, DOI 10.1093/molbev/msr065; Hirose Y, 2004, DEVELOPMENT, V131, P2553, DOI 10.1242/dev.01140; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Iwanami N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000171; Iwasaki T, 2001, CELL STRUCT FUNCT, V26, P677, DOI 10.1247/csf.26.677; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Maeda M, 2011, MOL BIOL CELL, V22, P3840, DOI 10.1091/mbc.E11-04-0364; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; MCDONALD JA, 1987, J BIOL CHEM, V262, P2957; Miesfeld JB, 2014, MECH DEVELOP, V133, P177, DOI 10.1016/j.mod.2014.02.003; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pinto IM, 2012, DEV CELL, V22, P1247, DOI 10.1016/j.devcel.2012.04.015; Porazinski SR, 2011, METHODS MOL BIOL, V770, P211, DOI 10.1007/978-1-61779-210-6_8; Rolo A, 2009, DEV BIOL, V327, P327, DOI 10.1016/j.ydbio.2008.12.009; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Thompson D.W, 1917, GROWTH FORM; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	38	159	166	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					217	+		10.1038/nature14215	http://dx.doi.org/10.1038/nature14215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25778702	Green Accepted			2022-12-28	WOS:000354377800058
J	Norton, ME; Jacobsson, B; Swamy, GK; Laurent, LC; Ranzini, AC; Brar, H; Tomlinson, MW; Pereira, L; Spitz, JL; Hollemon, D; Cuckle, H; Musci, TJ; Wapner, RJ				Norton, Mary E.; Jacobsson, Bo; Swamy, Geeta K.; Laurent, Louise C.; Ranzini, Angela C.; Brar, Herb; Tomlinson, Mark W.; Pereira, Leonardo; Spitz, Jean L.; Hollemon, Desiree; Cuckle, Howard; Musci, Thomas J.; Wapner, Ronald J.			Cell-free DNA Analysis for Noninvasive Examination of Trisomy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MATERNAL BLOOD; 1ST-TRIMESTER; ANEUPLOIDIES; RISK	BACKGROUND Cell-free DNA (cfDNA) testing for fetal trisomy is highly effective among high-risk women. However, there have been few direct, well-powered studies comparing cfDNA testing with standard screening during the first trimester in routine prenatal populations. METHODS In this prospective, multicenter, blinded study conducted at 35 international centers, we assigned pregnant women presenting for aneuploidy screening at 10 to 14 weeks of gestation to undergo both standard screening (with measurement of nuchal translucency and biochemical analytes) and cfDNA testing. Participants received the results of standard screening; the results of cfDNA testing were blinded. Determination of the birth outcome was based on diagnostic genetic testing or newborn examination. The primary outcome was the area under the receiver-operating-characteristic curve (AUC) for trisomy 21 (Down's syndrome) with cfDNA testing versus standard screening. We also evaluated cfDNA testing and standard screening to assess the risk of trisomies 18 and 13. RESULTS Of 18,955 women who were enrolled, results from 15,841 were available for analysis. The mean maternal age was 30.7 years, and the mean gestational age at testing was 12.5 weeks. The AUC for trisomy 21 was 0.999 for cfDNA testing and 0.958 for standard screening (P = 0.001). Trisomy 21 was detected in 38 of 38 women (100%; 95% confidence interval [CI], 90.7 to 100) in the cfDNA-testing group, as compared with 30 of 38 women (78.9%; 95% CI, 62.7 to 90.4) in the standard-screening group (P = 0.008). False positive rates were 0.06% (95% CI, 0.03 to 0.11) in the cfDNA group and 5.4% (95% CI, 5.1 to 5.8) in the standard-screening group (P<0.001). The positive predictive value for cfDNA testing was 80.9% (95% CI, 66.7 to 90.9), as compared with 3.4% (95% CI, 2.3 to 4.8) for standard screening (P<0.001). CONCLUSIONS In this large, routine prenatal-screening population, cfDNA testing for trisomy 21 had higher sensitivity, a lower false positive rate, and higher positive predictive value than did standard screening with the measurement of nuchal translucency and biochemical analytes.	[Norton, Mary E.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Laurent, Louise C.] Univ Calif San Diego, San Diego, CA 92103 USA; [Brar, Herb] Perinatal Diagnost Ctr, Riverside, CA USA; [Hollemon, Desiree; Musci, Thomas J.] Ariosa Diagnost, San Jose, CA USA; [Jacobsson, Bo] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Swamy, Geeta K.] Duke Univ, Durham, NC USA; [Ranzini, Angela C.] St Peters Univ Hosp, New Brunswick, NJ USA; [Tomlinson, Mark W.] Northwest Perinatal Ctr, Portland, OR USA; [Pereira, Leonardo] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Spitz, Jean L.] Perinatal Qual Fdn, Oklahoma City, OK USA; [Cuckle, Howard; Wapner, Ronald J.] Columbia Univ, New York, NY USA	University of California System; University of California San Francisco; University of California System; University of California San Diego; Sahlgrenska University Hospital; Duke University; Saint Peter's University Hospital; Oregon Health & Science University; Columbia University	Norton, ME (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 550 16th St,7th Fl, San Francisco, CA 94143 USA.	mary.norton@ucsf.edu	Jacobsson, Bo/O-8007-2014	Jacobsson, Bo/0000-0001-5079-2374; Hollemon, Desiree/0000-0003-4971-9334; Wapner, Ronald/0000-0003-0727-1244; Laurent, Louise/0000-0002-2095-7534	Ariosa Diagnostics; Perinatal Quality Foundation	Ariosa Diagnostics; Perinatal Quality Foundation	Funded by Ariosa Diagnostics and Perinatal Quality Foundation; NEXT ClinicalTrials.gov number, NCT01511458.	American College of Obstetricians and Gynecologists Committee on Genetics, 2012, Obstet Gynecol, V120, P1532, DOI 10.1097/01.AOG.0000423819.85283.f4; Ashoor G, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.029; Benn P, 2013, PRENATAL DIAG, V33, P622, DOI 10.1002/pd.4139; Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; CUCKLE H, 2010, GENETIC DISORDERS FE, P771; Cuckle H, 2013, PRENATAL DIAG, V33, P636, DOI 10.1002/pd.4157; Dan S, 2012, PRENATAL DIAG, V32, P1225, DOI 10.1002/pd.4002; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gil MM, 2015, ULTRASOUND OBST GYN, V45, P249, DOI 10.1002/uog.14791; Gregg AR, 2013, GENET MED, V15, P395, DOI 10.1038/gim.2013.29; Leisenring W, 2000, BIOMETRICS, V56, P345, DOI 10.1111/j.0006-341X.2000.00345.x; Liddell D, 1976, J ROY STAT SOC D-STA, V25, P295, DOI 10.2307/2988087; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Nicolaides KH, 2014, FETAL DIAGN THER, V35, P1, DOI 10.1159/000357198; Nicolaides KH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.033; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Pergament E, 2014, OBSTET GYNECOL, V124, P210, DOI 10.1097/AOG.0000000000000363; Petersen OB, 2014, ULTRASOUND OBST GYN, V43, P265, DOI 10.1002/uog.13270; Rava RP, 2014, CLIN CHEM, V60, P243, DOI 10.1373/clinchem.2013.207951; Samango-Sprouse C, 2013, PRENATAL DIAG, V33, P643, DOI 10.1002/pd.4159; Sparks AB, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.030; Sparks AB, 2012, PRENATAL DIAG, V32, P3, DOI 10.1002/pd.2922; Syngelaki A, 2014, FETAL DIAGN THER, V35, P174, DOI 10.1159/000358388; Wang E, 2013, PRENATAL DIAG, V33, P662, DOI 10.1002/pd.4119; Wapner R, 2003, NEW ENGL J MED, V349, P1405, DOI 10.1056/NEJMoa025273; Wilson KL, 2013, J GENET COUNS, V22, P4, DOI 10.1007/s10897-012-9545-3	26	475	518	7	89	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2015	372	17					1589	1597		10.1056/NEJMoa1407349	http://dx.doi.org/10.1056/NEJMoa1407349			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4XX	25830321	Green Published			2022-12-28	WOS:000353294000004
J	Dulvy, NK; Kindsvater, HK				Dulvy, Nicholas K.; Kindsvater, Holly K.			Recovering the potential of coral reefs	NATURE			English	News Item							FISHERIES; FISH	An analysis of fish declines in coral reefs shows that simple fishing limits and implementation of marine protected areas can be enough to support recovery of coral ecosystem resilience.	[Dulvy, Nicholas K.; Kindsvater, Holly K.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Dulvy, NK (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	dulvy@sfu.ca	Dulvy, Nicholas/I-2895-2012	Dulvy, Nicholas/0000-0002-4295-9725; Kindsvater, Holly/0000-0001-7580-4095				Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; De Santo EM, 2013, J ENVIRON MANAGE, V124, P137, DOI 10.1016/j.jenvman.2013.01.033; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; HAMNER WM, 1988, B MAR SCI, V42, P459; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; MacNeil MA, 2015, NATURE, V520, P341, DOI 10.1038/nature14358; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; PICKETT S T A, 1989, P110; Polunin NVC, 1996, REEF FISHERIES; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Wing SR, 2001, CORAL REEFS, V20, P1	11	3	3	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					304	305		10.1038/nature14384	http://dx.doi.org/10.1038/nature14384			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25855291				2022-12-28	WOS:000352974200028
J	Kim, D; Fiske, BP; Birsoy, K; Freinkman, E; Kami, K; Possemato, RL; Chudnovsky, Y; Pacold, ME; Chen, WW; Cantor, JR; Shelton, LM; Gui, DY; Kwon, M; Ramkissoon, SH; Ligon, KL; Kang, SW; Snuderl, M; Vander Heiden, MG; Sabatini, DM				Kim, Dohoon; Fiske, Brian P.; Birsoy, Kivanc; Freinkman, Elizaveta; Kami, Kenjiro; Possemato, Richard L.; Chudnovsky, Yakov; Pacold, Michael E.; Chen, Walter W.; Cantor, Jason R.; Shelton, Laura M.; Gui, Dan Y.; Kwon, Manjae; Ramkissoon, Shakti H.; Ligon, Keith L.; Kang, Seong Woo; Snuderl, Matija; Vander Heiden, Matthew G.; Sabatini, David M.			SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance	NATURE			English	Article							PYRUVATE-KINASE M2; TUMOR HYPOXIA; STEM-CELLS; CANCER; METABOLISM; SERINE; METHYLGLYOXAL; AMINOACETONE; CATABOLISM; THREONINE	Cancer cells adapt their metabolic processes to support rapid proliferation, but less is known about how cancer cells alter metabolism to promote cell survival in a poorly vascularized tumour microenvironment(1-3). Here we identify a key role for serine and glycine metabolism in the survival of brain cancer cells within the ischaemic zones of gliomas. Inhuman glioblastoma multiforme, mitochondrial serine hydroxymethyltransferase (SHMT2) and glycine decarboxylase (GLDC) are highly expressed in the pseudopalisading cells that surround necrotic foci. We find that SHMT2 activity limits that of pyruvate kinase (PKM2) and reduces oxygen consumption, eliciting a metabolic state that confers a profound survival advantage to cells in poorly vascularized tumour regions. GLDC inhibition impairs cells with high SHMT2 levels as the excess glycine not metabolized by GLDC can be converted to the toxic molecules aminoacetone and methylglyoxal. Thus, SHMT2 is required for cancer cells to adapt to the tumour environment, but also renders these cells sensitive to glycine cleavage system inhibition.	[Kim, Dohoon; Birsoy, Kivanc; Freinkman, Elizaveta; Possemato, Richard L.; Chudnovsky, Yakov; Pacold, Michael E.; Chen, Walter W.; Cantor, Jason R.; Kwon, Manjae; Kang, Seong Woo; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kim, Dohoon; Birsoy, Kivanc; Freinkman, Elizaveta; Possemato, Richard L.; Chudnovsky, Yakov; Pacold, Michael E.; Chen, Walter W.; Cantor, Jason R.; Kang, Seong Woo; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Kim, Dohoon; Birsoy, Kivanc; Freinkman, Elizaveta; Possemato, Richard L.; Chudnovsky, Yakov; Pacold, Michael E.; Chen, Walter W.; Cantor, Jason R.; Kwon, Manjae; Kang, Seong Woo; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Kim, Dohoon; Fiske, Brian P.; Birsoy, Kivanc; Freinkman, Elizaveta; Possemato, Richard L.; Chudnovsky, Yakov; Pacold, Michael E.; Chen, Walter W.; Cantor, Jason R.; Gui, Dan Y.; Kang, Seong Woo; Vander Heiden, Matthew G.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Kim, Dohoon; Fiske, Brian P.; Birsoy, Kivanc; Freinkman, Elizaveta; Possemato, Richard L.; Chudnovsky, Yakov; Pacold, Michael E.; Chen, Walter W.; Cantor, Jason R.; Gui, Dan Y.; Kang, Seong Woo; Vander Heiden, Matthew G.; Sabatini, David M.] Broad Inst Harvard & MIT, Seven Cambridge Ctr, Cambridge, MA 02142 USA; [Kami, Kenjiro] Human Metabolome Technol Inc, Tsuruoka, Yamagata 9970052, Japan; [Pacold, Michael E.; Ramkissoon, Shakti H.; Ligon, Keith L.; Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Shelton, Laura M.] Human Metabolome Technol Ameri Inc, Boston, MA 02134 USA; [Ramkissoon, Shakti H.; Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ramkissoon, Shakti H.; Ligon, Keith L.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Snuderl, Matija] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Snuderl, Matija] NYU, Sch Med, New York, NY 10016 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; New York University; NYU Langone Medical Center; New York University	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		Chen, Walter/0000-0002-7752-9581; Fiske, Brian/0000-0001-5891-4268; Snuderl, Matija/0000-0003-0752-0917; /0000-0002-1446-7256; Possemato, Richard/0000-0002-2401-0030	Basic Research Fellowship from the American Brain Tumor Association; MIT School of Science Fellowship in Cancer Research; National Institutes of Health (NIH) [T32GM007287, K99 CA168940, K08-NS087118, R01CA168653, 5P30CA14051]; Jane Coffin Childs Memorial Fund; Leukemia and Lymphoma Society; American Cancer Society; American Brain Tumor Association Discovery Grant; US National Institute of Aging; Smith Family Foundation; Burroughs Wellcome Fund; Damon Runyon Cancer Research Foundation; Stern family; DOD CDMRP Discovery Award; David H. Koch Institute for Integrative Cancer Research at MIT; Alexander and Margaret Stewart Trust Fund; NIH [CA103866, CA129105, AI07389]; NATIONAL CANCER INSTITUTE [R01CA168653, P30CA014051, R01CA103866, K99CA168940, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007389, R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM007287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS087118] Funding Source: NIH RePORTER	Basic Research Fellowship from the American Brain Tumor Association; MIT School of Science Fellowship in Cancer Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society); American Brain Tumor Association Discovery Grant; US National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Smith Family Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Cancer Research Foundation; Stern family; DOD CDMRP Discovery Award; David H. Koch Institute for Integrative Cancer Research at MIT; Alexander and Margaret Stewart Trust Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Sabatini laboratory for assistance and feedback, in particular Y. Shaul, T. Wang, S. Wang and O. Yilmaz. Authors would like to thank J. Taylor for GBM sample collection, and T. DiCesare for illustrations. This work was supported by a Basic Research Fellowship from the American Brain Tumor Association to D.K.; MIT School of Science Fellowship in Cancer Research and National Institutes of Health (NIH) T32GM007287 to B.P.F., fellowships from the Jane Coffin Childs Memorial Fund and Leukemia and Lymphoma Society to K.B.; a grant from the NIH (K99 CA168940) to R.P.; an American Cancer Society fellowship and an American Brain Tumor Association Discovery Grant to Y.C.; a fellowship from the US National Institute of Aging to W.W.C.; NIH (K08-NS087118) to S.H.R.; support from NIH (R01CA168653, 5P30CA14051), the Smith Family Foundation, the Burroughs Wellcome Fund, the Damon Runyon Cancer Research Foundation, and the Stern family to M.G.V.H.; DOD CDMRP Discovery Award, grants from the David H. Koch Institute for Integrative Cancer Research at MIT, The Alexander and Margaret Stewart Trust Fund, and NIH (CA103866, CA129105, and AI07389) to D.M.S.; D.M.S. is an investigator of the Howard Hughes Medical Institute.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Brat DJ, 2004, LAB INVEST, V84, P397, DOI 10.1038/labinvest.3700070; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Chudnovsky Y, 2014, CELL REP, V6, P313, DOI 10.1016/j.celrep.2013.12.032; DALE RA, 1978, BIOCHIM BIOPHYS ACTA, V544, P496, DOI 10.1016/0304-4165(78)90324-0; Gui DY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003925; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; JOIS M, 1989, J BIOL CHEM, V264, P3347; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Kami K, 2013, METABOLOMICS, V9, P444, DOI 10.1007/s11306-012-0452-2; Kazachkov M, 2005, J CHROMATOGR B, V824, P116, DOI 10.1016/j.jchromb.2005.07.006; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; Narkewicz MR, 1996, BIOCHEM J, V313, P991, DOI 10.1042/bj3130991; Nelson DA, 2004, GENE DEV, V18, P2095, DOI 10.1101/gad.1204904; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Ptolemy AS, 2011, CLIN CHEM, V57, P545, DOI 10.1373/clinchem.2010.144899; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Rotem R, 2005, CANCER RES, V65, P1984, DOI 10.1158/0008-5472.CAN-04-3091; Sartori A, 2008, CHEM RES TOXICOL, V21, P1841, DOI 10.1021/tx8001753; Saudubray JM, INBORN METABOLIC DIS, V7th; Shikano N, 2010, NUCL MED BIOL, V37, P189, DOI 10.1016/j.nucmedbio.2009.10.003; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; TRESSEL T, 1986, J BIOL CHEM, V261, P6428; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	39	228	238	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					363	+		10.1038/nature14363	http://dx.doi.org/10.1038/nature14363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25855294	Green Submitted, Green Accepted			2022-12-28	WOS:000352974200042
J	Wagenblast, E; Soto, M; Gutierrez-Angel, S; Hartl, CA; Gable, AL; Maceli, AR; Erard, N; Williams, AM; Kim, SY; Dickopf, S; Harrell, JC; Smith, AD; Perou, CM; Wilkinson, JE; Hannon, GJ; Knott, SRV				Wagenblast, Elvin; Soto, Mar; Gutierrez-Angel, Sara; Hartl, Christina A.; Gable, Annika L.; Maceli, Ashley R.; Erard, Nicolas; Williams, Alissa M.; Kim, Sun Y.; Dickopf, Steffen; Harrell, J. Chuck; Smith, Andrew D.; Perou, Charles M.; Wilkinson, John E.; Hannon, Gregory J.; Knott, Simon R. V.			A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis	NATURE			English	Article							VASCULOGENIC MIMICRY; GENOMIC ANALYSIS; TUMOR; MAMMARY; CELLS; EXPRESSION; MELANOMA; SURVIVAL; ORIGINS; BRAIN	Cancer metastasis requires that primary tumour cells evolve the capacity to intravasate into the lymphatic system or vasculature, and extravasate into and colonize secondary sites(1). Others have demonstrated that individual cells within complex populations show heterogeneity in their capacity to form secondary lesions(2-5). Here we develop a polyclonal mouse model of breast tumour heterogeneity, and show that distinct clones within a mixed population display specialization, for example, dominating the primary tumour, contributing to metastatic populations, or showing tropism for entering the lymphatic or vasculature systems. We correlate these stable properties to distinct gene expression profiles. Those clones that efficiently enter the vasculature express two secreted proteins, Serpine2 and Slpi, which were necessary and sufficient to program these cells for vascular mimicry. Our data indicate that these proteins not only drive the formation of extravascular networks but also ensure their perfusion by acting as anticoagulants. We propose that vascular mimicry drives the ability of some breast tumour cells to contribute to distant metastases while simultaneously satisfying a critical need of the primary tumour to be fed by the vasculature. Enforced expression of SERPINE2 and SLPI in human breast cancer cell lines also programmed them for vascular mimicry, and SERPINE2 and SLPI were overexpressed preferentially in human patients that had lung-metastatic relapse. Thus, these two secreted proteins, and the phenotype they promote, may be broadly relevant as drivers of metastatic progression in human cancer.	[Wagenblast, Elvin; Soto, Mar; Gutierrez-Angel, Sara; Hartl, Christina A.; Gable, Annika L.; Maceli, Ashley R.; Erard, Nicolas; Williams, Alissa M.; Kim, Sun Y.; Dickopf, Steffen; Hannon, Gregory J.; Knott, Simon R. V.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Erard, Nicolas; Hannon, Gregory J.; Knott, Simon R. V.] Univ Cambridge, Li Ka Shing Ctr, CRUK Cambridge Inst, Cambridge CB2 0RE, England; [Harrell, J. Chuck; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet & Pathol, Chapel Hill, NC 27599 USA; [Smith, Andrew D.] Univ So Calif, Mol & Computat Biol, Los Angeles, CA 90089 USA; [Wilkinson, John E.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; CRUK Cambridge Institute; University of Cambridge; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; University of Michigan System; University of Michigan	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Perou, Charles M/H-9934-2014; Hannon, Gregory/AAB-3568-2019; Smith, Andrew D./G-4104-2013	Perou, Charles M/0000-0001-9827-2247; Smith, Andrew D./0000-0002-3337-1970; Kim, Sun/0000-0001-8133-865X; Gable, Annika Lisa/0000-0002-8965-0848; Harrell, J. Chuck/0000-0003-3541-8418; Wagenblast, Elvin/0000-0002-0709-2759	Howard Hughes Medical Institute; NIH; Cancer Center [5P30CA045508]; Boehringer Ingelheim Fonds; NCI Breast SPORE program [P50-CA58223-09A1]; Breast Cancer Research Foundation; Triple Negative Breast Cancer Foundation; Hope Funds For Cancer Research; NATIONAL CANCER INSTITUTE [P30CA045508, P50CA058223, P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062534, R01GM062534] Funding Source: NIH RePORTER; Cancer Research UK [21143] Funding Source: researchfish	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; Boehringer Ingelheim Fonds(Boehringer Ingelheim); NCI Breast SPORE program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Triple Negative Breast Cancer Foundation; Hope Funds For Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK)	This work was supported by the Howard Hughes Medical Institute as well as grants from the NIH (G.J.H.). This work was performed with assistance from CSHL Shared Resources, which are funded, in part, by the Cancer Center Support Grant 5P30CA045508. We thank M. Mosquera, M. Cahn, J. Coblentz, L. Bianco for support with mouse work; J. Ratcliff and P. Moody for assistance with flow cytometry; D. Hoppe, A. Nourjanova, R. Puzis for histology support and S. Hearn for microscopy assistance. We thank E. Hodges and E. Lee for support with next-generation sequencing; K. Chang for the lentiviral barcode library; E. Mardis and C. Sawyers for comments on the manuscript. E.W. is a Starr Centennial Scholar and is supported by a fellowship from the Boehringer Ingelheim Fonds. J.C.H. and C. M. P. were supported by funds from the NCI Breast SPORE program (P50-CA58223-09A1), the Breast Cancer Research Foundation and the Triple Negative Breast Cancer Foundation. S.R.V.K. is supported by a fellowship from The Hope Funds For Cancer Research.	Amiano NO, 2013, J CELL PHYSIOL, V228, P469, DOI 10.1002/jcp.24153; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Braun S, 2000, NEW ENGL J MED, V342, P525, DOI 10.1056/NEJM200002243420801; Cao ZF, 2013, EUR J CANCER, V49, P3914, DOI 10.1016/j.ejca.2013.07.148; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Fayard B, 2009, CANCER RES, V69, P5690, DOI 10.1158/0008-5472.CAN-08-4573; FIDLER IJ, 1978, CANCER RES, V38, P2651; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Folberg R, 2000, AM J PATHOL, V156, P361, DOI 10.1016/S0002-9440(10)64739-6; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; MILLER BE, 1988, CANCER RES, V48, P5747; MILLER FR, 1983, INVAS METAST, V3, P22; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Rosso M, 2014, BIOL CELL, V106, P308, DOI 10.1111/boc.201300075; Ruf W, 2003, CANCER RES, V63, P5381; Sayers KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104223; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007	26	246	263	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					358	+		10.1038/nature14403	http://dx.doi.org/10.1038/nature14403			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25855289	Green Accepted, Green Submitted			2022-12-28	WOS:000352974200041
J	Ran, FA; Cong, L; Yan, WX; Scott, DA; Gootenberg, JS; Kriz, AJ; Zetsche, B; Shalem, O; Wu, XB; Makarova, KS; Koonin, EV; Sharp, PA; Zhang, F				Ran, F. Ann; Cong, Le; Yan, Winston X.; Scott, David A.; Gootenberg, Jonathan S.; Kriz, Andrea J.; Zetsche, Bernd; Shalem, Ophir; Wu, Xuebing; Makarova, Kira S.; Koonin, Eugene V.; Sharp, Phillip A.; Zhang, Feng			In vivo genome editing using Staphylococcus aureus Cas9	NATURE			English	Article							OFF-TARGET SITES; GUIDE RNA; NUCLEASE SPECIFICITY; DNA CLEAVAGE; CRISPR RNA; GENE; IMMUNITY; SYSTEMS; ENDONUCLEASE; SEQUENCE	The RNA-guided endonuclease Cas9 has emerged as a versatile genom-editing platform. However, the size of the commonly used Cas9 from Streptococcus pyogenes (SpCas9) limits its utility for basic research and therapeutic applications that use the highly versatileaderio-assolated virus (AAV) delivery vehicle. Here, we we characterize six smaller Cas9 ortholocgues and show that Cas9 from Staphylococcus aureus (SaCas9) can edit the genome with efficiencies similar to those of spcas9, while being more than 1 kilobase shorter. We packaged SaCas9 and its single guide RNA expression cassette into a single AAV vector and targeted the cholesterol regulatory gene Pcsk9 in the mouse liver. Within one week of injection we observed >40%. gene modification, accompanied by significant reductions in serum Pcsk9 and total cholesterol le; Is We further assess the genome -wide targeting specificity of SaCas9 and SpCas9 using BLESS, and demonstrate that SaCas9-mediated in vivo genome editing has the potential to be efficient and specific.	[Ran, F. Ann; Cong, Le; Yan, Winston X.; Scott, David A.; Gootenberg, Jonathan S.; Zetsche, Bernd; Shalem, Ophir; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ran, F. Ann] Harvard Univ, Soc Fellows, Cambridge, MA 02138 USA; [Cong, Le; Kriz, Andrea J.; Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Yan, Winston X.] Harvard Univ, Sch Med, Grad Program Biophys, Boston, MA 02115 USA; [Yan, Winston X.] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA; [Scott, David A.; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Scott, David A.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Wu, Xuebing; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Wu, Xuebing] MIT, Computat & Syst Biol Grad Program, Cambridge, MA 02139 USA; [Makarova, Kira S.; Koonin, Eugene V.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Massachusetts Institute of Technology (MIT)	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	zhang@broadinstitute.org	Huang, ZhiXin/H-5123-2017; Cong, Le/M-9981-2013; Wu, Xuebing/C-9152-2013; Gootenberg, Jonathan/AAY-8174-2021; Wilson, Matthew H/K-3193-2013; Macrae, Rhiannon/AAX-1536-2020	Huang, ZhiXin/0000-0003-0705-1970; Cong, Le/0000-0003-4725-8714; Wu, Xuebing/0000-0003-0369-5269; Gootenberg, Jonathan/0000-0003-2757-2175; Shalem, Ophir/0000-0002-2267-0801	National Institute of General Medical Sciences [T32GM007753]; Paul and Daisy Soros Fellowship; US Department of Energy Computational Science Graduate Fellowship; United States Public Health Service from the National Institutes of Health [RO1-GM34277, R01-CA133404]; United States Public Health Service from the National Cancer Institute [PO1-CA42063]; Cancer Center from the National Cancer Institute [P30-CA14051]; National Institutes of Health through NIMH [5DP1-MH100706]; National Institutes of Health through NIDDK [5R01DK097768-03]; Waterman Award from the National Science Foundation; Keck Foundation; New York Stem Cell Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Merkin Foundation; Vallee Foundation; NIH core grant [5P30EY012196-17]; NATIONAL CANCER INSTITUTE [P01CA042063, P30CA014051, R01CA133404] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012196, R01EY024259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, R01GM034277, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Paul and Daisy Soros Fellowship; US Department of Energy Computational Science Graduate Fellowship(United States Department of Energy (DOE)); United States Public Health Service from the National Institutes of Health; United States Public Health Service from the National Cancer Institute; Cancer Center from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health through NIMH; National Institutes of Health through NIDDK; Waterman Award from the National Science Foundation; Keck Foundation(W.M. Keck Foundation); New York Stem Cell Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Merkin Foundation; Vallee Foundation; NIH core grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E. Charpentier, I. Fonfara and K. Chylinski for discussions; A. Scherer-Hoock, B. Clear and the MIT Division of Comparative Medicine for assistance with animal experiments; Boston Children's Hospital Viral Core and R. Xiao for assistance with AAV production; N. Crosetto for advice on BLESS; C.-Y. Lin and I. Slaymaker for experimental assistance; and the entire Zhang laboratory for support and advice. F.A.R. is a Junior Fellow at the Harvard Society of Fellows. W.X.Y. is supported by T32GM007753 from the National Institute of General Medical Sciences and a Paul and Daisy Soros Fellowship. J.S.G. is supported by a US Department of Energy Computational Science Graduate Fellowship. X.W. is a Howard Hughes Medical Institute International Student Research Fellow. P.A.S. is supported by United States Public Health Service grants RO1-GM34277, R01-CA133404 from the National Institutes of Health, and PO1-CA42063 from the National Cancer Institute, and partially by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute. F.Z. is supported by the National Institutes of Health through NIMH (5DP1-MH100706) and NIDDK (5R01DK097768-03), a Waterman Award from the National Science Foundation, the Keck, New York Stem Cell, Damon Runyon, Searle Scholars, Merkin, and Vallee Foundations, and B. Metcalfe. F.Z. is a New York Stem Cell Foundation Robertson Investigator. The Children's Hospital virus core is supported by an NIH core grant (5P30EY012196-17). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. CRISPR reagents are available to the academic community through Addgene, and information about the protocols, plasmids, and reagents can be found at the Zhang laboratory website http://www.genome-engineering.org.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gaudet D, 2010, ATHEROSCLEROSIS SUPP, V11, P55, DOI 10.1016/j.atherosclerosissup.2010.03.004; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Rozema DB, 2007, P NATL ACAD SCI USA, V104, P12982, DOI 10.1073/pnas.0703778104; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vasileva A, 2005, NAT REV MICROBIOL, V3, P837, DOI 10.1038/nrmicro1266; Veldwijk MR, 2002, MOL THER, V6, P272, DOI 10.1006/mthe.2002.0569; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; YOUNG SG, 1990, CIRCULATION, V82, P1574, DOI 10.1161/01.CIR.82.5.1574; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	1632	1954	27	691	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					186	U98		10.1038/nature14299	http://dx.doi.org/10.1038/nature14299			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25830891	Green Submitted, Green Accepted			2022-12-28	WOS:000352454600031
J	Pradarelli, JC; Campbell, DA; Dimick, JB				Pradarelli, Jason C.; Campbell, Darrell A., Jr.; Dimick, Justin B.			Hospital Credentialing and Privileging of Surgeons A Potential Safety Blind Spot	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pradarelli, Jason C.; Dimick, Justin B.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Pradarelli, Jason C.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Campbell, Darrell A., Jr.] Univ Michigan, Michigan Surg Qual Collaborat, Ann Arbor, MI 48109 USA; [Campbell, Darrell A., Jr.; Dimick, Justin B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pradarelli, JC (corresponding author), Univ Michigan, Sch Med, Ctr Healthcare Outcomes & Policy, 2800 Plymouth Rd,Bldg 16,Off 100N-07, Ann Arbor, MI 48109 USA.	jcprad@med.umich.edu	Mihalache, Dumitru/I-8684-2012		NCATS NIH HHS [2UL1TR000433] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		[Anonymous], MED STAFF HDB GUID J; Birkmeyer JD, 2013, NEW ENGL J MED, V369, P1434, DOI 10.1056/NEJMsa1300625; Harrysson IJ, 2014, ANN SURG, V260, P37, DOI 10.1097/SLA.0000000000000596; Herron DM, CONSENSUS DOCUMENT R; Hu YY, 2012, J AM COLL SURGEONS, V214, P115, DOI 10.1016/j.jamcollsurg.2011.10.009; Smith R, 2014, INT J MED ROBOT COMP, V10, P379, DOI 10.1002/rcs.1559	6	37	38	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2015	313	13					1313	1314		10.1001/jama.2015.1943	http://dx.doi.org/10.1001/jama.2015.1943			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF1OL	25849177				2022-12-28	WOS:000352315900013
J	Zhang, XY; Zhu, Y; Liu, XD; Hong, XY; Xu, Y; Zhu, P; Shen, Y; Wu, HH; Ji, YS; Wen, X; Zhang, C; Zhao, Q; Wang, YC; Lu, J; Guo, HW				Zhang, Xinyan; Zhu, Ying; Liu, Xiaodan; Hong, Xinyu; Xu, Yang; Zhu, Ping; Shen, Yang; Wu, Huihui; Ji, Yusi; Wen, Xing; Zhang, Chen; Zhao, Qiong; Wang, Yichuan; Lu, Jian; Guo, Hongwei			Suppression of endogenous gene silencing by bidirectional cytoplasmic RNA decay in Arabidopsis	SCIENCE			English	Article							ETHYLENE GAS; TRANSCRIPTION; ETHYLENE-INSENSITIVE3; BIOGENESIS; RESPONSES; TURNOVER	Plant immunity against foreign gene invasion takes advantage of posttranscriptional gene silencing (PTGS). How plants elaborately avert inappropriate PTGS of endogenous coding genes remains unclear. We demonstrate in Arabidopsis that both 5'-3' and 3'-5' cytoplasmic RNA decay pathways act as repressors of transgene and endogenous PTGS. Disruption of bidirectional cytoplasmic RNA decay leads to pleiotropic developmental defects and drastic transcriptomic alterations, which are substantially rescued by PTGS mutants. Upon dysfunction of bidirectional RNA decay, a large number of 21- to 22-nucleotide endogenous small interfering RNAs are produced from coding transcripts, including multiple microRNA targets, which could interfere with their cognate gene expression and functions. This study highlights the risk of unwanted PTGS and identifies cytoplasmic RNA decay pathways as safeguards of plant transcriptome and development.	[Zhang, Xinyan; Zhu, Ying; Liu, Xiaodan; Hong, Xinyu; Wu, Huihui; Ji, Yusi; Wen, Xing; Zhang, Chen; Zhao, Qiong; Wang, Yichuan; Lu, Jian; Guo, Hongwei] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Xu, Yang; Zhu, Ping] Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Shen, Yang; Lu, Jian; Guo, Hongwei] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Guo, HW (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	hongweig@pku.edu.cn	Wen, Xing/ABI-5408-2020; zhao, qiong/AAB-4655-2020; Zhang, Xinyan/O-3442-2016	Wen, Xing/0000-0002-9322-2272; Zhu, Ping/0000-0002-4521-7524	National Basic Research Program of China (973 Program) [2012CB910902]; National Natural Science Foundation of China [91217305, 91017010]; 111 Project of Peking University	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project of Peking University	We thank Y. Qi (Tsinghua University) and F. Tang and Y. Li (Peking University) for assistance in RNA sequencing experiments. We also thank J. Olson (Peking University) for assistance in English editing. This work is supported by the National Basic Research Program of China (973 Program; grant 2012CB910902) and the National Natural Science Foundation of China (grants 91217305 and 91017010 to H.G.). The publication fee is covered by the 111 Project of Peking University. Data have been deposited in the Gene Expression Omnibus under accession numbers GSE52407 and GSE57936. The supplementary materials contain additional data.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Bologna NG, 2014, ANNU REV PLANT BIOL, V65, P473, DOI 10.1146/annurev-arplant-050213-035728; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Diaz U, 2006, PLANT CELL PHYSIOL, V47, P74, DOI 10.1093/pcp/pci225; Dorcey E, 2012, PLOS GENET, V8, P395, DOI 10.1371/journal.pgen.1002652; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Hwang CF, 1997, PLANT PHYSIOL, V113, P853, DOI 10.1104/pp.113.3.853; Incarbone M, 2013, TRENDS PLANT SCI, V18, P382, DOI 10.1016/j.tplants.2013.04.001; Moreno AB, 2013, NUCLEIC ACIDS RES, V41, P4699, DOI 10.1093/nar/gkt152; Olmedo G, 2006, P NATL ACAD SCI USA, V103, P13286, DOI 10.1073/pnas.0605528103; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; Schubert D, 2004, PLANT CELL, V16, P2561, DOI 10.1105/tpc.104.024547; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Vazquez F, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/783253; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Zhang XY, 2013, MOL PLANT, V6, P1661, DOI 10.1093/mp/sst071	25	103	108	3	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					120	123		10.1126/science.aaa2618	http://dx.doi.org/10.1126/science.aaa2618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838384				2022-12-28	WOS:000352079500040
J	Benitez-Llambay, P; Masset, F; Koenigsberger, G; Szulagyi, J				Benitez-Llambay, Pablo; Masset, Frederic; Koenigsberger, Gloria; Szulagyi, Judit			Planet heating prevents inward migration of planetary cores	NATURE			English	Article							TORQUE FORMULA; SUPER-EARTHS; MASS; DISK; DIFFUSION; ACCRETION; GAS	Planetary systems are born in the disks of gas, dust and rocky fragments that surround newly formed stars. Solid content assembles into ever-larger rocky fragments that eventually become planetary embryos. These then continue their growth by accreting leftover material in the disk. Concurrently, tidal effects in the disk cause a radial drift in the embryo orbits, a process known as migration(1-4). Fast inward migration is predicted by theory for embryos smaller than three to five Earth masses(5-7). With only inward migration, these embryos can only rarely become giant planets located at Earth's distance from the Sun and beyond(8,9), in contrast with observations(10). Here we report that asymmetries in the temperature rise associated with accreting infalling material(11,12) produce a force (which gives rise to an effect that we call 'heating torque') that counteracts inward migration. This provides a channel for the formation of giant planets(8) and also explains the strong planet-metallicity correlation found between the incidence of giant planets and the heavy-element abundance of the host stars(13,14).	[Benitez-Llambay, Pablo] Univ Nacl Cordoba, IATE, Observ Astron, RA-5000 Cordoba, Argentina; [Masset, Frederic; Koenigsberger, Gloria] Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62210, Morelos, Mexico; [Szulagyi, Judit] Univ Nice Sophia Antipolis, CNRS, Observ Cote Azur, Lab Lagrange, F-06304 Nice, France	National University of Cordoba; Universidad Nacional Autonoma de Mexico; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur	Masset, F (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Ave Univ S-N, Cuernavaca 62210, Morelos, Mexico.	fmasset@cea.fr	Benítez-Llambay, Pablo/N-1680-2016	Benítez-Llambay, Pablo/0000-0002-3728-3329; Szulagyi, Judit/0000-0001-8442-4043	CONICET; UNAM [PAPIIT IA101113, IN105313]; CONACyT [178377, 129343]; Capital Fund Management's J. P. Aguilar Grant	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UNAM(Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Capital Fund Management's J. P. Aguilar Grant	We thank A. Morbidelli for a critical reading of a first version of this manuscript. P.B.-Ll. thanks CONICET for financial support. This research was supported by UNAM grants PAPIIT IA101113 and IN105313 and by CONACyT grants 178377 and 129343. J.Sz. acknowledges support from the Capital Fund Management's J. P. Aguilar Grant. We also thank U. Amaya Olvera, R. Garcia Carreon and J. Verleyen for their assistance in setting up the GPU cluster on which the calculations presented here have been run.	Baruteau C., 2013, PREPRINT; Bitsch B, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220159; Chiang E, 2013, MON NOT R ASTRON SOC, V431, P3444, DOI 10.1093/mnras/stt424; Commercon B, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201322858; Cossou C, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201424157; Crida A, 2009, ASTRON ASTROPHYS, V502, P679, DOI 10.1051/0004-6361/200811608; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; Hansen BMS, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/53; Hayashi C., 1985, PROTOSTARS PLANETS, VII, P1100; Howard AW, 2013, SCIENCE, V340, P572, DOI 10.1126/science.1233545; Jenkins JS, 2013, EPJ WEB CONF, V47, DOI 10.1051/epjconf/20134705001; Levison HF, 2010, ASTRON J, V139, P1297, DOI 10.1088/0004-6256/139/4/1297; Mordasini C., 2014, PREPRINT; Paardekooper SJ, 2011, MON NOT R ASTRON SOC, V410, P293, DOI 10.1111/j.1365-2966.2010.17442.x; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Ramsey J. P., 2014, PREPRINT; Szulagyi J, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/65; Tanaka H, 2002, ASTROPHYS J, V565, P1257, DOI 10.1086/324713	26	97	97	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					63	U127		10.1038/nature14277	http://dx.doi.org/10.1038/nature14277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25832403	Green Submitted			2022-12-28	WOS:000352027700036
J	Baeza-Trinidad, R; Revuelta, JAO				Baeza-Trinidad, Ramon; Oteo Revuelta, Jose A.			Spina Ventosa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Baeza-Trinidad, Ramon; Oteo Revuelta, Jose A.] Hosp San Pedro, La Rioja, Spain		Baeza-Trinidad, R (corresponding author), Hosp San Pedro, La Rioja, Spain.	ramonbaezat@yahoo.es	Oteo, Jose A./AAB-3134-2020	Oteo, Jose A./0000-0001-7080-6542; Baeza-Trinidad, Ramon/0000-0002-7854-3115					0	1	1	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2015	372	13					E18	E18		10.1056/NEJMicm1315601	http://dx.doi.org/10.1056/NEJMicm1315601			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1QD	25806937				2022-12-28	WOS:000351585900001
J	Hawkes, N				Hawkes, Nigel			THE BMJ AWARDS 2015 Dementia team award	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2015	350									10.1136/bmj.h1556	http://dx.doi.org/10.1136/bmj.h1556			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7OC	25812566				2022-12-28	WOS:000352030200009
J	Thompson, JK				Thompson, James K.			QUANTUM PHYSICS Atomic doughnuts from single photons	NATURE			English	Editorial Material							ENTANGLEMENT; LIMIT		[Thompson, James K.] JILA, Boulder, CO 80309 USA; [Thompson, James K.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Thompson, James K.] NIST, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA	Thompson, JK (corresponding author), JILA, Boulder, CO 80309 USA.	jkt@jila.colorado.edu						Appel J, 2009, P NATL ACAD SCI USA, V106, P10960, DOI 10.1073/pnas.0901550106; Bohnet JG, 2014, NAT PHOTONICS, V8, P731, DOI [10.1038/nphoton.2014.151, 10.1038/NPHOTON.2014.151]; Christensen SL, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.033801; Haas F, 2014, SCIENCE, V344, P180, DOI 10.1126/science.1248905; Lucke B, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.155304; McConnell R, 2015, NATURE, V519, P439, DOI 10.1038/nature14293; McConnell R, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.063802; Sorensen AS, 2001, PHYS REV LETT, V86, P4431, DOI 10.1103/PhysRevLett.86.4431	8	0	0	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					420	422		10.1038/519420b	http://dx.doi.org/10.1038/519420b			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25810201				2022-12-28	WOS:000351602800043
J	Vora, NM; Li, Y; Geleishvili, M; Emerson, GL; Khmaladze, E; Maghlakelidze, G; Navdarashvili, A; Zakhashvili, K; Kokhreidze, M; Endeladze, M; Mokverashvili, G; Satheshkumar, PS; Gallardo-Romero, N; Goldsmith, CS; Metcalfe, MG; Damon, I; Maes, EF; Reynolds, MG; Morgan, J; Carroll, DS				Vora, Neil M.; Li, Yu; Geleishvili, Marika; Emerson, Ginny L.; Khmaladze, Ekaterine; Maghlakelidze, Giorgi; Navdarashvili, Archil; Zakhashvili, Khatuna; Kokhreidze, Maka; Endeladze, Marina; Mokverashvili, Gela; Satheshkumar, P. S.; Gallardo-Romero, Nadia; Goldsmith, Cynthia S.; Metcalfe, Maureen G.; Damon, Inger; Maes, Edmond F.; Reynolds, Mary G.; Morgan, Juliette; Carroll, Darin S.			Human Infection with a Zoonotic Orthopoxvirus in the Country of Georgia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COWPOX VIRUS-INFECTION; TIME PCR ASSAYS; MONKEYPOX-VIRUS; UNITED-STATES; WILD RODENTS; POXVIRUS; AFRICAN	During 2013, cutaneous lesions developed in two men in the country of Georgia after they were exposed to ill cows. The men had never received vaccination against smallpox. Tests of lesion material with the use of a quantitative real-time polymerase-chain-reaction assay for non-variola virus orthopoxviruses were positive, and DNA sequence analysis implicated a novel orthopoxvirus species. During the ensuing epidemiologic investigation, no additional human cases were identified. However, serologic evidence of exposure to an orthopoxvirus was detected in cows in the patients' herd and in captured rodents and shrews. A third case of human infection that occurred in 2010 was diagnosed retrospectively during testing of archived specimens that were originally submitted for tests to detect anthrax. Orthopoxvirus infection should be considered in persons in whom cutaneous lesions develop after contact with animals.	[Vora, Neil M.] Ctr Dis Control & Prevent CDC, Epidem Intelligence Serv, Atlanta, GA USA; [Vora, Neil M.; Li, Yu; Emerson, Ginny L.; Satheshkumar, P. S.; Gallardo-Romero, Nadia; Goldsmith, Cynthia S.; Metcalfe, Maureen G.; Damon, Inger; Reynolds, Mary G.; Carroll, Darin S.] Ctr Dis Control & Prevent CDC, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Vora, Neil M.; Geleishvili, Marika; Maes, Edmond F.; Morgan, Juliette] Ctr Dis Control & Prevent CDC, Div Global Hlth Protect, Atlanta, GA USA; [Geleishvili, Marika; Morgan, Juliette] CDC Georgia Country Off, Tbilisi, Georgia; [Khmaladze, Ekaterine; Navdarashvili, Archil; Zakhashvili, Khatuna] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Maghlakelidze, Giorgi; Kokhreidze, Maka] Lab Minist Agr, Tbilisi, Georgia; [Endeladze, Marina] Infect Dis AIDS & Clin Immunol Res Ctr, Tbilisi, Georgia; [Mokverashvili, Gela] Natl Food Agcy, Tianeti, Georgia	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; National Center for Disease Control & Public Health - Georgia	Carroll, DS (corresponding author), CDC, Div High Consequence Pathogens & Pathol, 1600 Clifton Rd NE,Mailstop G43, Atlanta, GA 30333 USA.	zuz4@cdc.gov	Vora, Neil Manhar/AAJ-7269-2021	Vora, Neil Manhar/0000-0002-4989-3108; Reynolds, Mary/0000-0001-7882-4614	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		BAXBY D, 1994, BRIT J DERMATOL, V131, P598, DOI 10.1111/j.1365-2133.1994.tb04969.x; BAXBY D, 1977, BMJ-BRIT MED J, V1, P1379, DOI 10.1136/bmj.1.6073.1379; Bennett M, 1997, J COMP PATHOL, V116, P35, DOI 10.1016/S0021-9975(97)80041-2; Berthet N, 2011, LANCET, V378, P1354, DOI 10.1016/S0140-6736(11)61142-2; Campe H, 2009, EMERG INFECT DIS, V15, P777, DOI 10.3201/eid1505.090159; Carroll DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023086; Chantrey J, 1999, EPIDEMIOL INFECT, V122, P455, DOI 10.1017/S0950268899002423; da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223; Dabrowski PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079953; Damle AS, 2011, J GLOB INFECT DIS, V3, P187, DOI 10.4103/0974-777X.81698; Dhar AD, 2004, NEW ENGL J MED, V350, P361, DOI 10.1056/NEJMoa031467; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Emerson GL, 2013, EMERG INFECT DIS, V19, P1002, DOI 10.3201/eid1906.121713; Frey SE, 2004, NEW ENGL J MED, V350, P324, DOI 10.1056/NEJMp038208; Goldsmith CS, 2003, VIRUS RES, V92, P89, DOI 10.1016/S0168-1702(02)00323-4; Gross C P, 1998, Int J Infect Dis, V3, P54; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kinnunen PM, 2011, VECTOR-BORNE ZOONOT, V11, P1133, DOI 10.1089/vbz.2010.0170; Li Y, 2006, J CLIN VIROL, V36, P194, DOI 10.1016/j.jcv.2006.03.012; Li Y, 2010, J VIROL METHODS, V169, P223, DOI 10.1016/j.jviromet.2010.07.012; Li Y, 2010, J CLIN MICROBIOL, V48, P268, DOI 10.1128/JCM.01697-09; McCollum AM, 2012, J INFECT DIS, V206, P63, DOI 10.1093/infdis/jis302; Mombouli JV, 2012, LANCET, V379, P10, DOI 10.1016/S0140-6736(11)60694-6; Pahlitzsch R, 2006, CLIN INFECT DIS, V43, P737, DOI 10.1086/506937; Reynolds MG, 2012, TRENDS MICROBIOL, V20, P80, DOI 10.1016/j.tim.2011.12.001; Reynolds MG, 2010, AM J TROP MED HYG, V82, P746, DOI 10.4269/ajtmh.2010.09-0716; Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756; Tryland M, 1998, J WILDLIFE DIS, V34, P240, DOI 10.7589/0090-3558-34.2.240; TSANAVA SA, 1989, VOP VIRUSOL+, P95; TSANAVA SA, 1989, ACTA VIROL, V33, P91	32	43	44	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2015	372	13					1223	1230		10.1056/NEJMoa1407647	http://dx.doi.org/10.1056/NEJMoa1407647			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1QD	25806914	Green Accepted			2022-12-28	WOS:000351585900008
J	[Anonymous]				[Anonymous]			India	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S66	S67		10.1038/519S66a	http://dx.doi.org/10.1038/519S66a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE1WF	25806698	Bronze			2022-12-28	WOS:000351602800013
J	[Anonymous]				[Anonymous]			China	NATURE			English	Editorial Material																			0	0	0	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S54	S55		10.1038/519S54a	http://dx.doi.org/10.1038/519S54a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE1WF	25806694	Bronze			2022-12-28	WOS:000351602800009
J	Hergott, LJ				Hergott, Lawrence J.			The Absence of Something	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Colorado, Sch Med, Dept Med, Denver, CO 80204 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Hergott, LJ (corresponding author), Univ Colorado, Sch Med, Dept Med, Denver, CO 80204 USA.	lhergott@comcast.net						Hergott LJ, 2014, EXPOSITORY TIMES, V126, P104, DOI 10.1177/0014524614543431; Hergott LJ, 2009, JAMA-J AM MED ASSOC, V302, P2188, DOI 10.1001/jama.2009.1586; Hergott LJ, 2009, ANN INTERN MED, V151, P753; O'Donohue J, 2008, TO BLESS THE SPACE B	4	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1215	1216		10.1001/jama.2015.0874	http://dx.doi.org/10.1001/jama.2015.0874			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25803344				2022-12-28	WOS:000351435500017
J	Lieberman, J; Sharp, PA				Lieberman, Judy; Sharp, Philip A.			Harnessing RNA Interference for Therapy The Silent Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lieberman, Judy] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Sharp, Philip A.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Lieberman, J (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, 200 Longwood Ave, Boston, MA 02115 USA.	judy.lieberman@childrens.harvard.edu	Lieberman, Judy/A-2717-2015					Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Nair JK, 2014, J AM CHEM SOC, V136, P16958, DOI 10.1021/ja505986a; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828	6	10	10	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1207	1208		10.1001/jama.2015.1241	http://dx.doi.org/10.1001/jama.2015.1241			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25803342				2022-12-28	WOS:000351435500013
J	Coleman, MP; Allemani, C				Coleman, Michel P.; Allemani, Claudia			Cancer: the elephant in the room	LANCET			English	Editorial Material									[Coleman, Michel P.; Allemani, Claudia] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, London WC1E 7HT, England	Cancer Research UK; University of London; London School of Hygiene & Tropical Medicine	Coleman, MP (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, London WC1E 7HT, England.	michel.coleman@lshtm.ac.uk	Coleman, Michel/AAA-9543-2020	Coleman, Michel/0000-0001-8940-3807	Cancer Research UK [11700, 16148] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Ahmad AS, 2015, BRIT J CANCER, V112, P943, DOI 10.1038/bjc.2014.606; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; [Anonymous], 2013, LANCET, V381, P426, DOI 10.1016/S0140-6736(13)60060-4; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Cavalli F, 2013, LANCET, V381, P425, DOI 10.1016/S0140-6736(13)60059-8; Coleman MP, 2014, LANCET, V383, P564, DOI 10.1016/S0140-6736(13)62225-4; Department of Health, 2011, IMPR OUTC STRAT CANC; Department of Health, 2000, NHS CANC PLAN PLAN I; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Knaul FM, 2011, CLOSING CANC DIVIDE, P71; NHS England, 2015, NHS LAUNCH NEW BID B; Office for National Statistics, 2014, OFF NAT STAT SER MB1, V43; Pui CH, 2013, SEMIN HEMATOL, V50, P185, DOI 10.1053/j.seminhematol.2013.06.007; Quaresma M, 2015, LANCET, V385, P1206, DOI 10.1016/S0140-6736(14)61396-9	14	10	10	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1047	1048		10.1016/S0140-6736(15)60571-2	http://dx.doi.org/10.1016/S0140-6736(15)60571-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD7KX	25797546				2022-12-28	WOS:000351270400005
J	Kalogeropoulos, AS; Siva, A; Anderson, L				Kalogeropoulos, Andreas S.; Siva, Arun; Anderson, Lisa			Abiotrophia defectivus infectious endocarditis: think beyond the heart	LANCET			English	Editorial Material									[Kalogeropoulos, Andreas S.; Siva, Arun; Anderson, Lisa] St Georges Univ Hosp NHS Fdn Trust, Dept Cardiol, London SW17 0QT, England		Kalogeropoulos, AS (corresponding author), St Georges Univ Hosp NHS Fdn Trust, Dept Cardiol, London SW17 0QT, England.	andkalog@gmail.com						BOUVET A, 1995, EUR HEART J, V16, P24, DOI 10.1093/eurheartj/16.suppl_B.24; Flor-de-Lima F, 2013, EUR J PEDIATR, V172, P1285, DOI 10.1007/s00431-013-2032-5; Haeusler GM, 2012, LANCET, V380, P858, DOI 10.1016/S0140-6736(12)60573-X; Kiernan TJ, 2008, INT J INFECT DIS, V12, P478, DOI 10.1016/j.ijid.2008.01.014; Ramos JN, 2014, INFECTION, V42, P579, DOI 10.1007/s15010-014-0595-3	5	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					1044	1044		10.1016/S0140-6736(15)60090-3	http://dx.doi.org/10.1016/S0140-6736(15)60090-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD2EK	25784351	Green Accepted			2022-12-28	WOS:000350886900036
J	Purcell, C; Cant, A; Irvine, AD				Purcell, Claire; Cant, Andrew; Irvine, Alan D.			DOCK8 primary immunodeficiency syndrome	LANCET			English	Editorial Material									[Purcell, Claire] Our Ladys Childrens Hosp, Dept Paediat Dermatol, Dublin, Ireland; [Cant, Andrew] Great North Childrens Hosp, Paediat Immunol, Newcastle Upon Tyne, Tyne & Wear, England; [Irvine, Alan D.] Natl Childrens Res Ctr, Dublin, Ireland; [Irvine, Alan D.] Univ Dublin Trinity Coll, Dept Clin Med, Dublin 2, Ireland	National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; National Children's Research Centre (NCRC); Trinity College Dublin; Trinity College Dublin	Irvine, AD (corresponding author), Our Ladys Childrens Hosp Crumlin, Paediat Dermatol, Dublin 12, Ireland.	irvinea@tcd.ie	Irvine, Alan D/A-3982-2008	Irvine, Alan D/0000-0002-9048-2044					0	2	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					982	982		10.1016/S0140-6736(14)62039-0	http://dx.doi.org/10.1016/S0140-6736(14)62039-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2TE	25798541				2022-12-28	WOS:000361182700030
J	Caskey, M; Klein, F; Lorenzi, JCC; Seaman, MS; West, AP; Buckley, N; Kremer, G; Nogueira, L; Braunschweig, M; Scheid, JF; Horwitz, JA; Shimeliovich, I; Ben-Avraham, S; Witmer-Pack, M; Platten, M; Lehmann, C; Burke, LA; Hawthorne, T; Gorelick, RJ; Walker, BD; Keler, T; Gulick, RM; Fatkenheuer, G; Schlesinger, SJ; Nussenzweig, MC				Caskey, Marina; Klein, Florian; Lorenzi, Julio C. C.; Seaman, Michael S.; West, Anthony P., Jr.; Buckley, Noreen; Kremer, Gisela; Nogueira, Lilian; Braunschweig, Malte; Scheid, Johannes F.; Horwitz, Joshua A.; Shimeliovich, Irina; Ben-Avraham, Sivan; Witmer-Pack, Maggi; Platten, Martin; Lehmann, Clara; Burke, Leah A.; Hawthorne, Thomas; Gorelick, Robert J.; Walker, Bruce D.; Keler, Tibor; Gulick, Roy M.; Faetkenheuer, Gerd; Schlesinger, Sarah J.; Nussenzweig, Michel C.			Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117	NATURE			English	Article							MONOCLONAL-ANTIBODIES; HIV-1 NEUTRALIZATION; GENETIC-DETERMINANTS; PASSIVE TRANSFER; IN-VIVO; THERAPY; VIRUS; IMMUNOTHERAPY; VACCINE; MICE	HIV-1 immunotherapy with a combination of first generation monoclonal antibodies was largely ineffective in pre-clinical and clinical settings and was therefore abandoned(1-3). However, recently developed single-cell-based antibody cloning methods have uncovered a new generation of far more potent broadly neutralizing antibodies to HIV-1 (refs 4, 5). These antibodies can prevent infection and suppress viraemia in humanized mice and nonhuman primates, but their potential for human HIV-1 immunotherapy has not been evaluated(6-10). Here we report the results of a first-in-man dose escalation phase 1 clinical trial of 3BNC117, a potent human CD4 binding site antibody(11), in uninfected and HIV-1-infected individuals. 3BNC117 infusion was well tolerated and demonstrated favourable pharmacokinetics. A single 30mg kg(-1) infusion of 3BNC117 reduced the viral load in HIV-1-infected individuals by 0.8-2.5 log(10) and viraemia remained significantly reduced for 28 days. Emergence of resistant viral strains was variable, with some individuals remaining sensitive to 3BNC117 for a period of 28 days. We conclude that, as a single agent, 3BNC117 is safe and effective in reducing HIV-1 viraemia, and that immunotherapy should be explored as a new modality for HIV-1 prevention, therapy and cure.	[Caskey, Marina; Klein, Florian; Lorenzi, Julio C. C.; Buckley, Noreen; Nogueira, Lilian; Braunschweig, Malte; Scheid, Johannes F.; Horwitz, Joshua A.; Shimeliovich, Irina; Ben-Avraham, Sivan; Witmer-Pack, Maggi; Burke, Leah A.; Schlesinger, Sarah J.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Seaman, Michael S.] Harvard Univ, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [West, Anthony P., Jr.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Kremer, Gisela; Platten, Martin; Lehmann, Clara; Faetkenheuer, Gerd] Univ Hosp Cologne, Dept Internal Med 1, D-50924 Cologne, Germany; [Kremer, Gisela] Univ Cologne, Clin Trials Ctr Cologne, ZKS Koln, D-50931 Cologne, Germany; [Braunschweig, Malte] Univ Freiburg, D-79085 Freiburg, Germany; [Platten, Martin; Lehmann, Clara; Faetkenheuer, Gerd] Partner Site Bonn Cologne, German Ctr Infect Res DZIF, Cologne, Germany; [Burke, Leah A.; Gulick, Roy M.] Cornell Univ, Div Infect Dis, Weill Med Coll, New York, NY 10065 USA; [Hawthorne, Thomas; Keler, Tibor] Celldex Therapeut Inc, Hampton, NJ 08827 USA; [Gorelick, Robert J.] Frederick Natl Lab Canc Res, Leidos Biomed Res, AIDS & Canc Virus Program, Frederick, MD 21702 USA; [Walker, Bruce D.] Massachusetts Gen Hosp, Radon Inst MGH MIT & Harvard, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Walker, Bruce D.] Harvard Univ, Sch Med, Cambridge, MA 02139 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; California Institute of Technology; University of Cologne; University of Cologne; University of Freiburg; German Center for Infection Research; University of Cologne; Cornell University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu	Lorenzi, Julio/S-2394-2019; Nussenzweig, Michel/AAE-7292-2019; Lorenzi, Julio Cesar C.C. Cetrulo/B-5264-2008; Lehmann, Clara/F-9671-2016	Lorenzi, Julio/0000-0003-2492-3961; Lorenzi, Julio Cesar C.C. Cetrulo/0000-0003-2492-3961; Lehmann, Clara/0000-0002-7042-1578; Caskey, Marina/0000-0003-1727-8693; Ben-Avraham, Sivan/0000-0002-9130-0062	CNPq "Ciencia sem Fronteiras" Brazil [248676/2013-0]; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) [OPP1033115, OPP1092074, OPP1040753, OPP1032144]; Cooperative Centers on Human Immunology from NIH [U19A1111825-01]; National Center for Advancing Translational Sciences (NCATS) [UL1 TR000043]; Robertson Foundation; NCI/NIH [HHSN261200800001E]; German Center for Infection Research (DZIF) [3BNC117]; Mark and Lisa Schwartz Foundation; CAVD [43307]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111825] Funding Source: NIH RePORTER	CNPq "Ciencia sem Fronteiras" Brazil; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD); Cooperative Centers on Human Immunology from NIH; National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Robertson Foundation; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Center for Infection Research (DZIF); Mark and Lisa Schwartz Foundation; CAVD; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all individuals who participated in this study. We thank the Rockefeller University Hospital Clinical Research Support Office and nursing staff, as well as T. Kummerle, C. Wyen, and L. Siegel for help with recruitment; S. Kiss for ophthalmologic assessments; F. Maldarelli and J. Lifson for single-copy analysis and B. Freemire for technical assistance; J. Pring, A. Almaktari, C. Unsen, S. Hadrigan, E. Thomas, H. Gruell, D. Gillor, and U. Sandaradura de Silva for sample processing and study coordination, and N. Rodziewicz for help with HIV-1 culturing. We thank A. Louie and C. Conrad for help with regulatory submissions; L. Thomas for IND-enabling studies, L Vitale for cell line and anti-idiotype antibody development, B. Riordan, A. Rayo and J. Andreozzi for anti-idiotype ELISA method development and sample analysis, R. Hammond for process development, and S. DiSciullo for 3BNC117 manufacturing; J. Perry for performing neutralization assays. We thank M. Suarez-Farinas for support with statistical analysis; P. Fast and H. Park for clinical monitoring; and E. Gotschlich and B. Caller for input on study design. J.C.C.L. is supported by an award from CNPq "Ciencia sem Fronteiras" Brazil (248676/2013-0). This work was supported in part by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) Grants OPP1033115 (M.C.N.), OPP1092074 (M.C.N.), OPP1040753 (A.P.W.) and OPP1032144 (M.S.S.), and U19A1111825-01 Cooperative Centers on Human Immunology from NIH to M.C.N., by grant #UL1 TR000043 from the National Center for Advancing Translational Sciences (NCATS), by a grant from the Robertson Foundation to M.C.N., in part with Federal funds from the NCI/NIH, under Contract No. HHSN261200800001E, and a grant from the German Center for Infection Research (DZIF) to G.F. 3BNC117 was generated from a subject in the International HIV Controller Study, supported by the Mark and Lisa Schwartz Foundation and CAVD Grant 43307. M.C.N. and B.D.W. are Howard Hughes Medical Institute Investigators. The authors declare no competing financial interests.	Armbruster C, 2004, J ANTIMICROB CHEMOTH, V54, P915, DOI 10.1093/jac/dkh428; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Glassman Patrick M., 2014, Cancer Biology Medicine, V11, P20, DOI 10.7497/j.issn.2095-3941.2014.01.002; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Matsushita S, 2015, AIDS, V29, P453, DOI 10.1097/QAD.0000000000000570; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; MONTEFIORI DC, 2005, CURR PROTOC IMMUNOL, V12; Nettles RE, 2012, J INFECT DIS, V206, P1002, DOI 10.1093/infdis/jis432; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Somsouk M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116306; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; van't Wout AB, 2008, NAT PROTOC, V3, P363, DOI 10.1038/nprot.2008.3; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110	40	511	525	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					487	+		10.1038/nature14411	http://dx.doi.org/10.1038/nature14411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	25855300	Green Accepted			2022-12-28	WOS:000356782900052
J	Jolly, SS; Mehta, SR				Jolly, Sanjit S.; Mehta, Shamir R.			Coronary intervention: radial artery access comes of age	LANCET			English	Editorial Material							ST-SEGMENT ELEVATION; ACUTE MYOCARDIAL-INFARCTION; FEMORAL ACCESS; ANGIOGRAPHY; CLOPIDOGREL; OUTCOMES; IMPACT		[Jolly, Sanjit S.] McMaster Univ, Hamilton, ON L8L 2X2, Canada; Hamilton Gen Hosp, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada	McMaster University; McMaster University; Population Health Research Institute	Jolly, SS (corresponding author), McMaster Univ, Hamilton, ON L8L 2X2, Canada.	sanjit.jollly@phri.ca	Jolly, Sanjit/O-2534-2015					Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Feldman DN, 2013, CIRCULATION, V127, P2295, DOI 10.1161/CIRCULATIONAHA.112.000536; Jolly SS, 2014, J AM COLL CARDIOL, V63, P954, DOI 10.1016/j.jacc.2013.10.052; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023; Levine GN, 2012, CATHETER CARDIO INTE, V79, P453, DOI 10.1002/ccd.23438; Mehta SR, 2012, J AM COLL CARDIOL, V60, P2490, DOI 10.1016/j.jacc.2012.07.050; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Valgimigli M, 2015, LANCET; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Yusuf S, 2001, NEW ENGL J MED, V345, P494	13	8	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2437	2439		10.1016/S0140-6736(15)60507-4	http://dx.doi.org/10.1016/S0140-6736(15)60507-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK9AR	25791213				2022-12-28	WOS:000356532500005
J	Curzen, N				Curzen, Nick			Prolonged antiplatelet therapy after drug-eluting stents	LANCET			English	Editorial Material							THROMBOSIS		Univ Hosp Southampton NHS Fdn Trust, Southampton SO16 6YD, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust	Curzen, N (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Southampton SO16 6YD, Hants, England.	nick.curzen@uhs.nhs.uk	curzen, nick/AAD-8161-2020					Alfonso F, 2014, EUR HEART J, V35, P2541, DOI [DOI 10.1093/EURHEARTJ/EHU278, 10.1093/eurheartj/ ehu278, 10.1093/eurheartj/ehu278]; Curzen N, 2012, HEART, V98, P1617, DOI 10.1136/heartjnl-2012-302299; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Giustino G, 2015, J AM COLL CARDIOL, V65, P1298, DOI 10.1016/j.jacc.2015.01.039; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Palmerini T, 2015, LANCET, V385, P2371, DOI 10.1016/S0140-6736(15)60263-X; Raber L, 2012, CIRCULATION, V125, P1110, DOI 10.1161/CIRCULATIONAHA.111.058560	8	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2332	2333		10.1016/S0140-6736(15)60448-2	http://dx.doi.org/10.1016/S0140-6736(15)60448-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1XV	25777664				2022-12-28	WOS:000356003700009
J	Harris, RP				Harris, Russell P.			Incidental Findings in the Pancreas (and Elsewhere): Putting Our Patients (and Ourselves) in a Difficult Situation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INTERNATIONAL CONSENSUS GUIDELINES; PREVALENCE; MANAGEMENT; CYSTS; CARE		[Harris, Russell P.] Univ N Carolina, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Harris, RP (corresponding author), Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, 725 Martin Luther King Blvd,CB 7590, Chapel Hill, NC 27599 USA.	rharris@med.unc.edu						Berland LL, 2010, J AM COLL RADIOL, V7, P754, DOI 10.1016/j.jacr.2010.06.013; de Jong K, 2010, CLIN GASTROENTEROL H, V8, P806, DOI 10.1016/j.cgh.2010.05.017; Harris RP, 2015, ANN INTERN MED, V162, P712, DOI 10.7326/M14-2327; Laffan TA, 2008, AM J ROENTGENOL, V191, P802, DOI 10.2214/AJR.07.3340; Scheiman JM, 2015, GASTROENTER IN PRESS; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Vege SS, 2015, GASTROENTER IN PRESS	9	7	9	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2015	162	11					787	789		10.7326/M15-0590	http://dx.doi.org/10.7326/M15-0590			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ5ZH	25807075				2022-12-28	WOS:000355572300007
J	Ganguli, I; Wasfy, JH; Ferris, TG				Ganguli, Ishani; Wasfy, Jason H.; Ferris, Timothy G.			What Is the Right Number of Clinic Appointments? Visit Frequency and the Accountable Care Organization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ganguli, Ishani; Wasfy, Jason H.; Ferris, Timothy G.] Harvard Univ, Sch Med, Boston, MA USA; [Ganguli, Ishani; Wasfy, Jason H.; Ferris, Timothy G.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ferris, Timothy G.] Partners HealthCare, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Partners Healthcare System	Ganguli, I (corresponding author), Massachusetts Gen Hosp, 55 Fruit St,Bulfinch 205, Boston, MA 02114 USA.	ishani.ganguli@gmail.com						Agency for Healthcare Research and Quality, 2014, MED EXP PAN SURV; Centers for Disease Control and Prevention, 2009, NAT AMB MED CAR SURV; Chen AH, 2009, ARCH INTERN MED, V169, P1024, DOI 10.1001/archinternmed.2009.140; Cutler D, 2013, 19320 NAT BUR EC RES; Javorsky E, 2014, AM J MANAG CARE, V20, P17; Muhlestein D., 2014, ACCOUTABLE CARE GROW; Virani SS, 2013, JAMA INTERN MED, V173, P1439, DOI 10.1001/jamainternmed.2013.8198; Yasaitis LC, 2013, MED CARE, V51, P524, DOI 10.1097/MLR.0b013e3182928f67	8	18	18	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2015	313	19					1905	1906		10.1001/jama.2015.3356	http://dx.doi.org/10.1001/jama.2015.3356			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4BK	25844726				2022-12-28	WOS:000354691200007
J	Taylor, DW; Zhu, YF; Staals, RHJ; Kornfeld, JE; Shinkai, A; van der Oost, J; Nogales, E; Doudna, JA				Taylor, David W.; Zhu, Yifan; Staals, Raymond H. J.; Kornfeld, Jack E.; Shinkai, Akeo; van der Oost, John; Nogales, Eva; Doudna, Jennifer A.			Structures of the CRISPR-Cmr complex reveal mode of RNA target positioning	SCIENCE			English	Article							GUIDED SURVEILLANCE COMPLEX; CRYSTAL-STRUCTURE; DNA RECOGNITION; CLEAVAGE; ENDONUCLEASE; PROKARYOTES; SYSTEM; CAS9	Adaptive immunity in bacteria involves RNA-guided surveillance complexes that use CRISPR (clustered regularly interspaced short palindromic repeats)-associated (Cas) proteins together with CRISPR RNAs (crRNAs) to target invasive nucleic acids for degradation. Whereas type I and type II CRISPR-Cas surveillance complexes target double-stranded DNA, type III complexes target single-stranded RNA. Near-atomic resolution cryo-electron microscopy reconstructions of native type III Cmr (CRISPR RAMP module) complexes in the absence and presence of target RNA reveal a helical protein arrangement that positions the crRNA for substrate binding. Thumblike b hairpins intercalate between segments of duplexed crRNA: target RNA to facilitate cleavage of the target at 6-nucleotide intervals. The Cmr complex is architecturally similar to the type I CRISPR-Cascade complex, suggesting divergent evolution of these immune systems from a common ancestor.	[Taylor, David W.; Kornfeld, Jack E.; Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Taylor, David W.; Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Zhu, Yifan; Staals, Raymond H. J.; van der Oost, John] Wageningen Univ, Lab Microbiol, Dept Agrotechnol & Food Sci, NL-6703 HB Wageningen, Netherlands; [Shinkai, Akeo] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan; [Shinkai, Akeo] RIKEN Struct Biol, Yokohama, Kanagawa 2300045, Japan; [Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Wageningen University & Research; RIKEN; RIKEN; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	enogales@lbl.gov; doudna@berkeley.edu	Shinkai, Akeo/E-8354-2013; van+der+Oost, John/Y-2548-2019; Staals, Raymond/AAD-6871-2020	Shinkai, Akeo/0000-0002-9867-0832; Staals, Raymond/0000-0002-5741-9457; Taylor, David/0000-0002-6198-1194; Zhu, Yifan/0000-0002-8403-7833	Damon Runyon Cancer Research Foundation [DRG-2218-15]; University of Otago's Division of Health Sciences Career Development postdoctoral fellowship; Netherlands Organisation for Scientific Research (NWO) [024.002.002, 854.10.003]; Japan Society for the Promotion of Science [25440013]	Damon Runyon Cancer Research Foundation; University of Otago's Division of Health Sciences Career Development postdoctoral fellowship; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The structures of intact apo-Cmr, smaller apo-Cmr, and target-bound Cmr have been deposited into the EMDataBank with accession codes EMD-2898, EMD-2899, and EMD-2900, respectively. We thank R. Louder, S. Howes, E. Kellogg, R. Zhang, P. Grob, Y. He, T. Houweling, Z. Yu, and M. J. de la Cruz for expert electron microscopy assistance. D.W.T is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-2218-15). R.H.J.S. was supported by the University of Otago's Division of Health Sciences Career Development postdoctoral fellowship. Y. Z. and J.v.d.O. received financial support from the Netherlands Organisation for Scientific Research (NWO), via a Gravitation grant to the Soehngen Institute for Anaerobic Microbiology (024.002.002) and an ALW-TOP project (854.10.003), respectively. This work was supported in part by Japan Society for the Promotion of Science KAKENHI grant 25440013 (to A. S.). J. A. D and E.N. are Howard Hughes Medical Institute Investigators. The T. thermophilus Cmr complex and T. thermophilus strain-producing Cmr6-His protein are available from A. S. under a material transfer agreement with RIKEN.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Benda C, 2014, MOL CELL, V56, P43, DOI 10.1016/j.molcel.2014.09.002; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Hale CR, 2014, GENE DEV, V28, P2432, DOI 10.1101/gad.250712.114; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402	22	92	95	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					581	585		10.1126/science.aaa4535	http://dx.doi.org/10.1126/science.aaa4535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25837515	Green Accepted			2022-12-28	WOS:000353778100044
J	Clapham, DE				Clapham, David E.			STRUCTURAL BIOLOGY Pain-sensing TRPA1 channel resolved	NATURE			English	Editorial Material							GATED SODIUM-CHANNEL; CRYSTAL-STRUCTURE; MECHANISMS	The TRPA1 ion channel activates pain pathways in response to noxious compounds. The structure of TRPA1 has now been solved, providing insight into how it functions.	[Clapham, David E.] Boston Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA; [Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428				Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Herbert MH, 2015, VIRUSES-BASEL, V7, P709, DOI 10.3390/v7020709; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Nilius B, 2012, PFLUG ARCH EUR J PHY, V464, P425, DOI 10.1007/s00424-012-1158-z; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	11	9	9	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					439	441		10.1038/nature14383	http://dx.doi.org/10.1038/nature14383			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25855290				2022-12-28	WOS:000353334500022
J	Kruijer, TS; Kleine, T; Fischer-Godde, M; Sprung, P				Kruijer, Thomas S.; Kleine, Thorsten; Fischer-Goedde, Mario; Sprung, Peter			Lunar tungsten isotopic evidence for the late veneer	NATURE			English	Article							HF-W CHRONOMETRY; SIDEROPHILE ELEMENT SYSTEMATICS; EARLY MANTLE DIFFERENTIATION; CORE FORMATION; OSMIUM ISOTOPE; GIANT IMPACT; MOON; CONSTRAINTS; EARTH; ACCRETION	According to the most widely accepted theory of lunar origin, a giant impact on the Earth led to the formation of the Moon, and also initiated the final stage of the formation of the Earth's core(1). Core formation should have removed the highly siderophile elements (HSE) from Earth's primitive mantle (that is, the bulk silicate Earth), yet HSE abundances are higher than expected(2). One explanation for this overabundance is that a 'late veneer' of primitive material was added to the bulk silicate Earth after the core formed(2). To test this hypothesis, tungsten isotopes are useful for two reasons: first, because the late veneer material had a different W-182/W-184 ratio to that of the bulk silicate Earth, and second, proportionally more material was added to the Earth than to the Moon(3). Thus, if a late veneer did occur, the bulk silicate Earth and the Moon must have different W-182/W-184 ratios. Moreover, the Moon-forming impact would also have created W-182 differences because the mantle and core material of the impactor with distinct W-182/W-184 would have mixed with the proto-Earth during the giant impact. However the W-182/W-184 of the Moon has not been determined precisely enough to identify signatures of a late veneer or the giant impact. Here, using more-precise measurement techniques, we show that the Moon exhibits a W-182 excess of 27 +/- 4 parts per million over the present-day bulk silicate Earth. This excess is consistent with the expected W-182 difference resulting from a late veneer with a total mass and composition inferred from HSE systematics(2). Thus, our data independently show that HSE abundances in the bulk silicate Earth were established after the giant impact and core formation, as predicted by the late veneer hypothesis. But, unexpectedly, we find that before the late veneer, no W-182 anomaly existed between the bulk silicate Earth and the Moon, even though one should have arisen through the giant impact. The origin of the homogeneous W-182 of the pre-late-veneer bulk silicate Earth and the Moon is enigmatic and constitutes a challenge to current models of lunar origin.	[Kruijer, Thomas S.; Kleine, Thorsten; Fischer-Goedde, Mario; Sprung, Peter] Univ Munster, Inst Planetol, D-48149 Munster, Germany	University of Munster	Kruijer, TS (corresponding author), Univ Munster, Inst Planetol, Wilhelm Klemm Str 10, D-48149 Munster, Germany.	thomas.kruijer@wwu.de	Kleine, Thorsten/S-2792-2017	Kleine, Thorsten/0000-0003-4657-5961; Fischer-Godde, Mario/0000-0001-6839-9001; Kruijer, Thomas/0000-0003-0974-4324; Sprung, Peter/0000-0003-4862-1415				Arevalo R, 2008, EARTH PLANET SC LETT, V272, P656, DOI 10.1016/j.epsl.2008.05.031; Armytage RMG, 2012, GEOCHIM COSMOCHIM AC, V77, P504, DOI 10.1016/j.gca.2011.10.032; Becker H, 2006, GEOCHIM COSMOCHIM AC, V70, P4528, DOI 10.1016/j.gca.2006.06.004; Borg LE, 2011, NATURE, V477, P70, DOI 10.1038/nature10328; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Carlson RW, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0246; Cohen AS, 1996, ANAL CHIM ACTA, V332, P269, DOI 10.1016/0003-2670(96)00226-7; Cottrell E, 2009, EARTH PLANET SC LETT, V281, P275, DOI 10.1016/j.epsl.2009.02.024; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Dahl TW, 2010, EARTH PLANET SC LETT, V295, P177, DOI 10.1016/j.epsl.2010.03.038; Day JMD, 2010, EARTH PLANET SC LETT, V289, P595, DOI 10.1016/j.epsl.2009.12.001; Fischer-Godde M, 2010, GEOCHIM COSMOCHIM AC, V74, P356, DOI 10.1016/j.gca.2009.09.024; Fischer-Godde M, 2012, GEOCHIM COSMOCHIM AC, V77, P135, DOI 10.1016/j.gca.2011.11.014; Fischer-Godde M, 2011, CHEM GEOL, V280, P365, DOI 10.1016/j.chemgeo.2010.11.024; Gaffney AM, 2014, GEOCHIM COSMOCHIM AC, V140, P227, DOI 10.1016/j.gca.2014.05.028; Herwartz D, 2014, SCIENCE, V344, P1146, DOI 10.1126/science.1251117; Horan MF, 2003, CHEM GEOL, V196, P5, DOI 10.1016/S0009-2541(02)00405-9; Khan A, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002608; Kleine T, 2005, SCIENCE, V310, P1671, DOI 10.1126/science.1118842; Kleine T, 2004, GEOCHIM COSMOCHIM AC, V68, P2935, DOI 10.1016/j.gca.2004.01.009; Kleine T, 2012, GEOCHIM COSMOCHIM AC, V84, P186, DOI 10.1016/j.gca.2012.01.032; Kleine T, 2009, GEOCHIM COSMOCHIM AC, V73, P5150, DOI 10.1016/j.gca.2008.11.047; Konig S, 2011, GEOCHIM COSMOCHIM AC, V75, P2119, DOI 10.1016/j.gca.2011.01.031; KOROTEV RL, 1987, J GEOPHYS RES-SOLID, V92, pE491, DOI 10.1029/JB092iB04p0E491; Kruijer TS, 2014, EARTH PLANET SC LETT, V403, P317, DOI 10.1016/j.epsl.2014.07.003; Kruijer TS, 2013, EARTH PLANET SC LETT, V361, P162, DOI 10.1016/j.epsl.2012.10.014; Kruijer TS, 2012, GEOCHIM COSMOCHIM AC, V99, P287, DOI 10.1016/j.gca.2012.09.015; Leya I, 2000, EARTH PLANET SC LETT, V175, P1, DOI 10.1016/S0012-821X(99)00295-2; Lyubetskaya T, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004223; McCoy TJ, 2011, GEOCHIM COSMOCHIM AC, V75, P6821, DOI 10.1016/j.gca.2011.09.006; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Meisel T, 2001, GEOCHIM COSMOCHIM AC, V65, P1311, DOI 10.1016/S0016-7037(00)00566-4; Meyer C., 2013, LUNAR SAMPLE COMPEND; Morgan J. W., 1974, GEOCHIM COSM SUPPL, P1703; Morgan JW, 2001, METEORIT PLANET SCI, V36, P1257, DOI 10.1111/j.1945-5100.2001.tb01959.x; Munker C, 2010, GEOCHIM COSMOCHIM AC, V74, P7340, DOI 10.1016/j.gca.2010.09.021; Norman MD, 2002, EARTH PLANET SC LETT, V202, P217, DOI 10.1016/S0012-821X(02)00780-X; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Palme H., 2014, PLANETS ASTERIODS CO, V2, P15, DOI DOI 10.1016/B978-0-08-095975-7.00118-2; Palme H., 2003, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; Pattou L, 1996, NATURE, V379, P712, DOI 10.1038/379712a0; Puchtel IS, 2008, GEOCHIM COSMOCHIM AC, V72, P3022, DOI 10.1016/j.gca.2008.04.006; Reufer A, 2012, ICARUS, V221, P296, DOI 10.1016/j.icarus.2012.07.021; Righter K, 2003, GEOCHIM COSMOCHIM AC, V67, P2497, DOI 10.1016/S0016-7037(02)01349-2; Sprung P, 2013, EARTH PLANET SC LETT, V380, P77, DOI 10.1016/j.epsl.2013.08.018; Taylor S.R., 1974, P 5 LUNAR SCI C, V1287-1305; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Touboul M, 2012, SCIENCE, V335, P1065, DOI 10.1126/science.1216351; Walker RJ, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0258; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001; Wang ZC, 2013, NATURE, V499, P328, DOI 10.1038/nature12285; WARREN PH, 1979, REV GEOPHYS, V17, P73, DOI 10.1029/RG017i001p00073; Weber RC, 2011, SCIENCE, V331, P309, DOI 10.1126/science.1199375; Willbold M, 2011, NATURE, V477, P195, DOI 10.1038/nature10399; Wood J.A., 1970, P AP 11 LUN SCI C, P965; Zhang JJ, 2012, NAT GEOSCI, V5, P251, DOI [10.1038/NGEO1429, 10.1038/ngeo1429]	60	115	119	2	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					534	+		10.1038/nature14360	http://dx.doi.org/10.1038/nature14360			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25855296				2022-12-28	WOS:000353334500041
J	Karreth, FA; Reschke, M; Ruocco, A; Ng, C; Chapuy, B; Leopold, V; Sjoberg, M; Keane, TM; Verma, A; Ala, U; Tay, Y; Wu, D; Seitzer, N; Velasco-Herrera, MD; Bothmer, A; Fung, J; Langellotto, F; Rodig, SJ; Elemento, O; Shipp, MA; Adams, DJ; Chiarle, R; Pandolfi, PP				Karreth, Florian A.; Reschke, Markus; Ruocco, Anna; Ng, Christopher; Chapuy, Bjoern; Leopold, Valentine; Sjoberg, Marcela; Keane, Thomas M.; Verma, Akanksha; Ala, Ugo; Tay, Yvonne; Wu, David; Seitzer, Nina; Velasco-Herrera, Martin Del Castillo; Bothmer, Anne; Fung, Jacqueline; Langellotto, Fernanda; Rodig, Scott J.; Elemento, Olivier; Shipp, Margaret A.; Adams, David J.; Chiarle, Roberto; Pandolfi, Pier Paolo			The BRAF Pseudogene Functions as a Competitive Endogenous RNA and Induces Lymphoma In Vivo	CELL			English	Article							B-CELL LYMPHOMA; X-CHROMOSOME; CERNA HYPOTHESIS; GENE-EXPRESSION; MICRORNA; PTEN; MALIGNANCIES; IDIC(X)(Q13); ACTIVATION; ABSENCE	Research over the past decade has suggested important roles for pseudogenes in physiology and disease. In vitro experiments demonstrated that pseudogenes contribute to cell transformation through several mechanisms. However, in vivo evidence for a causal role of pseudogenes in cancer development is lacking. Here, we report that mice engineered to overexpress either the full-length murine B-Raf pseudogene Braf-rs1 or its pseudo "CDS'' or "3' UTR'' develop an aggressive malignancy resembling human diffuse large B cell lymphoma. We show that Braf-rs1 and its human ortholog, BRAFP1, elicit their oncogenic activity, at least in part, as competitive endogenous RNAs (ceRNAs) that elevate BRAF expression and MAPK activation in vitro and in vivo. Notably, we find that transcriptional or genomic aberrations of BRAFP1 occur frequently in multiple human cancers, including B cell lymphomas. Our engineered mouse models demonstrate the oncogenic potential of pseudogenes and indicate that ceRNA-mediated microRNA sequestration may contribute to the development of cancer.	[Karreth, Florian A.; Reschke, Markus; Ruocco, Anna; Ng, Christopher; Leopold, Valentine; Ala, Ugo; Tay, Yvonne; Seitzer, Nina; Bothmer, Anne; Fung, Jacqueline; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr, Canc Res Inst,Dept Med & Pathol,Med Sch, Boston, MA 02215 USA; [Chapuy, Bjoern; Shipp, Margaret A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Sjoberg, Marcela; Keane, Thomas M.; Velasco-Herrera, Martin Del Castillo; Adams, David J.] Wellcome Trust Sanger Inst, Expt Canc Genet, Hinxton CB10 1HH, England; [Verma, Akanksha; Elemento, Olivier] Weill Cornell Med Coll, Inst Computat Biomed, Dept Physiol & Biophys, New York, NY 10021 USA; [Wu, David] Weill Cornell Med Coll, Meyer Canc Ctr, New York, NY 10021 USA; [Langellotto, Fernanda; Chiarle, Roberto] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Langellotto, Fernanda; Chiarle, Roberto] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Rodig, Scott J.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Chiarle, Roberto] Univ Torino, Dept Mol Biotechnol & Hlth Sci, I-10124 Turin, Italy	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Wellcome Trust Sanger Institute; Cornell University; Cornell University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Turin	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr, Canc Res Inst,Dept Med & Pathol,Med Sch, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Verma, Akanksha/HGT-9212-2022; Rodig, Scott/Y-3889-2019; Ala, Ugo/K-2029-2016; Verma, Akanksha/W-1810-2019	Verma, Akanksha/0000-0001-6121-801X; Ala, Ugo/0000-0001-5408-6397; CHIARLE, Roberto/0000-0003-1564-8531; Sjoberg Herrera, Marcela K./0000-0001-7173-048X; Adams, David/0000-0001-9490-0306; Leopold, Valentine/0000-0002-2131-5760; Del Castillo Velasco Herrera, Martin/0000-0001-5956-0211; Keane, Thomas/0000-0001-7532-6898; Pandolfi, Pier Paolo/0000-0002-5352-5295; Ng, Christopher/0000-0001-8815-7958; Wu, David/0000-0003-4513-2739	Department of Defense Prostate Cancer Research Program; American Cancer Society; German Academy of Sciences Leopoldina; CHB-MIT fellowship; Italian Association for Cancer Research (AIRC) [IG-9408]; Cancer Research UK; Wellcome Trust; FP7 ERC-StG grant [242965]; AIRC [IG-12023]; International Association for Cancer Research (AICR) [12-0216]; NIH [CA170158-01]; NATIONAL CANCER INSTITUTE [R01CA170158] Funding Source: NIH RePORTER; Cancer Research UK [13031] Funding Source: researchfish; Worldwide Cancer Research [12-0216] Funding Source: researchfish	Department of Defense Prostate Cancer Research Program(United States Department of Defense); American Cancer Society(American Cancer Society); German Academy of Sciences Leopoldina; CHB-MIT fellowship; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); FP7 ERC-StG grant; AIRC(Fondazione AIRC per la ricerca sul cancro); International Association for Cancer Research (AICR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	We are grateful to L. Cantley for hosting F.A.K. in his lab for part of this study. We thank S. Lowe for CAG-rtTA3 mice; L. Cantley, B. Vogelstein, and P. Sharp for cell lines; G. DeNicola for helpful discussions; and the Nikon Imaging Center at Harvard Medical School for help with light microscopy, the Dana Farber/Harvard Cancer Center Specialized Histopathology Core for help with immunohistochemistry, J. Clohessy and B. Padmani for help with ultrasound imaging, and S. Annunziato, A. Nyein, A. Bester, and K Berry for technical assistance. F.A.K. was supported by fellowships from the Department of Defense Prostate Cancer Research Program and the American Cancer Society. M.R. was supported by the German Academy of Sciences Leopoldina, F.L. received a CHB-MIT fellowship, and U.A. acknowledges support from the Italian Association for Cancer Research (AIRC) under grant IG-9408. M.S., T.M.K., M.D.C.V.-H., and D.J.A. are funded by Cancer Research UK and the Wellcome Trust. R.C. was supported by a FP7 ERC-2009-StG grant (Proposal No. 242965, "Lunely''), AIRC grant IG-12023, and an International Association for Cancer Research (AICR) grant 12-0216. P.P.P. was supported by NIH grant CA170158-01.	Ala U, 2013, P NATL ACAD SCI USA, V110, P7154, DOI 10.1073/pnas.1222509110; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bier A, 2009, MOL CANCER THER, V8, P786, DOI 10.1158/1535-7163.MCT-08-0930; Bosia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066609; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chiefari E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1040; Chiu HS, 2015, GENOME RES, V25, P257, DOI 10.1101/gr.178194.114; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; DEWALD GW, 1989, CANCER GENET CYTOGEN, V42, P173, DOI 10.1016/0165-4608(89)90085-X; DIERLAMM J, 1995, BRIT J HAEMATOL, V91, P885, DOI 10.1111/j.1365-2141.1995.tb05405.x; Figliuzzi M, 2013, BIOPHYS J, V104, P1203, DOI 10.1016/j.bpj.2013.01.012; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Han YJ, 2011, FASEB J, V25, P2305, DOI 10.1096/fj.10-177808; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hawkins PG, 2010, TRANSCR-AUSTIN, V1, P165, DOI 10.4161/trns.1.3.13332; Heinonen K, 1999, MED PEDIATR ONCOL, V32, P360, DOI 10.1002/(SICI)1096-911X(199905)32:5<360::AID-MPO9>3.0.CO;2-7; Jens M, 2015, NAT REV GENET, V16, P113, DOI 10.1038/nrg3853; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; Libri V, 2012, P NATL ACAD SCI USA, V109, P279, DOI 10.1073/pnas.1114204109; Marcinowski L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002510; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Monni O, 1996, BLOOD, V87, P5269, DOI 10.1182/blood.V87.12.5269.bloodjournal87125269; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Paulsson K, 2010, HUM MOL GENET, V19, P1507, DOI 10.1093/hmg/ddq024; Poliseno L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002858; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; RACK KA, 1994, HUM MOL GENET, V3, P1053, DOI 10.1093/hmg/3.7.1053; Ravi A, 2012, CANCER CELL, V21, P848, DOI 10.1016/j.ccr.2012.04.037; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yamamoto K, 2002, CANCER GENET CYTOGEN, V134, P84, DOI 10.1016/S0165-4608(01)00603-3; Zou MJ, 2009, NEOPLASIA, V11, P57, DOI 10.1593/neo.81044	44	242	250	2	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					319	332		10.1016/j.cell.2015.02.043	http://dx.doi.org/10.1016/j.cell.2015.02.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25843629	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000352708300024
J	Jakes, AD; Phillips, R; Scales, M				Jakes, Adam D.; Phillips, Robert; Scales, Michael			10-MINUTE CONSULTATION Teenagers with back pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jakes, Adam D.] Leeds Teaching Hosp NHS Trust, St Jamess Univ Hosp, Leeds L59 7TF, W Yorkshire, England; [Phillips, Robert] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Phillips, Robert] Leeds Gen Infirm, Leeds, W Yorkshire, England; [Scales, Michael] Univ Leeds, Acad Unit Primary Care, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds; University of York - UK; Leeds General Infirmary; University of Leeds; University of Leeds	Jakes, AD (corresponding author), Leeds Teaching Hosp NHS Trust, St Jamess Univ Hosp, Leeds L59 7TF, W Yorkshire, England.	adam.jakes@hyms.ac.uk			MRC [G0800472] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		American Academy of Pediatrics HealthyChildren.org., 2013, BACKP SAF; Arthritis Research UK, 2011, BACK PAIN; Bhatia NN, 2008, J PEDIATR ORTHOPED, V28, P230, DOI 10.1097/BPO.0b013e3181651bc8; Brown MA, 1996, ANN RHEUM DIS, V55, P268, DOI 10.1136/ard.55.4.268; d'Hemecourt PA, 2000, CLIN SPORT MED, V19, P663, DOI 10.1016/S0278-5919(05)70231-3; Davis PJC, 2008, ARCH DIS CHILDHOOD-E, V93, P73, DOI 10.1136/adc.2006.115535; Michaleff ZA, 2014, EUR SPINE J, V23, P2046, DOI 10.1007/s00586-014-3461-1; National Institute of Health and Clinical Excellence, 2005, REF GUID SUSP CANC C	8	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2015	350								h1275	10.1136/bmj.h1275	http://dx.doi.org/10.1136/bmj.h1275			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3IB	25838410				2022-12-28	WOS:000352440700001
J	Scott, AR				Scott, Andrew R.			POLYMERS Secrets from the deep sea	NATURE			English	Editorial Material																		Fathi A, 2014, EUR POLYM J, V59, P161, DOI 10.1016/j.eurpolymj.2014.07.011; Jorfi M, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/011001; Lim HL, 2014, BIOMATER SCI-UK, V2, P603, DOI 10.1039/c3bm60288e; Meredith HJ, 2014, ADV FUNCT MATER, V24, P3259, DOI 10.1002/adfm.201303536; Nguyen JK, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056014; Shubhra QTH, 2014, POLYM REV, V54, P112, DOI 10.1080/15583724.2013.862544	6	14	16	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S12	S13		10.1038/519S12a	http://dx.doi.org/10.1038/519S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25806491	Bronze			2022-12-28	WOS:000351602800004
J	Scull, A				Scull, Andrew			The art of medicine Madness in civilisation	LANCET			English	Editorial Material									Univ Calif San Diego, Dept Sociol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Scull, A (corresponding author), Univ Calif San Diego, Dept Sociol, La Jolla, CA 92093 USA.	ascull@ucsd.edu						Bellick P, 2013, NY TIMES; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Gross BG, 2011, MED CARE, V249, P599; Insel TR, 2014, AM J PSYCHIAT, V171, P395, DOI 10.1176/appi.ajp.2014.14020138; Parks J., 2006, MORBIDITY MORTALITY; Scull A, 2015, MADNESS IN CIVILIZATION: A CULTURAL HISTORY OF INSANITY FROM THE BIBLE TO FREUD, FROM THE MADHOUSE TO MODERN MEDICINE, P1, DOI 10.1515/9781400865710	7	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1066	1067		10.1016/S0140-6736(15)60591-8	http://dx.doi.org/10.1016/S0140-6736(15)60591-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	CD7KX	25802901				2022-12-28	WOS:000351270400014
J	Friedman, MJ				Friedman, Matthew J.			Risk Factors for Suicides Among Army Personnel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RESILIENCE; STARRS; PREVALENCE; SOLDIERS; CARE	IMPORTANCE The Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS) is a multicomponent study designed to generate actionable recommendations to reduce Army suicides and increase knowledge of risk and resilience factors for suicidality. OBJECTIVES To present data on prevalence, trends, and basic sociodemographic and Army experience correlates of suicides and accident deaths among active duty Regular Army soldiers between January 1, 2004, and December 31, 2009, and thereby establish a foundation for future Army STARRS investigations. DESIGN, SETTING, AND PARTICIPANTS Analysis of trends and predictors of suicide and accident deaths using Army and Department of Defense administrative data systems. Participants were all members of the US Regular Army serving at any time between 2004 and 2009. MAIN OUTCOMES AND MEASURES Death by suicide or accident during active Army service. RESULTS The suicide rate rose between 2004 and 2009 among never deployed and currently and previously deployed Regular Army soldiers. Increased suicide risk was associated with being a man (or a woman during deployment), white race/ethnicity, junior enlisted rank, recent demotion, and current or previous deployment. Sociodemographic and Army experience predictors were generally similar for suicides and accident deaths. CONCLUSION Predictors of Army suicides were largely similar to those reported elsewhere for civilians, although some predictors distinct to Army service emerged that deserve more in-depth analysis. The existence of a time trend in suicide risk among never-deployed soldiers argues indirectly against the view that exposure to combat-related trauma is the exclusive cause of the increase in Army suicides.	[Friedman, Matthew J.] US Dept Vet Affairs, Natl Ctr PTSD, White River Jct, VT USA; [Friedman, Matthew J.] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA; [Friedman, Matthew J.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA	US Department of Veterans Affairs; Dartmouth College; Dartmouth College	Friedman, MJ (corresponding author), Natl Ctr PTSD, Dept Vet Affairs, 215 N Main St 116D, White River Jct, VT 05009 USA.	matthew.friedman@dartmouth.edu						Engel CC, 2008, MIL MED, V173, P935, DOI 10.7205/MILMED.173.10.935; Greenberg N, 2010, J TRAUMA STRESS, V23, P430, DOI 10.1002/jts.20538; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jaffe G., WASHINGTON POST; Kessler RC, 2014, JAMA PSYCHIAT, V71, P504, DOI 10.1001/jamapsychiatry.2014.28; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Nock MK, 2014, JAMA PSYCHIAT, V71, P514, DOI 10.1001/jamapsychiatry.2014.30; Schoenbaum M, 2014, JAMA PSYCHIAT, V71, P493, DOI 10.1001/jamapsychiatry.2013.4417	8	7	7	2	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1154	+		10.1001/jama.2014.15303	http://dx.doi.org/10.1001/jama.2014.15303			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25781444				2022-12-28	WOS:000351102500017
J	Olson, MA; Wieland, CN; Newman, CC				Olson, Meredith A.; Wieland, Carilyn N.; Newman, Catherine C.			Diffuse Vesicular Rash With Intractable Pruritus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DERMATITIS-HERPETIFORMIS; CELIAC-DISEASE; PREVALENCE		[Olson, Meredith A.; Wieland, Carilyn N.; Newman, Catherine C.] Mayo Clin, Dept Dermatol, Rochester, MN 55905 USA	Mayo Clinic	Newman, CC (corresponding author), Mayo Clin, Dept Dermatol, 200 First St SW, Rochester, MN 55905 USA.	newman.catherine@mayo.edu						Caproni M, 2009, J EUR ACAD DERMATOL, V23, P633, DOI 10.1111/j.1468-3083.2009.03188.x; Collin P, 1996, GUT, V38, P528, DOI 10.1136/gut.38.4.528; CUNNINGHAM MJ, 1985, ANN INTERN MED, V102, P194, DOI 10.7326/0003-4819-102-2-194; Nicolas MEO, 2003, INT J DERMATOL, V42, P588, DOI 10.1046/j.1365-4362.2003.01804.x; Sardy M, 2002, J EXP MED, V195, P747, DOI 10.1084/jem.20011299; SMITH JB, 1992, ARCH DERMATOL, V128, P1608, DOI 10.1001/archderm.128.12.1608; Zone JJ, 2005, GASTROENTEROLOGY, V128, pS87, DOI 10.1053/j.gastro.2005.02.026	7	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1158	1159		10.1001/jama.2014.17575	http://dx.doi.org/10.1001/jama.2014.17575			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25781446				2022-12-28	WOS:000351102500019
J	Liyanage, T; Ninomiya, T; Jha, V; Neal, B; Patrice, HM; Okpechi, I; Zhao, MH; Lv, JC; Garg, AX; Knight, J; Rodgers, A; Gallagher, M; Kotwal, S; Cass, A; Perkovic, V				Liyanage, Thaminda; Ninomiya, Toshiharu; Jha, Vivekanand; Neal, Bruce; Patrice, Halle Marie; Okpechi, Ikechi; Zhao, Ming-hui; Lv, Jicheng; Garg, Amit X.; Knight, John; Rodgers, Anthony; Gallagher, Martin; Kotwal, Sradha; Cass, Alan; Perkovic, Vlado			Worldwide access to treatment for end-stage kidney disease: a systematic review	LANCET			English	Review							RENAL-DISEASE; CARE; PROGRESSION; DIALYSIS; FAILURE; PROGRAM	Background End-stage kidney disease is a leading cause of morbidity and mortality worldwide. Prevalence of the disease and worldwide use of renal replacement therapy (RRT) are expected to rise sharply in the next decade. We aimed to quantify estimates of this burden. Methods We systematically searched Medline for observational studies and renal registries, and contacted national experts to obtain RRT prevalence data. We used Poisson regression to estimate the prevalence of RRT for countries without reported data. We estimated the gap between needed and actual RRT, and projected needs to 2030. Findings In 2010, 2.618 million people received RRT worldwide. We estimated the number of patients needing RRT to be between 4.902 million (95% CI 4.438-5.431 million) in our conservative model and 9.701 million (8.544-11.021 million) in our high-estimate model, suggesting that at least 2.284 million people might have died prematurely because RRT could not be accessed. We noted the largest treatment gaps in low-income countries, particularly Asia (1.907 million people needing but not receiving RRT; conservative model) and Africa (432 000 people; conservative model). Worldwide use of RRT is projected to more than double to 5.439 million (3.899-7.640 million) people by 2030, with the most growth in Asia (0.968 million to a projected 2.162 million [1.571-3.014 million]). Interpretation The large number of people receiving RRT and the substantial number without access to it show the need to both develop low-cost treatments and implement effective population-based prevention strategies.	[Liyanage, Thaminda; Ninomiya, Toshiharu; Neal, Bruce; Knight, John; Rodgers, Anthony; Gallagher, Martin; Kotwal, Sradha; Cass, Alan; Perkovic, Vlado] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2050, Australia; [Liyanage, Thaminda; Perkovic, Vlado] Royal N Shore Hosp, Sydney, NSW, Australia; [Jha, Vivekanand] George Inst Global Hlth, Splendor Forum, Jasola New Delhi, India; [Jha, Vivekanand] Postgrad Inst Med Educ & Res, Dept Nephrol, Chandigarh 160012, India; [Jha, Vivekanand] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Patrice, Halle Marie] Univ Douala, Fac Med, Dept Clin Sci, Douala, Cameroon; [Okpechi, Ikechi] Univ Cape Town, Div Internal Med, ZA-7925 Cape Town, South Africa; [Zhao, Ming-hui; Lv, Jicheng] Peking Univ, Dept Med, Div Renal, Hosp 1, Beijing 100871, Peoples R China; [Garg, Amit X.] Univ Western Ontario, Dept Med, London, ON, Canada; [Garg, Amit X.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Cass, Alan] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia	George Institute for Global Health; University of Sydney; Royal North Shore Hospital; University of Sydney; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Oxford; University of Cape Town; Peking University; Western University (University of Western Ontario); Western University (University of Western Ontario); Charles Darwin University; Menzies School of Health Research	Perkovic, V (corresponding author), Univ Sydney, George Inst Global Hlth, Sydney, NSW 2050, Australia.	vperkovic@georgeinstitute.org.au	Garg, Amit X/G-3295-2011; Perkovic, Vlado/AAY-1933-2021	Rodgers, Anthony/0000-0003-1282-1896; Cass, Alan/0000-0002-3923-3173; Jha, Vivekanand/0000-0002-8015-9470; Neal, Bruce/0000-0002-0490-7465; Gallagher, Martin/0000-0001-9187-6187; Kotwal, Sradha/0000-0002-3294-4087; Perkovic, Vlado/0000-0002-4257-7620	Australian National Health and Medical Research Council Program Grant [105255]	Australian National Health and Medical Research Council Program Grant(National Health and Medical Research Council (NHMRC) of Australia)	Australian National Health and Medical Research Council.; This work was supported by an Australian National Health and Medical Research Council Program Grant (ID number 105255).	Anand S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072860; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bedford M, 2012, AM J KIDNEY DIS, V59, P485, DOI 10.1053/j.ajkd.2011.09.010; Ehrich JHH, 2005, NEPHROL DIAL TRANSPL, V20, P297, DOI 10.1093/ndt/gfh299; Frederick S., COUNTR PROF; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; Hemmelgarn BR, 2012, JAMA-J AM MED ASSOC, V307, P2507, DOI 10.1001/jama.2012.6455; International Diabetes Federation, 2013, IDF DIABETES ATLAS; International Monetary Fund, WORLD EC OUTL DAT; International Society of Nephrology, J INT SOC NEPHROL, V3, P1; Jha V, 2004, RENAL FAILURE, V26, P201, DOI 10.1081/JDI-120039516; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Joshi R, 2008, J AM COLL CARDIOL, V52, P1817, DOI 10.1016/j.jacc.2008.08.049; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lin CM, 2013, J FORMOS MED ASSOC, V112, P773, DOI 10.1016/j.jfma.2013.10.021; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lv JC, 2013, CAN MED ASSOC J, V185, P949, DOI 10.1503/cmaj.121468; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Mazzuchi N, 2006, RENAL FAILURE, V28, P617, DOI 10.1080/08860220600925677; Perkovic V, 2013, KIDNEY INT, V83, P517, DOI 10.1038/ki.2012.401; Rayner HC, 2014, NEPHROL DIAL TRANSPL, V29, P644, DOI 10.1093/ndt/gft486; Sparke C, 2013, AM J KIDNEY DIS, V61, P413, DOI 10.1053/j.ajkd.2012.10.012; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; The World Bank, GNI PER CAP ATL METH; United Nations' Department of Economic and Social Affairs, WORLD POP PROSP 2012; United States Renal Data System, 2012, USRDS 2012 ANN DAT R; Wei SY, 2010, NEPHROLOGY, V15, P108, DOI 10.1111/j.1440-1797.2009.01154.x; White SL, 2008, B WORLD HEALTH ORGAN, V86, P229, DOI 10.2471/BLT.07.041715; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, GLOB HLTH OBS DAT RE	31	1045	1107	6	128	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1975	1982		10.1016/S0140-6736(14)61601-9	http://dx.doi.org/10.1016/S0140-6736(14)61601-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1YR	25777665				2022-12-28	WOS:000354541700031
J	Carreno, BM; Magrini, V; Becker-Hapak, M; Kaabinejadian, S; Hundal, J; Petti, AA; Ly, A; Lie, WR; Hildebrand, WH; Mardis, ER; Linette, GP				Carreno, Beatriz M.; Magrini, Vincent; Becker-Hapak, Michelle; Kaabinejadian, Saghar; Hundal, Jasreet; Petti, Allegra A.; Ly, Amy; Lie, Wen-Rong; Hildebrand, William H.; Mardis, Elaine R.; Linette, Gerald P.			A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells	SCIENCE			English	Article							CANCER-IMMUNOTHERAPY; EPITOPE DISCOVERY; VIRUS-INFECTION; TUMOR-ANTIGENS; LYMPHOCYTES; IDENTIFICATION; PATIENT; RECOGNITION; REPERTOIRE; RESISTANCE	T cell immunity directed against tumor-encoded amino acid substitutions occurs in some melanoma patients. This implicates missense mutations as a source of patient-specific neoantigens. However, a systematic evaluation of these putative neoantigens as targets of antitumor immunity is lacking. Moreover, it remains unknown whether vaccination can augment such responses. We found that a dendritic cell vaccine led to an increase in naturally occurring neoantigen-specific immunity and revealed previously undetected human leukocyte antigen (HLA) class I-restricted neoantigens in patients with advanced melanoma. The presentation of neoantigens by HLA-A* 02: 01 in human melanoma was confirmed by mass spectrometry. Vaccination promoted a diverse neoantigen-specific T cell receptor (TCR) repertoire in terms of both TCR-beta usage and clonal composition. Our results demonstrate that vaccination directed at tumor-encoded amino acid substitutions broadens the antigenic breadth and clonal diversity of antitumor immunity.	[Carreno, Beatriz M.; Becker-Hapak, Michelle; Linette, Gerald P.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Magrini, Vincent; Hundal, Jasreet; Petti, Allegra A.; Ly, Amy; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Kaabinejadian, Saghar; Hildebrand, William H.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Lie, Wen-Rong] EMD Millipore Corp, Billerica, MA USA	Washington University (WUSTL); Washington University (WUSTL); University of Oklahoma System; University of Oklahoma Health Sciences Center; Merck KGaA; MilliporeSigma	Carreno, BM (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.	bcarreno@dom.wustl.edu	Mardis, Elaine/W-2202-2019; Magrini, Vincent/AAT-5830-2020	Magrini, Vincent/0000-0002-2019-4872; lie, wen-rong/0000-0001-9014-1680	Barnes-Jewish Hospital Foundation; Siteman Cancer Frontier Fund; Our Mark on Melanoma (MOM) Foundation; Come Out Swinging (COS) Foundation; Blackout Melanoma Foundation; National Cancer Institute [P30 CA91842, R21 CA179695]; National Human Genome Research Institute [5U54HG00307]; NATIONAL CANCER INSTITUTE [P30CA091842, R21CA179695] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000307, U54HG003079] Funding Source: NIH RePORTER	Barnes-Jewish Hospital Foundation; Siteman Cancer Frontier Fund; Our Mark on Melanoma (MOM) Foundation; Come Out Swinging (COS) Foundation; Blackout Melanoma Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. Hansen, D. Link, and J. DiPersio for critical review; T. Ley, M. Walter, and J. Welch for advice and helpful discussions; R. Austin, R. Demeter, W. Eades, S. McGrath, W. Swaney, T. Vickery, J. Walker, and T. Wylie for technical assistance; L. Cornelius, R. Fields, R. Aft, J. Moley, A. Schaffer, and J. Steel for clinical collaboration; A. Alyasiry, S. Kalathiveetil, I. King, M. Schellhardt, and C. Rush for clinical research support; and B. Fritz from Adaptive Biotechnologies for technical guidance. Supported by Barnes-Jewish Hospital Foundation, Siteman Cancer Frontier Fund, Our Mark on Melanoma (MOM) Foundation, Come Out Swinging (COS) Foundation, Blackout Melanoma Foundation, and National Cancer Institute grants P30 CA91842 and R21 CA179695 (B. Carreno, PI). We acknowledge the Genome Institute at Washington University School of Medicine for the sequencing production pipeline that generated data, established by National Human Genome Research Institute grant 5U54HG00307 (R. Wilson, PI). The Siteman Cancer Center provided the use of the Flow Cytometry Core, Clinical Trials Core, Tissue Procurement Core, and Biologic Therapy Core. The data presented in this manuscript are tabulated in the main paper and the supplementary materials. The raw exome and transcriptome sequence data are available on the Sequence Read Archive database: Bioproject PRJNA278450. The raw proteomic data are available at MassIVE database ID MSV000079125. Washington University and the authors (B.M.C., V.M., E.R.M., and G.P.L.) have filed a patent application (US62/050,195) related to the use of tumor somatic mutations for cancer immunotherapy entitled "Cancer Immunotherapy, Methods, Compositions and Uses Thereof." We thank the patients and families for their dedicated participation in this study.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; Buchli R, 2005, BIOCHEMISTRY-US, V44, P12491, DOI 10.1021/bi050255v; Cabanski CR, 2014, J MOL DIAGN, V16, P440, DOI 10.1016/j.jmoldx.2014.03.004; Carreno BM, 2013, J CLIN INVEST, V123, P3383, DOI 10.1172/JCI68395; Carreno BM, 2012, J IMMUNOL, V188, P5839, DOI 10.4049/jimmunol.1103647; Cha E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008211; COULIE PG, 1995, P NATL ACAD SCI USA, V92, P7976, DOI 10.1073/pnas.92.17.7976; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441; DARROW TL, 1989, J IMMUNOL, V142, P3329; ELVIN J, 1993, J IMMUNOL METHODS, V158, P161, DOI 10.1016/0022-1759(93)90210-X; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gerlinger M, 2014, ANNU REV GENET, V48, P215, DOI 10.1146/annurev-genet-120213-092314; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Kim Y, 2011, J IMMUNOL METHODS, V374, P62, DOI 10.1016/j.jim.2010.10.010; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lossius A, 2014, EUR J IMMUNOL, V44, P3439, DOI 10.1002/eji.201444662; McMurtrey CP, 2008, P NATL ACAD SCI USA, V105, P2981, DOI 10.1073/pnas.0711874105; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Rajasagi M, 2014, BLOOD, V124, P453, DOI 10.1182/blood-2014-04-567933; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robins H, 2012, J IMMUNOL METHODS, V375, P14, DOI 10.1016/j.jim.2011.09.001; Robins HS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007247; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577	30	801	850	18	239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					803	808		10.1126/science.aaa3828	http://dx.doi.org/10.1126/science.aaa3828			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25837513	Green Accepted			2022-12-28	WOS:000354428700045
J	Joyce, JA; Fearon, DT				Joyce, Johanna A.; Fearon, Douglas T.			T cell exclusion, immune privilege, and the tumor microenvironment	SCIENCE			English	Review							LYMPHOCYTE INFILTRATION; VASCULAR NORMALIZATION; ANTI-PD-L1 ANTIBODY; PROGNOSTIC-FACTOR; TNF-ALPHA; CANCER; IMMUNOTHERAPY; SUPPRESSION; ACTIVATION; EXPRESSION	Effective immunotherapy promotes the killing of cancer cells by cytotoxic T cells. This requires not only that cancer-specific Tcells be generated, but also that these Tcells physically contact cancer cells. The coexistence in some patients of cancer cells and T cells that recognize them indicates that tumors may exhibit the phenomenon of immune privilege, in which immunogenic tissue is protected from immune attack. Here, we review the evidence that stromal cells of the tumor microenvironment mediate this restriction by excluding T cells from the vicinity of cancer cells. Overcoming this T cell checkpoint may thus enable optimal immunotherapy.	[Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Fearon, Douglas T.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Fearon, Douglas T.] Weill Cornell Med Sch, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Joyce, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	joycej@mskcc.org; dfearon@cshl.edu			National Cancer Institute; American Cancer Society; Breast Cancer Research Foundation; New York State Health Research Science Board; Cycle for Survival; Center for Metastasis Research at MSKCC; Lustgarten Distinguished Scholar Award; Cancer Research UK [22310] Funding Source: researchfish	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Breast Cancer Research Foundation; New York State Health Research Science Board; Cycle for Survival; Center for Metastasis Research at MSKCC; Lustgarten Distinguished Scholar Award; Cancer Research UK(Cancer Research UK)	J.A.J. is supported by grants from the National Cancer Institute, the American Cancer Society, the Breast Cancer Research Foundation, New York State Health Research Science Board, Cycle for Survival, and the Center for Metastasis Research at MSKCC. D.T.F. is the Walter B. Wriston Professor of Pancreatic Cancer Research and is supported by a Lustgarten Distinguished Scholar Award. D.T.F. is a cofounder of Myosotis, which has licensed the potential intellectual property that may be associated with the finding that interfering with the interaction of CXCR4 with CXCL12 promotes the antitumor effects of T cell checkpoint antagonists. The authors thank C. Connell for Fig. 1C. We apologize to all the investigators whose research could not be appropriately cited because of the journal's space limitations.	Affara NI, 2014, CANCER CELL, V25, P809, DOI 10.1016/j.ccr.2014.04.026; Akishima-Fukasawa Y, 2009, AM J CLIN PATHOL, V132, P202, DOI 10.1309/AJCPK35VZJEWCUTL; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Calcinotto A, 2012, J IMMUNOL, V188, P2687, DOI 10.4049/jimmunol.1101877; Cavnar MJ, 2013, J EXP MED, V210, P2873, DOI 10.1084/jem.20130875; Chiba T, 2004, BRIT J CANCER, V91, P1711, DOI 10.1038/sj.bjc.6602201; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garcia AJ, 2014, MOL CELL BIOL, V34, P2017, DOI 10.1128/MCB.00090-14; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Holmgaard RB, 2013, J EXP MED, V210, P1389, DOI 10.1084/jem.20130066; Huang YH, 2013, CANCER RES, V73, P2943, DOI 10.1158/0008-5472.CAN-12-4354; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; Jayson GC, 2012, NAT REV CLIN ONCOL, V9, P297, DOI 10.1038/nrclinonc.2012.8; Johansson A, 2012, P NATL ACAD SCI USA, V109, P7841, DOI 10.1073/pnas.1118296109; Jones FS, 1914, J EXP MED, V20, P404, DOI 10.1084/jem.20.4.404; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; KLEIN G, 1960, CANCER RES, V20, P1561; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Lesokhin AM, 2012, CANCER RES, V72, P876, DOI 10.1158/0008-5472.CAN-11-1792; Liang JJ, 2010, CANCER EPIDEM BIOMAR, V19, P2598, DOI 10.1158/1055-9965.EPI-10-0405; Ma YT, 2014, CANCER RES, V74, P436, DOI 10.1158/0008-5472.CAN-13-1265; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Molon B, 2011, J EXP MED, V208, P1949, DOI 10.1084/jem.20101956; Motz GT, 2014, NAT MED, V20, P607, DOI 10.1038/nm.3541; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Murata Y, 2014, J BIOCHEM, V155, P335, DOI 10.1093/jb/mvu017; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Naito Y, 1998, CANCER RES, V58, P3491; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; PAPADOPOULOS EB, 1994, NEW ENGL J MED, V330, P1185, DOI 10.1056/NEJM199404283301703; Platten M, 2012, CANCER RES, V72, P5435, DOI 10.1158/0008-5472.CAN-12-0569; Pommier A, 2013, P NATL ACAD SCI USA, V110, P13085, DOI 10.1073/pnas.1300314110; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Predina J, 2013, P NATL ACAD SCI USA, V110, pE415, DOI 10.1073/pnas.1211850110; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; RIDDELL SR, 1992, SCIENCE, V257, P238; Roberts EW, 2013, J EXP MED, V210, P1137, DOI 10.1084/jem.20122344; Rosenberg SA, 2005, J IMMUNOL, V175, P6169, DOI 10.4049/jimmunol.175.9.6169; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Royal RE, 2010, J IMMUNOTHER, V33, P828, DOI 10.1097/CJI.0b013e3181eec14c; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Scotton CJ, 2002, CANCER RES, V62, P5930; Sharma MD, 2013, IMMUNITY, V38, P998, DOI 10.1016/j.immuni.2013.01.013; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Shrimali RK, 2010, CANCER RES, V70, P6171, DOI 10.1158/0008-5472.CAN-10-0153; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Smith C, 2012, CANCER DISCOV, V2, P722, DOI 10.1158/2159-8290.CD-12-0014; Strachan DC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26968; Thompson ED, 2010, J EXP MED, V207, P1791, DOI 10.1084/jem.20092454; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Wei F, 2013, P NATL ACAD SCI USA, V110, pE2480, DOI 10.1073/pnas.1305394110; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Yang XM, 2014, CANCER CELL, V25, P37, DOI 10.1016/j.ccr.2013.12.004; Zang XX, 2010, MODERN PATHOL, V23, P1104, DOI 10.1038/modpathol.2010.95; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhou PH, 2014, NATURE, V506, P52, DOI 10.1038/nature12988; Zhu Y, 2014, CANCER RES, V74, P5057, DOI 10.1158/0008-5472.CAN-13-3723	82	1217	1268	29	501	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					74	80		10.1126/science.aaa6204	http://dx.doi.org/10.1126/science.aaa6204			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838376				2022-12-28	WOS:000352079500029
J	Lauressergues, D; Couzigou, JM; Clemente, HS; Martinez, Y; Dunand, C; Becard, G; Combier, JP				Lauressergues, Dominique; Couzigou, Jean-Malo; Clemente, Helene San; Martinez, Yves; Dunand, Christophe; Becard, Guillaume; Combier, Jean-Philippe			Primary transcripts of microRNAs encode regulatory peptidesPrimary transcripts of microRNAs encode regulatory peptides	NATURE			English	Article							EXPRESSION	MicroRNAs (miRNAs) are small regulatory RNA molecules that inhibit the expression of specific target genes by binding to and cleaving their messenger RNAs or otherwise inhibiting their translation into proteins(1). miRNAs are transcribed as much larger primary transcripts (pri-miRNAs), the function of which is not fully understood. Here we show that plant pri-miRNAs contain short open reading frame sequences that encode regulatory peptides. The pri-miR171b of Medicago truncatula and the pri-miR165a of Arabid-opsis thaliana produce peptides, which we term miPEP171b and miPEP165a, respectively, that enhance the accumulation of their corresponding mature miRNAs, resulting in downregulation of target genes involved in root development. The mechanism of miRNA-encoded peptide (miPEP) action involves increasing transcription of the pri-miRNA. Five other pri-miRNAs of A. thaliana and M. truncatula encode active miPEPs, suggesting that miPEPs are widespread throughout the plant kingdom. Synthetic miPEP171b and miPEP165a peptides applied to plants specifically trigger the accumulation of miR171b and miR165a, leading to reduction of lateral root development and stimulation of mainroot growth, respectively, suggesting that miPEPs might have agronomical applications.	[Lauressergues, Dominique; Couzigou, Jean-Malo; Clemente, Helene San; Dunand, Christophe; Becard, Guillaume; Combier, Jean-Philippe] Univ Toulouse, UPS, UMR5546, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France; [Lauressergues, Dominique; Couzigou, Jean-Malo; Clemente, Helene San; Dunand, Christophe; Becard, Guillaume; Combier, Jean-Philippe] CNRS, UMR5546, F-31326 Castanet Tolosan, France; [Martinez, Yves] Federat Rech FR3450 CNRS, F-31326 Castanet Tolosan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Combier, JP (corresponding author), Univ Toulouse, UPS, UMR5546, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France.	combier@lrsv.ups-tlse.fr	Dunand, Christophe/I-6424-2012	Dunand, Christophe/0000-0003-1637-4042; Couzigou, Jean-Malo/0000-0002-1362-6286	French ANR project miRcorrhiza [ANR-12-JSV7-0002-01]; CNRS; Paul Sabatier University Toulouse; Toulouse Tech Transfer	French ANR project miRcorrhiza(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Paul Sabatier University Toulouse; Toulouse Tech Transfer	This work was funded by the French ANR project miRcorrhiza (ANR-12-JSV7-0002-01), the CNRS, Paul Sabatier University Toulouse. This work is also supported by Toulouse Tech Transfer (http://www.toulouse-tech-transfer.com) for valorization and transfer. It was carried out in the LRSV which belongs to the Laboratoire d'Excellence entitled TULIP (ANR-10-LABX-41). We thank the GenoToul bioinformatics facility for providing computing and storage resources. We also thank J.-M. Prosperi (UMR AGAP 1334, Montpellier, France) for M. truncatula seeds, X. Chen (University of California, USA) for nrpb2-3 seeds, V. Cotelle (LRSV) for help with protein analyses, C. Rosenberg (LIPM, Castanet Tolosan, France) for providing modified pCAMBIA 2200, and F. Payre and S. Plaza (CBD CNRS, Toulouse), J. Cavaille (LBME CNRS, Toulouse) and C. Featherstone for critical reading of the manuscript.	Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Combier JP, 2008, GENE DEV, V22, P1549, DOI 10.1101/gad.461808; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fliegmann J, 2013, ACS CHEM BIOL, V8, P1900, DOI 10.1021/cb400369u; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Juntawong P, 2014, P NATL ACAD SCI USA, V111, pE203, DOI 10.1073/pnas.1317811111; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; Lauressergues D, 2012, PLANT J, V72, P512, DOI 10.1111/j.1365-313X.2012.05099.x; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Zheng BL, 2009, GENE DEV, V23, P2850, DOI 10.1101/gad.1868009	13	254	291	5	301	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					90	U205		10.1038/nature14346	http://dx.doi.org/10.1038/nature14346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25807486				2022-12-28	WOS:000352027700043
J	Waterhouse, PM; Hellens, RP				Waterhouse, Peter M.; Hellens, Roger P.			Coding in non-coding RNAs	NATURE			English	Editorial Material									[Waterhouse, Peter M.; Hellens, Roger P.] Queensland Univ Technol, Ctr Trop Crops & Biocommod, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT)	Waterhouse, PM (corresponding author), Queensland Univ Technol, Ctr Trop Crops & Biocommod, Brisbane, Qld 4001, Australia.	peter.waterhouse@qut.edu.au		Waterhouse, Peter/0000-0002-2812-3753; Hellens, Roger/0000-0003-2094-0887				Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fang YD, 2007, CURR BIOL, V17, P818, DOI 10.1016/j.cub.2007.04.005; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Laing W. A., 2015, PLANT CELL; Lauressergues D, 2015, NATURE, V520, P90, DOI 10.1038/nature14346; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716	10	30	32	4	238	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					41	42		10.1038/nature14378	http://dx.doi.org/10.1038/nature14378			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25807488				2022-12-28	WOS:000352027700031
J	Harvey, D; Massey, R; Kitching, T; Taylor, A; Tittley, E				Harvey, David; Massey, Richard; Kitching, Thomas; Taylor, Andy; Tittley, Eric			The nongravitational interactions of dark matter in colliding galaxy clusters	SCIENCE			English	Article							INTERACTION CROSS-SECTION; SUBSTRUCTURE; SIMULATIONS; CONSTRAINTS; EXISTENCE; SCALE; MILKY	Collisions between galaxy clusters provide a test of the nongravitational forces acting on dark matter. Dark matter's lack of deceleration in the "bullet cluster" collision constrained its self-interaction cross section sigma(DM)/m <1.25 square centimeters per gram (cm(2)/g) [68% confidence limit (CL)] (sigma(DM), self-interaction cross section; m, unit mass of dark matter) for long-ranged forces. Using the Chandra and Hubble Space Telescopes, we have now observed 72 collisions, including both major and minor mergers. Combining these measurements statistically, we detect the existence of dark mass at 7.6 sigma significance. The position of the dark mass has remained closely aligned within 5.8 +/- 8.2 kiloparsecs of associated stars, implying a self-interaction cross section sigma(DM)/m < 0.47 cm(2)/g (95% CL) and disfavoring some proposed extensions to the standard model.	[Harvey, David] Ecole Polytech Fed Lausanne, Astrophys Lab, Observ Sauverny, CH-1290 Versoix, Switzerland; [Harvey, David; Taylor, Andy; Tittley, Eric] Univ Edinburgh, Royal Observ, Edinburgh EH9 3HJ, Midlothian, Scotland; [Massey, Richard] Univ Durham, Inst Computat Cosmol, Durham DH1 3LE, England; [Kitching, Thomas] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Edinburgh; Durham University; University of London; University College London	Harvey, D (corresponding author), Ecole Polytech Fed Lausanne, Astrophys Lab, Observ Sauverny, CH-1290 Versoix, Switzerland.	david.harvey@epfl.ch	; Massey, Richard/D-1300-2016	Harvey, David/0000-0002-6066-6707; Massey, Richard/0000-0002-6085-3780	Swiss National Science Foundation; Science and Technology Facilities Council; Royal Society; Science and Technology Facilities Council [ST/K000977/1, ST/L00075X/1] Funding Source: researchfish; STFC [ST/K000977/1, ST/L00075X/1] Funding Source: UKRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Royal Society(Royal Society of London); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	D.H. is supported by the Swiss National Science Foundation and Science and Technology Facilities Council. R.M. and T.K. are supported by the Royal Society. The raw HST and Chandra data are all publicly accessible from the mission archives (29, 30). We thank the anonymous referees; S. Kay, E. Lau, D. Nagai, and S. Pike for sharing mock data on which we developed our analysis methods; R. Bowler for help stacking HST exposures; E. Jullo, J. Rhodes, and P. Marshall for help with shear measurement and mass reconstruction; D. Clowe, H. Dahle, and J. Jee for discussions of individual systems; and C. Boehm, F. Kahlhoefer, and A. Robertson for interpreting particle physics.	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Akerib DS, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.091303; BARDEEN JM, 1986, ASTROPHYS J, V304, P15, DOI 10.1086/164143; Bartelmann M, 2001, PHYS REP, V340, P291, DOI 10.1016/S0370-1573(00)00082-X; Boddy KK, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.115017; Boylan-Kolchin M, 2011, MON NOT R ASTRON SOC, V415, pL40, DOI 10.1111/j.1745-3933.2011.01074.x; Cline JM, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.015023; Clowe D, 2004, ASTROPHYS J, V604, P596, DOI 10.1086/381970; Clowe D, 2006, ASTROPHYS J, V648, pL109, DOI 10.1086/508162; DAVIS M, 1985, ASTROPHYS J, V292, P371, DOI 10.1086/163168; DUBINSKI J, 1991, ASTROPHYS J, V378, P496, DOI 10.1086/170451; Eckert D, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201424259; Fernandez-Trincado JG, 2014, ASTROPHYS J LETT, V787, DOI 10.1088/2041-8205/787/2/L34; Gastaldello F, 2014, MON NOT R ASTRON SOC, V442, pL76, DOI 10.1093/mnrasl/slu058; Giodini S, 2009, ASTROPHYS J, V703, P982, DOI 10.1088/0004-637X/703/1/982; Harvey D, 2014, MON NOT R ASTRON SOC, V441, P404, DOI 10.1093/mnras/stu337; Harvey D, 2013, MON NOT R ASTRON SOC, V433, P1517, DOI 10.1093/mnras/stt819; Hochberg Y, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.171301; Kahlhoefer F, 2014, MON NOT R ASTRON SOC, V437, P2865, DOI 10.1093/mnras/stt2097; Klypin A, 1999, ASTROPHYS J, V522, P82, DOI 10.1086/307643; Markevitch M, 2004, ASTROPHYS J, V606, P819, DOI 10.1086/383178; Massey R, 2011, MON NOT R ASTRON SOC, V413, P1709, DOI 10.1111/j.1365-2966.2011.18246.x; Moore B, 1999, ASTROPHYS J, V524, pL19, DOI 10.1086/312287; Pontzen A, 2014, NATURE, V506, P171, DOI 10.1038/nature12953; Randall SW, 2008, ASTROPHYS J, V679, P1173, DOI 10.1086/587859; Rocha M, 2013, MON NOT R ASTRON SOC, V430, P81, DOI 10.1093/mnras/sts514; Spergel DN, 2000, PHYS REV LETT, V84, P3760, DOI 10.1103/PhysRevLett.84.3760; Tulin S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.111301; Williams LLR, 2011, MON NOT R ASTRON SOC, V415, P448, DOI 10.1111/j.1365-2966.2011.18716.x	31	306	307	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1462	1465		10.1126/science.1261381	http://dx.doi.org/10.1126/science.1261381			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814581	Green Submitted, Green Accepted			2022-12-28	WOS:000352136400037
J	Fares, S; Mugnozza, GS; Corona, P; Palahi, M				Fares, Silvano; Mugnozza, Giuseppe Scarascia; Corona, Piermaria; Palahi, Marc			Five steps for managing Europe's forests	NATURE			English	Editorial Material									[Fares, Silvano] Council Agr Res & Econ, Res Ctr Soil Plant Syst, Rome, Italy; [Mugnozza, Giuseppe Scarascia] Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst, Viterbo, Italy; [Corona, Piermaria] Council Agr Res & Econ, Forestry Res Ctr, Arezzo, Italy; [Palahi, Marc] European Forest Inst, Joensuu, Finland	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Tuscia University; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Fares, S (corresponding author), Council Agr Res & Econ, Res Ctr Soil Plant Syst, Rome, Italy.	silvano.fares@entecra.it	Corona, Piermaria/G-1565-2011; Fares, Silvano/H-4322-2011	Corona, Piermaria/0000-0002-8105-0792; Fares, Silvano/0000-0002-1990-0928				Bellassen V, 2014, NATURE, V506, P153, DOI 10.1038/506153a; Birot Y., 2009, LIVING WITH WILDFIRE; Forest Europe UNECE and FAO, 2011, STATE OF EUROPES FOR; Hardiman BS, 2013, FOREST ECOL MANAG, V298, P111, DOI 10.1016/j.foreco.2013.02.031; Hetemaki L., 2014, THINKFOREST FOREST B; Kolstrom M, 2011, FORESTS, V2, P961, DOI 10.3390/f2040961; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Myhre G., 2013, CONTRIBUTION WORKING; Nabuurs GJ, 2013, NAT CLIM CHANGE, V3, P792, DOI [10.1038/NCLIMATE1853, 10.1038/nclimate1853]; Prokofieva I., 2012, PAYMENTS FOR ENVIRON	10	58	61	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					407	409		10.1038/519407a	http://dx.doi.org/10.1038/519407a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE1WF	25810187	Bronze			2022-12-28	WOS:000351602800029
J	Hazen, EP; Sherry, NA; Parangi, S; Rabito, CA; Sadow, PM				Hazen, Eric P.; Sherry, Nicole A.; Parangi, Sareh; Rabito, Carlos A.; Sadow, Peter M.			Case 10-2015: A 15-Year-Old Girl with Graves' Disease and Psychotic Symptoms	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPERTHYROIDISM; MANIFESTATIONS; THYROTOXICOSIS; COMPLAINTS		[Hazen, Eric P.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Sherry, Nicole A.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Parangi, Sareh] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Rabito, Carlos A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sadow, Peter M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hazen, Eric P.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Sherry, Nicole A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Parangi, Sareh] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Rabito, Carlos A.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Sadow, Peter M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Hazen, EP (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.		Sadow, Peter/AAO-9878-2020; Sadow, Peter/E-7691-2015	Sadow, Peter/0000-0003-1036-6367; Sadow, Peter/0000-0003-1036-6367	Novo Nordisk	Novo Nordisk(Novo Nordisk)	Dr. Sherry reports receiving consulting fees from Novo Nordisk. No other potential conflict of interest relevant to this article was reported.	Abidi S, 2013, PEDIATR REV, V34, P296, DOI 10.1542/pir.34-7-296; [Anonymous], 2007, J AM ACAD CHILD PSY, V46, P107, DOI 10.1097/01.chi.0000242240.69678.c4; ASHER R, 1949, BRIT MED J, V2, P555, DOI 10.1136/bmj.2.4627.555; Brownlie BEW, 2000, EUR J ENDOCRINOL, V142, P438, DOI 10.1530/eje.0.1420438; Bunevicius R, 2006, CNS DRUGS, V20, P897, DOI 10.2165/00023210-200620110-00003; Dralle H, 2004, SURGERY, V136, P1310, DOI 10.1016/j.surg.2004.07.018; Dunlap HT, 1935, AM J PSYCHIAT, V91, P1215, DOI 10.1176/ajp.91.6.1215; Freudenreich O, 2009, EARLY INTERV PSYCHIA, V3, P10, DOI 10.1111/j.1751-7893.2008.00105.x; KATHOL RG, 1986, GEN HOSP PSYCHIAT, V8, P23, DOI 10.1016/0163-8343(86)90060-5; Lee JA, 2007, J CLIN ENDOCR METAB, V92, P801, DOI 10.1210/jc.2006-1238; Loomba-Albrecht LA, 2011, J PEDIATR ENDOCR MET, V24, P209, DOI 10.1515/JPEM.2011.093; Macedo Livia R, 2013, J Pharm Pract, V26, P59, DOI 10.1177/0897190012451934; Meagher DJ, 2007, BRIT J PSYCHIAT, V190, P135, DOI 10.1192/bjp.bp.106.023911; Nebesio TD, 2002, J PEDIATR-US, V141, P99, DOI 10.1067/mpd.2002.125494; Rivkees SA, 2007, J CLIN ENDOCR METAB, V92, P797, DOI 10.1210/jc.2006-1239; Rivkees SA, 2010, J CLIN ENDOCR METAB, V95, P3260, DOI 10.1210/jc.2009-2546; Schlosser K, 2007, SURGERY, V142, P858, DOI 10.1016/j.surg.2007.09.008; Stern RA, 1996, J NEUROPSYCH CLIN N, V8, P181; Williamson S, 2010, CLIN ENDOCRINOL, V72, P358, DOI 10.1111/j.1365-2265.2009.03717.x	19	5	6	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2015	372	13					1250	1258		10.1056/NEJMcpc1314239	http://dx.doi.org/10.1056/NEJMcpc1314239			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1QD	25806918				2022-12-28	WOS:000351585900012
J	McConnell, R; Zhang, H; Hu, JZ; Cuk, S; Vuletic, V				McConnell, Robert; Zhang, Hao; Hu, Jiazhong; Cuk, Senka; Vuletic, Vladan			Entanglement with negative Wigner function of almost 3,000 atoms heralded by one photon	NATURE			English	Article							STANDARD QUANTUM LIMIT; SCHRODINGER CAT STATE; SPIN STATES; ENSEMBLES; COMMUNICATION; INFORMATION; GENERATION; OPTICS	Quantum-mechanically correlated (entangled) states of many particles are of interest in quantum information, quantum computing and quantum metrology. Metrologically useful entangled states of large atomic ensembles have been experimentally realized(1-10), but these states display Gaussian spin distribution functions with a non-negative Wigner quasiprobability distribution function. Non-Gaussian entangled states have been produced in small ensembles of ions(11,12), and very recently in large atomic ensembles(13-15). Here we generate entanglement in a large atomic ensemble via an interaction with a very weak laser pulse; remarkably, the detection of a single photon prepares several thousand atoms in an entangled state. We reconstruct a negative-valued Wigner function-an important hallmark of non-classicality-and verify an entanglement depth (the minimum number of mutually entangled atoms) of 2,9106190 out of 3,100 atoms. Attaining such a negative Wigner function and the mutual entanglement of virtually all atoms is unprecedented for an ensemble containing more than a few particles. Although the achieved purity of the state is slightly below the threshold for entanglement-induced metrological gain, further technical improvement should allow the generation of states that surpass this threshold, and of more complex Schrodinger cat states for quantum metrology and information processing. More generally, our results demonstrate the power of heralded methods for entanglement generation, and illustrate how the information contained in a single photon can drastically alter the quantum state of a large system.	[McConnell, Robert; Zhang, Hao; Hu, Jiazhong; Cuk, Senka; Vuletic, Vladan] MIT, Dept Phys, MIT Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA; [McConnell, Robert; Zhang, Hao; Hu, Jiazhong; Cuk, Senka; Vuletic, Vladan] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Cuk, Senka] Univ Belgrade, Inst Phys, Belgrade 11080, Serbia	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Belgrade	Vuletic, V (corresponding author), MIT, Dept Phys, MIT Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA.	vuletic@mit.edu	Hu, Jiazhong/AAP-2848-2021; Vuletic, Vladan/M-8736-2019	Hu, Jiazhong/0000-0002-2937-4810; 	NSF; DARPA (QUASAR); MURI grant through AFOSR; Ministry of Education, Science and Technological Development of the Republic of Serbia [III45016, OI171038]; Direct For Mathematical & Physical Scien [1505862, 1125846] Funding Source: National Science Foundation; Division Of Physics [1205554] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); DARPA (QUASAR); MURI grant through AFOSR; Ministry of Education, Science and Technological Development of the Republic of Serbia; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank M. H. Schleier-Smith, E. S. Polzik and S. L. Christensen for discussions. This work was supported by the NSF, DARPA (QUASAR), and a MURI grant through AFOSR. S.C. acknowledges support from the Ministry of Education, Science and Technological Development of the Republic of Serbia, through grant numbers III45016 and OI171038.	Agarwal GS, 2005, J MOD OPTIC, V52, P1397, DOI 10.1080/09500340512331337920; Appel J, 2009, P NATL ACAD SCI USA, V106, P10960, DOI 10.1073/pnas.0901550106; ARECCHI FT, 1972, PHYS REV A, V6, P2211, DOI 10.1103/PhysRevA.6.2211; Bohnet JG, 2014, NAT PHOTONICS, V8, P731, DOI [10.1038/nphoton.2014.151, 10.1038/NPHOTON.2014.151]; Choi KS, 2010, NATURE, V468, P412, DOI 10.1038/nature09568; Christensen SL, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.033801; Christensen SL, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015002; DOWLING JP, 1994, PHYS REV A, V49, P4101, DOI 10.1103/PhysRevA.49.4101; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Gross C, 2010, NATURE, V464, P1165, DOI 10.1038/nature08919; Haas F, 2014, SCIENCE, V344, P180, DOI 10.1126/science.1248905; Hamley CD, 2012, NAT PHYS, V8, P305, DOI [10.1038/nphys2245, 10.1038/NPHYS2245]; KITAGAWA M, 1993, PHYS REV A, V47, P5138, DOI 10.1103/PhysRevA.47.5138; Kuzmich A, 2003, NATURE, V423, P731, DOI 10.1038/nature01714; Leibfried D, 2005, NATURE, V438, P639, DOI 10.1038/nature04251; Leroux ID, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073602; Lucke B, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.155304; Lvovsky AI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.050402; Matsukevich DN, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.013601; McConnell R, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.063802; Monz T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130506; Riedel MF, 2010, NATURE, V464, P1170, DOI 10.1038/nature08988; Schleier-Smith MH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073604; Sewell RJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.253605; Simon J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.183601; Sorensen AS, 2001, PHYS REV LETT, V86, P4431, DOI 10.1103/PhysRevLett.86.4431; Strobel H, 2014, SCIENCE, V345, P424, DOI 10.1126/science.1250147; Takano T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.013602; Tanji-Suzuki H, 2011, ADV ATOM MOL OPT PHY, V60, P201, DOI 10.1016/B978-0-12-385508-4.00004-8; Vlastakis B, 2013, SCIENCE, V342, P607, DOI 10.1126/science.1243289	31	142	142	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					439	+		10.1038/nature14293	http://dx.doi.org/10.1038/nature14293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25810205	Green Submitted			2022-12-28	WOS:000351602800049
J	Sadlier, M; O'Regan, GM				Sadlier, Muriel; O'Regan, Grainne M.			Becker's Nevus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sadlier, Muriel; O'Regan, Grainne M.] Adelaide & Meath Hosp, Dublin, Ireland	Trinity College Dublin	Sadlier, M (corresponding author), Adelaide & Meath Hosp, Dublin, Ireland.	murielsadlier@gmail.com							0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2015	372	13					1249	1249		10.1056/NEJMicm1402443	http://dx.doi.org/10.1056/NEJMicm1402443			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1QD	25806917				2022-12-28	WOS:000351585900011
J	Yanovski, SZ; Yanovski, JA				Yanovski, Susan Z.; Yanovski, Jack A.			Naltrexone Extended-Release Plus Bupropion Extended-Release for Treatment of Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OVERWEIGHT; WEIGHT		[Yanovski, Susan Z.] NIDDK, Div Digest Dis & Nutr, Bethesda, MD 20892 USA; [Yanovski, Jack A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Obes, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yanovski, SZ (corresponding author), NIDDK, Off Obes Res, 6707 Democracy Blvd,Room 675, Bethesda, MD 20892 USA.	sy29f@nih.gov		Yanovski, Jack/0000-0001-8542-1637	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000641] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HD999999, ZIA HD000641-21, ZIA HD000641] Funding Source: Medline; PHS HHS [1ZIAHD000641] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 2014, CONTRAVE NALTREXONE; [Anonymous], FDA BRIEFING DOCUMEN; Apovian CM, 2013, OBESITY, V21, P935, DOI 10.1002/oby.20309; Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4; Hollander P, 2013, DIABETES CARE, V36, P4022, DOI 10.2337/dc13-0234; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012; Wadden TA, 2011, OBESITY, V19, P110, DOI 10.1038/oby.2010.147; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361	9	43	43	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1213	1214		10.1001/jama.2015.1617	http://dx.doi.org/10.1001/jama.2015.1617			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25803343	Green Accepted			2022-12-28	WOS:000351435500016
J	Frick, M; von Delft, D; Kumar, B				Frick, Mike; von Delft, Dalene; Kumar, Blessina			PERSONAL VIEW End stigmatizing language in tuberculosis research and practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PATHWAYS; CARE; HIV		[Frick, Mike] Treatment Act GrpN, New York, NY 10016 USA; [von Delft, Dalene] TB Proof, Cape Town, South Africa; [Kumar, Blessina] Global Coalit TB Activists, New Delhi, India		Frick, M (corresponding author), Treatment Act GrpN, New York, NY 10016 USA.	mike.frick@treatmentactiongroup.org						[Anonymous], 2011, SUGG LANG US TUB CAR; Courtwright A, 2010, PUBLIC HEALTH REP, V125, P34, DOI 10.1177/00333549101250S407; Daftary A, 2015, AIDS, V29, P1, DOI 10.1097/QAD.0000000000000515; DeLuca A, 2014, LANCET RESP MED, V2, P258, DOI 10.1016/S2213-2600(14)70035-9; Ditiu L, 2012, INT J TUBERC LUNG D, V16, P711, DOI 10.5588/ijtld.12.0297; Edginton ME, 2002, INT J TUBERC LUNG D, V6, P1075; Harrington M, 2010, CLIN INFECT DIS, V50, pS260, DOI 10.1086/651500; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Naidoo P, 2009, QUAL HEALTH RES, V19, P55, DOI 10.1177/1049732308327893; Rocha C, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P50, DOI 10.5588/ijtld.10.0447; Shaw Dorothy, 2015, COMMUNICATION; SUMARTOJO E, 1993, AM REV RESPIR DIS, V147, P1311, DOI 10.1164/ajrccm/147.5.1311; Watkins RE, 2004, QUAL HEALTH RES, V14, P691, DOI 10.1177/1049732304263628; Zachariah R, 2012, INT J TUBERC LUNG D, V16, P714, DOI 10.5588/ijtld.11.0635	14	14	15	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2015	350								h1479	10.1136/bmj.h1479	http://dx.doi.org/10.1136/bmj.h1479			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NK	25805838				2022-12-28	WOS:000352028400005
J	Watts, G				Watts, Geoff			Beryl Benacerraf: new AIUM President gets the picture	LANCET			English	Biographical-Item																			0	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1065	1065		10.1016/S0140-6736(15)60590-6	http://dx.doi.org/10.1016/S0140-6736(15)60590-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25797550	Bronze			2022-12-28	WOS:000351270400013
J	Sokol, DK				Sokol, Daniel K.			Update on the UK law on consent	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									12 Kings Bench Walk, London, England		Sokol, DK (corresponding author), 12 Kings Bench Walk, London, England.	Sokol@12kbw.co.uk						Brody H., 1992, THE HEALERS POWER; Dyer C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1414	2	67	67	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2015	350								h1481	10.1136/bmj.h1481	http://dx.doi.org/10.1136/bmj.h1481			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KM	25779588				2022-12-28	WOS:000351570500012
J	Klingberg-Allvin, M; Cleeve, A; Atuhairwe, S; Tumwesigye, NM; Faxelid, E; Byamugisha, J; Gemzell-Danielsson, K				Klingberg-Allvin, Marie; Cleeve, Amanda; Atuhairwe, Susan; Tumwesigye, Nazarius Mbona; Faxelid, Elisabeth; Byamugishat, Josaphat; Gemzell-Danielsson, Kristina			Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial	LANCET			English	Article							MANUAL VACUUM ASPIRATION; POSTABORTION CARE; NONPHYSICIAN CLINICIAN; SUBLINGUAL MISOPROSTOL; HEALTH-CARE; PROVISION; SAFE	Background Misoprostol is established for the treatment of incomplete abortion but has not been systematically assessed when provided by midwives at district level in a low-resource setting. We investigated the effectiveness and safety of midwives diagnosing and treating incomplete abortion with misoprostol, compared with physicians. Methods We did a multicentre randomised controlled equivalence trial at district level at six facilities in Uganda. Eligibility criteria were women with signs of incomplete abortion. We randomly allocated women with first-trimester incomplete abortion to clinical assessment and treatment with misoprostol either by a physician or a midwife. The randomisation (1:1) was done in blocks of 12 and was stratified for study site. Primary outcome was complete abortion not needing surgical intervention within 14-28 days after initial treatment. The study was not masked. Analysis of the primary outcome was done on the per-protocol population with a generalised linear-mixed effects model. The predefined equivalence range was -4% to 4%. The trial was registered at ClinicalTrials.gov, number NCT01844024. Findings From April 30, 2013, to July 21, 2014, 1108 women were assessed for eligibility. 1010 women were randomly assigned to each group (506 to midwife group and 504 to physician group). 955 women (472 in the midwife group and 483 in the physician group) were included in the per-protocol analysis. 452 (95.8%) of women in the midwife group had complete abortion and 467 (96.7%) in the physician group. The model-based risk difference for midwife versus physician group was -0.8% (95% CI -2.9 to 1.4), falling within the predefined equivalence range (-4% to 4%). The overall proportion of women with incomplete abortion was 3.8% (36/955), similarly distributed between the two groups (4.2% [20/472] in the midwife group, 3.3% [16/483] in the physician group). No serious adverse events were recorded. Interpretation Diagnosis and treatment of incomplete abortion with misoprostol by midwives is equally safe and effective as when provided by physicians, in a low-resource setting. Scaling up midwives' involvement in treatment of incomplete abortion with misoprostol at district level would increase access to safe post-abortion care.	[Klingberg-Allvin, Marie] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden; [Klingberg-Allvin, Marie; Cleeve, Amanda; Gemzell-Danielsson, Kristina] Karolinska Inst, Dept Womens & Childrens Hlth, SE-17176 Stockholm, Sweden; [Faxelid, Elisabeth] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth IHCAR, SE-17176 Stockholm, Sweden; [Atuhairwe, Susan; Byamugishat, Josaphat] Mulago Hosp, Dept Obstet & Gynaecol, Kampala, Uganda; [Tumwesigye, Nazarius Mbona] Makerere Univ, Coll Hlth Sci, Dept Epidemiol & Biostat, Sch Publ Hlth, Kampala, Uganda; [Atuhairwe, Susan; Byamugishat, Josaphat] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Gemzell-Danielsson, Kristina] Karolinska Univ Hosp, Stockholm, Sweden	Dalarna University; Karolinska Institutet; Karolinska Institutet; Mulago National Referral Hospital; Makerere University; Makerere University; Karolinska Institutet; Karolinska University Hospital	Klingberg-Allvin, M (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, WHO Ctr, C1 05, SE-17176 Stockholm, Sweden.	mkl@du.se	Byamugisha, Josaphat/AAL-5776-2020	Byamugisha, Josaphat/0000-0002-3438-9662; Klingberg-Allvin, Marie/0000-0002-8947-2949; Cleeve, Amanda/0000-0001-8115-5503; Tumwesigye, Nazarius Mbona/0000-0001-7085-8780	Swedish Research Council [521-2009-2605]; Karolinska Institutet; Dalarna University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Dalarna University	The Swedish Research Council, Karolinska Institutet, and Dalarna University.; UNDPA/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction provided technical support. The funders were the Swedish Research Council (521-2009-2605), Karolinska Institutet, and Dalarna University. We thank the women who participated for sharing their experiences and attending follow- up. We thank all the providers involved in the study who remained committed and motivated throughout.	Berer M, 2009, B WORLD HEALTH ORGAN, V87, P58, DOI 10.2471/BLT.07.050138; Blum J, 2007, INT J GYNECOL OBSTET, V99, pS186, DOI 10.1016/j.ijgo.2007.09.009; Dabash R, 2010, INT J GYNECOL OBSTET, V111, P131, DOI 10.1016/j.ijgo.2010.06.021; Dao B, 2007, BJOG-INT J OBSTET GY, V114, P1368, DOI 10.1111/j.1471-0528.2007.01468.x; Escandon I, 2006, INDICATORS ESSENTIAL; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Ganatra B, 2014, B WORLD HEALTH ORGAN, V92, P155, DOI 10.2471/BLT.14.136333; Gaye A, 2014, INT J GYNECOL OBSTET, V126, P223, DOI 10.1016/j.ijgo.2014.03.028; Gemzell-Danielsson K, 2007, BJOG-INT J OBSTET GY, V114, P1337, DOI 10.1111/j.1471-0528.2007.01491.x; Gessessew A, 2011, INT J GYNECOL OBSTET, V113, P28, DOI 10.1016/j.ijgo.2010.10.023; Haddad Lisa B, 2009, Rev Obstet Gynecol, V2, P122; Kallner HK, 2015, BJOG-INT J OBSTET GY, V122, P510, DOI 10.1111/1471-0528.12982; Nabudere H, 2011, INT J TECHNOL ASSESS, V27, P173, DOI 10.1017/S0266462311000055; Neilson JP, 2013, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD007223.PUB3; Paul M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-28; Pereira C, 2011, INT J GYNECOL OBSTET, V114, P180, DOI 10.1016/j.ijgo.2011.05.004; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Rasch V, 2011, ACTA OBSTET GYN SCAN, V90, P692, DOI 10.1111/j.1600-0412.2011.01165.x; Renfrew MJ, 2014, LANCET, V384, P1129, DOI 10.1016/S0140-6736(14)60789-3; Renner RM, 2013, BJOG-INT J OBSTET GY, V120, P23, DOI 10.1111/j.1471-0528.2012.03464.x; Shah IH, 2014, CONTRACEPTION, V90, pS39, DOI 10.1016/j.contraception.2014.04.004; Shochet T, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-127; Turner KL, 2004, WOMAN CTR COMPREHENS; Turner KL, 2010, MED ABORTION TRAININ; Vlassoff M, 2014, HEALTH POLICY PLANN, V29, P56, DOI 10.1093/heapol/czs133; Warriner IK, 2006, LANCET, V368, P1965, DOI 10.1016/S0140-6736(06)69742-0; Warriner IK, 2011, LANCET, V377, P1155, DOI 10.1016/S0140-6736(10)62229-5; Weeks A, 2005, OBSTET GYNECOL, V106, P540, DOI 10.1097/01.AOG.0000173799.82687.dc; Weeks A, 2001, Afr Health Sci, V1, P52; WHO UNICEF, 2013, TRENDS MAT MORT 1990; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; Yarnall J, 2009, REPROD HEALTH MATTER, V17, P61, DOI 10.1016/S0968-8080(09)33445-X	32	28	28	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2392	2398		10.1016/S0140-6736(14)61935-8	http://dx.doi.org/10.1016/S0140-6736(14)61935-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1XV	25817472	Bronze, Green Submitted			2022-12-28	WOS:000356003700032
J	Granger, DE; Gibbon, RJ; Kuman, K; Clarke, RJ; Bruxelles, L; Caffee, MW				Granger, Darryl E.; Gibbon, Ryan J.; Kuman, Kathleen; Clarke, Ronald J.; Bruxelles, Laurent; Caffee, Marc W.			New cosmogenic burial ages for Sterkfontein Member 2 Australopithecus and Member 5 Oldowan	NATURE			English	Article							SOUTH-AFRICA; HOMINID; SKELETON; STRATIGRAPHY	The cave infills at Sterkfontein contain one of the richest assemblages of Australopithecus fossils in the world, including the nearly complete skeleton StW 573 ('Little Foot')(1-4) in its lower section, as well as early stone tools(5-7) in higher sections. However, the chronology of the site remains controversial(8-14) owing to the complex history of cave infilling. Much of the existing chronology based on uranium-lead dating(10,11) and palaeomagnetic stratigraphy(8,12) has recently been called into question by the recognition that dated flowstones fill cavities formed within previously cemented breccias and therefore do not form a stratigraphic sequence(4,14). Earlier dating with cosmogenic nuclides(9) suffered a high degree of uncertainty and has been questioned on grounds of sediment reworking(10,11,13). Here we use isochron burial dating with cosmogenic aluminium-26 and beryllium-10 to show that the breccia containing StW 573 did not undergo significant reworking, and that it was deposited 3.67 +/- 0.16 million years ago, far earlier than the 2.2 million year flowstones found within it(10,11). The skeleton is thus coeval with early Australopithecus afar-ensis in eastern Africa(15,16). We also date the earliest stone tools at Sterkfontein to 2.18 +/- 0.21 million years ago, placing them in the Oldowan at a time similar to that found elsewhere in South Africa at Swartkans(17) and Wonderwerk(18).	[Granger, Darryl E.; Caffee, Marc W.] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Gibbon, Ryan J.] Univ New Brunswick, Dept Anthropol, Fredericton, NB E3B 5A3, Canada; [Kuman, Kathleen; Clarke, Ronald J.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Kuman, Kathleen; Bruxelles, Laurent] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, ZA-2050 Johannesburg, South Africa; [Bruxelles, Laurent] French Natl Inst Prevent Archaeol Res Inrap, F-30900 Nimes, France; [Bruxelles, Laurent] Univ Toulouse Jean Jaures, UMR 5608, CNRS, TRACES,Maison Rech, F-31058 Toulouse, France; [Caffee, Marc W.] Purdue Univ, Dept Phys & Astron, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of New Brunswick; University of Witwatersrand; University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite de Toulouse - Jean Jaures; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Granger, DE (corresponding author), Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA.	dgranger@purdue.edu		Kuman, Kathleen/0000-0003-1252-9895; Bruxelles, Laurent/0000-0002-7174-2111	National Science Foundation [EAR1153689, EAR0844151]; Palaeontological Scientific Trust (PAST); National Research Foundation (NRF) of South Africa; NRF (SA) [AOP1207112551-82611, AOP1207173196-82591]	National Science Foundation(National Science Foundation (NSF)); Palaeontological Scientific Trust (PAST); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); NRF (SA)	This work results from a collaboration begun with T. C. Partridge (deceased). AMS development and measurements were funded by National Science Foundation EAR1153689 to M.W.C. and D.E.G. and National Science Foundation EAR0844151 to D.E.G. Major funding to R.J.G., K.K. and R.J.C. was received from the Palaeontological Scientific Trust (PAST), which has supported research at Sterkfontein for 20 years. R.J.G. received bursary support from the National Research Foundation (NRF) of South Africa. K.K. thanks the NRF (SA) for substantial funding (AOP1207112551-82611 and AOP1207173196-82591) and Prof. Bruce Rubidge of the Evolutionary Studies Institute for additional support. Figure 1 includes modified material from J. Hum Evol. vol. 70, Bruxelles L. et al., Stratigraphic analysis of the Sterkfontein StW 573 Australopithecus skeleton and implications for its age, 36-48 (2014), with permission from Elsevier.	Balco G, 2013, QUAT GEOCHRONOL, V18, P149, DOI 10.1016/j.quageo.2013.02.002; Balco G, 2008, AM J SCI, V308, P1083, DOI 10.2475/10.2008.02; Bruxelles L, 2014, J HUM EVOL, V70, P36, DOI 10.1016/j.jhevol.2014.02.014; Chazan M, 2012, J HUM EVOL, V63, P859, DOI 10.1016/j.jhevol.2012.08.008; Chmeleff J, 2010, NUCL INSTRUM METH B, V268, P192, DOI 10.1016/j.nimb.2009.09.012; Clarke R. J., 2006, Transactions of the Royal Society of South Africa, V61, P111; CLARKE RJ, 1995, SCIENCE, V269, P521, DOI 10.1126/science.7624772; Clarke RJ, 2002, S AFR J SCI, V98, P523; Clarke RJ, 1998, S AFR J SCI, V94, P460; Clarke RJ, 1994, INTEGRATIVE PATHS ES, P205; Dart RA, 1948, AM J PHYS ANTHROP-NE, V6, P259, DOI 10.1002/ajpa.1330060304; Drake R., 1987, LAETOLI PLIOCENE SIT, P48; Erlanger ED, 2012, GEOLOGY, V40, P1019, DOI 10.1130/G33172.1; Gibbon RJ, 2014, QUAT GEOCHRONOL, V24, P10, DOI 10.1016/j.quageo.2014.07.004; Granger D. E., 2014, TREATISE GEOCHEMISTR, P81; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; Herries Andy I.R., 2013, P21; Herries AIR, 2011, J HUM EVOL, V60, P523, DOI 10.1016/j.jhevol.2010.09.001; KUMAN K, 1994, J HUM EVOL, V27, P471, DOI 10.1006/jhev.1994.1065; Kuman K, 2000, J HUM EVOL, V38, P827, DOI 10.1006/jhev.1999.0392; Kuman K., 2009, CUTTING EDGE NEW APP, P151; Nishiizumi K, 2004, NUCL INSTRUM METH B, V223, P388, DOI 10.1016/j.nimb.2004.04.075; Nishiizumi K, 2007, NUCL INSTRUM METH B, V258, P403, DOI 10.1016/j.nimb.2007.01.297; PARTRIDGE T C, 1991, Palaeontologia Africana, V28, P35; PARTRIDGE TC, 1978, NATURE, V275, P282, DOI 10.1038/275282a0; Partridge TC, 2003, SCIENCE, V300, P607, DOI 10.1126/science.1081651; Partridge TC, 1999, J QUATERNARY SCI, V14, P293, DOI 10.1002/(SICI)1099-1417(199907)14:4<293::AID-JQS471>3.0.CO;2-X; Pickering R, 2010, J HUM EVOL, V59, P70, DOI 10.1016/j.jhevol.2010.03.014; Pickering TR, 2004, J HUM EVOL, V46, P279, DOI 10.1016/j.jhevol.2003.12.001; Walker J, 2006, SCIENCE, V314, P1592, DOI 10.1126/science.1132916	30	134	141	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					85	U200		10.1038/nature14268	http://dx.doi.org/10.1038/nature14268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25830884				2022-12-28	WOS:000355543400034
J	Jiang, JS; Pentelute, BL; Collier, RJ; Zhou, ZH				Jiang, Jiansen; Pentelute, Bradley L.; Collier, R. John; Zhou, Z. Hong			Atomic structure of anthrax protective antigen pore elucidates toxin translocation	NATURE			English	Article							PROTEIN TRANSLOCATION; PHENYLALANINE CLAMP; CRYSTAL-STRUCTURE; RECEPTOR; BINDING; SYSTEM; VISUALIZATION; MUTATIONS; SOFTWARE; DRIVEN	Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Protective antigen forms oligomeric prepores that undergo conversion to membrane-spanning pores by endosomal acidification, and these pores translocate the enzymes lethal factor and oedema factor into the cytosol of target cells(1). Protective antigen is not only a vaccine component and therapeutic target for anthrax infections but also an excellent model system for understanding the mechanism of protein translocation. On the basis of biochemical and electrophysiological results, researchers have proposed that a phi (Phi)-clamp composed of phenylalanine (Phe)427 residues of protective antigen catalyses protein translocation via a charge-state-dependent Brownian ratchet(2-9). Although atomic structures of protective antigen prepores are available(10-14), how protective antigen senses low pH, converts to active pore, and translocates lethal factor and oedema factor are not well defined without an atomic model of its pore. Here, by cryoelectron microscopy with direct electron counting, we determine the protective antigen pore structure at 2.9-angstrom resolution. The structure reveals the long-sought-after catalytic Phi-clamp and the membrane-spanning translocation channel, and supports the Brownian ratchet model for protein translocation. Comparisons of four structures reveal conformational changes in prepore to pore conversion that support a multi-step mechanism by which low pH is sensed and the membrane-spanning channel is formed.	[Jiang, Jiansen; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Jiang, Jiansen; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Pentelute, Bradley L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Collier, R. John] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Zhou, ZH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	Hong.Zhou@ucla.edu	Jiang, Jiansen/J-2057-2015; Zhou, Z Hong/HDN-0747-2022	Jiang, Jiansen/0000-0002-1692-7906; 	National Institutes of Health [AI094386/AI046420, GM071940, AI022021, AI057159, 1S10RR23057, 1S10OD018111]; American Heart Association [14POST18870059]; Damon Runyon Cancer Research Foundation; National Science Foundation (CAREER) [CHE-1351807]; National Science Foundation [DBI-1338135]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046420, R01AI094386, U54AI057159, R01AI022021, R37AI022021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018111] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1338135] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Damon Runyon Cancer Research Foundation; National Science Foundation (CAREER)(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by grants from the National Institutes of Health (AI094386/AI046420 and GM071940 to Z.H.Z., and AI022021 to R.J.C.), the American Heart Association (Postdoctoral Fellowship 14POST18870059 to J.J.), Damon Runyon Cancer Research Foundation Innovation Award (B.L.P.), and National Science Foundation (CAREER Award CHE-1351807 to B.L.P.). We thank the NERCE facility (the National Institutes of Health grant AI057159) for expression of toxin proteins. We acknowledge the use of instruments at the Electron Imaging Center for Nanomachines supported by University of California, Los Angeles, and by instrumentation grants from the National Institutes of Health (1S10RR23057, 1S10OD018111) and National Science Foundation (DBI-1338135). We thank L. Jin for initial efforts on this project and J. Feigon for discussion.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Ballester P., 2012, IMPORTANCE PI INTERA, P79, DOI DOI 10.1002/9781119945888; Basilio D, 2011, J GEN PHYSIOL, V137, P343, DOI 10.1085/jgp.201010578; Basilio D, 2009, J GEN PHYSIOL, V133, P307, DOI 10.1085/jgp.200810170; Brown MJ, 2011, J BIOL CHEM, V286, P23189, DOI 10.1074/jbc.M111.231167; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feld GK, 2012, PROTEIN SCI, V21, P606, DOI 10.1002/pro.2052; Feld GK, 2010, NAT STRUCT MOL BIOL, V17, P1383, DOI 10.1038/nsmb.1923; Finkelstein A, 2009, PHILOS T R SOC B, V364, P209, DOI 10.1098/rstb.2008.0126; Goyal P, 2014, NATURE, V516, P250, DOI 10.1038/nature13768; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Janowiak BE, 2010, J BIOL CHEM, V285, P8130, DOI 10.1074/jbc.M109.093195; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kintzer AF, 2012, P NATL ACAD SCI USA, V109, P18378, DOI 10.1073/pnas.1208280109; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Melnyk RA, 2006, P NATL ACAD SCI USA, V103, P9802, DOI 10.1073/pnas.0604000103; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mourez M, 2003, P NATL ACAD SCI USA, V100, P13803, DOI 10.1073/pnas.2436299100; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019; Swint-Kruse L, 2005, BIOINFORMATICS, V21, P3327, DOI 10.1093/bioinformatics/bti511; The PyMOL, 2014, PYMOL MOL GRAPH SYST; Vernier G, 2009, PROTEIN SCI, V18, P1882, DOI 10.1002/pro.199; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Wang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006280; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Wynia-Smith SL, 2012, J BIOL CHEM, V287, P43753, DOI 10.1074/jbc.M112.419598; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Ziv G, 2005, P NATL ACAD SCI USA, V102, P18956, DOI 10.1073/pnas.0508234102	49	161	165	0	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					545	U323		10.1038/nature14247	http://dx.doi.org/10.1038/nature14247			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25778700	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000355286600049
J	Cantor, AG; Bougatsos, C; Dana, T; Blazina, I; McDonagh, M				Cantor, Amy G.; Bougatsos, Christina; Dana, Tracy; Blazina, Ian; McDonagh, Marian			Routine Iron Supplementation and Screening for Iron Deficiency Anemia in Pregnancy: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; STATUS MARKERS; SERUM ERYTHROPOIETIN; PROPHYLACTIC IRON; PRETERM BIRTH; WOMEN; WEIGHT	Background: Routine screening and supplementation for iron deficiency anemia (IDA) in asymptomatic, nonanemic pregnant women could improve maternal and infant health outcomes. Purpose: Update of a 2006 systematic review by the U.S. Preventive Services Task Force on screening and supplementation for IDA in pregnancy. Data Sources: MEDLINE and the Cochrane Library (1996 to August 2014) and reference lists of relevant systematic reviews to identify studies published since 1996. Study Selection: English-language trials and controlled observational studies about effectiveness of screening and routine supplementation for IDA in developed countries. Data Extraction: Data extraction and quality assessment confirmed and dual-rated by a second investigator using prespecified criteria. Data Synthesis: No study directly compared clinical outcomes or harms of screening or not screening pregnant women for IDA. Twelve supplementation trials were included, and no controlled observational studies met inclusion criteria. On the basis of 11 trials, routine maternal iron supplementation had inconsistent effects on rates of cesarean delivery, small size for gestational age, and low birthweight and no effect on maternal quality of life, gestational age, Apgar scores, preterm birth, or infant mortality. Twelve trials reported improvements in maternal hematologic indices, although not all were statistically significant. Pooled analysis of 4 trials resulted in a statistically significant difference in IDA incidence at term, favoring supplementation (risk ratio, 0.29 [95% CI, 0.17 to 0.49]; I-2 = 0%). Maternal iron supplementation did not affect infant iron status at 6 months. Harms, none of which were serious or had long-term consequences, were inconsistently reported in 10 of the trials, with most finding no difference between groups. Limitations: Data from trials in countries with limited generalizability to U.S. populations were included. Studies were methodologically heterogeneous, and some were small and underpowered. Conclusion: There is inconclusive evidence that routine prenatal supplementation for IDA improves maternal or infant clinical health outcomes, but supplementation may improve maternal hematologic indices.	[Cantor, Amy G.; Bougatsos, Christina; Dana, Tracy; Blazina, Ian; McDonagh, Marian] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Portland, OR 97239 USA	Oregon Health & Science University	Cantor, AG (corresponding author), Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Mail Code BICC,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.			Cantor, Amy/0000-0002-4467-8484; Blazina, Ian/0000-0003-0164-6674	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	American College of Obstetricians and Gynecologists, 2008, Obstet Gynecol, V112, P201, DOI 10.1097/AOG.0b013e3181809c0d; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], AHRQ PUBLICATION; [Anonymous], IR FOL SUPPL STAND M; BARTON DPJ, 1994, AM J OBSTET GYNECOL, V170, P896, DOI 10.1016/S0002-9378(94)70305-1; Bothwell TH, 2000, AM J CLIN NUTR, V72, p257S, DOI 10.1093/ajcn/72.1.257S; Chan KKL, 2009, BJOG-INT J OBSTET GY, V116, P789, DOI 10.1111/j.1471-0528.2008.02014.x; Cogswell ME, 2003, AM J CLIN NUTR, V78, P773, DOI 10.1093/ajcn/78.4.773; CUERVO LG, 2001, COCHRANE DB SYST REV; DiGuiseppi C, 1996, SCREENING IRON DEFIC; Earl RO, 1993, IRON DEFICIENCY ANEM; Eskeland B, 1997, ACTA OBSTET GYN SCAN, V76, P822, DOI 10.3109/00016349709024359; Falahi E, 2011, FOOD NUTR BULL, V32, P213, DOI 10.1177/156482651103200305; Griffin IJ, 2001, PEDIATR CLIN N AM, V48, P401, DOI 10.1016/S0031-3955(08)70033-6; Hoffman R., 2012, HEMATOLOGY BASIC PRI; KLEBANOFF MA, 1991, AM J OBSTET GYNECOL, V164, P59, DOI 10.1016/0002-9378(91)90626-3; Krishnamurti L, 2009, AM ACAD PEDIAT TXB P; LU ZM, 1991, OBSTET GYNECOL, V77, P190; Makrides M, 2003, AM J CLIN NUTR, V78, P145, DOI 10.1093/ajcn/78.1.145; Mei ZG, 2011, AM J CLIN NUTR, V93, P1312, DOI 10.3945/ajcn.110.007195; Meier Paul R, 2003, Clin Med Res, V1, P29; MILMAN N, 1991, DAN MED BULL, V38, P471; MILMAN N, 1994, ACTA OBSTET GYN SCAN, V73, P200, DOI 10.3109/00016349409023439; MURPHY JF, 1986, LANCET, V1, P992; Oregon Evidence-based Practice Center, 2006, AHRQ PUBLICATION; Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009997; Pena-Rosas JP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub3; Reveiz L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003094.pub3; ROMSLO I, 1983, BRIT J OBSTET GYNAEC, V90, P101, DOI 10.1111/j.1471-0528.1983.tb08891.x; SCHOLL TO, 1992, AM J CLIN NUTR, V55, P985, DOI 10.1093/ajcn/55.5.985; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Siega-Riz AM, 2006, AM J OBSTET GYNECOL, V194, P512, DOI 10.1016/j.ajog.2005.08.011; Singh K, 1998, EUR J CLIN NUTR, V52, P65, DOI 10.1038/sj.ejcn.1600517; U.S. Preventive Services Task Force, 2008, AHRQ PUBLICATION; U.S. Preventive Services Task Force, 2006, REC STAT SCREEN IR D; United Nations Development Programme, 2014, HUM DEV IND HDI 2012; WHO, 2001, IRON DEFICIENCY ANAE; Zhou LM, 1998, AM J EPIDEMIOL, V148, P998; Zhou SJ, 2007, J PEDIATR-US, V151, P438, DOI 10.1016/j.jpeds.2007.06.001; Ziaei S, 2007, BJOG-INT J OBSTET GY, V114, P684, DOI 10.1111/j.1471-0528.2007.01325.x; Ziaei S, 2008, INT J GYNECOL OBSTET, V100, P130, DOI 10.1016/j.ijgo.2007.07.027	41	88	93	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8					566	+		10.7326/M14-2932	http://dx.doi.org/10.7326/M14-2932			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25820661				2022-12-28	WOS:000353244300017
J	Emmrich, M; Huber, F; Pielmeier, F; Welker, J; Hofmann, T; Schneiderbauer, M; Meuer, D; Polesya, S; Mankovsky, S; Kodderitzsch, D; Ebert, H; Giessibl, FJ				Emmrich, Matthias; Huber, Ferdinand; Pielmeier, Florian; Welker, Joachim; Hofmann, Thomas; Schneiderbauer, Maximilian; Meuer, Daniel; Polesya, Svitlana; Mankovsky, Sergiy; Koedderitzsch, Diemo; Ebert, Hubert; Giessibl, Franz J.			Subatomic resolution force microscopy reveals internal structure and adsorption sites of small iron clusters	SCIENCE			English	Article							CO MOLECULES; DYNAMICS; ATOM; SURFACE	Clusters built from individual iron atoms adsorbed on surfaces (adatoms) were investigated by atomic force microscopy (AFM) with subatomic resolution. Single copper and iron adatoms appeared as toroidal structures and multiatom clusters as connected structures, showing each individual atom as a torus. For single adatoms, the toroidal shape of the AFM image depends on the bonding symmetry of the adatom to the underlying structure [ twofold for copper on copper(110) and threefold for iron on copper(111)]. Density functional theory calculations support the experimental data. The findings correct our previous work, in which multiple minima in the AFM signal were interpreted as a reflection of the orientation of a single front atom, and suggest that dual and triple minima in the force signal are caused by dimer and trimer tips, respectively.	[Emmrich, Matthias; Huber, Ferdinand; Pielmeier, Florian; Welker, Joachim; Hofmann, Thomas; Schneiderbauer, Maximilian; Meuer, Daniel; Giessibl, Franz J.] Univ Regensburg, Inst Expt & Appl Phys, Dept Phys, D-93053 Regensburg, Germany; [Polesya, Svitlana; Mankovsky, Sergiy; Koedderitzsch, Diemo; Ebert, Hubert] Univ Munich, Dept Chem, D-81377 Munich, Germany	University of Regensburg; University of Munich	Giessibl, FJ (corresponding author), Univ Regensburg, Inst Expt & Appl Phys, Dept Phys, D-93053 Regensburg, Germany.	franz.giessibl@ur.de	Giessibl, Franz J/K-8022-2013	Giessibl, Franz J/0000-0002-5585-1326; Huber, Ferdinand/0000-0001-8647-6971	Deutsche Forschungsgemeinschaft [Graduiertenkolleg 1570, Sonderforschungsbereich 689]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank G. Binnig, J. Repp, and A. J. Weymouth for discussions and the Deutsche Forschungsgemeinschaft for funding under Graduiertenkolleg 1570 and Sonderforschungsbereich 689, as well as M. Grifoni (speaker of GRK) and D. Weiss (speaker of SFB) for support. F.J.G. thanks A. Heinrich for hosting several visits at the IBM Almaden Research Center from 2005 until 2010, where first attempts to resolve metallic adatoms with subatomic resolution were performed together with C. Lutz, C. Hirjibehedin, and M. Ternes. Author contributions: M.E. performed most of the measurements and data analysis, constructed the low-temperature scan head, and prepared most figures; F.H. optimized the electronics and performed crucial measurements; J.W. performed measurements on Cu adatoms on Cu(111); T.H. and F.P. performed measurements on Cu/Cu(110) and inverse measurements using CO/Cu(111) to characterize Cu and Fe tips; M.S. constructed most of the vacuum system and sample-preparation facilities; D.M. performed the AFM measurements on Si; D.K., S.P., S.M., and H.E. performed the DFT calculations; and F.J.G. initiated and directed the project, employed the STO model, and wrote the manuscript.	Bartels L, 1997, APPL PHYS LETT, V71, P213, DOI 10.1063/1.119503; Biedermann A, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.165418; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BRUNE H, 1990, EUROPHYS LETT, V13, P123, DOI 10.1209/0295-5075/13/2/005; Chaika AN, 2008, J PHYS CONF SER, V100, DOI 10.1088/1742-6596/100/1/012020; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; de Oteyza DG, 2013, SCIENCE, V340, P1434, DOI 10.1126/science.1238187; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Feng M, 2011, ACS NANO, V5, P8877, DOI 10.1021/nn203041c; Giessibl FJ, 2000, SCIENCE, V289, P422, DOI 10.1126/science.289.5478.422; Giessibl FJ, 2001, ANN PHYS-BERLIN, V10, P887, DOI 10.1002/1521-3889(200111)10:11/12<887::AID-ANDP887>3.0.CO;2-B; GORDON RG, 1972, J CHEM PHYS, V56, P3122, DOI 10.1063/1.1677649; Gross L, 2012, SCIENCE, V337, P1326, DOI 10.1126/science.1225621; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Hapala P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.226101; Hembacher S, 2004, SCIENCE, V305, P380, DOI 10.1126/science.1099730; Herz M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.045301; Hofmann T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.066101; Huang MH, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.256101; Khajetoorians AA, 2013, SCIENCE, V339, P55, DOI 10.1126/science.1228519; Lantz MA, 2001, SCIENCE, V291, P2580, DOI 10.1126/science.1057824; Moll N, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125020; Pielmeier F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.266101; Pivetta M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.086102; Repp J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.206102; Schneiderbauer M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.166102; Schuler B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.106103; Slater JC, 1930, PHYS REV, V36, P0057, DOI 10.1103/PhysRev.36.57; Smoluchowski R, 1941, PHYS REV, V60, P661, DOI 10.1103/PhysRev.60.661; Stroscio JA, 2004, SCIENCE, V306, P242, DOI 10.1126/science.1102370; Ternes M, 2008, SCIENCE, V319, P1066, DOI 10.1126/science.1150288; Thouin F, 2019, NAT MATER, V18, P349, DOI [10.1038/s41563-018-0262-7, 10.1016/0022-3093(95)00355-X]; Welker J, 2012, SCIENCE, V336, P444, DOI 10.1126/science.1219850; Weymouth AJ, 2014, SCIENCE, V343, P1120, DOI 10.1126/science.1249502; Wright CA, 2011, NANO LETT, V11, P5026, DOI 10.1021/nl2030773; Zangwill A., 1988, PHYS ON SURFACES; Zotti LA, 2006, CHEM PHYS LETT, V420, P177, DOI 10.1016/j.cplett.2005.12.065	37	105	107	8	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					308	311		10.1126/science.aaa5329	http://dx.doi.org/10.1126/science.aaa5329			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25791086	Green Submitted			2022-12-28	WOS:000352999000036
J	Abe, N; Dror, I; Yang, L; Slattery, M; Zhou, TY; Bussemaker, HJ; Rohs, R; Mann, RS				Abe, Namiko; Dror, Iris; Yang, Lin; Slattery, Matthew; Zhou, Tianyin; Bussemaker, Harmen J.; Rohs, Remo; Mann, Richard S.			Deconvolving the Recognition of DNA Shape from Sequence	CELL			English	Article							TRANSCRIPTION-FACTOR-BINDING; HOX SPECIFICITY; GENOMIC SCALE; SITES; FEATURES; PREDICTION; COMPLEXES; PROTEINS; DATABASE	Protein-DNA binding is mediated by the recognition of the chemical signatures of the DNA bases and the 3D shape of the DNA molecule. Because DNA shape is a consequence of sequence, it is difficult to dissociate these modes of recognition. Here, we tease them apart in the context of Hox-DNA binding by mutating residues that, in a co-crystal structure, only recognize DNA shape. Complexes made with these mutants lose the preference to bind sequences with specific DNA shape features. Introducing shape-recognizing residues from one Hox protein to another swapped binding specificities in vitro and gene regulation in vivo. Statistical machine learning revealed that the accuracy of binding specificity predictions improves by adding shape features to a model that only depends on sequence, and feature selection identified shape features important for recognition. Thus, shape readout is a direct and independent component of binding site selection by Hox proteins.	[Abe, Namiko; Mann, Richard S.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Abe, Namiko; Mann, Richard S.] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Dror, Iris; Yang, Lin; Zhou, Tianyin; Rohs, Remo] Univ So Calif, Mol & Computat Biol Program, Dept Biol Sci, Los Angeles, CA 90089 USA; [Rohs, Remo] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Rohs, Remo] Univ So Calif, Dept Phys & Astron, Los Angeles, CA 90089 USA; [Rohs, Remo] Univ So Calif, Dept Comp Sci, Los Angeles, CA 90089 USA; [Dror, Iris] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Slattery, Matthew] Univ Minnesota, Sch Med, Dept Biomed Sci, Duluth, MN 55812 USA; [Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA	Columbia University; Columbia University; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Technion Israel Institute of Technology; University of Minnesota System; University of Minnesota Duluth; Columbia University	Rohs, R (corresponding author), Univ So Calif, Mol & Computat Biol Program, Dept Biol Sci, Los Angeles, CA 90089 USA.	rohs@usc.edu; rsm10@columbia.edu			NIH [R01GM058575, F32GM099160, R01GM106056, U01GM103804, R01HG003008]; USC-Technion Visiting Fellows Program; Alfred P. Sloan Research Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM103804, R01GM054510, F32GM099160, R01GM106056, R35GM118336, R01GM058575] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USC-Technion Visiting Fellows Program; Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Barry Honig, David Stern, and members of the R.R., H.J.B., and R.S.M. laboratories for feedback and comments on this project, and Vince FitzPatrick, Gabriella Martini, Todd Riley, and Roumen Voutev for technical assistance. This work was supported by the NIH (grants R01GM058575 to R.S.M., F32GM099160 to N.A., R01GM106056 and U01GM103804 to R.R., and R01HG003008 to H.J.B. and R.R.), the USC-Technion Visiting Fellows Program, and an Alfred P. Sloan Research Fellowship (to R.R.).	Barozzi I, 2014, MOL CELL, V54, P844, DOI 10.1016/j.molcel.2014.04.006; Chang YP, 2013, CELL REP, V3, P1117, DOI 10.1016/j.celrep.2013.03.002; Crocker J, 2015, CELL, V160, P191, DOI 10.1016/j.cell.2014.11.041; Dror I, 2014, NUCLEIC ACIDS RES, V42, P430, DOI 10.1093/nar/gkt862; Gordan R, 2013, CELL REP, V3, P1093, DOI 10.1016/j.celrep.2013.03.014; Hooghe B, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks283; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; Jaffe L, 1997, GENE DEV, V11, P1327, DOI 10.1101/gad.11.10.1327; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Lazarovici A, 2013, P NATL ACAD SCI USA, V110, P6376, DOI 10.1073/pnas.1216822110; Maienschein-Cline M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks771; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Meysman P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1071; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Riley TR, 2014, METHODS MOL BIOL, V1196, P255, DOI 10.1007/978-1-4939-1242-1_16; Rohs R, 2009, CURR OPIN STRUC BIOL, V19, P171, DOI 10.1016/j.sbi.2009.03.002; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Yang L, 2014, NUCLEIC ACIDS RES, V42, pD148, DOI 10.1093/nar/gkt1087; Zhou T., 2015, P NATL ACAD SCI US; Zhou TY, 2013, NUCLEIC ACIDS RES, V41, pW56, DOI 10.1093/nar/gkt437; Zhu LHJ, 2011, NUCLEIC ACIDS RES, V39, pD111, DOI 10.1093/nar/gkq858	29	115	115	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					307	318		10.1016/j.cell.2015.02.008	http://dx.doi.org/10.1016/j.cell.2015.02.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25843630	Green Accepted, Bronze			2022-12-28	WOS:000352708300023
J	Torjesen, I				Torjesen, Ingrid			The pilot, depression, and the salacious headlines that feed stigma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ingrid_torjesen@hotmail.com						Health and Social Care Information Centre, 2014, PRESCR DISP COMM ENG; Office for National Statistics, 2015, MEAS NAT WELL BEING; Time to Change, ORG PLEDG FAQS; Time to Change, 2014, ATT MENT ILLN 2013 R; Time to Change, MENT HLTH STAT FACTS	5	4	4	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2015	350								h1874	10.1136/bmj.h1874	http://dx.doi.org/10.1136/bmj.h1874			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9SM	25852132				2022-12-28	WOS:000352906900014
J	Jacobs, M				Jacobs, Madeleine			A career is like a love affair	SCIENCE			English	Editorial Material																			0	0	0	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					150	150		10.1126/science.348.6230.150	http://dx.doi.org/10.1126/science.348.6230.150			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8GJ	25838387				2022-12-28	WOS:000352079500045
J	Blumenthal, D; Hsiao, W				Blumenthal, David; Hsiao, William			Lessons from the East - China's Rapidly Evolving Health Care System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blumenthal, David] Commonwealth Fund, New York, NY 10021 USA; [Hsiao, William] Harvard Univ, Dept Hlth Policy & Management, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Commonwealth Fund; Harvard University; Harvard T.H. Chan School of Public Health	Blumenthal, D (corresponding author), Commonwealth Fund, New York, NY 10021 USA.							Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Cheng TM, 2012, HEALTH AFFAIR, V31, P2536, DOI 10.1377/hlthaff.2012.1017; Fu R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108571; Loo D., 2012, BLOOMBERG BUISNESS; Yip W, 2015, HEALTH SYST REFORM, V1, P52, DOI 10.4161/23288604.2014.995005	5	160	171	3	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14					1281	1285		10.1056/NEJMp1410425	http://dx.doi.org/10.1056/NEJMp1410425			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CE7NL	25830419				2022-12-28	WOS:000352028500001
J	Miller, LS				Miller, Lloyd S.			Adipocytes Armed against Staphylococcus aureus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTIOUS-DISEASES SOCIETY; PRACTICE GUIDELINES; SKIN		Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA	Johns Hopkins University	Miller, LS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA.			Miller, Lloyd/0000-0002-8332-2210				DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Zhang LJ, 2015, SCIENCE, V347, P67, DOI 10.1126/science.1260972	5	6	6	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14					1368	1370		10.1056/NEJMcibr1500271	http://dx.doi.org/10.1056/NEJMcibr1500271			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NL	25830428				2022-12-28	WOS:000352028500015
J	Machado, GC; Maher, CG; Ferreira, PH; Pinheiro, MB; Lin, CWC; Day, RO; McLachlan, AJ; Ferreira, ML				Machado, Gustavo C.; Maher, Chris G.; Ferreira, Paulo H.; Pinheiro, Marina B.; Lin, Chung-Wei Christine; Day, Richard O.; McLachlan, Andrew J.; Ferreira, Manuela L.			Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BACK-PAIN; ACETAMINOPHEN EXTENDED-RELEASE; DOUBLE-BLIND; KNEE OSTEOARTHRITIS; GLOBAL BURDEN; STANDING-COMMITTEE; AMERICAN-COLLEGE; TASK-FORCE; HIP; GUIDELINES	OBJECTIVE To investigate the efficacy and safety of paracetamol (acetaminophen) in the management of spinal pain and osteoarthritis of the hip or knee. DESIGN Systematic review and meta-analysis. DATA SOURCES Medline, Embase, AMED, CINAHL, Web of Science, LILACS, International Pharmaceutical Abstracts, and Cochrane Central Register of Controlled Trials from inception to December 2014. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Randomised controlled trials comparing the efficacy and safety of paracetamol with placebo for spinal pain (neck or low back pain) and osteoarthritis of the hip or knee. DATA EXTRACTION Two independent reviewers extracted data on pain, disability, and quality of life. Secondary outcomes were adverse effects, patient adherence, and use of rescue medication. Pain and disability scores were converted to a scale of 0 (no pain or disability) to 100 (worst possible pain or disability). We calculated weighted mean differences or risk ratios and 95% confidence intervals using a random effects model. The Cochrane Collaboration's tool was used for assessing risk of bias, and the GRADE approach was used to evaluate the quality of evidence and summarise conclusions. RESULTS 12 reports (13 randomised trials) were included. There was "high quality" evidence that paracetamol is ineffective for reducing pain intensity (weighted mean difference -0.5, 95% confidence interval -2.9 to 1.9) and disability (0.4, -1.7 to 2.5) or improving quality of life (0.4, -0.9 to 1.7) in the short term in people with low back pain. For hip or knee osteoarthritis there was "high quality" evidence that paracetamol provides a significant, although not clinically important, effect on pain (-3.7, -5.5 to -1.9) and disability (-2.9, -4.9 to -0.9) in the short term. The number of patients reporting any adverse event (risk ratio 1.0, 95% confidence interval 0.9 to 1.1), any serious adverse event (1.2, 0.7 to 2.1), or withdrawn from the study because of adverse events (1.2, 0.9 to 1.5) was similar in the paracetamol and placebo groups. Patient adherence to treatment (1.0, 0.9 to 1.1) and use of rescue medication (0.7, 0.4 to 1.3) was also similar between groups. "High quality" evidence showed that patients taking paracetamol are nearly four times more likely to have abnormal results on liver function tests (3.8, 1.9 to 7.4), but the clinical importance of this effect is uncertain. CONCLUSIONS Paracetamol is ineffective in the treatment of low back pain and provides minimal short term benefit for people with osteoarthritis. These results support the reconsideration of recommendations to use paracetamol for patients with low back pain and osteoarthritis of the hip or knee in clinical practice guidelines. SYSTEMATIC REVIEW REGISTRATION PROSPERO registration number CRD42013006367.	[Machado, Gustavo C.; Maher, Chris G.; Lin, Chung-Wei Christine; Ferreira, Manuela L.] Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Sydney, NSW 2000, Australia; [Ferreira, Paulo H.; Pinheiro, Marina B.] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2141, Australia; [Day, Richard O.] St Vincents Hosp, Dept Clin Pharmacol, Sydney, NSW 2010, Australia; [Day, Richard O.] Univ New S Wales, Sydney, NSW 2010, Australia; [Day, Richard O.] Univ New S Wales, Dept Med, Sch Med Sci, Kensington, NSW 2033, Australia; [McLachlan, Andrew J.] Univ Sydney, Fac Pharm, Sydney, NSW 2050, Australia; [McLachlan, Andrew J.] Concord Hosp, Ctr Educ & Res Ageing, Sydney, NSW 2139, Australia; [Ferreira, Manuela L.] Univ Sydney, Sydney Med Sch, Kolling Inst, Inst Bone & Joint Res, Sydney, NSW 2065, Australia	George Institute for Global Health; University of Sydney; University of Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; Concord Repatriation General Hospital; University of Sydney; Kolling Institute of Medical Research	Machado, GC (corresponding author), Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Sydney, NSW 2000, Australia.	gmachado@georgeinstitute.org.au	Lin, Chung-Wei Christine/S-8840-2019; Ferreira, Manuela/AAQ-5446-2020; Machado, Gustavo/H-5453-2016; Day, Richard/D-8699-2011; Ferreira, Paulo H/N-3061-2017; Maher, Christopher/AAC-6267-2019	Lin, Chung-Wei Christine/0000-0001-6192-7238; Ferreira, Manuela/0000-0002-3479-0683; Machado, Gustavo/0000-0002-8544-0448; Day, Richard/0000-0002-6045-6937; Ferreira, Paulo H/0000-0002-5861-7770; Maher, Christopher/0000-0002-1628-7857; manniche, claus/0000-0001-5938-1483; Pinheiro, Marina/0000-0001-7459-5105; McLachlan, Andrew/0000-0003-4674-0242	Australian Government; National Health and Medical Research Council; Sydney Medical Foundation/Sydney Medical School; National Health and Medical Research Council, Australia; NHMRC [1054146]	Australian Government(Australian GovernmentCGIAR); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sydney Medical Foundation/Sydney Medical School; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. GCM and MBP hold an international postgraduate research scholarship/postgraduate award from the Australian Government. CGM is supported by a research fellowship from the National Health and Medical Research Council. MLF holds a fellowship from Sydney Medical Foundation/Sydney Medical School. CCL holds a career development fellowship from the National Health and Medical Research Council, Australia. RD is a chief investigator on NH&MRC Programme Grant No 1054146. AJM is an investigator on the NHMRC Centre for Research Excellence in Medicines and Ageing.	Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, P454, DOI 10.1016/j.joca.2006.10.008; Altman RD, 1999, ARTHRITIS RHEUM, V42, pS403; AMADIO P, 1983, CURR THER RES CLIN E, V34, P59; Amar PJ, 2007, EXPERT OPIN DRUG SAF, V6, P341, DOI 10.1517/14740338.6.4.341; [Anonymous], 2012, LANCET, V380, P2163; [Anonymous], 2010, TYL AC PROF PROD INF; Barthel HR, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2906; Bellamy N, 2000, WOMAC OSTEOARTHRITIS, V4; Bertin P, 2013, J NUTR HEALTH AGING, V17, P681, DOI 10.1007/s12603-013-0338-7; Case JP, 2003, ARCH INTERN MED, V163, P169, DOI 10.1001/archinte.163.2.169; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Davies RA, 2008, EUR SPINE J, V17, P1423, DOI 10.1007/s00586-008-0783-x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferreira ML, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5913; Freedman Benjamin, 1990, IRB, V12, P1, DOI 10.2307/3564541; Glimet TJ, 1989, REV RHUM, V56, P269; Golden Harvey E, 2004, Am J Ther, V11, P85, DOI 10.1097/00045391-200403000-00002; Graham GG, 2013, INFLAMMOPHARMACOLOGY, V21, P201, DOI 10.1007/s10787-013-0172-x; Graham Garry G., 2010, Inflammopharmacology, V18, P47, DOI 10.1007/s10787-010-0036-6; GRONBLAD M, 1993, CLIN J PAIN, V9, P189; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Herrero-Beaumont G, 2007, ARTHRITIS RHEUM-US, V56, P555, DOI 10.1002/art.22371; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hoy D, 2014, ANN RHEUM DIS, V73, P1309, DOI 10.1136/annrheumdis-2013-204431; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Jalan R, 2006, LANCET, V368, P2195, DOI 10.1016/S0140-6736(06)69874-7; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Kersten P, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-80; Laba TL, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-160; Langan D, 2012, J CLIN EPIDEMIOL, V65, P511, DOI 10.1016/j.jclinepi.2011.10.009; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Miceli-Richard C, 2004, ANN RHEUM DIS, V63, P923, DOI 10.1136/ard.2003.017236; Nadler SF, 2002, SPINE, V27, P1012, DOI 10.1097/00007632-200205150-00003; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Pincus T, 2005, CLIN EXP RHEUMATOL, V23, pS19; Pincus T, 2004, ANN RHEUM DIS, V63, P931, DOI 10.1136/ard.2003.020313; Prior MJ, 2014, CURR MED RES OPIN, V30, P2377, DOI 10.1185/03007995.2014.949646; Schein JR, 2008, CURR MED RES OPIN, V24, P1255, DOI [10.1185/030079908X291912, 10.1185/030079908X291912 ]; Sheldon EA, 2008, SPINE, V33, P533, DOI 10.1097/BRS.0b013e3181657d24; Towheed TE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004257.pub2; United States Bone and Joint Initiative, 2014, BURD MUSC DIS US; Uthman OA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5555; Wandel S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4675; Watkins PB, 2006, JAMA-J AM MED ASSOC, V296, P87, DOI 10.1001/jama.296.1.87; Wetzel L, 2014, EUR J ANAESTH, V31, P35, DOI 10.1097/EJA.0b013e328365ae28; Williams CM, 2014, LANCET, V384, P1586, DOI 10.1016/S0140-6736(14)60805-9; Wise J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1545; Zhang W, 2005, ANN RHEUM DIS, V64, P669, DOI 10.1136/ard.2004.028886; Zhang W, 2004, ANN RHEUM DIS, V63, P901, DOI 10.1136/ard.2003.018531; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013; Zoppi M, 1995, EUR J PAIN, V16, P42	58	285	303	3	80	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2015	350								h1225	10.1136/bmj.h1225	http://dx.doi.org/10.1136/bmj.h1225			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3HD	25828856	hybrid, Green Published			2022-12-28	WOS:000352438100001
J	Bich, TD; Pham, OKN; Hai, DHT; Nguyen, NM; Van, HN; The, TD; Wills, B; Yacoub, S				Thuy Duong Bich; Oanh Kieu Nguyet Pham; Duong Ha Thi Hai; Nguyet Minh Nguyen; Hao Nguyen Van; Trung Dinh The; Wills, Bridget; Yacoub, Sophie			A pregnant woman with acute cardiorespiratory failure: dengue myocarditis	LANCET			English	Editorial Material							INFECTION		[Thuy Duong Bich; Oanh Kieu Nguyet Pham; Duong Ha Thi Hai; Nguyet Minh Nguyen; Hao Nguyen Van; Trung Dinh The] Hosp Trop Dis, Intens Care Unit, Ho Chi Minh City, Vietnam; [Nguyet Minh Nguyen; Trung Dinh The; Wills, Bridget; Yacoub, Sophie] Univ Oxford, Clin Res Unit, WellcomeTrust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Wills, Bridget] Univ Oxford, Dept Trop Med, Oxford OX1 2JD, England; [Yacoub, Sophie] Univ London Imperial Coll Sci Technol & Med, Dept Med, London SW7 2AZ, England	University of Oxford; University of Oxford; Imperial College London	Yacoub, S (corresponding author), Univ Oxford, Clin Res Unit, WellcomeTrust Major Overseas Programme, 764 Vo Van Kiet St, Ho Chi Minh City, Vietnam.	syacoub@oucru.org	amsalu, ribka/G-8780-2019	Kieu Nguyet Oanh, Pham/0000-0002-1128-7620; Nguyen, Nguyet/0000-0002-5960-7849; Yacoub, Sophie/0000-0002-2910-7819; Wills, Bridget/0000-0001-9086-8804				Friedman EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003226; Kariyawasam S, 2010, J INFECT DEV COUNTR, V4, P767, DOI 10.3855/jidc.908; Miranda CH, 2013, CLIN INFECT DIS, V57, P812, DOI 10.1093/cid/cit403; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Yacoub S, 2014, NAT REV CARDIOL, V11, P335, DOI 10.1038/nrcardio.2014.40	5	10	10	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1260	1260		10.1016/S0140-6736(15)60239-2	http://dx.doi.org/10.1016/S0140-6736(15)60239-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE3GQ	25845796				2022-12-28	WOS:000351715100039
J	Dal-Re, R; Bracken, MB; Ioannidis, JPA				Dal-Re, Rafael; Bracken, Michael B.; Ioannidis, John P. A.			Call to improve transparency of trials of non-regulated interventions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							REGISTRATION; PUBLICATION; JOURNALS; DISEASE		[Dal-Re, Rafael] Univ Autonoma Madrid, BUC Biosci UAM CSIC Program, E-28049 Madrid, Spain; [Bracken, Michael B.] Yale Univ, Ctr Perinatal Pediat & Environm Epidemiol, Sch Publ Hlth, New Haven, CT USA; [Bracken, Michael B.] Yale Univ, Sch Med, New Haven, CT USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Dept Hlth Res & Policy,Sch Humanities & Sci, Stanford Prevent Res Ctr,Dept Med,Sch Med,Dept St, Stanford, CA 94305 USA	Autonomous University of Madrid; Yale University; Yale University; Stanford University	Dal-Re, R (corresponding author), Univ Autonoma Madrid, BUC Biosci UAM CSIC Program, Int Campus Excellence, E-28049 Madrid, Spain.	rafael.dalre@fuam.uam.es	Ioannidis, John P. A./G-9836-2011					Agha Riaz, 2007, Int J Surg, V5, P413, DOI 10.1016/j.ijsu.2007.06.002; [Anonymous], INV NEW DRUG IND APP; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Babu AS, 2014, PHYS THER, V94, P83, DOI 10.2522/ptj.20120531; Bach B., 2014, STANFORD MED NE 0917; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Doshi P, 2013, TRENDS PHARMACOL SCI, V34, P645, DOI 10.1016/j.tips.2013.10.006; Egger M, 2001, BRIT MED J, V323, P1253, DOI 10.1136/bmj.323.7323.1253a; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; European Medicines Agency, 2014, EUR MED AG POL PUBL; European Medicines Agency, 2005, POST CLIN TRIAL SUMM; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; Hudson KL, 2015, JAMA-J AM MED ASSOC, V313, P355, DOI 10.1001/jama.2014.10716; International Committee of Medical Journal Editors (ICMJE), 2014, REC COND REP ED PUBL; Jorgensen T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3617; Milette K, 2011, J PSYCHOSOM RES, V70, P205, DOI 10.1016/j.jpsychores.2010.09.015; National Institutes of Health, 2014, NIH REQ PUBL COMM DR; NHS Health Research Authority, 2014, HRA RES TRANSP REG; Powell JT, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7661; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Schemm Y., 2014, ELSEVIER SUPPORTS CL; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; US Food and Drug Administration, DEV ADV INV DEV EX I; van de Wetering FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049599; Wager E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5248; WHO, INT CLIN TRIALS REG; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112	29	39	39	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2015	350								h1323	10.1136/bmj.h1323	http://dx.doi.org/10.1136/bmj.h1323			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7OK	25820265				2022-12-28	WOS:000352031000001
J	Schauss, P; Zeiher, J; Fukuhara, T; Hild, S; Cheneau, M; Macri, T; Pohl, T; Bloch, I; Gross, C				Schauss, P.; Zeiher, J.; Fukuhara, T.; Hild, S.; Cheneau, M.; Macri, T.; Pohl, T.; Bloch, I.; Gross, C.			Crystallization in Ising quantum magnets	SCIENCE			English	Article							RYDBERG; PROPAGATION	Dominating finite-range interactions in many-body systems can lead to intriguing self-ordered phases of matter. For quantum magnets, Ising models with power-law interactions are among the most elementary systems that support such phases. These models can be implemented by laser coupling ensembles of ultracold atoms to Rydberg states. Here, we report on the experimental preparation of crystalline ground states of such spin systems. We observe a magnetization staircase as a function of the system size and show directly the emergence of crystalline states with vanishing susceptibility. Our results demonstrate the precise control of Rydberg many-body systems and may enable future studies of phase transitions and quantum correlations in interacting quantum magnets.	[Schauss, P.; Zeiher, J.; Fukuhara, T.; Hild, S.; Bloch, I.; Gross, C.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Cheneau, M.] Univ Paris Sud, CNRS, Grad Sch, Lab Charles Fabry,Inst Opt, F-91127 Palaiseau, France; [Macri, T.; Pohl, T.] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Bloch, I.] Univ Munich, Fak Phys, D-80799 Munich, Germany	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society; University of Munich	Schauss, P (corresponding author), Max Planck Inst Quantum Opt, D-85748 Garching, Germany.	peter.schauss@mpq.mpg.de	Bloch, Immanuel/G-3174-2010; Schauss, Peter/AAV-1298-2020; Cheneau, Marc/O-9312-2014; Gross, Christian/P-5475-2014; Macrì, Tommaso/S-9634-2017; Bloch, Immanuel/N-9169-2019; Fukuhara, Takeshi/A-6254-2014	Bloch, Immanuel/0000-0002-0679-4759; Schauss, Peter/0000-0002-8505-5195; Cheneau, Marc/0000-0001-7261-566X; Gross, Christian/0000-0003-2292-5234; Macrì, Tommaso/0000-0002-7778-8014; Fukuhara, Takeshi/0000-0002-6702-9882; Pohl, Thomas/0000-0002-4093-3644; Zeiher, Johannes/0000-0002-8466-1863	Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft; European Union (UQUAM); European Union (SIQS); European Union (ITN-COHERENCE); European Union (HAIRS); European Union	Max-Planck-Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (UQUAM); European Union (SIQS); European Union (ITN-COHERENCE); European Union (HAIRS); European Union(European Commission)	We acknowledge funding by Max-Planck-Gesellschaft, Deutsche Forschungsgemeinschaft, European Union (UQUAM, SIQS, ITN-COHERENCE, and HAIRS, and a Marie Curie Fellowship to M.C.).	Anderson WR, 1998, PHYS REV LETT, V80, P249, DOI 10.1103/PhysRevLett.80.249; Ates C, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.043620; Baranov MA, 2008, PHYS REP, V464, P71, DOI 10.1016/j.physrep.2008.04.007; Beterov II, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.023413; Brierley RT, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.043002; Ebert M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.043602; Fukuhara T, 2013, NATURE, V502, P76, DOI 10.1038/nature12541; Glaetzle AW, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041037; Hazzard KRA, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.063622; Jurcevic P, 2014, NATURE, V511, P202, DOI 10.1038/nature13461; Lechner W, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185306; Lesanovsky I, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.100603; Mourachko I, 1998, PHYS REV LETT, V80, P253, DOI 10.1103/PhysRevLett.80.253; Petrosyan D, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.053414; Petrosyan D, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.033416; Pohl T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.043002; Richerme P, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.100506; Richerme P, 2014, NATURE, V511, P198, DOI 10.1038/nature13450; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Schachenmayer J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103044; Schauss P, 2012, NATURE, V491, P87, DOI 10.1038/nature11596; Sela E, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.085434; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; van Bijnen RMW, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/18/184008; Viteau M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.060402; Weimer H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.230403; Weimer H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.250601	28	213	213	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1455	1458		10.1126/science.1258351	http://dx.doi.org/10.1126/science.1258351			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814579	Green Submitted			2022-12-28	WOS:000352136400035
J	Singleton, AB; Traynor, BJ				Singleton, Andrew B.; Traynor, Bryan J.			For complex disease genetics, collaboration drives progress	SCIENCE			English	Editorial Material							RISK LOCI; METAANALYSIS		[Singleton, Andrew B.; Traynor, Bryan J.] NIA, Neurogenet Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Singleton, AB (corresponding author), NIA, Neurogenet Lab, Bethesda, MD 20892 USA.	singleta@mail.nih.gov	Singleton, Andrew B/C-3010-2009		Intramural NIH HHS [ZIA AG000933-03] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [ZIAAG000949, ZIAAG000933] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Singleton A, 2011, HUM MOL GENET, V20, pR158, DOI 10.1093/hmg/ddr358	5	2	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1422	1423		10.1126/science.aaa9838	http://dx.doi.org/10.1126/science.aaa9838			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AT	25814571	Green Accepted			2022-12-28	WOS:000352136400024
J	Sanderson, K				Sanderson, Katharine			STRUCTURE Artificial armour	NATURE			English	Editorial Material																		Barber A. H., 2015, R SOC INTERFACE; Libanori R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2281; Mirkhalaf M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4166	3	15	16	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S14	S15		10.1038/519S14a	http://dx.doi.org/10.1038/519S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25806492	Bronze			2022-12-28	WOS:000351602800005
J	Xu, HJ; Xue, J; Lu, B; Zhang, XC; Zhuo, JC; He, SF; Ma, XF; Jiang, YQ; Fan, HW; Xu, JY; Ye, YX; Pan, PL; Li, Q; Bao, YY; Nijhout, HF; Zhang, CX				Xu, Hai-Jun; Xue, Jian; Lu, Bo; Zhang, Xue-Chao; Zhuo, Ji-Chong; He, Shu-Fang; Ma, Xiao-Fang; Jiang, Ya-Qin; Fan, Hai-Wei; Xu, Ji-Yu; Ye, Yu-Xuan; Pan, Peng-Lu; Li, Qiao; Bao, Yan-Yuan; Nijhout, H. Frederik; Zhang, Chuan-Xi			Two insulin receptors determine alternative wing morphs in planthoppers	NATURE			English	Article							NILAPARVATA-LUGENS; BROWN PLANTHOPPER; JUVENILE-HORMONE; GROWTH-CONTROL; DROSOPHILA; INSECTS; POLYMORPHISM; PATHWAY; FORM; POLYPHENISM	Wing polyphenism is an evolutionarily successful feature found in a wide range of insects(1). Long-winged morphs can fly, which allows them to escape adverse habitats and track changing resources, whereas short-winged morphs are flightless, but usually possess higher fecundity than the winged morphs(1-3). Studies on aphids, crickets and planthoppers have revealed that alternative wing morphs develop in response to various environmental cues(1,2,4-8), and that the response to these cuesmay be mediated by developmental hormones, although research in this area has yielded equivocal and conflicting results about exactly which hormones are involved(4,8-10). As it stands, the molecular mechanism underlying wing morph determination in insects has remained elusive. Here we show that two insulin receptors in the migratory brown planthopper Nilaparvata lugens, InR1 and InR2, have opposing roles in controlling long wing versus short wing development by regulating the activity of the forkhead transcription factor Foxo. InR1, acting via the phosphatidylinositol-3-OH kinase (PI(3)K)-protein kinase B (Akt) signalling cascade, leads to the long-winged morph if active and the short-winged morph if inactive. InR2, by contrast, functions as a negative regulator of the InR1-PI(3)K-Akt pathway: suppression of InR2 results in development of the long-winged morph. The brain-secreted ligand Ilp3 triggers development of long-winged morphs. Our findings provide the first evidence of a molecular basis for the regulation of wing polyphenism in insects, and they are also the first demonstration-to our knowledge-of binary control over alternative developmental outcomes, and thus deepen our understanding of the development and evolution of phenotypic plasticity.	[Xu, Hai-Jun; Xue, Jian; Lu, Bo; Zhang, Xue-Chao; Zhuo, Ji-Chong; He, Shu-Fang; Ma, Xiao-Fang; Jiang, Ya-Qin; Fan, Hai-Wei; Xu, Ji-Yu; Ye, Yu-Xuan; Pan, Peng-Lu; Li, Qiao; Bao, Yan-Yuan; Zhang, Chuan-Xi] Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Xu, Hai-Jun; Xue, Jian; Lu, Bo; Zhang, Xue-Chao; Zhuo, Ji-Chong; He, Shu-Fang; Ma, Xiao-Fang; Jiang, Ya-Qin; Fan, Hai-Wei; Xu, Ji-Yu; Ye, Yu-Xuan; Pan, Peng-Lu; Li, Qiao; Bao, Yan-Yuan; Zhang, Chuan-Xi] Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou 310058, Zhejiang, Peoples R China; [Nijhout, H. Frederik] Duke Univ, Dept Biol, Durham, NC 27708 USA	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; Duke University	Zhang, CX (corresponding author), Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310058, Zhejiang, Peoples R China.	haijunxu@zju.edu.cn; chxzhang@zju.edu.cn	卓, 继冲/HCH-4822-2022; Jian, Xue/M-2381-2019; Zhang, Chuan-Xi/K-7978-2019	卓, 继冲/0000-0001-9956-8621; Zhang, Chuan-Xi/0000-0002-7784-1188; Xu, Hai-Jun/0000-0002-7314-377X	National Basic Research Program of China (973 Program) [2010CB126205]; National Science Foundation of China [31201509, 31471765]; Division Of Integrative Organismal Systems [1121065] Funding Source: National Science Foundation	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R.-Z. Zhang for help with BPH imaging (Fig. 1a). This work was supported by the National Basic Research Program of China (973 Program, no. 2010CB126205) and by the National Science Foundation of China (no. 31201509 and no. 31471765).	Braendle C, 2006, HEREDITY, V97, P192, DOI 10.1038/sj.hdy.6800863; Braendle C, 2005, P ROY SOC B-BIOL SCI, V272, P657, DOI 10.1098/rspb.2004.2995; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; DENNO RF, 1985, ECOLOGY, V66, P1588, DOI 10.2307/1938021; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Geminard C., 2009, CELL METAB, V10, P199; Hartfelder K., 2012, INSECT ENDOCRINOLOGY, P464, DOI [10.1016/B978-0-12-384749-2.10011-1, DOI 10.1016/B978-0-12-384749-2.10011-1]; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Hirumi H., 1971, INVERTEBRATE TISSUE, P307; IWANAGA K, 1986, J INSECT PHYSIOL, V32, P585, DOI 10.1016/0022-1910(86)90076-4; IWANAGA K, 1985, ENTOMOL EXP APPL, V38, P101, DOI 10.1007/BF00361919; KISIMOTO R, 1956, NATURE, V178, P641, DOI 10.1038/178641a0; LEES AD, 1977, NATURE, V267, P46, DOI 10.1038/267046a0; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Marshall L, 2012, EMBO J, V31, P1916, DOI 10.1038/emboj.2012.33; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Roff DA, 2007, BIOSCIENCE, V57, P155, DOI 10.1641/B570210; Simpson SJ, 2011, CURR BIOL, V21, pR738, DOI 10.1016/j.cub.2011.06.006; Syobu S, 2002, JPN J APPL ENTOMOL Z, V46, P135, DOI 10.1303/jjaez.2002.135; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu HJ, 2013, INSECT MOL BIOL, V22, P635, DOI 10.1111/imb.12051; Xue J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0521-0; Xue J, 2013, INSECT BIOCHEM MOLEC, V43, P433, DOI 10.1016/j.ibmb.2013.02.006; Zera A. J., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P609; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zhao ZW, 2002, P NATL ACAD SCI USA, V99, P16829, DOI 10.1073/pnas.262533999	37	267	304	15	369	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					464	+		10.1038/nature14286	http://dx.doi.org/10.1038/nature14286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25799997				2022-12-28	WOS:000351602800055
J	Halstead, JM; Lionnet, T; Wilbertz, JH; Wippich, F; Ephrussi, A; Singer, RH; Chao, JA				Halstead, James M.; Lionnet, Timothee; Wilbertz, Johannes H.; Wippich, Frank; Ephrussi, Anne; Singer, Robert H.; Chao, Jeffrey A.			An RNA biosensor for imaging the first round of translation from single cells to living animals	SCIENCE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; STRESS GRANULES; PROCESSING BODIES; OSKAR; ELONGATION; DYNAMICS; PROTEIN; YEAST; DECAY	Analysis of single molecules in living cells has provided quantitative insights into the kinetics of fundamental biological processes; however, the dynamics of messenger RNA (mRNA) translation have yet to be addressed. We have developed a fluorescence microscopy technique that reports on the first translation events of individual mRNA molecules. This allowed us to examine the spatiotemporal regulation of translation during normal growth and stress and during Drosophila oocyte development. We have shown that mRNAs are not translated in the nucleus but translate within minutes after export, that sequestration within P-bodies regulates translation, and that oskar mRNA is not translated until it reaches the posterior pole of the oocyte. This methodology provides a framework for studying initiation of protein synthesis on single mRNAs in living cells.	[Halstead, James M.; Wilbertz, Johannes H.; Chao, Jeffrey A.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Lionnet, Timothee; Singer, Robert H.; Chao, Jeffrey A.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Lionnet, Timothee; Singer, Robert H.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Lionnet, Timothee; Singer, Robert H.] Howard Hughes Med Inst, Transcript Imaging Consortium, Ashburn, VA 20147 USA; [Wilbertz, Johannes H.] Univ Basel, CH-4003 Basel, Switzerland; [Wippich, Frank; Ephrussi, Anne] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany	Friedrich Miescher Institute for Biomedical Research; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; University of Basel; European Molecular Biology Laboratory (EMBL)	Ephrussi, A (corresponding author), European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany.	ephrussi@embl.de; robert.singer@einstein.yu.edu; jeffrey.chao@fmi.ch	Ephrussi, Anne/AAG-4075-2020; Ephrussi, Anne/ABD-4393-2021; Lemke, Henrik Till/N-7419-2016	Ephrussi, Anne/0000-0002-5061-4620; Wilbertz, Johannes/0000-0002-0002-6847; Lionnet, Timothee/0000-0003-1508-0202; Wippich, Frank/0000-0003-2633-9777; Halstead, James/0000-0002-8321-2927; Chao, Jeffrey/0000-0002-5895-9156; Lemke, Henrik Till/0000-0003-1577-8643	Novartis Research Foundation; NIH [NS83085, EB013571, GM57071]; Howard Hughes Medical Institute; European Molecular Biology Laboratory (EMBL); EMBL Interdisciplinary Postdoc Program (EIPOD) under Marie Curie COFUND actions; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083085] Funding Source: NIH RePORTER	Novartis Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Molecular Biology Laboratory (EMBL); EMBL Interdisciplinary Postdoc Program (EIPOD) under Marie Curie COFUND actions; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This was work supported by the Novartis Research Foundation (J.A.C); NIH grants NS83085, EB013571, and GM57071 (R.H.S); Howard Hughes Medical Institute (R.H.S and T.L.); European Molecular Biology Laboratory (EMBL) (A.E.); and a postdoctoral fellowship from the EMBL Interdisciplinary Postdoc Program (EIPOD) under Marie Curie COFUND actions (F.W.). We thank C. Damgaard (University of Aarhus) for providing the rpL32-beta-globin plasmid; S. Shenoy (Albert Einstein College of Medicine), L. Gelman and S. Bourke (Friedrich Miescher Institute), and EMBL Advanced Light Microscopy Facility for microscopy support; D. Ciepielewski (Nikon) for providing access to NIS tracking software; C. Eliscovich (Albert Einstein College of Medicine) for advice on IF-FISH; L. Lavis (Janelia Farm) for providing JF549 dye; M. Beal (Biosearch Technologies) for Stellaris FISH probes;	Al-Jubran K, 2013, RNA, V19, P1669, DOI 10.1261/rna.038356.113; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chao JA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012310; Colak D, 2013, CELL, V153, P1252, DOI 10.1016/j.cell.2013.04.056; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Hocine S, 2013, NAT METHODS, V10, P119, DOI 10.1038/nmeth.2305; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lin MD, 2008, DEV BIOL, V322, P276, DOI 10.1016/j.ydbio.2008.07.033; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Morais-de-Sa E, 2013, DEV CELL, V26, P303, DOI 10.1016/j.devcel.2013.06.011; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; STANNERS CP, 1966, BIOCHEM BIOPH RES CO, V24, P758, DOI 10.1016/0006-291X(66)90390-1; Tanenbaum M.E., 2014, SCIENCE, V159, P635; Trcek T, 2013, GENE DEV, V27, P541, DOI 10.1101/gad.209635.112	27	174	177	9	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1367	1371		10.1126/science.aaa3380	http://dx.doi.org/10.1126/science.aaa3380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792328	Green Accepted			2022-12-28	WOS:000351219600043
J	Baptista, MAFB				Baptista, Marco A. F. B.			Nasal Myiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Clin Hosp, Sao Paulo, Brazil		Baptista, MAFB (corresponding author), Clin Hosp, Sao Paulo, Brazil.	medicinamarco@gmail.com							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2015	372	12					E17	E17		10.1056/NEJMicm1403473	http://dx.doi.org/10.1056/NEJMicm1403473			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EZ	25785986				2022-12-28	WOS:000351183600011
J	Moore, GF; Audrey, S; Barker, M; Bond, L; Bonell, C; Hardeman, W; Moore, L; O'Cathain, A; Tinati, T; Wight, D; Baird, J				Moore, Graham F.; Audrey, Suzanne; Barker, Mary; Bond, Lyndal; Bonell, Chris; Hardeman, Wendy; Moore, Laurence; O'Cathain, Alicia; Tinati, Tannaze; Wight, Daniel; Baird, Janis			Process evaluation of complex interventions: Medical Research Council guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; PUBLIC-HEALTH INTERVENTION; EXERCISE REFERRAL SCHEME; FRAMEWORK; IMPLEMENTATION; REVIEWS; DESIGN		[Moore, Graham F.] Cardiff Univ, Sch Social Sci, DECIPHer UKCRC Publ Hlth Res Ctr Excellence, Cardiff CF10 3AX, S Glam, Wales; [Audrey, Suzanne] Univ Bristol, Sch Social & Community Med, DECIPHer UKCRC Publ Hlth Res Ctr Excellence, Bristol, Avon, England; [Barker, Mary; Tinati, Tannaze; Baird, Janis] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Bond, Lyndal] Ctr Excellence Intervent & Prevent Sci, Melbourne, Vic, Australia; [Bonell, Chris] Univ London, Inst Educ, Dept Childhood Families & Hlth, London, England; [Hardeman, Wendy] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England; [Moore, Laurence; Wight, Daniel] Univ Glasgow, MRC, CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [O'Cathain, Alicia] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	Cardiff University; University of Bristol; University of Southampton; University of London; University College London; UCL Institute of Education; University of Cambridge; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Sheffield	Moore, GF (corresponding author), Cardiff Univ, Sch Social Sci, DECIPHer UKCRC Publ Hlth Res Ctr Excellence, Cardiff CF10 3AX, S Glam, Wales.	MooreG@cardiff.ac.uk		BOND, LYNDAL/0000-0003-1693-5508; Moore, Laurence/0000-0003-2182-823X; Barker, Mary/0000-0003-2976-0217; Hardeman, Wendy/0000-0002-6498-9407	MRC Population Health Science Research Network [PHSRN45]; MRC [MC_UU_12017/14, MR/K023233/1, G0901335, MR/K025643/1, MC_UU_12011/4, MR/N011848/1, G106/1116, MC_UP_A620_1017, MC_UU_12017/4] Funding Source: UKRI; Medical Research Council [MR/N011848/1, MC_UP_A620_1017, G0901335, MR/K023233/1, MR/K025643/1, MC_UU_12017/4, MC_UU_12011/4, MC_UU_12017/14] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10114] Funding Source: researchfish; Chief Scientist Office [SPHSU14, SPHSU1] Funding Source: researchfish	MRC Population Health Science Research Network(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	The work was funded by the MRC Population Health Science Research Network (PHSRN45).	Armstrong R, 2008, J PUBLIC HEALTH-UK, V30, P103, DOI 10.1093/pubmed/fdm082; Audrey S, 2006, HEALTH EDUC RES, V21, P366, DOI 10.1093/her/cyl029; Bonell C, HLTH TECHNO IN PRESS; Bonell C, 2012, SOC SCI MED, V75, P2299, DOI 10.1016/j.socscimed.2012.08.032; Bumbarger BK, 2008, J CHILD SERV, V3, P55, DOI 10.1108/17466660200800012; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Carroll C, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-40; Craig P., 2008, DEV EVALUATING COMPL; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; De Silva MJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-267; Fretheim A, 2005, J CLIN EPIDEMIOL, V58, P119, DOI 10.1016/j.jclinepi.2004.10.003; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Grant A, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-15; Hawe P, 2004, BMJ-BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Hawe P, 2009, AM J COMMUN PSYCHOL, V43, P267, DOI 10.1007/s10464-009-9229-9; Kellogg Foundation WK, 2004, LOG MOD DEV GUID; Littlecott HJ, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0109-9; Markham WA, 2003, SOC SCI MED, V56, P1209, DOI 10.1016/S0277-9536(02)00120-X; Mermelstein R, 2008, LANCET, V371, P1556, DOI 10.1016/S0140-6736(08)60668-6; Montgomery P, 2013, J CLIN EPIDEMIOL, V66, P874, DOI 10.1016/j.jclinepi.2013.03.006; Moore G, 2014, J EPIDEMIOL COMMUN H, V68, P101, DOI 10.1136/jech-2013-202869; Moore GF, 2013, HEALTH EDUC, V113, P476, DOI 10.1108/HE-08-2012-0046; Moore GF, 2012, BEHAV COGN PSYCHOTH, V40, P313, DOI 10.1017/S1352465811000531; Munro A, 2010, QUAL RES, V10, P699, DOI 10.1177/1468794110380522; O'Cathain A, 2008, QUAL HEALTH RES, V18, P1574, DOI 10.1177/1049732308325535; Oakley A, 2006, BRIT MED J, V332, P413, DOI 10.1136/bmj.332.7538.413; Pawson R., 1997, REALISTIC EVALUATION; Sawyer MG, 2010, J CHILD PSYCHOL PSYC, V51, P199, DOI 10.1111/j.1469-7610.2009.02136.x; Shiell A, 2008, BMJ-BRIT MED J, V336, P1281, DOI 10.1136/bmj.39569.510521.AD; Steckler A., 2002, PROCESS EVALUATION P; Waters E, 2011, J PUBLIC HEALTH-UK, V33, P462, DOI 10.1093/pubmed/fdr064	31	2557	2573	7	69	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2015	350								h1258	10.1136/bmj.h1258	http://dx.doi.org/10.1136/bmj.h1258			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CE1KV	25791983	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-28	WOS:000351571400002
J	Rockstrom, J; Falkenmark, M				Rockstrom, Johan; Falkenmark, Malin			Increase water harvesting in Africa	NATURE			English	Editorial Material									[Rockstrom, Johan] Stockholm Univ, Water Syst & Global Sustainabil, Stockholm, Sweden; [Rockstrom, Johan] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Rockstrom, Johan] CGIAR Res Program Water Land & Ecosyst, Stockholm, Sweden; [Falkenmark, Malin] Stockholm Univ, Stockholm Resilience Ctr, Appl Int Hydrol, Stockholm, Sweden; [Falkenmark, Malin] Stockholm Univ, Stockholm Int Water Inst, Stockholm, Sweden	Stockholm University; Stockholm University; CGIAR; Stockholm University; Stockholm University	Rockstrom, J (corresponding author), Stockholm Univ, Water Syst & Global Sustainabil, Stockholm, Sweden.	johan.rockstrom@su.se		Rockstrom, Johan/0000-0001-8988-2983				Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; McIntyre B. D., 2009, AGR CROSSROADS GLOBA; Rockstrom J, 2000, CRIT REV PLANT SCI, V19, P319, DOI 10.1016/S0735-2689(00)80007-6; Rockstrom J., 2014, WATER RESILIENCE HUM; Schewe J, 2014, P NATL ACAD SCI USA, V111, P3245, DOI 10.1073/pnas.1222460110; Tadross M, 2009, CLIM RES, V40, P147, DOI 10.3354/cr00821; Vorosmarty CJ, 2005, AMBIO, V34, P230, DOI 10.1639/0044-7447(2005)034[0230:GIOEWS]2.0.CO;2; Wani S.P., 2009, RAINFED AGR UNLOCKIN; Zhu QiAng, 2006, Waterlines, V24, P4, DOI 10.3362/0262-8104.2006.017	10	107	109	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					283	285		10.1038/519283a	http://dx.doi.org/10.1038/519283a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25788079	Bronze			2022-12-28	WOS:000351171900012
J	Hunter, DJ; Frenk, J				Hunter, David J.; Frenk, Julio			The Birth of Public Health Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hunter, David J.; Frenk, Julio] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Hunter, DJ (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	dhunter@hsph.harvard.edu						Abbott AC, 1921, AM J PUBLIC HEALTH, V11, P371, DOI 10.2105/AJPH.11.4.371; [Anonymous], 1992, WELCH ROS REP PUBL H; Flexner A, 1910, MED ED US CANADA REP; Rose W, 1915, SCH PUBLIC HLTH; Rosenau MJ, JAMA-J AM MED ASSOC, DOI [10.1001/jama.1915.02580040031010, DOI 10.1001/JAMA.1915.02580040031010]; Rosenau MJ, JAMA-J AM MED ASSOC, DOI [10.1001/jama.1915 02570360010003, DOI 10.1001/JAMA.191502570360010003]; Welch WH, 1992, WELCH ROSE REPORT PU; WILLIAMS G, 1976, MILBANK FUND Q, V54, P489, DOI 10.2307/3349679	8	3	4	4	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1105	1106		10.1001/jama.2015.1595	http://dx.doi.org/10.1001/jama.2015.1595			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD5BP	25781436				2022-12-28	WOS:000351102500009
J	Head, S				Head, Stephen			We need a drug formulary for obese people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Nottinghamshire Healthcare Trust, Edwinstowe Hlth Ctr, Mansfield NG21 9QS, Notts, England		Head, S (corresponding author), Nottinghamshire Healthcare Trust, Edwinstowe Hlth Ctr, Mansfield NG21 9QS, Notts, England.	shead@doctors.org.uk						Hanley MJ, 2010, CLIN PHARMACOKINET, V49, P71, DOI 10.2165/11318100-000000000-00000; Martin JH, 2012, BRIT J CLIN PHARMACO, V73, P685, DOI 10.1111/j.1365-2125.2011.04159.x; UK Medicines Information (UKMi), 2013, Q A 378 1 SHOULD ANT	3	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2015	350								h1356	10.1136/bmj.h1356	http://dx.doi.org/10.1136/bmj.h1356			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KM	25779677				2022-12-28	WOS:000351570500005
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Drugs with anticholinergic side effects and cognitive decline-cause or effect?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICATION USE; POPULATION; MORTALITY; BURDEN; DEMENTIA; RISK					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Carriere I, 2009, ARCH INTERN MED, V169, P1317, DOI 10.1001/archinternmed.2009.229; Ellett LMK, 2014, J AM GERIATR SOC, V62, P1916, DOI 10.1111/jgs.13054; Fox C, 2011, J AM GERIATR SOC, V59, P1477, DOI 10.1111/j.1532-5415.2011.03491.x; Gray SL, 2015, JAMA INTERN MED, V175, P401, DOI 10.1001/jamainternmed.2014.7663; Han L, 2008, J AM GERIATR SOC, V56, P2203, DOI 10.1111/j.1532-5415.2008.02009.x; Kersten H, 2013, J GERONTOL A-BIOL, V68, P271, DOI 10.1093/gerona/gls176; Kumpula EK, 2011, J CLIN PHARMACOL, V51, P256, DOI 10.1177/0091270010368410; Myint PK, 2015, AGE AGEING, V44, P219, DOI 10.1093/ageing/afu185; Nishtala PS, 2014, PHARMACOEPIDEM DR S, V23, P753, DOI 10.1002/pds.3624; Tjia J, 2013, DRUG AGING, V30, P285, DOI 10.1007/s40266-013-0064-1	10	1	1	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2015	350								h1428	10.1136/bmj.h1428	http://dx.doi.org/10.1136/bmj.h1428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KM	25775913	Bronze			2022-12-28	WOS:000351570500006
J	Wedemeyer, H				Wedemeyer, Heiner			Towards interferon-free treatment for all HCV genotypes	LANCET			English	Editorial Material									Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany	Hannover Medical School	Wedemeyer, H (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany.	wedemeyer.heiner@mh-hannover.de						Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hezode C, 2015, LANCET; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Maasoumy B, 2013, ALIMENT PHARM THER, V38, P1365, DOI 10.1111/apt.12523; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Ruane PJ, 2015, J HEPATOL, V62, P1040, DOI 10.1016/j.jhep.2014.10.044; Siederdissen CHZ, 2015, LIVER INT, V35, P1845, DOI 10.1111/liv.12774; van der Meer AJ, 2015, GUT, V64, P322, DOI 10.1136/gutjnl-2013-305357; Webster D. P., 2015, LANCET; Wedemeyer H, 2015, J VIRAL HEPATITIS, V22, P1, DOI 10.1111/jvh.12371; Wedemeyer H, 2014, J VIRAL HEPATITIS, V21, P60, DOI 10.1111/jvh.12249; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012	12	14	14	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2443	2445		10.1016/S0140-6736(15)60605-5	http://dx.doi.org/10.1016/S0140-6736(15)60605-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK9AR	25837828				2022-12-28	WOS:000356532500008
J	Welker, F; Collins, MJ; Thomas, JA; Wadsley, M; Brace, S; Cappellini, E; Turvey, ST; Reguero, M; Gelfo, JN; Kramarz, A; Burger, J; Thomas-Oates, J; Ashford, DA; Ashton, PD; Rowsell, K; Porter, DM; Kessler, B; Fischer, R; Baessmann, C; Kaspar, S; Olsen, JV; Kiley, P; Elliott, JA; Kelstrup, CD; Mullin, V; Hofreiter, M; Willerslev, E; Hublin, JJ; Orlando, L; Barnes, I; MacPhee, RDE				Welker, Frido; Collins, Matthew J.; Thomas, Jessica A.; Wadsley, Marc; Brace, Selina; Cappellini, Enrico; Turvey, Samuel T.; Reguero, Marcelo; Gelfo, Javier N.; Kramarz, Alejandro; Burger, Joachim; Thomas-Oates, Jane; Ashford, David A.; Ashton, Peter D.; Rowsell, Keri; Porter, Duncan M.; Kessler, Benedikt; Fischer, Roman; Baessmann, Carsten; Kaspar, Stephanie; Olsen, Jesper V.; Kiley, Patrick; Elliott, James A.; Kelstrup, Christian D.; Mullin, Victoria; Hofreiter, Michael; Willerslev, Eske; Hublin, Jean-Jacques; Orlando, Ludovic; Barnes, Ian; MacPhee, Ross D. E.			Ancient proteins resolve the evolutionary history of Darwin's South American ungulates	NATURE			English	Article							DENTAL ERUPTION; DNA; SOFTWARE; SEQUENCE; MODEL	No large group of recently extinct placental mammals remains as evolutionarily cryptic as the approximately 280 genera grouped as 'South American native ungulates'. To Charles Darwin(1,)2, who first collected their remains, they included perhaps the 'strangest animal[s] ever discovered'. Today, much like 180 years ago, it is no clearer whether they had one origin or several, arose before or after the Cretaceous/Palaeogene transition 66.2 million years ago(3), or are more likely to belong with the elephants and sirenians of superorder Afrotheria than with the euungulates (cattle, horses, and allies) of superorder Laurasiatheria(4-6). Morphology-based analyses have proved unconvincing because convergences are pervasive among unrelated ungulate-like placentals. Approaches using ancient DNA have also been unsuccessful, probably because of rapid DNA degradation in semitropical and temperate deposits. Here we apply proteomic analysis to screen bone samples of the Late Quaternary South American native ungulate taxa Toxodon (Notoungulata) and Macrauchenia (Litopterna) for phylogenetically informative protein sequences. For each ungulate, we obtain approximately 90% direct sequence coverage of type I collagen alpha 1-and alpha 2-chains, representing approximately 900 of 1,140 amino-acid residues for each subunit. A phylogeny is estimated from an alignment of these fossil sequences with collagen (I) gene transcripts from available mammalian genomes or mass spectrometrically derived sequence data obtained for this study. The resulting consensus tree agrees well with recent higher-level mammalian phylogenies(7-9). Toxodon and Macrauchenia form a monophyletic group whose sister taxon is not Afrotheria or any of its constituent clades as recently claimed(5,6), but instead crown Perissodactyla (horses, tapirs, and rhinoceroses). These results are consistent with the origin of at least some South American native ungulates(4,6) from 'condylarths', a paraphyletic assembly of archaic placentals. With ongoing improvements in instrumentation and analytical procedures, proteomics may produce a revolution in systematics such as that achieved by genomics, but with the possibility of reaching much further back in time.	[Welker, Frido; Collins, Matthew J.; Thomas, Jessica A.; Wadsley, Marc; Rowsell, Keri; Hofreiter, Michael] Univ York, BioArCh, York YO10 5DD, N Yorkshire, England; [Welker, Frido; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Brace, Selina; Barnes, Ian] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Cappellini, Enrico; Willerslev, Eske; Orlando, Ludovic] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen K, Denmark; [Turvey, Samuel T.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Reguero, Marcelo; Gelfo, Javier N.] Univ Nacl La Plata, Fac Ciencias Nat & Museo La Plata, CONICET, Div Paleontol Vertebrados,Museo La Plata, RA-1900 La Plata, Buenos Aires, Argentina; [Kramarz, Alejandro] Museo Argentino Ciencias Nat Bernardino Rivadavia, Secc Paleontol Vertebrados, Buenos Aires, DF, Argentina; [Burger, Joachim] Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55128 Mainz, Germany; [Thomas-Oates, Jane] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Ashford, David A.; Ashton, Peter D.] Univ York, Dept Biol, Biosci Technol Facil, York YO10 5DD, N Yorkshire, England; [Porter, Duncan M.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Kessler, Benedikt; Fischer, Roman] Univ Oxford, Target Discovery Inst, Nuffield Dept Med, Oxford OX3 7FZ, England; [Baessmann, Carsten; Kaspar, Stephanie] Bruker Daltonik GmbH, Applicat Dev, D-28359 Bremen, Germany; [Olsen, Jesper V.; Kelstrup, Christian D.] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Kiley, Patrick; Elliott, James A.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB3 0FS, England; [Mullin, Victoria] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Hofreiter, Michael] Inst Biochem & Biol, D-14476 Potsdam Ot Golm, Germany; [MacPhee, Ross D. E.] Amer Museum Nat Hist, Dept Mammal, New York, NY 10024 USA	University of York - UK; Max Planck Society; Natural History Museum London; University of Copenhagen; Zoological Society of London; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Johannes Gutenberg University of Mainz; University of York - UK; University of York - UK; Virginia Polytechnic Institute & State University; University of Oxford; Bruker Corporation; Bruker Daltonik GmbH; University of Copenhagen; University of Cambridge; Trinity College Dublin; American Museum of Natural History (AMNH)	Barnes, I (corresponding author), Nat Hist Museum, Dept Earth Sci, Cromwell Rd, London SW7 5BD, England.	frido.welker@palaeo.eu; matthew.collins@york.ac.uk; i.barnes@nhm.ac.uk; macphee@amnh.org	Gelfo, Javier N./AAW-1905-2021; Elliott, James A/A-4135-2009; Fischer, Roman/N-4408-2017; Kessler, Benedikt/AAY-8614-2021; Barnes, Ian C/B-8081-2008; Cappellini, Enrico/F-9346-2013; Willerslev, Eske/A-9619-2011; Elliott, James/M-9821-2019; Collins, Matthew J/A-7534-2008; Olsen, Jesper/ABH-4638-2020; Collins, Matthew James/O-1095-2019; Willerslev, Eske/AAA-5686-2019; Orlando, Ludovic/A-8932-2013; Hofreiter, Michael/A-3996-2017	Gelfo, Javier N./0000-0002-9989-5902; Elliott, James A/0000-0002-4887-6250; Fischer, Roman/0000-0002-9715-5951; Kessler, Benedikt/0000-0002-8160-2446; Barnes, Ian C/0000-0001-8322-6918; Cappellini, Enrico/0000-0001-7885-7811; Willerslev, Eske/0000-0002-7081-6748; Elliott, James/0000-0002-4887-6250; Collins, Matthew J/0000-0003-4226-5501; Olsen, Jesper/0000-0002-4747-4938; Collins, Matthew James/0000-0003-4226-5501; Orlando, Ludovic/0000-0003-3936-1850; Kelstrup, Christian Dahl/0000-0003-4647-1425; Ashton, Peter/0000-0002-7446-5009; Hofreiter, Michael/0000-0003-0441-4705	SYNTAX award "Barcode of Death"; European Research Council (ERC); ERC; Engineering and Physical Sciences Research Council [NE/G012237/1]; National Science Foundation [OPP 1142052]; Northern Way Initiative; SYNTHESYS FP7 grant [226506]; Directorate For Geosciences [1142104] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1142129, 1142052] Funding Source: National Science Foundation; NERC [NE/J009342/1] Funding Source: UKRI; Natural Environment Research Council [NE/J009342/1] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Jesper Velgaard Olsen] Funding Source: researchfish	SYNTAX award "Barcode of Death"; European Research Council (ERC)(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Science Foundation(National Science Foundation (NSF)); Northern Way Initiative; SYNTHESYS FP7 grant; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Novo Nordisk Foundation Center for Protein Research	We thank the Museo Argentino de Ciencias Naturales "Bernardino Rivadavia", Buenos Aires (MACN), the Museo de La Plata (MLP), and the Natural History Museum of Denmark, Copenhagen (ZMK), for allowing us to sample fossil specimens in their collections for this project. The American Museum of Natural History and the Copenhagen Zoo provided samples of extant mammals suitable for collagen extraction. Mogens Andersen and Kristian Gregersen of ZMK provided information on specimens in their care. This work was partly supported by SYNTAX award "Barcode of Death", European Research Council (ERC) Advanced Award CodeX, ERC Consolidator Award GeneFlow, SYNTHESYS FP7 grant agreement 226506, Engineering and Physical Sciences Research Council NE/G012237/1 and National Science Foundation OPP 1142052. J.T.-O. and D.A.A. are members of the York Centre of Excellence in Mass Spectrometry, created thanks to a major capital investment through Science City York, supported by Yorkshire Forward with funds from the Northern Way Initiative.	Agnolin FL, 2011, MAMM BIOL, V76, P101, DOI 10.1016/j.mambio.2010.12.001; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Asher RJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-14; Benton Michael J., 2009, P35; Billet G, 2011, NATURWISSENSCHAFTEN, V98, P509, DOI 10.1007/s00114-011-0795-y; Brace S, 2012, MOL ECOL, V21, P2239, DOI 10.1111/j.1365-294X.2012.05514.x; Buckley M., 2011, ANTIQUA, V1, pe1, DOI [10.4081/antiqua.2011.e1.-e1, DOI 10.4081/ANTIQUA.2011.E1.-E1, DOI 10.4081/ANTIQUA.2011.E1]; Buckley M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059614; Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316; Buckley M, 2008, SCIENCE, V319, DOI 10.1126/science.1147046; CIFELLI RL, 1993, MAMMAL PHYLOGENY : PLACENTALS, P195; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Darwin Charles, 1839, J RES GEOLOGY NATURA; De Muizon C., 2000, GEODIVERSITAS, V22, P1; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Drummond A., 2007, BEAUTI V 1 4 2 BAYES; Drummond A. J., 2010, GENEIOUS V4 7; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Hamza VM, 2011, CLIMATE CHANGE - GEOPHYSICAL FOUNDATIONS AND ECOLOGICAL EFFECTS, P113; Horovitz Ines, 2004, Bulletin of Carnegie Museum of Natural History, V36, P63, DOI 10.2992/0145-9058(2004)36[63:EMSATO]2.0.CO;2; Hudson DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093467; Hudson DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019336; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Husson D, 2011, EARTH PLANET SC LETT, V305, P328, DOI 10.1016/j.epsl.2011.03.008; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kramarz A, 2014, MAMM BIOL, V79, P170, DOI 10.1016/j.mambio.2013.11.001; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McKenna MC, 1997, CLASSIFICATION MAMMA; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Meyer M., 2010, COLD SPRING HARB PRO; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Owen R., 1838, ZOOLOGY VOYAGE HMS 1; PATTERSON B, 1968, Q REV BIOL, V43, P409, DOI 10.1086/405916; Rambaut A., 2013, TRACER V16; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sanchez-Villagra MR, 2007, SYST BIODIVERS, V5, P1, DOI 10.1017/S1477200006002258; SARICH VM, 1967, P NATL ACAD SCI USA, V58, P142, DOI 10.1073/pnas.58.1.142; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Simpson GG., 1967, B AM MUS NAT HIST, V137, P1; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swofford D.L., 2003, PAUP VERSION 40 B10; Terajima M., 2014, J BIOL CHEM; US. Central Intelligence Agency, 2013, WORLD FACTB 2013 14; Van Bocxlaer I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000074; van Doorn N. L., 2014, ENCY GLOBAL ARCHAEOL, P7998, DOI DOI 10.1007/978-1-4419-0465-2_2418; van Doorn NL, 2012, RAPID COMMUN MASS SP, V26, P2319, DOI 10.1002/rcm.6351; van Valen L.M., 1988, Evolutionary Monographs, V10, P1; Vizcaino M, 2010, CLIM DYNAM, V34, P301, DOI 10.1007/s00382-009-0591-y; Wilf P, 2013, ANNU REV EARTH PL SC, V41, P561, DOI 10.1146/annurev-earth-050212-124217; ZUCKERKANDL E, 1960, P NATL ACAD SCI USA, V46, P1349, DOI 10.1073/pnas.46.10.1349	58	208	227	1	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					81	U192		10.1038/nature14249	http://dx.doi.org/10.1038/nature14249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25799987	Green Published, Green Accepted			2022-12-28	WOS:000355543400033
J	Paolo, FS; Fricker, HA; Padman, L				Paolo, Fernando S.; Fricker, Helen A.; Padman, Laurie			Volume loss from Antarctic ice shelves is accelerating	SCIENCE			English	Article							PINE ISLAND; WEST ANTARCTICA; SHEET; PENINSULA; THWAITES; RETREAT	The floating ice shelves surrounding the Antarctic Ice Sheet restrain the grounded ice-sheet flow. Thinning of an ice shelf reduces this effect, leading to an increase in ice discharge to the ocean. Using 18 years of continuous satellite radar altimeter observations, we have computed decadal-scale changes in ice-shelf thickness around the Antarctic continent. Overall, average ice-shelf volume change accelerated from negligible loss at 25 +/- 64 cubic kilometers per year for 1994-2003 to rapid loss of 310 +/- 74 cubic kilometers per year for 2003-2012. West Antarctic losses increased by similar to 70% in the past decade, and earlier volume gain by East Antarctic ice shelves ceased. In the Amundsen and Bellingshausen regions, some ice shelves have lost up to 18% of their thickness in less than two decades.	[Paolo, Fernando S.; Fricker, Helen A.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA; [Padman, Laurie] Earth & Space Res, Corvallis, OR USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Paolo, FS (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA.	fpaolo@ucsd.edu	Paolo, Fernando/AGQ-9348-2022; Padman, Laurence/AAH-3808-2021	Paolo, Fernando/0000-0002-6439-2918; Padman, Laurence/0000-0003-2010-642X; Fricker, Helen Amanda/0000-0002-0921-1432	NASA [NNX12AN50H 002 (93735A), NNX10AG19G, NNX13AP60G]	NASA(National Aeronautics & Space Administration (NASA))	This work was funded by NASA [awards NNX12AN50H 002 (93735A), NNX10AG19G, and NNX13AP60G]. This is ESR contribution 154. We thank J. Zwally's Ice Altimetry group at the NASA Goddard Space Flight Center for distributing their RA data sets for all satellite radar altimeter missions (http://icesat4.gsfc.nasa.gov). We thank C. Davis and D. Wingham for RA-processing advice. We thank A. Shepherd and anonymous reviewers for their comments on the manuscript.	Borstad CP, 2013, CRYOSPHERE, V7, P1931, DOI 10.5194/tc-7-1931-2013; Cook AJ, 2010, CRYOSPHERE, V4, P77, DOI 10.5194/tc-4-77-2010; Davis CH, 2004, IEEE T GEOSCI REMOTE, V42, P2437, DOI 10.1109/TGRS.2004.836789; Depoorter MA, 2013, NATURE, V502, P89, DOI 10.1038/nature12567; Dutrieux P, 2014, SCIENCE, V343, P174, DOI 10.1126/science.1244341; Efron B., 1993, INTRO BOOTSTRAP, V57; Favier L, 2014, NAT CLIM CHANGE, V4, P117, DOI [10.1038/nclimate2094, 10.1038/NCLIMATE2094]; Fricker HA, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007126; Goldberg D, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001227; Holland P. R., 2015, CRYOSPHERE DISCUSS, V9, P251, DOI DOI 10.5194/TCD-9-251-2015; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; Joughin I, 2011, NAT GEOSCI, V4, P506, DOI [10.1038/ngeo1194, 10.1038/NGEO1194]; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140; Rignot E, 2013, SCIENCE, V341, P266, DOI 10.1126/science.1235798; Scambos T, 2003, ANTARCT RES SER, V79, P79; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Shepherd A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042496; Sutterley TC, 2014, GEOPHYS RES LETT, V41, P8421, DOI 10.1002/2014GL061940; Thoma M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034939; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]; Wingham DJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039126; Zwally HJ, 2005, J GLACIOL, V51, P509, DOI 10.3189/172756505781829007	27	443	455	9	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					327	331		10.1126/science.aaa0940	http://dx.doi.org/10.1126/science.aaa0940			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25814064				2022-12-28	WOS:000352999000042
J	Beaugerie, L; Itzkowitz, SH				Beaugerie, Laurent; Itzkowitz, Steven H.			Cancers Complicating Inflammatory Bowel Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CAUSE-SPECIFIC MORTALITY; ORGAN TRANSPLANT RECIPIENTS; NONMELANOMA SKIN CANCERS; EVIDENCE-BASED CONSENSUS; POPULATION-BASED COHORT; ULCERATIVE-COLITIS; COLORECTAL-CANCER; INCREASED RISK; CROHNS-DISEASE; RECEIVE THIOPURINES		[Beaugerie, Laurent] Hop St Antoine, Dept Gastroenterol, AP HP, F-75571 Paris 12, France; [Beaugerie, Laurent] Univ Paris 06, Equipe Rech Labellisee 1057, INSERM, Unite Mixte Rech 7203, Paris, France; [Beaugerie, Laurent] Univ Paris 06, Grp Rech Clin, Univ Pierre & Marie Curie UPMC 3, Paris, France; [Itzkowitz, Steven H.] Icahn Sch Med Mt Sinai, Samuel Bronfman Dept Med, Dr Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Icahn School of Medicine at Mount Sinai	Beaugerie, L (corresponding author), Hop St Antoine, Serv Gastroenterol & Nutr, 184 Rue Faubourg St Antoine, F-75571 Paris 12, France.	laurent.beaugerie@sat.aphp.fr			Abbott; AbbVie; Ferring; Merck; Sharp; Dohme; Biocodex; Exact Sciences	Abbott(Abbott Laboratories); AbbVie(AbbVie); Ferring(Ferring Pharmaceuticals); Merck(Merck & Company); Sharp; Dohme; Biocodex; Exact Sciences	Dr. Beaugerie reports receiving consulting fees from Abbott, lecture fees and travel support from Abbott, AbbVie, Ferring, and Merck, Sharp, and Dohme, and grant support from AbbVie, Biocodex, and Ferring; and Dr. Itzkowitz, grant support and fees for serving on a scientific advisory board from Exact Sciences.	Abreu MT, 2014, GASTROENTEROLOGY, V146; Andersen NN, 2014, JAMA-J AM MED ASSOC, V311, P2406, DOI 10.1001/jama.2014.5613; Annese V, 2013, J CROHNS COLITIS, V7, P982, DOI 10.1016/j.crohns.2013.09.016; Ariyaratnam J, 2014, AM J GASTROENTEROL, V109, P163, DOI 10.1038/ajg.2013.451; Beaugerie L, 2013, GASTROENTEROLOGY, V145; Beaugerie L, 2014, GUT, V63, P1416, DOI 10.1136/gutjnl-2013-305763; Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; BRENTNALL TA, 1994, GASTROENTEROLOGY, V107, P369, DOI 10.1016/0016-5085(94)90161-9; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Chang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069981; Duricova D, 2010, INFLAMM BOWEL DIS, V16, P347, DOI 10.1002/ibd.21007; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Elriz K, 2013, INFLAMM BOWEL DIS, V19, P1823, DOI 10.1097/MIB.0b013e31828c84f2; Erichsen R, 2009, EUR J EPIDEMIOL, V24, P513, DOI 10.1007/s10654-009-9365-4; Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI [10.1053/j.gastro.2009.12.037, 10.1053/j.gastro.2009.12.035]; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Galandiuk S, 2012, GASTROENTEROLOGY, V142, P855, DOI 10.1053/j.gastro.2011.12.004; Gong JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081487; Gupta RB, 2007, GASTROENTEROLOGY, V133, P1099, DOI 10.1053/j.gastro.2007.08.001; Gutierrez-Dalmau A, 2007, DRUGS, V67, P1167, DOI 10.2165/00003495-200767080-00006; Harwood CA, 2008, BRIT J CANCER, V99, P1276, DOI 10.1038/sj.bjc.6604665; Herrinton LJ, 2012, GASTROENTEROLOGY, V143, P382, DOI 10.1053/j.gastro.2012.04.054; Irrazabal T, 2014, MOL CELL, V54, P309, DOI 10.1016/j.molcel.2014.03.039; Itzkowitz SH, 2004, GASTROENTEROLOGY, V126, P1634, DOI 10.1053/j.gastro.2004.03.025; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Jess T, 2005, AM J GASTROENTEROL, V100, P2724, DOI 10.1111/j.1572-0241.2005.00287.x; Jess T, 2012, GASTROENTEROLOGY, V143; Jess T, 2007, AM J GASTROENTEROL, V102, P609, DOI 10.1111/j.1572-0241.2006.01000.x; Jess T, 2014, CLIN GASTROENTEROL H, V12, P1793, DOI 10.1016/j.cgh.2014.05.019; Jess T, 2013, CLIN GASTROENTEROL H, V11, P43, DOI 10.1016/j.cgh.2012.09.026; Kandiel A, 2005, GUT, V54, P1121, DOI 10.1136/gut.2004.049460; Kotlyar DS, 2011, CLIN GASTROENTEROL H, V9, P36, DOI 10.1016/j.cgh.2010.09.016; Kotlyar DS, 2014, CLIN GASTROENTEROL H; Laine L, 2015, GASTROENTEROLOGY, V148, P639, DOI 10.1053/j.gastro.2015.01.031; Laukoetter MG, 2011, J GASTROINTEST SURG, V15, P576, DOI 10.1007/s11605-010-1402-9; Lewis JD, 2001, GASTROENTEROLOGY, V121, P1080, DOI 10.1053/gast.2001.28703; Long MD, 2012, GASTROENTEROLOGY, V143, P390, DOI 10.1053/j.gastro.2012.05.004; Lopez A, 2014, CLIN GASTROENTEROL H, V12, P1324, DOI 10.1016/j.cgh.2014.02.026; Lutgens MWMD, 2008, GUT, V57, P1246, DOI 10.1136/gut.2007.143453; Lutgens MWMD, 2013, INFLAMM BOWEL DIS, V19, P789, DOI 10.1097/MIB.0b013e31828029c0; Lyakhovich A, 2010, ALIMENT PHARM THER, V31, P202, DOI 10.1111/j.1365-2036.2009.04195.x; Mariette X, 2002, BLOOD, V99, P3909, DOI 10.1182/blood.V99.11.3909; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Munz C, 2008, SEMIN CANCER BIOL, V18, P381, DOI 10.1016/j.semcancer.2008.10.002; Nguyen GC, 2012, AM J GASTROENTEROL, V107, P1298, DOI 10.1038/ajg.2012.198; O'Donovan P, 2005, SCIENCE, V309, P1871, DOI 10.1126/science.1114233; Offman J, 2004, BLOOD, V104, P822, DOI 10.1182/blood-2003-11-3938; Pasternak B, 2013, AM J EPIDEMIOL, V177, P1296, DOI 10.1093/aje/kws375; Peyrin-Biroulet L, 2012, AM J GASTROENTEROL, V107, P1443, DOI 10.1038/ajg.2012.181; Peyrin-Biroulet L, 2011, GASTROENTEROLOGY, V141, P1621, DOI 10.1053/j.gastro.2011.06.050; Pietersma F, 2008, LEUKEMIA LYMPHOMA, V49, P1028, DOI 10.1080/10428190801911662; Piton G, 2008, AM J GASTROENTEROL, V103, P1730, DOI 10.1111/j.1572-0241.2008.01847.x; Risques RA, 2011, CANCER RES, V71, P1669, DOI 10.1158/0008-5472.CAN-10-1966; Rubin DT, 2007, GASTROINTEST ENDOSC, V65, P998, DOI 10.1016/j.gie.2006.09.025; Rubin DT, 2013, CLIN GASTROENTEROL H, V11, P1601, DOI 10.1016/j.cgh.2013.06.023; Rungoe C, 2015, CLIN GASTROENTEROL H, V13, P693, DOI 10.1016/j.cgh.2014.07.036; Rutter M, 2004, GASTROENTEROLOGY, V126, P451, DOI 10.1053/j.gastro.2003.11.010; Scarpa M, 2014, WORLD J GASTROENTERO, V20, P6774, DOI 10.3748/wjg.v20.i22.6774; Scott FI, 2015, CLIN GASTROENTEROL H, V13; Siegel CA, 2009, CLIN GASTROENTEROL H, V7, P874, DOI 10.1016/j.cgh.2009.01.004; Singh S, 2014, CLIN GASTROENTEROL H, V12, P210, DOI 10.1016/j.cgh.2013.04.033; Singh S, 2013, CLIN GASTROENTEROL H, V11, P898, DOI 10.1016/j.cgh.2013.02.016; Slesser AAP, 2013, SURG ONCOL, V22, P230, DOI 10.1016/j.suronc.2013.08.002; Sokol H, 2012, INFLAMM BOWEL DIS, V18, P2063, DOI 10.1002/ibd.22889; Svrcek M, 2014, INFLAMM BOWEL DIS, V20, P1584, DOI 10.1097/MIB.0000000000000112; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Van Assche G, 2013, J CROHNS COLITIS, V7, P1, DOI 10.1016/j.crohns.2012.09.005; van Schaik FDM, 2012, GUT, V61, P235, DOI 10.1136/gut.2011.237412; Velayos FS, 2005, AM J GASTROENTEROL, V100, P1345, DOI 10.1111/j.1572-0241.2005.41442.x; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wanders LK, 2014, CLIN GASTROENTEROL H, V12, P756, DOI 10.1016/j.cgh.2013.07.024; Weber NK, 2014, ABDOM IMAGING; Wong NACS, 2003, J PATHOL, V201, P312, DOI 10.1002/path.1442; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	75	330	338	5	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2015	372	15					1441	1452		10.1056/NEJMra1403718	http://dx.doi.org/10.1056/NEJMra1403718			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF2ZV	25853748				2022-12-28	WOS:000352417900008
J	Lacroix, J; Hebert, PC; Fergusson, DA; Tinmouth, A; Cook, DJ; Marshall, JC; Clayton, L; McIntyre, L; Callum, J; Turgeon, AF; Blajchman, MA; Walsh, TS; Stanworth, SJ; Campbell, H; Capellier, G; Tiberghien, P; Bardiaux, L; van de Watering, L; van der Meer, NJ; Sabri, E; Vo, D				Lacroix, Jacques; Hebert, Paul C.; Fergusson, Dean A.; Tinmouth, Alan; Cook, Deborah J.; Marshall, John C.; Clayton, Lucy; McIntyre, Lauralyn; Callum, Jeannie; Turgeon, Alexis F.; Blajchman, Morris A.; Walsh, Timothy S.; Stanworth, Simon J.; Campbell, Helen; Capellier, Gilles; Tiberghien, Pierre; Bardiaux, Laurent; van de Watering, Leo; van der Meer, Nardo J.; Sabri, Elham; Vo, Dong		ABLE Investigators; Canadian Critical Care Trials Grp	Age of Transfused Blood in Critically Ill Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RED-CELL STORAGE; ORGAN DYSFUNCTION SCORE; IN-HOSPITAL MORTALITY; FEASIBILITY TRIAL; DURATION; OUTCOMES; TIME; CARE	Background Fresh red cells may improve outcomes in critically ill patients by enhancing oxygen delivery while minimizing the risks of toxic effects from cellular changes and the accumulation of bioactive materials in blood components during prolonged storage. Methods In this multicenter, randomized, blinded trial, we assigned critically ill adults to receive either red cells that had been stored for less than 8 days or standard-issue red cells (the oldest compatible units available in the blood bank). The primary outcome measure was 90-day mortality. Results Between March 2009 and May 2014, at 64 centers in Canada and Europe, 1211 patients were assigned to receive fresh red cells (fresh-blood group) and 1219 patients were assigned to receive standard-issue red cells (standard-blood group). Red cells were stored a mean (+/- SD) of 6.1 +/- 4.9 days in the fresh-blood group as compared with 22.0 +/- 8.4 days in the standard-blood group (P< 0.001). At 90 days, 448 patients (37.0%) in the fresh-blood group and 430 patients (35.3%) in the standard-blood group had died (absolute risk difference, 1.7 percentage points; 95% confidence interval [CI], -2.1 to 5.5). In the survival analysis, the hazard ratio for death in the fresh-blood group, as compared with the standard-blood group, was 1.1 (95% CI, 0.9 to 1.2; P = 0.38). There were no significant between-group differences in any of the secondary outcomes (major illnesses; duration of respiratory, hemodynamic, or renal support; length of stay in the hospital; and transfusion reactions) or in the subgroup analyses. Conclusions Transfusion of fresh red cells, as compared with standard-issue red cells, did not decrease the 90-day mortality among critically ill adults.	[Lacroix, Jacques; Clayton, Lucy] Univ Montreal, Ctr Hosp Univ CHU St Justine, Montreal, PQ H3C 3J7, Canada; [Hebert, Paul C.] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ H2X 0A9, Canada; [Fergusson, Dean A.; Tinmouth, Alan; McIntyre, Lauralyn; Sabri, Elham; Vo, Dong] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Cook, Deborah J.; Blajchman, Morris A.] McMaster Univ, Hamilton, ON, Canada; [Marshall, John C.; Callum, Jeannie] Univ Toronto, Toronto, ON, Canada; [Turgeon, Alexis F.] Univ Laval, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada; [Walsh, Timothy S.] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; [Stanworth, Simon J.; Campbell, Helen] Univ Oxford, NHS Blood & Transplant Oxford Univ Hosp NHS Trust, Oxford OX1 2JD, England; [Capellier, Gilles; Tiberghien, Pierre] Univ Franche Comte, F-25030 Besancon, France; [Tiberghien, Pierre; Bardiaux, Laurent] Etab Francais Sang, La Plaine St Denis, France; [van de Watering, Leo] Sanquin Blood Supply, Amsterdam, Netherlands; [van der Meer, Nardo J.] Amphia Hosp, Breda, Netherlands; [van der Meer, Nardo J.] Amphia Hosp, Oosterhout, Netherlands; [van der Meer, Nardo J.] Tilburg Univ, TIAS Sch Business & Soc, NL-5000 LE Tilburg, Netherlands	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; University of Ottawa; Ottawa Hospital Research Institute; McMaster University; University of Toronto; Laval University; University of Edinburgh; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Universite de Franche-Comte; Amphia Hospital; Amphia Hospital; Tilburg University	Hebert, PC (corresponding author), Ctr Hosp Univ Montreal, Ctr Rech, 900 St Denis St, Montreal, PQ H2X 0A9, Canada.	paul.hebert.chum@ssss.gouv.qc.ca	Chin-Yee, Ian/G-3286-2011; Tiberghien, Pierre/AAH-5878-2019; Mehta, Sangeeta/C-4623-2015; Martin, Claudio/G-3327-2011; McIntyre, Lauralyn/AAR-7710-2021; Sabri, Elham/GXG-8198-2022; Young, John D/M-9756-2016	McIntyre, Lauralyn/0000-0001-7421-1407; Binda, Delphine/0000-0002-8052-4730; QUENOT, Jean-Pierre/0000-0003-2351-682X; Tiberghien, Pierre/0000-0002-9310-8322; Fergusson, Dean/0000-0002-3389-2485	Canadian Institutes of Health Research; MRC [G0800803] Funding Source: UKRI; Medical Research Council [G0800803] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by the Canadian Institutes of Health Research and others; Current Controlled Trials number, ISRCTN44878718.	Antonelou MH, 2010, TRANSFUSION, V50, P376, DOI 10.1111/j.1537-2995.2009.02449.x; Aubron C, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-2; Aubron C, 2012, TRANSFUSION, V52, P1196, DOI 10.1111/j.1537-2995.2011.03437.x; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Bennett-Guerrero E, 2009, TRANSFUSION, V49, P1375, DOI 10.1111/j.1537-2995.2009.02152.x; Fergusson DA, 2012, JAMA-J AM MED ASSOC, V308, P1443, DOI 10.1001/2012.jama.11953; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 2005, ANESTH ANALG, V100, P1433, DOI 10.1213/01.ANE.0000148690.48803.27; Heddle NM, 2015, TRANSFUSION, V55, P364, DOI 10.1111/trf.12861; Heddle NM, 2012, TRANSFUSION, V52, P1203, DOI 10.1111/j.1537-2995.2011.03521.x; Hess JR, 2010, TRANSFUS APHER SCI, V43, P51, DOI 10.1016/j.transci.2010.05.009; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Kaukonen KM, 2013, CRIT CARE, V17, DOI 10.1186/cc13045; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kor DJ, 2012, AM J RESP CRIT CARE, V185, P842, DOI 10.1164/rccm.201107-1332OC; LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Lacroix J, 2011, TRANSFUS MED REV, V25, P197, DOI 10.1016/j.tmrv.2011.03.001; Lelubre C, 2013, CRIT CARE, V17, DOI 10.1186/cc12600; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Middelburg RA, 2013, TRANSFUS MED REV, V27, P36, DOI 10.1016/j.tmrv.2012.06.002; Spinella PC, 2011, TRANSFUSION, V51, P894, DOI 10.1111/j.1537-2995.2011.03103.x; Steiner ME, 2014, TRANSFUSION, V54, p15A; Steiner ME, 2010, TRANSFUS APHER SCI, V43, P107, DOI 10.1016/j.transci.2010.05.014; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Vamvakas EC, 2010, TRANSFUSION, V50, P600, DOI 10.1111/j.1537-2995.2009.02465.x; van de Watering L, 2011, VOX SANG, V100, P36, DOI 10.1111/j.1423-0410.2010.01441.x; van de Watering L, 2011, TRANSFUSION, V51, P1847, DOI 10.1111/j.1537-2995.2010.03015.x; Walsh TS, 2004, CRIT CARE MED, V32, P364, DOI 10.1097/01.CCM.0000108878.23703.E0; Wang D, 2012, TRANSFUSION, V52, P1184, DOI 10.1111/j.1537-2995.2011.03466.x; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	32	388	398	2	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2015	372	15					1410	1418		10.1056/NEJMoa1500704	http://dx.doi.org/10.1056/NEJMoa1500704			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF2ZV	25853745	Green Published			2022-12-28	WOS:000352417900005
J	Yin, J; Boyce, MC				Yin, Jie; Boyce, Mary C.			MATERIALS SCIENCE Unique wrinkles as identity tags	NATURE			English	Editorial Material							SOFT MATTER	Spontaneously generated, random wrinkles of coatings on microscale particles have been found to be analogous to fingerprints - unique patterns with a wavy topography that can serve as unclonable tags for anti-counterfeiting purposes.	[Yin, Jie] Temple Univ, Dept Mech Engn, Philadelphia, PA 19122 USA; [Yin, Jie] Temple Univ, Temple Mat Inst, Philadelphia, PA 19122 USA; [Boyce, Mary C.] Columbia Univ, Fu Fdn Sch Engn & Appl Sci, New York, NY 10027 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Columbia University	Yin, J (corresponding author), Temple Univ, Dept Mech Engn, Philadelphia, PA 19122 USA.	jieyin@temple.edu; boyce@columbia.edu	Yin, Jie/C-5976-2008	Yin, Jie/0000-0002-6297-1262				Bae H. J., 2015, ADV MAT; Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; Cao GX, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.036102; Chung JY, 2011, ADV MATER, V23, P349, DOI 10.1002/adma.201001759; DeRisi V, 2007, SCI NETW HIST STUD, V33, P1, DOI 10.1007/978-3-7643-7986-5; Genzer J, 2006, SOFT MATTER, V2, P310, DOI 10.1039/b516741h; Kim JB, 2012, NAT PHOTONICS, V6, P327, DOI [10.1038/NPHOTON.2012.70, 10.1038/nphoton.2012.70]; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Timoshenko SP, 1961, THEORY ELASTIC STABI; Yang S, 2010, ADV FUNCT MATER, V20, P2550, DOI 10.1002/adfm.201000034	10	27	27	4	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					164	165		10.1038/nature14380	http://dx.doi.org/10.1038/nature14380			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25830887				2022-12-28	WOS:000352454600024
J	Akl, EA; Kahale, LA; Schunemann, HJ				Akl, Elie A.; Kahale, Lara A.; Schuenemann, Holger J.			Association Between Perioperative Low-Molecular-Weight Heparin vs Unfractionated Heparin and Clinical Outcomes in Patients With Cancer Undergoing Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VENOUS THROMBOEMBOLISM	Clinical Question In patients with cancer undergoing surgery, what is the association between perioperative thromboprophylaxis with low-molecular-weight heparin (LMWH) or unfractionated heparin and mortality, pulmonary embolism, deep venous thrombosis, thrombocytopenia, and bleeding outcomes? Bottom Line When used for perioperative thromboprophylaxis, there are no differences in the association of LMWH vs unfractionated heparin for preventing mortality, pulmonary embolism, deep venous thrombosis, bleeding outcomes, or thrombocytopenia in patients with cancer.	[Akl, Elie A.; Kahale, Lara A.] Amer Univ Beirut, Dept Internal Med, Clin Res Inst, Beirut, Lebanon; [Akl, Elie A.; Schuenemann, Holger J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 4K1, Canada; [Schuenemann, Holger J.] McMaster Univ, Dept Med, Hamilton, ON L8N 4K1, Canada	American University of Beirut; McMaster University; McMaster University	Schunemann, HJ (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, 1280 Main St W,Room 2C16, Hamilton, ON L8N 4K1, Canada.	schuneh@mcmaster.ca	Akl, Elie/K-5269-2019; Akl, Elie A/R-2079-2016	Akl, Elie A/0000-0002-3444-8618; Kahale, Lara/0000-0003-4466-0556; Schunemann, Holger/0000-0003-3211-8479	National Institute for Health Research (NIHR)	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Gynaecological Cancer Group.	Akl EA, 2014, COCHRANE DB SYST REV, V6; Einstein MH, 2007, GYNECOL ONCOL, V105, P813, DOI 10.1016/j.ygyno.2007.03.004; Gould MK, 2012, CHEST S, V141, pe2275; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Kakkar AK, 2005, THROMB HAEMOSTASIS, V94, P867, DOI 10.1160/TH04-03-0189; Lyman GH, 2013, J CLIN ONCOL, V31, P2189, DOI 10.1200/JCO.2013.49.1118; Mansour BA, 2013, J SHAHREKORD U MED S, V15, P22; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504	9	3	3	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2015	313	13					1364	1365		10.1001/jama.2015.498	http://dx.doi.org/10.1001/jama.2015.498			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF1OL	25849181				2022-12-28	WOS:000352315900023
J	Schmiedel, JM; Klemm, SL; Zheng, YN; Sahay, A; Bluthgen, N; Marks, DS; van Oudenaarden, A				Schmiedel, Joern M.; Klemm, Sandy L.; Zheng, Yannan; Sahay, Apratim; Bluethgen, Nils; Marks, Debora S.; van Oudenaarden, Alexander			MicroRNA control of protein expression noise	SCIENCE			English	Article							MAMMALIAN MICRORNAS; GENE-EXPRESSION; ENCODES; IMPACT	MicroRNAs (miRNAs) repress the expression of many genes in metazoans by accelerating messenger RNA degradation and inhibiting translation, thereby reducing the level of protein. However, miRNAs only slightly reduce the mean expression of most targeted proteins, leading to speculation about their role in the variability, or noise, of protein expression. We used mathematical modeling and single-cell reporter assays to show that miRNAs, in conjunction with increased transcription, decrease protein expression noise for lowly expressed genes but increase noise for highly expressed genes. Genes that are regulated by multiple miRNAs show more-pronounced noise reduction. We estimate that hundreds of (lowly expressed) genes in mouse embryonic stem cells have reduced noise due to substantial miRNA regulation. Our findings suggest that miRNAs confer precision to protein expression and thus offer plausible explanations for the commonly observed combinatorial targeting of endogenous genes by multiple miRNAs, as well as the preferential targeting of lowly expressed genes.	[Schmiedel, Joern M.; Bluethgen, Nils] Humboldt Univ, Integrat Res Inst Life Sci, D-10115 Berlin, Germany; [Schmiedel, Joern M.; Bluethgen, Nils] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; [Schmiedel, Joern M.; Bluethgen, Nils] Charite, Inst Pathol, D-10117 Berlin, Germany; [Schmiedel, Joern M.; Zheng, Yannan; Sahay, Apratim; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Klemm, Sandy L.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Marks, Debora S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Humboldt University of Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Bluthgen, N (corresponding author), Humboldt Univ, Integrat Res Inst Life Sci, D-10115 Berlin, Germany.	nils.bluethgen@charite.de; debbie@hms.harvard.edu; a.vanoudenaarden@hubrecht.eu	Schmiedel, Jörn/K-6833-2017; Bluthgen, Nils/A-1711-2011; van Oudenaarden, Alexander/AAA-1705-2019	Schmiedel, Jörn/0000-0002-6842-9837; Bluthgen, Nils/0000-0002-0171-7447; 	European Molecular Biology Organization; Koch Institute for Integrative Cancer Research; Deutsche Forschungsgemeinschaft [GK1772, SPP1395]; Bundesministerium fur Bildung und Forschung (FORSYS) [BCCN A5]; Harvard Medical School institutional support; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); European Research Council [ERC-AdG 294325-GeneNoiseControl]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Koch Institute for Integrative Cancer Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (FORSYS)(Federal Ministry of Education & Research (BMBF)); Harvard Medical School institutional support; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	We thank M. Ebert, S. Mukherji, D. Moojiman, L. Kester, D. Grun, M. Muraro, and R. Ward for discussions and help; the Boyer lab for mESC line V19; the Cuppen lab for sequencing; and S. van der Elst for help with FACS. Support was provided by the European Molecular Biology Organization (Short-Term Fellowship, J.M.S.), the Koch Institute for Integrative Cancer Research (Graduate Fellowship, S.L.K.), the Deutsche Forschungsgemeinschaft (GK1772, SPP1395, N.B.), the Bundesministerium fur Bildung und Forschung (FORSYS, BCCN A5, N.B.), Harvard Medical School institutional support (D.S.M.), the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) (Vici award, A.v.O.), and the European Research Council (grant ERC-AdG 294325-GeneNoiseControl, A.v.O.).	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Enright AJ, 2004, GENOME BIOL, V5; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Noorbakhsh J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072676; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	29	239	252	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					128	132		10.1126/science.aaa1738	http://dx.doi.org/10.1126/science.aaa1738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838385				2022-12-28	WOS:000352079500042
J	Mariner, WK; Annas, GJ				Mariner, Wendy K.; Annas, George J.			Informed Consent and the First Amendment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mariner, Wendy K.; Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Mariner, WK (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.								0	3	3	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14					1285	1287		10.1056/NEJMp1501190	http://dx.doi.org/10.1056/NEJMp1501190			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CE7NL	25830420	Green Published			2022-12-28	WOS:000352028500002
J	Sharma, G; Askari, R				Sharma, Gaurav; Askari, Reza			Transdiaphragmatic Intercostal Herniation of the Gallbladder	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sharma, Gaurav; Askari, Reza] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Sharma, G (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	gsharma1@partners.org							0	1	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14							e19	10.1056/NEJMicm1406566	http://dx.doi.org/10.1056/NEJMicm1406566			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NL	25830442				2022-12-28	WOS:000352028500012
J	Bourzac, K				Bourzac, Katherine			SPIDERS Web of intrigue	NATURE			English	Editorial Material							SILK											Andersson M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001921; Gregoric M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026847; Kronqvist N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4254; Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401; Tao H, 2014, P NATL ACAD SCI USA, V111, P17385, DOI 10.1073/pnas.1407743111; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120	6	23	24	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S4	S6		10.1038/519S4a	http://dx.doi.org/10.1038/519S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25806496	Bronze			2022-12-28	WOS:000351602800001
J	Smalldridge, A				Smalldridge, Ann			IF I RULED THE NHS Allow GPs and consultants to speak to each other again	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Locum GP, London, England		Smalldridge, A (corresponding author), Locum GP, London, England.	annsmalldridge@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2015	350									10.1136/bmj.h1623	http://dx.doi.org/10.1136/bmj.h1623			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7OC	25813648				2022-12-28	WOS:000352030200010
J	Soper, AK				Soper, Alan K.			PHYSICAL CHEMISTRY Square ice in a graphene sandwich	NATURE			English	Editorial Material							TOLMAN LENGTH; WATER		Rutherford Appleton Lab, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Soper, AK (corresponding author), Rutherford Appleton Lab, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England.	alan.soper@stfc.ac.uk		Soper, Alan/0000-0002-7903-8356				Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; Algara-Siller G, 2015, NATURE, V519, P443, DOI 10.1038/nature14295; Gruenloh CJ, 1997, SCIENCE, V276, P1678, DOI 10.1126/science.276.5319.1678; Keutsch FN, 2001, P NATL ACAD SCI USA, V98, P10533, DOI 10.1073/pnas.191266498; Kolesnikov AI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035503; Lei YA, 2005, J AM CHEM SOC, V127, P15346, DOI 10.1021/ja054297i; London F., 1937, T FARADAY SOC, V33, p8b, DOI [10.1039/tf937330008b, DOI 10.1039/TF937330008B]; Perera PN, 2009, P NATL ACAD SCI USA, V106, P12230, DOI 10.1073/pnas.0903675106; Petrenko VF, 1999, PHYS ICE; Rowlinson J. S., 1982, INT SER MONOGR CHEM; Xue YQ, 2011, J PHYS CHEM B, V115, P109, DOI 10.1021/jp1084313	11	6	6	2	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					417	418		10.1038/519417a	http://dx.doi.org/10.1038/519417a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25810198				2022-12-28	WOS:000351602800040
J	Spence, C				Spence, Charles			Multisensory Flavor Perception	CELL			English	Review							RETRONASAL OLFACTORY STIMULI; CROSSMODAL CORRESPONDENCES; PERCEIVED CRISPNESS; SUBTHRESHOLD TASTE; COLOR CUES; FOOD; INTEGRATION; ORTHONASAL; ILLUSION; TEXTURE	The perception of flavor is perhaps the most multisensory of our everyday experiences. The latest research by psychologists and cognitive neuroscientists increasingly reveals the complex multisensory interactions that give rise to the flavor experiences we all know and love, demonstrating how they rely on the integration of cues from all of the human senses. This Perspective explores the contributions of distinct senses to our perception of food and the growing realization that the same rules of multisensory integration that have been thoroughly explored in interactions between audition, vision, and touch may also explain the combination of the (admittedly harder to study) flavor senses. Academic advances are now spilling out into the real world, with chefs and food industry increasingly taking the latest scientific findings on board in their food design.	Univ Oxford, Dept Expt Psychol, Crossmodal Res Lab, Oxford OX1 3UD, England	University of Oxford	Spence, C (corresponding author), Univ Oxford, Dept Expt Psychol, Crossmodal Res Lab, S Parks Rd, Oxford OX1 3UD, England.	charles.spence@psy.ox.ac.uk			AHRC Rethinking [AH/L007053/1]; Arts and Humanities Research Council [AH/L007053/1] Funding Source: researchfish; AHRC [AH/L007053/1] Funding Source: UKRI	AHRC Rethinking(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	The author would like to acknowledge the AHRC Rethinking the Senses grant (AH/L007053/1).	[Anonymous], 2010, WORLD FINE WINE; Barnett-Cowan M, 2010, PERCEPTION, V39, P1684, DOI 10.1068/p6784; Barros-Loscertales A, 2012, CEREB CORTEX, V22, P2554, DOI 10.1093/cercor/bhr324; Bartoshuk LM, 2000, CHEM SENSES, V25, P447, DOI 10.1093/chemse/25.4.447; Blumenthal H., 2008, BIG FAT DUCK COOKBOO; Bremner A. J., 2012, MULTISENSORY DEV; Breslin PAS, 2001, CHEM SENSES, V26, P105, DOI 10.1093/chemse/26.2.105; Bult JHF, 2007, NEUROSCI LETT, V411, P6, DOI 10.1016/j.neulet.2006.09.036; Calvert G., 2004, HDB MULTISENSORY PRO; Chartier F., 2012, TASTE BUDS MOL ART S; Dalton P, 2000, NAT NEUROSCI, V3, P431, DOI 10.1038/74797; de Araujo IE, 2004, J NEUROSCI, V24, P3086, DOI 10.1523/JNEUROSCI.0130-04.2004; de Araujo IET, 2003, EUR J NEUROSCI, V18, P2059, DOI 10.1046/j.1460-9568.2003.02915.x; De Graaf C, 1997, APPETITE, V29, P305, DOI 10.1006/appe.1997.0097; Delwiche J., 2005, J SENS STUD, V20, P137, DOI DOI 10.1111/J.1745-459X.2005.00047.X; Dematte ML, 2014, FOOD QUAL PREFER, V38, P58, DOI 10.1016/j.foodqual.2014.05.009; Deroy O., 2014, FLAVOUR, V3, P6, DOI DOI 10.1186/2044-7248-3-6; Eldeghaidy S, 2011, J NEUROPHYSIOL, V105, P2572, DOI 10.1152/jn.00927.2010; Garneau NL, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00033; Grabenhorst F, 2008, CEREB CORTEX, V18, P1549, DOI 10.1093/cercor/bhm185; Guest S, 2002, EXP BRAIN RES, V146, P161, DOI 10.1007/s00221-002-1164-z; Harrar V, 2011, EXP BRAIN RES, V214, P351, DOI 10.1007/s00221-011-2833-6; Hayes JE, 2012, AM J ENOL VITICULT, V63, P80, DOI 10.5344/ajev.2011.11050; Jousmaki V, 1998, CURR BIOL, V8, pR190, DOI 10.1016/S0960-9822(98)70120-4; Knoferle K, 2012, PSYCHON B REV, V19, P992, DOI 10.3758/s13423-012-0321-z; Knoeferle KM, 2015, PSYCHOL MARKET, V32, P107, DOI 10.1002/mar.20766; Koza BJ, 2005, CHEM SENSES, V30, P643, DOI 10.1093/chemse/bji057; Lyman B., 1989, PSYCHOL FOOD MORE MA, P139; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Michel C., 2014, FLAVOUR, V3, P7; Michel C, 2015, APPETITE, V90, P45, DOI 10.1016/j.appet.2015.02.030; Michel C, 2014, PERCEPTION, V43, P818, DOI 10.1068/p7733; Moir HC, 1936, J CHEM TECHNOL BIOT, V55, P145, DOI [DOI 10.1002/JCTB.5000550803, 10.1002/jctb.5000550803]; Morrot G, 2001, BRAIN LANG, V79, P309, DOI 10.1006/brln.2001.2493; MURPHY C, 1977, SENS PROCESS, V1, P204; Oberfeld D, 2009, J SENS STUD, V24, P797, DOI 10.1111/j.1745-459X.2009.00239.x; Osterbauer RA, 2005, J NEUROPHYSIOL, V93, P3434, DOI 10.1152/jn.00555.2004; Parr W. V., 2003, Journal of Wine Research, V14, P79, DOI 10.1080/09571260410001677969; Pfeiffer JC, 2005, CHEM SENSES, V30, P539, DOI 10.1093/chemse/bji047; Piqueras-Fiszman B, 2015, FOOD QUAL PREFER, V40, P165, DOI 10.1016/j.foodqual.2014.09.013; Piqueras-Fiszman B, 2012, J SENS STUD, V27, P324, DOI 10.1111/j.1745-459X.2012.00397.x; Piqueras-Fiszman B, 2012, APPETITE, V58, P559, DOI 10.1016/j.appet.2011.12.021; Piqueras-Fiszman B, 2012, FOOD QUAL PREFER, V24, P205, DOI 10.1016/j.foodqual.2011.08.011; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Roudnitzky N, 2011, BEHAV BRAIN RES, V216, P109, DOI 10.1016/j.bbr.2010.07.019; ROZIN P, 1982, PERCEPT PSYCHOPHYS, V31, P397, DOI 10.3758/BF03202667; Schaal B, 2000, CHEM SENSES, V25, P729, DOI 10.1093/chemse/25.6.729; Shankar M, 2010, ATTEN PERCEPT PSYCHO, V72, P1981, DOI 10.3758/APP.72.7.1981; Shepherd G.M., 2012, NEUROGASTRONOMY BRAI; Small DM, 2008, NEURON, V57, P786, DOI 10.1016/j.neuron.2008.01.021; Small DM, 2012, PHYSIOL BEHAV, V107, P540, DOI 10.1016/j.physbeh.2012.04.011; Small DM, 2005, NEURON, V47, P593, DOI 10.1016/j.neuron.2005.07.022; Small DM, 2004, J NEUROPHYSIOL, V92, P1892, DOI 10.1152/jn.00050.2004; Spence C., 2012, Food oral processing: fundamentals of eating and sensory perception, P203; Spence C., 2015, PERCEPTION ITS MODAL, P247; Spence C., 2015, FLAVOUR, V4, p1, DOI [10.1186/2044-7248-4-3, DOI 10.1186/2044-7248-4-3]; Spence C., 2014, PERFECT MEAL MULTISE; Spence C., 2014, FLAVOUR, V3, P4, DOI DOI 10.1186/2044-7248-3-4; Spence C., 2013, FLAVOUR, V2, P1, DOI [10.1186/2044-7248-2-21., DOI 10.1186/2044-7248-2-21]; Spence C., 2014, FLAVOUR, V3, P1, DOI [10.1186/2044-7248-3-8, DOI 10.1186/2044-7248-3-8]; Spence C., 2014, FLAVOUR, DOI [10.1186/2044-7248-3-9, DOI 10.1186/2044-7248-3-9]; Spence C, 2010, CHEMOSENS PERCEPT, V3, P68, DOI 10.1007/s12078-010-9067-z; Stein B.E., 2012, NEW HDB MULTISENSORY; STEVENS JC, 1991, APPETITE, V16, P129, DOI 10.1016/0195-6663(91)90038-T; Stevenson R., 2004, HDB MULTISENSORY PRO, P69; Stevenson R. J., 2009, PSYCHOL FLAVOUR; Stevenson R. J., 2012, PSYCHOL BULL, V140, P487; Stevenson RJ, 2007, PSYCHOL BULL, V133, P294, DOI 10.1037/0033-2909.133.2.294; Stewart P.C., 2013, FLAVOUR, V2, P1, DOI DOI 10.1186/2044-7248-2-27; Stuckey B., 2012, TASTE WHAT YOURE MIS; TODRANK J, 1991, PHYSIOL BEHAV, V50, P1027, DOI 10.1016/0031-9384(91)90432-N; Toepel U, 2009, NEUROIMAGE, V44, P967, DOI 10.1016/j.neuroimage.2008.10.005; Triplett T., 1994, MARKETING NEWS, V28, P1; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Velasco C., 2013, FLAVOUR, P1, DOI [DOI 10.1186/2044-7248-2-23, 10.1186/2044-7248-2-23]; Velasco C, 2015, FOOD QUAL PREFER, V41, P151, DOI 10.1016/j.foodqual.2014.11.010; Wan X., 2014, FLAVOUR, V3, P3, DOI DOI 10.1186/2044-7248-3-3; Wan XA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01365; Yeomans MR, 2008, FOOD QUAL PREFER, V19, P565, DOI 10.1016/j.foodqual.2008.02.009; Young J. Z., 1968, BIOL MOUTH, P21; Zampini M, 2005, FOOD QUAL PREFER, V16, P632, DOI 10.1016/j.foodqual.2004.11.004; Zampini M, 2004, J SENS STUD, V19, P347, DOI 10.1111/j.1745-459x.2004.080403.x; Zampini M, 2008, FOOD QUAL PREFER, V19, P335, DOI 10.1016/j.foodqual.2007.11.001; Zampini M, 2007, FOOD QUAL PREFER, V18, P975, DOI 10.1016/j.foodqual.2007.04.001; Zellner DA, 2004, AM J PSYCHOL, V117, P363, DOI 10.2307/4149006; Zellner DA, 2014, APPETITE, V77, P31, DOI 10.1016/j.appet.2014.02.009	87	209	218	10	106	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					24	35		10.1016/j.cell.2015.03.007	http://dx.doi.org/10.1016/j.cell.2015.03.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815982	Bronze			2022-12-28	WOS:000351952200005
J	Weaver, SC; Lecuit, M				Weaver, Scott C.; Lecuit, Marc			Chikungunya Virus and the Global Spread of a Mosquito-Borne Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INDIAN-OCEAN; AEDES-ALBOPICTUS; REUNION ISLAND; YELLOW-FEVER; LA REUNION; INFECTION; DENGUE; EMERGENCE; OUTBREAK; TRANSMISSION		[Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Weaver, Scott C.; Lecuit, Marc] Global Virus Network, Baltimore, MD USA; [Lecuit, Marc] Paris Descartes Univ, Sorbonne Paris Cite, Biol Infect Unit, Paris, France; [Lecuit, Marc] Paris Descartes Univ, Sorbonne Paris Cite, INSERM, U1117,Inst Pasteur,Inst Imagine, Paris, France; [Lecuit, Marc] Necker Enfants Malad Univ Hosp, Div Infect Dis & Trop Med, Paris, France	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77555 USA.	sweaver@utmb.edu; marc.lecuit@pasteur.fr	Lecuit, Marc/M-4126-2019; Lecuit, Marc/J-4073-2013; Weaver, Scott C/D-6490-2011	Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063; Weaver, Scott C/0000-0001-8016-8556				Lorono-Pino MA, 2013, AM J TROP MED HYG, V89, P385, DOI 10.4269/ajtmh.12-0772; Briolant S, 2004, ANTIVIR RES, V61, P111, DOI 10.1016/j.antiviral.2003.09.005; Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x; Capeding MR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002331; CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243; Chang LJ, 2014, LANCET, V384, P2046, DOI 10.1016/S0140-6736(14)61185-5; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381; Delang L, 2014, J ANTIMICROB CHEMOTH, V69, P2770, DOI 10.1093/jac/dku209; Demanou Maurice, 2010, BMC Res Notes, V3, P128, DOI 10.1186/1756-0500-3-128; Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281; Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601; Ganu Mohini A, 2011, J Assoc Physicians India, V59, P83; Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060; Javelle E, 2014, J CLIN VIROL, V59, P270, DOI 10.1016/j.jcv.2014.01.011; Jupp PG, 1996, S AFR MED J, V86, P35; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; Leisnham PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091655; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x; Nhan TX, 2014, EMERG INFECT DIS, V20, P1773, DOI 10.3201/eid2010.141060; Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; ROSS R. W., 1956, JOUR HYG, V54, P177; Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403; Sang RC, 2008, AM J TROP MED HYG, V78, P77; Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Staikowsky F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007603; Stapleford KA, 2014, CELL HOST MICROBE, V15, P706, DOI 10.1016/j.chom.2014.05.008; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64; Teo TH, 2012, IMMUNOL RES, V53, P136, DOI 10.1007/s12026-012-8266-x; Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108; van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/ERV.12.84, 10.1586/erv.12.84]; WEINBREN M P, 1958, Trans R Soc Trop Med Hyg, V52, P258; Zhang R, 2011, EMBO J, V30, P3854, DOI 10.1038/emboj.2011.261	53	489	504	6	135	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2015	372	13					1231	1239		10.1056/NEJMra1406035	http://dx.doi.org/10.1056/NEJMra1406035			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1QD	25806915				2022-12-28	WOS:000351585900009
J	Doshi, P				Doshi, Peter			ANTIBIOTICS Speeding new antibiotics to market: a fake fix?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESISTANT STAPHYLOCOCCUS-AUREUS; DOUBLE-BLIND; TIGECYCLINE					pdoshi@bmj.com			UK National Institute for Health Research; American Association of Colleges of Pharmacy	UK National Institute for Health Research(National Institute for Health Research (NIHR)); American Association of Colleges of Pharmacy	I have read and understood BMJ policy on declaration of interests and declare I know and consider some of the people interviewed in this article as colleagues. I was a corecipient of a UK National Institute for Health Research grant (for the HTA Update and amalgamation of two Cochrane reviews of neuraminidase inhibitors). In addition, I received support from the European Respiratory Society for travel to give a talk at the society's 2012 annual congress in Vienna. I also received a 2015 new investigator award from the American Association of Colleges of Pharmacy to fund a PhD student to work on research on how the potential harms of statins are conveyed in drug labeling and pharmacy leaflets.	Bennet, 2015, HATCH REINTR PATH AC; Cerexa, 2014, INTR CEFT AV CAZ AV; Davies SC, 2013, LANCET, V381, P1606, DOI 10.1016/S0140-6736(13)60604-2; Davies SC, 2013, ANNUAL REPORT CHIEF; Duong M, 2010, ANN EMERG MED, V55, P401, DOI 10.1016/j.annemergmed.2009.03.014; Florescu I, 2008, J ANTIMICROB CHEMOTH, V62, pI17, DOI 10.1093/jac/dkn250; Food and Drug Administration, 2010, GUID IND NON CLIN TR; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Janssen Therapeutics, 2014, PRESCR INF SIRT BED; Komo S, 2012, ANTIINFECTIVE DRUGS; Murray BE, 2014, WRITTEN STATEMENT BA; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Obama B, 2014, COMBATING ANTIBIOTIC; Podolsky SH, 2015, ANTIBIOTIC ERA: REFORM, RESISTANCE, AND THE PURSUIT OF A RATIONAL THERAPEUTICS, P1; Prasad P, 2012, CLIN INFECT DIS, V54, P1699, DOI 10.1093/cid/cis270; Rajendran PM, 2007, ANTIMICROB AGENTS CH, V51, P4044, DOI 10.1128/AAC.00377-07; Schmitz GR, 2010, ANN EMERG MED, V56, P283, DOI 10.1016/j.annemergmed.2010.03.002; Sherman RE, 2013, NEW ENGL J MED, V369, P1877, DOI 10.1056/NEJMp1311439; Theravance, 2013, PRESCR INF VIB TEL; US Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; US Government Accountability Office, 2010, GAO 10 798 NEW DRUG; Walsh F, 2014, BBC NEWS; Woodcock J., 2014, 21 CENTURY CURES EXA; World Health Organization, ANT RES GLOB REP SUR; Yaw LK, 2014, LANCET INFECT DIS, V14, P967, DOI 10.1016/S1473-3099(14)70876-X	25	19	19	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2015	350								h1453	10.1136/bmj.h1453	http://dx.doi.org/10.1136/bmj.h1453			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NV	25814536				2022-12-28	WOS:000352029500001
J	Kapadia, SR; Leon, MB; Makkar, RR; Tuzcu, EM; Svensson, LG; Kodali, S; Webb, JG; Mack, MJ; Douglas, PS; Thourani, VH; Babaliaros, VC; Herrmann, HC; Szeto, WY; Pichard, AD; Williams, MR; Fontana, GP; Miller, DC; Anderson, WN; Akin, JJ; Davidson, MJ; Smith, CR				Kapadia, Samir R.; Leon, Martin B.; Makkar, Raj R.; Tuzcu, E. Murat; Svensson, Lars G.; Kodali, Susheel; Webb, John G.; Mack, Michael J.; Douglas, Pamela S.; Thourani, Vinod H.; Babaliaros, Vasilis C.; Herrmann, Howard C.; Szeto, Wilson Y.; Pichard, Augusto D.; Williams, Mathew R.; Fontana, Gregory P.; Miller, D. Craig; Anderson, William N.; Akin, Jodi J.; Davidson, Michael J.; Smith, Craig R.		PARTNER Trial Investigators	5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial	LANCET			English	Article							LONG-TERM OUTCOMES; IMPLANTATION; PREDICTORS; TAVI	Background Based on the early results of the Placement of Aortic Transcatheter Valves (PARTNER) trial, transcatheter aortic valve replacement (TAVR) is an accepted treatment for patients with severe aortic stenosis who are not suitable for surgery. However, little information is available about the late clinical outcomes in such patients. Methods We did this randomised controlled trial at 21 experienced valve centres in Canada, Germany, and the USA. We enrolled patients with severe symptomatic inoperable aortic stenosis and randomly assigned (1: 1) them to transfemoral TAVR or to standard treatment, which often included balloon aortic valvuloplasty. Patients and their treating physicians were not masked to treatment allocation. The randomisation was done centrally, and sites learned of the assignment only after a patient had been screened, consented, and entered into the database. The primary outcome of the trial was all-cause mortality at 1 year in the intention-to-treat population, here we present the prespecified findings after 5 years. This study is registered with ClinicalTrials.gov, number NCT00530894. Findings We screened 3015 patients, of whom 358 were enrolled (mean age 83 years, Society of Thoracic Surgeons Predicted Risk of Mortality 11.7%, 54% female). 179 were assigned to TAVR treatment and 179 were assigned to standard treatment. 20 patients crossed over from the standard treatment group and ten withdrew from study, leaving only six patients at 5 years, of whom five had aortic valve replacement treatment outside of the study. The risk of all-cause mortality at 5 years was 71.8% in the TAVR group versus 93.6% in the standard treatment group (hazard ratio 0.50, 95% CI 0.39-0.65; p < 00001). At 5 years, 42 (86%) of 49 survivors in the TAVR group had New York Heart Association class 1 or 2 symptoms compared with three (60%) of five in the standard treatment group. Echocardiography after TAVR showed durable haemodynamic benefit (aortic valve area 1.52 cm(2) at 5 years, mean gradient 10.6 mm Hg at 5 years), with no evidence of structural valve deterioration. Interpretation TAVR is more beneficial than standard treatment for treatment of inoperable aortic stenosis. TAVR should be strongly considered for patients who are not surgical candidates for aortic valve replacement to improve their survival and functional status. Appropriate selection of patients will help to maximise the benefit of TAVR and reduce mortality from severe comorbidities.	[Kapadia, Samir R.; Tuzcu, E. Murat; Svensson, Lars G.] Cleveland Clin, Cleveland, OH 44195 USA; [Leon, Martin B.; Kodali, Susheel; Smith, Craig R.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Makkar, Raj R.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Webb, John G.] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Mack, Michael J.] Baylor Scott & White Hlth, Plano, TX USA; [Douglas, Pamela S.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Thourani, Vinod H.; Babaliaros, Vasilis C.] Emory Univ, Sch Med, Atlanta, GA USA; [Herrmann, Howard C.; Szeto, Wilson Y.] Univ Penn, Philadelphia, PA 19104 USA; [Pichard, Augusto D.] Medstar Washington Hosp Ctr, Washington, DC USA; [Williams, Mathew R.] NYU Langone Med Ctr, New York, NY USA; [Fontana, Gregory P.] Lenox Hill Hosp, New York, NY 10021 USA; [Miller, D. Craig] Stanford Univ, Sch Med, Dept Cardiovasc Surg, Falk CV Res Ctr, Stanford, CA 94305 USA	Cleveland Clinic Foundation; Columbia University; NewYork-Presbyterian Hospital; Cedars Sinai Medical Center; St. Paul's Hospital; University of Saskatchewan; Baylor Health Care System; Duke University; Emory University; University of Pennsylvania; MedStar Washington Hospital Center; NYU Langone Medical Center; Northwell Health; Stanford University	Kapadia, SR (corresponding author), Cleveland Clin, Sones Cardiac Catheterizat Labs, 9500 Euclid Ave,J2-3, Cleveland, OH 44195 USA.	kapadis@ccf.org	thourani, vinod/AAP-5968-2020; Doğan, Ali/AAN-5331-2020	Miller, D. Craig/0000-0001-7619-0080; Williams, Mathew/0000-0003-2055-8741; Douglas, Pamela/0000-0001-9876-4049	Edwards Lifesciences	Edwards Lifesciences	Edwards Lifesciences.	BRAUNWALD E, 1990, J AM COLL CARDIOL, V15, P1018, DOI 10.1016/0735-1097(90)90235-H; Contratto AW, 1937, ANN INTERN MED, V10, P1636, DOI 10.7326/0003-4819-10-11-1636; Dewey TM, 2010, ANN THORAC SURG, V89, P758, DOI 10.1016/j.athoracsur.2009.12.033; Douglas PS, 2013, J AM SOC ECHOCARDIOG, V26, P348, DOI 10.1016/j.echo.2013.01.013; Genereux P, 2012, J AM COLL CARDIOL, V60, P1043, DOI 10.1016/j.jacc.2012.07.003; Green P, 2012, JACC-CARDIOVASC INTE, V5, P974, DOI 10.1016/j.jcin.2012.06.011; Kapadia S, 2015, JACC-CARDIOVASC INTE, V8, P324, DOI 10.1016/j.jcin.2014.08.015; Kapadia SR, 2014, CIRCULATION, V130, P1483, DOI 10.1161/CIRCULATIONAHA.114.009834; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Miller DC, 2012, J THORAC CARDIOV SUR, V143, P832, DOI 10.1016/j.jtcvs.2012.01.055; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Pilgrim T, 2013, J THROMB THROMBOLYS, V35, P456, DOI 10.1007/s11239-012-0842-3; Pilgrim T, 2012, CIRC-CARDIOVASC INTE, V5, P856, DOI 10.1161/CIRCINTERVENTIONS.112.974899; Reynolds MR, 2011, CIRCULATION, V124, P1964, DOI 10.1161/CIRCULATIONAHA.111.040022; Rodes-Cabau J, 2012, NAT REV CARDIOL, V9, P15, DOI 10.1038/nrcardio.2011.164; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; ROSS J, 1968, CIRCULATION, V38, pV61, DOI 10.1161/01.CIR.38.1S5.V-61; Sarkar K, 2013, CATHETER CARDIO INTE, V81, P864, DOI 10.1002/ccd.24479; Thomas M, 2011, CIRCULATION, V124, P425, DOI 10.1161/CIRCULATIONAHA.110.001545	22	556	567	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2485	2491		10.1016/S0140-6736(15)60290-2	http://dx.doi.org/10.1016/S0140-6736(15)60290-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK9AR	25788231				2022-12-28	WOS:000356532500023
J	Li, Y; Klena, NT; Gabriel, GC; Liu, XQ; Kim, AJ; Lemke, K; Chen, Y; Chatterjee, B; Devine, W; Damerla, RR; Chang, CF; Yagi, H; San Agustin, JT; Thahir, M; Anderton, S; Lawhead, C; Vescovi, A; Pratt, H; Morgan, J; Haynes, L; Smith, CL; Eppig, JT; Reinholdt, L; Francis, R; Leatherbury, L; Ganapathiraju, MK; Tobita, K; Pazour, GJ; Lo, CW				Li, You; Klena, Nikolai T.; Gabriel, George C.; Liu, Xiaoqin; Kim, Andrew J.; Lemke, Kristi; Chen, Yu; Chatterjee, Bishwanath; Devine, William; Damerla, Rama Rao; Chang, Chienfu; Yagi, Hisato; San Agustin, Jovenal T.; Thahir, Mohamed; Anderton, Shane; Lawhead, Caroline; Vescovi, Anita; Pratt, Herbert; Morgan, Judy; Haynes, Leslie; Smith, Cynthia L.; Eppig, Janan T.; Reinholdt, Laura; Francis, Richard; Leatherbury, Linda; Ganapathiraju, Madhavi K.; Tobita, Kimimasa; Pazour, Gregory J.; Lo, Cecilia W.			Global genetic analysis in mice unveils central role for cilia in congenital heart disease	NATURE			English	Article							FETAL ECHOCARDIOGRAPHY; HETEROTAXY SYNDROME; DEFECTS; MOUSE; DIAGNOSIS; MUTATIONS; SPECTRUM; ACCURACY; PROTEIN; SCREEN	Congenital heart disease (CHD) is the most prevalent birth defect, affecting nearly 1% of live births(1); the incidence of CHD is up to tenfold higher inhumanfetuses(2,3). Agenetic contributionis strongly suggested by the association of CHD with chromosome abnormalities and high recurrence risk(4). Here we report findings from a recessive forward genetic screen in fetal mice, showing that cilia and ciliatransduced cell signalling have important roles in the pathogenesis of CHD. The cilium is an evolutionarily conserved organelle projecting from the cell surface with essential roles in diverse cellular processes. Using echocardiography, we ultrasound scanned 87,355 chemically mutagenized C57BL/6J fetal mice and recovered 218 CHD mouse models. Whole-exome sequencing identified 91 recessive CHD mutations in 61 genes. This included 34 cilia-related genes, 16 genes involved in cilia-transduced cell signalling, and 10 genes regulating vesicular trafficking, a pathway important for ciliogenesis and cell signalling. Surprisingly, many CHD genes encoded interacting proteins, suggesting that an interactome protein network may provide a larger genomic context for CHD pathogenesis. These findings provide novel insights into the potential Mendelian genetic contribution to CHD in the fetal population, a segment of the human population not well studied. We note that the pathways identified show overlap with CHD candidate genes recovered in CHD patients(5), suggesting that they may have relevance to the more complex genetics of CHD overall. These CHD mouse models and >8,000 incidental mutations have been sperm archived, creating a rich public resource for human disease modelling.	[Li, You; Klena, Nikolai T.; Gabriel, George C.; Liu, Xiaoqin; Kim, Andrew J.; Lemke, Kristi; Chen, Yu; Chatterjee, Bishwanath; Damerla, Rama Rao; Chang, Chienfu; Yagi, Hisato; Anderton, Shane; Lawhead, Caroline; Vescovi, Anita; Francis, Richard; Tobita, Kimimasa; Lo, Cecilia W.] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15201 USA; [Devine, William] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [San Agustin, Jovenal T.; Pazour, Gregory J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Thahir, Mohamed; Ganapathiraju, Madhavi K.] Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15206 USA; [Thahir, Mohamed; Ganapathiraju, Madhavi K.] Univ Pittsburgh, Sch Arts & Sci, Intelligent Syst Program, Pittsburgh, PA 16260 USA; [Pratt, Herbert; Morgan, Judy; Haynes, Leslie; Smith, Cynthia L.; Eppig, Janan T.; Reinholdt, Laura] Jackson Lab, Bar Harbor, ME 04609 USA; [Leatherbury, Linda] Childrens Natl Med Ctr, Ctr Heart, Washington, DC 20010 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Massachusetts System; University of Massachusetts Worcester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jackson Laboratory; Children's National Health System	Lo, CW (corresponding author), Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15201 USA.	cel36@pitt.edu	Smith, Cynthia/AAY-6219-2020; Smith, Cynthia L/A-5646-2009; Francis, Richard/P-2524-2015	Smith, Cynthia/0000-0003-3691-0324; Smith, Cynthia L/0000-0003-3691-0324; Francis, Richard/0000-0002-4401-1946; Kim, Andrew/0000-0002-4923-6343; Tobita, Kimimasa/0000-0001-5435-8436; Klena, Nikolai/0000-0002-2631-2294; Pazour, Gregory/0000-0002-6285-8796; Gabriel, George/0000-0003-3250-2518; Yagi, Hisato/0000-0003-1460-4043; Damerla, Rama Rao/0000-0001-6815-0097; Ganapathiraju, Madhavi/0000-0002-3825-0924; Pratt, Herb/0000-0002-4964-8292	National Heart, Lung, and Blood Institute [U01HL098180, U01HL098188]; National Institute of Mental Health [R01MH094564]; National Human Genome Research Institute [HG000330]; University of Pittsburgh School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098180, U01HL098188] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG000330, P01HG000330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094564] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); University of Pittsburgh School of Medicine(University of Pittsburgh); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank R. Ramirez for early assistance with the mutagenesis breeding pipeline, R. Subramanian and D. Farkas for early assistance with necropsy and pathology examination of mutants, A. Srinivasan for early assistance with exome sequencing, S. Fatakia for assistance with sequencing data maintenance, M. Wong and C. Krise for assistance with mouse curation, B. Beutler for advice on mapping mutations using intercrosses with the C57BL/10J strain and whole-mouse exome sequencing analysis, D. Weeks and Y. Shan for assistance in statistical modelling of target gene size estimates, E. Goldmuntz for helpful discussions and critical review of the manuscript, and the New England Research Institutes (NERI) for constructing the CHD Mouse Mutation Database. The project was supported by award numbers U01HL098180 (to C.W.L.) and U01HL098188 (to NERI) from the National Heart, Lung, and Blood Institute, R01MH094564 (to M.K.G.) from the National Institute of Mental Health, and HG000330 (to J.E.) from the National Human Genome Research Institute. Funding was also provided by the University of Pittsburgh School of Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute, the National Human Genome Research Institute or the National Institutes of Health.	Atkinson DE, 1998, AM J CARDIOL, V82, P1147, DOI 10.1016/S0002-9149(98)00574-8; Berg C, 2003, ULTRASOUND OBST GYN, V22, P451, DOI 10.1002/uog.904; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Clement CA, 2013, CELL REP, V3, P1806, DOI 10.1016/j.celrep.2013.05.020; Coghill EL, 2002, NAT GENET, V30, P255, DOI 10.1038/ng847; Damerla RR, 2014, MAMM GENOME, V25, P120, DOI 10.1007/s00335-013-9494-7; Donoso M, 2009, MOL BIOL CELL, V20, P481, DOI 10.1091/mbc.E08-08-0805; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; HOFFMAN JIE, 1995, PEDIATR CARDIOL, V16, P103, DOI 10.1007/BF00801907; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kim AJ, 2013, CIRC-CARDIOVASC IMAG, V6, P551, DOI 10.1161/CIRCIMAGING.113.000279; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Liu XQ, 2014, CIRC-CARDIOVASC IMAG, V7, P31, DOI 10.1161/CIRCIMAGING.113.000451; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Oyen N, 2009, CIRCULATION, V120, P295, DOI 10.1161/CIRCULATIONAHA.109.857987; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Shen Y, 2005, PHYSIOL GENOMICS, V24, P23, DOI 10.1152/physiolgenomics.00129.2005; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Stagner EE, 2009, BIOCHEM BIOPH RES CO, V383, P16, DOI 10.1016/j.bbrc.2009.03.113; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Taketazu M, 2006, AM J CARDIOL, V97, P720, DOI 10.1016/j.amjcard.2005.09.119; Tan SY, 2007, J CLIN INVEST, V117, P3742, DOI 10.1172/JCI33284; Tennstedt C, 1999, HEART, V82, P34, DOI 10.1136/hrt.82.1.34; Ware Stephanie M, 2011, Proc Am Thorac Soc, V8, P444, DOI 10.1513/pats.201103-025SD; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	30	257	260	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					520	U224		10.1038/nature14269	http://dx.doi.org/10.1038/nature14269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25807483	Green Accepted			2022-12-28	WOS:000355286600043
J	Nelson, CP; Hamby, SE; Saleheen, D; Hopewell, JC; Zeng, L; Assimes, TL; Kanoni, S; Willenborg, C; Burgess, S; Amouyel, P; Anand, S; Blankenberg, S; Boehm, BO; Clarke, RJ; Collins, R; Dedoussis, G; Farrall, M; Franks, PW; Groop, L; Hall, AS; Hamsten, A; Hengstenberg, C; Hovingh, GK; Ingelsson, E; Kathiresan, S; Kee, F; Konig, IR; Kooner, J; Lehtimaki, T; Marz, W; McPherson, R; Metspalu, A; Nieminen, MS; O'Donnell, CJ; Palmer, CNA; Peters, A; Perola, M; Reilly, MP; Ripatti, S; Roberts, R; Salomaa, V; Shah, SH; Schreiber, S; Siegbahn, A; Thorsteinsdottir, U; Veronesi, G; Wareham, N; Willer, CJ; Zalloua, PA; Erdmann, J; Deloukas, P; Watkins, H; Schunkert, H; Danesh, J; Thompson, JR; Samani, NJ				Nelson, C. P.; Hamby, S. E.; Saleheen, D.; Hopewell, J. C.; Zeng, L.; Assimes, T. L.; Kanoni, S.; Willenborg, C.; Burgess, S.; Amouyel, P.; Anand, S.; Blankenberg, S.; Boehm, B. O.; Clarke, R. J.; Collins, R.; Dedoussis, G.; Farrall, M.; Franks, P. W.; Groop, L.; Hall, A. S.; Hamsten, A.; Hengstenberg, C.; Hovingh, G. Kees; Ingelsson, E.; Kathiresan, S.; Kee, F.; Koenig, I. R.; Kooner, J.; Lehtimaeki, T.; Maerz, W.; McPherson, R.; Metspalu, A.; Nieminen, M. S.; O'Donnell, C. J.; Palmer, C. N. A.; Peters, A.; Perola, M.; Reilly, M. P.; Ripatti, S.; Roberts, R.; Salomaa, V.; Shah, S. H.; Schreiber, S.; Siegbahn, A.; Thorsteinsdottir, U.; Veronesi, G.; Wareham, N.; Willer, C. J.; Zalloua, P. A.; Erdmann, J.; Deloukas, P.; Watkins, H.; Schunkert, H.; Danesh, J.; Thompson, J. R.; Samani, N. J.		CARDIoGRAM C4D Consortium	Genetically Determined Height and Coronary Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-PRESSURE; ASSOCIATION; LOCI; ATHEROSCLEROSIS; VARIANTS; IGF-1	BACKGROUND The nature and underlying mechanisms of an inverse association between adult height and the risk of coronary artery disease (CAD) are unclear. METHODS We used a genetic approach to investigate the association between height and CAD, using 180 height-associated genetic variants. We tested the association between a change in genetically determined height of 1 SD (6.5 cm) with the risk of CAD in 65,066 cases and 128,383 controls. Using individual-level genotype data from 18,249 persons, we also examined the risk of CAD associated with the presence of various numbers of height-associated alleles. To identify putative mechanisms, we analyzed whether genetically determined height was associated with known cardiovascular risk factors and performed a pathway analysis of the height-associated genes. RESULTS We observed a relative increase of 13.5% (95% confidence interval [CI], 5.4 to 22.1; P<0.001) in the risk of CAD per 1-SD decrease in genetically determined height. There was a graded relationship between the presence of an increased number of height-raising variants and a reduced risk of CAD (odds ratio for height quar-tile 4 versus quartile 1, 0.74; 95% CI, 0.68 to 0.84; P<0.001). Of the 12 risk factors that we studied, we observed significant associations only with levels of low-density lipoprotein cholesterol and triglycerides (accounting for approximately 30% of the association). We identified several overlapping pathways involving genes associated with both development and atherosclerosis. CONCLUSIONS There is a primary association between a genetically determined shorter height and an increased risk of CAD, a link that is partly explained by the association between shorter height and an adverse lipid profile. Shared biologic processes that determine achieved height and the development of atherosclerosis may explain some of the association.	[Nelson, C. P.; Hamby, S. E.; Samani, N. J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Thompson, J. R.] Univ Leicester, Dept Hlth Sci, Leicester LE3 9QP, Leics, England; [Nelson, C. P.; Hamby, S. E.; Samani, N. J.] Natl Inst Hlth Res Leicester, Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Saleheen, D.; Burgess, S.; Danesh, J.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Ripatti, S.; Deloukas, P.] Wellcome Trust Sanger Inst, Cambridge, England; [Wareham, N.] Addenbrookes Hosp, Inst Metab Sci, Med Res Council Epidemiol Unit, Cambridge, England; [Hopewell, J. C.; Clarke, R. J.; Collins, R.] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Hopewell, J. C.; Clarke, R. J.; Collins, R.] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Farrall, M.; Watkins, H.] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England; [Farrall, M.; Watkins, H.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Kanoni, S.; Deloukas, P.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Boehm, B. O.] Univ London Imperial Coll Sci Technol & Med, London, England; [Kooner, J.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Hall, A. S.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England; [Kee, F.] Queens Univ Belfast, Clin Res Collaborat Ctr Excellence Publ Hlth Nort, Belfast, Antrim, North Ireland; [Palmer, C. N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Saleheen, D.] Ctr Noncommunicable Dis, Karachi, Pakistan; [Saleheen, D.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Reilly, M. P.] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Zeng, L.; Clarke, R. J.; Collins, R.; Hengstenberg, C.; Schunkert, H.] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany; [Zeng, L.; Clarke, R. J.; Collins, R.; Hengstenberg, C.; Schunkert, H.] Partner Site Munich Heart Alliance, Deutsch Zentrum Herz Kreislauf Forsch, Munich, Germany; [Peters, A.] German Ctr Cardiovasc Res Partner Site Munich, Munich, Germany; [Willenborg, C.; Erdmann, J.] Med Univ Lubeck, Inst Integrat & Expt Genom, D-23538 Lubeck, Germany; [Willenborg, C.; Erdmann, J.] Partner Site Hamburg Lubeck Kiel, German Ctr Cardiovasc Res, Lubeck, Germany; [Koenig, I. R.] Med Univ Lubeck, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Blankenberg, S.] Univ Heart Ctr Hamburg, Clin Gen & Intervent Cardiol, Hamburg, Germany; [Boehm, B. O.] Univ Ulm, Med Ctr, Dept Internal Med 1, D-89069 Ulm, Germany; [Maerz, W.] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Maerz, W.] Heidelberg Univ, Mannheim Med Fac, Med Clin 5, Synlab Acad,Synlab Serv, Mannheim, Germany; [Peters, A.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Schreiber, S.] Univ Kiel, Inst Klin Mol Biol, Kiel, Germany; [Assimes, T. L.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Amouyel, P.] Univ Lille Nord France, INSERM, U744, Inst Pasteur Lille, Lille, France; [Anand, S.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [McPherson, R.; Roberts, R.] Univ Ottawa Heart Inst, John & Jennifer Ruddy Canadian Cardiovasc Genet C, Ottawa, ON, Canada; [McPherson, R.; Roberts, R.] Univ Ottawa Heart Inst, Atherogen Lab, Ottawa, ON, Canada; [Boehm, B. O.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Dedoussis, G.] Harokopio Univ, Dept Dietet Nutr, Athens, Greece; [Franks, P. W.] Lund Univ, Ctr Diabet, Skane Univ Hosp, Genet & Mol Epidemiol Unit,Dept Clin Sci, Malmo, Sweden; [Groop, L.] Lund Univ, Univ Hosp Malmo, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Franks, P. W.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Hamsten, A.] Karolinska Inst, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Ingelsson, E.] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Siegbahn, A.] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Franks, P. W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Kathiresan, S.] Massachusetts Gen Hosp, Div Cardiol, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, S.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Kathiresan, S.] Harvard Univ, Sch Med, Boston, MA USA; [Kathiresan, S.] Broad Inst Harvard & MIT, Cambridge, MA USA; [O'Donnell, C. J.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Lehtimaeki, T.] Univ Tampere, Fimlab Labs, Dept Clin Chem, FIN-33101 Tampere, Finland; [Lehtimaeki, T.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Nieminen, M. S.] Univ Helsinki, Cent Hosp, Dept Med, Div Cardiol, Helsinki, Finland; [Perola, M.; Salomaa, V.] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Ripatti, S.] Univ Helsinki, Hjelt Inst, Helsinki, Finland; [Ripatti, S.] Univ Helsinki, Inst Mol Med, Helsinki, Finland; [Metspalu, A.; Perola, M.] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Shah, S. H.] Duke Univ, Dept Med, Div Cardiol, Duke Mol Physiol Inst, Durham, NC USA; [Thorsteinsdottir, U.] deCODE Genet, Reykjavik, Iceland; [Veronesi, G.] Univ Insubria, Dept Clin & Expt Med, Res Ctr Epidemiol & Prevent Med, Varese, Italy; [Willer, C. J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Willer, C. J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Willer, C. J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Zalloua, P. A.] Lebanese Amer Univ, Beirut, Lebanon; [Deloukas, P.] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	University of Leicester; University of Leicester; University of Cambridge; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of London; Queen Mary University London; Imperial College London; Imperial College London; University of Leeds; Queens University Belfast; University of Dundee; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; German Centre for Cardiovascular Research; University of Lubeck; German Centre for Cardiovascular Research; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; Medical University of Graz; Ruprecht Karls University Heidelberg; SYNLAB Group; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; McMaster University; Population Health Research Institute; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Harokopio University Athens; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Umea University; Karolinska Institutet; Uppsala University; Uppsala University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Amsterdam; Academic Medical Center Amsterdam; Tampere University; Tampere University; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Tartu; Duke University; University of Insubria; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Lebanese American University; King Abdulaziz University	Samani, NJ (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, BHF Cardiovasc Res Ctr, Groby Rd, Leicester LE3 9QP, Leics, England.	njs@le.ac.uk	Erdmann, Jeanette/P-7513-2014; Lehtimäki, Terho/AAD-1094-2022; Hall, Alistair/K-1953-2019; Veronesi, Giovanni/E-3859-2010; Cazier, Jean-Baptiste/GLR-2949-2022; Boehm, Bernhard Otto/F-8750-2015; Peters, Annette/A-6117-2011; Kessler, Thorsten/O-7426-2015; Willenborg, Christina/D-2668-2012; Franks, Paul/AAA-3300-2020; Hengstenberg, Christian/U-5485-2019; Kanoni, Stavroula/AAN-7161-2021; Lyytikäinen, Leo-Pekka/C-8544-2016; Gudnason, Vilmundur/K-6885-2015; Gauguier, Dominique/G-2190-2016; Dedoussis, George/AAN-7252-2021; Assimes, Themistocles Leonard/D-9696-2015; König, Inke R/A-4544-2009; Study, GoDARTS/K-9448-2016; Tregouet, David-Alexandre/E-3961-2016; Trégouët, David-Alexandre/P-9210-2019; Langenberg, Claudia/ABG-9067-2021; Erdmann, Jeanette/A-4417-2009; Palmer, Colin NA/C-7053-2008; Veronesi, Giovanni/O-5678-2019; Müller-Nurasyid, Martina/I-8735-2018; Deloukas, Panos/B-2922-2013; Ripatti, Samuli/H-9446-2014; Strawbridge, Rona/H-5422-2012	Erdmann, Jeanette/0000-0002-4486-6231; Lehtimäki, Terho/0000-0002-2555-4427; Veronesi, Giovanni/0000-0002-4119-6615; Cazier, Jean-Baptiste/0000-0001-7581-9051; Peters, Annette/0000-0001-6645-0985; Willenborg, Christina/0000-0001-5217-6882; Kanoni, Stavroula/0000-0002-1691-9615; Lyytikäinen, Leo-Pekka/0000-0002-7200-5455; Gudnason, Vilmundur/0000-0001-5696-0084; Gauguier, Dominique/0000-0001-6156-9530; Dedoussis, George/0000-0002-7798-6221; Assimes, Themistocles Leonard/0000-0003-2349-0009; König, Inke R/0000-0003-0504-6465; Trégouët, David-Alexandre/0000-0001-9084-7800; Langenberg, Claudia/0000-0002-5017-7344; Palmer, Colin NA/0000-0002-6415-6560; Veronesi, Giovanni/0000-0002-4119-6615; Müller-Nurasyid, Martina/0000-0003-3793-5910; Deloukas, Panos/0000-0001-9251-070X; Ripatti, Samuli/0000-0002-0504-1202; Gigante, Bruna/0000-0003-4508-7990; Ouwehand, Willem/0000-0002-7744-1790; Nikus, Kjell/0000-0002-9345-9851; Shungin, Dmitry/0000-0001-7900-5856; Reilly, Muredach/0000-0002-3035-9386; Eriksson, Per/0000-0002-5635-2692; Strawbridge, Rona/0000-0001-8506-3585; Kleber, Marcus/0000-0003-0663-7275; Hopewell, Jemma/0000-0002-3870-8018; Hall, Alistair/0000-0003-0306-7887; Watkins, Hugh/0000-0002-5287-9016; Wild, Philipp/0000-0003-4413-9752; Franks, Paul/0000-0002-0520-7604; Esko, Tonu/0000-0003-1982-6569; Melander, Olle/0000-0002-2581-484X; Kristiansson, Kati/0000-0003-4688-107X; zalloua, pierre/0000-0002-8494-5081; Kuulasmaa, Kari/0000-0003-2165-1411; Ferrario, Marco M/0000-0003-2741-7124; Barroso, Ines/0000-0001-5800-4520; Kessler, Thorsten/0000-0003-3326-1621; Nelson, Christopher/0000-0001-8025-2897; Amouyel, Philippe/0000-0001-9088-234X; Burgess, Stephen/0000-0001-5365-8760	British Heart Foundation; MRC [MR/L003120/1, MR/L01629X/1, G0601463, MC_UU_12015/1] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, FS/14/55/30806] Funding Source: researchfish; Medical Research Council [MR/L01629X/1, MC_UU_12015/1, G0601463, MC_CF023241, MC_U106179471, MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165, NF-SI-0611-10170, NF-SI-0508-10235, NF-SI-0512-10135] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006173, ZIAHL006175, ZIAHL006002] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the British Heart Foundation and others.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Di Angelantonio E, 2012, JAMA-J AM MED ASSOC, V307, P2499, DOI 10.1001/jama.2012.6571; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Gharavi NM, 2007, J BIOL CHEM, V282, P31460, DOI 10.1074/jbc.M704267200; Gunnell D, 2003, J EPIDEMIOL COMMUN H, V57, P141, DOI 10.1136/jech.57.2.141; Higashi Y, 2010, TRENDS ENDOCRIN MET, V21, P245, DOI 10.1016/j.tem.2009.12.005; Lieb W, 2013, HYPERTENSION, V61, P995, DOI 10.1161/HYPERTENSIONAHA.111.00275; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; OConnor NJ, 1996, CIRCULATION, V93, P652, DOI 10.1161/01.CIR.93.4.652; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Toma I, 2012, CELL TISSUE RES, V347, P155, DOI 10.1007/s00441-011-1189-3; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; von der Thusen JH, 2011, AM J PATHOL, V178, P924, DOI 10.1016/j.ajpath.2010.10.007; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wanschel A, 2013, ARTERIOSCL THROM VAS, V33, P886, DOI 10.1161/ATVBAHA.112.300941; Wormser D, 2012, INT J EPIDEMIOL, V41, P1419, DOI 10.1093/ije/dys086; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401	27	166	168	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2015	372	17					1608	1618		10.1056/NEJMoa1404881	http://dx.doi.org/10.1056/NEJMoa1404881			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4XX	25853659	Green Published, Green Accepted			2022-12-28	WOS:000353294000006
J	Kaminski, T; Menten, KM; Tylenda, R; Hajduk, M; Patel, NA; Kraus, A				Kaminski, Tomasz; Menten, Karl M.; Tylenda, Romuald; Hajduk, Marcin; Patel, Nimesh A.; Kraus, Alexander			Nuclear ashes and outflow in the eruptive star Nova Vul 1670	NATURE			English	Article							CK-VUL; SUBMILLIMETER; NEBULA; OLDEST; SPECTROSCOPY; MILLIMETER; CANDIDATE; EVOLUTION; ABUNDANCE; FACILITY	CK Vulpeculae was observed in outburst in 1670-1672 (ref. 1), but no counterpart was seen until 1982, when a bipolar nebula was found at its location(1-3). Historically, CK Vul has been considered to be a nova (Nova Vul 1670), but its similarity to 'red transients', which are more luminous than classical novae and thought to be the results of stellar collisions(4), has re-opened the question of CK Vul's status5'6. Red transients cool to resemble late M-type stars, surrounded by circumstellar material rich in molecules and dust(7-9). No stellar source has been seen in CK Vul, though a radio continuum source was identified at the expansion centre of the nebula'. Here we report that CK Vul is surrounded by chemically rich molecular gas in the form of an outflow, as well as dust. The gas has peculiar isotopic ratios, revealing that CK Vul's composition was strongly enhanced by the nuclear ashes of hydrogen burning. The chemical composition cannot be reconciled with a nova or indeed any other known explosion. In addition, the mass of the surrounding gas is too large for a nova, though the conversion from observations of CO to a total mass is uncertain. We conclude that CK Vul is best explained as the remnant of a merger of two stars.	[Kaminski, Tomasz] European So Observ, Santiago, Chile; [Kaminski, Tomasz; Menten, Karl M.; Kraus, Alexander] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Tylenda, Romuald; Hajduk, Marcin] N Copernicus Astron Ctr, Dept Astrophys, PL-87100 Torun, Poland; [Patel, Nimesh A.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	European Southern Observatory; Max Planck Society; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Kaminski, T (corresponding author), European So Observ, Alonso de Cordova 3107, Santiago, Chile.	tkaminsk@eso.org	Kaminski, Tomasz/N-8550-2018; Hajduk, Marcin/C-9693-2014	Kaminski, Tomasz/0000-0001-8541-8024; Hajduk, Marcin/0000-0001-6028-9932; Tylenda, Romuald/0000-0001-9682-3535				Amari S, 2001, ASTROPHYS J, V551, P1065, DOI 10.1086/320235; Arnould M, 1999, ASTRON ASTROPHYS, V347, P572; BECKWITH SVW, 1991, ASTROPHYS J, V381, P250, DOI 10.1086/170646; BODE MF, 1987, MON NOT R ASTRON SOC, V228, P217, DOI 10.1093/mnras/228.2.217; Bujarrabal V, 2002, ASTRON ASTROPHYS, V389, P271, DOI 10.1051/0004-6361:20020455; Denissenkov PA, 2014, MON NOT R ASTRON SOC, V442, P2058, DOI 10.1093/mnras/stu1000; Draine BT, 2006, ASTROPHYS J, V636, P1114, DOI 10.1086/498130; Evans A, 2002, MON NOT R ASTRON SOC, V332, pL35, DOI 10.1046/j.1365-8711.2002.05476.x; Goldsmith PF, 1999, ASTROPHYS J, V517, P209, DOI 10.1086/307195; Gusten R, 2006, ASTRON ASTROPHYS, V454, pL13, DOI 10.1051/0004-6361:20065420; Hajduk M, 2008, ASTR SOC P, V391, P151; Hajduk M, 2007, MON NOT R ASTRON SOC, V378, P1298, DOI 10.1111/j.1365-2966.2007.11825.x; Hajduk M, 2013, MON NOT R ASTRON SOC, V432, P167, DOI 10.1093/mnras/stt426; Jose J, 2007, METEORIT PLANET SCI, V42, P1135, DOI 10.1111/j.1945-5100.2007.tb00565.x; Kaminski T, 2008, ASTRON ASTROPHYS, V482, P803, DOI 10.1051/0004-6361:20079189; Kaminski T, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201014406; Kaminski T, 2009, ASTROPHYS J SUPPL S, V182, P33, DOI 10.1088/0067-0049/182/1/33; Kasemann C., 2006, SPIE C SER, V6275; Kato T, 2003, ASTRON ASTROPHYS, V399, P695, DOI 10.1051/0004-6361:20021808; Klein B, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201218864; Klein T, 2014, IEEE T THZ SCI TECHN, V4, P588, DOI 10.1109/TTHZ.2014.2342498; Kobayashi C, 2011, MON NOT R ASTRON SOC, V414, P3231, DOI 10.1111/j.1365-2966.2011.18621.x; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Loinard L, 2012, ASTROPHYS J LETT, V749, DOI 10.1088/2041-8205/749/1/L4; MAMON GA, 1987, ASTROPHYS J, V323, P306, DOI 10.1086/165828; Molinari S, 2010, PUBL ASTRON SOC PAC, V122, P314, DOI 10.1086/651314; Muller H. S. P., 2005, IAU S, V235, p62P; Muller HSP, 2005, J MOL STRUCT, V742, P215, DOI 10.1016/j.molstruc.2005.01.027; Nicholls CP, 2013, MON NOT R ASTRON SOC, V431, pL33, DOI 10.1093/mnrasl/slt003; Nittler LR, 2005, ASTROPHYS J, V631, pL89, DOI 10.1086/497029; Pickett HM, 1998, J QUANT SPECTROSC RA, V60, P883, DOI 10.1016/S0022-4073(98)00091-0; Prieto JL, 2009, ASTROPHYS J, V705, P1425, DOI 10.1088/0004-637X/705/2/1425; Quintana-Lacaci G, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201322728; Romano D, 2003, MON NOT R ASTRON SOC, V342, P185, DOI 10.1046/j.1365-8711.2003.06526.x; Sault RJ, 1995, ASTR SOC P, V77, P433; SHARA MM, 1985, ASTROPHYS J, V294, P271, DOI 10.1086/163296; SHARA MM, 1982, ASTROPHYS J, V258, pL41, DOI 10.1086/183826; Soker N, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/100; Szyszka C, 2011, MON NOT R ASTRON SOC, V416, P715, DOI 10.1111/j.1365-2966.2011.19087.x; Tielens A.G.G.M., 1987, COMPOSITION STRUCTUR, V134, P397; Tylenda R, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321647; Tylenda R, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201016221; Vassilev V, 2008, ASTRON ASTROPHYS, V490, P1157, DOI 10.1051/0004-6361:200810459; Vastel C., 2014, FORMALISM CASSIS SOF; WEIGHT A, 1993, ASTRON ASTROPHYS, V268, P294; Williams G., 2014, CBAT LIST NOVAE MILK; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868; Yamauchi C, 2011, PUBL ASTRON SOC PAC, V123, P852, DOI 10.1086/660926; Ziurys LM, 2009, ASTROPHYS J, V695, P1604, DOI 10.1088/0004-637X/695/2/1604	49	40	42	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					322	+		10.1038/nature14257	http://dx.doi.org/10.1038/nature14257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25799986	Green Submitted			2022-12-28	WOS:000352974200032
J	Salas, IV; Miralbell, AF				Valenzuela Salas, Ignacio; Fernandez Miralbell, Andrea			Incisional Keloid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Valenzuela Salas, Ignacio] Hosp Valle de los Pedroches, Pozoblanco, Spain; [Fernandez Miralbell, Andrea] Hosp Univ Virgen de las Nieves, Granada, Spain	Hospital Universitario Virgen de las Nieves	Salas, IV (corresponding author), Hosp Valle de los Pedroches, Pozoblanco, Spain.	ivalensa@gmail.com							0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2015	372	15					1453	1453		10.1056/NEJMicm1407180	http://dx.doi.org/10.1056/NEJMicm1407180			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF2ZV	25853749				2022-12-28	WOS:000352417900009
J	Hawkes, N				Hawkes, Nigel			BMJ AWARDS 2015 Imaging team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2015	350								h1747	10.1136/bmj.h1747	http://dx.doi.org/10.1136/bmj.h1747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9SR	25854263				2022-12-28	WOS:000352907500001
J	Loopstra, R; Reeves, A; Taylor-Robinson, D; Barr, B; McKee, M; Stuckler, D				Loopstra, Rachel; Reeves, Aaron; Taylor-Robinson, David; Barr, Ben; McKee, Martin; Stuckler, David			Austerity, sanctions, and the rise of food banks in the UK	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Loopstra, Rachel; Reeves, Aaron; Stuckler, David] Univ Oxford, Dept Sociol, Oxford OX1 3UQ, England; [Taylor-Robinson, David; Barr, Ben] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [McKee, Martin] London Sch Hyg & Trop Med London, Fac Publ Hlth & Policy, London, England	University of Oxford; University of Liverpool	Loopstra, R (corresponding author), Univ Oxford, Dept Sociol, Manor Rd Bldg,Manor Rd, Oxford OX1 3UQ, England.	rachel.loopstra@sociology.ox.ac.uk	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011; Barr, Ben R/W-9989-2018; Loopstra, Rachel/I-7253-2013	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Barr, Ben R/0000-0002-4208-9475; Taylor-Robinson, David/0000-0002-5828-7724; Stuckler, David/0000-0002-1288-8401; Reeves, Aaron/0000-0001-9114-965X; Loopstra, Rachel/0000-0002-7541-6209	MRC [G0802448] Funding Source: UKRI; Medical Research Council [G0802448] Funding Source: researchfish; National Institute for Health Research [DRF-2009-02-12] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		All-Party Parliamentary Inquiry into Hunger and Food Poverty, 2014, FEED BRIT STRAT ZER; [Anonymous], TERMS OF REF; Ashton JR, 2014, LANCET, V383, P1631, DOI 10.1016/S0140-6736(14)60536-5; BMA, 2014, FOOD BANKS TAK BIT S; Butler P., 2014, GUARDIAN; Christian Fisher L., 2014, GUARDIAN; Cooper N, 2014, BREADLINE RELENTLESS; Department for Communities and Local Government, LOC AUTH REV EXP FIN; Department for Work and Pensions, BEN EXP LOC AUTH 200; Forsey A., 2014, EVIDENCE REV ALL PAR; Gentleman A., 2014, GUARDIAN; Lambie H., 2011, TRUSSELL TRUST FOODB; Lambie-Mumford H, 2014, HOUSEHOLD FOOD INSEC; Lambie-Mumford H., 2014, FOOD BANK PROVISION; Lambie-Mumford H., 2014, THESIS U SHEFFIELD; Lambie-Mumford H, 2013, J SOC POLICY, V42, P73, DOI 10.1017/S004727941200075X; Matthews-King A, 2014, PULSE           0218; National Records of Scotland, 2011, CENS 2011 REL COUNC; National Statistics, 2014, JOBS ALL JSA SANCT N; NELSON M, 2007, LOW INCOME DIET NUTR, V3; Office for National Statistics, NOM OFF LAB MARK STA; Office for National Statistics, 2012, 2011 CENS KEY STAT L; Perry J, 2014, EMERGENCY USE ONLY U; Scottish government, 2014, SCOTT LOC GOV FIN ST; The Trussell Trust, 2014, UK FOODB; Welsh government, 2014, LOC AUTH REV OUTT EX; Williams Z, 2013, GUARDIAN	27	162	162	2	40	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2015	350								h1775	10.1136/bmj.h1775	http://dx.doi.org/10.1136/bmj.h1775			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9SR	25854525	Green Published, Green Accepted			2022-12-28	WOS:000352907500004
J	Rosenberg, SA; Restifo, NP				Rosenberg, Steven A.; Restifo, Nicholas P.			Adoptive cell transfer as personalized immunotherapy for human cancer	SCIENCE			English	Review							TUMOR-INFILTRATING LYMPHOCYTES; CD8(+) T-CELLS; METASTATIC MELANOMA; AUTOLOGOUS TUMOR; ANTITUMOR-ACTIVITY; GENE-THERAPY; CD4+T CELLS; RECEPTOR; REGRESSION; ANTIGENS	Adoptive cell therapy (ACT) is a highly personalized cancer therapy that involves administration to the cancer-bearing host of immune cells with direct anticancer activity. ACT using naturally occurring tumor-reactive lymphocytes has mediated durable, complete regressions in patients with melanoma, probably by targeting somatic mutations exclusive to each cancer. These results have expanded the reach of ACT to the treatment of common epithelial cancers. In addition, the ability to genetically engineer lymphocytes to express conventional T cell receptors or chimeric antigen receptors has further extended the successful application of ACT for cancer treatment.	[Rosenberg, Steven A.; Restifo, Nicholas P.] NCI, Surg Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rosenberg, SA (corresponding author), NCI, Surg Branch, Ctr Canc Res, NIH, 9000 Rockville Pike,CRC Bldg,Room 3W-3940, Bethesda, MD 20892 USA.	sar@nih.gov; restifo@nih.gov	Restifo, Nicholas Phillip/M-6549-2019; Restifo, Nicholas Phillip/Z-1614-2019	Restifo, Nicholas P./0000-0003-4229-4580	Center for Cancer Research, NCI, NIH, Bethesda, Maryland; Milstein Family Foundation; NATIONAL CANCER INSTITUTE [ZIABC010984, ZIABC010763] Funding Source: NIH RePORTER	Center for Cancer Research, NCI, NIH, Bethesda, Maryland; Milstein Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Center for Cancer Research, NCI, NIH, Bethesda, Maryland, and the Milstein Family Foundation for their generous support.	BERENDT MJ, 1980, J EXP MED, V151, P69, DOI 10.1084/jem.151.1.69; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Besser MJ, 2013, CLIN CANCER RES, V19, P4792, DOI 10.1158/1078-0432.CCR-13-0380; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Bronte V, 1998, J IMMUNOL, V161, P5313; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Chapuis AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004916; Crompton JG, 2015, CANCER RES, V75, P296, DOI 10.1158/0008-5472.CAN-14-2277; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; DELORME EJ, 1964, LANCET, V2, P117; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; DONOHUE JH, 1984, J IMMUNOL, V132, P2123; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; EBERLEIN TJ, 1982, J EXP MED, V156, P385; FEFER A, 1969, CANCER RES, V29, P2177; FERNANDEZCRUZ E, 1980, J EXP MED, V152, P823, DOI 10.1084/jem.152.4.823; Gardner RA, 2014, CANCER J, V20, P107, DOI 10.1097/PPO.0000000000000030; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Gill S, 2015, IMMUNOL REV, V263, P68, DOI 10.1111/imr.12243; Gopal AK, 2015, BLOOD, V125, P1236, DOI 10.1182/blood-2014-08-595801; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; GROSS G, 1989, P NATL ACAD SCI USA, V86, P10024, DOI 10.1073/pnas.86.24.10024; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hinrichs C. S., 2014, AM SOC CLIN ONC ASCO; Hong JJ, 2010, CLIN CANCER RES, V16, P4892, DOI 10.1158/1078-0432.CCR-10-1507; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2011, IMMUNOL REV, V239, P27, DOI 10.1111/j.1600-065X.2010.00979.x; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kochenderfer JN, 2013, NAT REV CLIN ONCOL, V10, P267, DOI 10.1038/nrclinonc.2013.46; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Lamers CHJ, 2013, MOL THER, V21, P904, DOI 10.1038/mt.2013.17; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Li YQ, 2005, J IMMUNOL, V175, P2261, DOI 10.4049/jimmunol.175.4.2261; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; Lu YC, 2014, CLIN CANCER RES, V20, P3401, DOI 10.1158/1078-0432.CCR-14-0433; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Morgan RA, 2012, HUM GENE THER, V23, P1043, DOI 10.1089/hum.2012.041; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; MUUL LM, 1987, J IMMUNOL, V138, P989; Palmer DC, 2008, P NATL ACAD SCI USA, V105, P8061, DOI 10.1073/pnas.0710929105; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Pilon-Thomas S, 2012, J IMMUNOTHER, V35, P615, DOI 10.1097/CJI.0b013e31826e8f5f; Pizzitola I, 2014, LEUKEMIA, V28, P1596, DOI 10.1038/leu.2014.62; Radvanyi LG, 2012, CLIN CANCER RES, V18, P6758, DOI 10.1158/1078-0432.CCR-12-1177; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; ROSENBERG SA, 1990, NEW ENGL J MED, V323, P570, DOI 10.1056/NEJM199008303230904; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; ROSENBERG SA, 1985, J EXP MED, V161, P1169, DOI 10.1084/jem.161.5.1169; ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Savoldo B, 2007, BLOOD, V110, P2620, DOI 10.1182/blood-2006-11-059139; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Singh H, 2014, IMMUNOL REV, V257, P181, DOI 10.1111/imr.12137; Song DG, 2011, CANCER RES, V71, P4617, DOI 10.1158/0008-5472.CAN-11-0422; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Yao X, 2012, BLOOD, V119, P5688, DOI 10.1182/blood-2011-10-386482; Zhao YB, 2010, CANCER RES, V70, P9053, DOI 10.1158/0008-5472.CAN-10-2880	94	1426	1574	27	635	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					62	68		10.1126/science.aaa4967	http://dx.doi.org/10.1126/science.aaa4967			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838374	Green Accepted			2022-12-28	WOS:000352079500027
J	Cohen, D				Cohen, Deborah			DRUG REGULATION Attacks on publicly funded trials: what happens when industry does not want to know the answer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dcohen@bmj.com						Ball D., 2014, WALL ST J       0529; Cohen D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2006; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Moja L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011230.pub2	5	2	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2015	350								h1701	10.1136/bmj.h1701	http://dx.doi.org/10.1136/bmj.h1701			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3HO	25834025				2022-12-28	WOS:000352439300011
J	Savage, N				Savage, Neil			SYNTHETIC COATINGS Super surfaces	NATURE			English	Editorial Material																		Bird JC, 2013, NATURE, V503, P385, DOI 10.1038/nature12740; Bixler GD, 2014, J COLLOID INTERF SCI, V419, P114, DOI 10.1016/j.jcis.2013.12.019; Huang YJ, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-3; Sileika TS, 2013, ANGEW CHEM INT EDIT, V52, P10766, DOI 10.1002/anie.201304922; Zhang MJ, 2009, J BIOMED NANOTECHNOL, V5, P294, DOI 10.1166/jbn.2009.1034	5	23	25	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S7	S9		10.1038/519S7a	http://dx.doi.org/10.1038/519S7a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25806497				2022-12-28	WOS:000351602800002
J	Tombesi, F; Melendez, M; Veilleux, S; Reeves, JN; Gonzalez-Alfonso, E; Reynolds, CS				Tombesi, F.; Melendez, M.; Veilleux, S.; Reeves, J. N.; Gonzalez-Alfonso, E.; Reynolds, C. S.			Wind from the black-hole accretion disk driving a molecular outflow in an active galaxy	NATURE			English	Article							QUASAR FEEDBACK; X-RAY; LOCAL ULIRGS; AGN; MERGERS; DRIVEN; ENERGY	Powerful winds driven by active galactic nuclei are often thought to affect the evolution of both supermassive black holes and their host galaxies, quenching star formation and explaining the close relationship between black holes and galaxies(1,2). Recent observations of large-scale molecular outflows(3-8) in ultraluminous infrared galaxies support this quasar-feedback idea, because they directly trace the gas from which stars form. Theoreticalmodels(9-12) suggest that these outflows originate as energy-conserving flows driven by fast accretion-disk winds. Proposed connections between large-scale molecular outflows and accretion-disk activity in ultraluminous galaxies were incomplete(3-8) because no accretion-disk wind had been detected. Conversely, studies of powerful accretion-disk wind shave until now focused only on X-ray observations of local Seyfert galaxies(13,14) and a few higher-redshift quasars(15-19). Here we report observations of a powerful accretion-disk wind with a mildly relativistic velocity (a quarter that of light) in the X-ray spectrum of IRAS F11119+3257, a nearby (redshift 0.189) optically classified type 1 ultraluminous infrared galaxy hosting a powerful molecular outflow(6). The active galactic nucleus is responsible for about 80 per cent of the emission, with a quasar-like luminosity(6) of 1.5 x 10(46) ergs per second. The energetics of these two types of wide-angle outflows is consistent with the energy-conserving mechanism(9-12) that is the basis of the quasar feedback(1) in active galactic nuclei that lack powerful radio jets (such jets are an alternative way to drive molecular outflows).	[Tombesi, F.] NASA, Goddard Space Flight Ctr, Xray Astrophys Lab, Greenbelt, MD 20771 USA; [Tombesi, F.; Melendez, M.; Veilleux, S.; Reynolds, C. S.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Tombesi, F.; Melendez, M.; Veilleux, S.; Reynolds, C. S.] Univ Maryland, CRESST, College Pk, MD 20742 USA; [Veilleux, S.; Reynolds, C. S.] Univ Maryland, Joint Space Sci Inst, College Pk, MD 20742 USA; [Reeves, J. N.] Keele Univ, Sch Phys & Geog Sci, Astrophys Grp, Keele ST5 5BG, Staffs, England; [Reeves, J. N.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [Gonzalez-Alfonso, E.] Univ Alcala, Dept Fis & Matemat, E-28871 Madrid, Spain	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Keele University; University System of Maryland; University of Maryland Baltimore County; Universidad de Alcala	Tombesi, F (corresponding author), NASA, Goddard Space Flight Ctr, Xray Astrophys Lab, Greenbelt, MD 20771 USA.	ftombesi@astro.umd.edu	Alfonso, Eduardo González/AAA-4790-2019	Alfonso, Eduardo González/0000-0001-5285-8517; Tombesi, Francesco/0000-0002-6562-8654; Melendez, Marcio/0000-0001-8485-0325; Reynolds, Christopher/0000-0002-1510-4860	NASA [NNX12AH40G, NHSC/JPL RSA 1427277, 1454738, NNX14AF86G]; STFC; Spanish Ministerio de Economia y Competitividad [AYA2010-21697-C05-0, FIS2012-39162-C06-01]; US National Science Foundation [AST1333514];  [NSF-AST1009583]; Direct For Mathematical & Physical Scien [1333360, 1333514] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1332858] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Spanish Ministerio de Economia y Competitividad(Spanish Government); US National Science Foundation(National Science Foundation (NSF)); ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	F.T. would like to thank T. Kallman, J. Garcia, F. Tazaki, F. Paerels and M. Cappi for comments. F.T. acknowledges support from NASA (grant NNX12AH40G). M.M. and S.V. are supported in part by NASA grants NHSC/JPL RSA 1427277 and 1454738. S.V. also acknowledges partial support through grant NSF-AST1009583. J.N.R. acknowledges the financial support of the STFC. E.G.-A. is a Research Associate at the Harvard-Smithsonian Center for Astrophysics, and thanks the Spanish Ministerio de Economia y Competitividad for support under projects AYA2010-21697-C05-0 and FIS2012-39162-C06-01. C.S.R. thanks support from NASA (grant NNX14AF86G) and the US National Science Foundation (grant AST1333514).	Chartas G, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/57; Chartas G, 2009, ASTROPHYS J, V706, P644, DOI 10.1088/0004-637X/706/1/644; Fabian AC, 2012, ANNU REV ASTRON ASTR, V50, P455, DOI 10.1146/annurev-astro-081811-125521; Faucher-Giguere CA, 2012, MON NOT R ASTRON SOC, V425, P605, DOI 10.1111/j.1365-2966.2012.21512.x; Feruglio C, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201015164; Fischer J, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014676; Fukumura K, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/120; Garcia J, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/76; Gofford J, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/77; Gofford J, 2013, MON NOT R ASTRON SOC, V430, P60, DOI 10.1093/mnras/sts481; Gonzalez-Alfonso E, 2014, ASTRON ASTROPHYS, V561, DOI 10.1051/0004-6361/201321709; Hagino K, 2015, MON NOT R ASTRON SOC, V446, P663, DOI 10.1093/mnras/stu2095; Hopkins PF, 2010, MON NOT R ASTRON SOC, V401, P7, DOI 10.1111/j.1365-2966.2009.15643.x; Kallman T, 2001, ASTROPHYS J SUPPL S, V133, P221, DOI 10.1086/319184; Kawakatu N, 2007, ASTROPHYS J, V661, P660, DOI 10.1086/516563; King AR, 2003, MON NOT R ASTRON SOC, V345, P657, DOI 10.1046/j.1365-8711.2003.06980.x; Lanzuisi G, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219481; Lipari S, 2003, MON NOT R ASTRON SOC, V340, P289, DOI 10.1046/j.1365-8711.2003.06309.x; Miniutti G, 2004, MON NOT R ASTRON SOC, V349, P1435, DOI 10.1111/j.1365-2966.2004.07611.x; Nagar NM, 2003, ASTRON ASTROPHYS, V409, P115, DOI 10.1051/0004-6361:20031069; Pounds KA, 2009, MON NOT R ASTRON SOC, V397, P249, DOI 10.1111/j.1365-2966.2009.14971.x; Reynolds CS, 2012, ASTROPHYS J LETT, V759, DOI 10.1088/2041-8205/759/1/L15; Rupke DS, 2005, ASTROPHYS J, V632, P751, DOI 10.1086/444451; Sim SA, 2010, MON NOT R ASTRON SOC, V404, P1369, DOI 10.1111/j.1365-2966.2010.16396.x; Spoon HWW, 2009, ASTROPHYS J LETT, V702, pL42, DOI 10.1088/0004-637X/702/1/L42; Sturm E, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/1/L16; Tadhunter C, 2014, NATURE, V511, P440, DOI 10.1038/nature13520; Teng SH, 2010, ASTROPHYS J, V725, P1848, DOI 10.1088/0004-637X/725/2/1848; Tombesi F, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/200913440; Veilleux S, 2005, ANNU REV ASTRON ASTR, V43, P769, DOI 10.1146/annurev.astro.43.072103.150610; Veilleux S, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/27; Wagner AY, 2013, ASTROPHYS J LETT, V763, DOI 10.1088/2041-8205/763/1/L18; Zubovas K, 2014, MON NOT R ASTRON SOC, V440, P2625, DOI 10.1093/mnras/stu431; Zubovas K, 2012, ASTROPHYS J LETT, V745, DOI 10.1088/2041-8205/745/2/L34	35	246	246	1	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					436	+		10.1038/nature14261	http://dx.doi.org/10.1038/nature14261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25810204	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000351602800048
J	[Anonymous]				[Anonymous]			A guide to the Nature Index	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S75	S75		10.1038/519S75a	http://dx.doi.org/10.1038/519S75a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE1WF	25806700	Bronze			2022-12-28	WOS:000351602800015
J	Robertson, DP; Keys, W; Rautemaa-Richardson, R; Burns, R; Smith, AJ				Robertson, Douglas P.; Keys, William; Rautemaa-Richardson, Riina; Burns, Ronnie; Smith, Andrew J.			Management of severe acute dental infections	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ODONTOGENIC INFECTION; NECK ABSCESSES; ORAL-HEALTH; PENICILLIN		[Robertson, Douglas P.] Glasgow Dent Sch, Restorat Dent, Glasgow G2 3JZ, Lanark, Scotland; [Keys, William] Univ Dundee, Dundee Dent Sch, Restorat Dent, Dundee DD1 4HN, Scotland; [Rautemaa-Richardson, Riina] Wythenshawe Hosp, Resp Res Grp, Sch Translat Med, Educ & Res Ctr,Infect Dis & Med Educ, Manchester M23 9LT, Lancs, England; [Rautemaa-Richardson, Riina] Wythenshawe Hosp, Resp Res Grp, Sch Translat Med, Med Mycol,Educ & Res Ctr, Manchester M23 9LT, Lancs, England; [Burns, Ronnie] Parkhead Hlth Ctr, Glasgow, Lanark, Scotland; [Smith, Andrew J.] Glasgow Dent Sch, Infect & Immun Sect, Clin Bacteriol, Glasgow, Lanark, Scotland; [Smith, Andrew J.] Glasgow Dent Sch, Infect & Immun Sect, Microbiol, Glasgow, Lanark, Scotland	University of Glasgow; University of Dundee; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Glasgow; University of Glasgow	Robertson, DP (corresponding author), Glasgow Dent Sch, Restorat Dent, Glasgow G2 3JZ, Lanark, Scotland.	douglas.robertson.2@glasgow.ac.uk		Robertson, Douglas/0000-0002-7121-7413; Richardson, Riina/0000-0002-1071-6040				Al-Belasy FA, 2005, J ORAL MAXIL SURG, V63, P36, DOI 10.1016/j.joms.2004.05.218; Anderson R, 2000, BRIT DENT J, V188, P398, DOI 10.1038/sj.bdj.4800493a; [Anonymous], 2009, LANCET, V373, P1, DOI 10.1016/S0140-6736(08)61933-9; [Anonymous], 2014, DENT INT PREV CAR CH; Bater MC., 2005, QUAL PRIM CARE, V13, P139; Brennan MT, 2006, J AM DENT ASSOC, V137, P62, DOI 10.14219/jada.archive.2006.0022; Canadian Collaboration on Clinical Practice Guidelines in Dentistry (CCCD), 2004, Evid Based Dent, V5, P7; Ellison SJ, 2011, BRIT DENT J, V211, P591, DOI 10.1038/sj.bdj.2011.1051; Flynn TR, 2006, J ORAL MAXIL SURG, V64, P1093, DOI 10.1016/j.joms.2006.03.015; Fouad AF, 1996, ORAL SURG ORAL MED O, V81, P590, DOI 10.1016/S1079-2104(96)80054-0; House of Commons: Health Committee, 2008, HC2891 HOUS COMM HLT; Lee JJ, 2009, ORAL DIS, V15, P602, DOI 10.1111/j.1601-0825.2009.01596.x; Lee YQ, 2011, EUR ARCH OTO-RHINO-L, V268, P609, DOI 10.1007/s00405-010-1387-8; LEWIS MAO, 1986, BRIT DENT J, V161, P299, DOI 10.1038/sj.bdj.4805959; LEWIS MAO, 1990, BRIT J ORAL MAX SURG, V28, P359, DOI 10.1016/0266-4356(90)90032-G; LEWIS MAO, 1993, BRIT DENT J, V175, P169, DOI 10.1038/sj.bdj.4808263; Makeieff M, 2004, LARYNGOSCOPE, V114, P772, DOI 10.1097/00005537-200404000-00035; Marshman Z, 2010, BRIT DENT J, V209, DOI [10.1038/sj.bdj.2010.819, 10.1038/sj.bdj.2010.848]; Matthews Debora C, 2003, J Can Dent Assoc, V69, P660; Mora Renzo, 2004, Ear Nose Throat J, V83, P776; Pak JG, 2012, J ENDODONT, V38, P1170, DOI 10.1016/j.joen.2012.05.023; Pendlebury ME, 2004, DACULTY GEN DENTAL P; Robertson D, 2009, J MED MICROBIOL, V58, P155, DOI 10.1099/jmm.0.003517-0; Roche Y, 1997, J ANTIMICROB CHEMOTH, V40, P353, DOI 10.1093/jac/40.3.353; Runyon MS, 2004, ACAD EMERG MED, V11, P1268, DOI 10.1197/j.aem.2004.08.034; Seppanen L, 2011, J ORAL MAXIL SURG, V69, P986, DOI 10.1016/j.joms.2010.05.015; Seppanen L, 2008, J INFECTION, V57, P116, DOI 10.1016/j.jinf.2008.06.002; Srirompotong S, 2003, EUR ARCH OTO-RHINO-L, V260, P401, DOI 10.1007/s00405-003-0588-9; Surviving Sepsis Campaign, 2014, GUIDELINES; Thanos L, 2005, CARDIOVASC INTER RAD, V28, P196, DOI 10.1007/s00270-004-0003-y; Thomas SJ, 2008, BMJ-BRIT MED J, V336, P1219, DOI 10.1136/bmj.39549.605602.BE; VONKONOW L, 1992, EUR J CLIN MICROBIOL, V11, P1129; White DA, 2012, BRIT DENT J, V213, P567, DOI 10.1038/sj.bdj.2012.1088; Ylijoki S, 2001, J ORAL MAXIL SURG, V59, P867, DOI 10.1053/joms.2001.25017	34	24	24	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2015	350								h1300	10.1136/bmj.h1300	http://dx.doi.org/10.1136/bmj.h1300			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NO	25804417				2022-12-28	WOS:000352028800003
J	Venekamp, RP; Thompson, MJ; Rovers, MM				Venekamp, Roderick P.; Thompson, Matthew J.; Rovers, Maroeska M.			Systemic Corticosteroid Therapy for Acute Sinusitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ANTIBIOTICS		[Venekamp, Roderick P.] Univ Med Ctr Utrecht, Dept Otorhinolaryngol, Div Surg Specialties, NL-3508 GA Utrecht, Netherlands; [Venekamp, Roderick P.; Rovers, Maroeska M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Thompson, Matthew J.] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Rovers, Maroeska M.] Radboud Univ Nijmegen, Med Ctr, Dept Operating Rooms, NL-6525 ED Nijmegen, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Washington; University of Washington Seattle; Radboud University Nijmegen; Radboud University Nijmegen	Venekamp, RP (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, STR 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.	r.p.venekamp@umcutrecht.nl	Rovers, Maroeska/F-2969-2014	Rovers, Maroeska/0000-0002-3095-170X; Venekamp, Roderick P/0000-0002-1446-9614				Centers for Disease Control and Prevention, AC BACT RHIN; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gill JM, 2006, FAM MED, V38, P349; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS1, DOI 10.1016/j.otohns.2007.06.726; Venekamp RP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008115.pub3; Young J, 2008, LANCET, V371, P908, DOI 10.1016/S0140-6736(08)60416-X	6	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1258	1259		10.1001/jama.2014.14418	http://dx.doi.org/10.1001/jama.2014.14418			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25803348	Green Published			2022-12-28	WOS:000351435500026
J	Snyder, A				Snyder, Alison			John Evans Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1068	1068		10.1016/S0140-6736(15)60592-X	http://dx.doi.org/10.1016/S0140-6736(15)60592-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25802902				2022-12-28	WOS:000351270400015
J	Mohrin, M; Shin, JY; Liu, YF; Brown, K; Luo, HZ; Xi, YN; Haynes, CM; Chen, D				Mohrin, Mary; Shin, Jiyung; Liu, Yufei; Brown, Katharine; Luo, Hanzhi; Xi, Yannan; Haynes, Cole M.; Chen, Danica			A mitochondrial UPR-mediated metabolic checkpoint regulates hematopoietic stem cell aging	SCIENCE			English	Article							STRESS; GROWTH; HOMEOSTASIS; MECHANISMS; DISEASE	Deterioration of adult stem cells accounts for much of aging-associated compromised tissue maintenance. How stem cells maintain metabolic homeostasis remains elusive. Here, we identified a regulatory branch of the mitochondrial unfolded protein response (UPRmt), which is mediated by the interplay of SIRT7 and NRF1 and is coupled to cellular energy metabolism and proliferation. SIRT7 inactivation caused reduced quiescence, increased mitochondrial protein folding stress (PFSmt), and compromised regenerative capacity of hematopoietic stem cells (HSCs). SIRT7 expression was reduced in aged HSCs, and SIRT7 up-regulation improved the regenerative capacity of aged HSCs. These findings define the deregulation of a UPRmt-mediated metabolic checkpoint as a reversible contributing factor for HSC aging.	[Mohrin, Mary; Shin, Jiyung; Brown, Katharine; Luo, Hanzhi; Xi, Yannan; Chen, Danica] Univ Calif Berkeley, Program Metab Biol Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Liu, Yufei] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Haynes, Cole M.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Haynes, Cole M.] Weill Cornell Med Coll, Biochem Cell & Mol Biol Allied Program, New York, NY USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Memorial Sloan Kettering Cancer Center; Cornell University	Chen, D (corresponding author), Univ Calif Berkeley, Program Metab Biol Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	danicac@berkeley.edu		Liu, Yufei/0000-0003-3501-5790	NIH [R01 AG040990, R01AG040061, T32 AG000266]; Ellison Medical Foundation; Glenn Foundation; NSF Graduate Research Fellowship Program; Siebel Stem Cell Institute; NATIONAL INSTITUTE ON AGING [T32AG000266, R01AG040061, R01AG040990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn Foundation; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Siebel Stem Cell Institute; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Nolla, A. Valeros, and K. Heydari for cell sorting; R. Zalpuri for electron microscopy; U. Andersen for mass spectrometry; J. Kim for technical assistance; the Chua laboratory for SIRT7 antibody and constructs; and the Hoogenraad laboratory for OTC constructs. This work was supported by NIH R01 AG040990 (D.C.), R01AG040061 (C.M.H.), T32 AG000266 (M.M.), Ellison Medical Foundation (D.C.), Glenn Foundation (D.C.), NSF Graduate Research Fellowship Program (J.S.), and Siebel Stem Cell Institute (D.C. and M.M.). The supplementary materials contain additional data.	Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007; Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu J. Y., 2009, ACTA ACAD MED SINICA, V31, P724; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Ryu D, 2014, CELL METAB, V20, P856, DOI 10.1016/j.cmet.2014.08.001; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Shin JY, 2013, CELL REP, V5, P654, DOI 10.1016/j.celrep.2013.10.007; Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001; Vakhrusheva O, 2008, J PHYSIOL PHARMACOL, V59, P201; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Webb AE, 2013, CELL REP, V4, P477, DOI 10.1016/j.celrep.2013.06.035; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	25	308	319	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1374	1377		10.1126/science.aaa2361	http://dx.doi.org/10.1126/science.aaa2361			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792330	Green Accepted			2022-12-28	WOS:000351219600045
J	Berkley, S				Berkley, Seth			Share the risks of Ebola vaccine development	NATURE			English	Editorial Material									Gavi, Geneva, Switzerland		Berkley, S (corresponding author), Gavi, Geneva, Switzerland.	sberkley@gavi.org							0	2	2	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					263	263		10.1038/519263a	http://dx.doi.org/10.1038/519263a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25788059	Bronze			2022-12-28	WOS:000351171900004
J	Britton, J				Britton, John			Progress with the global tobacco epidemic	LANCET			English	Editorial Material							SMOKING		Univ Nottingham, City Hosp, UK Ctr Tobacco & Alcohol Studies, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Britton, J (corresponding author), Univ Nottingham, City Hosp, UK Ctr Tobacco & Alcohol Studies, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England.	j.britton@outlook.com			Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1, MR/K023195/1B] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abascal W, 2012, LANCET, V380, P1575, DOI 10.1016/S0140-6736(12)60826-5; Bilano V, 2015, LANCET, V385, P966, DOI 10.1016/S0140-6736(15)60264-1; British American Tobacco, 2013, ANN REV; Callard C, 2010, TOB CONTROL, V19, P285, DOI 10.1136/tc.2009.035071; Gilmore AB, 2015, LANCET, V385, P1029, DOI 10.1016/S0140-6736(15)60312-9; Jha P, 2000, BRIT MED J, V321, P358, DOI 10.1136/bmj.321.7257.358; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Office for National Statistics, 2013, AD SMOK HAB GREAT BR; World Health Organization, 2003, WHO FRAM CONV TOB CO	12	16	16	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					924	926		10.1016/S0140-6736(15)60498-6	http://dx.doi.org/10.1016/S0140-6736(15)60498-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD2EK	25784331				2022-12-28	WOS:000350886900009
J	Regules, JA; Beigel, JH; Paolino, KM; Voell, J; Castellano, AR; Hu, Z; Munoz, P; Moon, JE; Ruck, RC; Bennett, JW; Twomey, PS; Gutierrez, RL; Remich, SA; Hack, HR; Wisniewski, ML; Josleyn, MD; Kwilas, SA; Van Deusen, N; Mbaya, OT; Zhou, Y; Stanley, DA; Jing, W; Smith, KS; Shi, M; Ledgerwood, JE; Graham, BS; Sullivan, NJ; Jagodzinski, LL; Peel, SA; Alimonti, JB; Hooper, JW; Silvera, PM; Martin, BK; Monath, TP; Ramsey, WJ; Link, CJ; Lane, HC; Michael, NL; Davey, RT; Thomas, SJ				Regules, J. A.; Beigel, J. H.; Paolino, K. M.; Voell, J.; Castellano, A. R.; Hu, Z.; Munoz, P.; Moon, J. E.; Ruck, R. C.; Bennett, J. W.; Twomey, P. S.; Gutierrez, R. L.; Remich, S. A.; Hack, H. R.; Wisniewski, M. L.; Josleyn, M. D.; Kwilas, S. A.; Van Deusen, N.; Mbaya, O. T.; Zhou, Y.; Stanley, D. A.; Jing, W.; Smith, K. S.; Shi, M.; Ledgerwood, J. E.; Graham, B. S.; Sullivan, N. J.; Jagodzinski, L. L.; Peel, S. A.; Alimonti, J. B.; Hooper, J. W.; Silvera, P. M.; Martin, B. K.; Monath, T. P.; Ramsey, W. J.; Link, C. J.; Lane, H. C.; Michael, N. L.; Davey, R. T., Jr.; Thomas, S. J.		rVSV G-ZEBOV-GP Study Grp	A Recombinant Vesicular Stomatitis Virus Ebola Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONHUMAN-PRIMATES; MARBURG VIRUSES; VECTORS; PROTECTION; NEUROVIRULENCE; GLYCOPROTEINS; IMMUNIZATION; CHALLENGE	BACKGROUND The worst Ebola virus disease (EVD) outbreak in history has resulted in more than 28,000 cases and 11,000 deaths. We present the final results of two phase 1 trials of an attenuated, replication-competent, recombinant vesicular stomatitis virus (rVSV)-based vaccine candidate designed to prevent EVD. METHODS We conducted two phase 1, placebo-controlled, double-blind, dose-escalation trials of an rVSV-based vaccine candidate expressing the glycoprotein of a Zaire strain of Ebola virus (ZEBOV). A total of 39 adults at each site (78 participants in all) were consecutively enrolled into groups of 13. At each site, volunteers received one of three doses of the rVSV-ZEBOV vaccine (3 million plaque-forming units [PFU], 20 million PFU, or 100 million PFU) or placebo. Volunteers at one of the sites received a second dose at day 28. Safety and immunogenicity were assessed. RESULTS The most common adverse events were injection-site pain, fatigue, myalgia, and headache. Transient rVSV viremia was noted in all the vaccine recipients after dose 1. The rates of adverse events and viremia were lower after the second dose than after the first dose. By day 28, all the vaccine recipients had seroconversion as assessed by an enzyme-linked immunosorbent assay (ELISA) against the glycoprotein of the ZEBOV-Kikwit strain. At day 28, geometric mean titers of antibodies against ZEBOV glycoprotein were higher in the groups that received 20 million PFU or 100 million PFU than in the group that received 3 million PFU, as assessed by ELISA and by pseudovirion neutralization assay. A second dose at 28 days after dose 1 significantly increased antibody titers at day 56, but the effect was diminished at 6 months. CONCLUSIONS This Ebola vaccine candidate elicited anti-Ebola antibody responses. After vaccination, rVSV viremia occurred frequently but was transient. These results support further evaluation of the vaccine dose of 20 million PFU for preexposure prophylaxis and suggest that a second dose may boost antibody responses. (Funded by the National Institutes of Health and others; rVSV Delta G-ZEBOV-GP ClinicalTrials.gov numbers, NCT02269423 and NCT02280408.)	[Regules, J. A.; Paolino, K. M.; Castellano, A. R.; Moon, J. E.; Ruck, R. C.; Bennett, J. W.; Twomey, P. S.; Remich, S. A.; Hack, H. R.; Shi, M.; Jagodzinski, L. L.; Peel, S. A.; Michael, N. L.; Thomas, S. J.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Gutierrez, R. L.] Naval Med Res Ctr, Silver Spring, MD USA; [Beigel, J. H.; Jing, W.] Frederick Natl Lab Canc Res, Leidos Biomed Res, Frederick, MD USA; [Wisniewski, M. L.; Josleyn, M. D.; Kwilas, S. A.; Van Deusen, N.; Smith, K. S.; Hooper, J. W.; Silvera, P. M.] US Army Med Res Inst Infect Dis, Frederick, MD USA; [Voell, J.; Hu, Z.; Munoz, P.; Lane, H. C.; Davey, R. T., Jr.] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Mbaya, O. T.; Zhou, Y.; Stanley, D. A.; Ledgerwood, J. E.; Graham, B. S.; Sullivan, N. J.] NIAID, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Alimonti, J. B.] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Martin, B. K.; Monath, T. P.; Ramsey, W. J.; Link, C. J.] BioProtect Syst NewLink Genet, Ames, IA USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Naval Medical Research Center (NMRC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Public Health Agency of Canada	Regules, JA (corresponding author), Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.	jason.a.regules.mil@mail.mil	Beigel, John/AAQ-4289-2021; Moon, James E./B-6810-2011; Beigel, John H/GNP-2628-2022; Hooper, Jay/K-2362-2017; Graham, Barney S./AAC-5898-2019	Beigel, John/0000-0002-4879-4941; Moon, James E./0000-0002-9274-4554; Hooper, Jay/0000-0002-4475-0415; Graham, Barney S./0000-0001-8112-0853; Martin, Brian/0000-0002-4873-5351; Thomas, Stephen/0000-0002-8368-7682	Intramural Research Programs of the National Institute of Allergy and Infectious Diseases, NIH; National Cancer Institute, NIH [HHSN261200800001E]; Defense Threat Reduction Agency; Joint Vaccine Acquisition Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000984, ZIAAI000936] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute of Allergy and Infectious Diseases, NIH; National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Joint Vaccine Acquisition Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Intramural Research Programs of the National Institute of Allergy and Infectious Diseases, NIH; the National Cancer Institute, NIH (contract no. HHSN261200800001E); the Defense Threat Reduction Agency; and the Joint Vaccine Acquisition Program.	Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924; Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Food and Drug Administration (FDA), 2007, GUID IND TOX GRAD SC; Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004; Geisbert TW, 2011, J INFECT DIS, V204, pS1075, DOI 10.1093/infdis/jir349; Geisbert TW, 2008, VACCINE, V26, P6894, DOI 10.1016/j.vaccine.2008.09.082; Geisbert TW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000225; Henao-Restrepo AM, 2016, LANCET; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Hooper JW, NIH VIDEOCASTING POD; Huttner A, 2015, LANCET INFECT DIS, V15, P1156, DOI 10.1016/S1473-3099(15)00154-1; Johnson JE, 2007, VIROLOGY, V360, P36, DOI 10.1016/j.virol.2006.10.026; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kugelman JR, 2015, MBIO, V6, DOI 10.1128/mBio.02227-14; Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]; Marzi A, 2011, J BIOTERR BIODEF; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; Mire CE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001567; Qiu XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005547; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Watanabe S, 2000, J VIROL, V74, P10194, DOI 10.1128/JVI.74.21.10194-10201.2000; Wong G, 2014, VACCINE, V32, P5722, DOI 10.1016/j.vaccine.2014.08.028; Wong G, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004582; World Health Organisation, 2016, EB SIT REP 30 MARCH	27	227	230	0	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 26	2017	376	4					330	341		10.1056/NEJMoa1414216	http://dx.doi.org/10.1056/NEJMoa1414216			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ3KR	25830322	Bronze, Green Accepted			2022-12-28	WOS:000393111600008
J	Dawson, R; Diacon, AH; Everitt, D; van Niekerk, C; Donald, PR; Burger, DA; Schall, R; Spigelman, M; Conradie, A; Eisenach, K; Venter, A; Ive, P; Page-Shipp, L; Variava, E; Reither, K; Ntinginya, NE; Pym, A; von Groote-Bidlingmaier, F; Mendel, CM				Dawson, Rodney; Diacon, Andreas H.; Everitt, Daniel; van Niekerk, Christo; Donald, Peter R.; Burger, Divan A.; Schall, Robert; Spigelman, Melvin; Conradie, Almari; Eisenach, Kathleen; Venter, Amour; Ive, Prudence; Page-Shipp, Liesl; Variava, Ebrahim; Reither, Klaus; Ntinginya, Nyanda E.; Pym, Alexander; von Groote-Bidlingmaier, Florian; Mendel, Carl M.			Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis	LANCET			English	Article							EARLY BACTERICIDAL ACTIVITY; MYCOBACTERIUM-TUBERCULOSIS; PHARMACOKINETICS; ETHAMBUTOL	Background New antituberculosis regimens are urgently needed to shorten tuberculosis treatment. Following on from favourable assessment in a 2 week study, we investigated a novel regimen for efficacy and safety in drug-susceptible and multidrug-resistant (MDR) tuberculosis during the first 8 weeks of treatment. Methods We did this phase 2b study of bactericidal activity-defined as the decrease in colony forming units (CFUs) of Mycobacterium tuberculosis in the sputum of patients with microscopy smear-positive pulmonary tuberculosis-at eight sites in South Africa and Tanzania. We enrolled treatment-naive patients with drug-susceptible, pulmonary tuberculosis, who were randomly assigned by computer-generated sequences to receive either 8 weeks of moxifloxacin, 100 mg pretomanid (formerly known as PA-824), and pyrazinamide (MPa100Z regimen); moxifloxacin, 200 mg pretomanid, and pyrazinamide (MPa200Z regimen); or the current standard care for drug-susceptible pulmonary tuberculosis, isoniazid, rifampicin, PZA, and ethambutol (HRZE regimen). A group of patients with MDR tuberculosis received MPa200Z (DRMPa200Z group). The primary outcome was bactericidal activity measured by the mean daily rate of reduction in M tuberculosis CFUs per mL overnight sputum collected once a week, with joint Bayesian non-linear mixed-effects regression modelling. We also assessed safety and tolerability by monitoring adverse events. This study is registered with ClinicalTrials.gov, number NCT01498419. Findings Between March 24, 2012, and July 26, 2013 we enrolled 207 patients and randomly assigned them to treatment groups; we assigned 60 patients to the MPa100Z regimen, 62 to the MPa200Z regimen, and 59 to the HRZE regimen. We non-randomly assigned 26 patients with drug-resistant tuberculosis to the DRMPa200Z regimen. In patients with drug-susceptible tuberculosis, the bactericidal activity of MPa200Z (n=54) on days 0-56 (0.155, 95% Bayesian credibility interval 0.133-0.178) was significantly greater than for HRZE (n=54, 0.112, 0.093-0.131). DRMPa200Z (n=9) had bactericidal activity of 0.117 (0.070-0.174). The bactericidal activity on days 7-14 was strongly associated with bactericidal activity on days 7-56. Frequencies of adverse events were similar to standard treatment in all groups. The most common adverse event was hyperuricaemia in 59 (29%) patients (17 [28%] patients in MPa100Z group, 17 [27%] patients in MPa200Z group, 17 [29%] patients. in HRZE group, and 8 [31%] patients in DRMPa200Z group). Other common adverse events were nausea in (14 [23%] patients in MPa100Z group, 8 [13%] patients in MPa200Z group, 7 [12%] patients in HRZE group, and 8 [31%] patients in DRMPa200Z group) and vomiting (7 [12%] patients in MPa100Z group, 7 [11%] patients in MPa200Z group, 7 [12%] patients in HRZE group, and 4 [15%] patients in DRMPa200Z group). No on-treatment electrocardiogram occurrences of corrected QT interval more than 500 ms (an indicator of potential of ventricular tachyarrhythmia) were reported. No phenotypic resistance developed to any of the drugs in the regimen. Interpretation The combination of moxifloxacin, pretomanid, and pyrazinamide, was safe, well tolerated, and showed superior bactericidal activity in drug-susceptible tuberculosis during 8 weeks of treatment. Results were consistent between drug-susceptible and MDR tuberculosis. This new regimen is ready to enter phase 3 trials in patients with drug-susceptible tuberculosis and MDR-tuberculosis, with the goal of shortening and simplifying treatment.	[Dawson, Rodney] Univ Cape Town, Div Pulmonol, Lung Inst, ZA-7925 Cape Town, South Africa; [Dawson, Rodney] Univ Cape Town, Dept Med, Lung Inst, ZA-7925 Cape Town, South Africa; [Diacon, Andreas H.] Univ Stellenbosch, Div Physiol, Dept Med Biochem, ZA-7505 Tygerberg, South Africa; [Donald, Peter R.] Univ Stellenbosch, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, South Africa; [Venter, Amour] Univ Stellenbosch, MRC Ctr TB Res, ZA-7505 Tygerberg, South Africa; [Diacon, Andreas H.; von Groote-Bidlingmaier, Florian] TASK Appl Sci, Bellville, South Africa; [Everitt, Daniel; Spigelman, Melvin; Mendel, Carl M.] Global Alliance TB Drug Dev, New York, NY 10005 USA; [van Niekerk, Christo; Conradie, Almari] Global Alliance TB Drug Dev, Pretoria, South Africa; [Burger, Divan A.; Schall, Robert] Univ Orange Free State, Dept Math Stat & Actuarial Sci, Bloemfontein, South Africa; [Burger, Divan A.; Schall, Robert] Quintiles Biostat, Bloemfontein, South Africa; [Eisenach, Kathleen] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Venter, Amour] Task Appl Sci, Tygerberg, South Africa; [Ive, Prudence] Univ Witwatersrand, Clin HIV Res Unit, Johannesburg, South Africa; [Variava, Ebrahim] Univ Witwatersrand, Klerksdorp Tshepong Hosp Complex, Johannesburg, South Africa; [Page-Shipp, Liesl] Univ Witwatersrand, Dept Internal Med, Fac Hlth Sci, Johannesburg, South Africa; [Page-Shipp, Liesl] Aurum Inst, Johannesburg, South Africa; [Reither, Klaus] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Reither, Klaus] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Ntinginya, Nyanda E.] NIMR Mbeya Med Res Ctr, Mbeya, Tanzania; [Pym, Alexander] Nelson R Mandela Sch Med, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa	University of Cape Town; University of Cape Town; Stellenbosch University; Stellenbosch University; Stellenbosch University; University of the Free State; IQVIA; University of Arkansas System; University of Arkansas Medical Sciences; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Basel; Swiss Tropical & Public Health Institute; Ifakara Health Institute; University of Kwazulu Natal	Everitt, D (corresponding author), Global Alliance TB Drug Dev, New York, NY 10005 USA.	dan.everitt@tballiance.org	Burger, Divan Aristo A/V-1986-2017; Variava, Ebrahim/AAO-5717-2020	Burger, Divan Aristo A/0000-0001-8096-6371; Variava, Ebrahim/0000-0003-2888-789X; Reither, Klaus/0000-0001-6195-8237; Pym, Alexander/0000-0002-6260-8180	Global Alliance for TB Drug Development; Global Alliance for TB Drug Development (TB Alliance); Bill & Melinda Gates Foundation; US Agency for International Development; UK Department for International Development; Directorate General for International Cooperation of the Netherlands; Irish Aid; Australia Department of Foreign Affairs and Trade	Global Alliance for TB Drug Development; Global Alliance for TB Drug Development (TB Alliance); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); US Agency for International Development(United States Agency for International Development (USAID)); UK Department for International Development; Directorate General for International Cooperation of the Netherlands; Irish Aid(CGIAR); Australia Department of Foreign Affairs and Trade	Global Alliance for TB Drug Development.; This study was funded by the Global Alliance for TB Drug Development (TB Alliance). We thank all study participants and the supporters of the TB Alliance, including the Bill & Melinda Gates Foundation, the US Agency for International Development, the UK Department for International Development, the Directorate General for International Cooperation of the Netherlands, Irish Aid, and the Australia Department of Foreign Affairs and Trade.	Burger DA, 2015, J BIOPHARM STAT, V25, P1247, DOI 10.1080/10543406.2014.971170; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Davies GR, 2006, ANTIMICROB AGENTS CH, V50, P3154, DOI 10.1128/AAC.00774-05; Diacon AH, 2010, EUR J CLIN MICROBIOL, V29, P1561, DOI 10.1007/s10096-010-1043-7; Diacon AH, 2012, LANCET, V380, P986, DOI 10.1016/S0140-6736(12)61080-0; Diacon AH, 2010, ANTIMICROB AGENTS CH, V54, P3402, DOI 10.1128/AAC.01354-09; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; International Union Against Tuberculosis and Lung Disease, 2007, PRIOR TUB BACT SERV, V2nd; Li H, 2014, J CLIN MICROBIOL, V52, P260, DOI 10.1128/JCM.02285-13; Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312; NIAID Division of Microbiology and Infectious Diseases (DMID), 2007, AD TOX TABL IN PRESS; Nuermberger E, 2008, ANTIMICROB AGENTS CH, V52, P1522, DOI 10.1128/AAC.00074-08; Phillips PPJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063840; Rustomjee R, 2008, ANTIMICROB AGENTS CH, V52, P2831, DOI 10.1128/AAC.01204-07; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; Sloan D, 2011, PROG RESPIR RES, V40, P227; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894; Zumla AI, 2014, LANCET INFECT DIS, V14, P327, DOI 10.1016/S1473-3099(13)70328-1	21	171	182	2	44	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1738	1747		10.1016/S0140-6736(14)62002-X	http://dx.doi.org/10.1016/S0140-6736(14)62002-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH0PZ	25795076				2022-12-28	WOS:000353726000029
J	Tshefu, A; Lokangaka, A; Ngaima, S; Engmann, C; Esamai, F; Gisore, P; Ayede, AI; Falade, AG; Adejuyigbe, EA; Anyabolu, CH; Wammanda, RD; Ejembi, CL; Ogala, WN; Gram, L; Cousens, S				Tshefu, Antoinette; Lokangaka, Adrien; Ngaima, Serge; Engmann, Cyril; Esamai, Fabian; Gisore, Peter; Ayede, Adejumoke Idowu; Falade, Adegoke Gbadegesin; Adejuyigbe, Ebunoluwa A.; Anyabolu, Chineme Henry; Wammanda, Robinson D.; Ejembi, Clara L.; Ogala, William N.; Gram, Lu; Cousens, Simon		African Neonatal Sepsis Trial	Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial	LANCET			English	Article							CASE-MANAGEMENT; CARE-SEEKING; CHILDREN; BANGLADESH; PNEUMONIA; MORTALITY; NEWBORNS; SEPSIS	Background WHO recommends hospital-based treatment for young infants aged 0-59 days with clinical signs of possible serious bacterial infection, but most families in resource-poor settings cannot accept referral. We aimed to assess whether use of simplified antibiotic regimens to treat young infants with clinical signs of severe infection was as efficacious as an injectable procaine benzylpenicillin-gentamicin combination for 7 days for situations in which hospital referral was not possible. Methods In a multisite open-label equivalence trial in DR Congo, Kenya, and Nigeria, community health workers visited all newborn babies at home, identifying and referring unwell young infants to a study nurse. We stratified young infants with clinical signs of severe infection whose parents did not accept referral to hospital by age (0-6 days and 7-59 days), and randomly assigned each individual within these strata to receive one of the four treatment regimens. Randomisation was stratified by age group of infants. An age-stratified randomisation scheme with block size of eight was computer-generated off-site at WHO. The outcome assessor was masked. We randomly allocated infants to receive injectable procaine benzylpenicillin-gentamicin for 7 days (group A, reference group); injectable gentamicin and oral amoxicillin for 7 days (group B); injectable procaine benzylpenicillin-gentamicin for 2 days, then oral amoxicillin for 5 days (group C); or injectable gentamicin for 2 days and oral amoxicillin for 7 days (group D). Trained health professionals gave daily injections and the first dose of oral amoxicillin. Our primary outcome was treatment failure by day 8 after enrolment, defined as clinical deterioration, development of a serious adverse event (including death), no improvement by day 4, or not cured by day 8. Independent outcome assessors, who did not know the infant's treatment regimen, assessed study outcomes on days 4, 8, 11, and 15. Primary analysis was per protocol. We used a prespecified similarity margin of 5% to assess equivalence between regimens. This study is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12610000286044. Findings In Kenya and Nigeria, we started enrolment on April 4, 2011, and we enrolled the necessary number of young infants aged 7 days or older from Oct 17, 2011, to April 30, 2012. At these sites, we continued to enrol infants younger than 7 days until March 29, 2013. In DR Congo, we started enrolment on Sept 17, 2012, and continued until June 28, 2013. We randomly assigned 3564 young infants to either group A (n=894), group B (n=884), group C (n=896), or group D (n=890). We excluded 200 randomly assigned infants, who did not fulfil the predefined criteria of adherence to treatment and adequate follow-up. In the per-protocol analysis, 828 infants were included in group A, 826 in group B, 862 in group C, and 848 in group D. 67 (8%) infants failed treatment in group A compared with 51 (6%) infants in group B (risk difference -1.9%, 95% CI -4.4 to 0.1), 65 (8%) in group C (-0.6%, -3.1 to 2.0), and 46 (5%) in group D (-2.7%, -5.1 to 0.3). Treatment failure in groups B, C, and D was within the similarity margin compared with group A. During the 15 days after random allocation, 12 (1%) infants died in group A, compared with ten (1%) infants in group B, 20 (2%) infants in group C, and 11 (1%) infants in group D. An infant in group A had a serious adverse event other than death (injection abscess). Interpretation The three simplified regimens were as effective as injectable procaine benzylpenicillin-gentamicin for 7 days on an outpatient basis in young infants with clinical signs of severe infection, without signs of critical illness, and whose caregivers did not accept referral for hospital admission.	[Tshefu, Antoinette; Lokangaka, Adrien; Ngaima, Serge] Kinshasa Sch Publ Hlth, Dept Community Hlth, Kinshasa, DEM REP CONGO; [Engmann, Cyril] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC USA; [Engmann, Cyril] Univ N Carolina, Sch Med, Dept Maternal Child Hlth, Chapel Hill, NC USA; [Engmann, Cyril] Univ N Carolina, Sch Publ Hlth, Dept Pediat, Chapel Hill, NC USA; [Engmann, Cyril] Univ N Carolina, Sch Publ Hlth, Dept Maternal Child Hlth, Chapel Hill, NC USA; [Esamai, Fabian; Gisore, Peter] Moi Univ, Dept Child Hlth & Paediat, Sch Med, Eldoret 30100, Kenya; [Ayede, Adejumoke Idowu; Falade, Adegoke Gbadegesin] Univ Ibadan, Coll Med, Dept Paediat, Ibadan, Nigeria; [Ayede, Adejumoke Idowu; Falade, Adegoke Gbadegesin] Univ Coll Ibadan Hosp, Ibadan, Nigeria; [Adejuyigbe, Ebunoluwa A.; Anyabolu, Chineme Henry] Obafemi Awolowo Univ, Dept Paediat & Child Hlth, Ife, Nigeria; [Wammanda, Robinson D.; Ogala, William N.] Ahmadu Bello Univ, Teaching Hosp, Dept Paediat, Zaria, Nigeria; [Ejembi, Clara L.] Ahmadu Bello Univ, Teaching Hosp, Dept Community Med, Zaria, Nigeria; [Gram, Lu; Cousens, Simon] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1, England	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Moi University; University of Ibadan; Obafemi Awolowo University; Ahmadu Bello University; Ahmadu Bello University; University of London; London School of Hygiene & Tropical Medicine	Esamai, F (corresponding author), Moi Univ, Coll Hlth Sci, Sch Med, Dept Child Hlth & Paediat, Eldoret 30100, Kenya.	fesamai2007@gmail.com	ESAMAI, FABIAN/AAI-3268-2020	Adejuyigbe, Ebunoluwa/0000-0002-8671-4965	Bill & Melinda Gates Foundation; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Bill & Melinda Gates Foundation grant to WHO.	AFRIcan NEonatal Sepsis Trial Group, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS26, DOI 10.1097/INF.0b013e31829ff7d1; AFRIcan NEonatal Sepsis Trial Group, 2013, PEDIAT INFECT DIS S1, V32, pS33; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bhandari N, 1996, LANCET, V347, P1774, DOI 10.1016/S0140-6736(96)90856-9; Chowdhury EK, 2008, LANCET, V372, P822, DOI 10.1016/S0140-6736(08)61166-6; Darmstadt GL, 2009, J INFECT DIS, V200, P906, DOI 10.1086/605473; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Niermeyer S., 2003, PEDIAT DECISION MAKI, P584; Owais A, 2011, J PERINATOL, V31, P586, DOI 10.1038/jp.2010.191; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Siddiqi S, 2001, HEALTH POLICY PLANN, V16, P193, DOI 10.1093/heapol/16.2.193; SUTRISNA B, 1993, LANCET, V342, P787, DOI 10.1016/0140-6736(93)91545-W; UN Inter-Agency Group for Child Mortality Estimation, 2014, LEV TRENDS CHILD MOR; Wall Stephen N, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS39, DOI 10.1097/INF.0b013e31829ff801; WHO, 2008, INT MAN CHILDH ILLN; World Health Organization, 2013, POCK BOOK HOSP CAR C; Zaidi Anita K M, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS7, DOI 10.1097/INF.0b013e31829ff5fc; Zaidi AKM, 2012, PEDIATR INFECT DIS J, V31, P667, DOI 10.1097/INF.0b013e318256f86c; Zaidi AKM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S13	21	90	90	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1767	1776		10.1016/S0140-6736(14)62284-4	http://dx.doi.org/10.1016/S0140-6736(14)62284-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH0PZ	25842221				2022-12-28	WOS:000353726000032
J	Egnatchik, RA; DeBerardinis, RJ				Egnatchik, Robert A.; DeBerardinis, Ralph J.			METABOLISM Growth in the fat lane	NATURE			English	Editorial Material							CELL; ACETYLATION	Analysis of endothelial cells, which are involved in blood-vessel formation, unexpectedly reveals that proliferation in this cell type depends on fatty-acid oxidation to support DNA synthesis. See Article p. 192	[Egnatchik, Robert A.; DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Egnatchik, RA (corresponding author), Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA.	ralph.deberardinis@utsouthwestern.edu						Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097	8	3	3	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					165	166		10.1038/nature14375	http://dx.doi.org/10.1038/nature14375			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25830890				2022-12-28	WOS:000352454600025
J	Kowalik, KM; Shimada, Y; Flury, V; Stadler, MB; Batki, J; Buhler, M				Kowalik, Katarzyna Maria; Shimada, Yukiko; Flury, Valentin; Stadler, Michael Beda; Batki, Julia; Buehler, Marc			The Paf1 complex represses small-RNA-mediated epigenetic gene silencing	NATURE			English	Article							DOUBLE-STRANDED-RNA; POLYMERASE-II; HUMAN-CELLS; FISSION YEAST; HISTONE H3; HETEROCHROMATIN; TRANSCRIPTION; METHYLATION; RITS; INTERFERENCE	RNA interference (RNAi) refers to the ability of exogenously introduced double-stranded RNA to silence expression of homologous sequences. Silencing is initiated when the enzyme Dicer processes the double-stranded RNA into small interfering RNAs (siRNAs). Small RNA molecules are incorporated into Argonaute-protein-containing effector complexes, which they guide to complementary targets to mediate different types of gene silencing, specifically post-transcriptional gene silencing and chromatin-dependent gene silencing(1). Although endogenous small RNAs have crucial roles in chromatin-mediated processes across kingdoms, efforts to initiate chromatin modifications in trans by using siRNAs have been inherently difficult to achieve in all eukaryotic cells. Using fission yeast, here we show that RNAi-directed heterochromatin formation is negatively controlled by the highly conserved RNA polymerase-associated factor 1 complex (Paf1C). Temporary expression of a synthetic hairpin RNA in Paf1C mutants triggers stable heterochromatin formation at homologous loci, effectively silencing genes in trans. This repressed state is propagated across generations by the continual production of secondary siRNAs, independently of the synthetic hairpin RNA. Our data support a model in which Paf1C prevents targeting of nascent transcripts by the siRNA-containing RNA-induced transcriptional silencing complex and thereby epigenetic gene silencing, by promoting efficient transcription termination and rapid release of the RNA from the site of transcription. We show that although compromised transcription termination is sufficient to initiate the formation of bi-stable heterochromatin by trans-acting siRNAs, impairment of both transcription termination and nascent transcript release is imperative to confer stability to the repressed state. Our work uncovers a novel mechanism for small-RNA-mediated epigenome regulation and highlights fundamental roles for Paf1C and the RNAi machinery in building epigenetic memory.	[Kowalik, Katarzyna Maria; Shimada, Yukiko; Flury, Valentin; Stadler, Michael Beda; Buehler, Marc] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Kowalik, Katarzyna Maria; Shimada, Yukiko; Flury, Valentin; Stadler, Michael Beda; Buehler, Marc] Univ Basel, CH-4003 Basel, Switzerland; [Stadler, Michael Beda] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland; [Batki, Julia] Eotvos Lorand Univ, Fac Sci, Inst Chem, H-1117 Budapest, Hungary	Friedrich Miescher Institute for Biomedical Research; University of Basel; Swiss Institute of Bioinformatics; Eotvos Lorand University; Hungarian Academy of Sciences	Buhler, M (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	marc.buehler@fmi.ch	Buehler, Marc/S-5866-2019	Buehler, Marc/0000-0001-6661-9795; Flury, Valentin/0000-0003-0476-4940	Swiss National Science Foundation; European Research Council; Boehringer Ingelheim Fonds; Novartis Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Novartis Research Foundation	We thank T. Iida for providing the plasmid encoding the ade6-hp construct, N. Laschet and R. Tsuji for technical assistance, S. Thiry for hybridizing tiling arrays, K. Jacobeit and S. Dessus-Babus for small RNA sequencing, T. Roloff for archiving data sets, M. Kirschmann for developing the Matlab script for colony counting, and A. Tuck for comments on the manuscript. This work was supported by funds from the Swiss National Science Foundation, the European Research Council, and the Boehringer Ingelheim Fonds. The Friedrich Miescher Institute for Biomedical Research is supported by the Novartis Research Foundation.	Aranda A, 2001, MOL CELL, V7, P1003, DOI 10.1016/S1097-2765(01)00235-0; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; Chandler VL, 2010, SCIENCE, V330, P628, DOI 10.1126/science.1191044; Cheung ACM, 2012, CELL, V149, P1431, DOI 10.1016/j.cell.2012.06.006; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Emmerth S, 2010, DEV CELL, V18, P102, DOI 10.1016/j.devcel.2009.11.011; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Keller C, 2012, MOL CELL, V47, P215, DOI 10.1016/j.molcel.2012.05.009; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Luteijn MJ, 2012, EMBO J, V31, P3422, DOI 10.1038/emboj.2012.213; Mbogning J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004029; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Napoli S, 2009, EMBO J, V28, P1708, DOI 10.1038/emboj.2009.139; Ponnusamy MP, 2009, STEM CELLS, V27, P3001, DOI 10.1002/stem.237; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Schalch T, 2009, MOL CELL, V34, P36, DOI 10.1016/j.molcel.2009.02.024; Simmer F, 2010, EMBO REP, V11, P112, DOI 10.1038/embor.2009.273; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yu R, 2014, MOL CELL, V53, P262, DOI 10.1016/j.molcel.2013.11.014	41	64	66	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					248	U294		10.1038/nature14337	http://dx.doi.org/10.1038/nature14337			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25807481	Green Accepted			2022-12-28	WOS:000352454600045
J	Treon, SP; Tripsas, CK; Meid, K; Warren, D; Varma, G; Green, R; Argyropoulos, KV; Yang, G; Cao, Y; Xu, L; Patterson, CJ; Rodig, S; Zehnder, JL; Aster, JC; Harris, NL; Kanan, S; Ghobrial, I; Castillo, JJ; Laubach, JP; Hunter, ZR; Salman, Z; Li, JL; Cheng, M; Clow, F; Graef, T; Palomba, ML; Advani, RH				Treon, Steven P.; Tripsas, Christina K.; Meid, Kirsten; Warren, Diane; Varma, Gaurav; Green, Rebecca; Argyropoulos, Kimon V.; Yang, Guang; Cao, Yang; Xu, Lian; Patterson, Christopher J.; Rodig, Scott; Zehnder, James L.; Aster, Jon C.; Harris, Nancy Lee; Kanan, Sandra; Ghobrial, Irene; Castillo, Jorge J.; Laubach, Jacob P.; Hunter, Zachary R.; Salman, Zeena; Li, Jianling; Cheng, Mei; Clow, Fong; Graef, Thorsten; Palomba, M. Lia; Advani, Ranjana H.			Ibrutinib in Previously Treated Waldenstrom's Macroglobulinemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONSENSUS PANEL RECOMMENDATIONS; 2ND INTERNATIONAL WORKSHOP; BRUTON TYROSINE KINASE; MYD88 L265P; MONOCLONAL GAMMOPATHY; SOMATIC MUTATION; TARGETING BTK; CXCR4; RESISTANCE; SURVIVAL	BACKGROUND MYD88(L265P) and CXCR4(WHIM) mutations are highly prevalent in Waldenstrom's macro-globulinemia. MYD88(L265P) triggers tumor-cell growth through Bruton's tyrosine kinase, a target of ibrutinib. CXCR4(WHIM) mutations confer in vitro resistance to ibrutinib. METHODS We performed a prospective study of ibrutinib in 63 symptomatic patients with Waldenstrom's macroglobulinemia who had received at least one previous treatment, and we investigated the effect of MYD88 and CXCR4 mutations on outcomes. Ibrutinib at a daily dose of 420 mg was administered orally until disease progression or the development of unacceptable toxic effects. RESULTS After the patients received ibrutinib, median serum IgM levels decreased from 3520 mg per deciliter to 880 mg per deciliter, median hemoglobin levels increased from 10.5 g per deciliter to 13.8 g per deciliter, and bone marrow involvement decreased from 60% to 25% (P< 0.01 for all comparisons). The median time to at least a minor response was 4 weeks. The overall response rate was 90.5%, and the major response rate was 73.0%; these rates were highest among patients with MYD88(L265P)CXCR4(WT) (with WT indicating wild-type) (100% overall response rate and 91.2% major response rate), followed by patients with MYD88(L265P)CXCR4(WHIM) (85.7% and 61.9%, respectively) and patients with MYD88(WT)CXCR4(WT) (71.4% and 28.6%). The estimated 2-year progression-free and overall survival rates among all patients were 69.1% and 95.2%, respectively. Treatment-related toxic effects of grade 2 or higher included neutropenia (in 22% of the patients) and thrombocytopenia (in 14%), which were more common in heavily pretreated patients; postprocedural bleeding (in 3%); epistaxis associated with the use of fish-oil supplements (in 3%); and atrial fibrillation associated with a history of arrhythmia (5%). CONCLUSIONS Ibrutinib was highly active, associated with durable responses, and safe in pretreated patients with Waldenstrm's macroglobulinemia. MYD88 and CXCR4 mutation status affected responses to this drug.	[Treon, Steven P.; Tripsas, Christina K.; Meid, Kirsten; Warren, Diane; Yang, Guang; Cao, Yang; Xu, Lian; Patterson, Christopher J.; Kanan, Sandra; Ghobrial, Irene; Castillo, Jorge J.; Laubach, Jacob P.; Hunter, Zachary R.] Dana Farber Canc Inst, Bing Ctr Waldenstroms Macroglobulinemia, Boston, MA 02115 USA; [Treon, Steven P.; Yang, Guang; Cao, Yang; Rodig, Scott; Aster, Jon C.; Harris, Nancy Lee; Ghobrial, Irene; Castillo, Jorge J.; Laubach, Jacob P.] Harvard Univ, Sch Med, Boston, MA USA; [Rodig, Scott; Aster, Jon C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Harris, Nancy Lee] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hunter, Zachary R.] Boston Univ, Med Ctr, Dept Pathol, Boston, MA USA; [Green, Rebecca; Argyropoulos, Kimon V.; Palomba, M. Lia] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Varma, Gaurav; Zehnder, James L.; Advani, Ranjana H.] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Salman, Zeena; Li, Jianling; Cheng, Mei; Clow, Fong; Graef, Thorsten] Pharmacyclics, Sunnyvale, CA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Boston University; Memorial Sloan Kettering Cancer Center; Stanford University; Pharmacyclics	Treon, SP (corresponding author), Dana Farber Canc Inst, Bing Ctr Waldenstroms Macroglobulinemia, M548,450 Brookline Ave, Boston, MA 02115 USA.	steven_treon@dfci.harvard.edu	Hunter, Zachary Richard/H-3018-2013; Dimopoulos, Meletios Athanasios/AAD-4130-2019; Rodig, Scott/Y-3889-2019; Castillo, Jorge J/H-4372-2019	Hunter, Zachary Richard/0000-0002-1689-1691; Castillo, Jorge J/0000-0001-9490-7532; Advani, Ranjana/0000-0002-3219-2292; Yang, Guang/0000-0003-3049-4200; Varma, Gaurav/0000-0002-1903-9170	Pharmacyclics; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Pharmacyclics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Pharmacyclics and others; ClinicalTrials.gov number, NCT01614821.	Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Anderson KC, 2012, J NATL COMPR CANC NE, V10, P1211, DOI 10.6004/jnccn.2012.0128; Byrd JC, 2014, NEW ENGL J MED, V371, P213, DOI 10.1056/NEJMoa1400376; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Cao Y, 2015, LEUKEMIA, V29, P169, DOI 10.1038/leu.2014.187; Cao Y, 2015, BRIT J HAEMATOL, V168, P701, DOI 10.1111/bjh.13200; Chen CI, 2007, J CLIN ONCOL, V25, P1570, DOI 10.1200/JCO.2006.07.8659; de Rooij MFM, 2012, BLOOD, V119, P2590, DOI 10.1182/blood-2011-11-390989; Dimopoulos MA, 2002, J CLIN ONCOL, V20, P2327, DOI 10.1200/JCO.2002.09.039; Dimopoulos MA, 2014, BLOOD, V124, P1404, DOI 10.1182/blood-2014-03-565135; Dotta L, 2011, CURR MOL MED, V11, P317, DOI 10.2174/156652411795677963; Herman SEM, 2014, LEUKEMIA, V28, P2188, DOI 10.1038/leu.2014.122; Hodge LS, 2014, BLOOD, V123, P1055, DOI 10.1182/blood-2013-08-521963; Hunter ZR, 2014, BLOOD, V123, P1637, DOI 10.1182/blood-2013-09-525808; Jimenez C, 2013, LEUKEMIA, V27, P1722, DOI 10.1038/leu.2013.62; Kyle RA, 2003, SEMIN ONCOL, V30, P116, DOI 10.1053/sonc.2003.50038; Leger JM, 2013, NEUROLOGY, V80, P2217, DOI 10.1212/WNL.0b013e318296e92b; Lunn MPT, 2016, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002827.pub4, 10.1002/14651858.CD002827.pub3]; Mahajan S, 2001, J BIOL CHEM, V276, P31216, DOI 10.1074/jbc.M104874200; McDermott DH, 2011, BLOOD, V118, P4957, DOI 10.1182/blood-2011-07-368084; Morel P, 2009, BLOOD, V113, P4163, DOI 10.1182/blood-2008-08-174961; Ngo HT, 2008, BLOOD, V112, P150, DOI 10.1182/blood-2007-12-129395; Owen RG, 2003, SEMIN ONCOL, V30, P110, DOI 10.1053/sonc.2003.50082; Poulain S, 2013, BLOOD, V121, P4504, DOI 10.1182/blood-2012-06-436329; Roccaro AM, 2014, BLOOD, V123, P4120, DOI 10.1182/blood-2014-03-564583; Strauss SJ, 2006, J CLIN ONCOL, V24, P2105, DOI 10.1200/JCO.2005.04.6789; Treon SP, 2011, 53 ASH ANN M EXP SAN; Treon SP, 2014, BLOOD, V123, P2791, DOI 10.1182/blood-2014-01-550905; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Treon SP, 2009, BLOOD, V114, P2375, DOI 10.1182/blood-2009-05-174359; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Xu L, 2014, LEUKEMIA, V28, P1698, DOI 10.1038/leu.2014.65; Xu L, 2013, BLOOD, V121, P2051, DOI 10.1182/blood-2012-09-454355; Yang G, 2013, BLOOD, V122, P1222, DOI 10.1182/blood-2012-12-475111	34	605	624	1	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2015	372	15					1430	1440		10.1056/NEJMoa1501548	http://dx.doi.org/10.1056/NEJMoa1501548			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF2ZV	25853747				2022-12-28	WOS:000352417900007
J	Loxterkamp, D; Snider, B				Loxterkamp, David; Snider, Bruce			What doctors have in common with architects-part 1: A manual art	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Loxterkamp, David] Seaport Community Hlth Ctr, Belfast, ME 04915 USA; [Snider, Bruce] US Residential Architecture, San Francisco, CA USA		Loxterkamp, D (corresponding author), Seaport Community Hlth Ctr, Belfast, ME 04915 USA.	david.loxterkamp@gmail.com						Starr P., 1982, BASIC BOOKS	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2015	350								h1810	10.1136/bmj.h1810	http://dx.doi.org/10.1136/bmj.h1810			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9SM	25850418				2022-12-28	WOS:000352906900010
J	Renati, S; Cukras, A; Bigby, M				Renati, Sruthi; Cukras, Anthony; Bigby, Michael			Pityriasis versicolor	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TINEA VERSICOLOR		[Renati, Sruthi] Harvard Univ, Sch Med, Boston, MA USA; [Cukras, Anthony; Bigby, Michael] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02215 USA; [Cukras, Anthony; Bigby, Michael] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Bigby, M (corresponding author), Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02215 USA.	mbigby@bidmc.harvard.edu						Faergemann J, 2002, ARCH DERMATOL, V138, P69, DOI 10.1001/archderm.138.1.69; Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI 10.1128/CMR.00021-11; Gupta AK, 2014, J CUTAN MED SURG, V18, P79, DOI 10.2310/7750.2013.13062; Han A, 2009, ARCH DERMATOL, V145, P1078, DOI 10.1001/archdermatol.2009.203; HELLGREN L, 1983, J MED MICROBIOL, V16, P501, DOI 10.1099/00222615-16-4-501; Hu SW, 2010, ARCH DERMATOL, V146, P1132, DOI 10.1001/archdermatol.2010.259; Kaymak Yesim, 2008, Dermatol Nurs, V20, P367; Kyriakis KP, 2006, MYCOSES, V49, P517, DOI 10.1111/j.1439-0507.2006.01285.x; Schwartz RA, 2004, LANCET, V364, P1173, DOI 10.1016/S0140-6736(04)17107-9; Szepietowski JC, 2000, KOREAN J MED MYCOL, V5, P108; US Food and Drug Administration, 2013, DRUG SAF COMM FDA LI	11	20	21	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2015	350								h1394	10.1136/bmj.h1394	http://dx.doi.org/10.1136/bmj.h1394			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9SM	25852089				2022-12-28	WOS:000352906900001
J	Mueller, KL				Mueller, Kristen L.			REALIZING THE PROMISE	SCIENCE			English	Editorial Material																			0	21	21	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					54	55		10.1126/science.348.6230.54	http://dx.doi.org/10.1126/science.348.6230.54			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8GJ	25838372				2022-12-28	WOS:000352079500025
J	Postma, DF; van Werkhoven, CH; van Elden, LJR; Thijsen, SFT; Hoepelman, AIM; Kluytmans, JAJW; Boersma, WG; Compaijen, CJ; van der Wall, E; Prins, JM; Oosterheert, JJ; Bonten, MJM				Postma, Douwe F.; van Werkhoven, Cornelis H.; van Elden, Leontine J. R.; Thijsen, Steven F. T.; Hoepelman, Andy I. M.; Kluytmans, Jan A. J. W.; Boersma, Wim G.; Compaijen, Clara J.; van der Wall, Eva; Prins, Jan M.; Oosterheert, Jan J.; Bonten, Marc J. M.		CAP-START Study Grp	Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-LACTAM MONOTHERAPY; ATYPICAL PATHOGENS; ECONOMIC BURDEN; CLINICAL-TRIALS; THERAPY; DESIGN; GUIDELINES; NONINFERIORITY; AZITHROMYCIN; MANAGEMENT	BACKGROUND The choice of empirical antibiotic treatment for patients with clinically suspected community-acquired pneumonia (CAP) who are admitted to non-intensive care unit (ICU) hospital wards is complicated by the limited availability of evidence. We compared strategies of empirical treatment (allowing deviations for medical reasons) with beta-lactam monotherapy, beta-lactam-macrolide combination therapy, or fluoroquinolone monotherapy. METHODS In a cluster-randomized, crossover trial with strategies rotated in 4-month periods, we tested the noninferiority of the beta-lactam strategy to the beta-lactam-macrolide and fluoroquinolone strategies with respect to 90-day mortality, in an intention-to-treat analysis, using a noninferiority margin of 3 percentage points and a two-sided 90% confidence interval. RESULTS A total of 656 patients were included during the beta-lactam strategy periods, 739 during the beta-lactam-macrolide strategy periods, and 888 during the fluoroquinolone strategy periods, with rates of adherence to the strategy of 93.0%, 88.0%, and 92.7%, respectively. The median age of the patients was 70 years. The crude 90-day mortality was 9.0% (59 patients), 11.1% (82 patients), and 8.8% (78 patients), respectively, during these strategy periods. In the intention-to-treat analysis, the risk of death was higher by 1.9 percentage points (90% confidence interval [CI], -0.6 to 4.4) with the beta-lactam-macrolide strategy than with the beta-lactam strategy and lower by 0.6 percentage points (90% CI, -2.8 to 1.9) with the fluoroquinolone strategy than with the beta-lactam strategy. These results indicated noninferiority of the beta-lactam strategy. The median length of hospital stay was 6 days for all strategies, and the median time to starting oral treatment was 3 days (interquartile range, 0 to 4) with the fluoroquinolone strategy and 4 days (interquartile range, 3 to 5) with the other strategies. CONCLUSIONS Among patients with clinically suspected CAP admitted to non-ICU wards, a strategy of preferred empirical treatment with beta-lactam monotherapy was noninferior to strategies with a beta-lactam-macrolide combination or fluoroquinolone monotherapy with regard to 90-day mortality.	[Postma, Douwe F.; van Werkhoven, Cornelis H.; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Postma, Douwe F.; Hoepelman, Andy I. M.; Oosterheert, Jan J.] Univ Med Ctr Utrecht, Dept Internal Med, NL-3508 GA Utrecht, Netherlands; [Postma, Douwe F.; Hoepelman, Andy I. M.; Oosterheert, Jan J.] Univ Med Ctr Utrecht, Dept Infect Dis, NL-3508 GA Utrecht, Netherlands; [Bonten, Marc J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3508 GA Utrecht, Netherlands; [Postma, Douwe F.] Diakonessenhuis Utrecht, Dept Internal Med, Utrecht, Netherlands; [van Elden, Leontine J. R.] Diakonessenhuis Utrecht, Dept Pulmonol, Utrecht, Netherlands; [Thijsen, Steven F. T.] Diakonessenhuis Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Kluytmans, Jan A. J. W.] Amphia Ziekenhuis Breda, Dept Med Microbiol, Breda, Netherlands; [Boersma, Wim G.] Med Ctr Alkmaar, Dept Pulmonol, Alkmaar, Netherlands; [Compaijen, Clara J.] Kennemer Gasthuis Haarlem, Dept Internal Med, Haarlem, Netherlands; [van der Wall, Eva] Spaarne Ziekenhuis, Dept Pulmonol, Hoofddorp, Netherlands; [Prins, Jan M.] Acad Med Ctr Amsterdam, Dept Internal Med, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Diakonessenhuis; Diakonessenhuis; Diakonessenhuis; Amphia Hospital; Medical Center Of Alkmaar; Spaarne Hospital; Spaarne Hospital; University of Amsterdam; Academic Medical Center Amsterdam	van Werkhoven, CH (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, POB 85500, NL-3508 GA Utrecht, Netherlands.	c.h.vanwerkhoven@umcutrecht.nl	Postma, Douwe F./AAB-9922-2022; Prins, Jan M./AAF-4945-2020; van Werkhoven, Henri/F-7915-2013	Postma, Douwe F./0000-0002-0675-8459; Van Elden, Leontine/0000-0002-3878-8927; Prins, Jan/0000-0002-5415-8933; Oosterheert, Jan Jelrik/0000-0001-6146-3808; van Werkhoven, Henri/0000-0002-0626-4635	Netherlands Organization for Health Research and Development	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	Funded by the Netherlands Organization for Health Research and Development; CAP-START ClinicalTrials.gov number, NCT01660204.	Bruns AHW, 2011, CLIN MICROBIOL INFEC, V17, P763, DOI 10.1111/j.1469-0691.2010.03296.x; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Dutch National Institute for Public Health and the Environment, 2014, VIR WEEKST; Eliakim-Raz N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004418.pub4; European Centre for Disease Prevention and Control Antimicrobial Resistance, 2012, ANTIMICROBIAL RESIST; Ewig S, 2011, J INFECTION, V62, P218, DOI 10.1016/j.jinf.2011.01.009; File TM, 2013, INFECT DIS CLIN N AM, V27, P99, DOI 10.1016/j.idc.2012.11.005; Fuller JD, 2005, CLIN INFECT DIS, V41, P118, DOI 10.1086/430829; Garin N, 2014, JAMA INTERN MED, V174, P1894, DOI 10.1001/jamainternmed.2014.4887; Grobbee DE, 1997, BRIT MED J, V315, P1151; Huijts SM, 2013, NETH J MED, V71, P502; Huijts SM, 2013, EUR RESPIR J, V42, P1283, DOI 10.1183/09031936.00137412; Kleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.x; Klugman KP, 2002, EUR RESPIR J, V20, p3S, DOI 10.1183/09031936.02.00400402; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mills GD, 2005, BMJ-BRIT MED J, V330, P456, DOI 10.1136/bmj.38334.591586.82; Morris AM, 2014, NEW ENGL J MED, V370, P1862, DOI 10.1056/NEJMc1402692; Oosterheert JJ, 2003, J ANTIMICROB CHEMOTH, V52, P555, DOI 10.1093/jac/dkg413; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Powers JH, 2008, CLIN INFECT DIS, V46, P1152, DOI 10.1086/533442; R Foundation, R PROJECT STAT COMPU; Rietbergen C, 2011, J EDUC BEHAV STAT, V36, P472, DOI 10.3102/1076998610379136; Schembri S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1235; Schouten JA, 2005, NETH J MED, V63, P323; Spellberg B, 2008, CLIN INFECT DIS, V47, pS249, DOI 10.1086/591411; Spellberg B, 2014, NEW ENGL J MED, V370, P1861, DOI 10.1056/NEJMc1402692; Tessmer A, 2009, J ANTIMICROB CHEMOTH, V63, P1025, DOI 10.1093/jac/dkp088; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; Thomas CP, 2012, CHEST, V142, P973, DOI 10.1378/chest.11-1160; van Buuren S, 2011, J STAT SOFTW, V45, P1; van der Hoek W, 2012, ADV EXP MED BIOL, V984, P329, DOI 10.1007/978-94-007-4315-1_17; van Werkhoven CH, 2014, NETH J MED, V72, P170; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Wiersinga WJ, 2012, NETH J MED, V70, P90; Wunderink RG, 2014, NEW ENGL J MED, V370, P1863, DOI 10.1056/NEJMc1402692; Yu H, 2012, J AM GERIATR SOC, V60, P2137, DOI 10.1111/j.1532-5415.2012.04208.x	40	230	240	3	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14					1312	1323		10.1056/NEJMoa1406330	http://dx.doi.org/10.1056/NEJMoa1406330			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NL	25830421				2022-12-28	WOS:000352028500006
J	Horne, R; Bell, JI; Montgomery, JR; Ravn, MO; Tooke, JE				Horne, Rob; Bell, John I.; Montgomery, Jonathan R.; Ravn, Morten O.; Tooke, John E.			A new social contract for medical innovation	LANCET			English	Editorial Material							HEALTH		[Horne, Rob] UCL, Sch Pharm, London WC1E 6BT, England; [Bell, John I.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Montgomery, Jonathan R.; Ravn, Morten O.; Tooke, John E.] UCL, London WC1E 6BT, England	University of London; University College London; University of London School of Pharmacy; University of Oxford; University of London; University College London	Tooke, JE (corresponding author), UCL, Mortimer St, London WC1E 6BT, England.	j.tooke@ucl.ac.uk	; Montgomery, Jonathan/G-6034-2014	Ravn, Morten/0000-0003-2703-2558; Montgomery, Jonathan/0000-0002-4592-0930	Asthma UK [AUK-AC-2012-01] Funding Source: researchfish	Asthma UK		Burkhauser RV, 2010, 15811 NAT BUR EC RES; Carter P, 2015, J MED ETHICS, V41, P404, DOI 10.1136/medethics-2014-102374; Claxton K, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19140; Department of Health Office for Life Sciences, 2014, REV MED INN TECHN FU; Dormont B, 2006, HEALTH ECON, V15, P947, DOI 10.1002/hec.1165; Green DW, 2013, COMPLEMENT THER MED, V21, P487, DOI 10.1016/j.ctim.2013.07.007; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Tooke John, 2015, Lancet, V385 Suppl 1, pS1, DOI 10.1016/S0140-6736(15)60317-8; World Health Organisation, 2003, ADHERENCE LONG TERM; Zerhouni EA, 2008, NATL I HLTH STRATEGI	10	12	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1153	1154		10.1016/S0140-6736(15)60607-9	http://dx.doi.org/10.1016/S0140-6736(15)60607-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CE3GQ	25845777				2022-12-28	WOS:000351715100004
J	Simpson, SJ; Le Couteur, DG; Raubenheimer, D				Simpson, Stephen J.; Le Couteur, David G.; Raubenheimer, David			Putting the Balance Back in Diet	CELL			English	Article							HIGH-PROTEIN-DIET; ENERGY-INTAKE; LIFE-SPAN; CALORIC RESTRICTION; LEVERAGE HYPOTHESIS; SWEDISH WOMEN; COHORT; POPULATION; MORTALITY; OBESITY	The notion of dietary balance is fundamental to health yet is not captured by focusing on the intake of energy or single nutrients. Advances in nutritional geometry have begun to unravel and integrate the interactive effects of multiple nutrients on health, lifespan, aging, and reproduction.	[Simpson, Stephen J.; Le Couteur, David G.; Raubenheimer, David] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Simpson, Stephen J.; Raubenheimer, David] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Le Couteur, David G.] Univ Sydney, Concord Hosp, Ageing & Alzheimers Inst, Sydney, NSW 2139, Australia; [Le Couteur, David G.] Univ Sydney, Concord Hosp, Ctr Educ & Res Aging, Sydney, NSW 2139, Australia; [Le Couteur, David G.] Univ Sydney, Concord Hosp, ANZAC Res Inst, Sydney, NSW 2139, Australia; [Raubenheimer, David] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Concord Repatriation General Hospital; University of Sydney; Concord Repatriation General Hospital; University of Sydney; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of Sydney	Simpson, SJ (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.	stephen.simpson@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016	Simpson, Stephen J./0000-0003-0256-7687; Raubenheimer, David/0000-0001-9050-1447; Le Couteur, David/0000-0002-4227-5817	National Health and Medical Research Council; Australian Research Council, Gravida; Ageing and Alzheimers Institute	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council, Gravida(Australian Research Council); Ageing and Alzheimers Institute	We acknowledge funding support from the National Health and Medical Research Council, Australian Research Council, Gravida (The National Research Centre for Growth and Development, New Zealand), and the Ageing and Alzheimers Institute for supporting the fruit fly and mice studies discussed in this essay. We also thank our colleagues who contributed to these studies.	[Anonymous], CELL METAB, V19, P418; Austin GL, 2013, J NUTR, V143, P1651, DOI 10.3945/jn.113.180067; Austin GL, 2011, AM J CLIN NUTR, V93, P836, DOI 10.3945/ajcn.110.000141; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Blumfield M, 2012, NUTRIENTS, V4, P1958, DOI 10.3390/nu4121958; Curtis J, 2013, METHODS MOL BIOL, V1077, P303, DOI 10.1007/978-1-62703-637-5_20; Everitt AV, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P1, DOI 10.1007/978-90-481-8556-6; Feinman RD, 2011, CURR DIABETES REP, V11, P128, DOI 10.1007/s11892-011-0178-y; Fung TT, 2010, ANN INTERN MED, V153, P289, DOI 10.7326/0003-4819-153-5-201009070-00003; Gosby AK, 2014, OBES REV, V15, P183, DOI 10.1111/obr.12131; Gosby AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025929; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Griffioen-Roose S, 2014, AM J CLIN NUTR, V100, P113, DOI 10.3945/ajcn.113.079392; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Lagiou P, 2007, J INTERN MED, V261, P366, DOI 10.1111/j.1365-2796.2007.01774.x; Lagiou P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4026; Le Couteur DG, 2012, J GERONTOL A-BIOL, V67, P168, DOI 10.1093/gerona/glr095; LeCouteur D.G., 2014, J GERONTOL A; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; Lihoreau M, 2014, J INSECT PHYSIOL, V69, P2, DOI 10.1016/j.jinsphys.2014.03.004; Martens EA, 2014, AM J CLIN NUTR, V99, P1397, DOI 10.3945/ajcn.113.078774; Martens EA, 2013, AM J CLIN NUTR, V97, P86, DOI 10.3945/ajcn.112.046540; Martinez-Cordero C, 2012, APPETITE, V59, P312, DOI 10.1016/j.appet.2012.05.013; Mattson MP, 2014, P NATL ACAD SCI USA, V111, P16647, DOI 10.1073/pnas.1413965111; Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005; Noto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055030; Pedersen AN, 2013, FOOD NUTR RES, V57, P1, DOI [10.3402/fnr.v57i0.21245, 10.3402/fnrv57i0.21245]; Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013; Raubenheimer D, 1997, NUTR RES REV, V10, P151, DOI 10.1079/NRR19970009; Raubenheimer D, 2015, BRIT J NUTR, V113, pS26, DOI 10.1017/S0007114514002323; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Ruohonen K, 2004, AQUACULT NUTR, V10, P145, DOI 10.1111/j.1365-2095.2004.00277.x; Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x; Simpson SJ, 2012, NATURE NUTR UNIFYING; Simpson SJ, 2014, NATURE, V508, pS66, DOI 10.1038/508S66a; Simpson SJ, 2009, AGING-US, V1, P875, DOI 10.18632/aging.100098; Sorensen A, 2008, OBESITY, V16, P566, DOI 10.1038/oby.2007.58; Speakman JR, 2014, PHYSIOLOGY, V29, P88, DOI 10.1152/physiol.00053.2013; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Tatar M, 2011, EXP GERONTOL, V46, P363, DOI 10.1016/j.exger.2010.12.002; Trichopoulou A, 2007, EUR J CLIN NUTR, V61, P575, DOI 10.1038/sj.ejcn.1602557; Wells JCK, 2006, BIOL REV, V81, P183, DOI 10.1017/S1464793105006974; Willett WC, 2011, J AM DIET ASSOC, V111, P660, DOI 10.1016/j.jada.2011.03.029	46	120	125	1	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					18	23		10.1016/j.cell.2015.02.033	http://dx.doi.org/10.1016/j.cell.2015.02.033			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815981	Bronze			2022-12-28	WOS:000351952200004
J	Cooper, NAM; Clark, TJ; Middleton, L; Diwakar, L; Smith, P; Denny, E; Roberts, T; Stobert, L; Jowett, S; Daniels, J				Cooper, Natalie A. M.; Clark, T. Justin; Middleton, Lee; Diwakar, Lavanya; Smith, Paul; Denny, Elaine; Roberts, Tracy; Stobert, Lynda; Jowett, Susan; Daniels, Jane		OPT Trial Collaborative Grp	Outpatient versus inpatient uterine polyp treatment for abnormal uterine bleeding: randomised controlled non-inferiority study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENDOMETRIAL POLYPS; PREMENOPAUSAL WOMEN; HYSTEROSCOPIC POLYPECTOMY; RESECTION	Objective To compare the effectiveness and acceptability of outpatient polypectomy with inpatient polypectomy. Design Pragmatic multicentre randomised controlled non-inferiority study. Setting Outpatient hysteroscopy clinics in 31 UK National Health Service hospitals. Participants 507 women who attended as outpatients for diagnostic hysteroscopy because of abnormal uterine bleeding and were found to have uterine polyps. Interventions Participants were randomly assigned to either outpatient uterine polypectomy under local anaesthetic or inpatient uterine polypectomy under general anaesthesia. Data were collected on women's self reported bleeding symptoms at baseline and at 6, 12, and 24 months. Data were also collected on pain and acceptability of the procedure at the time of polypectomy. Main outcome measures The primary outcome was successful treatment, determined by the women's assessment of bleeding at six months, with a prespecified non-inferiority margin of 25%. Secondary outcomes included generic (EQ-5D) and disease specific (menorrhagia multi-attribute scale) quality of life, and feasibility and acceptability of the procedure. Results 73% (166/228) of women in the outpatient group and 80%(168/211) in the inpatient group reported successful treatment at six months (intention to treat relative risk 0.91, 95% confidence interval 0.82 to 1.02; per protocol relative risk 0.92, 0.82 to 1.02). Failure to remove polyps was higher (19% v 7%; relative risk 2.5, 1.5 to 4.1) and acceptability of the procedure was lower (83% v 92%; 0.90, 0.84 to 0.97) in the outpatient group Quality of life did not differ significantly between the groups. Four uterine perforations, one of which necessitated bowel resection, all occurred in the inpatient group. Conclusions Outpatient polypectomy was non-inferior to inpatient polypectomy. Failure to remove a uterine polyp was, however, more likely with outpatient polypectomy and acceptability of the procedure was slightly lower.	[Cooper, Natalie A. M.] Queen Mary Univ London, Womens Hlth Res Unit, London, England; [Cooper, Natalie A. M.; Middleton, Lee; Daniels, Jane] Univ Birmingham, Robert Aitken Inst Clin Res, Coll Med & Dent Sci, OPT Trial Off,Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England; [Clark, T. Justin; Smith, Paul] Birmingham Womens NHS Fdn Trust, Birmingham, W Midlands, England; [Diwakar, Lavanya; Roberts, Tracy; Jowett, Susan] Univ Birmingham, Sch Hlth & Populat Sci, Hlth Econ Unit, Birmingham B15 2TT, W Midlands, England; [Smith, Paul] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Denny, Elaine] Birmingham City Univ, Ctr Hlth & Social Care Res, Birmingham, W Midlands, England; [Stobert, Lynda] Birmingham City Univ, Sch Allied & Publ Hlth Profess, Birmingham, W Midlands, England	University of London; Queen Mary University London; University of Birmingham; University of Birmingham; University of Birmingham; Birmingham City University; Birmingham City University	Clark, TJ (corresponding author), Birmingham Womens NHS Fdn Trust, Birmingham, W Midlands, England.	justin.clark@bwhct.nhs.uk	Roberts, Tracy/AAO-4610-2021; Diwakar, Lavanya/G-7425-2016; Jowett, Sue/AAO-4198-2021; Thornton, Jim/B-8336-2008; Petrou, Stavros/ABD-8323-2021	Roberts, Tracy/0000-0002-0624-0537; Diwakar, Lavanya/0000-0003-4369-6637; Jowett, Sue/0000-0001-8936-3745; Thornton, Jim/0000-0001-9764-6876; Middleton, Lee/0000-0003-4621-1922; Petrou, Stavros/0000-0003-3121-6050	National Institute of Health Research (NIHR) Health Technology Assessment Programme [06/404/84]; Medical Research Council [G0700452, G0501681] Funding Source: researchfish; MRC [G0700452, G0501681] Funding Source: UKRI	National Institute of Health Research (NIHR) Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study sponsors were the University of Birmingham and Birmingham Women's NHS Foundation Trust. The study was funded by the National Institute of Health Research (NIHR) Health Technology Assessment Programme (06/404/84). The views and opinions expressed in this article are those of the authors and do not necessarily reflect those of the NIHR Health Technology Assessment Programme, the NIHR, the National Health Service, or the English Department of Health.	AlHilli MM, 2013, J MINIM INVAS GYN, V20, P215, DOI 10.1016/j.jmig.2012.10.013; Bradlow J, 1992, PATTERNS OF REFERRAL; Cicinelli E, 2010, J MINIM INVASIVE S1, V17; Clark TJ, 2002, GYNAECOL ENDOSC, V11, P91, DOI 10.1046/j.1365-2508.2002.00485.x; Clark TJ, 2005, HDB OUTPATIENT HYSTE; Clevenger-Hoeft M, 1999, OBSTET GYNECOL, V94, P516, DOI 10.1016/S0029-7844(99)00345-2; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; Cravello L, 2000, EUR J OBSTET GYN R B, V93, P131, DOI 10.1016/S0301-2115(00)00281-5; Diago Almela VJ, 1998, PROG OBSTET GINECOL, V41, P347; Eidson JL, 2011, J SURG RES, V168, P5, DOI 10.1016/j.jss.2010.12.027; EuroQol Group, 2013, EUORQOL EQ 5D; Grant AM, 2005, HLTH TECHNOL ASSESS, V9; Henriquez DDCA, 2007, J MINIM INVAS GYN, V14, P59, DOI 10.1016/j.jmig.2006.07.008; Lasmar RB, 2008, FERTIL STERIL, V89, P1803, DOI 10.1016/j.fertnstert.2007.05.045; Lieng M, 2010, ACTA OBSTET GYN SCAN, V89, P992, DOI 10.3109/00016349.2010.493196; Lieng M, 2010, J MINIM INVAS GYN, V17, P351, DOI 10.1016/j.jmig.2010.01.019; Longman RJ, 2006, COLORECTAL DIS, V8, P145, DOI 10.1111/j.1463-1318.2005.00873.x; Marsh FA, 2006, BJOG-INT J OBSTET GY, V113, P896, DOI 10.1111/j.1471-0528.2006.00967.x; Marwah V, 2003, FERTIL STERIL, V79, P413, DOI 10.1016/S0015-0282(02)04689-7; Nagele F, 1996, OBSTET GYNECOL, V88, P87, DOI 10.1016/0029-7844(96)00108-1; Nagele F, 1996, GYNECOL ENDOSCOPY, V5, P137; Nathani F, 2006, J MINIM INVAS GYN, V13, P260, DOI 10.1016/j.jmig.2006.03.015; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Polena V, 2005, Gynecol Obstet Fertil, V33, P382, DOI 10.1016/j.gyobfe.2005.04.021; Prasad P, 2008, J MINIM INVAS GYN, V15, P476, DOI 10.1016/j.jmig.2008.04.005; Preutthipan S, 2005, FERTIL STERIL, V83, P705, DOI 10.1016/j.fertnstert.2004.08.031; Shaw RW, 1998, BRIT J OBSTET GYNAEC, V105, P1155, DOI 10.1111/j.1471-0528.1998.tb09968.x; Spencer CP, 1999, BRIT J OBSTET GYNAEC, V106, P623, DOI 10.1111/j.1471-0528.1999.tb08358.x; van Dongen H, 2007, BJOG-INT J OBSTET GY, V114, P664, DOI 10.1111/j.1471-0528.2007.01326.x; van Dongen H, 2009, BJOG-INT J OBSTET GY, V116, P1387, DOI 10.1111/j.1471-0528.2009.02145.x; Verbeke G, 2007, BIOSTATISTICS, V8, P772, DOI 10.1093/biostatistics/kxm004	31	30	31	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2015	350								h1398	10.1136/bmj.h1398	http://dx.doi.org/10.1136/bmj.h1398			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NK	25801579	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000352028400003
J	Tumbleston, JR; Shirvanyants, D; Ermoshkin, N; Janusziewicz, R; Johnson, AR; Kelly, D; Chen, K; Pinschmidt, R; Rolland, JP; Ermoshkin, A; Samulski, ET; DeSimone, JM				Tumbleston, John R.; Shirvanyants, David; Ermoshkin, Nikita; Janusziewicz, Rima; Johnson, Ashley R.; Kelly, David; Chen, Kai; Pinschmidt, Robert; Rolland, Jason P.; Ermoshkin, Alexander; Samulski, Edward T.; DeSimone, Joseph M.			Continuous liquid interface production of 3D objects	SCIENCE			English	Article							ULTRALIGHT	Additive manufacturing processes such as 3D printing use time-consuming, stepwise layer-by-layer approaches to object fabrication. We demonstrate the continuous generation of monolithic polymeric parts up to tens of centimeters in size with feature resolution below 100 micrometers. Continuous liquid interface production is achieved with an oxygen-permeable window below the ultraviolet image projection plane, which creates a "dead zone" (persistent liquid interface) where photopolymerization is inhibited between the window and the polymerizing part. We delineate critical control parameters and show that complex solid parts can be drawn out of the resin at rates of hundreds of millimeters per hour. These print speeds allow parts to be produced in minutes instead of hours.	[Tumbleston, John R.; Shirvanyants, David; Ermoshkin, Nikita; Kelly, David; Chen, Kai; Pinschmidt, Robert; Rolland, Jason P.; Ermoshkin, Alexander; Samulski, Edward T.; DeSimone, Joseph M.] Carbon3D Inc, Redwood City, CA 94063 USA; [Janusziewicz, Rima; Samulski, Edward T.; DeSimone, Joseph M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Johnson, Ashley R.] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Johnson, Ashley R.] N Carolina State Univ, Raleigh, NC 27695 USA; [DeSimone, Joseph M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Ermoshkin, A (corresponding author), Carbon3D Inc, Redwood City, CA 94063 USA.	alex@carbon3d.com; et@unc.edu; desimone@email.unc.edu			Carbon3D Inc.	Carbon3D Inc.	This work was sponsored by Carbon3D Inc. J.R.T., D.S., N.E., D.K., R.P., J.P.R., A.E., E.T.S., and J.M.D. all have an equity stake in Carbon3D Inc., which is a venture-backed startup company. Continuous liquid interface printing is the subject of patent protection including Patent Cooperation Treaty publication numbers WO 2014/126837 A2, WO 2014/126830 A2, and WO 2014/126834 A2, and others.	Atala A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004890; Bauer J, 2014, P NATL ACAD SCI USA, V111, P2453, DOI 10.1073/pnas.1315147111; Bauer S, 2014, ADV MATER, V26, P149, DOI 10.1002/adma.201303349; Chakraborty P, 2013, P NATL ACAD SCI USA, V110, P13368, DOI 10.1073/pnas.1305741110; Chisholm G, 2014, ENERG ENVIRON SCI, V7, P3026, DOI 10.1039/c4ee01426j; Cvetkovic C, 2014, P NATL ACAD SCI USA, V111, P10125, DOI 10.1073/pnas.1401577111; Dendukuri D, 2006, NAT MATER, V5, P365, DOI 10.1038/nmat1617; Dendukuri D, 2008, MACROMOLECULES, V41, P8547, DOI 10.1021/ma801219w; Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340; Duoss EB, 2014, ADV FUNCT MATER, V24, P4905, DOI 10.1002/adfm.201400451; Erkal JL, 2014, LAB CHIP, V14, P2023, DOI 10.1039/c4lc00171k; Gibson I., 2021, POWDER BED FUSION AD, P125, DOI [10.1016/j.addma.2020.101465, DOI 10.1016/J.ADDMA.2020.101465]; Gonzalez-Meijome JM, 2008, IND ENG CHEM RES, V47, P3619, DOI 10.1021/ie071403b; Gross BC, 2014, ANAL CHEM, V86, P3240, DOI 10.1021/ac403397r; Jacobs P.F., 1992, RAPID PROTOTYPING MA; Kitson PJ, 2014, CRYST GROWTH DES, V14, P2720, DOI 10.1021/cg5003012; Ligon SC, 2014, CHEM REV, V114, P557, DOI 10.1021/cr3005197; Lipson H., 2013, FABRICATED NEW WORLD; Lu Y, 2006, J BIOMED MATER RES A, V77A, P396, DOI 10.1002/jbm.a.30601; Merkel T.C., 2006, MAT SCI MEMBRANES GA, P251; Pearce JM, 2012, SCIENCE, V337, P1303, DOI 10.1126/science.1228183; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Sun K, 2013, ADV MATER, V25, P4539, DOI 10.1002/adma.201301036; Symes MD, 2012, NAT CHEM, V4, P349, DOI [10.1038/NCHEM.1313, 10.1038/nchem.1313]; Travitzky N, 2014, ADV ENG MATER, V16, P729, DOI 10.1002/adem.201400097; Yagci Y, 2010, MACROMOLECULES, V43, P6245, DOI 10.1021/ma1007545; Zheng XY, 2014, SCIENCE, V344, P1373, DOI 10.1126/science.1252291	28	1190	1406	98	1639	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1349	1352		10.1126/science.aaa2397	http://dx.doi.org/10.1126/science.aaa2397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25780246				2022-12-28	WOS:000351219600038
J	Poulter, NR; Prabhakaran, D; Caulfield, M				Poulter, Neil R.; Prabhakaran, Dorairaj; Caulfield, Mark			Hypertension	LANCET			English	Article							AMBULATORY BLOOD-PRESSURE; ALDOSTERONE-PRODUCING ADENOMAS; TRANSIENT ISCHEMIC ATTACK; CARDIOVASCULAR-DISEASE; RISK-FACTORS; RENAL DENERVATION; EUROPEAN-SOCIETY; URINARY SODIUM; GLOBAL BURDEN; ANTIHYPERTENSIVE THERAPY	Raised blood pressure is the biggest single contributor to the global burden of disease and to global mortality. The numbers of people affected and the prevalence of high blood pressure worldwide are expected to increase over the next decade. Preventive strategies are therefore urgently needed, especially in less developed countries, and management of hypertension must be optimised. Genetic advances in some rare causes of hypertension have been made lately, but the aggregate effect on blood pressure of all the genetic loci identified to date is small. Hence, intervention on key environmental determinants and effective implementation of trial-based therapies are needed. Three-drug combinations can control hypertension in about 90% of patients but only if resources allow identification of patients and drug delivery is affordable. Furthermore, assessment of optimal drug therapy for each ethnic group is needed.	[Poulter, Neil R.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London W2 1LA, England; [Prabhakaran, Dorairaj] Fdn India, Ctr Chron Dis Control & Publ Hlth, New Delhi, India; [Caulfield, Mark] Queen Mary Univ London, William Harvey Res Inst, London, England; [Caulfield, Mark] Queen Mary Univ London, NIHR Biomed Res Unit Cardiovasc Dis Barts, London, England	Imperial College London; University of London; Queen Mary University London; University of London; Queen Mary University London	Poulter, NR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London W2 1LA, England.	n.poulter@imperial.ac.uk	Prabhakaran, Dorairaj/B-4147-2011	Prabhakaran, Dorairaj/0000-0002-3172-834X; Caulfield, Mark/0000-0001-9295-3594	UK National Institute for Health Research Biomedical Research Centre; Medical Research Council [G9521010, MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10113] Funding Source: researchfish; MRC [G9521010] Funding Source: UKRI	UK National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NRP has received funding from the UK National Institute for Health Research Biomedical Research Centre funding scheme and holds a Senior Investigator Award.	Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Agodoa L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5680; Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Agyemang C, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-7; Alnima T, 2012, J HYPERTENS, V30, P1665, DOI 10.1097/HJH.0b013e3283551f10; Ambrosius WT, 2014, CLIN TRIALS, V11, P532, DOI 10.1177/1740774514537404; AMERY A, 1985, LANCET, V1, P1349; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; Anchala R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047064; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1982, NEW ENGL J MED, V307, P976; [Anonymous], 1987, LANCET, V2, P1351; [Anonymous], 1980, LANCET, V1, P1261; Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793; Aronow WS, 2011, CIRCULATION, V123, pE616, DOI [10.1161/CIR.0b013e318222d03f, 10.1161/CIR.0b013e31821daaf6]; Asayama K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001591; Banegas JR, 2014, EUR HEART J, V35, P3304, DOI 10.1093/eurheartj/ehu016; Baser Onur, 2011, J Med Econ, V14, P576, DOI 10.3111/13696998.2011.596873; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; BING RF, 1981, BRIT J CLIN PHARMACO, V12, P883, DOI 10.1111/j.1365-2125.1981.tb01325.x; Bouri S, 2014, HEART, V100, P456, DOI 10.1136/heartjnl-2013-304262; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Brguljan-Hitij J, 2014, AM J HYPERTENS, V27, P956, DOI 10.1093/ajh/hpu002; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Brown MJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8218; Brown MJ, 2011, LANCET, V377, P312, DOI 10.1016/S0140-6736(10)62003-X; Chalmers J, 1999, J HYPERTENS, V17, P151; Chapman N, 2007, HYPERTENSION, V49, P839, DOI 10.1161/01.HYP.0000259805.18468.8c; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Clark CE, 2012, LANCET, V379, P905, DOI 10.1016/S0140-6736(11)61710-8; Colhoun HM, 1998, J HUM HYPERTENS, V12, P91, DOI 10.1038/sj.jhh.1000558; Cook NR, 2014, CIRCULATION, V129, P981, DOI 10.1161/CIRCULATIONAHA.113.006032; Corrao G, 2011, HYPERTENSION, V58, P566, DOI 10.1161/HYPERTENSIONAHA.111.177592; Cuffe RL, 2006, STROKE, V37, P2776, DOI 10.1161/01.STR.0000244761.62073.05; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; de la Sierra A, 2012, J HYPERTENS, V30, P713, DOI 10.1097/HJH.0b013e328350bb40; Devi P, 2013, J HUM HYPERTENS, V27, P281, DOI 10.1038/jhh.2012.33; Egan BM, 2012, HYPERTENSION, V59, P1124, DOI 10.1161/HYPERTENSIONAHA.112.194167; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ekinci EI, 2011, DIABETES CARE, V34, P703, DOI 10.2337/dc10-1723; Ernst ME, 2006, HYPERTENSION, V47, P352, DOI 10.1161/01.HYP.0000203309.07140.d3; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Falaschetti E, 2014, LANCET, V383, P1912, DOI 10.1016/S0140-6736(14)60688-7; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Faul J, 2014, J VASC SURG, V59, P1078, DOI 10.1016/j.jvs.2013.10.069; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Go AS, 2014, HYPERTENSION, V63, P878, DOI 10.1161/HYP.0000000000000003; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Gupta AK, 2010, HYPERTENSION, V55, P399, DOI 10.1161/HYPERTENSIONAHA.109.139816; HELGELAND A, 1980, AM J MED, V69, P725, DOI 10.1016/0002-9343(80)90438-6; Howard SC, 2003, J CLIN EPIDEMIOL, V56, P1084, DOI 10.1016/S0895-4356(03)00267-1; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; James K, 2014, BLOOD PRESS MONIT, V19, P134, DOI 10.1097/MBP.0000000000000034; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kattah AG, 2013, ADV CHRONIC KIDNEY D, V20, P229, DOI 10.1053/j.ackd.2013.01.014; Kayima J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-54; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Lawes CMM, 2006, J HYPERTENS, V24, P423, DOI 10.1097/01.hjh.0000209973.67746.f0; Lehmann U, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-49; Lekoubou A, 2010, INT J ENV RES PUB HE, V7, P353, DOI 10.3390/ijerph7020353; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liang MY, 2013, SEMIN NEPHROL, V33, P392, DOI [10.1016/j.semnephro1.2013.05.011, 10.1016/j.semnephrol.2013.05.011]; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Liu LS, 2005, J HYPERTENS, V23, P2157, DOI 10.1097/01.hjh.0000194120.42722.ac; Liu LS, 1998, J HYPERTENS, V16, P1823, DOI 10.1097/00004872-199816120-00016; LIU LS, 1995, CHINESE MED J-PEKING, V108, P710; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; Lovibond K, 2011, LANCET, V378, P1219, DOI 10.1016/S0140-6736(11)61184-7; Mancia G, 2002, J HYPERTENS, V20, P1461, DOI 10.1097/00004872-200208000-00001; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; McBryde FD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3395; McNamara BJ, 2012, INT J EPIDEMIOL, V41, P1661, DOI 10.1093/ije/dys190; Mente A, PURE SODIUM HETEROGE; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Messerli FH, 2014, NEW ENGL J MED, V370, P1454, DOI 10.1056/NEJMe1402388; Messerli FH, 2011, J AM COLL CARDIOL, V57, P590, DOI 10.1016/j.jacc.2010.07.053; Morgado MP, 2011, AM J HEALTH-SYST PH, V68, P241, DOI 10.2146/ajhp090656; Munroe PB, 2013, CIRC RES, V112, P1365, DOI 10.1161/CIRCRESAHA.112.300387; NICE, 2011, GUID HYP CLIN MAN PR; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; O'Donnell MJ, 2013, EUR HEART J, V34, P1034, DOI 10.1093/eurheartj/ehs409; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Okin PM, 2012, J HYPERTENS, V30, P802, DOI 10.1097/HJH.0b013e3283516499; Park IU, 2007, ANN FAM MED, V5, P444, DOI 10.1370/afm.708; Park MJ, 2009, INT J MED INFORM, V78, P704, DOI 10.1016/j.ijmedinf.2009.06.004; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Peters SAE, 2013, STROKE, V44, P2394, DOI 10.1161/STROKEAHA.113.001624; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Rosei EA, 1997, J HYPERTENS, V15, P1337, DOI 10.1097/00004872-199715110-00019; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Schlaich MP, 2013, J AM COLL CARDIOL, V62, P2031, DOI 10.1016/j.jacc.2013.08.1616; Schmieder RE, 2013, EUROINTERVENTION, V9, pR58, DOI 10.4244/EIJV9SRA11; Scholl UI, 2012, P NATL ACAD SCI USA, V109, P2533, DOI 10.1073/pnas.1121407109; Sleight P, 2009, J HYPERTENS, V27, P1360, DOI 10.1097/HJH.0b013e32832d7370; Stergiou GS, 2014, HYPERTENSION, V63, P675, DOI 10.1161/HYPERTENSIONAHA.113.02741; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Thomas MC, 2011, DIABETES CARE, V34, P861, DOI 10.2337/dc10-1722; Tomaszewski M, 2014, HEART, V100, P855, DOI 10.1136/heartjnl-2013-305063; Tragante V, 2014, AM J HUM GENET, V94, P349, DOI 10.1016/j.ajhg.2013.12.016; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; Van Abeelen AFM, 2012, J HYPERTENS, V30, P2255, DOI 10.1097/HJH.0b013e3283588e0f; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801; Veterans Administration Cooperative Study Group, 1970, JAMA-J AM MED ASSOC, V213, P1143, DOI DOI 10.1001/JAMA.1970.03170330025003; Volpe M, 2007, J HYPERTENS, V25, P1491, DOI 10.1097/HJH.0b013e3280fa83a6; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wald DS, 2009, AM J MED, V122, P290, DOI 10.1016/j.amjmed.2008.09.038; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; Whelton PK, 2012, CIRCULATION, V126, P2880, DOI 10.1161/CIR.0b013e318279acbf; WHO, 2012, GUID SOD INT AD CHIL; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Wiysonge CS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002003.pub4; World Health Organisation, 2007, TASK SHIFT RAT RED T; World Health Organization Rotary International Centers for Disease Control and Prevention and UNICEF, 2013, GLOBAL ACTION PLAN P; Wright JT, 2014, ANN INTERN MED, V160, P499, DOI 10.7326/M13-2981; Yang WY, 2010, CURR MED RES OPIN, V26, P2065, DOI 10.1185/03007995.2010.494462; Zanchetti A, 2014, J HYPERTENS, V32, P1888, DOI 10.1097/HJH.0000000000000254; Zanchetti A, 2012, J HYPERTENS, V30, P660, DOI 10.1097/HJH.0b013e328351b4e4; Zhang Y, 2013, HYPERTENS RES, V36, P725, DOI 10.1038/hr.2013.33	140	426	465	14	132	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2015	386	9995					801	812		10.1016/S0140-6736(14)61468-9	http://dx.doi.org/10.1016/S0140-6736(14)61468-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0LR	25832858				2022-12-28	WOS:000360287900026
J	Tshefu, A; Lokangaka, A; Ngaima, S; Engmann, C; Esamai, F; Gisore, P; Ayede, AI; Falade, AG; Adejuyigbe, EA; Anyabolu, CH; Wammanda, RD; Ejembi, CL; Ogala, WN; Gram, L; Cousens, S				Tshefu, Antoinette; Lokangaka, Adrien; Ngaima, Serge; Engmann, Cyril; Esamai, Fabian; Gisore, Peter; Ayede, Adejumoke Idowu; Falade, Adegoke Gbadegesin; Adejuyigbe, Ebunoluwa A.; Anyabolu, Chineme Henry; Wammanda, Robinson D.; Ejembi, Clara L.; Ogala, William N.; Gram, Lu; Cousens, Simon		African Neonatal Sepsis Trial	Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial	LANCET			English	Article							CASE-MANAGEMENT; COMMUNITY; PNEUMONIA; CARE; BANGLADESH; MORTALITY; CHILDREN; SEPSIS; INFECTIONS; NEWBORNS	Background WHO recommends referral to hospital for possible serious bacterial infection in young infants aged 0-59 days. We aimed to assess whether oral amoxicillin treatment for fast breathing, in the absence of other signs, is as efficacious as the combination of injectable procaine benzylpenicillin-gentamicin. Methods In a randomised, open-label, equivalence trial at five sites in DR Congo, Kenya, and Nigeria, community health workers followed up all births in the community, identified unwell young infants, and referred them to study nurses. We randomly assigned infants with fast breathing as a single sign of illness or possible serious bacterial infection, whose parents did not accept referral to hospital, to receive either injectable procaine benzylpenicillin-gentamicin once per day or oral amoxicillin treatment twice per day for 7 days. A person who was off-site generated randomisation lists using computer software. Trained health professionals gave injections, but outcome assessors were masked to group allocations. The primary outcome was treatment failure by day 8 after enrolment, defined as clinical deterioration, development of a serious adverse event including death, persistence of fast breathing on day 4, or recurrence up to day 8. The primary analysis was per protocol and we used a prespecified similarity margin of 5% to assess equivalence between regimens. This study is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12610000286044. Findings From April 4, 2011, to March 29, 2013, we enrolled 2333 infants aged 0-59 days with fast breathing as the only sign of possible serious bacterial infection at the five study sites. We assigned 1170 infants to receive injectable procaine benzylpenicillin-gentamicin and 1163 infants to receive oral amoxicillin. In the per-protocol analysis, from which 137 infants were excluded, we included 1061 (91%) infants who fulfilled predefined criteria of adherence to treatment and adequate follow-up in the injectable procaine benzylpenicillin-gentamicin group and 1145 (98%) infants in the oral amoxicillin group. In the procaine benzylpenicillin-gentamicin group, 234 infants (22%) failed treatment, compared with 221 (19%) infants in the oral amoxicillin group (risk difference -2.6%, 95% CI -6.0 to 0.8). Four infants died within 15 days of follow-up in each group. We detected no drug-related serious adverse events. Interpretation Young infants with fast breathing alone can be effectively treated with oral amoxicillin on an outpatient basis when referral to a hospital is not possible.	[Tshefu, Antoinette; Lokangaka, Adrien; Ngaima, Serge] Kinshasa Sch Publ Hlth, Dept Community Hlth, Kinshasa, DEM REP CONGO; [Engmann, Cyril] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC USA; [Engmann, Cyril] Univ N Carolina, Sch Med, Dept Maternal Child Hlth, Chapel Hill, NC USA; [Engmann, Cyril] Univ N Carolina, Sch Publ Hlth, Dept Pediat, Chapel Hill, NC USA; [Engmann, Cyril] Univ N Carolina, Sch Publ Hlth, Dept Maternal Child Hlth, Chapel Hill, NC USA; [Esamai, Fabian; Gisore, Peter] Moi Univ, Sch Med, Dept Child Hlth & Paediat, Eldoret, Kenya; [Ayede, Adejumoke Idowu; Falade, Adegoke Gbadegesin] Univ Ibadan, Coll Med, Dept Paediat, Ibadan, Nigeria; [Ayede, Adejumoke Idowu; Falade, Adegoke Gbadegesin] Univ Coll Ibadan Hosp, Ibadan, Nigeria; [Adejuyigbe, Ebunoluwa A.; Anyabolu, Chineme Henry] Obafemi Awolowo Univ, Dept Paediat & Child Hlth, Ife, Nigeria; [Wammanda, Robinson D.; Ogala, William N.] Ahmadu Bello Univ, Dept Paediat, Teaching Hosp, Zaria, Nigeria; [Ejembi, Clara L.] Ahmadu Bello Univ, Teaching Hosp, Dept Community Med, Zaria, Nigeria; [Gram, Lu; Cousens, Simon] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1, England	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Moi University; University of Ibadan; Obafemi Awolowo University; Ahmadu Bello University; Ahmadu Bello University; University of London; London School of Hygiene & Tropical Medicine	Adejuyigbe, EA (corresponding author), Obafemi Awolowo Univ, Sch Med, Ife 220005, Osun State, Nigeria.	ebunadejuyigbe@hotmail.com	ESAMAI, FABIAN/AAI-3268-2020	Adejuyigbe, Ebunoluwa/0000-0002-8671-4965	Bill & Melinda Gates Foundation; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Bill & Melinda Gates Foundation grant to WHO.	AFRIcan NEonatal Sepsis Trial Group, 2013, PEDIAT INFECT DIS S1, V32, pS33; AFRIcan NEonatal Sepsis Trial Group, 2013, PEDIAT INFECT DIS S1, V32, pS26; BANG AT, 1993, ARCH DIS CHILD-FETAL, V68, P550, DOI 10.1136/adc.68.5_Spec_No.550; Bang AT, 2005, PEDIATR INFECT DIS J, V24, P335, DOI 10.1097/01.inf.0000157094.43609.17; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Baqui AH, 2009, PEDIATR INFECT DIS J, V28, P304, DOI 10.1097/INF.0b013e31819069e8; Bhandari N, 1996, LANCET, V347, P1774, DOI 10.1016/S0140-6736(96)90856-9; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Chowdhury EK, 2008, LANCET, V372, P822, DOI 10.1016/S0140-6736(08)61166-6; Darmstadt GL, 2009, J INFECT DIS, V200, P906, DOI 10.1086/605473; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Niermeyer S., 2003, PEDIAT DECISION MAKI, P584; Owais A, 2011, J PERINATOL, V31, P586, DOI 10.1038/jp.2010.191; Reddy M Hanimi, 2005, J Perinatol, V25 Suppl 1, pS44, DOI 10.1038/sj.jp.7211272; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Siddiqi S, 2001, HEALTH POLICY PLANN, V16, P193, DOI 10.1093/heapol/16.2.193; Wall Stephen N, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS39, DOI 10.1097/INF.0b013e31829ff801; WHO, 2008, INT MAN CHILDH ILLN; World Health Organization, 2013, POCK BOOK HOSP CAR C; Zaidi Anita K M, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS7, DOI 10.1097/INF.0b013e31829ff5fc; Zaidi AKM, 2012, PEDIATR INFECT DIS J, V31, P667, DOI 10.1097/INF.0b013e318256f86c; Zaidi AKM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S13	24	53	54	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1758	1766		10.1016/S0140-6736(14)62285-6	http://dx.doi.org/10.1016/S0140-6736(14)62285-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH0PZ	25842223				2022-12-28	WOS:000353726000031
J	Perrillo, RP; Martin, P; Lok, AS				Perrillo, Robert P.; Martin, Paul; Lok, Anna S.			Preventing Hepatitis B Reactivation Due to Immunosuppressive Drug Treatments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIRUS REACTIVATION; INFECTION PRIOR; RECOMMENDATIONS; CHEMOTHERAPY; LAMIVUDINE; LYMPHOMA; AGENTS		[Perrillo, Robert P.] Baylor Univ, Med Ctr, Hepatol Div, Dallas, TX USA; [Martin, Paul] Univ Miami, Div Hepatol, Miami, FL USA; [Lok, Anna S.] Univ Michigan, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA	Baylor University; Baylor University Medical Center; University of Miami; University of Michigan System; University of Michigan	Lok, AS (corresponding author), Univ Michigan Hlth Syst, Div Gastroenterol & Hepatol, 1500 E Med Ctr Dr,3912 Taubman Ctr,SPC 5362, Ann Arbor, MI 48109 USA.	aslok@umich.edu						Di Bisceglie AM, 2015, HEPATOLOGY, V61, P703, DOI 10.1002/hep.27609; HUANG H, 2014, JAMA, V312, P2521; Loomba R, 2008, ANN INTERN MED, V148, P519, DOI 10.7326/0003-4819-148-7-200804010-00008; Motaparthi K, 2014, J AM ACAD DERMATOL, V70, P178, DOI 10.1016/j.jaad.2013.08.049; Perrillo RP, 2015, GASTROENTEROLOGY, V148, P221, DOI 10.1053/j.gastro.2014.10.038; Seto WK, 2014, J CLIN ONCOL, V32, P3736, DOI 10.1200/JCO.2014.56.7081; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Stine JG, 2010, ARTHRIT CARE RES, V62, P704, DOI 10.1002/acr.20209; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Yeo W, 2004, BRIT J CANCER, V90, P1306, DOI 10.1038/sj.bjc.6601699	10	48	48	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1617	1618		10.1001/jama.2015.2571	http://dx.doi.org/10.1001/jama.2015.2571			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25790287				2022-12-28	WOS:000353595200008
J	Touboul, M; Puchtel, IS; Walker, RJ				Touboul, Mathieu; Puchtel, Igor S.; Walker, Richard J.			Tungsten isotopic evidence for disproportional late accretion to the Earth and Moon	NATURE			English	Article							SIDEROPHILE ELEMENT CONSTRAINTS; CORE FORMATION; GIANT IMPACT; DIFFERENTIATION; OSMIUM; AGE; SYSTEMATICS; HF; METEORITES; EVOLUTION	Characterization of the hafnium-tungsten systematics (Hf-182 decaying to W-182 and emitting two electrons with a half-life of 8.9 million years) of the lunar mantle will enable better constraints on the timescale and processes involved in the currently accepted giant-impact theory for the formation and evolution of the Moon, and for testing the late-accretion hypothesis. Uniform, terrestrial-mantle-like W isotopic compositions have been reported(1,2) among crystallization products of the lunar magma ocean. These observations were interpreted to reflect formation of the Moon and crystallization of the lunar magma ocean after Hf-182 was no longer extant-that is, more than about 60 million years after the Solar System formed. Here we present W isotope data for three lunar samples that are more precise by a factor of >= 4 than those previously reported(1,2). The new data reveal that the lunar mantle has a well-resolved W-182 excess of 20.6 +/- 5.1 parts per million (+/- 2 standard deviations), relative to the modern terrestrial mantle. The offset between the mantles of the Moon and the modern Earth is best explained by assuming that the W isotopic compositions of the two bodies were identical immediately following formation of the Moon, and that they then diverged as a result of disproportional late accretion to the Earth and Moon(3,4). One implication of this model is that metal from the core of the Moon-forming impactor must have efficiently stripped the Earth's mantle of highly siderophile elements on its way to merge with the terrestrial core, requiring a substantial, but still poorly defined, level of metal-silicate equilibration.	[Touboul, Mathieu; Puchtel, Igor S.; Walker, Richard J.] Univ Maryland, Dept Geol, Isotope Geochem Lab, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Touboul, M (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, Lab Geol Lyon, Labex LIO, F-69364 Lyon 7, France.	mathieu.touboul@ens-lyon.fr; ipuchtel@umd.edu; rjwalker@umd.edu	, Igor/ABA-2434-2020; Walker, Richard/K-6869-2016	Walker, Richard/0000-0003-0348-2407	NASA [NNX13AF83G]	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by NASA Cosmochemistry grant NNX13AF83G. We thank the Lunar Sample Laboratory Facility at Johnson Space Center for the provision of appropriate samples for this study.	Arevalo R, 2008, EARTH PLANET SC LETT, V272, P656, DOI 10.1016/j.epsl.2008.05.031; Birck JL, 1997, GEOSTANDARD NEWSLETT, V21, P19, DOI 10.1111/j.1751-908X.1997.tb00528.x; Bottke WF, 2010, SCIENCE, V330, P1527, DOI 10.1126/science.1196874; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Chou CL., 1978, P 9 LUN SCI C, V1, P219; Cohen AS, 1996, ANAL CHIM ACTA, V332, P269, DOI 10.1016/0003-2670(96)00226-7; CREASER RA, 1991, GEOCHIM COSMOCHIM AC, V55, P397, DOI 10.1016/0016-7037(91)90427-7; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Deguen R, 2014, EARTH PLANET SC LETT, V391, P274, DOI 10.1016/j.epsl.2014.02.007; DROZD RJ, 1974, GEOCHIM COSMOCHIM AC, V38, P1625, DOI 10.1016/0016-7037(74)90178-1; Fischer-Godde M, 2012, GEOCHIM COSMOCHIM AC, V77, P135, DOI 10.1016/j.gca.2011.11.014; Halliday AN, 2008, PHILOS T R SOC A, V366, P4163, DOI 10.1098/rsta.2008.0209; Halliday AN, 2004, NATURE, V427, P505, DOI 10.1038/nature02275; Herwartz D, 2014, SCIENCE, V344, P1146, DOI 10.1126/science.1251117; Horan MF, 2003, CHEM GEOL, V196, P5, DOI 10.1016/S0009-2541(02)00405-9; Kleine T, 2005, SCIENCE, V310, P1671, DOI 10.1126/science.1118842; Kleine T, 2004, GEOCHIM COSMOCHIM AC, V68, P2935, DOI 10.1016/j.gca.2004.01.009; Konig S, 2011, GEOCHIM COSMOCHIM AC, V75, P2119, DOI 10.1016/j.gca.2011.01.031; Lee DC, 1997, SCIENCE, V278, P1098, DOI 10.1126/science.278.5340.1098; Leya I, 2000, EARTH PLANET SC LETT, V175, P1, DOI 10.1016/S0012-821X(99)00295-2; McCoy TJ, 2011, GEOCHIM COSMOCHIM AC, V75, P6821, DOI 10.1016/j.gca.2011.09.006; McLeod CL, 2014, EARTH PLANET SC LETT, V396, P179, DOI 10.1016/j.epsl.2014.04.007; Misra K. C., 1975, P LUNAR PLANET SCI C, V6, P615; Munker C, 2003, SCIENCE, V301, P84, DOI 10.1126/science.1084662; Norman MD, 2002, EARTH PLANET SC LETT, V202, P217, DOI 10.1016/S0012-821X(02)00780-X; Puchtel IS, 2014, GEOCHIM COSMOCHIM AC, V125, P394, DOI 10.1016/j.gca.2013.10.013; Righter K, 2003, GEOCHIM COSMOCHIM AC, V67, P2497, DOI 10.1016/S0016-7037(02)01349-2; Sharp M, 2014, GEOCHIM COSMOCHIM AC, V131, P62, DOI 10.1016/j.gca.2014.01.014; Stevenson DJ., 1990, ORIGIN EARTH, P231; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Touboul M, 2012, INT J MASS SPECTROM, V309, P109, DOI 10.1016/j.ijms.2011.08.033; Touboul M, 2009, ICARUS, V199, P245, DOI 10.1016/j.icarus.2008.11.018; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001; Yokoyama T, 2009, EARTH PLANET SC LETT, V279, P165, DOI 10.1016/j.epsl.2008.12.046	38	100	102	2	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					530	+		10.1038/nature14355	http://dx.doi.org/10.1038/nature14355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25855299	Green Accepted			2022-12-28	WOS:000353334500040
J	Steiner, ME; Ness, PM; Assmann, SF; Triulzi, DJ; Sloan, SR; Delaney, M; Granger, S; Bennett-Guerrero, E; Blajchman, MA; Scavo, V; Carson, JL; Levy, JH; Whitman, G; D'Andrea, P; Pulkrabek, S; Ortel, TL; Bornikova, L; Raife, T; Puca, KE; Kaufman, RM; Nuttall, GA; Young, PP; Youssef, S; Engelman, R; Greilich, PE; Miles, R; Josephson, CD; Bracey, A; Cooke, R; McCullough, J; Hunsaker, R; Uhl, L; McFarland, JG; Park, Y; Cushing, MM; Klodell, CT; Karanam, R; Roberts, PR; Dyke, C; Hod, EA; Stowell, CP				Steiner, M. E.; Ness, P. M.; Assmann, S. F.; Triulzi, D. J.; Sloan, S. R.; Delaney, M.; Granger, S.; Bennett-Guerrero, E.; Blajchman, M. A.; Scavo, V.; Carson, J. L.; Levy, J. H.; Whitman, G.; D'Andrea, P.; Pulkrabek, S.; Ortel, T. L.; Bornikova, L.; Raife, T.; Puca, K. E.; Kaufman, R. M.; Nuttall, G. A.; Young, P. P.; Youssef, S.; Engelman, R.; Greilich, P. E.; Miles, R.; Josephson, C. D.; Bracey, A.; Cooke, R.; McCullough, J.; Hunsaker, R.; Uhl, L.; McFarland, J. G.; Park, Y.; Cushing, M. M.; Klodell, C. T.; Karanam, R.; Roberts, P. R.; Dyke, C.; Hod, E. A.; Stowell, C. P.			Effects of Red-Cell Storage Duration on Patients Undergoing Cardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-CELLS; TRANSFUSION; TRIAL; AGE; MORBIDITY; MORTALITY; OUTCOMES	BACKGROUND Some observational studies have reported that transfusion of red-cell units that have been stored for more than 2 to 3 weeks is associated with serious, even fatal, adverse events. Patients undergoingcardiac surgery may be especially vulnerable to the adverse effects of transfusion. METHODS We conducted a randomized trial at multiple sites from 2010 to 2014. Participants 12 years of age or older who were undergoing complex cardiac surgery and were likely to undergo transfusion of red cells were randomly assigned to receive leukocyte-reduced red cells stored for 10 days or less (shorter-term storage group) or for 21 days or more (longer-term storage group) for all intraoperative and postoperative transfusions. The primary outcome was the change in Multiple Organ Dysfunction Score (MODS; range, 0 to 24, with higher scores indicating more severe organ dysfunction) from the preoperative score to the highest composite score through day 7 or the time of death or discharge. RESULTS The median storage time of red-cell units provided to the 1098 participants who received red-cell transfusion was 7 days in the shorter-term storage group and 28 days in the longer-term storage group. The mean change in MODS was an increase of 8.5 and 8.7 points, respectively (95% confidence interval for the difference, -0.6 to 0.3; P = 0.44). The 7-day mortality was 2.8% in the shorter-term storage group and 2.0% in the longer-term storage group (P = 0.43); 28-day mortality was 4.4% and 5.3%, respectively (P = 0.57). Adverse events did not differ significantly between groups except that hyperbilirubinemia was more common in the longer-term storage group. CONCLUSIONS The duration of red-cell storage was not associated with significant differences in the change in MODS. We did not find that the transfusion of red cells stored for 10 days or less was superior to the transfusion of red cells stored for 21 days or more among patients 12 years of age or older who were undergoing complex cardiac surgery.	[Steiner, M. E.; Pulkrabek, S.; McCullough, J.] Fairview Univ Med Ctr, Minneapolis, MN USA; [Nuttall, G. A.] Mayo Clin, Rochester, MN USA; [Ness, P. M.; Whitman, G.] Johns Hopkins Univ, Baltimore, MD USA; [Cooke, R.] Univ Maryland, Baltimore, MD 21201 USA; [Assmann, S. F.; Granger, S.] New England Res Inst, Data Coordinating Ctr, Watertown, MA 02172 USA; [Sloan, S. R.] Boston Childrens Hosp, Boston, MA USA; [Bornikova, L.; Stowell, C. P.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kaufman, R. M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Engelman, R.] Tufts Univ, Boston, MA 02111 USA; [Hunsaker, R.] St Elizabeths Med Ctr, Boston, MA USA; [Uhl, L.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Engelman, R.] Baystate Med Ctr, Springfield, MA USA; [Triulzi, D. J.; D'Andrea, P.] Univ Pittsburgh, Pittsburgh, PA USA; [Triulzi, D. J.; D'Andrea, P.] Univ Pittsburgh, Mercy Hosp, Pittsburgh, PA USA; [Delaney, M.] Puget Sound Blood Ctr, Seattle, WA 98104 USA; [Delaney, M.] Univ Washington, Seattle, WA 98195 USA; [Youssef, S.] Swedish Med Ctr, Seattle, WA USA; [Bennett-Guerrero, E.; Levy, J. H.; Ortel, T. L.] Duke Univ, Durham, NC USA; [Park, Y.] Univ N Carolina, Chapel Hill, NC USA; [Blajchman, M. A.] McMaster Univ, Hamilton, ON, Canada; [Scavo, V.] Indiana Ohio Heart, Ft Wayne, IN USA; [Scavo, V.] St Joseph Hosp, Ft Wayne, IN USA; [Carson, J. L.] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Karanam, R.] Newark Beth Israel Med Ctr, Newark, NJ USA; [Raife, T.] Univ Iowa, Iowa City, IA USA; [Puca, K. E.] Aurora St Lukes Med Ctr, Milwaukee, WI USA; [McFarland, J. G.] Med Coll Wisconsin, Froedtert Mem Lutheran Hosp, Milwaukee, WI 53226 USA; [Miles, R.] Aspirus Heart & Vasc Inst, Wausau, WI USA; [Young, P. P.] Vanderbilt Univ, Nashville, TN 37235 USA; [Greilich, P. E.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Josephson, C. D.] Emory Univ, Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Josephson, C. D.] Emory Univ Hosp, Atlanta, GA 30322 USA; [Bracey, A.] St Lukes Texas Heart Inst, Houston, TX USA; [Cushing, M. M.] Weill Cornell Med Coll, New York, NY USA; [Hod, E. A.] Columbia Univ, Med Ctr, New York, NY USA; [Klodell, C. T.] Univ Florida, Gainesville, FL USA; [Roberts, P. R.] Univ Oklahoma, Oklahoma City, OK USA; [Dyke, C.] Univ N Dakota, Sch Med & Hlth Sci, Fargo, ND USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota Hospital; Mayo Clinic; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; HealthCore, Inc; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Tufts University; St. Elizabeth's Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Baystate Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Puget Sound Blood Center; University of Washington; University of Washington Seattle; Swedish Medical Center; Duke University; University of North Carolina; University of North Carolina Chapel Hill; McMaster University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Newark Beth Israel Medical Center; University of Iowa; Medical College of Wisconsin; Vanderbilt University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University; Cornell University; Columbia University; State University System of Florida; University of Florida; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of North Dakota Grand Forks	Steiner, ME (corresponding author), Univ Minnesota, Dept Pediat, MB 532,2450 Riverside Ave, Minneapolis, MN 55454 USA.	stein083@umn.edu	Josephson, Cassandra/AFS-2243-2022; Kaufman, Richard M/E-8890-2018	Kaufman, Richard M/0000-0003-1520-4535; Cushing, Melissa/0000-0001-8042-1494	National Heart, Lung, and Blood Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072331, R01HL101382] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Heart, Lung, and Blood Institute; RECESS ClinicalTrials.gov number, NCT00991341.	Alghamdi AA, 2006, TRANSFUSION, V46, P1120, DOI 10.1111/j.1537-2995.2006.00860.x; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Bennett-Guerrero E, 2009, TRANSFUSION, V49, P1375, DOI 10.1111/j.1537-2995.2009.02152.x; de Watering LV, 2006, TRANSFUSION, V46, P1712, DOI 10.1111/j.1537-2995.00958.x; Edgren G, 2010, TRANSFUSION, V50, P1185, DOI 10.1111/j.1537-2995.2010.02583.x; Elahi MM, 2008, J CARDIOTHOR VASC AN, V22, P455, DOI 10.1053/j.jvca.2007.12.022; Fergusson DA, 2012, JAMA-J AM MED ASSOC, V308, P1443, DOI 10.1001/2012.jama.11953; Hebert PC, 2001, CRIT CARE MED, V29, P227, DOI 10.1097/00003246-200102000-00001; Hebert PC, 2005, ANESTH ANALG, V100, P1433, DOI 10.1213/01.ANE.0000148690.48803.27; Hess JR, 2006, VOX SANG, V91, P13, DOI 10.1111/j.1423-0410.2006.00778.x; Hess JR, 2010, TRANSFUS APHER SCI, V43, P51, DOI 10.1016/j.transci.2010.05.009; Hod EA, 2011, BLOOD, V118, P6675, DOI 10.1182/blood-2011-08-371849; Koch CG, 2006, CRIT CARE MED, V34, P1608, DOI 10.1097/01.CCM.0000217920.48559.D8; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Lacroix J, 2011, TRANSFUS MED REV, V25, P197, DOI 10.1016/j.tmrv.2011.03.001; Lelubre C, 2009, TRANSFUSION, V49, P1384, DOI 10.1111/j.1537-2995.2009.02211.x; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Roback JD, 2011, TECHNICAL MANUAL, P192; Somani A, 2010, TRANSFUS APHER SCI, V43, P61, DOI 10.1016/j.transci.2010.05.010; Steiner ME, 2010, TRANSFUS APHER SCI, V43, P107, DOI 10.1016/j.transci.2010.05.014; Triulzi DJ, 2010, TRANSFUS APHER SCI, V43, P95, DOI 10.1016/j.transci.2010.05.013; Tsai AG, 2010, TRANSFUS APHER SCI, V43, P69, DOI 10.1016/j.transci.2010.05.011; Vamvakas EC, 2010, TRANSFUSION, V50, P600, DOI 10.1111/j.1537-2995.2009.02465.x; van de Watering L, 2011, VOX SANG, V100, P36, DOI 10.1111/j.1423-0410.2010.01441.x; Whitaker BI, 2013, 2011 NATL BLODO COLL; Yap CH, 2008, ANN THORAC SURG, V86, P554, DOI 10.1016/j.athoracsur.2008.04.040; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0; Zimrin AB, 2009, VOX SANG, V96, P93, DOI 10.1111/j.1423-0410.2008.01117.x	28	318	326	3	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2015	372	15					1419	1429		10.1056/NEJMoa1414219	http://dx.doi.org/10.1056/NEJMoa1414219			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF2ZV	25853746	Green Accepted, Green Submitted			2022-12-28	WOS:000352417900006
J	Delitto, A; Piva, SR; Moore, CG; Fritz, JM; Wisniewski, SR; Josbeno, DA; Fye, M; Welch, WC				Delitto, Anthony; Piva, Sara R.; Moore, Charity G.; Fritz, Julie M.; Wisniewski, Stephen R.; Josbeno, Deborah A.; Fye, Mark; Welch, William C.			Surgery Versus Nonsurgical Treatment of Lumbar Spinal Stenosis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM OUTCOMES; CLINICALLY IMPORTANT DIFFERENCE; LOW-BACK-PAIN; MANAGEMENT; INTERVENTION; INSTRUMENTS; RELIABILITY; PREDICTORS; THERAPY; SF-36	Background: Primary care management decisions for patients with symptomatic lumbar spinal stenosis (LSS) are challenging, and nonsurgical guidance is limited by lack of evidence. Objective: To compare surgical decompression with physical therapy (PT) for LSS and evaluate sex differences. Design: Multisite randomized, controlled trial. (ClinicalTrials.gov: NCT00022776) Setting: Neurologic and orthopedic surgery departments and PT clinics. Participants: Surgical candidates with LSS aged 50 years or older who consented to surgery. Intervention: Surgical decompression or PT. Measurements: Primary outcome was physical function score on the Short Form-36 Health Survey at 2 years assessed by masked testers. Results: The study took place from November 2000 to September 2007. A total of 169 participants were randomly assigned and stratified by surgeon and sex (87 to surgery and 82 to PT), with 24-month follow-up completed by 74 and 73 participants in the surgery and PT groups, respectively. Mean improvement in physical function for the surgery and PT groups was 22.4 (95% CI, 16.9 to 27.9) and 19.2 (CI, 13.6 to 24.8), respectively. Intention-to-treat analyses revealed no difference between groups (24-month difference, 0.9 [CI, -7.9 to 9.6]). Sensitivity analyses using causal-effects methods to account for the high proportion of crossovers from PT to surgery (57%) showed no significant differences in physical function between groups. Limitation: Without a control group, it is not possible to judge success attributable to either intervention. Conclusion: Surgical decompression yielded similar effects to a PT regimen among patients with LSS who were surgical candidates. Patients and health care providers should engage in shared decision-making conversations that include full disclosure of evidence involving surgical and nonsurgical treatments for LSS.	Univ Pittsburgh, Pittsburgh, PA 16260 USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA 16260 USA; Univ Utah, Salt Lake City, UT USA; Univ Penn, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah; University of Pennsylvania	Delitto, A (corresponding author), Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Phys Therapy, 6035 Forbes Tower, Pittsburgh, PA 16260 USA.		Fritz, Julie/AAC-5638-2021	Wisniewski, Stephen/0000-0002-3877-9860; Patterson, Charity/0000-0002-0060-0124	National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR-NS45622]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	By the National Institutes of Health and National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant AR-NS45622; Dr. Delitto).	Amundsen T, 2000, SPINE, V25, P1424, DOI 10.1097/00007632-200006010-00016; Angst F, 2001, ARTHRIT RHEUM-ARTHR, V45, P384, DOI 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0; Atlas SJ, 2005, SPINE, V30, P936, DOI 10.1097/01.brs.0000158953.57966.c0; Atlas SJ, 2005, SPINE, V30, P927, DOI 10.1097/01.brs.0000158954.68522.2a; Atlas SJ, 2006, CLIN ORTHOP RELAT R, P198, DOI 10.1097/01.blo.0000198722.70138.96; Birkmeyer NJO, 2002, SPINE, V27, P1361, DOI 10.1097/00007632-200206150-00020; Boden SD, 1996, J BONE JOINT SURG AM, V78A, P114, DOI 10.2106/00004623-199601000-00017; Copay AG, 2008, SPINE J, V8, P968, DOI 10.1016/j.spinee.2007.11.006; Daltroy LH, 1996, SPINE, V21, P741, DOI 10.1097/00007632-199603150-00017; Davidson M, 2002, PHYS THER, V82, P8, DOI 10.1093/ptj/82.1.8; Deyo RA, 2010, SPINE J, V10, P625, DOI 10.1016/j.spinee.2010.05.006; Fairbank J C, 1980, Physiotherapy, V66, P271; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Fritz JM, 1997, PHYS THER, V77, P962, DOI 10.1093/ptj/77.9.962; Fritz JM, 2014, SPINE J, V14, P1611, DOI 10.1016/j.spinee.2013.09.044; JOHNSSON KE, 1989, SPINE, V14, P591, DOI 10.1097/00007632-198906000-00008; Katz JN, 2008, NEW ENGL J MED, V358, P818, DOI 10.1056/NEJMcp0708097; Katz JN, 1999, SPINE, V24, P2229, DOI 10.1097/00007632-199911010-00010; KATZ JN, 1995, ARTHRITIS RHEUM, V38, P1236, DOI 10.1002/art.1780380910; Kim HJ, 2013, PAIN PHYSICIAN, V16, pE715; Knox CR, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-17; Lauridsen HH, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-82; Malmivaara A, 2007, SPINE, V32, P1, DOI 10.1097/01.brs.0000251014.81875.6d; Pearson A, 2012, SPINE, V37, P1791, DOI 10.1097/BRS.0b013e3182634b04; Radcliff KE, 2011, SPINE, V36, P2197, DOI 10.1097/BRS.0b013e3182341edf; Rihn JA, 2012, SPINE, V37, P1933, DOI 10.1097/BRS.0b013e31825e21b2; Rothman R.H., 1992, SPINE; Shabat S, 2005, EUR SPINE J, V14, P1027, DOI 10.1007/s00586-004-0808-z; Skrondal A., 2004, GEN LATENT VARIABLE; Toh Sengwee, 2008, Int J Biostat, V4, P22, DOI 10.2202/1557-4679.1117; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136; Weinstein JN, 2006, SPINE, V31, P2707, DOI 10.1097/01.brs.0000248132.15231.fe; Weinstein JN, 2010, SPINE, V35, P1329, DOI 10.1097/BRS.0b013e3181e0f04d; WIESEL SW, 1984, SPINE, V9, P549, DOI 10.1097/00007632-198409000-00003	35	90	92	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2015	162	7					465	U120		10.7326/M14-1420	http://dx.doi.org/10.7326/M14-1420			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4UT	25844995	Green Accepted			2022-12-28	WOS:000353283400001
J	Hoenen, T; Safronetz, D; Groseth, A; Wollenberg, KR; Koita, OA; Diarra, B; Fall, IS; Haidara, FC; Diallo, F; Sanogo, M; Sarro, YS; Kone, A; Togo, ACG; Traore, A; Kodio, M; Dosseh, A; Rosenke, K; de Wit, E; Feldmann, F; Ebihara, H; Munster, VJ; Zoon, KC; Feldmann, H; Sow, S				Hoenen, T.; Safronetz, D.; Groseth, A.; Wollenberg, K. R.; Koita, O. A.; Diarra, B.; Fall, I. S.; Haidara, F. C.; Diallo, F.; Sanogo, M.; Sarro, Y. S.; Kone, A.; Togo, A. C. G.; Traore, A.; Kodio, M.; Dosseh, A.; Rosenke, K.; de Wit, E.; Feldmann, F.; Ebihara, H.; Munster, V. J.; Zoon, K. C.; Feldmann, H.; Sow, S.			Mutation rate and genotype variation of Ebola virus from Mali case sequences	SCIENCE			English	Article							OUTBREAK; TRANSMISSION; CONGO	The occurrence of Ebola virus (EBOV) in West Africa during 2013-2015 is unprecedented. Early reports suggested that in this outbreak EBOV is mutating twice as fast as previously observed, which indicates the potential for changes in transmissibility and virulence and could render current molecular diagnostics and countermeasures ineffective. We have determined additional full-length sequences from two clusters of imported EBOV infections into Mali, and we show that the nucleotide substitution rate (9.6 x 10(-4) substitutions per site per year) is consistent with rates observed in Central African outbreaks. In addition, overall variation among all genotypes observed remains low. Thus, our data indicate that EBOV is not undergoing rapid evolution in humans during the current outbreak. This finding has important implications for outbreak response and public health decisions and should alleviate several previously raised concerns.	[Hoenen, T.; Safronetz, D.; Groseth, A.; Rosenke, K.; de Wit, E.; Ebihara, H.; Munster, V. J.; Feldmann, H.] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT 59840 USA; [Wollenberg, K. R.] NIAID, Bioinformat & Computat Biosci Branch, NIH, Bethesda, MD 20892 USA; [Koita, O. A.; Diarra, B.; Sanogo, M.; Sarro, Y. S.; Kone, A.; Togo, A. C. G.] Univ Sci Tech & Technol Bamako, Ctr Res & Training HIV & TB, Bamako, Mali; [Fall, I. S.] World Hlth Org Off, Bamako, Mali; [Haidara, F. C.; Diallo, F.; Traore, A.; Kodio, M.; Sow, S.] Minist Sante & Hyg Publ, Ctr Natl Appui Lutte Maladie, Ctr Dev Vaccins CVD Mali, Ctr Operat Urgence, Bamako, Mali; [Dosseh, A.] WHO, Inter Country Support Team, Ouagadougou, Burkina Faso; [Feldmann, F.] NIAID, Rocky Mt Vet Branch, Div Intramural Res, NIH, Hamilton, MT 59840 USA; [Zoon, K. C.] NIAID, Off Sci Director, NIH, Bethesda, MD 20895 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Science & Technology of Bamako; World Health Organization; World Health Organization; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Feldmann, H (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT 59840 USA.	feldmannh@niaid.nih.gov; ssow@medicine.umaryland.edu	Groseth, Allison/AAJ-9076-2020; Munster, Vincent/I-7607-2018; Hoenen, Thomas/H-8990-2019; de Wit, Emmie/A-1549-2019	Groseth, Allison/0000-0001-9528-5130; Munster, Vincent/0000-0002-2288-3196; Hoenen, Thomas/0000-0002-5829-6305; de Wit, Emmie/0000-0002-9763-7758; Diarra, Bassirou/0000-0002-1795-9379	Intramural Research Program of the NIH, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001190, ZIAAI001089, ZIAAI001136, ZIAAI001179] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Nichol and U. Stroher (U. S. Centers for Disease Control and Prevention); T. Schwan, R. Sakai, M. Niang, and M. Pineda (NIH, NIAID); and S. Diop, S. Tounkara, and F. Daou Centre de Recherche et de Formation sur le VIH/TB SEREFO for helpful discussion and help with logistics and sample preparation. We also thank the Research Technology Branch at the Rocky Mountain Laboratories, particularly S. Kramer, K. Barbian, and S. Porcella, for sequencing services. This study made use of the high-performance computational capabilities of the Biowulf Linux cluster at the NIH, Bethesda, MD (http://biowulf.nih.gov), and the Office of Cyber Infrastructure and Computational Biology High-Performance Computing cluster at the NIAID, Bethesda, MD. This work was supported in part by the Intramural Research Program of the NIH, NIAID. The full-length sequences of the Malian EBOVs were deposited at GenBank under the accession numbers KP260799.1, KP260800.1, KP260801.1, and KP260802.1 (Ebola virus/H.sapiens-wt/MLI/2014/Makona-Mali-DPR1 to 4). There are no conflicts of interest, material transfer agreements, patents, or patent applications that apply to reagents, methods, or data in the paper for any of the authors.	Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Biek R, 2006, PLOS PATHOG, V2, P885, DOI 10.1371/journal.ppat.0020090; Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12; Dowall SD, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0540-x; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Grolla A, 2012, ZOONOSES PUBLIC HLTH, V59, P151, DOI 10.1111/j.1863-2378.2012.01477.x; Groseth A, 2005, J VIROL, V79, P4425, DOI 10.1128/JVI.79.7.4425-4433.2005; Groseth A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002847; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291; Towner JS, 2006, J VIROL, V80, P6497, DOI 10.1128/JVI.00069-06; Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108; Walsh PD, 2005, PLOS BIOL, V3, P1946, DOI 10.1371/journal.pbio.0030371	14	101	105	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					117	119		10.1126/science.aaa5646	http://dx.doi.org/10.1126/science.aaa5646			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25814067				2022-12-28	WOS:000352079500039
J	Wu, SF; Buckley, S; Schaibley, JR; Feng, LF; Yan, JQ; Mandrus, DG; Hatami, F; Yao, W; Vuckovic, J; Majumdar, A; Xu, XD				Wu, Sanfeng; Buckley, Sonia; Schaibley, John R.; Feng, Liefeng; Yan, Jiaqiang; Mandrus, David G.; Hatami, Fariba; Yao, Wang; Vuckovic, Jelena; Majumdar, Arka; Xu, Xiaodong			Monolayer semiconductor nanocavity lasers with ultralow thresholds	NATURE			English	Article							TRANSITION; LINEWIDTH; DIODES	Engineering the electromagnetic environment of a nanometre-scale light emitter by use of a photonic cavity can significantly enhance its spontaneous emission rate, through cavity quantum electrodynamics in the Purcell regime. This effect can greatly reduce the lasing threshold of the emitter(1-5), providing a low-threshold laser system with small footprint, low power consumption and ultrafast modulation. An ultralow-threshold nanoscale laser has been successfully developed by embedding quantum dots into a photonic crystal cavity (PCC)(6-8). However, several challenges impede the practical application of this architecture, including the randompositions and compositional fluctuations of the dots(7), extreme difficulty in current injection(8), and lack of compatibility with electronic circuits(7,8). Here we report a new lasing strategy: an atomically thin crystalline semiconductor-that is, a tungsten diselenide monolayer-is non-destructively and deterministically introduced as a gain medium at the surface of a pre-fabricated PCC. A continuous-wave nanolaser operating in the visible regime is thereby achieved with an optical pumping threshold as low as 27 nanowatts at 130 kelvin, similar to the value achieved in quantum-dot PCC lasers(7). The key to the lasing action lies in the monolayer nature of the gain medium, which confines direct-gap excitons to within one nanometre of the PCC surface. The surface-gain geometry gives unprecedented accessibility and hence the ability to tailor gain properties via external controls such as electrostatic gating and current injection, enabling electrically pumped operation. Our scheme is scalable and compatible with integrated photonics for on-chip optical communication technologies.	[Wu, Sanfeng; Schaibley, John R.; Feng, Liefeng; Xu, Xiaodong] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Buckley, Sonia; Vuckovic, Jelena] Stanford Univ, Ginzton Lab, Stanford, CA 94305 USA; [Feng, Liefeng] Tianjin Univ, Dept Appl Phys, Tianjin 300072, Peoples R China; [Yan, Jiaqiang; Mandrus, David G.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Yan, Jiaqiang; Mandrus, David G.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA; [Mandrus, David G.] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; [Hatami, Fariba] Humboldt Univ, Dept Phys, D-12489 Berlin, Germany; [Yao, Wang] Univ Hong Kong, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Yao, Wang] Univ Hong Kong, Ctr Theoret & Computat Phys, Hong Kong, Hong Kong, Peoples R China; [Majumdar, Arka] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA; [Xu, Xiaodong] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Stanford University; Tianjin University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; Humboldt University of Berlin; University of Hong Kong; University of Hong Kong; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Xu, XD (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	arka@uw.edu; xuxd@uw.edu	Yao, Wang/C-1353-2008; Wu, Sanfeng/L-1323-2016; Vuckovic, Jelena/A-7335-2019; Kochubei, Viktoria/P-7623-2019	Yao, Wang/0000-0003-2883-4528; Wu, Sanfeng/0000-0002-6227-6286; Vuckovic, Jelena/0000-0002-4603-9686; Yan, Jiaqiang/0000-0001-6625-4706; Majumdar, Arka/0000-0003-0917-590X	AFOSR [FA9550-14-1-0277]; NSF [ECS-9731293]; State of Washington through the University of Washington Clean Energy Institute; Presidential Early Award for Scientists and Engineers (PECASE) [N00014-08-1-0561]; Stanford Graduate Fellowship; US DoE, BES, Materials Sciences and Engineering Division; European Commission [FP7-ICT-2013-613024-GRASP];  [NSF-EFRI-1433496]; Directorate For Engineering [1433496, 1542152] Funding Source: National Science Foundation	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); State of Washington through the University of Washington Clean Energy Institute; Presidential Early Award for Scientists and Engineers (PECASE); Stanford Graduate Fellowship(Stanford University); US DoE, BES, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); European Commission(European CommissionEuropean Commission Joint Research Centre); ; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank C. Dodson for helping with reflection measurements of nanocavities. This work was mainly supported by AFOSR (FA9550-14-1-0277). A.M. is supported by NSF-EFRI-1433496. Photonic crystal fabrication was performed in part at the Stanford Nanofabrication Facility of NNIN supported by the NSF under grant no. ECS-9731293, and at the Stanford Nano Center. S.W. was partially supported by the State of Washington through the University of Washington Clean Energy Institute. S.B. and J.V. were supported by the Presidential Early Award for Scientists and Engineers (PECASE) administered through the Office of Naval Research, under grant number N00014-08-1-0561. S.B. was also supported by a Stanford Graduate Fellowship. J.Y. and D.G.M. were supported by US DoE, BES, Materials Sciences and Engineering Division. F.H. acknowledges support from the European Commission (FP7-ICT-2013-613024-GRASP).	Baugher BWH, 2014, NAT NANOTECHNOL, V9, P262, DOI [10.1038/nnano.2014.25, 10.1038/NNANO.2014.25]; BJORK G, 1992, APPL PHYS LETT, V60, P304, DOI 10.1063/1.106693; BJORK G, 1994, PHYS REV A, V50, P1675, DOI 10.1103/PhysRevA.50.1675; Chalcraft ARA, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2748310; Ellis B, 2011, NAT PHOTONICS, V5, P297, DOI [10.1038/nphoton.2011.51, 10.1038/NPHOTON.2011.51]; Gan XT, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826679; HENRY CH, 1982, IEEE J QUANTUM ELECT, V18, P259, DOI 10.1109/JQE.1982.1071522; Hill MT, 2007, NAT PHOTONICS, V1, P589, DOI 10.1038/nphoton.2007.171; Jones AM, 2013, NAT NANOTECHNOL, V8, P634, DOI [10.1038/NNANO.2013.151, 10.1038/nnano.2013.151]; Khajavikhan M, 2012, NATURE, V482, P204, DOI 10.1038/nature10840; Liu X.-L., 2014, PREPRINT; Lopez-Sanchez O, 2013, NAT NANOTECHNOL, V8, P497, DOI [10.1038/NNANO.2013.100, 10.1038/nnano.2013.100]; Lu YJ, 2012, SCIENCE, V337, P450, DOI 10.1126/science.1223504; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Mak KF, 2013, NAT MATER, V12, P207, DOI [10.1038/NMAT3505, 10.1038/nmat3505]; Oulton RF, 2009, NATURE, V461, P629, DOI 10.1038/nature08364; Painter O, 1999, SCIENCE, V284, P1819, DOI 10.1126/science.284.5421.1819; Pospischil A, 2014, NAT NANOTECHNOL, V9, P257, DOI [10.1038/nnano.2014.14, 10.1038/NNANO.2014.14]; Radisavljevic B, 2013, NAT MATER, V12, P815, DOI [10.1038/NMAT3687, 10.1038/nmat3687]; Rivoire K, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2971200; Ross JS, 2014, NAT NANOTECHNOL, V9, P268, DOI [10.1038/nnano.2014.26, 10.1038/NNANO.2014.26]; Ross JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2498; Schwarz S, 2014, NANO LETT, V14, P7003, DOI 10.1021/nl503312x; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Strauf S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127404; Strauf S, 2011, LASER PHOTONICS REV, V5, P607, DOI 10.1002/lpor.201000039; Sundaram RS, 2013, NANO LETT, V13, P1416, DOI 10.1021/nl400516a; Tanaka Y, 2003, APPL PHYS LETT, V82, P1661, DOI 10.1063/1.1559947; Wu SF, 2014, 2D MATER, V1, DOI 10.1088/2053-1583/1/1/011001; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Xu XD, 2014, NAT PHYS, V10, P343, DOI [10.1038/NPHYS2942, 10.1038/nphys2942]	31	600	611	28	870	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					69	U142		10.1038/nature14290	http://dx.doi.org/10.1038/nature14290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25778703	Green Submitted			2022-12-28	WOS:000352027700038
J	Watts, G				Watts, Geoff			Wayne Jay Katon Psychiatrist and pioneer of US collaborative care. Born in Brooklyn, NY, USA, on Sept 14, 1950, he died from lymphoma in Seattle, WA, USA, on March 1, 2015 Obituary	LANCET			English	Biographical-Item																		KATON W, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1176	1176		10.1016/S0140-6736(15)60625-0	http://dx.doi.org/10.1016/S0140-6736(15)60625-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE3GQ	25845783				2022-12-28	WOS:000351715100018
J	Byrne, JM; Klueglein, N; Pearce, C; Rosso, KM; Appel, E; Kappler, A				Byrne, James M.; Klueglein, Nicole; Pearce, Carolyn; Rosso, Kevin M.; Appel, Erwin; Kappler, Andreas			Redox cycling of Fe(II) and Fe(III) in magnetite by Fe-metabolizing bacteria	SCIENCE			English	Article							PALUSTRIS STRAIN TIE-1; NANOPARTICULATE MAGNETITE; FE3-XTIXO4 NANOPARTICLES; ELECTRON-TRANSFER; REDUCTION; OXIDATION; IRON; STOICHIOMETRY; OXIDE	Microorganisms are a primary control on the redox-induced cycling of iron in the environment. Despite the ability of bacteria to grow using both Fe(II) and Fe(III) bound in solid-phase iron minerals, it is currently unknown whether changing environmental conditions enable the sharing of electrons in mixed-valent iron oxides between bacteria with different metabolisms. We show through magnetic and spectroscopic measurements that the phototrophic Fe(II)-oxidizing bacterium Rhodopseudomonas palustris TIE-1 oxidizes magnetite (Fe3O4) nanoparticles using light energy. This process is reversible in co-cultures by the anaerobic Fe(III)-reducing bacterium Geobacter sulfurreducens. These results demonstrate that Fe ions bound in the highly crystalline mineral magnetite are bioavailable as electron sinks and electron sources under varying environmental conditions, effectively rendering magnetite a naturally occurring battery.	[Byrne, James M.; Klueglein, Nicole; Kappler, Andreas] Univ Tubingen, Ctr Appl Geosci, Geomicrobiol, D-72076 Tubingen, Germany; [Pearce, Carolyn] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England; [Pearce, Carolyn; Rosso, Kevin M.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Appel, Erwin] Univ Tubingen, Ctr Appl Geosci, Geophys, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; University of Manchester; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Eberhard Karls University of Tubingen	Byrne, JM (corresponding author), Univ Tubingen, Ctr Appl Geosci, Geomicrobiol, Sigwartstr 10, D-72076 Tubingen, Germany.	James.Byrne@uni-tuebingen.de	Rosso, Kevin/AAQ-1561-2021; Byrne, James/L-4860-2016; Kappler, Andreas/G-7221-2016	Byrne, James/0000-0002-4399-7336; Kappler, Andreas/0000-0002-3558-9500	Deutsche Forschungsgemeinschaft; Pacific Northwest National Laboratory Science Focus Area, the Subsurface Biogeochemical Research program of the U.S. Department of Energy Office of Biological and Environmental Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Pacific Northwest National Laboratory Science Focus Area, the Subsurface Biogeochemical Research program of the U.S. Department of Energy Office of Biological and Environmental Research	We thank G. Ojha for help with kappa-T measurements and C. Berthold for advice on mu-XRD. This work was funded by the Deutsche Forschungsgemeinschaft. Part of this work was funded by the Pacific Northwest National Laboratory Science Focus Area, the Subsurface Biogeochemical Research program of the U.S. Department of Energy Office of Biological and Environmental Research. We thank J. Liu (Peking University) for providing TEM images, which were taken in the Environmental Molecular Science Laboratory (EMSL), a national user facility supported by the OBER and located at PNNL. All data associated with this publication are available at www.pangaea.de.	Berkowitz AE, 1999, J MAGN MAGN MATER, V196, P591, DOI 10.1016/S0304-8853(98)00845-2; Bird LJ, 2011, TRENDS MICROBIOL, V19, P330, DOI 10.1016/j.tim.2011.05.001; Bose A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4391; COEY JMD, 1971, PHYS REV LETT, V27, P1140, DOI 10.1103/PhysRevLett.27.1140; Cutting RS, 2009, GEOCHIM COSMOCHIM AC, V73, P4004, DOI 10.1016/j.gca.2009.04.009; Dong HL, 2000, CHEM GEOL, V169, P299, DOI 10.1016/S0009-2541(00)00210-2; Dunlop D. J., 1997, ROCK MAGNETISM FUNDA; Evans M.E., 2003, INT GEOPHYS SERIES, V86; Gorski CA, 2010, AM MINERAL, V95, P1017, DOI 10.2138/am.2010.3435; Gorski CA, 2009, ENVIRON SCI TECHNOL, V43, P3675, DOI 10.1021/es803613a; Jiao YYQ, 2005, APPL ENVIRON MICROB, V71, P4487, DOI 10.1128/AEM.71.8.4487-4496.2005; JOLIVET JP, 1988, J COLLOID INTERF SCI, V125, P688, DOI 10.1016/0021-9797(88)90036-7; Kato S, 2012, P NATL ACAD SCI USA, V109, P10042, DOI 10.1073/pnas.1117592109; Liu J, 2013, J AM CHEM SOC, V135, P8896, DOI 10.1021/ja4015343; LOVLEY DR, 1989, APPL ENVIRON MICROB, V55, P700, DOI 10.1128/AEM.55.3.700-706.1989; Maher BA, 2009, ELEMENTS, V5, P229, DOI 10.2113/gselements.5.4.229; Melton ED, 2014, GEOMICROBIOL J, V31, P835, DOI 10.1080/01490451.2014.901439; Melton ED, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00197; Melton ED, 2014, NAT REV MICROBIOL, V12, P797, DOI 10.1038/nrmicro3347; OZDEMIR O, 1993, GEOPHYS RES LETT, V20, P1671, DOI 10.1029/93GL01483; Pearce CI, 2012, J COLLOID INTERF SCI, V387, P24, DOI 10.1016/j.jcis.2012.06.092; Porsch K, 2010, ENVIRON SCI TECHNOL, V44, P3846, DOI 10.1021/es903954u; Rebodos RL, 2010, LANGMUIR, V26, P16745, DOI 10.1021/la102461z; Smith JA, 2013, APPL ENVIRON MICROB, V79, P901, DOI 10.1128/AEM.02954-12; Vikesland PJ, 2007, ENVIRON SCI TECHNOL, V41, P5277, DOI 10.1021/es062082i	25	179	188	51	624	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1473	1476		10.1126/science.aaa4834	http://dx.doi.org/10.1126/science.aaa4834			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814583				2022-12-28	WOS:000352136400040
J	Lee, IH; Shin, S; Choi, TL				Lee, In-Hwan; Shin, Suyong; Choi, Tae-Lim			Building supermicelles from simple polymers	SCIENCE			English	Editorial Material							CYLINDRICAL MICELLES; DIBLOCK COPOLYMERS; CO-MICELLES; POLYMERIZATION		[Lee, In-Hwan; Shin, Suyong; Choi, Tae-Lim] Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea	Seoul National University (SNU)	Lee, IH (corresponding author), Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea.	tlc@snu.ac.kr	Choi, Tae-Lim/GFS-2612-2022	Lee, In-Hwan/0000-0002-4848-939X				Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; Gilroy JB, 2010, NAT CHEM, V2, P566, DOI [10.1038/NCHEM.664, 10.1038/nchem.664]; Groschel AH, 2013, NATURE, V503, P247, DOI 10.1038/nature12610; Lee IH, 2013, J AM CHEM SOC, V135, P17695, DOI 10.1021/ja409206p; Nicolaou KC, 2014, J AM CHEM SOC, V136, P16444, DOI 10.1021/ja509829e; Pochan DJ, 2004, SCIENCE, V306, P94, DOI 10.1126/science.1102866; Qiu HB, 2015, SCIENCE, V347, P1329, DOI 10.1126/science.1261816; Qiu HB, 2012, ANGEW CHEM INT EDIT, V51, P11882, DOI 10.1002/anie.201205764; Rupar PA, 2012, SCIENCE, V337, P559, DOI 10.1126/science.1221206; Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382; Warren NJ, 2014, J AM CHEM SOC, V136, P10174, DOI 10.1021/ja502843f; WEBSTER OW, 1991, SCIENCE, V251, P887, DOI 10.1126/science.251.4996.887; Yoon KY, 2012, J AM CHEM SOC, V134, P14291, DOI 10.1021/ja305150c	15	6	6	0	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1310	1311		10.1126/science.aaa8681	http://dx.doi.org/10.1126/science.aaa8681			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6SM	25792314				2022-12-28	WOS:000351219600018
J	Atkins, KE; Wenzel, NS; Ndeffo-Mbah, M; Altice, FL; Townsend, JP; Galvani, AP				Atkins, Katherine E.; Wenzel, Natasha S.; Ndeffo-Mbah, Martial; Altice, Frederick L.; Townsend, Jeffrey P.; Galvani, Alison P.			Under-reporting and case fatality estimates for emerging epidemics	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EBOLA-VIRUS DISEASE; INFECTION		[Atkins, Katherine E.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Atkins, Katherine E.; Wenzel, Natasha S.; Ndeffo-Mbah, Martial; Galvani, Alison P.] Yale Univ, Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT USA; [Altice, Frederick L.] Yale Univ, Dept Med, Infect Dis Sect, New Haven, CT 06520 USA; [Townsend, Jeffrey P.] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA	University of London; London School of Hygiene & Tropical Medicine; Yale University; Yale University; Yale University	Atkins, KE (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.	katherine.atkins@lshtm.ac.uk	Townsend, Jeffrey/H-2747-2019	Townsend, Jeffrey/0000-0002-9890-3907; Altice, Frederick/0000-0002-7860-693X; Ndeffo Mbah, Martial/0000-0003-4158-7613	National Institutes of Health [NIH U01 GM087719, U01 GM105627, K24 DA017072]; National Science Foundation [NSF RAPID 1514673]; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine; Public Health England (PHE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM105627, U01GM087719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine; Public Health England (PHE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	All authors have completed the unified competing interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare the work was supported by the National Institutes of Health (NIH U01 GM087719, U01 GM105627, and K24 DA017072), and the National Science Foundation (NSF RAPID 1514673). This research was partly funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine in partnership with Public Health England (PHE). The views expressed are those of the authors and not necessarily those of the NIH, NSF, NHS, NIHR, the Department of Health or Public Health England.	Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bellan SE, 2014, LANCET, V384, P1499, DOI 10.1016/S0140-6736(14)61839-0; Centers for Disease Control, 2014, OUTBR CHRON EB HEM F; Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Kucharski AJ, 2014, LANCET, V384, P1260, DOI 10.1016/S0140-6736(14)61706-2; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; World Health Organization, 2014, WHO GLOB AL RESP; World Health Organization, 2014, WHY EB OUTBR HAS BEE	10	28	28	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2015	350								h1115	10.1136/bmj.h1115	http://dx.doi.org/10.1136/bmj.h1115			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KM	25779635	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000351570500002
J	Beaglehole, R; Bonita, R; Yach, D; Mackay, J; Reddy, KS				Beaglehole, Robert; Bonita, Ruth; Yach, Derek; Mackay, Judith; Reddy, K. Srinath			Tobacco-free world 1 A tobacco-free world: a call to action to phase out the sale of tobacco products by 2040	LANCET			English	Article							SMOKING; COUNTRIES; DEATHS; FUTURE; CHINA	The time has come for the world to acknowledge the unacceptability of the damage being done by the tobacco industry and work towards a world essentially free from the sale (legal and illegal) of tobacco products. A tobacco-free world by 2040, where less than 5% of the world's adult population use tobacco, is socially desirable, technically feasible, and could become politically practical. Three possible ways forward exist: so-called business-as-usual, with most countries steadily implementing the WHO Framework Convention on Tobacco Control (FCTC) provisions; accelerated implementation of the FCTC by all countries; and a so-called turbo-charged approach that complements FCTC actions with strengthened UN leadership, full engagement of all sectors, and increased investment in tobacco control. Only the turbo-charged approach will achieve a tobacco-free world by 2040 where tobacco is out of sight, out of mind, and out of fashion-yet not prohibited. The first and most urgent priority is the inclusion of an ambitious tobacco target in the post-2015 sustainable development health goal. The second priority is accelerated implementation of the FCTC policies in all countries, with full engagement from all sectors including the private sector-from workplaces to pharmacies-and with increased national and global investment. The third priority is an amendment of the FCTC to include an ambitious global tobacco reduction goal. The fourth priority is a UN high-level meeting on tobacco use to galvanise global action towards the 2040 tobacco-free world goal on the basis of new strategies, new resources, and new players. Decisive and strategic action on this bold vision will prevent hundreds of millions of unnecessary deaths during the remainder of this century and safeguard future generations from the ravages of tobacco use.	[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1010, New Zealand; [Yach, Derek] Vital Inst Part Discovery Holdings, New York, NY USA; [Mackay, Judith] World Lung Fdn, Hong Kong, Hong Kong, Peoples R China; [Reddy, K. Srinath] Publ Hlth Fdn India, Gurgaon, Haryana, India	University of Auckland; Public Health Foundation of India	Beaglehole, R (corresponding author), Univ Auckland, Auckland 1010, New Zealand.	r.beaglehole@auckland.ac.nz		Reddy, K Srinath/0000-0003-3416-3548				Abascal W, 2012, LANCET, V380, P1575, DOI 10.1016/S0140-6736(12)60826-5; Anand Nayak Prathibha, 2013, J Indian Soc Pedod Prev Dent, V31, P180, DOI 10.4103/0970-4388.117980; [Anonymous], 2012, C PART WHO FRAM CONV; [Anonymous], 2014, 2012 NATL HLTH SURVE; [Anonymous], 2014, SYNTHESIS REPORT SEC; Chapman S, E CIGARETTES BEST WO; Chapman S, 2014, REMOVING EMPERORS CL; Department of Health Ireland, TOB FREE IR; Dowell D, 2012, LANCET, V380, P1787, DOI 10.1016/S0140-6736(12)60733-8; Edwards R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-580; Frieden TR, 2007, LANCET, V369, P1758, DOI 10.1016/S0140-6736(07)60782-X; Gilmore AB, 2015, LANCET, V385, P1029, DOI 10.1016/S0140-6736(15)60312-9; Jha P., 2011, Economic and Political Weekly, V46, P44; John RM, 2009, TOB CONTROL, V18, P138, DOI 10.1136/tc.2008.027466; Khalil J, 2013, WOMEN HEALTH, V53, P100, DOI 10.1080/03630242.2012.753978; Kishore SP, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-22; Leppan W, 2014, TOBACCO CONTROL TOBA; Li VC, 2012, AM J PUBLIC HEALTH, V102, P1660, DOI 10.2105/AJPH.2012.300733; Liberman J, 2014, POWER WHO FCTC UNDER; Malone R, 2014, GLOBAL INITIATIVES I; Malone RE, 2013, TOB CONTROL, V22, P42, DOI 10.1136/tobaccocontrol-2012-050820; Malone RE, 2012, TOB CONTROL, V21, P162, DOI 10.1136/tobaccocontrol-2011-050200; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Mendez D, 2013, TOB CONTROL, V22, P46, DOI 10.1136/tobaccocontrol-2011-050147; Ministry of Social Affairs and Health, MSAH OV TOB CONTR FI; National Cancer Institute and Centers for Disease Control and Prevention, 2014, NIH PUBLICATION, V14-7983; Otanez M, 2011, TOB CONTROL, V20, P403, DOI 10.1136/tc.2010.039537; Proctor RN, 2011, GOLDEN HOLOCAUST: ORIGINS OF THE CIGARETTE CATASTROPHE AND THE CASE FOR ABOLITION, P1; Rogers T, 2010, TOB CONTROL, V19, pI1, DOI 10.1136/tc.2010.036293; Rorandelli R, 2013, CHINA TOBACCO LESSON; Statistics New Zealand, QUITT NOT START SMOK; The Scottish Government, TOB CONTR STRAT CREA; UNDP, 2014, INT WHO FRAM CONV TO; US CDC, UPD CDC POL ER EFF; US Surgeon General, 2014, HLTH CONS SMOK 50 YE; Vitality Institute, 2014, INV PREV NAT IMP; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; Warner KE, 2014, NICOTINE FIX    1113; Warren Charles W, 2009, Glob Health Promot, V16, P38, DOI 10.1177/1757975909342192; WHO, 2007, REP PUBL HEAR AGR DI; WHO, 2013, GUID IMPL WHO FCTC; WHO, TOB FREE PAC 2025; World Health Organization, 2019, WHO REP GLOB TOB EP; World Health Organization, 2013, GLOB ACT PLAN PREV C; Yach D, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-39; Yach D, 2014, LANCET, V383, P1771, DOI 10.1016/S0140-6736(13)62155-8; Yang GH, 2015, LANCET, V385, P1019, DOI 10.1016/S0140-6736(15)60174-X	47	63	65	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					1011	1018		10.1016/S0140-6736(15)60133-7	http://dx.doi.org/10.1016/S0140-6736(15)60133-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD2EK	25784348				2022-12-28	WOS:000350886900033
J	Mohammadi, D				Mohammadi, Dara			David Nott: providing surgical care at the frontline of conflicts	LANCET			English	Biographical-Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					935	935		10.1016/S0140-6736(15)60516-5	http://dx.doi.org/10.1016/S0140-6736(15)60516-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD2EK	25784335				2022-12-28	WOS:000350886900014
J	Engert, A				Engert, Andreas			Hodgkin's lymphoma: who needs consolidation treatment?	LANCET			English	Editorial Material							HIGH-DOSE CHEMOTHERAPY; BRENTUXIMAB VEDOTIN; RANDOMIZED-TRIAL; DISEASE; TRANSPLANTATION; POPULATION; RESISTANT; RELAPSE; ABVD		Univ Hosp, Dept Internal Med 1, German Hodgkin Study Grp, D-50937 Cologne, Germany	University of Cologne	Engert, A (corresponding author), Univ Hosp, Dept Internal Med 1, German Hodgkin Study Grp, D-50937 Cologne, Germany.	a.engert@uni-koeln.de						Arai S, 2013, LEUKEMIA LYMPHOMA, V54, P2531, DOI 10.3109/10428194.2013.798868; BONADONNA G, 1982, CANCER TREAT REV, V9, P21, DOI 10.1016/S0305-7372(82)80003-0; Diehl V, 2003, NEW ENGL J MED, V348, P2386, DOI 10.1056/NEJMoa022473; Ferme C, 2002, J CLIN ONCOL, V20, P467, DOI 10.1200/JCO.20.2.467; Goodman KA, 2008, J CLIN ONCOL, V26, P5240, DOI 10.1200/JCO.2007.15.5507; Josting A, 2002, J CLIN ONCOL, V20, P221, DOI 10.1200/JCO.20.1.221; Josting A, 2010, J CLIN ONCOL, V28, P5074, DOI 10.1200/JCO.2010.30.5771; LINCH DC, 1993, LANCET, V341, P1051, DOI 10.1016/0140-6736(93)92411-L; Moskowitz CH, 2015, LANCET; Moskowitz CH, 2012, BLOOD, V119, P1665, DOI 10.1182/blood-2011-10-388058; Schmitz N, 2002, LANCET, V359, P2065, DOI 10.1016/S0140-6736(02)08938-9; Sjoberg J, 2012, BLOOD, V119, P990, DOI 10.1182/blood-2010-08-302604; Younes A, 2012, J CLIN ONCOL, V30, P2183, DOI 10.1200/JCO.2011.38.0410; Younes A, 2011, NAT REV CLIN ONCOL, V8, P85, DOI 10.1038/nrclinonc.2010.189; Younes A, 2010, NEW ENGL J MED, V363, P1812, DOI 10.1056/NEJMoa1002965; Zucca E, 2008, ANN ONCOL, V19, P77, DOI 10.1093/annonc/mdn204	16	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1810	1812		10.1016/S0140-6736(15)60583-9	http://dx.doi.org/10.1016/S0140-6736(15)60583-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6ZE	25796457				2022-12-28	WOS:000354184500007
J	Li, HB; Yuen, KH; Otto, F; Leung, PK; Sridharan, TK; Zhang, QZ; Liu, HY; Tang, YW; Qiu, KP				Li, Hua-bai; Yuen, Ka Ho; Otto, Frank; Leung, Po Kin; Sridharan, T. K.; Zhang, Qizhou; Liu, Hauyu; Tang, Ya-Wen; Qiu, Keping			Self-similar fragmentation regulated by magnetic fields in a region forming massive stars	NATURE			English	Article							NGC 6334 I; SUBMILLIMETER POLARIZATION; ZEEMAN OBSERVATIONS; FILAMENTARY CLOUDS; MOLECULAR CLOUDS; COLLAPSE; DUST; DIMENSIONS; KINEMATICS; STRENGTHS	Most molecular clouds are filamentary or elongated(1-3). For those forming low-mass stars (<8 solar masses), the competition between self-gravity and turbulent pressure along the dynamically dominant intercloud magnetic field (10 to 100 parsecs) shapes the clouds to be elongated either perpendicularly(4) or parallel(5) to the fields. A recent study(6) also suggested that on the scales of 0.1 to 0.01 parsecs, such fields are dynamically important within cloud cores forming massive stars (>8 solar masses). But whether the core fieldmorphologies are inherited from the intercloud medium or governed by cloud turbulence is unknown, as is the effect of magnetic fields on cloud fragmentation at scales of 10 to 0.1 parsecs(7-9). Here we report magnetic-field maps inferred from polarimetric observations of NGC6334, a region forming massive stars, on the 100 to 0.01 parsec scale. NGC6334 hosts young star-forming sites(10-12) where fields are not severely affected by stellar feedback, and their directions do not change much over the entire scale range. This means that the fields are dynamically important. The ordered fields lead to a self-similar gas fragmentation: at all scales, there exist elongated gas structures nearly perpendicular to the fields. Many gas elongations have density peaks near the ends, which symmetrically pinch the fields. The field strength is proportional to the 0.4th power of the density, which is an indication of anisotropic gas contractions along the field. We conclude that magnetic fields have a crucial role in the fragmentation of NGC6334.	[Li, Hua-bai; Yuen, Ka Ho; Otto, Frank; Leung, Po Kin] Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China; [Sridharan, T. K.; Zhang, Qizhou] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Liu, Hauyu; Tang, Ya-Wen] Natl Taiwan Univ, Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan; [Qiu, Keping] Nanjing Univ, Sch Astron & Space Sci, Nanjing 210093, Jiangsu, Peoples R China	Chinese University of Hong Kong; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Academia Sinica - Taiwan; National Taiwan University; Nanjing University	Li, HB (corresponding author), Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China.	hbli@phy.cuhk.edu.hk	呂浩宇, Hauyu Baobab Liu/ABA-1430-2020; Tang湯雅雯, Ya-Wen/AAZ-7382-2020	呂浩宇, Hauyu Baobab Liu/0000-0003-2300-2626; Tang湯雅雯, Ya-Wen/0000-0002-0675-276X; Yuen, Ka Ho/0000-0003-1683-9153; Zhang, Qizhou/0000-0003-2384-6589; Tirupati Kumara, Sridharan/0000-0001-5921-5784; Otto, Frank/0000-0003-4009-1974	Hong Kong Research Grants Council [ECS 24300314]; CUHK; Deutsche Forschungsgemeinschaft priority programme 1573 [46]; Smithsonian Institution; Academia Sinica	Hong Kong Research Grants Council(Hong Kong Research Grants Council); CUHK(Chinese University of Hong Kong); Deutsche Forschungsgemeinschaft priority programme 1573; Smithsonian Institution(Smithsonian Institution); Academia Sinica(Academia Sinica - Taiwan)	We thank R. Blundell for the SMA Director's Discretionary Time that allowed the project to take off. We also thank the SPARO team led by G. Novak and the Hertz team led by R. Hildebrand. Discussions with Z.-Y. Li and the proofread by D. Wilmshurst and T.T. Wu improved the manuscript. The experiment was supported by the Hong Kong Research Grants Council, project ECS 24300314; by CUHK Direct Grant for Research 2013-2014, project 'Modelling Star Formation with GPU Computing'; and by the Deutsche Forschungsgemeinschaft priority programme 1573, project number 46. The Submillimeter Array is a joint project between the Smithsonian Astrophysical Observatory and the Academia Sinica Institute of Astronomy and Astrophysics and is funded by the Smithsonian Institution and the Academia Sinica.	Andre P, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014666; Bertram E, 2012, MON NOT R ASTRON SOC, V420, P3163, DOI 10.1111/j.1365-2966.2011.20244.x; Beuther H, 2007, ASTRON ASTROPHYS, V466, P989, DOI 10.1051/0004-6361:20066799; Bourke TL, 2001, ASTROPHYS J, V554, P916, DOI 10.1086/321405; Burkert A, 2004, ASTROPHYS J, V616, P288, DOI 10.1086/424895; CHANDRASEKHAR S, 1953, ASTROPHYS J, V118, P113, DOI 10.1086/145731; Chapman NL, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/151; Chibueze JO, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/2/114; Crutcher RM, 2010, ASTROPHYS J, V725, P466, DOI 10.1088/0004-637X/725/1/466; Dotson JL, 2010, ASTROPHYS J SUPPL S, V186, P406, DOI 10.1088/0067-0049/186/2/406; Elmegreen BG, 2007, ASTROPHYS J, V668, P1064, DOI 10.1086/521327; Falceta-Goncalves D, 2008, ASTROPHYS J, V679, P537, DOI 10.1086/587479; Girart JM, 2006, SCIENCE, V313, P812, DOI 10.1126/science.1129093; Hayes JC, 2006, ASTROPHYS J SUPPL S, V165, P188, DOI 10.1086/504594; Heiles C, 2000, ASTRON J, V119, P923, DOI 10.1086/301236; Heyer MH, 2004, ASTROPHYS J, V615, pL45, DOI 10.1086/425978; Hull CLH, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/159; Hunter TR, 2006, ASTROPHYS J, V649, P888, DOI 10.1086/505965; Kainulainen J, 2009, ASTRON ASTROPHYS, V508, pL35, DOI 10.1051/0004-6361/200913605; Kraemer KE, 1999, ASTROPHYS J SUPPL S, V124, P439, DOI 10.1086/313260; Li H, 2006, ASTROPHYS J, V648, P340, DOI 10.1086/505858; Li H.B., 2014, PROTOSTARS PLANETS, P101; Li HB, 2013, MON NOT R ASTRON SOC, V436, P3707, DOI 10.1093/mnras/stt1849; Li HB, 2010, ASTROPHYS J, V718, P905, DOI 10.1088/0004-637X/718/2/905; Lunttila T, 2008, ASTROPHYS J LETT, V686, pL91, DOI 10.1086/593032; Matthews HE, 2008, ASTRON J, V136, P2083, DOI 10.1088/0004-6256/136/5/2083; McCutcheon WH, 2000, MON NOT R ASTRON SOC, V316, P152, DOI 10.1046/j.1365-8711.2000.03487.x; McKee C. F, 1993, PROTOSTARS PLANETS, P327; Mouschovias TC, 2009, MON NOT R ASTRON SOC, V400, pL15, DOI 10.1111/j.1745-3933.2009.00752.x; Myers AT, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/97; Nakamura F, 2008, ASTROPHYS J, V687, P354, DOI 10.1086/591641; NAKANO T, 1978, PUBL ASTRON SOC JPN, V30, P671; Novak G, 2009, ASTROPHYS J, V695, P1362, DOI 10.1088/0004-637X/695/2/1362; Ostriker EC, 2001, ASTROPHYS J, V546, P980, DOI 10.1086/318290; Reid MJ, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/130; Rodriguez L., 2003, RMXAA C SER, V15, P194; Sandell G, 2000, ASTRON ASTROPHYS, V358, P242; Sarma AP, 2000, ASTROPHYS J, V533, P271, DOI 10.1086/308667; Schleuning DA, 1998, ASTROPHYS J, V493, P811, DOI 10.1086/305139; Stone JM, 1998, ASTROPHYS J, V508, pL99, DOI 10.1086/311718; STRITTMATTER PA, 1966, MON NOT R ASTRON SOC, V132, P359, DOI 10.1093/mnras/132.2.359; Tomisaka K, 2011, PUBL ASTRON SOC JPN, V63, P147, DOI 10.1093/pasj/63.1.147; Vaillancourt JE, 2011, ASTR SOC P, V449, P169; Williams J.P., 2000, PROTOSTARS PLANETS 4, P97; Zhang QZ, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/2/116; Zhang QZ, 2009, ASTROPHYS J, V696, P268, DOI 10.1088/0004-637X/696/1/268	48	79	80	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					518	+		10.1038/nature14291	http://dx.doi.org/10.1038/nature14291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25822792	Green Submitted			2022-12-28	WOS:000353334500037
J	Zaratiegui, M				Zaratiegui, Mikel			MOLECULAR BIOLOGY RNA interference hangs by a thread	NATURE			English	Editorial Material							TRANSCRIPTION TERMINATION; ARABIDOPSIS; COMPLEX; POMBE	The Paf1 protein complex in fission yeast has been found to protect protein-coding genes from inhibition by RNA-mediated silencing of transcription, by stimulating the release of nascent transcripts from DNA. See Letter p. 248	Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Zaratiegui, M (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	zaratiegui@dls.rutgers.edu		Zaratiegui, Mikel/0000-0002-0342-0268				Castel SE, 2014, CELL, V159, P572, DOI 10.1016/j.cell.2014.09.031; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Kowalik KM, 2015, NATURE, V520, P248, DOI 10.1038/nature14337; Liu FQ, 2012, SCIENCE, V335, P1621, DOI 10.1126/science.1214402; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Sigova A, 2004, GENE DEV, V18, P2359, DOI 10.1101/gad.1218004; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Yu R, 2014, MOL CELL, V53, P262, DOI 10.1016/j.molcel.2013.11.014; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501	11	2	2	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					162	164		10.1038/nature14376	http://dx.doi.org/10.1038/nature14376			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25807482				2022-12-28	WOS:000352454600023
J	Carrasco-Gonzalez, C; Torrelles, JM; Canto, J; Curiel, S; Surcis, G; Vlemmings, WHT; van Langevelde, HJ; Goddi, C; Anglada, G; Kim, SW; Kim, JS; Gomez, JF				Carrasco-Gonzalez, C.; Torrelles, J. M.; Canto, J.; Curiel, S.; Surcis, G.; Vlemmings, W. H. T.; van Langevelde, H. J.; Goddi, C.; Anglada, G.; Kim, S. -W.; Kim, J. -S.; Gomez, J. F.			Observing the onset of outflow collimation in a massive protostar	SCIENCE			English	Article							YOUNG STELLAR OBJECTS; H2O MASER OUTFLOW; STAR-FORMATION; MAGNETIC-FIELDS; W75N; EVOLUTION; REGIONS; CEPHEUS; SYSTEM; CORES	The current paradigm of star formation through accretion disks, and magnetohydrodynamically driven gas ejections, predicts the development of collimated outflows, rather than expansion without any preferential direction. We present radio continuum observations of the massive protostar W75N(B)-VLA 2, showing that it is a thermal, collimated ionized wind and that it has evolved in 18 years from a compact source into an elongated one. This is consistent with the evolution of the associated expanding water-vapor maser shell, which changed from a nearly circular morphology, tracing an almost isotropic outflow, to an elliptical one outlining collimated motions. We model this behavior in terms of an episodic, short-lived, originally isotropic ionized wind whose morphology evolves as it moves within a toroidal density stratification.	[Carrasco-Gonzalez, C.] UNAM, Ctr Radioastron & Astrofis, Morelia 58089, Michoacan, Mexico; [Torrelles, J. M.] CSIC, Inst Ciencies Espai, E-08028 Barcelona, Spain; [Torrelles, J. M.] UB, Inst Ciencies Cosmos, Inst Estudis Espacials Catalunya, Barcelona 08028, Spain; [Canto, J.; Curiel, S.] Univ Nacl Autonoma Mexico, Inst Astron, Mexico City 04510, DF, Mexico; [Surcis, G.; van Langevelde, H. J.; Goddi, C.] Joint Inst VLBI Europe, NL-79990 AA Dwingeloo, Netherlands; [Vlemmings, W. H. T.] Chalmers, Onsala Space Observ, SE-43992 Onsala, Sweden; [van Langevelde, H. J.] Leiden Univ, Sterrewacht Leiden, NL-2300 RA Leiden, Netherlands; [Goddi, C.] Radboud Univ Nijmegen, Inst Math Astrophys & Particle Phys, Dept Astrophys, NL-6500 GL Nijmegen, Netherlands; [Anglada, G.; Gomez, J. F.] CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; [Kim, S. -W.] Korea Astron & Space Sci Inst, Taejon 305348, South Korea; [Kim, S. -W.] Korea Univ Sci & Technol, Taejon 305350, South Korea; [Kim, J. -S.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan	Universidad Nacional Autonoma de Mexico; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; Universidad Nacional Autonoma de Mexico; Chalmers University of Technology; Leiden University; Leiden University - Excl LUMC; Radboud University Nijmegen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Korea Astronomy & Space Science Institute (KASI); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ)	Carrasco-Gonzalez, C (corresponding author), UNAM, Ctr Radioastron & Astrofis, Apartado Postal 3-72 Xangari, Morelia 58089, Michoacan, Mexico.	carrasco@crya.unam.mx	Torrelles, Jose Maria/ABF-5543-2020; Goddi, Ciriaco/AAN-4033-2021; Torrelles, Jose Maria/ABD-8181-2020; Gomez, Jose Francisco/D-8392-2016	Goddi, Ciriaco/0000-0002-2542-7743; van Langevelde, Huib Jan/0000-0002-0230-5946; Canto, Jorge Daniel/0000-0003-3863-7114; /0000-0002-2700-9916; SURCIS, Gabriele/0000-0003-2775-442X; Carrasco-Gonzalez, Carlos/0000-0003-2862-5363; Anglada, Guillem/0000-0002-7506-5429; Torrelles, Jose Maria/0000-0002-6896-6085; Gomez, Jose Francisco/0000-0002-7065-542X; Curiel, Salvador/0000-0003-4576-0436	UNAM-Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica grant [IA101214]; Ministerio de Ciencia e Innovacion (Spain) [AYA2011-30228-C03]; Fondo Europeo de Desarrollo Regional funds; Direccion General de Asuntos del Personal Academico, UNAM; Consejo Nacional de Ciencia y Tecnologia (Mexico); European Research Council through consolidator grant [614264]	UNAM-Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica grant; Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo Europeo de Desarrollo Regional funds; Direccion General de Asuntos del Personal Academico, UNAM(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); European Research Council through consolidator grant	The National Radio Astronomy Observatory is a facility of the National Science Foundation, operated under cooperative agreement by Associated Universities, Inc. C.C.-G. acknowledges support by UNAM-Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica grant IA101214. G.A., J.F.G., and J.M.T. acknowledge support from Ministerio de Ciencia e Innovacion (Spain) grant AYA2011-30228-C03 (cofunded with Fondo Europeo de Desarrollo Regional funds). J.C. and S.C. acknowledge the support of Direccion General de Asuntos del Personal Academico, UNAM, and Consejo Nacional de Ciencia y Tecnologia (Mexico). W.H.T.V. acknowledges support from the European Research Council through consolidator grant 614264.	Anglada G, 1998, ASTRON J, V116, P2953, DOI 10.1086/300637; Garay G, 1999, PUBL ASTRON SOC PAC, V111, P1049, DOI 10.1086/316416; Girart JM, 2009, SCIENCE, V324, P1408, DOI 10.1126/science.1171807; Greenhill LJ, 2013, ASTROPHYS J LETT, V770, DOI 10.1088/2041-8205/770/2/L32; Hollenbach D, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/70; Keto E, 2007, ASTROPHYS J, V666, P976, DOI 10.1086/520320; Kim JS, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/86; Matthews LD, 2010, ASTROPHYS J, V708, P80, DOI 10.1088/0004-637X/708/1/80; Maud LT, 2013, MON NOT R ASTRON SOC, V428, P609, DOI 10.1093/mnras/sts049; McKee CF, 2003, ASTROPHYS J, V585, P850, DOI 10.1086/346149; Minh YC, 2010, ASTROPHYS J, V723, P1231, DOI 10.1088/0004-637X/723/2/1231; Moscadelli L, 2007, ASTRON ASTROPHYS, V472, P867, DOI 10.1051/0004-6361:20077823; Osorio M, 1999, ASTROPHYS J, V525, P808, DOI 10.1086/307929; REYNOLDS SP, 1986, ASTROPHYS J, V304, P713, DOI 10.1086/164209; RODRIGUEZ LF, 1994, ASTROPHYS J, V430, pL65, DOI 10.1086/187439; Rygl KLJ, 2012, ASTRON ASTROPHYS, V539, DOI [10.1051/0004-6361/201118211, 10.1051/0004-6361/20111821]; Seifried D, 2012, MON NOT R ASTRON SOC, V422, P347, DOI 10.1111/j.1365-2966.2012.20610.x; Shepherd DS, 2004, ASTROPHYS J, V601, P952, DOI 10.1086/380633; Shepherd DS, 2003, ASTROPHYS J, V584, P882, DOI 10.1086/345743; Surcis G, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201423877; Surcis G, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201015825; Surcis G, 2009, ASTRON ASTROPHYS, V506, P757, DOI 10.1051/0004-6361/200912790; Torrelles JM, 2014, MON NOT R ASTRON SOC, V442, P148, DOI 10.1093/mnras/stu847; Torrelles JM, 2011, MON NOT R ASTRON SOC, V410, P627, DOI 10.1111/j.1365-2966.2010.17483.x; Torrelles JM, 1997, ASTROPHYS J, V489, P744, DOI 10.1086/304824; Torrelles JM, 2003, ASTROPHYS J, V598, pL115, DOI 10.1086/380750; Torrelles JM, 2001, NATURE, V411, P277, DOI 10.1038/35077020	27	34	34	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					114	117		10.1126/science.aaa7216	http://dx.doi.org/10.1126/science.aaa7216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838383	Green Submitted, Green Published			2022-12-28	WOS:000352079500038
J	Hirschberger, M; Krizan, JW; Cava, RJ; Ong, NP				Hirschberger, Max; Krizan, Jason W.; Cava, R. J.; Ong, N. P.			Large thermal Hall conductivity of neutral spin excitations in a frustrated quantum magnet	SCIENCE			English	Article								In frustrated quantum magnets, long-range magnetic order fails to develop despite a large exchange coupling between the spins. In contrast to the magnons in conventional magnets, their spin excitations are poorly understood. Here, we show that the thermal Hall conductivity kappa(xy) provides a powerful probe of spin excitations in the "quantum spin ice" pyrochlore Tb2Ti2O7. The thermal Hall response is large, even though the material is transparent. The Hall response arises from spin excitations with specific characteristics that distinguish them from magnons. At low temperature (<1 kelvin), the thermal conductivity resembles that of a dirty metal. Using the Hall angle, we construct a phase diagram showing how the excitations are suppressed by a magnetic field.	[Hirschberger, Max; Ong, N. P.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Krizan, Jason W.; Cava, R. J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University	Ong, NP (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	npo@princeton.edu	Ong, N. Phuan/Z-1626-2019; Hirschberger, Max/AAE-8003-2019	Hirschberger, Max/0000-0002-1780-1619; Ong, N. Phuan/0000-0001-7166-1058	Army Research Office [ARO W911NF-11-1-0379, ARO W911NF-12-1-0461]; US National Science Foundation [DMR 1420541]; DOE, Division of Basic Energy Sciences [DE-FG-02-08ER46544]	Army Research Office; US National Science Foundation(National Science Foundation (NSF)); DOE, Division of Basic Energy Sciences	We acknowledge discussions with P. A. Lee, S. Murakami, and N. Nagaosa. The research is supported by the Army Research Office (ARO W911NF-11-1-0379, ARO W911NF-12-1-0461) and the US National Science Foundation (grant DMR 1420541). The growth of the crystal and characterization were performed by J.W.K. and R.J.C. with the support of the DOE, Division of Basic Energy Sciences, grant DE-FG-02-08ER46544.	Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Castelnovo C, 2012, ANNU REV CONDEN MA P, V3, P35, DOI 10.1146/annurev-conmatphys-020911-125058; Fennell T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.017201; Fritsch K, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.094410; Gardner JS, 2010, REV MOD PHYS, V82, P53, DOI 10.1103/RevModPhys.82.53; Gardner JS, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.180401; Gardner JS, 1999, PHYS REV LETT, V82, P1012, DOI 10.1103/PhysRevLett.82.1012; Gingras MJP, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/5/056501; Gingras MJP, 2000, PHYS REV B, V62, P6496, DOI 10.1103/PhysRevB.62.6496; Katsura H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.066403; Legl S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.047201; Li QJ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.214408; LUTTINGER JM, 1964, PHYS REV, V135, P1505; Matsumoto R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.197202; Molavian HR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.157204; OBRAZTSOV YN, 1964, SOV PHYS-SOL STATE, V6, P331; OJI H, 1985, PHYS REV B, V31, P7291, DOI 10.1103/PhysRevB.31.7291; Onose Y, 2010, SCIENCE, V329, P297, DOI 10.1126/science.1188260; Ross KA, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021002; Rule KC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.177201; Savary L, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.205130; Savary L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.037202; Strohm C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.155901	23	109	110	6	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					106	109		10.1126/science.1257340	http://dx.doi.org/10.1126/science.1257340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838381	Green Submitted			2022-12-28	WOS:000352079500036
J	Crawford, R; Stoye, G				Crawford, Rowena; Stoye, George			The outlook for public spending on the National Health Service	LANCET			English	Editorial Material									[Crawford, Rowena; Stoye, George] Inst Fiscal Studies, London WC1E 7AE, England	University of London; London School Economics & Political Science	Crawford, R (corresponding author), Inst Fiscal Studies, London WC1E 7AE, England.	rowena_c@ifs.org.uk	Stoye, George/AAM-2292-2021		ESRC [ES/H021221/1] Funding Source: UKRI; Economic and Social Research Council [ES/H021221/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Baker M, 2015, THE GUARDIAN; Bojke C, 2013, RESEARCH PAPER 87; Crawford R, 2015, THE IFS GREEN BUDGET, V2015, P151; Crawford R, 2015, THE IFS GREEN BUDGET, P176; HM Treasury, 2014, PUBLIC EXPENDITURE S; Keynes S, 2015, PUBLIC SERVICES SPEN; Massey F, 2012, PUBLIC SERVICE PRODU; NHS England, 2014, NHS FIVE YEAR FORWAR; NHS England, 2013, THE NHS BELONGS TO T	9	2	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1155	1156		10.1016/S0140-6736(15)60612-2	http://dx.doi.org/10.1016/S0140-6736(15)60612-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CE3GQ	25845778				2022-12-28	WOS:000351715100005
J	Ryu, JK; Min, D; Rah, SH; Kim, SJ; Park, Y; Kim, H; Hyeon, C; Kim, HM; Jahn, R; Yoon, TY				Ryu, Je-Kyung; Min, Duyoung; Rah, Sang-Hyun; Kim, Soo Jin; Park, Yongsoo; Kim, Haesoo; Hyeon, Changbong; Kim, Ho Min; Jahn, Reinhard; Yoon, Tae-Young			Spring-loaded unraveling of a single SNARE complex by NSF in one round of ATP turnover	SCIENCE			English	Article							CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; ALPHA-SNAP; PROTEIN; DOMAIN; TRANSPORT; VANADATE	During intracellular membrane trafficking, N-ethylmaleimide-sensitive factor (NSF) and alpha-soluble NSF attachment protein (alpha-SNAP) disassemble the soluble NSF attachment protein receptor (SNARE) complex for recycling of the SNARE proteins. The molecular mechanism by which NSF disassembles the SNARE complex is largely unknown. Using single-molecule fluorescence spectroscopy and magnetic tweezers, we found that NSF disassembled a single SNARE complex in only one round of adenosine triphosphate (ATP) turnover. Upon ATP cleavage, the NSF hexamer developed internal tension with dissociation of phosphate ions. After latent time measuring tens of seconds, NSF released the built-up tension in a burst within 20 milliseconds, resulting in disassembly followed by immediate release of the SNARE proteins. Thus, NSF appears to use a "spring-loaded" mechanism to couple ATP hydrolysis and unfolding of substrate proteins.	[Ryu, Je-Kyung; Min, Duyoung; Rah, Sang-Hyun; Yoon, Tae-Young] Korea Adv Inst Sci & Technol KAIST, Natl Creat Res Initiat Ctr Single Mol Syst Biol, Taejon 305701, South Korea; [Ryu, Je-Kyung; Min, Duyoung; Rah, Sang-Hyun; Yoon, Tae-Young] Korea Adv Inst Sci & Technol, Dept Phys, Taejon 305701, South Korea; [Kim, Soo Jin; Kim, Haesoo; Kim, Ho Min] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Park, Yongsoo; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Hyeon, Changbong] Korea Inst Adv Study, Seoul 130722, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Max Planck Society; Korea Institute for Advanced Study (KIAS)	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.	rjahn@gwdg.de; tyyoon@kaist.ac.kr	Park, Yongsoo/G-9285-2014; Yoon, Tae-Young/C-1687-2011; Kim, Ho Min/G-2712-2011; Hyeon, Changbong/AAU-7862-2021; Min, Duyoung/AAA-5205-2019; Hyeon, Changbong/H-3295-2011	Park, Yongsoo/0000-0001-8336-8051; Yoon, Tae-Young/0000-0002-5184-7725; Min, Duyoung/0000-0002-2856-8082; Hyeon, Changbong/0000-0002-4844-7237; Jahn, Reinhard/0000-0003-1542-3498; Ryu, Je-Kyung/0000-0002-0545-9502; Rah, Sang-Hyun/0000-0002-9480-7731	National Creative Research Initiative Program (Center for Single-Molecule Systems Biology); National Research Foundation of Korea (NRF) - Korean government [NRF-2012R1A1A1010456]; National Institutes of Health [3P01GM072694-05S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	National Creative Research Initiative Program (Center for Single-Molecule Systems Biology); National Research Foundation of Korea (NRF) - Korean government; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Jo and B. Choi for help with preparing illustrations and S. E. Lee for help with single-molecule analysis. This work was supported by the National Creative Research Initiative Program (Center for Single-Molecule Systems Biology to T.-Y.Y.) and a grant (NRF-2012R1A1A1010456 to H.M.K.) through the National Research Foundation of Korea (NRF) funded by the Korean government. Funding was also generously provided by the National Institutes of Health (3P01GM072694-05S1 to R.J.).	Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Davies DR, 2004, FEBS LETT, V577, P315, DOI 10.1016/j.febslet.2004.10.022; De Vlaminck I, 2012, ANNU REV BIOPHYS, V41, P453, DOI 10.1146/annurev-biophys-122311-100544; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Min D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2692; Moeller A, 2012, J STRUCT BIOL, V177, P335, DOI 10.1016/j.jsb.2011.12.018; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Park Y, 2014, J BIOL CHEM, V289, P16326, DOI 10.1074/jbc.M114.556803; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; SHIMIZU T, 1983, J BIOL CHEM, V258, P3833; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286; Yoon TY, 2006, P NATL ACAD SCI USA, V103, P19731, DOI 10.1073/pnas.0606032103; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zhao CX, 2010, J BIOL CHEM, V285, P761, DOI 10.1074/jbc.M109.056739; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148	31	59	60	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1485	1489		10.1126/science.aaa5267	http://dx.doi.org/10.1126/science.aaa5267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814585	Green Accepted			2022-12-28	WOS:000352136400043
J	Widom, CS; Czaja, SJ; DuMont, KA				Widom, Cathy Spatz; Czaja, Sally J.; DuMont, Kimberly A.			Intergenerational transmission of child abuse and neglect: Real or detection bias?	SCIENCE			English	Article							RISK-FACTORS; MALTREATMENT; VIOLENCE; CONTINUITY; CYCLE; MECHANISMS; BEHAVIOR	The literature has been contradictory regarding whether parents who were abused as children have a greater tendency to abuse their own children. A prospective 30-year follow-up study interviewed individuals with documented histories of childhood abuse and neglect and matched comparisons and a subset of their children. The study assessed maltreatment based on child protective service (CPS) agency records and reports by parents, nonparents, and offspring. The extent of the intergenerational transmission of abuse and neglect depended in large part on the source of the information used. Individuals with histories of childhood abuse and neglect have higher rates of being reported to CPS for child maltreatment but do not self-report more physical and sexual abuse than matched comparisons. Offspring of parents with histories of childhood abuse and neglect are more likely to report sexual abuse and neglect and that CPS was concerned about them at some point in their lives. The strongest evidence for the intergenerational transmission of maltreatment indicates that offspring are at risk for childhood neglect and sexual abuse, but detection or surveillance bias may account for the greater likelihood of CPS reports.	[Widom, Cathy Spatz; Czaja, Sally J.] CUNY John Jay Coll Criminal Justice, Dept Psychol, New York, NY 10019 USA; [Widom, Cathy Spatz; Czaja, Sally J.] CUNY, Grad Ctr, New York, NY USA; [DuMont, Kimberly A.] William T Grant Fdn, New York, NY USA	City University of New York (CUNY) System; John Jay College of Criminal Justice (CUNY); City University of New York (CUNY) System	Widom, CS (corresponding author), CUNY John Jay Coll Criminal Justice, Dept Psychol, New York, NY 10019 USA.	cwidom@jjay.cuny.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD40774]; National Institute of Justice [86-IJ-CX-0033, 89-IJ-CX-0007]; National Institute of Mental Health [MH49467, MH58386]; National Institute on Drug Abuse [DA17842, DA10060]; National Institute on Alcohol Abuse and Alcoholism [AA09238, AA11108]; Doris Duke Charitable Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058386, R01MH049467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R03AA009238, R21AA011108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010060, R01DA017842] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Justice(US National Institute of Justice); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported in part by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD40774), the National Institute of Justice (86-IJ-CX-0033 and 89-IJ-CX-0007), the National Institute of Mental Health (MH49467 and MH58386), the National Institute on Drug Abuse (DA17842 and DA10060), the National Institute on Alcohol Abuse and Alcoholism (AA09238 and AA11108), and the Doris Duke Charitable Foundation. The opinions, findings, and conclusions or recommendations expressed in this paper are those of the authors and do not necessarily reflect those of the funding agencies.	ALTEMEIER WA, 1986, CHILD ABUSE NEGLECT, V10, P319, DOI 10.1016/0145-2134(86)90007-4; Bandura A., 1973, AGGRESSION SOCIAL LE; Berlin LJ, 2011, CHILD DEV, V82, P162, DOI 10.1111/j.1467-8624.2010.01547.x; Brown J, 1998, CHILD ABUSE NEGLECT, V22, P1065, DOI 10.1016/S0145-2134(98)00087-8; Dixon L, 2005, J CHILD PSYCHOL PSYC, V46, P47, DOI 10.1111/j.1469-7610.2004.00339.x; DODGE KA, 1990, SCIENCE, V250, P1678, DOI 10.1126/science.2270481; Egeland B, 1987, CHILD ABUSE NEGLECT, P255; Ertem IO, 2000, LANCET, V356, P814, DOI 10.1016/S0140-6736(00)02656-8; Everson MD, 2008, CHILD MALTREATMENT, V13, P14, DOI 10.1177/1077559507307837; Falshaw L, 1996, AGGRESS VIOLENT BEH, V1, P389, DOI 10.1016/S1359-1789(96)00005-5; Finkelhor D., 2012, HAVE SEXUAL ABUSE PH; Garbarino N.L., 1980, UNDERSTANDING ABUSIV; HERZBERGER SD, 1990, AM BEHAV SCI, V33, P529, DOI 10.1177/0002764290033005003; HUNTER RS, 1979, AM J PSYCHIAT, V136, P1320; KAUFMAN J, 1987, AM J ORTHOPSYCHIAT, V57, P186, DOI 10.1111/j.1939-0025.1987.tb03528.x; Kempe R.S., 1978, CHILD ABUSE; Leventhal J M, 1982, Child Abuse Negl, V6, P113, DOI 10.1016/0145-2134(82)90003-5; Pears KC, 2001, CHILD ABUSE NEGLECT, V25, P1439, DOI 10.1016/S0145-2134(01)00286-1; Renner LM, 2006, CHILD ABUSE NEGLECT, V30, P599, DOI 10.1016/j.chiabu.2005.12.005; Schulsinger F., 1981, LONGITUDINAL RES MET; Sedlak A. J., 2010, US DEP HLTH HUM SERV; Sidebotham P, 2001, CHILD ABUSE NEGLECT, V25, P1177, DOI 10.1016/S0145-2134(01)00261-7; Steele B. F., 1968, BATTERED CHILD, P103; STRAUS MA, 1986, J MARRIAGE FAM, V48, P465, DOI 10.2307/352033; Thompson R., 2006, J TRAUMA PRACTICE, V5, P57, DOI DOI 10.1300/J189V05N02_04; Thornberry TP, 2012, TRAUMA VIOLENCE ABUS, V13, P135, DOI 10.1177/1524838012447697; Thornberry TP, 2009, CRIMINOLOGY, V47, P297, DOI 10.1111/j.1745-9125.2009.00153.x; WIDOM CS, 1989, PSYCHOL BULL, V106, P3, DOI 10.1037/0033-2909.115.2.287; WIDOM CS, 1989, AM J ORTHOPSYCHIAT, V59, P355, DOI 10.1111/j.1939-0025.1989.tb01671.x; WIDOM CS, 1989, SCIENCE, V244, P160, DOI 10.1126/science.2704995	30	167	168	8	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1480	1485		10.1126/science.1259917	http://dx.doi.org/10.1126/science.1259917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AT	25814584	Green Accepted			2022-12-28	WOS:000352136400042
J	Brenner, MP; Sorensen, PM				Brenner, Michael P.; Soerensen, Pia M.			Biophysics of Molecular Gastronomy	CELL			English	Editorial Material								Chefs and scientists exploring biophysical processes have given rise to molecular gastronomy. In this Commentary, we describe how a scientific understanding of recipes and techniques facilitates the development of new textures and expands the flavor palette. The new dishes that result engage our senses in unexpected ways.	[Brenner, Michael P.; Soerensen, Pia M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University	Brenner, MP (corresponding author), Harvard Univ, Sch Engn & Appl Sci, 29 Oxford St, Cambridge, MA 02138 USA.	brenner@seas.harvard.edu		Sorensen, Pia M./0000-0001-7433-0844				Blumenthal H., 2009, FAT DUCK COOKBOOK; Maxime B., 2011, MODERNIST CUISINE AR; MCGEE H, 1984, FOOD COOKING SCI LOR	3	8	8	0	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					5	8		10.1016/j.cell.2015.03.002	http://dx.doi.org/10.1016/j.cell.2015.03.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815978	Bronze			2022-12-28	WOS:000351952200001
J	Zuker, CS				Zuker, Charles S.			Food for the Brain	CELL			English	Article							GUT MICROBIOTA; TASTE	Diet is a major issue facing humanity. To combat malnourishment and diseases associated with overnutrition, both research and technological breakthroughs are needed.	[Zuker, Charles S.] Columbia Univ, Coll Physicians & Surg, Howard Hughes Med Inst, Dept Biochem, New York, NY 10032 USA; [Zuker, Charles S.] Columbia Univ, Coll Physicians & Surg, Howard Hughes Med Inst, Dept Neurosci, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Zuker, CS (corresponding author), Columbia Univ, Coll Physicians & Surg, Howard Hughes Med Inst, Dept Biochem, New York, NY 10032 USA.	cz2195@columbia.edu						Cassidy ES, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034015; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Elliott P., 1917, PRODUCTION SUGAR US; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Lutter M, 2009, J NUTR, V139, P629, DOI 10.3945/jn.108.097618; Mekonnen MM, 2012, ECOSYSTEMS, V15, P401, DOI 10.1007/s10021-011-9517-8; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; Sclafani A, 2015, PHYSIOL BEHAV, V140, P156, DOI 10.1016/j.physbeh.2014.12.027; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Smith B.D., 1995, EMERGENCE AGR; USDA, 2014, US PER CAP CAL SWEET; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zhu JW, 2012, BIOTECHNOL ADV, V30, P1158, DOI 10.1016/j.biotechadv.2011.08.022	18	22	23	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					9	11		10.1016/j.cell.2015.03.016	http://dx.doi.org/10.1016/j.cell.2015.03.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815979	Bronze			2022-12-28	WOS:000351952200002
J	[Anonymous]				[Anonymous]			Why Physicians Err in Diagnosis (Reprinted from vol 64, pg 1076-1077, 1915)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Abrahams Adolphe, 1914, COMMON ERRORS DIAGNO, Vxciv, P380; [Anonymous], 1913, SUMM FIND CONCL REC; Cabot RC, 1912, J AMER MED ASSOC, V59, P2295; 1915, JAMA, V64, P1076	4	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1273	1273		10.1001/jama.2014.11660	http://dx.doi.org/10.1001/jama.2014.11660			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25803358				2022-12-28	WOS:000351435500035
J	Kurrle, SE; Cameron, ID; Geeves, RB				Kurrle, S. E.; Cameron, I. D.; Geeves, R. B.			THE COMPETENT NOVICE A quick ward assessment of older patients by junior doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVALENCE; ADMISSION; DELIRIUM		[Kurrle, S. E.; Cameron, I. D.; Geeves, R. B.] Univ Sydney, Fac Med, Northern Clin Sch, St Leonards, NSW 2065, Australia	University of Sydney	Kurrle, SE (corresponding author), Univ Sydney, Fac Med, Northern Clin Sch, St Leonards, NSW 2065, Australia.	kurrle@bigpond.com						Bellelli G, 2014, AGE AGEING, V43, P496, DOI 10.1093/ageing/afu021; Ellis G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006211.pub2; Goldberg SE, 2012, AGE AGEING, V41, P80, DOI 10.1093/ageing/afr106; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Kane RL, 2009, ESSENTIALS CLIN GERI; Kurrle SE, 2006, MED J AUSTRALIA, V184, P427, DOI 10.5694/j.1326-5377.2006.tb00310.x; Oliver D, 2008, J ROY SOC MED, V101, P168, DOI 10.1258/jrsm.2008.080017; Parliamentary and Health Service Ombudsman, 2011, CAR COMP REP HLTH SE; Quinn TJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4681; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Tam VC, 2005, CAN MED ASSOC J, V173, P510, DOI 10.1503/cmaj.045311; Watkin L, 2012, INT J GERIATR PSYCH, V27, P76, DOI 10.1002/gps.2693	13	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2015	350								h607	10.1136/bmj.h607	http://dx.doi.org/10.1136/bmj.h607			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KV	25791221				2022-12-28	WOS:000351571400001
J	Turner, JL; Beck, SC; Benford, DJ; Consiglio, SM; Ho, PTP; Kovacs, A; Meier, DS; Zhao, JH				Turner, J. L.; Beck, S. C.; Benford, D. J.; Consiglio, S. M.; Ho, P. T. P.; Kovacs, A.; Meier, D. S.; Zhao, J-H.			Highly efficient star formation in NGC 5253 possibly from stream-fed accretion	NATURE			English	Article							SMALL-MAGELLANIC-CLOUD; GALAXY NGC-5253; DWARF GALAXIES; CENTRAL REGION; COLD STREAMS; GAS; CLUSTER; STARBURST; DUST; SPECTROSCOPY	Gas clouds in present-day galaxies are inefficient at forming stars. Low star-formation efficiency is a critical parameter in galaxy evolution: it is why stars are still forming nearly 14 billion years after the Big Bang(1) and why star clusters generally do not survive their births, instead dispersing to form galactic disks or bulges'. Yet the existence of ancient massive bound star clusters (globular clusters) in the Milky Way suggests that efficiencies were higher when they formed ten billion years ago. A local dwarf galaxy, NGC 5253, has a young star cluster that provides an example of highly efficient star formation(3). Here we report the detection of the J = 3 -> 2 rotational transition of CO at the location of the massive cluster. The gas cloud is hot, dense, quiescent and extremely dusty. Its gas-to-dust ratio is lower than the Galactic value, which we attribute to dust enrichment by the embedded star cluster. Its star-formation efficiency exceeds 50 percent, tenfold that of clouds in the Milky Way. We suggest that high efficiency results from the force-feeding of star formation by a streamer of gas falling into the galaxy.	[Turner, J. L.; Consiglio, S. M.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Beck, S. C.] Tel Aviv Univ, Dept Phys & Astron, IL-69978 Ramat Aviv, Israel; [Benford, D. J.] NASA, Goddard Space Flight Ctr, Observat Cosmol Lab, Greenbelt, MD 20771 USA; [Ho, P. T. P.] Acad Sinica, Astron & Astrophys, Taipei 10617, Taiwan; [Kovacs, A.] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Kovacs, A.] Univ Minnesota, Inst Astrophys, Minneapolis, MN 55405 USA; [Meier, D. S.] New Mexico Inst Min & Technol, Dept Phys, Socorro, NM USA; [Meier, D. S.] Natl Radio Astron Observ, Socorro, NM USA; [Zhao, J-H.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	University of California System; University of California Los Angeles; Tel Aviv University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Academia Sinica - Taiwan; California Institute of Technology; University of Minnesota System; University of Minnesota Twin Cities; New Mexico Institute of Mining Technology; National Radio Astronomy Observatory (NRAO); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Turner, JL (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	turner@astro.ucla.edu	Benford, Dominic/D-4760-2012; Kovacs, Attila/C-1171-2010; Ho, Paul/AAZ-5108-2020	Benford, Dominic/0000-0002-9884-4206; Kovacs, Attila/0000-0001-8991-9088; Ho, Paul/0000-0002-3412-4306; Beck, Sara/0000-0002-5770-8494; Meier, David/0000-0001-9436-9471	Smithsonian Institution; Academica Sinica	Smithsonian Institution(Smithsonian Institution); Academica Sinica	We thank J. Carpenter, S. Goodwin, M. Heyer, L. Hunt, R. Hurt, M. Jura, C. Lada, C. Leitherer and S. Van Dyk for assistance with the analysis. The Submillimeter Array is a joint project between the Smithsonian Astrophysical Observatory and the Academia Sinica Institute of Astronomy and Astrophysics and is funded by the Smithsonian Institution and the Academica Sinica.	Alonso-Herrero A, 2004, ASTROPHYS J, V612, P222, DOI 10.1086/422448; Bastian N, 2006, MON NOT R ASTRON SOC, V369, pL9, DOI 10.1111/j.1745-3933.2006.00162.x; Beck SC, 1996, ASTROPHYS J, V457, P610, DOI 10.1086/176757; Bot C, 2004, ASTRON ASTROPHYS, V423, P567, DOI 10.1051/0004-6361:20035918; CALDWELL N, 1989, ASTROPHYS J, V338, P789, DOI 10.1086/167236; Cen RY, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/1/L21; Cresci G, 2005, ASTRON ASTROPHYS, V433, P447, DOI 10.1051/0004-6361:20041028; Cresci G, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/201014864; de Grijs R, 2013, MON NOT R ASTRON SOC, V431, P2917, DOI 10.1093/mnras/stt392; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Galliano F, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201117952; Gordon KD, 2009, ASTROPHYS J LETT, V690, pL76, DOI 10.1088/0004-637X/690/1/L76; Gray WJ, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/174; Harris J, 2004, ASTROPHYS J, V603, P503, DOI 10.1086/381669; Hirashita H, 2013, MON NOT R ASTRON SOC, V429, P3390, DOI 10.1093/mnras/sts602; Karachentsev ID, 2007, ASTRON J, V133, P504, DOI 10.1086/510125; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; Kobulnicky HA, 1997, ASTROPHYS J, V477, P679, DOI 10.1086/303742; Kobulnicky HA, 2008, ASTRON J, V135, P527, DOI 10.1088/0004-6256/135/2/527; Krumholz MR, 2005, ASTROPHYS J, V630, P250, DOI 10.1086/431734; Lopez-Sanchez AR, 2012, MON NOT R ASTRON SOC, V419, P1051, DOI 10.1111/j.1365-2966.2011.19762.x; Lopez-Sanchez AR, 2007, ASTROPHYS J, V656, P168, DOI 10.1086/510112; Martin CL, 1998, ASTROPHYS J, V506, P222, DOI 10.1086/306219; Meier DS, 2002, ASTRON J, V124, P877, DOI 10.1086/341752; MORAN JM, 1994, P SOC PHOTO-OPT INS, V2200, P335, DOI 10.1117/12.177251; Olmi L, 2002, ASTRON ASTROPHYS, V392, P1053, DOI 10.1051/0004-6361:20020959; Persic M, 1996, MON NOT R ASTRON SOC, V281, P27, DOI 10.1093/mnras/278.1.27; Radburn-Smith DJ, 2011, ASTROPHYS J SUPPL S, V195, DOI 10.1088/0067-0049/195/2/18; Rodriguez-Rico CA, 2007, ASTROPHYS J, V670, P295, DOI 10.1086/520709; Roman-Duval J, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014575; Sault RJ, 1995, ASTR SOC P, V77, P433; Shi Y, 2014, NATURE, V514, P335, DOI 10.1038/nature13820; Smith R, 2013, MON NOT R ASTRON SOC, V428, P1303, DOI 10.1093/mnras/sts106; Turner JL, 2000, ASTROPHYS J, V532, pL109, DOI 10.1086/312586; Turner JL, 1997, ASTROPHYS J, V474, pL11, DOI 10.1086/310412; van der Tak FFS, 2007, ASTRON ASTROPHYS, V468, P627, DOI 10.1051/0004-6361:20066820	36	51	51	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					331	+		10.1038/nature14218	http://dx.doi.org/10.1038/nature14218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25788096	Green Submitted, Green Accepted			2022-12-28	WOS:000351171900036
J	Douglas, PS				Douglas, Pamela S.			The theory and practice of imaging outcomes research	LANCET			English	Editorial Material							CORONARY-DISEASE; ANGIOGRAPHY		Duke Univ, Duke Clin Res Inst, Durham, NC 27715 USA	Duke University	Douglas, PS (corresponding author), Duke Univ, Duke Clin Res Inst, Durham, NC 27715 USA.	pamela.douglas@duke.edu		Douglas, Pamela/0000-0001-9876-4049				Beanlands RSB, 2007, J AM COLL CARDIOL, V50, P2002, DOI 10.1016/j.jacc.2007.09.006; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Douglas PS, 2006, J AM COLL CARDIOL, V48, P2141, DOI 10.1016/j.jacc.2006.06.076; Douglas PS, 2009, JACC-CARDIOVASC IMAG, V2, P897, DOI 10.1016/j.jcmg.2009.01.018; Douglas PS, N ENGL J ME IN PRESS; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074; The SCOT-HEART investigators, 2015, LANCET; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611	9	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2334	2335		10.1016/S0140-6736(15)60463-9	http://dx.doi.org/10.1016/S0140-6736(15)60463-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1XV	25788232	hybrid			2022-12-28	WOS:000356003700010
J	Xu, GT; Chapman, JR; Brandsma, I; Yuan, JS; Mistrik, M; Bouwman, P; Bartkova, J; Gogola, E; Warmerdam, D; Barazas, M; Jaspers, JE; Watanabe, K; Pieterse, M; Kersbergen, A; Sol, W; Celie, PHN; Schouten, PC; van den Broek, B; Salman, A; Nieuwland, M; de Rink, I; de Ronde, J; Jalink, K; Boulton, SJ; Chen, JJ; van Gent, DC; Bartek, J; Jonkers, J; Borst, P; Rottenberg, S				Xu, Guotai; Chapman, J. Ross; Brandsma, Inger; Yuan, Jingsong; Mistrik, Martin; Bouwman, Peter; Bartkova, Jirina; Gogola, Ewa; Warmerdam, Daniel; Barazas, Marco; Jaspers, Janneke E.; Watanabe, Kenji; Pieterse, Mark; Kersbergen, Ariena; Sol, Wendy; Celie, Patrick H. N.; Schouten, Philip C.; van den Broek, Bram; Salman, Ahmed; Nieuwland, Marja; de Rink, Iris; de Ronde, Jorma; Jalink, Kees; Boulton, Simon J.; Chen, Junjie; van Gent, Dik C.; Bartek, Jiri; Jonkers, Jos; Borst, Piet; Rottenberg, Sven			REV7 counteracts DNA double-strand break resection and affects PARP inhibition	NATURE			English	Article							CLASS SWITCH RECOMBINATION; POLYMERASE-ZETA; POL-ZETA; REPAIR; 53BP1; DAMAGE; CELLS; RESISTANCE; COMPLEX	Error-free repair of DNA double-strand breaks (DSBs) is achieved by homologous recombination (HR), and BRCA1 is an important factor for this repair pathway(1). In the absence of BRCA1-mediated HR, the administration of PARP inhibitors induces synthetic lethality of tumour cells of patients with breast or ovarian cancers(2,3). Despite the benefit of this tailored therapy, drug resistance can occur by HR restoration(4). Genetic reversion of BRCA1-inactivating mutations can be the underlying mechanism of drug resistance, but this does not explain resistance in all cases(5). In particular, little is known about BRCA1-independent restoration of HR. Here we show that loss of REV7 (also known as MAD2L2) in mouse and human cell lines re-establishes CTIP-dependent endresection of DSBs in BRCA1 deficient cells, leading to HR restoration and PARP inhibitor resistance, which is reversed by ATM kinase inhibition. REV7 is recruited to DSBs in a manner dependent on the H2AX-MDC1-RNF8-RNF168-53BP1 chromatin pathway, and seems to block HR and promote end joining in addition to its regulatory role in DNA damage tolerance(6). Finally, we establish that REV7 blocks DSB resection to promote non-homologous end-joining during immunoglobulin class switch recombination. Our results reveal an unexpected crucial function of REV7 downstream of 53BP1 in coordinating pathological DSB repair pathway choices in BRCA1-deficient cells.	[Xu, Guotai; Gogola, Ewa; Barazas, Marco; Jaspers, Janneke E.; Kersbergen, Ariena; Sol, Wendy; Borst, Piet; Rottenberg, Sven] Netherlands Canc Inst, Div Mol Oncol, NL-1066 CX Amsterdam, Netherlands; [Chapman, J. Ross; Salman, Ahmed] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Brandsma, Inger; van Gent, Dik C.] Erasmus, Univ Med Ctr, Dept Genet, NL-3000 CA Rotterdam, Netherlands; [Yuan, Jingsong; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Mistrik, Martin; Bartek, Jiri] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc 77900, Czech Republic; [Bouwman, Peter; Pieterse, Mark; Schouten, Philip C.; Jonkers, Jos] Netherlands Canc Inst, Div Mol Pathol, NL-1066 CX Amsterdam, Netherlands; [Bartkova, Jirina; Watanabe, Kenji; Bartek, Jiri] Danish Canc Soc, Res Ctr, DK-2100 Copenhagen, Denmark; [Warmerdam, Daniel; van den Broek, Bram; Jalink, Kees] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Celie, Patrick H. N.] Netherlands Canc Inst, Prot Facil, NL-1066 CX Amsterdam, Netherlands; [Nieuwland, Marja; de Rink, Iris] Netherlands Canc Inst, Deep Sequencing Core Facil, NL-1066 CX Amsterdam, Netherlands; [de Ronde, Jorma] Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Boulton, Simon J.] Canc Res UK, London Res Inst, DNA Damage Response Lab, South Mimms EN6 3LD, Herts, England; [Rottenberg, Sven] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, CH-3012 Bern, Switzerland	Netherlands Cancer Institute; University of Oxford; Wellcome Centre for Human Genetics; Erasmus University Rotterdam; University of Texas System; UTMD Anderson Cancer Center; Palacky University Olomouc; Netherlands Cancer Institute; Danish Cancer Society; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Cancer Research UK; University of Bern	Rottenberg, S (corresponding author), Netherlands Canc Inst, Div Mol Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	sven.rottenberg@vetsuisse.unibe.ch	Bouwman, Peter/AAO-7813-2021; Jonkers, Jos/AAG-3246-2019; Chapman, Ross/GYD-7815-2022; Celie, Patrick/AAY-9559-2021	Bouwman, Peter/0000-0002-9252-5896; Jonkers, Jos/0000-0002-9264-9792; Chapman, Ross/0000-0002-6477-4254; van den Broek, Bram/0000-0003-1037-907X; Barazas, Marco/0000-0002-4497-6000; Warmerdam, Daniel/0000-0003-1606-7448; Xu, Guotai/0000-0001-5265-3407; /0000-0003-1850-1340; Gogola, Ewa/0000-0002-5733-770X; Salman, Ahmed/0000-0003-4300-2033; salman, ahmed/0000-0002-5634-2726; van Gent, Dik C./0000-0003-1473-8148; Jalink, Kees/0000-0001-7019-3440; Rottenberg, Sven/0000-0003-2044-9844; Mistrik, Martin/0000-0002-2321-0348	Netherlands Organization for Scientific Research (NWO-Toptalent); Netherlands Organization for Scientific Research (NWO-VIDI); Dutch Cancer Society; CTMM Breast Care; Swiss National Science Foundation; European Union (EU); Wellcome Trust; Danish Cancer Society; Danish Council for Independent Research; Lundbeck Foundation; Czech National Program of Sustainability; Cancer Research UK; ERC; Royal Society; Cancer Research UK [11581] Funding Source: researchfish; Medical Research Council [MR/M009971/1] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0002290] Funding Source: researchfish; Wellcome Trust [104558/Z/14/Z] Funding Source: researchfish; The Francis Crick Institute [10267, 10048] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; MRC [MR/M009971/1] Funding Source: UKRI	Netherlands Organization for Scientific Research (NWO-Toptalent)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); CTMM Breast Care; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union (EU)(CGIAREuropean Commission); Wellcome Trust(Wellcome Trust); Danish Cancer Society(Danish Cancer Society); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Czech National Program of Sustainability; Cancer Research UK(Cancer Research UK); ERC(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank B. Gerritsen, P. Halonen, B. Morris, T. Halazonetis and O. Kallioniemi for advice on the DDR shRNA library, A. Gasparini and G. Borst for their assistance with the cone beam micro-irradiator, R. Kanaar for his RAD51 antibody, J. Jacobs for the pMSCV-GFP vector, and M. O'Connor for olaparib and AZD2461. This work was supported by the Netherlands Organization for Scientific Research (NWO-Toptalent to J.E.J. and NWO-VIDI to S.R.), the Dutch Cancer Society, CTMM Breast Care, the Swiss National Science Foundation, and the European Union (EU) FP6 Integrated Project CHEMORES and FP7 Project DDResponse. Work in J.R.C.'s group is funded by the Wellcome Trust. The work in the J.B.'s laboratories was funded by the Danish Cancer Society, the Danish Council for Independent Research, the Lundbeck Foundation and the Czech National Program of Sustainability. S.J.B. is funded by Cancer Research UK and an ERC Advanced Investigator Grant (RecMitMei) and is a Royal Society Wolfson Research Merit Award Holder.	Ang JE, 2013, CLIN CANCER RES, V19, P5485, DOI 10.1158/1078-0432.CCR-13-1262; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bouwman P, 2013, CANCER DISCOV, V3, P1142, DOI 10.1158/2159-8290.CD-13-0094; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chun ACS, 2013, CELL CYCLE, V12, P365, DOI 10.4161/cc.23214; de Jager M, 2001, NUCLEIC ACIDS RES, V29, P1317, DOI 10.1093/nar/29.6.1317; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Evers B, 2008, CLIN CANCER RES, V14, P3916, DOI 10.1158/1078-0432.CCR-07-4953; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Jaspers JE, 2013, CANCER DISCOV, V3, P68, DOI 10.1158/2159-8290.CD-12-0049; Khalaj M, 2014, J BIOL CHEM, V289, P3811, DOI 10.1074/jbc.M113.514752; Kikuchi S, 2012, J BIOL CHEM, V287, P33847, DOI 10.1074/jbc.M112.396838; Lee JM, 2014, ANN ONCOL, V25, P32, DOI 10.1093/annonc/mdt384; Listovsky T, 2013, J CELL BIOL, V203, P87, DOI 10.1083/jcb.201302060; Lord CJ, 2013, NAT MED, V19, P1381, DOI 10.1038/nm.3369; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schenten D, 2009, J EXP MED, V206, P477, DOI 10.1084/jem.20080669; Stap J, 2008, NAT METHODS, V5, P261, DOI [10.1038/nmeth.f.206, 10.1038/NMETH.f.206]; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Watanabe S, 2013, NAT STRUCT MOL BIOL, V20, P1425, DOI 10.1038/nsmb.2702; Zimmerman M, 2014, TRENDS CELL BIOL, V24, P108, DOI 10.1016/j.tcb.2013.09.003	30	385	390	4	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					541	U308		10.1038/nature14328	http://dx.doi.org/10.1038/nature14328			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25799992	Green Accepted			2022-12-28	WOS:000355286600048
J	Katajisto, P; Dohla, J; Chaffer, CL; Pentinmikko, N; Marjanovic, N; Iqbal, S; Zoncu, R; Chen, W; Weinberg, RA; Sabatini, DM				Katajisto, Pekka; Doehla, Julia; Chaffer, Christine L.; Pentinmikko, Nalle; Marjanovic, Nemanja; Iqbal, Sharif; Zoncu, Roberto; Chen, Walter; Weinberg, Robert A.; Sabatini, David M.			Asymmetric apportioning of aged mitochondria between daughter cells is required for stemness	SCIENCE			English	Article							BUDDING YEAST; DAMAGED PROTEINS; QUALITY-CONTROL; LIFE-SPAN; IN-VITRO; DIVISION; INHERITANCE; PLURIPOTENCY; MITOPHAGY; REVEALS	By dividing asymmetrically, stem cells can generate two daughter cells with distinct fates. However, evidence is limited in mammalian systems for the selective apportioning of subcellular contents between daughters. We followed the fates of old and young organelles during the division of human mammary stemlike cells and found that such cells apportion aged mitochondria asymmetrically between daughter cells. Daughter cells that received fewer old mitochondria maintained stem cell traits. Inhibition of mitochondrial fission disrupted both the age-dependent subcellular localization and segregation of mitochondria and caused loss of stem cell properties in the progeny cells. Hence, mechanisms exist for mammalian stemlike cells to asymmetrically sort aged and young mitochondria, and these are important for maintaining stemness properties.	[Katajisto, Pekka; Chaffer, Christine L.; Marjanovic, Nemanja; Zoncu, Roberto; Chen, Walter; Weinberg, Robert A.; Sabatini, David M.] Whitehead Inst Biomed Res, Boston, MA 02142 USA; [Katajisto, Pekka; Marjanovic, Nemanja; Zoncu, Roberto; Chen, Walter; Weinberg, Robert A.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Katajisto, Pekka; Zoncu, Roberto; Chen, Walter; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Katajisto, Pekka; Doehla, Julia; Pentinmikko, Nalle; Iqbal, Sharif] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; [Sabatini, David M.] Broad Inst, Cambridge, MA 02142 USA; [Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Katajisto, P (corresponding author), Whitehead Inst Biomed Res, Boston, MA 02142 USA.	pekka.katajisto@helsinki.fi; sabatini@wi.mit.edu	Pentinmikko, Nalle/ABB-8148-2021	Pentinmikko, Nalle/0000-0003-3578-1073; /0000-0002-1446-7256; IQBAL, MD SHARIF/0000-0002-0366-2080; Katajisto, Pekka/0000-0002-3033-4189; Chen, Walter/0000-0002-7752-9581	U.S. National Institutes of Health [R01 CA103866, R01 CA129105, R37 AI047389]; Foundations' Post Doc Pool; Academy of Finland; Juselius Foundation; NATIONAL CANCER INSTITUTE [R01CA129105, P30CA014051, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundations' Post Doc Pool; Academy of Finland(Academy of Finland); Juselius Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the Sabatini and Katajisto laboratories-especially A. Efeyan, W. Comb, Y. Chudnovsky, and L. Schweitzer-for comments on this manuscript; K. Birsoy and E. Salminen for help and reagents; and K. Ottina for RNAi reagents. This work was supported by the U.S. National Institutes of Health (R01 CA103866, R01 CA129105, and R37 AI047389) (D.M.S.), Foundations' Post Doc Pool (P.K.), Academy of Finland (P.K.), Juselius Foundation (P.K.) and Marie Curie Actions (P.K.). D.M.S. is an Investigator of the Howard Hughes Medical Institute.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Charruyer A, 2012, J INVEST DERMATOL, V132, P2522, DOI 10.1038/jid.2012.196; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; DuBoff B, 2012, NEURON, V75, P618, DOI 10.1016/j.neuron.2012.06.026; Fichelson P, 2009, NAT CELL BIOL, V11, P685, DOI 10.1038/ncb1874; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Hernebring M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01381; Higuchi R, 2013, CURR BIOL, V23, P2417, DOI 10.1016/j.cub.2013.10.022; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Lai CY, 2002, GENETICS, V162, P73; Lee GM, 2002, IN VITRO CELL DEV-AN, V38, P90; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Mantel C, 2010, CELL CYCLE, V9, P2008, DOI 10.4161/cc.9.10.11733; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Rafelski SM, 2012, SCIENCE, V338, P822, DOI 10.1126/science.1225720; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Vazquez-Martin A, 2012, AGING-US, V4, P393, DOI 10.18632/aging.100465; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107	31	326	331	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					340	343		10.1126/science.1260384	http://dx.doi.org/10.1126/science.1260384			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25837514	Green Submitted, Green Accepted			2022-12-28	WOS:000352999000046
J	Gates, B				Gates, Bill			The Next Epidemic - Lessons from Ebola	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Bill & Melinda Gates Fdn, Seattle, WA 98109 USA	Bill & Melinda Gates Foundation	Gates, B (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.							[Anonymous], PAND RISK ON HLTH; Myhrvold N., 2013, STRATEGIC TERRORISM	2	156	161	0	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2015	372	15					1381	1384		10.1056/NEJMp1502918	http://dx.doi.org/10.1056/NEJMp1502918			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF2ZV	25853741	Bronze			2022-12-28	WOS:000352417900001
J	Helled, R; Galanti, E; Kaspi, Y				Helled, Ravit; Galanti, Eli; Kaspi, Yohai			Saturn's fast spin determined from its gravitational field and oblateness	NATURE			English	Article							ROTATION PERIOD; GIANT PLANETS; INTERIOR; RADIO; SATELLITES; ATMOSPHERE; JUPITER; MODELS; SYSTEM	The alignment of Saturn's magnetic pole with its rotation axis precludes the use of magnetic field measurements to determine its rotation period(1). The period was previously determined from radio measurements by the Voyager spacecraft to be 10 h 39 min 22.4s (ref. 2). When the Cassini spacecraft measured a period of 10 h 47 min 6s, which was additionally found to change between sequential measurements(3,4,5), it became clear that the radio period could not be used to determine the bulk planetary rotation period. Estimates based upon Saturn's measured wind fields have increased the uncertainty even more, giving numbers smaller than the Voyager rotation period, and at present Saturn's rotation period is thought to be between 10 h 32 mm and 10 h 47 min, which is unsatisfactory for such a fundamental property. Here we report a period of 10 h 32 mm 45 s 46 s, based upon an optimization approach using Saturn's measured gravitational field and limits on the observed shape and possible internal density profiles. Moreover, even when solely using the constraints from its gravitational field, the rotation period can be inferred with a precision of several minutes. To validate our method, we applied the same procedure to Jupiter and correctly recovered its well-known rotation period.	[Helled, Ravit] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Dept Geosci, IL-69978 Tel Aviv, Israel; [Galanti, Eli; Kaspi, Yohai] Weizmann Inst Sci, Dept Earth & Planetary Sci, IL-76100 Rehovot, Israel	Tel Aviv University; Weizmann Institute of Science	Helled, R (corresponding author), Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Dept Geosci, IL-69978 Tel Aviv, Israel.	rhelled@post.tau.ac.il	Galanti, Eli/ABC-9597-2021	Kaspi, Yohai/0000-0003-4089-0020; Galanti, Eli/0000-0002-5440-8779; Helled, Ravit/0000-0001-5555-2652	Israel Space Agency [3-11485, 3-11481]	Israel Space Agency	We thank G. Schubert, M. Podolak, J. Anderson, L. Bary-Soroker, and the Juno science team for discussions and suggestions. We acknowledge support from the Israel Space Agency under grants 3-11485 (R.H.) and 3-11481 (Y.K.).	Anderson JD, 2007, SCIENCE, V317, P1384, DOI 10.1126/science.1144835; Carter JA, 2010, ASTROPHYS J, V709, P1219, DOI 10.1088/0004-637X/709/2/1219; Clairaut A. C., 1743, TRAITE FIGURE TERRE; Dowling TE, 2014, INT J MOD PHYS D, V23, DOI 10.1142/S0218271814300067; Finocchiaro S, 2010, ADV ASTRONAUT SCI, V136, P1417; Flasar F., 2013, AGU FALL M, VB8; Giampieri G, 2006, NATURE, V441, P62, DOI 10.1038/nature04750; Guillot T, 2005, ANNU REV EARTH PL SC, V33, P493, DOI 10.1146/annurev.earth.32.101802.120325; Gurnett DA, 2007, SCIENCE, V316, P442, DOI 10.1126/science.1138562; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; Helled R, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/113; Helled R, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047107; Helled R, 2009, PLANET SPACE SCI, V57, P1467, DOI 10.1016/j.pss.2009.07.008; Higgins CA, 1996, GEOPHYS RES LETT, V23, P2653, DOI 10.1029/96GL02388; Hubbard W. B., 1984, PLANETARY INTERIORS, P1; Hubbard WB, 1997, ICARUS, V130, P404, DOI 10.1006/icar.1997.5839; Iess L., 2013, AGU FALL M, VB1; Jacobson RA, 2006, ASTRON J, V132, P2520, DOI 10.1086/508812; Jacobson R.A., 2003, JUP230 ORBIT SOLUTIO; Kaspi Y, 2013, NATURE, V497, P344, DOI 10.1038/nature12131; Kramm U, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201118141; LINDAL GF, 1985, ASTRON J, V90, P1136, DOI 10.1086/113820; Nocedal J., 2006, CONJUGATE GRADIENT M, P102; Porco CC, 2003, SCIENCE, V299, P1541, DOI 10.1126/science.1079462; Read PL, 2009, NATURE, V460, P608, DOI 10.1038/nature08194; Sanchez-Lavega A, 2000, ICARUS, V147, P405, DOI 10.1006/icar.2000.6449; Schubert G, 2011, PHYS EARTH PLANET IN, V187, P364, DOI 10.1016/j.pepi.2011.05.014; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; Sterenborg MG, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043250; Zharkov V. N., 1978, PHYS PLANETARY INTER, P388	31	41	41	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					202	U140		10.1038/nature14278	http://dx.doi.org/10.1038/nature14278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25807487	Green Submitted			2022-12-28	WOS:000352454600034
J	Hoare, MG				Hoare, M. G.			How young stars grow and become focused	SCIENCE			English	Editorial Material							JET		Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Hoare, MG (corresponding author), Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England.	m.g.hoare@leeds.ac.uk		Hoare, Melvin/0000-0003-2684-399X	STFC [ST/L000628/1] Funding Source: UKRI	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Carrasco-Gonzalez C, 2015, SCIENCE, V348, P114, DOI 10.1126/science.aaa7216; Carrasco-Gonzalez C, 2010, SCIENCE, V330, P1209, DOI 10.1126/science.1195589; Cunningham AJ, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/107; Curiel S, 2006, ASTROPHYS J, V638, P878, DOI 10.1086/498931; Frank A., 2014, PROTOSTARS PLANETS, VVI, P451, DOI [DOI 10.2458/AZU_UAPRESS_9780816531240-CH020, 10.2458/azu_uapress_9780816531240-ch020]; Hoare MG, 2006, ASTROPHYS J, V649, P856, DOI 10.1086/506961; Hosokawa T, 2009, ASTROPHYS J, V691, P823, DOI 10.1088/0004-637X/691/1/823; Krumholz MR, 2009, SCIENCE, V323, P754, DOI 10.1126/science.1165857; Kuiper R, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/2/86	9	1	1	0	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					44	45		10.1126/science.aaa8915	http://dx.doi.org/10.1126/science.aaa8915			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838369				2022-12-28	WOS:000352079500021
J	Bonjer, HJ; Deijen, CL; Abis, GA; Cuesta, MA; van der Pas, MHGM; de Lange-de Klerk, ESM; Lacy, AM; Bemelman, WA; Andersson, J; Angenete, E; Rosenberg, J; Fuerst, A; Haglind, E				Bonjer, H. Jaap; Deijen, Charlotte L.; Abis, Gabor A.; Cuesta, Miguel A.; van der Pas, Martijn H. G. M.; de lange-de Klerk, Elly S. M.; Lacy, Antonio M.; Bemelman, Willem A.; Andersson, John; Angenete, Eva; Rosenberg, Jacob; Fuerst, Alois; Haglind, Eva		COLOR II Study Grp	A Randomized Trial of Laparoscopic versus Open Surgery for Rectal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOTAL MESORECTAL EXCISION; SHORT-TERM OUTCOMES; MRC CLASICC TRIAL; COLON-CANCER; OPEN-LABEL; RECURRENCE; COLECTOMY; SURVIVAL; CARCINOMA; RESECTION	BACKGROUND Laparoscopic resection of colorectal cancer is widely used. However, robust evidence to conclude that laparoscopic surgery and open surgery have similar outcomes in rectal cancer is lacking. A trial was designed to compare 3-year rates of cancer recurrence in the pelvic or perineal area (locoregional recurrence) and survival after laparoscopic and open resection of rectal cancer. METHODS In this international trial conducted in 30 hospitals, we randomly assigned patients with a solitary adenocarcinoma of the rectum within 15 cm of the anal verge, not invading adjacent tissues, and without distant metastases to undergo either laparoscopic or open surgery in a 2: 1 ratio. The primary end point was locoregional recurrence 3 years after the index surgery. Secondary end points included disease-free and overall survival. RESULTS A total of 1044 patients were included (699 in the laparoscopic-surgery group and 345 in the open-surgery group). At 3 years, the locoregional recurrence rate was 5.0% in the two groups (difference, 0 percentage points; 90% confidence interval [CI], -2.6 to 2.6). Disease-free survival rates were 74.8% in the laparoscopic-surgery group and 70.8% in the open-surgery group (difference, 4.0 percentage points; 95% CI, -1.9 to 9.9). Overall survival rates were 86.7% in the laparoscopic-surgery group and 83.6% in the open-surgery group (difference, 3.1 percentage points; 95% CI, -1.6 to 7.8). CONCLUSIONS Laparoscopic surgery in patients with rectal cancer was associated with rates of locoregional recurrence and disease-free and overall survival similar to those for open surgery.	[Bonjer, H. Jaap; Deijen, Charlotte L.; Abis, Gabor A.; Cuesta, Miguel A.; van der Pas, Martijn H. G. M.; de lange-de Klerk, Elly S. M.] Vrije Univ Amsterdam, Med Ctr, NL-1081 HV Amsterdam, Netherlands; [Bemelman, Willem A.] Amsterdam Med Ctr, Amsterdam, Netherlands; [Lacy, Antonio M.] Hosp Clin I Prov Barcelona, Barcelona, Spain; [Andersson, John; Angenete, Eva; Haglind, Eva] Univ Gothenburg, Dept Surg, Inst Clin Sci, Sahlgrenska Acad,Sahlgrenska Univ Hosp Ostra, Gothenburg, Sweden; [Rosenberg, Jacob] Univ Copenhagen, Dept Surg, Herlev Hosp, Copenhagen, Denmark; [Fuerst, Alois] Caritas Krankenhaus St Josef, Regensburg, Germany	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Sahlgrenska University Hospital; University of Gothenburg; University of Copenhagen; Herlev & Gentofte Hospital	Bonjer, HJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Surg, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	j.bonjer@vumc.nl	Bemelman, Wilhelmus Adrianus/AAA-1635-2021; Angenete, Eva/AAG-8383-2020	Bemelman, Wilhelmus Adrianus/0000-0002-1037-9945; Angenete, Eva/0000-0001-9966-4904; Valero, Graciela/0000-0002-7881-4763; van der Peet, Donald L./0000-0003-3883-3705; Rosenberg, Jacob/0000-0002-0063-1086; Targarona, Eduardo m/0000-0001-7557-6934; Birch, Daniel/0000-0001-8737-4184	Ethicon Endo-Surgery Europe	Ethicon Endo-Surgery Europe	Funded by Ethicon Endo-Surgery Europe and others; COLOR II ClinicalTrials.gov number, NCT00297791.	American Cancer Society, 2014, CANC FACTS FIG 2014; BERENDS FJ, 1994, LANCET, V344, P58, DOI 10.1016/S0140-6736(94)91079-0; Bonjer HJ, 2009, LANCET ONCOL, V10, P44, DOI 10.1016/S1470-2045(08)70310-3; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Bouvy ND, 1997, BRIT J SURG, V84, P358; CIROCCO WC, 1994, SURGERY, V116, P842; Ferlay J, 2012, GLOBOCAN 2012 EST CA; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Harrysson IJ, 2014, ANN SURG, V260, P37, DOI 10.1097/SLA.0000000000000596; HEALD RJ, 1986, LANCET, V1, P1479; Health and Social Care Information Centre, 2013, NAT BOW CANC AUD ANN; Holm T, 2007, BRIT J SURG, V94, P232, DOI 10.1002/bjs.5489; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Jeong SY, 2014, LANCET ONCOL, V15, P767, DOI 10.1016/S1470-2045(14)70205-0; Kang SB, 2010, LANCET ONCOL, V11, P637, DOI 10.1016/S1470-2045(10)70131-5; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Laurent C, 2009, ANN SURG, V250, P54, DOI 10.1097/SLA.0b013e3181ad6511; MACFARLANE JK, 1993, LANCET, V341, P457, DOI 10.1016/0140-6736(93)90207-W; Marr R, 2005, ANN SURG, V242, P74, DOI 10.1097/01.sla.0000167926.60908.15; Milsom JW, 2009, DIS COLON RECTUM, V52, P1215, DOI 10.1007/DCR0b013e3181a73e81; Nagtegaal ID, 2002, AM J SURG PATHOL, V26, P350, DOI 10.1097/00000478-200203000-00009; Slaney G, 1971, Mod Trends Surg, V3, P69; van der Pas MHGM, 2013, LANCET ONCOL, V14, P210, DOI 10.1016/S1470-2045(13)70016-0; Van Leersum N, 2013, EJSO-EUR J SURG ONC, V39, P1063, DOI 10.1016/j.ejso.2013.05.008; Veenhof AAFA, 2012, ANN SURG, V255, P216, DOI 10.1097/SLA.0b013e31824336e2	26	839	960	2	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14					1324	1332		10.1056/NEJMoa1414882	http://dx.doi.org/10.1056/NEJMoa1414882			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NL	25830422	Green Published			2022-12-28	WOS:000352028500007
J	Kelly, PL; Filippenko, AV; Burke, DL; Hicken, M; Ganeshalingam, M; Zheng, WK				Kelly, Patrick L.; Filippenko, Alexei V.; Burke, David L.; Hicken, Malcolm; Ganeshalingam, Mohan; Zheng, WeiKang			Distances with < 4% precision from type Ia supernovae in young star-forming environments	SCIENCE			English	Article							LIGHT-CURVE SHAPES; H-ALPHA; ABSOLUTE MAGNITUDES; HUBBLE RESIDUALS; HOST GALAXIES; LUMINOSITIES; ULTRAVIOLET; EXTINCTION; REGRESSION; MORPHOLOGY	The luminosities of type Ia supernovae (SNe), the thermonuclear explosions of white-dwarf stars, vary systematically with their intrinsic color and the rate at which they fade. From images taken with the Galaxy Evolution Explorer (GALEX), we identified SNe Ia that erupted in environments that have high ultraviolet surface brightness and star-formation surface density. When we apply a steep model extinction law, we calibrate these SNe using their broadband optical light curves to within similar to 0.065 to 0.075 magnitude, corresponding to <4% in distance. The tight scatter, probably arising from a small dispersion among progenitor ages, suggests that variation in only one progenitor property primarily accounts for the relationship between their light-curve widths, colors, and luminosities.	[Kelly, Patrick L.; Filippenko, Alexei V.; Zheng, WeiKang] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Burke, David L.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Hicken, Malcolm] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Ganeshalingam, Mohan] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kelly, PL (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	pkelly@astro.berkeley.edu			Christopher R. Redlich Fund; TABASGO Foundation; NSF [AST-1211916]; SLAC Department of Energy [DE-AC02-76SF00515]; Division Of Astronomical Sciences [1211916] Funding Source: National Science Foundation	Christopher R. Redlich Fund; TABASGO Foundation; NSF(National Science Foundation (NSF)); SLAC Department of Energy; Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank S. Sim, J. C. Wheeler, J. Silverman, A. Conley, M. Graham, D. Kasen, I. Shivvers, and R. Kessler for useful discussions and comments on the paper and J. Schwab for his help providing background about theoretical modeling. We are grateful to the staffs at Lick Observatory and Kitt Peak National Observatory (KPNO) for their assistance. The late Weidong Li was instrumental to the success of LOSS. A.V.F.'s supernova group at the University of California Berkeley has received generous financial assistance from the Christopher R. Redlich Fund, the TABASGO Foundation, and NSF grant AST-1211916. The Katzman Automatic Imaging Telescope and its ongoing operation were made possible by donations from Sun Microsystems, the Hewlett-Packard Company, AutoScope Corporation, Lick Observatory, NSF, the University of California, the Sylvia and Jim Katzman Foundation, and the TABASGO Foundation. The SLAC Department of Energy contract number is DE-AC02-76SF00515. GALEX data are available from http://galex.stsci.edu/GR6/, SDSS data may be obtained at www.sdss.org, the KPNO imaging is archived at http://portal-nvo.noao.edu, and the Lick Observatory images are available from http://astro.berkeley.edu/bait/public_html/iahostpaper/.	Bailey S, 2009, ASTRON ASTROPHYS, V500, pL17, DOI 10.1051/0004-6361/200911973; Blondin S, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201015792; Fitzpatrick EL, 2007, ASTROPHYS J, V663, P320, DOI 10.1086/518158; Foley RJ, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/55; Gogarten SM, 2009, ASTROPHYS J, V691, P115, DOI 10.1088/0004-637X/691/1/115; Hicken M, 2009, ASTROPHYS J, V700, P1097, DOI 10.1088/0004-637X/700/2/1097; Hutton S, 2014, MON NOT R ASTRON SOC, V440, P150, DOI 10.1093/mnras/stu185; Jones DO, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/166; Kasen D, 2009, NATURE, V460, P869, DOI 10.1038/nature08256; Kessler R, 2009, PUBL ASTRON SOC PAC, V121, P1028, DOI 10.1086/605984; Kim AG, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/84; Kushnir D, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/2/L37; Mandel KS, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/2/75; Moll R, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/105; ODONNELL JE, 1994, ASTROPHYS J, V422, P158, DOI 10.1086/173713; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Riess AG, 1996, ASTROPHYS J, V473, P88, DOI 10.1086/178129; Scolnic DM, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/37; Silverman JM, 2012, MON NOT R ASTRON SOC, V425, P1889, DOI 10.1111/j.1365-2966.2012.21526.x; Sim SA, 2013, MON NOT R ASTRON SOC, V436, P333, DOI 10.1093/mnras/stt1574; Stewart SG, 2000, ASTROPHYS J, V529, P201, DOI 10.1086/308241; Wang LF, 2008, ANNU REV ASTRON ASTR, V46, P433, DOI 10.1146/annurev.astro.46.060407.145139; Wang X, 2009, ASTROPHYS J LETT, V699, pL139, DOI 10.1088/0004-637X/699/2/L139; Weinberg DH, 2013, PHYS REP, V530, P87, DOI 10.1016/j.physrep.2013.05.001; Woosley SE, 2007, ASTROPHYS J, V662, P487, DOI 10.1086/513732	35	39	39	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1459	1462		10.1126/science.1261475	http://dx.doi.org/10.1126/science.1261475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814580	Green Submitted			2022-12-28	WOS:000352136400036
J	Mugnier, MR; Cross, GAM; Papavasiliou, FN				Mugnier, Monica R.; Cross, George A. M.; Papavasiliou, F. Nina			The in vivo dynamics of antigenic variation in Trypanosoma brucei	SCIENCE			English	Article							CLONES; GENES; POPULATIONS	Trypanosoma brucei, a causative agent of African Sleeping Sickness, constantly changes its dense variant surface glycoprotein (VSG) coat to avoid elimination by the immune system of its mammalian host, using an extensive repertoire of dedicated genes. However, the dynamics of VSG expression in T. brucei during an infection are poorly understood. We have developed a method, based on de novo assembly of VSGs, for quantitatively examining the diversity of expressed VSGs in any population of trypanosomes and monitored VSG population dynamics in vivo. Our experiments revealed unexpected diversity within parasite populations and a mechanism for diversifying the genome-encoded VSG repertoire. The interaction between T. brucei and its host is substantially more dynamic and nuanced than previously expected.	[Mugnier, Monica R.; Cross, George A. M.; Papavasiliou, F. Nina] Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10021 USA; [Mugnier, Monica R.; Cross, George A. M.; Papavasiliou, F. Nina] Rockefeller Univ, Lab Mol Parasitol, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Papavasiliou, FN (corresponding author), Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10021 USA.	papavasiliou@rockefeller.edu	Cross, George/B-7444-2011	Cross, George/0000-0003-1374-6955; Mugnier, Monica/0000-0002-1535-2530	NIH/National Institute of Allergy and Infectious Diseases [AI085973]; NSF Graduate Research Fellowship [DGE-1325261]; Rockefeller University Women in Science Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097127, R01AI085973] Funding Source: NIH RePORTER	NIH/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Rockefeller University Women in Science Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Ivens, K. Matthews, K. Gunasekera, and I. Roditi for generously sharing their independently assembled genome sequences and J. Scott for help with early optimization experiments. The work presented has been supported in part by the NIH/National Institute of Allergy and Infectious Diseases (AI085973) to F.N.P., by an NSF Graduate Research Fellowship (DGE-1325261) to M.R.M., and by a Rockefeller University Women in Science Fellowship to M.R.M. All raw data has been deposited to the National Center for Biotechnology Information's Sequence Read Archive under accession number SRP051697, along with all the methods used to generate the figures.	Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Claes F, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000486; Cross GAM, 2014, MOL BIOCHEM PARASIT, V195, P59, DOI 10.1016/j.molbiopara.2014.06.004; Eyford BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071463; Frank SA, 1999, P ROY SOC B-BIOL SCI, V266, P1397, DOI 10.1098/rspb.1999.0793; Gjini E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2129; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRAY AR, 1965, J GEN MICROBIOL, V41, P195, DOI 10.1099/00221287-41-2-195; Hall JPJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003502; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; KAMPER SM, 1992, MOL BIOCHEM PARASIT, V53, P33, DOI 10.1016/0166-6851(92)90004-4; LIU AYC, 1985, J MOL BIOL, V182, P383, DOI 10.1016/0022-2836(85)90198-6; Lu J, 2014, MOL IMMUNOL, V57, P274, DOI 10.1016/j.molimm.2013.09.008; Lythgoe KA, 2007, P NATL ACAD SCI USA, V104, P8095, DOI 10.1073/pnas.0606206104; MacGregor P, 2011, CELL HOST MICROBE, V9, P310, DOI 10.1016/j.chom.2011.03.013; Marcello L, 2007, J EUKARYOT MICROBIOL, V54, P14, DOI 10.1111/j.1550-7408.2006.00227.x; MILLER EN, 1981, PARASITOLOGY, V82, P63, DOI 10.1017/S0031182000041871; Morrison LJ, 2005, INT J PARASITOL, V35, P961, DOI 10.1016/j.ijpara.2005.05.004; MYLER PJ, 1985, INFECT IMMUN, V47, P684, DOI 10.1128/IAI.47.3.684-690.1985; Ross R, 1910, P R SOC LOND B-CONTA, V82, P411, DOI 10.1098/rspb.1910.0035; ROTH C, 1989, P NATL ACAD SCI USA, V86, P9375, DOI 10.1073/pnas.86.23.9375; SEED JR, 1978, J PROTOZOOL, V25, P526, DOI 10.1111/j.1550-7408.1978.tb04179.x; Turner CMR, 1997, FEMS MICROBIOL LETT, V153, P227, DOI 10.1111/j.1574-6968.1997.tb10486.x; TURNER CMR, 1989, PARASITOLOGY, V99, P67, DOI 10.1017/S0031182000061035; van Meirvenne N., 1975, Annales Soc belge Med trop, V55, P1	25	92	92	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1470	1473		10.1126/science.aaa4502	http://dx.doi.org/10.1126/science.aaa4502			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814582	Green Accepted			2022-12-28	WOS:000352136400039
J	Ben-Zvi, D; Melton, DA				Ben-Zvi, Danny; Melton, Douglas A.			Modeling Human Nutrition Using Human Embryonic Stem Cells	CELL			English	Article							WEIGHT-LOSS DIETS; GUT MICROBIOTA; IN-VITRO; DISEASE; HEALTH; DIFFERENTIATION; MECHANISMS; GENERATION	Nutrition presents unanswered scientific questions of high public health importance. We envision model systems composed of interacting gastrointestinal and metabolic tissues derived from human embryonic stem cells, populated by gut microbiota. The culture will be embedded in 3D scaffolds, creating a controlled experimental system that enables tissue sampling and imaging.	[Ben-Zvi, Danny; Melton, Douglas A.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University	Ben-Zvi, D (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, 7 Divinity Ave, Cambridge, MA 02138 USA.	benzvi@fas.harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Ben-Zvi, Danny/0000-0002-8697-9744	Human Frontiers in Science post-doctoral fellowship	Human Frontiers in Science post-doctoral fellowship	D.B.-Z. is supported by the Human Frontiers in Science post-doctoral fellowship. D.A.M. is an Investigator of the Howard Hughes Medical Institute. We thank Dr. Jonathan Schneidermann and Dr. Sagi Levy for critical reading of this manuscript.	[Anonymous], 2014, NATURE, V511, P264, DOI 10.1038/511264a; Antico A, 2012, AUTOIMMUN REV, V12, P127, DOI 10.1016/j.autrev.2012.07.007; Baranski M, 2014, BRIT J NUTR, V112, P794, DOI 10.1017/S0007114514001366; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Cuaranta-Monroy I, 2014, STEM CELL RES, V13, P88, DOI 10.1016/j.scr.2014.04.015; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Feinman RD, 2015, NUTRITION, V31, P1, DOI 10.1016/j.nut.2014.06.011; Figueiredo JC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004228; Gardner C, 2012, DIABETES CARE, V35, P1798, DOI 10.2337/dc12-9002; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Key TJ, 2006, P NUTR SOC, V65, P35, DOI 10.1079/PNS2005481; Kim HJ, 2013, INTEGR BIOL-UK, V5, P1130, DOI 10.1039/c3ib40126j; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Malik VS, 2007, NAT CLIN PRACT CARD, V4, P34, DOI 10.1038/ncpcardio0726; Matarese LE, 2014, NUTR CLIN PRACT, V29, P759, DOI 10.1177/0884533614550251; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Parfrey LW, 2012, CLIN MICROBIOL INFEC, V18, P5, DOI 10.1111/j.1469-0691.2012.03861.x; Psichas A, 2015, J CLIN INVEST, V125, P908, DOI 10.1172/JCI76309; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Ryan KK, 2014, NATURE, V509, P183, DOI 10.1038/nature13135; Sachs N, 2014, CURR OPIN GENET DEV, V24, P68, DOI 10.1016/j.gde.2013.11.012; Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; van der Meer AD, 2013, LAB CHIP, V13, P3562, DOI 10.1039/c3lc50435b; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Willett WC, 2013, ANNU REV PUBL HEALTH, V34, P77, DOI 10.1146/annurev-publhealth-031811-124646; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034	38	8	9	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					12	17		10.1016/j.cell.2015.02.039	http://dx.doi.org/10.1016/j.cell.2015.02.039			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815980	Bronze			2022-12-28	WOS:000351952200003
J	Zaidat, OO; Fitzsimmons, BF; Woodward, BK; Wang, ZG; Killer-Oberpfalzer, M; Wakhloo, A; Gupta, R; Kirshner, H; Megerian, JT; Lesko, J; Pitzer, P; Ramos, J; Castonguay, AC; Barnwell, S; Smith, WS; Gress, DR				Zaidat, Osama O.; Fitzsimmons, Brian-Fred; Woodward, Britton Keith; Wang, Zhigang; Killer-Oberpfalzer, Monika; Wakhloo, Ajay; Gupta, Rishi; Kirshner, Howard; Megerian, J. Thomas; Lesko, James; Pitzer, Pamela; Ramos, Jandira; Castonguay, Alicia C.; Barnwell, Stanley; Smith, Wade S.; Gress, Daryl R.		VISSIT Investigators	Effect of a Balloon-Expandable Intracranial Stent vs Medical Therapy on Risk of Stroke in Patients With Symptomatic Intracranial Stenosis The VISSIT Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ARTERIAL-STENOSIS; RECURRENT STROKE; SAMMPRIS TRIAL; ISCHEMIC-STROKE; WINGSPAN STENT; ATHEROSCLEROSIS; EXPERIENCE; MANAGEMENT; DISEASE; DESIGN	IMPORTANCE Intracranial stenosis is one of the most common etiologies of stroke. To our knowledge, no randomized clinical trials have compared balloon-expandable stent treatment with medical therapy in symptomatic intracranial arterial stenosis. OBJECTIVE To evaluate the efficacy and safety of the balloon-expandable stent plus medical therapy vs medical therapy alone in patients with symptomatic intracranial stenosis (>= 70%). DESIGN, SETTING, AND PATIENTS VISSIT (the Vitesse Intracranial Stent Study for Ischemic Stroke Therapy) trial is an international, multicenter, 1: 1 randomized, parallel group trial that enrolled patients from 27 sites (January 2009-June 2012) with last follow-up in May 2013. INTERVENTIONS Patients (N = 112) were randomized to receive balloon-expandable stent plus medical therapy (stent group; n = 59) or medical therapy alone (medical group; n = 53). MAIN OUTCOMES AND MEASURES Primary outcome measure: a composite of stroke in the same territory within 12 months of randomization or hard transient ischemic attack (TIA) in the same territory day 2 through month 12 postrandomization. A hard TIA was defined as a transient episode of neurological dysfunction caused by focal brain or retinal ischemia lasting at least 10 minutes but resolving within 24 hours. Primary safety measure: a composite of any stroke, death, or intracranial hemorrhage within 30 days of randomization and any hard TIA between days 2 and 30 of randomization. Disability was measured with the modified Rankin Scale and general health status with the EuroQol-5D, both through month 12. RESULTS Enrollment was halted by the sponsor after negative results from another trial prompted an early analysis of outcomes, which suggested futility after 112 patients of a planned sample size of 250 were enrolled. The 30-day primary safety end point occurred in more patients in the stent group (14/58; 24.1%[95% CI, 13.9%-37.2%]) vs the medical group (5/53; 9.4%[95% CI, 3.1%-20.7%]) (P =.05). Intracranial hemorrhage within 30 days occurred in more patients in the stent group (5/58; 8.6%[95% CI, 2.9%-19.0%]) vs none in the medical group (95% CI, 0%-5.5%) (P =.06). The 1-year primary outcome of stroke or hard TIA occurred in more patients in the stent group (21/58; 36.2%[95% CI, 24.0-49.9]) vs the medical group (8/53; 15.1% [95% CI, 6.7-27.6]) (P =.02). Worsening of baseline disability score (modified Rankin Scale) occurred in more patients in the stent group (14/58; 24.1%[95% CI, 13.9%-37.2%]) vs the medical group (6/53; 11.3%[95% CI, 4.3%-23.0%]) (P =.09). The EuroQol-5D showed no difference in any of the 5 dimensions between groups at 12-month follow-up. CONCLUSIONS AND RELEVANCE Among patients with symptomatic intracranial arterial stenosis, the use of a balloon-expandable stent compared with medical therapy resulted in an increased 12-month risk of added stroke or TIA in the same territory, and increased 30-day risk of any stroke or TIA. These findings do not support the use of a balloon-expandable stent for patients with symptomatic intracranial arterial stenosis.	[Zaidat, Osama O.; Fitzsimmons, Brian-Fred; Castonguay, Alicia C.] Med Coll Wisconsin, Froedtert Hosp, Dept Neurol, Milwaukee, WI 53226 USA; [Zaidat, Osama O.; Fitzsimmons, Brian-Fred] Med Coll Wisconsin, Froedtert Hosp, Dept Neurosurg, Milwaukee, WI 53226 USA; [Zaidat, Osama O.; Fitzsimmons, Brian-Fred] Med Coll Wisconsin, Froedtert Hosp, Dept Radiol, Milwaukee, WI 53226 USA; [Woodward, Britton Keith] Vista Radiol, Knoxville, TN USA; [Wang, Zhigang] Shandong Univ, Hosp 2, Dept Neurol, Jinan, Shandong, Peoples R China; [Killer-Oberpfalzer, Monika] Paracelsus Med Univ, Dept Neurol, Salzburg, Austria; [Wakhloo, Ajay] Univ Massachusetts, Dept Radiol, Worcester, MA 01605 USA; [Gupta, Rishi] Wellstar Hlth Syst, Neurosci Ctr, Atlanta, GA USA; [Kirshner, Howard] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA; [Megerian, J. Thomas; Lesko, James; Pitzer, Pamela; Ramos, Jandira] Codman & Shurtleff Inc, Raynham, MA USA; [Barnwell, Stanley] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA; [Barnwell, Stanley] Oregon Hlth & Sci Univ, Dotter Intervent Inst, Portland, OR 97201 USA; [Smith, Wade S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Gress, Daryl R.] Univ Virginia, Dept Neurol, Charlottesville, VA USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Shandong University; Paracelsus Private Medical University; University of Massachusetts System; University of Massachusetts Worcester; Vanderbilt University; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California San Francisco; University of Virginia	Zaidat, OO (corresponding author), Med Coll Wisconsin, Froedtert Hosp, Neurointervent Div, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	szaidat@mcw.edu		Do, Huy/0000-0001-9682-3412; Killer-Oberpfalzer, Monika/0000-0001-5572-7694	Micrus Endovascular	Micrus Endovascular	The trial was initiated and funded by Micrus Endovascular.	Abou-Chebl A, 2012, STROKE, V43, P616, DOI 10.1161/STROKEAHA.111.641563; Arenillas JF, 2011, STROKE, V42, pS20, DOI 10.1161/STROKEAHA.110.597278; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Bose A, 2007, STROKE, V38, P1531, DOI 10.1161/STROKEAHA.106.477711; Carson P, 2010, AM HEART J, V160, P649, DOI 10.1016/j.ahj.2010.07.004; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Chimowitz MI, 2011, J STROKE CEREBROVASC, V20, P357, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.001; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Clinicaltrials.gov, VISSIT INTR STENT ST; Derdeyn CP, 2014, LANCET, V383, P333, DOI 10.1016/S0140-6736(13)62038-3; Derdeyn CP, 2013, J NEUROINTERV SURG, V5, P528, DOI 10.1136/neurintsurg-2012-010504; Derdeyn CP, 2013, NEUROSURGERY, V72, P777, DOI 10.1227/NEU.0b013e318286fdc8; Fiorella D, 2007, STROKE, V38, P881, DOI 10.1161/01.STR.0000257963.65728.e8; Fleg JL, 2012, JACC-CARDIOVASC IMAG, V5, P941, DOI 10.1016/j.jcmg.2012.07.007; Gordon NF, 2004, AM J CARDIOL, V94, P1558, DOI 10.1016/j.amjcard.2004.08.039; Gorelick PB, 2008, STROKE, V39, P2396, DOI 10.1161/STROKEAHA.107.505776; Jiang WJ, 2007, AM J NEURORADIOL, V28, P830; Kasner SE, 2006, CIRCULATION, V113, P555, DOI 10.1161/CIRCULATIONAHA.105.578229; Liebeskind DS, 2011, ANN NEUROL, V69, P963, DOI 10.1002/ana.22354; Lutsep HL, 2004, STROKE, V35, P1388, DOI 10.1161/01.STR.0000128708.86762.d6; Freitas JMM, 2007, SURG NEUROL, V68, P378, DOI 10.1016/j.surneu.2006.11.062; Nahab F, 2009, NEUROLOGY, V72, P2014, DOI 10.1212/01.wnl.0b013e3181a1863c; Nguyen TN, 2011, STROKE, V42, P107, DOI 10.1161/STROKEAHA.110.583245; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; Tollard E, 2012, AM J NEURORADIOL, V33, P626, DOI 10.3174/ajnr.A2848; Turan TN, 2012, CIRC-CARDIOVASC QUAL, V5, pE51, DOI 10.1161/CIRCOUTCOMES.112.966911; US Food and Drug Administration, SUMM SAF PROB BEN; US Food and Drug Administration, FDA SAF COMM NARR IN; von Schoenfeldt P, 2015, J NEUROINTERV SURG, V7, P188, DOI 10.1136/neurintsurg-2013-011019; Wang X, 2013, INT J STROKE, V8, P663, DOI 10.1111/j.1747-4949.2012.00828.x; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Wityk RJ, 1996, STROKE, V27, P1974, DOI 10.1161/01.STR.27.11.1974; Wong KS, 2003, STROKE, V34, P2361, DOI 10.1161/01.STR.0000089017.90037.7A; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Zaidat OO, 2008, NEUROLOGY, V70, P1518, DOI 10.1212/01.wnl.0000306308.08229.a3; Zaidat OO, 2014, J NEUROINTERV SURG, V6, P225, DOI 10.1136/neurintsurg-2013-010667; Zaidat OO, 2013, J STROKE CEREBROVASC, V22, P1131, DOI 10.1016/j.jstrokecerebrovasdis.2012.10.021	38	269	294	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1240	1248		10.1001/jama.2015.1693	http://dx.doi.org/10.1001/jama.2015.1693			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25803346	Bronze, Green Submitted			2022-12-28	WOS:000351435500023
J	Mega, JL; Simon, T				Mega, Jessica L.; Simon, Tabassome			Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments	LANCET			English	Article							ACUTE CORONARY SYNDROMES; LOW-DOSE ASPIRIN; PRASUGREL 10 MG; PLATELET REACTIVITY; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; ACTIVE METABOLITE; CLINICAL-OUTCOMES; DOUBLE-BLIND; CONVENTIONAL ANTICOAGULATION	Antithrombotic drugs, which include antiplatelet and anticoagulant therapies, prevent and treat many cardiovascular disorders and, as such, are some of the most commonly prescribed drugs worldwide. The first drugs designed to inhibit platelets or coagulation factors, such as the antiplatelet clopidogrel and the anticoagulant warfarin, significantly reduced the risk of thrombotic events at the cost of increased bleeding in patients. However, both clopidogrel and warfarin have some pharmacological limitations including interpatient variability in antithrombotic effects in part due to the metabolism, interactions (eg, drug, environment, and genetic), or targets of the drugs. Increased knowledge of the pharmacology of antithrombotic drugs and the mechanisms underlying thrombosis has led to the development of newer drugs with faster onset of action, fewer interactions, and less interpatient variability in their antithrombotic effects than previous antithrombotic drugs. Treatment options now include the next-generation antiplatelet drugs prasugrel and ticagrelor, and, in terms of anticoagulants, inhibitors that directly target factor IIa (dabigatran) or Xa (rivaroxaban, apixaban, edoxaban) are available. In this Series paper we review the pharmacological properties of these most commonly used oral antithrombotic drugs, and explore the development of antiplatelet and anticoagulant therapies.	[Mega, Jessica L.] Harvard Univ, Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc Med,Sch Med, Boston, MA 02115 USA; [Simon, Tabassome] Hop St Antoine, AP HP, Dept Clin Pharmacol, F-75571 Paris, France; [Simon, Tabassome] Unite Rech Clin URCEST, Paris, France; [Simon, Tabassome] Univ Paris 06, Paris, France; [Simon, Tabassome] Natl Inst Hlth & Med Res, U 698, Inst Natl Sante & Rech Med, Paris, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mega, JL (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	jmega@partners.org		SIMON, Tabassome/0000-0002-4550-0450	Janssen Pharmaceutica; Bayer AG; Daiichi Sankyo; AstraZeneca; Eli Lilly; Bristol-Myers Squibb; Sanofi-Aventis; Boehringer Ingelheim; Portola; American Genomics; Daiichi-Sankyo; Merck Co; Novartis; Pfizer; Sanofi; Servier; Astellas	Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bayer AG(Bayer AG); Daiichi Sankyo(Daiichi Sankyo Company Limited); AstraZeneca(AstraZeneca); Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis); Boehringer Ingelheim(Boehringer Ingelheim); Portola; American Genomics; Daiichi-Sankyo(Daiichi Sankyo Company Limited); Merck Co(Merck & Company); Novartis(Novartis); Pfizer(Pfizer); Sanofi; Servier(Servier); Astellas(Astellas Pharmaceuticals)	JLM has received research grants from Janssen Pharmaceutica, Bayer AG, Daiichi Sankyo, AstraZeneca, Eli Lilly, Bristol-Myers Squibb, and Sanofi-Aventis. JLM has received personal feees from AstraZeneca, Bayer AG, Boehringer Ingelheim, Janssen Pharmaceutica, Portola, and American Genomics. JLM has received research supplies from Accumetrics and Nanosphere. TS has received grants from AstraZeneca, Daiichi-Sankyo, Eli Lilly, GlaxoSmithKleine, Merck & Co, Novartis, Pfizer, Sanofi, and Servier. TS has received personal fees from AstraZeneca, Astellas, Bayer AG, Bristol-Myers Squibb, Eli Lilly, Merck & Co, and Sanofi.	Alexander JH, 2011, NEW ENGL J MED, V365, P699, DOI 10.1056/NEJMoa1105819; Alexander JH, 2009, CIRCULATION, V119, P2877, DOI 10.1161/CIRCULATIONAHA.108.832139; Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920; Angiolillo DJ, 2011, CLIN PHARMACOL THER, V89, P65, DOI 10.1038/clpt.2010.219; Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Angiolillo DJ, 2010, EUR HEART J, V31, P17, DOI 10.1093/eurheartj/ehp504; [Anonymous], HOT TOPICS CARDIOL; Aradi D, 2015, THROMB HAEMOSTASIS, V113, P221, DOI 10.1160/TH14-05-0449; Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; BARRAGAN P, 1994, CATHETER CARDIO DIAG, V32, P133, DOI 10.1002/ccd.1810320208; Barragan P, 1996, ARCH MAL COEUR VAISS, V89, P1515; Benedek IH, 1995, J CLIN PHARMACOL, V35, P1181, DOI 10.1002/j.1552-4604.1995.tb04044.x; Bergmeijer TO, 2014, AM HEART J, V168, P16, DOI 10.1016/j.ahj.2014.03.006; Bertrand ME, 2000, CIRCULATION, V102, P624, DOI 10.1161/01.CIR.102.6.624; Bertrand ME, 1998, CIRCULATION, V98, P1597, DOI 10.1161/01.CIR.98.16.1597; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Blech S, 2008, DRUG METAB DISPOS, V36, P386, DOI 10.1124/dmd.107.019083; Bonaca MP, 2014, AM HEART J, V167, P437, DOI 10.1016/j.ahj.2013.12.020; Bonello L, 2012, J THROMB HAEMOST, V10, P1999, DOI 10.1111/j.1538-7836.2012.04875.x; Born G, 2006, BRIT J PHARMACOL, V147, pS241, DOI 10.1038/sj.bjp.0706401; Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Capodanno D, 2011, CIRC-CARDIOVASC INTE, V4, P180, DOI 10.1161/CIRCINTERVENTIONS.110.960187; Capra V, 2014, J THROMB HAEMOST, V12, P126, DOI 10.1111/jth.12472; Cattaneo M, 2014, J AM COLL CARDIOL, V63, P2503, DOI 10.1016/j.jacc.2014.03.031; Chyou JY, 2013, CARDIOVASCULAR THERA, V4th, P53; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Collet JP, 2011, JACC-CARDIOVASC INTE, V4, P392, DOI 10.1016/j.jcin.2011.03.002; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cornel JH, 2014, AM HEART J, V168, P76, DOI 10.1016/j.ahj.2014.04.011; Crowther MA, 2000, LANCET, V356, P1551, DOI 10.1016/S0140-6736(00)03125-1; Cuker A, 2014, J AM COLL CARDIOL, V64, P1128, DOI 10.1016/j.jacc.2014.05.065; DAVIE EW, 1964, SCIENCE, V145, P1310, DOI 10.1126/science.145.3638.1310; Desai J, 2013, THROMB HAEMOSTASIS, V110, P205, DOI 10.1160/TH13-02-0150; Erlinge D, 2013, J AM COLL CARDIOL, V62, P577, DOI 10.1016/j.jacc.2013.05.023; Erlinge D, 2012, J AM COLL CARDIOL, V60, P2032, DOI 10.1016/j.jacc.2012.08.964; Franchi F, 2015, NAT REV CARDIOL, V12, P30, DOI 10.1038/nrcardio.2014.156; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Garratt KN, 2015, CIRCULATION, V131, P62, DOI 10.1161/CIRCULATIONAHA.114.013570; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Godier A, 2015, NEW ENGL J MED, V372, P196, DOI 10.1056/NEJMc1409373; Goodman SG, 2012, CIRCULATION, V125, P978, DOI 10.1161/CIRCULATIONAHA.111.032912; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Gurbel PA, 2013, J AM COLL CARDIOL, V62, P505, DOI 10.1016/j.jacc.2013.03.037; Gurbel PA, 2009, CIRCULATION, V120, P2577, DOI 10.1161/CIRCULATIONAHA.109.912550; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Harrington AR, 2013, STROKE, V44, P1676, DOI 10.1161/STROKEAHA.111.000402; Heidbuchel H, 2013, EUROPACE, V15, P625, DOI 10.1093/europace/eut083; HEIMARK LD, 1992, CLIN PHARMACOL THER, V51, P398, DOI 10.1038/clpt.1992.39; Holmberg MT, 2014, CLIN PHARMACOL THER, V95, P307, DOI 10.1038/clpt.2013.192; Holmberg MT, 2013, BRIT J CLIN PHARMACO, V75, P1488, DOI 10.1111/bcp.12026; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Husted S, 2009, CARDIOVASC THER, V27, P259, DOI 10.1111/j.1755-5922.2009.00096.x; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; Karrillon GJ, 1996, CIRCULATION, V94, P1519, DOI 10.1161/01.CIR.94.7.1519; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Lablanche JM, 1996, EUR HEART J, V17, P1373; LOLL PJ, 1995, NAT STRUCT BIOL, V2, P637, DOI 10.1038/nsb0895-637; Maffrand JP, 2012, CR CHIM, V15, P737, DOI 10.1016/j.crci.2012.05.006; Mangiacapra F, 2012, JACC-CARDIOVASC INTE, V5, P281, DOI 10.1016/j.jcin.2012.01.009; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mega JL, 2009, LANCET, V374, P29, DOI 10.1016/S0140-6736(09)60738-8; Mega JL, 2013, AM J CARDIOL, V112, P472, DOI 10.1016/j.amjcard.2013.04.011; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Montalescot G, 2006, J AM COLL CARDIOL, V48, P931, DOI 10.1016/j.jacc.2006.04.090; Montalescot G, 2013, NEW ENGL J MED, V369, P999, DOI 10.1056/NEJMoa1308075; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Moukarbel GV, 2012, CIRCULATION, V125, P375, DOI 10.1161/CIRCULATIONAHA.111.019745; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Oldgren J, 2011, EUR HEART J, V32, P2781, DOI 10.1093/eurheartj/ehr113; Parodi G, 2013, J AM COLL CARDIOL, V61, P1601, DOI 10.1016/j.jacc.2013.01.024; Parodi G, 2011, JAMA-J AM MED ASSOC, V306, P1215, DOI 10.1001/jama.2011.1332; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Patrono C, 2007, NAT CLIN PRACT CARD, V4, P42, DOI 10.1038/ncpcardio0728; Patti G, 2005, CIRCULATION, V111, P2099, DOI 10.1161/01.CIR.0000161383.06692.D4; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Rehmel JLF, 2006, DRUG METAB DISPOS, V34, P600, DOI 10.1124/dmd.105.007989; Roberts JD, 2012, LANCET, V379, P1705, DOI 10.1016/S0140-6736(12)60161-5; Rocca B, 2012, J THROMB HAEMOST, V10, P1220, DOI 10.1111/j.1538-7836.2012.04723.x; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; Sibbing D, 2010, CIRCULATION, V121, P512, DOI 10.1161/CIRCULATIONAHA.109.885194; Simon T, 2011, CLIN PHARMACOL THER, V90, P287, DOI 10.1038/clpt.2011.127; Simon T, 2011, CIRCULATION, V123, P474, DOI 10.1161/CIRCULATIONAHA.110.965640; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; SMITH JB, 1971, NATURE-NEW BIOL, V231, P235, DOI 10.1038/newbio231235a0; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stone GW, 2013, LANCET, V382, P614, DOI 10.1016/S0140-6736(13)61170-8; Sugidachi A, 2013, BRIT J PHARMACOL, V169, P82, DOI 10.1111/bph.12108; Swiger KJ, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0361-7; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Toggweiler S, 2014, NEW ENGL J MED, V371, P2338, DOI [10.1056/NEJMc1412729, 10.1056/NEJMoa1412729]; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Verhoef TI, 2013, NEW ENGL J MED, V369, P2304, DOI 10.1056/NEJMoa1311388; Vilahur G, 2007, J THROMB HAEMOST, V5, P82, DOI 10.1111/j.1538-7836.2006.02245.x; von Beckerath N, 2005, CIRCULATION, V112, P2946, DOI 10.1161/CIRCULATIONAHA.105.559088; Wallentin L, 2008, EUR HEART J, V29, P21, DOI 10.1093/eurheartj/ehm545; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Watala C, 2004, THROMB RES, V113, P101, DOI 10.1016/j.thromres.2003.12.016; Weitz JI, 2014, BRAUNWALDS HEART DIS, P1809; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; You JHS, 2014, J GEN INTERN MED, V29, P438, DOI 10.1007/s11606-013-2639-2; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zineh I, 2013, NEW ENGL J MED, V369, P2273, DOI 10.1056/NEJMp1314529	114	153	170	1	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2015	386	9990					281	291		10.1016/S0140-6736(15)60243-4	http://dx.doi.org/10.1016/S0140-6736(15)60243-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN1XI	25777662				2022-12-28	WOS:000358213700033
J	Omand, MM; D'Asaro, EA; Lee, CM; Perry, MJ; Briggs, N; Cetinic, I; Mahadevan, A				Omand, Melissa M.; D'Asaro, Eric A.; Lee, Craig M.; Perry, Mary Jane; Briggs, Nathan; Cetinic, Ivona; Mahadevan, Amala			Eddy-driven subduction exports particulate organic carbon from the spring bloom	SCIENCE			English	Article							SUBPOLAR NORTH-ATLANTIC; OCEANS TWILIGHT ZONE; PHYTOPLANKTON BLOOMS; SUBTROPICAL GYRE; VERTICAL MOTION; HIGH-RESOLUTION; PARTICLE-FLUX; DIATOM BLOOM; FRONTS; PUMP	The export of particulate organic carbon (POC) from the surface ocean to depth is traditionally ascribed to sinking. Here, we show that a dynamic eddying flow field subducts surface water with high concentrations of nonsinking POC. Autonomous observations made by gliders during the North Atlantic spring bloom reveal anomalous features at depths of 100 to 350 meters with elevated POC, chlorophyll, oxygen, and temperature-salinity characteristics of surface water. High-resolution modeling reveals that during the spring transition, intrusions of POC-rich surface water descend as coherent, 1- to 10-kilometer-scale filamentous features, often along the perimeter of eddies. Such a submesoscale eddy-driven flux of POC is unresolved in global carbon cycle models but can contribute as much as half of the total springtime export of POC from the highly productive subpolar oceans.	[Omand, Melissa M.; Mahadevan, Amala] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [D'Asaro, Eric A.; Lee, Craig M.] Univ Washington, Appl Ocean Phys Lab, Seattle, WA 98195 USA; [Perry, Mary Jane; Briggs, Nathan; Cetinic, Ivona] Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA	Woods Hole Oceanographic Institution; University of Washington; University of Washington Seattle; University of Maine System; University of Maine Orono	Mahadevan, A (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	amala@whoi.edu	Cetinic, Ivona/I-7252-2012; Cetinic, Ivona/GSI-5613-2022; Cetinic, Ivona/Q-6281-2019		National Science Foundation (NSF) [OCE 1260080, 1434788]; Office of Naval Research; Radcliffe Institute for Advanced Study; NSF [OCE-0628107, OCE-0628379]; NASA [NNX-08AL92G]; Division Of Ocean Sciences [1434512] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Radcliffe Institute for Advanced Study; NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	M.M.O. and A.M. were supported by the National Science Foundation (NSF OCE 1260080, 1434788), the Office of Naval Research, and a fellowship to A.M. from the Radcliffe Institute for Advanced Study. The NAB08 field experiment was supported by NSF OCE-0628107 and OCE-0628379 and NASA NNX-08AL92G. Data from NAB08 is publicly available at the Biological and Chemical Oceanography Data Management Office: http://osprey.bcodmo.org/project.cfm?flag=view&id=102&sortby=project.	Alkire MB, 2012, DEEP-SEA RES PT I, V64, P157, DOI 10.1016/j.dsr.2012.01.012; Bagniewski W, 2011, BIOGEOSCIENCES, V8, P1291, DOI 10.5194/bg-8-1291-2011; Barth JA, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000956; Briggs N, 2011, DEEP-SEA RES PT I, V58, P1031, DOI 10.1016/j.dsr.2011.07.007; BUESSELER KO, 1992, DEEP-SEA RES, V39, P1115, DOI 10.1016/0198-0149(92)90060-7; Burd AB, 2010, DEEP-SEA RES PT II, V57, P1557, DOI 10.1016/j.dsr2.2010.02.022; Dall'Olmo G, 2014, GEOPHYS RES LETT, V41, P2921, DOI 10.1002/2014GL059244; DUCKLOW HW, 1993, DEEP-SEA RES PT II, V40, P1, DOI 10.1016/0967-0645(93)90003-6; Fielding S, 2001, J MARINE SYST, V30, P287, DOI 10.1016/S0924-7963(01)00063-X; Follows MJ, 1996, J MAR RES, V54, P605, DOI 10.1357/0022240963213682; Fox-Kemper B, 2008, J PHYS OCEANOGR, V38, P1145, DOI 10.1175/2007JPO3792.1; GARDNER WD, 1995, DEEP-SEA RES PT II, V42, P757, DOI 10.1016/0967-0645(95)00037-Q; Giering SLC, 2014, NATURE, V507, P480, DOI 10.1038/nature13123; Held IM, 1999, J ATMOS SCI, V56, P1688, DOI 10.1175/1520-0469(1999)056<1688:TSBOTZ>2.0.CO;2; Johnston TMS, 2009, DEEP-SEA RES PT II, V56, P246, DOI 10.1016/j.dsr2.2008.08.006; Karleskind P, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006446; Kortzinger A, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004347; Lee MM, 2012, J PHYS OCEANOGR, V42, P1762, DOI 10.1175/JPO-D-11-0219.1; Levy M, 2001, J MAR RES, V59, P535, DOI 10.1357/002224001762842181; Mahadevan A, 1996, J PHYS OCEANOGR, V26, P1868, DOI 10.1175/1520-0485(1996)026<1868:ANMOMP>2.0.CO;2; Mahadevan A, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC005203; Mahadevan A, 2006, OCEAN MODEL, V14, P241, DOI 10.1016/j.ocemod.2006.05.006; Mahadevan A, 2006, OCEAN MODEL, V14, P222, DOI 10.1016/j.ocemod.2006.05.005; Mahadevan A, 2012, SCIENCE, V337, P54, DOI 10.1126/science.1218740; Martin P, 2011, DEEP-SEA RES PT I, V58, P338, DOI 10.1016/j.dsr.2011.01.006; McWilliams JC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039402; Palter JB, 2005, NATURE, V437, P687, DOI 10.1038/nature03969; POLLARD RT, 1990, NATURE, V348, P227, DOI 10.1038/348227a0; Richardson TL, 2007, SCIENCE, V315, P838, DOI 10.1126/science.1133471; Rynearson TA, 2013, DEEP-SEA RES PT I, V82, P60, DOI 10.1016/j.dsr.2013.07.013; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sallee JB, 2012, NAT GEOSCI, V5, P579, DOI [10.1038/ngeo1523, 10.1038/NGEO1523]; Sanders R, 2014, PROG OCEANOGR, V129, P200, DOI 10.1016/j.pocean.2014.05.005; Siegel DA, 2014, GLOBAL BIOGEOCHEM CY, V28, P181, DOI 10.1002/2013GB004743; SPALL MA, 1995, J GEOPHYS RES-OCEANS, V100, P2543, DOI 10.1029/94JC02860; Steinberg DK, 2008, LIMNOL OCEANOGR, V53, P1327, DOI 10.4319/lo.2008.53.4.1327; Sverdrup H.U., 1953, J CONSEILCONSEIL PER, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Taylor JR, 2011, LIMNOL OCEANOGR, V56, P2293, DOI 10.4319/lo.2011.56.6.2293	38	200	204	10	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					222	225		10.1126/science.1260062	http://dx.doi.org/10.1126/science.1260062			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25814062	Green Accepted			2022-12-28	WOS:000352613700042
J	Cichon, J; Gan, WB				Cichon, Joseph; Gan, Wen-Biao			Branch-specific dendritic Ca2+ spikes cause persistent synaptic plasticity	NATURE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; LONG-TERM POTENTIATION; BARREL CORTEX; IN-VIVO; CALCIUM SIGNALS; TRANSGENIC MICE; INTEGRATION; CELLS; MEMORY; SPINES	The brain has an extraordinary capacity for memory storage, but how it or new information without disrupting previously acquired memories remains unknown. Here we show that different motor learning tasks induce dendritic Ca2+ spikes on different apical tuft branches of individual layer V pyramidal neurons in the mouse motor cortex . These ask-related, branch-specific Ca2+ spikes cause long-lasting potentiation of postsynaptic dendritic spines active at the time of spike generation. When somatostatin-expressing interneurons are inactivated, different motor tasks frequently induce Ca2+ spikes on the same branches. On those branches, spines potentiated during one task are depotentiated when they are active seconds before Ca2+ spikes induced by another task. Concomitantly, increased neuronal activity and performance improvement after learning one task are disrupted when another task is learned. These findings indicate that dendritic-branch-specific generation of Ca2+ spikes is crucial for establishing long-lasting synaptic plasticity, thereby facilitating information storage associated with different learning experiences	[Cichon, Joseph; Gan, Wen-Biao] NYU, Sch Med, Skirball Inst, Dept Neurosci & Physiol, New York, NY 10016 USA	New York University	Gan, WB (corresponding author), NYU, Sch Med, Skirball Inst, Dept Neurosci & Physiol, New York, NY 10016 USA.	gan@saturn.med.nyu.edu	Core, Vector/CAF-4832-2022		National Institutes of Health [R01 NS047325, P01 NS074972]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074972, R01NS047325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health R01 NS047325 and P01 NS074972 to W.-B.G. We thank L. Looger, G. Chen and members of the Gan laboratory for their comments on the manuscript. We thank the Genetically-Encoded Neuronal Indicator and Effector (GENIE) Project and the Janelia Farm Research Campus of the Howard Hughes Medical Institute for sharing GCaMP6 constructs.	Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Grienberger C, 2014, NEURON, V81, P1274, DOI 10.1016/j.neuron.2014.01.014; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Harnett MT, 2013, NEURON, V79, P516, DOI 10.1016/j.neuron.2013.06.005; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Holthoff K, 2004, J PHYSIOL-LONDON, V560, P27, DOI 10.1113/jphysiol.2004.072678; Humeau Y, 2007, NEUROPHARMACOLOGY, V52, P234, DOI 10.1016/j.neuropharm.2006.07.010; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lavzin M, 2012, NATURE, V490, P397, DOI 10.1038/nature11451; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Major G, 2013, ANNU REV NEUROSCI, V36, P1, DOI 10.1146/annurev-neuro-062111-150343; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; Palmer LM, 2014, NAT NEUROSCI, V17, P383, DOI 10.1038/nn.3646; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Remy S, 2007, P NATL ACAD SCI USA, V104, P17192, DOI 10.1073/pnas.0707919104; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yang G, 2014, SCIENCE, V344, P1173, DOI 10.1126/science.1249098; Yang Guang, 2013, Methods Mol Biol, V1010, P35, DOI 10.1007/978-1-62703-411-1_3; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	47	273	276	6	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					180	U80		10.1038/nature14251	http://dx.doi.org/10.1038/nature14251			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25822789	Green Accepted			2022-12-28	WOS:000352454600030
J	Jolly, SS; Cairns, JA; Yusuf, S; Meeks, B; Pogue, J; Rokoss, MJ; Kedev, S; Thabane, L; Stankovic, G; Moreno, R; Gershlick, A; Chowdhary, S; Lavi, S; Niemela, K; Steg, PG; Bernat, I; Xu, Y; Cantor, WJ; Overgaard, CB; Naber, CK; Cheema, AN; Welsh, RC; Bertrand, OF; Avezum, A; Bhindi, R; Pancholy, S; Rao, SV; Natarajan, MK; ten Berg, JM; Shestakovska, O; Gao, P; Widimsky, P; Dzavik, V				Jolly, S. S.; Cairns, J. A.; Yusuf, S.; Meeks, B.; Pogue, J.; Rokoss, M. J.; Kedev, S.; Thabane, L.; Stankovic, G.; Moreno, R.; Gershlick, A.; Chowdhary, S.; Lavi, S.; Niemela, K.; Steg, P. G.; Bernat, I.; Xu, Y.; Cantor, W. J.; Overgaard, C. B.; Naber, C. K.; Cheema, A. N.; Welsh, R. C.; Bertrand, O. F.; Avezum, A.; Bhindi, R.; Pancholy, S.; Rao, S. V.; Natarajan, M. K.; ten Berg, J. M.; Shestakovska, O.; Gao, P.; Widimsky, P.; Dzavik, V.		TOTAL Investigators	Randomized Trial of Primary PCI with or without Routine Manual Thrombectomy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; THROMBUS ASPIRATION; METAANALYSIS; ANGIOPLASTY; GUIDELINES; MANAGEMENT; PERFUSION; OUTCOMES	Background During primary percutaneous coronary intervention (PCI), manual thrombectomy may reduce distal embolization and thus improve microvascular perfusion. Small trials have suggested that thrombectomy improves surrogate and clinical outcomes, but a larger trial has reported conflicting results. Methods We randomly assigned 10,732 patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI to a strategy of routine upfront manual thrombectomy versus PCI alone. The primary outcome was a composite of death from cardiovascular causes, recurrent myocardial infarction, cardiogenic shock, or New York Heart Association (NYHA) class IV heart failure within 180 days. The key safety outcome was stroke within 30 days. Results The primary outcome occurred in 347 of 5033 patients (6.9%) in the thrombectomy group versus 351 of 5030 patients (7.0%) in the PCI-alone group (hazard ratio in the thrombectomy group, 0.99; 95% confidence interval [CI], 0.85 to 1.15; P = 0.86). The rates of cardiovascular death (3.1% with thrombectomy vs. 3.5% with PCI alone; hazard ratio, 0.90; 95% CI, 0.73 to 1.12; P = 0.34) and the primary outcome plus stent thrombosis or target-vessel revascularization (9.9% vs. 9.8%; hazard ratio, 1.00; 95% CI, 0.89 to 1.14; P = 0.95) were also similar. Stroke within 30 days occurred in 33 patients (0.7%) in the thrombectomy group versus 16 patients (0.3%) in the PCI-alone group (hazard ratio, 2.06; 95% CI, 1.13 to 3.75; P = 0.02). Conclusions In patients with STEMI who were undergoing primary PCI, routine manual thrombectomy, as compared with PCI alone, did not reduce the risk of cardiovascular death, recurrent myocardial infarction, cardiogenic shock, or NYHA class IV heart failure within 180 days but was associated with an increased rate of stroke within 30 days.	[Jolly, S. S.; Yusuf, S.; Meeks, B.; Pogue, J.; Rokoss, M. J.; Thabane, L.; Natarajan, M. K.; Shestakovska, O.; Gao, P.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Jolly, S. S.; Yusuf, S.; Meeks, B.; Pogue, J.; Rokoss, M. J.; Thabane, L.; Natarajan, M. K.; Shestakovska, O.; Gao, P.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Jolly, S. S.; Yusuf, S.; Meeks, B.; Pogue, J.; Rokoss, M. J.; Thabane, L.; Natarajan, M. K.; Shestakovska, O.; Gao, P.] Hamilton Hlth Sci, Hamilton, ON, Canada; [Cairns, J. A.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Lavi, S.] London Hlth Sci Ctr, Dept Med, London, ON, Canada; [Cantor, W. J.] Southlake Reg Hlth Ctr, Newmarket, ON, Canada; [Overgaard, C. B.; Dzavik, V.] Univ Hlth Network, Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Cheema, A. N.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Welsh, R. C.] Mazankowski Alberta Heart Inst, Dept Med, Edmonton, AB, Canada; [Bertrand, O. F.] Univ Laval, Quebec Heart Lung Inst, Quebec City, PQ, Canada; [Kedev, S.] Sts Cyril & Methodius Univ, Univ Clin Cardiol, Skopje, Macedonia; [Stankovic, G.] Univ Belgrade, Fac Med, Clin Ctr Serbia, Belgrade, Serbia; [Stankovic, G.] Univ Belgrade, Fac Med, Dept Cardiol, Belgrade, Serbia; [Moreno, R.] Univ Hosp La Paz, Madrid, Spain; [Gershlick, A.] Univ Hosp Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Chowdhary, S.] Univ S Manchester Hosp, Manchester Acad Hlth Sci Ctr, Manchester M20 8LR, Lancs, England; [Niemela, K.] Tampere Univ Hosp, Ctr Heart, Tampere, Finland; [Steg, P. G.] Univ Paris Diderot, Sorbonne Paris Cite, Hop Bichat, AP HP,INSERM,U1148, Paris, France; [Bernat, I.] Univ Hosp, Plzen, Czech Republic; [Bernat, I.] Fac Med Pilsen, Plzen, Czech Republic; [Widimsky, P.] Charles Univ Prague, Univ Hosp Kralovske Vinohrady, Fac Med 3, Prague, Czech Republic; [Xu, Y.] Tongji Univ, Peoples Hosp 10, Shanghai 200092, Peoples R China; [Naber, C. K.] Elisabeth Hosp, Dept Cardiol & Angiol, Contilla Heart & Vasc Ctr, Essen, Germany; [Avezum, A.] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Bhindi, R.] Royal N Shore Hosp, Sydney, NSW, Australia; [Pancholy, S.] Northeast Clin Trials Grp, Scranton, PA USA; [Rao, S. V.] Duke Clin Res Inst, Durham, NC USA; [ten Berg, J. M.] St Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands	McMaster University; Population Health Research Institute; McMaster University; McMaster University; University of British Columbia; London Health Sciences Centre; Southlake Regional Health Centre; University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Laval University; Quebec Heart & Lung Institute; Saints Cyril & Methodius University of Skopje; Clinical Centre of Serbia; University of Belgrade; University of Belgrade; Hospital Universitario La Paz; University Hospitals of Leicester NHS Trust; University of Leicester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Tampere University; Tampere University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University Hospital Plzen; Charles University Prague; Charles University Prague; University Hospital Vinohrady; Tongji University; Instituto Dante Pazzanese de Cardiologia; Royal North Shore Hospital; University of Sydney; Duke University; St. Antonius Hospital Utrecht	Jolly, SS (corresponding author), Hamilton Gen Hosp, Rm C3-118,DBCVSRI Bldg,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	sanjit.jolly@phri.ca	Welsh, Robert/ABH-3526-2021; Jolly, Sanjit/O-2534-2015; Cheema, Asim N./AAA-7676-2020; Bernat, Ivo/U-1655-2017; Avezum, Alvaro AA/K-6137-2016; STEG, Philippe Gabriel/Z-1567-2019; Kočka, Viktor/K-7552-2017; Cairns, John/AAI-8744-2021; Widimsky, Petr/P-8088-2016; Moreno, Raul/AAB-9983-2021; Avezum, Alvaro/AAP-7687-2020; Lavi, Shahar/G-3317-2011; Stankovic, Goran/Q-8507-2019	Cheema, Asim N./0000-0002-3174-8957; Bernat, Ivo/0000-0003-3142-7667; Avezum, Alvaro AA/0000-0002-3073-6890; Kočka, Viktor/0000-0002-2806-0545; Widimsky, Petr/0000-0001-5686-7752; Lavi, Shahar/0000-0002-6105-8084; Stankovic, Goran/0000-0002-9414-0885; Moreno, Raul/0000-0001-7179-1426; STEG, Philippe Gabriel/0000-0001-6896-2941; Torzewski, Jan/0000-0003-4959-7293; Shestakovska, Olga/0000-0002-4175-4680; Welsh, Robert/0000-0003-2613-9142; Yusuf, Salim/0000-0003-4776-5601	Medtronic; Canadian Institutes of Health Research	Medtronic(Medtronic); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by Medtronic and the Canadian Institutes of Health Research; TOTAL ClinicalTrials.gov number, NCT01149044.	Budaj A, 2005, CIRCULATION, V111, P3242, DOI 10.1161/CIRCULATIONAHA.104.512806; Buller CE, 2008, CIRCULATION, V118, P1335, DOI 10.1161/CIRCULATIONAHA.108.767772; De Luca G, 2008, EUR HEART J, V29, P3002, DOI 10.1093/eurheartj/ehn389; Frobert O, 2014, NEW ENGL J MED, V371, P786; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Guptill JT, 2013, CIRC-CARDIOVASC INTE, V6, P176, DOI 10.1161/CIRCINTERVENTIONS.112.000159; Jolly SS, 2014, AM HEART J, V167, P315, DOI 10.1016/j.ahj.2013.12.002; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Lagerqvist B, 2014, NEW ENGL J MED, V371, P1111, DOI 10.1056/NEJMoa1405707; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stone GW, 2012, JAMA-J AM MED ASSOC, V307, P1817, DOI 10.1001/jama.2012.421; Stone GW, 2002, J AM COLL CARDIOL, V39, P591, DOI 10.1016/S0735-1097(01)01779-X; Svilaas T, 2008, NEW ENGL J MED, V358, P557, DOI 10.1056/NEJMoa0706416; Tamhane UU, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-10; Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8	16	400	425	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2015	372	15					1389	1398		10.1056/NEJMoa1415098	http://dx.doi.org/10.1056/NEJMoa1415098			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF2ZV	25853743	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000352417900003
J	Amunts, A; Brown, A; Toots, J; Scheres, SHW; Ramakrishnan, V				Amunts, Alexey; Brown, Alan; Toots, Jaan; Scheres, Sjors H. W.; Ramakrishnan, V.			The structure of the human mitochondrial ribosome	SCIENCE			English	Article							MESSENGER-RNA; STRANDED-RNA; PROTEIN S1; SUBUNIT; INITIATION; BINDING; TRANSLOCATION; TRANSLATION; SEQUENCES; COMPLEX	The highly divergent ribosomes of human mitochondria (mitoribosomes) synthesize 13 essential proteins of oxidative phosphorylation complexes. We have determined the structure of the intact mitoribosome to 3.5 angstrom resolution by means of single-particle electron cryogenic microscopy. It reveals 80 extensively interconnected proteins, 36 of which are specific to mitochondria, and three ribosomal RNA molecules. The head domain of the small subunit, particularly the messenger (mRNA) channel, is highly remodeled. Many intersubunit bridges are specific to the mitoribosome, which adopts conformations involving ratcheting or rolling of the small subunit that are distinct from those seen in bacteria or eukaryotes. An intrinsic guanosine triphosphatase mediates a contact between the head and central protuberance. The structure provides a reference for analysis of mutations that cause severe pathologies and for future drug design.	[Amunts, Alexey; Brown, Alan; Toots, Jaan; Scheres, Sjors H. W.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk	Amunts, A./AAZ-2279-2020; Scheres, Sjors H.W./AAY-2265-2021; Brown, Alan/I-1473-2019	Amunts, A./0000-0002-5302-1740; Scheres, Sjors H.W./0000-0002-0462-6540; Brown, Alan/0000-0002-0021-0476; Ramakrishnan, V/0000-0002-4699-2194	UK MRC [MC_U105184332, MC_UP_A025_1013]; Wellcome Trust [WT096570]; Agouron Institute; Jeantet Foundation; MRC [MC_UP_A025_1013]; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332, MC_UP_A025_1013] Funding Source: researchfish; Wellcome Trust [096570/Z/11/Z] Funding Source: researchfish	UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank S. Peak-Chew and M. Skehel for mass spectrometry; G. McMullan, S. Chen, and C. Savva for help with data collection; J. Grimmett and T. Darling for help with computing; A. Pulk and J. Cate for scripts to visualize conformational changes; R. Nicholls for help with the structure comparison features of ProSmart; and P. Emsley for help with ligand analysis in Coot. This work was funded by grants from the UK MRC (MC_U105184332 to V.R. and MC_UP_A025_1013 to S.H.W.S.), a Wellcome Trust Senior Investigator award (WT096570), the Agouron Institute, and the Jeantet Foundation (V.R.). J. T. was funded by a MRC summer studentship (MC_UP_A025_1013). Cryo-EM density maps have been deposited with the Electron Microscopy Data Bank (accession numbers EMD-2876, EMD-2877, EMD-2878, EMD-2879, EMD-2880, and EMD-2881), and coordinates have been deposited with the Protein Data Bank (entry code 3J9M). A. A. dedicates his share of the work to his mentor N. Nelson.	Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Budkevich TV, 2014, CELL, V158, P121, DOI 10.1016/j.cell.2014.04.044; Byrgazov K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032702; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Chen J, 2012, CURR OPIN STRUC BIOL, V22, P804, DOI 10.1016/j.sbi.2012.09.004; Chen Y, 2013, NAT STRUCT MOL BIOL, V20, P1077, DOI 10.1038/nsmb.2645; Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048; DENSLOW ND, 1991, J BIOL CHEM, V266, P9586; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Heublein M, 2014, MOL BIOL CELL, V25, P3342, DOI 10.1091/mbc.E14-07-1178; Kaushal PS, 2014, P NATL ACAD SCI USA, V111, P7284, DOI 10.1073/pnas.1401657111; Keeling KM, 2012, CRIT REV BIOCHEM MOL, V47, P444, DOI 10.3109/10409238.2012.694846; Kim HR, 2007, FASEB J, V21, P188, DOI 10.1096/fj.06-6283com; Manavski N, 2012, PLANT CELL, V24, P3087, DOI 10.1105/tpc.112.099051; Mohan S, 2014, P NATL ACAD SCI USA, V111, P13325, DOI 10.1073/pnas.1413731111; MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0; Qian YP, 2009, ANTIMICROB AGENTS CH, V53, P4612, DOI 10.1128/AAC.00965-08; Qu XH, 2012, P NATL ACAD SCI USA, V109, P14458, DOI 10.1073/pnas.1208950109; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Selimoglu E, 2007, CURR PHARM DESIGN, V13, P119, DOI 10.2174/138161207779313731; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Soriano A, 2005, NEW ENGL J MED, V353, P2305, DOI 10.1056/NEJM200511243532123; Takeshita D, 2014, NUCLEIC ACIDS RES, V42, P10809, DOI 10.1093/nar/gku745; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; VanLoock MS, 2000, J MOL BIOL, V304, P507, DOI 10.1006/jmbi.2000.4213; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	35	311	370	5	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					95	98		10.1126/science.aaa1193	http://dx.doi.org/10.1126/science.aaa1193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838379	Green Accepted			2022-12-28	WOS:000352079500033
J	McGill, B				McGill, Brian			Land use matters	NATURE			English	Editorial Material							BIODIVERSITY; TIME		[McGill, Brian] Univ Maine, Sch Biol & Ecol, Orono, ME 04469 USA; [McGill, Brian] Univ Maine, Mitchell Ctr Sustainabil Solut, Orono, ME 04469 USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	McGill, B (corresponding author), Univ Maine, Sch Biol & Ecol, Orono, ME 04469 USA.	mail@brianmcgill.org	McGill, Brian J/A-3476-2008	McGill, Brian J/0000-0002-0850-1913				Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Ernest SKM, 2008, AM NAT, V172, pE257, DOI 10.1086/592402; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; MAC ARTHUR ROBERT H., 1967; McGill BJ, 2015, TRENDS ECOL EVOL, V30, P104, DOI 10.1016/j.tree.2014.11.006; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS AND HUMAN; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Supp SR, 2014, ECOLOGY, V95, P1717, DOI 10.1890/13-2250.1; Vellend M, 2013, P NATL ACAD SCI USA, V110, P19456, DOI 10.1073/pnas.1312779110; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	11	23	27	3	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					38	39		10.1038/520038a	http://dx.doi.org/10.1038/520038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25832399				2022-12-28	WOS:000352027700029
J	Newbold, T; Hudson, LN; Hill, SLL; Contu, S; Lysenko, I; Senior, RA; Borger, L; Bennett, DJ; Choimes, A; Collen, B; Day, J; De Palma, A; Diaz, S; Echeverria-Londono, S; Edgar, MJ; Feldman, A; Garon, M; Harrison, MLK; Alhusseini, T; Ingram, DJ; Itescu, Y; Kattge, J; Kemp, V; Kirkpatrick, L; Kleyer, M; Correia, DLP; Martin, CD; Meiri, S; Novosolov, M; Pan, Y; Phillips, HRP; Purves, DW; Robinson, A; Simpson, J; Tuck, SL; Weiher, E; White, HJ; Ewers, RM; Mace, GM; Scharlemann, JPW; Purvis, A				Newbold, Tim; Hudson, Lawrence N.; Hill, Samantha L. L.; Contu, Sara; Lysenko, Igor; Senior, Rebecca A.; Boerger, Luca; Bennett, Dominic J.; Choimes, Argyrios; Collen, Ben; Day, Julie; De Palma, Adriana; Diaz, Sandra; Echeverria-Londono, Susy; Edgar, Melanie J.; Feldman, Anat; Garon, Morgan; Harrison, Michelle L. K.; Alhusseini, Tamera; Ingram, Daniel J.; Itescu, Yuval; Kattge, Jens; Kemp, Victoria; Kirkpatrick, Lucinda; Kleyer, Michael; Correia, David Laginha Pinto; Martin, Callum D.; Meiri, Shai; Novosolov, Maria; Pan, Yuan; Phillips, Helen R. P.; Purves, Drew W.; Robinson, Alexandra; Simpson, Jake; Tuck, Sean L.; Weiher, Evan; White, Hannah J.; Ewers, Robert M.; Mace, Georgina M.; Scharlemann, Joern P. W.; Purvis, Andy			Global effects of land use on local terrestrial biodiversity	NATURE			English	Article							PLANT COMMUNITY COMPOSITION; BOMBUS SPP. HYMENOPTERA; DUNG BEETLE COLEOPTERA; BUMBLEBEE NEST DENSITY; BIRD SPECIES RICHNESS; SARISKA-TIGER RESERVE; POST-LOGGING RECOVERY; VOLANT SMALL MAMMALS; TROPICAL FOREST; RAIN-FOREST	Human activities, especially conversion and degradation of habitats, are causing global biodiversity declines. How local ecological assemblages are responding is less clear-a concern given their importance for many ecosystem functions and services. We analysed a terrestrial assemblage database of unprecedented geographic and taxonomic coverage to quantify local biodiversity responses to land use and related changes. Here we show that in the worst-affected habitats, these pressures reducewithin-sample species richness by anaverage of 76.5%, total abundance by 39.5% andrarefaction-based richness by 40.3%. We estimate that, globally, these pressures have already slightly reduced average within-sample richness (by 13.6%), total abundance (10.7%) and rarefaction-based richness (8.1%), with changes showing marked spatial variation. Rapid further losses are predicted under a business-as-usual land-use scenario; within-sample richness is projected to fall by a further 3.4% globally by 2100, with losses concentrated in biodiverse but economically poor countries. Strongmitigationcan delivermuchmore positive biodiversity changes (up to a 1.9% average increase) that are less strongly related to countries' socioeconomic status.	[Newbold, Tim; Hill, Samantha L. L.; Senior, Rebecca A.; Scharlemann, Joern P. W.] World Conservat Monitoring Ctr, United Nations Environm Programme, Cambridge CB3 0DL, England; [Newbold, Tim; Purves, Drew W.] Microsoft Res Cambridge, Computat Sci Lab, Cambridge CB1 2FB, England; [Hudson, Lawrence N.; Hill, Samantha L. L.; Contu, Sara; Choimes, Argyrios; De Palma, Adriana; Echeverria-Londono, Susy; Edgar, Melanie J.; Correia, David Laginha Pinto; Phillips, Helen R. P.; Purvis, Andy] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Lysenko, Igor; Bennett, Dominic J.; Choimes, Argyrios; Day, Julie; De Palma, Adriana; Garon, Morgan; Harrison, Michelle L. K.; Alhusseini, Tamera; Ingram, Daniel J.; Kemp, Victoria; Kirkpatrick, Lucinda; Martin, Callum D.; Pan, Yuan; Phillips, Helen R. P.; Robinson, Alexandra; Simpson, Jake; White, Hannah J.; Ewers, Robert M.; Purvis, Andy] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Boerger, Luca] Swansea Univ, Coll Sci, Dept Biosci, Swansea SA2 8PP, W Glam, Wales; [Collen, Ben; Mace, Georgina M.] UCL, Ctr Biodivers & Environm Res, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Diaz, Sandra] Univ Nacl Cordoba, Inst Multidisciplinario Biol Vegetal CONICET UNC, RA-5000 Cordoba, Argentina; [Diaz, Sandra] Univ Nacl Cordoba, FCEFyN, RA-5000 Cordoba, Argentina; [Feldman, Anat; Itescu, Yuval; Meiri, Shai; Novosolov, Maria] Tel Aviv Univ, Fac Life Sci, Dept Zool, IL-6997801 Tel Aviv, Israel; [Kattge, Jens] Max Planck Inst Biogeochem, D-07743 Jena, Germany; [Kattge, Jens] German Ctr Integrat Biodivers Res iDiv Halle Jane, D-04103 Leipzig, Germany; [Kleyer, Michael] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, Landscape Ecol Grp, D-26111 Oldenburg, Germany; [Tuck, Sean L.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Weiher, Evan] Univ Wisconsin, Biol Dept, Eau Claire, WI 54701 USA; [Scharlemann, Joern P. W.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	Microsoft; Natural History Museum London; Imperial College London; Swansea University; University of London; University College London; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; Tel Aviv University; Max Planck Society; Carl von Ossietzky Universitat Oldenburg; University of Oxford; University of Wisconsin System; University of Sussex	Newbold, T (corresponding author), World Conservat Monitoring Ctr, United Nations Environm Programme, 219 Huntingdon Rd, Cambridge CB3 0DL, England.	Tim.Newbold@unep-wcmc.org	Purvis, Andy/A-7529-2008; Mace, Georgina M/I-3072-2016; Newbold, Tim/D-1524-2012; White, Hannah/AAJ-8117-2021; Newbold, Tim/R-8958-2019; Kattge, Jens/J-8283-2016; Novosolov, Maria/Q-3929-2017; Díaz, Sandra/ABE-7349-2020; Collen, Ben/F-2543-2016; Meiri, Shai/D-2403-2010; Scharlemann, Jorn/A-4737-2008; Day, Julie/M-4643-2013; Börger, Luca/C-6003-2008; De Palma, Adriana/H-9591-2019; Diaz, Sandra/Q-9804-2018; Hudson, Lawrence/H-2918-2013	Purvis, Andy/0000-0002-8609-6204; Mace, Georgina M/0000-0001-8965-5211; Newbold, Tim/0000-0001-7361-0051; White, Hannah/0000-0002-6793-8613; Newbold, Tim/0000-0001-7361-0051; Kattge, Jens/0000-0002-1022-8469; Novosolov, Maria/0000-0002-4034-3441; Díaz, Sandra/0000-0003-0012-4612; Collen, Ben/0000-0003-2564-4243; Meiri, Shai/0000-0003-3839-6330; Scharlemann, Jorn/0000-0002-2834-6367; Day, Julie/0000-0003-1035-2117; Börger, Luca/0000-0001-8763-5997; De Palma, Adriana/0000-0002-5345-4917; Hudson, Lawrence/0000-0003-4072-7469; Phillips, Helen/0000-0002-7435-5934; Choimes, Argyrios/0000-0002-9849-1500; Tuck, Sean/0000-0002-1542-3589; Pan, Yuan/0000-0003-2729-6377; /0000-0001-5843-220X; Echeverria-Londono, Susy/0000-0002-0038-146X; Senior, Rebecca/0000-0002-8208-736X	UK Natural Environment Research Council (NERC) [NE/J011193/1]; Biotechnology and Biological Sciences Research Council [BB/F017324/1]; TRY initiative on plant traits, whose database is maintained at Max-Planck-Institute for Biogeochemistry, Jena, Germany; DIVERSITAS; IGBP; Global Land Project; NERC; French Foundation for Biodiversity Research; GIS 'Climat, Environnement et Societe' France; NERC [NE/J011193/2, NE/J011193/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [982737] Funding Source: researchfish; Natural Environment Research Council [NE/J011193/2, NE/J011193/1, 1282072] Funding Source: researchfish	UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); TRY initiative on plant traits, whose database is maintained at Max-Planck-Institute for Biogeochemistry, Jena, Germany; DIVERSITAS; IGBP; Global Land Project; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); French Foundation for Biodiversity Research; GIS 'Climat, Environnement et Societe' France; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank all the many researchers who have made their data available to us; S. Butchart and Birdlife International for sharing bird body-size data; F. Gilbert for hoverfly body-size data; the IMAGE, HYDE, MESSAGE and MiniCAM teams, especially R. Alkemade, M. Bakkenes and A. Thomson for sharing additional data from their integrated assessment models; D. Tittensor for statistical advice; C. Sleep and S. Patlola at the Natural History Museum in London for IT support with the database; members of the GARD initiative (http://www.gardinitiative.org/index.html) for help with estimating the reptile species richness map; K. Jones, J. Tylianakis, M. Crawley and E. J. Milner-Gulland for discussion, N. Burgess for comments on a draft of the paper. We also thank C. D. Thomas and two anonymous reviewers for very helpful comments on the manuscript. This study is part of the PREDICTS (Projecting Responses of Ecological Diversity in Changing Terrestrial Systems) project, which is supported by the UK Natural Environment Research Council (NERC, grant number: NE/J011193/1), the Biotechnology and Biological Sciences Research Council (grant number: BB/F017324/1) a Hans Rausing PhD scholarship. The study was also supported by the TRY initiative on plant traits, whose database is maintained at Max-Planck-Institute for Biogeochemistry, Jena, Germany, and which is supported by DIVERSITAS, IGBP, the Global Land Project, NERC, the French Foundation for Biodiversity Research, and GIS 'Climat, Environnement et Societe' France. This is a contribution from the Imperial College Grand Challenges in Ecosystem and the Environment Initiative.	Aben J, 2008, BIRD CONSERV INT, V18, P363, DOI 10.1017/S0959270908007326; Adum GB, 2013, CONSERV BIOL, V27, P354, DOI 10.1111/cobi.12006; Aguilar Barquero Virginia, 2009, Rev. biol. trop, V57, P83; Alberta BiodiversityMonitoring Institute (ABMI), 2007, THE RAW SOIL ARTHROP, V1; Alcala EL, 2004, ENVIRON CONSERV, V31, P254, DOI 10.1017/S0376892904001407; Alcayaga OE, 2013, REV COLOMB ENTOMOL, V39, P150; Alkemade R, 2009, ECOSYSTEMS, V12, P374, DOI 10.1007/s10021-009-9229-5; Ancrenaz M, 2004, ANIM CONSERV, V7, P375, DOI 10.1017/S136794300400157X; Anderson MT, 1999, J HERPETOL, V33, P601, DOI 10.2307/1565576; [Anonymous], 2009, AMPHIBIANS REPTILES; Ao J. Meren, 2003, Zoos' Print Journal, V18, P1117; Arbelaez-Cortes E, 2011, REV MEX BIODIVERS, V82, P639; Armbrecht I, 2006, ECOL ENTOMOL, V31, P403, DOI 10.1111/j.1365-2311.2006.00802.x; Arroyo J, 2005, J NAT HIST, V39, P3453, DOI 10.1080/00222930500240346; Arroyo Sandy B., 2008, Phyllomedusa, V7, P109; Azhar B, 2013, IBIS, V155, P297, DOI 10.1111/ibi.12025; Azpiroz AB, 2009, CONDOR, V111, P21, DOI 10.1525/cond.2009.080111; Baeten L, 2010, RESTOR ECOL, V18, P379, DOI 10.1111/j.1526-100X.2009.00627.x; Baeten L, 2010, J ECOL, V98, P1447, DOI 10.1111/j.1365-2745.2010.01711.x; Bain RH, 2004, COPEIA, P507; Baldi A, 2005, AGR ECOSYST ENVIRON, V108, P251, DOI 10.1016/j.agee.2005.02.006; Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Banksi JE, 2007, PAN-PAC ENTOMOL, V83, P152, DOI 10.3956/0031-0603-83.2.152; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barrio-Amoros Cesar L., 2012, PHYLLOMEDUSA, V11, P83; Bartolommei P, 2013, REND LINCEI-SCI FIS, V24, P13, DOI 10.1007/s12210-012-0211-3; Basset Y, 2008, CONSERV BIOL, V22, P1552, DOI 10.1111/j.1523-1739.2008.01017.x; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baur B, 2006, BIOL CONSERV, V132, P261, DOI 10.1016/j.biocon.2006.04.018; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bennett WO, 1999, COPEIA, P206; Berg A, 2011, BIOL CONSERV, V144, P2819, DOI 10.1016/j.biocon.2011.07.035; Bernard H, 2009, MAMM STUDY, V34, P85, DOI 10.3106/041.034.0204; Bernarde PS, 2009, IHERINGIA SER ZOOL, V99, P368, DOI 10.1590/S0073-47212009000400005; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Bicknell J, 2010, FOREST ECOL MANAG, V259, P2267, DOI 10.1016/j.foreco.2010.02.027; Bihn JH, 2008, BIOL CONSERV, V141, P733, DOI 10.1016/j.biocon.2007.12.028; Billeter R, 2008, J APPL ECOL, V45, P141, DOI 10.1111/j.1365-2664.2007.01393.x; Bivand R., 2017, SPDEP SPATIAL DEPEND; Blomquist SM, 2009, HERPETOL CONSERV BIO, V4, P142; Bocon R., 2010, THESIS; Borges SH, 2007, J TROP ECOL, V23, P469, DOI 10.1017/S0266467407004105; Boutin C, 2008, AGR ECOSYST ENVIRON, V123, P185, DOI 10.1016/j.agee.2007.05.010; Bouyer J, 2007, BIOL CONSERV, V138, P73, DOI 10.1016/j.biocon.2007.04.001; Bragagnolo C, 2007, BIOL CONSERV, V139, P389, DOI 10.1016/j.biocon.2007.07.008; Brasileiro Cínthia Aguirre, 2005, Biota Neotrop., V5, P93, DOI 10.1590/S1676-06032005000300006; Brearley FQ, 2011, J TROP ECOL, V27, P413, DOI 10.1017/S0266467411000149; Brito I, 2012, SOIL TILL RES, V121, P63, DOI 10.1016/j.still.2012.01.012; Brunet J, 2011, FOREST ECOL MANAG, V262, P1863, DOI 10.1016/j.foreco.2011.08.007; Buczkowski G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041729; Buczkowski G, 2010, BIOL INVASIONS, V12, P3343, DOI 10.1007/s10530-010-9727-6; Buddle Christopher M., 2008, Canadian Entomologist, V140, P437, DOI 10.4039/N07-Ls01; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Buscardo E, 2008, BIODIVERS CONSERV, V17, P1057, DOI 10.1007/s10531-007-9275-2; Cabra-Garcia J, 2012, BIODIVERS CONSERV, V21, P1493, DOI 10.1007/s10531-012-0259-5; Caceres NC, 2010, J NAT HIST, V44, P491, DOI 10.1080/00222930903477768; Cagle NL, 2008, BIOL CONSERV, V141, P744, DOI 10.1016/j.biocon.2008.01.003; Calvino-Cancela M, 2012, FOREST ECOL MANAG, V270, P153, DOI 10.1016/j.foreco.2012.01.019; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Campbell JA, 1998, HERPETOLOGICA, V54, P301; Caramaschi U, 1997, HERPETOLOGICA, V53, P259; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardinale B, 2014, SCIENCE, V344, P1098, DOI 10.1126/science.344.6188.1098-a; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carrijo TF, 2009, J INSECT CONSERV, V13, P575, DOI 10.1007/s10841-008-9205-y; Castro H, 2010, AGR ECOSYST ENVIRON, V137, P183, DOI 10.1016/j.agee.2010.02.002; Castro-Luna AA, 2007, ANIM CONSERV, V10, P219, DOI 10.1111/j.1469-1795.2007.00097.x; Center for International Earth Science Information Network (CIESIN) Columbia University & Information Technology Outreach Services (ITOS) University of Georgia, 2013, GLOBAL ROADS OPEN AC; Center for International Earth Science Information Network (CIESIN) Columbia University International Food Policy Research Institute (IFPRI) The World Bank & Centro Internacional de Agricultura Tropical (CIAT), 2011, GLOBAL RURAL URBAN M; Center For International Forestry Research(CIFOR), 2013, MULTIDISCIPLINARY LA; Centro Agronomico Tropical de Investigacion y Ensenanza(CATIE), 2010, UNPUBLISHED DATA OF; Cerezo A, 2011, BIODIVERS CONSERV, V20, P2649, DOI 10.1007/s10531-011-0096-y; Chapman A. D., 2009, NUMBERS OF LIVING SP; Chapman KA, 2007, BIOL CONSERV, V135, P527, DOI 10.1016/j.biocon.2006.10.050; Chauvat M, 2007, ECOGRAPHY, V30, P183, DOI [10.1111/j.2007.0906-7590.04888.x, 10.1111/j.0906-7590.2007.04888.x]; Chris O, 2013, AFR J ECOL, V51, P244, DOI 10.1111/aje.12029; Clarke FM, 2005, J APPL ECOL, V42, P409, DOI 10.1111/j.1365-2664.2005.01024.x; Cleary DFR, 2006, DIVERS DISTRIB, V12, P409, DOI 10.1111/j.1366-9516.2006.00256.x; Cleary DFR, 2004, OIKOS, V105, P426, DOI 10.1111/j.0030-1299.2004.12219.x; Clements GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115376; Cockle KL, 2005, BIODIVERS CONSERV, V14, P3265, DOI 10.1007/s10531-004-0446-0; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Connop S, 2011, INSECT CONSERV DIVER, V4, P212, DOI 10.1111/j.1752-4598.2010.00116.x; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; D'Aniello B, 2011, BIODIVERS CONSERV, V20, P1731, DOI 10.1007/s10531-011-0058-4; da Silva Emanuel Teixeira, 2009, South American Journal of Herpetology, V4, P286; da Silva P. G., 2011, THESIS; Darvill B, 2004, OIKOS, V107, P471, DOI 10.1111/j.0030-1299.2004.13510.x; Davis ALV, 2005, ENVIRON ENTOMOL, V34, P1081, DOI 10.1603/0046-225X(2005)034[1081:EODOAS]2.0.CO;2; Davis ES, 2010, MOL ECOL, V19, P4922, DOI 10.1111/j.1365-294X.2010.04868.x; Dawson J, 2011, TROP CONSERV SCI, V4, P317, DOI 10.1177/194008291100400309; Carvalho Anelena Lima de, 2010, Acta Amaz., V40, P657, DOI 10.1590/S0044-59672010000400004; De Carvalho TR, 2010, ZOOTAXA, P37; De Souza VM, 2008, REV BRAS ZOOL, V25, P49, DOI 10.1590/S0101-81752008000100008; Delabie JHC, 2009, CR BIOL, V332, P673, DOI 10.1016/j.crvi.2009.01.006; Dent DH, 2009, BIOL CONSERV, V142, P2833, DOI 10.1016/j.biocon.2009.05.035; Diaz S, 2013, ECOL EVOL, V3, P2958, DOI 10.1002/ece3.601; Diekotter T, 2006, BIODIVERS CONSERV, V15, P57, DOI 10.1007/s10531-004-2932-9; Domínguez Erwin, 2012, Anales Instituto Patagonia (Chile), V40, P37, DOI 10.4067/S0718-686X2012000200003; Dominguez-Haydar Y, 2011, RESTOR ECOL, V19, P178, DOI 10.1111/j.1526-100X.2010.00735.x; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Dumont B, 2009, GRASS FORAGE SCI, V64, P92, DOI 10.1111/j.1365-2494.2008.00674.x; Dures SG, 2010, BIOL CONSERV, V143, P768, DOI 10.1016/j.biocon.2009.12.019; Edenius L, 2011, AMBIO, V40, P521, DOI 10.1007/s13280-011-0137-5; Edgar M., 2014, THESIS; Otavo SE, 2013, REV BIOL TROP, V61, P735; Elek Z, 2007, ACTA OECOL, V32, P104, DOI 10.1016/j.actao.2007.03.008; Gonzalez CE, 2008, REV BIOL TROP, V56, P2147; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Endo W, 2010, BIOTROPICA, V42, P251, DOI 10.1111/j.1744-7429.2009.00546.x; ESRI, 2020, ARCGIS DESKT REL 10; Faruk A, 2013, CONSERV BIOL, V27, P615, DOI 10.1111/cobi.12062; Farwig N, 2008, FOREST ECOL MANAG, V255, P3885, DOI 10.1016/j.foreco.2008.03.042; Fayle TM, 2010, BASIC APPL ECOL, V11, P337, DOI 10.1016/j.baae.2009.12.009; Feldman A, 2013, BIOL J LINN SOC, V108, P161, DOI 10.1111/j.1095-8312.2012.02001.x; Felton AM, 2003, BIOL CONSERV, V114, P91, DOI 10.1016/S0006-3207(03)00013-2; Fensham RJ, 2012, AUSTRAL ECOL, V37, P183, DOI 10.1111/j.1442-9993.2011.02261.x; Fermon H, 2005, BIODIVERS CONSERV, V14, P333, DOI 10.1007/s10531-004-5354-9; Ferreira C., 2005, IMPACTO DA IMPLEMENT; Fierro MM, 2012, NEOTROP ENTOMOL, V41, P95, DOI 10.1007/s13744-011-0009-5; Filgueiras BKC, 2011, BIOL CONSERV, V144, P362, DOI 10.1016/j.biocon.2010.09.013; Flaspohler DJ, 2010, BIOL CONSERV, V143, P280, DOI 10.1016/j.biocon.2009.10.009; Fouquet A, 2007, ZOOTAXA, P17; Fukuda D, 2009, RAFFLES B ZOOL, V57, P213; Furlani D, 2009, ZOOL SCI, V26, P197, DOI 10.2108/zsj.26.197; Garden JG, 2010, LANDSCAPE ECOL, V25, P1013, DOI 10.1007/s10980-010-9476-z; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Gheler-Costa C, 2012, MAMMALIA, V76, P185, DOI 10.1515/mammalia-2011-0109; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gilbert F, 1994, PHYLOGENETICS ECOLOG, P324; Giordani P, 2012, PLANT BIOSYST, V146, P628, DOI 10.1080/11263504.2011.654136; Giordano S, 2004, PLANT ECOL, V170, P1, DOI 10.1023/B:VEGE.0000019025.36121.5d; Goldberg Stephen R., 2008, PHYLLOMEDUSA, V7, P25; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Golodets C, 2010, PLANT SOIL, V329, P365, DOI 10.1007/s11104-009-0164-1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gottschalk MS, 2007, NEOTROP ENTOMOL, V36, P848, DOI 10.1590/S1519-566X2007000600005; Goulson D, 2008, BIODIVERS CONSERV, V17, P3269, DOI 10.1007/s10531-008-9428-y; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Gove AD, 2005, BIOL CONSERV, V126, P328, DOI 10.1016/j.biocon.2005.06.008; Grogan J, 2008, FOREST ECOL MANAG, V255, P269, DOI 10.1016/j.foreco.2007.09.048; [谷卫彬 Gu Weibin], 2004, [生物多样性, Chinese Biodiversity], V12, P262; Guayasamin JM, 2006, HERPETOLOGICA, V62, P191, DOI 10.1655/05-40.1; Gutierrez-Lamus Doris L., 2004, Caldasia, V26, P245; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Hanley ME, 2011, OIKOS, V120, P1618, DOI 10.1111/j.1600-0706.2011.19233.x; Hanson TR, 2008, MOL ECOL, V17, P2060, DOI 10.1111/j.1365-294X.2008.03726.x; Harfoot M, 2014, GLOBAL ECOL BIOGEOGR, V23, P124, DOI 10.1111/geb.12100; Hashim NR, 2010, ASIAN MYRMECOL, V3, P5; Hatfield RG, 2007, BIOL CONSERV, V139, P150, DOI 10.1016/j.biocon.2007.06.019; Hawes J, 2009, J TROP ECOL, V25, P281, DOI 10.1017/S0266467409006038; Helden AJ, 2004, BASIC APPL ECOL, V5, P367, DOI 10.1016/j.baae.2004.06.004; Hernandez L, 2012, INTERCIENCIA, V37, P891; Herrmann F, 2007, MOL ECOL, V16, P1167, DOI 10.1111/j.1365-294X.2007.03226.x; Hertz A, 2012, ZOOKEYS, P23, DOI 10.3897/zookeys.196.2774; HEYER W.R, 1994, SMITHSON CONTRIB ZOO, V546, P1; Heyer W.R., 2002, CATALOGUE AM AMPHIBI, V742, P1; Heyer W. Ronald, 1996, Amphibia-Reptilia, V17, P7, DOI 10.1163/156853896X00252; Hietz P, 2005, CONSERV BIOL, V19, P391, DOI 10.1111/j.1523-1739.2005.00145.x; Higuera D, 2010, CALDASIA, V32, P161; Hijmans R. J, 2014, GEOGRAPHIC DATA ANAL; Hilje B, 2012, BIOL CONSERV, V146, P170, DOI 10.1016/j.biocon.2011.12.007; Hoffmann A, 2005, BELG J ZOOL, V135, P91; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Horgan FG, 2009, BIODIVERS CONSERV, V18, P3519, DOI 10.1007/s10531-009-9658-7; Hsu MY, 2005, HERPETOL J, V15, P73; Hu C, 2008, EXP AGR, V44, P485, DOI 10.1017/S0014479708006716; Hudson LN, 2014, ECOL EVOL, V4, P4701, DOI 10.1002/ece3.1303; Hung NFLM, 2008, J ARACHNOL, V36, P394, DOI 10.1636/CT07-136.1; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; Hylander K, 2012, J APPL ECOL, V49, P1316, DOI 10.1111/j.1365-2664.2012.02218.x; Hylander K, 2009, CONSERV BIOL, V23, P400, DOI 10.1111/j.1523-1739.2008.01097.x; Ibanez R, 2012, ZOOTAXA, P67; Ims RA, 2012, BIOL CONSERV, V149, P2, DOI 10.1016/j.biocon.2012.02.008; Isaacs-Cubides PJ, 2011, NAT CONSERVACAO, V9, P39, DOI 10.4322/natcon.2011.004; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Ishitani M, 2003, ECOGRAPHY, V26, P481, DOI 10.1034/j.1600-0587.2003.03436.x; Itescu Y, 2014, GLOBAL ECOL BIOGEOGR, V23, P689, DOI 10.1111/geb.12149; Jacobs CT, 2010, J INSECT CONSERV, V14, P389, DOI 10.1007/s10841-010-9270-x; Jared C, 2011, AMPHIBIA-REPTILIA, V32, P546, DOI 10.1163/156853811X603724; Johnson MF, 2008, J MED ENTOMOL, V45, P1023, DOI 10.1603/0022-2585(2008)45[1023:LUAMDI]2.0.CO;2; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jonsell M, 2012, BIODIVERS CONSERV, V21, P619, DOI 10.1007/s10531-011-0203-0; Julier HE, 2009, J ECON ENTOMOL, V102, P563, DOI 10.1603/029.102.0214; Jung TS, 2011, MAMM BIOL, V76, P678, DOI 10.1016/j.mambio.2011.08.002; Jungfer KH, 2002, AMPHIBIA-REPTILIA, V23, P21, DOI 10.1163/156853802320877609; Kan F. W., 2010, THESIS; Kapoor V, 2008, J INSECT CONSERV, V12, P53, DOI 10.1007/s10841-006-9062-5; Kappes H, 2012, METEOROL Z, V21, P525, DOI 10.1127/0941-2948/2012/0361; Kati V, 2012, J INSECT CONSERV, V16, P807, DOI 10.1007/s10841-012-9467-2; Katovai E, 2012, BIOL CONSERV, V145, P214, DOI 10.1016/j.biocon.2011.11.008; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kessler M, 2005, BIODIVERS CONSERV, V14, P547, DOI 10.1007/s10531-004-3914-7; Kessler M, 2009, ECOL APPL, V19, P2142, DOI 10.1890/08-1074.1; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Knop E, 2004, BIOL CONSERV, V120, P183, DOI 10.1016/j.biocon.2004.02.010; Kohler F, 2008, J APPL ECOL, V45, P753, DOI 10.1111/j.1365-2664.2007.01394.x; Koivula M, 2004, J INSECT CONSERV, V8, P297, DOI 10.1007/s10841-004-0296-9; Kolb A, 2004, J VEG SCI, V15, P199, DOI 10.1111/j.1654-1103.2004.tb02255.x; Korosi A, 2012, INSECT CONSERV DIVER, V5, P57, DOI 10.1111/j.1752-4598.2011.00153.x; Krauss J, 2003, J BIOGEOGR, V30, P889, DOI 10.1046/j.1365-2699.2003.00878.x; Krauss J, 2004, BIODIVERS CONSERV, V13, P1427, DOI 10.1023/B:BIOC.0000021323.18165.58; Kumar R, 2005, ENVIRON CONSERV, V32, P248, DOI 10.1017/S0376892905002316; Lachat T, 2006, BIODIVERS CONSERV, V15, P3, DOI 10.1007/s10531-004-1234-6; LANCE SL, 1993, COPEIA, P1162; Lantschner MV, 2008, BIODIVERS CONSERV, V17, P969, DOI 10.1007/s10531-007-9243-x; Latta SC, 2011, CONDOR, V113, P24, DOI 10.1525/cond.2011.090252; Legare JP, 2011, SILVA FENN, V45, P937, DOI 10.14214/sf.79; Letcher SG, 2009, BIOTROPICA, V41, P608, DOI 10.1111/j.1744-7429.2009.00517.x; Littlewood NA, 2012, INSECT CONSERV DIVER, V5, P67, DOI 10.1111/j.1752-4598.2011.00135.x; Liu YH, 2012, RESTOR ECOL, V20, P234, DOI 10.1111/j.1526-100X.2010.00755.x; Lopez-Quintero CA, 2012, BIODIVERS CONSERV, V21, P2221, DOI 10.1007/s10531-012-0280-8; Louhaichi M, 2009, INT J AGRIC BIOL, V11, P681; Lucas-Borja ME, 2011, LAND DEGRAD DEV, V22, P383, DOI 10.1002/ldr.1014; Luja VH, 2008, BIOTROPICA, V40, P747, DOI 10.1111/j.1744-7429.2008.00439.x; Luskin MS, 2010, BIOTROPICA, V42, P246, DOI 10.1111/j.1744-7429.2009.00577.x; LYNCH JD, 1989, COPEIA, P577, DOI 10.2307/1445483; MacSwiney MC, 2007, BIOL CONSERV, V136, P499, DOI 10.1016/j.biocon.2006.12.021; Maeto K, 2004, FOREST ECOL MANAG, V187, P213, DOI 10.1016/S0378-1127(03)00333-5; Magura T, 2010, LANDSCAPE ECOL, V25, P621, DOI 10.1007/s10980-009-9445-6; Magurran A.E., 2004, MEASURING BIOL DIVER; Mallari NAD, 2011, ORYX, V45, P234, DOI 10.1017/S0030605310001031; Malone L, 2010, J APICULT RES, V49, P284, DOI 10.3896/IBRA.1.49.3.09; Marin-Spiotta E, 2007, ECOL APPL, V17, P828, DOI 10.1890/06-1268; Marshall EJP, 2006, AGR ECOSYST ENVIRON, V113, P36, DOI 10.1016/j.agee.2005.08.036; Martin PS, 2012, FOREST ECOL MANAG, V282, P185, DOI 10.1016/j.foreco.2012.07.002; MATSON TO, 1990, OHIO J SCI, V90, P98; Matsumoto T, 2009, BIODIVERS CONSERV, V18, P3139, DOI 10.1007/s10531-009-9632-4; Mayfield MM, 2013, AM J BOT, V100, P1356, DOI 10.3732/ajb.1200461; Mayfield MM, 2006, J ECOL, V94, P522, DOI 10.1111/j.1365-2745.2006.01108.x; MCCRANIE JR, 1993, SOUTHWEST NAT, V38, P100, DOI 10.2307/3672060; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; McNamara S, 2012, FOREST ECOL MANAG, V281, P93, DOI 10.1016/j.foreco.2012.06.004; Meiri S, 2010, J ZOOL, V281, P218, DOI 10.1111/j.1469-7998.2010.00696.x; Meiri S, 2008, GLOBAL ECOL BIOGEOGR, V17, P724, DOI 10.1111/j.1466-8238.2008.00414.x; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; Meyer B, 2007, ENTOMOL GEN, V30, P173; Meyer B, 2009, BASIC APPL ECOL, V10, P178, DOI 10.1016/j.baae.2008.01.001; Mico E, 2013, BIODIVERS CONSERV, V22, P889, DOI 10.1007/s10531-013-0456-x; Milder JC, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00003.1; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS AND HUMAN; Moller AP, 2001, TRENDS ECOL EVOL, V16, P580, DOI 10.1016/S0169-5347(01)02235-2; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Moreno-Mateos D, 2011, ACTA ORNITHOL, V46, P173, DOI 10.3161/000164511X625946; Muchane M. N., 2012, International Journal of Biodiversity and Conservation, V4, P500; Mudri-Stojnic S, 2012, ARCH BIOL SCI, V64, P777, DOI 10.2298/ABS1202777S; Murphy GEP, 2014, ECOL EVOL, V4, P91, DOI 10.1002/ece3.909; Naidoo R, 2004, ANIM CONSERV, V7, P93, DOI 10.1017/S1367943003001185; Nakamura Akihiro, 2003, Ecological Management & Restoration, V4, pS20, DOI 10.1046/j.1442-8903.4.s.3.x; Naoe S, 2012, J FOREST RES-JPN, V17, P219, DOI 10.1007/s10310-011-0296-z; Navarrete D, 2008, BIODIVERS CONSERV, V17, P2869, DOI 10.1007/s10531-008-9402-8; Navarro I. L., 2011, Revista Colombiana de Ciencia Animal, V3, P102; Nelson A, 2008, CHRISTIAN TRAVEL PLA; Neuschulz EL, 2011, OIKOS, V120, P1371, DOI 10.1111/j.1600-0706.2011.19097.x; Newbold T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1371; Nicolas V, 2009, BIODIVERS CONSERV, V18, P2043, DOI 10.1007/s10531-008-9572-4; Nielsen A, 2011, ECOL RES, V26, P969, DOI 10.1007/s11284-011-0852-1; Ningombam Banita, 2007, Zoos Print Journal, V22, P2688; Noske NM, 2008, BASIC APPL ECOL, V9, P4, DOI 10.1016/j.baae.2007.06.014; Noreika N, 2012, J INSECT CONSERV, V16, P867, DOI 10.1007/s10841-012-9474-3; Noreika Norbertas, 2009, New and Rare for Lithuania Insect Species Records and Descriptions, V21, P68; Norfolk O, 2012, AGR ECOSYST ENVIRON, V162, P8, DOI 10.1016/j.agee.2012.08.007; Noriega J.A., 2007, Universitas Scientiarum, V12, P51; Noriega Jorge Ari, 2012, Actualidades Biologicas (Medellin), V34, P43; Numa C, 2012, RANGELAND ECOL MANAG, V65, P137, DOI 10.2111/REM-D-10-00050.1; O'Connor TG, 2005, J APPL ECOL, V42, P975, DOI 10.1111/j.1365-2664.2005.01065.x; O'Dea N, 2007, BIODIVERS CONSERV, V16, P1131, DOI 10.1007/s10531-006-9095-9; Ofori-Boateng C, 2013, BIOTROPICA, V45, P94, DOI 10.1111/j.1744-7429.2012.00887.x; Ohler Annemarie, 2011, Zootaxa, V3147, P1; Oke O.C., 2009, AFR SCI, V10, P95; Oldfield F, 2014, ANTHROPOCENE REV, V1, P70, DOI 10.1177/2053019613514862; Oliveira DE, 2013, SOCIOBIOLOGY, V60, P190; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Osgathorpe LM, 2012, APIDOLOGIE, V43, P113, DOI 10.1007/s13592-011-0083-z; Otto CRV, 2012, FOREST ECOL MANAG, V284, P241, DOI 10.1016/j.foreco.2012.07.016; Paradis S, 2011, FOREST ECOL MANAG, V262, P2079, DOI 10.1016/j.foreco.2011.08.032; Paritsis J, 2008, FOREST ECOL MANAG, V255, P1575, DOI 10.1016/j.foreco.2007.11.015; Parra-H A, 2007, REV BIOL TROP, V55, P931; Pelegrin N, 2012, J ARID ENVIRON, V79, P13, DOI 10.1016/j.jaridenv.2011.11.004; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pillsbury FC, 2008, ECOL APPL, V18, P1107, DOI 10.1890/07-1899.1; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pineda E, 2004, BIOL CONSERV, V117, P499, DOI 10.1016/j.biocon.2003.08.009; Politi N, 2012, BIODIVERS CONSERV, V21, P3131, DOI 10.1007/s10531-012-0358-3; Pombal JP, 2011, HERPETOLOGICA, V67, P288, DOI 10.1655/HERPETOLOGICA-D-10-00067.1; Poveda K, 2012, J APPL ECOL, V49, P513, DOI 10.1111/j.1365-2664.2012.02120.x; Power EF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038073; Power EF, 2011, J APPL ECOL, V48, P561, DOI 10.1111/j.1365-2664.2010.01949.x; Prado CPA, 2000, J HERPETOL, V34, P135; Prado CPA, 2003, THESIS; Presley SJ, 2008, J APPL ECOL, V45, P14, DOI 10.1111/j.1365-2664.2007.01373.x; Proenca VM, 2010, ACTA OECOL, V36, P219, DOI 10.1016/j.actao.2010.01.002; Quaranta Marino, 2004, Bulletin of Insectology, V57, P11; Quintero C, 2010, BIODIVERS CONSERV, V19, P257, DOI 10.1007/s10531-009-9720-5; R Development Core Team, 2009, R LANG ENV STAT COMP; Redpath N, 2010, BIOL CONSERV, V143, P492, DOI 10.1016/j.biocon.2009.11.019; Reid JL, 2012, BIOTROPICA, V44, P350, DOI 10.1111/j.1744-7429.2011.00814.x; Reis YT, 2007, IHERINGIA SER ZOOL, V97, P229, DOI 10.1590/S0073-47212007000300001; Rey-Velasco J. C., 2010, THESIS; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Ribeiro DB, 2012, J INSECT CONSERV, V16, P733, DOI 10.1007/s10841-012-9458-3; Richardson BA, 2005, J ANIM ECOL, V74, P926, DOI 10.1111/j.1365-2656.2005.00990.x; Rigby RA, 2008, COMPUT STAT DATA AN, V53, P381, DOI 10.1016/j.csda.2008.07.043; Robles CA, 2011, LANDSCAPE URBAN PLAN, V100, P129, DOI 10.1016/j.landurbplan.2010.12.003; Rodrigues MM, 2013, BRAZ J BIOL, V73, P211, DOI 10.1590/S1519-69842013000100023; Rombke J, 2009, PESQUI AGROPECU BRAS, V44, P1040, DOI 10.1590/S0100-204X2009000800037; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Romero-Duque LP, 2007, FOREST ECOL MANAG, V253, P38, DOI 10.1016/j.foreco.2007.07.002; Roskov Y, 2013, SPECIES 2000 ITIS CA; Rosselli L., 2011, THESIS; Rousseau L, 2013, ECOL INDIC, V27, P71, DOI 10.1016/j.ecolind.2012.11.020; Safian S, 2011, J INSECT CONSERV, V15, P351, DOI 10.1007/s10841-010-9343-x; Sakchoowong W, 2008, ENTOMOL SCI, V11, P301, DOI 10.1111/j.1479-8298.2008.00281.x; Saldana-Vazquez RA, 2010, BIODIVERS CONSERV, V19, P2111, DOI 10.1007/s10531-010-9829-6; Samnegard U, 2011, BIOL CONSERV, V144, P2602, DOI 10.1016/j.biocon.2011.07.008; Santana J, 2012, J APPL ECOL, V49, P632, DOI 10.1111/j.1365-2664.2012.02141.x; Savage J, 2011, WETLANDS, V31, P125, DOI 10.1007/s13157-010-0133-8; Savage JM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)357<0001:FOTEBG>2.0.CO;2; Schmidt AC, 2012, RANGELAND ECOL MANAG, V65, P292, DOI 10.2111/REM-D-11-00100.1; Schon NL, 2011, PEDOBIOLOGIA, V54, P161, DOI 10.1016/j.pedobi.2011.01.001; Schuepp C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052109; Schuepp C, 2011, OECOLOGIA, V165, P713, DOI 10.1007/s00442-010-1746-6; Scott DM, 2006, BIOL CONSERV, V127, P72, DOI 10.1016/j.biocon.2005.07.014; Sedlock JL, 2008, ACTA CHIROPTEROL, V10, P349, DOI 10.3161/150811008X414926; Seguin A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04616; Shafie NJ, 2011, TROP LIFE SCI RES, V22, P13; Shahabuddin G, 2007, FOREST ECOL MANAG, V246, P175, DOI 10.1016/j.foreco.2007.03.061; Shahriza Shahrudin, 2010, Tropical Natural History, V10, P131; Sheil D., 2002, EXPLORING BIOLOGICAL; Sheldon FH, 2010, BIOL CONSERV, V143, P399, DOI 10.1016/j.biocon.2009.11.004; Shepard DB, 2005, COPEIA, P803, DOI 10.1643/0045-8511(2005)005[0803:FFTFEO]2.0.CO;2; Shuler RE, 2005, J ECON ENTOMOL, V98, P790, DOI 10.1603/0022-0493-98.3.790; Silva FAB, 2010, ENVIRON ENTOMOL, V39, P359, DOI 10.1603/EN09180; Simoes P. I., 2010, THESIS; Slade EM, 2011, BIOL CONSERV, V144, P166, DOI 10.1016/j.biocon.2010.08.011; SMITH PARDO ALLAN, 2007, Acta biol.Colomb., V12, P43; Sodhi NS, 2010, CONSERV BIOL, V24, P1290, DOI 10.1111/j.1523-1739.2010.01495.x; Sosa RA., 2010, REV ASOCIACION ARGEN, V1, P101; Sridhar H, 2008, CURR SCI INDIA, V94, P748; St-Laurent MH, 2007, CAN J FOREST RES, V37, P1298, DOI 10.1139/X06-295; Strom L, 2009, BIOL CONSERV, V142, P1580, DOI 10.1016/j.biocon.2009.02.028; Struebig MJ, 2008, BIOL CONSERV, V141, P2112, DOI 10.1016/j.biocon.2008.06.009; STUART BL, 2006, FIELDIANA ZOOL 1213, P1; Su ZM, 2011, J INSECT CONSERV, V15, P367, DOI 10.1007/s10841-010-9310-6; Sugiura S, 2009, J INSECT CONSERV, V13, P377, DOI 10.1007/s10841-008-9185-y; Summerville KS, 2006, ECOL APPL, V16, P891, DOI 10.1890/1051-0761(2006)016[0891:STAPOL]2.0.CO;2; Summerville KS, 2011, ECOL APPL, V21, P806, DOI 10.1890/10-0715.1; Sung YH, 2012, FOREST ECOL MANAG, V270, P71, DOI 10.1016/j.foreco.2012.01.011; Sunyer Javier, 2009, Herpetology Notes, V2, P189; Thomson AM, 2011, CLIMATIC CHANGE, V109, P77, DOI 10.1007/s10584-011-0151-4; Threlfall CG, 2012, BIOL CONSERV, V146, P41, DOI 10.1016/j.biocon.2011.11.026; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Tonietto R, 2011, LANDSCAPE URBAN PLAN, V103, P102, DOI 10.1016/j.landurbplan.2011.07.004; Turner EC, 2009, J TROP ECOL, V25, P23, DOI 10.1017/S0266467408005658; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; United Nations Population Division, 2011, WORLD POPULATION PRO; Van Asselen S, 2013, GLOBAL CHANGE BIOL, V19, P3648, DOI 10.1111/gcb.12331; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Vanbergen AJ, 2005, ECOGRAPHY, V28, P3, DOI 10.1111/j.0906-7590.2005.03991.x; Vassilev K, 2011, PLANT BIOSYST, V145, P654, DOI 10.1080/11263504.2011.601337; Vazquez DP, 2002, AM NAT, V159, P606, DOI 10.1086/339991; Vellend M, 2013, P NATL ACAD SCI USA, V110, P19456, DOI 10.1073/pnas.1312779110; Verboven HAF, 2012, LANDSCAPE URBAN PLAN, V106, P158, DOI 10.1016/j.landurbplan.2012.02.015; Verdasca MJ, 2012, BIOL CONSERV, V146, P14, DOI 10.1016/j.biocon.2011.10.031; Verdu JR, 2007, BIOL CONSERV, V140, P308, DOI 10.1016/j.biocon.2007.08.015; Vergara CH, 2009, AGR ECOSYST ENVIRON, V129, P117, DOI 10.1016/j.agee.2008.08.001; Vergara PM, 2004, ORYX, V38, P383, DOI 10.1017/S0030605304000742; Miranda MV, 2010, ORNITOL NEOTROP, V21, P323; Lantschner MV, 2012, FOREST ECOL MANAG, V269, P271, DOI 10.1016/j.foreco.2011.12.045; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Walker TR, 2006, ECOL INDIC, V6, P369, DOI 10.1016/j.ecolind.2005.03.015; Wang YP, 2010, DIVERS DISTRIB, V16, P862, DOI 10.1111/j.1472-4642.2010.00682.x; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Watling JI, 2009, ANIM CONSERV, V12, P467, DOI 10.1111/j.1469-1795.2009.00274.x; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013; Weber E, 2008, BIOSCIENCE, V58, P437, DOI 10.1641/B580511; Weller B, 2004, BASIC APPL ECOL, V5, P193, DOI 10.1078/1439-1791-00220; Wells K, 2007, J BIOGEOGR, V34, P1087, DOI 10.1111/j.1365-2699.2006.01677.x; Williams CD, 2009, INSECT CONSERV DIVER, V2, P270, DOI 10.1111/j.1752-4598.2009.00064.x; Willig MR, 2007, BIOTROPICA, V39, P737, DOI 10.1111/j.1744-7429.2007.00322.x; Winfree R, 2007, CONSERV BIOL, V21, P213, DOI 10.1111/j.1523-1739.2006.00574.x; Woinarski JCZ, 2009, WILDLIFE RES, V36, P675, DOI 10.1071/WR08128; Wollenberg KC, 2006, COPEIA, P623, DOI 10.1643/0045-8511(2006)6[623:PVSROL]2.0.CO;2; Woodcock BA, 2007, J APPL ECOL, V44, P60, DOI 10.1111/j.1365-2664.2006.01258.x; Wunderle JM, 2006, BIOTROPICA, V38, P235, DOI 10.1111/j.1744-7429.2006.00138.x; Yoshikura S, 2011, MAMM STUDY, V36, P189, DOI 10.3106/041.036.0402; Zaitsev AS, 2006, APPL SOIL ECOL, V34, P230, DOI 10.1016/j.apsoil.2006.01.005; Zaitsev AS, 2002, SOIL BIOL BIOCHEM, V34, P1919, DOI 10.1016/S0038-0717(02)00208-0; ZIMMERMAN BL, 1983, HERPETOLOGICA, V39, P235; Zimmerman G, 2011, FOREST CHRON, V87, P217, DOI 10.5558/tfc2011-009; ZUG G.R., 1979, SMITHSON CONTRIB ZOO, V284, P1; Zuur Alain F., 2009, P1	395	1826	1906	161	1994	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					45	+		10.1038/nature14324	http://dx.doi.org/10.1038/nature14324			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25832402	Green Accepted, Green Submitted			2022-12-28	WOS:000352027700033
J	Arie, S				Arie, Sophie			PATIENT PARTICIPATION The health coaches from Dunkin' Donuts	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						[Anonymous], 2013, WHAT WORKS CREATIVE; [Anonymous], 2012, THEEDITORIAL    1017; Gawande Atul, 2011, New Yorker, P40; King's Fund, ACT SUPP SELF MAN; Newman P., HLTH COACHING PATIEN; Newman P., DOES HLTH COACHING W; Wolever Ruth Q, 2013, Glob Adv Health Med, V2, P38, DOI 10.7453/gahmj.2013.042; Zimmerman R., 2011, HAITI HARVARD CRUCIA	8	0	0	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2015	350								h1456	10.1136/bmj.h1456	http://dx.doi.org/10.1136/bmj.h1456			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7OK	25817137				2022-12-28	WOS:000352031000002
J	Borsanyi, S; Durr, S; Fodor, Z; Hoelbling, C; Katz, SD; Krieg, S; Lellouch, L; Lippert, T; Portelli, A; Szabo, KK; Toth, BC				Borsanyi, Sz.; Durr, S.; Fodor, Z.; Hoelbling, C.; Katz, S. D.; Krieg, S.; Lellouch, L.; Lippert, T.; Portelli, A.; Szabo, K. K.; Toth, B. C.			Ab initio calculation of the neutron-proton mass difference	SCIENCE			English	Article								The existence and stability of atoms rely on the fact that neutrons are more massive than protons. The measured mass difference is only 0.14% of the average of the two masses. A slightly smaller or larger value would have led to a dramatically different universe. Here, we show that this difference results from the competition between electromagnetic and mass isospin breaking effects. We performed lattice quantum-chromodynamics and quantum-electrodynamics computations with four nondegenerate Wilson fermion flavors and computed the neutron-proton mass-splitting with an accuracy of 300 kilo-electron volts, which is greater than 0 by 5 standard deviations. We also determine the splittings in the Sigma, Xi, D, and Xi(cc) isospin multiplets, exceeding in some cases the precision of experimental measurements.	[Borsanyi, Sz.; Durr, S.; Fodor, Z.; Hoelbling, C.; Krieg, S.; Lippert, T.; Szabo, K. K.; Toth, B. C.] Berg Univ Wuppertal, Dept Phys, Fachbereich 9, D-42119 Wuppertal, Germany; [Durr, S.; Fodor, Z.; Krieg, S.; Lippert, T.; Szabo, K. K.] Forschungszentrum Julich, Julich Supercomp Ctr, D-52428 Julich, Germany; [Fodor, Z.; Katz, S. D.] Eotvos Lorand Univ, Inst Theoret Phys, H-1117 Budapest, Hungary; [Katz, S. D.] Eotvos Lorand Univ, Lendulet Lattice Gauge Theory Res Grp, Magyar Tudomanyos Akad, H-1117 Budapest, Hungary; [Lellouch, L.; Portelli, A.] Aix Marseille Univ, Univ Toulon, CNRS, CPT UMR 7332, F-13288 Marseille, France; [Portelli, A.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England	University of Wuppertal; Helmholtz Association; Research Center Julich; Eotvos Lorand University; Eotvos Lorand University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite; University of Southampton	Fodor, Z (corresponding author), Berg Univ Wuppertal, Dept Phys, Fachbereich 9, D-42119 Wuppertal, Germany.	fodor@bodri.elte.hu	Katz, Sandor D/A-4154-2011	Krieg, Stefan/0000-0002-8417-9823; Katz, Sandor/0000-0001-6524-2965; Portelli, Antonin/0000-0002-6059-917X	Deutsche Forschungsgemeinschaft [SFB/TR55]; Partnership for Advanced Computing in Europe (PRACE) initiative; Gauss Centre for Supercomputing e.V; European Research Council [208740]; Lendulet program of the Hungarian Academy of Sciences [LP2012-44/2012]; "Origines, Constituants et Evolution de l'Univers" (OCEVU) Labex [ANR-11-LABX-0060]; A*MIDEX project - "Investissements d'Avenir" French government program;  [52275]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Partnership for Advanced Computing in Europe (PRACE) initiative; Gauss Centre for Supercomputing e.V; European Research Council(European Research Council (ERC)European Commission); Lendulet program of the Hungarian Academy of Sciences; "Origines, Constituants et Evolution de l'Univers" (OCEVU) Labex; A*MIDEX project - "Investissements d'Avenir" French government program(French National Research Agency (ANR)); 	This project was supported by the Deutsche Forschungsgemeinschaft grant SFB/TR55, the Partnership for Advanced Computing in Europe (PRACE) initiative, the Gauss Centre for Supercomputing e.V, a European Research Council grant (FP7/2007-2013/ERC No 208740), the Lendulet program of the Hungarian Academy of Sciences (LP2012-44/2012), "Origines, Constituants et Evolution de l'Univers" (OCEVU) Labex (ANR-11-LABX-0060) and the A*MIDEX project (ANR-11-IDEX-0001-02) funded by the "Investissements d'Avenir" French government program and managed by the Agence Nationale de la Recherche (ANR), and the Grand Equipement National de Calcul Intensif-Institut du Developpement et des Ressources en Informatique Scientifique (IDRIS) Grand Challenge grant 2012 "StabMat" as well as grant 52275. The computations were performed on JUQUEEN and JUROPA at Forschungszentrum Julich (FZJ), on Turing at IDRIS in Orsay, on SuperMUC at Leibniz Supercomputing Centre in Munchen, on Hermit at the High Performance Computing Center in Stuttgart, and on local machines in Wuppertal and Budapest. The data described in the paper are 60 TB and archived in FZJ.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aoki S, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.034507; Aoki S, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.034503; Arthur R, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.094514; Baron R, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2010)111; Basak S., 2013, P SCI CD, V12; Bazavov A, 2010, REV MOD PHYS, V82, P1349, DOI 10.1103/RevModPhys.82.1349; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Bietenholz W, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.054509; Blum T, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.094508; Borsanyi S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.252001; COLEMAN S, 1961, PHYS REV LETT, V6, P423, DOI 10.1103/PhysRevLett.6.423; de Divitiis GM, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.114505; Durr S, 2008, SCIENCE, V322, P1224, DOI 10.1126/science.1163233; Durr S, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP08(2011)148; Durr S, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.014501; Duncan A, 1996, PHYS REV LETT, V76, P3894, DOI 10.1103/PhysRevLett.76.3894; Fritzsch P, 2012, NUCL PHYS B, V865, P397, DOI 10.1016/j.nuclphysb.2012.07.026; GROSS DJ, 1973, PHYS REV LETT, V30, P1343, DOI 10.1103/PhysRevLett.30.1343; Horsley R., 2013, POS LATTICE, V2013, P499; Ishikawa T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.072002; Kronfeld A., 2013, 100 YEARS SUBATOMIC; Lin HW, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.034502; Luscher M, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2010)110; Ohki H, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.054502; POLITZER HD, 1973, PHYS REV LETT, V30, P1346, DOI 10.1103/PhysRevLett.30.1346; Uno S, 2008, PROG THEOR PHYS, V120, P413, DOI 10.1143/PTP.120.413; WILSON KG, 1974, PHYS REV D, V10, P2445, DOI 10.1103/PhysRevD.10.2445	29	199	199	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1452	1455		10.1126/science.1257050	http://dx.doi.org/10.1126/science.1257050			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814578	Green Accepted, Green Submitted			2022-12-28	WOS:000352136400034
J	Sugimoto, Y; Vigilante, A; Darbo, E; Zirra, A; Militti, C; D'Ambrogio, A; Luscombe, NM; Ule, J				Sugimoto, Yoichiro; Vigilante, Alessandra; Darbo, Elodie; Zirra, Alexandra; Militti, Cristina; D'Ambrogio, Andrea; Luscombe, Nicholas M.; Ule, Jernej			hiCLIP reveals the in vivo atlas of mRNA secondary structures recognized by Staufen 1	NATURE			English	Article							ROUGH ENDOPLASMIC-RETICULUM; INTEGRATIVE GENOMICS VIEWER; THROUGHPUT SEQUENCE DATA; EMBRYONIC STEM-CELLS; BINDING PROTEIN; NUCLEOTIDE RESOLUTION; CROSS-LINKING; WIDE ANALYSIS; ALU ELEMENTS; RIBOSOME	The structure of messenger RNA is important for post-transcriptional regulation, mainly because it affects binding of trans-acting factors(1). However, little is known about the in vivo structure of full-length mRNAs. Here we present hiCLIP, a biochemical technique for transcriptome-wide identification of RNA secondary structures interacting with RNA-binding proteins (RBPs). Using this technique to investigate RNA structures bound by Staufen 1 (STAU1) in human cells, we uncover a dominance of intra-molecular RNA duplexes, a depletion of duplexes from coding regions of highly translated mRNAs, an unexpected prevalence of long-range duplexes in 39 untranslated regions (UTRs), and a decreased incidence of single nucleotide polymorphisms in duplex-forming regions. We also discover a duplex spanning 858 nucleotides in the 39 UTR of the X-box binding protein 1 (XBP1) mRNA that regulates its cytoplasmic splicing and stability. Our study reveals the fundamental role of mRNA secondary structures in gene expression and introduce shiCLIPas a widely applicable method for discovering new, especially long-range, RNA duplexes.	[Sugimoto, Yoichiro; D'Ambrogio, Andrea; Ule, Jernej] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Zirra, Alexandra; Militti, Cristina; D'Ambrogio, Andrea; Ule, Jernej] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Vigilante, Alessandra; Darbo, Elodie; Luscombe, Nicholas M.] Canc Res UK London Res Inst, London WC2A 3LY, England; [Vigilante, Alessandra; Luscombe, Nicholas M.] UCL, UCL Genet Inst, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Luscombe, Nicholas M.] Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan	MRC Laboratory Molecular Biology; University of London; University College London; Cancer Research UK; University of London; University College London; Okinawa Institute of Science & Technology Graduate University	Ule, J (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	nicholas.luscombe@ucl.ac.uk; j.ule@ucl.ac.uk	D'Ambrogio, Andrea/AAN-9429-2021; Ule, Jernej/C-6315-2013	Ule, Jernej/0000-0002-2452-4277; Sugimoto, Yoichiro/0000-0003-1646-7679; Vigilante, Alessandra/0000-0002-8768-8287	Human Frontier Science Program [RGP0024/2008-C]; European Research Council [206726-CLIP, 617837-Translate]; Medical Research Council [U105185858]; Cancer Research UK; UCL; Wellcome Trust [103760/Z/14/Z]; Nakajima Foundation; MRC; Cancer Research UK [16358] Funding Source: researchfish; Medical Research Council [MC_U105185858] Funding Source: researchfish; The Francis Crick Institute [10110, 10111] Funding Source: researchfish; MRC [MC_U105185858] Funding Source: UKRI	Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); UCL; Wellcome Trust(Wellcome Trust); Nakajima Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We wish to thank S. Granneman and C. Sibley for discussions on the development of hiCLIP protocol; K. Zarnack, N. Haberman, C. Ravarani and B. Lang for assistance with bioinformatic analyses; D. Daujotyte and P. Lukavsky for sharing the STAU1 plasmid and helping in setting up the project; L. Maquat for sharing the ARF1 SBS plasmid; the genomic team at the Cancer Research UK Cambridge Institute for Illumina HiSeq sequencing, and M. Babu Mohan and Ule group members for support and comments on the manuscript. This work was supported by funding from Human Frontier Science Program (RGP0024/2008-C), European Research Council (206726-CLIP and 617837-Translate) and Medical Research Council (U105185858) to J.U., Cancer Research UK and UCL to N.M.L., a Wellcome Trust Joint Investigator Award to N.M.L. and J.U. (103760/Z/14/Z), the Nakajima Foundation fellowship and MRC Centenary Early Career Award to Y.S.	Aboyoun P., PLOS COMPUTATIONAL B, V9; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Bartonicek N, 2010, BIOINFORMATICS, V26, P2900, DOI 10.1093/bioinformatics/btq545; Boulay K, 2014, NUCLEIC ACIDS RES, V42, P7867, DOI 10.1093/nar/gku506; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Day DS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r69; de Lucas S, 2014, NUCLEIC ACIDS RES, V42, P4516, DOI 10.1093/nar/gku073; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Elbarbary RA, 2013, GENE DEV, V27, P1495, DOI 10.1101/gad.220962.113; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Goodarzi H, 2014, NATURE, V513, P256, DOI 10.1038/nature13466; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Heraud-Farlow JE, 2014, TRENDS NEUROSCI, V37, P470, DOI 10.1016/j.tins.2014.05.009; Heraud-Farlow JE, 2013, CELL REP, V5, P1511, DOI 10.1016/j.celrep.2013.11.039; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kudla G, 2011, P NATL ACAD SCI USA, V108, P10010, DOI 10.1073/pnas.1017386108; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laver JD, 2013, NUCLEIC ACIDS RES, V41, P9438, DOI 10.1093/nar/gkt702; LeGendre JB, 2013, J BIOL CHEM, V288, P2532, DOI 10.1074/jbc.M112.397349; Li F, 2012, CELL REP, V1, P69, DOI 10.1016/j.celrep.2011.10.002; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Luo M, 2002, BIOCHEM J, V365, P817, DOI 10.1042/BJ20020263; Marion RM, 1999, MOL CELL BIOL, V19, P2212; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2012, LANG ENV STAT COMP; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ricci EP, 2014, NAT STRUCT MOL BIOL, V21, P26, DOI 10.1038/nsmb.2739; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Roy B, 2013, TRENDS GENET, V29, P691, DOI 10.1016/j.tig.2013.09.002; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; The Bioconductor Dev Team, BSGENOME HS UCSC HG1; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1; Wickham L, 1999, MOL CELL BIOL, V19, P2220; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023	59	187	192	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					491	+		10.1038/nature14280	http://dx.doi.org/10.1038/nature14280			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25799984	Green Accepted			2022-12-28	WOS:000351602800060
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION Randomised controlled trials: the importance of sample size	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P., 2010, BMJ-BRIT MED J, V340, pc2059; Sedgwick P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2981; Wiegersma M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7378	3	4	4	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2015	350								h1586	10.1136/bmj.h1586	http://dx.doi.org/10.1136/bmj.h1586			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NK	25801454				2022-12-28	WOS:000352028400009
J	Monteleone, G; Neurath, MF; Ardizzone, S; Di Sabatino, A; Fantini, MC; Castiglione, F; Scribano, ML; Armuzzi, A; Caprioli, F; Sturniolo, GC; Rogai, F; Vecchi, M; Atreya, R; Bossa, F; Onali, S; Fichera, M; Corazza, GR; Biancone, L; Savarino, V; Pica, R; Orlando, A; Pallone, F				Monteleone, Giovanni; Neurath, Markus F.; Ardizzone, Sandro; Di Sabatino, Antonio; Fantini, Massimo C.; Castiglione, Fabiana; Scribano, Maria L.; Armuzzi, Alessandro; Caprioli, Flavio; Sturniolo, Giacomo C.; Rogai, Francesca; Vecchi, Maurizio; Atreya, Raja; Bossa, Fabrizio; Onali, Sara; Fichera, Maria; Corazza, Gino R.; Biancone, Livia; Savarino, Vincenzo; Pica, Roberta; Orlando, Ambrogio; Pallone, Francesco			Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PLACEBO-CONTROLLED TRIAL; NECROSIS-FACTOR-ALPHA; TGF-BETA-1-MEDIATED SUPPRESSION; COLITIS; INDUCTION; ACTIVATION; EFFICACY; THERAPY; MICE	BACKGROUND Crohn's disease-related inflammation is characterized by reduced activity of the immunosuppressive cytokine transforming growth factor beta 1 (TGF-beta 1) due to high levels of SMAD7, an inhibitor of TGF-beta 1 signaling. Preclinical studies and a phase 1 study have shown that an oral SMAD7 antisense oligonucleotide, mongersen, targets ileal and colonic SMAD7. METHODS In a double-blind, placebo-controlled, phase 2 trial, we evaluated the efficacy of mongersen for the treatment of persons with active Crohn's disease. Patients were randomly assigned to receive 10, 40, or 160 mg of mongersen or placebo per day for 2 weeks. The primary outcomes were clinical remission at day 15, defined as a Crohn's Disease Activity Index (CDAI) score of less than 150, with maintenance of remission for at least 2 weeks, and the safety of mongersen treatment. A secondary outcome was clinical response (defined as a reduction of 100 points or more in the CDAI score) at day 28. RESULTS The proportions of patients who reached the primary end point were 55% and 65% for the 40-mg and 160-mg mongersen groups, respectively, as compared with 10% for the placebo group (P<0.001). There was no significant difference in the percentage of participants reaching clinical remission between the 10-mg group (12%) and the placebo group. The rate of clinical response was significantly greater among patients receiving 10 mg (37%), 40 mg (58%), or 160 mg (72%) of mongersen than among those receiving placebo (17%) (P=0.04, P<0.001, and P<0.001, respectively). Most adverse events were related to complications and symptoms of Crohn's disease. CONCLUSIONS We found that study participants with Crohn's disease who received mongersen had significantly higher rates of remission and clinical response than those who received placebo.	[Monteleone, Giovanni; Fantini, Massimo C.; Onali, Sara; Biancone, Livia; Pallone, Francesco] Univ Roma Tor Vergata, Dept Syst Med, I-00133 Rome, Italy; [Scribano, Maria L.] Azienda Osped San Camillo Forlanini, Gastroenterol Unit, Rome, Italy; [Armuzzi, Alessandro] Univ Cattolica Sacro Cuore, Complesso Integrato Columbus, Inflammatory Bowel Dis Unit, I-00168 Rome, Italy; [Pica, Roberta] Sandro Pertini Hosp Rome, Inflammatory Bowel Dis Unit, Dept Internal Med, Div Gastroenterol, Rome, Italy; [Ardizzone, Sandro; Fichera, Maria] L Sacco Univ Hosp, Dept Surg, Milan, Italy; [Caprioli, Flavio] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Caprioli, Flavio] Osped Policlin Milano, Milan, Italy; [Vecchi, Maurizio] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Vecchi, Maurizio] Policlin San Donato, IRCCS, Gastroenterol Unit, Milan, Italy; [Di Sabatino, Antonio; Corazza, Gino R.] Univ Pavia, Dept Internal Med 1, St Matteo Hosp Fdn, I-27100 Pavia, Italy; [Castiglione, Fabiana] Univ Naples Federico II, Gastroenterol, Naples, Italy; [Sturniolo, Giacomo C.] Univ Padua, Unita Operat Gastroenterol, Dipartimento Sci Chirurg Oncol & Gastroenterol, Padua, Italy; [Rogai, Francesca] Azienda Osped Univ Careggi, Gastroenterol SOD2, Dept Med & Surg Specialties, Florence, Italy; [Bossa, Fabrizio] IRCCS, Casa Sollievo Sofferenza Hosp, Div Gastroenterol, San Giovanni Rotondo, Italy; [Savarino, Vincenzo] Univ Genoa, Dept Internal Med, Gastroenterol & Hepatol Unit, I-16126 Genoa, Italy; [Orlando, Ambrogio] Univ Palermo, Div Internal Med, Villa Sofia Cervello Hosp, Palermo, Italy; [Neurath, Markus F.; Atreya, Raja] Univ Erlangen Nurnberg, Dept Med, Med Clin 1, D-91054 Erlangen, Germany	University of Rome Tor Vergata; Azienda Ospedaliera San Camillo-Forlanini; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Ospedale Sandro Pertini; University of Milan; Luigi Sacco Hospital; University of Milan; University of Milan; Luigi Sacco Hospital; University of Milan; IRCCS Policlinico San Donato; University of Pavia; University of Naples Federico II; University of Padua; University of Florence; Azienda Ospedaliero Universitaria Careggi; IRCCS Casa Sollievo Della Sofferenza; University of Genoa; University of Palermo; University of Erlangen Nuremberg	Monteleone, G (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Via Montpellier 1, I-00133 Rome, Italy.	gi.monteleone@med.uniroma2.it	Di Sabatino, Antonio/K-8015-2016; Corazza, Gino Roberto/K-8500-2016; Armuzzi, Alessandro/AIC-5188-2022; Bossa, Fabrizio/B-3078-2017; Ardizzone, Sandro/J-3251-2017; Caprioli, Flavio/AAB-5176-2019; Pica, Roberta/AAP-4526-2020; Monteleone, Giovanni/AAE-1418-2021; Vecchi, Maurizio/AAB-7383-2019	Di Sabatino, Antonio/0000-0002-0302-8645; Corazza, Gino Roberto/0000-0001-9532-0573; Bossa, Fabrizio/0000-0002-4518-9949; Ardizzone, Sandro/0000-0001-9915-2992; Caprioli, Flavio/0000-0002-8077-8175; Scribano, Maria Lia/0000-0003-1839-8136; Orlando, Ambrogio/0000-0002-5298-2638	Giuliani	Giuliani	Funded by Giuliani; EudraCT number, 2011-002640-27.	Boirivant M, 2006, GASTROENTEROLOGY, V131, P1786, DOI 10.1053/j.gastro.2006.09.016; Committee for Medicinal Products for Human Use (CHMP), 2007, CPMPEWP228499 EUR ME; Florin THJ, 2006, SCAND J GASTROENTERO, V41, P306, DOI 10.1080/00365520500217118; Ford AC, 2011, AM J GASTROENTEROL, V106, P644, DOI 10.1038/ajg.2011.73; GALBRAITH WM, 1994, ANTISENSE RES DEV, V4, P201, DOI 10.1089/ard.1994.4.201; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Keshav S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060094; Kitani A, 2000, J EXP MED, V192, P41, DOI 10.1084/jem.192.1.41; KULKARNI AB, 1993, AM J PATHOL, V143, P3; Lawrance IC, 2010, J GASTROEN HEPATOL, V25, P1732, DOI 10.1111/j.1440-1746.2010.06407.x; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; Magro F, 2013, J CROHNS COLITIS, V7, P827, DOI 10.1016/j.crohns.2013.06.001; Monteleone G, 2008, MUCOSAL IMMUNOL, V1, pS50, DOI 10.1038/mi.2008.55; Monteleone G, 2004, J BIOL CHEM, V279, P3925, DOI 10.1074/jbc.M303654200; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Monteleone G, 2012, MOL THER, V20, P870, DOI 10.1038/mt.2011.290; Neurath MF, 1996, J EXP MED, V183, P2605, DOI 10.1084/jem.183.6.2605; Peyrin-Biroulet L, 2011, INFLAMM BOWEL DIS, V17, P471, DOI 10.1002/ibd.21417; Rodgers AD, 2007, DIGEST DIS SCI, V52, P2063, DOI 10.1007/s10620-006-9691-2; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Schreiber S, 2005, GASTROENTEROLOGY, V129, P807, DOI 10.1053/j.gastro.2005.06.064; Schreiber S, 2001, GASTROENTEROLOGY, V120, P1339, DOI 10.1053/gast.2001.24015; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Yacyshyn BR, 2002, GUT, V51, P30, DOI 10.1136/gut.51.1.30; Zorzi F, 2012, ALIMENT PHARM THER, V36, P850, DOI 10.1111/apt.12051	28	279	296	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2015	372	12					1104	1113		10.1056/NEJMoa1407250	http://dx.doi.org/10.1056/NEJMoa1407250			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EZ	25785968	Green Published			2022-12-28	WOS:000351183600005
J	Ford, JA				Ford, John A.			Extending opening hours in general practice won't improve access for patients most in need	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ E Anglia, Fac Med & Hlth Sci, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Ford, JA (corresponding author), Univ E Anglia, Fac Med & Hlth Sci, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	john.ford@uea.ac.uk		Ford, John/0000-0001-8033-7081	National Institute for Health Research [DRF-2014-07-083] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], 2013, THE WEEK        1111; Cowling Thomas E, 2013, PLoS One, V8, pe66699, DOI 10.1371/journal.pone.0066699; Department of Health Prime Minister's Office, 2013, 7 DAY 8AM 8PM G 1001; Gill P, 2013, IMPROVING ACCESS HLT; Goddard M, 2008, 40 CHE; Harvey S, 2008, SHIFTING BALANCE HLT; Health and Social Care Information Centre, PRIMARY CARE; Royal College of General Practitioners, 2014, OV 500 SURG RISK CLO; SALISBURY C, 2002, NATL EVALUATION NHS; Shi LY, 2005, J GEN INTERN MED, V20, P148, DOI 10.1111/j.1525-1497.2005.40136.x; Soljak M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613142	11	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2015	350								h1373	10.1136/bmj.h1373	http://dx.doi.org/10.1136/bmj.h1373			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KO	25784722				2022-12-28	WOS:000351570700006
J	Coffelt, SB; Kersten, K; Doornebal, CW; Weiden, J; Vrijland, K; Hau, CS; Verstegen, NJM; Ciampricotti, M; Hawinkels, LJAC; Jonkers, J; de Visser, KE				Coffelt, Seth B.; Kersten, Kelly; Doornebal, Chris W.; Weiden, Jorieke; Vrijland, Kim; Hau, Cheei-Sing; Verstegen, Niels J. M.; Ciampricotti, Metamia; Hawinkels, Lukas J. A. C.; Jonkers, Jos; de Visser, Karin E.			IL-17-producing gamma delta T cells and neutrophils conspire to promote breast cancer metastasis	NATURE			English	Article							COLONY-STIMULATING FACTOR; MAMMARY-CARCINOMA; MOUSE MODEL; TUMOR; PROGRESSION; BETA; INFLAMMATION; RECRUITMENT; SUPPRESSION; INDUCTION	Metastatic disease remains the primary cause of death for patients with breast cancer. The different steps of the metastatic cascade rely on reciprocal interactions between cancer cells and their microenvironment. Within this local microenvironment and in distant organs, immune cells and their mediators are known to facilitate metastasis formation(1,2). However, theprecisecontributionof tumour-induced systemic inflammation to metastasis and the mechanisms regulating systemic inflammation are poorly understood. Here we show that tumours maximize their chance of metastasizing by evoking a systemic inflammatory cascade in mouse models of spontaneous breast cancer metastasis. We mechanistically demonstrate that interleukin (IL)-1 beta elicits IL-17 expression from gamma delta (gamma delta) T cells, resulting in systemic, granulocyte colony-stimulating factor (G-CSF)-dependent expansion and polarization of neutrophils in mice bearing mammary tumours. Tumour-induced neutrophils acquire the ability to suppress cytotoxic T lymphocytes carrying the CD8 antigen, which limit the establishment of metastases. Neutralization of IL-17 or G-CSF and absence of gamma delta T cells prevents neutrophil accumulation and downregulates the T-cell-suppressive phenotype of neutrophils. Moreover, the absence of gamma delta T cells or neutrophils profoundly reduces pulmonary and lymph node metastases without influencing primary tumour progression. Our data indicate that targeting this novel cancer-cell-initiated domino effect within the immune system-the gamma delta T cell/IL-17/neutrophil axis-represents a new strategy to inhibit metastatic disease.	[Coffelt, Seth B.; Kersten, Kelly; Doornebal, Chris W.; Weiden, Jorieke; Vrijland, Kim; Hau, Cheei-Sing; Verstegen, Niels J. M.; Ciampricotti, Metamia; de Visser, Karin E.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Hawinkels, Lukas J. A. C.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Hawinkels, Lukas J. A. C.] Leiden Univ, Med Ctr, Ctr Biomed Genet, NL-2300 RC Leiden, Netherlands; [Jonkers, Jos] Netherlands Canc Inst, Div Mol Pathol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute	de Visser, KE (corresponding author), Netherlands Canc Inst, Div Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	k.d.visser@nki.nl	Jonkers, Jos/AAG-3246-2019; Coffelt, Seth/O-9929-2019; Weiden, Jorieke/M-5843-2015; Hawinkels, Lukas/Q-5098-2019	Jonkers, Jos/0000-0002-9264-9792; Coffelt, Seth/0000-0003-2257-2862; Weiden, Jorieke/0000-0002-2485-0590; Hawinkels, Lukas/0000-0002-2274-9325; ciampricotti, metamia/0000-0001-5382-0481; de Visser, Karin/0000-0002-0293-868X; Verstegen, Niels/0000-0001-5732-4979	Marie Curie Intra-European Fellowship [BMDCMET 275610]; European Research Council [INFLAMET 615300]; Dutch Cancer Society [2011-5004]; Worldwide Cancer Research [AICR 11-0677]; Netherlands Organization for Scientific Research NWO VIDI [917.96.307]; Dutch Cancer Society/Bas Mulder Award [UL2011-5051]; Worldwide Cancer Research [11-0677] Funding Source: researchfish	Marie Curie Intra-European Fellowship(European Commission); European Research Council(European Research Council (ERC)European Commission); Dutch Cancer Society(KWF Kankerbestrijding); Worldwide Cancer Research; Netherlands Organization for Scientific Research NWO VIDI(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society/Bas Mulder Award; Worldwide Cancer Research	This work was supported by a Marie Curie Intra-European Fellowship to S.B.C. (BMDCMET 275610); a European Research Council Consolidator award (INFLAMET 615300) to K.E.dV; grants from the Dutch Cancer Society to K.E.dV and J.J. (2011-5004); Worldwide Cancer Research (AICR 11-0677) to K.E.dV; the Netherlands Organization for Scientific Research NWO VIDI (917.96.307) to K.E.dV; and a Dutch Cancer Society/Bas Mulder Award to L.J.A.C.H. (UL2011-5051). We thank J. Borst, T. Schumacher and J. Coquet for discussions. We thank the core facilities at the Netherlands Cancer Institute. We thank L. Coussens for Rag1<SUP>-/-</SUP> mice and A. Hayday for Tcrd<SUP>-/-</SUP> mice. We thank C. Ries and K. Wartha for technical assistance.	Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chen WC, 2013, HISTOPATHOLOGY, V63, P225, DOI 10.1111/his.12156; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Ciampricotti M, 2012, NAT MED, V18, P344, DOI 10.1038/nm.2652; Ciampricotti M, 2011, J PATHOL, V224, P56, DOI 10.1002/path.2837; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Doornebal CW, 2013, CANCER RES, V73, P353, DOI 10.1158/0008-5472.CAN-11-4208; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Hamilton JA, 2013, TRENDS IMMUNOL, V34, P81, DOI 10.1016/j.it.2012.08.006; Han YW, 2012, BREAST CANCER RES TR, V131, P483, DOI 10.1007/s10549-011-1799-1; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Kuonen F, 2012, CLIN CANCER RES, V18, P4365, DOI 10.1158/1078-0432.CCR-11-3028; LEJEUNE P, 1994, J IMMUNOL, V152, P5077; Ma CL, 2012, J IMMUNOL, V189, P5029, DOI 10.4049/jimmunol.1201892; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Mei JJ, 2012, J CLIN INVEST, V122, P974, DOI 10.1172/JCI60588; Noh H, 2013, J BREAST CANCER, V16, P55, DOI 10.4048/jbc.2013.16.1.55; Novitskiy SV, 2011, CANCER DISCOV, V1, P430, DOI 10.1158/2159-8290.CD-11-0100; Pillay J, 2013, CELL MOL LIFE SCI, V70, P3813, DOI 10.1007/s00018-013-1286-4; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Sutherland TE, 2014, NAT IMMUNOL, V15, P1116, DOI 10.1038/ni.3023; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Young MRI, 1996, J IMMUNOL, V156, P1916	34	954	992	9	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					345	+		10.1038/nature14282	http://dx.doi.org/10.1038/nature14282			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	25822788	Green Accepted			2022-12-28	WOS:000356425400054
J	Okun, M; Steinmetz, NA; Cossell, L; Iacaruso, MF; Ko, H; Bartho, P; Moore, T; Hofer, SB; Mrsic-Flogel, TD; Carandini, M; Harris, KD				Okun, Michael; Steinmetz, Nicholas A.; Cossell, Lee; Iacaruso, M. Florencia; Ko, Ho; Bartho, Peter; Moore, Tirin; Hofer, Sonja B.; Mrsic-Flogel, Thomas D.; Carandini, Matteo; Harris, Kenneth D.			Diverse coupling of neurons to populations in sensory cortex	NATURE			English	Article							PRIMARY VISUAL-CORTEX; FUNCTIONAL-ORGANIZATION; PROJECTION NEURONS; IN-VIVO; DYNAMICS; RECORDINGS; RESPONSES; STATE	A large population of neurons can, in principle, produce an astronomical number of distinct firing patterns. In cortex, however, these patterns lie in a space of lower dimension(1-4), as if individual neurons were "obedientmembers of a huge orchestra''(5). Here we use recordings from the visual cortex of mouse (Mus musculus) and monkey (Macaca mulatta) to investigate the relationship between individual neurons and the population, and to establish the underlying circuit mechanisms. We show that neighbouring neurons can differ in their coupling to the overall firing of the population, ranging from strongly coupled 'choristers' to weakly coupled 'soloists'. Population coupling is largely independent of sensory preferences, and it is a fixed cellular attribute, invariant to stimulus conditions. Neurons with high population coupling are more strongly affected by non-sensory behavioural variables such as motor intention. Population coupling reflects a causal relationship, predicting the response of a neuron to optogenetically driven increases in local activity. Moreover, population coupling indicates synaptic connectivity; the population coupling of a neuron, measured in vivo, predicted subsequent in vitro estimates of the number of synapses received from its neighbours. Finally, population coupling provides a compact summary of population activity; knowledge of the population couplings of n neurons predicts a substantial portion of their n(2) pairwise correlations. Population coupling therefore represents a novel, simple measure that characterizes the relationship of each neuron to a larger population, explaining seemingly complex network firing patterns in terms of basic circuit variables.	[Okun, Michael; Steinmetz, Nicholas A.; Harris, Kenneth D.] UCL, UCL Inst Neurol, London WC1N 3BG, England; [Okun, Michael; Steinmetz, Nicholas A.; Cossell, Lee; Iacaruso, M. Florencia; Ko, Ho; Hofer, Sonja B.; Mrsic-Flogel, Thomas D.; Harris, Kenneth D.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6DE, England; [Okun, Michael; Steinmetz, Nicholas A.; Carandini, Matteo] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England; [Steinmetz, Nicholas A.; Moore, Tirin] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Steinmetz, Nicholas A.; Moore, Tirin] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Cossell, Lee; Iacaruso, M. Florencia; Hofer, Sonja B.; Mrsic-Flogel, Thomas D.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Bartho, Peter; Harris, Kenneth D.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	University of London; University College London; University of London; University College London; University of London; University College London; Howard Hughes Medical Institute; Stanford University; Stanford University; University of Basel; Rutgers State University Newark; Rutgers State University New Brunswick	Okun, M (corresponding author), UCL, UCL Inst Neurol, London WC1N 3BG, England.	m.okun@ucl.ac.uk; kenneth.harris@ucl.ac.uk	Steinmetz, Nick/B-8555-2018; Carandini, Matteo/ABD-8296-2021; Ko, Ho/AAH-2755-2020; Ko, Ho/I-7513-2016	Steinmetz, Nick/0000-0001-7029-2908; Carandini, Matteo/0000-0003-4880-7682; Ko, Ho/0000-0002-0254-3274; Ko, Ho/0000-0002-0254-3274; Hofer, Sonja/0000-0003-4921-8521; Harris, Kenneth/0000-0002-5930-6456; Okun, Michael/0000-0002-7795-5513; Mrsic-Flogel, Tom/0000-0002-8947-408X	Wellcome Trust; Engineering and Physical Sciences Research Council; European Research Council; Medical Research Council; National Institutes of Health [EY014924]; Simons Foundation; EPSRC [EP/I005102/1, EP/K015141/1, EP/I005102/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K015141/1, EP/I005102/1, EP/I005102/2] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY014924, R56EY014924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank L. Buesing for advice on latent variable analysis, C. Reddy and T. Sato for technical assistance, and M. Hausser for advice on the manuscript. This work was supported by the Wellcome Trust (S.B.H., T.D.M.-F., M.C., K.D.H.), Engineering and Physical Sciences Research Council (K.D.H.), the European Research Council (T.D.M.-F.), the Medical Research Council (L.C.), National Institutes of Health (EY014924, N.A.S. and T.M.) and the Simons Foundation (M.C. and K.D.H.). M.C. holds the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Ayaz A, 2013, CURR BIOL, V23, P890, DOI 10.1016/j.cub.2013.04.012; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Chen JL, 2013, NATURE, V499, P336, DOI 10.1038/nature12236; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Dorn JD, 2003, J NEUROPHYSIOL, V89, P2271, DOI 10.1152/jn.000889.2002; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Gulati T, 2014, NAT NEUROSCI, V17, P1107, DOI 10.1038/nn.3759; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Kenet T., 2006, 23 PROBLEMS SYSTEMS; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Luczak A, 2013, J NEUROSCI, V33, P1684, DOI 10.1523/JNEUROSCI.2928-12.2013; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Macke Jakob H, 2012, ADV NEURAL INFORM PR, V24, P1350; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Martin KAC, 2013, J NEUROSCI, V33, P7325, DOI 10.1523/JNEUROSCI.4071-12.2013; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Okun M, 2012, J NEUROSCI, V32, P17108, DOI 10.1523/JNEUROSCI.1831-12.2012; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Paninski L., 2013, ADV NEURAL INF PROCE, V26, P2391; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Steinmetz NA, 2014, NEURON, V83, P496, DOI 10.1016/j.neuron.2014.06.014; Tkacik G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003408; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Yamashita T, 2013, NEURON, V80, P1477, DOI 10.1016/j.neuron.2013.10.059; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008; Zagha E, 2013, NEURON, V79, P567, DOI 10.1016/j.neuron.2013.06.008	42	211	214	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					511	U189		10.1038/nature14273	http://dx.doi.org/10.1038/nature14273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25849776	Green Submitted, Green Accepted			2022-12-28	WOS:000355286600041
J	Lujan, E; Zunder, ER; Ng, YH; Goronzy, IN; Nolan, GP; Wernig, M				Lujan, Ernesto; Zunder, Eli R.; Ng, Yi Han; Goronzy, Isabel N.; Nolan, Garry P.; Wernig, Marius			Early reprogramming regulators identified by prospective isolation and mass cytometry	NATURE			English	Article							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS; MOLECULAR ROADMAP; FIBROBLASTS; EXPRESSION; INDUCTION; MARKERS	In the context of most induced pluripotent stem(iPS) cell reprogramming methods, heterogeneous populations of non-productive and staggered productive intermediates arise at different reprogramming time points(1-11). Despite recent reports claiming substantially increased reprogramming efficiencies using genetically modified donor cells(12,13), prospectively isolating distinct reprogramming intermediates remains an important goal to decipher reprogramming mechanisms. Previous attempts to identify surface markers of intermediate cell populations were based on the assumption that, during reprogramming, cells progressively lose donor cell identity and gradually acquire iPS cell properties(1,2,7,8,10). Here we report that iPS cell and epithelial markers, such as SSEA1 and EpCAM, respectively, are not predictive of reprogramming during early phases. Instead, in a systematic functional surface marker screen, we find that early reprogramming-prone cells express a unique set of surface markers, including CD73, CD49d and CD200, that are absent in both fibroblasts and iPS cells. Single-cell mass cytometry and prospective isolation show that these distinct intermediates are transient and bridge the gap between donor cell silencing and pluripotency marker acquisition during the early, presumably stochastic, reprogramming phase(2). Expression profiling reveals early upregulation of the transcriptional regulators Nr0b1 and Etv5 in this reprogramming state, preceding activation of key pluripotency regulators such asRex1 (also known as Zfp42), Dppa2, Nanog and Sox2. Both factors are required for the generation of the early intermediate state and fully reprogrammed iPS cells, and thus represent some of the earliest known regulators of iPS cell induction. Our study deconvolutes the first steps in a hierarchical series of events that lead to pluripotency acquisition.	[Lujan, Ernesto; Ng, Yi Han; Goronzy, Isabel N.; Wernig, Marius] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Lujan, Ernesto] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Lujan, Ernesto; Ng, Yi Han; Goronzy, Isabel N.; Wernig, Marius] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Zunder, Eli R.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Ng, Yi Han] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Wernig, M (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	wernig@stanford.edu	Nolan, Garry/AAE-7903-2019	Zunder, Eli/0000-0002-0356-1685; Nolan, Garry/0000-0002-8862-9043	California Institute of Regenerative Medicine [RB2-01592]; Institute for Stem Cell Biology and Regenerative Medicine at Stanford; New York Stem Cell Foundation-Robertson Investigator Award; California Institute for Regenerative Medicine Predoctoral Fellowship [TG2-01159]; National Science Foundation Graduate Research Fellowship [DGE-114747]; National Institutes of Health National Research Service Award [F32 GM093508-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC4NS073015] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Institute for Stem Cell Biology and Regenerative Medicine at Stanford; New York Stem Cell Foundation-Robertson Investigator Award; California Institute for Regenerative Medicine Predoctoral Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Lovelace, R. Finck, K. M. Loh, K. Tanabe and S. Marro for advice. We thank J. Hanna for his the secondary Mbd3<SUP>fl/-</SUP> MEFs. We also thank S. Knobel for them EF-SK4 antibody. This work was supported by the California Institute of Regenerative Medicine grant RB2-01592 (to G.P.N.), the Institute for Stem Cell Biology and Regenerative Medicine at Stanford, and a New York Stem Cell Foundation-Robertson Investigator Award. E.L. was supported by the California Institute for Regenerative Medicine Predoctoral Fellowship TG2-01159 and National Science Foundation Graduate Research Fellowship DGE-114747. E.R.Z. was supported by National Institutes of Health National Research Service Award F32 GM093508-01. M.W. is a New York Stem Cell Foundation-Robertson Investigator and a Tashia and John Morgridge Faculty Scholar at the Child Health Research Institute at Stanford.	Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Di Stefano B, 2014, NATURE, V506, P235, DOI 10.1038/nature12885; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fienberg HG, 2012, CYTOM PART A, V81A, P467, DOI 10.1002/cyto.a.22067; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Ho R, 2013, CELL REP, V3, P2113, DOI 10.1016/j.celrep.2013.05.015; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Linderman MD, 2012, BIOINFORMATICS, V28, P2400, DOI 10.1093/bioinformatics/bts425; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; O'Malley J, 2013, NATURE, V499, P88, DOI 10.1038/nature12243; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4678; Tanabe K, 2013, P NATL ACAD SCI USA, V110, P12172, DOI 10.1073/pnas.1310291110; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Zhang JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6042; Zunder ER, 2015, CELL STEM CELL, V16, P323, DOI 10.1016/j.stem.2015.01.015	31	69	71	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					352	+		10.1038/nature14274	http://dx.doi.org/10.1038/nature14274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25830878	Green Accepted			2022-12-28	WOS:000354816500056
J	Benzon, HT; Huntoon, MA; Rathmell, JP				Benzon, Honorio T.; Huntoon, Marc A.; Rathmell, James P.			Improving the Safety of Epidural Steroid Injections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Benzon, Honorio T.] Northwestern Univ, Dept Anesthesiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Huntoon, Marc A.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA; [Rathmell, James P.] Massachusetts Gen Hosp, Dept Anesthesiol, Boston, MA 02114 USA; [Rathmell, James P.] Harvard Univ, Sch Med, Boston, MA USA	Northwestern University; Feinberg School of Medicine; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Benzon, HT (corresponding author), Northwestern Univ, Dept Anesthesiol, Feinberg Sch Med, 251 E Huron St,Feinberg Pavil,Ste 5-704, Chicago, IL 60611 USA.	h-benzon@northwestern.edu	Rathmell, James/GQZ-1503-2022					[Anonymous], SUMM MIN AN AN DRUG; Benzon HT, 2007, ANESTHESIOLOGY, V106, P331, DOI 10.1097/00000542-200702000-00022; Dawley JD, 2009, SPINE, V34, P1638, DOI 10.1097/BRS.0b013e3181ac0018; Huntoon MA, 2005, PAIN, V117, P104, DOI 10.1016/j.pain.2005.05.030; Karasek M, 2004, PAIN MED, V5, P202, DOI 10.1111/j.1526-4637.2004.04028.x; Kennedy DJ, 2014, PAIN MED, V15, P548, DOI 10.1111/pme.12325; Malani AN, 2013, JAMA-J AM MED ASSOC, V309, P2465, DOI 10.1001/jama.2013.6293; Manchikanti L, 2013, PAIN PHYSICIAN, V16, pE349; Rathmell JP, 2015, ANESTHESIOLOGY, V122, P974, DOI 10.1097/ALN.0000000000000614	9	20	21	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2015	313	17					1713	1714		10.1001/jama.2015.2912	http://dx.doi.org/10.1001/jama.2015.2912			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3HQ	25822848	Bronze			2022-12-28	WOS:000353921000014
J	Hoffman, Y; Pilpel, Y				Hoffman, Yonit; Pilpel, Yitzhak			MicroRNAs silence the noisy genome	SCIENCE			English	Editorial Material							CELL RNA-SEQ; SINGLE-CELL; GENE-EXPRESSION		[Hoffman, Yonit; Pilpel, Yitzhak] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Hoffman, Yonit] Weizmann Inst Sci, Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Pilpel, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	pilpel@weizmann.ac.il						Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Schmiedel JM, 2015, SCIENCE, V348, P128, DOI 10.1126/science.aaa1738	10	4	4	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					41	42		10.1126/science.aaa9841	http://dx.doi.org/10.1126/science.aaa9841			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838367				2022-12-28	WOS:000352079500019
J	Kim, SI; Lee, KH; Mun, HA; Kim, HS; Hwang, SW; Roh, JW; Yang, DJ; Shin, WH; Li, XS; Lee, YH; Snyder, GJ; Kim, SW				Kim, Sang Il; Lee, Kyu Hyoung; Mun, Hyeon A.; Kim, Hyun Sik; Hwang, Sung Woo; Roh, Jong Wook; Yang, Dae Jin; Shin, Weon Ho; Li, Xiang Shu; Lee, Young Hee; Snyder, G. Jeffrey; Kim, Sung Wng			Dense dislocation arrays embedded in grain boundaries for high-performance bulk thermoelectrics	SCIENCE			English	Article							LATTICE THERMAL-CONDUCTIVITY; BI2TE3; POWER	The widespread use of thermoelectric technology is constrained by a relatively low conversion efficiency of the bulk alloys, which is evaluated in terms of a dimensionless figure of merit (zT). The zT of bulk alloys can be improved by reducing lattice thermal conductivity through grain boundary and point-defect scattering, which target low-and high-frequency phonons. Dense dislocation arrays formed at low-energy grain boundaries by liquid-phase compaction in Bi0.5Sb1.5Te3 (bismuth antimony telluride) effectively scatter midfrequency phonons, leading to a substantially lower lattice thermal conductivity. Full-spectrum phonon scattering with minimal charge-carrier scattering dramatically improved the zT to 1.86 +/- 0.15 at 320 kelvin (K). Further, a thermoelectric cooler confirmed the performance with a maximum temperature difference of 81 K, which is much higher than current commercial Peltier cooling devices.	[Kim, Sang Il; Kim, Hyun Sik; Hwang, Sung Woo; Roh, Jong Wook; Yang, Dae Jin; Shin, Weon Ho; Li, Xiang Shu] Samsung Elect, Samsung Adv Inst Technol, Mat Res Ctr, Suwon 443803, South Korea; [Lee, Kyu Hyoung] Kangwon Natl Univ, Dept Nano Appl Engn, Chunchon 200701, South Korea; [Mun, Hyeon A.; Lee, Young Hee; Snyder, G. Jeffrey; Kim, Sung Wng] Sungkyunkwan Univ, Dept Energy Sci, Suwon 440746, South Korea; [Mun, Hyeon A.; Lee, Young Hee; Kim, Sung Wng] Sungkyunkwan Univ, Inst Basic Sci, IBS Ctr Integrated Nanostruct Phys, Suwon 440746, South Korea; [Kim, Hyun Sik; Snyder, G. Jeffrey] CALTECH, Mat Sci, Pasadena, CA 91125 USA	Samsung; Samsung Electronics; Kangwon National University; Sungkyunkwan University (SKKU); Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU); California Institute of Technology	Kim, SI (corresponding author), Samsung Elect, Samsung Adv Inst Technol, Mat Res Ctr, Suwon 443803, South Korea.	sang.il.kim@samsung.com; kimsungwng@skku.edu	Snyder, G. Jeffrey/E-4453-2011; Shin, Weon Ho/AAH-4031-2020; Kim, Sung Wng/A-4747-2013; Lee, Young Hee/A-5424-2013; Roh, Jong-wook/P-2646-2019; Snyder, G J/I-2263-2015	Snyder, G. Jeffrey/0000-0003-1414-8682; Shin, Weon Ho/0000-0003-0487-5480; Kim, Sung Wng/0000-0002-4802-5421; Kim, Hyun-Sik/0000-0001-8934-4042	National Research Foundation of Korea [2013R1A1A1008025]; Human Resources Development program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) - Korea government Ministry of Trade, Industry, and Energy [20124010203270]; AFOSR MURI [FA9550-10-1-0533];  [IBS-R011-D1]	National Research Foundation of Korea(National Research Foundation of Korea); Human Resources Development program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) - Korea government Ministry of Trade, Industry, and Energy; AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); 	This work was supported by IBS-R011-D1, the National Research Foundation of Korea (2013R1A1A1008025), the Human Resources Development program (no. 20124010203270) of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant funded by the Korea government Ministry of Trade, Industry, and Energy, and AFOSR MURI FA9550-10-1-0533.	ABELES B, 1963, PHYS REV, V131, P1906, DOI 10.1103/PhysRev.131.1906; Bell LE, 2008, SCIENCE, V321, P1457, DOI 10.1126/science.1158899; Buist R. J., 1980, 3 INT C THERM EN CON, P130; Cahn JW, 2006, ACTA MATER, V54, P4953, DOI 10.1016/j.actamat.2006.08.004; CALLAWAY J, 1960, PHYS REV, V120, P1149, DOI 10.1103/PhysRev.120.1149; Clarke DR, 2005, MATER TODAY, V8, P22, DOI 10.1016/S1369-7021(05)70934-2; COCKAYNE DJ, 1969, PHILOS MAG, V20, P1265, DOI 10.1080/14786436908228210; Dresselhaus MS, 2007, ADV MATER, V19, P1043, DOI 10.1002/adma.200600527; Fan SF, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3427427; German R, 2009, J MATER SCI, V44, P1, DOI 10.1007/s10853-008-3008-0; Goldsmid H. J., 1986, ELECT REFRIGERATION; He JQ, 2010, ADV FUNCT MATER, V20, P764, DOI 10.1002/adfm.200901905; Herzig C., 2005, DIFFUSION CONDENSED; Hu LP, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2013.86; Humphreys F.J., 2004, RECRYSTALLIZATION RE, DOI 10.1016/B978-0-08-044164-1.X5000-2; JORGENSEN PJ, 1973, J APPL PHYS, V44, P2876, DOI 10.1063/1.1662663; Kim P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.215502; KLEMENS PG, 1955, P PHYS SOC LOND A, V68, P1113, DOI 10.1088/0370-1298/68/12/303; Medlin DL, 2014, J MATER SCI, V49, P3970, DOI 10.1007/s10853-014-8035-4; Medlin DL, 2009, CURR OPIN COLLOID IN, V14, P226, DOI 10.1016/j.cocis.2009.05.001; Morelli DT, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.195304; MOTT NF, 1952, PHILOS MAG, V43, P1151; Nader M, 1999, J MATER SCI, V34, P1197, DOI 10.1023/A:1004552704872; Nazare S., 1971, RELATIONS STEREOMETR, P171; Peranio N, 2009, PHYS STATUS SOLIDI A, V206, P42, DOI 10.1002/pssa.200824224; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; ROUFOSSE M, 1973, PHYS REV B, V7, P5379, DOI 10.1103/PhysRevB.7.5379; Scherrer H., 2006, THERMOELECTRICS HDB; SLACK GA, 1964, PHYS REV, V133, pA253, DOI 10.1103/PhysRev.133.A253; Toberer ES, 2011, J MATER CHEM, V21, P15843, DOI 10.1039/c1jm11754h; Wang H, 2013, ADV FUNCT MATER, V23, P1586, DOI 10.1002/adfm.201201576; Williams and Carter, 2010, TRANSMISSION ELECT M; Zhao DL, 2014, APPL THERM ENG, V66, P15, DOI 10.1016/j.applthermaleng.2014.01.074	33	1209	1225	94	872	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					109	114		10.1126/science.aaa4166	http://dx.doi.org/10.1126/science.aaa4166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838382				2022-12-28	WOS:000352079500037
J	Lipsitch, M; Eyal, N; Halloran, ME; Hernan, MA; Longini, IM; Perencevich, EN; Grais, RF				Lipsitch, Marc; Eyal, Nir; Halloran, M. Elizabeth; Hernan, Miguel A.; Longini, Ira M.; Perencevich, Eli N.; Grais, Rebecca F.			Ebola and beyond	SCIENCE			English	Editorial Material									[Lipsitch, Marc; Hernan, Miguel A.] Harvard Univ, TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Lipsitch, Marc; Hernan, Miguel A.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Eyal, Nir] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Eyal, Nir] Harvard Univ, Sch Med, Ctr Bioeth, Boston, MA 02115 USA; [Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Ctr Inference & Dynam Infect Dis, Seattle, WA 98104 USA; [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98105 USA; [Hernan, Miguel A.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Hernan, Miguel A.] Harvard Mit Div Hlth Sci & Technol, Boston, MA USA; [Longini, Ira M.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Ctr Inference & Dynam Infect Dis, Gainesville, FL USA; [Longini, Ira M.] Univ Florida, Coll Med, Gainesville, FL USA; [Perencevich, Eli N.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Perencevich, Eli N.] Iowa Vet Affairs Hlth Care Syst, Ctr Comprehens Access & Delivery Res & Evaluat, Iowa City, IA USA; [Grais, Rebecca F.] Epicentre, Paris, France	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Lipsitch, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	mlipsitc@hsph.harvard.edu; Rebecca.grais@epicentre.msf.org		Freeman Grais, Rebecca/0000-0002-5037-8218; Perencevich, Eli/0000-0002-3721-3355; Hernan, Miguel/0000-0003-1619-8456	NIAID NIH HHS [R37 AI032042] Funding Source: Medline; NIGMS NIH HHS [U54GM111274, U54GM088558, U54 GM111274, U54 GM088558] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558, U54GM111274] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adebamowo C, 2014, LANCET, V384, P1423, DOI 10.1016/S0140-6736(14)61734-7; Branswell H., 2014, IMPROVED EBOLA SITUA; Fleck F, 2015, B WORLD HEALTH ORGAN, V93, P7, DOI 10.2471/BLT.15.020115; Giahyue J. H., 2015, REUTERS; Iwuji CC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-230; Jennison C, 2000, GROUP SEQUENTIAL MET; King G, 2007, J POLICY ANAL MANAG, V26, P479, DOI 10.1002/pam.20279; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; MATTS JP, 1988, CONTROL CLIN TRIALS, V9, P327, DOI 10.1016/0197-2456(88)90047-5; Maxmen A., 2015, AL JAZEERA AM   0311; NIAID, 2015, PREVAIL PHAS 2 3 CLI; SAGE Working Group on Vaccination in Acute Humanitarian Emergencies, 2013, VACC AC HUM EM FRAM; WHO/MSF/NIPH, 2015, EB VACC EFF TRIAL RE; World Health Organization, 2014, EXP EB VACC SIT REP; World Health Organization, 2014, WHO HIGH LEV M EB VA	15	14	14	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					46	48		10.1126/science.aaa3178	http://dx.doi.org/10.1126/science.aaa3178			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838371	Green Accepted			2022-12-28	WOS:000352079500023
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: General practice is still the best job in the world	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				BMA, 2015, STRUGGL FILL GP VAC; Rimmer A, 2014, BMJ CAREERS	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2015	350								h1721	10.1136/bmj.h1721	http://dx.doi.org/10.1136/bmj.h1721			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3GV	25825207	Bronze			2022-12-28	WOS:000352437200013
J	Miller, DAB				Miller, David A. B.			Sorting out light	SCIENCE			English	Editorial Material							DESIGN		Stanford Univ, Ginzton Lab, Stanford, CA 94305 USA	Stanford University	Miller, DAB (corresponding author), Stanford Univ, Ginzton Lab, 348 Via Pueblo Mall, Stanford, CA 94305 USA.	dabm@ee.stanford.edu	Miller, David A/C-4829-2009	Miller, David A/0000-0002-3633-7479				Bogaerts W., 2014, IEEE J SEL TOP QUANT, V20, P1; Goorden SA, 2014, OPTICA, V1, P421, DOI 10.1364/OPTICA.1.000421; Lalau-Keraly CM, 2013, OPT EXPRESS, V21, P21693, DOI 10.1364/OE.21.021693; Liu V, 2013, P IEEE, V101, P484, DOI 10.1109/JPROC.2012.2207649; Lu J, 2013, OPT EXPRESS, V21, P13351, DOI 10.1364/OE.21.013351; Miller DAB, 2013, J LIGHTWAVE TECHNOL, V31, P3987, DOI 10.1109/JLT.2013.2278809; Miller DAB, 2013, PHOTONICS RES, V1, P1, DOI 10.1364/PRJ.1.000001; Mosk AP, 2012, NAT PHOTONICS, V6, P283, DOI [10.1038/NPHOTON.2012.88, 10.1038/nphoton.2012.88]; Ryf R, 2012, J LIGHTWAVE TECHNOL, V30, P521, DOI 10.1109/JLT.2011.2174336; Shadbolt PJ, 2012, NAT PHOTONICS, V6, P45, DOI [10.1038/nphoton.2011.283, 10.1038/NPHOTON.2011.283]; Sun J, 2013, NATURE, V493, P195, DOI 10.1038/nature11727; Yu NF, 2014, NAT MATER, V13, P139, DOI [10.1038/nmat3839, 10.1038/NMAT3839]	12	21	22	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1423	1424		10.1126/science.aaa6801	http://dx.doi.org/10.1126/science.aaa6801			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814572				2022-12-28	WOS:000352136400025
J	Temel, Y; Jahanshahi, A				Temel, Yasin; Jahanshahi, Ali			Treating brain disorders with neuromodulation	SCIENCE			English	Editorial Material							STIMULATION; REVERSAL		[Temel, Yasin; Jahanshahi, Ali] Maastricht Univ, Med Ctr, Dept Neurosurg, NL-6202 AZ Maastricht, Netherlands	Maastricht University	Temel, Y (corresponding author), Maastricht Univ, Med Ctr, Dept Neurosurg, P Debyelaan 25, NL-6202 AZ Maastricht, Netherlands.	y.temel@maastrichtuniversity.nl						BENAZZOUZ A, 1993, EUR J NEUROSCI, V5, P382, DOI 10.1111/j.1460-9568.1993.tb00505.x; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Chen R, 2015, SCIENCE, V347, P1477, DOI 10.1126/science.1261821; Contarino MF, 2014, NEUROLOGY, V83, P1163, DOI 10.1212/WNL.0000000000000823; Hamani C., 2012, SCI TRANSL MED, V4; HEATH RG, 1977, J NERV MENT DIS, V165, P300; Ineichen C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00730; Katzel D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4847; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Morishita T, 2014, NEUROTHERAPEUTICS, V11, P475, DOI 10.1007/s13311-014-0282-1; Osmundsen A. J., 1965, NY TIMES, P20; Osmundsen A. J., 1965, NY TIMES, P1; POLLAK P, 1993, REV NEUROL, V149, P175; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; SPIEGEL EA, 1947, SCIENCE, V106, P349, DOI 10.1126/science.106.2754.349	16	23	23	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1418	1419		10.1126/science.aaa9610	http://dx.doi.org/10.1126/science.aaa9610			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814569				2022-12-28	WOS:000352136400022
J	Algara-Siller, G; Lehtinen, O; Wang, FC; Nair, RR; Kaiser, U; Wu, HA; Geim, AK; Grigorieva, IV				Algara-Siller, G.; Lehtinen, O.; Wang, F. C.; Nair, R. R.; Kaiser, U.; Wu, H. A.; Geim, A. K.; Grigorieva, I. V.			Square ice in graphene nanocapillaries	NATURE			English	Article							CARBON NANOTUBES; MOLECULAR-DYNAMICS; ELECTRON-MICROSCOPY; PHASE-TRANSITIONS; AQUEOUS-SOLUTIONS; RADIATION-DAMAGE; WATER-STRUCTURE; ORDERED WATER; GRAPHITE; INTERFACES	Bulk water exists in many forms, including liquid, vapour and numerous crystalline and amorphous phases of ice, with hexagonal ice being responsible for the fascinating variety of snowflakes(1,2). Much less noticeable but equally ubiquitous is water adsorbed at interfaces and confined in microscopic pores. Such low-dimensional water determines aspects of various phenomena in materials science, geology, biology, tribology and nanotechnology(3-8). Theory suggests many possible phases for adsorbed and confined water(9-17), but it has proved challenging to assess its crystal structure experimentally(17-23). Here we report high-resolution electron microscopy imaging of water locked between two graphene sheets, an archetypal example of hydrophobic confinement. The observations show that the nanoconfined water at room temperature forms 'square ice'-a phase having symmetry qualitatively different from the conventional tetrahedral geometry of hydrogen bonding between water molecules. Square ice has a high packing density with a lattice constant of 2.83 angstrom and can assemble in bilayer and trilayer crystallites. Molecular dynamics simulations indicate that square ice should be present inside hydrophobic nano-channels independently of their exact atomic nature.	[Algara-Siller, G.; Lehtinen, O.; Kaiser, U.] Univ Ulm, Grp Electron Microscopy Mat Sci, Cent Facil Electron Microscopy, D-89081 Ulm, Germany; [Wang, F. C.; Wu, H. A.] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Mech Behav & Design Mat, Dept Modern Mech, Hefei 230027, Anhui, Peoples R China; [Nair, R. R.; Geim, A. K.; Grigorieva, I. V.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England	Ulm University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Manchester	Grigorieva, IV (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England.	ute.kaiser@uni-ulm.de; wuha@ustc.edu.cn; irina.grigorieva@manchester.ac.uk	Wu, Hengan/A-3646-2009; Wang, Fengchao/G-1708-2012; Raveendran Nair, Rahul/G-5839-2010; Nair, Rahul Raveendran/Z-1566-2019; Geim, Andre K/J-7888-2012	Wu, Hengan/0000-0003-0288-1617; Wang, Fengchao/0000-0002-5954-3881; Geim, Andre K/0000-0003-2861-8331; Algara-Siller, Gerardo/0000-0002-1675-7273	DFG (Germany); European Research Council; EU Graphene Flagship; National Natural Science Foundation of China; Ministry of Science, Research and Arts of Baden-Wuerttemberg (Germany); Office of Naval Research; Air Force Office of Scientific Research; Anhui Provincial Natural Science Foundation (China); Finnish Cultural Foundation; Fundamental Research Funds for the Central Universities of China; Engineering and Physical Sciences Research Council [EP/G035954/1, EP/K005014/1] Funding Source: researchfish; EPSRC [EP/G035954/1, EP/K005014/1] Funding Source: UKRI	DFG (Germany)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); EU Graphene Flagship; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science, Research and Arts of Baden-Wuerttemberg (Germany); Office of Naval Research(Office of Naval Research); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Anhui Provincial Natural Science Foundation (China)(Natural Science Foundation of Anhui Province); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the DFG (Germany), the European Research Council, the EU Graphene Flagship, the National Natural Science Foundation of China, the Ministry of Science, Research and Arts of Baden-Wuerttemberg (Germany), the Office of Naval Research, the Air Force Office of Scientific Research, the Anhui Provincial Natural Science Foundation (China), the Finnish Cultural Foundation and the Fundamental Research Funds for the Central Universities of China. MD simulations were carried out at Supercomputing Center of the University of Science and Technology of China.	Abascal JLF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121687; ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; Algara-Siller G, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4871997; Algara-Siller G, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4830036; Appelo C. A. J, 2005, GEOCHEMISTRY GROUNDW; Bai JI, 2012, P NATL ACAD SCI USA, V109, P21240, DOI 10.1073/pnas.1213342110; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bjorkman T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.235502; Brown GE, 2001, SCIENCE, V294, P67, DOI 10.1126/science.1063544; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chaplin MF, 2010, ADSORPTION AND PHASE BEHAVIOUR IN NANOCHANNELS AND NANOTUBES, P241, DOI 10.1007/978-90-481-2481-7_11; DUBOCHET J, 1982, J MICROSC-OXFORD, V128, P219, DOI 10.1111/j.1365-2818.1982.tb04625.x; Egerton RF, 2004, MICRON, V35, P399, DOI 10.1016/j.micron.2004.02.003; Giovambattista N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.050603; Han SH, 2010, NAT PHYS, V6, P685, DOI 10.1038/NPHYS1708; He KT, 2012, NANO LETT, V12, P2665, DOI 10.1021/nl202613t; Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0; Kalra A, 2003, P NATL ACAD SCI USA, V100, P10175, DOI 10.1073/pnas.1633354100; Kimmel GA, 2009, J AM CHEM SOC, V131, P12838, DOI 10.1021/ja904708f; Kobayashi K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.206101; Koch C. T., 2002, THESIS ARIZ STATE; Koenig SP, 2011, NAT NANOTECHNOL, V6, P543, DOI [10.1038/nnano.2011.123, 10.1038/NNANO.2011.123]; Kolesnikov AI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035503; Longchamp Jean-Nicolas, 2013, Journal of Vacuum Science & Technology B (Microelectronics and Nanometer Structures), V31, DOI 10.1116/1.4793746; Malenkov G, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/28/283101; Maniwa Y, 2005, CHEM PHYS LETT, V401, P534, DOI 10.1016/j.cplett.2004.11.112; Matsumoto M, 2002, NATURE, V416, P409, DOI 10.1038/416409a; Meyer JC, 2008, NANO LETT, V8, P3582, DOI 10.1021/nl801386m; Meyer JC, 2008, NATURE, V454, P319, DOI 10.1038/nature07094; Meyer JC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196102; Molhave K, 2007, ULTRAMICROSCOPY, V108, P52, DOI 10.1016/j.ultramic.2007.03.001; Myneni S, 2002, J PHYS-CONDENS MAT, V14, pL213, DOI 10.1088/0953-8984/14/8/106; Nair RR, 2012, SCIENCE, V335, P442, DOI 10.1126/science.1211694; Naslund LA, 2005, J PHYS CHEM A, V109, P5995, DOI 10.1021/jp050413s; Natoli C. R., 1988, EXAFS NEAR EDGE STRU, V3, P573; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Srivastava R, 2011, J PHYS CHEM C, V115, P12448, DOI 10.1021/jp2003563; Takaiwa D, 2008, P NATL ACAD SCI USA, V105, P39, DOI 10.1073/pnas.0707917105; TSE JS, 1990, CHEM PHYS LETT, V174, P603, DOI 10.1016/0009-2614(90)85494-W; Verdaguer A, 2006, CHEM REV, V106, P1478, DOI 10.1021/cr040376l; Werder T, 2003, J PHYS CHEM B, V107, P1345, DOI 10.1021/jp0268112; Whitworth R. W., 2002, PHYS ICE; Xu K, 2010, SCIENCE, V329, P1188, DOI 10.1126/science.1192907; Yang DS, 2009, P NATL ACAD SCI USA, V106, P4122, DOI 10.1073/pnas.0812409106; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654; Yuzvinsky TD, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1857081; Zan R, 2013, ACS NANO, V7, P10167, DOI 10.1021/nn4044035; Zangi R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.025502; Zheng Y, 2013, ANGEW CHEM INT EDIT, V52, P8708, DOI 10.1002/anie.201302608	49	493	506	39	1063	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					443	+		10.1038/nature14295	http://dx.doi.org/10.1038/nature14295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25810206	Green Submitted			2022-12-28	WOS:000351602800050
J	Gautron, L; Elmquist, JK; Williams, KW				Gautron, Laurent; Elmquist, Joel K.; Williams, Kevin W.			Neural Control of Energy Balance: Translating Circuits to Therapies	CELL			English	Review							Y GASTRIC BYPASS; DIRECT-CURRENT STIMULATION; GLUCAGON-LIKE PEPTIDE-1; DEEP BRAIN-STIMULATION; CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE; REVERSES INSULIN-RESISTANCE; LATERAL HYPOTHALAMIC AREA; TYPE-2 DIABETES-MELLITUS; MELANOCORTIN 4 RECEPTORS; NEURONS REGULATE ENERGY	Recent insights into the neural circuits controlling energy balance and glucose homeostasis have rekindled the hope for development of novel treatments for obesity and diabetes. However, many therapies contribute relatively modest beneficial gains with accompanying side effects, and the mechanisms of action for other interventions remain undefined. This Review summarizes current knowledge linking the neural circuits regulating energy and glucose balance with current and potential pharmacotherapeutic and surgical interventions for the treatment of obesity and diabetes.	[Gautron, Laurent; Elmquist, Joel K.; Williams, Kevin W.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; [Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Williams, Kevin W.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gautron, L (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA.	laurent.gautron@utsouthwestern.edu; kevin.williams@utsouthwestern.edu	Williams, Kevin W/AAA-4243-2020; Williams, Kevin W/ABD-5818-2021; gautron, laurent/AAQ-5983-2021	Williams, Kevin W/0000-0002-8434-8658; Williams, Kevin W/0000-0002-8434-8658; 	NIH [R01 DK100699]; ANMS Research Grant;  [R01DK53301];  [R01DK088423];  [RL1DK081185]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088423, R37DK053301, R01DK100699, RL1DK081185, R01DK053301] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANMS Research Grant; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to K.W.W. (NIH R01 DK100699), L.G. (ANMS Research Grant 2014), and J.K.E. (R01DK53301, R01DK088423, and RL1DK081185).	Adams AC, 2012, CURR DIABETES REV, V8, P285, DOI 10.2174/157339912800840505; Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Allison DB, 2012, OBESITY, V20, P330, DOI 10.1038/oby.2011.330; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Asai M, 2013, SCIENCE, V341, P275, DOI 10.1126/science.1233000; Astrup A, 2004, OBES RES, V12, P1658, DOI 10.1038/oby.2004.206; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001; Berglund ED, 2014, NAT NEUROSCI, V17, P911, DOI 10.1038/nn.3737; Berglund ED, 2013, J CLIN INVEST, V123, P5061, DOI 10.1172/JCI70338; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Boggio PS, 2009, J CHILD NEUROL, V24, P642, DOI 10.1177/0883073808322339; Bookout AL, 2013, NAT MED, V19, P1147, DOI 10.1038/nm.3249; Borg CM, 2006, BRIT J SURG, V93, P210, DOI 10.1002/bjs.5227; Bray GA, 2014, BEST PRACT RES CL GA, V28, P665, DOI 10.1016/j.bpg.2014.07.015; Bray GA, 2009, CLIN CHEST MED, V30, P525, DOI 10.1016/j.ccm.2009.05.014; Browning KN, 2013, J PHYSIOL-LONDON, V591, P2357, DOI 10.1113/jphysiol.2012.249268; Bruce JM, 2012, SURG OBES RELAT DIS, V8, P602, DOI 10.1016/j.soard.2011.07.006; Buchwald H, 2014, OBES SURG, V24, P1954, DOI 10.1007/s11695-014-1307-x; Camilleri M, 2008, SURGERY, V143, P723, DOI 10.1016/j.surg.2008.03.015; Chambers AP, 2012, AM J PHYSIOL-ENDOC M, V303, pE1076, DOI 10.1152/ajpendo.00211.2012; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Clemmensen C, 2014, DIABETES, V63, P1422, DOI 10.2337/db13-1609; Cohen D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4838; Colquitt JL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub4; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Considine RV, 1996, CLIN CHEM, V42, P843; Cota D, 2006, BRAIN RES REV, V51, P85, DOI 10.1016/j.brainresrev.2005.10.004; Czupryn A, 2011, SCIENCE, V334, P1133, DOI 10.1126/science.1209870; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Dayan E, 2013, NAT NEUROSCI, V16, P838, DOI 10.1038/nn.3422; de Lartigue G, 2011, PHYSIOL BEHAV, V105, P100, DOI 10.1016/j.physbeh.2011.02.040; Deisseroth K, 2012, BIOL PSYCHIAT, V71, P1030, DOI 10.1016/j.biopsych.2011.12.021; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Drucker DJ, 2001, CURR PHARM DESIGN, V7, P1399, DOI 10.2174/1381612013397401; Fang S, 2015, NAT MED, V21, P159, DOI 10.1038/nm.3760; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Fehm HL, 2001, J CLIN ENDOCR METAB, V86, P1144, DOI 10.1210/jc.86.3.1144; Finan B, 2012, NAT MED, V18, P1847, DOI 10.1038/nm.3009; Fregni F, 2008, APPETITE, V51, P34, DOI 10.1016/j.appet.2007.09.016; Fujikawa T, 2013, CELL METAB, V18, P431, DOI 10.1016/j.cmet.2013.08.004; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Garber AJ, 1997, AM J MED, V103, P491, DOI 10.1016/S0002-9343(97)00254-4; Garvey WT, 2012, AM J CLIN NUTR, V95, P297, DOI 10.3945/ajcn.111.024927; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Greenway FL, 2009, J CLIN ENDOCR METAB, V94, P4898, DOI 10.1210/jc.2009-1350; Heisler LK, 2003, ANN NY ACAD SCI, V994, P169, DOI 10.1111/j.1749-6632.2003.tb03177.x; Herrmann K, 2014, ENDOCR PRACT, V20, P1070, DOI 10.4158/EP13477.OR; Horowitz M, 2012, DIABETES RES CLIN PR, V97, P258, DOI 10.1016/j.diabres.2012.02.016; Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33; Ikramuddin S, 2014, JAMA-J AM MED ASSOC, V312, P915, DOI 10.1001/jama.2014.10540; Jackson VM, 2014, EXPERT OPIN INV DRUG, V23, P1055, DOI 10.1517/13543784.2014.918952; Javor ED, 2005, DIABETES, V54, P1994, DOI 10.2337/diabetes.54.7.1994; Juhl CB, 2002, DIABETES, V51, P424, DOI 10.2337/diabetes.51.2.424; JULIUS D, 1988, COLD SPRING HARB SYM, V53, P385, DOI 10.1101/SQB.1988.053.01.046; Kentish S, 2012, J PHYSIOL-LONDON, V590, P209, DOI 10.1113/jphysiol.2011.222158; Kievit P, 2013, DIABETES, V62, P490, DOI 10.2337/db12-0598; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Laurenius A, 2012, INT J OBESITY, V36, P348, DOI 10.1038/ijo.2011.217; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; Soto-Montenegro ML, 2014, MOL IMAGING BIOL, V16, P830, DOI 10.1007/s11307-014-0753-0; Lutz TA, 2014, DIGEST SURG, V31, P13, DOI 10.1159/000354319; Madsbad S, 2004, DIABETES CARE, V27, P1335, DOI 10.2337/diacare.27.6.1335; Martin CK, 2011, J CLIN ENDOCR METAB, V96, P837, DOI 10.1210/jc.2010-1848; MCGUIRK J, 1991, BEHAV PHARMACOL, V2, P113; Montenegro RA, 2012, APPETITE, V58, P333, DOI 10.1016/j.appet.2011.11.008; Mul JD, 2013, AM J PHYSIOL-REG I, V305, pR68, DOI 10.1152/ajpregu.00588.2012; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; O'Neil PM, 2012, OBESITY, V20, P1426, DOI 10.1038/oby.2012.66; Obici S, 2003, ENDOCRINOLOGY, V144, P5172, DOI 10.1210/en.2003-0999; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Ostlund MP, 2013, JAMA SURG, V148, P374, DOI 10.1001/jamasurg.2013.700; Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012; Pardo JV, 2007, INT J OBESITY, V31, P1756, DOI 10.1038/sj.ijo.0803666; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Powley TL, 2005, PHYSIOL BEHAV, V86, P698, DOI 10.1016/j.physbeh.2005.08.059; Ravussin E, 2009, OBESITY, V17, P1736, DOI 10.1038/oby.2009.184; Rosenbaum M, 2008, J CLIN INVEST, V118, P2583, DOI 10.1172/JCI35055; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; Roth JD, 2008, INT J OBESITY, V32, P1201, DOI 10.1038/ijo.2008.91; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Ryan KK, 2014, NATURE, V509, P183, DOI 10.1038/nature13135; Sarr MG, 2012, OBES SURG, V22, P1771, DOI 10.1007/s11695-012-0751-8; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Scott MM, 2011, J CLIN INVEST, V121, P2413, DOI 10.1172/JCI43703; Sebag JA, 2013, SCIENCE, V341, P278, DOI 10.1126/science.1232995; Secher A, 2014, J CLIN INVEST, V124, P4473, DOI 10.1172/JCI75276; Seeley RJ, 2006, NAT MED, V12, P47, DOI 10.1038/nm0106-47; Shikora S, 2013, J OBES, V2013, DOI 10.1155/2013/245683; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Shin AC, 2013, OBES SURG, V23, P531, DOI 10.1007/s11695-012-0846-2; Sisley S, 2014, J CLIN INVEST, V124, P2456, DOI 10.1172/JCI72434; Skibicka KP, 2009, ENDOCRINOLOGY, V150, P1705, DOI 10.1210/en.2008-1316; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Sohn JW, 2013, CELL, V152, P612, DOI 10.1016/j.cell.2012.12.022; Steele KE, 2010, OBES SURG, V20, P369, DOI 10.1007/s11695-009-0015-4; Stefater MA, 2012, ENDOCR REV, V33, P595, DOI 10.1210/er.2011-1044; Stefater MA, 2010, GASTROENTEROLOGY, V138, P2426, DOI 10.1053/j.gastro.2010.02.059; Suzuki J, 2012, OBES SURG, V22, P201, DOI 10.1007/s11695-010-0346-1; Thirlby RC, 2006, J GASTROINTEST SURG, V10, P270, DOI 10.1016/j.gassur.2005.06.012; Thomsen WJ, 2008, J PHARMACOL EXP THER, V325, P577, DOI 10.1124/jpet.107.133348; Trevaskis JL, 2008, ENDOCRINOLOGY, V149, P5679, DOI 10.1210/en.2008-0770; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Truong DQ, 2013, NEUROIMAGE-CLIN, V2, P759, DOI 10.1016/j.nicl.2013.05.011; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Val-Laillet D, 2010, APPETITE, V55, P245, DOI 10.1016/j.appet.2010.06.008; Van der Ploeg LHT, 2006, PROG BRAIN RES, V153, P107, DOI 10.1016/S0079-6123(06)53005-5; Van der Ploeg LHT, 2002, P NATL ACAD SCI USA, V99, P11381, DOI 10.1073/pnas.172378699; Vetter ML, 2010, NAT REV ENDOCRINOL, V6, P578, DOI 10.1038/nrendo.2010.121; Wade JM, 2008, ENDOCRINOLOGY, V149, P955, DOI 10.1210/en.2007-0927; Wellhoner P, 2012, INT J OBESITY, V36, P703, DOI 10.1038/ijo.2011.105; Whiting DM, 2013, J NEUROSURG, V119, P56, DOI 10.3171/2013.2.JNS12903; Wichmann T, 2006, NEURON, V52, P197, DOI 10.1016/j.neuron.2006.09.022; Wikberg JES, 2008, NAT REV DRUG DISCOV, V7, P307, DOI 10.1038/nrd2331; Williams KW, 2014, CELL METAB, V20, P471, DOI 10.1016/j.cmet.2014.06.002; Wilson-Perez HE, 2013, INT J OBESITY, V37, P288, DOI 10.1038/ijo.2012.18; Wright FL, 2013, PSYCHOPHARMACOLOGY, V228, P291, DOI 10.1007/s00213-013-3036-6; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Xu Y, 2010, NAT NEUROSCI, V13, P1457, DOI 10.1038/nn.2664; Xu Y, 2010, J NEUROSCI, V30, P14630, DOI 10.1523/JNEUROSCI.5412-09.2010; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; Yamamoto H, 2002, J CLIN INVEST, V110, P43, DOI 10.1172/JCI200215595; Yulyaningsih E, 2011, BRIT J PHARMACOL, V163, P1170, DOI 10.1111/j.1476-5381.2011.01363.x; Zechner JF, 2013, GASTROENTEROLOGY, V144, P580, DOI 10.1053/j.gastro.2012.11.022; Zhan C, 2013, J NEUROSCI, V33, P3624, DOI 10.1523/JNEUROSCI.2742-12.2013; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zheng HY, 2008, PHYSIOLOGY, V23, P75, DOI 10.1152/physiol.00047.2007; Zheng HY, 2009, AM J PHYSIOL-REG I, V297, pR1273, DOI 10.1152/ajpregu.00343.2009	146	150	154	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					133	145		10.1016/j.cell.2015.02.023	http://dx.doi.org/10.1016/j.cell.2015.02.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815991	Bronze, Green Accepted			2022-12-28	WOS:000351952200014
J	Long, SP; Marshall-Colon, A; Zhu, XG				Long, Stephen P.; Marshall-Colon, Amy; Zhu, Xin-Guang			Meeting the Global Food Demand of the Future by Engineering Crop Photosynthesis and Yield Potential	CELL			English	Review							CO2 CONCENTRATING MECHANISMS; CARBON-DIOXIDE; VASCULAR PLANTS; ANTENNA SIZE; INCREASE; LIGHT; RUBISCO; ENERGY; PRODUCTIVITY; ARABIDOPSIS	Increase in demand for our primary foodstuffs is outstripping increase in yields, an expanding gap that indicates large potential food shortages by mid-century. This comes at a time when yield improvements are slowing or stagnating as the approaches of the Green Revolution reach their biological limits. Photosynthesis, which has been improved little in crops and falls far short of its biological limit, emerges as the key remaining route to increase the genetic yield potential of our major crops. Thus, there is a timely need to accelerate our understanding of the photosynthetic process in crops to allow informed and guided improvements via in-silico-assisted genetic engineering. Potential and emerging approaches to improving crop photosynthetic efficiency are discussed, and the new tools needed to realize these changes are presented.	[Long, Stephen P.; Marshall-Colon, Amy] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Long, Stephen P.; Marshall-Colon, Amy] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Long, Stephen P.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Zhu, Xin-Guang] CAS MPG Partner Inst Computat Biol, CAS Key Lab Computat Biol, Shanghai 200031, Peoples R China; [Zhu, Xin-Guang] State Key Lab Hybrid Rice, Changsha 410125, Hunan, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Long, SP (corresponding author), Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA.	slong@illinois.edu	Long, Stephen/AAA-1741-2019	Long, Stephen/0000-0002-8501-7164; Zhu, Xinguang/0000-0002-4435-130X; Marshall-Colon, Amy/0000-0001-6752-4982	Bill & Melinda Gates Foundation RIPE Project; US Department of Energy ARPA-E PETRO Program; Chinese Academy of Sciences; National Science Foundation [EF-1105584]; Direct For Biological Sciences [1105511] Funding Source: National Science Foundation	Bill & Melinda Gates Foundation RIPE Project; US Department of Energy ARPA-E PETRO Program(United States Department of Energy (DOE)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	S.P.L and X.-G.Z. acknowledge the support of the Bill & Melinda Gates Foundation RIPE Project, the US Department of Energy ARPA-E PETRO Program, and the Chinese Academy of Sciences. S.P.L. also acknowledges support from the National Science Foundation (grant number EF-1105584). We thank Ms. Haley Ahlers and Dr. Diwakar Shukla of the University of Illinois for help in the preparation of Figures 3 and 4, respectively.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Alexandratos N., 2012, WORLD AGR 2030 2050, DOI [10.22004/ag.econ.288998, DOI 10.22004/AG.ECON.288998]; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Bar-Even A, 2010, P NATL ACAD SCI USA, V107, P8889, DOI 10.1073/pnas.0907176107; Barampuram S, 2011, METHODS MOL BIOL, V701, P1, DOI 10.1007/978-1-61737-957-4_1; Beintema N., 2009, SETTING MEANINGFUL I; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Blankenship RE, 2013, CURR OPIN CHEM BIOL, V17, P457, DOI 10.1016/j.cbpa.2013.03.031; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; Carvalho JDC, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-111; Chew YH, 2014, P NATL ACAD SCI USA, V111, pE4127, DOI 10.1073/pnas.1410238111; Costa JH, 2014, MITOCHONDRION, V19, P172, DOI 10.1016/j.mito.2014.04.007; DeLucia EH, 2014, ENVIRON SCI TECHNOL, V48, P9471, DOI 10.1021/es502348e; Drewry DT, 2014, GLOBAL CHANGE BIOL, V20, P1955, DOI 10.1111/gcb.12567; Engel BD, 2015, ELIFE, V4, DOI 10.7554/eLife.04889; Farquhar G. D., 1982, Encyclopedia of plant physiology. New series. Volume 12B. Physiological plant ecology. II. Water relations and carbon assimilation. [Lange, O.L.; Nobel, P.S.; Osmond, C.B.; Ziegler, H. (Editors)], P549; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Farquhar GD, 2001, PLANT PHYSIOL, V125, P42, DOI 10.1104/pp.125.1.42; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Kebeish R, 2007, NAT BIOTECHNOL, V25, P593, DOI 10.1038/nbt1299; KIMBALL BA, 1983, AGRON J, V75, P779, DOI 10.2134/agronj1983.00021962007500050014x; Lee HS, 2014, PLANT BIOTECHNOL REP, V8, P443, DOI 10.1007/s11816-014-0337-0; Liu HJ, 2013, SCIENCE, V342, P1104, DOI 10.1126/science.1242321; Logan DC., 2007, PLANT MITOCHONDRIA, DOI [10.1002/9780470986592, DOI 10.1002/9780470986592]; Long S.P., 1993, PHOTOSYNTHESIS PHOTO, P547; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; LONG SP, 1993, PLANTA, V189, P226, DOI 10.1007/BF00195081; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; Long SP, 2014, PLANT CELL ENVIRON, V37, P19, DOI 10.1111/pce.12193; Long SP, 2013, ANNU REV PLANT BIOL, V64, P701, DOI 10.1146/annurev-arplant-050312-120033; Long SP, 2010, CURR OPIN PLANT BIOL, V13, P241, DOI 10.1016/j.pbi.2010.04.008; Maier A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00038; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Masuda T, 2003, PLANT MOL BIOL, V51, P757, DOI 10.1023/A:1022545118212; Mattozzi MD, 2013, METAB ENG, V16, P130, DOI 10.1016/j.ymben.2013.01.005; Maurino VG, 2010, CURR OPIN PLANT BIOL, V13, P249, DOI 10.1016/j.pbi.2010.01.006; Meyer M, 2013, J EXP BOT, V64, P769, DOI 10.1093/jxb/ers390; Mitchell MC, 2014, PLANT PHYSIOL, V166, P1073, DOI 10.1104/pp.114.246918; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Murchie EH, 2011, PLANT PHYSIOL, V155, P86, DOI 10.1104/pp.110.168831; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Ort DR, 2011, PLANT PHYSIOL, V155, P79, DOI 10.1104/pp.110.165886; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Peckmann K, 2012, J EXP BOT, V63, P2909, DOI 10.1093/jxb/err458; PIEDADE MTF, 1991, ECOLOGY, V72, P1456, DOI 10.2307/1941118; Price GD, 2011, PHOTOSYNTH RES, V109, P47, DOI 10.1007/s11120-010-9608-y; Ray D. K., 2013, PLOS ONE, V8; ROBSON MJ, 1982, ANN BOT-LONDON, V49, P331, DOI 10.1093/oxfordjournals.aob.a086257; Rosenthal DM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-123; Sage RF, 2012, ANNU REV PLANT BIOL, V63, P19, DOI 10.1146/annurev-arplant-042811-105511; Scharff LB, 2014, PLANT J, V78, P783, DOI 10.1111/tpj.12356; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Smil V., 2000, FEEDING WORLD CHALLE; Song QF, 2013, FUNCT PLANT BIOL, V40, P109, DOI 10.1071/FP12056; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Suelter T, 2014, IN VITRO CELL DEV-AN, V50, pS14; Sweetlove LJ, 2010, TRENDS PLANT SCI, V15, P462, DOI 10.1016/j.tplants.2010.05.006; Tcherkez G, 2013, PLANT CELL ENVIRON, V36, P1586, DOI 10.1111/pce.12066; Tholen D, 2012, PLANT SCI, V197, P92, DOI 10.1016/j.plantsci.2012.09.005; Tholen D, 2011, PLANT PHYSIOL, V156, P90, DOI 10.1104/pp.111.172346; USCB, 2015, WORLD POP 1950 2050; von Caemmerer S, 2003, PHOTOSYNTH RES, V77, P191, DOI 10.1023/A:1025830019591; von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177; Wang Y, 2014, PLANT PHYSIOL, V164, P2231, DOI 10.1104/pp.113.230284; Zhu XG, 2005, PLANTA, V223, P114, DOI 10.1007/s00425-005-0064-4; Zhu XG, 2004, J EXP BOT, V55, P1167, DOI 10.1093/jxb/erh141; Zhu XG, 2004, PLANT CELL ENVIRON, V27, P155, DOI 10.1046/j.1365-3040.2004.01142.x; Zhu XG, 2008, CURR OPIN BIOTECH, V19, P153, DOI 10.1016/j.copbio.2008.02.004; Zhu XG, 2007, PLANT PHYSIOL, V145, P513, DOI 10.1104/pp.107.103713; Zhu XG, 2013, PLANT CELL ENVIRON, V36, P1711, DOI 10.1111/pce.12025; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206; Zhu XG, 2009, ADV PHOTOSYNTH RESP, V29, P401; Zhu XG, 2011, SCI CHINA INFORM SCI, V54, P589, DOI 10.1007/s11432-011-4197-8	79	526	554	47	380	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					56	66		10.1016/j.cell.2015.03.019	http://dx.doi.org/10.1016/j.cell.2015.03.019			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815985	Bronze			2022-12-28	WOS:000351952200008
J	Gonsalves, G; Zuckerman, D				Gonsalves, Gregg; Zuckerman, Diana			Commentary: Will 20th century patient safeguards be reversed in the 21st century?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gonsalves, Gregg] Yale Univ, Law, New Haven, CT USA; [Zuckerman, Diana] Natl Ctr Hlth Res, Washington, DC 20230 USA	Yale University	Zuckerman, D (corresponding author), Natl Ctr Hlth Res, Washington, DC 20230 USA.	info@center4research.org		Gonsalves, Gregg/0000-0002-5789-9841				Darrow JJ, 2014, NEW ENGL J MED, V370, P1252, DOI 10.1056/NEJMhle1311493; Energy and Commerce Committee of the US House of Representatives, 2015, 21 CENT CUR DISC DRA; Epstein S, 1996, Med Soc (Berkeley), P1; Food and Drug Administration, 2013, APPL ORPH DRUG DES; Food and Drug Administration, 2014, FDA PROP NEW EXP ACC; Food and Drug Administration, 2011, AN PREM REV TIM 510; Food and Drug Administration, 2014, EXP ACC PREM APPR ME; Hilts P, 2003, PROTECTING AM HLTH F; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Moore TJ, 2014, JAMA INTERN MED, V174, P90, DOI 10.1001/jamainternmed.2013.11813; Perrone M, 2014, AIDS ACTIVIST TAKES; US Food and Drug Administration, 2014, GUID IND EXP PROGR S; US Government Accountability Office, 2009, MED DEV FDA SHOULD T; Washburn J, 2001, AM PROSPECT	14	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2015	350								h1500	10.1136/bmj.h1500	http://dx.doi.org/10.1136/bmj.h1500			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NV	25814537				2022-12-28	WOS:000352029500002
J	Cameron, R; Schussler, M				Cameron, Robert; Schuessler, Manfred			The crucial role of surface magnetic fields for the solar dynamo	SCIENCE			English	Article							CYCLE; ROTATION	Sunspots and the plethora of other phenomena occurring in the course of the 11-year cycle of solar activity are a consequence of the emergence of magnetic flux at the solar surface. The observed orientations of bipolar sunspot groups imply that they originate from toroidal (azimuthally orientated) magnetic flux in the convective envelope of the Sun. We show that the net toroidal magnetic flux generated by differential rotation within a hemisphere of the convection zone is determined by the emerged magnetic flux at the solar surface and thus can be calculated from the observed magnetic field distribution. The main source of the toroidal flux is the roughly dipolar surface magnetic field at the polar caps, which peaks around the minima of the activity cycle.	[Cameron, Robert; Schuessler, Manfred] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany	Max Planck Society	Cameron, R (corresponding author), Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany.	cameron@mps.mpg.de		Cameron, Robert/0000-0001-9474-8447				BABCOCK HW, 1961, ASTROPHYS J, V133, P572, DOI 10.1086/147060; Cameron RH, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201219914; Charbonneau P, 2010, LIVING REV SOL PHYS, V7, DOI 10.12942/lrsp-2010-3; Hale GS, 1919, ASTROPHYS J, V49, P153, DOI 10.1086/142452; Howe R, 2011, J PHYS CONF SER, V271, DOI 10.1088/1742-6596/271/1/012074; Jiang J, 2014, SPACE SCI REV, V186, P491, DOI 10.1007/s11214-014-0083-1; Jiang J, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201016168; Krause F., 1980, MEAN FIELD MAGNETOHY; LEIGHTON RB, 1969, ASTROPHYS J, V156, P1, DOI 10.1086/149943; Mackay DH, 2012, LIVING REV SOL PHYS, V9, DOI 10.12942/lrsp-2012-6; Munoz-Jaramillo A, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/2/L25; Petrovay K, 2010, LIVING REV SOL PHYS, V7, DOI 10.12942/lrsp-2010-6; SCHATTEN KH, 1978, GEOPHYS RES LETT, V5, P411, DOI 10.1029/GL005i005p00411; Schou J, 1998, ASTROPHYS J, V505, P390, DOI 10.1086/306146; SNODGRASS HB, 1983, ASTROPHYS J, V270, P288, DOI 10.1086/161121; Spruit HC, 2011, IAGA SPEC SOPRON, V4, P39, DOI 10.1007/978-90-481-9787-3_5; Stenflo JO, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/129; Wang YM, 2009, ASTROPHYS J LETT, V694, pL11, DOI 10.1088/0004-637X/694/1/L11; Wang YM, 2002, ASTROPHYS J, V577, pL53, DOI 10.1086/344196	19	87	91	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1333	1335		10.1126/science.1261470	http://dx.doi.org/10.1126/science.1261470			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792324	Green Submitted			2022-12-28	WOS:000351219600033
J	Rockey, DC; Bell, PD; Hill, JA				Rockey, Don C.; Bell, P. Darwin; Hill, Joseph A.			Fibrosis - A Common Pathway to Organ Injury and Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CARDIOVASCULAR MAGNETIC-RESONANCE; IDIOPATHIC PULMONARY-FIBROSIS; CONTROLLED CLINICAL-TRIAL; PLACEBO-CONTROLLED TRIAL; CHRONIC HEPATITIS-B; LIVER FIBROSIS; OPEN-LABEL; MESENCHYMAL TRANSITION; MOLECULAR-MECHANISMS; SKIN FIBROSIS		[Rockey, Don C.; Bell, P. Darwin] Med Univ S Carolina, Dept Internal Med, Charleston, SC 29425 USA; [Bell, P. Darwin] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rockey, DC (corresponding author), Med Univ S Carolina, Dept Internal Med, 96 Jonathan Lucas St,Suite 803,MSC 623, Charleston, SC 29425 USA.	rockey@musc.edu		Vaglio, Augusto/0000-0002-3814-9172				Antonopoulos AS, 2012, CURR PHARM DESIGN, V18, P1519; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Bianchi S, 2005, AM J KIDNEY DIS, V46, P45, DOI 10.1053/j.ajkd.2005.03.007; Bonventre JV, 2012, SEMIN NEPHROL, V32, P452, DOI 10.1016/j.semnephrol.2012.07.008; Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Cigna N, 2012, AM J PATHOL, V181, P2126, DOI 10.1016/j.ajpath.2012.08.019; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Dimas V, 2011, PACE, V34, P309, DOI 10.1111/j.1540-8159.2010.02888.x; Du XY, 2012, LAB INVEST, V92, P1149, DOI 10.1038/labinvest.2012.68; Dufour JF, 1997, ANN INTERN MED, V127, P981, DOI 10.7326/0003-4819-127-11-199712010-00006; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019; Gansner JM, 2012, NEW ENGL J MED, V366, P1551, DOI 10.1056/NEJMc1200999; Giannetta E, 2012, CIRCULATION, V125, P2323, DOI 10.1161/CIRCULATIONAHA.111.063412; Guney I, 2009, RENAL FAILURE, V31, P779, DOI 10.3109/08860220903150312; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Huang HJ, 2007, HEPATOLOGY, V46, P297, DOI 10.1002/hep.21695; Huang SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107055; Hung C, 2013, AM J RESP CRIT CARE, V188, P820, DOI 10.1164/rccm.201212-2297OC; Hunninghake GM, 2013, NEW ENGL J MED, V368, P2192, DOI 10.1056/NEJMoa1216076; Jinnin M, 2010, J DERMATOL, V37, P11, DOI 10.1111/j.1346-8138.2009.00738.x; Johnson A, 2013, FASEB J, V27, P3893, DOI 10.1096/fj.12-214189; Kaissling B, 2013, BBA-MOL BASIS DIS, V1832, P931, DOI 10.1016/j.bbadis.2013.02.010; Kay J, 2008, ARTHRITIS RHEUM, V58, P2543, DOI 10.1002/art.23696; KERSHENOBICH D, 1988, NEW ENGL J MED, V318, P1709, DOI 10.1056/NEJM198806303182602; Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002; Kida Y, 2011, CLIN EXP PHARMACOL P, V38, P417, DOI 10.1111/j.1440-1681.2011.05531.x; Kim MY, 2012, LIVER INT, V32, P977, DOI 10.1111/j.1478-3231.2012.02774.x; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kosmala W, 2011, JACC-CARDIOVASC IMAG, V4, P1239, DOI 10.1016/j.jcmg.2011.08.014; Kuhn A, 2010, RHEUMATOLOGY, V49, P1336, DOI 10.1093/rheumatology/keq077; Lakner AM, 2012, HEPATOLOGY, V56, P300, DOI 10.1002/hep.25613; Lambers Heerspink HJ, 2013, NAT REV NEPHROL, V9, P112, DOI 10.1038/nrneph.2012.281; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Levine D, 2000, AM J PATHOL, V156, P1927, DOI 10.1016/S0002-9440(10)65066-3; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2013, J HEPATOL, V59, P880, DOI 10.1016/j.jhep.2013.05.007; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Martin ML, 2012, J CARDIOVASC TRANSL, V5, P768, DOI 10.1007/s12265-012-9404-5; Martinez FJ, 2014, NEW ENGL J MED, V370, P2093, DOI 10.1056/NEJMoa1401739; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Massare J, 2010, J CARDIOVASC ELECTR, V21, P1031, DOI 10.1111/j.1540-8167.2010.01736.x; Maylin S, 2008, GASTROENTEROLOGY, V135, P821, DOI 10.1053/j.gastro.2008.05.044; McHutchison J, 2010, GASTROENTEROLOGY, V138, P1365, DOI 10.1053/j.gastro.2009.12.003; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Mezzano SA, 2001, HYPERTENSION, V38, P635, DOI 10.1161/hy09t1.094234; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; Moore-Morris T, 2014, J CLIN INVEST, V124, P2921, DOI 10.1172/JCI74783; Morgan TR, 2005, GASTROENTEROLOGY, V128, P882, DOI 10.1053/j.gastro.2005.01.057; Muir AJ, 2006, J VIRAL HEPATITIS, V13, P322, DOI 10.1111/j.1365-2893.2005.00689.x; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Pockros PJ, 2007, HEPATOLOGY, V45, P569, DOI 10.1002/hep.21561; Putta S, 2012, J AM SOC NEPHROL, V23, P458, DOI 10.1681/ASN.2011050485; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; Raghu G, 2013, EUR RESPIR J, V42, P1622, DOI 10.1183/09031936.00104612; Raghu G, 2013, ANN INTERN MED, V158, P641, DOI 10.7326/0003-4819-158-9-201305070-00003; Ramachandran P, 2012, J HEPATOL, V56, P1417, DOI 10.1016/j.jhep.2011.10.026; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; ROCKEY DC, 1993, J CLIN INVEST, V92, P1795, DOI 10.1172/JCI116769; Rockey DC, 2013, CLIN GASTROENTEROL H, V11, P224, DOI 10.1016/j.cgh.2013.01.005; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Roubille F, 2014, EXPERT REV CARDIOVAS, V12, P111, DOI 10.1586/14779072.2013.839942; Ruggenenti P, 2010, NAT REV NEPHROL, V6, P319, DOI 10.1038/nrneph.2010.58; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Sanyal AJ, 2008, GASTROENTEROLOGY, V134, P1715, DOI 10.1053/j.gastro.2008.03.007; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sharma K, 2011, J AM SOC NEPHROL, V22, P1144, DOI 10.1681/ASN.2010101049; Shechter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027969; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Spach MS, 1997, PACE, V20, P397, DOI 10.1111/j.1540-8159.1997.tb06199.x; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Swaminathan S, 2007, NEW ENGL J MED, V357, P720, DOI 10.1056/NEJMc070248; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; Tanaka K, 2007, CIRC RES, V101, P839, DOI 10.1161/CIRCRESAHA.107.153858; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; TORAFIC Investigators Group, 2011, CLIN THER, V33; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; van Rooij E, 2009, CIRC RES, V104, P138, DOI 10.1161/CIRCRESAHA.108.192492; Vespasiani-Gentilucci U, 2015, LIVER INT, V35, P569, DOI 10.1111/liv.12531; Wong TC, 2012, CIRCULATION, V126, P1206, DOI 10.1161/CIRCULATIONAHA.111.089409; Wu KC, 2008, J AM COLL CARDIOL, V51, P2414, DOI 10.1016/j.jacc.2008.03.018; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012; Zhou WB, 2012, NAT GENET, V44, P910, DOI 10.1038/ng.2347	102	686	740	18	197	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2015	372	12					1138	1149		10.1056/NEJMra1300575	http://dx.doi.org/10.1056/NEJMra1300575			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EZ	25785971				2022-12-28	WOS:000351183600008
J	Bateman, BT; Hernandez-Diaz, S; Fischer, MA; Seely, EW; Ecker, JL; Franklin, JM; Desai, RJ; Allen-Coleman, C; Mogun, H; Avorn, J; Huybrechts, KF				Bateman, Brian T.; Hernandez-Diaz, Sonia; Fischer, Michael A.; Seely, Ellen W.; Ecker, Jeffrey L.; Franklin, Jessica M.; Desai, Rishi J.; Allen-Coleman, Cora; Mogun, Helen; Avorn, Jerry; Huybrechts, Krista F.			Statins and congenital malformations: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MATERNAL EXPOSURE; RISK; PREGNANCY; OUTCOMES; SURVEILLANCE; SIMVASTATIN; PRAVASTATIN; ANOMALIES; SYSTEM; WOMEN	OBJECTIVE To examine the teratogenic potential of statins. DESIGN Cohort study. SETTING United States. PARTICIPANTS A cohort of 886 996 completed pregnancies linked to liveborn infants of women enrolled in Medicaid from 2000 to 2007. METHODS We examined the risk of major congenital malformations and organ specific malformations in offspring associated with maternal use of a statin in the first trimester. Propensity score based methods were used to control for potential confounders, including maternal demographic characteristics, obstetric and medical conditions, and use of other drugs. RESULTS 1152 (0.13%) women used a statin during the first trimester. In unadjusted analyses, the prevalence of malformations in the offspring of these women was 6.34% compared with 3.55% in those of women who did not use a statin in the first trimester (relative risk 1.79, 95% confidence interval 1.43 to 2.23). Controlling for confounders, particularly pre-existing diabetes, accounted for this increase in risk (1.07, 0.85 to 1.37). There were also no statistically significant increases in any of the organ specific malformations assessed after accounting for confounders. Results were similar across a range of sensitivity analyses. CONCLUSIONS Our analysis did not find a significant teratogenic effect from maternal use of statins in the first trimester. However, these findings need to be replicated in other large studies, and the long term effects of in utero exposure to statins needs to be assessed, before use of statins in pregnancy can be considered safe.	[Bateman, Brian T.; Fischer, Michael A.; Franklin, Jessica M.; Desai, Rishi J.; Allen-Coleman, Cora; Mogun, Helen; Avorn, Jerry; Huybrechts, Krista F.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Bateman, Brian T.; Fischer, Michael A.; Franklin, Jessica M.; Desai, Rishi J.; Allen-Coleman, Cora; Mogun, Helen; Avorn, Jerry; Huybrechts, Krista F.] Harvard Univ, Sch Med, Boston, MA USA; [Bateman, Brian T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Obstet Anesthesia,Dept Anesthesia Crit Care &, Boston, MA USA; [Hernandez-Diaz, Sonia] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Seely, Ellen W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Metab,Dept Med, Boston, MA 02115 USA; [Ecker, Jeffrey L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Obstet & Gynecol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Bateman, BT (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.	bbateman@partners.org	Desai, Rishi/AAH-8988-2021		Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH (Bethesda, MD) [K08HD075831]; National Heart Lung and Blood Institute of the NIH [K24HL096141]; National Institute of Mental Health of the NIH [K01MH099141]; Agency for Healthcare Research and Quality (AHRQ) [R01HS018533]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018533] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD075831] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083806, K24HL096141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099141] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH (Bethesda, MD); National Heart Lung and Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Mental Health of the NIH; Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH (Bethesda, MD) under award No K08HD075831 (BTB), the National Heart Lung and Blood Institute of the NIH under award No K24HL096141 (EWS), and the National Institute of Mental Health of the NIH under award No K01MH099141 (KFH). Medicaid Analytic eXtract pregnancy cohort creation was supported by the Agency for Healthcare Research and Quality (AHRQ) (grant R01HS018533). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrade SE, 2008, PHARMACOEPIDEM DR S, V17, P240, DOI 10.1002/pds.1550; Briggs GG., 2017, DRUGS PREGNANCY LACT; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; Costantine MM, 2013, OBSTET GYNECOL, V121, P349, DOI 10.1097/AOG.0b013e31827d8ad5; Edison RJ, 2005, NEW ENGL J MED, V352, P2759, DOI 10.1056/NEJM200506303522622; Edison RJ, 2004, AM J MED GENET A, V131A, P287, DOI 10.1002/ajmg.a.30386; Edison RJ, 2004, NEW ENGL J MED, V350, P1579, DOI 10.1056/NEJM200404083501524; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Garcia G, 2014, MAT CHILD HLTH MCH U; Godfrey LM, 2012, ANN PHARMACOTHER, V46, P1419, DOI 10.1345/aph.1R202; Greenland S, 1996, INT J EPIDEMIOL, V25, P1107, DOI 10.1093/ije/25.6.1107-a; Hayes DK, 2011, PREV CHRONIC DIS, V8; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; KHOURY MJ, 1989, AM J EPIDEMIOL, V130, P361, DOI 10.1093/oxfordjournals.aje.a115342; Manson JM, 1996, REPROD TOXICOL, V10, P439, DOI 10.1016/S0890-6238(96)00130-X; Margulis AV, 2013, PHARMACOEPIDEM DR S, V22, P16, DOI 10.1002/pds.3284; Ofori B, 2007, BRIT J CLIN PHARMACO, V64, P496, DOI 10.1111/j.1365-2125.2007.02905.x; Palmsten K, 2014, PHARMACOEPIDEM DR S, V23, P646, DOI 10.1002/pds.3627; Palmsten K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067405; Patel C, 2006, J FAM PRACTICE, V55, P75; Petersen EE, 2008, AM J MED GENET A, V146A, P2701, DOI 10.1002/ajmg.a.32493; Pollack PS, 2005, BIRTH DEFECTS RES A, V73, P888, DOI 10.1002/bdra.20181; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taguchi N, 2008, REPROD TOXICOL, V26, P175, DOI 10.1016/j.reprotox.2008.06.009; Vaughan CJ, 2004, CIRCULATION, V110, P886, DOI 10.1161/01.CIR.0000139312.10076.BA; Winterfeld U, 2013, BJOG-INT J OBSTET GY, V120, P463, DOI 10.1111/1471-0528.12066; Zarek J, 2013, PLACENTA, V34, P719, DOI 10.1016/j.placenta.2013.05.002; Zarek J, 2014, J OBSTET GYNAECOL CA, V36, P506, DOI 10.1016/S1701-2163(15)30565-X	31	135	144	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2015	350								h1035	10.1136/bmj.h1035	http://dx.doi.org/10.1136/bmj.h1035			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KO	25784688	hybrid, Green Published			2022-12-28	WOS:000351570700001
J	Metzger, BPH; Yuan, DC; Gruber, JD; Duveau, F; Wittkopp, PJ				Metzger, Brian P. H.; Yuan, David C.; Gruber, Jonathan D.; Duveau, Fabien; Wittkopp, Patricia J.			Selection on noise constrains variation in a eukaryotic promoter	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; BIOCONDUCTOR PACKAGE; REGULATORY ELEMENTS; SEQUENCE; CIS; MUTATION; DISSECTION; EVOLUTION; ENHANCERS	Genetic variation segregating within a species reflects the combined activities of mutation, selection, and genetic drift. In the absence of selection, polymorphisms are expected to be a randomsubset of new mutations; thus, comparing the effects of polymorphisms and new mutations provides a test for selection(1-4). When evidence of selection exists, such comparisons can identify properties of mutations that are most likely to persist in natural populations(2). Here we investigate how mutation and selection have shaped variation in a cis-regulatory sequence controlling gene expression by empirically determining the effects of polymorphisms segregating in the TDH3 promoter among 85 strains of Saccharomyces cerevisiae and comparing their effects to a distribution of mutational effects defined by 236 point mutations in the same promoter. Surprisingly, we find that selection on expression noise (that is, variability in expression among genetically identical cells(5)) appears to have had a greater impact on sequence variation in the TDH3 promoter than selection on mean expression level. This is not necessarily because variation in expression noise impacts fitness more than variation in mean expression level, but rather because of differences in the distributions of mutational effects for these two phenotypes. This study shows how systematically examining the effects of new mutations can enrich our understanding of evolutionary mechanisms. It also provides rare empirical evidence of selection acting on expression noise.	[Metzger, Brian P. H.; Gruber, Jonathan D.; Duveau, Fabien; Wittkopp, Patricia J.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Yuan, David C.; Wittkopp, Patricia J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wittkopp, PJ (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	wittkopp@umich.edu	Metzger, Brian P H/AAX-9217-2021; Metzger, Brian/ABE-2059-2020; Duveau, Fabien/AAC-5596-2019	Metzger, Brian P H/0000-0003-4878-2913; Duveau, Fabien/0000-0003-4784-0640	March of Dimes [5-FY07-181]; Alfred P. Sloan Research Foundation; National Science Foundation [MCB-1021398]; National Institutes of Health [1R01 GM108826]; University of Michigan; University of Michigan Rackham Graduate School, Ecology and Evolutionary Biology Department; National Institutes of Health Genome Sciences training grant [T32 HG000040]; National Institutes of Health Genetics training grant [T32 GM007544]; National Institutes of Health National Research Service Award (NRSA) postdoctoral fellowship [1 F32 GM083513-0]; European Molecular Biology Organization postdoctoral fellowship [EMBO ALTF 1114-2012]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083513, R01GM108826, T32GM007544] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); Alfred P. Sloan Research Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); University of Michigan Rackham Graduate School, Ecology and Evolutionary Biology Department; National Institutes of Health Genome Sciences training grant; National Institutes of Health Genetics training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Research Service Award (NRSA) postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization postdoctoral fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Maclean, J. Zhang, and C. Hittinger for strains, the University of Michigan Center for Chemical Genomics for technical assistance with flow cytometry, and J. Coolon, R. Lusk, K. Stevenson, A. Hodgins-Davis, J. Lachowiec, C. Maclean, J. Yang, C. Landry, J. Townsend, and D. Petrov for comments on the manuscript. Funding for this work was provided to P.J.W. by the March of Dimes (5-FY07-181), Alfred P. Sloan Research Foundation, National Science Foundation (MCB-1021398), National Institutes of Health (1R01 GM108826) and the University of Michigan. Additional support was provided by the University of Michigan Rackham Graduate School, Ecology and Evolutionary Biology Department, and the National Institutes of Health Genome Sciences training grant (T32 HG000040) to B.P.H.M.; by a National Institutes of Health Genetics training grant (T32 GM007544) to D.C.Y.; by a National Institutes of Health National Research Service Award (NRSA) postdoctoral fellowship (1 F32 GM083513-0) to J.D.G.; and by a European Molecular Biology Organization postdoctoral fellowship (EMBO ALTF 1114-2012) to F.D.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Batada NN, 2007, NAT GENET, V39, P945, DOI 10.1038/ng2071; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; De Vries H., 1905, SPECIES VARIETIES TH, P825; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; FONTANA W, 1994, B MATH BIOL, V56, P1; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gruber JD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002497; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Hittinger CT, 2013, TRENDS GENET, V29, P309, DOI 10.1016/j.tig.2013.01.002; Hornung G, 2012, GENOME RES, V22, P2409, DOI 10.1101/gr.139378.112; HUIE MA, 1992, MOL CELL BIOL, V12, P2690, DOI 10.1128/MCB.12.6.2690; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kwasnieski JC, 2012, P NATL ACAD SCI USA, V109, P19498, DOI 10.1073/pnas.1210678109; Lehner B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.11; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; Liti G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-69; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lo K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-145; Loytynoja A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-579; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; MCALISTER L, 1985, J BIOL CHEM, V260, P5019; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; R Development Core Team, 2009, R LANG ENV STAT COMP; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rice DP, 2012, GENETICS, V190, P1533, DOI 10.1534/genetics.111.137075; Ringel AE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003871; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Smith JD, 2013, MOL BIOL EVOL, V30, P2509, DOI 10.1093/molbev/mst134; Stoltzfus A, 2009, J HERED, V100, P637, DOI 10.1093/jhered/esp048; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang QM, 2012, MOL ECOL, V21, P5404, DOI 10.1111/j.1365-294X.2012.05732.x; Wang Z, 2011, P NATL ACAD SCI USA, V108, pE67, DOI 10.1073/pnas.1100059108; Wittkopp PJ, 2011, METHODS MOL BIOL, V772, P297, DOI 10.1007/978-1-61779-228-1_18; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; YAGI S, 1994, J VET MED SCI, V56, P235, DOI 10.1292/jvms.56.235; Zhang ZH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.58	46	89	90	1	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					344	+		10.1038/nature14244	http://dx.doi.org/10.1038/nature14244			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25778704	Green Accepted			2022-12-28	WOS:000354816500054
J	Kato, HE; Inoue, K; Abe-Yoshizumi, R; Kato, Y; Ono, H; Konno, M; Hososhima, S; Ishizuka, T; Hoque, MR; Kunitomo, H; Ito, J; Yoshizawa, S; Yamashita, K; Takemoto, M; Nishizawa, T; Taniguchi, R; Kogure, K; Maturana, AD; Iino, Y; Yawo, H; Ishitani, R; Kandori, H; Nureki, O				Kato, Hideaki E.; Inoue, Keiichi; Abe-Yoshizumi, Rei; Kato, Yoshitaka; Ono, Hikaru; Konno, Masae; Hososhima, Shoko; Ishizuka, Toru; Hoque, Mohammad Razuanul; Kunitomo, Hirofumi; Ito, Jumpei; Yoshizawa, Susumu; Yamashita, Keitaro; Takemoto, Mizuki; Nishizawa, Tomohiro; Taniguchi, Reiya; Kogure, Kazuhiro; Maturana, Andres D.; Iino, Yuichi; Yawo, Hiromu; Ishitani, Ryuichiro; Kandori, Hideki; Nureki, Osamu			Structural basis for Na+ transport mechanism by a light-driven Na+ pump	NATURE			English	Article							CHLORIDE PUMP; PROTON PUMP; C-ELEGANS; CHANNELRHODOPSIN; RHODOPSIN; BACTERIORHODOPSIN; XANTHORHODOPSIN; HALORHODOPSIN; ACTIVATION; MEMBRANE	Krokinobacter eikastus rhodopsin 2 (KR2) is the first light-driven Na+ pump discovered, and is viewed as a potential next-generation optogenetics tool. Since the positively charged Schiff base proton, located within the ion-conducting pathway of all light-driven ion pumps, was thought to prohibit the transport of a non-proton cation, the discovery of KR2 raised the question of how it achieves Na+ transport. Here we present crystal structures of KR2 under neutral and acidic conditions, which represent the resting and M-like intermediate states, respectively. Structural and spectroscopic analyses revealed the gating mechanism, whereby the flipping of Asp116 sequesters the Schiff base proton from the conducting pathway to facilitate Na+ transport. Together with the structure-based engineering of the first light-driven K1 pumps, electrophysiological assays in mammalian neurons and behavioural assays in a nematode, our studies reveal the molecular basis for light-driven non-proton cation pumps and thus provide a framework that may advance the development of next-generation optogenetics.	[Kato, Hideaki E.; Kunitomo, Hirofumi; Takemoto, Mizuki; Nishizawa, Tomohiro; Taniguchi, Reiya; Iino, Yuichi; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Inoue, Keiichi; Abe-Yoshizumi, Rei; Kato, Yoshitaka; Ono, Hikaru; Konno, Masae; Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Inoue, Keiichi; Kandori, Hideki] Nagoya Inst Technol, OptoBioTechnol Res Ctr, Showa Ku, Nagoya, Aichi 4668555, Japan; [Inoue, Keiichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Hososhima, Shoko; Ishizuka, Toru; Hoque, Mohammad Razuanul; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808577, Japan; [Hososhima, Shoko; Ishizuka, Toru; Hoque, Mohammad Razuanul; Iino, Yuichi; Yawo, Hiromu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Ito, Jumpei] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yoshizawa, Susumu; Kogure, Kazuhiro] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Yamashita, Keitaro] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan	University of Tokyo; Nagoya Institute of Technology; Nagoya Institute of Technology; Japan Science & Technology Agency (JST); Tohoku University; Japan Science & Technology Agency (JST); Nagoya University; University of Tokyo; RIKEN	Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	kandori@nitech.ac.jp; nureki@bs.s.u-tokyo.ac.jp	Inoue, Keiichi/AEO-3337-2022; Yawo, Hiromu/I-4871-2015; NUREKI, OSAMU/G-4960-2014; Konno, Masae/C-1066-2009; Kato, Hideaki/AAQ-4323-2020; KUNITOMO, HIROFUMI/G-4963-2014; Ishizuka, Toru/L-8191-2017	Inoue, Keiichi/0000-0002-6898-4347; Yawo, Hiromu/0000-0002-4299-3288; Konno, Masae/0000-0002-0605-1816; Kato, Hideaki/0000-0002-1941-5535; KUNITOMO, HIROFUMI/0000-0001-7312-7051; Ishizuka, Toru/0000-0003-4405-8792; Ito, Jumpei/0000-0001-5149-9962; Takemoto, Mizuki/0000-0002-6339-6431; Yamashita, Keitaro/0000-0002-5442-7582; yoshizawa, susumu/0000-0001-9667-6010	Platform for Drug Discovery, Informatics and Structural Life Science, of the Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI [11J06643, 24115508, 24655009, 25104009, 24681003, 24227004, 25291011]; FIRST program, PRESTO, CREST, JST; Grants-in-Aid for Scientific Research [25115010, 15K15025, 25620011, 14J40214, 15H01413] Funding Source: KAKEN	Platform for Drug Discovery, Informatics and Structural Life Science, of the Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); FIRST program, PRESTO, CREST, JST; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Hattori and H. Nishimasu for useful discussions and critical comments on the manuscript; A. Kurabayashi, N. Sahara, and J. Sasaki for technical assistance; and S. Doki, K. Hirata and the beam-line staff members at BL32XU of SPring-8 for assistance in data collection. The synchrotron radiation experiments were performed at BL32XU of SPring-8, with approval from RIKEN. This work was supported by the Platform for Drug Discovery, Informatics and Structural Life Science, of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), by JSPS KAKENHI (grant nos. 11J06643, 24115508, 24655009, 25104009, 24681003, 24227004, and 25291011), by the FIRST program, PRESTO, CREST, JST, and by a Grant-in-Aid for JSPS Fellows.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aston-Jones G, 2013, BRAIN RES, V1511, P1, DOI 10.1016/j.brainres.2013.01.026; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; BRENNER S, 1974, GENETICS, V77, P71; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Essen LO, 2002, CURR OPIN STRUC BIOL, V12, P516, DOI 10.1016/S0959-440X(02)00356-1; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Grote M, 2011, FEMS MICROBIOL REV, V35, P1082, DOI 10.1111/j.1574-6976.2011.00281.x; Gushchin I, 2011, J MOL BIOL, V412, P591, DOI 10.1016/j.jmb.2011.07.022; Hirata K, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/1/012002; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kandori H, 2004, BBA-BIOENERGETICS, V1658, P72, DOI 10.1016/j.bbabio.2004.03.015; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kouyama T, 2010, PHOTOCH PHOTOBIO SCI, V9, P1458, DOI 10.1039/c0pp00236d; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Li TB, 2014, J BIOL CHEM, V289, P15441, DOI 10.1074/jbc.M114.550012; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Matsui Y, 2002, J MOL BIOL, V324, P469, DOI 10.1016/S0022-2836(02)01110-5; Matsuki M, 2006, P NATL ACAD SCI USA, V103, P1112, DOI 10.1073/pnas.0506954103; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Okumura H, 2005, J MOL BIOL, V351, P481, DOI 10.1016/j.jmb.2005.06.026; Ono H, 2014, J PHYS CHEM B, V118, P4784, DOI 10.1021/jp500756f; Ran TT, 2013, ACTA CRYSTALLOGR D, V69, P1965, DOI 10.1107/S0907444913017575; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Shinkai Y, 2011, J NEUROSCI, V31, P3007, DOI 10.1523/JNEUROSCI.4691-10.2011; Spudich JL, 2014, BBA-BIOENERGETICS, V1837, P546, DOI 10.1016/j.bbabio.2013.06.006; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Yoshida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1750; Yoshizawa S, 2014, P NATL ACAD SCI USA, V111, P6732, DOI 10.1073/pnas.1403051111; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	48	153	157	3	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					48	U347		10.1038/nature14322	http://dx.doi.org/10.1038/nature14322			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25849775				2022-12-28	WOS:000354040900029
J	Sotgiu, G; Migliori, GB				Sotgiu, Giovanni; Migliori, Giovanni Battista			New effective antituberculosis regimens	LANCET			English	Editorial Material							MULTIDRUG-RESISTANT TUBERCULOSIS; OUTCOMES; DRUGS		[Sotgiu, Giovanni] Univ Sassari, Dept Biomed Sci, Clin Epidemiol & Med Stat Unit, I-07100 Sassari, Italy; [Migliori, Giovanni Battista] Fdn S Maugeri, Care & Res Inst, WHO Collaborating Ctr TB & Lung Dis, I-21049 Tradate, Italy	University of Sassari; Istituti Clinici Scientifici Maugeri IRCCS; World Health Organization	Migliori, GB (corresponding author), Fdn S Maugeri, Care & Res Inst, WHO Collaborating Ctr TB & Lung Dis, I-21049 Tradate, Italy.	giovannibattista.migliori@fsm.it	Sotgiu, Giovanni/N-1032-2017; Migliori, Giovanni Battista/AAB-8589-2020	Sotgiu, Giovanni/0000-0002-1600-4474; Migliori, Giovanni Battista/0000-0002-2597-574X				Dawson R, 2015, LANCET; Diacon AH, 2014, NEW ENGL J MED, V371, P723, DOI 10.1056/NEJMoa1313865; Diel R, 2012, EUR RESPIR J, V40, P143, DOI 10.1183/09031936.00204611; Falzon D, 2013, EUR RESPIR J, V42, P156, DOI 10.1183/09031936.00134712; Migliori GB, 2014, LANCET, V383, P2026, DOI 10.1016/S0140-6736(14)60032-5; Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312; Raviglione M, 2014, LANCET GLOB HEALTH, V2, pE71, DOI 10.1016/S2214-109X(13)70166-9; Skripconoka V, 2013, EUR RESPIR J, V41, P1393, DOI 10.1183/09031936.00125812; Sotgiu G, 2014, LANCET INFECT DIS, V14, P364, DOI 10.1016/S1473-3099(14)70030-1; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; Weyer K, 2013, EUR RESPIR J, V42, P252, DOI 10.1183/09031936.00157212; WHO, 2014, GLOB TUB REP 2014; Zumla AI, 2014, LANCET INFECT DIS, V14, P267, DOI 10.1016/S1473-3099(14)70028-3	13	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1703	1704		10.1016/S0140-6736(14)62303-5	http://dx.doi.org/10.1016/S0140-6736(14)62303-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH0PZ	25795077				2022-12-28	WOS:000353726000006
J	Ragunathan, K; Jih, G; Moazed, D				Ragunathan, Kaushik; Jih, Gloria; Moazed, Danesh			Epigenetic inheritance uncoupled from sequence-specific recruitment	SCIENCE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; LYSINE-9 METHYLATION; CHROMODOMAIN PROTEIN; CHROMATIN-STRUCTURE; BYPASSES RNAI; HISTONE CODE; HETEROCHROMATIN; MAINTENANCE; COMPLEX	Changes in histone posttranslational modifications are associated with epigenetic states that define distinct patterns of gene expression. It remains unclear whether epigenetic information can be transmitted through histone modifications independently of specific DNA sequence, DNA methylation, or RNA interference. Here we show that, in the fission yeast Schizosaccharomyces pombe, ectopically induced domains of histone H3 lysine 9 methylation (H3K9me), a conserved marker of heterochromatin, are inherited through several mitotic and meiotic cell divisions after removal of the sequence-specific initiator. The putative JmjC domain H3K9 demethylase, Epe1, and the chromodomain of the H3K9 methyltransferase, Clr4/Suv39h, play opposing roles in maintaining silent H3K9me domains. These results demonstrate how a direct "read-write" mechanism involving Clr4 propagates histone modifications and allows histones to act as carriers of epigenetic information.	[Ragunathan, Kaushik; Jih, Gloria; Moazed, Danesh] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Moazed, D (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	danesh@hms.harvard.edu			Leukemia and Lymphoma Society [CDP-5025-14]; NIH [GM072805, T32 GM007226]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007226, R01GM072805] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Shetty for help with tetrad dissections; D. Shea for help in data processing; DNA 2.0 (Menlo Park, CA) for synthesis of the plasmid containing tetO binding sites; D. Landgraf for the gift of a yeast codon-optimized GFP plasmid; T. Hattori and S. Koide for the gift of a H3K9me3 recombinant antibody; and members of the Moazed lab for helpful discussions and comments-particularly E. Egan, N. Iglesias, and J. Xiol for providing valuable experimental help and advice and R. Behrouzi for advice and help with FACS analysis. The raw and processed ChIP-seq data are publicly available at the National Center for Biotechnology Information Gene Expression Omnibus under accession number GSE63304. This work was supported by a postdoctoral fellowship from the Leukemia and Lymphoma Society (CDP-5025-14 to K.R.) and a grant from the NIH (GM072805 to D.M.). G.J. was supported partly by an NIH training grant (T32 GM007226). D.M. is an investigator of the Howard Hughes Medical Institute.	ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Baba A, 2011, NAT CELL BIOL, V13, P668, DOI 10.1038/ncb2228; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Buhler M, 2009, EMBO J, V28, P2149, DOI 10.1038/emboj.2009.185; Busturia A, 1997, DEVELOPMENT, V124, P4343; Cheng TH, 2000, GENE DEV, V14, P452; CHIEN CT, 1993, CELL, V75, P531, DOI 10.1016/0092-8674(93)90387-6; Egan ED, 2014, RNA, V20, P867, DOI 10.1261/rna.044479.114; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gomez EB, 2005, MOL CELL BIOL, V25, P8887, DOI 10.1128/MCB.25.20.8887-8903.2005; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hattori T, 2013, NAT METHODS, V10, P992, DOI 10.1038/nmeth.2605; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Holmes SG, 1996, GENE DEV, V10, P1021, DOI 10.1101/gad.10.8.1021; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; JACKSON V, 1974, BIOCHEMISTRY-US, V13, P3952, DOI 10.1021/bi00716a021; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kagansky A, 2009, SCIENCE, V324, P1716, DOI 10.1126/science.1172026; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lyons DB, 2013, CELL, V154, P325, DOI 10.1016/j.cell.2013.06.039; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Radman-Livaja M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001075; Rando OJ, 2012, CURR OPIN GENET DEV, V22, P148, DOI 10.1016/j.gde.2012.02.013; Reddy BD, 2011, GENE DEV, V25, P214, DOI 10.1101/gad.1993611; Reyes-Turcu FE, 2011, NAT STRUCT MOL BIOL, V18, P1132, DOI 10.1038/nsmb.2122; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Sengupta AK, 2004, DEVELOPMENT, V131, P1959, DOI 10.1242/dev.01084; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tadeo X, 2013, GENE DEV, V27, P2489, DOI 10.1101/gad.226118.113; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wheeler BS, 2012, GENETICS, V190, P549, DOI 10.1534/genetics.111.137083; Yu R, 2014, MOL CELL, V53, P262, DOI 10.1016/j.molcel.2013.11.014; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhong XH, 2014, CELL, V157, P1050, DOI 10.1016/j.cell.2014.03.056	57	177	177	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230							1258699	10.1126/science.1258699	http://dx.doi.org/10.1126/science.1258699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25831549	Green Accepted			2022-12-28	WOS:000352079500031
J	Bieging, KT; Attardi, LD				Bieging, Kathryn T.; Attardi, Laura D.			A piece of the p53 puzzle	NATURE			English	Editorial Material							TUMOR SUPPRESSION; CELL-DEATH; FERROPTOSIS; ABSENCE; CANCER		[Bieging, Kathryn T.; Attardi, Laura D.] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Attardi, Laura D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Bieging, KT (corresponding author), Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA.	attardi@stanford.edu						Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Valente LJ, 2013, CELL REP, V3, P1339, DOI 10.1016/j.celrep.2013.04.012; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010	11	14	14	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					37	38		10.1038/nature14374	http://dx.doi.org/10.1038/nature14374			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25799989				2022-12-28	WOS:000352027700028
J	Knepper, MA; Kwon, TH; Nielsen, S				Knepper, Mark A.; Kwon, Tae-Hwan; Nielsen, Soren			Molecular Physiology of Water Balance	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RENAL COLLECTING DUCT; THICK ASCENDING LIMB; VASOPRESSIN-INDUCED ANTIDIURESIS; URINARY CONCENTRATING MECHANISM; RAT-KIDNEY; AQUAPORIN-2 TRAFFICKING; DIABETES-INSIPIDUS; HENLES LOOP; TRANSCRIPTIONAL REGULATION; PHOSPHORYLATION SITES	THE HYPOTHALAMIC-NEUROHYPOPHYSEAL-RENAL AXIS NORMALLY MAINtains water balance during variations in water intake and nonrenal losses of water. Failure of this mechanism is common in hospitalized patients, and it results in a variety of water-balance disorders. In this article, we begin by reviewing the classic, integrative principles of water balance in mammals and then use this classic model as a framework to discuss the genes and gene products (proteins) involved in water balance. In so doing, our goal is to provide clinicians with a mechanistic basis for decisions regarding the diagnosis and treatment of water-balance disorders. The regulation of water balance is governed by a high-gain feedback mechanism involving the hypothalamus, the neurohypophysis, and the kidneys (Fig. 1). Osmoreceptors in the hypothalamus, which originally were described by Verney,(1) sense plasma osmolality. The molecular mechanism of "osmosensing" has recently been described by Danziger and Zeidel.(2) It is, in part, dependent on activation of nonselective calcium-permeable cation channels in osmosensing neurons that can serve as stretch receptors. When plasma osmolality increases to levels above a physiologic threshold (290 to 295 mOsm per kilogram of water in most persons), there is increased secretion of the peptide hormone vasopressin from vasopressinergic nerve endings in the neurohypophysis. High osmolality also triggers thirst. Vasopressin binds to receptors in the kidney that decrease excretion of water (Fig. 2), and a greater fraction of filtered water is returned to the blood. The rate of water excretion can vary over a broad range in response to changes in plasma vasopressin levels without substantial changes in net solute excretion (osmolar clearance). This independent control of water and solute excretion is the result of specialized urinary concentrating and diluting mechanisms; these mechanisms are reviewed elsewhere.(3) Increased renal reabsorption of water in response to vasopressin lowers plasma osmolality, thereby reducing the stimulus for vasopressin secretion and thirst and completing the feedback loop (Fig. 1). Table 1 provides a list of the major proteins that are responsible for components of the integrative model shown in Figure 1. These proteins are the focus of this review.	[Knepper, Mark A.] NHLBI, Epithelial Syst Biol Lab, NIH, Bethesda, MD 20892 USA; [Kwon, Tae-Hwan] Kyungpook Natl Univ, Dept Biochem & Cell Biol, Sch Med, Taegu 702701, South Korea; [Nielsen, Soren] Aalborg Univ, Inst Med & Hlth Technol, Aalborg, Denmark	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Kyungpook National University; Aalborg University	Knepper, MA (corresponding author), NIH, 10 Ctr Dr,Bldg 10,Rm 6N307, Bethesda, MD 20892 USA.	knep@helix.nih.gov	Knepper, Mark/AAF-8412-2020; Kwon, Tae-Hwan/ABA-1981-2020	Morelle, Johann/0000-0002-6925-1989; Knepper, Mark/0000-0002-2276-8091	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006128, ZIAHL001285, ZIAHL006129] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HL999999, Z01 HL001285-22] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		AGRE P, 1993, AM J PHYSIOL, V265, pF463; Bansal AD, 2010, J AM SOC NEPHROL, V21, P303, DOI 10.1681/ASN.2009070728; Blount MA, 2008, AM J PHYSIOL-RENAL, V295, pF295, DOI 10.1152/ajprenal.00102.2008; Brewster UC, 2005, OBSTET GYNECOL, V105, P1173, DOI 10.1097/01.AOG.0000161811.02155.68; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; CHOU CL, 1995, AM J PHYSIOL-RENAL, V269, pF70, DOI 10.1152/ajprenal.1995.269.1.F70; Chou CL, 1998, AM J PHYSIOL-CELL PH, V274, pC549, DOI 10.1152/ajpcell.1998.274.2.C549; Christensen BM, 2010, J AM SOC NEPHROL, V21, P1942, DOI 10.1681/ASN.2009101077; Danziger J., 2014, CLIN J AM SOC NEPHRO; DIGIOVANNI SR, 1994, P NATL ACAD SCI USA, V91, P8984, DOI 10.1073/pnas.91.19.8984; Ecelbarger CA, 1998, AM J PHYSIOL-RENAL, V274, pF1161, DOI 10.1152/ajprenal.1998.274.6.F1161; Ecelbarger CA, 1997, J CLIN INVEST, V99, P1852, DOI 10.1172/JCI119352; Ecelbarger CA, 2000, AM J PHYSIOL-RENAL, V279, pF46, DOI 10.1152/ajprenal.2000.279.1.F46; ECELBARGER CA, 1995, AM J PHYSIOL-RENAL, V269, pF663, DOI 10.1152/ajprenal.1995.269.5.F663; Fenske WK, 2014, J AM SOC NEPHROL, V25, P2376, DOI 10.1681/ASN.2013080895; Fenton RA, 2005, J AM SOC NEPHROL, V16, P1583, DOI 10.1681/ASN.2005010031; Fenton RA, 2004, P NATL ACAD SCI USA, V101, P7469, DOI 10.1073/pnas.0401704101; Fenton RA, 2007, PHYSIOL REV, V87, P1083, DOI 10.1152/physrev.00053.2006; Fujita N, 1995, AM J PHYSIOL-RENAL, V269, pF926, DOI 10.1152/ajprenal.1995.269.6.F926; Fujiwara TM, 2005, J AM SOC NEPHROL, V16, P2836, DOI 10.1681/ASN.2005040371; Furgeson SB, 2010, J AM SOC NEPHROL, V21, P1842, DOI 10.1681/ASN.2010050457; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; GOTTSCHALK CW, 1959, AM J PHYSIOL, V196, P927, DOI 10.1152/ajplegacy.1959.196.4.927; GREGER R, 1983, PFLUG ARCH EUR J PHY, V396, P308, DOI 10.1007/BF01063936; HALL DA, 1980, J CLIN INVEST, V66, P792, DOI 10.1172/JCI109917; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Jovanovich AJ, 2013, KIDNEY INT, V83, P563, DOI 10.1038/ki.2012.402; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Katsura T, 1997, Am J Physiol, V272, pF817; Kim GH, 1998, P NATL ACAD SCI USA, V95, P14552, DOI 10.1073/pnas.95.24.14552; Kim GH, 1999, AM J PHYSIOL-RENAL, V276, pF96, DOI 10.1152/ajprenal.1999.276.1.F96; King LS, 2001, NEW ENGL J MED, V345, P175, DOI 10.1056/NEJM200107193450304; KOKKO JP, 1972, KIDNEY INT, V2, P214, DOI 10.1038/ki.1972.97; Leviel F, 2010, J CLIN INVEST, V120, P1627, DOI 10.1172/JCI40145; Lu HJ, 2008, AM J PHYSIOL-RENAL, V295, pF290, DOI 10.1152/ajprenal.00072.2008; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Moeller HB, 2009, KIDNEY INT, V75, P295, DOI 10.1038/ki.2008.505; Morris RG, 2006, AM J PHYSIOL-RENAL, V290, pF1416, DOI 10.1152/ajprenal.00421.2005; Mutig K, 2010, AM J PHYSIOL-RENAL, V298, pF502, DOI 10.1152/ajprenal.00476.2009; NAKANISHI K, 1995, AM J PHYSIOL-REG I, V269, pR193, DOI 10.1152/ajpregu.1995.269.1.R193; Nedvetsky PI, 2010, J AM SOC NEPHROL, V21, P1645, DOI 10.1681/ASN.2009111190; Nicco C, 2001, HYPERTENSION, V38, P1143, DOI 10.1161/hy1001.092641; NIELSEN S, 1993, AM J PHYSIOL, V265, pF204, DOI 10.1152/ajprenal.1993.265.2.F204; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; NIELSEN S, 1993, J CELL BIOL, V120, P371, DOI 10.1083/jcb.120.2.371; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Nishimoto G, 1999, AM J PHYSIOL-RENAL, V276, pF254, DOI 10.1152/ajprenal.1999.276.2.F254; Noda Y, 2008, J CELL BIOL, V182, P587, DOI 10.1083/jcb.200709177; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; OSTROWSKI NL, 1993, ENDOCRINOLOGY, V133, P1849, DOI 10.1210/en.133.4.1849; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; REIF MC, 1986, J CLIN INVEST, V77, P1291, DOI 10.1172/JCI112433; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Roudier N, 2002, J BIOL CHEM, V277, P45854, DOI 10.1074/jbc.M208999200; Sandoval PC, 2013, J AM SOC NEPHROL, V24, P1793, DOI 10.1681/ASN.2013030279; SASAKI S, 1980, PFLUG ARCH EUR J PHY, V383, P215, DOI 10.1007/BF00587521; Schnermann J, 2008, KIDNEY INT, V74, P418, DOI 10.1038/ki.2008.145; Schrier RW, 2008, SEMIN NEPHROL, V28, P289, DOI 10.1016/j.semnephrol.2008.03.009; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Thompson C, 2012, BEST PRACT RES CL EN, V26, pS1, DOI 10.1016/S1521-690X(12)00019-X; TOMITA K, 1986, J CLIN INVEST, V77, P136, DOI 10.1172/JCI112268; TOMITA K, 1985, J CLIN INVEST, V76, P132, DOI 10.1172/JCI111935; Valenti G, 2005, ENDOCRINOLOGY, V146, P5063, DOI 10.1210/en.2005-0868; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; VERNEY EB, 1947, PROC R SOC SER B-BIO, V135, P25, DOI 10.1098/rspb.1947.0037; Weingarten-Gabbay S, 2014, HUM GENET, V133, P701, DOI 10.1007/s00439-013-1413-1; Wilson JLL, 2013, CLIN EXP NEPHROL, V17, P751, DOI 10.1007/s10157-013-0789-5; WINDLE RJ, 1993, J ENDOCRINOL, V137, P311, DOI 10.1677/joe.0.1370311; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106	75	133	145	2	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14					1349	1358		10.1056/NEJMra1404726	http://dx.doi.org/10.1056/NEJMra1404726			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NL	25830425	Green Accepted			2022-12-28	WOS:000352028500010
J	Raymond, EG; Cleland, K				Raymond, Elizabeth G.; Cleland, Kelly			Emergency Contraception	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEXUALLY-TRANSMITTED INFECTION; PERICOITAL ORAL-CONTRACEPTION; INTRAUTERINE-DEVICE; ULIPRISTAL ACETATE; UNINTENDED PREGNANCY; INCREASED ACCESS; LEVONORGESTREL; WOMEN; PILLS; RISK	A 19-year-old woman calls your office for advice. She does not want to have a baby for several years but has trouble remembering to refill her prescription for birth-control pills and often misses pills. She finished her last pack of birth-control pills 2 weeks ago, and last night she and her boyfriend had sex without using any contraception. What can you recommend to reduce her risk of pregnancy?	[Raymond, Elizabeth G.] Gynu Hlth Projects, New York, NY 10010 USA; [Cleland, Kelly] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA	Princeton University	Raymond, EG (corresponding author), Gynu Hlth Projects, 15 E 26th St,Suite 801, New York, NY 10010 USA.	eraymond@gynuity.org		Cleland, Kelly/0000-0001-9966-1260				American Society for Emergency Contraception, 2013, COST EM CONTR RES NA; Cheng L, 2012, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD001324.PUB4.; Chin-Quee DS, 2010, CONTRACEPTION, V81, P133, DOI 10.1016/j.contraception.2009.08.015; Cleland K, 2012, HUM REPROD, V27, P1994, DOI 10.1093/humrep/des140; Cleland K, 2010, OBSTET GYNECOL, V115, P1263, DOI [10.1097/AOG.0b013e3181dd22ef, 10.1097/AOG.0b013e3181deff2a]; Creinin MD, 2006, OBSTET GYNECOL, V108, P1089, DOI 10.1097/01.AOG.0000239440.02284.45; Dada OA, 2010, CONTRACEPTION, V82, P373, DOI 10.1016/j.contraception.2010.06.004; De Santis M, 2005, FERTIL STERIL, V84, P296, DOI 10.1016/j.fertnstert.2005.01.136; Dermish AI, 2013, CONTRACEPTION, V87, P182, DOI 10.1016/j.contraception.2012.06.015; Ekstrand M, 2008, ACTA OBSTET GYN SCAN, V87, P354, DOI 10.1080/00016340801936024; European Medicines Agency, 2014, LEV UL REM SUIT EM; European Medicines Agency, 2014, REV EM CONTR START; Faculty of Sexual and Reproductive Healthcare, 2011, CLIN GUID EM CONTR; Finer LB, 2014, AM J PUBLIC HEALTH, V104, pS43, DOI 10.2105/AJPH.2013.301416; Gemzell-Danielsson K, 2014, GYNECOL ENDOCRINOL, V30, P685, DOI 10.3109/09513590.2014.950648; Glasier A, 2011, CONTRACEPTION, V84, P363, DOI 10.1016/j.contraception.2011.02.009; Glasier AF, 2010, LANCET, V375, P555, DOI 10.1016/S0140-6736(10)60101-8; Gold Melanie A, 2004, J Pediatr Adolesc Gynecol, V17, P87, DOI 10.1016/j.jpag.2003.11.018; Grimes D, 1998, LANCET, V352, P428; Healthy Canadians, 2014, EM CONTR PILLS CARR; HO PC, 1993, HUM REPROD, V8, P389, DOI 10.1093/oxfordjournals.humrep.a138057; International Consortium, 2012, EM CONTR PILLS MED S; Kapp N, 2015, CONTRACEPTION, V91, P97, DOI 10.1016/j.contraception.2014.11.001; Levy DP, 2014, CONTRACEPTION, V89, P431, DOI 10.1016/j.contraception.2014.01.003; Luchowski AT, 2014, CONTRACEPTION, V89, P572, DOI 10.1016/j.contraception.2014.02.008; Michie L, 2014, CONTRACEPTION, V90, P447, DOI 10.1016/j.contraception.2014.05.004; Mohllajee AP, 2006, CONTRACEPTION, V73, P145, DOI 10.1016/j.contraception.2005.08.007; Murphy PA, 2012, J MIDWIFERY WOM HEAL, V57, P622, DOI 10.1111/j.1542-2011.2012.00228.x; Piaggio G, 2011, CONTRACEPTION, V84, P35, DOI 10.1016/j.contraception.2010.11.010; Polis CB, 2010, ADV PROVISION EMERGE; Raine TR, 2005, JAMA-J AM MED ASSOC, V293, P54, DOI 10.1001/jama.293.1.54; Raymond EG, 2008, CONTRACEPTION, V77, P333, DOI 10.1016/j.contraception.2008.02.001; Raymond EG, 2007, OBSTET GYNECOL, V109, P181, DOI 10.1097/01.AOG.0000250904.06923.4a; Raymond EG, 2006, OBSTET GYNECOL, V108, P1098, DOI 10.1097/01.AOG.0000235708.91572.db; Raymond EG, 2014, CONTRACEPTION, V90, P105, DOI 10.1016/j.contraception.2014.04.008; Raymond EG, 2011, OBSTET GYNECOL, V117, P673, DOI 10.1097/AOG.0b013e318209dc25; Rowe PJ, 1997, CONTRACEPTION, V56, P341; Schwarz EB, 2009, OBSTET GYNECOL, V113, P833, DOI 10.1097/AOG.0b013e31819c856c; Sivin I, 2007, CONTRACEPTION, V75, pS70, DOI 10.1016/j.contraception.2007.01.016; Sonfield A, 2014, MOVING FORWARD FAMIL; Taylor DJ, 2014, CONTRACEPTION, V89, P215, DOI 10.1016/j.contraception.2013.11.013; Trussell J, 2008, CONTRACEPTION, V77, P1, DOI 10.1016/j.contraception.2007.09.001; Trussell J, 2015, CONTRACEPTION, V91, P49, DOI 10.1016/j.contraception.2014.08.011; Turok DK, 2013, HUM REPROD, V28, P2672, DOI 10.1093/humrep/det330; Turok DK, 2011, CONTRACEPTION, V83, P441, DOI 10.1016/j.contraception.2010.08.011; von Hertzen H, 2002, LANCET, V360, P1803, DOI 10.1016/S0140-6736(02)11767-3; WHO, 2015, MED EL CRIT CONTR US, V5th; Wu S, 2010, BJOG-INT J OBSTET GY, V117, P1205, DOI 10.1111/j.1471-0528.2010.02652.x; Zhang L, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.117226; Zhang L, 2009, HUM REPROD, V24, P1605, DOI 10.1093/humrep/dep076	50	14	15	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14					1342	1348		10.1056/NEJMcp1406328	http://dx.doi.org/10.1056/NEJMcp1406328			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NL	25830424				2022-12-28	WOS:000352028500009
J	Cohen, D				Cohen, Deborah			BANNER Why have UK doctors been deterred from prescribing Avastin?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dcohen@bmj.com						Hawkes N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6867; Lock D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1377; Martin DF, 2010, NEW ENGL J MED, V363, P105, DOI 10.1056/NEJMp1001201; Moja L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011230.pub2	4	25	25	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2015	350								h1654	10.1136/bmj.h1654	http://dx.doi.org/10.1136/bmj.h1654			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3HO	25834024				2022-12-28	WOS:000352439300008
J	Kuhn, M				Kuhn, Michaela			CARDIOLOGY A big-hearted molecule	NATURE			English	Editorial Material							CARDIOMYOCYTE-RESTRICTED INACTIVATION; PRESERVED EJECTION FRACTION; GUANYLYL CYCLASE-A; PHOSPHODIESTERASE-5 INHIBITION; CARDIAC-HYPERTROPHY; FAILURE; PRESSURE; MICE		Univ Wurzburg, Inst Physiol, D-97070 Wurzburg, Germany	University of Wurzburg	Kuhn, M (corresponding author), Univ Wurzburg, Inst Physiol, D-97070 Wurzburg, Germany.	michaela.kuhn@mail.uni-wuerzburg.de						Ampadu J, 2015, INT J CARDIOL, V178, P12, DOI 10.1016/j.ijcard.2014.10.087; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Frantz S, 2013, EUR HEART J, V34, P1233, DOI 10.1093/eurheartj/ehr445; Guazzi M, 2011, CIRCULATION, V124, P164, DOI 10.1161/CIRCULATIONAHA.110.983866; Holtwick R, 2003, J CLIN INVEST, V111, P1399, DOI 10.1172/JCI200317061; Kuhn M, 2003, CIRC RES, V93, P700, DOI 10.1161/01.RES.0000094745.28948.4D; Lee DI, 2015, NATURE, V519, P472, DOI 10.1038/nature14332; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Zakeri R, 2011, CAN J PHYSIOL PHARM, V89, P593, DOI [10.1139/Y11-048, 10.1139/y11-048]	12	11	12	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					416	417		10.1038/nature14373	http://dx.doi.org/10.1038/nature14373			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25799985				2022-12-28	WOS:000351602800039
J	Cohen, DM; Ellison, DH				Cohen, David M.; Ellison, David H.			Evaluating Hyponatremia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cohen, David M.; Ellison, David H.] Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Dept Med, Portland, OR 97239 USA; [Cohen, David M.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Cohen, David M.; Ellison, David H.] Portland VA Med Ctr, Portland, OR USA; [Ellison, David H.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University	Ellison, DH (corresponding author), Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, CH12R,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	ellisond@ohsu.edu	, David/X-5730-2019	Ellison, David/0000-0003-2915-265X	NIDDK NIH HHS [R01 DK084004] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084004] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON RJ, 1985, ANN INTERN MED, V102, P164, DOI 10.7326/0003-4819-102-2-164; EDELMAN IS, 1958, J CLIN INVEST, V37, P1236, DOI 10.1172/JCI103712; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; Furst H, 2000, AM J MED SCI, V319, P240, DOI 10.1097/00000441-200004000-00007; Kerns E, 2014, CLIN NEPHROL, V82, P397, DOI 10.5414/CN108014	5	4	5	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1260	1261		10.1001/jama.2014.13967	http://dx.doi.org/10.1001/jama.2014.13967			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25803349	Green Accepted			2022-12-28	WOS:000351435500027
J	Oka, T				Oka, Takeshi			Taming CH5+, the "enfant terrible" of chemical structures	SCIENCE			English	Editorial Material							INFRARED-SPECTRUM; STORY		[Oka, Takeshi] Univ Chicago, Enrico Fermi Inst, Dept Chem, Chicago, IL 60637 USA; [Oka, Takeshi] Univ Chicago, Enrico Fermi Inst, Dept Astron & Astrophys, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Oka, T (corresponding author), Univ Chicago, Enrico Fermi Inst, Dept Chem, 5640 S Ellis Ave, Chicago, IL 60637 USA.	t-oka@uchicago.edu		OKA, TAKESHI/0000-0002-9434-8977	Division Of Astronomical Sciences [1109014] Funding Source: National Science Foundation	Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Asvany O, 2015, SCIENCE, V347, P1346, DOI 10.1126/science.aaa3304; Bunker PR, 2004, J MOL STRUCT, V695, P253, DOI 10.1016/j.molstruc.2003.12.020; GUDEMAN CS, 1983, PHYS REV LETT, V50, P727, DOI 10.1103/PhysRevLett.50.727; Jin Z, 2006, J PHYS CHEM A, V110, P1569, DOI 10.1021/jp053848o; Muller H, 1997, J CHEM PHYS, V106, P1863, DOI 10.1063/1.473340; OKA T, 1980, PHYS REV LETT, V45, P531, DOI 10.1103/PhysRevLett.45.531; Oka T, 2013, J PHYS CHEM A, V117, P9308, DOI 10.1021/jp4035826; OLAH GA, 1995, ANGEW CHEM INT EDIT, V34, P1393, DOI 10.1002/anie.199513931; Schlemmer S, 1999, INT J MASS SPECTROM, V185, P589, DOI 10.1016/S1387-3806(98)14141-6; SCHREINER PR, 1993, J CHEM PHYS, V99, P3716, DOI 10.1063/1.466147; Wang XG, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3027825; White ET, 1999, SCIENCE, V284, P135, DOI 10.1126/science.284.5411.135	12	25	25	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1313	1314		10.1126/science.aaa6935	http://dx.doi.org/10.1126/science.aaa6935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6SM	25792316				2022-12-28	WOS:000351219600020
J	Debije, M				Debije, Michael			RENEWABLE ENERGY Better luminescent solar panels in prospect	NATURE			English	Editorial Material							CONCENTRATORS; NANOCRYSTALS		Eindhoven Univ Technol, Dept Chem Engn & Chem, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology	Debije, M (corresponding author), Eindhoven Univ Technol, Dept Chem Engn & Chem, NL-5600 MB Eindhoven, Netherlands.	m.g.debije@tue.nl						Bradshaw LR, 2015, NANO LETT, V15, P1315, DOI 10.1021/nl504510t; Debije MG, 2012, ADV ENERGY MATER, V2, P12, DOI 10.1002/aenm.201100554; Debije MG, 2010, APPL OPTICS, V49, P745, DOI 10.1364/AO.49.000745; Meinardi F, 2014, NAT PHOTONICS, V8, P392, DOI 10.1038/nphoton.2014.54; WEBER WH, 1976, APPL OPTICS, V15, P2299, DOI 10.1364/AO.15.002299	5	41	42	4	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					298	299		10.1038/519298a	http://dx.doi.org/10.1038/519298a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25788093				2022-12-28	WOS:000351171900028
J	Elmore, JG; Longton, GM; Carney, PA; Geller, BM; Onega, T; Tosteson, ANA; Nelson, HD; Pepe, MS; Allison, KH; Schnitt, SJ; O'Malley, FP; Weaver, DL				Elmore, Joann G.; Longton, Gary M.; Carney, Patricia A.; Geller, Berta M.; Onega, Tracy; Tosteson, Anna N. A.; Nelson, Heidi D.; Pepe, Margaret S.; Allison, Kimberly H.; Schnitt, Stuart J.; O'Malley, Frances P.; Weaver, Donald L.			Diagnostic Concordance Among Pathologists interpreting Breast Biopsy Specimens	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MAMMOGRAPHIC DENSITY; CANCER; AGREEMENT; RISK; WOMEN; VARIABILITY; DISEASE; LESIONS; MANAGEMENT; OUTCOMES	IMPORTANCE A breast pathology diagnosis provides the basis for clinical treatment and management decisions; however, its accuracy is inadequately understood. 0BJECTIVES To quantify the magnitude of diagnostic disagreement among pathologists compared with a consensus panel reference diagnosis and to evaluate associated patient and pathologist characteristics. PARTICIPANTS Study of pathologists who interpret breast biopsies in clinical practices in 8 US states. EXPOSURES Participants independently interpreted slides between November 2011 and May 2014 from test sets of 60 breast biopsies (240 total cases, 1 slide per case), including 23 cases of invasive breast cancer, 73 ductal carcinoma in situ (DCIS), 72 with atypical hyperplasia (atypia), and 72 benign cases without atypia. Participants were blinded to the interpretations of other study pathologists and consensus panel members. Among the 3 consensus panel members, unanimous agreement of their independent diagnoses was 75%, and concordance with the consensus-derived reference diagnoses was 90.3%. MAIN OUTCOMES AND MEASURES The proportions of diagnoses overinterpreted and underinterpreted relative to the consensus-derived reference diagnoses were assessed. RESULTS Sixty-five percent of invited, responding pathologists were eligible and consented to participate. Of these, 91% (N = 115) completed the study, providing 6900 individual case diagnoses. Compared with the consensus-derived reference diagnosis, the overall concordance rate of diagnostic interpretations of participating pathologists was 75.3% (95% Cl, 73.4%-77.0%; 5194 of 6900 interpretations). [GRAPHICS] Disagreement with the reference diagnosis was statistically significantly higher among biopsies from women with higher (n = 122) vs lower (n = 118) breast density on prior mammograms (overall concordance rate, 73% [95% Cl, 71%-75%] for higher vs 77% [95% Cl, 75%-80%] for lower, P < .001), and among pathologists who interpreted lower weekly case volumes (P < .001) or worked in smaller practices (P = .034) or nonacademic settings (P = .007). CONCLUSIONS AND RELEVANCE In this study of pathologists, in which diagnostic interpretation was based on a single breast biopsy slide, overall agreement between the individual pathologists' interpretations and the expert consensus-derived reference diagnoses was 75.3%, with the highest level of concordance for invasive carcinoma and lower levels of concordance for DCIS and atypia. Further research is needed to understand the relationship of these findings with patient management.	[Elmore, Joann G.] Univ Washington, Dept Med, Sch Med, Seattle, WA 98104 USA; [Longton, Gary M.; Pepe, Margaret S.] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Seattle, WA 98104 USA; [Carney, Patricia A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Geller, Berta M.] Univ Vermont, Family Med, Vineyard Haven, MA USA; [Onega, Tracy; Tosteson, Anna N. A.] Norris Cotton Canc Ctr, Dept Community & Family Med, Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med Dartmouth, Lebanon, NH USA; [Tosteson, Anna N. A.] Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH USA; [Nelson, Heidi D.] Providence Hlth & Serv Oregon, Providence Canc Ctr, Portland, OR USA; [Nelson, Heidi D.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Nelson, Heidi D.] Oregon Hlth & Sci Univ, Dept Clin Epidemiol & Med, Portland, OR 97201 USA; [Allison, Kimberly H.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Schnitt, Stuart J.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Schnitt, Stuart J.] Harvard Univ, Sch Med, Boston, MA USA; [O'Malley, Frances P.] Li Ka Shing Knowledge Inst, Dept Lab Med, Toronto, ON, Canada; [O'Malley, Frances P.] Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [O'Malley, Frances P.] St Michaels Hosp, Toronto, ON, Canada; [O'Malley, Frances P.] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Weaver, Donald L.] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Weaver, Donald L.] Univ Vermont, Ctr Canc, Burlington, VT 05405 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Oregon Health & Science University; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Oregon Health & Science University; Oregon Health & Science University; Stanford University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Vermont; University of Vermont	Elmore, JG (corresponding author), Univ Washington, Dept Med, 325 Ninth Ave,POB 359780, Seattle, WA 98104 USA.	jelmore@u.washington.edu			National Cancer Institute [R01CA140560, R01CA172343, K05CA104699, U01CA70013, HHSN261201100031C]; NATIONAL CANCER INSTITUTE [P30CA023108, K05CA104699, U01CA070013, R01CA172343, R01CA140560] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (R01CA140560, R01CA172343, and K05CA104699) and by the National Cancer Institute-funded Breast Cancer Surveillance Consortium (U01CA70013 and HHSN261201100031C). The collection of cancerand vital status data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. For a full description of sources, visit http://www.breastscreening.cancer.gov/work /acknowledgement.html. The American Medical Association (AMA) is the source for the raw physician data; statistics, tables, or tabulations were prepared by the authors using AMA Physician Masterfile data. The AMA Physician Masterfile data on pathologist age, sex, level of direct medical care, and proportion working in a population of 250 000 or more were used in comparing characteristics of participants and nonparticipants.	Allison KH, 2014, HISTOPATHOLOGY, V65, P240, DOI 10.1111/his.12387; American Medical Association, PHYS; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Carney PA, 1998, J COMMUN HEALTH, V23, P85, DOI 10.1023/A:1018779022971; Collins LC, 2004, AM J SURG PATHOL, V28, P126, DOI 10.1097/00000478-200401000-00015; DellaMea V, 1997, MODERN PATHOL, V10, P636; DUPONT WD, 1993, CANCER, V71, P1258, DOI 10.1002/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; ELMORE JG, 1994, NEW ENGL J MED, V331, P1493, DOI 10.1056/NEJM199412013312206; ELMORE JG, 1992, J CLIN EPIDEMIOL, V45, P567, DOI 10.1016/0895-4356(92)90128-A; FEINSTEIN AR, 1985, J CHRON DIS, V38, P619, DOI 10.1016/0021-9681(85)90016-5; Feng S, 2014, ARCH PATHOL LAB MED, V138, P955, DOI 10.5858/arpa.2013-0263-OA; Ginsburg OM, 2008, BRIT J CANCER, V99, P1369, DOI 10.1038/sj.bjc.6604635; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Haas JS, 2000, J GEN INTERN MED, V15, P321, DOI 10.1046/j.1525-1497.2000.08030.x; Hall FM, 2010, RADIOLOGY, V254, P655, DOI 10.1148/radiol.09092100; Harris JR, 2014, DIS BREAST; Hartmann LC, 2015, NEW ENGL J MED, V372, P78, DOI 10.1056/NEJMsr1407164; Helmer O, SYSTEMATIC USE EXPER; Lee CI, 2012, RADIOLOGY, V264, P632, DOI 10.1148/radiol.12120184; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P941, DOI 10.1001/jama.267.7.941; National Cancer Institute, BREAST CANC SURV CON; O'Malley FP, 2011, BREAST PATHOLOGY; Oster NV, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-3; Rakovitch E, 2004, BREAST CANCER RES TR, V87, P265, DOI 10.1007/s10549-004-9454-8; ROSAI J, 1991, AM J SURG PATHOL, V15, P209, DOI 10.1097/00000478-199103000-00001; RUBIN E, 1988, CANCER, V61, P2077, DOI 10.1002/1097-0142(19880515)61:10<2077::AID-CNCR2820611024>3.0.CO;2-M; Saul S, 2010, NY TIMES; SCHNITT SJ, 1992, AM J SURG PATHOL, V16, P1133, DOI 10.1097/00000478-199212000-00001; Schnitt SJ, 2009, BIOPSY INTERPRETATIO; Shaw EC, 2012, J CLIN PATHOL, V65, P403, DOI 10.1136/jclinpath-2011-200369; Silverstein M, 2009, J AM COLL SURGEONS, V208, P78, DOI 10.1016/j.jamcollsurg.2008.09.022; Silverstein Melvin J, 2009, J Am Coll Surg, V209, P504, DOI 10.1016/j.jamcollsurg.2009.07.006; Stang A, 2011, HISTOPATHOLOGY, V59, P939, DOI 10.1111/j.1365-2559.2011.04032.x; Trocchi P, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-554; Weaver DL, 2006, CANCER, V106, P732, DOI 10.1002/cncr.21652; Wells WA, 1998, J NATL CANCER I, V90, P142, DOI 10.1093/jnci/90.2.142; Willis G.B, 2004, COGNITIVE INTERVIEWI; Zahl PH, 2013, BRIT J CANCER, V109, P2014, DOI 10.1038/bjc.2013.427	39	177	188	4	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1122	1132		10.1001/jama.2015.1405	http://dx.doi.org/10.1001/jama.2015.1405			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25781441	Green Accepted, Bronze			2022-12-28	WOS:000351102500014
J	Coresh, J; Jafar, TH				Coresh, Josef; Jafar, Tazeen H.			Disparities in worldwide treatment of kidney failure	LANCET			English	Editorial Material							DIALYSIS; CARE		[Coresh, Josef] George W Comstock Ctr Publ Hlth Res & Prevent, Baltimore, MD 21287 USA; [Coresh, Josef] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Jafar, Tazeen H.] Duke NUS Grad Med Sch, Singapore, Singapore	Johns Hopkins University; National University of Singapore	Coresh, J (corresponding author), George W Comstock Ctr Publ Hlth Res & Prevent, Baltimore, MD 21287 USA.	coresh@jhu.edu						Archdeacon P, 2013, CLIN J AM SOC NEPHRO, V8, P1609, DOI 10.2215/CJN.01140113; Bamgboye EL, 2003, KIDNEY INT, V63, P93, DOI 10.1046/j.1523-1755.63.s83.19.x; Dirks JH, 2006, KIDNEY INT, V70, P982, DOI 10.1038/sj.ki.5001798; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Hoerger TJ, 2010, AM J KIDNEY DIS, V55, P463, DOI 10.1053/j.ajkd.2009.11.017; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Liyanage T, 2015, LANCET; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Morad Z, 2015, AM J KIDNEY DIS, V65, P799, DOI 10.1053/j.ajkd.2014.09.031; Pecoits R, 2009, PERITON DIALYSIS INT, V29, pS222; Ramachandran R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067812; Wagstaff A, 2014, WHO BENEFITS GOVT HL; Williams ME, 2012, SEMIN DIALYSIS, V25, P633, DOI 10.1111/sdi.12018	13	31	31	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1926	1928		10.1016/S0140-6736(14)61890-0	http://dx.doi.org/10.1016/S0140-6736(14)61890-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI1YR	25777668				2022-12-28	WOS:000354541700008
J	Uplekar, M; Weil, D; Lonnroth, K; Jaramillo, E; Lienhardt, C; Dias, HM; Falzon, D; Floyd, K; Gargioni, G; Getahun, H; Gilpin, C; Glaziou, P; Grzemska, M; Mirzayev, F; Nakatani, H; Raviglione, M				Uplekar, Mukund; Weil, Diana; Lonnroth, Knut; Jaramillo, Ernesto; Lienhardt, Christian; Dias, Hannah Monica; Falzon, Dennis; Floyd, Katherine; Gargioni, Giuliano; Getahun, Haileyesus; Gilpin, Christopher; Glaziou, Philippe; Grzemska, Malgorzata; Mirzayev, Fuad; Nakatani, Hiroki; Raviglione, Mario		WHO's Global TB Programme	WHO's new End TB Strategy	LANCET			English	Editorial Material							TUBERCULOSIS; COUNTRIES; TARGETS		[Uplekar, Mukund; Weil, Diana; Lonnroth, Knut; Jaramillo, Ernesto; Lienhardt, Christian; Dias, Hannah Monica; Falzon, Dennis; Floyd, Katherine; Gargioni, Giuliano; Getahun, Haileyesus; Gilpin, Christopher; Glaziou, Philippe; Grzemska, Malgorzata; Mirzayev, Fuad; Nakatani, Hiroki; Raviglione, Mario] WHO, Global TB Programme, CH-1211 Geneva, Switzerland	World Health Organization	Uplekar, M (corresponding author), WHO, Global TB Programme, CH-1211 Geneva, Switzerland.	uplekarm@who.int	Lienhardt, Christian/AAU-4969-2021; Lonnroth, Knut/H-5470-2017; Getahun, Haileyesus/ABC-5181-2020; Lönnroth, Knut/L-2339-2014	Lienhardt, Christian/0000-0003-0233-893X; Lonnroth, Knut/0000-0001-6944-0256; Lönnroth, Knut/0000-0001-5054-8240; Yesudian DIAS, Hannah Monica/0000-0003-0114-5757; RAVIGLIONE, Mario/0000-0002-9331-2067; Mirzayev, Fuad/0000-0001-6658-0325; Glaziou, Philippe/0000-0002-0649-1272	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Floyd K, 2013, LANCET GLOB HEALTH, V1, pE105, DOI 10.1016/S2214-109X(13)70032-9; Lonnroth K, 2014, ANN INTERN MED, V161, P670, DOI 10.7326/M14-1888; Lonnroth K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001693; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; Raviglione M, 2014, LANCET GLOB HEALTH, V2, pE71, DOI 10.1016/S2214-109X(13)70166-9; Raviglione MC, 2013, NAT MED, V19, P263, DOI 10.1038/nm.3129; United Nations, OP WORK GROUP PROP S; WHO, 2011, INT ROADM TUB RES WO; WHO, 2013, WHOHTMTB201304; WHO, DOC WORLD HLTH ASS 6; World Health Organization, WHOHTMTB201316; World Health Organization Geneva, 2014, GLOB TUB CONTR WHO R; World Health Organization (WHO), 2015, GUIDELINES MANAGEMEN	14	609	630	2	35	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1799	1801		10.1016/S0140-6736(15)60570-0	http://dx.doi.org/10.1016/S0140-6736(15)60570-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH0PZ	25814376				2022-12-28	WOS:000353726000036
J	Chu, C; Zhang, QFC; da Rocha, ST; Flynn, RA; Bharadwaj, M; Calabrese, JM; Magnuson, T; Heard, E; Chang, HY				Chu, Ci; Zhang, Qiangfeng Cliff; da Rocha, Simao Teixeira; Flynn, Ryan A.; Bharadwaj, Maheetha; Calabrese, J. Mauro; Magnuson, Terry; Heard, Edith; Chang, Howard Y.			Systematic Discovery of Xist RNA Binding Proteins	CELL			English	Article							X-CHROMOSOME INACTIVATION; EMBRYONIC STEM-CELLS; LONG NONCODING RNAS; U1 SNRNP; CRYSTAL-STRUCTURE; PRC2 RECRUITMENT; HISTONE H2A; POLYCOMB; MOUSE; PLURIPOTENCY	Noncoding RNAs (ncRNAs) function with associated proteins to effect complex structural and regulatory outcomes. To reveal the composition and dynamics of specific noncoding RNA-protein complexes (RNPs) in vivo, we developed comprehensive identification of RNA binding proteins by mass spectrometry (ChIRP-MS). ChIRP-MS analysis of four ncRNAs captures key protein interactors, including a U1-specific link to the 3' RNA processing machinery. Xist, an essential lncRNA for X chromosome inactivation (XCI), interacts with 81 proteins from chromatin modification, nuclear matrix, and RNA remodeling pathways. The Xist RNA-protein particle assembles in two steps coupled with the transition from pluripotency to differentiation. Specific interactors include HnrnpK, which participates in Xist-mediated gene silencing and histone modifications but not Xist localization, and Drosophila Split ends homolog Spen, which interacts via the A-repeat domain of Xist and is required for gene silencing. Thus, Xist lncRNA engages with proteins in a modular and developmentally controlled manner to coordinate chromatin spreading and silencing.	[Chu, Ci; Zhang, Qiangfeng Cliff; Flynn, Ryan A.; Bharadwaj, Maheetha; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Chu, Ci; Zhang, Qiangfeng Cliff; Flynn, Ryan A.; Bharadwaj, Maheetha; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Chu, Ci] Genome Inst Singapore, Singapore 138672, Singapore; [da Rocha, Simao Teixeira; Heard, Edith] Inst Curie, CNRS UMR3215, INSERM U934, F-75248 Paris, France; [Calabrese, J. Mauro] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Calabrese, J. Mauro; Magnuson, Terry] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Magnuson, Terry] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	howchang@stanford.edu	da Rocha, Simão Teixeira/ABG-4589-2020; Zhang, Qiangfeng/C-2902-2011; Heard, Edith/D-7197-2017	da Rocha, Simão Teixeira/0000-0002-9683-7942; Heard, Edith/0000-0001-8052-7117; Flynn, Ryan/0000-0001-5013-0442	NIH [NS069375, P50-HG007735]; California Institute for Regenerative Medicine; Equipe labellisee "La Ligue Contre Le Cancer" (Equipe Labellise); Labex DEEP, IDEX Idex PSL [ANR-11-LBX-0044, ANR-10-IDEX-000102 PSL]; EpiGeneSys Network of Excellence [FP7 257082]; ERC [250367]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Equipe labellisee "La Ligue Contre Le Cancer" (Equipe Labellise); Labex DEEP, IDEX Idex PSL; EpiGeneSys Network of Excellence; ERC(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Wutz (ETH), A. Surani, J. Zylicz (University of Cambridge), A. Smith (University of Cambridge), and A. Gillich (Stanford) for reagents and advice; W. Lane and R. Robinson (Harvard) for MS analysis; A. Olson for assistance with confocal microscopy (Stanford Neuroscience Microscopy Service supported by NIH NS069375); and P. Walker (Stanford PAN facility) for ChIRP oligo synthesis. This work was supported by NIH P50-HG007735 and California Institute for Regenerative Medicine. H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute. E.H. is supported as an Equipe labellisee "La Ligue Contre Le Cancer" (Equipe Labellise to E.H.) and by Labex DEEP (ANR-11-LBX-0044) part of the IDEX Idex PSL (ANR-10-IDEX-000102 PSL), as well as the EpiGeneSys FP7 257082 Network of Excellence and ERC Advanced Investigator award 250367. H.Y.C. is a founder of Epinomics, Inc. and is a member of the Scientific Advisory Board of RaNA Therapeutics.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Arieti F, 2014, NUCLEIC ACIDS RES, V42, P6742, DOI 10.1093/nar/gku277; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; BUZIN CH, 1994, DEVELOPMENT, V120, P3529; Calabrese JM, 2012, CELL, V151, P951, DOI 10.1016/j.cell.2012.10.037; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chaumeil Julie, 2008, V463, P297, DOI 10.1007/978-1-59745-406-3_18; Chu C, 2015, NAT STRUCT MOL BIOL, V22, P29, DOI 10.1038/nsmb.2921; Chu C, 2012, JOVE-J VIS EXP, DOI 10.3791/3912; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; Flynn RA, 2015, RNA, V21, P135, DOI 10.1261/rna.047803.114; Gendrel AV, 2011, DEVELOPMENT, V138, P5049, DOI 10.1242/dev.068320; Gesteland RF., 1993, RNA WORLD NATURE MOD; Gillich A, 2012, CELL STEM CELL, V10, P425, DOI 10.1016/j.stem.2012.01.020; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Hayashi K, 2009, CELL STEM CELL, V4, P493, DOI 10.1016/j.stem.2009.05.007; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kalantry S, 2006, PLOS GENET, V2, P656, DOI 10.1371/journal.pgen.0020066; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; RASTAN S, 1982, J EMBRYOL EXP MORPH, V71, P11; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Riley KJ, 2013, MOL CELL, V49, P601, DOI 10.1016/j.molcel.2013.01.030; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Song J, 2012, MOL CELL PROTEOMICS, V11, P1036, DOI 10.1074/mcp.M111.011114; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TAKAGI N, 1982, CHROMOSOMA, V85, P275, DOI 10.1007/BF00294971; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	55	634	657	12	175	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					404	416		10.1016/j.cell.2015.03.025	http://dx.doi.org/10.1016/j.cell.2015.03.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25843628	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000352708300030
J	Ruddiman, WF; Ellis, EC; Kaplan, JO; Fuller, DQ				Ruddiman, William F.; Ellis, Erle C.; Kaplan, Jed O.; Fuller, Dorian Q.			Defining the epoch we live in	SCIENCE			English	Editorial Material							ANTHROPOCENE; HUMANS; CARBON		[Ruddiman, William F.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Ellis, Erle C.] Univ Maryland Baltimore Cty, Dept Geog & Environm Syst, Baltimore, MD 21250 USA; [Kaplan, Jed O.] Univ Lausanne, Inst Earth Surface Dynam, CH-1015 Lausanne, Switzerland; [Fuller, Dorian Q.] UCL, Inst Archeol, London WC1H 0PY, England	University of Virginia; University System of Maryland; University of Maryland Baltimore County; University of Lausanne; University of London; University College London	Ruddiman, WF (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	wfr5c@virginia.edu	Kaplan, Jed O./P-1796-2015; Ellis, Erle C./B-8264-2008; Fuller, Dorian Q/C-1908-2008; Fuller, Dorian/AAF-7400-2019	Kaplan, Jed O./0000-0001-9919-7613; Ellis, Erle C./0000-0002-2006-3362; Fuller, Dorian Q/0000-0002-4859-080X; Fuller, Dorian/0000-0002-4859-080X	Natural Environment Research Council [NE/K003402/1] Funding Source: researchfish; NERC [NE/K003402/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Crutzen P, 2000, GLOBAL CHANGE NEWSLE, V41, P17; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Fuller DQ, 2011, HOLOCENE, V21, P743, DOI 10.1177/0959683611398052; Hoffmann T, 2013, EARTH SURF DYNAM, V1, P45, DOI 10.5194/esurf-1-45-2013; Kaplan JO, 2011, HOLOCENE, V21, P775, DOI 10.1177/0959683610386983; Larson G, 2014, P NATL ACAD SCI USA, V111, P6139, DOI 10.1073/pnas.1323964111; RUDDIMAN W.F., 2013, EARTH TRANSFORMED; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Zalasiewicz J, 2015, QUATERN INT, V383, P204, DOI DOI 10.1016/J.QUAINT.2014.11.045; Zhuang YJ, 2014, HOLOCENE, V24, P1602, DOI 10.1177/0959683614544058	12	165	169	3	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					38	39		10.1126/science.aaa7297	http://dx.doi.org/10.1126/science.aaa7297			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838365				2022-12-28	WOS:000352079500017
J	Marsh, H				Marsh, Henry			IF I RULED THE NHS Fund the service from a hypothecated tax	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									St George Hosp, London, England	St Georges University London	Marsh, H (corresponding author), St George Hosp, London, England.	henrymarsh952@gmail.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2015	350								h1483	10.1136/bmj.h1483	http://dx.doi.org/10.1136/bmj.h1483			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3HO	25832670				2022-12-28	WOS:000352439300004
J	Alarcon, CR; Lee, H; Goodarzi, H; Halberg, N; Tavazoie, SF				Alarcon, Claudio R.; Lee, Hyeseung; Goodarzi, Hani; Halberg, Nils; Tavazoie, Sohail F.			N-6-methyladenosine marks primary microRNAs for processing	NATURE			English	Article							RNA; PLATFORM; SUBUNIT; COMPLEX; REGION	The first step in the biogenesis of microRNAs is the processing of primary microRNAs (pri-miRNAs) by the microprocessor complex, composed of the RNA-binding protein DGCR8 and the type III RNase DROSHA(1-4). This initial event requires recognition of the junction between the stem and the flanking single-stranded RNA of the pri-miRNA hairpin by DGCR8 followed by recruitment of DROSHA, which cleaves the RNA duplex to yield the pre-miRNA product(5). While the mechanisms underlying pri-miRNA processing have been determined, the mechanism by which DGCR8 recognizes and binds pri-miRNAs, as opposed to other secondary structures present in transcripts, is not understood. Here we find in mammalian cells that methyltransferase-like 3(METTL3) methylates pri-miRNAs, marking them for recognition and processing by DGCR8. Consistent with this, METTL3 depletion reduced the binding of DGCR8 to pri-miRNAs and resulted in the global reduction of mature miRNAs and concomitant accumulation of unprocessed pri-miRNAs. In vitro processing reactions confirmed the sufficiency of the N6-methyladenosine (m(6)A) mark in promoting pri-miRNA processing. Finally, gain-of-function experiments revealed that METTL3 is sufficient to enhance miRNA maturation in a global and non-cell-type-specific manner. Our findings reveal that the m(6)A mark acts as a key post-transcriptional modification that promotes the initiation of miRNA biogenesis.	[Alarcon, Claudio R.; Lee, Hyeseung; Goodarzi, Hani; Halberg, Nils; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA	Rockefeller University	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10065 USA.	stavazoie@rockefeller.edu	Halberg, Nils/AAF-8153-2019	Halberg, Nils/0000-0002-2943-3147; Goodarzi, Hani/0000-0002-9648-8949	Era of Hope Department of Defense Award; Department of Defense	Era of Hope Department of Defense Award; Department of Defense(United States Department of Defense)	We thank members of the Tavazoie laboratory as well as S. Kurdistani for comments on previous versions of this manuscript. We thank D. Bartel for suggestions about conservation analysis. We thank L. Fish for technical advice. We thank C. Zhao and C. Lai of the Rockefeller Genomics Resource Center for assistance with next-generation RNA-seq. We thank H. Molina of the Rockefeller Proteomics Center for his input in proteomics analysis. We thank C. Eicken of LC Sciences for assistance with microarray analysis. We thank H. Chang and P. Batista for providing targeted embryonic stem cells. C.R.A. was an Anderson Cancer Center Fellow at Rockefeller University. This work was supported by an Era of Hope Department of Defense Award to S.F.T. S.F.T. is a Department of Defense Breast Cancer Collaborative Scholars and Innovators Award recipient.	Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bokar JA, 1997, RNA, V3, P1233; Bujnicki JM, 2002, J MOL EVOL, V55, P431, DOI 10.1007/s00239-002-2339-8; CAMPER SA, 1984, MOL CELL BIOL, V4, P538, DOI 10.1128/MCB.4.3.538; CARROLL SM, 1990, MOL CELL BIOL, V10, P4456, DOI 10.1128/MCB.10.9.4456; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee Y, 2007, METHOD ENZYMOL, V427, P89, DOI 10.1016/S0076-6879(07)27005-3; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sibbritt T, 2013, WIRES RNA, V4, P397, DOI 10.1002/wrna.1166; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873	26	742	782	17	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					482	+		10.1038/nature14281	http://dx.doi.org/10.1038/nature14281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25799998	Green Accepted			2022-12-28	WOS:000351602800058
J	Dolgin, E				Dolgin, Elie			TEXTILES Fabrics of life	NATURE			English	Editorial Material							HYDRODYNAMIC FUNCTION; SHARK SKIN											Oeffner J, 2012, J EXP BIOL, V215, P785, DOI 10.1242/jeb.063040; Phan L., 2015, J MAT CHEM; Shillingford C, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/1/014019; Wen L, 2014, J EXP BIOL, V217, P1656, DOI 10.1242/jeb.097097; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447; Yu CJ, 2014, P NATL ACAD SCI USA, V111, P12998, DOI 10.1073/pnas.1410494111	6	5	5	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S10	S11		10.1038/519S10a	http://dx.doi.org/10.1038/519S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25806490				2022-12-28	WOS:000351602800003
J	Greene, JA; Riggs, KR				Greene, Jeremy A.; Riggs, Kevin R.			Why Is There No Generic Insulin? Historical Origins of a Modern Problem	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LONG-ACTING INSULIN; PATENTS		[Greene, Jeremy A.; Riggs, Kevin R.] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD 21218 USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD USA; [Riggs, Kevin R.] Johns Hopkins Univ, Sch Med, Berman Inst Bioeth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Greene, JA (corresponding author), Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD 21218 USA.			Riggs, Kevin/0000-0002-0015-5809	NATIONAL LIBRARY OF MEDICINE [G13LM010890] Funding Source: NIH RePORTER; NLM NIH HHS [G13 LM010890] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Bliss Michael, 1982, DISCOVERY INSULIN; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Cassier M, 2008, HIST TECHNOL, V24, P153, DOI 10.1080/07341510701810948; DiMasi J., 2012, TUFTS CTR STUDY DRUG, P21, DOI DOI 10.1093/OXFORDHB/9780199742998.013.0002; Dusetzina SB, 2014, J CLIN ONCOL, V32, P306, DOI 10.1200/JCO.2013.52.9123; Engelberg AB, 2010, NEW ENGL J MED, V362, P664; FELIG P, 1984, JAMA-J AM MED ASSOC, V251, P393, DOI 10.1001/jama.251.3.393; Feudtner C., 2003, BITTERSWEET DIABETES; Frank RG, 2007, NEW ENGL J MED, V357, P1993, DOI 10.1056/NEJMp078193; Gabriel Joseph M., 2014, MED MONOPOLY INTELLE; GOEDDEL DV, 1979, P NATL ACAD SCI USA, V76, P106, DOI 10.1073/pnas.76.1.106; Grabowski H, 1996, PHARMACOECONOMICS, V10, P110, DOI 10.2165/00019053-199600102-00017; Greene JA, 2014, GENERIC UNBRANDING M; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; HAGEDORS H. C., 1936, Journal of the American Medical Association, V106, P177; Heinemann L, 2000, DIABETES CARE, V23, P644, DOI 10.2337/diacare.23.5.644; Heinemann L, 2012, DIABETES TECHNOL THE, V14, P986, DOI 10.1089/dia.2012.0247; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Hitchings AW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7941; Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3; LAWRENCE RD, 1953, BRIT MED J, V1, P242, DOI 10.1136/bmj.1.4804.242; Light DW, 2011, BIOSOCIETIES, V6, P34, DOI 10.1057/biosoc.2010.40; LOGIE AW, 1976, BRIT MED J, V1, P879, DOI 10.1136/bmj.1.6014.879-a; Louet S, 2003, NAT BIOTECHNOL, V21, P956, DOI 10.1038/nbt0903-956; Owens DR, 2012, DIABETES TECHNOL THE, V14, P989, DOI 10.1089/dia.2012.0105; Piette JD, 2004, DIABETES CARE, V27, P384, DOI 10.2337/diacare.27.2.384; Richter B, 2002, ENDOCRIN METAB CLIN, V31, P723, DOI 10.1016/S0889-8529(02)00020-8; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; SLAYTON RE, 1955, NEW ENGL J MED, V253, P722, DOI 10.1056/NEJM195510272531704; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421	30	52	53	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2015	372	12					1171	1175		10.1056/NEJMms1411398	http://dx.doi.org/10.1056/NEJMms1411398			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD6EZ	25785977				2022-12-28	WOS:000351183600016
J	Rosenau, MJ				Rosenau, M. J.			Courses and Degrees in Public Health Work	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Rosenau MJ, 1915, J AMER MED ASSOC, V64, P794	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1172	1172		10.1001/jama.2015.1736	http://dx.doi.org/10.1001/jama.2015.1736			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25781455				2022-12-28	WOS:000351102500027
J	Mehta, RL; Cerda, J; Burdmann, EA; Tonelli, M; Garcia-Garcia, G; Jha, V; Susantitaphong, P; Rocco, M; Vanholder, R; Sever, MS; Cruz, D; Jaber, B; Lameire, NH; Lombardi, R; Lewington, A; Feehally, J; Finkelstein, F; Levin, N; Pannu, N; Thomas, B; Aronoff-Spencer, E; Remuzzi, G				Mehta, Ravindra L.; Cerda, Jorge; Burdmann, Emmanuel A.; Tonelli, Marcello; Garcia-Garcia, Guillermo; Jha, Vivekanand; Susantitaphong, Paweena; Rocco, Michael; Vanholder, Raymond; Sever, Mehmet Sukru; Cruz, Dinna; Jaber, Bertrand; Lameire, Norbert H.; Lombardi, Raul; Lewington, Andrew; Feehally, John; Finkelstein, Fredric; Levin, Nathan; Pannu, Neesh; Thomas, Bernadette; Aronoff-Spencer, Eliah; Remuzzi, Giuseppe			International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology	LANCET			English	Review							ACUTE-RENAL-FAILURE; INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; VOLUME PERITONEAL-DIALYSIS; CLINICAL-PRACTICE GUIDELINE; BYPASS GRAFT-SURGERY; LOW-DOSE DOPAMINE; RISK-FACTORS; REPLACEMENT THERAPY; RIFLE CRITERIA		[Mehta, Ravindra L.; Cruz, Dinna; Aronoff-Spencer, Eliah] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Cerda, Jorge] Albany Med Coll, Dept Med, Div Nephrol, Albany, NY 12208 USA; [Burdmann, Emmanuel A.] Univ Sao Paulo, Sch Med, Div Nephrol, LIM 12, Sao Paulo, Brazil; [Tonelli, Marcello] Univ Calgary, Calgary, AB, Canada; [Garcia-Garcia, Guillermo] Univ Guadalajara, Hlth Sci Ctr, Hosp Civil Guadalajara, Serv Nephrol, Guadalajara 44430, Jalisco, Mexico; [Jha, Vivekanand] Univ Oxford, George Inst Global Hlth, Oxford, England; [Susantitaphong, Paweena] Chulalongkorn Univ, Fac Med, King Chulalongkorn Mem Hosp, Div Nephrol,Dept Med, Bangkok 10330, Thailand; [Susantitaphong, Paweena] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Rocco, Michael] Wake Forest Sch Med, Dept Internal Med, Nephrol Sect, Winston Salem, NC USA; [Vanholder, Raymond; Lameire, Norbert H.] Univ Hosp, Nephrol Sect, Dept Internal Med, Ghent, Belgium; [Sever, Mehmet Sukru] Istanbul Univ, Istanbul Sch Med, Dept Nephrol, Mehmet, Turkey; [Jaber, Bertrand] St Elizabeths Med Ctr, Boston, MA USA; [Lombardi, Raul] SMI, Dept Crit Care Med, Montevideo, Uruguay; [Lewington, Andrew] Leeds Teaching Hosp, Dept Nephrol, Leeds, W Yorkshire, England; [Feehally, John] Univ Leicester, Leicester, Leics, England; [Finkelstein, Fredric] Yale Univ, New Haven, CT USA; [Levin, Nathan] Renal Res Inst, New York, NY USA; [Pannu, Neesh] Univ Alberta, Edmonton, AB, Canada; [Thomas, Bernadette] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [Remuzzi, Giuseppe] Ist Ric Farmacol Mario Negri, IRCCS, Bergamo, Italy; [Remuzzi, Giuseppe] Azienda Osped Papa Giovanni XXIII, Dept Med, Unit Nephrol Dialysis & Transplantat, Bergamo, Italy	University of California System; University of California San Diego; Albany Medical College; Universidade de Sao Paulo; University of Calgary; Universidad de Guadalajara; University of Oxford; Chulalongkorn University; Tufts University; Wake Forest University; Ghent University; Ghent University Hospital; Istanbul University; St. Elizabeth's Medical Center; University of Leeds; University of Leicester; Yale University; Renal Research Institute; University of Alberta; University of Washington; University of Washington Seattle; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ASST Papa Giovanni XXIII	Mehta, RL (corresponding author), Univ Calif San Diego, Med Ctr, Dept Med, San Diego, CA 92103 USA.	rmehta@ucsd.edu	Burdmann, Emmanuel/AAY-1966-2020; Burdmann, Emmanuel/B-7023-2009; Sever, Mehmet Sukru/AAY-6272-2020; Mehta, Ravindra/ACD-4769-2022; Tonelli, Marcello/B-3028-2009; Remuzzi, Giuseppe/V-9766-2017	Burdmann, Emmanuel/0000-0002-7644-8579; Mehta, Ravindra/0000-0002-0908-2968; Tonelli, Marcello/0000-0002-0846-3187; Garcia Garcia, Guillermo/0000-0003-0558-0035; Remuzzi, Giuseppe/0000-0002-6194-3446; Jha, Vivekanand/0000-0002-8015-9470	International Society of Nephrology (ISN); Astute Medical (San Diego, CA, USA); Danone Nutricia Research (Palaiseau, France); Bellco (Mirandola, Italy)	International Society of Nephrology (ISN); Astute Medical (San Diego, CA, USA); Danone Nutricia Research (Palaiseau, France)(Danone Nutricia); Bellco (Mirandola, Italy)	We thank Arjan van der Tol, Valerie Luyckx, and Noel Gibney for their wonderful work with the RDRTF/ISN (Renal Disaster Relief Task Force of the International Society of Nephrology) for providing the epidemiologic earthquake data; and Sue Lahey and Ann Marie L'Hommedieu from the Schaffer Library, Albany Medical College (NY, USA) for their invaluable help in the literature search. The International Society of Nephrology (ISN) provided funding through unrestricted grants to the 0by25 initiative, gave logistic support for this study, and holds all copyrights on the data obtained through this study. Further support has been provided through unrestricted grants from Astute Medical (San Diego, CA, USA), Danone Nutricia Research (Palaiseau, France) and Bellco (Mirandola, Italy).	Ademola AD, 2012, PERITON DIALYSIS INT, V32, P267, DOI 10.3747/pdi.2011.00275; Aitken E, 2013, QJM-INT J MED, V106, P323, DOI 10.1093/qjmed/hcs237; Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Arora P, 2008, CLIN J AM SOC NEPHRO, V3, P1266, DOI 10.2215/CJN.05271107; Arthur JM, 2014, KIDNEY INT, V85, P431, DOI 10.1038/ki.2013.333; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P1203, DOI 10.1093/ndt/gfm744; Bagshaw SM, 2007, CONTRIB NEPHROL, V156, P236; Bagshaw SM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-50; Bagshaw SM, 2008, CRIT CARE, V12, DOI 10.1186/cc6948; Bailey D, 2007, PEDIATR CRIT CARE ME, V8, P29, DOI 10.1097/01.pcc.0000256612.40265.67; Basoor Abhijeet, 2013, Congest Heart Fail, V19, P200, DOI 10.1111/chf.12031; Basso F, 2010, BLOOD PURIFICAT, V30, P213, DOI 10.1159/000320126; Beaglehole R, 2013, LANCET, V381, P602, DOI 10.1016/S0140-6736(13)60101-4; Bedford M, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-95; Bedford M, 2012, AM J KIDNEY DIS, V59, P485, DOI 10.1053/j.ajkd.2011.09.010; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2000, LANCET, V356, P2139; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bonilla-Felix M, 2013, BLOOD PURIFICAT, V35, P77, DOI 10.1159/000345186; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Boyer A, 2013, DRUG SAFETY, V36, P217, DOI 10.1007/s40264-013-0031-0; Brienza N, 2009, CRIT CARE MED, V37, P2079, DOI 10.1097/CCM.0b013e3181a00a43; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Burdmann EA, 2011, SEMIN DIALYSIS, V24, P149, DOI 10.1111/j.1525-139X.2011.00868.x; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Callegari J, 2013, BLOOD PURIFICAT, V36, P226, DOI 10.1159/000356627; Cerda J, 2008, CLIN J AM SOC NEPHRO, V3, P881, DOI 10.2215/CJN.04961107; Cerda J, 2008, NAT CLIN PRACT NEPHR, V4, P138, DOI 10.1038/ncpneph0722; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Chawla LS, 2014, CLIN J AM SOC NEPHRO, V9, P448, DOI 10.2215/CJN.02440213; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Chionh CY, 2013, CLIN J AM SOC NEPHRO, V8, P1649, DOI 10.2215/CJN.01540213; Cho A, 2012, AM J KIDNEY DIS, V60, P74, DOI 10.1053/j.ajkd.2012.02.331; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Coca SG, 2010, CURR OPIN NEPHROL HY, V19, P266, DOI 10.1097/MNH.0b013e3283375538; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; COFFEY D, 2014, INDIA TODAY; Colpaert K, 2012, CRIT CARE MED, V40, P1164, DOI 10.1097/CCM.0b013e3182387a6b; Silva VTCE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070482; Cruz DN, 2014, NAT REV NEPHROL, V10, P74, DOI 10.1038/nrneph.2013.268; Cullis B, 2014, PERITON DIALYSIS INT, V34, P494, DOI 10.3747/pdi.2013.00222; Daher ED, 2014, REV SOC BRAS MED TRO, V47, P86, DOI 10.1590/0037-8682-0223-2013; Daher EF, 2012, CLIN NEPHROL, V78, P449, DOI 10.5414/CN107167; Dahl R, 2013, RESP MED, V107, P1558, DOI 10.1016/j.rmed.2013.05.016; Das P, 2012, LANCET, V380, P2067, DOI 10.1016/S0140-6736(12)62174-6; Dass B, 2012, CLIN NEPHROL, V77, P438, DOI 10.5414/CN107278; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Esezobor CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051229; Evans RG, 2008, AM J PHYSIOL-RENAL, V295, pF1259, DOI 10.1152/ajprenal.90230.2008; Evenepoel Pieter, 2004, Best Pract Res Clin Anaesthesiol, V18, P37, DOI 10.1016/j.bpa.2003.09.007; Finlay S, 2013, CLIN MED, V13, P233, DOI 10.7861/clinmedicine.13-3-233; Fliser D, 2012, NEPHROL DIAL TRANSPL, V27, P4263, DOI 10.1093/ndt/gfs375; Fournier JP, 2014, RENAL FAILURE, V36, P1166, DOI 10.3109/0886022X.2014.917943; Friedrich JO, 2005, ANN INTERN MED, V142, P510, DOI 10.7326/0003-4819-142-7-200504050-00010; Ftouh S, 2014, CLIN MED, V14, P61, DOI 10.7861/clinmedicine.14-1-61; Fujii T, 2014, CLIN J AM SOC NEPHRO, V9, P457, DOI 10.2215/CJN.04120413; Gabriel DP, 2008, KIDNEY INT, V73, pS87, DOI 10.1038/sj.ki.5002608; Gillespie S, 2013, LANCET, V382, P552, DOI 10.1016/S0140-6736(13)60842-9; Goldstein SL, 2013, CLIN J AM SOC NEPHRO, V8, P476, DOI 10.2215/CJN.12101112; Gordon AC, 2010, INTENS CARE MED, V36, P83, DOI 10.1007/s00134-009-1687-x; Grams ME, 2014, CLIN J AM SOC NEPHRO, V9, P682, DOI 10.2215/CJN.07650713; Gunal AI, 2004, J AM SOC NEPHROL, V15, P1862, DOI 10.1097/01.asn.0000129336.09976.73; Hassinger AB, 2014, PEDIATR CRIT CARE ME, V15, P131, DOI 10.1097/PCC.0000000000000043; Herath Nalaka J, 2014, BMC Res Notes, V7, P398, DOI 10.1186/1756-0500-7-398; Heung M, 2012, CURR OPIN NEPHROL HY, V21, P628, DOI 10.1097/MNH.0b013e3283588f24; Ho KM, 2006, BMJ-BRIT MED J, V333, P420, DOI 10.1136/bmj.38902.605347.7C; Hoste EAJ, 2007, ACTA CLIN BELG, V62, P314, DOI 10.1179/acb.2007.071; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; Huang TM, 2011, J AM SOC NEPHROL, V22, P156, DOI 10.1681/ASN.2010050553; Hwang YJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001821; Jamal JA, 2014, NEPHROLOGY, V19, P507, DOI 10.1111/nep.12276; James M, 2013, AM J KIDNEY DIS, V61, P673, DOI 10.1053/j.ajkd.2013.02.350; Jha V, 2013, NAT REV NEPHROL, V9, P278, DOI 10.1038/nrneph.2013.36; Joannidis M, 2009, INTENS CARE MED, V35, P1692, DOI 10.1007/s00134-009-1530-4; Jones J, 2012, AM J KIDNEY DIS, V60, P402, DOI 10.1053/j.ajkd.2012.03.014; Joyce VR, 2012, CLIN J AM SOC NEPHRO, V7, P1063, DOI 10.2215/CJN.00450112; Kambhampati G, 2012, CLIN EXP NEPHROL, V16, P730, DOI 10.1007/s10157-012-0623-5; Karkouti K, 2011, ANESTHESIOLOGY, V115, P523, DOI 10.1097/ALN.0b013e318229a7e8; Kellum JA, 2008, INT J ARTIF ORGANS, V31, P96, DOI 10.1177/039139880803100204; Kellum JA, 2001, CRIT CARE MED, V29, P1526, DOI 10.1097/00003246-200108000-00005; Kellum JA, 2007, CRIT CARE MED, V35, P1983, DOI 10.1097/01.CCM.0000277518.67114.F8; Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007; Kerr KF, 2014, CLIN J AM SOC NEPHRO, V9, P1488, DOI 10.2215/CJN.10351013; Kerr M, 2014, NEPHROL DIAL TRANSPL, V29, P1362, DOI 10.1093/ndt/gfu016; Khan UA, 2014, J THORAC CARDIOV SUR, V148, P726, DOI 10.1016/j.jtcvs.2013.09.080; Kilonzo K, 2013, KIDNEY INT SUPPL, V3, P186, DOI 10.1038/kisup.2013.11; Kilonzo KG, 2012, PERITON DIALYSIS INT, V32, P261, DOI 10.3747/pdi.2012.00083; Kinfu Y, 2009, B WORLD HEALTH ORGAN, V87, P225, DOI 10.2471/BLT.08.051599; Lameire NH, 2005, ANN MED, V37, P13, DOI 10.1080/07853890510007205; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Lapi F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8525; Legrand M, 2013, INTENS CARE MED, V39, P101, DOI 10.1007/s00134-012-2706-x; Leung KCW, 2013, NAT REV NEPHROL, V9, P77, DOI 10.1038/nrneph.2012.280; Levi TM, 2012, BRAZ J MED BIOL RES, V45, P827, DOI 10.1590/S0100-879X2012007500093; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Li H, 2010, J CRIT CARE, V25, P225, DOI 10.1016/j.jcrc.2009.07.009; Li PKT, 2013, KIDNEY INT, V83, P372, DOI 10.1038/ki.2012.427; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; Lima EQ, 2012, RENAL FAILURE, V34, P1238, DOI 10.3109/0886022X.2012.723581; Lin SM, 2006, SHOCK, V26, P551, DOI 10.1097/01.shk.0000232271.09440.8f; Lombardi R, 1998, RENAL FAILURE, V20, P725, DOI 10.3109/08860229809045169; Lombardi R, 2003, RENAL FAILURE, V25, P775, DOI 10.1081/JDI-120024293; Lombardi R, 2008, SEMIN NEPHROL, V28, P320, DOI 10.1016/j.semnephrol.2008.04.001; Lombardi R, 2014, NEPHROL DIAL TRANSPL, V29, P1369, DOI 10.1093/ndt/gfu078; Macedo E, 2010, CRIT CARE, V14, DOI 10.1186/cc9004; Macedo E, 2008, CURR OPIN CRIT CARE, V14, P660, DOI 10.1097/MCC.0b013e328317ee6e; Maitland K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-68; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Mammen C, 2012, AM J KIDNEY DIS, V59, P523, DOI 10.1053/j.ajkd.2011.10.048; Mathew AJ, 2011, ANN SAUDI MED, V31, P451, DOI 10.4103/0256-4947.84620; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; McMahon GM, 2013, JAMA INTERN MED, V173, P1821, DOI 10.1001/jamainternmed.2013.9774; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mehta RL, 2002, AM J MED, V113, P456, DOI 10.1016/S0002-9343(02)01230-5; Meier P, 2011, CLIN J AM SOC NEPHRO, V6, P2215, DOI 10.2215/CJN.01880211; Murakami R, 2013, EUR J RADIOL, V82, pE521, DOI 10.1016/j.ejrad.2013.06.004; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray PT, 2014, KIDNEY INT, V85, P513, DOI 10.1038/ki.2013.374; Naicker S, 2008, SEMIN NEPHROL, V28, P348, DOI 10.1016/j.semnephrol.2008.04.003; Najar M Saleem, 2008, Indian J Nephrol, V18, P159, DOI 10.4103/0971-4065.45291; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Neto AS, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.09.031; Nielson E, 2014, J HOSP MED, V9, P283, DOI 10.1002/jhm.2155; Obiagwu PN, 2015, TROP MED INT HEALTH, V20, P2, DOI 10.1111/tmi.12409; Okusa MD, 2014, KIDNEY INT, V85, P39, DOI 10.1038/ki.2013.378; Ostermann M, 2007, CRIT CARE MED, V35, P1837, DOI 10.1097/01.CCM.0000277041.13090.0A; Overberger P, 2007, CLIN J AM SOC NEPHRO, V2, P623, DOI 10.2215/CJN.00780207; Palevsky PM, 2013, AM J KIDNEY DIS, V61, P649, DOI 10.1053/j.ajkd.2013.02.349; Palmieri T, 2010, BURNS, V36, P205, DOI 10.1016/j.burns.2009.08.012; Pannu N, 2008, CRIT CARE MED, V36, pS216, DOI 10.1097/CCM.0b013e318168e375; Petit-Zeman S, 2010, LANCET, V376, P667, DOI 10.1016/S0140-6736(10)60712-X; Philips BJ, 2014, EXPERT OPIN DRUG MET, V10, P11, DOI 10.1517/17425255.2013.835802; Ponce D, 2013, INT UROL NEPHROL, V45, P869, DOI 10.1007/s11255-012-0301-2; Ponce D, 2012, CLIN J AM SOC NEPHRO, V7, P887, DOI 10.2215/CJN.11131111; Ponce D, 2011, NEPHROL DIAL TRANSPL, V26, P3202, DOI 10.1093/ndt/gfr359; Porter CJ, 2014, NEPHROL DIAL TRANSPL, V29, P1888, DOI 10.1093/ndt/gfu082; Prakash J, 2010, RENAL FAILURE, V32, P309, DOI 10.3109/08860221003606265; RENAL Study Investigators, 2008, Crit Care Resusc, V10, P225; Rewa O, 2014, NAT REV NEPHROL, V10, P193, DOI 10.1038/nrneph.2013.282; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Rizwan Naushaba, 2011, J Ayub Med Coll Abbottabad, V23, P66; Ng RRG, 2014, J THORAC CARDIOV SUR, V147, P1356, DOI 10.1016/j.jtcvs.2013.09.040; Rosinski AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067320; Safdar A, 2010, MEDICINE, V89, P236, DOI 10.1097/MD.0b013e3181e9441b; Santacruz F, 1996, RENAL FAILURE, V18, P601, DOI 10.3109/08860229609047683; Santos UP, 2015, KIDNEY INT, V87, P792, DOI 10.1038/ki.2014.306; Santos WJQ, 2006, CRIT CARE, V10, DOI 10.1186/cc4904; Saravu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090419; Save the Children, 2012, NUTR 1 1000 DAYS STA; Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494; Selewski DT, 2014, INTENS CARE MED, V40, P1481, DOI 10.1007/s00134-014-3391-8; Sever MS, 2006, NEW ENGL J MED, V354, P1052, DOI 10.1056/NEJMra054329; Sever MS, 2004, J NEPHROL, V17, P399; Sharma SK, 2014, LANCET GLOB HEALTH, V2, pE506, DOI 10.1016/S2214-109X(14)70281-5; Shephard Mark Ds, 2011, Clin Biochem Rev, V32, P109; Siddiqui NF, 2012, CAN MED ASSOC J, V184, P1237, DOI 10.1503/cmaj.110895; Stewart J, 2009, ADDING INSULT INJURY; Suchithra N, 2008, EMERG MED J, V25, P200, DOI 10.1136/emj.2007.051136; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Swaminathan M, 2007, CRIT CARE MED, V35, P2286, DOI 10.1097/01.CCM.0000282079.05994.57; Swaminathan M, 2010, ANN THORAC SURG, V89, P1098, DOI 10.1016/j.athoracsur.2009.12.018; Swanepoel CR, 2013, NAT REV NEPHROL, V9, P610, DOI 10.1038/nrneph.2013.168; Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f; Thomas ME, 2015, NEPHROL DIAL TRANSPL, V30, P239, DOI 10.1093/ndt/gfu316; Thomas ME, 2015, KIDNEY INT, V87, P62, DOI 10.1038/ki.2014.328; Tonelli M, 2014, KIDNEY INT, V85, P1269, DOI 10.1038/ki.2012.488; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Ujah I A O, 2005, Afr J Reprod Health, V9, P27; Vachiat AI, 2013, CLIN KIDNEY J, V6, P584, DOI 10.1093/ckj/sft128; Vanholder R, 2007, KIDNEY INT, V71, P17, DOI 10.1038/sj.ki.5001956; Vanholder R, 2011, NEPHRON CLIN PRACT, V117, pC184, DOI 10.1159/000320200; Vanholder R, 2001, KIDNEY INT, V59, P783, DOI 10.1046/j.1523-1755.2001.059002783.x; Venkataraman R, 2007, CHEST, V131, P300, DOI 10.1378/chest.06-1246; Vikrant S, 2013, RENAL FAILURE, V35, P1338, DOI 10.3109/0886022X.2013.828257; Waikar SS, 2007, CURR OPIN NEPHROL HY, V16, P227, DOI 10.1097/MNH.0b013e3280dd8c35; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; Wald R, 2015, AM J KIDNEY DIS, V65, P870, DOI 10.1053/j.ajkd.2014.10.017; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wasnik Preetam N, 2012, J Assoc Physicians India, V60, P33; William T, 2011, EMERG INFECT DIS, V17, P1248, DOI 10.3201/eid1707.101017; Xu G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004388; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Zeng XX, 2014, CLIN J AM SOC NEPHRO, V9, P12, DOI 10.2215/CJN.02730313; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	205	566	610	7	87	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2616	2643		10.1016/S0140-6736(15)60126-X	http://dx.doi.org/10.1016/S0140-6736(15)60126-X			28	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL4NQ	25777661				2022-12-28	WOS:000356930000029
J	Badawy, AM; Elnashar, AM				Badawy, Ahmed M.; Elnashar, Aboubakr M.			Treatment with misoprostol by midwives is safe and effective	LANCET			English	Editorial Material							INCOMPLETE ABORTION; MEDICAL ABORTION; CARE		[Badawy, Ahmed M.] Mansura Univ, Dept Obstet & Gynecol, Mansoura 35111, Egypt; [Elnashar, Aboubakr M.] Benha Univ, Dept Obstet & Gynecol, Banha, Egypt	Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Benha University	Badawy, AM (corresponding author), Mansura Univ, Dept Obstet & Gynecol, Mansoura 35111, Egypt.	ambadawy@hotmail.com						Bagratee JS, 2004, HUM REPROD, V19, P266, DOI 10.1093/humrep/deh049; Escandon I, 2006, INDICATORS ESSENTIAL; Gessessew A, 2011, INT J GYNECOL OBSTET, V113, P28, DOI 10.1016/j.ijgo.2010.10.023; Kallner HK, 2015, BJOG-INT J OBSTET GY, V122, P510, DOI 10.1111/1471-0528.12982; Klingberg-Allvin M, 2015, LANCET; Nabudere H, 2011, INT J TECHNOL ASSESS, V27, P173, DOI 10.1017/S0266462311000055; National Institute for Health and Care Excellence National Collaborating Centre for Ws. Children's H. National Institute for Health and Clinical excellence: Guidance, 2012, NATL I HEAL CARE EXC; Ngo TD, 2011, B WORLD HEALTH ORGAN, V89, P360, DOI 10.2471/BLT.10.084046; Shochet T, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-127; Shwekerel B, 2007, BJOG-INT J OBSTET GY, V114, P1363, DOI 10.1111/j.1471-0528.2007.01469.x; Tang OS, 2006, CURR OPIN OBSTET GYN, V18, P581, DOI 10.1097/GCO.0b013e32800feedb; Ujah I A O, 2005, Afr J Reprod Health, V9, P27; Warriner IK, 2011, LANCET; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; Yarnall J, 2009, REPROD HEALTH MATTER, V17, P61, DOI 10.1016/S0968-8080(09)33445-X	15	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2335	2337		10.1016/S0140-6736(14)62287-X	http://dx.doi.org/10.1016/S0140-6736(14)62287-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1XV	25817471				2022-12-28	WOS:000356003700011
J	Newby, D; Williams, M; Hunter, A; Pawade, T; Shah, A; Flapan, A; Forbes, J; Hargreaves, A; Leslie, S; Lewis, S; McKillop, G; McLean, S; Reid, J; Spratt, J; Uren, N; Timmis, A; Berry, C; Boon, N; Clark, L; Craig, P; Barlow, T; Flather, M; Forbes, J; McCormack, C; McLean, S; Roditi, G; van Beek, E; Williams, M; Hunter, A; Shepherd, S; Bucukoglu, M; Assi, V; Parker, R; Krishan, A; McCormack, C; Wee, F; Wackett, A; Walker, A; Milne, L; Oatey, K; Neary, P; Donaldson, G; Fairbairn, T; Fotheringham, M; Hargreaves, A; Spratt, J; Glen, S; Perkins, S; Taylor, F; Cram, L; Beveridge, C; Cairns, A; Dougherty, F; Eteiba, H; Rae, A; Robb, K; Crawford, W; Clarkin, P; Lennon, E; Houston, G; Pringle, S; Ramkumar, PG; Sudarshan, T; Fogarty, Y; Barrie, D; Bissett, K; Dawson, A; Dundas, S; Letham, D; O'Neill, L; Ritchie, V; Weir-McCall, J; Dougall, H; Ahmed, F; Cormack, A; Findlay, I; Hood, S; Murphy, C; Peat, E; McCabe, L; McCubbin, M; Allen, B; Behan, M; Bertram, D; Brian, D; Cowan, A; Cruden, N; Denvir, M; Dweck, M; Flint, L; Flapan, A; Fyfe, S; Grubb, N; Keanie, C; Lang, C; MacGillivray, T; MacLachlan, D; MacLeod, M; Mirsadraee, S; Morrison, A; Mills, N; Northridge, D; Phillips, A; Queripel, L; Reid, J; Uren, N; Weir, N; Jacob, A; Bett, F; Divers, F; Fairley, K; Keegan, E; White, T; Fowler, J; Gemmill, J; McGowan, J; Henry, M; Francis, M; Sandeman, D; Dinnel, L; Bloomfield, P; Denvir, M; Henriksen, P; MacLeod, D; Morrison, A; Berry, C; Mangion, K; Mordi, I; Roditi, G; Tzemos, N; Connolly, E; Boylan, H; Brown, A; Farrell, L; Frood, A; Glover, C; Johnstone, J; Lanaghan, K; McGlynn, D; McGregor, L; McLennan, E; Murdoch, L; Paterson, V; Teyhan, F; Teenan, M; Woodward, R; Steedman, T				Newby, David; Williams, Michelle; Hunter, Amanda; Pawade, Tania; Shah, Anoop; Flapan, Andrew; Forbes, John; Hargreaves, Allister; Leslie, Stephen; Lewis, Steff; McKillop, Graham; McLean, Scott; Reid, John; Spratt, James; Uren, Neal; Timmis, Adam; Berry, Colin; Boon, Nicholas; Clark, Liz; Craig, Peter; Barlow, Tom; Flather, Marcus; Forbes, John; McCormack, Chiara; McLean, Scott; Roditi, Giles; van Beek, Edwin; Williams, Michelle; Hunter, Amanda; Shepherd, Susan; Bucukoglu, Marise; Assi, Valentina; Parker, Richard; Krishan, Ashma; McCormack, Chiara; Wee, Fiona; Wackett, Anthony; Walker, Allan; Milne, Lynsey; Oatey, Kat; Neary, Paul; Donaldson, Gillian; Fairbairn, Terry; Fotheringham, Marlene; Hargreaves, Allister; Spratt, James; Glen, Stephen; Perkins, Sarah; Taylor, Fiona; Cram, Louisa; Beveridge, Catherine; Cairns, Avril; Dougherty, Frances; Eteiba, Hany; Rae, Alan; Robb, Kate; Crawford, Wenda; Clarkin, Patricia; Lennon, Elisabeth; Houston, Graeme; Pringle, Stuart; Ramkumar, Prasad Guntur; Sudarshan, Thiru; Fogarty, Yvonne; Barrie, Dawn; Bissett, Kim; Dawson, Adelle; Dundas, Scott; Letham, Deborah; O'Neill, Linda; Ritchie, Valerie; Weir-McCall, Jonathan; Dougall, Hamish; Ahmed, Faheem; Cormack, Alistair; Findlay, Iain; Hood, Stuart; Murphy, Clare; Peat, Eileen; McCabe, Lynne; McCubbin, Margaret; Allen, Barbara; Behan, Miles; Bertram, Danielle; Brian, David; Cowan, Amy; Cruden, Nicholas; Denvir, Martin; Dweck, Marc; Flint, Laura; Flapan, Andrew; Fyfe, Samantha; Grubb, Neil; Keanie, Collette; Lang, Chris; MacGillivray, Tom; MacLachlan, David; MacLeod, Margaret; Mirsadraee, Saeed; Morrison, Avril; Mills, Nicholas; Northridge, David; Phillips, Alyson; Queripel, Laura; Reid, John; Uren, Neal; Weir, Nicholas; Jacob, Ashok; Bett, Fiona; Divers, Frances; Fairley, Katie; Keegan, Edith; White, Tricia; Fowler, Julia; Gemmill, John; McGowan, James; Henry, Margo; Francis, Mark; Sandeman, Dennis; Dinnel, Lorraine; Bloomfield, Peter; Denvir, Martin; Henriksen, Peter; MacLeod, Donald; Morrison, Avril; Berry, Colin; Mangion, Kenneth; Mordi, Ify; Roditi, Giles; Tzemos, Nikolaos; Connolly, Eugene; Boylan, Heather; Brown, Ammani; Farrell, Lesley; Frood, Alison; Glover, Caroline; Johnstone, Janet; Lanaghan, Kirsten; McGlynn, Deborah; McGregor, Lorraine; McLennan, Evonne; Murdoch, Laura; Paterson, Victoria; Teyhan, Fiona; Teenan, Marion; Woodward, Rosie; Steedman, Tracey		SCOT-HEART Investigators	CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial	LANCET			English	Article							COMPUTED-TOMOGRAPHY; RISK; MANAGEMENT; ACCURACY; COHORT	Background The benefit of CT coronary angiography (CTCA) in patients presenting with stable chest pain has not been systematically studied. We aimed to assess the effect of CTCA on the diagnosis, management, and outcome of patients referred to the cardiology clinic with suspected angina due to coronary heart disease. Methods In this prospective open-label, parallel-group, multicentre trial, we recruited patients aged 18-75 years referred for the assessment of suspected angina due to coronary heart disease from 12 cardiology chest pain clinics across Scotland. We randomly assigned (1:1) participants to standard care plus CTCA or standard care alone. Randomisation was done with a web-based service to ensure allocation concealment. The primary endpoint was certainty of the diagnosis of angina secondary to coronary heart disease at 6 weeks. All analyses were intention to treat, and patients were analysed in the group they were allocated to, irrespective of compliance with scanning. This study is registered with ClinicalTrials.gov, number NCT01149590. Findings Between Nov 18, 2010, and Sept 24, 2014, we randomly assigned 4146 (42%) of 9849 patients who had been referred for assessment of suspected angina due to coronary heart disease. 47% of participants had a baseline clinic diagnosis of coronary heart disease and 36% had angina due to coronary heart disease. At 6 weeks, CTCA reclassified the diagnosis of coronary heart disease in 558 (27%) patients and the diagnosis of angina due to coronary heart disease in 481 (23%) patients (standard care 22 [1%] and 23 [1%]; p<0.0001). Although both the certainty (relative risk [RR] 2.56, 95% CI 2.33-2.79; p<0.0001) and frequency of coronary heart disease increased (1.09, 1.02-1.17; p=0.0172), the certainty increased (1.79, 1.62-1.96; p<0.0001) and frequency seemed to decrease (0.93, 0.85-1.02; p=0.1289) for the diagnosis of angina due to coronary heart disease. This changed planned investigations (15% vs 1%; p<0.0001) and treatments (23% vs 5%; p<0.0001) but did not affect 6-week symptom severity or subsequent admittances to hospital for chest pain. After 1.7 years, CTCA was associated with a 38% reduction in fatal and non-fatal myocardial infarction (26 vs 42, HR 0.62, 95% CI 0.38-1.01; p=0.0527), but this was not significant. Interpretation In patients with suspected angina due to coronary heart disease, CTCA clarifies the diagnosis, enables targeting of interventions, and might reduce the future risk of myocardial infarction. Copyright (C) Newby et al. Open Access article distributed under the terms of CC BY.	[Newby, David; Lewis, Steff; Timmis, Adam; Berry, Colin; Boon, Nicholas; Clark, Liz; Craig, Peter; Barlow, Tom; Flather, Marcus; Forbes, John; McCormack, Chiara; McLean, Scott; Roditi, Giles; van Beek, Edwin; Williams, Michelle; Hunter, Amanda; Shepherd, Susan; Bucukoglu, Marise] Trial Steering Comm, London, England; [Lewis, Steff; Assi, Valentina; Parker, Richard; Krishan, Ashma; McCormack, Chiara; Wee, Fiona; Wackett, Anthony; Walker, Allan; Milne, Lynsey; Oatey, Kat] Edinburgh Clin Trials Unit, Edinburgh, Midlothian, Scotland; [Neary, Paul; Donaldson, Gillian; Fairbairn, Terry; Fotheringham, Marlene] Borders Gen Hosp, Melrose, Scotland; [Hargreaves, Allister; Spratt, James; Glen, Stephen; Perkins, Sarah; Taylor, Fiona; Cram, Louisa; Beveridge, Catherine; Cairns, Avril; Dougherty, Frances] Forth Valley Royal Hosp, Larbert, England; [Eteiba, Hany; Rae, Alan; Robb, Kate; Crawford, Wenda; Clarkin, Patricia; Lennon, Elisabeth] Glasgow Royal Infirm, Glasgow, Lanark, Scotland; [Houston, Graeme; Pringle, Stuart; Ramkumar, Prasad Guntur; Sudarshan, Thiru; Fogarty, Yvonne; Barrie, Dawn; Bissett, Kim; Dawson, Adelle; Dundas, Scott; Letham, Deborah; O'Neill, Linda; Ritchie, Valerie; Weir-McCall, Jonathan] Ninewells Hosp, Dundee DD1 9SY, Scotland; [Dougall, Hamish] Perth Royal Infirm, Perth, Scotland; [Ahmed, Faheem; Cormack, Alistair; Findlay, Iain; Hood, Stuart; Murphy, Clare; Peat, Eileen; McCabe, Lynne; McCubbin, Margaret] Royal Alexandra Hosp, Paisley, Renfrew, Scotland; [van Beek, Edwin; Allen, Barbara; Behan, Miles; Bertram, Danielle; Brian, David; Cowan, Amy; Cruden, Nicholas; Denvir, Martin; Dweck, Marc; Flint, Laura; Flapan, Andrew; Fyfe, Samantha; Grubb, Neil; Keanie, Collette; Lang, Chris; MacGillivray, Tom; MacLachlan, David; MacLeod, Margaret; Mirsadraee, Saeed; Morrison, Avril; Mills, Nicholas; Northridge, David; Phillips, Alyson; Queripel, Laura; Reid, John; Uren, Neal; Weir, Nicholas] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland; [Jacob, Ashok; Bett, Fiona; Divers, Frances; Fairley, Katie; Keegan, Edith; White, Tricia; Fowler, Julia] St Johns Hosp, Livingston, Scotland; [Gemmill, John; McGowan, James; Henry, Margo] Univ Hosp, Ayr, Scotland; [Francis, Mark; Sandeman, Dennis; Dinnel, Lorraine] Victoria Hosp, Kirkcaldy, Scotland; [Newby, David; Bloomfield, Peter; Denvir, Martin; Henriksen, Peter; MacLeod, Donald; Morrison, Avril] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Berry, Colin; Berry, Colin; Mangion, Kenneth; Mordi, Ify; Roditi, Giles; Tzemos, Nikolaos; Connolly, Eugene; Boylan, Heather; Brown, Ammani; Farrell, Lesley; Frood, Alison; Glover, Caroline; Johnstone, Janet; Lanaghan, Kirsten; McGlynn, Deborah; McGregor, Lorraine; McLennan, Evonne; Murdoch, Laura; Paterson, Victoria; Teyhan, Fiona; Teenan, Marion; Woodward, Rosie; Steedman, Tracey] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland; [Berry, Colin; Mangion, Kenneth; Mordi, Ify; Roditi, Giles; Tzemos, Nikolaos; Connolly, Eugene; Boylan, Heather; Brown, Ammani; Farrell, Lesley; Frood, Alison; Glover, Caroline; Johnstone, Janet; Lanaghan, Kirsten; McGlynn, Deborah; McGregor, Lorraine; McLennan, Evonne; Murdoch, Laura; Paterson, Victoria; Teyhan, Fiona; Teenan, Marion; Woodward, Rosie; Steedman, Tracey] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Dundee; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; University of Glasgow; University of Glasgow	Newby, D (corresponding author), Univ Edinburgh, Ctr Cardiovasc Sci, British Heart Fdn, Chancellors Bldg, Edinburgh EH16 4SA, Midlothian, Scotland.	d.e.newby@ed.ac.uk	Spratt, James/AAH-3589-2020; Williams, Michelle C/K-7555-2012; Mordi, Ify/J-9920-2019; Newby, David Ernest/AAB-1364-2019; 刘, 李陆/H-8469-2015; Berry, Colin/AAF-5268-2020; Roditi, Giles H/AAV-9565-2021; Henriksen, Peter/W-2164-2019; Dweck, Marc/AAY-1509-2021	Spratt, James/0000-0001-8719-4538; Williams, Michelle C/0000-0003-3556-2428; Mordi, Ify/0000-0002-2686-729X; Henriksen, Peter/0000-0003-4974-0344; dweck, marc/0000-0001-9847-5917; Mills, Nicholas/0000-0003-0533-7991; Shah, Anoop/0000-0002-2825-3419; Fairbairn, Tim/0000-0003-1491-6231; Sandeman, Dennis/0000-0003-4626-9024; Lewis, Steff/0000-0003-1210-2314	The Chief Scientist Office of the Scottish Government Health and Social Care Directorates [CZH/4/588]; Edinburgh and Lothian's Health Foundation Trust; Heart Diseases Research Fund; British Heart Foundation [CH/09/002, FS/11/014]; Wellcome Trust [WT103782AIA]; Barts Cardiovascular Biomedical Research Unit - National Institute for Health Research; Scottish Imaging Network: A Platform of Scientific Excellence (SINAPSE); National Health Service Research Scotland (NRS) through National Health Service Lothian Health Board; National Health Service Research Scotland (NRS); British Heart Foundation [FS/14/78/31020] Funding Source: researchfish; Medical Research Council [MR/K006584/1] Funding Source: researchfish; Chief Scientist Office [CZH/4/588] Funding Source: researchfish	The Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Edinburgh and Lothian's Health Foundation Trust; Heart Diseases Research Fund; British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Barts Cardiovascular Biomedical Research Unit - National Institute for Health Research; Scottish Imaging Network: A Platform of Scientific Excellence (SINAPSE); National Health Service Research Scotland (NRS) through National Health Service Lothian Health Board; National Health Service Research Scotland (NRS); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The Chief Scientist Office of the Scottish Government Health and Social Care Directorates funded the trial with supplementary awards from Edinburgh and Lothian's Health Foundation Trust and the Heart Diseases Research Fund.; This trial was funded by The Chief Scientist Office of the Scottish Government Health and Social Care Directorates (CZH/4/588), with supplementary awards from Edinburgh and Lothian's Health Foundation Trust and the Heart Diseases Research Fund. DN (CH/09/002) and MW (FS/11/014) are supported by the British Heart Foundation. DEN is the recipient of a Wellcome Trust Senior Investigator Award (WT103782AIA). AT is supported by Barts Cardiovascular Biomedical Research Unit, funded by the National Institute for Health Research. EvB is supported by the Scottish Imaging Network: A Platform of Scientific Excellence (SINAPSE). The Royal Bank of Scotland supported the provision of 320-multidetector CT for NHS Lothian and the University of Edinburgh. The Clinical Research Imaging Centre (Edinburgh) is supported by the National Health Service Research Scotland (NRS) through National Health Service Lothian Health Board. The Clinical Research Facility Glasgow and Clinical Research Facility Tayside are supported by National Health Service Research Scotland (NRS).	Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Boyle RM, 2007, HEART, V93, P415, DOI 10.1136/hrt.2006.100248; Dewey M, 2009, CIRCULATION, V120, P867, DOI 10.1161/CIRCULATIONAHA.109.859280; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; GANDHI MM, 1995, BRIT HEART J, V73, P193; Hoffmann U, 2012, NEW ENGL J MED, V367, P299, DOI 10.1056/NEJMoa1201161; KRAVITZ RL, 1995, JAMA-J AM MED ASSOC, V274, P632, DOI 10.1001/jama.274.8.632; Layritz C, 2014, EUR HEART J-CARD IMG, V15, P1238, DOI 10.1093/ehjci/jeu113; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Mowatt G, 2008, HEALTH TECHNOL ASSES, V12, p[iii, ix]; National Institute for Health and Care Excellence (NICE), 2010, CHEST PAIN REC ONS A, V95; Newby DE, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-184; Newby DE, 1998, QJM-MON J ASSOC PHYS, V91, P333, DOI 10.1093/qjmed/91.5.333; Schroeder S, 2008, EUR HEART J, V29, P531, DOI 10.1093/eurheartj/ehm544; Sekhri N, 2007, HEART, V93, P458, DOI 10.1136/hrt.2006.090894; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	19	566	596	3	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2383	2391		10.1016/S0140-6736(15)60291-4	http://dx.doi.org/10.1016/S0140-6736(15)60291-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1XV	25788230	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000356003700031
J	Kaukonen, KM; Bailey, M; Pilcher, D; Cooper, DJ; Bellomo, R				Kaukonen, Kirsi-Maija; Bailey, Michael; Pilcher, David; Cooper, D. Jamie; Bellomo, Rinaldo			Systemic Inflammatory Response Syndrome Criteria in Defining Severe Sepsis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GOAL-DIRECTED RESUSCITATION; NEW-ZEALAND RISK; MORTALITY; ADULTS; PREDICTION; THERAPY; TIME; SIRS	BACKGROUND The consensus definition of severe sepsis requires suspected or proven infection, organ failure, and signs that meet two or more criteria for the systemic inflammatory response syndrome (SIRS). We aimed to test the sensitivity, face validity, and construct validity of this approach. METHODS We studied data from patients from 172 intensive care units in Australia and New Zealand from 2000 through 2013. We identified patients with infection and organ failure and categorized them according to whether they had signs meeting two or more SIRS criteria (SIRS-positive severe sepsis) or less than two SIRS criteria (SIRS-negative severe sepsis). We compared their characteristics and outcomes and assessed them for the presence of a step increase in the risk of death at a threshold of two SIRS criteria. RESULTS Of 1,171,797 patients, a total of 109,663 had infection and organ failure. Among these, 96,385 patients (87.9%) had SIRS-positive severe sepsis and 13,278 (12.1%) had SIRS-negative severe sepsis. Over a period of 14 years, these groups had similar characteristics and changes in mortality (SIRS-positive group: from 36.1% [829 of 2296 patients] to 18.3% [2037 of 11,119], P<0.001; SIRS-negative group: from 27.7% [100 of 361] to 9.3% [122 of 1315], P<0.001). Moreover, this pattern remained similar after adjustment for baseline characteristics (odds ratio in the SIRS-positive group, 0.96; 95% confidence interval [CI], 0.96 to 0.97; odds ratio in the SIRS-negative group, 0.96; 95% CI, 0.94 to 0.98; P = 0.12 for between-group difference). In the adjusted analysis, mortality increased linearly with each additional SIRS criterion (odds ratio for each additional criterion, 1.13; 95% CI, 1.11 to 1.15; P<0.001) without any transitional increase in risk at a threshold of two SIRS criteria. CONCLUSIONS The need for two or more SIRS criteria to define severe sepsis excluded one in eight otherwise similar patients with infection, organ failure, and substantial mortality and failed to define a transition point in the risk of death.	[Kaukonen, Kirsi-Maija; Bailey, Michael; Pilcher, David; Cooper, D. Jamie; Bellomo, Rinaldo] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Pilcher, David] Australian & New Zealand Intens Care Soc, Ctr Outcome & Resource Evaluat, Melbourne, Vic, Australia; [Pilcher, David] Alfred Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Bellomo, Rinaldo] Austin Hlth, Intens Care Unit, Heidelberg, Vic, Australia; [Kaukonen, Kirsi-Maija] Univ Helsinki, Cent Hosp, Dept Anesthesiol Intens Care & Pain Med, Neurosurg Unit, Helsinki, Finland	Monash University; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Helsinki; Helsinki University Central Hospital	Bellomo, R (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Alfred Ctr, Level 6,99 Commercial Rd, Melbourne, Vic 3004, Australia.	rinaldo.bellomo@austin.org.au	Bailey, Michael J/A-4499-2012; Cooper, D. James/G-7961-2013	Bailey, Michael J/0000-0002-5551-1401; Cooper, D. James/0000-0002-5872-9051; Pilcher, David/0000-0002-8939-7985; Bellomo, Rinaldo/0000-0002-1650-8939	Australian and New Zealand Intensive Care Research Centre	Australian and New Zealand Intensive Care Research Centre	Funded by the Australian and New Zealand Intensive Care Research Centre.	Alberti C, 2005, AM J RESP CRIT CARE, V171, P461, DOI 10.1164/rccm.200403-324OC; Annane D, 2010, JAMA-J AM MED ASSOC, V303, P1698; Annane D, 2010, JAMA-J AM MED ASSOC, V303, P341, DOI 10.1001/jama.2010.2; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Karlsson S, 2007, INTENS CARE MED, V33, P435, DOI 10.1007/s00134-006-0504-z; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Liao MM, 2014, AM J EMERG MED, V32, P1319, DOI 10.1016/j.ajem.2014.07.035; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Paul E, 2012, ANAESTH INTENS CARE, V40, P980, DOI 10.1177/0310057X1204000609; Paul E, 2013, J CRIT CARE, V28, P935, DOI 10.1016/j.jcrc.2013.07.058; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Pilcher D, 2014, CRIT CARE RESUSC, V16, P3; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Sprung CL, 2006, INTENS CARE MED, V32, P421, DOI 10.1007/s00134-005-0039-8; Stow PJ, 2006, J CRIT CARE, V21, P133, DOI 10.1016/j.jcrc.2005.11.010; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Vincent JL, 1997, CRIT CARE MED, V25, P372, DOI 10.1097/00003246-199702000-00029	27	646	711	6	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2015	372	17					1629	1638		10.1056/NEJMoa1415236	http://dx.doi.org/10.1056/NEJMoa1415236			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4XX	25776936				2022-12-28	WOS:000353294000008
J	Snyder, MW; Simmons, LE; Kitzman, JO; Coe, BP; Henson, JM; Daza, RM; Eichler, EE; Shendure, J; Gammill, HS				Snyder, Matthew W.; Simmons, LaVone E.; Kitzman, Jacob O.; Coe, Bradley P.; Henson, Jessica M.; Daza, Riza M.; Eichler, Evan E.; Shendure, Jay; Gammill, Hilary S.			Copy-Number Variation and False Positive Prenatal Aneuploidy Screening Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL-FREE DNA; FETAL DNA; ABNORMALITIES; TRISOMY-18; MOSAICISM; DIAGNOSIS	Investigations of noninvasive prenatal screening for aneuploidy by analysis of circulating cell-free DNA (cfDNA) have shown high sensitivity and specificity in both high-risk and low-risk cohorts. However, the overall low incidence of aneuploidy limits the positive predictive value of these tests. Currently, the causes of false positive results are poorly understood. We investigated four pregnancies with discordant prenatal test results and found in two cases that maternal duplications on chromosome 18 were the likely cause of the discordant results. Modeling based on population-level copy-number variation supports the possibility that some false positive results of noninvasive prenatal screening may be attributable to large maternal copy-number variants.	[Snyder, Matthew W.; Kitzman, Jacob O.; Coe, Bradley P.; Daza, Riza M.; Eichler, Evan E.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Simmons, LaVone E.; Henson, Jessica M.; Gammill, Hilary S.] Univ Washington, Dept Obstet & Gynecol, Div Maternal Fetal Med, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Gammill, Hilary S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@uw.edu; hgammill@uw.edu	Shendure, Jay/AAU-3684-2021; Coe, Bradley/A-2878-2009; Daza, Riza M./HCH-4047-2022	Kitzman, Jacob/0000-0002-6145-882X; Snyder, Matthew/0000-0001-7433-4343; Coe, Bradley/0000-0001-8471-4016	National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD067221] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [DP1HG007811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by the National Institutes of Health and others.	Ashoor G, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.029; Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; Cheung SW, 2015, NEW ENGL J MED, V372, P1675, DOI 10.1056/NEJMc1412222; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Grati FR, 2014, GENET MED, V16, P620, DOI 10.1038/gim.2014.3; Lau TK, 2014, ULTRASOUND OBST GYN, V43, P254, DOI 10.1002/uog.13277; Lau TK, 2013, PRENATAL DIAG, V33, P602, DOI 10.1002/pd.4076; Mao J, 2014, CLIN CHIM ACTA, V433, P190, DOI 10.1016/j.cca.2014.03.011; Mennuti MT, 2013, AM J OBSTET GYNECOL, V209, P415, DOI 10.1016/j.ajog.2013.03.027; Nicolaides KH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.033; Norton ME, 2015, NEW ENGL J MED, V372, P1589, DOI 10.1056/NEJMoa1407349; Nygren AOH, 2010, CLIN CHEM, V56, P1627, DOI 10.1373/clinchem.2010.146290; Osborne CM, 2013, PRENATAL DIAG, V33, P609, DOI 10.1002/pd.4100; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Rava RP, 2014, CLIN CHEM, V60, P243, DOI 10.1373/clinchem.2013.207951; Sparks AB, 2012, PRENATAL DIAG, V32, P3, DOI 10.1002/pd.2922; Srinivasan A, 2013, AM J HUM GENET, V92, P167, DOI 10.1016/j.ajhg.2012.12.006; Wang YL, 2014, CLIN CHEM, V60, P251, DOI 10.1373/clinchem.2013.215145; Zimmermann B, 2012, PRENATAL DIAG, V32, P1233, DOI 10.1002/pd.3993	20	92	109	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2015	372	17					1639	1645		10.1056/NEJMoa1408408	http://dx.doi.org/10.1056/NEJMoa1408408			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4XX	25830323	Green Accepted			2022-12-28	WOS:000353294000009
J	Manian, FA; Alame, D				Manian, Farrin A.; Alame, Diana			Case 11-2015: A 28-Year-Old Woman with Headache, Fever, and a Rash	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PURPURA FULMINANS; BACTERIAL-MENINGITIS; CLINICAL-FEATURES; MENINGOCOCCAL DISEASE; ADULTS; DIAGNOSIS; PATHOGENESIS; INFECTION; FAILURE; SEPSIS		[Manian, Farrin A.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Alame, Diana] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Manian, Farrin A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Alame, Diana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Manian, FA (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Akil I, 2004, PEDIATR NEPHROL, V19, P237, DOI 10.1007/s00467-003-1345-4; Barak V, 1998, AM J MED, V104, P40, DOI 10.1016/S0002-9343(97)00275-1; Bennett JE, 2015, MANDELL DOUGLAS BENN; Betrosian AP, 2006, AM J MED SCI, V332, P339, DOI 10.1097/00000441-200612000-00006; Block SL, 2014, PEDIATR ANN, V43, P297, DOI 10.3928/00904481-20140723-03; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Rodriguez SC, 2006, MEDICINE, V85, P214, DOI 10.1097/01.md.0000229757.78057.50; Centers for Disease Control and Prevention, 2012, PCR DET CHAR BACT ME; Centers for Disease Control and Prevention, 2014, MEN DIS TECHN CLIN I; Chambers HF, 2005, CLIN INFECT DIS, V40, P948, DOI 10.1086/428584; Delgado-Jimenez Y, 2013, INT J DERMATOL, V52, P1071, DOI 10.1111/j.1365-4632.2012.05468.x; Densen P, 2010, MANDELL DOUGLAS BENN, P77; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Endo A, 2014, J INTENSIVE CARE, V2, DOI 10.1186/2052-0492-2-13; FEIGIN RD, 1973, NEW ENGL J MED, V289, P571, DOI 10.1056/NEJM197309132891108; GEISELER PJ, 1982, SOUTHERN MED J, V75, P448, DOI 10.1097/00007611-198204000-00018; Glaser CA, 2012, CLIN INFECT DIS, V55, P514, DOI 10.1093/cid/cis454; Guarner J, 2004, AM J CLIN PATHOL, V122, P754, DOI 10.1309/3489075U03LMK9AE; Heckenberg SGB, 2008, MEDICINE, V87, P185, DOI 10.1097/MD.0b013e318180a6b4; Heegaard ED, 2002, CLIN MICROBIOL REV, V15, P485, DOI 10.1128/CMR.15.3.485-505.2002; Huang CR, 2007, JPN J INFECT DIS, V60, P397; Ihekwaba UK, 2008, CLIN INFECT DIS, V47, P783, DOI 10.1086/591129; Kim M, 2008, J NEUROCRIT CARE, V1, P62; KULLBERG BJ, 1991, MEDICINE, V70, P287, DOI 10.1097/00005792-199109000-00001; Lewis LA, 2014, VIRULENCE, V5, P98, DOI 10.4161/viru.26515; MASSEY EW, 1985, SOUTHERN MED J, V78, P1288, DOI 10.1097/00007611-198511000-00004; McQueen A, 2012, J FAM PRACTICE, V61, P71; Mofredj A, 2000, AM J MED, V109, P71, DOI 10.1016/S0002-9343(00)00439-3; Pollard AJ, 1999, ARCH DIS CHILD, V80, P290, DOI 10.1136/adc.80.3.290; Ram S, 2010, CLIN MICROBIOL REV, V23, P740, DOI 10.1128/CMR.00048-09; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Seehusen DA, 2003, AM FAM PHYSICIAN, V68, P1103; Simerville JA, 2005, AM FAM PHYSICIAN, V71, P1153; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Stephens DS, 2011, LANCET INFECT DIS, V11, P421, DOI 10.1016/S1473-3099(11)70096-2; Stephens DS, 1999, LANCET, V353, P941, DOI 10.1016/S0140-6736(98)00279-7; Steppberger K, 2001, INFECTION, V29, P286, DOI 10.1007/s15010-001-1065-2; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Taylor GH, 2003, AM FAM PHYSICIAN, V67, P519; Tebruegge M, 2008, CLIN MICROBIOL REV, V21, P519, DOI 10.1128/CMR.00009-08; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Yagupsky P, 2011, PEDIATRICS, V127, P557, DOI 10.1542/peds.2010-1867	44	0	0	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2015	372	15					1454	1462		10.1056/NEJMcpc1415165	http://dx.doi.org/10.1056/NEJMcpc1415165			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF2ZV	25853750				2022-12-28	WOS:000352417900012
J	Cohen, AB; Trentalange, M; Fried, T				Cohen, Andrew B.; Trentalange, Mark; Fried, Terri			Patients With Next-of-Kin Relationships Outside the Nuclear Family	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Cohen, Andrew B.; Trentalange, Mark] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; [Fried, Terri] VA Connecticut Hlth Syst, West Haven, CT USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Cohen, AB (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Geriatr, 333 Cedar St, New Haven, CT 06520 USA.	andrew.b.cohen@yale.edu		Cohen, Andrew/0000-0001-9161-8436	NIA NIH HHS [T32AG1934, P30AG021342, P30 AG021342, T32 AG019134] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG001934, T32AG019134, P30AG021342] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agree E.M., 2012, HDB FAMILIES AGING, V2nd ed., P9; American Bar Association, DEF SURR CONS STAT; Bravo G, 2008, SOC SCI MED, V67, P1122, DOI 10.1016/j.socscimed.2008.06.006; Castillo LS, 2011, ANN INTERN MED, V154, P121, DOI 10.7326/0003-4819-154-2-201101180-00012; Pope Thaddeus Mason, 2012, J Clin Ethics, V23, P84; US Department of Veterans Affairs, PROF VET 2012 DAT AM	6	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2015	313	13					1369	1370		10.1001/jama.2015.2409	http://dx.doi.org/10.1001/jama.2015.2409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF1OL	25849183	Green Accepted, Bronze			2022-12-28	WOS:000352315900025
J	Birn, AE; Nervi, L				Birn, Anne-Emanuelle; Nervi, Laura			Political roots of the struggle for health justice in Latin America	LANCET			English	Biographical-Item									[Birn, Anne-Emanuelle] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; [Nervi, Laura] Univ New Mexico, Publ Hlth Program, Albuquerque, NM 87131 USA; [Nervi, Laura] Human Ecol Inst, Concepcion, Chile	University of Toronto; University of New Mexico	Birn, AE (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada.	ae.birn@utoronto.ca						PUBLICATION LIST	1	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1174	1175		10.1016/S0140-6736(14)61844-4	http://dx.doi.org/10.1016/S0140-6736(14)61844-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE3GQ	25845782				2022-12-28	WOS:000351715100017
J	Searchinger, T; Edwards, R; Mulligan, D; Heimlich, R; Plevin, R				Searchinger, T.; Edwards, R.; Mulligan, D.; Heimlich, R.; Plevin, R.			Do biofuel policies seek to cut emissions by cutting food?	SCIENCE			English	Editorial Material									[Searchinger, T.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Edwards, R.; Mulligan, D.] Commiss European Communities, Joint Res Ctr, I-21027 Ispra, Italy; [Heimlich, R.] Agr Conservat Econ, Laurel, MD 20723 USA; [Plevin, R.] Univ Calif Davis, Inst Transportat Studies, Davis, CA 95616 USA	Princeton University; European Commission Joint Research Centre; EC JRC ISPRA Site; University of California System; University of California Davis	Searchinger, T (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.	tsearchi@princeton.edu; robert.edwards@jrc.it						Berry S., 2011, BIOFUEL POLICY EMPIR; CARB, 2009, PROPOSED REGULATION, VI; Decara S.A., 2012, LAND USE CHANGE ENV; Dorward A, 2012, FOOD SECUR, V4, P633, DOI 10.1007/s12571-012-0210-3; Edwards R, 2010, INDIRECT LAND USE CH, DOI 10.2788/54137; Filipski M., 2010, AGR POLICIES POVERTY; Finkbeiner M, 2014, BIOMASS BIOENERG, V62, P218, DOI 10.1016/j.biombioe.2014.01.024; Food and Agricultural Policy Research Institute, EL DAT; High Level Panel on Food Security, 2011, PRIC VOL FOOD SEC; High Level Panel on Food Security, 2013, BIOF FOOD SEC; Hochman G, 2014, BIOMASS BIOENERG, V68, P106, DOI 10.1016/j.biombioe.2014.06.012; Laborde D., 2011, ASSESSING LAND USE C; National Research Council, 2011, REN FUEL STAND POT E; Plevin RJ, 2014, J IND ECOL, V18, P73, DOI 10.1111/jiec.12074; Roberts MJ, 2013, AM ECON REV, V103, P2265, DOI 10.1257/aer.103.6.2265; Searchinger TD, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024007; Searchinger TD, 2009, SCIENCE, V326, P527, DOI 10.1126/science.1178797; U.S. Environmental Protection Agency, 2010, REN FUEL STAND PROGR; UK Renewable Fuels Agency, 2008, GALL REV IND EFF BIO; Zilberman D., 2010, AGBIOL FORUM, V13, P11	20	62	62	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1420	1422		10.1126/science.1261221	http://dx.doi.org/10.1126/science.1261221			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AT	25814570				2022-12-28	WOS:000352136400023
J	Chantranupong, L; Wolfson, RL; Sabatini, DM				Chantranupong, Lynne; Wolfson, Rachel L.; Sabatini, David M.			Nutrient-Sensing Mechanisms across Evolution	CELL			English	Review							ACTIVATED PROTEIN-KINASE; GLUTAMINE-SYNTHETASE ADENYLYLATION; SIGNAL-TRANSDUCTION PROTEINS; ADENYLATE ENERGY-CHARGE; AMINO-ACID DEPRIVATION; GTP-BINDING PROTEINS; P70 S6 KINASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; FISSION YEAST	For organisms to coordinate their growth and development with nutrient availability, they must be able to sense nutrient levels in their environment. Here, we review select nutrient-sensing mechanisms in a few diverse organisms. We discuss how these mechanisms reflect the nutrient requirements of specific species and how they have adapted to the emergence of multicellularity in eukaryotes.	[Chantranupong, Lynne; Wolfson, Rachel L.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Chantranupong, Lynne; Wolfson, Rachel L.; Sabatini, David M.] MIT, Cambridge Ctr 9, Dept Biol, Cambridge, MA 02142 USA; [Chantranupong, Lynne; Wolfson, Rachel L.; Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Chantranupong, Lynne; Wolfson, Rachel L.; Sabatini, David M.] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256	NIH [R01 CA103866, AI47389, F31 CA180271, T32 GM007753]; Department of Defense [W81XWH- 07-0448]; NATIONAL CANCER INSTITUTE [F31CA180271, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM007287] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Zhi-Yang Tsun for insightful input and Tom DiCesare for assistance with figures. This work was supported by grants from the NIH (R01 CA103866 and AI47389) and Department of Defense (W81XWH- 07-0448) to D.M.S. and by fellowship support from the NIH to L.C. (F31 CA180271) and to R.L.W. (T32 GM007753). D.M.S. is an Investigator of the Howard Hughes Medical Institute.	ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; Abdel-Sater F, 2004, MOL CELL BIOL, V24, P9771, DOI 10.1128/MCB.24.22.9771-9785.2004; Abdel-Sater F, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.200592; ADLER SP, 1975, J BIOL CHEM, V250, P6264; Anand GS, 2002, BIOCHEMISTRY-US, V41, P6752, DOI 10.1021/bi012102n; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Andrade SLA, 2005, ACTA CRYSTALLOGR F, V61, P861, DOI 10.1107/S1744309105027004; Andreasson C, 2006, GENE DEV, V20, P1563, DOI 10.1101/gad.374206; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Bernard F, 2001, MOL MICROBIOL, V41, P489, DOI 10.1046/j.1365-2958.2001.02538.x; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; BISSON LF, 1987, J BACTERIOL, V169, P1656, DOI 10.1128/jb.169.4.1656-1662.1987; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; Bjordal M, 2014, CELL, V156, P510, DOI 10.1016/j.cell.2013.12.024; BORKOVICH KA, 1989, P NATL ACAD SCI USA, V86, P1208, DOI 10.1073/pnas.86.4.1208; BORKOVICH KA, 1990, CELL, V63, P1339, DOI 10.1016/0092-8674(90)90429-I; Bourrellier ABF, 2010, P NATL ACAD SCI USA, V107, P502, DOI 10.1073/pnas.0910097107; Braun KA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005000; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Briegel A, 2009, P NATL ACAD SCI USA, V106, P17181, DOI 10.1073/pnas.0905181106; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; CAFFERKEY R, 1993, MOL CELL BIOL, V13, P6012, DOI 10.1128/MCB.13.10.6012; CARLING D, 1986, BIOCHEM SOC T, V14, P1076, DOI 10.1042/bst0141076; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; CARLSON M, 1981, GENETICS, V98, P25; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010; Davis MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027434; De Virgilio C, 2006, INT J BIOCHEM CELL B, V38, P1476, DOI 10.1016/j.biocel.2006.02.013; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; DIALLINAS G, 1994, GENE, V143, P21, DOI 10.1016/0378-1119(94)90599-1; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Dietrich MO, 2011, CELL, V146, P863, DOI 10.1016/j.cell.2011.08.031; DUBOIS E, 1979, MOL GEN GENET, V175, P67, DOI 10.1007/BF00267857; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Dyer CM, 2009, J MOL BIOL, V388, P71, DOI 10.1016/j.jmb.2009.02.004; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Eisenbach M, 1996, MOL MICROBIOL, V20, P903, DOI 10.1111/j.1365-2958.1996.tb02531.x; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; Forchhammer K, 2007, FRONT BIOSCI-LANDMRK, V12, P358, DOI 10.2741/2069; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; GARVIN JL, 1988, AM J PHYSIOL, V255, pF56; Gietzen DW, 2004, J NUTR, V134, P717, DOI 10.1093/jn/134.4.717; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Gowans GJ, 2014, BIOCHEM SOC T, V42, P71, DOI 10.1042/BST20130244; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; HARDIE DG, 1992, BIOESSAYS, V14, P699, DOI 10.1002/bies.950141011; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; HARMS E, 1981, BIOCHEM BIOPH RES CO, V99, P830, DOI 10.1016/0006-291X(81)91239-0; HEDBLOM ML, 1980, J BACTERIOL, V144, P1048, DOI 10.1128/JB.144.3.1048-1060.1980; Heinrich A, 2004, MOL MICROBIOL, V52, P1303, DOI 10.1111/j.1365-2958.2004.04058.x; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; HESS JF, 1987, P NATL ACAD SCI USA, V84, P7609, DOI 10.1073/pnas.84.21.7609; HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HINNEBUSCH AG, 1993, MOL MICROBIOL, V10, P215, DOI 10.1111/j.1365-2958.1993.tb01947.x; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; Hirose E, 1998, J CELL SCI, V111, P11; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Howell JJ, 2013, BIOCHEM SOC T, V41, P906, DOI 10.1042/BST20130041; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jaggi R, 1997, EMBO J, V16, P5562, DOI 10.1093/emboj/16.18.5562; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Jiang P, 1998, BIOCHEMISTRY-US, V37, P12802, DOI 10.1021/bi980666u; Jiang P, 1998, BIOCHEMISTRY-US, V37, P12795, DOI 10.1021/bi9802420; Jiang P, 1998, BIOCHEMISTRY-US, V37, P12782, DOI 10.1021/bi980667m; Jiang P, 2007, BIOCHEMISTRY-US, V46, P12979, DOI 10.1021/bi701062t; Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017; Jouandot D, 2011, J CELL BIOCHEM, V112, P3268, DOI 10.1002/jcb.23253; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim JH, 2006, EUKARYOT CELL, V5, P167, DOI 10.1128/EC.5.1.167-173.2006; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; Kim SG, 2013, MOL CELLS, V35, P463, DOI 10.1007/s10059-013-0138-2; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; Klasson H, 1999, MOL CELL BIOL, V19, P5405; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; KNEPPER MA, 1989, PHYSIOL REV, V69, P179, DOI 10.1152/physrev.1989.69.1.179; Koehnle TJ, 2003, J NUTR, V133, P2331, DOI 10.1093/jn/133.7.2331; Kogan K, 2010, J MOL BIOL, V402, P388, DOI 10.1016/j.jmb.2010.07.034; KONDOH H, 1979, P NATL ACAD SCI USA, V76, P260, DOI 10.1073/pnas.76.1.260; Krokowski D, 2013, J BIOL CHEM, V288, P17202, DOI 10.1074/jbc.M113.466920; Kubler E, 1997, J BIOL CHEM, V272, P20321, DOI 10.1074/jbc.272.33.20321; Kubota H, 2003, J BIOL CHEM, V278, P20457, DOI 10.1074/jbc.C300133200; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lakshmanan J, 2003, CURR GENET, V44, P19, DOI 10.1007/s00294-003-0423-2; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LARSEN SH, 1974, NATURE, V249, P74, DOI 10.1038/249074a0; Laxman S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005948; Laxman S, 2013, CELL, V154, P416, DOI 10.1016/j.cell.2013.06.043; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Levit MN, 2002, J BIOL CHEM, V277, P36748, DOI 10.1074/jbc.M204317200; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Ma N, 2013, GENETICS, V195, P457, DOI 10.1534/genetics.113.154674; MADDOCK JR, 1993, SCIENCE, V259, P1717; MANGUM JH, 1973, ARCH BIOCHEM BIOPHYS, V158, P514, DOI 10.1016/0003-9861(73)90543-2; MANSON MD, 1986, NATURE, V321, P253, DOI 10.1038/321253a0; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; MASANORI BY, 1992, MOL CELL BIOL, V12, P2958, DOI 10.1128/MCB.12.7.2958; Matsumoto S, 2002, GENETICS, V161, P1053; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; Morris R.E., 1992, TRANSPLANT REV-ORLAN, P39; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Omnus DJ, 2013, MOL BIOL CELL, V24, P1480, DOI 10.1091/mbc.E13-01-0019; Omnus DJ, 2011, MOL BIOL CELL, V22, P2754, DOI 10.1091/mbc.E11-04-0282; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Panchaud N, 2013, CELL CYCLE, V12, P2948, DOI 10.4161/cc.26000; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Papamichos-Chronakis M, 2004, EMBO REP, V5, P368, DOI 10.1038/sj.embor.7400120; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Pfirrmann T, 2010, MOL CELL BIOL, V30, P3299, DOI 10.1128/MCB.00323-10; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Polish JA, 2005, GENETICS, V169, P583, DOI 10.1534/genetics.104.034512; Poulsen P, 2008, MOL MEMBR BIOL, V25, P164, DOI 10.1080/09687680701771917; Radchenko MV, 2013, P NATL ACAD SCI USA, V110, P12948, DOI 10.1073/pnas.1304386110; READER RW, 1979, J GEN MICROBIOL, V111, P363, DOI 10.1099/00221287-111-2-363; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Ribeiro C, 2010, CURR BIOL, V20, P1000, DOI 10.1016/j.cub.2010.03.061; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Roy A, 2013, MOL BIOL CELL, V24, P1493, DOI 10.1091/mbc.E13-01-0047; Rutherford JC, 2008, MOL BIOL CELL, V19, P3028, DOI 10.1091/mbc.E08-01-0033; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarkar MK, 2010, P NATL ACAD SCI USA, V107, P9370, DOI 10.1073/pnas.1000935107; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Schmidt MC, 1999, MOL CELL BIOL, V19, P4561; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Siewe RM, 1996, J BIOL CHEM, V271, P5398, DOI 10.1074/jbc.271.10.5398; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Sood R, 2000, GENETICS, V154, P787; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2012, CURR OPIN CELL BIOL, V24, P262, DOI 10.1016/j.ceb.2011.11.008; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; Staschke KA, 2010, J BIOL CHEM, V285, P16893, DOI 10.1074/jbc.M110.121947; STOCK A, 1988, P NATL ACAD SCI USA, V85, P1403, DOI 10.1073/pnas.85.5.1403; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Stracka D, 2014, J BIOL CHEM, V289, P25010, DOI 10.1074/jbc.M114.574335; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Sutter BM, 2013, CELL, V154, P403, DOI 10.1016/j.cell.2013.06.041; Svanberg E, 1996, AM J PHYSIOL-ENDOC M, V271, pE718, DOI 10.1152/ajpendo.1996.271.4.E718; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; THEODORIS G, 1994, GENETICS, V137, P957; Tomas-Cobos L, 2002, BIOCHEM J, V368, P657, DOI 10.1042/BJ20020984; Toshima N, 2012, J EXP BIOL, V215, P2827, DOI 10.1242/jeb.069146; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Uritani M, 2006, GENES CELLS, V11, P1367, DOI 10.1111/j.1365-2443.2006.01025.x; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; van Slegtenhorst M, 2004, J BIOL CHEM, V279, P12706, DOI 10.1074/jbc.M313874200; vanHeeswijk WC, 1996, MOL MICROBIOL, V21, P133, DOI 10.1046/j.1365-2958.1996.6281349.x; Vargas MA, 2010, CURR BIOL, V20, P1006, DOI 10.1016/j.cub.2010.04.009; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; WANG EA, 1980, P NATL ACAD SCI-BIOL, V77, P7157, DOI 10.1073/pnas.77.12.7157; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; WEIS RM, 1988, P NATL ACAD SCI USA, V85, P83, DOI 10.1073/pnas.85.1.83; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; WEK SA, 1995, MOL CELL BIOL, V15, P4497; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8787, DOI 10.1073/pnas.90.19.8787; WOODS A, 1994, J BIOL CHEM, V269, P19509; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang PJ, 2007, P NATL ACAD SCI USA, V104, P3777, DOI 10.1073/pnas.0610106104; Zhang YP, 2009, J BACTERIOL, V191, P5526, DOI 10.1128/JB.00585-09; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835	247	206	210	2	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					67	83		10.1016/j.cell.2015.02.041	http://dx.doi.org/10.1016/j.cell.2015.02.041			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815986	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000351952200009
J	Olfson, M				Olfson, Mark			Surveillance of Adverse Psychiatric Medication Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EMERGENCY-DEPARTMENT VISITS; ADULTS	IMPORTANCE In 2011, an estimated 26.8 million US adults used prescription medications for mental illness. OBJECTIVE To estimate the numbers and rates of adverse drug event (ADE) emergency department (ED) visits involving psychiatric medications among US adults between January 1, 2009, and December 31, 2011. DESIGN AND SETTING Descriptive analyses of active, nationally representative surveillance of ADEED visits using the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance system and of drug prescribing during outpatient visits using the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey. PARTICIPANTS Medical records from national probability samples of ED and outpatient visits by adults 19 years or older were reviewed and analyzed. EXPOSURES Antidepressants, antipsychotics, lithium salts, sedatives and anxiolytics, and stimulants. MAIN OUTCOMES AND MEASURES National estimates of ADE ED visits resulting from therapeutic psychiatric medication use and psychiatric medication ADE ED visits per 10 000 outpatient visits at which psychiatric medications were prescribed. RESULTS From 2009 through 2011, there were an estimated 89 094 (95% CI, 68 641-109 548) psychiatric medication ADE ED visits annually, with 19.3%(95% CI, 16.3%-22.2%) resulting in hospitalization and 49.4%(95% CI, 46.5%-52.4%) involving patients aged 19 to 44 years. Sedatives and anxiolytics, antidepressants, antipsychotics, lithium salts, and stimulants were implicated in an estimated 30 707 (95% CI, 23 406-38 008), 25 377 (95% CI, 19 051-31 704), 21 578 (95% CI, 16 599-26 557), 3620 (95% CI, 2311-4928), and 2779 (95% CI, 1764-3794) respective ADE ED visits annually. Antipsychotics and lithium salts were implicated in 11.7 (95% CI, 10.1-13.2) and 16.4 (95% CI, 13.0-19.9) ADE ED visits per 10 000 outpatient prescription visits, respectively, compared with 3.6 (95% CI, 3.2-4.1) for sedatives and anxiolytics, 2.9 (95% CI, 2.3-3.5) for stimulants, and 2.4 (95% CI, 2.1-2.7) for antidepressants. The commonly used sedative zolpidem tartrate was implicated in 11.5%(95% CI, 9.5%-13.4%) of all adult psychiatric medication ADE ED visits and in 21.0%(95% CI, 16.3%-25.7%) of visits involving adults 65 years or older, in both cases significantly more than any other psychiatric medication. CONCLUSIONS AND RELEVANCE Psychiatric medications are implicated in many ADEs treated in US EDs. Efforts to reduce ADEs should include adults of all ages but might prioritize medications causing high numbers and rates of ED visits.	Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Olfson, M (corresponding author), Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	mo49@.columbia.edu	Olfson, Mark/AAA-8547-2021		Agency for Healthcare Research and Quality [U19 HS021112]; New York State Psychiatric Institute; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS021112] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); New York State Psychiatric Institute; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by the Agency for Healthcare Research and Quality (U19 HS021112) and New York State Psychiatric Institute.	Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Cipriani A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3646; Habel LA, 2011, JAMA-J AM MED ASSOC, V306, P2673, DOI 10.1001/jama.2011.1830; Hampton LM, 2014, JAMA PSYCHIAT, V71, P1006, DOI 10.1001/jamapsychiatry.2014.436; IMS Health, TOP THER CLASS DISP; Walton SN, 2008, PHARMACOTHERAPY, V28, P1443, DOI 10.1592/phco.28.12.1443; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629	7	4	4	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1256	1257		10.1001/jama.2014.15743	http://dx.doi.org/10.1001/jama.2014.15743			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD9RJ	25803347				2022-12-28	WOS:000351435500025
J	Bilano, V; Gilmour, S; Moffiet, T; d'Espaignet, ET; Stevens, GA; Commar, A; Tuyl, F; Hudson, I; Shibuya, K				Bilano, Ver; Gilmour, Stuart; Moffiet, Trevor; d'Espaignet, Edouard Tursan; Stevens, Gretchen A.; Commar, Alison; Tuyl, Frank; Hudson, Irene; Shibuya, Kenji			Global trends and projections for tobacco use, 1990-2025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control	LANCET			English	Article							HEALTH WARNING LABELS; SNUS; COUNTRIES; RISK	Background Countries have agreed on reduction targets for tobacco smoking stipulated in the WHO global monitoring framework, for achievement by 2025. In an analysis of data for tobacco smoking prevalence from nationally representative survey data, we aimed to provide comprehensive estimates of recent trends in tobacco smoking, projections for future tobacco smoking, and country-level estimates of probabilities of achieving tobacco smoking targets. Methods We used a Bayesian hierarchical meta-regression modelling approach using data from the WHO Comprehensive Information Systems for Tobacco Control to assess trends from 1990 to 2010 and made projections up to 2025 for current tobacco smoking, daily tobacco smoking, current cigarette smoking, and daily cigarette smoking for 173 countries for men and 178 countries for women. Modelling was implemented in Python with DisMod-MR and PyMC. We estimated trends in country-specific prevalence of tobacco use, projections for future tobacco use, and probabilities for decreased tobacco use, increased tobacco use, and achievement of targets for tobacco control from posterior distributions. Findings During the most recent decade (2000-10), the prevalence of tobacco smoking in men fell in 125 (72%) countries, and in women fell in 156 (88%) countries. If these trends continue, only 37 (21%) countries are on track to achieve their targets for men and 88 (49%) are on track for women, and there would be an estimated 1.1 billion current tobacco smokers (95% credible interval 700 million to 1.6 billion) in 2025. Rapid increases are predicted in Africa for men and in the eastern Mediterranean for both men and women, suggesting the need for enhanced measures for tobacco control in these regions. Interpretation Our findings show that striking between-country disparities in tobacco use would persist in 2025, with many countries not on track to achieve tobacco control targets and several low-income and middle-income countries at risk of worsening tobacco epidemics if these trends remain unchanged. Immediate, effective, and sustained action is necessary to attain and maintain desirable trajectories for tobacco control and achieve global convergence towards elimination of tobacco use.	[Bilano, Ver; Gilmour, Stuart; Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Moffiet, Trevor; Tuyl, Frank; Hudson, Irene] Univ Newcastle, Sch Math & Phys Sci, Newcastle, NSW 2300, Australia; [d'Espaignet, Edouard Tursan; Commar, Alison] WHO, Comprehens Informat Syst Tobacco Control, Tobacco Free Initiat, CH-1211 Geneva, Switzerland; [Stevens, Gretchen A.] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland	University of Tokyo; University of Newcastle; World Health Organization; World Health Organization	Shibuya, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan.	shibuyak@m.u-tokyo.ac.jp	d'Espaignet, Edouard Tursan/V-3857-2019	Tuyl, Frank/0000-0003-0001-195X; Hudson, Irene/0000-0002-9000-9556; Bilano, Ver/0000-0002-1220-6220; Shibuya, Kenji/0000-0003-2528-7530	Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports and Technology, Japan; Department of Health, Australia; Bloomberg Philanthropies	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Department of Health, Australia; Bloomberg Philanthropies	Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports and Technology, Japan; Department of Health, Australia; Bloomberg Philanthropies.	Aaro LE LK, 2009, EVALUERING MYNDIGHET; Ahmad OB, AGE STANDARDIZATION; [Anonymous], GLOB AD TOB SURV; [Anonymous], 2014, ESAPWP235; Bryant J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-153; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Drake F., 2001, PYTHON REFERENCE MAN; Edwards R, 2004, BRIT MED J, V328, P217, DOI 10.1136/bmj.328.7433.217; England LJ, 2003, AM J OBSTET GYNECOL, V189, P939, DOI 10.1067/S0002-9378(03)00661-6; Eriksen M. P., 2012, TOBACCO ATLAS, Vfouth; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flaxman A, 2014, INTEGRATIVE METAREGR; Foulds J, 2003, TOB CONTROL, V12, P349, DOI 10.1136/tc.12.4.349; Fu M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006552; Helsedirektoratet, NORW STRAT POL TOB C; Helsedirektoratet, FACTS AND FIGURES; Hiilamo H, 2015, SOC SCI MED, V124, P241, DOI 10.1016/j.socscimed.2014.11.054; IARC Working Group on Methods for Evaluating Tobacco Control Policies, 2008, METH EV TOB CONTR PO; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Luo J, 2007, LANCET, V369, P2015, DOI 10.1016/S0140-6736(07)60678-3; Manuel Douglas G, 2014, CMAJ Open, V2, pE94, DOI 10.9778/cmajo.2012-0015; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Mendez D, 2013, TOB CONTROL, V22, P46, DOI 10.1136/tobaccocontrol-2011-050147; National Center for Chronic Disease Prevention and Health Promotion Division of Population Health, 2014, CDC BRFSS BEH RISK F; Norwegian Institute of Public Health, 2014, HLTH RISKS SCAND SNU; Patil A, 2010, J STAT SOFTW, V35, P1; Perry CL, 1994, TOB CONTROL, V3, P97; Ramstrom LM, 2006, TOB CONTROL, V15, P210, DOI 10.1136/tc.2005.014969; Sanders-Jackson AN, 2013, AM J PUBLIC HEALTH, V103, P2041, DOI 10.2105/AJPH.2013.301324; Sozmen K, 2015, INT J PUBLIC HEALTH, V60, pS3, DOI 10.1007/s00038-014-0610-6; UN General Assembly, POL DECL HIGH LEV M; United Nations Statistics Division, COMP MACR GEOGR CONT; van der Deen FS, 2014, NEW ZEAL MED J, V127, P71; WHO, WHO PROT GUID; WHO, PART WHO FRAM CONV T; WHO, 2014, STEPW APPR SURV; WHO, DRAFT COMPR GLOB MON; Wong SL, 2012, HEALTH REP, V23, P47; World Health Organization, 2014, WHO FRAM CONV TOB CO; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization, 2009, GLOBAL ADULT TOBACCO; World Health Organization, 2003, WHO FRAM CONV TOB CO; World Health Organization, WORLD HLTH SURV; World Health Organization, 2012, WHO GLOB REP MORT AT; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP	48	290	297	2	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					966	976		10.1016/S0140-6736(15)60264-1	http://dx.doi.org/10.1016/S0140-6736(15)60264-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD2EK	25784347				2022-12-28	WOS:000350886900031
J	Yang, GH; Wang, Y; Wu, YQ; Yang, J; Wan, X				Yang, Gonghuan; Wang, Yu; Wu, Yiqun; Yang, Jie; Wan, Xia			Tobacco-free world 2 The road to effective tobacco control in China	LANCET			English	Article							HEALTH; TAX; PREVALENCE; INDUSTRY; SMOKING; HAZARDS	The non-communicable disease burden in China is enormous, with tobacco use a leading risk factor for the major non-communicable diseases. The prevalence of tobacco use in men is one of the highest in the world, with more than 300 million smokers and 740 million non-smokers exposed to second-hand smoke. In the past decade public awareness of the health hazards of tobacco use and exposure to second-hand smoke has grown, social customs and habits have changed, aggressive tactics used by the tobacco industry have been revealed, and serious tobacco control policies have been actively promoted. In 2014, national legislators in China began actively considering national bans on smoking in public and work places and tobacco advertising. However, tobacco control in China has remained particularly difficult because of interference by the tobacco industry. Changes to the interministerial coordinating mechanism for implementation of the WHO Framework Convention on Tobacco Control are now crucial. Progress towards a tobacco-free world will be dependent on more rapid action in China.	[Yang, Gonghuan; Wan, Xia] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Yang, Gonghuan; Wan, Xia] Peking Union Med Coll, Sch Basic Med, Beijing 100005, Peoples R China; [Wang, Yu; Yang, Jie] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Wu, Yiqun] Think Tank Res Ctr Hlth Dev, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention	Yang, GH (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100005, Peoples R China.	yangghuan@vip.sina.com			CMB project Strengthen Capacity of Study and Application on Burden of Disease in Health Care System of China [12-107]	CMB project Strengthen Capacity of Study and Application on Burden of Disease in Health Care System of China	This work was supported by CMB project Strengthen Capacity of Study and Application on Burden of Disease in Health Care System of China (12-107). We thank the following people for their helpful comments on earlier drafts of this paper: R Beaglehole, R Bonita, J Mackay, TW Hu, J Koplan, J Samet, A Pratt, and LD Wang.	[Anonymous], 2013, RULES CONTROL TOBACC; [Anonymous], 2008, CHIN TOB CONTR NEG E; [Anonymous], 2007, REPLY STATE COUNCIL; [Anonymous], 2010, LIST NAT SCI TECHN P; [Anonymous], 2012, JIAO ZI PANDER TOP M; Beaglehole R, 2015, LANCET, V385, P1011, DOI 10.1016/S0140-6736(15)60133-7; Bloomberg Initiative to reduce tobacco use grants program, SMOK FREE CHIN; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Borzekowski DLG, 2014, J PUBLIC HEALTH-HEID, V22, P175, DOI 10.1007/s10389-014-0612-0; Canadian Cancer Society, 2014, CIG PACK HLTH WARN I; Chi Z., PICTURE POSTER SANIT; China Center for Disease Control and Prevention, 2014, GLOB YOUTH TOB SURV; Chinese Academy of Preventive Medicine, 1997, SMOK HLTH CHIN 1996; Chinese Center for Disease Control and Prevention, 2011, GLOB AD TOB SURV GAT; Chinese Center of Disease Control and Prevention, TOB CONTR REP 2013; Data of industry of China, TOB PROD; Eriksen M.P., TOBACCO ATLAS; Gao LP, STORY FEMALE MODEL W; Gao S, 2012, TOB CONTROL, V21, P560, DOI 10.1136/tobaccocontrol-2011-050027; General Office of State Administration of Press, PUBL RAD FILM TEL; Gilmore AB, 2015, LANCET, V385, P1029, DOI 10.1016/S0140-6736(15)60312-9; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; He JL, 2010, J SCI RES TOBACCO, V35, P35; He Q., MAKE UPGRADED VERSIO; Hu TW, 2010, TOB CONTROL, V19, P80, DOI 10.1136/tc.2009.032631; Hu TW, 2010, TOB CONTROL, V19, P58, DOI 10.1136/tc.2009.031799; Hvistendahl M, 2012, SCIENCE, V335, P153, DOI 10.1126/science.335.6065.153; Industry information network, 2013, STAT CIG OUTP PROV C; Information Office of the State Council, MED HLTH SERV CHIN; ITC Project, 2012, TOB PRIC TAX ITC CRO; Jiang CK, 2009, 2009 NAT TOB WORK C; Jiang CK., 2013, NAT C TOB; Legislation Office of the State Council, 2014, NOT HEAR PUBL OP COM; Li JX, HIGHEST VOICE COMPRE; Li Q, 2012, TOB CONTROL, V21, P381, DOI 10.1136/tobaccocontrol-2011-050111; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Ministry of Health, 2010, CHIN REP HLTH HAZ SM; Ministry of Health People's Republic of China, 2007, CHIN TOB CONTR REP; Ministry of Industry and Information Technology of the People's Republic of China, 2012, CHIN TOB CONTR PLAN; Ministry of Science and Technology of the People's Republic of China, 2003, 2003 J 211 203 RES I; Ministry of Science and Technology of the People's Republic of China, 2004, LIST NAT SCI TECHN P; National Center for Cardiovascular Disease, 2012, CHIN REP CARD DIS CH; National Health and Family Planning Commission, STAT B DEV HLTH FAM; National health and family planning committee, 1 NAT REG SMOK BAN P; Rich ZC, 2012, NICOTINE TOB RES, V14, P258, DOI 10.1093/ntr/ntr156; Stillman FA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-964; STMA, 2008, QAQSIQ DOMESTIC REGU; The Central People's Government of the People's Republic of China, 2012, TOB CONTR 5 YEARS; The Health and Family Planning Commission, 2014, NOT FURTH STRENGTH T; The Think Tank Health Development Center, WHO SELLS DEATH SPEC; Topic Group of Party School of the Central Committee of CPC, 2013, TOB CONTR INT EXP CH; United Nations General Assembly, 2011, POL DECL HIGH LEV M; Varma S, 2005, TOB CONTROL, V14, P4; Verguet S, 2015, LANCET GLOB HEALTH, V3, pE206, DOI 10.1016/S2214-109X(15)70095-1; Wan X, 2012, TOB CONTROL, V21, P412, DOI 10.1136/tc.2010.041327; Wang CC, 2011, NEW DEV CHINESE CIGA; WENG XZ, 1987, CHINESE MED J-PEKING, V100, P886; Western Pacific Region WHO. University of Waterloo ITC Project and ThinkTank Research Center for Health Development, 2014, TOB HLTH WARN CHIN E; WHO, 2013, GLOB ACT PLAN PREV; Xiao D., PROGR CHALLENGES EXP; Xinhua network, 2013, CIRC GEN OFF COMM PA; Xinhua network, EXP ADV LAW DOES FUL; Xinhua-PR Newswire, 2008, XINHUA PR NEWSWIRE; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yang Gong-huan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P77; Yang GH, 2014, TOB CONTROL, V23, P167, DOI 10.1136/tobaccocontrol-2012-050691; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yang Y, 2010, BIOMED ENVIRON SCI, V23, P437, DOI 10.1016/S0895-3988(11)60004-4; Yao TT, 2015, TOB CONTROL, V24, pE221, DOI 10.1136/tobaccocontrol-2014-051621; Zheng PP, 2014, TOB CONTROL, V23, P389, DOI 10.1136/tobaccocontrol-2012-050661; Zheng R, 2013, TOBACCO TAX TOBACCO, P183; Zhou RZ, 2006, RES COUNTERING TACTI	72	153	158	5	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					1019	1028		10.1016/S0140-6736(15)60174-X	http://dx.doi.org/10.1016/S0140-6736(15)60174-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD2EK	25784349				2022-12-28	WOS:000350886900034
J	LeFevre, ML				LeFevre, Michael L.		US Preventive Serv Task Force	Screening for Thyroid Dysfunction: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							ISCHEMIC-HEART-DISEASE; INCREASED SERUM THYROTROPIN; SUBCLINICAL HYPOTHYROIDISM; CLINICAL ENDOCRINOLOGISTS; CARDIOVASCULAR HEALTH; AMERICAN ASSOCIATION; COGNITIVE FUNCTION; THYROXINE THERAPY; CONTROLLED-TRIAL; OLDER-ADULTS	Description: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for thyroid disease. Methods: The USPSTF reviewed the evidence on the benefits and harms of screening for subclinical and "overt" thyroid dysfunction without clinically obvious symptoms, as well as the effects of treatment on intermediate and final health outcomes. Population: This recommendation applies to nonpregnant, asymptomatic adults. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (I statement)	[LeFevre, Michael L.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD 20850 USA		LeFevre, ML (corresponding author), US Prevent Serv Task Force, Rockville, MD 20850 USA.		; Phillips, William/V-1065-2017	Kemper, Alex/0000-0001-5491-3997; Phillips, William/0000-0003-2802-4349	USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	American Academy of Family Physicians, 2015, CLIN PREV SERV REC T; [Anonymous], 2003, THYROID, V13, P3; Atzmon G, 2009, J CLIN ENDOCR METAB, V94, P1251, DOI 10.1210/jc.2008-2325; Beastall G, 2006, UK GUIDELINES USE TH; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Boucai L, 2011, THYROID, V21, P5, DOI 10.1089/thy.2010.0092; Brooks M., 2013, MEDSCAPE MED NEWS; CARON PJ, 1986, J CLIN ENDOCR METAB, V62, P960, DOI 10.1210/jcem-62-5-960; COOPER DS, 1984, ANN INTERN MED, V101, P18, DOI 10.7326/0003-4819-101-1-18; Diez JJ, 2004, J CLIN ENDOCR METAB, V89, P4890, DOI 10.1210/jc.2003-032061; Fatourechi V, 2003, MAYO CLIN PROC, V78, P554, DOI 10.4065/78.5.554; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Gharib H, 2005, J CLIN ENDOCR METAB, V90, P581, DOI 10.1210/jc.2004-1231; Helfand M., 2004, SCREENING THYROID DI; Helfand M, 2011, SCREENING TREATMENT; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; IMS Institute for Healthcare Informatics, 2011, US MED US REV 2010; Jorde R, 2006, J CLIN ENDOCR METAB, V91, P145, DOI 10.1210/jc.2005-1775; Jorgensen P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004962; Karmisholt J, 2008, THYROID, V18, P303, DOI 10.1089/thy.2007.0241; Meyerovitch J, 2007, ARCH INTERN MED, V167, P1533, DOI 10.1001/archinte.167.14.1533; Ochs N, 2008, ANN INTERN MED, V148, P832, DOI 10.7326/0003-4819-148-11-200806030-00225; Parle J, 2010, J CLIN ENDOCR METAB, V95, P3623, DOI 10.1210/jc.2009-2571; Razvi S, 2008, J CLIN ENDOCR METAB, V93, P2998, DOI 10.1210/jc.2008-0167; Razvi S, 2012, ARCH INTERN MED, V172, P811, DOI 10.1001/archinternmed.2012.1159; Razvi S, 2010, J CLIN ENDOCR METAB, V95, P1734, DOI 10.1210/jc.2009-1749; Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460; Rodondi N, 2008, J AM COLL CARDIOL, V52, P1152, DOI 10.1016/j.jacc.2008.07.009; Rosario PW, 2010, CLIN ENDOCRINOL, V72, P685, DOI 10.1111/j.1365-2265.2009.03696.x; Rugge JB, 2015, ANN INTERN MED, V162, P35, DOI 10.7326/M14-1456; Rugge JB, 2014, AHRQ PUBLICATION, V15-05217-EF-1; Safi S, 2006, ANN ENDOCRINOL-PARIS, V67, P27; Shrier DK, 2002, AM FAM PHYSICIAN, V65, P431; Simonsick EM, 2009, ARCH INTERN MED, V169, P2011, DOI 10.1001/archinternmed.2009.392; Singh S, 2008, INT J CARDIOL, V125, P41, DOI 10.1016/j.ijcard.2007.02.027; Somwaru LL, 2011, J GERONTOL A-BIOL, V66, P809, DOI 10.1093/gerona/glr063; Surks MI, 2007, J CLIN ENDOCR METAB, V92, P4575, DOI 10.1210/jc.2007-1499; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Taylor PN, 2014, JAMA INTERN MED, V174, P32, DOI 10.1001/jamainternmed.2013.11312; Vanderpump MPJ, 1996, THYROID, V6, P155; Volzke H, 2007, J CLIN ENDOCR METAB, V92, P2421, DOI 10.1210/jc.2007-0179; Wartofsky L, 2005, J CLIN ENDOCR METAB, V90, P5483, DOI 10.1210/jc.2005-0455; Westendorp RG, 2004, JAMA-J AM MED ASSOC, V292, P2591; Wirth CD, 2014, ANN INTERN MED, V161, P189, DOI 10.7326/M14-0125	44	90	95	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					641	U244		10.7326/M15-0483	http://dx.doi.org/10.7326/M15-0483			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6AZ	25798805				2022-12-28	WOS:000354119100009
J	Obenauf, AC; Zou, YL; Ji, AL; Vanharanta, S; Shu, WP; Shi, HB; Kong, XJ; Bosenberg, MC; Wiesner, T; Rosen, N; Lo, RS; Massague, J				Obenauf, Anna C.; Zou, Yilong; Ji, Andrew L.; Vanharanta, Sakari; Shu, Weiping; Shi, Hubing; Kong, Xiangju; Bosenberg, Marcus C.; Wiesner, Thomas; Rosen, Neal; Lo, Roger S.; Massague, Joan			Therapy-induced tumour secretomes promote resistance and tumour progression	NATURE			English	Article							TRANSLATIONAL PROFILING APPROACH; ACQUIRED-RESISTANCE; DRUG-RESISTANCE; RAF INHIBITORS; MELANOMA; SURVIVAL; EVOLUTION	Drug resistance invariably limits the clinical efficacy of targeted therapy with kinase inhibitors against cancer(1,2). Here we show that targeted therapy with BRAF, ALK or EGFR kinase inhibitors induces a complex network of secreted signals in drug-stressed human and mouse melanoma and human lung adenocarcinoma cells. This therapy-induced secretome stimulates the outgrowth, dissemination and metastasis of drug-resistant cancer cell clones and supports the survival of drug-sensitive cancer cells, contributing to incomplete tumour regression. The tumour-promoting secretome of melanoma cells treated with the kinase inhibitor vemurafenib is driven by down-regulation of the transcription factor FRA1. In situ transcriptome analysis of drug-resistant melanoma cells responding to the regressing tumour microenvironment revealed hyperactivation of several signalling pathways, most prominently the AKT pathway. Dual inhibition of RAF and the PI(3) K/AKT/mTOR intracellular signalling pathways blunted the outgrowth of the drug-resistant cell population in BRAF mutant human melanoma, suggesting this combination therapy as a strategy against tumour relapse. Thus, therapeutic inhibition of oncogenic drivers induces vast secretome changes in drug-sensitive cancer cells, paradoxically establishing a tumour microenvironment that supports the expansion of drug-resistant clones, but is susceptible to combination therapy.	[Obenauf, Anna C.; Zou, Yilong; Ji, Andrew L.; Vanharanta, Sakari; Shu, Weiping; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Zou, Yilong] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Sch Biomed Sci, New York, NY 10065 USA; [Vanharanta, Sakari] Univ Cambridge, MRC Canc Unit, Cambridge CB2 0XZ, England; [Shi, Hubing; Kong, Xiangju; Lo, Roger S.] Univ Calif Los Angeles, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Shi, Hubing; Kong, Xiangju; Lo, Roger S.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Bosenberg, Marcus C.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Bosenberg, Marcus C.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; [Wiesner, Thomas] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Rosen, Neal] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Cambridge; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Yale University; Yale University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	j-massague@ski.mskcc.org	Rosen, Neal/ABF-2677-2020	Obenauf, Anna/0000-0002-9556-5914; Wiesner, Thomas/0000-0001-5877-2992; Ji, Andrew/0000-0001-9688-5680; Shi, Hubing/0000-0002-2926-3440; Zou, Yilong/0000-0001-8198-6067; Massague, Joan/0000-0001-9324-8408	AACR [SU2C]; MSK Metastasis Research Center; NIH [CA163167, CA129243]; Congressionally Directed Medical Research Program of the Department of Defense; Howard Hughes Medical Institute; Cancer Center [P30 CA008748]; Erwin Schroedinger Fellowship (FWF, Austrian Science Fund) [J3013]; Medical Research Council; NATIONAL CANCER INSTITUTE [R01CA176111, P01CA094060, P01CA129243, P30CA008748, P30CA016042, U54CA163167] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_1101/4, MC_UU_12022/7] Funding Source: researchfish; MRC [MC_UU_12022/7] Funding Source: UKRI	AACR; MSK Metastasis Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Congressionally Directed Medical Research Program of the Department of Defense; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Center; Erwin Schroedinger Fellowship (FWF, Austrian Science Fund); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank members of the Massague laboratory for discussions; L. Sevenich and L. Akkari for technical advice. This work was supported by grants from the AACR (SU2C) to R.S.L., the MSK Metastasis Research Center, the NIH (CA163167 and CA129243), the Congressionally Directed Medical Research Program of the Department of Defense, the Howard Hughes Medical Institute, and the Cancer Center Support Grant P30 CA008748 to J.M., A.C.O. was an Erwin Schroedinger Fellowship awardee (J3013, FWF, Austrian Science Fund). A.L.J. was a Medical Research Fellow of the Howard Hughes Medical Institute. S.V. is supported by the Medical Research Council.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Engelman JA, 2008, CURR OPIN GENET DEV, V18, P73, DOI 10.1016/j.gde.2008.01.004; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shaw AT, 2013, J CLIN ONCOL, V31, P1105, DOI 10.1200/JCO.2012.44.5353; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Shi HB, 2014, CANCER DISCOV, V4, P69, DOI 10.1158/2159-8290.CD-13-0279; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Villanueva J, 2008, CURR ONCOL REP, V10, P439, DOI 10.1007/s11912-008-0067-y; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	38	315	337	3	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					368	+		10.1038/nature14336	http://dx.doi.org/10.1038/nature14336			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25807485	Green Accepted, Green Submitted			2022-12-28	WOS:000352974200043
J	Quinn, J; Todd, S; Agrawal, S; Tsitsikas, DA				Quinn, Joanna; Todd, Sophie; Agrawal, Samir; Tsitsikas, Dimitris A.			A curious case of facial swelling in the night-time	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							C1 INHIBITOR DEFICIENCY; ACQUIRED C1-INHIBITOR DEFICIENCY; HEREDITARY ANGIOEDEMA; LYMPHOPROLIFERATIVE DISORDERS; ANGIONEUROTIC-EDEMA; ACTIVATION; ASSOCIATION; CONSENSUS; DISEASE		[Quinn, Joanna; Todd, Sophie; Tsitsikas, Dimitris A.] Homerton Univ Hosp NHS Fdn Trust, Dept Haematol, London, England; [Agrawal, Samir] St Bartholomews Hosp, Dept Haematol Oncol, London, England	University of London; Queen Mary University London	Quinn, J (corresponding author), Homerton Univ Hosp NHS Fdn Trust, Dept Haematol, London, England.	quinn.j@icloud.com	Tsitsikas, Dimitris A./AGL-2303-2022; TSITSIKAS, DIMITRIS/GNW-3079-2022	Tsitsikas, Dimitris A./0000-0003-3468-049X; 				AGOSTONI A, 1992, MEDICINE, V71, P206, DOI 10.1097/00005792-199207000-00003; Agostoni A, 2004, J ALLERGY CLIN IMMUN, V114, pS51, DOI 10.1016/j.jaci.2004.06.047; [Anonymous], 2015, BRIT NATL FORMULARY; Bork K, 2006, AM J MED, V119, P267, DOI 10.1016/j.amjmed.2005.09.064; Bork K, 2000, MAYO CLIN PROC, V75, P349, DOI 10.4065/75.4.349; Bork K, 2012, J ALLERGY CLIN IMMUN, V130, P692, DOI 10.1016/j.jaci.2012.05.055; Bouillet-Claveyrolas L, 2003, AM J MED, V115, P420, DOI 10.1016/S0002-9343(03)00396-6; Caldwell JR, 1972, CLIN IMMUNOL IMMUNOP, V1, P39; Castelli R, 2007, HAEMATOL-HEMATOL J, V92, P716, DOI 10.3324/haematol.10769; Castelli R, 2013, CRIT REV ONCOL HEMAT, V87, P323, DOI 10.1016/j.critrevonc.2013.02.004; Chadenat ML, 2000, PRESSE MED, V29, P1465; Chevailler A, 1996, J ALLERGY CLIN IMMUN, V97, P998, DOI 10.1016/S0091-6749(96)80076-5; CHEVRANTBRETON J, 1982, ANN DERMATOL VENER, V109, P1049; Cicardi M, 2005, SPRINGER SEMIN IMMUN, V27, P286, DOI 10.1007/s00281-005-0001-4; Cicardi M, 1996, CLIN EXP IMMUNOL, V106, P475, DOI 10.1046/j.1365-2249.1996.d01-866.x; Cicardi M, 2010, CURR MOL MED, V10, P354, DOI 10.2174/156652410791317066; Cicardi M, 2002, MEDICINE, V82, P274; Cicardi Marco, 2010, Allergy Asthma Clin Immunol, V6, P14, DOI 10.1186/1710-1492-6-14; Cugno M, 1997, BLOOD, V89, P3213, DOI 10.1182/blood.V89.9.3213; CUGNO M, 1990, J CLIN INVEST, V85, P1215, DOI 10.1172/JCI114555; Davis AE, 2004, DRUG NEWS PERSPECT, V17, P439, DOI 10.1358/dnp.2004.17.7.863703; Davis AE, 2008, ANN ALLERG ASTHMA IM, V100, pS7, DOI 10.1016/S1081-1206(10)60580-7; Dias C, 2011, NAT REV RHEUMATOL, V7, P360, DOI 10.1038/nrrheum.2011.62; Fremeaux-Bacchi V, 2002, AM J MED, V113, P194, DOI 10.1016/S0002-9343(02)01124-5; Gompels MM, 2005, CLIN EXP IMMUNOL, V139, P379, DOI 10.1111/j.1365-2249.2005.02726.x; Gompels MM, 2002, J CLIN PATHOL, V55, P145, DOI 10.1136/jcp.55.2.145; Guilarte M, 2008, J INVEST ALLERG CLIN, V18, P126; Gunatilake Sonali Sihindi Chapa, 2014, BMC Res Notes, V7, P495, DOI 10.1186/1756-0500-7-495; Hassan A, 2011, ACTA DERM-VENEREOL, V91, P733, DOI 10.2340/00015555-1157; HAUPTMANN G, 1979, CLIN EXP IMMUNOL, V37, P523; JACKSON J, 1986, NATURE, V323, P722, DOI 10.1038/323722a0; Janeway CA., 2001, IMMUNOBIOLOGY IMMUNE; Jolles S, 2014, CLIN EXP IMMUNOL, V175, P59, DOI 10.1111/cei.12159; Kaplan AP, 2005, J AM ACAD DERMATOL, V53, P373, DOI 10.1016/j.jaad.2004.09.032; Lam DH, 2012, J CLIN ONCOL, V30, pE151, DOI 10.1200/JCO.2011.38.9957; Lang DM, 2012, ANN ALLERG ASTHMA IM, V109, P395, DOI 10.1016/j.anai.2012.10.008; Levi M, 2006, AM J MED, V119, pE3, DOI 10.1016/j.amjmed.2005.09.018; Manson AL, 2013, CLIN EXP IMMUNOL, V173, P1, DOI 10.1111/cei.12083; Markovic SN, 2000, ANN INTERN MED, V133, P839, DOI [10.7326/0003-4819-133-10-200011210-00025, 10.7326/0003-4819-132-2-200001180-00009]; Monti G, 2005, ARCH INTERN MED, V165, P101, DOI 10.1001/archinte.165.1.101; Nussberger J, 2002, NEW ENGL J MED, V347, P621, DOI 10.1056/NEJM200208223470820; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; SCHAPIRA M, 1983, NEW ENGL J MED, V308, P1050, DOI 10.1056/NEJM198305053081802; SCHREIBER AD, 1976, BLOOD, V48, P567; Zanichelli A, 2011, INTERN EMERG MED, V6, P279, DOI 10.1007/s11739-010-0431-4; Ziakas PD, 2004, HAEMATOLOGICA, V89, pe104; Zingale LC, 2006, CAN MED ASSOC J, V175, P1065, DOI 10.1503/cmaj.060535; Zingale LC, 2006, IMMUNOL ALLERGY CLIN, V26, P669, DOI 10.1016/j.iac.2006.08.002; ZURAW BL, 1986, J ALLERGY CLIN IMMUN, V78, P1115, DOI 10.1016/0091-6749(86)90259-9; Zuraw BL, 2010, NEW ENGL J MED, V363, P513, DOI 10.1056/NEJMoa0805538	50	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2015	350								h1487	10.1136/bmj.h1487	http://dx.doi.org/10.1136/bmj.h1487			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9SM	25852105				2022-12-28	WOS:000352906900002
J	Audergon, PNCB; Catania, S; Kagansky, A; Tong, P; Shukla, M; Pidoux, AL; Allshire, RC				Audergon, Pauline N. C. B.; Catania, Sandra; Kagansky, Alexander; Tong, Pin; Shukla, Manu; Pidoux, Alison L.; Allshire, Robin C.			Restricted epigenetic inheritance of H3K9 methylation	SCIENCE			English	Article							JMJC DOMAIN PROTEIN; FISSION YEAST; HETEROCHROMATIN NUCLEATION; HISTONE DEMETHYLATION; RNA INTERFERENCE; LYSINE 9; MAINTENANCE; TRANSCRIPTION; ROLES; REPLICATION	Posttranslational histone modifications are believed to allow the epigenetic transmission of distinct chromatin states, independently of associated DNA sequences. Histone H3 lysine 9 (H3K9) methylation is essential for heterochromatin formation; however, a demonstration of its epigenetic heritability is lacking. Fission yeast has a single H3K9 methyltransferase, Clr4, that directs all H3K9 methylation and heterochromatin. Using releasable tethered Clr4 reveals that an active process rapidly erases H3K9 methylation from tethering sites in wild-type cells. However, inactivation of the putative histone demethylase Epe1 allows H3K9 methylation and silent chromatin maintenance at the tethering site through many mitotic divisions, and transgenerationally throughmeiosis, after release of tethered Clr4. Thus, H3K9 methylation is a heritable epigenetic mark whose transmission is usually countered by its active removal, which prevents the unauthorized inheritance of heterochromatin.	[Allshire, Robin C.] Univ Edinburgh, Max Born Crescent, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland; Univ Edinburgh, Max Born Crescent, Inst Cell Biol, Sch Biol Sci, Edinburgh EH9 3BF, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Allshire, RC (corresponding author), Univ Edinburgh, Max Born Crescent, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland.	robin.allshire@ed.ac.uk	Kagansky, Alexander/B-3137-2011	Kagansky, Alexander/0000-0002-6219-6892; Allshire, Robin/0000-0002-8005-3625	Wellcome Trust 4 Year PhD program in Cell Biology [093852]; Wellcome Trust Principal Research Fellowship [095021]; EC-NOE-EpiGeneSys [HEALTH-F4-2010-257082]; Wellcome Trust Centre for Cell Biology [092076]	Wellcome Trust 4 Year PhD program in Cell Biology; Wellcome Trust Principal Research Fellowship(Wellcome Trust); EC-NOE-EpiGeneSys; Wellcome Trust Centre for Cell Biology(Wellcome Trust)	We thank I. Stancheva and the Allshire lab for valuable discussions; E. S. Choi for RNA-seq data; and S. Grewal, F. van Leeuwen, L. Bayne, Y. Shi, H. D. Madhani, T. Urano, and H. Watanabe for providing strains and materials. P.N.C.B.A. was supported by the Wellcome Trust 4 Year PhD program in Cell Biology (grant 093852). R.C.A. is supported by a Wellcome Trust Principal Research Fellowship (grant 095021), the EC-NOE-EpiGeneSys (grant HEALTH-F4-2010-257082), and core funding to the Wellcome Trust Centre for Cell Biology (grant 092076). RNA-seq data have been deposited with the National Center for Biotechnology Information Gene Expression Omnibus under accession code SRX689922.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Almouzni G, 2011, NUCLEUS-PHILA, V2, P332, DOI 10.4161/nucl.2.5.17707; Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Baba A, 2011, NAT CELL BIOL, V13, P668, DOI 10.1038/ncb2228; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Buscaino A, 2013, EMBO J, V32, P1250, DOI 10.1038/emboj.2013.72; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Cheng XD, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018747; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kagansky A, 2009, SCIENCE, V324, P1716, DOI 10.1126/science.1172026; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; Rivera C, 2014, BBA-GENE REGUL MECH, V1839, P1433, DOI 10.1016/j.bbagrm.2014.03.009; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052977; Wheeler BS, 2012, GENETICS, V190, P549, DOI 10.1534/genetics.111.137083; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhu B, 2011, CELL RES, V21, P435, DOI 10.1038/cr.2011.26; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	30	158	161	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					132	135		10.1126/science.1260638	http://dx.doi.org/10.1126/science.1260638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838386	Green Submitted, Green Accepted			2022-12-28	WOS:000352079500043
J	Victor, DG				Victor, David G.			Embed the social sciences in climate policy	NATURE			English	Editorial Material							POLITICAL-SCIENCE		[Victor, David G.] Univ Calif San Diego, Int Relat, San Diego, CA 92103 USA; [Victor, David G.] Univ Calif San Diego, Lab Int Law & Regulat, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Victor, DG (corresponding author), Univ Calif San Diego, Int Relat, San Diego, CA 92103 USA.							Committee to Review the Intergovernmental Panel on Climate Change, 2010, CLIM CHNAG ASS REV P; Hafner-Burton EM, 2012, AM J INT LAW, V106, P47, DOI 10.5305/amerjintelaw.106.1.0047; Hulme M, 2009, WHY WE DISAGREE ABOUT CLIMATE CHANGE: UNDERSTANDING CONTROVERSY, INACTION AND OPPORTUNITY, P1; Hulme M, 2010, NATURE, V463, P730, DOI 10.1038/463730a; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; Intergovernmental Panel on Climate Change (IPCC), 2015, FUT WORK IPCC CHAIRM; Keohane RO, 2015, PS-POLIT SCI POLIT, V48, P19, DOI 10.1017/S1049096514001541; Victor DG, 2014, NATURE, V514, P30, DOI 10.1038/514030a; Victor DG, 2014, SCIENCE, V345, P34, DOI 10.1126/science.1255302	9	130	131	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					27	29		10.1038/520027a	http://dx.doi.org/10.1038/520027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE7NE	25832390	Bronze			2022-12-28	WOS:000352027700020
J	Subramanian, S; Blanton, LV; Frese, SA; Charbonneau, M; Mills, DA; Gordon, JI				Subramanian, Sathish; Blanton, Laura V.; Frese, Steven A.; Charbonneau, Mark; Mills, David A.; Gordon, Jeffrey I.			Cultivating Healthy Growth and Nutrition through the Gut Microbiota	CELL			English	Review							HUMAN-MILK OLIGOSACCHARIDES; SECRETORY IMMUNOGLOBULIN-A; MAL-ED COHORT; BOVINE-MILK; INTESTINAL INFLAMMATION; FECAL BIFIDOBACTERIA; BREAST-MILK; N-GLYCANS; PRETERM; INFANTS	Microbiota assembly is perturbed in children with undernutrition, resulting in persistent microbiota immaturity that is not rescued by current nutritional interventions. Evidence is accumulating that this immaturity is causally related to the pathogenesis of undernutrition and its lingering sequelae. Preclinical models in which human gut communities are replicated in gnotobiotic mice have provided an opportunity to identify and predict the effects of different dietary ingredients on microbiota structure, expressed functions, and host biology. This capacity sets the stage for proof-of-concept tests designed to deliberately shape the developmental trajectory and configurations of microbiota in children representing different geographies, cultural traditions, and states of health. Developing these capabilities for microbial stewardship is timely given the global health burden of childhood undernutrition, the effects of changing eating practices brought about by globalization, and the realization that affordable nutritious foods need to be developed to enhance our capacity to cultivate healthier microbiota in populations at risk for poor nutrition.	[Subramanian, Sathish; Blanton, Laura V.; Charbonneau, Mark; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Subramanian, Sathish; Blanton, Laura V.; Charbonneau, Mark; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63108 USA; [Frese, Steven A.; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Frese, Steven A.; Mills, David A.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA	Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Davis; University of California System; University of California Davis	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu	Mills, David/GXF-1821-2022; Frese, Steven/GNH-1991-2022; Mills, David Andrew/G-2282-2011	Mills, David Andrew/0000-0003-1913-9865	Bill & Melinda Gates Foundation (BMGF); NIH [DK078669, DK30292, DK70977]; National Center for Complementary & Integrative Health [R01AT007079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, R01DK030292, P01DK078669, R01DK070977] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work cited from the authors' labs was supported in part by grants from the Bill & Melinda Gates Foundation (BMGF) and the NIH (DK078669, DK30292, and DK70977). We thank our colleagues in the BMGF-sponsored Breast Milk, Gut Microbiome, and Immunity Project, Tahmeed Ahmed and other members of our collaboration with the International Center for Diarrheal Disease Research, Bangladesh (ICDDR, B), Michael Barratt, Jeanette Gehrig, Siddarth Venkatesh and other members of our laboratories, plus William Petri and Andrew Serazin for their insights and inspiration. J.I.G. is a co-founder of Matatu, Inc., a company characterizing the role of diet-by-microbiota interactions in animal health. D.A.M. is a co-founder and President of Evolve Biosystems, Inc., a company focused on diet-based manipulation of the gut microbiota.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; Aldredge DL, 2013, GLYCOBIOLOGY, V23, P664, DOI 10.1093/glycob/cwt007; Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; Ardeshir A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008791; Arslanoglu S, 2009, J PERINATOL, V29, P489, DOI 10.1038/jp.2009.50; Bergmann KR, 2013, AM J PATHOL, V182, P1595, DOI 10.1016/j.ajpath.2013.01.013; Boehm G, 2002, ARCH DIS CHILD-FETAL, V86, P178, DOI 10.1136/fn.86.3.F178; Bogin B., 1999, PATTERNS HUMAN GROWT, V2nd ed.; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Castellote C, 2011, J NUTR, V141, P1181, DOI 10.3945/jn.110.133652; Caulfield LE, 2014, CLIN INFECT DIS, V59, pS248, DOI 10.1093/cid/ciu421; Chichlowski M, 2012, J PEDIATR GASTR NUTR, V55, P321, DOI 10.1097/MPG.0b013e31824fb899; COPPA GV, 1993, PEDIATRICS, V91, P637; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; De Leoz MLA, 2015, J PROTEOME RES, V14, P491, DOI 10.1021/pr500759e; De Leoz MLA, 2012, J PROTEOME RES, V11, P4662, DOI 10.1021/pr3004979; Degnan PH, 2014, CELL HOST MICROBE, V15, P47, DOI 10.1016/j.chom.2013.12.007; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Dogra S, 2015, MBIO, V6, DOI 10.1128/mBio.02419-14; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Drewnowski A, 2010, AM J CLIN NUTR, V91, p1095S, DOI 10.3945/ajcn.2010.28450D; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Gaayeb L, 2014, AM J TROP MED HYG, V90, P566, DOI 10.4269/ajtmh.12-0657; Gabrielli O, 2011, PEDIATRICS, V128, pE1520, DOI 10.1542/peds.2011-1206; Galler JR, 2012, PEDIATRICS, V130, pE1, DOI 10.1542/peds.2012-0073; Garrido D, 2013, MICROBIOL-SGM, V159, P649, DOI 10.1099/mic.0.064113-0; Garrido D, 2012, MOL CELL PROTEOMICS, V11, P775, DOI 10.1074/mcp.M112.018119; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Goyal MS, 2014, CELL METAB, V19, P49, DOI 10.1016/j.cmet.2013.11.020; Gronlund MM, 2011, GUT MICROBES, V2, P227, DOI 10.4161/gmic.2.4.16799; Haarman M, 2005, APPL ENVIRON MICROB, V71, P2318, DOI 10.1128/AEM.71.5.2318-2324.2005; HENNART PF, 1991, AM J CLIN NUTR, V53, P32, DOI 10.1093/ajcn/53.1.32; Hsiao A, 2014, NATURE, V515, P423, DOI 10.1038/nature13738; Huda MN, 2014, PEDIATRICS, V134, pE362, DOI 10.1542/peds.2013-3937; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Jantscher-Krenn E, 2012, BRIT J NUTR, V108, P1839, DOI 10.1017/S0007114511007392; Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics, 2001, HLTH NUTR PROP PROB, P1; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Keusch GT, 2014, CLIN INFECT DIS, V59, pS207, DOI 10.1093/cid/ciu485; Kleinman RE, 2000, PEDIATRICS, V106, P1274; Knol J, 2005, ACTA PAEDIATR, V94, P31, DOI 10.1080/08035320510043529; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Korpe PS, 2013, CLIN INFECT DIS, V56, P988, DOI 10.1093/cid/cis1044; Kosek M, 2014, CLIN INFECT DIS, V59, pS239, DOI 10.1093/cid/ciu457; Kosek M, 2013, AM J TROP MED HYG, V88, P390, DOI 10.4269/ajtmh.2012.12-0549; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kramer M. S., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003517; KRAMER MS, 1992, AM J EPIDEMIOL, V136, P574, DOI 10.1093/oxfordjournals.aje.a116535; Lazzerini M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009584.pub2; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; LEMONS JA, 1982, PEDIATR RES, V16, P113, DOI 10.1203/00006450-198202000-00007; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Muthana S, 2009, CURR OPIN CHEM BIOL, V13, P573, DOI 10.1016/j.cbpa.2009.09.013; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Platts-Mills JA, 2014, CLIN INFECT DIS, V59, pS233, DOI 10.1093/cid/ciu408; Richard SA, 2014, CLIN INFECT DIS, V59, pS255, DOI 10.1093/cid/ciu436; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Smilowitz JT, 2013, J NUTR, V143, P1906, DOI 10.3945/jn.113.180695; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wang M, 2015, J PEDIAT GASTROENTER; Weber A, 2001, ACTA PAEDIATR, V90, P772, DOI 10.1080/080352501750315681; Weng MQ, 2014, AM J PHYSIOL-GASTR L, V306, pG779, DOI 10.1152/ajpgi.00183.2013; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yilmaz B, 2014, CELL, V159, P1277, DOI 10.1016/j.cell.2014.10.053; Zivkovic AM, 2011, ADV NUTR, V2, P284, DOI 10.3945/an.111.000455	78	100	108	1	117	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					36	48		10.1016/j.cell.2015.03.013	http://dx.doi.org/10.1016/j.cell.2015.03.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815983	Bronze, Green Accepted			2022-12-28	WOS:000351952200006
J	Vitorino, P; Yeung, S; Crow, A; Bakke, J; Smyczek, T; West, K; McNamara, E; Eastham-Anderson, J; Gould, S; Harris, SF; Ndubaku, C; Ye, WL				Vitorino, Philip; Yeung, Stacey; Crow, Ailey; Bakke, Jesse; Smyczek, Tanya; West, Kristina; McNamara, Erin; Eastham-Anderson, Jeffrey; Gould, Stephen; Harris, Seth F.; Ndubaku, Chudi; Ye, Weilan			MAP4K4 regulates integrin-FERM binding to control endothelial cell motility	NATURE			English	Article							SIGNALING PATHWAY; ADHESION DYNAMICS; KINASE MISSHAPEN; MATRIX ADHESIONS; LUMEN FORMATION; ERM PROTEINS; ANGIOGENESIS; MIGRATION; POLARITY; GROWTH	Cell migration is a stepwise process that coordinates multiple molecular machineries. Using in vitro angiogenesis screens with short interfering RNA and chemical inhibitors, we define here a MAP4K4-moesin-talin-beta 1-integrin molecular pathway that promotes efficient plasma membrane retraction during endothelial cell migration. Loss of MAP4K4 decreased membrane dynamics, slowed endothelial cell migration, and impaired angiogenesis in vitro and in vivo. In migrating endothelial cells, MAP4K4 phosphorylates moesin in retracting membranes at sites of focal adhesion disassembly. Epistasis analyses indicated that moesin functions downstream of MAP4K4 to inactivate integrin by competing with talin for binding to beta 1-integrin intracellular domain. Consequently, loss of moesin (encoded by the MSN gene) or MAP4K4 reduced adhesion disassembly rate in endothelial cells. Additionally, alpha 5 beta 1-integrin blockade reversed the membrane retraction defects associated with loss of Map4k4 in vitro and in vivo. Our study uncovers a novel aspect of endothelial cell migration. Finally, loss of MAP4K4 function suppressed pathological angiogenesis in disease models, identifying MAP4K4 as a potential therapeutic target.	[Vitorino, Philip; Yeung, Stacey; Crow, Ailey; Smyczek, Tanya; Ye, Weilan] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Bakke, Jesse] St Jude Childrens Res Hosp, Chem Biol & Therapeut Dept, Memphis, TN 38105 USA; [West, Kristina; McNamara, Erin; Gould, Stephen] Genentech Inc, Translat Oncol Dept, San Francisco, CA 94080 USA; [Eastham-Anderson, Jeffrey] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Harris, Seth F.] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Ndubaku, Chudi] Genentech Inc, Discovery Chem Dept, San Francisco, CA 94080 USA	Roche Holding; Genentech; St Jude Children's Research Hospital; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ye, WL (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	loni@gene.com		Bakke, Jesse/0000-0003-0305-5165; Ndubaku, Chudi/0000-0003-4183-0417; Ye, Weilan/0000-0002-6219-3982				AMIEVA MR, 1995, EXP CELL RES, V219, P180, DOI 10.1006/excr.1995.1218; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Baumgartner M, 2006, P NATL ACAD SCI USA, V103, P13391, DOI 10.1073/pnas.0605950103; Becker E, 2000, MOL CELL BIOL, V20, P1537, DOI 10.1128/MCB.20.5.1537-1545.2000; Bentley K, 2014, NAT CELL BIOL, V16, P309, DOI 10.1038/ncb2926; Berginski Matthew E, 2013, F1000Res, V2, P68, DOI 10.12688/f1000research.2-68.v1; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Bhatt A, 2002, J CELL SCI, V115, P3415; Bouaouina M, 2011, METHODS MOL BIOL, V757, P325, DOI 10.1007/978-1-61779-166-6_20; Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599; Bridgewater RE, 2012, J CELL SCI, V125, P3695, DOI 10.1242/jcs.095810; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Carlson TR, 2008, DEVELOPMENT, V135, P2193, DOI 10.1242/dev.016378; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Dorrell MI, 2006, PROG RETIN EYE RES, V25, P277, DOI 10.1016/j.preteyeres.2006.01.001; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gatto CL, 2007, J CELL PHYSIOL, V210, P122, DOI 10.1002/jcp.20844; Guntur KVP, 2010, J BIOL CHEM, V285, P6595, DOI 10.1074/jbc.M109.068502; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kaneko S, 2011, P NATL ACAD SCI USA, V108, P11127, DOI 10.1073/pnas.1104128108; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Lewellyn L, 2013, J CELL BIOL, V200, P721, DOI 10.1083/jcb.201209129; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Poinat P, 2002, CURR BIOL, V12, P622, DOI 10.1016/S0960-9822(02)00764-9; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Su YC, 1998, GENE DEV, V12, P2371, DOI 10.1101/gad.12.15.2371; Teuliere J, 2011, DEVELOPMENT, V138, P4475, DOI 10.1242/dev.061952; Wilson CW, 2013, BLOOD, V122, P3678, DOI 10.1182/blood-2013-02-483156; Xue YZ, 2001, DEVELOPMENT, V128, P1559; Yue JP, 2014, DEV CELL, V31, P572, DOI 10.1016/j.devcel.2014.10.025; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006	42	82	84	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					425	+		10.1038/nature14323	http://dx.doi.org/10.1038/nature14323			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25799996				2022-12-28	WOS:000351602800046
J	Weinreich, M				Weinreich, Michael			MOLECULAR BIOLOGY DNA replication reconstructed	NATURE			English	Editorial Material							EUKARYOTIC CELLS; HELICASE; ACTIVATION; INITIATION; KINASES		Van Andel Inst, Genome Integr & Tumorigenesis Lab, Grand Rapids, MI 49503 USA	Van Andel Institute	Weinreich, M (corresponding author), Van Andel Inst, Genome Integr & Tumorigenesis Lab, Grand Rapids, MI 49503 USA.	michael.weinreich@vai.org						Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Li Y, 2013, GENES CELLS, V18, P266, DOI 10.1111/gtc.12040; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Yardimci H, 2014, NAT STRUCT MOL BIOL, V21, P20, DOI 10.1038/nsmb.2738; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285	10	3	3	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					418	419		10.1038/519418a	http://dx.doi.org/10.1038/519418a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25810199				2022-12-28	WOS:000351602800041
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Can doctors fix cold homes?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				McCartney M., 2014, BMJ-BRIT MED J, V349, pg5688; National Institute for Health and Care Excellence, 2015, EXC DEATHS WINT MORT; Public Health England, 2014, COLD WEATH PLAN ENGL; Thomson H, 2009, AM J PUBLIC HEALTH, V99, pS681, DOI DOI 10.2105/AJPH.2008.143909	4	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2015	350								h1595	10.1136/bmj.h1595	http://dx.doi.org/10.1136/bmj.h1595			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NK	25800586	Bronze			2022-12-28	WOS:000352028400011
J	Brackel, CLH; Ropers, FG; Vermaas-Fricot, SFN; Koens, L; Willems, LNA; Rikkers-Mutsaerts, ERVM				Brackel, Caroline L. H.; Ropers, Fabienne G.; Vermaas-Fricot, Sophie F. N.; Koens, Lianne; Willems, Luuk N. A.; Rikkers-Mutsaerts, Eleonora R. V. M.			Acute eosinophilic pneumonia after recent start of smoking	LANCET			English	Editorial Material									[Brackel, Caroline L. H.; Ropers, Fabienne G.; Rikkers-Mutsaerts, Eleonora R. V. M.] Leiden Univ, Med Ctr, Dept Paediat, Willem Alexander Childrens Hosp, NL-2333 ZA Leiden, Netherlands; [Vermaas-Fricot, Sophie F. N.] Leiden Univ, Med Ctr, Dept Radiol, NL-2333 ZA Leiden, Netherlands; [Koens, Lianne] Leiden Univ, Med Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands; [Willems, Luuk N. A.] Leiden Univ, Med Ctr, Dept Pulmonol, NL-2333 ZA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Brackel, CLH (corresponding author), Leiden Univ, Med Ctr, Dept Paediat, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	c.l.h.brackel@lumc.nl						Bhatt NY, 2012, SEMIN RESP CRIT CARE, V33, P555, DOI 10.1055/s-0032-1325164; Cottin V, 2005, ALLERGY, V60, P841, DOI 10.1111/j.1398-9995.2005.00812.x; Solomon J, 2006, SEMIN RESP CRIT CARE, V27, P192, DOI 10.1055/s-2006-939522; Uchiyama H, 2008, CHEST, V133, P1174, DOI 10.1378/chest.07-2669; Weyers CM, 2005, CLIN CHEST MED, V26, P143, DOI 10.1016/j.ccm.2004.10.011	5	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1150	1150		10.1016/S0140-6736(15)60128-3	http://dx.doi.org/10.1016/S0140-6736(15)60128-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25797559				2022-12-28	WOS:000351270400034
J	Beste, RM; Bellolio, MF				Beste, Rachelle M.; Bellolio, M. Fernanda			Disseminated Zoster	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Beste, Rachelle M.; Bellolio, M. Fernanda] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Beste, RM (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	beste.rachelle@mayo.edu		Bellolio, Fernanda/0000-0002-1632-4750					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2015	372	12					1150	1150		10.1056/NEJMicm1404522	http://dx.doi.org/10.1056/NEJMicm1404522			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EZ	25785972				2022-12-28	WOS:000351183600010
J	Stanbrook, MB				Stanbrook, Matthew B.			For preventing exacerbations of COPD, withdrawal of inhaled glucocorticoids was noninferior to continuation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CORTICOSTEROIDS		Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Health Network Toronto	Stanbrook, MB (corresponding author), Univ Toronto, Univ Hlth Network, Toronto, ON, Canada.							Gershon AS, 2014, JAMA-J AM MED ASSOC, V312, P1114, DOI 10.1001/jama.2014.11432; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010115.pub2; van der Valk P, 2002, AM J RESP CRIT CARE, V166, P1358, DOI 10.1164/rccm.200206-512OC	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6							JC5	10.7326/ACPJC-2015-162-6-005	http://dx.doi.org/10.7326/ACPJC-2015-162-6-005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775348				2022-12-28	WOS:000351279600004
J	Agnandji, ST; Huttner, A; Zinser, ME; Njuguna, P; Dahlke, C; Fernandes, JF; Yerly, S; Dayer, JA; Kraehling, V; Kasonta, R; Adegnika, AA; Altfeld, M; Auderset, F; Bache, EB; Biedenkopf, N; Borregaard, S; Brosnahan, JS; Burrow, R; Combescure, C; Desmeules, J; Eickmann, M; Fehling, SK; Finckh, A; Goncalves, AR; Grobusch, MP; Hooper, J; Jambrecina, A; Kabwende, AL; Kaya, G; Kimani, D; Lell, B; Lemaitre, B; Lohse, AW; Massinga-Loembe, M; Matthey, A; Mordmuller, B; Nolting, A; Ogwang, C; Ramharter, M; Schmidt-Chanasit, J; Schmiedel, S; Silvera, P; Stahl, FR; Staines, HM; Strecker, T; Stubbe, HC; Tsofa, B; Zaki, S; Fast, P; Moorthy, V; Kaiser, L; Krishna, S; Becker, S; Kieny, MP; Bejon, P; Kremsner, PG; Addo, MM; Siegrist, CA				Agnandji, S. T.; Huttner, A.; Zinser, M. E.; Njuguna, P.; Dahlke, C.; Fernandes, J. F.; Yerly, S.; Dayer, J. -A.; Kraehling, V.; Kasonta, R.; Adegnika, A. A.; Altfeld, M.; Auderset, F.; Bache, E. B.; Biedenkopf, N.; Borregaard, S.; Brosnahan, J. S.; Burrow, R.; Combescure, C.; Desmeules, J.; Eickmann, M.; Fehling, S. K.; Finckh, A.; Goncalves, A. R.; Grobusch, M. P.; Hooper, J.; Jambrecina, A.; Kabwende, A. L.; Kaya, G.; Kimani, D.; Lell, B.; Lemaitre, B.; Lohse, A. W.; Massinga-Loembe, M.; Matthey, A.; Mordmueller, B.; Nolting, A.; Ogwang, C.; Ramharter, M.; Schmidt-Chanasit, J.; Schmiedel, S.; Silvera, P.; Stahl, F. R.; Staines, H. M.; Strecker, T.; Stubbe, H. C.; Tsofa, B.; Zaki, S.; Fast, P.; Moorthy, V.; Kaiser, L.; Krishna, S.; Becker, S.; Kieny, M. -P.; Bejon, P.; Kremsner, P. G.; Addo, M. M.; Siegrist, C. -A.			Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VESICULAR STOMATITIS-VIRUS; PROTECTS NONHUMAN-PRIMATES; MARBURG VIRUS; INFECTION; IMMUNITY	BACKGROUND The replication-competent recombinant vesicular stomatitis virus (rVSV)-based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety and immunogenicity testing before its use in West Africa. METHODS We performed three open-label, dose-escalation phase 1 trials and one randomized, double-blind, controlled phase 1 trial to assess the safety, side-effect profile, and immunogenicity of rVSV-ZEBOV at various doses in 158 healthy adults in Europe and Africa. All participants were injected with doses of vaccine ranging from 300,000 to 50 million plaque-forming units (PFU) or placebo. RESULTS No serious vaccine-related adverse events were reported. Mild-to-moderate early-onset reactogenicity was frequent but transient (median, 1 day). Fever was observed in up to 30% of vaccinees. Vaccine viremia was detected within 3 days in 123 of the 130 participants (95%) receiving 3 million PFU or more; rVSV was not detected in saliva or urine. In the second week after injection, arthritis affecting one to four joints developed in 11 of 51 participants (22%) in Geneva, with pain lasting a median of 8 days (interquartile range, 4 to 87); 2 self-limited cases occurred in 60 participants (3%) in Hamburg, Germany, and Kilifi, Kenya. The virus was identified in one synovial-fluid aspirate and in skin vesicles of 2 other vaccinees, showing peripheral viral replication in the second week after immunization. ZEBOV-glycoprotein-specific antibody responses were detected in all the participants, with similar glycoprotein-binding antibody titers but significantly higher neutralizing antibody titers at higher doses. Glyco-protein-binding antibody titers were sustained through 180 days in all participants. CONCLUSIONS In these studies, rVSV-ZEBOV was reactogenic but immunogenic after a single dose and warrants further evaluation for safety and efficacy.	[Siegrist, C. -A.] Univ Hosp Geneva, Ctr Vaccinol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland; [Agnandji, S. T.; Fernandes, J. F.; Adegnika, A. A.; Bache, E. B.; Brosnahan, J. S.; Grobusch, M. P.; Kabwende, A. L.; Lell, B.; Massinga-Loembe, M.; Mordmueller, B.; Ramharter, M.; Krishna, S.; Kremsner, P. G.] Ctr Rech Med Lambarene, Lambarene, Gabon; [Agnandji, S. T.; Fernandes, J. F.; Adegnika, A. A.; Bache, E. B.; Brosnahan, J. S.; Grobusch, M. P.; Kabwende, A. L.; Lell, B.; Massinga-Loembe, M.; Mordmueller, B.; Ramharter, M.; Krishna, S.; Kremsner, P. G.] Univ Klinikum Tubinen, Inst Tropenmed, Tubingen, Germany; [Agnandji, S. T.; Fernandes, J. F.; Adegnika, A. A.; Bache, E. B.; Brosnahan, J. S.; Grobusch, M. P.; Kabwende, A. L.; Lell, B.; Massinga-Loembe, M.; Mordmueller, B.; Ramharter, M.; Krishna, S.; Kremsner, P. G.] German Ctr Infect Res, Tubingen, Germany; [Zinser, M. E.; Dahlke, C.; Kasonta, R.; Lohse, A. W.; Nolting, A.; Schmiedel, S.; Stubbe, H. C.; Addo, M. M.] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Stahl, F. R.] Inst Clin Chem & Lab Med, Hamburg, Germany; [Dahlke, C.; Nolting, A.; Schmidt-Chanasit, J.; Stubbe, H. C.; Addo, M. M.] German Ctr Infect Res, Partner Site Standort Hamburg lUBECK Borstel, Hamburg, Germany; [Altfeld, M.] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Borregaard, S.; Jambrecina, A.] Clin Trial Ctr North, Hamburg, Germany; [Schmidt-Chanasit, J.] WHO, Collaborating Ctr Arbovirus & Hemorrhag Fever Ref, Natl Reference Ctr Trop Infect Dis, Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Kraehling, V.; Biedenkopf, N.; Eickmann, M.; Fehling, S. K.; Strecker, T.; Becker, S.] Univ Marburg, Inst Virol, Partner Site Giessen Marburg Langen, D-35032 Marburg, Germany; [Kraehling, V.; Biedenkopf, N.; Eickmann, M.; Fehling, S. K.; Strecker, T.; Becker, S.] German Ctr Infect Res DZIF, Partner Site Giessen Marburg Langen, Marburg, Germany; [Kasonta, R.] Paul Ehrlich Inst, Div Vet Med, Langen, Germany; [Huttner, A.] Univ Hosp Geneva, Infect Control Program, CH-1211 Geneva 4, Switzerland; [Huttner, A.; Dayer, J. -A.; Kaiser, L.] Univ Hosp Geneva, Div Infect Dis, CH-1211 Geneva 4, Switzerland; [Combescure, C.] Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva 4, Switzerland; [Finckh, A.] Univ Hosp Geneva, Div Rheumatol, CH-1211 Geneva 4, Switzerland; [Kaya, G.] Univ Hosp Geneva, Div Dermatol, CH-1211 Geneva 4, Switzerland; [Desmeules, J.; Matthey, A.] Univ Hosp Geneva, Clin Res Ctr, CH-1211 Geneva 4, Switzerland; [Yerly, S.; Goncalves, A. R.; Kaiser, L.] Univ Hosp Geneva, Fac Med, CH-1211 Geneva 4, Switzerland; [Yerly, S.; Goncalves, A. R.; Kaiser, L.] Univ Hosp Geneva, Virol Lab, CH-1211 Geneva 4, Switzerland; [Auderset, F.; Lemaitre, B.; Siegrist, C. -A.] WHO, Collaborat Ctr Vaccinol, Fac Med, Geneva, Switzerland; [Fast, P.; Moorthy, V.; Kieny, M. -P.] WHO, Geneva, Switzerland; [Njuguna, P.; Kimani, D.; Ogwang, C.; Tsofa, B.; Bejon, P.] Ctr Geog Med Res, Kenya Med Res Inst, Wellcome Trust Res Program, Kilifi, Kenya; [Adegnika, A. A.] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands; [Grobusch, M. P.] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis,Div Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Burrow, R.; Staines, H. M.; Krishna, S.] Univ London, Inst Infect & Immun, London WC1E 7HU, England; [Hooper, J.; Silvera, P.] US Army, Dept Mol Virol, Med Res Inst Infect, Frederick, MD USA; [Hooper, J.; Silvera, P.] US Army, Div Translat Sci, Med Res Inst Infect, Frederick, MD USA; [Ramharter, M.] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria; [Zaki, S.] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Atlanta, GA USA; [Fast, P.] Int AIDS Vaccine Initiat, New York, NY USA	University of Geneva; German Center for Infection Research; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Center for Infection Research; Heinrich Pette Institute; Bernhard Nocht Institut fur Tropenmedizin; World Health Organization; Philipps University Marburg; German Center for Infection Research; Paul Ehrlich Institute; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; World Health Organization; World Health Organization; Kenya Medical Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of London; Medical University of Vienna; Centers for Disease Control & Prevention - USA; International AIDS Vaccine Initiative	Addo, MM (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Div Trop Med, Martinistr 52, D-20246 Hamburg, Germany.; Siegrist, CA (corresponding author), Univ Hosp Geneva, Ctr Vaccinol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.; Siegrist, CA (corresponding author), Ctr Med Univ Geneva, Fac Med, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	m.addo@uke.de; claire-anne.siegrist@unige.ch	Kieny, Marie-Paule/Q-1238-2019; ADEGNIKA, Ayola Akim/AAK-7307-2020; Altfeld, Marcus/AAE-7306-2019; Strecker, Thomas/AAR-8442-2020; Staines, Henry M/B-6281-2009; Stahl, Felix/O-8715-2019; Kieny, Marie-Paule/N-3914-2017; Hooper, Jay/K-2362-2017; Huttner, Angela/AAM-1197-2020; Mordmüller, Benjamin/A-5749-2010; Addo, Marylyn M./GNP-2548-2022; Ramharter, Michael/C-5273-2013	Altfeld, Marcus/0000-0001-5972-2997; Staines, Henry M/0000-0001-5890-3040; Stahl, Felix/0000-0002-7443-8967; Kieny, Marie-Paule/0000-0002-5943-6488; Hooper, Jay/0000-0002-4475-0415; Huttner, Angela/0000-0002-8380-368X; Mordmüller, Benjamin/0000-0001-9101-2768; Moorthy, Vasee/0000-0002-6535-2854; Dahlke, Christine/0000-0002-2056-9195; Strecker, Thomas/0000-0002-7857-937X; Massinga Loembe, Marguerite/0000-0002-7822-566X; /0000-0001-9585-3820; Krishna, Sanjeev/0000-0003-0066-0634; Goncalves, Ana Rita/0000-0002-7893-0158; Addo, Marylyn/0000-0003-2836-9224; Ramharter, Michael/0000-0002-9259-1885; Kaiser, Laurent/0000-0002-0857-2252; Burrow, Rebekah/0000-0002-4757-9465	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Funded by the Wellcome Trust and others; ClinicalTrials.gov numbers, NCT02283099, NCT02287480, and NCT02296983; Pan African Clinical Trials Registry number, PACTR201411000919191.	CARTWRIGHT T, 1977, J GEN VIROL, V36, P317, DOI 10.1099/0022-1317-36-2-317; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627; FIELDS BN, 1967, NEW ENGL J MED, V277, P889, DOI 10.1056/NEJM196711092771901; Fransen J, 2003, ANN RHEUM DIS, V62, P151; Geisbert TW, 2011, J INFECT DIS, V204, pS1075, DOI 10.1093/infdis/jir349; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Geisbert TW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000225; Gunther S, 2011, J INFECT DIS, V204, pS785, DOI 10.1093/infdis/jir298; HANSON RP, 1957, AM J PUBLIC HEALTH N, V47, P205, DOI 10.2105/AJPH.47.2.205; Hastie E, 2013, VIRUS RES, V176, P16, DOI 10.1016/j.virusres.2013.06.003; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; JOHNSON KM, 1966, AM J TROP MED HYG, V15, P244, DOI 10.4269/ajtmh.1966.15.244; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Jones SM, 2007, J INFECT DIS, V196, pS404, DOI 10.1086/520591; Kanapathipillai R, 2014, NEW ENGL J MED, V371, P2249, DOI 10.1056/NEJMp1412166; Krauss H., 2003, ZOONOSES INFECT DIS, P119; Kwilas S, 2014, CURR GENE THER, V14, P200, DOI 10.2174/1566523214666140522122633; Lai LL, 2015, JAMA-J AM MED ASSOC, V313, P1249, DOI 10.1001/jama.2015.1995; Letchworth GJ, 1999, VET J, V157, P239, DOI 10.1053/tvjl.1998.0303; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Pincus T, 2013, BULL HOSP JT DIS, V71, P117; Pulendran B, 2013, IMMUNOL REV, V255, P243, DOI 10.1111/imr.12099; Qiu XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005547; QUIROZ E, 1988, AM J TROP MED HYG, V39, P312, DOI 10.4269/ajtmh.1988.39.312; REIF JS, 1987, AM J TROP MED HYG, V36, P177, DOI 10.4269/ajtmh.1987.36.177; Roberts A, 1999, J VIROL, V73, P3723, DOI 10.1128/JVI.73.5.3723-3732.1999; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Stojdl DF, 2000, J VIROL, V74, P9580, DOI 10.1128/JVI.74.20.9580-9585.2000; WEIBEL RE, 1969, NEW ENGL J MED, V280, P682, DOI 10.1056/NEJM196903272801302; Zhu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064119	32	268	275	2	102	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2016	374	17					1647	1660		10.1056/NEJMoa1502924	http://dx.doi.org/10.1056/NEJMoa1502924			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK3UR	25830326	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000374843400008
J	Thornton, J; Duley, L				Thornton, Jim; Duley, Lelia			Gestational hypertension before term: observe or deliver?	LANCET			English	Editorial Material									[Thornton, Jim; Duley, Lelia] Univ Nottingham, Nottingham NG7 2RD, England; [Thornton, Jim] City Hosp, Matern Unit, Nottingham NG5 1PB, England	University of Nottingham; University of Nottingham	Thornton, J (corresponding author), Univ Nottingham, Nottingham NG7 2RD, England.	jim.thornton@nottingham.ac.uk	Duley, Lelia/E-8107-2015; Thornton, Jim/B-8336-2008	Duley, Lelia/0000-0001-6721-5178; Thornton, Jim/0000-0001-9764-6876	MRC [G116/98] Funding Source: UKRI; Medical Research Council [G116/98] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], [No title captured]; Churchill D, 2013, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD003106.PUB2.SEE; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; Langenveld J, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-50; National Institute for Health and Clinical Excellence, 2010, HYPERTENSION PREGNAN; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; von Dadelszen P, 2011, LANCET, V377, P219, DOI 10.1016/S0140-6736(10)61351-7; WHO, 2011, REC PREV TREATM PREE	8	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2441	2443		10.1016/S0140-6736(14)62454-5	http://dx.doi.org/10.1016/S0140-6736(14)62454-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK9AR	25817376				2022-12-28	WOS:000356532500007
J	Schulkey, CE; Regmi, SD; Magnan, RA; Danzo, MT; Luther, H; Hutchinson, AK; Panzer, AA; Grady, MM; Wilson, DB; Jay, PY				Schulkey, Claire E.; Regmi, Suk D.; Magnan, Rachel A.; Danzo, Megan T.; Luther, Herman; Hutchinson, Alayna K.; Panzer, Adam A.; Grady, Mary M.; Wilson, David B.; Jay, Patrick Y.			The maternal-age-associated risk of congenital heart disease is modifiable	NATURE			English	Article							CHROMOSOME SUBSTITUTION STRAINS; CARDIOVASCULAR DEFECTS; BIRTH-DEFECTS; MALFORMATIONS; MICE; EPIDEMIOLOGY; POPULATION; METABOLOME; MUTATIONS; COUNCIL	Maternal age is a risk factor for congenital heart disease even in the absence of any chromosomal abnormality in the newborn(1-7). Whether the basis of this risk resides with the mother or oocyte is unknown. The impact of maternal age on congenital heart disease can be modelled in mouse pups that harbour a mutation of the cardiac transcription factor gene Nkx2-5 (ref. 8). Here, reciprocal ovarian transplants between young and old mothers establish a maternal basis for the age-associated risk in mice. A high-fat diet does not accelerate the effect of maternal ageing, so hyperglycaemia and obesity do not simply explain the mechanism. The age-associated risk varies with the mother's strain background, making it a quantitative genetic trait. Most remarkably, voluntary exercise, whether begun by mothers at a young age or later in life, can mitigate the risk when they are older. Thus, even when the offspring carry a causal mutation, an intervention aimed at the mother can meaningfully reduce their risk of congenital heart disease.	[Schulkey, Claire E.; Regmi, Suk D.; Magnan, Rachel A.; Danzo, Megan T.; Luther, Herman; Hutchinson, Alayna K.; Panzer, Adam A.; Grady, Mary M.; Wilson, David B.; Jay, Patrick Y.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Wilson, David B.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Jay, Patrick Y.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Jay, PY (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	jay_p@kids.wustl.edu	Wilson, David/K-7433-2014	Wilson, David/0000-0002-1826-7745	Ruth L. Kirschstein National Research Service Award from the Developmental Cardiology and Pulmonary Training Program (National Institutes ofHealth (NIH)) [T32HL007873]; Children's Discovery Institute of Washington University; St Louis Children's Hospital, the Children's Heart Foundation; NIH [R01 HL105857, P30 DK52574, P30 DK020579]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105857, T32HL007873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, P30DK020579] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award from the Developmental Cardiology and Pulmonary Training Program (National Institutes ofHealth (NIH)); Children's Discovery Institute of Washington University; St Louis Children's Hospital, the Children's Heart Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	C.E.S. was supported by a Ruth L. Kirschstein National Research Service Award from the Developmental Cardiology and Pulmonary Training Program (National Institutes ofHealth (NIH) T32HL007873). P.Y.J. isan Established Investigator of the American Heart Association and the Lawrence J. & Florence A. DeGeorge Charitable Trust. This work was supported by the Children's Discovery Institute of Washington University and St Louis Children's Hospital, the Children's Heart Foundation, and the NIH (R01 HL105857). The Washington University Digestive Diseases Research Core Center provided histology services and is supported by the NIH (P30 DK52574). MRI studies were performed in the Washington University Diabetes Research Center, which is supported by the NIH (P30 DK020579). We thank J. Magee, J. Rubin, D. Rudnick and A. Schwartz for comments.	Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; BAIRD PA, 1991, LANCET, V337, P527, DOI 10.1016/0140-6736(91)91306-F; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Burrage LC, 2010, MAMM GENOME, V21, P115, DOI 10.1007/s00335-010-9247-9; Bye A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042330; Chorell E, 2012, MOL BIOSYST, V8, P1187, DOI 10.1039/c2mb05428k; Forrester MB, 2004, PAEDIATR PERINAT EP, V18, P415, DOI 10.1111/j.1365-3016.2004.00594.x; Hollier LM, 2000, OBSTET GYNECOL, V96, P701, DOI 10.1016/S0029-7844(00)01019-X; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; KIDD SA, 1993, J PAEDIATR CHILD H, V29, P344, DOI 10.1111/j.1440-1754.1993.tb00531.x; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Li M, 2014, GENET EPIDEMIOL, V38, P198, DOI 10.1002/gepi.21793; Loane M, 2009, BJOG-INT J OBSTET GY, V116, P1111, DOI 10.1111/j.1471-0528.2009.02227.x; Lustgarten MS, 2013, EUR J APPL PHYSIOL, V113, P1311, DOI 10.1007/s00421-012-2555-x; Materna-Kiryluk A, 2009, PAEDIATR PERINAT EP, V23, P29, DOI 10.1111/j.1365-3016.2008.00979.x; Miller A, 2011, AM J MED GENET A, V155A, P2137, DOI 10.1002/ajmg.a.34130; Mukherjee K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092031; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Pradat P, 2003, PEDIATR CARDIOL, V24, P195, DOI 10.1007/s00246-002-9401-6; Reefhuis J, 2004, BIRTH DEFECTS RES A, V70, P572, DOI 10.1002/bdra.20065; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Tanaka M, 1999, DEVELOPMENT, V126, P1269; WALD N, 1991, LANCET, V338, P131; Winston JB, 2012, CIRC-CARDIOVASC GENE, V5, P293, DOI 10.1161/CIRCGENETICS.111.961136; Winston JB, 2010, CIRCULATION, V121, P1313, DOI 10.1161/CIRCULATIONAHA.109.887687	27	57	59	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					230	U225		10.1038/nature14361	http://dx.doi.org/10.1038/nature14361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25830876	Green Accepted			2022-12-28	WOS:000352454600041
J	Schumacher, TN; Schreiber, RD				Schumacher, Ton N.; Schreiber, Robert D.			Neoantigens in cancer immunotherapy	SCIENCE			English	Review							EXOME ANALYSIS REVEALS; MHC CLASS-I; T-CELLS; PD-1 BLOCKADE; NEO-ANTIGENS; CD4+T CELLS; LYMPHOCYTES; THERAPY; IDENTIFICATION; NEOEPITOPES	The clinical relevance of T cells in the control of a diverse set of human cancers is now beyond doubt. However, the nature of the antigens that allow the immune system to distinguish cancer cells from noncancer cells has long remained obscure. Recent technological innovations have made it possible to dissect the immune response to patient-specific neoantigens that arise as a consequence of tumor-specific mutations, and emerging data suggest that recognition of such neoantigens is a major factor in the activity of clinical immunotherapies. These observations indicate that neoantigen load may form a biomarker in cancer immunotherapy and provide an incentive for the development of novel therapeutic approaches that selectively enhance T cell reactivity against this class of antigens.	[Schumacher, Ton N.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Schreiber, Robert D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Netherlands Cancer Institute; Washington University (WUSTL)	Schumacher, TN (corresponding author), Netherlands Canc Inst, Div Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	t.schumacher@nki.nl; schreiber@immunology.wustl.edu	Schreiber, Robert/Q-7550-2019; Schumacher, Ton/Y-2432-2019	Schumacher, Ton/0000-0003-0517-8804; Schreiber, Robert/0000-0003-1590-2341	Worldwide Cancer Research grant [14-0321]; Dutch Cancer Society grant [NKI 2012-5463]; Dutch Cancer Society Queen Wilhelmina Award; Stand Up To Cancer-Cancer Research Institute Cancer Immunology Translational Cancer Research Grant; National Cancer Institute [RO1CA04305926]; Cancer Research Institute; WWWW Foundation; Cancer Frontier Fund from The Siteman Cancer Center/Barnes-Jewish Hospital; Third Rock Ventures; Kite Pharma; Jounce Therapeutics; Worldwide Cancer Research [14-0321] Funding Source: researchfish	Worldwide Cancer Research grant; Dutch Cancer Society grant(KWF Kankerbestrijding); Dutch Cancer Society Queen Wilhelmina Award; Stand Up To Cancer-Cancer Research Institute Cancer Immunology Translational Cancer Research Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Institute; WWWW Foundation; Cancer Frontier Fund from The Siteman Cancer Center/Barnes-Jewish Hospital; Third Rock Ventures; Kite Pharma; Jounce Therapeutics; Worldwide Cancer Research	This work is supported by Worldwide Cancer Research grant 14-0321, Dutch Cancer Society grant NKI 2012-5463, the Dutch Cancer Society Queen Wilhelmina Award, the Stand Up To Cancer-Cancer Research Institute Cancer Immunology Translational Cancer Research Grant (to T.N.S.), the National Cancer Institute (RO1CA04305926), the Cancer Research Institute, the WWWW Foundation, and the Cancer Frontier Fund from The Siteman Cancer Center/Barnes-Jewish Hospital (to R.D.S.). SU2C is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. We thank J. Haanen, M. van Buuren, and P. Kvistborg for valuable discussions. T.N.S. has an paid advisory relationship with Third Rock Ventures and Kite Pharma. R.D.S. has a paid advisory relationship with Third Rock Ventures and Jounce Therapeutics.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Boisguerin V, 2014, BRIT J CANCER, V111, P1469, DOI 10.1038/bjc.2013.820; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Cabrera CM, 2003, TISSUE ANTIGENS, V61, P211, DOI 10.1034/j.1399-0039.2003.00020.x; Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Duan F, 2014, J EXP MED, V211, P2231, DOI 10.1084/jem.20141308; Dudley ME, 2013, J CLIN ONCOL, V31, P2152, DOI 10.1200/JCO.2012.46.6441; Dudley ME, 1996, J EXP MED, V184, P441, DOI 10.1084/jem.184.2.441; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fortier MH, 2008, J EXP MED, V205, P595, DOI 10.1084/jem.20071985; Fritsch EF, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29311; Fritsch EF, 2014, CANCER IMMUNOL RES, V2, P522, DOI 10.1158/2326-6066.CIR-13-0227; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gilboa E, 1999, IMMUNITY, V11, P263, DOI 10.1016/S1074-7613(00)80101-6; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Heemskerk B, 2013, EMBO J, V32, P194, DOI 10.1038/emboj.2012.333; Hinrichs CS, 2014, IMMUNOL REV, V257, P56, DOI 10.1111/imr.12132; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Joseph CG, 2014, SCIENCE, V343, P152, DOI 10.1126/science.1246886; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Kvistborg P, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.18851; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Lu YC, 2014, CLIN CANCER RES, V20, P3401, DOI 10.1158/1078-0432.CCR-14-0433; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Rajasagi M, 2014, BLOOD, V124, P453, DOI 10.1182/blood-2014-04-567933; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Schumacher TN, 2015, CANCER CELL, V27, P12, DOI 10.1016/j.ccell.2014.12.004; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Bergen CAM, 2010, CANCER RES, V70, P9073, DOI 10.1158/0008-5472.CAN-10-1832; van Buuren MM, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28836; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Vonderheide RH, 2013, NAT MED, V19, P1098, DOI 10.1038/nm.3317; Wick DA, 2014, CLIN CANCER RES, V20, P1125, DOI 10.1158/1078-0432.CCR-13-2147; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001	52	2849	2975	44	878	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					69	74		10.1126/science.aaa4971	http://dx.doi.org/10.1126/science.aaa4971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838375				2022-12-28	WOS:000352079500028
J	Duncan, MJ				Duncan, Martin J.			Preventing stars from eating their young	NATURE			English	Editorial Material							ACCRETION; MIGRATION; GROWTH		Queens Univ, Dept Phys Engn Phys & Astron, Kingston, ON K7L 7N6, Canada	Queens University - Canada	Duncan, MJ (corresponding author), Queens Univ, Dept Phys Engn Phys & Astron, Kingston, ON K7L 7N6, Canada.	duncan@astro.queensu.ca						Baruteau C., 2013, PREPRINT; Howard AW, 2013, SCIENCE, V340, P572, DOI 10.1126/science.1233545; Levison HF, 2010, ASTRON J, V139, P1297, DOI 10.1088/0004-6256/139/4/1297; Ormel CW, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/201014903; Paardekooper SJ, 2011, MON NOT R ASTRON SOC, V410, P293, DOI 10.1111/j.1365-2966.2010.17442.x	9	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					40	41		10.1038/520040a	http://dx.doi.org/10.1038/520040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25832400				2022-12-28	WOS:000352027700030
J	Wernet, P; Kunnus, K; Josefsson, I; Rajkovic, I; Quevedo, W; Beye, M; Schreck, S; Grubel, S; Scholz, M; Nordlund, D; Zhang, W; Hartsock, RW; Schlotter, WF; Turner, JJ; Kennedy, B; Hennies, F; de Groot, FMF; Gaffney, KJ; Techert, S; Odelius, M; Fohlisch, A				Wernet, Ph.; Kunnus, K.; Josefsson, I.; Rajkovic, I.; Quevedo, W.; Beye, M.; Schreck, S.; Gruebel, S.; Scholz, M.; Nordlund, D.; Zhang, W.; Hartsock, R. W.; Schlotter, W. F.; Turner, J. J.; Kennedy, B.; Hennies, F.; de Groot, F. M. F.; Gaffney, K. J.; Techert, S.; Odelius, M.; Foehlisch, A.			Orbital-specific mapping of the ligand exchange dynamics of Fe(CO)(5) in solution	NATURE			English	Article							BOND ACTIVATION; METAL-COMPLEXES; SPIN; CHEMISTRY; PHOTOSUBSTITUTION; PHOTOCHEMISTRY; INTERPLAY; CHARGE	Transition-metal complexes have long attracted interest for fundamental chemical reactivity studies and possible use in solar energy conversion(1,2). Electronic excitation, ligand loss from the metal centre, or a combination of both, creates changes in charge and spin density at the metal site(3-11) that need to be controlled to optimize complexes for photocatalytic hydrogen production(8) and selective carbon-hydrogen bond activation(9-11). An understanding at the molecular level of how transition-metal complexes catalyse reactions, and in particular of the role of the short-lived and reactive intermediate states involved, will be critical for such optimization. However, suitable methods for detailed characterization of electronic excited states have been lacking. Here we show, with the use of X-ray laser-based femtosecond-resolution spectroscopy and advanced quantum chemical theory to probe the reaction dynamics of the benchmark transition-metal complex Fe(CO)(5) in solution, that the photo-induced removal of CO generates the 16-electron Fe(CO)(4) species, a homogeneous catalyst(12,13) with an electron deficiency at the Fe centre(14,15), in a hitherto unreported excited singlet state that either converts to the triplet ground state or combines with a CO or solvent molecule to regenerate a penta-coordinated Fe species on a sub-picosecond timescale. This finding, which resolves the debate about the relative importance of different spin channels in the photochemistry of Fe(CO)(5) (refs 4, 16-20), was made possible by the ability of femtosecond X-ray spectroscopy to probe frontier-orbital interactions with atom specificity. We expect the method to be broadly applicable in the chemical sciences, and to complement approaches that probe structural dynamics in ultrafast processes.	[Wernet, Ph.; Kunnus, K.; Beye, M.; Schreck, S.; Foehlisch, A.] Helmholtz Zentrum Berlin Mat & Energie GmbH, Inst Methods & Instrumentat Synchrotron Radiat Re, D-12489 Berlin, Germany; [Kunnus, K.; Schreck, S.; Foehlisch, A.] Univ Potsdam, Inst Phys & Astron, D-14476 Potsdam, Germany; [Josefsson, I.; Odelius, M.] Stockholm Univ, Dept Phys, AlbaNova Univ Ctr, S-10691 Stockholm, Sweden; [Rajkovic, I.; Quevedo, W.; Gruebel, S.; Scholz, M.] Max Planck Inst Biophys Chem, IFG Struct Dynam Bio Chem Syst, D-37077 Gottingen, Germany; [Nordlund, D.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Zhang, W.; Hartsock, R. W.; Gaffney, K. J.] Stanford Univ, PULSE Inst, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Schlotter, W. F.; Turner, J. J.] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Kennedy, B.; Hennies, F.] MAX Lab, S-22100 Lund, Sweden; [de Groot, F. M. F.] Univ Utrecht, Dept Chem, NL-3584 CG Utrecht, Netherlands; [Techert, S.] Univ Gottingen, Inst Xray Phys, D-37077 Gottingen, Germany; [Techert, S.] DESY, Struct Dynam Bio Chem Syst, D-22607 Hamburg, Germany	Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); University of Potsdam; Stockholm University; Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Utrecht University; University of Gottingen; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Wernet, P (corresponding author), Helmholtz Zentrum Berlin Mat & Energie GmbH, Inst Methods & Instrumentat Synchrotron Radiat Re, Albert Einstein Str 15, D-12489 Berlin, Germany.	wernet@helmholtz-berlin.de; odelius@fysik.su.se; alexander.foehlisch@helmholtz-berlin.de	Nordlund, Dennis/A-8902-2008; Young, Michelle A/N-7228-2017; Beye, Martin/F-1165-2011; Zhang, Wenkai/H-1301-2012; Gaffney, Kelly/AAG-7136-2020; Josefsson, Ida/L-5778-2014; Odelius, Michael/J-6142-2019; Wernet, Philippe/A-7085-2013; de Groot, Frank M F/A-1918-2009; Hennies, Franz/A-4643-2009; Gaffney, Kelly J/N-1597-2017; Odelius, Michael/A-7628-2014	Nordlund, Dennis/0000-0001-9524-6908; Beye, Martin/0000-0002-3924-2993; Josefsson, Ida/0000-0002-8621-4282; Wernet, Philippe/0000-0001-7011-9072; de Groot, Frank M F/0000-0002-1340-2186; Hennies, Franz/0000-0003-3904-1937; Gaffney, Kelly J/0000-0002-0525-6465; Odelius, Michael/0000-0002-7023-2486; Kunnus, Kristjan/0000-0002-9777-2685; Techert, Simone/0000-0002-7549-7651; Alexander, Fohlisch/0000-0003-4126-8233	Volkswagen Stiftung; Swedish Research Council; Carl Tryggers Foundation; Magnus Bergvall Foundation; Collaborative Research Centers [SFB 755, SFB 1073]; Helmholtz Virtual Institute 'Dynamic Pathways in Multidimensional Landscapes'; AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, US Department of Energy; LCLS; Stanford University through the Stanford Institute for Materials Energy Sciences (SIMES); Lawrence Berkeley National Laboratory (LBNL); University of Hamburg through the BMBF priority program [FSP 301]; Center for Free Electron Laser Science (CFEL)	Volkswagen Stiftung(Volkswagen); Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Foundation; Magnus Bergvall Foundation; Collaborative Research Centers; Helmholtz Virtual Institute 'Dynamic Pathways in Multidimensional Landscapes'; AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, US Department of Energy(United States Department of Energy (DOE)); LCLS; Stanford University through the Stanford Institute for Materials Energy Sciences (SIMES); Lawrence Berkeley National Laboratory (LBNL); University of Hamburg through the BMBF priority program; Center for Free Electron Laser Science (CFEL)	This work was supported by the Volkswagen Stiftung (M.B.) the Swedish Research Council (M.O.), the Carl Tryggers Foundation (M.O.), the Magnus Bergvall Foundation (M.O.), the Collaborative Research Centers SFB 755 and SFB 1073 (I.R., S.G., W.Q., M.S. and S.T.) and the Helmholtz Virtual Institute 'Dynamic Pathways in Multidimensional Landscapes'. W.Z., R.W.H. and K.J.G. acknowledge support through the AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, US Department of Energy. Portions of this research were performed on the Soft X-ray Materials Science (SXR) Instrument at the Linac Coherent Light Source (LCLS), a division of SLAC National Accelerator Laboratory and an Office of Science user facility operated by Stanford University for the US Department of Energy. The SXR Instrument is funded by a consortium whose membership includes the LCLS, Stanford University through the Stanford Institute for Materials Energy Sciences (SIMES), Lawrence Berkeley National Laboratory (LBNL), the University of Hamburg through the BMBF priority program FSP 301, and the Center for Free Electron Laser Science (CFEL).	Ahr B, 2011, PHYS CHEM CHEM PHYS, V13, P5590, DOI 10.1039/c0cp01856b; ARNDTSEN BA, 1995, ACCOUNTS CHEM RES, V28, P154, DOI 10.1021/ar00051a009; BENGALI AA, 1995, J AM CHEM SOC, V117, P3879, DOI 10.1021/ja00118a029; Besora M, 2009, J AM CHEM SOC, V131, P3583, DOI 10.1021/ja807149t; Bressler C, 2009, SCIENCE, V323, P489, DOI 10.1126/science.1165733; Bromberg SE, 1997, SCIENCE, V278, P260, DOI 10.1126/science.278.5336.260; Chergui M, 2012, DALTON T, V41, P13022, DOI 10.1039/c2dt30764b; FUKUI K, 1982, ANGEW CHEM INT EDIT, V21, P801, DOI 10.1002/anie.198208013; GRAY HB, 1981, SCIENCE, V214, P1201, DOI 10.1126/science.214.4526.1201; Greaves SJ, 2011, SCIENCE, V331, P1423, DOI 10.1126/science.1197796; Heyduk AF, 2001, SCIENCE, V293, P1639, DOI 10.1126/science.1062965; HOFFMANN R, 1982, ANGEW CHEM INT EDIT, V21, P711, DOI 10.1002/anie.198207113; Huse N, 2011, J PHYS CHEM LETT, V2, P880, DOI 10.1021/jz200168m; Ihee H, 2001, ANGEW CHEM INT EDIT, V40, P1532, DOI 10.1002/1521-3773(20010417)40:8<1532::AID-ANIE1532>3.0.CO;2-E; JOLY AG, 1991, CHEM PHYS, V152, P69, DOI 10.1016/0301-0104(91)80035-G; Juban EA, 2006, COORDIN CHEM REV, V250, P1783, DOI 10.1016/j.ccr.2006.02.010; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Langmuir I, 1921, SCIENCE, V54, P59, DOI 10.1126/science.54.1386.59; LIM M, 1995, SCIENCE, V269, P962, DOI 10.1126/science.7638619; NAYAK SK, 1994, INORG CHEM, V33, P2236, DOI 10.1021/ic00088a028; Nibbering ETJ, 2005, ANNU REV PHYS CHEM, V56, P337, DOI 10.1146/annurev.physchem.56.092503.141314; PARSHALL GW, 1980, SCIENCE, V208, P1221, DOI 10.1126/science.208.4449.1221; Poliakoff M, 2001, ANGEW CHEM INT EDIT, V40, P2809, DOI 10.1002/1521-3773(20010803)40:15<2809::AID-ANIE2809>3.0.CO;2-U; Portius P, 2004, J AM CHEM SOC, V126, P10713, DOI 10.1021/ja048411t; Snee PT, 2001, J AM CHEM SOC, V123, P6909, DOI 10.1021/ja010648r; Snee PT, 2001, J AM CHEM SOC, V123, P2255, DOI 10.1021/ja002350r; Trushin SA, 2000, J PHYS CHEM A, V104, P1997, DOI 10.1021/jp992474u; WHETTEN RL, 1982, J AM CHEM SOC, V104, P4270, DOI 10.1021/ja00379a048; WRIGHTON MS, 1975, PURE APPL CHEM, V41, P671, DOI 10.1351/pac197541040671; Zhang WK, 2014, NATURE, V509, P345, DOI 10.1038/nature13252	30	202	202	4	288	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					78	81		10.1038/nature14296	http://dx.doi.org/10.1038/nature14296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25832405	Green Published			2022-12-28	WOS:000352027700040
J	Lepping, P; Huber, M; Freudenmann, RW				Lepping, Peter; Huber, Markus; Freudenmann, Roland W.			PRACTICE POINTER How to approach delusional infestation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PARASITOSIS; ANTIPSYCHOTICS		[Lepping, Peter] Betsi Cadwaladr Univ Hlth Board, North Wales, Wrexham, Wales; [Lepping, Peter] Bangor Univ, Ctr Mental Hlth & Soc, Bangor, Gwynedd, Wales; [Lepping, Peter] Mysore Med Coll & Res Inst, Mysore, Karnataka, India; [Huber, Markus] Gen Hosp Bruneck, Dept Psychiat, South Tyrol, Italy; [Freudenmann, Roland W.] Univ Ulm, Dept Psychiat & Psychotherapy 3, D-89069 Ulm, Germany	Bangor University; Ulm University	Lepping, P (corresponding author), Betsi Cadwaladr Univ Hlth Board, North Wales, Wrexham, Wales.	peter.lepping@wales.nhs.uk	Freudenmann, Roland W/M-3047-2013	Freudenmann, Roland W/0000-0003-1067-719X				Ahmed A, 2013, BRIT J DERMATOL, V169, P607, DOI 10.1111/bjd.12392; Bailey CH, 2014, BRIT J DERMATOL, V170, P1130, DOI 10.1111/bjd.12848; Bostwick JM, 2011, GEN HOSP PSYCHIAT, V33, P533, DOI 10.1016/j.genhosppsych.2011.07.002; Corlett PR, 2010, PROG NEUROBIOL, V92, P345, DOI 10.1016/j.pneurobio.2010.06.007; Foster AA, 2012, J AM ACAD DERMATOL, V67, DOI 10.1016/j.jaad.2011.12.012; Freudenmann RW, 2012, BRIT J DERMATOL, V167, P247, DOI 10.1111/j.1365-2133.2012.10995.x; Freudenmann RW, 2008, J CLIN PSYCHOPHARM, V28, P500, DOI 10.1097/JCP.0b013e318185e774; Freudenmann RW, 2009, CLIN MICROBIOL REV, V22, P690, DOI 10.1128/CMR.00018-09; Huber M, 2011, GEN HOSP PSYCHIAT, V33, P604, DOI 10.1016/j.genhosppsych.2011.05.013; Hylwa SA, 2012, PSYCHOSOMATICS, V53, P258, DOI 10.1016/j.psym.2011.11.003; Hylwa SA, 2011, ARCH DERMATOL, V147, P1041, DOI 10.1001/archdermatol.2011.114; Lepping P, 2008, CLIN EXP DERMATOL, V33, P113, DOI 10.1111/j.1365-2230.2007.02635.x; Lepping P, 2007, BRIT J PSYCHIAT, V191, P198, DOI 10.1192/bjp.bp.106.029660; Lepping P, 2015, BRIT J PSYCHIAT, V206, P160, DOI 10.1192/bjp.bp.114.144469; Pearson ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029908; TRABERT W, 1995, PSYCHOPATHOLOGY, V28, P238, DOI 10.1159/000284934; Wolf RC, 2014, PROG NEURO-PSYCHOPH, V48, P112, DOI 10.1016/j.pnpbp.2013.09.019	17	16	16	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2015	350								h1328	10.1136/bmj.h1328	http://dx.doi.org/10.1136/bmj.h1328			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3HO	25832416	Green Published			2022-12-28	WOS:000352439300001
J	Cowling, TE; Harris, MJ; Majeed, A				Cowling, Thomas E.; Harris, Matthew J.; Majeed, Azeem			Evidence and rhetoric about access to UK primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISCRETE-CHOICE EXPERIMENT; GENERAL-PRACTICE; HOSPITAL ADMISSIONS; IMPROVE ACCESS; HIGHER QUALITY; ENGLAND; ASSOCIATION; PATIENT; GP		[Cowling, Thomas E.; Harris, Matthew J.; Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London W6 8RP, England; [Harris, Matthew J.] NYU, Dept Nutr Food Studies & Publ Hlth, New York, NY USA	Imperial College London; New York University	Cowling, TE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London W6 8RP, England.	t.cowling@imperial.ac.uk		Majeed, Azeem/0000-0002-2357-9858; Cowling, Thomas E/0000-0003-1524-4393; Harris, Matthew/0000-0002-0005-9710	National Institute for Health Research [DRF-2013-06-142] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Aboulghate A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X653624; Atherton H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007978.pub2; Bottle A, 2012, BRIT J CANCER, V107, P1213, DOI 10.1038/bjc.2012.320; Brettell Rachel, 2013, Eur J Heart Fail, V15, P1335, DOI 10.1093/eurjhf/hft107; Bunn F, 2004, COCHRANE DB SYST REV, V2; Calderon-Larranaga A, 2014, DIABETIC MED, V31, P657, DOI 10.1111/dme.12413; Calderon-Larranaga A, 2014, SEIZURE-EUR J EPILEP, V23, P657, DOI 10.1016/j.seizure.2014.05.008; Calderon-Larranaga A, 2011, THORAX, V66, P191, DOI 10.1136/thx.2010.147058; Campbell JL, 2014, LANCET, V384, P1859, DOI 10.1016/S0140-6736(14)61058-8; Cheraghi-Sohi S, 2008, ANN FAM MED, V6, P107, DOI 10.1370/afm.816; College of Emergency Medicine Royal College of Physicians Royal College of Paediatrics and Child Health, 2014, ACT EM CAR PRESCR RE; Cowling Thomas E, 2013, PLoS One, V8, pe66699, DOI 10.1371/journal.pone.0066699; Cowling TE, 2014, BRIT J GEN PRACT, V64, pE434, DOI 10.3399/bjgp14X680533; Davis K., 2014, MIRROR MIRROR WALL P; Department of Health, 2013, SEV DAY 8AM 8PM GP A; Gerard K, 2008, J HEALTH SERV RES PO, V13, P3, DOI 10.1258/jhsrp.2007.007087; Goodall S, 2006, BRIT J GEN PRACT, V56, P918; Health and Social Care Information Centre, 2014, GEN PERS MED SERV EN; Health and Social Care Information Centre, 2014, GEN PERS MED SERV EN; Health and Social Care Information Centre, 2007, GO WORKL SURV RES; Health and Social Care Information Centre, 2009, TREDNS CONS RAT GEN; HM TREASURY, 2014, AUT STAT 2014; Iacobucci G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6033; Iacobucci G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5960; Ipsos MORI, 2014, GP PAT TECHN ANN 201; Ipsos MORI, 2015, GP APT SURV SURV  RE; Kmietowicz Z, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3300; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Lewin S, 2010, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004015.PUB3; Liberal Democrats, 2014, LIB DEM MEMB PASS NH; Martinez-Gonzalez NA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-214; National Institute for Health Research, 2014, COMM BRIEF 14 196 OR; NHS Employers, 2015, QUAL OUTC FRAM; NHS England, 2015, A E ATT EM ADM 2014; NHS England Health Education England Royal College of General Practitioners, 2015, BUILD WORKF NEW DEAL; NHS GP Taskforce, 2014, SEC FUT GP WORKF DEL; O'Dowd A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5864; Paddison CAM, 2015, HEALTH EXPECT, V18, P1081, DOI 10.1111/hex.12081; Roland M, 2014, HS DR 3 59 40 TELE 1; Rubin G, 2006, BRIT J GEN PRACT, V56, P743; Salisbury C, 2014, HS DR 13 59 08 POT A; Salisbury C, 2007, BRIT J GEN PRACT, V57, P615; Soljak M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613142; Tan S, 2014, HEALTH POLICY, V118, P304, DOI 10.1016/j.healthpol.2014.07.011; Turner David, 2007, J Health Serv Res Policy, V12, P132, DOI 10.1258/135581907781543021; Zhou Y, 2014, EMERG MED J	46	31	31	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2015	350								h1513	10.1136/bmj.h1513	http://dx.doi.org/10.1136/bmj.h1513			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3HD	25828858				2022-12-28	WOS:000352438100004
J	McGrath, PS; Wells, JM				McGrath, Patrick S.; Wells, James M.			SnapShot: GI Tract Development	CELL			English	Editorial Material								The endoderm germ layer contributes to the respiratory and gastrointestinal (GI) lineages during development, giving rise to an array of specialized epithelial cell types lining organs, including the thyroid, thymus, lungs, liver, biliary system, pancreas, and intestines. This SnapShot timelines and summarizes key stages following gastrulation, including endoderm patterning, organ specification, and organogenesis. A lineage tree of the developing endocrine pancreas is outlined to further illustrate this process.	[McGrath, Patrick S.; Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	McGrath, PS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.			McGrath, Patrick/0000-0002-1498-371X				Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Pagliuca FW, 2013, DEVELOPMENT, V140, P2472, DOI 10.1242/dev.093187; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	4	6	7	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1							176.e1	10.1016/j.cell.2015.03.014	http://dx.doi.org/10.1016/j.cell.2015.03.014			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815994	Bronze			2022-12-28	WOS:000351952200018
J	Ropper, AH; Zafonte, RD				Ropper, Allan H.; Zafonte, Ross D.			Sciatica	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LUMBAR DISC HERNIATION; LOW-BACK-PAIN; MANAGEMENT; SURGERY; EFFICACY; CARE		[Ropper, Allan H.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Zafonte, Ross D.] Spaulding Rehabil Hosp, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Spaulding Rehabilitation Hospital	Ropper, AH (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							BATTLE JD, 1966, NEW ENGL J MED, V274, P467; Bronfort G, 2014, ANN INTERN MED, V161, P381, DOI 10.7326/M14-0006; Buchmuller A, 2012, EUR J PAIN, V16, P656, DOI 10.1002/j.1532-2149.2011.00061.x; Carette S, 1997, NEW ENGL J MED, V336, P1634, DOI 10.1056/NEJM199706053362303; Chang X, 2014, INT ORTHOP, V38, P1225, DOI 10.1007/s00264-014-2331-0; el Barzouhi A, 2013, NEW ENGL J MED, V368, P999, DOI 10.1056/NEJMoa1209250; Fishman LM, 2002, AM J PHYS MED REHAB, V81, P936, DOI 10.1097/00002060-200212000-00009; FORREST JS, 1972, J AMER MED ASSOC, V222, P1177, DOI 10.1001/jama.222.9.1177; FRYMOYER JW, 1988, NEW ENGL J MED, V318, P291, DOI 10.1056/NEJM198802043180506; Genevay S, 2010, ARTHRITIS RHEUM-US, V62, P2339, DOI 10.1002/art.27499; GOULD N, 1974, NEW ENGL J MED, V290, P633; Hopayian K, 2010, EUR SPINE J, V19, P2095, DOI 10.1007/s00586-010-1504-9; Jacobs WCH, 2012, EUR SPINE J, V21, P2232, DOI 10.1007/s00586-012-2422-9; Jacobs WCH, 2011, EUR SPINE J, V20, P513, DOI 10.1007/s00586-010-1603-7; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Kennedy DJ, 2011, PHYS MED REH CLIN N, V22, P91, DOI 10.1016/j.pmr.2010.12.002; Konstantinou K, 2008, SPINE, V33, P2464, DOI 10.1097/BRS.0b013e318183a4a2; Kreiner DS, 2014, SPINE J, V14, P180, DOI 10.1016/j.spinee.2013.08.003; Lee J, 2013, BRIT J ANAESTH, V111, P112, DOI 10.1093/bja/aet172; Leininger B, 2011, PHYS MED REH CLIN N, V22, P105, DOI 10.1016/j.pmr.2010.11.002; Lequin MB, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002534; Lewis R, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15390; Lewis RA, 2013, SPINE J; LINDBLOM K, 1948, NEUROSURGERY, V5, P413; Luijsterburg PAJ, 2007, EUR SPINE J, V16, P881, DOI 10.1007/s00586-007-0367-1; Mafi JN, 2013, JAMA INTERN MED, V173, P1573, DOI 10.1001/jamainternmed.2013.8992; Mixter W.J., 1934, NEW ENGL J MED, V211, P210, DOI [10.1056/NEJM193408022110506, DOI 10.1056/NEJM193408022110506]; Pearce JMS, 2007, SPINAL CORD, V45, P592, DOI 10.1038/sj.sc.3102080; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Porchet F, 2002, NEUROSURGERY, V50, P1253, DOI 10.1097/00006123-200206000-00014; Savage NJ, 2014, EUR SPINE J; Surkitt LD, 2012, PHYS THER, V92, P652, DOI 10.2522/ptj.20100251; Tsao BE, 2003, MUSCLE NERVE, V27, P60, DOI 10.1002/mus.10291; Valat JP, 2010, BEST PRACT RES CL RH, V24, P241, DOI 10.1016/j.berh.2009.11.005; van den Hout WB, 2008, BMJ-BRIT MED J, V336, P1351, DOI 10.1136/bmj.39583.709074.BE; van der Windt DAWM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007431.pub2; Vroomen PCAJ, 1999, NEW ENGL J MED, V340, P418, DOI 10.1056/NEJM199902113400602; Vroomen PCAJ, 2002, BRIT J GEN PRACT, V52, P119; Wegner I, 2013, COCHRANE DB SYST REV, V8	39	146	154	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2015	372	13					1240	1248		10.1056/NEJMra1410151	http://dx.doi.org/10.1056/NEJMra1410151			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1QD	25806916				2022-12-28	WOS:000351585900010
J	Traverso, G; Langer, R				Traverso, Giovanni; Langer, Robert			PERSPECTIVE Special delivery for the gut	NATURE			English	Editorial Material									[Traverso, Giovanni] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Traverso, Giovanni] Harvard Univ, Sch Med, Boston, MA USA; [Langer, Robert] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Traverso, G (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	ctraverso@partners.org; rlanger@mit.edu	Traverso, Carlo Giovanni/ABC-9065-2020	Traverso, Carlo Giovanni/0000-0001-7851-4077				CARGILL R, 1988, PHARM RES-DORDR, V5, P533, DOI 10.1023/A:1015981627525; Ereqat S, 2011, LANCET INFECT DIS, V11, P662, DOI 10.1016/S1473-3099(11)70227-4; Fallon SC, 2013, J PEDIATR SURG, V48, P830, DOI 10.1016/j.jpedsurg.2012.07.046; Gordi T, 2008, CLIN THER, V30, P909, DOI 10.1016/j.clinthera.2008.05.008; Kethu SR, 2012, GASTROINTEST ENDOSC, V76, P1, DOI 10.1016/j.gie.2012.02.020; Lam PL, 2014, J CONTROL RELEASE, V178, P25, DOI 10.1016/j.jconrel.2013.12.028; World Health Organisation, 2003, ADHERENCE LONG TERM	7	48	53	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S19	S19		10.1038/519S19a	http://dx.doi.org/10.1038/519S19a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25806494	Bronze			2022-12-28	WOS:000351602800007
J	[Anonymous]				[Anonymous]			Asian Tigers, Pacific Panthers	NATURE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S70	S73		10.1038/519S70a	http://dx.doi.org/10.1038/519S70a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE1WF	25806699	Bronze			2022-12-28	WOS:000351602800014
J	Power, MC; Kioumourtzoglou, MA; Hart, JE; Okereke, OI; Laden, F; Weisskopf, MG				Power, Melinda C.; Kioumourtzoglou, Marianthi-Anna; Hart, Jaime E.; Okereke, Olivia I.; Laden, Francine; Weisskopf, Marc G.			The relation between past exposure to fine particulate air pollution and prevalent anxiety: observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CORONARY-HEART-DISEASE; MIDDLESEX-HOSPITAL QUESTIONNAIRE; EMERGENCY-DEPARTMENT VISITS; C-REACTIVE PROTEIN; QUALITY-OF-LIFE; OXIDATIVE STRESS; PHOBIC ANXIETY; ULTRAFINE PARTICLES; MENTAL-DISORDERS	OBJECTIVE To determine whether higher past exposure to particulate air pollution is associated with prevalent high symptoms of anxiety. DESIGN Observational cohort study. SETTING Nurses' Health Study. PARTICIPANTS 71 271 women enrolled in the Nurses' Health Study residing throughout the contiguous United States who had valid estimates on exposure to particulate matter for at least one exposure period of interest and data on anxiety symptoms. MAIN OUTCOME MEASURES Meaningfully high symptoms of anxiety, defined as a score of 6 points or greater on the phobic anxiety subscale of the Crown-Crisp index, administered in 2004. RESULTS The 71 271 eligible women were aged between 57 and 85 years (mean 70 years) at the time of assessment of anxiety symptoms, with a prevalence of high anxiety symptoms of 15%. Exposure to particulate matter was characterized using estimated average exposure to particulate matter < 2.5 mu m in diameter (PM2.5) and 2.5 to 10 mu m in diameter (PM2.5-10) in the one month, three months, six months, one year, and 15 years prior to assessment of anxiety symptoms, and residential distance to the nearest major road two years prior to assessment. Significantly increased odds of high anxiety symptoms were observed with higher exposure to PM2.5 for multiple averaging periods (for example, odds ratio per 10 mu g/m(3) increase in prior one month average PM2.5: 1.12, 95% confidence interval 1.06 to 1.19; in prior 12 month average PM2.5: 1.15, 1.06 to 1.26). Models including multiple exposure windows suggested short term averaging periods were more relevant than long term averaging periods. There was no association between anxiety and exposure to PM2.5-10. Residential proximity to major roads was not related to anxiety symptoms in a dose dependent manner. CONCLUSIONS Exposure to fine particulate matter (PM2.5) was associated with high symptoms of anxiety, with more recent exposures potentially more relevant than more distant exposures. Research evaluating whether reductions in exposure to ambient PM2.5 would reduce the population level burden of clinically relevant symptoms of anxiety is warranted.	[Power, Melinda C.; Okereke, Olivia I.; Laden, Francine; Weisskopf, Marc G.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Power, Melinda C.; Kioumourtzoglou, Marianthi-Anna; Hart, Jaime E.; Laden, Francine; Weisskopf, Marc G.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Power, Melinda C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Hart, Jaime E.; Okereke, Olivia I.; Laden, Francine] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Hart, Jaime E.; Okereke, Olivia I.; Laden, Francine] Harvard Univ, Sch Med, Boston, MA USA; [Okereke, Olivia I.] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Power, MC (corresponding author), Johns Hopkins Univ, Phipps 446D,600 North Wolfe St, Baltimore, MD 21287 USA.	melindacpower@gmail.com	Okereke, Olivia/AAF-7031-2021; Okereke, Olivia I/R-9934-2016		National Institute of Environmental Health Sciences [R21 ES019982, R01 ES017017]; National Institute of Aging [T32 AG027668]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002, R01ES017017, R21ES019982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG027668] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute of Environmental Health Sciences (R21 ES019982, R01 ES017017). MCP was supported by a training grant from the National Institute of Aging (T32 AG027668). The funding agencies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. The authors were independent of the study funders.	Albert CM, 2005, CIRCULATION, V111, P480, DOI 10.1161/01.CIR.0000153813.64165.5D; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Araujo JA, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-24; Babisch W, 2014, ENVIRON HEALTH PERSP, V122, P492, DOI 10.1289/ehp.1306981; Bankier B, 2008, EUR HEART J, V29, P2212, DOI 10.1093/eurheartj/ehn326; Bell ML, 2007, ENVIRON HEALTH PERSP, V115, P1591, DOI 10.1289/ehp.10108; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Biermann T, 2009, MED HYPOTHESES, V72, P338, DOI 10.1016/j.mehy.2008.09.042; Bind MA, 2012, EPIDEMIOLOGY, V23, P332, DOI 10.1097/EDE.0b013e31824523f0; Bowler RM, 2012, INT J HYG ENVIR HEAL, V215, P393, DOI 10.1016/j.ijheh.2011.10.005; Brenes GA, 2003, PSYCHOSOM MED, V65, P963, DOI 10.1097/01.PSY.0000097339.75789.81; BRIERE J, 1983, J ABNORM PSYCHOL, V92, P77, DOI 10.1037/0021-843X.92.1.77; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Buchner D M, 1992, Clin Geriatr Med, V8, P1; Calderon-Garciduenas L, 2003, TOXICOL PATHOL, V31, P524, DOI 10.1080/01926230390226645; Campbell A, 2005, NEUROTOXICOLOGY, V26, P133, DOI 10.1016/j.neuro.2004.08.003; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; CROWN S, 1966, BRIT J PSYCHIAT, V112, P917, DOI 10.1192/bjp.112.490.917; Dagher Z, 2006, TOXICOLOGY, V225, P12, DOI 10.1016/j.tox.2006.04.038; de Oliveira MR, 2007, NEUROTOXICOLOGY, V28, P1191, DOI 10.1016/j.neuro.2007.07.008; Delfino RJ, 2002, ENVIRON HEALTH PERSP, V110, P573, DOI 10.1289/ehp.02110s4573; Diociaiuti M, 2001, ENVIRON RES, V86, P254, DOI 10.1006/enrs.2001.4275; Dodd S, 2008, INT J NEUROPSYCHOPH, V11, P179; Dubowsky SD, 2006, ENVIRON HEALTH PERSP, V114, P992, DOI 10.1289/ehp.8469; Engler H, 2011, BRAIN BEHAV IMMUN, V25, P1384, DOI 10.1016/j.bbi.2011.04.005; EVANS GW, 1988, ENVIRON RES, V45, P1, DOI 10.1016/S0013-9351(88)80002-1; Faustini A, 2012, EPIDEMIOLOGY, V23, P861, DOI 10.1097/EDE.0b013e31826767c2; Gehi AK, 2012, J CARDIOVASC ELECTR, V23, P473, DOI 10.1111/j.1540-8167.2011.02264.x; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Griez E, 1998, J PSYCHOSOM RES, V45, P493, DOI 10.1016/S0022-3999(98)00027-0; HAINES AP, 1987, BRIT MED J, V295, P297, DOI 10.1136/bmj.295.6593.297; Hou RH, 2012, HUM PSYCHOPHARM CLIN, V27, P6, DOI 10.1002/hup.1259; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; JACOBS SV, 1984, POPUL ENVIRON, V7, P260, DOI 10.1007/BF01256411; Karner AA, 2010, ENVIRON SCI TECHNOL, V44, P5334, DOI 10.1021/es100008x; Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005; KAWACHI I, 1994, CIRCULATION, V89, P1992, DOI 10.1161/01.CIR.89.5.1992; KAWACHI I, 1995, AM J CARDIOL, V75, P882, DOI 10.1016/S0002-9149(99)80680-8; Kelly FJ, 2003, OCCUP ENVIRON MED, V60, P612, DOI 10.1136/oem.60.8.612; Kesavachandran C, 2013, ENVIRON MONIT ASSESS, V185, P1265, DOI 10.1007/s10661-012-2630-0; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Kim C, 2010, AM J PSYCHIAT, V167, P1100, DOI 10.1176/appi.ajp.2010.09050706; Kim JY, 2004, ENVIRON HEALTH PERSP, V112, P666, DOI 10.1289/ehp.6827; Kioumourtzoglou MA, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-2; Kunzli N, 2009, THORAX, V64, P664, DOI 10.1136/thx.2008.110031; Lane DA, 2009, J PSYCHOSOM RES, V66, P203, DOI 10.1016/j.jpsychores.2008.10.007; Lanouette NM, 2010, FOCUS, V8, P501, DOI DOI 10.1176/F0C.8.4.F0C501; Lepine JP, 2002, J CLIN PSYCHIAT, V63, P4; Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000; Lim YH, 2012, ENVIRON HEALTH PERSP, V120, P1023, DOI 10.1289/ehp.1104100; Ling Sean H, 2009, Int J Chron Obstruct Pulmon Dis, V4, P233; Link MS, 2013, J AM COLL CARDIOL, V62, P816, DOI 10.1016/j.jacc.2013.05.043; Liukkonen T, 2011, EUR PSYCHIAT, V26, P363, DOI 10.1016/j.eurpsy.2011.02.001; Livermore N, 2010, RESP MED, V104, P1246, DOI 10.1016/j.rmed.2010.04.011; MAVISSAKALIAN M, 1981, BRIT J PSYCHIAT, V139, P336, DOI 10.1192/bjp.139.4.336; McGrath M, 2004, AM J PSYCHIAT, V161, P1703, DOI 10.1176/appi.ajp.161.9.1703; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Mikkelsen RL, 2004, NORD J PSYCHIAT, V58, P65, DOI 10.1080/08039480310000824; MohanKumar SMJ, 2008, NEUROTOXICOLOGY, V29, P479, DOI 10.1016/j.neuro.2007.12.004; Okereke OI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040516; Pakkanen TA, 2001, ATMOS ENVIRON, V35, P5381, DOI 10.1016/S1352-2310(01)00307-7; Patki G, 2013, BRAIN RES, V1539, P73, DOI 10.1016/j.brainres.2013.09.033; Pitsavos C, 2006, ATHEROSCLEROSIS, V185, P320, DOI 10.1016/j.atherosclerosis.2005.06.001; Pope CA, 2000, AEROSOL SCI TECH, V32, P4, DOI 10.1080/027868200303885; Ranft U, 2009, ENVIRON RES, V109, P1004, DOI 10.1016/j.envres.2009.08.003; Rich DQ, 2006, ENVIRON HEALTH PERSP, V114, P120, DOI 10.1289/ehp.8371; ROTTON J, 1984, POPUL ENVIRON, V7, P3, DOI 10.1007/BF01257469; Roy-Byrne PP, 2008, GEN HOSP PSYCHIAT, V30, P208, DOI 10.1016/j.genhosppsych.2007.12.006; Salim S, 2012, ADV PROTEIN CHEM STR, V88, P1, DOI 10.1016/B978-0-12-398314-5.00001-5; Salim S, 2010, BRAIN RES, V1359, P178, DOI 10.1016/j.brainres.2010.08.093; Salim S, 2010, BEHAV BRAIN RES, V208, P545, DOI 10.1016/j.bbr.2009.12.039; Scott KM, 2007, GEN HOSP PSYCHIAT, V29, P123, DOI 10.1016/j.genhosppsych.2006.12.006; Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3; Sioutas C, 2005, ENVIRON HEALTH PERSP, V113, P947, DOI 10.1289/ehp.7939; Sorensen M, 2003, ENVIRON HEALTH PERSP, V111, P161, DOI 10.1289/ehp.5646; Spitzer C, 2011, J PSYCHOSOM RES, V71, P174, DOI 10.1016/j.jpsychores.2011.03.005; STRAHILEVITZ M, 1979, AM J PSYCHIAT, V136, P205; Szyszkowicz M, 2010, ENVIRON HEALTH INSIG, V4, P79, DOI 10.4137/EHI.S5662; Szyszkowicz M, 2009, INT J OCCUP MED ENV, V22, P355, DOI 10.2478/v10001-009-0031-6; Szyszkowicz Mieczyslaw, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P167, DOI 10.2478/v10001-007-0015-3; Thrall G, 2007, CHEST, V132, P1259, DOI 10.1378/chest.07-0036; United States Department of Agriculture, 2014, DOC 2010 RUR URB COM; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watkins LL, 2010, PSYCHOSOM MED, V72, P664, DOI 10.1097/PSY.0b013e3181e9f357; Weisskopf MG, 2003, MOVEMENT DISORD, V18, P646, DOI 10.1002/mds.10425; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Yanosk JD, 2008, ATMOS ENVIRON, V42, P4047, DOI 10.1016/j.atmosenv.2008.01.044; Yanosky JD, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-63; Yanosky JD, 2009, ENVIRON HEALTH PERSP, V117, P522, DOI 10.1289/ehp.11692; Yohannes AM, 2010, INT J GERIATR PSYCH, V25, P1209, DOI 10.1002/gps.2463; Zhu YF, 2002, J AIR WASTE MANAGE, V52, P1032, DOI 10.1080/10473289.2002.10470842	94	200	206	3	75	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2015	350								h1111	10.1136/bmj.h1111	http://dx.doi.org/10.1136/bmj.h1111			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CE7NO	25810495	Green Published, hybrid			2022-12-28	WOS:000352028800001
J	Gaudet, A				Gaudet, Andrew			A grad school survival guide	SCIENCE			English	Editorial Material									Univ Colorado, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Gaudet, A (corresponding author), Univ Colorado, Boulder, CO 80309 USA.			Gaudet, Andrew/0000-0001-8828-1553					0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1386	1386		10.1126/science.347.6228.1386	http://dx.doi.org/10.1126/science.347.6228.1386			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6SM	25792331				2022-12-28	WOS:000351219600046
J	Scharfman, HE				Scharfman, Helen E.			Metabolic control of epilepsy	SCIENCE			English	Editorial Material									[Scharfman, Helen E.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Scharfman, Helen E.] NYU, Langone Med Ctr, Orangeburg, NY 10962 USA	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center	Scharfman, HE (corresponding author), Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA.	helen.scharfman@nyumc.org						Coulter DA, 2012, GLIA, V60, P1215, DOI 10.1002/glia.22341; de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89; Desagher S, 1997, J NEUROSCI, V17, P9060; Heinemann U, 2012, GLIA, V60, P1251, DOI 10.1002/glia.22311; Isopi E, 2015, NEUROBIOL DIS, V81, P214, DOI 10.1016/j.nbd.2014.11.013; Kaminski RM, 2014, NEUROTHERAPEUTICS, V11, P385, DOI 10.1007/s13311-014-0266-1; Lutas A, 2013, TRENDS NEUROSCI, V36, P32, DOI 10.1016/j.tins.2012.11.005; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Sada N, 2015, SCIENCE, V347, P1362, DOI 10.1126/science.aaa1299; Stafstrom CE, 2008, EPILEPSIA, V49, P97, DOI 10.1111/j.1528-1167.2008.01848.x; Stafstrom CE., 2004, EPILEPSY KETOGENIC D; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178	12	14	15	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1312	1313		10.1126/science.aaa9607	http://dx.doi.org/10.1126/science.aaa9607			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6SM	25792315				2022-12-28	WOS:000351219600019
J	Benabid, AL				Benabid, Alim Louis			NEUROSCIENCE Spotlight on deep-brain stimulation	NATURE			English	Editorial Material							CORTEX		CEA Grenoble, LETI Minatec, Edmond J Safra Res Ctr, F-38054 Grenoble, France	CEA	Benabid, AL (corresponding author), CEA Grenoble, LETI Minatec, Edmond J Safra Res Ctr, F-38054 Grenoble, France.	alimlouis@sfr.fr	Benabid, Alim L/Q-3506-2017					Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Carron R, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00095; Chang JY, 2008, NEUROSCI BIOBEHAV R, V32, P352, DOI 10.1016/j.neubiorev.2007.09.002; Creed M, 2015, SCIENCE, V347, P659, DOI 10.1126/science.1260776; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Li Q, 2012, NEURON, V76, P1030, DOI 10.1016/j.neuron.2012.09.032; Little S, 2014, CURR BIOL, V24, pR898, DOI 10.1016/j.cub.2014.08.002; McCracken CB, 2007, J NEUROSCI, V27, P12601, DOI 10.1523/JNEUROSCI.3750-07.2007; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	9	10	13	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					299	300		10.1038/519299a	http://dx.doi.org/10.1038/519299a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25788094				2022-12-28	WOS:000351171900029
J	Morley, B				Morley, Bob			IF I RULED THE NHS Only the mother of all reorganisations can save the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												robert.morley@blmc.co.uk							0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2015	350								h1488	10.1136/bmj.h1488	http://dx.doi.org/10.1136/bmj.h1488			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KV	25791377				2022-12-28	WOS:000351571400005
J	Al Efishat, M; Wolfgang, CL; Weiss, MJ				Al Efishat, Mohammad; Wolfgang, Christopher L.; Weiss, Matthew J.			Stage III pancreatic cancer and the role of irreversible electroporation	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MODULATED RADIATION-THERAPY; RADIOFREQUENCY ABLATION; DISTAL PANCREATECTOMY; MICROWAVE ABLATION; PHASE-II; GEMCITABINE; CHEMOTHERAPY; RESECTION; SURVIVAL; CHEMORADIOTHERAPY		[Al Efishat, Mohammad; Wolfgang, Christopher L.; Weiss, Matthew J.] Johns Hopkins Univ Hosp, Dept Surg, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Weiss, MJ (corresponding author), Johns Hopkins Univ Hosp, Dept Surg, Baltimore, MD 21287 USA.	mweiss5@jhmi.edu	Wolfgang, Christopher/HGD-0863-2022					Abrams RA, 2009, ANN SURG ONCOL, V16, P1751, DOI 10.1245/s10434-009-0413-9; Arcidiacono PG, 2012, GASTROINTEST ENDOSC, V76, P1142, DOI 10.1016/j.gie.2012.08.006; Bagla S, 2012, J VASC INTERV RADIOL, V23, P142, DOI 10.1016/j.jvir.2011.10.002; Bai YR, 2003, WORLD J GASTROENTERO, V9, P2561; Baxter NN, 2007, ANN SURG ONCOL, V14, P1320, DOI 10.1245/s10434-006-9249-8; Ben-Josef E, 2004, INT J RADIAT ONCOL, V59, P454; Berber B, 2013, EXPERT REV ANTICANC, V13, P481, DOI [10.1586/ERA.13.19, 10.1586/era.13.19]; Bloom DC, 2005, EJSO, V31, P1029, DOI 10.1016/j.ejso.2005.04.007; Bockbrader M, 2009, EXPERT REV ANTICANC, V9, P637, DOI 10.1586/ERA.09.16; Bockhorn M, 2011, BRIT J SURG, V98, P86, DOI 10.1002/bjs.7270; Bockhorn M, 2014, SURGERY, V155, P977, DOI 10.1016/j.surg.2014.02.001; Bower M, 2011, J SURG ONCOL, V104, P22, DOI 10.1002/jso.21899; Breton M, 2011, BIOELECTROMAGNETICS, DOI 10.1002/bem.20692; Cadossi R, 2014, FUTURE ONCOL, V10, P877, DOI [10.2217/fon.13.235, 10.2217/FON.13.235]; Cao HST, 2014, J GASTROINTEST SURG, V18, P269, DOI 10.1007/s11605-013-2374-3; Cao HS Tran, 2014, J GASTROINTEST SURG, V18, P8; Carrafiello G, 2013, J VASC INTERV RADIOL, V24, P1513, DOI 10.1016/j.jvir.2013.07.005; Carrafiello Gianpaolo, 2008, Int J Surg, V6 Suppl 1, pS65, DOI 10.1016/j.ijsu.2008.12.028; Casadei R, 2010, HEPATOB PANCREAT DIS, V9, P306; CHANG DC, 1990, BIOPHYS J, V58, P1, DOI 10.1016/S0006-3495(90)82348-1; Charpentier KP, 2010, HPB, V12, P348, DOI 10.1111/j.1477-2574.2010.00174.x; Chauffert B, 2008, ANN ONCOL, V19, P1592, DOI 10.1093/annonc/mdn281; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cooray P, 2012, ASCO M, V30; Crane CH, 2001, J GASTROINTEST CANC, V30, P123, DOI 10.1385/IJGC:30:3:123; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Deodhar A, 2011, AM J ROENTGENOL, V196, pW330, DOI 10.2214/AJR.10.4490; Dunki-Jacobs EM, 2014, J AM COLL SURGEONS, V218, P179, DOI 10.1016/j.jamcollsurg.2013.10.013; Faris JE, 2013, ONCOLOGIST, V18, P543, DOI 10.1634/theoncologist.2012-0435; Fuss Martin, 2007, Gastrointest Cancer Res, V1, P2; Gardner TB, 2010, J ONCOL PRACT, V6, P288, DOI 10.1200/JOP.2010.000041; Gehl J, 2014, METHODS MOL BIOL, V1121, P241, DOI 10.1007/978-1-4614-9632-8_21; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Girelli R, 2010, BRIT J SURG, V97, P220, DOI 10.1002/bjs.6800; Girelli R, 2013, LANGENBECK ARCH SURG, V398, P63, DOI 10.1007/s00423-012-1011-z; Golan T, 2014, J CLIN ONCOL S3, V32, pA270; Goodman KA, 2013, J SURG ONCOL, V107, P86, DOI 10.1002/jso.23137; Gorovets D, 2014, J PANCREAS, V15, P95, DOI 10.6092/1590-8577/2284; Halperin DM, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-013-0366-9; Hammel P, 2013, J CLIN ONCOL, V31; Hirano S, 2007, ANN SURG, V246, P46, DOI 10.1097/01.sla.0000258608.52615.5a; Hishinuma S, 2007, J GASTROINTEST SURG, V11, P743, DOI 10.1007/s11605-007-0143-x; Huguet F, 2007, J CLIN ONCOL, V25, P326, DOI 10.1200/JCO.2006.07.5663; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Jose A, 2012, CANCER LETT, V317, P16, DOI 10.1016/j.canlet.2011.11.004; Katz MHG, 2008, J AM COLL SURGEONS, V206, P833, DOI 10.1016/j.jamcollsurg.2007.12.020; Katz MHG, 2014, SEMIN RADIAT ONCOL, V24, P105, DOI 10.1016/j.semradonc.2013.11.006; Katz MHG, 2013, ANN SURG ONCOL, V20, P2787, DOI 10.1245/s10434-013-2886-9; Katz MHG, 2012, CANCER-AM CANCER SOC, V118, P5749, DOI 10.1002/cncr.27636; Katz MHG, 2012, J AM COLL SURGEONS, V215, pE11, DOI 10.1016/j.jamcollsurg.2012.05.015; Katz MHG, 2012, J GASTROINTEST SURG, V16, P68, DOI 10.1007/s11605-011-1748-7; Katz MHG, 2011, ANN SURG ONCOL, V18, P337, DOI 10.1245/s10434-010-1282-y; Katz MH, 2012, J GASTROINTEST SURG, V16, P9; Keane MG, 2014, WORLD J GASTROENTERO, V20, P2267, DOI 10.3748/wjg.v20.i9.2267; Krishnan S, 2007, CANCER-AM CANCER SOC, V110, P47, DOI 10.1002/cncr.22735; Landry J, 2010, J SURG ONCOL, V101, P587, DOI 10.1002/jso.21527; Lavee J, 2007, HEART SURG FORUM, V10, pE162, DOI 10.1532/HSF98.20061202; Lee EW, 2007, TECHNOL CANCER RES T, V6, P287, DOI 10.1177/153303460700600404; Lee EW, 2010, RADIOLOGY, V255, P426, DOI 10.1148/radiol.10090337; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li JD, 2011, POSTGRAD MED J, V87, P89, DOI 10.1136/pgmj.2010.098350; Lima CMR, 2004, J CLIN ONCOL, V22, P3776, DOI 10.1200/JCO.2004.12.082; Lloyd S, 2013, J GASTROINTEST ONCOL, V4, P123, DOI 10.3978/j.issn.2078-6891.2013.011; Louvet C, 2005, J CLIN ONCOL, V23, P3509, DOI 10.1200/JCO.2005.06.023; Lu DSK, 2013, TECH VASC INTERV RAD, V16, P277, DOI 10.1053/j.tvir.2013.08.010; Lygidakis N, 2007, HEPATO-GASTROENTEROL, V54, P1305; Mansson C, 2014, ANTICANCER RES, V34, P289; Martin RC, 2013, ANN SURG ONCOL S3, V20, pS443; Martin RCG, 2013, J GASTROINTEST SURG, V17, P1850, DOI 10.1007/s11605-013-2309-z; Martin RCG, 2012, J AM COLL SURGEONS, V215, P361, DOI 10.1016/j.jamcollsurg.2012.05.021; Mayo SC, 2012, CANCER-AM CANCER SOC, V118, P2674, DOI 10.1002/cncr.26553; Milano MT, 2004, INT J RADIAT ONCOL, V59, P445, DOI 10.1016/j.ijrobp.2003.11.003; Mollberg N, 2011, ANN SURG, V254, P882, DOI 10.1097/SLA.0b013e31823ac299; Moutardier V, 2004, INT J RADIAT ONCOL, V60, P437, DOI 10.1016/j.ijrobp.2004.04.004; Mukherjee S, 2013, LANCET ONCOL, V14, P317, DOI 10.1016/S1470-2045(13)70021-4; Narayanan G, 2012, J VASC INTERV RADIOL, V23, P1613, DOI 10.1016/j.jvir.2012.09.012; National Comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Pai M, 2013, GUT, V62, pA153, DOI 10.1136/gutjnl-2013-304907.344; Patel M, 2011, J SURG ONCOL, V104, P155, DOI 10.1002/jso.21954; Pawlik TM, 2008, ANN SURG ONCOL, V15, P2081, DOI 10.1245/s10434-008-9929-7; Rabussay DP, 2002, TECHNOL CANCER RES T, V1, P71, DOI 10.1177/153303460200100110; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Scheffer HJ, 2014, J VASC INTERV RADIOL, V25, P997, DOI 10.1016/j.jvir.2014.01.028; Siegel R, 2004, CA-CANCER J CLIN, V2014, P9; Spiliotis JD, 2007, LANGENBECK ARCH SURG, V392, P55, DOI 10.1007/s00423-006-0098-5; Stokes JB, 2011, ANN SURG ONCOL, V18, P619, DOI 10.1245/s10434-010-1456-7; Sultana A, 2007, J CLIN ONCOL, V25, P2607, DOI 10.1200/JCO.2006.09.2551; Thomson KR, 2011, J VASC INTERV RADIOL, V22, P611, DOI 10.1016/j.jvir.2010.12.014; Tseng JF, 2004, J GASTROINTEST SURG, V8, P935, DOI 10.1016/j.gassur.2004.09.046; Van Cutsem E, 2004, J CLIN ONCOL, V22, P1430, DOI 10.1200/JCO.2004.10.112; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Weiss MJ, 2013, CURR PROB CANCER, V37, P262, DOI 10.1016/j.currproblcancer.2013.10.002; Worni M, 2013, PANCREAS, V42, P1157, DOI 10.1097/MPA.0b013e318291fbc5; Xu KC, 2008, J DIGEST DIS, V9, P32, DOI 10.1111/j.1443-9573.2007.00322.x; Yovino S, 2011, INT J RADIAT ONCOL, V79, P158, DOI 10.1016/j.ijrobp.2009.10.043; Zhou YM, 2012, WORLD J SURG, V36, P884, DOI 10.1007/s00268-012-1461-z; Zhu CP, 2011, RADIOTHER ONCOL, V99, P108, DOI 10.1016/j.radonc.2011.04.001	98	35	34	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2015	350								h521	10.1136/bmj.h521	http://dx.doi.org/10.1136/bmj.h521			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KT	25787829				2022-12-28	WOS:000351571200001
J	Muck, A; Adams, BD				Muck, Andrew; Adams, Bruce D.			Early goal-directed therapy did not reduce mortality more than usual care in early septic shock	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SEVERE SEPSIS		[Muck, Andrew] Univ Hosp, Dept Emergency Med, San Antonio, TX 78229 USA; UT Sch Med San Antonio, San Antonio, TX USA		Muck, A (corresponding author), Univ Hosp, Dept Emergency Med, San Antonio, TX 78229 USA.							Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	4	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6							JC4	10.7326/ACPJC-2015-162-6-004	http://dx.doi.org/10.7326/ACPJC-2015-162-6-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775347				2022-12-28	WOS:000351279600003
J	Smith, JM				Smith, Jeanette M.			Do-Si-Do	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1084	1085		10.1001/jama.2014.11639	http://dx.doi.org/10.1001/jama.2014.11639			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25781427				2022-12-28	WOS:000351102500001
J	Iorio, A; Spencer, FA; Falavigna, M; Alba, C; Lang, E; Burnand, B; McGinn, T; Hayden, J; Williams, K; Shea, B; Wolff, R; Kujpers, T; Perel, P; Vandvik, PO; Glasziou, P; Schunemann, H; Guyatt, G				Iorio, Alfonso; Spencer, Frederick A.; Falavigna, Maicon; Alba, Carolina; Lang, Eddie; Burnand, Bernard; McGinn, Tom; Hayden, Jill; Williams, Katrina; Shea, Beverly; Wolff, Robert; Kujpers, Ton; Perel, Pablo; Vandvik, Per Olav; Glasziou, Paul; Schunemann, Holger; Guyatt, Gordon			Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FINDINGS TABLES; RISK; METAANALYSIS; QUALITY; BIAS		[Iorio, Alfonso; Schunemann, Holger; Guyatt, Gordon] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Iorio, Alfonso; Spencer, Frederick A.; Schunemann, Holger; Guyatt, Gordon] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Falavigna, Maicon] Univ Fed Rio Grande do Sul, Hosp Moinhos de Vento, Natl Inst Hlth Technol Assessment, Porto Alegre, RS, Brazil; [Alba, Carolina] Univ Hlth Network, Toronto Gen Hosp, Heart Failure & Transplant Program, Toronto, ON, Canada; [Lang, Eddie] Univ Calgary, Dept Emergency Med, Alberta Hlth Serv, Calgary Zone, AB, Canada; [Burnand, Bernard] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [McGinn, Tom] North Shore LIJ Hlth Syst, Hofstra North Shore LIJ Med Sch, Hempstead, NY USA; [Hayden, Jill] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Williams, Katrina] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Williams, Katrina] Royal Childrens Hosp, Dev Med, Melbourne, Vic, Australia; [Williams, Katrina] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Shea, Beverly] Univ Ottawa, Ottawa Hosp Res Inst, Ctr Practice Changing Res, Ottawa, ON, Canada; [Shea, Beverly] Bruyere Res Inst, Ottawa, ON, Canada; [Shea, Beverly] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Wolff, Robert] Kleijnen Systemat Reviews Ltd, York, N Yorkshire, England; [Kujpers, Ton] Dutch Coll Gen Practitioners, Dept Guideline Dev, Utrecht, Netherlands; [Perel, Pablo] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Vandvik, Per Olav] Innlandet Hosp Trust, Dept Med, Div Gjovik, Oslo, Norway; [Glasziou, Paul] Bond Univ, Fac Hlth Sci, Ctr Res Evidence Based Practice, Gold Coast, Australia	McMaster University; McMaster University; Universidade Federal do Rio Grande do Sul; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Alberta Health Services (AHS); University of Calgary; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Hofstra University; Northwell Health; Dalhousie University; University of Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto; Kleijnen Systematic Reviews; University of London; London School of Hygiene & Tropical Medicine; Innlandet Hospital Trust; Bond University	Iorio, A (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	iorioa@mcmaster.ca	Glasziou, Paul/A-7832-2008; Iorio, Alfonso/B-9478-2013; Wolff, Robert F/E-2322-2016	Glasziou, Paul/0000-0001-7564-073X; Iorio, Alfonso/0000-0002-3331-8766; Wolff, Robert F/0000-0003-3270-7791; Alba, Ana/0000-0003-2744-2696; /0000-0002-2342-301X; Hayden, Jill Alison/0000-0001-7026-144X; Schunemann, Holger/0000-0003-3211-8479				Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BUKH J, 1993, J INFECT DIS, V168, P1343, DOI 10.1093/infdis/168.6.1343; Busse JW., TOOL ASSESS RISK BIA; COUROUCE AM, 1994, TRANSFUSION, V34, P790, DOI 10.1046/j.1537-2995.1994.34994378281.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P158, DOI 10.1016/j.jclinepi.2012.01.012; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P173, DOI 10.1016/j.jclinepi.2012.08.001; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Hamza TH, 2008, J CLIN EPIDEMIOL, V61, P41, DOI 10.1016/j.jclinepi.2007.03.016; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hemingway H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5595; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Higgins JP, 2010, COCHRANE HDB SYSTEMA, P391; Hingorani AD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5793; Januel JM, 2012, JAMA-J AM MED ASSOC, V307, P294, DOI 10.1001/jama.2011.2029; Lopes LC, 2013, CLIN PHARMACOL THER, V94, P367, DOI 10.1038/clpt.2013.99; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; Oldenburg J, 2006, HAEMOPHILIA, V12, P15, DOI 10.1111/j.1365-2516.2006.01361.x; Randolph A, 2008, USERS GUIDES MED LIT, P509; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Riley RD, 2010, RES SYNTH METHODS, V1, P2, DOI 10.1002/jrsm.4; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Spencer FA, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7401; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Su YY, 2013, HEMODIAL INT, V17, P532, DOI 10.1111/j.1542-4758.2012.00761.x; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Thompson M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7027; Yousef F, 2008, AM J EPIDEMIOL, V168, P237, DOI 10.1093/aje/kwn121	31	329	334	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2015	350								h870	10.1136/bmj.h870	http://dx.doi.org/10.1136/bmj.h870			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KM	25775931	Bronze, Green Accepted			2022-12-28	WOS:000351570500001
J	Fisher, EMC; Peters, J				Fisher, Elizabeth M. C.; Peters, Jo			Mary Frances Lyon (1925-2014) Obituary	CELL			English	Biographical-Item									[Fisher, Elizabeth M. C.] UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Peters, Jo] MRC, Mammalian Genet Unit, Harwell OX11 0RD, Oxon, England	University of London; University College London	Fisher, EMC (corresponding author), UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England.	e.fisher@prion.ucl.ac.uk; j.peters@har.mrc.ac.uk	Fisher, Elizabeth/C-2168-2008	Fisher, Elizabeth/0000-0003-2850-9936	MRC [MC_U142636336] Funding Source: UKRI; Medical Research Council [MC_U142636336] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		LYON MF, 1961, PUBLICATION LIST	1	1	1	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 12	2015	160	4					577	578		10.1016/j.cell.2015.01.039	http://dx.doi.org/10.1016/j.cell.2015.01.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8ZE	25823359	Bronze			2022-12-28	WOS:000349208800001
J	Horton, R; Berman, P				Horton, Richard; Berman, Philippa			Eliminating acute kidney injury by 2025: an achievable goal	LANCET			English	Editorial Material									[Horton, Richard; Berman, Philippa] The Lancet, London EC2Y 5AS, England		Horton, R (corresponding author), The Lancet, London EC2Y 5AS, England.							Mehta RL, 2015, LANCET; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Remuzzi G, 2013, LANCET, V382, P353, DOI 10.1016/S0140-6736(13)60438-9	3	14	14	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2551	2552		10.1016/S0140-6736(15)60269-0	http://dx.doi.org/10.1016/S0140-6736(15)60269-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL4NQ	25777660				2022-12-28	WOS:000356930000005
J	Kappetein, AP				Kappetein, Arie P.			PARTNERs in the future of surgical aortic valve replacement	LANCET			English	Editorial Material									Erasmus Univ, Med Ctr, Dept Cardiothorac Surg, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Kappetein, AP (corresponding author), Erasmus Univ, Med Ctr, Dept Cardiothorac Surg, NL-3000 CA Rotterdam, Netherlands.	a.kappetein@erasmusmc.nl						Eltchaninoff H, 2014, AM HEART J, V167, P235, DOI 10.1016/j.ahj.2013.10.019; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Genereux P, 2013, J AM COLL CARDIOL, V61, P1125, DOI 10.1016/j.jacc.2012.08.1039; Head SJ, 2013, JAMA-J AM MED ASSOC, V310, P2097, DOI 10.1001/jama.2013.281630; Head SJ, 2013, EUR HEART J, V34, P2510, DOI 10.1093/eurheartj/eht059; Heath I, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3883; Kapadia SR, 2015, LANCET; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1093/ejcts/ezs533, 10.1016/j.jacc.2012.09.001]; Mack M, 2008, J THORAC CARDIOV SUR, V136, P816, DOI 10.1016/j.jtcvs.2008.06.010; Mack MJ, 2015, LANCET; Span P., 2015, NY TIMES, pD1; TVERSKY A, 1986, J BUS, V59, pS251, DOI 10.1086/296365	12	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2439	2441		10.1016/S0140-6736(15)60568-2	http://dx.doi.org/10.1016/S0140-6736(15)60568-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK9AR	25788233				2022-12-28	WOS:000356532500006
J	Iwasaki, S; Sasaki, HM; Sakaguchi, Y; Suzuki, T; Tadakuma, H; Tomari, Y				Iwasaki, Shintaro; Sasaki, Hiroshi M.; Sakaguchi, Yuriko; Suzuki, Tsutomu; Tadakuma, Hisashi; Tomari, Yukihide			Defining fundamental steps in the assembly of the Drosophila RNAi enzyme complex	NATURE			English	Article							RISC; ARGONAUTE; HSP90; DICER; SIRNA; INTERFERENCE; CLEAVES; MIRNAS; STRAND; C3PO	SmallRNAs suchas small interfering RNAs(siRNAs) and microRNAs (miRNAs) silence the expression of their complementary target messenger RNAs1,2 via the formation of effector RNA-induced silencing complexes (RISCs), which contain Argonaute (Ago) family proteins at their core. Although loading of siRNA duplexes into Drosophila Ago2 requires the Dicer-2-R2D2 heterodimer(3-5) and the Hsc70/Hsp90 (Hsp90 also known as Hsp83) chaperone machinery6-8, the details of RISC assembly remain unclear. Here we reconstitute RISC assembly using only Ago2, Dicer-2, R2D2, Hsc70, Hsp90, Hop, Droj2 (an Hsp40 homologue) and p23. By following the assembly of single RISC molecules, we find that, in the absence of the chaperone machinery, an siRNA bound to Dicer-2-R2D2 associates with Ago2 only transiently. The chaperone machinery extends the dwell time of the Dicer-2-R2D2-siRNA complex on Ago2, in a manner dependent on recognition of the 59-phosphate on the siRNA guide strand. We propose that the chaperone machinery supports a productive state of Ago2, allowing it to load siRNA duplexes from Dicer-2-R2D2 and thereby assemble RISC.	[Iwasaki, Shintaro; Sasaki, Hiroshi M.; Tomari, Yukihide] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Sakaguchi, Yuriko; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1130033, Japan; [Tadakuma, Hisashi; Tomari, Yukihide] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Tomari, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	tadakuma@k.u-tokyo.ac.jp; tomari@iam.u-tokyo.ac.jp	Tomari, Yukihide/A-8009-2009; Iwasaki, Shintaro/D-1472-2017; Iwasaki, Shintaro/AAO-7743-2021; Suzuki, Tsutomu/J-1776-2015	Tomari, Yukihide/0000-0001-8442-0851; Iwasaki, Shintaro/0000-0001-7724-3754; Iwasaki, Shintaro/0000-0001-7724-3754; Suzuki, Tsutomu/0000-0002-9731-1731; Sasaki, Hiroshi/0000-0001-9201-8766	Ministry of Education, Culture, Sports, Science and Technology in Japan; Grants-in-Aid for Scientific Research [26113007] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Q. Liu for providing vectors for Dicer-2 and R2D2 expression, M. Horwich and P. D. Zamore for Ago2 cDNA, and H. Siomi and M. C. Siomi for anti-Ago2 antibody and ago2<SUP>414</SUP> flies. We are also grateful to P. B. Kwak and A. Tsutsumi for assistance with plasmid constructions, S. Katsuma for support for Dicer-2-R2D2 preparation, and A. Yamashita for advice on protein purification. We thank H. Taguchi and T. Ueda for fruitful discussions and P. D. Zamore, H. Seitz and the members of the Tomari laboratory for critical comments on the manuscript. This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas ('Functional machinery for non-coding RNAs' and 'Non-coding RNA neo-taxonomy'), a Grant-in-Aid for Young Scientists (A) (to H.T. and Y.T.), a Grant-in-Aid for Research Activity start-up (to S.I.), and Grants-in-Aid for challenging Exploratory Research (to H.M.S.) from The Ministry of Education, Culture, Sports, Science and Technology in Japan.	Betancur JG, 2012, RNA, V18, P24, DOI 10.1261/rna.029785.111; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001; Dittmar KD, 1997, J BIOL CHEM, V272, P13047, DOI 10.1074/jbc.272.20.13047; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Iki T, 2010, MOL CELL, V39, P282, DOI 10.1016/j.molcel.2010.05.014; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Johnston M, 2010, MOL BIOL CELL, V21, P1462, DOI 10.1091/mbc.E09-10-0885; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kawamata T, 2011, METHODS MOL BIOL, V725, P91, DOI 10.1007/978-1-61779-046-1_7; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Kim Y, 2014, CELL REP, V9, P1061, DOI 10.1016/j.celrep.2014.09.039; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Miyazono Y, 2010, EMBO J, V29, P93, DOI 10.1038/emboj.2009.319; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Miyoshi T, 2010, NAT STRUCT MOL BIOL, V17, P1024, DOI 10.1038/nsmb.1875; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Zhou ZP, 2011, J BIOCHEM, V149, P609, DOI 10.1093/jb/mvr010	42	85	88	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					533	U274		10.1038/nature14254	http://dx.doi.org/10.1038/nature14254			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25822791				2022-12-28	WOS:000355286600046
J	Heymann, DL; Rodier, GR; Ryan, MJ				Heymann, David L.; Rodier, Guenael R.; Ryan, Michael J.			Ebola vaccines: keep the clinical trial protocols on the shelf and ready to roll out	LANCET			English	Editorial Material							HEMORRHAGIC-FEVER; CONGO		[Heymann, David L.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Heymann, David L.] Royal Inst Int Affairs, Ctr Global Hlth Secur, London, England; [Rodier, Guenael R.] WHO Reg Off Europe, Copenhagen, Denmark; [Ryan, Michael J.] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland	University of London; London School of Hygiene & Tropical Medicine; World Health Organization; University College Dublin	Heymann, DL (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	david.heymann@lshtm.ac.uk			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 1978, Bull World Health Organ, V56, P271; Cassels FJ., 2012, SEVERE ACUTE RESP SY, P98; GAVI Vaccine Alliance, 2014, GAV COMM PURCH EB VA; Heymann D, 1999, J INFECT DIS, V142, P372; Jezek Z, 1999, J INFECT DIS, V179, pS60, DOI 10.1086/514295; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Lamunu M, 2004, INT J INFECT DIS, V8, P27, DOI 10.1016/j.ijid.2003.04.001; Maganga GD, 2014, NEW ENGL J MED, V371, P2083, DOI 10.1056/NEJMoa1411099; van Alken WG, 2004, WHO TECH REP SER, V926, P1; Wellcome Trust and the Center for Infectious Disease Research and Policy (CIDRAP) University of Minnesota, 2015, REC ACC DEV EB VACC; WHO, 2015, WHO EB R D EFF VACC	11	5	5	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1913	1915		10.1016/S0140-6736(15)60645-6	http://dx.doi.org/10.1016/S0140-6736(15)60645-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH6ZE	25843891	Green Published, Bronze			2022-12-28	WOS:000354184500035
J	Maiuri, P; Rupprecht, JF; Wieser, S; Ruprecht, V; Benichou, O; Carpi, N; Coppey, M; De Beco, S; Gov, N; Heisenberg, CP; Crespo, CL; Lautenschlaeger, F; Le Berre, M; Lennon-Dumenil, AM; Raab, M; Thiam, HR; Piel, M; Sixt, M; Voituriez, R				Maiuri, Paolo; Rupprecht, Jean-Francois; Wieser, Stefan; Ruprecht, Verena; Benichou, Olivier; Carpi, Nicolas; Coppey, Mathieu; De Beco, Simon; Gov, Nir; Heisenberg, Carl-Philipp; Crespo, Carolina Lage; Lautenschlaeger, Franziska; Le Berre, Maeil; Lennon-Dumenil, Ana-Maria; Raab, Matthew; Thiam, Hawa-Racine; Piel, Matthieu; Sixt, Michael; Voituriez, Raphael			Actin Flows Mediate a Universal Coupling between Cell Speed and Cell Persistence	CELL			English	Article							MYOSIN-II; PAR PROTEINS; MIGRATION; DYNAMICS; CONTRACTILITY; MECHANISMS; MOTILITY; ADHESION; POLARITY; SYSTEM	Cell movement has essential functions in development, immunity, and cancer. Various cell migration patterns have been reported, but no general rule has emerged so far. Here, we show on the basis of experimental data in vitro and in vivo that cell persistence, which quantifies the straightness of trajectories, is robustly coupled to cell migration speed. We suggest that this universal coupling constitutes a generic law of cell migration, which originates in the advection of polarity cues by an actin cytoskeleton undergoing flows at the cellular scale. Our analysis relies on a theoretical model that we validate by measuring the persistence of cells upon modulation of actin flow speeds and upon optogenetic manipulation of the binding of an actin regulator to actin filaments. Beyond the quantitative prediction of the coupling, the model yields a generic phase diagram of cellular trajectories, which recapitulates the full range of observed migration patterns.	[Maiuri, Paolo; Carpi, Nicolas; Lautenschlaeger, Franziska; Le Berre, Maeil; Raab, Matthew; Thiam, Hawa-Racine; Piel, Matthieu] CNRS UMR 144, Inst Curie, F-75005 Paris, France; [Rupprecht, Jean-Francois; Benichou, Olivier; Voituriez, Raphael] UPMC, UMR CNRS 7600, Lab Phys Theor Mat Condensee, F-75255 Paris, France; [Wieser, Stefan; Ruprecht, Verena; Heisenberg, Carl-Philipp; Sixt, Michael] IST Austria, A-3400 Klosterneuburg, Austria; [Coppey, Mathieu; De Beco, Simon] CNRS UMR 168, Inst Curie, F-75005 Paris, France; [Gov, Nir] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel; [Crespo, Carolina Lage] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Lennon-Dumenil, Ana-Maria] Inst Curie, U653, INSERM, F-75248 Paris 05, France; [Voituriez, Raphael] UPMC, UMR CNRS 8237, Lab Jean Perrin, F-75255 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite; Institute of Science & Technology - Austria; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Weizmann Institute of Science; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite	Piel, M (corresponding author), CNRS UMR 144, Inst Curie, 26 Rue Ulm, F-75005 Paris, France.	matthieu.piel@curie.fr; sixt@ist.ac.at; voiturie@lptmc.jussieu.fr	Coppey, Mathieu/AAR-3207-2020; Le Berre, Maël/E-3538-2010; voituriez, raphael/V-3418-2017; Lennon-Dumenil, Ana-Maria/I-6716-2016; wieser, stefan/ABH-4102-2020; Thiam, Hawa Racine/AAY-4658-2021; Ruprecht, Verena/H-7563-2017; Thiam, Hawa Racine/AAQ-2006-2020; Crespo, Carolina L/M-3546-2017; Lautenschläger, Franziska/L-3484-2016; GOV, NIR/K-1415-2012	Coppey, Mathieu/0000-0001-8924-3233; Le Berre, Maël/0000-0002-2293-3659; wieser, stefan/0000-0002-2670-2217; Thiam, Hawa Racine/0000-0002-2381-1442; Ruprecht, Verena/0000-0003-4088-8633; Crespo, Carolina L/0000-0001-8659-648X; Lautenschläger, Franziska/0000-0001-8263-3386; Sixt, Michael/0000-0002-6620-9179; voituriez, raphael/0000-0001-8746-5713; Rupprecht, Jean-Francois/0000-0001-8904-5878; de Beco, Simon/0000-0003-1730-3000; CARPI, Nicolas/0000-0002-7494-5555; Maiuri, Paolo/0000-0001-5079-445X; Heisenberg, Carl-Philipp/0000-0002-0912-4566; GOV, NIR/0000-0001-7774-1139	Fondation pour la Recherche Medicale; Austrian Science Fund (FWF) [T560-B17]; AIRC-IG; PRIN; EMBO ALTF [1163-2010]; ANR [ANR-09-PIRI-0027]; InNaBioSant; ERC [311205-PROMICO, 281556_Leukocyte Forces]; HFSP Program Grant; Austrian Science Fund (FWF) [T 560] Funding Source: researchfish	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); AIRC-IG(Fondazione AIRC per la ricerca sul cancro); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); EMBO ALTF; ANR(French National Research Agency (ANR)); InNaBioSant; ERC(European Research Council (ERC)European Commission); HFSP Program Grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We acknowledge J. Wittbrodt for providing the medaka fish transgenic line and D. Riveline and J.F. Joanny for discussions and comments on the manuscript. The authors greatly acknowledge Lucie Sengmanivong from the Nikon Imaging Centre at Institut Curie-CNRS and Vincent Fraisier from the PICT-IBiSA Lhomond Imaging facility of Institut Curie for their help on microscopy. P.M. was supported by a "Fondation pour la Recherche Medicale" fellowship. V.R. was supported by the Austrian Science Fund (FWF) T560-B17. C.L.C. was supported by grant AIRC-IG and PRIN 2010-2011 to Ruggero Pardi. F.L. was supported by EMBO ALTF 1163-2010. O.B., R.V., and M.P. were supported by ANR (ANR-09-PIRI-0027) and InNaBioSant. M.P. was supported by ERC (311205-PROMICO). M.S. was supported by ERC (281556_Leukocyte Forces) and a HFSP Program Grant.	[Anonymous], 2004, HDB STOCHASTIC METHO; Benichou O, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.81; Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Callan-Jones AC, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/025022; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; Czirok A, 1998, PHYS REV LETT, V81, P3038, DOI 10.1103/PhysRevLett.81.3038; Dang I, 2013, NATURE, V503, P281, DOI 10.1038/nature12611; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Goehring NW, 2011, SCIENCE, V334, P1137, DOI 10.1126/science.1208619; Gole L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026901; Grabher C, 2007, J LEUKOCYTE BIOL, V81, P263, DOI 10.1189/jlb.0806526; Hawkins RJ, 2011, BIOPHYS J, V101, P1041, DOI 10.1016/j.bpj.2011.07.038; Heuze ML, 2013, IMMUNOL REV, V256, P240, DOI 10.1111/imr.12108; Hong L, 2013, J BIOL CHEM, V288, P8531, DOI 10.1074/jbc.M112.435941; Julicher F, 2007, PHYS REP, V449, P3, DOI 10.1016/j.physrep.2007.02.018; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kondo T, 2011, BIOCHEM J, V435, P569, DOI 10.1042/BJ20100837; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Maiuri P, 2012, CURR BIOL, V22, pR673, DOI 10.1016/j.cub.2012.07.052; Mallick K, 2004, EUR PHYS J B, V38, P99, DOI 10.1140/epjb/e2004-00104-3; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Miyoshi H, 2003, PROTOPLASMA, V222, P175, DOI 10.1007/s00709-003-0013-7; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Ofera N, 2011, P NATL ACAD SCI USA, V108, P20394, DOI 10.1073/pnas.1105333108; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Romanczuk P, 2012, EUR PHYS J-SPEC TOP, V202, P1, DOI 10.1140/epjst/e2012-01529-y; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Selmeczi D, 2008, EUR PHYS J-SPEC TOP, V157, P1, DOI 10.1140/epjst/e2008-00626-x; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Tejedor V, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.088103; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Toner J, 2005, ANN PHYS-NEW YORK, V318, P170, DOI 10.1016/j.aop.2005.04.011; Vedel S, 2013, P NATL ACAD SCI USA, V110, P129, DOI 10.1073/pnas.1204291110; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111; Zhang J, 2014, P NATL ACAD SCI USA, V111, P16383, DOI 10.1073/pnas.1410533111	43	231	234	1	91	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					374	386		10.1016/j.cell.2015.01.056	http://dx.doi.org/10.1016/j.cell.2015.01.056			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25799384	Bronze			2022-12-28	WOS:000352708300028
J	Sharma, P; Allison, JP				Sharma, Padmanee; Allison, James P.			The future of immune checkpoint therapy	SCIENCE			English	Review							COLONY-STIMULATING FACTOR; CTLA-4 BLOCKADE SYNERGIZES; CD8(+) T-CELLS; PD-1 BLOCKADE; TUMOR MICROENVIRONMENT; CANCER-IMMUNOTHERAPY; ANTI-PD-L1 ANTIBODY; UP-REGULATION; REGULATORY T; IPILIMUMAB	Immune checkpoint therapy, which targets regulatory pathways in T cells to enhance antitumor immune responses, has led to important clinical advances and provided a new weapon against cancer. This therapy has elicited durable clinical responses and, in a fraction of patients, long-term remissions where patients exhibit no clinical signs of cancer for many years. The way forward for this class of novel agents lies in our ability to understand human immune responses in the tumor microenvironment. This will provide valuable information regarding the dynamic nature of the immune response and regulation of additional pathways that will need to be targeted through combination therapies to provide survival benefit for greater numbers of patients.	[Sharma, Padmanee; Allison, James P.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Genitourinary Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	padsharma@mdanderson.org; jallison@mdanderson.org		Allison, James/0000-0001-8980-5697	PCF Challenge Grant in Immunology; NCI/NIH [1-R01 CA1633793-01]; Cancer Prevention Research in Texas grants; Stand Up To Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Cancer Research Grant; NATIONAL CANCER INSTITUTE [R01CA163793] Funding Source: NIH RePORTER	PCF Challenge Grant in Immunology; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention Research in Texas grants; Stand Up To Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Cancer Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	P.S. and J.P.A. are founders and advisors for Jounce Therapeutics. P.S. also serves as a consultant for Bristol-Myers Squibb, Amgen, and GlaxoSmithKline. J.P.A. is an inventor of intellectual property owned by the University of California, Berkeley, and licensed to Bristol-Myers Squibb and has received royalties from Bristol-Myers Squibb. Our research is supported by a PCF Challenge Grant in Immunology (J.P.A. and P.S.), NCI/NIH 1-R01 CA1633793-01 (P.S.), Cancer Prevention Research in Texas grants (J.P.A. and P.S.), and a Stand Up To Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Cancer Research Grant (P.S. and J.P.A.). Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Amin A., 2014, J CLIN ONCOL S, V32, P4010; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Carthon BC, 2010, CLIN CANCER RES, V16, P2861, DOI 10.1158/1078-0432.CCR-10-0569; Crittenden M, 2015, SEMIN RADIAT ONCOL, V25, P54, DOI 10.1016/j.semradonc.2014.07.003; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Derre L, 2010, J CLIN INVEST, V120, P157, DOI 10.1172/JCI40070; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Engeland CE, 2014, MOL THER, V22, P1949, DOI 10.1038/mt.2014.160; Fan XZ, 2014, J EXP MED, V211, P715, DOI 10.1084/jem.20130590; Fourcade J, 2012, CANCER RES, V72, P887, DOI 10.1158/0008-5472.CAN-11-2637; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fu TH, 2011, CANCER RES, V71, P5445, DOI 10.1158/0008-5472.CAN-11-1138; Goldberg MV, 2011, CURR TOP MICROBIOL, V344, P269, DOI 10.1007/82_2010_114; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Grosso J, 2013, J CLIN ONCOL, V31; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hammers J. H., 2014, J CLIN ONCOL S, V32, P4504; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hodi F. S., 2014, J AM MED ASS, V312, P1744; Hodi FS, 2008, P NATL ACAD SCI USA, V105, P3005, DOI 10.1073/pnas.0712237105; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hurwitz AA, 1998, P NATL ACAD SCI USA, V95, P10067, DOI 10.1073/pnas.95.17.10067; Kohrt HE, 2014, J CLIN INVEST, V124, P2668, DOI 10.1172/JCI73014; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Le DT, 2013, J IMMUNOTHER, V36, P382, DOI 10.1097/CJI.0b013e31829fb7a2; Le Mercier I, 2014, CANCER RES, V74, P1933, DOI 10.1158/0008-5472.CAN-13-1506; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Liakou CI, 2008, P NATL ACAD SCI USA, V105, P14987, DOI 10.1073/pnas.0806075105; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Madore J, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12340; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Redmond WL, 2014, CANCER IMMUNOL RES, V2, P142, DOI 10.1158/2326-6066.CIR-13-0031-T; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Tang C, 2014, CANCER IMMUNOL RES, V2, P831, DOI 10.1158/2326-6066.CIR-14-0069; Tang DN, 2013, CANCER IMMUNOL RES, V1, P229, DOI 10.1158/2326-6066.CIR-13-0020; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van den Eertwegh AJM, 2012, LANCET ONCOL, V13, P509, DOI 10.1016/S1470-2045(12)70007-4; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Waitz R, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19442; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang L, 2011, J EXP MED, V208, P577, DOI 10.1084/jem.20100619; Weber JS, 2008, J CLIN ONCOL, V26, P5950, DOI 10.1200/JCO.2008.16.1927; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Yang JC, 2007, J IMMUNOTHER, V30, P825, DOI 10.1097/CJI.0b013e318156e47e; Zamarin D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008095	68	2846	2982	81	1737	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					56	61		10.1126/science.aaa8172	http://dx.doi.org/10.1126/science.aaa8172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838373				2022-12-28	WOS:000352079500026
J	Mouncey, PR; Osborn, TM; Power, GS; Harrison, DA; Sadique, MZ; Grieve, RD; Jahan, R; Harvey, SE; Bell, D; Bion, JF; Coats, TJ; Singer, M; Young, JD; Rowan, KM				Mouncey, Paul R.; Osborn, Tiffany M.; Power, G. Sarah; Harrison, David A.; Sadique, M. Zia; Grieve, Richard D.; Jahan, Rahi; Harvey, Sheila E.; Bell, Derek; Bion, Julian F.; Coats, Timothy J.; Singer, Mervyn; Young, J. Duncan; Rowan, Kathryn M.		ProMISe Trial Investigators	Trial of Early, Goal-Directed Resuscitation for Septic Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURVIVING SEPSIS CAMPAIGN; ORGAN FAILURE; CRITICAL-CARE; GUIDELINES; MANAGEMENT; THERAPY; SCORE; UNITS	BACKGROUND Early, goal-directed therapy (EGDT) is recommended in international guidelines for the resuscitation of patients presenting with early septic shock. However, adoption has been limited, and uncertainty about its effectiveness remains. METHODS We conducted a pragmatic randomized trial with an integrated cost-effectiveness analysis in 56 hospitals in England. Patients were randomly assigned to receive either EGDT (a 6-hour resuscitation protocol) or usual care. The primary clinical outcome was all-cause mortality at 90 days. RESULTS We enrolled 1260 patients, with 630 assigned to EGDT and 630 to usual care. By 90 days, 184 of 623 patients (29.5%) in the EGDT group and 181 of 620 patients (29.2%) in the usual-care group had died (relative risk in the EGDT group, 1.01; 95% confidence interval [CI], 0.85 to 1.20; P = 0.90), for an absolute risk reduction in the EGDT group of -0.3 percentage points (95% CI, -5.4 to 4.7). Increased treatment intensity in the EGDT group was indicated by increased use of intravenous fluids, vasoactive drugs, and red-cell transfusions and reflected by significantly worse organ-failure scores, more days receiving advanced cardiovascular support, and longer stays in the intensive care unit. There were no significant differences in any other secondary outcomes, including health-related quality of life, or in rates of serious adverse events. On average, EGDT increased costs, and the probability that it was cost-effective was below 20%. CONCLUSIONS In patients with septic shock who were identified early and received intravenous antibiotics and adequate fluid resuscitation, hemodynamic management according to a strict EGDT protocol did not lead to an improvement in outcome.	[Mouncey, Paul R.; Power, G. Sarah; Harrison, David A.; Jahan, Rahi; Harvey, Sheila E.; Rowan, Kathryn M.] Intens Care Natl Audit & Res Ctr, Clin Trials Unit, London WC1V 6AZ, England; [Sadique, M. Zia; Grieve, Richard D.] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Bell, Derek] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Bell, Derek] Chelsea & Westminster Hosp NHS Fdn Trust, Dept Acute Med, London, England; [Singer, Mervyn] UCL, Bloomsbury Inst Intens Care Med, London, England; [Bion, Julian F.] Univ Birmingham, Dept Intens Care Med, Birmingham, W Midlands, England; [Coats, Timothy J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Young, J. Duncan] Univ Oxford, Nuffield Div Anaesthet, Oxford, England; [Osborn, Tiffany M.] Washington Univ, Dept Surg, St Louis, MO 63130 USA; [Osborn, Tiffany M.] Washington Univ, Dept Emergency Med, St Louis, MO 63130 USA	Intensive Care National Audit & Research Centre; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Imperial College London; University of London; University College London; University of Birmingham; University of Leicester; University of Oxford; Washington University (WUSTL); Washington University (WUSTL)	Rowan, KM (corresponding author), Intens Care Natl Audit & Res Ctr, Napier House,24 High Holborn, London WC1V 6AZ, England.	kathy.rowan@icnarc.org	Skene, Imogen/D-6153-2018; Osborn, Tiffany/AAT-2281-2020; Harrison, David A/O-4355-2018; Young, John D/M-9756-2016; Coats, Timothy/AAW-1254-2021; Singer, Mervyn/Q-6142-2019	Skene, Imogen/0000-0001-5215-2899; Harrison, David A/0000-0002-9002-9098; Coats, Timothy/0000-0003-2736-2784; Singer, Mervyn/0000-0002-1042-6350; Brealey, David/0000-0002-1982-3379; Young, John Duncan/0000-0002-6838-4835; Mouncey, Paul/0000-0002-8510-8517; Weldring, Theresa/0000-0001-6955-6822; Harvey, Sheila/0000-0001-7604-8607; Sadique, Zia/0000-0001-5814-0258; Rowan, Kathryn/0000-0001-8217-5602; Bion, Julian/0000-0003-0344-5403; Harvey, Daniel/0000-0002-5165-3277; Grieve, Richard/0000-0001-8899-1301	United Kingdom National Institute for Health Research Health Technology Assessment Programme; National Institute for Health Research [SRF-2013-06-016, 07/37/47] Funding Source: researchfish	United Kingdom National Institute for Health Research Health Technology Assessment Programme; National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the United Kingdom National Institute for Health Research Health Technology Assessment Programme; ProMISe Current Controlled Trials number, ISRCTN36307479.	[Anonymous], 2014, NEW ENGL J MED, DOI DOI 10.1056/NEJMoa1401602; [Anonymous], 2013, GUID METH TECHN APPR; [Anonymous], 2005, MENTAL CAPACITY ACT; Ara R, 2010, VALUE HEALTH, V13, P509, DOI 10.1111/j.1524-4733.2010.00700.x; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chapman M, 2005, CRIT CARE, V9, P307, DOI 10.1186/cc3726; Cuthbertson BH, 2013, CRIT CARE, V17, DOI 10.1186/cc12616; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dellinger RP, 2004, CRIT CARE MED, V32, P1448; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Harrison DA, 2004, CRIT CARE, V8, pR99, DOI 10.1186/cc2834; Harvey SE, 2006, INTENS CARE MED, V32, P2020, DOI 10.1007/s00134-006-0358-4; Ho BCH, 2006, CRIT CARE, V10, DOI 10.1186/cc4918; Huang DT, 2013, INTENS CARE MED, V39, P1760, DOI 10.1007/s00134-013-3024-7; Jawad Issrah, 2012, J Glob Health, V2, P010404, DOI 10.7189/jogh.02.010404; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Levy MM, 2015, CRIT CARE MED, V43, P3, DOI [10.1097/CCM.0000000000000723, 10.1007/s00134-014-3496-0]; Levy MM, 2012, LANCET INFECT DIS, V12, P919, DOI 10.1016/S1473-3099(12)70239-6; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Power GS, 2013, CRIT CARE RESUSC, V15, P311; Reade MC, 2010, INTENS CARE MED, V36, P11, DOI 10.1007/s00134-009-1650-x; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; [No title captured]	25	942	1032	1	109	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14					1301	1311		10.1056/NEJMoa1500896	http://dx.doi.org/10.1056/NEJMoa1500896			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NL	25776532	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000352028500005
J	Ashrafian, H				Ashrafian, Hutan			Intelligent robots must uphold human rights	NATURE			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Ashrafian, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	h.ashrafian@imperial.ac.uk							0	9	9	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					391	391		10.1038/519391a	http://dx.doi.org/10.1038/519391a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE1WF	25810170	Bronze			2022-12-28	WOS:000351602800020
J	[Anonymous]				[Anonymous]			South Korea	NATURE			English	Editorial Material																			0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S62	S63		10.1038/519S62a	http://dx.doi.org/10.1038/519S62a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE1WF	25806696				2022-12-28	WOS:000351602800011
J	Powell, I; McKee, M				Powell, Ian; McKee, Martin			HEALTH AND SOCIAL CARE ACT Amend or repeal? How New Zealand tackled unpopular healthcare legislation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NHS		[Powell, Ian] Assoc Salaried Med Specialists, Wellington, New Zealand; [McKee, Martin] London Sch Hyg & Trop Med, European Publ Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine	Powell, I (corresponding author), Assoc Salaried Med Specialists, Wellington, New Zealand.	ip@asms.org.nz; Martin.McKee@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683				Cumming Jacqueline, 2011, Int J Integr Care, V11, pe138; Devlin N, 2001, BRIT MED J, V322, P1171, DOI 10.1136/bmj.322.7295.1171; Helm T, 2015, GUARDIAN; Iacobucci G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1110; Iacobucci G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5248; iley-Smith B., 2014, DAILY TELEGRAPH; Limb M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1507; Limb M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1206; Mays N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6513; New Zealand Ministry of Health, 2012, HLTH EXP TRENDS NZ 2; Organisation for Economic Co-operation and Development, 2015, HLTH DAT; Powell I, 2000, NEW ZEAL MED J, V113, P101; Thomas K., 2015, GUARDIAN; Timmins N, 2013, THE QUEST FOR INTEGR; Watt N, 2012, GUARDIAN; White C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4369	16	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2015	350								h1502	10.1136/bmj.h1502	http://dx.doi.org/10.1136/bmj.h1502			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NO	25804955	Green Accepted			2022-12-28	WOS:000352028800013
J	Corbelli, J				Corbelli, Jennifer			PERSONAL VIEW US healthcare: how losing your job can kill you in the world's richest country	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Pittsburgh, Med, Gen Internal Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Corbelli, J (corresponding author), Univ Pittsburgh, Med, Gen Internal Med, Pittsburgh, PA 15213 USA.	corbellija@upmc.edu							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2015	350								h1517	10.1136/bmj.h1517	http://dx.doi.org/10.1136/bmj.h1517			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KX	25795063				2022-12-28	WOS:000351571600002
J	He, FJ; Wu, YF; Feng, XX; Ma, J; Ma, Y; Wang, HJ; Zhang, J; Yuan, JH; Lin, CP; Nowson, C; MacGregor, GA				He, Feng J.; Wu, Yangfeng; Feng, Xiang-Xian; Ma, Jun; Ma, Yuan; Wang, Haijun; Zhang, Jing; Yuan, Jianhui; Lin, Ching-Ping; Nowson, Caryl; MacGregor, Graham A.			School based education programme to reduce salt intake in children and their families (School-EduSalt): cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE; GLOBAL BURDEN; CHINA; METAANALYSIS; DISEASE; SODIUM; HYPERTENSION; CHILDHOOD; EXCRETION	OBJECTIVE To determine whether an education programme targeted at schoolchildren could lower salt intake in children and their families. DESIGN Cluster randomised controlled trial, with schools randomly assigned to either the intervention or control group. SETTING 28 primary schools in urban Changzhi, northern China. PARTICIPANTS 279 children in grade 5 of primary school, with mean age of 10.1; 553 adult family members (mean age 43.8). INTERVENTION Children in the intervention group were educated on the harmful effects of salt and how to reduce salt intake within the schools' usual health education lessons. Children then delivered the salt reduction message to their families. The intervention lasted for one school term (about 3.5 months). MAIN OUTCOME MEASURES The primary outcome was the difference between the groups in the change in salt intake (as measured by 24 hour urinary sodium excretion) from baseline to the end of the trial. The secondary outcome was the difference between the two groups in the change in blood pressure. RESULTS At baseline, the mean salt intake in children was 7.3 (SE 0.3) g/day in the intervention group and 6.8 (SE 0.3) g/day in the control group. In adult family members the salt intakes were 12.6 (SE 0.4) and 11.3 (SE 0.4) g/day, respectively. During the study there was a reduction in salt intake in the intervention group, whereas in the control group salt intake increased. The mean effect on salt intake for intervention versus control group was -1.9 g/day (95% confidence interval -2.6 to -1.3 g/day; P<0.001) in children and -2.9 g/day (-3.7 to -2.2 g/day; P<0.001) in adults. The mean effect on systolic blood pressure was -0.8 mm Hg (-3.0 to 1.5 mm Hg; P=0.51) in children and -2.3 mm Hg (-4.5 to -0.04 mm Hg; P<0.05) in adults. CONCLUSIONS An education programme delivered to primary school children as part of the usual curriculum is effective in lowering salt intake in children and their families. This offers a novel and important approach to reducing salt intake in a population in which most of the salt in the diet is added by consumers.	[He, Feng J.; Ma, Yuan; MacGregor, Graham A.] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England; [Wu, Yangfeng; Ma, Yuan; Zhang, Jing; Lin, Ching-Ping] Peking Univ, George Inst Global Hlth, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Wu, Yangfeng; Ma, Yuan] Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Beijing 100871, Peoples R China; [Wu, Yangfeng] Peking Univ, Clin Res Inst, Beijing 100871, Peoples R China; [Feng, Xiang-Xian; Yuan, Jianhui] Changzhi Med Coll, Changzhi, Shanxi, Peoples R China; [Ma, Jun; Wang, Haijun] Peking Univ, Inst Child & Adolescent Hlth, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Lin, Ching-Ping] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Nowson, Caryl] Deakin Univ, Sch Exercise & Nutr Sci, Geelong, Vic 3217, Australia	University of London; Queen Mary University London; Peking University; Peking University; Peking University; Changzhi Medical College; Peking University; University of Michigan System; University of Michigan; Deakin University	He, FJ (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England.	f.he@qmul.ac.uk	He, Feng/HHS-6457-2022; Wang, Haijun/AAD-1302-2021	He, Feng/0000-0002-1996-0744; Wang, Haijun/0000-0003-0849-2903; Nowson, Caryl/0000-0001-6586-7965; He, Feng/0000-0003-2807-4119; Ma, Yuan/0000-0002-0207-3620	UK Medical Research Council [MR/J015903/1]; FOGARTY INTERNATIONAL CENTER [R25TW009345] Funding Source: NIH RePORTER; Medical Research Council [MR/J015903/1] Funding Source: researchfish; MRC [MR/J015903/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the UK Medical Research Council (MR/J015903/1). The study is part of the GACD (Global Alliance for Chronic Disease) Hypertension Programme. The funder of the study had no role in the design of the study; the collection, analysis, and interpretation of the data; the writing of the manuscript; and the decision to submit the article for publication.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; [Anonymous], 2011, 1 GLOB MIN C HLTH LI; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078963; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Du SF, 2014, AM J CLIN NUTR, V99, P334, DOI 10.3945/ajcn.113.059121; ELLIOTT P, 1988, BRIT MED J, V297, P319; He F. J., 2013, BMJ, V346; He FJ, 2014, J HUM HYPERTENS, V28, P345, DOI 10.1038/jhh.2013.105; He FJ, 2006, HYPERTENSION, V48, P861, DOI 10.1161/01.HYP.0000245672.27270.4a; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; He FJ, 2009, HYPERTENSION, V54, P482, DOI 10.1161/HYPERTENSIONAHA.109.133223; He FJ, 2013, BMJ OPEN, V3; LAUER RM, 1989, PEDIATRICS, V84, P633; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2012, J HYPERTENS, V30, P1383, DOI 10.1097/HJH.0b013e32835465b5; Li N, 2013, AM HEART J, V166, P815, DOI 10.1016/j.ahj.2013.07.009; Liu Q, 2011, LANCET, V377, P2064, DOI 10.1016/S0140-6736(11)60167-0; Maldonaldo-Martin A, 2002, J HUM HYPERTENS, V16, P473, DOI 10.1038/sj.jhh.1001424; Marrero NM, 2014, HYPERTENSION, V63, P1026, DOI 10.1161/HYPERTENSIONAHA.113.02264; National Institute for Health and Clinical Excellence, 2010, GUID PREV CARD DIS P; WHO, 2002, RED RISKS PROM HLTH; WU Y, 1991, Chinese Medical Sciences Journal, V6, P148; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Xu JW, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-136; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Zhang JY, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005089; Zhao LC, 2004, HYPERTENSION, V43, P1332, DOI 10.1161/01.HYP.0000128243.06502.bc	35	106	116	2	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2015	350								h770	10.1136/bmj.h770	http://dx.doi.org/10.1136/bmj.h770			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KT	25788018	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000351571200002
J	Verheugt, FWA; Granger, CB				Verheugt, Freek W. A.; Granger, Christopher B.			Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs	LANCET			English	Article							ACUTE CORONARY SYNDROME; ANTITHROMBOTIC THERAPY; PERCUTANEOUS CORONARY; RANDOMIZED EVALUATION; CATHETER ABLATION; CLINICAL EVENTS; VS. WARFARIN; DABIGATRAN; RIVAROXABAN; APIXABAN	In patients with non-valvular atrial fibrillation, oral anticoagulation with vitamin K antagonists reduces the risk of stroke by more than 60%. But vitamin K antagonists have limitations, including causing serious bleeding such as intracranial haemorrhage and the need for anticoagulation monitoring. In part related to these limitations, they are used in only about half of patients who should be treated according to guideline recommendations. In the past decade, oral agents have been developed that directly block the activity of thrombin (factor IIa), as well as drugs that directly inhibit activated factor X (Xa), which is the first protein in the final common pathway to the activation of thrombin. These novel non-vitamin K antagonist oral anticoagulants (NOACs) have been shown to be at least as good as warfarin for stroke prevention in atrial fibrillation and they have proved to have better safety profiles. Their net advantage is underscored by significantly lower all-cause mortality compared with warfarin in large clinical trials. Because of these features and their ease of use, they are recommended for stroke prevention in atrial fibrillation. They have also a fast onset and off set of action, but they currently lack specific antidotes. This paper addresses the role of anticoagulation for stroke prevention in atrial fibrillation in the era of NOACs, with a focus on special situations including management in the event of bleeding and around the time of procedures including cardioversion, catheter ablation, and device implantation. Also their use in patients with concomitant coronary artery disease, with advanced age, with chronic kidney disease, or with valvular heart disease will be discussed as well as the interaction of NOACs with other cardiac medication, and switching between anticoagulants.	[Verheugt, Freek W. A.] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [Granger, Christopher B.] Duke Univ, Durham, NC USA	Onze Lieve Vrouwe Gasthuis Hospital; Duke University	Verheugt, FWA (corresponding author), PC Hooftstr 188, NL-1071 CH Amsterdam, Netherlands.	f.w.a.verheugt@olvg.nl	Verheugt, F.W.A./H-8105-2014		Bayer Healthcare; Janssen; BMS/Pfizer; Daiichi-Sankyo; Armetheon; Boehringer Ingelheim	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); BMS/Pfizer(Pfizer); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Armetheon; Boehringer Ingelheim(Boehringer Ingelheim)	FWAV has received educational and research grants from Bayer Healthcare, as well as honoraria for consultancies or presentations from Bayer Healthcare, BMS/Pfizer, Daiichi-Sankyo, and Boehringer Ingelheim. CBG has received research grants and consulting fees from Bayer Healthcare, Janssen, BMS/Pfizer, Daiichi-Sankyo, Armetheon, and Boehringer Ingelheim.	Alexander JH, 2014, EUR HEART J, V35, P224, DOI 10.1093/eurheartj/eht445; Ansell JE, 2014, NEW ENGL J MED, V371, P2141, DOI 10.1056/NEJMc1411800; Beyer-Westendorf J, 2014, EUR HEART J, V35, P1888, DOI 10.1093/eurheartj/eht557; Breithardt G, 2014, EUR HEART J, V35, P3377, DOI 10.1093/eurheartj/ehu305; Camm AJ, 2012, EUR HEART J, V33; Cappato R, 2014, EUR HEART J, V35, P3346, DOI 10.1093/eurheartj/ehu367; Chatterjee S, 2014, MAYO CLIN PROC, V89, P896, DOI 10.1016/j.mayocp.2014.01.030; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Connolly SJ, 2013, CIRCULATION, V128, P237, DOI 10.1161/CIRCULATIONAHA.112.001139; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cuker A, 2014, J AM COLL CARDIOL, V64, P1128, DOI 10.1016/j.jacc.2014.05.065; Dans AL, 2013, CIRCULATION, V127, P634, DOI 10.1161/CIRCULATIONAHA.112.115386; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Di Biase L, 2014, CIRCULATION, V129, P2638, DOI 10.1161/CIRCULATIONAHA.113.006426; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Eikelboom JW, 2014, J AM COLL CARDIOL, V64, P585, DOI 10.1016/j.jacc.2014.06.008; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Flaker G, 2014, J AM COLL CARDIOL, V64, P1541, DOI 10.1016/j.jacc.2014.07.967; Flaker G, 2014, J AM COLL CARDIOL, V63, P1082, DOI 10.1016/j.jacc.2013.09.062; Gallego P, 2014, AM J MED, V127, P1083, DOI 10.1016/j.amjmed.2014.05.023; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Gorst-Rasmussen A, 2015, J THROMB HAEMOST, V13, P495, DOI 10.1111/jth.12845; Graham DJ, 2015, CIRCULATION, V131, P157, DOI 10.1161/CIRCULATIONAHA.114.012061; Granger CB, 2015, AM HEART J, V169, P25, DOI 10.1016/j.ahj.2014.09.006; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Halperin JL, 2014, CIRCULATION, V130, P138, DOI 10.1161/CIRCULATIONAHA.113.005008; Halvorsen S, 2014, EUR HEART J, V35, P1864, DOI 10.1093/eurheartj/ehu046; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Heidbuchel H, 2013, EUROPACE, V15, P625, DOI 10.1093/europace/eut083; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Kasmeridis C, 2013, PHARMACOECONOMICS, V31, P971, DOI 10.1007/s40273-013-0090-1; Kim JS, 2013, HEART RHYTHM, V10, P483, DOI 10.1016/j.hrthm.2012.12.011; LaHaye SA, 2012, EUR HEART J, V33, P2163, DOI 10.1093/eurheartj/ehs167; Lakkireddy D, 2012, J AM COLL CARDIOL, V59, P1168, DOI 10.1016/j.jacc.2011.12.014; Lip GYH, 2014, EUR HEART J, V35, P3155, DOI 10.1093/eurheartj/ehu298; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Matchar DB, 2002, AM J MED, V113, P42, DOI 10.1016/S0002-9343(02)01131-2; Nagarakanti R, 2011, CIRCULATION, V123, P131, DOI 10.1161/CIRCULATIONAHA.110.977546; Oldgren J, 2014, CIRCULATION, V129, P1568, DOI 10.1161/CIRCULATIONAHA.113.005451; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Piccini JP, 2013, J AM COLL CARDIOL, V61, P1998, DOI 10.1016/j.jacc.2013.02.025; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Sardar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077694; Savelieva I, 2014, CLIN CARDIOL, V37, P32, DOI 10.1002/clc.22204; Schiele F, 2013, BLOOD, V121, P3554, DOI 10.1182/blood-2012-11-468207; Shore S, 2014, AM HEART J, V167, P810, DOI 10.1016/j.ahj.2014.03.023; Verheugt FWA, 2013, EUR HEART J, V34, P1618, DOI 10.1093/eurheartj/eht075; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	51	87	90	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2015	386	9990					303	310		10.1016/S0140-6736(15)60245-8	http://dx.doi.org/10.1016/S0140-6736(15)60245-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN1XI	25777666				2022-12-28	WOS:000358213700035
J	Nair, H; Campbell, H				Nair, Harish; Campbell, Harry			Community management of neonatal infections	LANCET			English	Editorial Material							SEVERE BACTERIAL-INFECTION; SUB-SAHARAN AFRICA; HEALTH WORKERS; LATIN-AMERICA; SOUTH-ASIA; SEPSIS; ANTIBIOTICS		[Nair, Harish; Campbell, Harry] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh EH8 9AG, Midlothian, Scotland; [Nair, Harish] Publ Hlth Fdn India, New Delhi, India	University of Edinburgh; Public Health Foundation of India	Nair, H (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh EH8 9AG, Midlothian, Scotland.	harish.nair@ed.ac.uk	Nair, Harish/E-7431-2010; Campbell, Harry/E-2959-2010	Nair, Harish/0000-0002-9432-9100; Campbell, Harry/0000-0002-6169-6262				Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui Abdullah H, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS12, DOI 10.1097/INF.0b013e31829ff790; Baqui AH, 2009, PEDIATR INFECT DIS J, V28, P304, DOI 10.1097/INF.0b013e31819069e8; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Coffey P, 2012, INJECTABLE ANTIBIOTI; Darmstadt G, 2010, INFECT DIS FETUS NEW, P24; Downie L, 2013, ARCH DIS CHILD, V98, P146, DOI 10.1136/archdischild-2012-302033; Khanal S, 2011, J HEALTH POPUL NUTR, V29, P255, DOI 10.3329/jhpn.v29i3.7873; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Margolis P, 1999, PEDIATR INFECT DIS J, V18, pS23; Mulholland K, 2014, LANCET RESP MED, V2, P952, DOI 10.1016/S2213-2600(14)70273-5; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Seale AC, 2013, PEDIATR RES, V74, P73, DOI 10.1038/pr.2013.207; Tshefu A, 2015, LANCET; Waters Donald, 2011, J Glob Health, V1, P154; Weber MW, 2003, PEDIATR INFECT DIS J, V22, P711, DOI 10.1097/01.inf.0000078163.80807.88; WHO, 2013, POCK HOSP CAR CHILDR; World Health Organization, 2014, INTEGRATED MANAGEMEN; Zaidi AK, 2013, PEDIATR INFECT DI S1, V32, P19	19	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1706	1709		10.1016/S0140-6736(15)60204-5	http://dx.doi.org/10.1016/S0140-6736(15)60204-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH0PZ	25842222				2022-12-28	WOS:000353726000008
J	Hendrix, MJC				Hendrix, Mary J. C.			An extravascular route for tumour cells	NATURE			English	News Item							STEM-LIKE CELLS; VASCULOGENIC MIMICRY	Molecular tracing of populations of breast-cancer cells in a primary tumour in mice reveals that two proteins, Serpine 2 and Slpi, enable tumour cells to form vascular-like networks, facilitating perfusion and metastasis.	Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Stanley Manne Childrens Res Inst, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Hendrix, MJC (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Stanley Manne Childrens Res Inst, Chicago, IL 60611 USA.	m-hendrix@northwestern.edu						Cao ZF, 2013, EUR J CANCER, V49, P3914, DOI 10.1016/j.ejca.2013.07.148; Fayard B, 2009, CANCER RES, V69, P5690, DOI 10.1158/0008-5472.CAN-08-4573; Fidler IJ, 2011, SEMIN CANCER BIOL, V21, P71, DOI 10.1016/j.semcancer.2010.12.004; Kirschmann DA, 2012, CLIN CANCER RES, V18, P2726, DOI 10.1158/1078-0432.CCR-11-3237; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Ruf W, 2003, CANCER RES, V63, P5381; Sayers KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104223; Seftor REB, 2012, AM J PATHOL, V181, P1115, DOI 10.1016/j.ajpath.2012.07.013; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624	11	1	1	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					300	302		10.1038/nature14382	http://dx.doi.org/10.1038/nature14382			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25855292				2022-12-28	WOS:000352974200025
J	Garrett, WS				Garrett, Wendy S.			Cancer and the microbiota	SCIENCE			English	Review							ENTEROTOXIGENIC BACTEROIDES-FRAGILIS; CHAIN FATTY-ACIDS; NF-KAPPA-B; INTESTINAL INFLAMMATION; FUSOBACTERIUM-NUCLEATUM; GUT MICROBIOTA; PROTEIN AVRA; COLON; BACTERIA; ACTIVATION	A host's microbiota may increase, diminish, or have no effect at all on cancer susceptibility. Assigning causal roles in cancer to specific microbes and microbiotas, unraveling host-microbiota interactions with environmental factors in carcinogenesis, and exploiting such knowledge for cancer diagnosis and treatment are areas of intensive interest. This Review considers how microbes and the microbiota may amplify or mitigate carcinogenesis, responsiveness to cancer therapeutics, and cancer-associated complications.	[Garrett, Wendy S.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Garrett, Wendy S.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Garrett, Wendy S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Garrett, Wendy S.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Garrett, Wendy S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Garrett, WS (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	wendy_garrett@dfci.harvard.edu			NIH [R01CA154426]; Burroughs Wellcome Career in Medical Sciences Award; Searle Scholars Award; Cancer Research Institute Investigator Award; Hoffman-LaRoche; NATIONAL CANCER INSTITUTE [R01CA154426] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career in Medical Sciences Award; Searle Scholars Award; Cancer Research Institute Investigator Award; Hoffman-LaRoche; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	W.S.G. thanks C. Brennan, C. Gallini, G. Hold, C. Lesser, and M. Howitt for critical reading of the manuscript. Supported by NIH grant R01CA154426, a Burroughs Wellcome Career in Medical Sciences Award, a Searle Scholars Award, a Cancer Research Institute Investigator Award, and a research grant from Hoffman-LaRoche. W.S.G. is a Synlogic SAB member.	Abreu MT, 2014, GASTROENTEROLOGY, V146, P1534, DOI 10.1053/j.gastro.2014.01.001; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Allen-Vercoe E, 2011, GUT MICROBES, V2, P294, DOI 10.4161/gmic.2.5.18603; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arthur JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5724; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Baxter NT, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-20; Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051; Berger NA, 2014, ANN NY ACAD SCI, V1311, P57, DOI 10.1111/nyas.12416; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Bindels LB, 2012, BRIT J CANCER, V107, P1337, DOI 10.1038/bjc.2012.409; Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787; Boyle KE, 2013, CURR OPIN MICROBIOL, V16, P207, DOI 10.1016/j.mib.2013.01.003; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Bultman SJ, 2014, CELL HOST MICROBE, V16, P143, DOI 10.1016/j.chom.2014.07.011; Carmody RN, 2014, J CLIN INVEST, V124, P4173, DOI 10.1172/JCI72335; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Curtis MA, 2011, CELL HOST MICROBE, V10, P302, DOI 10.1016/j.chom.2011.09.008; Dang LH, 2001, P NATL ACAD SCI USA, V98, P15155, DOI 10.1073/pnas.251543698; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Donohoe DR, 2014, CANCER DISCOV, V4, P1387, DOI 10.1158/2159-8290.CD-14-0501; Dutta U, 2000, AM J GASTROENTEROL, V95, P784, DOI 10.1111/j.1572-0241.2000.01860.x; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Faber F, 2014, IMMUNOL LETT, V162, P48, DOI 10.1016/j.imlet.2014.04.014; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gedye C, 2015, INTERN MED J, V45, P696, DOI 10.1111/imj.12653; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grivennikov SI, 2013, CANCER CELL, V24, P145, DOI 10.1016/j.ccr.2013.07.018; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Guerra L, 2011, FEBS J, V278, P4577, DOI 10.1111/j.1742-4658.2011.08125.x; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ingersoll MA, 2013, MUCOSAL IMMUNOL, V6, P1041, DOI 10.1038/mi.2013.72; Irrazabal T, 2014, MOL CELL, V54, P309, DOI 10.1016/j.molcel.2014.03.039; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Lazcano-Ponce EC, 2001, CA-CANCER J CLIN, V51, P349, DOI 10.3322/canjclin.51.6.349; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Li N, 2011, CANCER CELL, V19, P429, DOI 10.1016/j.ccr.2011.03.018; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Lu R, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.20; Lu R, 2012, AM J PHYSIOL-GASTR L, V303, pG1113, DOI 10.1152/ajpgi.00453.2011; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Milward MR, 2007, CLIN EXP IMMUNOL, V148, P307, DOI 10.1111/j.1365-2249.2007.03342.x; Nair N, 2014, ANTICANCER RES, V34, P6289; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Nuccio SP, 2014, MBIO, V5, DOI 10.1128/mBio.00929-14; O'Rourke RW, 2014, SURG OBES RELAT DIS, V10, P1208, DOI 10.1016/j.soard.2014.08.012; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; PAN ZK, 1995, NAT MED, V1, P471, DOI 10.1038/nm0595-471; Park J, 2014, NAT REV ENDOCRINOL, V10, P455, DOI 10.1038/nrendo.2014.94; Park SR, 2014, INFECT IMMUN, V82, P1914, DOI 10.1128/IAI.01226-13; Patterson AD, 2014, CELL METAB, V20, P761, DOI 10.1016/j.cmet.2014.07.002; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; Redelman-Sidi G, 2014, NAT REV UROL, V11, P153, DOI 10.1038/nrurol.2014.15; Riley DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003107; Rivera-Chavez F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003267; Roberts AB, 2013, MOL PHARMACOL, V84, P208, DOI 10.1124/mol.113.085852; Roberts NJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008982; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Schulz MD, 2014, NATURE, V514, P508, DOI 10.1038/nature13398; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Sears CL, 2008, CLIN INFECT DIS, V47, P797, DOI 10.1086/591130; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Sizova MV, 2012, APPL ENVIRON MICROB, V78, P194, DOI 10.1128/AEM.06813-11; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Song MY, 2015, GASTROENTEROLOGY, V148, P1244, DOI 10.1053/j.gastro.2014.12.035; Tang Y, 2011, INT J CANCER, V128, P847, DOI 10.1002/ijc.25638; Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Ubeda C, 2013, INFECT IMMUN, V81, P965, DOI 10.1128/IAI.01197-12; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vanwonterghem I, 2014, CURR OPIN BIOTECH, V27, P55, DOI 10.1016/j.copbio.2013.11.004; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warren RL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-16; Winter SE, 2014, GUT MICROBES, V5, P71, DOI 10.4161/gmic.27129; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wistuba II, 2004, NAT REV CANCER, V4, P695, DOI 10.1038/nrc1429; Wright CJ, 2013, MOL ORAL MICROBIOL, V28, P83, DOI 10.1111/omi.12012; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt1211; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129; Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046; Zhang G, 2011, J PERIODONTAL RES, V46, P558, DOI 10.1111/j.1600-0765.2011.01373.x	118	633	671	19	315	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					80	86		10.1126/science.aaa4972	http://dx.doi.org/10.1126/science.aaa4972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838377	Green Accepted			2022-12-28	WOS:000352079500030
J	Stahl, AE; Feigenson, L				Stahl, Aimee E.; Feigenson, Lisa			Observing the unexpected enhances infants' learning and exploration	SCIENCE			English	Article							OBJECT PERMANENCE; EXPLANATION; LOCATION; BEHAVIOR; ORIGINS	Given the overwhelming quantity of information available from the environment, how do young learners know what to learn about and what to ignore? We found that 11-month-old infants (N = 110) used violations of prior expectations as special opportunities for learning. The infants were shown events that violated expectations about object behavior or events that were nearly identical but did not violate expectations. The sight of an object that violated expectations enhanced learning and promoted information-seeking behaviors; specifically, infants learned more effectively about objects that committed violations, explored those objects more, and engaged in hypothesis-testing behaviors that reflected the particular kind of violation seen. Thus, early in life, expectancy violations offer a wedge into the problem of what to learn.	[Stahl, Aimee E.; Feigenson, Lisa] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA	Johns Hopkins University	Stahl, AE (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.	astahl4@jhu.edu			NSF [DGE-1232825]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD077407] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by NSF Graduate Research Fellowship DGE-1232825 (A.E.S.). We thank J. Halberda for comments; J. Taggart, S. Folsom, M. Santoru, C. Veazey, G. Lisandrelli, and K. Grubb for assistance with data collection and coding; and J. Garmon for construction of the experimental apparatus. Data can be found on the Harvard Institute for Quantitative Social Sciences dataverse (DOI: 10.7910/DVN/29315).	BAILLARGEON R, 1986, COGNITION, V23, P21, DOI 10.1016/0010-0277(86)90052-1; BAILLARGEON R, 1985, COGNITION, V20, P191, DOI 10.1016/0010-0277(85)90008-3; Berger A, 2006, P NATL ACAD SCI USA, V103, P12649, DOI 10.1073/pnas.0605350103; Bonawitz EB, 2012, COGNITIVE PSYCHOL, V64, P215, DOI 10.1016/j.cogpsych.2011.12.002; Camras LA, 2002, EMOTION, V2, P179, DOI 10.1037//1528-3542.2.2.179; Chiandetti C, 2010, ANIM COGN, V13, P463, DOI 10.1007/s10071-009-0297-x; Chomsky N., 1980, LANGUAGE LEARNING DE, P393; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; Dehaene S, 2006, SCIENCE, V311, P381, DOI 10.1126/science.1121739; Gredeback G, 2010, COGNITION, V114, P197, DOI 10.1016/j.cognition.2009.09.004; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Jaswal VK, 2010, COGNITIVE PSYCHOL, V61, P248, DOI 10.1016/j.cogpsych.2010.06.002; KUHL PK, 1984, INFANT BEHAV DEV, V7, P361, DOI 10.1016/S0163-6383(84)80050-8; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; Legare CH, 2012, CHILD DEV, V83, P173, DOI 10.1111/j.1467-8624.2011.01691.x; McCrink K, 2004, PSYCHOL SCI, V15, P776, DOI 10.1111/j.0956-7976.2004.00755.x; NEEDHAM A, 1993, COGNITION, V47, P121, DOI 10.1016/0010-0277(93)90002-D; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; REGOLIN L, 1995, PERCEPT PSYCHOPHYS, V57, P971, DOI 10.3758/BF03205456; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Schulz L, 2012, TRENDS COGN SCI, V16, P382, DOI 10.1016/j.tics.2012.06.004; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; SPELKE ES, 1992, PSYCHOL REV, V99, P605, DOI 10.1037/0033-295X.99.4.605; SPELKE ES, 1995, BRIT J DEV PSYCHOL, V13, P113, DOI 10.1111/j.2044-835X.1995.tb00669.x; Teglas E, 2011, SCIENCE, V332, P1054, DOI 10.1126/science.1196404; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Wilcox T, 1996, INFANT BEHAV DEV, V19, P309, DOI 10.1016/S0163-6383(96)90031-4; Wilcox T, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852551	29	227	228	6	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					91	94		10.1126/science.aaa3799	http://dx.doi.org/10.1126/science.aaa3799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8GJ	25838378	Green Accepted			2022-12-28	WOS:000352079500032
J	Sedgwick, P				Sedgwick, Philip			Randomised controlled trials: understanding effect sizes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Adamsen L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3410; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1586; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h267; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7257	4	8	8	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2015	350								h1690	10.1136/bmj.h1690	http://dx.doi.org/10.1136/bmj.h1690			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7OK	25820302				2022-12-28	WOS:000352031000006
J	Shih, WM				Shih, William M.			Exploiting weak interactions in DNA self-assembly	SCIENCE			English	Editorial Material							NANOSCALE SHAPES; FOLDING DNA; ORIGAMI		[Shih, William M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Shih, William M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Shih, WM (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	william.shih@wyss.harvard.edu						Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Endo M, 2010, CHEM-EUR J, V16, P5362, DOI 10.1002/chem.200903057; Gerling T, 2015, SCIENCE, V347, P1446, DOI 10.1126/science.aaa5372; Green SJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.238101; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Rajendran A, 2011, ACS NANO, V5, P665, DOI 10.1021/nn1031627; Rogers WB, 2015, SCIENCE, V347, P639, DOI 10.1126/science.1259762; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; Zhang DY, 2012, NAT CHEM, V4, P208, DOI [10.1038/NCHEM.1246, 10.1038/nchem.1246]	14	6	7	3	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1417	1418		10.1126/science.aaa9483	http://dx.doi.org/10.1126/science.aaa9483			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814568				2022-12-28	WOS:000352136400021
J	Lanphier, E; Urnov, F; Haecker, SE; Werner, M; Smolenski, J				Lanphier, Edward; Urnov, Fyodor; Haecker, Sarah Ehlen; Werner, Michael; Smolenski, Joanna			Don't edit the human germ line	NATURE			English	Editorial Material							RATS		[Lanphier, Edward; Urnov, Fyodor] Sangamo BioSci, Richmond, CA 94804 USA; [Lanphier, Edward; Werner, Michael] Alliance Regenerat Med, Washington, DC USA; [Haecker, Sarah Ehlen] Alliance Regenerat Med, Technol Sect, Washington, DC USA; [Smolenski, Joanna] CUNY, Grad Ctr, Philosophy, New York, NY USA	Sangamo Therapeutics, Inc.; City University of New York (CUNY) System	Lanphier, E (corresponding author), Sangamo BioSci, Richmond, CA 94804 USA.	lanphier@sangamo.com		Smolenski, Joanna/0000-0002-1652-770X				Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Han HB, 2014, FRONT AGRIC SCI ENG, V1, P2, DOI 10.15302/J-FASE-2014007; Heo YT, 2015, STEM CELLS DEV, V24, P393, DOI 10.1089/scd.2014.0278; Kang Q., 2014, P 10 WORLD C GEN APP; Regalado A., 2015, MIT TECH REV; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240	9	318	342	0	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					410	411		10.1038/519410a	http://dx.doi.org/10.1038/519410a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE1WF	25810189	Bronze			2022-12-28	WOS:000351602800031
J	van der Klaauw, AA; Farooqi, IS				van der Klaauw, Agatha A.; Farooqi, I. Sadaf			The Hunger Genes: Pathways to Obesity	CELL			English	Review							EARLY-ONSET OBESITY; PRADER-WILLI-SYNDROME; BODY-MASS INDEX; MELANOCYTE-STIMULATING HORMONE; CONGENITAL LEPTIN DEFICIENCY; MELANOCORTIN-4 RECEPTOR MUTATIONS; ADULT OBESITY; FOOD-INTAKE; FTO GENE; WEIGHT REGULATION	The global rise in the prevalence of obesity and associated co-morbidities such as type 2 diabetes, cardiovascular disease, and cancer represents a major public health concern. The biological response to increased consumption of palatable foods or a reduction in energy expenditure is highly variable between individuals. A more detailed mechanistic understanding of the molecular, physiological, and behavioral pathways involved in the development of obesity in susceptible individuals is critical for identifying effective mechanism-based preventative and therapeutic interventions.	[van der Klaauw, Agatha A.; Farooqi, I. Sadaf] Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England; [van der Klaauw, Agatha A.; Farooqi, I. Sadaf] Addenbrookes Hosp, Wellcome Trust MRC Inst Metab Sci, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Farooqi, IS (corresponding author), Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England.	isf20@cam.ac.uk	Farooqi, Ismaa Sadaf/AAZ-3046-2020; O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Farooqi, Sadaf/0000-0001-7609-3504; van der Klaauw, Agatha/0000-0001-6971-8828	Wellcome Trust; MRC; ERC; NIHR Cambridge Biomedical Research Centre; Bernard Wolfe endowment	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Bernard Wolfe endowment	We would like to thank the many colleagues, collaborators, and referring Physicians with whom we have worked over the years. We thank the Wellcome Trust, MRC, ERC, NIHR Cambridge Biomedical Research Centre, and Bernard Wolfe endowment for their support for this work. Importantly, we would like to thank the patients and their families for their contributions. Further information can be found at http://www.goos.org.uk.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Ainsworth C, 2007, NATURE, V448, P638, DOI 10.1038/448638a; Allison DB, 1996, INT J OBESITY, V20, P501; ANAND BK, 1951, YALE J BIOL MED, V24, P123; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Asai M, 2013, SCIENCE, V341, P275, DOI 10.1126/science.1233000; Batterham RL, 2006, CELL METAB, V4, P223, DOI 10.1016/j.cmet.2006.08.001; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Biebermann H, 2006, CELL METAB, V3, P141, DOI 10.1016/j.cmet.2006.01.007; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Bonnefond A, 2013, J CLIN INVEST, V123, P3037, DOI 10.1172/JCI68035; BOUCHARD C, 1990, INT J OBESITY, V14, P57; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Brommage R, 2008, OBESITY, V16, P2362, DOI 10.1038/oby.2008.361; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Carnell S, 2008, INT J OBESITY, V32, P1468, DOI 10.1038/ijo.2008.127; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Choquet H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057857; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Clemmensen C, 2015, EMBO MOL MED, V7, P288, DOI 10.15252/emmm.201404508; COLEMAN DL, 1969, AM J PHYSIOL, V217, P1298; COLEMAN DL, 1973, DIABETOLOGIA, V9, P294, DOI 10.1007/BF01221857; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; Cowley MA, 2003, ANN NY ACAD SCI, V994, P175, DOI 10.1111/j.1749-6632.2003.tb03178.x; Cox AJ, 2015, LANCET DIABETES ENDO, V3, P207, DOI 10.1016/S2213-8587(14)70134-2; Cummings DE, 2002, NAT MED, V8, P643, DOI 10.1038/nm0702-643; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Doche ME, 2012, J CLIN INVEST, V122, P4732, DOI 10.1172/JCI62696; Fagot-Campagna A, 2000, J PEDIATR ENDOCR MET, V13, P1395; Falchi M, 2014, NAT GENET, V46, P492, DOI 10.1038/ng.2939; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gray J, 2006, DANCING TIMES, V96, P55; Gray LJ, 2012, OBES REV, V13, P483, DOI 10.1111/j.1467-789X.2011.00981.x; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Haqq AM, 2003, J CLIN ENDOCR METAB, V88, P174, DOI 10.1210/jc.2002-021052; Hetherington AW, 1940, ANAT REC, V78, P149, DOI 10.1002/ar.1090780203; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Hinton EC, 2006, INT J OBESITY, V30, P313, DOI 10.1038/sj.ijo.0803128; Holder JL, 2000, HUM MOL GENET, V9, P101; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Keskitalo K, 2008, PHYSIOL BEHAV, V93, P235, DOI 10.1016/j.physbeh.2007.08.025; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Kublaoui BM, 2008, MOL ENDOCRINOL, V22, P1723, DOI 10.1210/me.2008-0067; Lee YS, 2006, CELL METAB, V3, P135, DOI 10.1016/j.cmet.2006.01.006; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lubrano-Berthelier C, 2006, J CLIN ENDOCR METAB, V91, P1811, DOI 10.1210/jc.2005-1411; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Martin MG, 2013, GASTROENTEROLOGY, V145, P138, DOI 10.1053/j.gastro.2013.03.048; Maures TJ, 2007, TRENDS ENDOCRIN MET, V18, P38, DOI 10.1016/j.tem.2006.11.007; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Morton GJ, 2014, NAT REV NEUROSCI, V15, P367, DOI 10.1038/nrn3745; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; O'Rahilly S, 2008, DIABETES, V57, P2905, DOI 10.2337/db08-0210; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; OLSON BR, 1991, PEPTIDES, V12, P113, DOI 10.1016/0196-9781(91)90176-P; ORAHILLY S, 1995, NEW ENGL J MED, V333, P1386, DOI 10.1056/NEJM199511233332104; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Ozata M, 1999, J CLIN ENDOCR METAB, V84, P3686, DOI 10.1210/jc.84.10.3686; Panaro BL, 2013, P NATL ACAD SCI USA, V110, P7050, DOI 10.1073/pnas.1304707110; Pearce LR, 2013, CELL, V155, P765, DOI 10.1016/j.cell.2013.09.058; Pecina S, 2003, J NEUROSCI, V23, P9395; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Perreault M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062616; PERUSSE L, 1989, AM J EPIDEMIOL, V129, P1012, DOI 10.1093/oxfordjournals.aje.a115205; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Pritchard LE, 2002, J ENDOCRINOL, V172, P411, DOI 10.1677/joe.0.1720411; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Ramachandrappa S, 2013, J CLIN INVEST, V123, P3042, DOI 10.1172/JCI68016; Ravussin Y, 2014, CELL METAB, V20, P565, DOI 10.1016/j.cmet.2014.09.002; Rene P, 2010, J PHARMACOL EXP THER, V335, P520, DOI 10.1124/jpet.110.172098; Rossger K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3825; Rosenbaum M, 2002, J CLIN ENDOCR METAB, V87, P2391, DOI 10.1210/jc.87.5.2391; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Rosenbaum M, 2008, J CLIN INVEST, V118, P2583, DOI 10.1172/JCI35055; Rouskas K, 2012, OBESITY, V20, P389, DOI 10.1038/oby.2011.177; Sabatier N, 2003, J NEUROSCI, V23, P10351; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Salbe AD, 2004, AM J CLIN NUTR, V79, P372; Sayk F, 2010, J CLIN ENDOCR METAB, V95, P1998, DOI 10.1210/jc.2009-2297; Sebag JA, 2013, SCIENCE, V341, P278, DOI 10.1126/science.1232995; Selvarajah D, 2014, DIABETES, V63, P4016, DOI 10.2337/db14-1311; Silventoinen K, 2008, GENET EPIDEMIOL, V32, P341, DOI 10.1002/gepi.20308; Simonds SE, 2014, CELL, V159, P1404, DOI 10.1016/j.cell.2014.10.058; Singh G. K., 2013, ISRN PREV MED, V2013; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Smith SR, 2007, AM J PHYSIOL-ENDOC M, V293, pE620, DOI 10.1152/ajpendo.00217.2007; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; SORENSEN TIA, 1989, BRIT MED J, V298, P87, DOI 10.1136/bmj.298.6666.87; Speakman JR, 2007, CELL METAB, V6, P5, DOI 10.1016/j.cmet.2007.06.004; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; SWAAB DF, 1995, J CLIN ENDOCR METAB, V80, P573, DOI 10.1210/jc.80.2.573; Tan T, 2013, CURR OPIN PHARMACOL, V13, P996, DOI 10.1016/j.coph.2013.09.005; Thomas DM, 2014, OBESITY, V22, P590, DOI 10.1002/oby.20520; Tsao D, 2008, ENDOCRINOLOGY, V149, P1038, DOI 10.1210/en.2007-1166; Tung YCL, 2014, CELL METAB, V20, P710, DOI 10.1016/j.cmet.2014.09.010; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; van der Klaauw AA, 2014, J CLIN ENDOCR METAB, V99, pE2101, DOI 10.1210/jc.2014-1651; Van der Ploeg LHT, 2002, P NATL ACAD SCI USA, V99, P11381, DOI 10.1073/pnas.172378699; Wabitsch M, 2015, NEW ENGL J MED, V372, P48, DOI 10.1056/NEJMoa1406653; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang L, 2015, J CLIN INVEST, V125, P796, DOI 10.1172/JCI79220; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xiang ZM, 2006, BIOCHEMISTRY-US, V45, P7277, DOI 10.1021/bi0600300; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yang YJ, 2014, PHARMACOL BIOCHEM BE, V122, P30, DOI 10.1016/j.pbb.2014.03.013; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhu ZH, 2015, AM J HUM GENET, V96, P377, DOI 10.1016/j.ajhg.2015.01.001; Ziauddeen H, 2013, MOL PSYCHIATR, V18, P1287, DOI 10.1038/mp.2012.154; Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212	149	214	215	2	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					119	132		10.1016/j.cell.2015.03.008	http://dx.doi.org/10.1016/j.cell.2015.03.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815990	Bronze			2022-12-28	WOS:000351952200013
J	Spertus, JA; Decker, C; Gialde, E; Jones, PG; McNulty, EJ; Bach, R; Chhatriwalla, AK				Spertus, John A.; Decker, Carole; Gialde, Elizabeth; Jones, Philip G.; McNulty, Edward J.; Bach, Richard; Chhatriwalla, Adnan K.			Precision medicine to improve use of bleeding avoidance strategies and reduce bleeding in patients undergoing percutaneous coronary intervention: prospective cohort study before and after implementation of personalized bleeding risks	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-TRANSFUSION; INFORMED-CONSENT; CLOSURE DEVICES; BIVALIRUDIN; THERAPY; ANGIOGRAPHY; MORTALITY; IMPACT; REVASCULARIZATION; ASSOCIATION	OBJECTIVE To examine whether prospective bleeding risk estimates for patients undergoing percutaneous coronary intervention could improve the use of bleeding avoidance strategies and reduce bleeding. DESIGN Prospective cohort study comparing the use of bleeding avoidance strategies and bleeding rates before and after implementation of prospective risk stratification for peri-procedural bleeding. SETTING Nine hospitals in the United States. PARTICIPANTS All patients undergoing percutaneous coronary intervention for indications other than primary reperfusion for ST elevation myocardial infarction. MAIN OUTCOME MEASURES Use of bleeding avoidance strategies, including bivalirudin, radial approach, and vascular closure devices, and peri-procedural bleeding rates, stratified by bleeding risk. Observed changes were adjusted for changes observed in a pool of 1135 hospitals without access to pre-procedural risk stratification. Hospital level and physician level variability in use of bleeding avoidance strategies was examined. RESULTS In a comparison of 7408 pre-intervention procedures with 3529 post-intervention procedures, use of bleeding avoidance strategies within intervention sites increased with pre-procedural risk stratification (odds ratio 1.81, 95% confidence interval 1.44 to 2.27), particularly among higher risk patients (2.03, 1.58 to 2.61; 1.41, 1.09 to 1.83 in low risk patients, after adjustment for control sites; P for interaction=0.05). Bleeding rates within intervention sites were significantly lower after implementation of risk stratification (1.0% v 1.7%; odds ratio 0.56, 0.40 to 0.78; 0.62, 0.44 to 0.87, after adjustment); the reduction in bleeding was greatest in high risk patients. Marked variability in use of bleeding avoidance strategies was observed across sites and physicians, both before and after implementation. CONCLUSIONS Prospective provision of individualized bleeding risk estimates was associated with increased use of bleeding avoidance strategies and lower bleeding rates. Marked variability between providers highlights an important opportunity to improve the consistency, safety, and quality of care.	[Spertus, John A.; Decker, Carole; Gialde, Elizabeth; Jones, Philip G.; Chhatriwalla, Adnan K.] St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Spertus, John A.; Decker, Carole; McNulty, Edward J.; Chhatriwalla, Adnan K.] Univ Missouri, Kansas City, MO 64110 USA; [McNulty, Edward J.] Kaiser San Francisco, San Francisco, CA USA; [Bach, Richard] Washington Univ, St Louis, MO USA	Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Washington University (WUSTL)	Spertus, JA (corresponding author), St Lukes Mid Amer Heart Inst, 4401 Wornall Rd, Kansas City, MO 64111 USA.	spertusj@umkc.edu	Spertus, John/ABD-3075-2021; Bach, Richard G/G-9764-2011; Bach, Richard/AAI-2515-2021		American Heart Association [0875149N]; National Heart Lung and Blood Institute [R01-HL096624]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096624] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by grants from the American Heart Association (0875149N) and the National Heart Lung and Blood Institute (R01-HL096624).	Arnold SV, 2008, CIRC-CARDIOVASC QUAL, V1, P21, DOI 10.1161/CIRCOUTCOMES.108.791863; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Brogan GX, 2006, DIABETES CARE, V29, P9, DOI 10.2337/diacare.29.1.9; Chhatriwalla AK, 2013, JAMA-J AM MED ASSOC, V309, P1022, DOI 10.1001/jama.2013.1556; Cohen DJ, 2004, J AM COLL CARDIOL, V44, P1792, DOI 10.1016/j.jacc.2004.05.085; Dauerman HL, 2011, J AM COLL CARDIOL, V58, P1, DOI 10.1016/j.jacc.2011.02.039; Decker C, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-58; Doyle BJ, 2009, J AM COLL CARDIOL, V53, P2019, DOI 10.1016/j.jacc.2008.12.073; Feit F, 2007, AM J CARDIOL, V100, P1364, DOI 10.1016/j.amjcard.2007.06.026; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; Institute of Medicine, 2001, CROSSING QUALITY CHA; James BC, 2011, HEALTH AFFAIR, V30, P1185, DOI 10.1377/hlthaff.2011.0358; Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023; Kastrati A, 2008, NEW ENGL J MED, V359, P688, DOI 10.1056/NEJMoa0802944; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Lee DS, 2005, JAMA-J AM MED ASSOC, V294, P1240, DOI 10.1001/jama.294.10.1240; Mangiacapra F, 2012, JACC-CARDIOVASC INTE, V5, P281, DOI 10.1016/j.jcin.2012.01.009; Marso SP, 2010, JAMA-J AM MED ASSOC, V303, P2156, DOI 10.1001/jama.2010.708; McAlister FA, 2007, ARCH INTERN MED, V167, P1019, DOI 10.1001/archinte.167.10.1019; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Ndrepepa G, 2008, J AM COLL CARDIOL, V51, P690, DOI 10.1016/j.jacc.2007.10.040; Patel MR, 2010, CIRCULATION, V122, P1882, DOI 10.1161/CIR.0b013e3181f9b345; Pilote L, 1996, NEW ENGL J MED, V335, P1198, DOI 10.1056/NEJM199610173351606; R Project for Statistical Computing, 2006, R LANG ENV STAT COMP; Rao SC, 2013, J AM COLL CARDIOL; Rao SV, 2007, REV CARDIOVASC MED, V8, pS18; Rao SV, 2010, CIRC-CARDIOVASC INTE, V3, P80, DOI 10.1161/CIRCINTERVENTIONS.109.884478; Sanborn TA, 2010, CIRC-CARDIOVASC INTE, V3, P57, DOI 10.1161/CIRCINTERVENTIONS.109.896704; Shahzad A, 2014, LANCET, V384, P1849, DOI 10.1016/S0140-6736(14)60924-7; Soto GE, 2007, COMPUT CARDIOL, V34, P205, DOI 10.1109/CIC.2007.4745457; Soto GE, 2004, COMPUT CARDIOL, V31, P193; SPERTUS JA, 1995, ARCH INTERN MED, V155, P2309, DOI 10.1001/archinte.155.21.2309; Spertus J, 2011, CIRCULATION, V124, P2368; Spertus JA, 2007, ARCH INTERN MED, V167, P987, DOI 10.1001/archinte.167.10.987; Spertus JA, 2015, AM HEART J, V169, P234, DOI 10.1016/j.ahj.2014.11.008; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Yan AT, 2007, ARCH INTERN MED, V167, P1009, DOI 10.1001/archinte.167.10.1009	39	60	60	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2015	350								h1302	10.1136/bmj.h1302	http://dx.doi.org/10.1136/bmj.h1302			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NO	25805158	Green Published, hybrid			2022-12-28	WOS:000352028800005
J	Brienen, RJW; Phillips, OL; Feldpausch, TR; Gloor, E; Baker, TR; Lloyd, J; Lopez-Gonzalez, G; Monteagudo-Mendoza, A; Malhi, Y; Lewis, SL; Martinez, RV; Alexiades, M; Davila, EA; Alvarez-Loayza, P; Andrade, A; Aragao, LEOC; Araujo-Murakami, A; Arets, EJMM; Arroyo, L; Aymard, GA; Banki, OS; Baraloto, C; Barroso, J; Bonal, D; Boot, RGA; Camargo, JLC; Castilho, CV; Chama, V; Chao, KJ; Chave, J; Comiskey, JA; Valverde, FC; da Costa, L; de Oliveira, EA; Di Fiore, A; Erwin, TL; Fauset, S; Forsthofer, M; Galbraith, DR; Grahame, ES; Groot, N; Herault, B; Higuchi, N; Coronado, ENH; Keeling, H; Killeen, TJ; Laurance, WF; Laurance, S; Licona, J; Magnussen, WE; Marimon, BS; Marimon, BH; Mendoza, C; Neill, DA; Nogueira, EM; Nunez, P; Camacho, NCP; Parada, A; Pardo-Molina, G; Peacock, J; Pena-Claros, M; Pickavance, GC; Pitman, NCA; Poorter, L; Prieto, A; Quesada, CA; Ramirez, F; Ramirez-Angulo, H; Restrepo, Z; Roopsind, A; Rudas, A; Salomao, RP; Schwarz, M; Silva, N; Silva-Espejo, JE; Silveira, M; Stropp, J; Talbot, J; ter Steege, H; Teran-Aguilar, J; Terborgh, J; Thomas-Caesar, R; Toledo, M; Torello-Raventos, M; Umetsu, RK; Van der Heijden, GMF; Van der Hout, P; Vieira, ICG; Vieira, SA; Vilanova, E; Vos, VA; Zagt, RJ				Brienen, R. J. W.; Phillips, O. L.; Feldpausch, T. R.; Gloor, E.; Baker, T. R.; Lloyd, J.; Lopez-Gonzalez, G.; Monteagudo-Mendoza, A.; Malhi, Y.; Lewis, S. L.; Vasquez Martinez, R.; Alexiades, M.; Alvarez Davila, E.; Alvarez-Loayza, P.; Andrade, A.; Aragao, L. E. O. C.; Araujo-Murakami, A.; Arets, E. J. M. M.; Arroyo, L.; Aymard C, G. A.; Banki, O. S.; Baraloto, C.; Barroso, J.; Bonal, D.; Boot, R. G. A.; Camargo, J. L. C.; Castilho, C. V.; Chama, V.; Chao, K. J.; Chave, J.; Comiskey, J. A.; Cornejo Valverde, F.; da Costa, L.; de Oliveira, E. A.; Di Fiore, A.; Erwin, T. L.; Fauset, S.; Forsthofer, M.; Galbraith, D. R.; Grahame, E. S.; Groot, N.; Herault, B.; Higuchi, N.; Coronado, E. N. Honorio; Keeling, H.; Killeen, T. J.; Laurance, W. F.; Laurance, S.; Licona, J.; Magnussen, W. E.; Marimon, B. S.; Marimon-Junior, B. H.; Mendoza, C.; Neill, D. A.; Nogueira, E. M.; Nunez, P.; Pallqui Camacho, N. C.; Parada, A.; Pardo-Molina, G.; Peacock, J.; Pena-Claros, M.; Pickavance, G. C.; Pitman, N. C. A.; Poorter, L.; Prieto, A.; Quesada, C. A.; Ramirez, F.; Ramirez-Angulo, H.; Restrepo, Z.; Roopsind, A.; Rudas, A.; Salomao, R. P.; Schwarz, M.; Silva, N.; Silva-Espejo, J. E.; Silveira, M.; Stropp, J.; Talbot, J.; ter Steege, H.; Teran-Aguilar, J.; Terborgh, J.; Thomas-Caesar, R.; Toledo, M.; Torello-Raventos, M.; Umetsu, R. K.; Van der Heijden, G. M. F.; Van der Hout, P.; Vieira, I. C. Guimaraes; Vieira, S. A.; Vilanova, E.; Vos, V. A.; Zagt, R. J.			Long-term decline of the Amazon carbon sink	NATURE			English	Article							TROPICAL FOREST; EXPERIMENTAL DROUGHT; WOOD PRODUCTIVITY; TREE MORTALITY; TURNOVER RATES; SENSITIVITY; GROWTH; RECRUITMENT; DISTURBANCE; DYNAMICS	Atmospheric carbon dioxide records indicate that the land surface has acted as a strong global carbon sink over recent decades(1,2), with a substantial fraction of this sink probably located in the tropics', particularly in the Amazon(4). Nevertheless, it is unclear how the terrestrial carbon sink will evolve as climate and atmospheric composition continue to change. Here we analyse the historical evolution of the biomass dynamics of the Amazon rainforest over three decades using a distributed network of 321 plots. While this analysis confirms that Amazon forests have acted as a long-term net biomass sink, we find a long-term decreasing trend of carbon accumulation. Rates of net increase in above-ground biomass declined by one-third during the past decade compared to the 1990s. This is a consequence of growth rate increases levelling off recently, while biomass mortality persistently increased throughout, leading to a shortening of carbon residence times. Potential drivers for the mortality increase include greater climate variability, and feedbacks of faster growth on mortality, resulting in shortened tree longevity(5). The observed decline of the Amazon sink diverges markedly from the recent increase in terrestrial carbon uptake at the global scale", and is contrary to expectations based on models(6).	[Brienen, R. J. W.; Phillips, O. L.; Feldpausch, T. R.; Gloor, E.; Baker, T. R.; Lopez-Gonzalez, G.; Lewis, S. L.; Chao, K. J.; Fauset, S.; Galbraith, D. R.; Grahame, E. S.; Groot, N.; Coronado, E. N. Honorio; Keeling, H.; Peacock, J.; Pickavance, G. C.; Schwarz, M.; Talbot, J.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Feldpausch, T. R.; Aragao, L. E. O. C.] Univ Exeter, Coll Life & Environm Sci, Geog, Exeter EX4 4RJ, Devon, England; [Lloyd, J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Lloyd, J.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4870, Australia; [Monteagudo-Mendoza, A.; Vasquez Martinez, R.] Prolongac Bolognesi Mze, Jardin Bot Missouri, Oxapampa, Pasco, Peru; [Malhi, Y.] Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford OX1 3QK, England; [Lewis, S. L.] UCL, Dept Geog, London WC1E 6BT, England; [Alexiades, M.] Univ Kent, Sch Anthropol & Conservat, Canterbury CT1 3EH, Kent, England; [Alvarez Davila, E.; Restrepo, Z.] Jardin Bot Medellin, Serv Ecosistemicosy Cambio Climat, Medellin 050010, Colombia; [Alvarez-Loayza, P.; Pitman, N. C. A.; Terborgh, J.] Duke Univ, Ctr Trop Conservat, Durham, NC 27708 USA; [Andrade, A.; Camargo, J. L. C.; Higuchi, N.] INPA, Biol Dynam Forest Fragment Project, BR-69011970 Manaus, Amazonas, Brazil; [Andrade, A.; Camargo, J. L. C.; Higuchi, N.] STRI, BR-69011970 Manaus, Amazonas, Brazil; [Aragao, L. E. O. C.] Natl Inst Space Res INPE, BR-12227010 Sao Paulo, Brazil; [Araujo-Murakami, A.; Arroyo, L.; Parada, A.] Univ Autonoma Gabriel Rene Moreno, Museo Hist Nat Noel Kempff Mercado, Santa Cruz, Bolivia; [Arets, E. J. M. M.] Univ Wageningen & Res Ctr, Alterra, NL-6700 AA Wageningen, Netherlands; [Aymard C, G. A.] Herbario Univ PORT, Programa Cienclas Agro & Mar, UNELLEZ Guanare, Mesa De Cavacas 3350, Estado Portugue, Venezuela; [Banki, O. S.] Univ Amsterdam, Biodiversiteit Ecosyst Dynam, NL-1090 GE Amsterdam, Netherlands; [Baraloto, C.] INRA, UMR EcoFoG, F-97310 Kourou, French Guiana; [Baraloto, C.] Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL 33199 USA; [Barroso, J.] Univ Fed Acre, Rio Branco, Brazil; [Bonal, D.] INRA, UMR Ecol & Ecophysiol Forestiere 1137, F-54280 Seichamps, France; [Boot, R. G. A.; Zagt, R. J.] Tropenbos Int, NL-6700 AE Wageningen, Netherlands; [Castilho, C. V.] Embrapa Roraima, BR-69301970 Bio Vista, RR, Brazil; [Chama, V.; Nunez, P.; Pallqui Camacho, N. C.; Silva-Espejo, J. E.] Univ Nacl San Antonio Abad Cusco, Cuzco, Peru; [Chao, K. J.] Natl Chung Hsing Univ, Coll Agr & Nat Resources, Int Master Program Agr, Taichung 40227, Taiwan; [Chave, J.] Univ Toulouse 3, CNRS, UMR Evolut & Divers Biol 5174, F-31062 Toulouse, France; [Comiskey, J. A.] Natl Pk Serv, Northeast Reg Inventory & Monitoring Program, Fredericksburg, VA 22405 USA; [Cornejo Valverde, F.] Andes toAmazon Biodivers Program, Madre De Dios, Peru; [da Costa, L.] Fed Univ Para, Ctr Geociencias, BR-66017970 Belem, Para, Brazil; [de Oliveira, E. A.; Forsthofer, M.; Marimon, B. S.; Marimon-Junior, B. H.; Umetsu, R. K.] Univ Estado Mato Grosso, BR-78690000 Nova Xavantina, MT, Brazil; [Di Fiore, A.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Erwin, T. L.] Smithsonian Inst, Dept Entomol, Washington, DC 20013 USA; [Herault, B.] Cirad, UMR Ecol Forets Guyane, F-97310 Kourou, French Guiana; [Coronado, E. N. Honorio] Inst Invest Amazonia Peruana, Iquitos, Peru; [Killeen, T. J.] World Wildlife Fund, Washington, DC 20037 USA; [Laurance, W. F.; Laurance, S.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld 4878, Australia; [Laurance, W. F.; Laurance, S.] James Cook Univ, Sch Marine & Environm Sci, Cairns, Qld 4878, Australia; [Licona, J.; Pena-Claros, M.; Toledo, M.] Inst Boliviano Invest Forestal, Santa Cruz 6201, Bolivia; [Magnussen, W. E.] Natl Inst Res Amazonia INPA, BR-69011970 Manaus, Amazonas, Brazil; [Mendoza, C.] FOMABO, Manejo Forestal Tierras Trop Bolivia, Sacta, Bolivia; [Mendoza, C.] UMSS, Escuela Ciencias Forestales ESFOR, Sacta, Bolivia; [Neill, D. A.] Univ Estatal Amazon, Fac Ingn Ambiental, Puyo, Pastaza, Ecuador; [Nogueira, E. M.; Quesada, C. A.] Natl Inst Res Amazonia INPA, BR-69080971 Manaus, Amazonas, Brazil; [Pardo-Molina, G.; Vos, V. A.] Univ Autonoma Beni, Riberalta, Beni, Bolivia; [Pena-Claros, M.; Poorter, L.] Wageningen Univ, Forest Ecol & Forest Management Grp, NL-6700 AA Wageningen, Netherlands; [Pitman, N. C. A.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Prieto, A.; Ramirez, F.] Univ Nacl Amazonia Peruana, Iquitos, Loreto, Peru; [Ramirez-Angulo, H.; Vilanova, E.] Univ Los Andes, Inst Invest Desarrollo Forestal INDEFOR, Fac Cienclas Forestales & Ambientales, Merida 5101, Venezuela; [Roopsind, A.] Iwokrama Int Ctr Rainforest Conservat & Dev, Georgetown, Guyana; [Rudas, A.] Univ Nacl Colombia, Inst Ciencias Nat, Bogota 111321, Colombia; [Salomao, R. P.; Vieira, I. C. Guimaraes] Museu Paraense Emilio Goeldi, BR-66040170 Belem, Para, Brazil; [Silva, N.; Thomas-Caesar, R.] Univ Fed Rural Amazonia, BR-66077901 Belem, Para, Brazil; [Silveira, M.] Univ Fed Acre, Museu Univ, BR-69910900 Rio Branco, AC, Brazil; [Stropp, J.] Commiss European Communities, DG Joint Res Ctr, Inst Environm & Sustainabil, I-21010 Ispra, Italy; [ter Steege, H.] Nat Biodivers Ctr, NL-2300 RA Leiden, Netherlands; [ter Steege, H.] Univ Utrecht, Ecol & Biodivers Grp, NL-3508 TB Utrecht, Netherlands; [Teran-Aguilar, J.] Museo Hist Nat Alcide DOrbigny, Cochabamba, Bolivia; [Torello-Raventos, M.] James Cook Univ, Sch Earth & Environm Sci, Cairns, Qld 4870, Australia; [Torello-Raventos, M.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld 4878, Australia; [Torello-Raventos, M.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4878, Australia; [Van der Heijden, G. M. F.] Northumbria Univ, Sch Geog, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Van der Heijden, G. M. F.] Univ Wisconsin, Milwaukee, WI 53202 USA; [Van der Heijden, G. M. F.] Smithsonian Trop Res Inst, Panama City, Panama; [Van der Hout, P.] Van der Hout Forestry Consulting, NL-3078 HP Rotterdam, Netherlands; [Vieira, S. A.] Univ Estadual Campinas, NEPAM, BR-13083867 Sao Paulo, Brazil; [Vos, V. A.] Ctr Invest & Promoc Campesinado, Reg Norte Amazon, Riberalta, Bolivia	University of Leeds; University of Exeter; Imperial College London; James Cook University; University of Oxford; University of London; University College London; University of Kent; Duke University; Institute Nacional de Pesquisas da Amazonia; Instituto Nacional de Pesquisas Espaciais (INPE); Wageningen University & Research; University of Amsterdam; INRAE; State University System of Florida; Florida International University; Universidade Federal do Acre (UFAC); INRAE; Universite de Lorraine; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidad Nacional de San Antonio Abad del Cusco; National Chung Hsing University; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); United States Department of the Interior; Universidade Federal do Para; Universidade do Estado de Mato Grosso; University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian National Museum of Natural History; CIRAD; World Wildlife Fund; James Cook University; James Cook University; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Wageningen University & Research; Field Museum of Natural History (Chicago); Universidad Nacional de la Amazonia Peruana; University of Los Andes Venezuela; Universidad Nacional de Colombia; Museu Paraense Emilio Goeldi; Universidade Federal Rural da Amazonia (UFRA); European Commission Joint Research Centre; EC JRC ISPRA Site; Naturalis Biodiversity Center; Utrecht University; James Cook University; James Cook University; James Cook University; Northumbria University; University of Wisconsin System; University of Wisconsin Milwaukee; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidade Estadual de Campinas	Brienen, RJW (corresponding author), Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.	r.brienen@leeds.ac.uk	de Castilho, Carolina Volkmer/I-6618-2019; Lloyd, Jonathan J/F-8893-2010; Vilanova, Emilio/AAG-9543-2020; Baraloto, Christopher/ABG-2500-2020; Vos, Vincent/ABA-1492-2020; Phillips, Oliver/A-1523-2011; Steege, Hans ter/B-5866-2011; Feldpausch, Ted/D-3436-2009; Poorter, Lourens/AAL-1709-2021; Arets, Eric/C-1050-2008; Marimon, Beatriz/J-6389-2012; SALOMÃO, RAFAEL/AAU-1306-2020; Vieira, Ima C.G./H-6897-2012; Higuchi, Niro/ABC-8890-2020; Brienen, Roel/AAU-9959-2020; Higuchi, Niro/J-1287-2016; Junior, Ben Hur Marimon/AAT-9354-2020; Higuchi, Niro/ABC-9134-2020; Vieira, Sabrina Nunes/X-1702-2018; Silveira, Marcos/H-7906-2013; Laurance, Susan/G-6021-2011; Hérault, Bruno/B-2765-2011; Alvarez-Davila, Esteban/AAP-4231-2020; aragao, luiz eoc/G-8387-2012; Junior, Ben Hur Marimon/E-7330-2013; Aymard, Gerardo/ABE-9203-2020; Pallqui Camacho, Nadir Carolina/G-2529-2017; Barroso, Jorcely G./H-5852-2017; van der Heijden, Geertje/AAB-4102-2019; Galbraith, David/AAE-8162-2019; Feldpausch, Ted/ABH-3123-2020; Coronado, Eurídice Nora Honorio/K-3412-2015; Camargo, José Luís C/C-3137-2015; Vieira, Simone/H-1225-2011; Laurance, William F/B-2709-2012; Pitman, Nigel C A/A-7681-2008; Stropp, Juliana/AAF-7946-2020; Noojipady, Praveen/B-2511-2010; Vos, Vincent Antoine/I-7209-2019; Umetsu, Ricardo Keichi/AAG-9014-2019; Silva Espejo, Javier Eduardo/U-2962-2017; Ramirez, Fredy/R-1522-2016	de Castilho, Carolina Volkmer/0000-0002-1064-2758; Lloyd, Jonathan J/0000-0002-5458-9960; Vilanova, Emilio/0000-0001-6289-5127; Baraloto, Christopher/0000-0001-7322-8581; Vos, Vincent/0000-0002-0388-8530; Phillips, Oliver/0000-0002-8993-6168; Steege, Hans ter/0000-0002-8738-2659; Feldpausch, Ted/0000-0002-6631-7962; Arets, Eric/0000-0001-7209-9028; Marimon, Beatriz/0000-0003-3105-2914; SALOMÃO, RAFAEL/0000-0003-0947-0132; Vieira, Ima C.G./0000-0003-1233-318X; Brienen, Roel/0000-0002-5397-5755; Higuchi, Niro/0000-0002-1203-4502; Higuchi, Niro/0000-0002-1203-4502; Silveira, Marcos/0000-0003-0485-7872; Laurance, Susan/0000-0002-2831-2933; Hérault, Bruno/0000-0002-6950-7286; Alvarez-Davila, Esteban/0000-0001-9032-0099; aragao, luiz eoc/0000-0002-4134-6708; Aymard, Gerardo/0000-0001-9405-0508; Pallqui Camacho, Nadir Carolina/0000-0003-4596-0905; Barroso, Jorcely G./0000-0003-3017-9462; van der Heijden, Geertje/0000-0002-2110-5173; Feldpausch, Ted/0000-0002-6631-7962; Coronado, Eurídice Nora Honorio/0000-0003-2314-590X; Vieira, Simone/0000-0002-0129-4181; Laurance, William F/0000-0003-4430-9408; Pitman, Nigel C A/0000-0002-9211-2880; Stropp, Juliana/0000-0002-2831-4066; Vos, Vincent Antoine/0000-0002-0388-8530; Umetsu, Ricardo Keichi/0000-0002-0345-269X; Neill, David Alan/0000-0002-5143-9430; Marimon Junior, Ben Hur/0000-0002-6359-6281; Pena-Claros, Marielos/0000-0001-9134-6733; Silva Espejo, Javier Eduardo/0000-0003-1954-3817; Ramirez, Fredy/0000-0003-2441-9984; Groot, Nikee/0000-0003-3594-4311; Banki, Olaf/0000-0001-6197-9951; Lopez-Gonzalez, Gabriela/0000-0002-0814-8830; Fauset, Sophie/0000-0003-4246-1828; Poorter, Lourens/0000-0003-1391-4875; Lewis, Simon/0000-0002-8066-6851; Talbot, Joey/0000-0002-6520-4560; Galbraith, David/0000-0002-5555-4823; Alvarez-Loayza, Patricia/0000-0002-0090-4013; Comiskey, James/0000-0001-6710-1269; Campana Camargo, Jose Luis/0000-0003-0370-9878; Chama Moscoso, Victor/0000-0002-4455-0157	Natural Environment Research Council [NE/B503384/1, NE/D01025X/1, NE/I02982X/1, NE/F005806/1, NE/D005590/1, NE/I028122/1]; Gordon and Betty Moore Foundation; EU Seventh Framework Programme [GEOCARBON-283080, AMAZALERT-282664]; NERC Research Fellowship [NE/I021160/1]; ERC Advanced Grant; Royal Society-Wolfson Research Merit Award; Investissement d'Avenir grants of the French ANR [CEBA: ANR-10-LABX-0025, TULIP: ANR-10-LABX-0041]; Conservation International; Missouri Botanical Garden; Smithsonian Institution; Wildlife Conservation Society; Natural Environment Research Council [NE/B504630/1, NE/I021160/1, NE/D010306/1] Funding Source: researchfish; NERC [NE/D005590/1, NE/F005776/1, NE/D010306/1, NE/I021160/1, NE/I028122/1, NE/F005806/1, NE/I02982X/1, NE/D01025X/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); EU Seventh Framework Programme; NERC Research Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ERC Advanced Grant(European Research Council (ERC)); Royal Society-Wolfson Research Merit Award(Royal Society of London); Investissement d'Avenir grants of the French ANR(French National Research Agency (ANR)); Conservation International; Missouri Botanical Garden; Smithsonian Institution(Smithsonian Institution); Wildlife Conservation Society; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The RAINFOR forest monitoring network has been supported principally by the Natural Environment Research Council (grants NE/B503384/1, NE/D01025X/1, NE/I02982X/1, NE/F005806/1, NE/D005590/1 and NE/I028122/1), the Gordon and Betty Moore Foundation, and by the EU Seventh Framework Programme (GEOCARBON-283080 and AMAZALERT-282664). R.J.W.B. is funded by NERC Research Fellowship NE/I021160/1. O.P. is supported by an ERC Advanced Grant and is a Royal Society-Wolfson Research Merit Award holder. Additional data were supported by Investissement d'Avenir grants of the French ANR (CEBA: ANR-10-LABX-0025; TULIP: ANR-10-LABX-0041), and contributed by the Tropical Ecology Assessment and Monitoring (TEAM) Network, funded by Conservation International, the Missouri Botanical Garden, the Smithsonian Institution, the Wildlife Conservation Society and the Gordon and Betty Moore Foundation. This paper is 656 in the Technical Series of the Biological Dynamics of Forest Fragments Project (BDFFP-INPA/STRI). The field data summarized here involve vital contributions from many field assistants and rural communities in Bolivia, Brazil, Colombia, Ecuador, French Guiana, Guyana, Peru and Venezuela, most of whom have been specifically acknowledged elsewhere<SUP>4</SUP>. We additionally thank A. Alarcon, I. Amaral, P. P. Barbosa Camargo, I. F. Brown, L. Blanc, B. Burban, N. Cardozo, J. Engel, M. A. de Freitas, A. de Oliveira, T. S. Fredericksen, L. Ferreira, N. T. Hinojosa, E. Jimenez, E. Lenza, C. Mendoza, I. Mendoza Polo, A. Pena Cruz, M. C. Penuela, P. Petronelli, J. Singh, P. Maquirino, J. Serano, A. Sota,C. Oliveira dos Santos, J. Ybarnegaray and J. Ricardo for contributions. CNPq (Brazil), MCT (Brazil), Ministerio del Medio Ambiente, Vivienda y Desarrollo Territorial (Colombia), Ministerio de Ambiente (Ecuador), the Forestry Commission (Guyana), INRENA (Peru), SERNANP (Peru), and Ministerio del Ambiente para el Poder Popular (Venezuela) granted research permissions. We thank our deceased colleagues and friends, A. H. Gentry, J. P. Veillon, S. Almeida and S. Patino for invaluable contributions to this work; their pioneering efforts to understand neotropical forests continue to inspire South American ecologists.	[Anonymous], [No title captured]; Ballantyne AP, 2012, NATURE, V488, P70, DOI 10.1038/nature11299; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bigler C, 2009, OIKOS, V118, P1130, DOI 10.1111/j.1600-0706.2009.17592.x; Booth BBB, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024002; Bugmann H, 2011, OECOLOGIA, V165, P533, DOI 10.1007/s00442-010-1837-4; Chambers JQ, 2004, OECOLOGIA, V141, P596, DOI 10.1007/s00442-004-1676-2; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Clark DA, 2013, J GEOPHYS RES-BIOGEO, V118, P783, DOI 10.1002/jgrg.20067; Condit R, 1997, TRENDS ECOL EVOL, V12, P249, DOI 10.1016/S0169-5347(97)01095-1; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Di Filippo A, 2012, GLOBAL CHANGE BIOL, V18, P960, DOI 10.1111/j.1365-2486.2011.02617.x; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Friend AD, 2014, P NATL ACAD SCI USA, V111, P3280, DOI 10.1073/pnas.1222477110; Gatti LV, 2014, NATURE, V506, P76, DOI 10.1038/nature12957; Huntingford C, 2013, NAT GEOSCI, V6, P268, DOI [10.1038/ngeo1741, 10.1038/NGEO1741]; Jimenez-Munoz JC, 2013, J GEOPHYS RES-ATMOS, V118, P5204, DOI 10.1002/jgrd.50456; Kloke JD, 2012, R J, V4, P57, DOI 10.32614/rj-2012-014; LaDeau SL, 2001, SCIENCE, V292, P95, DOI 10.1126/science.1057547; Le Quere C, 2013, EARTH SYST SCI DATA, V5, P165, DOI 10.5194/essd-5-165-2013; Lewis SL, 2004, J ECOL, V92, P929, DOI 10.1111/j.0022-0477.2004.00923.x; LIEBERMAN D, 1985, J ECOL, V73, P915, DOI 10.2307/2260157; da Costa ACL, 2010, NEW PHYTOL, V187, P579, DOI 10.1111/j.1469-8137.2010.03309.x; Lopez-Gonzalez G, 2011, J VEG SCI, V22, P610, DOI 10.1111/j.1654-1103.2011.01312.x; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Manusch C, 2012, ECOL MODEL, V243, P101, DOI 10.1016/j.ecolmodel.2012.06.008; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; Muller-Landau H. C., 2014, FORESTS GLOBAL CHANG, P462; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; PHILLIPS OL, 1994, SCIENCE, V263, P954, DOI 10.1126/science.263.5149.954; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; R Development Core Team, 2011, R FDN STAT COMP; Ryan MG, 2006, PLANT CELL ENVIRON, V29, P367, DOI 10.1111/j.1365-3040.2005.01478.x; Saleska SR, 2003, SCIENCE, V302, P1554, DOI 10.1126/science.1091165; Sheil D, 1996, J ECOL, V84, P91, DOI 10.2307/2261703; Talbot J, 2014, FOREST ECOL MANAG, V320, P30, DOI 10.1016/j.foreco.2014.02.021; Thomas SC, 2011, TREE PHYSIOL-NETH, V4, P33, DOI 10.1007/978-94-007-1242-3_2; van Breugel M, 2006, J TROP ECOL, V22, P663, DOI 10.1017/S0266467406003452; Wang XH, 2014, NATURE, V506, P212, DOI 10.1038/nature12915; Wood S, 2011, GEN ADDITIVE MIXED M	45	620	632	54	810	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					344	+		10.1038/nature14283	http://dx.doi.org/10.1038/nature14283			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25788097	Green Accepted			2022-12-28	WOS:000351171900039
J	Leslie, S; Winney, B; Hellenthal, G; Davison, D; Boumertit, A; Day, T; Hutnik, K; Royrvik, EC; Cunliffe, B; Lawson, DJ; Falush, D; Freeman, C; Pirinen, M; Myers, S; Robinson, M; Donnelly, P; Bodmer, W				Leslie, Stephen; Winney, Bruce; Hellenthal, Garrett; Davison, Dan; Boumertit, Abdelhamid; Day, Tammy; Hutnik, Katarzyna; Royrvik, Ellen C.; Cunliffe, Barry; Lawson, Daniel J.; Falush, Daniel; Freeman, Colin; Pirinen, Matti; Myers, Simon; Robinson, Mark; Donnelly, Peter; Bodmer, Walter		Wellcome Trust Case Control; Int Multiple Sclerosis Genetics	The fine-scale genetic structure of the British population	NATURE			English	Article							LINKAGE DISEQUILIBRIUM; INFERENCE; ADMIXTURE; ANCESTRY; AFRICA; MODEL	Fine-scale genetic variation between human Populations is interesting as a signature of historical demographic events and because of its potential for confounding disease studies. We use haplotype-based statistical methods to analyse genome-wide single nucleotide polymorphism (SNP) data from a carefully chosen geographically diverse sample of 2,039 individuals from the United Kingdom. This reveals a rich and detailed pattern of genetic differentiation with remarkable concordance between genetic clusters and geography. The regional genetic differentiation and differing patterns of shared ancestry with 6,209 individuals from across Europe carry clear signals of historical demographic events. We estimate the genetic contribution to southeastern England from Anglo-Saxon migrations to be under half, and identify the regions not carrying genetic material from these migrations. We suggest significant pre-Roman but post-Mesolithic movement into southeastern England from continental Europe, and show that in non-Saxon parts of the United Kingdom, there exist genetically differentiated subgroups rather than a general 'Celtic' population.	[Leslie, Stephen] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Leslie, Stephen] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3010, Australia; [Leslie, Stephen; Winney, Bruce; Boumertit, Abdelhamid; Day, Tammy; Hutnik, Katarzyna; Royrvik, Ellen C.; Bodmer, Walter] Univ Oxford, Dept Oncol, Oxford OX3 7DQ, England; [Hellenthal, Garrett] Univ Coll London Genet Inst, London WC1E 6BT, England; [Davison, Dan] Counsyl, San Francisco, CA 94080 USA; [Cunliffe, Barry] Univ Oxford, Inst Archaeol, Oxford OX1 2PG, England; [Lawson, Daniel J.] Univ Bristol, Dept Math, Bristol BS8 1TW, Avon, England; [Falush, Daniel] Swansea Univ, Coll Med, Swansea SA2 8PP, W Glam, Wales; [Freeman, Colin; Donnelly, Peter] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Pirinen, Matti] Univ Helsinki, FI-00014 Helsinki, Finland; [Myers, Simon; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Robinson, Mark] Univ Oxford, Univ Museum Nat Hist, Oxford OX1 3PW, England	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Oxford; University of London; University College London; University of Oxford; University of Bristol; Swansea University; University of Oxford; Wellcome Centre for Human Genetics; University of Helsinki; University of Oxford; University of Oxford	Donnelly, P (corresponding author), Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	donnelly@well.ox.ac.uk	Myers, Simon R/A-6792-2015; Brown, Matthew A/E-5749-2010; Lawson, Daniel/A-8550-2011	Myers, Simon R/0000-0002-2585-9626; Brown, Matthew A/0000-0003-0538-8211; Bodmer, Walter/0000-0001-6244-9792; Lawson, Daniel/0000-0002-5311-6213; Pirinen, Matti/0000-0002-1664-1350	Wellcome Trust [072974/Z/03/Z, 088262/Z/09/Z, 075491/Z/04/Z, 075491/Z/04/A, 075491/Z/04/B, 090532/Z/09/Z, 084818/Z/08/Z, 095552/Z/11/Z, 085475/Z/08/Z, 098387/Z/12/Z, 098386/Z/12/Z]; Academy of Finland [257654]; Australian National Health and Medical Research Council [APP1053756]; Wolfson-Royal Society Merit Award; AHRC [AH/K002600/1] Funding Source: UKRI; MRC [MC_UU_12013/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/K002600/1] Funding Source: researchfish; Medical Research Council [MC_UU_12013/1, MR/M501608/1] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049477] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Finland(Academy of Finland); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wolfson-Royal Society Merit Award(Royal Society of London); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Cheshire for his advice. We thank the UK Office for National Statistics, the National Records of Scotland, and the Northern Ireland Statistics and Research Agency for providing the boundaries used for the UK maps. We note that census output is Crown copyright and is reproduced with the permission of the Controller of HMSO and the Queen's Printer for Scotland. We further acknowledge the provision of maps from Eurostat, which are copyright EuroGeographics for the administrative boundaries. We acknowledge support from the Wellcome Trust (072974/Z/03/Z, 088262/Z/09/Z, 075491/Z/04/Z, 075491/Z/04/A, 075491/Z/04/B, 090532/Z/09/Z, 084818/Z/08/Z, 095552/Z/11/Z, 085475/Z/08/Z, 098387/Z/12/Z, 098386/Z/12/Z), the Academy of Finland (257654) and the Australian National Health and Medical Research Council (APP1053756). P.D. was supported in part by a Wolfson-Royal Society Merit Award.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Bodmer JG, 1980, POPULATION STRUCTURE, P211; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Capelli C, 2003, CURR BIOL, V13, P979, DOI 10.1016/S0960-9822(03)00373-7; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Falush D, 2003, GENETICS, V164, P1567; Goodacre S, 2005, HEREDITY, V95, P129, DOI 10.1038/sj.hdy.6800661; Hellenthal G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000078; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Lawson CL., 1995, SOLVING LEAST SQUARE; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; National Records of Scotland, 2011, 2011 CENS DIG BOUND; Northern Ireland Statistics and Research Agency, 2011 CENS DIG BOUND; O'Dushlaine CT, 2010, EUR J HUM GENET, V18, P1248, DOI 10.1038/ejhg.2010.87; Office for National Statistics, 2011, 2011 CENS DIG BOUND; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pirinen M, 2013, ANN APPL STAT, V7, P369, DOI 10.1214/12-AOAS586; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Rousset F., 2004, GENETIC STRUCTURE SE; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wilson JF, 2001, P NATL ACAD SCI USA, V98, P5078, DOI 10.1073/pnas.071036898; Winney B, 2012, EUR J HUM GENET, V20, P203, DOI 10.1038/ejhg.2011.127; Wright S, 1943, GENETICS, V28, P114	38	237	238	4	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					309	+		10.1038/nature14230	http://dx.doi.org/10.1038/nature14230			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25788095	Green Submitted, Green Accepted			2022-12-28	WOS:000351171900032
J	Atun, R				Atun, Rifat			The National Health Service: value for money, value for many	LANCET			English	Editorial Material									[Atun, Rifat] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Atun, Rifat] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Atun, R (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	ratun@hsph.harvard.edu	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983				Davis K, 2014, MIRROR MIRROR WALL 2; Francis R., 2013, REPORT MID STAFFORDS; Gershlick B, 2015, PUBLIC ATTITUDES NHS; Ingleby D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1079; Jones NM, 2013, ANATOMY HLTH SPENDIN; McKee M, 2015, LANCET, V385, P665, DOI 10.1016/S0140-6736(15)60268-9; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; National Audit Office, 2014, FIN SUST NHS BOD REP; NHS England Care Quality Commission Public Health England Health Education England Monitor Trust Development Authority, 2014, NHS 5 YEAR FORW VIEW; Nolte E, 2011, HEALTH POLICY, V103, P47, DOI 10.1016/j.healthpol.2011.08.002; OECD, 2015, OECD HLTH STAT 2014; OECD, 2010, OECD EC DEP POL NOT OECD EC DEP POL NOT, V2; OECD, 2013, HLTH GLANC 2013 OECD, DOI [10.1787/health_glance-2013-49-en, DOI 10.1787/HEALTH_GLANCE-2013-49-EN]; Osborn R, 2014, HEALTH AFFAIR, V33, P2247, DOI 10.1377/hlthaff.2014.0947; Smith P.C., 2013, HLTH SYSTEM PERFORMA	15	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					917	918		10.1016/S0140-6736(15)60499-8	http://dx.doi.org/10.1016/S0140-6736(15)60499-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD2EK	25784329				2022-12-28	WOS:000350886900005
J	Shah, ASV; Lee, KK; McAllister, DA; Hunter, A; Nair, H; Whiteley, W; Langrish, JP; Newby, DE; Mills, NL				Shah, Anoop S. V.; Lee, Kuan Ken; McAllister, David A.; Hunter, Amanda; Nair, Harish; Whiteley, William; Langrish, Jeremy P.; Newby, David E.; Mills, Nicholas L.			Short term exposure to air pollution and stroke: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DAILY HOSPITAL ADMISSIONS; CAUSE-SPECIFIC MORTALITY; CASE-CROSSOVER ANALYSIS; EMERGENCY-DEPARTMENT VISITS; TRANSIENT ISCHEMIC ATTACK; 11 EUROPEAN COHORTS; PARTICULATE MATTER; CARDIOVASCULAR-DISEASES; SAHARAN DUST; CIRCULATORY-SYSTEM	OBJECTIVE To review the evidence for the short term association between air pollution and stroke. DESIGN Systematic review and meta-analysis of observational studies DATA SOURCES Medline, Embase, Global Health, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Web of Science searched to January 2014 with no language restrictions. ELIGIBILITY CRITERIA Studies investigating the short term associations (up to lag of seven days) between daily increases in gaseous pollutants (carbon monoxide, sulphur dioxide, nitrogen dioxide, ozone) and particulate matter (< 2.5 mu m or < 10 mu m diameter (PM2.5 and PM10)), and admission to hospital for stroke or mortality. MAIN OUTCOME MEASURES Admission to hospital and mortality from stroke. RESULTS From 2748 articles, 238 were reviewed in depth with 103 satisfying our inclusion criteria and 94 contributing to our meta-estimates. This provided a total of 6.2 million events across 28 countries. Admission to hospital for stroke or mortality from stroke was associated with an increase in concentrations of carbon monoxide (relative risk 1.015 per 1 ppm, 95% confidence interval 1.004 to 1.026), sulphur dioxide (1.019 per 10 ppb, 1.011 to 1.027), and nitrogen dioxide (1.014 per 10 ppb, 1.009 to 1.019). Increases in PM2.5 and PM10 concentration were also associated with admission and mortality (1.011 per 10 (I) over cap1/4g/m(3) (1.011 to 1.012) and 1.003 per 10 mu g/m(3) (1.002 to 1.004), respectively). The weakest association was seen with ozone (1.001 per 10 ppb, 1.000 to 1.002). Strongest associations were observed on the day of exposure with more persistent effects observed for PM2-5. CONCLUSION Gaseous and particulate air pollutants have a marked and close temporal association with admissions to hospital for stroke or mortality from stroke. Public and environmental health policies to reduce air pollution could reduce the burden of stroke.	[Shah, Anoop S. V.; Lee, Kuan Ken; Hunter, Amanda; Langrish, Jeremy P.; Newby, David E.; Mills, Nicholas L.] Univ Edinburgh, BHF Univ Ctr Cardiovasc Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [McAllister, David A.; Nair, Harish] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Whiteley, William] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH16 4SB, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Shah, ASV (corresponding author), Univ Edinburgh, BHF Univ Ctr Cardiovasc Sci, Edinburgh EH16 4SB, Midlothian, Scotland.	anoopsshah@gmail.com	Newby, David Ernest/AAB-1364-2019; Nair, Harish/E-7431-2010	Nair, Harish/0000-0002-9432-9100; Whiteley, William/0000-0002-4816-8991; Shah, Anoop/0000-0002-2825-3419; McAllister, David/0000-0003-3550-1764; Mills, Nicholas/0000-0003-0533-7991	British Heart Foundation [RG/10/9/28286, SS/CH/09/002, FS/10/024/28266, CH/09/002]; MRC [G0902303] Funding Source: UKRI; British Heart Foundation [PG/11/27/28842] Funding Source: researchfish; Medical Research Council [G0902303] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by a British Heart Foundation programme grant (RG/10/9/28286). ASVS, DEN, and NLM were supported by a British Heart Foundation clinical research scholarship (SS/CH/09/002), intermediate fellowship (FS/10/024/28266), chair award (CH/09/002), and programme grant (RG/10/9/28286), respectively. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Adar SD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001430; Alessandrini ER, 2013, EPIDEMIOL PREV, V37, P220; Alessandrini ER, 2013, OCCUP ENVIRON MED, V70, P432, DOI 10.1136/oemed-2012-101182; Amancio CT, 2012, BRAZ J MED BIOL RES, V45, P1080, DOI 10.1590/S0100-879X2012007500131; Andersen ZJ, 2010, EUR HEART J, V31, P2034, DOI 10.1093/eurheartj/ehq188; Anderson HR, 2001, OCCUP ENVIRON MED, V58, P504, DOI 10.1136/oem.58.8.504; Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492; Ballester F, 2001, J EPIDEMIOL COMMUN H, V55, P57, DOI 10.1136/jech.55.1.57; Barnett AG, 2006, ENVIRON HEALTH PERSP, V114, P1018, DOI 10.1289/ehp.8674; Bedada GB, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-77; Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Bell ML, 2008, OCCUP ENVIRON MED, V65, P104, DOI 10.1136/oem.2006.031500; Bell ML, 2009, CIRCULATION, V120, P949, DOI 10.1161/CIRCULATIONAHA.109.851113; Briggs D, 2003, BRIT MED BULL, V68, P1, DOI 10.1093/bmb/ldg019; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Burnett RT, 1999, ARCH ENVIRON HEALTH, V54, P130, DOI 10.1080/00039899909602248; Carlsen HK, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-28; Cesaroni G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7412; Chan CC, 2006, EUR HEART J, V27, P1238, DOI 10.1093/eurheartj/ehi835; Chen RJ, 2013, STROKE, V44, P954, DOI 10.1161/STROKEAHA.111.673442; Chiu HF, 2013, J TOXICOL ENV HEAL A, V76, P1188, DOI 10.1080/15287394.2013.842463; Chiusolo M, 2011, ENVIRON HEALTH PERSP, V119, P1233, DOI 10.1289/ehp.1002904; Corea F, 2012, NEUROL INT, V4, P44, DOI 10.4081/ni.2012.e11; Nascimento LFC, 2012, CAD SAUDE PUBLICA, V28, P1319, DOI 10.1590/S0102-311X2012000700010; Diaz J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-11; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Donaldson K, 2013, NANOMEDICINE-UK, V8, P403, DOI [10.2217/NNM.13.16, 10.2217/nnm.13.16]; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Forastiere F, 2008, EPIDEMIOLOGY, V19, P571, DOI 10.1097/EDE.0b013e3181761f8a; Franklin M, 2008, EPIDEMIOLOGY, V19, P680, DOI 10.1097/EDE.0b013e3181812bb7; Franklin M, 2007, J EXPO SCI ENV EPID, V17, P279, DOI 10.1038/sj.jes.7500530; Fung KY, 2003, INT J EPIDEMIOL, V32, P1064, DOI 10.1093/ije/dyg246; Gianicolo EAL, 2013, INT J ENVIRON HEAL R, V23, P446, DOI 10.1080/09603123.2012.755154; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Guttikunda S., 2009, WORKING PAPER SERIES, V25; Haley VB, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-42; Halonen JI, 2010, J EPIDEMIOL COMMUN H, V64, P814, DOI 10.1136/jech.2009.087106; Halonen JI, 2009, EPIDEMIOLOGY, V20, P143, DOI 10.1097/EDE.0b013e31818c7237; Henrotin JB, 2007, OCCUP ENVIRON MED, V64, P439, DOI 10.1136/oem.2006.029306; Henrotin JB, 2010, HEART, V96, P1990, DOI 10.1136/hrt.2010.200337; Hoek G, 2001, EPIDEMIOLOGY, V12, P355, DOI 10.1097/00001648-200105000-00017; Hong YC, 2002, STROKE, V33, P2165, DOI 10.1161/01.STR.0000026865.52610.5B; Hong YC, 2002, ENVIRON HEALTH PERSP, V110, P187, DOI 10.1289/ehp.02110187; Hori A, 2012, INT J ENVIRON HEAL R, V22, P416, DOI 10.1080/09603123.2011.650155; Bin J, 2006, J EXPO SCI ENV EPID, V16, P225, DOI 10.1038/sj.jea.7500451; Jimenez E, 2011, INT J ENVIRON HEAL R, V21, P372, DOI 10.1080/09603123.2011.560251; Johnsen SP, 2002, J CLIN EPIDEMIOL, V55, P602, DOI 10.1016/S0895-4356(02)00391-8; Kan Haidong, 2010, Res Rep Health Eff Inst, P17; Kan HD, 2003, J OCCUP HEALTH, V45, P321, DOI 10.1539/joh.45.321; Kelley George A, 2012, World J Methodol, V2, P27, DOI 10.5662/wjm.v2.i4.27; Kettunen J, 2007, STROKE, V38, P918, DOI 10.1161/01.STR.0000257999.49706.3b; Kim H, 2003, INT J BIOMETEOROL, V48, P25, DOI 10.1007/s00484-003-0176-0; Kim SY, 2012, ENVIRON HEALTH PERSP, V120, P1094, DOI 10.1289/ehp.1104721; Kloog I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034664; Lall R, 2011, ENVIRON HEALTH PERSP, V119, P455, DOI 10.1289/ehp.1002638; Langrish JP, 2012, ENVIRON HEALTH PERSP, V120, P367, DOI 10.1289/ehp.1103898; Larrieu S, 2007, SCI TOTAL ENVIRON, V387, P105, DOI 10.1016/j.scitotenv.2007.07.025; Le Tertre A, 2002, J EPIDEMIOL COMMUN H, V56, P773, DOI 10.1136/jech.56.10.773; Leiva MA, 2013, ENVIRON POLLUT, V181, P1, DOI 10.1016/j.envpol.2013.05.057; Li GX, 2011, SCI TOTAL ENVIRON, V409, P1811, DOI 10.1016/j.scitotenv.2011.02.005; Li XY, 2012, CNS NEUROSCI THER, V18, P501, DOI 10.1111/j.1755-5949.2012.00325.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Linn WS, 2000, ENVIRON HEALTH PERSP, V108, P427, DOI 10.2307/3454383; Lippmann M, 2000, Res Rep Health Eff Inst, P5; Lisabeth LD, 2008, ANN NEUROL, V64, P53, DOI 10.1002/ana.21403; Lokken PR, 2009, EPIDEMIOLOGY, V20, P137, DOI 10.1097/EDE.0b013e31818ef34a; Low RB, 2006, STROKE, V37, P951, DOI 10.1161/01.STR.0000214681.94680.66; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lucking AJ, 2011, CIRCULATION, V123, P1721, DOI 10.1161/CIRCULATIONAHA.110.987263; Lucking AJ, 2008, EUR HEART J, V29, P3043, DOI 10.1093/eurheartj/ehn464; Lumley T, 2000, ENVIRONMETRICS, V11, P689, DOI 10.1002/1099-095X(200011/12)11:6<689::AID-ENV439>3.0.CO;2-N; Lundback M, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-7; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Mallone S, 2011, ENVIRON HEALTH PERSP, V119, P1409, DOI [10.12989/ehp.1003026, 10.1289/ehp.1003026]; Mate T, 2010, SCI TOTAL ENVIRON, V408, P5750, DOI 10.1016/j.scitotenv.2010.07.083; Mateen FJ, 2011, JAMA-J AM MED ASSOC, V305, P1240, DOI 10.1001/jama.2011.352; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092286; Mechtouff L, 2012, INT J STROKE, V7, P669, DOI 10.1111/j.1747-4949.2011.00737.x; Metzger KB, 2004, EPIDEMIOLOGY, V15, P46, DOI 10.1097/01.EDE.0000101748.28283.97; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mills NL, 2011, EUR HEART J, V32, P2660, DOI 10.1093/eurheartj/ehr195; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Moolgavkar SH, 2000, ENVIRON HEALTH PERSP, V108, P777, DOI 10.2307/3434732; Moolgavkar SH, 2000, J AIR WASTE MANAGE, V50, P1199, DOI 10.1080/10473289.2000.10464162; Morgan G, 2010, EPIDEMIOLOGY, V21, P47, DOI 10.1097/EDE.0b013e3181c15d5a; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; Nabavi SM, 2012, INT J PREVENTIVE MED, V3, P723; Neuberger M, 2007, ATMOS ENVIRON, V41, P8549, DOI 10.1016/j.atmosenv.2007.07.013; O'Donnell MJ, 2011, EPIDEMIOLOGY, V22, P422, DOI 10.1097/EDE.0b013e3182126580; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Oudin A, 2010, NEUROEPIDEMIOLOGY, V34, P131, DOI 10.1159/000274807; Peel JL, 2007, AM J EPIDEMIOL, V165, P625, DOI 10.1093/aje/kwk051; Perez L, 2012, ENVIRON INT, V48, P150, DOI 10.1016/j.envint.2012.07.001; Poloniecki JD, 1997, OCCUP ENVIRON MED, V54, P535, DOI 10.1136/oem.54.8.535; Ponka A, 1996, AM J PUBLIC HEALTH, V86, P1273, DOI 10.2105/AJPH.86.9.1273; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Qian YF, 2013, J EPIDEMIOL COMMUN H, V67, P635, DOI 10.1136/jech-2012-201096; Qian ZM, 2008, ENVIRON HEALTH PERSP, V116, P1172, DOI 10.1289/ehp.10847; Qian ZM, 2008, ENVIRON INT, V34, P248, DOI 10.1016/j.envint.2007.08.006; Qian ZM, 2007, ENVIRON RES, V105, P380, DOI 10.1016/j.envres.2007.05.007; Qian Z, 2007, J AIR WASTE MANAGE, V57, P785, DOI 10.3155/1047-3289.57.7.785; Qian Zhengmin, 2010, Res Rep Health Eff Inst, P91; Qian ZM, 2010, J AIR WASTE MANAGE, V60, P481, DOI 10.3155/1047-3289.60.4.481; Ren C, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-3; Revich B, 2010, AIR QUAL ATMOS HLTH, V3, P117, DOI 10.1007/s11869-009-0058-7; Romieu Isabelle, 2012, Res Rep Health Eff Inst, P5; Samoli E, 2013, ENVIRON HEALTH PERSP, V121, P932, DOI 10.1289/ehp.1206124; Scarinzi C, 2013, EPIDEMIOL PREV, V37, P230; Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3; Shah ASV, 2010, HEART, V96, P1953, DOI 10.1136/hrt.2010.205583; Sicard P, 2011, ATMOS ENVIRON, V45, P1145, DOI 10.1016/j.atmosenv.2010.12.052; Stafoggia M, 2014, ENVIRON HEALTH PERSP, V122, P919, DOI 10.1289/ehp.1307301; Stafoggia M, 2010, AM J RESP CRIT CARE, V182, P376, DOI 10.1164/rccm.200908-1269OC; Sunyer J, 2003, EUR HEART J, V24, P752, DOI 10.1016/S0195-668X(02)00808-4; Szyszkowicz M, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/824724; Szyszkowicz M, 2008, INT J OCCUP MED ENV, V21, P295, DOI 10.2478/v10001-008-0029-5; Thach TQ, 2010, ATMOS ENVIRON, V44, P1437, DOI 10.1016/j.atmosenv.2010.01.036; Tsai SS, 2003, STROKE, V34, P2612, DOI 10.1161/01.STR.0000095564.33543.64; Turin TC, 2012, NEUROEPIDEMIOLOGY, V38, P84, DOI 10.1159/000335654; Valdes A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-82; Vichit-Vadakan N, 2010, HLTH EFFECTS I, V154, P231; Vidale S, 2010, NEUROL SCI, V31, P179, DOI 10.1007/s10072-009-0206-8; Villeneuve PJ, 2006, EUR J EPIDEMIOL, V21, P689, DOI 10.1007/s10654-006-9050-9; Villeneuve PJ, 2012, SCI TOTAL ENVIRON, V430, P193, DOI 10.1016/j.scitotenv.2012.05.002; Wang Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000983; Wellenius GA, 2005, STROKE, V36, P2549, DOI 10.1161/01.STR.0000189687.78760.47; Wellenius GA, 2013, STROKE, V44, P1533, DOI 10.1161/STROKEAHA.111.000395; Wellenius GA, 2012, ARCH INTERN MED, V172, P229, DOI 10.1001/archinternmed.2011.732; Wichmann J, 2012, INT J ENV RES PUB HE, V9, P3978, DOI 10.3390/ijerph9113978; Wong CA, 1999, J EPIDEMIOL COMMUN H, V53, P580, DOI 10.1136/jech.53.9.580; Wong TW, 2002, OCCUP ENVIRON MED, V59, P30, DOI 10.1136/oem.59.1.30; Wong TW, 1999, OCCUP ENVIRON MED, V56, P679, DOI 10.1136/oem.56.10.679; Wordley J, 1997, OCCUP ENVIRON MED, V54, P108, DOI 10.1136/oem.54.2.108; World Bank, WE CLASS COUNTR; Xiang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061168; Xu XH, 2013, NEUROEPIDEMIOLOGY, V41, P2, DOI 10.1159/000345138; Yamazaki S, 2007, OCCUP ENVIRON MED, V64, P17, DOI 10.1136/oem.2005.021097; Yorifuji T, 2013, J OCCUP ENVIRON MED, V55, P768, DOI 10.1097/JOM.0b013e3182973092; Yorifuji T, 2011, J OCCUP ENVIRON MED, V53, P124, DOI 10.1097/JOM.0b013e3182099175; Yu XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095682; Zanobetti A, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-58; Zeka A, 2006, AM J EPIDEMIOL, V163, P849, DOI 10.1093/aje/kwj116; Zheng S, 2013, INT J ENV RES PUB HE, V10, P462, DOI 10.3390/ijerph10020462	147	447	466	9	47	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2015	350								h1295	10.1136/bmj.h1295	http://dx.doi.org/10.1136/bmj.h1295			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NO	27600637	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000352028800002
